ASSAY_ID ASSAY PROJECT PLATE WELL WELL_TYPE RAW_VALUE_A BSUB_VALUE_A Z_SCORE_A RAW_VALUE_B BSUB_VALUE_B Z_SCORE_B COMPOSITE_Z REPRODUCIBILITY CHEMBANK_ID VIRTUAL_ID SMILES 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 A01 mock treatment 9.76 -0.24099 -0.0647 9.4764 -0.4145 -0.0982 -0.1152 -0.9794 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 A02 mock treatment 19.985 9.984 2.679 11.2617 1.3708 0.3248 2.124 0.7871 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 A03 compound treatment 12.1098 2.1088 0.5658 10.3014 0.41054 0.0973 0.4689 0.8167 3076292 SMP2_000001 C[C@H](CCCC(C)(C)O)C1CCC2C3CC=C4CC(O)CCC4(C)C3CCC12C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 A04 compound treatment 11.4641 1.4631 0.3926 11.0951 1.2042 0.2853 0.4794 0.9877 170 SMP2_000002 CCCCCCCC[C@@H](O)/C=C/C=C/C=C\[C@@H](O)CCCC(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 A05 compound treatment 9.73 -0.27099 -0.0727 12.1416 2.2508 0.5333 0.3257 0.6051 3076293 SMP2_000003 CN(C)CC/C=C/1\c2ccccc2CC(O)c3ccccc13 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 A06 compound treatment 15.0664 5.0654 1.3592 15.1717 5.2808 1.2512 1.8458 0.9991 2153 SMP2_000004 C[C@@H]1[C@@H](OC(=O)/C=C/C=C/c2ccccc2)[C@@]3(OC4(O[C@@H]3[C@@H]5[C@@H]6O[C@]6(CO)[C@@H](O)[C@@]7(O)[C@@H](C=C(C)C7=O)[C@@]15O4)c8ccccc8)C(=C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 A07 compound treatment 10.7289 0.72796 0.1953 8.8398 -1.051 -0.249 -0.038 -0.12 3471112 SMP2_000005 CCOC(=O)CCC(=O)OC1C(CC(C)OC1OC2C(C)C(OC3CC(C)(OC)C(O)C(C)O3)C(C)C(=O)OC(CC)C(C)(O)C(O)C(C)C(=O)C(C)CC2(C)O)N(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 A08 compound treatment 10.6568 0.65582 0.176 10.8919 1.001 0.2372 0.2921 0.9892 2199 SMP2_000006 CC(C(C)c1ccc(O)cn1)C(N)C(=O)NC([C@H]2O[C@H]([C@@H](O)[C@H]2O)N3C=CC(=O)CC3=O)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 A09 compound treatment 9.9196 -0.081417 -0.0218 11.8643 1.9735 0.4676 0.3152 0.6733 698 SMP2_000007 NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 A10 compound treatment 49.157 39.156 10.5066 44.3552 34.464 8.1658 13.2034 0.9922 3199281 SMP2_000008 CC(=C[C@@H](O)C1=C[C@@H](O)[C@@H]2O[C@@H]2C1=O)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 A11 compound treatment 10.4562 0.45519 0.1221 10.6039 0.71303 0.1689 0.2058 0.9873 1001979 SMP2_000009 NCCC[C@H](N)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 A12 compound treatment 47.4415 37.441 10.0463 46.185 36.294 8.5994 13.1844 0.997 3199282 SMP2_000010 C[C@@H]1[C@@H](OC(=O)C)[C@]2(OC(=O)C)[C@H]([C@@H]3C=C(CO)C[C@]4(O)[C@@H](C=C(C)C4=O)[C@]13O)C2(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 A13 compound treatment 10.3716 0.37063 0.0994 9.4045 -0.48633 -0.1152 -0.0112 -0.0733 1497 SMP2_000011 NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O)C2O[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)[C@H](N)[C@@H](O)[C@@H]1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 A14 compound treatment 8.7009 -1.3001 -0.3489 10.3429 0.45209 0.1071 -0.1709 -0.4684 1000212 SMP2_000012 C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3[C@@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 A15 compound treatment 11.9718 1.9708 0.5288 10.4526 0.56173 0.1331 0.468 0.8583 3199283 SMP2_000013 COC1/C=C\OC2(C)Oc3c(C2=O)c4c(O)cc(NC(=O)\C(=C/C=C\C(C)C(O)C(C)C(O)C(C)C(OC(=O)C)C1C)\C)c(O)c4c(O)c3C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 A16 compound treatment 18.2716 8.2706 2.2192 15.772 5.8812 1.3935 2.5545 0.9749 2267 SMP2_000014 CO[C@H]1[C@H](O)C(O)[C@@H](OC1CO)n2c3c(Cl)cccc3c4c5C(=O)NC(=O)c5c6c7cccc(Cl)c7[nH]c6c24 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 A17 compound treatment 9.6998 -0.3012 -0.0808 10.6326 0.74172 0.1757 0.0671 0.347 706 SMP2_000015 Nc1ccc(cc1)S(=O)(=O)Nc2cnc3ccccc3n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 A18 compound treatment 18.2143 8.2133 2.2038 19.9778 10.087 2.3899 3.2483 0.9992 1098997 SMP2_000016 CCC1(O)C(=O)OCc2c1cc3-c4nc5ccccc5cc4Cn3c2=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 A19 compound treatment 14.0786 4.0776 1.0941 14.8124 4.9215 1.1661 1.5982 0.9995 1001956 SMP2_000017 CC(C)C1N(C)c2cccc3[nH]cc(CC(CO)NC1=O)c23 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 A20 compound treatment 8.7854 -1.2156 -0.3262 11.1858 1.295 0.3068 -0.0137 -0.0306 1912779 SMP2_000018 CC(NC(=O)c1ccccc1/N=C/c2c(O)ccc3ccccc23)c4ccccc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 A21 compound treatment 9.4609 -0.54011 -0.1449 12.121 2.2301 0.5284 0.2712 0.4949 230 SMP2_000019 CCCCCC(=O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 A22 compound treatment 29.9599 19.959 5.3555 23.2772 13.386 3.1717 6.0296 0.9687 464 SMP2_000020 CN(Cc1cnc2nc(N)nc(N)c2n1)c3ccc(cc3)C(=O)N[C@@H](CCC(=O)O)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 A23 compound treatment 11.9094 1.9084 0.5121 11.0609 1.17 0.2772 0.5581 0.9585 548 SMP2_000021 N[C@H]1C[C@H]([C@H](O)[C@@H]1O)n2cc(I)c3c(N)ncnc23 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 A24 compound treatment 10.6295 0.62854 0.1687 11.6051 1.7142 0.4062 0.4065 0.9242 3199284 SMP2_000022 C/C(=C/CNc1ncnc2[nH]cnc12)/CO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 B01 mock treatment 11.1655 1.1646 0.3125 8.3271 -1.5638 -0.3705 -0.041 -0.0847 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 B02 mock treatment 9.3056 -0.69543 -0.1866 11.9295 2.0386 0.483 0.2096 0.4048 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 B03 compound treatment 8.7448 -1.2562 -0.3371 9.8642 -0.026665 -0.0063 -0.2428 -0.7202 1001866 SMP2_000023 NC(CCCNC(=N)N)C(=O)CC(Cc1ccccc1)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 B04 compound treatment 12.879 2.878 0.7722 14.0342 4.1433 0.9817 1.2402 0.9929 3076299 SMP2_000024 C[C@@H]1CCOC(=O)/C=C\C=C/C(=O)O[C@@H]2C[C@@H]3OC4C=C(C)CCC4(COC(=O)[C@H]1O)[C@]2(C)[C@@]53CO5 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 B05 compound treatment 17.189 7.188 1.9287 15.7123 5.8214 1.3793 2.3391 0.9865 3199377 SMP2_000025 CO[C@@H]1C[C@H](C)O[C@@H](CC[C@H](C)[C@H](O)[C@H](C)[C@H]2OC(=O)/C(=C/C[C@H](O)C[C@H]3O[C@@H](CC=C3)C[C@H](OC)[C@@H](C)[C@@H](O)C[C@@H](O)[C@H](C)[C@H](OC(=O)/C(=C/C[C@H](O)C[C@H]4O[C@@H](CC=C4)C[C@H](OC)[C@@H](C)[C@@H](O)C[C@@H](O)[C@@H]2C)/C)[C@@H](C)[C@@H](O)[C@@H](C)CC[C@@H]5C[C@@H](C[C@H](C)O5)OC)/C)C1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 B06 compound treatment 11.8145 1.8135 0.4866 13.4832 3.5923 0.8511 0.9459 0.9648 3076300 SMP2_000026 CC1(C)C(O)C2(C)CCC1C2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 B07 compound treatment 10.4575 0.45655 0.1225 10.8564 0.96557 0.2288 0.2484 0.9572 3199378 SMP2_000027 CC(CO)C1CC(O)C2(C)OC3CC4OC5CC6(C)OC7CCC8OC9CC%10(C)OC%11C(CC%10OC9CC(C)C8OC7CC6OC5(C)CC=CC4OC3CC2O1)OC(=O)C=C%11C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 B08 compound treatment 11.2726 1.2716 0.3412 10.0947 0.20388 0.0483 0.2754 0.7992 3076301 SMP2_000028 Cn1cc(C[C@@H](N)C(=O)O)c2ccccc12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 B09 compound treatment 43.6028 33.602 9.0162 24.9884 15.097 3.5771 8.9049 0.918 28 SMP2_000029 CNc1ccc2oc(C[C@@H]3OC4(CC[C@@H]3C)O[C@H](C(C)C(=O)c5ccc[nH]5)[C@H](C)C[C@H]4C)nc2c1C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 B10 compound treatment 11.904 1.903 0.5106 15.09 5.1991 1.2318 1.2321 0.924 3199379 SMP2_000030 CC(C)CC(CO)NC(=O)C(CCC(=O)N)NC(=O)C(C)(C)NC(=O)C(CC(C)C)NC(=O)C(CCC(=O)N)NC(=O)C(C)(C)NC(=O)C(C)(C)NC(=O)C(C)(C)NC(=O)C(CCC(=O)N)NC(=O)C(C)(C)NC(=O)C(CC(C)C)NC(=O)C(C)(C)NC(=O)C(C)(C)NC(=O)C(C)NC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 B11 compound treatment 10.6321 0.63108 0.1693 8.3647 -1.5262 -0.3616 -0.136 -0.3405 2006 SMP2_000031 O[C@H]1C2OC2[C@H](O)[C@@H](O)[C@@H]1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 B12 compound treatment 10.0953 0.09435 0.0253 10.0796 0.18878 0.0447 0.0495 0.9637 3076303 SMP2_000032 CN(C)c1nc2c(Br)c(Br)c(Br)c(Br)c2[nH]1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 B13 compound treatment 141.3975 131.4 35.2571 129.0755 119.18 28.2391 44.8985 0.9939 3076304 SMP2_000033 CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C/2\C(=O)Nc3ccc(Cl)cc23)c1C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 B14 compound treatment 10.6684 0.66745 0.1791 9.6914 -0.19943 -0.0473 0.0932 0.5033 1000114 SMP2_000034 CCN(CC)CCCC(C)Nc1ccnc2cc(Cl)ccc12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 B15 compound treatment 9.7237 -0.27731 -0.0744 9.9866 0.095703 0.0227 -0.0366 -0.4703 277 SMP2_000035 OC[C@H]1O[C@H]([C@H](O)[C@H]1O)n2cnc3cc(Cl)c(Cl)cc23 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 B16 compound treatment 12.3049 2.3039 0.6182 9.383 -0.50787 -0.1203 0.352 0.559 3076306 SMP2_000036 CC(=O)c1ccc(cc1O)N2CCOCC2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 B17 compound treatment 9.7648 -0.23614 -0.0634 9.3749 -0.51593 -0.1222 -0.1312 -0.9532 2095622 SMP2_000037 CC(=CCC/C(=C/CC/C(=C/Cc1c(O)c2ccccc2oc1=O)/C)/C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 B18 compound treatment 13.4572 3.4562 0.9274 10.5328 0.64198 0.1521 0.7633 0.8122 1670 SMP2_000038 Nc1nc2n(COC(CO)CO)cnc2c(=O)[nH]1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 B19 compound treatment 12.2308 2.2298 0.5983 12.0433 2.1525 0.51 0.7837 0.9968 2090 SMP2_000039 CCOC(=O)C(C#N)C1C(=C(N)Oc2ccc(Br)cc12)C(=O)OCC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 B20 compound treatment 13.084 3.083 0.8272 17.5767 7.6858 1.821 1.8726 0.9362 1096696 SMP2_000040 Oc1ccc(cc1CC=C)c2cc(CC=C)ccc2O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 B21 compound treatment 8.5939 -1.407 -0.3775 8.4212 -1.4696 -0.3482 -0.5132 -0.9992 3199380 SMP2_000041 NC1=NC(=O)/C(=C\2/CCNC(=O)c3[nH]c(Br)cc23)/N1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 B22 compound treatment 9.5412 -0.45982 -0.1234 9.3083 -0.58258 -0.138 -0.1848 -0.9984 2137 SMP2_000042 Oc1cc(O)c2c(=O)cc(oc2c1)c3ccc(O)c(O)c3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 B23 compound treatment 36.2626 26.262 7.0467 29.9904 20.1 4.7623 8.3502 0.9818 3104545 SMP2_000043 CC1CC(C)/C=C(/C)\CC(C)C(=O)NC(C)C(=O)N(C)C(Cc2c(Br)[nH]c3ccccc23)C(=O)NC(CC(=O)O1)c4ccc(O)cc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 B24 compound treatment 12.8066 2.8057 0.7528 11.122 1.2312 0.2917 0.7386 0.9148 907437 SMP2_000044 CCCCCCCCCCCCC(=O)N1CCCCC1CNC(=O)[C@@H](N)CCCCN 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 C01 mock treatment 10.3703 0.3693 0.0991 10.4364 0.54552 0.1293 0.1615 0.9914 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 C02 mock treatment 8.7228 -1.2782 -0.343 9.9407 0.04983 0.0118 -0.2342 -0.6824 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 C03 compound treatment 44.5416 34.541 9.2681 44.8261 34.935 8.2774 12.4066 0.9984 907417 SMP2_000045 COc1cc2[C@H]3CC[C@]4(C)[C@@H](O)CC[C@H]4[C@@H]3CCc2cc1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 C04 compound treatment 11.9647 1.9637 0.5269 9.2494 -0.64147 -0.152 0.2651 0.4834 180 SMP2_000046 CCCCC/C=C\C/C=C\C=C\C=C\[C@@H](SCC(N)C(=O)NCC(=O)O)[C@@H](O)CCCC(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 C05 compound treatment 10.4239 0.42295 0.1135 11.1236 1.2328 0.2921 0.2868 0.9152 3199382 SMP2_000047 C[C@@H]1CCC2[C@H](C[C@]3(C)C(=CCC4[C@]5(C)C[C@@H](O)[C@H](O)[C@@](C)(CO)C5CC[C@]43C)C2[C@H]1C)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 C06 compound treatment 215.4348 205.43 55.1232 207.2985 197.41 46.7728 72.0514 0.9967 3104900 SMP2_000048 C/C(=C\CCC1C=CC(OC1O)C2=CC(=O)OC2O)/CCC3=C(C)CCCC3(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 C07 compound treatment 9.6449 -0.35606 -0.0955 12.3925 2.5016 0.5927 0.3516 0.5856 907313 SMP2_000049 Oc1c(I)cc2c(Oc3c(I)c(O)c(I)cc3C42OC(=O)c5ccccc54)c1I 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 C08 compound treatment 11.0936 1.0926 0.2932 8.9042 -0.98669 -0.2338 0.042 0.112 3076308 SMP2_000050 CCCCCCCCCCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)CCCCCCCCCCCCCCC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 C09 compound treatment 9.8384 -0.16255 -0.0436 11.6198 1.7289 0.4096 0.2588 0.6283 1002910 SMP2_000051 OC(C(O)C(=O)O)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 C10 compound treatment 9.8242 -0.17682 -0.0474 9.3373 -0.55352 -0.1311 -0.1263 -0.9055 453 SMP2_000052 COc1cccc(c1N)c2cc(=O)c3ccccc3o2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 C11 compound treatment 15.5 5.499 1.4755 15.1556 5.2648 1.2474 1.9254 0.9965 3199383 SMP2_000053 C[C@@H]1C[C@H]2[C@@H](CC[C@@H]3C[C@@H](O)CC[C@@]32C)[C@]45O[C@@H]5C[C@@H](C14)c6ccc(=O)oc6 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 C12 compound treatment 10.8239 0.82291 0.2208 8.4469 -1.444 -0.3421 -0.0858 -0.2107 3199384 SMP2_000054 CC[C@H]1OC(=O)C[C@@H](O)C[C@@H](OC[C@]2(C)OC(C)[C@@H](O[C@@]3(C)C[C@@](C)(O)[C@@H](O)C(C)O3)[C@H](C2O)N(C)C)[C@@H](CC=O)C[C@@H](C)C(=O)/C=C\C(=C/C1CO[C@@H]4OC(C)[C@@H](O)[C@H](OC)C4OC)\C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 C13 compound treatment 10.3061 0.30507 0.0819 8.9729 -0.91801 -0.2175 -0.0959 -0.4127 3076309 SMP2_000055 C[C@]12CC[C@H](C3CCC(C)(C)OC3)[C@@]2(C)[C@H](O)C[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5[C@@H](O)C[C@]41C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 C14 compound treatment 10.6117 0.61068 0.1639 10.5162 0.62534 0.1482 0.2206 0.9987 222 SMP2_000056 CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 C15 compound treatment 23.0512 13.05 3.5017 21.1507 11.26 2.6679 4.3625 0.991 3076310 SMP2_000057 CC1(C)CC[C@H](F)[C@@]2(CO[C@@]3(O)[C@H](O)[C@H]12)[C@@H]4CC[C@@H]5[C@@H](O)[C@@]43C(=O)C5=C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 C16 compound treatment 11.1565 1.1555 0.31 8.9077 -0.98313 -0.2329 0.0545 0.1406 3199385 SMP2_000058 OC[C@@H]1C[C@H](N[C@@H]2C=C(CO)[C@@H](O)[C@H](O)[C@H]2O)C(O)C(O)[C@@H]1O[C@@H]3OC(CO)[C@@H](O)[C@H](O)[C@@H]3O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 C17 compound treatment 9.1292 -0.87177 -0.2339 8.185 -1.7058 -0.4042 -0.4512 -0.9662 1448 SMP2_000059 OC(=O)c1cc(N=Nc2ccc(cc2)S(=O)(=O)Nc3ccccn3)ccc1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 C18 compound treatment 13.3934 3.3925 0.9103 13.4393 3.5485 0.8408 1.2382 0.9992 31 SMP2_000060 CCCCCCCCCCCCCCC[C@H](O)[C@@H](N)CO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 C19 compound treatment 8.3482 -1.6528 -0.4435 8.6094 -1.2814 -0.3036 -0.5283 -0.9829 95 SMP2_000061 CCCCCC(O)/C=C/C=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 C20 compound treatment 43.0959 33.095 8.8802 46.5538 36.663 8.6867 12.4217 0.9999 2065223 SMP2_000062 CN(C)c1ccc(cc1)C(O)(c2ccccc2)c3ccc(cc3)N(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 C21 compound treatment 16.4432 6.4422 1.7286 16.4022 6.5114 1.5428 2.3132 0.9984 3199386 SMP2_000063 CO[C@H]1C[C@H](C)CC2=C(NCC=C)C(=O)C=C(NC(=O)/C(=C\C=C/[C@H](O)[C@@H](OC(=O)N)/C(=C\[C@H](C)[C@H]1O)/C)/C)C2=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 C22 compound treatment 8.9731 -1.0279 -0.2758 10.1351 0.24426 0.0579 -0.1541 -0.5468 2041 SMP2_000064 OC(=O)CNC(=O)C(CS)Cc1ccccc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 C23 compound treatment 15.9523 5.9513 1.5969 9.9938 0.10295 0.0244 1.1464 0.7178 3076311 SMP2_000065 COc1cc2ccnc3cc[nH]c(c1OC)c23 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 C24 compound treatment 13.2344 3.2334 0.8676 11.9621 2.0713 0.4908 0.9605 0.9636 907566 SMP2_000066 C/C(=C\CNc1ncnc2n(cnc12)C3OC(CO)[C@@H](O)[C@H]3O)/CO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 D01 mock treatment 10.6197 0.61876 0.166 9.215 -0.67581 -0.1601 0.0042 0.0181 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 D02 mock treatment 12.4551 2.4541 0.6585 9.4589 -0.43194 -0.1023 0.3933 0.5901 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 D03 compound treatment 9.4564 -0.54455 -0.1461 9.7609 -0.12992 -0.0308 -0.1251 -0.8377 3199387 SMP2_000067 CCC1/C=C(/C)\CC(C)CC(OC)C2OC(O)(C(C)CC2OC)C(=O)C(=O)N3CCCCC3C(=O)OC(C(C)C(O)CC1=O)/C(=C/C4CCC(O)C(C4)OC)/C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 D04 compound treatment 10.5139 0.5129 0.1376 10.8073 0.91643 0.2171 0.2509 0.9758 907555 SMP2_000068 CC1=C[C@H]2O[C@@H]3C[C@@H](O)C(C)(C43CO4)[C@@]2(CO)CC1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 D05 compound treatment 10.6085 0.60757 0.163 10.7024 0.81153 0.1923 0.2512 0.9966 1962 SMP2_000069 CN(CC[C@H](N)CC(=O)N[C@H]1C=C[C@H](O[C@@H]1C(=O)O)n2ccc(N)nc2=O)C(=N)N 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 D06 compound treatment 8.811 -1.1899 -0.3193 10.8692 0.97829 0.2318 -0.0619 -0.1568 852250 SMP2_000070 C1CCC(NC1)c2cccnc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 D07 compound treatment 10.6384 0.63737 0.171 8.9522 -0.93864 -0.2224 -0.0363 -0.1295 3076314 SMP2_000071 O[C@@H]1C=CC(Br)[C@H](O)[C@H]1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 D08 compound treatment 8.4886 -1.5124 -0.4058 9.6379 -0.25294 -0.0599 -0.3293 -0.8028 3076315 SMP2_000072 OC[C@H]1O[C@H](C[C@@H]1O)n2cc(I)c(O)nc2=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 D09 compound treatment 7.6442 -2.3568 -0.6324 10.0983 0.20748 0.0492 -0.4124 -0.6502 3199389 SMP2_000073 CCCCCCCc1c(C)c(O)cc2c3ccccc3[nH]c12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 D10 compound treatment 8.4387 -1.5623 -0.4192 10.6453 0.75444 0.1788 -0.17 -0.3731 3199390 SMP2_000074 COc1ccc(cc1)C(O)(C2CC2)c3cncnc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 D11 compound treatment 9.2952 -0.70578 -0.1894 9.2525 -0.63834 -0.1512 -0.2409 -0.9938 832324 SMP2_000075 COc1cc(OC)c2c(=O)c(C)c(CC[C@@H](C)[C@@H](C)[C@@H](C)[C@@H](C)/C=C/C=C/C(=C/C)/C)oc2c1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 D12 compound treatment 9.038 -0.96295 -0.2584 10.8326 0.94177 0.2231 -0.0249 -0.073 2085117 SMP2_000076 COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 D13 compound treatment 10.7709 0.76992 0.2066 9.4003 -0.49053 -0.1162 0.0639 0.2696 251 SMP2_000077 Nc1ncnc2n(cnc12)C3(CO)OC(=C)C(O)C3O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 D14 compound treatment 9.274 -0.72699 -0.1951 9.9242 0.03337 0.0079 -0.1323 -0.6779 2007 SMP2_000078 CO[C@@H]1[C@@H](OC(=O)c2ccc(C)[nH]2)[C@@H](O)[C@H](CC1(C)C)Oc3ccc4CC(NC(=O)c5[nH]cc(CC(=O)Nc6cc7ccc(O[C@@H]8OC(C)(C)[C@H](OC)[C@@H](OC(=O)c9ccc(C)[nH]9)[C@H]8O)c(C)c7oc6=O)c5C)C(=O)Oc4c3C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 D15 compound treatment 11.7204 1.7194 0.4614 9.2866 -0.60429 -0.1432 0.225 0.4658 751 SMP2_000079 COc1cc(NS(=O)(=O)c2ccc(N)cc2)nc(OC)n1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 D16 compound treatment 9.6947 -0.30625 -0.0822 8.2274 -1.6635 -0.3941 -0.3368 -0.8365 3076316 SMP2_000080 Oc1cc(ccc1C(=O)c2ccccc2)N3CCOCC3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 D17 compound treatment 10.862 0.86098 0.231 8.6132 -1.2777 -0.3027 -0.0507 -0.1331 3076317 SMP2_000081 CO[C@@H]1C[C@@H](CC[C@H]1O)/C=C(\C)/[C@H]2OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@]4(O)O[C@H](C[C@H](C[C@@H](C)C\C(=C/[C@@H](CC=C)C(=O)C[C@H](O)[C@H]2C)\C)OC)[C@H](C[C@H]4C)OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 D18 compound treatment 9.9849 -0.016127 -0.0043 7.7035 -2.1874 -0.5183 -0.3695 -0.713 1392 SMP2_000082 CNC(C)[C@@H]1CC[C@@H](N)[C@@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@@H]3OC[C@](C)(O)[C@H](NC)[C@H]3O)[C@H]2O)O1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 D19 compound treatment 8.5299 -1.471 -0.3947 9.3848 -0.50603 -0.1199 -0.3639 -0.8821 610 SMP2_000083 O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 D20 compound treatment 9.342 -0.65899 -0.1768 8.5087 -1.3822 -0.3275 -0.3566 -0.9582 3076318 SMP2_000084 Oc1nccc2c(cccc12)S(=O)(=O)N3CCCNCC3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 D21 compound treatment 10.8991 0.89815 0.241 10.6998 0.80897 0.1917 0.3059 0.9936 616 SMP2_000085 COc1cc(O)c2c(=O)c(OC)c3CC(C)C(C(=O)C)c4c(OC)c(=O)c5c(O)cc(OC)c6c1c2c3c4c56 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 D22 compound treatment 9.4073 -0.59365 -0.1593 9.9886 0.09775 0.0232 -0.0963 -0.598 1096695 SMP2_000086 Oc1ccc(CC=C)cc1c2cc(CC=C)ccc2O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 D23 compound treatment 9.399 -0.60196 -0.1615 8.7481 -1.1428 -0.2708 -0.3057 -0.9695 3176136 SMP2_000087 C[C@@H]1C2NCC(C)C[C@H]2O[C@@]31CCC4C5CC=C6CC(O)CCC6(C)C5C(=O)C4=C3C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 D24 compound treatment 10.6564 0.65542 0.1759 9.496 -0.39483 -0.0935 0.0582 0.2922 3076319 SMP2_000088 Nc1nc(OCC2CCCCC2)c3[nH]cnc3n1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 E01 mock treatment 8.8714 -1.1296 -0.3031 8.432 -1.4589 -0.3457 -0.4587 -0.9979 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 E02 mock treatment 8.9225 -1.0785 -0.2894 11.2306 1.3397 0.3174 0.0198 0.0462 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 E03 compound treatment 10.7397 0.73869 0.1982 9.1719 -0.71894 -0.1703 0.0197 0.0754 445 SMP2_000089 NC(=O)c1cccc(N)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 E04 compound treatment 7.7737 -2.2273 -0.5976 8.6664 -1.2245 -0.2901 -0.6277 -0.9449 1057045 SMP2_000090 COC(=O)c1ccc(O)c2nc3c(C=O)c(O)cc(O)c3nc12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 E05 compound treatment 6.9942 -3.0068 -0.8068 9.1576 -0.73327 -0.1737 -0.6934 -0.8401 1949 SMP2_000091 NOC(=O)C1=CC(=C(c2ccc(O)c(c2)C(=O)ON)c3ccc(O)c(c3)C(=O)ON)C=CC1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 E06 compound treatment 13.2248 3.2238 0.865 14.2517 4.3609 1.0332 1.3423 0.9961 2180 SMP2_000092 COc1ccc(CNc2nc(NCc3ccc(OC)cc3)c4ncn(C(C)C)c4n2)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 E07 compound treatment 11.3775 1.3766 0.3694 9.5698 -0.32106 -0.0761 0.2074 0.5499 1020463 SMP2_000093 Oc1cc2ccc(=O)oc2cc1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 E08 compound treatment 11.2267 1.2257 0.3289 8.7321 -1.1588 -0.2745 0.0384 0.0897 3076699 SMP2_000094 CN1CCC[C@H]1CO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 E09 compound treatment 12.1735 2.1725 0.5829 9.3536 -0.53723 -0.1273 0.3222 0.54 1694 SMP2_000095 Oc1ccc(cc1)c2sc3cc(O)ccc3c2C(=O)c4ccc(OCCN5CCCCC5)cc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 E10 compound treatment 22.2965 12.295 3.2992 15.288 5.3971 1.2788 3.2371 0.9149 2345 SMP2_000096 Nc1ncnc2n(ccc12)[C@@H]3O[C@H](CO)[C@H](O)[C@H]3O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 E11 compound treatment 9.9341 -0.06686 -0.0179 9.4202 -0.47063 -0.1115 -0.0915 -0.8104 3199487 SMP2_000097 C[C@@H]1CC[C@@]2(C[C@H](C)C3C(=CCC4[C@@]3(C)C[C@@H](O)C5[C@](C)(CO)[C@@H](O)[C@H](O)C[C@]45C)C2[C@H]1C)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 E12 compound treatment 10.7623 0.76134 0.2043 9.823 -0.06788 -0.0161 0.1331 0.6494 2240 SMP2_000098 CC(C)C[C@H](NP(=O)(O)OC1OC(C)C(O)C(O)C1O)C(=O)N[C@H](Cc2c[nH]c3ccccc23)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 E13 compound treatment 10.218 0.21703 0.0582 8.8095 -1.0814 -0.2562 -0.14 -0.5328 1000145 SMP2_000099 NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3OC4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 E14 compound treatment 15.2782 5.2772 1.416 11.7574 1.8665 0.4422 1.314 0.8858 267 SMP2_000100 CCCCC[C@H](O)/C=C/[C@@H]1[C@@H](C/C=C\CCCC(=O)O)C=CC1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 E15 compound treatment 12.2097 2.2087 0.5926 10.5163 0.62548 0.1482 0.5239 0.8575 1114632 SMP2_000101 CC1OC(OCC2OC(Oc3c(oc4cc(O)cc(O)c4c3=O)c5ccc(O)c(O)c5)C(O)C(O)C2O)C(O)C(O)C1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 E16 compound treatment 10.112 0.11103 0.0298 9.1671 -0.72375 -0.1715 -0.1002 -0.5756 1000121 SMP2_000102 C/C(=C\CO)/C=C/C=C(\C)/C=C/C1=C(C)CCCC1(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 E17 compound treatment 10.8064 0.80538 0.2161 11.7267 1.8359 0.435 0.4604 0.9479 1599897 SMP2_000103 O=c1n2CCc3c([nH]c4ccccc34)-c2nc5ccccc15 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 E18 compound treatment 10.0929 0.091875 0.0247 9.4498 -0.44102 -0.1045 -0.0565 -0.5258 2354 SMP2_000104 COc1ccc2C3C4[C@H](CC(C)(C)OO[C@H](C=C(C)C)N4c2c1)N5C(=O)[C@@H]6CCCN6C(=O)[C@]5(O)[C@H]3O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 E19 compound treatment 9.3398 -0.66114 -0.1774 9.9641 0.073213 0.0173 -0.1132 -0.6349 1001870 SMP2_000105 C/C(=C/C(=O)O)/C=C/[C@@]1(O)C(=CC(=O)CC1(C)C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 E20 compound treatment 9.2888 -0.71219 -0.1911 10.2709 0.38007 0.0901 -0.0715 -0.3382 296 SMP2_000106 Nc1ncnc2N(=CNc21)C3CCCO3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 E21 compound treatment 27.5293 17.528 4.7033 30.2612 20.37 4.8265 6.7386 0.9999 600 SMP2_000107 COC(=O)/C=C/c1cc(O)ccc1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 E22 compound treatment 101.1357 91.135 24.4538 91.5169 81.626 19.3401 30.9669 0.9933 2327 SMP2_000108 CCC(C)C1NC2C=Cc3c(cc(nc3C2O)C(=O)OC(C)C(NCC(=O)c4csc(n4)C(NC(=O)c5csc(n5)/C(=C\C)/NC(=O)C(NC(=O)c6csc(n6)C7(CCC(=NC7)c8nc(cs8)C(=O)NC(=C)C(=O)NC(=C)C(=O)N)NC(=C)C(C)NC(=O)C(=C)NCC(C)NC1=O)C(C)O)C(C)(O)C(C)O)c9nccs9)C(C)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 E23 compound treatment 10.4588 0.45778 0.1228 11.8837 1.9929 0.4722 0.4207 0.8624 3076759 SMP2_000109 CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](COP(=O)(O)OCC[N+](C)(C)C)NC(=O)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 E24 compound treatment 9.2582 -0.74282 -0.1993 9.4044 -0.48644 -0.1153 -0.2224 -0.9661 3199491 SMP2_000110 C/C=C/C1OC2=C(C(=O)C[C@H](C)O2)C(=O)[C@@H]1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 F01 mock treatment 9.2015 -0.7995 -0.2145 8.4039 -1.487 -0.3523 -0.4008 -0.9717 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 F02 mock treatment 8.7849 -1.2161 -0.3263 9.3171 -0.57378 -0.1359 -0.3269 -0.9247 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 F03 compound treatment 9.8698 -0.13122 -0.0352 10.149 0.25811 0.0612 0.0183 0.26 907179 SMP2_000111 C/C(=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)C(=O)C(O)CC1(C)C)/C=C/C=C(\C)/C=C/C2=C(C)C(=O)C(O)CC2(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 F04 compound treatment 10.633 0.632 0.1696 11.5612 1.6704 0.3958 0.3998 0.9285 3076760 SMP2_000112 COc1cc(O)c2c3oc4cc(O)c(O)cc4c3c(=O)oc2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 F05 compound treatment 8.5597 -1.4413 -0.3867 8.071 -1.8199 -0.4312 -0.5784 -0.9985 328 SMP2_000113 C/C=C(/C)\C=C\1/CN=C2N(CCC2(O)C1=O)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 F06 compound treatment 10.7628 0.76185 0.2044 8.8573 -1.0336 -0.2449 -0.0286 -0.0897 3076761 SMP2_000114 CNCC/C=C/1\c2ccccc2CC(O)c3ccccc13 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 F07 compound treatment 10.1526 0.1516 0.0407 8.1885 -1.7024 -0.4034 -0.2565 -0.6326 3199493 SMP2_000115 CCC/C=C/C=C/C(=O)O[C@H]1\C(=C\C(=O)OC)\C[C@H]2C[C@@H](OC(=O)C[C@H](O)C[C@H]3C[C@H](OC(=O)C)C(C)(C)[C@](O)(C[C@@H]4C/C(=C/C(=O)OC)/C[C@@H](O4)/C=C\C(C)(C)[C@]1(O)O2)O3)[C@@H](C)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 F08 compound treatment 10.8194 0.81841 0.2196 10.3383 0.44748 0.106 0.2302 0.9442 1046629 SMP2_000116 Nc1cc2c3ccccc3ccc2c4ccccc14 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 F09 compound treatment 23.0315 13.03 3.4964 18.8886 8.9977 2.1319 3.9798 0.9718 1037664 SMP2_000117 CSCS(=O)CC(CO)NC(=O)C=Cc1c(C)nc(O)nc1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 F10 compound treatment 8.0619 -1.9391 -0.5203 8.5449 -1.346 -0.3189 -0.5934 -0.9724 1943 SMP2_000118 CN[C@H]1[C@@H](O)[C@H]2O[C@H](O[C@@H]3[C@@H](N)C[C@@H](N)[C@H](O)[C@H]3O)[C@H](N)C[C@@H]2O[C@@H]1O[C@@]4(C)O[C@H](CO)[C@@H](N)[C@H](O)[C@H]4O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 F11 compound treatment 10.8479 0.84688 0.2272 9.2123 -0.67854 -0.1608 0.047 0.1688 3199494 SMP2_000119 CC[C@@H]1C[C@@]1(NC(=O)C2=C[C@H](CC)C[C@H]3[C@@H]2CCC3=O)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 F12 compound treatment 63.2396 53.239 14.2853 33.7886 23.898 5.6622 14.105 0.9179 1320 SMP2_000120 C[C@]1(CC[C@]2(C)CC[C@]3(C)C4=CC=C5C=C(O)C(=O)C=C5[C@]4(C)CC[C@@]3(C)[C@@H]2C1)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 F13 compound treatment 8.4188 -1.5821 -0.4245 9.1198 -0.77109 -0.1827 -0.4294 -0.929 745 SMP2_000121 CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 F14 compound treatment 64.7412 54.74 14.6882 56.3916 46.501 11.0177 18.1768 0.99 2008 SMP2_000122 CC1=C(SCCO)C(=O)c2ccccc2C1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 F15 compound treatment 9.9864 -0.014557 -0.0039 9.6231 -0.26773 -0.0634 -0.0476 -0.7492 3199495 SMP2_000123 CCCCCCCCCCCCCC[C@@H](O)[C@@H](O)[C@@H](N)COP(=O)(O)[O-] 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 F16 compound treatment 13.7393 3.7383 1.0031 11.4281 1.5372 0.3642 0.9668 0.906 3076763 SMP2_000124 Oc1ccc2c(Oc3cc(O)ccc3C42OC(=O)c5ccc(Nc6nc(Cl)nc(Cl)n6)cc54)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 F17 compound treatment 9.0692 -0.93177 -0.25 10.1435 0.25264 0.0599 -0.1345 -0.523 1433 SMP2_000125 CS(=O)(=O)c1ccc(cc1)[C@@H](O)[C@@H](CO)NC(=O)C(Cl)Cl 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 F18 compound treatment 9.5831 -0.41784 -0.1121 10.5715 0.68067 0.1613 0.0348 0.177 1100216 SMP2_000126 CC(=CCCC(C)(OC1OC(COC2OC(CO)C(O)C2O)C(O)C(O)C1O)C3CCC4(C)C3C(O)CC5C6(C)CCC(OC7OC(CO)C(O)C(O)C7OC8OC(CO)C(O)C(O)C8O)C(C)(C)C6CCC54C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 F19 compound treatment 47.2813 37.28 10.0033 41.7535 31.863 7.5494 12.4116 0.9904 3000453 SMP2_000127 C[C@@H]1CC2OC(=O)C(=C)C2[C@H](O)[C@@]3(C)[C@H]1C=CC3=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 F20 compound treatment 9.9575 -0.043512 -0.0117 11.0252 1.1344 0.2688 0.1818 0.6758 3060680 SMP2_000128 Oc1ccccc1N2CC=C(NC2=O)c3cccc(c3)[N+](=O)[O-] 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 F21 compound treatment 20.5894 10.588 2.8411 32.8195 22.929 5.4326 5.8504 0.9543 1907753 SMP2_000129 CC[C@@H]1[C@H](C)C[C@@H]2[C@H]3C[C@H]4CCC(=O)C5=C(O)[C@H](CCCNC(=O)/C=C\C[C@@H]4[C@H]3C=C[C@@H]12)NC5=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 F22 compound treatment 113.3055 103.3 27.7193 128.913 119.02 28.2005 39.5413 1.0 1001972 SMP2_000130 CCCC[C@@H](C)/C=C(\C)/C=C(\C)/C(=O)NC1=C[C@@](O)(\C=C\C=C\C=C\C(=O)NC2=C(O)CCC2=O)[C@@H]3O[C@@H]3C1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 F23 compound treatment 12.3002 2.2992 0.6169 9.6842 -0.20668 -0.049 0.4016 0.6489 3076765 SMP2_000131 CO[C@H]1[C@@H](CC(=O)O[C@H](C)C/C=C\C=C/[C@H](O)[C@H](C)C[C@H](CC=O)[C@@H]1O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(O)[C@@H](OC(=O)CC(C)C)[C@H](C)O3)[C@@H]([C@H]2O)N(C)C)OC(=O)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 F24 compound treatment 9.7504 -0.25063 -0.0673 8.9882 -0.90261 -0.2139 -0.1988 -0.8867 288 SMP2_000132 C[C@@H]1Cc2c(Cl)cc(C(=O)N[C@@H](Cc3ccccc3)C(=O)O)c(O)c2C(=O)O1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 G01 mock treatment 8.5958 -1.4052 -0.3771 10.3671 0.47624 0.1128 -0.1868 -0.4747 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 G02 mock treatment 9.3365 -0.66445 -0.1783 8.0372 -1.8536 -0.4392 -0.4366 -0.9211 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 G03 compound treatment 9.5394 -0.46155 -0.1238 9.2827 -0.60815 -0.1441 -0.1895 -0.9972 2407 SMP2_000133 CN1C(=C(O)c2ccccc2S1(=O)=O)C(=O)Nc3ncc(C)s3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 G04 compound treatment 9.7782 -0.22279 -0.0598 9.3508 -0.54009 -0.128 -0.1328 -0.9399 907364 SMP2_000134 CCC(C(=O)NC/C=C\C=C(\C)/C(OC)C(C)C1OC(\C=C/C=C\C=C(\C)/C(=O)c2c(O)cc[nH]c2=O)C(O)C1O)C3(O)OC(\C=C/C=C\C)C(C)(C)C(O)C3O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 G05 compound treatment 9.7437 -0.25725 -0.069 9.5482 -0.34263 -0.0812 -0.1062 -0.9967 1978 SMP2_000135 OC(=O)/C=C/c1ccc(O)c(O)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 G06 compound treatment 9.6152 -0.38581 -0.1035 11.6406 1.7497 0.4146 0.2199 0.5147 3076766 SMP2_000136 CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO)[N+](C)(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 G07 compound treatment 8.5895 -1.4115 -0.3787 10.1944 0.30356 0.0719 -0.217 -0.5628 1117 SMP2_000137 Nc1nc(=O)c2nc(CNc3ccc(cc3)C(=O)N[C@@H](CCC(=O)O)C(=O)O)cnc2[nH]1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 G08 compound treatment 7.3825 -2.6185 -0.7026 9.2569 -0.63401 -0.1502 -0.603 -0.8393 313 SMP2_000138 CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(=O)CCCCCCC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 G09 compound treatment 7.4659 -2.5351 -0.6802 9.6827 -0.20815 -0.0493 -0.5159 -0.7564 3076819 SMP2_000139 COCC(=O)c1ncn-2c1[C@@H]3CCNC3C(=O)c4cc(OC)ccc42 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 G10 compound treatment 36.5213 26.52 7.1161 38.5138 28.623 6.7818 9.8273 0.9997 3199591 SMP2_000140 CCCCCCCCCC(=O)O[C@@H]1[C@@H](C)[C@@]2(O)[C@@H]3C=C(C)C(=O)[C@]3(O)CC(=C[C@H]2[C@@H]4C(C)(C)[C@@]41OC(=O)CCCCCCCCC)COC(=O)Cc5ccc(O)c(OC)c5 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 G11 compound treatment 11.0988 1.0978 0.2946 10.3171 0.42623 0.101 0.2797 0.8982 939 SMP2_000141 Cc1cccc(Nc2ccccc2C(=O)O)c1C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 G12 compound treatment 16.6482 6.6472 1.7836 8.5485 -1.3423 -0.318 1.0363 0.572 3076821 SMP2_000142 CCCCCCCCCCCCCC[C@@H](O)[C@@H](O)[C@@H](N)CO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 G13 compound treatment 8.6762 -1.3248 -0.3555 9.0796 -0.81127 -0.1922 -0.3873 -0.9583 1012954 SMP2_000143 OC(Cc1ccncc1)C(Cl)(Cl)Cl 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 G14 compound treatment 22.3174 12.316 3.3048 22.8734 12.983 3.076 4.5119 0.9994 4637 SMP2_000144 C[C@@H]1C[C@]2(OC(=O)C)[C@H]([C@@H]3C=C(CO)C[C@@]4(O)[C@@H](C=C(C)C4=O)[C@@]13O)C2(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 G15 compound treatment 10.2079 0.2069 0.0555 9.415 -0.47591 -0.1128 -0.0405 -0.3221 942 SMP2_000145 OC(=O)c1ccccc1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 G16 compound treatment 7.877 -2.124 -0.5699 10.367 0.47617 0.1128 -0.3232 -0.5563 3199592 SMP2_000146 CCCC[C@]1(CC[C@]2(CC[C@H](C)[C@@H](C/C=C(\C)/C=C/[C@H](O)[C@@H](C)/C=C/C(=O)O)O2)O[C@H]1\C=C\C(=C\C(=O)O)\C)OC(=O)CCC(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 G17 compound treatment 9.4049 -0.59613 -0.16 8.5667 -1.3242 -0.3137 -0.335 -0.9511 1011013 SMP2_000147 Nc1ccc2nc3ccc(N)cc3[s+]c2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 G18 compound treatment 8.9568 -1.0441 -0.2802 11.3506 1.4597 0.3459 0.0464 0.1043 3076824 SMP2_000148 NC(=O)OCC1N=C(N)N2CCC(O)(O)C32NC(=NC13)N 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 G19 compound treatment 9.5624 -0.43861 -0.1177 10.8528 0.96198 0.2279 0.0779 0.3039 3199593 SMP2_000149 COc1cc(ccc1O)[C@H]2Oc3cc(ccc3O[C@H]2CO)[C@H]4Oc5cc(O)cc(O)c5C(=O)[C@@H]4O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 G20 compound treatment 8.0067 -1.9943 -0.5351 10.0706 0.17972 0.0426 -0.3483 -0.6488 3185114 SMP2_000150 CC[C@]1(C=CCN2CC[C@]3([C@H]4N(C)c5cc(OC)ccc53)[C@@H]21)[C@@H](OC(=O)C)[C@]4(O)C(=O)OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 G21 compound treatment 9.3722 -0.62874 -0.1687 10.7731 0.88221 0.209 0.0285 0.1061 3199594 SMP2_000151 C[C@@H]1[C@@H](O)[C@]2(O)[C@H]([C@@H]3C=C(CO)C[C@@]4(O)[C@@H](C=C(C)C4=O)[C@@]13O)C2(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 G22 compound treatment 10.1573 0.15632 0.0419 11.6155 1.7246 0.4086 0.3186 0.7756 3076825 SMP2_000152 NC(=O)C1CCCN1C(=O)C(Cc2c[nH]cn2)NC(=O)C3CCC(=O)N3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 G23 compound treatment 17.4706 7.4696 2.0043 29.3541 19.463 4.6115 4.6781 0.9304 1095351 SMP2_000153 COC1=C(Br)C(O)C(O)(CC#N)C=C1Br 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 G24 compound treatment 9.6926 -0.30835 -0.0827 14.1633 4.2724 1.0123 0.6573 0.6472 3 SMP2_000154 Oc1ccc(/C=C(\C#N)/C(=O)NCc2ccccc2)cc1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 H01 mock treatment 8.3224 -1.6786 -0.4504 11.6946 1.8037 0.4274 -0.0163 -0.0262 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 H02 mock treatment 10.2162 0.21524 0.0578 10.4323 0.54147 0.1283 0.1316 0.9351 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 H03 compound treatment 8.8076 -1.1934 -0.3202 9.7109 -0.17995 -0.0426 -0.2566 -0.7942 3199595 SMP2_000155 CCC(C)C(NC(=O)C1CC(=O)NCC(=O)NC(Cc2ccccc2)C(=O)NC(C(C)CC)C(=O)NCC(=O)NC(Cc3c[nH]c4ccccc34)C(=O)NCC(=O)NC(CC(=O)N)C(=O)N1)C(=O)NC(Cc5ccccc5)C(=O)NCC(=O)NC(Cc6c[nH]cn6)C(=O)NC(Cc7ccc(O)cc7)C(=O)NC(CO)C(=O)NCC(=O)NC(CC(=O)O)C(=O)NC(Cc8ccccc8)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 H04 compound treatment 13.2697 3.2687 0.8771 15.3809 5.4901 1.3008 1.54 0.9816 1303231 SMP2_000156 CN(C)CC(O)Cn1c2ccc(Br)cc2c3cc(Br)ccc13 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 H05 compound treatment 58.1167 48.116 12.9107 62.701 52.81 12.5126 17.977 0.9999 3076826 SMP2_000157 Nc1ccccc1NC(=O)CCCCCCC(=O)Nc2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 H06 compound treatment 14.3088 4.3078 1.1559 8.6947 -1.1961 -0.2834 0.6169 0.5184 3076827 SMP2_000158 OC[C@H]1CC2CCN1CC2C=C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 H07 compound treatment 7.8677 -2.1333 -0.5724 10.1335 0.24261 0.0575 -0.3641 -0.6329 3199596 SMP2_000159 OC(=O)c1cc(/C=C/c2ccc(/C=C/c3ccc(O)c(c3)C(=O)O)c(Br)c2)ccc1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 H08 compound treatment 13.084 3.083 0.8273 10.6409 0.75005 0.1777 0.7106 0.8398 1088673 SMP2_000160 CC(C)C1NC(=O)C(NC(=O)c2cc(N)c(C)c3oc4c(C)c(=O)c(N)c(C(=O)NC5C(C)OC(=O)C(C(C)C)N(C)C(=O)CN(C)C(=O)C6CCCN6C(=O)C(NC5=O)C(C)C)c4nc23)C(C)OC(=O)C(C(C)C)N(C)C(=O)CN(C)C(=O)C7CCCN7C1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 H09 compound treatment 11.508 1.507 0.4044 9.9686 0.077775 0.0184 0.299 0.7386 3069011 SMP2_000161 NCCC(=O)NCCc1c[nH]cn1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 H10 compound treatment 10.3086 0.30759 0.0825 10.1164 0.22549 0.0534 0.0961 0.9778 1025 SMP2_000162 CC(C)CC(=O)OC1C(O[C@@H]2C[C@H]([C@H]3CC[C@]4(C[C@@H]5CC[C@H]4[C@]3(C)C2)[C@@H](O)C5=C)C(=O)O)OC(CO)C(OS(=O)(=O)O)C1OS(=O)(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 H11 compound treatment 10.3115 0.31049 0.0833 8.2947 -1.5962 -0.3782 -0.2085 -0.5384 1018447 SMP2_000163 Oc1ccc2c(c1)oc3c2c(=O)oc4cc(O)ccc34 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 H12 compound treatment 10.3699 0.36888 0.099 8.3329 -1.558 -0.3691 -0.191 -0.4998 1000068 SMP2_000164 CC1=C(N2[C@H](SC1)C(NC(=O)C(N)c3ccccc3)C2=O)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 H13 compound treatment 93.8731 83.872 22.5051 97.9515 88.061 20.8647 30.667 0.9993 526 SMP2_000165 C[C@@H](O)[C@@H]1O[C@H]1/C=C/[C@@H]2O[C@H]2[C@H](O)C=C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 H14 compound treatment 12.1383 2.1373 0.5735 22.307 12.416 2.9418 2.4857 0.8293 460 SMP2_000166 CCC1NC(=O)C([C@H](O)[C@H](C)C/C=C/C)N(C)C(=O)C(C(C)C)N(C)C(=O)C(CC(C)C)N(C)C(=O)C(CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)C(C)NC(=O)C(CC(C)C)N(C)C(=O)C(NC(=O)C(CC(C)C)N(C)C(=O)CN(C)C1=O)C(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 H15 compound treatment 8.6319 -1.3691 -0.3674 10.3856 0.49474 0.1172 -0.1769 -0.4587 907301 SMP2_000167 CCC(C)C(O)C(C)C(=O)C(C)/C=C(\C)/CC(C)C1OC(=O)C1CC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 H16 compound treatment 10.8414 0.84046 0.2255 8.3961 -1.4947 -0.3542 -0.091 -0.2166 3076266 SMP2_000168 CO[C@@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@H]1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 H17 compound treatment 10.1055 0.10453 0.028 8.4638 -1.427 -0.3381 -0.2192 -0.6462 1001938 SMP2_000169 COC[C@H]1CC[C@H]2[C@@H](C)[C@@H](O)[C@H](OC3OC(COC(C)(C)C=C)[C@H](O)C(OC(=O)C)[C@@H]3O)C4=C(CC(O)[C@]4(C)C=C12)C(C)COC(=O)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 H18 compound treatment 9.2404 -0.76053 -0.2041 11.7178 1.8269 0.4329 0.1618 0.3381 829 SMP2_000170 CC(C)c1c(O)c(O)c(C=O)c2c(O)c(c(C)cc12)c3c(C)cc4c(C(C)C)c(O)c(O)c(C=O)c4c3O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 H19 compound treatment 98.0788 88.078 23.6335 74.8133 64.922 15.3824 27.5885 0.9784 2334 SMP2_000171 C/C(=C\1/C(=O)NC(Cc2ccccc2)C1=O)/Nc3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 H20 compound treatment 8.7102 -1.2907 -0.3463 12.6182 2.7274 0.6462 0.212 0.2892 2109 SMP2_000172 OCc1c[nH]c2ccccc12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 H21 compound treatment 9.8849 -0.11606 -0.0311 8.5943 -1.2965 -0.3072 -0.2392 -0.7748 2106 SMP2_000173 COC1=CC(=O)C(=C(C[C@]2(C)[C@@H](C)CC[C@@]3(C)[C@H]2CCCC3=C)C1=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 H22 compound treatment 7.8474 -2.1536 -0.5779 7.4532 -2.4376 -0.5776 -0.817 -1.0 1260 SMP2_000174 N[C@@H](Cc1ccc(cc1)N(CCCl)CCCl)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 H23 compound treatment 14.7064 4.7054 1.2626 15.3012 5.4104 1.2819 1.7992 1.0 3076270 SMP2_000175 C[C@]12C=Cc3occc3C2CC[C@]4(C[C@H]5CCC41)C[C@]5(O)CO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 H24 compound treatment 9.2311 -0.76988 -0.2066 9.7989 -0.091932 -0.0218 -0.1615 -0.7774 3199601 SMP2_000176 CCC(C)C1NC(=O)C(Cc2ccc(O)cc2)NC(=O)C(N)CSSCC(NC(=O)C(CC(=O)N)NC(=O)C(CCC(=O)N)NC1=O)C(=O)N3CCCC3C(=O)NC(CC(C)C)C(=O)NCC(=O)N 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 I01 mock treatment 9.073 -0.92801 -0.249 10.5035 0.61262 0.1452 -0.0734 -0.2548 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 I02 mock treatment 9.4642 -0.53677 -0.144 11.4493 1.5584 0.3693 0.1593 0.4018 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 I03 compound treatment 11.0817 1.0807 0.29 9.5919 -0.29899 -0.0708 0.155 0.5191 3076271 SMP2_000177 OC(=O)/C=C/c1c[nH]c2ccccc12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 I04 compound treatment 16.1554 6.1544 1.6514 14.2364 4.3455 1.0296 1.8957 0.9741 3199602 SMP2_000178 C/C(=C\CCC1=CC(=O)OC1O)/CC/C=C(\C)/CCC2=C(C)CCCC2(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 I05 compound treatment 26.373 16.372 4.393 20.3518 10.461 2.4786 4.859 0.9633 1135 SMP2_000179 OCCNCCNc1ccc(NCCNCCO)c2C(=O)c3c(O)ccc(O)c3C(=O)c12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 I06 compound treatment 10.8853 0.88428 0.2373 8.7002 -1.1907 -0.2821 -0.0317 -0.086 252 SMP2_000180 CCCCCCOC(=O)[C@]1(O)C[C@H]2O[C@@]1(C)n3c4ccccc4c5c6CNC(=O)c6c7c8ccccc8n2c7c35 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 I07 compound treatment 10.2284 0.2274 0.061 11.1488 1.2579 0.2981 0.2539 0.8346 3076272 SMP2_000181 COC(=O)C1=CO[C@@H](O[C@@H]2OC(CO)[C@H](O)[C@@H](O)[C@H]2O)[C@H]3[C@@H]1CC=C3CO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 I08 compound treatment 12.6367 2.6357 0.7072 7.9219 -1.9689 -0.4665 0.1702 0.2009 3199603 SMP2_000182 CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(=O)CCCCCCCCCCCCCCC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 I09 compound treatment 9.9562 -0.044807 -0.012 9.7654 -0.12545 -0.0297 -0.0295 -0.9207 2129 SMP2_000183 OCC(O)C1OC(=O)C(=C1O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 I10 compound treatment 32.3696 22.369 6.0021 29.4313 19.54 4.6298 7.5179 0.9918 3199692 SMP2_000184 CCCCCCCCC(=O)O[C@@H]1[C@@H](C)[C@@]2(O)[C@@H]3C=C(C)C(=O)[C@]3(O)CC(=C[C@H]2[C@@H]4C(C)(C)[C@@]41OC(=O)CCCCCCCC)COC(=O)Cc5ccc(O)c(OC)c5 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 I11 compound treatment 17.4049 7.4039 1.9866 7.9358 -1.9551 -0.4632 1.0772 0.5281 1865 SMP2_000185 Clc1cccc(Nc2nnc(c3ccccc3)c4ccccc24)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 I12 mock treatment 11.0075 1.0065 0.2701 9.7135 -0.17739 -0.042 0.1613 0.59 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 I13 compound treatment 8.5065 -1.4945 -0.401 8.5677 -1.3232 -0.3135 -0.5052 -0.9926 3472730 SMP2_000186 CC12CCC3C(CC=C4CC(O)CCC34C)C2CCC1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 I14 compound treatment 10.7376 0.73664 0.1977 8.5032 -1.3877 -0.3288 -0.0927 -0.2417 3076274 SMP2_000187 Oc1ccc(cc1)C2COc3cc(O)ccc3C2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 I15 compound treatment 10.1851 0.18416 0.0494 11.7835 1.8927 0.4484 0.352 0.7803 2288 SMP2_000188 CC(=CCC(O)C1=CC(=O)c2c(O)ccc(O)c2C1=O)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 I16 compound treatment 134.1892 124.19 33.3229 114.4614 104.57 24.7765 41.0825 0.9894 3199693 SMP2_000189 COC(C(C)C1CC(O)C2(C)OC2/C=C\C(C)C3CC(CC(=O)O3)CC4OC4C(=O)O1)C(=CC=CC(=Cc5coc(C)n5)C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 I17 compound treatment 9.7451 -0.25593 -0.0687 9.9127 0.021843 0.0052 -0.0449 -0.652 1025605 SMP2_000190 OCCN(CCO)CCO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 I18 compound treatment 10.7978 0.79682 0.2138 8.5147 -1.3762 -0.3261 -0.0794 -0.2036 3060146 SMP2_000191 Oc1ccc(cc1)c2nc(c([nH]2)c3ccc(F)cc3)c4ccncc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 I19 compound treatment 11.0817 1.0807 0.29 9.5895 -0.30137 -0.0714 0.1546 0.5175 1874 SMP2_000192 Oc1cccc2c(O)nccc12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 I20 compound treatment 7.9022 -2.0988 -0.5632 8.9905 -0.90038 -0.2133 -0.5491 -0.9117 1080610 SMP2_000193 COc1ccc(O)c2c(=O)c3c(OC)cc4OC5OC=CC5c4c3oc12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 I21 compound treatment 10.5726 0.57158 0.1534 9.053 -0.83784 -0.1985 -0.0319 -0.1272 2290 SMP2_000194 C[C@]1(CC(N)CCC(N)C(=O)O)O[C@](C)([C@@H](O)[C@H]1O)n2cnc3c(N)ncnc23 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 I22 compound treatment 10.4645 0.46352 0.1244 10.4103 0.51947 0.1231 0.175 1.0 3076167 SMP2_000195 CC(C)C1OC(=O)C2=CCCN2C(=O)c3coc(CC(=O)C[C@H](O)/C=C(/C)\C=C/CNC(=O)\C=C/C1C)n3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 I23 compound treatment 11.198 1.197 0.3212 10.6567 0.76587 0.1815 0.3554 0.9635 1077786 SMP2_000196 CC(C)CC1N2C(=O)C(NC(=O)C3CN(C)C4Cc5c[nH]c6cccc(C4=C3)c56)(OC2(O)C7CCCN7C1=O)C(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 I24 compound treatment 8.716 -1.285 -0.3448 9.7119 -0.17901 -0.0424 -0.2738 -0.7881 325 SMP2_000197 N/C(=C(/C#N)\C(=C(/N)\Sc1ccccc1N)\C#N)/Sc2ccccc2N 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 J01 mock treatment 9.7414 -0.25954 -0.0696 10.5895 0.69866 0.1655 0.0678 0.3776 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 J02 mock treatment 12.7028 2.7018 0.725 10.2917 0.40082 0.095 0.5798 0.793 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 J03 compound treatment 8.785 -1.2159 -0.3263 10.8667 0.97585 0.2312 -0.0672 -0.1681 3076170 SMP2_000198 OC[C@@H]1[C@@H](O)[C@H](O)[C@H]2[C@@H](O)CCN12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 J04 compound treatment 10.8235 0.82251 0.2207 8.5307 -1.3602 -0.3223 -0.0718 -0.1839 677 SMP2_000199 C[C@@H](N)[C@H]1CC[C@@H](CC1)C(=O)Nc2ccncc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 J05 compound treatment 15.4434 5.4424 1.4603 15.6663 5.7754 1.3684 2.0002 0.9995 2060246 SMP2_000200 C[C@@]1(CO)[C@H](O)CC[C@@]2(C)[C@H](C/C=C/3\[C@H](O)COC3=O)C(=C)CCC12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 J06 compound treatment 10.9552 0.95423 0.256 9.0085 -0.88236 -0.2091 0.0332 0.1005 414 SMP2_000201 CC1CNCCN1S(=O)(=O)c2cccc3cnccc23 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 J07 compound treatment 11.3605 1.3595 0.3648 9.1537 -0.73719 -0.1747 0.1344 0.3324 1972 SMP2_000202 COC(=O)/C(=C\Nc1ccc(Oc2ccccc2OC(C)C)nc1)/NC(=O)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 J08 compound treatment 10.344 0.34298 0.092 9.7254 -0.16545 -0.0392 0.0374 0.3734 3189311 SMP2_000203 CC(=O)OCC1=C(N2[C@H](SC1)[C@H](N)C2=O)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 J09 compound treatment 10.6796 0.67865 0.1821 8.5695 -1.3214 -0.3131 -0.0926 -0.2557 2109607 SMP2_000204 CC(C)c1cc2CC[C@H]3C(C)(C)CCC[C@]3(C(=O)O)c2c(O)c1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 J10 compound treatment 10.5392 0.53824 0.1444 9.4741 -0.41677 -0.0987 0.0323 0.1846 1960 SMP2_000205 CC(=C)[C@@H]1CC[C@@]2(CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 J11 compound treatment 12.5161 2.5151 0.6749 10.7267 0.83586 0.198 0.6172 0.8776 3199694 SMP2_000206 CC1[C@H]2NC[C@@H](C)C[C@H]2O[C@@]31CC[C@H]4[C@@H]5CC=C6C[C@@H](O)CC[C@]6(C)[C@H]5CC4=C3C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 J12 compound treatment 13.0987 3.0977 0.8312 13.4459 3.5551 0.8423 1.1834 1.0 874122 SMP2_000207 COc1c(O)c2c(=O)cc3OCOc4cc(O)c5c(=O)c(OC)c(CC(C)O)c6c(c1CC(C)O)c2c3c4c56 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 J13 compound treatment 12.4961 2.4951 0.6695 15.1647 5.2738 1.2496 1.357 0.9572 1301 SMP2_000208 OCCN(CCO)c1nc(N2CCCCC2)c3nc(nc(N4CCCCC4)c3n1)N(CCO)CCO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 J14 compound treatment 9.743 -0.25801 -0.0692 7.8982 -1.9927 -0.4721 -0.3828 -0.8022 1001900 SMP2_000209 Nc1ccn(C2OC(CO)C(O)C2O)c(=O)n1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 J15 compound treatment 10.6251 0.62408 0.1675 9.8717 -0.019117 -0.0045 0.1152 0.6877 2056 SMP2_000210 CC(C)CC(NC(=O)NC(C1CCNC(=N1)N)C(=O)NC(CCC(=O)N)C(=O)NC(C)C=O)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 J16 compound treatment 9.8257 -0.17533 -0.047 11.5063 1.6155 0.3828 0.2374 0.6156 599 SMP2_000211 Cc1cc(O)c2C(=O)c3c(O)cc(O)cc3C(=O)c2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 J17 compound treatment 9.8727 -0.12831 -0.0344 8.1859 -1.705 -0.404 -0.31 -0.7646 162 SMP2_000212 CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)CC(=O)NO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 J18 compound treatment 11.3783 1.3773 0.3696 8.5382 -1.3526 -0.3205 0.0347 0.0709 3076285 SMP2_000213 CN1C(=O)/C(=C/2\Nc3ccccc3\C2=N\O)/c4ccc(Br)cc14 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 J19 compound treatment 16.1558 6.1548 1.6515 12.9907 3.0999 0.7345 1.6871 0.9334 3199695 SMP2_000214 CC1O[C@@H](O[C@H]2C[C@@H](C=O)C3C(CCC4C3CC[C@]5(C)[C@H](CC[C@]45O)c6ccc(=O)oc6)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O[C@@H]7OC(CO)[C@@H](O)[C@@H](O)[C@H]7O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 J20 compound treatment 9.7241 -0.27691 -0.0743 10.9493 1.0584 0.2508 0.1248 0.4771 3076287 SMP2_000215 COc1cc(O)c(CC=C(C)C)c2OC(CC(=O)c12)c3ccc(O)cc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 J21 compound treatment 10.271 0.27 0.0724 9.6534 -0.23748 -0.0563 0.0114 0.1247 2411 SMP2_000216 NCC1O[C@@H](O[C@@H]2[C@H](N)C[C@@H](N)C(O[C@H]3OC(CO)[C@@H](O)[C@@H](N)[C@H]3O)C2O)[C@H](N)C[C@@H]1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 J22 compound treatment 17.0369 7.0359 1.8879 9.8688 -0.02206 -0.0052 1.3313 0.7051 3199697 SMP2_000217 CCC(=O)O[C@H]1C(C)O[C@](C)(C[C@]1(C)O)O[C@@H]2C(C)O[C@@H](CO[C@@H]3[C@@H](C)[C@@H](CC(=O)O[C@H](C)C/C=C\C=C/[C@H](O)[C@H](C)C[C@@H]3CC(=O)C)OC(=O)CC)[C@H](O)[C@@H]2N(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 J23 compound treatment 25.7357 15.735 4.222 30.4103 20.519 4.8618 6.4232 0.9975 3076290 SMP2_000218 C[C@@H]1[C@H](O)[C@@H](C)[C@H]2O[C@@H]1CC[C@H](C)/C=C(/C)\C[C@@H](C)C[C@H](C)[C@]3(O)OC4=C(C)C(=O)C(=C2C4=C3)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 J24 compound treatment 13.0594 3.0584 0.8206 12.3507 2.4599 0.5828 0.9924 0.9859 3199698 SMP2_000219 CC(NC(=O)C(NC(=O)c1nc(nc(N)c1C)C(CC(=O)N)NCC(N)C(=O)N)C(OC2OC(CO)C(O)C(O)C2(C)OC3OC(CO)C(O)C(O)(C3O)C(=O)N)c4cnc[nH]4)C(O)C(C)C(=O)NC(C(=O)C)C(=O)NCCC5=NC(CS5)c6nc(cs6)C(=O)N 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 K01 mock treatment 9.2162 -0.78481 -0.2106 8.4393 -1.4515 -0.3439 -0.3921 -0.9723 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 K02 mock treatment 12.2136 2.2126 0.5937 10.0952 0.20429 0.0484 0.454 0.7622 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 K03 compound treatment 8.9196 -1.0814 -0.2902 8.8616 -1.0292 -0.2439 -0.3776 -0.9963 3076443 SMP2_000220 CC(C)CCC[C@@H](C)C1CCC2C3C(O)C=C4CC(O)CCC4(C)C3CCC12C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 K04 compound treatment 11.9906 1.9896 0.5339 8.422 -1.4689 -0.348 0.1314 0.2062 25 SMP2_000221 CCCCCCCCCCCCC/C=C/[C@@H](O)[C@@H](N)COP(=O)(O)OCC[N+](C)(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 K05 compound treatment 10.845 0.84398 0.2265 9.3751 -0.5158 -0.1222 0.0737 0.2865 3076448 SMP2_000222 CCC1=CC2C[C@@H]3c4[nH]c5ccccc5c4CCN(C2)[C@@]31C(=O)OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 K06 compound treatment 17.8458 7.8448 2.105 14.5633 4.6725 1.1071 2.2712 0.955 309 SMP2_000223 CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO)N(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 K07 compound treatment 8.7009 -1.3001 -0.3489 10.4945 0.60363 0.143 -0.1455 -0.386 1000097 SMP2_000224 Cc1c(C)c2OC(C)(COc3ccc(CC4SC(=O)NC4=O)cc3)CCc2c(C)c1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 K08 compound treatment 12.0228 2.0218 0.5425 12.2625 2.3717 0.5619 0.7809 0.9998 2113458 SMP2_000225 CCC(=O)NCCc1c2scnc2c3nccc4c5ccccc5[nH]c1c43 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 K09 compound treatment 7.5189 -2.4821 -0.666 9.1018 -0.78902 -0.1869 -0.6031 -0.8719 3076491 SMP2_000226 CCCCCCCCCCCCCCCC(=O)OCC(O)[C@H]1OC(=O)C(=C1O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 K10 compound treatment 8.8489 -1.1521 -0.3091 7.7904 -2.1005 -0.4977 -0.5705 -0.9738 3184 SMP2_000227 CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)C[C@@H]2O/C(=C\CCCC(=O)O)/C[C@H]12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 K11 compound treatment 9.9769 -0.02406 -0.0065 8.6277 -1.2631 -0.2993 -0.2162 -0.7222 1313 SMP2_000228 Oc1ccc(Cl)cc1C(=O)Nc2ccc(cc2Cl)[N+](=O)[O-] 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 K12 compound treatment 9.3894 -0.61159 -0.1641 8.0562 -1.8346 -0.4347 -0.4234 -0.9113 3199699 SMP2_000229 CC(C)Nc1cccnc1N2CCN(CC2)C(=O)c3cc4cc(O)ccc4[nH]3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 K13 compound treatment 10.2775 0.27647 0.0742 10.5858 0.69496 0.1647 0.1689 0.9352 2709 SMP2_000230 Cc1ncc(CO)c(CO)c1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 K14 compound treatment 17.7472 7.7462 2.0785 18.5892 8.6984 2.0609 2.927 1.0 3076498 SMP2_000231 CC1CC2OC2/C=C\C=C/C(=O)Cc3c(Cl)c(O)cc(O)c3C(=O)O1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 K15 compound treatment 9.3726 -0.62839 -0.1686 8.5413 -1.3496 -0.3198 -0.3453 -0.9553 3076544 SMP2_000232 CCN(CC)CCCC(C)Nc1nc(C)cc(Nc2ccc3nc(C)cc(N)c3c2)n1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 K16 compound treatment 11.1047 1.1037 0.2961 8.9269 -0.96395 -0.2284 0.0479 0.1281 633 SMP2_000233 OC(=O)c1cc(ccc1O)N(Cc2ccccc2O)Cc3ccccc3O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 K17 compound treatment 22.683 12.682 3.4029 37.541 27.65 6.5513 7.0387 0.9534 3199700 SMP2_000234 CC1OC2OC3[C@@H](O)[C@@H](O)CO[C@H]3OC(=O)[C@@]45CCC(C)(C)C[C@H]5C6=CC[C@@H]7[C@@]8(C)C[C@H](O)[C@H](O[C@@H]9OC(CO)[C@@H](O)[C@H](O)C9O[C@@H]%10OC[C@@H](OC(=O)C[C@](C)(O)CC(=O)O[C@@H]1C(O[C@@H]%11OC[C@@H](O)[C@H](O)C%11O)[C@@H]2O)C(O)C%10O)[C@@](C)(CO)[C@@H]8CC[C@@]7(C)[C@]6(C)CC4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 K18 compound treatment 12.4413 2.4403 0.6548 9.5079 -0.38295 -0.0907 0.3989 0.6034 3076548 SMP2_000235 NC1N=CC(=N1)[C@H]2[C@H](CNC(=O)c3cc(Br)c[nH]3)[C@@H](CNC(=O)c4cc(Br)c[nH]4)[C@@H]2C5=NC(N)N=C5 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 K19 compound treatment 10.8551 0.85414 0.2292 8.5891 -1.3018 -0.3084 -0.056 -0.1458 3076550 SMP2_000236 CCCCC[C@H](O)[C@H](SCC(N)C(=O)O)/C=C/C=C/C=C\C/C=C\CCCC(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 K20 compound treatment 57.0861 47.085 12.6341 48.6737 38.783 9.189 15.4313 0.9878 3199701 SMP2_000237 CO[C@@H]1C[C@H](C)O[C@@H](CC[C@H](C)[C@H](O)[C@H](C)[C@H]2OC(=O)/C=C\C(=C/C[C@@H](O)C[C@@H]3CCC[C@@H](C[C@H](OC)[C@@H](C)[C@@H](O)C[C@@H](O)[C@H](C)[C@H](OC(=O)/C=C\C(=C/C[C@@H](O)C[C@@H]4CCC[C@@H](CC(OC)[C@@H](C)[C@@H](O)C[C@@H](O)[C@@H]2C)O4)\C)[C@@H](C)[C@@H](O)[C@@H](C)CC[C@H]5C[C@@H](C[C@H](C)O5)OC)O3)\C)C1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 K21 compound treatment 14.4832 4.4822 1.2027 10.2087 0.31787 0.0753 0.9037 0.7499 3076553 SMP2_000238 CC(C)CCC[C@@H](C)[C@H]1C[C@H](O)C2=C3CC[C@H]4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 K22 compound treatment 13.3666 3.3656 0.9031 13.0578 3.167 0.7504 1.1692 0.9958 2329 SMP2_000239 C[C@@H]1C[C@@]2(OC3(Cc4ccccc4)O[C@@H]2[C@@H]5C=C(COC(=O)Cc6ccc(O)cc6)C[C@@]7(O)[C@@H](C=C(C)C7=O)[C@@]15O3)C(=C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 K23 compound treatment 10.8607 0.85976 0.2307 9.1649 -0.72592 -0.172 0.0415 0.1442 1000035 SMP2_000240 O=C1c2ccccc2-c3n[nH]c4cccc1c34 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 K24 compound treatment 10.6088 0.60778 0.1631 9.2604 -0.63047 -0.1494 0.0097 0.0438 1100080 SMP2_000241 OCC1OC(C(O)C1O)n2cccnc2=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 L01 mock treatment 10.2996 0.29858 0.0801 8.7424 -1.1484 -0.2721 -0.1358 -0.4786 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 L02 mock treatment 7.9097 -2.0913 -0.5612 9.6812 -0.20965 -0.0497 -0.4319 -0.7667 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 L03 compound treatment 9.258 -0.74298 -0.1994 10.9428 1.0519 0.2492 0.0353 0.1105 155 SMP2_000242 CSCC[C@H](NC(=O)[C@H](Cc1ccccc1)NC[C@@H](NC[C@@H](N)CS)C(C)C)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 L04 compound treatment 10.2974 0.29644 0.0795 8.137 -1.7539 -0.4156 -0.2376 -0.5616 410 SMP2_000243 CC(=N)NCc1cccc(CN)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 L05 compound treatment 8.2834 -1.7176 -0.4609 8.0626 -1.8283 -0.4332 -0.6322 -0.9995 1000029 SMP2_000244 CSCCC(NC(=O)C(CC(C)C)NC(=O)C(Cc1c[nH]cn1)NC(=O)CNC(=O)C(NC(=O)C(C)NC(=O)C(Cc2c[nH]c3ccccc23)NC(=O)C(CCC(=O)N)NC(=O)C(CC(=O)N)NC(=O)CNC(=O)C(CC(C)C)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCC(=O)N)NC(=O)C4CCC(=O)N4)C(C)C)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 L06 compound treatment 10.8645 0.86353 0.2317 8.1453 -1.7455 -0.4136 -0.1286 -0.2713 3199703 SMP2_000245 CCC1OC2(C[C@@H]3CC(C/C=C(/C)\C(O[C@@H]4C[C@@H](C)C(O[C@H]5C[C@H](OC)C(O)[C@H](C)O5)[C@H](C4)OC)C(C)\C=C/C=C\6/COC7C6[C@@H](C=C(C)[C@H]7O)C(=O)O3)O2)C=CC1C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 L07 compound treatment 113.0371 103.04 27.6472 116.0578 106.17 25.1547 37.3366 0.9989 3076615 SMP2_000246 COC1/C=C\C=C(\C)/Cc2cc(OC)c(Cl)c(c2)N(C)C(=O)CC(OC(=O)C(C)C)C3(C)OC3C(C)C4CC1(O)NC(=O)O4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 L08 compound treatment 9.1647 -0.83627 -0.2244 9.7502 -0.14067 -0.0333 -0.1822 -0.8033 3199793 SMP2_000247 CCN1C[C@]2(COC)CCC(OC)[C@]3(C4C[C@@]5(O)[C@H](OC(=O)c6ccc(OC)cc6)C4[C@](C[C@H]5OC)(OC(=O)C)[C@H]7[C@H](OC)C32)[C@@H]71 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 L09 compound treatment 11.5862 1.5852 0.4253 8.76 -1.1308 -0.2679 0.1113 0.2214 1983 SMP2_000248 CC(C)c1cc2C3CC4C(C)(C)CCCC4(C(=O)O3)c2c(O)c1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 L10 compound treatment 10.5833 0.58236 0.1563 10.3783 0.48746 0.1155 0.1922 0.9889 3199794 SMP2_000249 C[C@@H]1C[C@H]2[C@@H](CC[C@@H]3C[C@@H](O)CC[C@@]32C)[C@]45O[C@@H]5[C@H](OC(=O)C)[C@@H](C14)c6ccc(=O)oc6 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 L11 compound treatment 20.3991 10.398 2.7901 20.8078 10.917 2.5866 3.8019 0.9993 3199795 SMP2_000250 CC1C2C(Cc3ccccc3)NC(=O)C24C(/C=C\CC(C)CC(C)(O)/C=C\C4O)C(O)C1=C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 L12 compound treatment 14.3729 4.3719 1.1731 11.9262 2.0353 0.4822 1.1705 0.9229 964 SMP2_000251 CN(C)N=Nc1[nH]cnc1C(=O)N 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 L13 compound treatment 9.3507 -0.65024 -0.1745 10.4612 0.57029 0.1351 -0.0278 -0.1261 3076672 SMP2_000252 CCCCCCCCCCCCC/C=C/[C@@H](O)[C@@H](N)CO[C@@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O)C(O)C2O)C(O)C1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 L14 compound treatment 12.175 2.174 0.5833 9.5065 -0.38432 -0.0911 0.3481 0.5896 1001931 SMP2_000253 C[C@@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@]34C)[C@@H]2CC[C@H]1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 L15 compound treatment 9.0012 -0.9998 -0.2683 8.3073 -1.5836 -0.3752 -0.455 -0.9865 831956 SMP2_000254 COc1c(O)ccc2c1cc([N+](=O)[O-])c3c(cc4OCOc4c23)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 L16 compound treatment 11.4575 1.4565 0.3908 9.3075 -0.58334 -0.1382 0.1786 0.4309 604 SMP2_000255 Oc1c(Br)cc(/C=C\2/C3C=C(I)C=CC3NC2=O)cc1Br 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 L17 compound treatment 11.0634 1.0624 0.2851 9.688 -0.20286 -0.0481 0.1676 0.5797 3199797 SMP2_000256 C[C@@]1([C@H]2[C@H](C(=O)O)[C@]3(CC4CC[C@H]3[C@@]52CC[C@@H]1O)CC4=C)C(=O)O5 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 L18 compound treatment 11.1627 1.1618 0.3117 10.7681 0.87724 0.2078 0.3674 0.9806 604 SMP2_000257 Oc1c(Br)cc(/C=C\2/C3C=C(I)C=CC3NC2=O)cc1Br 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 L19 compound treatment 9.7539 -0.24706 -0.0663 7.4465 -2.4443 -0.5792 -0.4564 -0.7829 97 SMP2_000258 CCCCC/C=C\C[C@@H]1O[C@H]1\C=C\C(O)C/C=C\CCCC(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 L20 compound treatment 11.8707 1.8697 0.5017 8.6877 -1.2032 -0.2851 0.1532 0.2654 3199798 SMP2_000259 CC1CC(OC2C(O)C(O)C(O)C(O)C2O)C(N)CC1NC(=N)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 L21 compound treatment 110.6638 100.66 27.0104 93.0014 83.111 19.6918 33.0235 0.9879 2108 SMP2_000260 COc1cc2C/C(=C\c3cc(C)c(O)c(C)c3)/C(=O)c2c(N)c1OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 L22 compound treatment 95.005 85.004 22.8088 117.9125 108.02 25.5941 34.226 0.9983 440 SMP2_000261 COC(=O)Nc1nc2cc(ccc2[nH]1)C(=O)c3cccs3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 L23 compound treatment 9.0503 -0.95069 -0.2551 8.4429 -1.448 -0.3431 -0.423 -0.9894 1201 SMP2_000262 COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 L24 compound treatment 10.2614 0.26043 0.0699 10.3855 0.49461 0.1172 0.1323 0.9695 648 SMP2_000263 Oc1cc(O)cc(/C=C/c2ccc(O)c(O)c2)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 M01 mock treatment 8.687 -1.314 -0.3526 10.5226 0.63177 0.1497 -0.1435 -0.3745 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 M02 mock treatment 10.0577 0.056708 0.0152 10.3148 0.42397 0.1005 0.0818 0.805 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 M03 compound treatment 9.9082 -0.092782 -0.0249 8.3674 -1.5234 -0.361 -0.2728 -0.7541 549 SMP2_000264 Nc1ncnc2nc(cc(c3cccc(Br)c3)c12)c4ccc(nc4)N5CCOCC5 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 M04 compound treatment 9.0262 -0.97479 -0.2616 8.9107 -0.9802 -0.2322 -0.3492 -0.9982 1092656 SMP2_000265 CC1OC(CC(=O)O)CC2=C1C(=O)c3c(O)cccc3C2=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 M05 compound treatment 8.9216 -1.0794 -0.2896 10.1069 0.21602 0.0512 -0.1686 -0.5733 1000067 SMP2_000266 NC(C(=O)NC1[C@H]2SCC(=C(N2C1=O)C(=O)O)Cl)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 M06 compound treatment 27.5531 17.552 4.7097 23.6069 13.716 3.2498 5.6282 0.9836 535 SMP2_000267 ONC(=O)CCCN1C(=O)c2cccc3cccc(C1=O)c23 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 M07 compound treatment 13.1697 3.1687 0.8502 14.2486 4.3578 1.0325 1.3313 0.9953 3177114 SMP2_000268 CN(C)c1cc2c(Nc3ccc4n(Cc5ccccc5)ncc4c3)ncnc2cn1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 M08 compound treatment 10.0711 0.0701 0.0188 8.8288 -1.062 -0.2516 -0.1646 -0.6524 241 SMP2_000269 CC[C@@H](C)[C@@H](CO[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCS(=O)(=O)C)C(=O)OC(C)C)NCC(N)CS 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 M09 compound treatment 8.8331 -1.1679 -0.3134 11.4475 1.5566 0.3688 0.0392 0.081 3076808 SMP2_000270 CC1(C)[C@H]2C[C@@H]1C(=C)[C@H](O)C2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 M10 compound treatment 9.5324 -0.46856 -0.1257 9.4202 -0.47066 -0.1115 -0.1678 -0.9982 220 SMP2_000271 CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 M11 compound treatment 9.9035 -0.097475 -0.0262 9.1166 -0.77424 -0.1834 -0.1482 -0.7998 1579 SMP2_000272 CC(Cc1ccc(O)c(O)c1)C(C)Cc2ccc(O)c(O)c2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 M12 compound treatment 25.6843 15.683 4.2083 7.9001 -1.9907 -0.4717 2.6422 0.6239 284 SMP2_000273 OC(=O)c1cc(ccc1O)N(Cc2ccccc2O)Cc3cc(O)ccc3O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 M13 compound treatment 10.5391 0.53816 0.1444 8.0865 -1.8044 -0.4275 -0.2002 -0.4436 3076815 SMP2_000274 CC(O)CCCCn1c(=O)n(C)c2ncn(C)c2c1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 M14 compound treatment 9.7651 -0.2359 -0.0633 9.0153 -0.87552 -0.2074 -0.1914 -0.8827 1102317 SMP2_000275 COc1ccc(cc1)C23Oc4cc(OC)cc(OC)c4C3(O)C(O)C(C2c5ccccc5)C(=O)N(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 M15 compound treatment 10.0048 0.0037851 0.001 8.2499 -1.641 -0.3888 -0.2742 -0.7053 1907751 SMP2_000276 CN/C(=N\c1ccc(cc1)C2=NNC(=O)CC2C)/NC#N 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 M16 compound treatment 14.5914 4.5904 1.2317 12.9176 3.0267 0.7171 1.3781 0.9669 536 SMP2_000277 ONC(=O)CCCCCN1C(=O)c2cccc3cccc(C1=O)c23 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 M17 compound treatment 11.0336 1.0326 0.2771 11.4738 1.583 0.3751 0.4611 0.9889 3076873 SMP2_000278 COc1cc(O)c(CC=C(C)C)c(O)c1C(=O)/C=C/c2ccc(O)cc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 M18 compound treatment 318.9457 308.94 82.8978 288.544 278.65 66.0228 105.3028 0.9936 536 SMP2_000279 ONC(=O)CCCCCN1C(=O)c2cccc3cccc(C1=O)c23 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 M19 compound treatment 13.1293 3.1283 0.8394 13.2105 3.3196 0.7865 1.1497 0.9995 3199800 SMP2_000280 CC(C)CCC[C@@H](C)[C@H]1CC(=O)[C@H]2[C@@H]3CC[C@H]4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 M20 compound treatment 9.974 -0.026975 -0.0072 7.893 -1.9979 -0.4734 -0.3398 -0.7178 3199801 SMP2_000281 CO[C@@H]([C@H](O)CC(=O)[C@@H](C)[C@@H](O)CC[C@@H](C)C1O[C@]2(CC[C@@H](C)C(CC[C@H](C)C(=O)C)O2)CC[C@@H]1C)[C@H](OC(=O)C[C@@H](O)C3=C(C)C(=O)OC3=O)C(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 M21 compound treatment 8.797 -1.204 -0.3231 7.8463 -2.0446 -0.4844 -0.571 -0.9806 257 SMP2_000282 CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)C[C@H](O)[C@@H]1CC(=O)CCCCC(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 M22 compound treatment 9.88 -0.12099 -0.0325 8.2853 -1.6055 -0.3804 -0.2919 -0.7647 3076883 SMP2_000283 CCC(C)C1NC(=O)C(Cc2ccc(O)cc2)NC(=O)C(N)CSSCC(NC(=O)C(CC(=O)N)NC(=O)C(CCC(=O)N)NC1=O)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 M23 compound treatment 9.7876 -0.21336 -0.0572 8.0649 -1.826 -0.4326 -0.3464 -0.7938 2059 SMP2_000284 CC(C)CC(N)C(O)C(=O)NC(C(C)C)C(=O)NC(C(C)C)C(=O)NC(CC(=O)O)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 M24 compound treatment 9.4556 -0.54543 -0.1464 8.6512 -1.2397 -0.2937 -0.3112 -0.9482 2350 SMP2_000285 Cc1c(C)c2OC(C)(CN3CCN(CC3)c4cc(nc(n4)N5CCCC5)N6CCCC6)CCc2c(C)c1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 N01 mock treatment 9.3114 -0.6896 -0.185 8.948 -0.94286 -0.2234 -0.2888 -0.9956 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 N02 mock treatment 10.5727 0.57174 0.1534 10.6275 0.73659 0.1745 0.2319 0.9979 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 N03 compound treatment 9.2155 -0.78547 -0.2108 10.2765 0.3856 0.0914 -0.0844 -0.3675 3076955 SMP2_000286 CC(C)(C)[C@]1(O)C[C@@H]2OC(=O)CC23C(=O)O[C@@H]4OC(=O)[C@H](O)C413 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 N04 compound treatment 13.2972 3.2962 0.8845 9.3265 -0.56439 -0.1337 0.5309 0.5935 907302 SMP2_000287 CN1CC[C@]2(C)C1N(C)c3ccc(O)cc32 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 N05 compound treatment 9.8903 -0.11064 -0.0297 9.0557 -0.83519 -0.1979 -0.1609 -0.8042 3199802 SMP2_000288 CSC(=S)NCc1c[nH]c2ccccc12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 N06 compound treatment 7.8694 -2.1316 -0.572 8.095 -1.7959 -0.4255 -0.7053 -0.9894 398 SMP2_000289 OC[C@H]1NC[C@@H](O)[C@@H](O)[C@@H]1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 N07 compound treatment 11.9848 1.9838 0.5323 12.3499 2.459 0.5826 0.7884 0.999 1975 SMP2_000290 C[C@@]12CC[C@H]3[C@@H](CC[C@@H]4C[C@@H](O)CC[C@@]43C)[C@@]2(O)CC[C@@H]1c5ccc(=O)oc5 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 N08 compound treatment 11.089 1.088 0.2919 8.7769 -1.114 -0.2639 0.0198 0.0503 1026746 SMP2_000291 OCc1cc(O)c2C(=O)c3c(O)cccc3C(=O)c2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 N09 compound treatment 9.4679 -0.53311 -0.143 7.9662 -1.9247 -0.456 -0.4236 -0.8863 810 SMP2_000292 CCCCC[C@@H]1[C@@H](OC(=O)CC(C)C)[C@H](C)OC(=O)[C@@H](NC(=O)c2cccc(NC=O)c2O)[C@@H](C)OC1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 N10 compound treatment 9.5021 -0.49891 -0.1339 9.3935 -0.4974 -0.1179 -0.178 -0.998 3176068 SMP2_000293 CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO)NC(=O)CCCCC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 N11 compound treatment 8.9833 -1.0177 -0.2731 9.7295 -0.16135 -0.0382 -0.2201 -0.7983 2018 SMP2_000294 NC1=NC(=O)/C(=C/2\CCNC(=O)c3[nH]ccc23)/N1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 N12 compound treatment 8.0155 -1.9855 -0.5328 10.5867 0.69583 0.1649 -0.2601 -0.4665 1090 SMP2_000295 CCC[C@@H]1C[C@H](N(C)C1)C(=O)NC(C(C)Cl)C2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 N13 compound treatment 9.2476 -0.75343 -0.2022 8.3824 -1.5085 -0.3574 -0.3957 -0.9636 3199804 SMP2_000296 CC(C)CC(NC(=O)C(Cc1ccc(OP(O)(O)O)cc1)NC(=O)C2CCCN2C(=O)C)C(=O)NC(CCCCN)C(=O)NC(C(C)O)C(=O)NC(CCCCN)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 N14 compound treatment 53.6542 43.653 11.7133 45.3323 35.441 8.3973 14.2203 0.9867 1000674 SMP2_000297 COc1cccc2C(=O)c3c(O)c4CC(O)(CC(OC5CC(N)C(O)C(C)O5)c4c(O)c3C(=O)c12)C(=O)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 N15 compound treatment 24.8728 14.872 3.9905 24.3784 14.488 3.4326 5.2489 0.9972 1084811 SMP2_000298 Cc1c2[nH]c3ccc(O)cc3c2c(C)c4cnccc14 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 N16 compound treatment 11.1088 1.1078 0.2973 10.4464 0.5555 0.1316 0.3033 0.9328 3077040 SMP2_000299 CC(C)[C@H]1CN2CCC[C@H]2[C@@]3(O)O[C@](CC(=O)[C@H]4CN(C)[C@@H]5Cc6c[nH]c7cccc(C5=C4)c67)(C(C)C)C(=O)N13 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 N17 compound treatment 9.1557 -0.84531 -0.2268 8.0806 -1.8103 -0.4289 -0.4637 -0.9556 1108916 SMP2_000300 NCCCCC(NC(=O)C(Cc1c[nH]cn1)NC(=O)CN)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 N18 compound treatment 14.0057 4.0047 1.0746 13.643 3.7521 0.889 1.3885 0.9956 3177114 SMP2_000301 CN(C)c1cc2c(Nc3ccc4n(Cc5ccccc5)ncc4c3)ncnc2cn1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 N19 compound treatment 9.4322 -0.56877 -0.1526 7.8176 -2.0732 -0.4912 -0.4553 -0.8851 3076041 SMP2_000302 COc1cc(/C=C/c2cccc[n+]2C)ccc1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 N20 compound treatment 10.0305 0.029555 0.0079 10.2866 0.39573 0.0938 0.0719 0.7642 1734 SMP2_000303 Nc1nnc(c(N)n1)c2cccc(Cl)c2Cl 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 N21 compound treatment 9.6711 -0.32993 -0.0885 7.8905 -2.0004 -0.474 -0.3977 -0.8249 3076048 SMP2_000304 OC[C@H]1O[C@@H](Oc2c[nH]c3ccccc23)[C@H](O)[C@@H](O)[C@@H]1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 N22 compound treatment 15.332 5.331 1.4305 8.4317 -1.4592 -0.3457 0.767 0.5212 1000089 SMP2_000305 COC1C(C)OC(OC2CC(C)(O)C(C(=O)OC)c3cc4C(=O)c5c6OC7OC(C)(C(O)C(C7O)N(C)C)c6cc(O)c5C(=O)c4c(O)c23)C(OC)C1(C)OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 N23 compound treatment 27.3524 17.351 4.6558 16.3251 6.4343 1.5245 4.3702 0.892 628 SMP2_000306 Brc1ccc2[nH]c-3c(CC(=O)Nc4ccccc34)c2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 N24 compound treatment 10.9681 0.9671 0.2595 10.9385 1.0476 0.2482 0.359 0.9998 1273 SMP2_000307 C[C@@]12CC(=O)C3C(CCC4=CC(=O)C=C[C@]34C)C2CC[C@]1(O)C(=O)CO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 O01 mock treatment 8.4389 -1.5621 -0.4192 7.8535 -2.0374 -0.4827 -0.6377 -0.9975 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 O02 mock treatment 8.8676 -1.1334 -0.3041 9.3297 -0.5612 -0.133 -0.3091 -0.9312 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 O03 compound treatment 8.0179 -1.9831 -0.5321 9.1188 -0.77203 -0.1829 -0.5056 -0.8986 1059696 SMP2_000308 CC1CCC2(C)CCC3(C)C(=CCC4C5(C)CCC(O)C(C)(C)C5CCC43C)C2C1C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 O04 compound treatment 10.3708 0.36977 0.0992 10.9718 1.081 0.2561 0.2513 0.9148 988 SMP2_000309 COc1ccc2[nH]cc(CCNC(=O)C)c2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 O05 compound treatment 7.0774 -2.9236 -0.7845 10.89 0.99914 0.2367 -0.3873 -0.4727 413 SMP2_000310 CCCCCC[C@@H]([C@@H](C)O)n1cnc2c(N)ncnc12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 O06 compound treatment 10.1927 0.19171 0.0514 9.0614 -0.82949 -0.1965 -0.1026 -0.505 3199805 SMP2_000311 NC(=O)OC[C@H]1[C@@H]2NC(=N)N[C@]23N(CCC3(O)O)C(=N)N1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 O07 compound treatment 8.873 -1.128 -0.3027 9.3749 -0.51596 -0.1223 -0.3005 -0.9205 2081802 SMP2_000312 CC[C@@]1(O)C(=O)OCc2c1cc3-c4nc5ccc(O)c(CN(C)C)c5cc4Cn3c2=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 O08 compound treatment 8.3277 -1.6733 -0.449 8.4387 -1.4522 -0.3441 -0.5608 -0.9914 1080649 SMP2_000313 CC1(CC2(O)OC3O1)C4(CC2C34COC(=O)c5ccccc5)OC6OC(CO)C(O)C(O)C6O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 O09 compound treatment 10.0165 0.015545 0.0042 8.6746 -1.2163 -0.2882 -0.2008 -0.6968 3076119 SMP2_000314 CNc1ccc2ccccc2c1N=Nc3ccc(N=Nc4ccccc4)cc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 O10 compound treatment 11.721 1.72 0.4615 9.0837 -0.80713 -0.1912 0.1911 0.3826 1072985 SMP2_000315 CC1C(O)C2(O)C(C3C=C(CO)CC4(O)C(C=C(C)C4=O)C13O)C2(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 O11 compound treatment 9.3338 -0.66721 -0.179 8.2214 -1.6695 -0.3956 -0.4063 -0.9358 3076122 SMP2_000316 CC(=C[C@H](C=C)C(C)(C)O)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 O12 compound treatment 29.0872 19.086 5.1213 24.6123 14.721 3.488 6.0877 0.9825 3001166 SMP2_000317 C[C@H]/1CC[C@@H]2C[C@H](C[C@@](O)(O2)[C@@H]3CSC(=O)N3)OC(=O)\C=C(\C)/CC/C=C1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 O13 compound treatment 9.5698 -0.43114 -0.1157 8.9066 -0.98425 -0.2332 -0.2467 -0.9477 189 SMP2_000318 CCCCCC(O)c1cccc(OCc2ccc3ccccc3n2)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 O14 compound treatment 10.7549 0.7539 0.2023 11.2334 1.3426 0.3181 0.368 0.9761 3199895 SMP2_000319 CSCCC(NC(=O)C(CC(C)C)NC(=O)CNC(=O)C(Cc1ccc(O)cc1)NC(=O)C(Cc2ccccc2)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCC(=O)O)NC(=O)C3CCCN3C(=O)C(CC(=O)N)NC(=O)C4CCCN4C(=O)C(N)CCCCN)C(=O)N 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 O15 compound treatment 24.1164 14.115 3.7875 20.7458 10.855 2.5719 4.4968 0.9822 2305 SMP2_000320 COC1=C(N)C(=O)c2nc(ccc2C1=O)c3nc(C(=O)O)c(C)c(c3N)c4ccc(OC)c(OC)c4O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 O16 compound treatment 10.5705 0.56948 0.1528 7.9443 -1.9465 -0.4612 -0.2181 -0.4488 3076126 SMP2_000321 Nc1ncnc2n([C@@H]3OC4COP(O)(S)O[C@@H]4C3O)c(nc12)N5CCCCC5 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 O17 compound treatment 7.6752 -2.3258 -0.6241 7.3962 -2.4946 -0.5911 -0.8592 -0.9996 2080871 SMP2_000322 CC1=C(O)C(=O)[C@@H]2O[C@@H]2C1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 O18 compound treatment 8.1367 -1.8642 -0.5002 8.366 -1.5248 -0.3613 -0.6092 -0.9872 3076175 SMP2_000323 COc1cc(ccc1O)[C@H]2Oc3cc(ccc3O[C@@H]2CO)[C@H]4Oc5cc(O)cc(O)c5C(=O)[C@@H]4O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 O19 compound treatment 12.7934 2.7924 0.7493 28.4026 18.512 4.3861 3.6312 0.8161 3199896 SMP2_000324 CC(C)CCC[C@@H](C)[C@H]1CC(=O)C2=C3CC[C@H]4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 O20 compound treatment 8.357 -1.644 -0.4411 9.1988 -0.69211 -0.164 -0.4279 -0.9092 3076177 SMP2_000325 COc1cc(ccc1O)c2cc(=O)c3c(O)cc(OC4OC(CO)C(O)C(O)C4OS(=O)(=O)O)cc3o2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 O21 compound treatment 13.8592 3.8582 1.0353 13.8115 3.9206 0.9289 1.3889 0.9985 2119025 SMP2_000326 Nc1nc(S)c2nc[nH]c2n1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 O22 compound treatment 14.096 4.095 1.0988 13.035 3.1442 0.745 1.3037 0.9821 2081802 SMP2_000327 CC[C@@]1(O)C(=O)OCc2c1cc3-c4nc5ccc(O)c(CN(C)C)c5cc4Cn3c2=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 O23 compound treatment 9.9054 -0.09556 -0.0256 8.5462 -1.3447 -0.3186 -0.2434 -0.7616 316 SMP2_000328 CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)NCCO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 O24 compound treatment 8.5153 -1.4857 -0.3986 9.8873 -0.0035573 -8.0E-4 -0.2825 -0.7086 1004963 SMP2_000329 CC1CCC2(CCC3(C)C(=CCC4C5(C)CCC(O)C(C)(C)C5CCC43C)C2C1C)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 P01 mock treatment 8.7151 -1.2859 -0.345 12.9043 3.0134 0.714 0.2609 0.329 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 P02 mock treatment 9.119 -0.88193 -0.2366 8.432 -1.4589 -0.3457 -0.4117 -0.9829 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 P03 compound treatment 7.9633 -2.0377 -0.5468 7.6252 -2.2656 -0.5368 -0.7662 -1.0 3199897 SMP2_000330 CS[C@]12CC3=CC=CC(O)[C@H]3N2C(=O)[C@@](CO)(SC)N(C)C1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 P04 compound treatment 9.0187 -0.98231 -0.2636 27.3326 17.442 4.1326 2.7358 0.6607 2060488 SMP2_000331 CC(=CCC[C@@](C)(O)C=C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 P05 compound treatment 11.656 1.655 0.4441 9.2009 -0.68999 -0.1635 0.1984 0.4193 1968 SMP2_000332 C[C@@H]1CC2OC3CC4OC(=O)C=C(C)C4O[C@@]3(C)CC2OC5CC[C@@]6(C)O[C@@]7(C)CC8OC9CC%10O[C@@]%11(C)[C@@H](O)C[C@@H](CC(=C)C=O)OC%11CC%10OC9C=CC[C@]8(C)OC7CC6OC15 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 P06 compound treatment 10.5255 0.52453 0.1407 9.7728 -0.11803 -0.028 0.0797 0.5557 1000053 SMP2_000333 OC[C@H]1NC[C@H](O)[C@@H](O)[C@@H]1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 P07 compound treatment 11.6815 1.6805 0.4509 8.8809 -1.01 -0.2393 0.1496 0.2931 1977 SMP2_000334 CC12CCc3occc3[C@H]2CCC4(CC5CC[C@H]41)C[C@]5(O)CO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 P08 compound treatment 9.5859 -0.41506 -0.1114 8.7516 -1.1393 -0.2699 -0.2696 -0.9233 1693 SMP2_000335 NCCCNCCSP(=O)(O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 P09 compound treatment 11.8744 1.8734 0.5027 11.1593 1.2684 0.3005 0.568 0.9698 3199899 SMP2_000336 CC[C@@H]1[C@H](O)[C@@H](C)C/C(=C\C=C/C(=C(\OC(=O)\C(=C/C(=C\[C@H](C)C1O)/C)\OC)/[C@@H](C)[C@@H](O)[C@H](C)[C@@]2(O)C[C@@H](OC3CC(O)C(OC(=O)N)C(C)O3)[C@H](C)[C@H](O2)/C=C/C)/OC)/C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 P10 compound treatment 10.0568 0.055808 0.015 8.6035 -1.2873 -0.305 -0.2051 -0.6716 446 SMP2_000337 COc1cc(CNC(=O)CCCC/C=C/C(C)C)ccc1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 P11 compound treatment 9.7195 -0.28147 -0.0755 10.3908 0.49993 0.1184 0.0304 0.2161 360 SMP2_000338 Oc1ccc(cc1)c2cc(=O)c3c(O)cc(O)cc3o2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 P12 compound treatment 9.305 -0.69598 -0.1867 9.1711 -0.71974 -0.1705 -0.2526 -0.999 3068886 SMP2_000339 CC(C)/N=c/1\cc2n(c3ccc(Cl)cc3)c4ccccc4nc2cc1Nc5ccc(Cl)cc5 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 P13 compound treatment 42.7001 32.699 8.774 49.6432 39.752 9.4187 12.8642 0.9994 1817 SMP2_000340 CC(=O)O[C@@]12CO[C@H]2C[C@@H](O)[C@@]3(C)[C@H]1[C@H](OC(=O)c4ccccc4)[C@@]5(O)C[C@H](OC(=O)[C@@H](O)[C@H](NC(=O)OC(C)(C)C)c6ccccc6)C(=C([C@H](O)C3=O)C5(C)C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 P14 compound treatment 8.801 -1.2 -0.322 8.7576 -1.1332 -0.2685 -0.4175 -0.9959 3076236 SMP2_000341 COc1ccc(C=Cc2cc(O)cc(O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)c2)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 P15 compound treatment 158.952 148.95 39.9674 136.4543 126.56 29.9873 49.4655 0.99 832320 SMP2_000342 CC[C@H](C)[C@H](NC(=O)[C@H]([C@@H](C)CC)N(C)C(=O)C)C(=O)N[C@@H](C(=O)C)C(=O)N[C@@H](CC(C)C)[C@@]1(O)O[C@H](C)[C@H](N[C@@]1(C)CO)C=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 P16 compound treatment 10.806 0.80499 0.216 13.036 3.1451 0.7452 0.6797 0.876 2069 SMP2_000343 CC12CCC3C(CCC4=C(O)C(=O)CCC34C)C2CCC1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 P17 compound treatment 10.5381 0.53715 0.1441 9.1842 -0.70667 -0.1674 -0.0165 -0.0746 3199902 SMP2_000344 CCC(C)C(NC(=O)C(Cc1ccc(O)cc1)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCCNC(=N)N)NC(=O)C2CCCN2C(=O)C(C)NC(=O)C(N)CO)C(=O)N3CCCC3C(=O)NC(CC(C)C)C(=O)NC(Cc4ccccc4)C(=O)NCC(=O)NC(Cc5ccccc5)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 P18 compound treatment 16.4269 6.4259 1.7242 15.9566 6.0657 1.4372 2.2354 0.9959 2100 SMP2_000345 COC(=O)CC(O)(CCCC(C)(C)O)C(=O)O[C@H]1[C@H]2c3cc4OCOc4cc3CCN5CCC[C@]25C=C1OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 P19 compound treatment 11.2115 1.2105 0.3248 8.4837 -1.4072 -0.3334 -0.0061 -0.0131 613 SMP2_000346 Oc1cc(/C=C/c2ccc(O)c(O)c2)oc(=O)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 P20 compound treatment 10.6232 0.62224 0.167 7.7257 -2.1652 -0.513 -0.2447 -0.4536 3076242 SMP2_000347 CC1(C)O[C@H]2CC(=O)OC[C@]23[C@H]4CC[C@@](C)([C@@H](OC5OC(CO)C(O)C(O)C5O)c6ccoc6)[C@@]7(O[C@@H]7C(=O)O)[C@]4(C)C(=O)C[C@]13C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 P21 compound treatment 12.2556 2.2547 0.605 11.0552 1.1644 0.2759 0.6229 0.9368 3199903 SMP2_000348 C/C=C(/C)\C(=O)O[C@H]1C(=C[C@]2([C@H](C)C[C@H]3[C@@H](C3(C)C)[C@]4(C)C=C(CO)[C@@H](O)[C@@]12O)C4=O)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 P22 compound treatment 9.3407 -0.66031 -0.1772 8.6066 -1.2842 -0.3043 -0.3404 -0.9669 1048361 SMP2_000349 c1ccc2c(c1)[nH]c3cnccc32 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 P23 compound treatment 8.249 -1.752 -0.4701 7.879 -2.0119 -0.4767 -0.6695 -1.0 832145 SMP2_000350 OC[C@@H]1[C@@H](O)[C@H](O)[C@H](O)[C@H]2NC(=O)C(=O)N21 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2099 P24 compound treatment 7.7457 -2.2553 -0.6051 9.9163 0.02546 0.006 -0.4236 -0.7 2260 SMP2_000351 Cc1cc(O)c2c(=O)c3c(O)cc(O)c4c5c(O)cc(O)c6c(=O)c7c(O)cc(CO)c8c1c2c(c34)c(c65)c78 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 A01 compound treatment 9.453 -0.0025644 -7.0E-4 12.4197 2.9621 0.7018 0.4958 0.7064 3214214 Ald1-H_000593 NNC(=O)CCCCCC(=O)NO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 A02 compound treatment 11.605 2.1494 0.5767 9.8424 0.38477 0.0912 0.4723 0.8088 3214215 Ald1-H_000594 NNC(=O)CCCCCC(=O)Nc1ccccc1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 A03 compound treatment 235.048 225.59 60.5322 251.1165 241.66 57.2575 83.29 0.9996 3214216 Ald1-H_000595 ONC(=O)CCCCCC(=O)N/N=C/c1ccccc1OCC=C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 A04 compound treatment 34.5962 25.141 6.7459 39.0732 29.616 7.017 9.7318 0.9998 3214218 Ald1-H_000596 Oc1ccccc1NC(=O)CCCCCC(=O)N/N=C/c2ccccc2OCC=C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 A05 compound treatment 285.59 276.13 74.094 298.4783 289.02 68.4792 100.8145 0.9992 3214220 Ald1-H_000597 COc1ccc(/C=N/NC(=O)CCCCCC(=O)NO)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 A06 compound treatment 31.3443 21.889 5.8733 32.9255 23.468 5.5604 8.0848 0.9996 3214222 Ald1-H_000598 COc1ccc(/C=N/NC(=O)CCCCCC(=O)Nc2ccccc2O)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 A07 compound treatment 229.952 220.5 59.1649 241.2175 231.76 54.9121 80.6646 0.9993 3214224 Ald1-H_000599 ONC(=O)CCCCCC(=O)N/N=C/c1ccccc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 A08 compound treatment 19.1877 9.7321 2.6114 18.1479 8.6903 2.059 3.3025 0.9931 3214226 Ald1-H_000600 Oc1ccccc1NC(=O)CCCCCC(=O)N/N=C/c2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 A09 compound treatment 149.0983 139.64 37.4697 180.6403 171.18 40.5592 55.1748 0.9992 3214228 Ald1-H_000601 ONC(=O)CCCCCC(=O)N/N=C/c1ccc2OCCOc2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 A10 compound treatment 39.1408 29.685 7.9653 40.2126 30.755 7.2869 10.785 0.999 3214230 Ald1-H_000602 Oc1ccccc1NC(=O)CCCCCC(=O)N/N=C/c2ccc3OCCOc3c2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 A11 compound treatment 14.3737 4.9181 1.3197 14.6797 5.2221 1.2373 1.808 0.9995 3214232 Ald1-H_000603 ONC(=O)CCCCCC(=O)N/N=C/COCc1ccccc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 A12 compound treatment 11.3842 1.9286 0.5175 11.0948 1.6372 0.3879 0.6402 0.9899 3214234 Ald1-H_000604 Oc1ccccc1NC(=O)CCCCCC(=O)N/N=C/COCc2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 A13 mock treatment 9.7061 0.25056 0.0672 10.2181 0.76054 0.1802 0.175 0.9097 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 A14 mock treatment 9.9756 0.52006 0.1395 11.3966 1.939 0.4594 0.4235 0.8821 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 A15 compound treatment 277.0197 267.56 71.7943 320.9622 311.5 73.8065 102.9553 0.9999 3214236 Ald1-H_000605 ONC(=O)CCCCCC(=O)N/N=C/c1ccc(cc1)c2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 A16 compound treatment 13.2872 3.8316 1.0281 18.892 9.4344 2.2354 2.3076 0.9379 3214238 Ald1-H_000606 Oc1ccccc1NC(=O)CCCCCC(=O)N/N=C/c2ccc(cc2)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 A17 compound treatment 58.143 48.687 13.0641 101.8515 92.394 21.8914 24.7172 0.9696 3214240 Ald1-H_000607 ONC(=O)CCCCCC(=O)N/N=C/c1ccccc1Br 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 A18 compound treatment 48.4315 38.976 10.4582 51.7615 42.304 10.0233 14.4826 0.9998 3214242 Ald1-H_000608 Oc1ccccc1NC(=O)CCCCCC(=O)N/N=C/c2ccccc2Br 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 A19 compound treatment 34.5068 25.051 6.7219 51.213 41.755 9.8933 11.7487 0.9823 3214244 Ald1-H_000609 ONC(=O)CCCCCC(=O)N/N=C/c1cccc(Br)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 A20 compound treatment 11.5585 2.1029 0.5643 12.0058 2.5482 0.6038 0.8259 0.9994 3214246 Ald1-H_000610 Oc1ccccc1NC(=O)CCCCCC(=O)N/N=C/c2cccc(Br)c2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 A21 compound treatment 219.0895 209.63 56.2502 260.0928 250.64 59.3843 81.7659 0.9996 3214248 Ald1-H_000611 ONC(=O)CCCCCC(=O)N/N=C/c1ccc(Br)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 A22 compound treatment 9.5913 0.13569 0.0364 11.9805 2.5229 0.5978 0.4484 0.7488 3214250 Ald1-H_000612 Oc1ccccc1NC(=O)CCCCCC(=O)N/N=C/c2ccc(Br)cc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 A23 compound treatment 11.3746 1.9191 0.5149 15.6208 6.1632 1.4603 1.3967 0.902 3214252 Ald1-H_000613 ONC(=O)CCCCCC(=O)N/N=C/C(=C/c1ccccc1)/Br 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 A24 compound treatment 14.8239 5.3683 1.4405 17.034 7.5764 1.7951 2.2879 0.994 3214254 Ald1-H_000614 Oc1ccccc1NC(=O)CCCCCC(=O)N/N=C/C(=C/c2ccccc2)/Br 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 B01 compound treatment 31.8909 22.435 6.02 35.2533 25.796 6.1119 8.5785 1.0 3214256 Ald1-H_000615 Oc1ccccc1NC(=O)CCCCCC(=O)N/N=C/c2c(O)ccc3ccccc23 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 B02 compound treatment 16.2552 6.7996 1.8245 13.9578 4.5002 1.0663 2.0441 0.9673 3214258 Ald1-H_000616 ONC(=O)CCCCCC(=O)N/N=C/c1c(O)ccc2ccccc12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 B03 compound treatment 14.4314 4.9758 1.3351 15.5088 6.0512 1.4337 1.9579 0.9994 3214260 Ald1-H_000617 Oc1ccccc1NC(=O)CCCCCC(=O)N/N=C/c2ccc(O)c3ccccc23 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 B04 compound treatment 13.3483 3.8927 1.0445 11.6798 2.2222 0.5265 1.1109 0.9497 3214262 Ald1-H_000618 ONC(=O)CCCCCC(=O)N/N=C/c1ccc(O)c2ccccc12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 B05 compound treatment 11.5605 2.105 0.5648 10.4 0.94241 0.2233 0.5573 0.9176 3214264 Ald1-H_000619 Oc1ccccc1NC(=O)CCCCCC(=O)N/N=C/c2ccc([N+](=O)[O-])c(O)c2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 B06 compound treatment 10.8526 1.397 0.3749 13.5118 4.0542 0.9606 0.9443 0.9158 3214266 Ald1-H_000620 ONC(=O)CCCCCC(=O)N/N=C/c1ccc([N+](=O)[O-])c(O)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 B07 compound treatment 11.3269 1.8714 0.5021 10.328 0.87045 0.2062 0.5009 0.9227 3214268 Ald1-H_000621 Oc1ccc([N+](=O)[O-])c(/C=N/NC(=O)CCCCCC(=O)Nc2ccccc2O)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 B08 compound treatment 10.7238 1.2682 0.3403 12.1969 2.7393 0.649 0.6996 0.9546 3214270 Ald1-H_000622 ONC(=O)CCCCCC(=O)N/N=C/c1cc(O)ccc1[N+](=O)[O-] 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 B09 compound treatment 12.9868 3.5312 0.9475 15.285 5.8274 1.3807 1.6463 0.9831 3214272 Ald1-H_000623 Oc1ccccc1NC(=O)CCCCCC(=O)N/N=C/c2ccc(cc2)n3ccnc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 B10 compound treatment 11.1495 1.6939 0.4545 11.8354 2.3778 0.5634 0.7198 0.9943 3214274 Ald1-H_000624 ONC(=O)CCCCCC(=O)N/N=C/c1ccc(cc1)n2ccnc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 B11 compound treatment 156.2763 146.82 39.3958 181.0635 171.61 40.6595 56.6076 0.9999 3214276 Ald1-H_000625 Oc1ccccc1NC(=O)CCCCCC(=O)N/N=C/c2c[nH]c3ccccc23 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 B12 compound treatment 14.6912 5.2356 1.4049 17.1722 7.7147 1.8279 2.2859 0.9915 3214278 Ald1-H_000626 ONC(=O)CCCCCC(=O)N/N=C/c1c[nH]c2ccccc12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 B13 mock treatment 10.8243 1.3687 0.3673 10.2786 0.82103 0.1945 0.3972 0.9558 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 B14 mock treatment 9.5716 0.11602 0.0311 9.7877 0.33012 0.0782 0.0773 0.9185 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 B15 compound treatment 15.6994 6.2438 1.6754 17.3988 7.9412 1.8816 2.5151 0.9983 3214280 Ald1-H_000627 Oc1ccccc1NC(=O)CCCCCC(=O)N/N=C/c2ccc(I)cc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 B16 compound treatment 284.1475 274.69 73.7069 279.943 270.49 64.0876 97.4354 0.9976 3214282 Ald1-H_000628 ONC(=O)CCCCCC(=O)N/N=C/c1ccc(I)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 B17 compound treatment 11.5425 2.0869 0.56 11.5821 2.1245 0.5034 0.7519 0.9986 3214284 Ald1-H_000629 C/C=C(/C)\C=N\NC(=O)CCCCCC(=O)Nc1ccccc1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 B18 compound treatment 18.7598 9.3042 2.4966 22.2168 12.759 3.0231 3.903 0.9955 3214286 Ald1-H_000630 C/C=C(/C)\C=N\NC(=O)CCCCCC(=O)NO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 B19 compound treatment 18.1911 8.7355 2.344 22.9627 13.505 3.1998 3.9201 0.9883 3214288 Ald1-H_000631 Oc1ccccc1NC(=O)CCCCCC(=O)N/N=C/c2ccccc2[N+](=O)[O-] 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 B20 compound treatment 13.7898 4.3342 1.163 23.7893 14.332 3.3957 3.2235 0.8981 3214290 Ald1-H_000632 ONC(=O)CCCCCC(=O)N/N=C/c1ccccc1[N+](=O)[O-] 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 B21 compound treatment 16.9553 7.4997 2.0124 17.1416 7.6841 1.8206 2.7103 0.9988 3214292 Ald1-H_000633 Cc1ccc(/C=N/NC(=O)CCCCCC(=O)Nc2ccccc2O)o1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 B22 compound treatment 123.935 114.48 30.7178 153.4375 143.98 34.1139 45.8429 0.9986 3214294 Ald1-H_000634 Cc1ccc(/C=N/NC(=O)CCCCCC(=O)NO)o1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 B23 compound treatment 10.023 0.56742 0.1523 10.6352 1.1776 0.279 0.305 0.9594 3214296 Ald1-H_000635 Cc1[nH]cnc1/C=N/NC(=O)CCCCCC(=O)Nc2ccccc2O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 B24 compound treatment 10.8518 1.3962 0.3746 10.0525 0.59488 0.1409 0.3646 0.9108 3214298 Ald1-H_000636 Cc1[nH]cnc1/C=N/NC(=O)CCCCCC(=O)NO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 C01 compound treatment 12.4631 3.0076 0.807 10.0952 0.63765 0.1511 0.6775 0.8252 3214300 Ald1-H_000637 ONC(=O)CCCCCC(=O)N/N=C/c1ccc(Br)o1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 C02 compound treatment 25.9606 16.505 4.4287 31.1589 21.701 5.1418 6.7674 0.9972 3214302 Ald1-H_000638 Oc1ccccc1NC(=O)CCCCCC(=O)N/N=C/c2ccc(Br)o2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 C03 compound treatment 12.2463 2.7907 0.7488 12.4201 2.9625 0.7019 1.0258 0.9995 3214304 Ald1-H_000639 ONC(=O)CCCCCC(=O)N/N=C/c1ccc(O)cc1Br 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 C04 compound treatment 155.3738 145.92 39.1536 176.0673 166.61 39.4757 55.5993 1.0 3214306 Ald1-H_000640 Oc1ccc(/C=N/NC(=O)CCCCCC(=O)Nc2ccccc2O)c(Br)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 C05 compound treatment 12.2115 2.7559 0.7395 10.4955 1.0379 0.2459 0.6968 0.8941 3214308 Ald1-H_000641 ONC(=O)CCCCCC(=O)N/N=C/c1cc(O)ccc1Br 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 C06 compound treatment 161.5515 152.1 40.8112 146.9758 137.52 32.5829 51.8975 0.9938 3214310 Ald1-H_000642 Oc1ccc(Br)c(/C=N/NC(=O)CCCCCC(=O)Nc2ccccc2O)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 C07 compound treatment 11.3064 1.8508 0.4966 12.7377 3.2801 0.7772 0.9007 0.9766 3214312 Ald1-H_000643 COc1cc(Br)cc(/C=N/NC(=O)CCCCCC(=O)NO)c1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 C08 compound treatment 11.1258 1.6702 0.4482 9.2778 -0.17983 -0.0426 0.2868 0.637 3214314 Ald1-H_000644 COc1cc(Br)cc(/C=N/NC(=O)CCCCCC(=O)Nc2ccccc2O)c1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 C09 compound treatment 27.808 18.352 4.9244 60.5371 51.08 12.1026 12.0399 0.9215 3214316 Ald1-H_000645 COc1ccc(Br)c(/C=N/NC(=O)CCCCCC(=O)NO)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 C10 compound treatment 164.91 155.45 41.7124 161.4013 151.94 36.0008 54.9516 0.9973 3214318 Ald1-H_000646 COc1ccc(Br)c(/C=N/NC(=O)CCCCCC(=O)Nc2ccccc2O)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 C11 mock treatment 8.5651 -0.89043 -0.2389 8.7775 -0.68012 -0.1611 -0.2829 -0.9816 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 C12 mock treatment 7.7715 -1.684 -0.4519 10.2461 0.78848 0.1868 -0.1874 -0.3833 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 C13 compound treatment 18.8948 9.4392 2.5328 22.9679 13.51 3.2011 4.0545 0.9933 3214320 Ald1-H_000647 COc1ccc(Br)cc1/C=N/NC(=O)CCCCCC(=O)NO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 C14 compound treatment 108.9143 99.459 26.6873 101.593 92.135 21.8301 34.307 0.995 3214322 Ald1-H_000648 COc1ccc(Br)cc1/C=N/NC(=O)CCCCCC(=O)Nc2ccccc2O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 C15 mock treatment 10.5516 1.096 0.2941 9.5903 0.13272 0.0314 0.2302 0.7783 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 C16 mock treatment 10.085 0.62942 0.1689 9.0545 -0.40305 -0.0955 0.0519 0.2675 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 C17 compound treatment 12.6069 3.1513 0.8456 19.469 10.011 2.372 2.2752 0.9035 3214324 Ald1-H_000649 ONC(=O)CCCCCC(=O)N/N=C/c1cc2OCOc2cc1Br 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 C18 compound treatment 114.5993 105.14 28.2128 100.5448 91.087 21.5818 35.21 0.9912 3214326 Ald1-H_000650 Oc1ccccc1NC(=O)CCCCCC(=O)N/N=C/c2cc3OCOc3cc2Br 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 C19 compound treatment 11.1002 1.6446 0.4413 12.1885 2.731 0.6471 0.7696 0.9826 3214328 Ald1-H_000651 ONC(=O)CCCCCC(=O)N/N=C/c1cccnc1Br 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 C20 compound treatment 112.1165 102.66 27.5466 91.028 81.57 19.3269 33.1446 0.985 3214330 Ald1-H_000652 Oc1ccccc1NC(=O)CCCCCC(=O)N/N=C/c2cccnc2Br 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 C21 compound treatment 14.3844 4.9288 1.3225 19.2808 9.8232 2.3275 2.5809 0.9641 3214332 Ald1-H_000653 ONC(=O)CCCCCC(=O)N/N=C/c1ccncc1Br 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 C22 compound treatment 146.6075 137.15 36.8014 138.7115 129.25 30.6248 47.6775 0.9958 3214334 Ald1-H_000654 Oc1ccccc1NC(=O)CCCCCC(=O)N/N=C/c2ccncc2Br 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 C23 compound treatment 10.5202 1.0646 0.2857 10.9974 1.5398 0.3648 0.46 0.9927 3214336 Ald1-H_000655 ONC(=O)CCCCCC(=O)N/N=C/c1cc(Br)ccc1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 C24 compound treatment 11.1523 1.6967 0.4553 9.345 -0.11262 -0.0267 0.3031 0.6645 3214338 Ald1-H_000656 Oc1ccccc1NC(=O)CCCCCC(=O)N/N=C/c2cc(Br)ccc2O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 D01 compound treatment 121.4719 112.02 30.0568 112.0228 102.57 24.3013 38.437 0.9944 3214340 Ald1-H_000657 Cc1ccsc1/C=N/NC(=O)CCCCCC(=O)Nc2ccccc2O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 D02 compound treatment 255.7833 246.33 66.096 261.191 251.73 59.6445 88.912 0.9987 3214342 Ald1-H_000658 Cc1ccsc1/C=N/NC(=O)CCCCCC(=O)NO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 D03 compound treatment 9.5284 0.072783 0.0195 11.7821 2.3245 0.5508 0.4033 0.7317 3214344 Ald1-H_000659 CC1(C)[C@@H]2C[C@H]1C(=CC2)/C=N/NC(=O)CCCCCC(=O)Nc3ccccc3O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 D04 compound treatment 32.2312 22.776 6.1113 48.0611 38.604 9.1465 10.7889 0.9808 3214346 Ald1-H_000660 CC1(C)[C@@H]2C[C@H]1C(=CC2)/C=N/NC(=O)CCCCCC(=O)NO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 D05 compound treatment 66.6808 57.225 15.355 61.4153 51.958 12.3106 19.5625 0.994 3214348 Ald1-H_000661 Oc1ccccc1NC(=O)CCCCCC(=O)N/N=C/c2cccc3ccccc23 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 D06 compound treatment 89.5513 80.096 21.4917 125.1795 115.72 27.4186 34.5848 0.9927 3214350 Ald1-H_000662 ONC(=O)CCCCCC(=O)N/N=C/c1cccc2ccccc12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 D07 compound treatment 21.3258 11.87 3.1851 21.2754 11.818 2.8001 4.2321 0.9979 3214352 Ald1-H_000663 COc1cc(/C=N/NC(=O)CCCCCC(=O)Nc2ccccc2O)c(cc1OC)[N+](=O)[O-] 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 D08 compound treatment 177.1173 167.66 44.9879 197.512 188.05 44.5567 63.3176 1.0 3214354 Ald1-H_000664 COc1cc(/C=N/NC(=O)CCCCCC(=O)NO)c(cc1OC)[N+](=O)[O-] 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 D09 compound treatment 26.5153 17.06 4.5775 29.7011 20.244 4.7964 6.6284 0.9997 3214356 Ald1-H_000665 Oc1ccccc1NC(=O)CCCCCC(=O)N/N=C/c2ccc3ccccc3c2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 D10 compound treatment 142.3243 132.87 35.6521 193.2245 183.77 43.5409 55.9979 0.9951 3214358 Ald1-H_000666 ONC(=O)CCCCCC(=O)N/N=C/c1ccc2ccccc2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 D11 mock treatment 9.7808 0.32526 0.0873 10.2675 0.80993 0.1919 0.1974 0.9364 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 D12 mock treatment 9.012 -0.44355 -0.119 8.7948 -0.66275 -0.157 -0.1952 -0.9907 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 D13 compound treatment 12.5016 3.046 0.8173 11.8352 2.3776 0.5633 0.9763 0.9835 3214360 Ald1-H_000667 Oc1ccccc1NC(=O)CCCCCC(=O)N/N=C/c2ccc(s2)[N+](=O)[O-] 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 D14 compound treatment 9.5075 0.051918 0.0139 10.4361 0.97851 0.2318 0.1738 0.7482 3214362 Ald1-H_000668 ONC(=O)CCCCCC(=O)N/N=C/c1ccc(s1)[N+](=O)[O-] 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 D15 mock treatment 7.4103 -2.0452 -0.5488 10.1078 0.65017 0.154 -0.2791 -0.4897 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 D16 mock treatment 9.3023 -0.15326 -0.0411 8.9738 -0.48376 -0.1146 -0.1101 -0.9044 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 D17 compound treatment 9.9152 0.45967 0.1233 11.2112 1.7536 0.4155 0.381 0.8791 3214364 Ald1-H_000669 Oc1ccccc1NC(=O)CCCCCC(=O)N/N=C/c2c(F)c(F)c(F)c(F)c2F 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 D18 compound treatment 137.7775 128.32 34.4321 148.5507 139.09 32.9561 47.6506 0.9998 3214366 Ald1-H_000670 ONC(=O)CCCCCC(=O)N/N=C/c1c(F)c(F)c(F)c(F)c1F 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 D19 compound treatment 9.2066 -0.24895 -0.0668 11.1396 1.682 0.3985 0.2346 0.5805 3214368 Ald1-H_000671 Oc1ccccc1NC(=O)CCCCCC(=O)N/N=C/CCC=C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 D20 compound treatment 12.2644 2.8088 0.7537 10.6384 1.1808 0.2798 0.7308 0.909 3214370 Ald1-H_000672 ONC(=O)CCCCCC(=O)N/N=C/CCC=C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 D21 compound treatment 10.7654 1.3098 0.3514 10.9534 1.4958 0.3544 0.4991 1.0 3214372 Ald1-H_000673 CC(=C)[C@H]1CCC(=CC1)/C=N/NC(=O)CCCCCC(=O)Nc2ccccc2O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 D22 compound treatment 262.33 252.87 67.8527 246.501 237.04 56.164 87.693 0.9956 3214374 Ald1-H_000674 CC(=C)[C@H]1CCC(=CC1)/C=N/NC(=O)CCCCCC(=O)NO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 D23 compound treatment 9.2099 -0.24567 -0.0659 10.456 0.99841 0.2366 0.1207 0.4913 3214376 Ald1-H_000675 Oc1ccccc1NC(=O)CCCCCC(=O)N/N=C/c2cccc(Oc3ccccc3)c2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 D24 compound treatment 108.0745 98.619 26.462 117.2168 107.76 25.532 36.7653 0.9998 3214378 Ald1-H_000676 ONC(=O)CCCCCC(=O)N/N=C/c1cccc(Oc2ccccc2)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 E01 mock treatment 7.4535 -2.0021 -0.5372 9.4488 -0.0087677 -0.0021 -0.3813 -0.7098 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 E02 mock treatment 10.1472 0.69157 0.1856 10.9816 1.524 0.3611 0.3865 0.9521 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 E03 compound treatment 107.2906 97.835 26.2516 120.9362 111.48 26.4132 37.2397 1.0 3214380 Ald1-H_000677 ONC(=O)CCCCCC(=O)N/N=C/c1ccc(Br)s1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 E04 compound treatment 10.654 1.1984 0.3216 8.1824 -1.2751 -0.3021 0.0137 0.0312 3214382 Ald1-H_000678 Oc1ccccc1NC(=O)CCCCCC(=O)N/N=C/c2ccc(Br)s2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 E05 compound treatment 8.1923 -1.2633 -0.339 10.971 1.5135 0.3586 0.0139 0.0281 3214384 Ald1-H_000679 COc1cc(/C=N/NC(=O)CCCCCC(=O)NO)c(Br)cc1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 E06 compound treatment 106.6757 97.22 26.0867 99.0032 89.546 21.2165 33.4484 0.9947 3214386 Ald1-H_000680 COc1cc(/C=N/NC(=O)CCCCCC(=O)Nc2ccccc2O)c(Br)cc1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 E07 compound treatment 15.1476 5.692 1.5273 21.0342 11.577 2.7429 3.0195 0.9618 3214388 Ald1-H_000681 ONC(=O)CCCCCC(=O)N/N=C/c1ccc(OCc2ccccc2)cc1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 E08 compound treatment 9.4186 -0.036999 -0.0099 8.7693 -0.68831 -0.1631 -0.1223 -0.7488 3214390 Ald1-H_000682 Oc1ccccc1NC(=O)CCCCCC(=O)N/N=C/c2ccc(OCc3ccccc3)cc2O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 E09 mock treatment 10.1871 0.7315 0.1963 8.4224 -1.0352 -0.2453 -0.0346 -0.1103 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 E10 mock treatment 10.165 0.70942 0.1904 9.3533 -0.10428 -0.0247 0.1171 0.6102 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 E11 compound treatment 69.4562 60.001 16.0997 71.4074 61.95 14.6781 21.7632 0.9989 3214392 Ald1-H_000683 CC(C)(C)OC(=O)NC1(CCCC1)/C=N/NC(=O)CCCCCC(=O)NO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 E12 compound treatment 11.6789 2.2233 0.5966 11.8943 2.4367 0.5773 0.8301 0.9999 3214394 Ald1-H_000684 CC(C)(C)OC(=O)NC1(CCCC1)/C=N/NC(=O)CCCCCC(=O)Nc2ccccc2O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 E13 compound treatment 49.2936 39.838 10.6896 39.5106 30.053 7.1206 12.5937 0.9805 3214396 Ald1-H_000685 CC(C)(C)OC(=O)N1CCC[C@H]1/C=N/NC(=O)CCCCCC(=O)NO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 E14 compound treatment 12.5989 3.1433 0.8434 10.992 1.5345 0.3636 0.8535 0.9293 3214398 Ald1-H_000686 CC(C)(C)OC(=O)N1CCC[C@H]1/C=N/NC(=O)CCCCCC(=O)Nc2ccccc2O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 E15 compound treatment 90.2912 80.836 21.6903 86.085 76.627 18.1557 28.1754 0.9961 3214400 Ald1-H_000687 CC(C)(C)OC(=O)Nc1cccc(/C=N/NC(=O)CCCCCC(=O)NO)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 E16 compound treatment 11.5815 2.1259 0.5704 14.0438 4.5862 1.0866 1.1717 0.9547 3214402 Ald1-H_000688 CC(C)(C)OC(=O)Nc1cccc(/C=N/NC(=O)CCCCCC(=O)Nc2ccccc2O)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 E17 mock treatment 10.8728 1.4173 0.3803 8.1464 -1.3111 -0.3107 0.0492 0.1003 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 E18 mock treatment 9.1998 -0.25574 -0.0686 9.9719 0.51435 0.1219 0.0377 0.2692 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 E19 compound treatment 9.0886 -0.367 -0.0985 9.6341 0.17646 0.0418 -0.0401 -0.3745 3214404 Ald1-H_000689 ONC(=O)CCCCCC(=O)N/N=C/c1cccc(c1)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 E20 compound treatment 9.0379 -0.41767 -0.1121 9.1698 -0.28775 -0.0682 -0.1275 -0.9716 3214406 Ald1-H_000690 OC(=O)c1cccc(/C=N/NC(=O)CCCCCC(=O)Nc2ccccc2O)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 E21 compound treatment 9.8382 0.38266 0.1027 9.722 0.26438 0.0626 0.1169 0.9719 3214408 Ald1-H_000691 ONC(=O)CCCCCC(=O)N/N=C/c1ccccc1C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 E22 compound treatment 9.5786 0.12304 0.033 9.808 0.35042 0.083 0.0821 0.9183 3214410 Ald1-H_000692 OC(=O)c1ccccc1/C=N/NC(=O)CCCCCC(=O)Nc2ccccc2O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 E23 compound treatment 8.9916 -0.46394 -0.1245 9.0392 -0.41843 -0.0991 -0.1581 -0.9936 3214412 Ald1-H_000693 ONC(=O)CCCCCC(=O)N/N=C/c1ccc(cc1)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 E24 compound treatment 9.6427 0.18714 0.0502 9.0362 -0.42137 -0.0998 -0.0351 -0.314 3214414 Ald1-H_000694 OC(=O)c1ccc(/C=N/NC(=O)CCCCCC(=O)Nc2ccccc2O)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 F01 mock treatment 8.1374 -1.3182 -0.3537 8.5552 -0.9024 -0.2138 -0.4013 -0.9709 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 F02 mock treatment 8.6726 -0.78297 -0.2101 9.1984 -0.25921 -0.0614 -0.192 -0.8771 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 F03 compound treatment 10.4911 1.0355 0.2779 11.2881 1.8305 0.4337 0.5032 0.9768 3214416 Ald1-H_000695 Oc1ccccc1NC(=O)CCCCCC(=O)N/N=C/c2cn(c3ccccc23)S(=O)(=O)c4ccccc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 F04 compound treatment 12.1767 2.7211 0.7301 11.7193 2.2617 0.5359 0.8952 0.9884 3214418 Ald1-H_000696 ONC(=O)CCCCCC(=O)N/N=C/c1cn(c2ccccc12)S(=O)(=O)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 F05 compound treatment 14.2366 4.781 1.2829 17.0133 7.5557 1.7902 2.173 0.9866 3214420 Ald1-H_000697 Oc1ccccc1NC(=O)CCCCCC(=O)N/N=C/c2ccccn2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 F06 compound treatment 18.017 8.5614 2.2972 25.0823 15.625 3.702 4.2421 0.9737 3214422 Ald1-H_000698 ONC(=O)CCCCCC(=O)N/N=C/c1ccccn1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 F07 compound treatment 20.8675 11.412 3.0621 16.7265 7.2689 1.7223 3.3831 0.963 3214424 Ald1-H_000699 Oc1ccccc1NC(=O)CCCCCC(=O)N/N=C/c2cccnc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 F08 compound treatment 11.5733 2.1177 0.5682 11.8923 2.4347 0.5769 0.8097 1.0 3214426 Ald1-H_000700 ONC(=O)CCCCCC(=O)N/N=C/c1cccnc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 F09 mock treatment 8.7543 -0.70125 -0.1882 10.5554 1.0978 0.2601 0.0509 0.1585 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 F10 mock treatment 9.9167 0.46114 0.1237 11.7367 2.2791 0.54 0.4693 0.8472 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 F11 compound treatment 12.1574 2.7018 0.725 8.2897 -1.1679 -0.2767 0.317 0.4085 3214428 Ald1-H_000701 Cc1ncc(CO)c(/C=N/NC(=O)CCCCCC(=O)Nc2ccccc2O)c1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 F12 compound treatment 9.2465 -0.20912 -0.0561 10.0941 0.63648 0.1508 0.067 0.4161 3214430 Ald1-H_000702 Cc1ncc(CO)c(/C=N/NC(=O)CCCCCC(=O)NO)c1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 F13 compound treatment 21.3822 11.927 3.2002 21.3079 11.85 2.8078 4.2483 0.9979 3214432 Ald1-H_000703 Oc1ccccc1NC(=O)CCCCCC(=O)N/N=C/c2ccc[nH]2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 F14 compound treatment 11.9167 2.4611 0.6604 14.6653 5.2077 1.2339 1.3394 0.9571 3214434 Ald1-H_000704 ONC(=O)CCCCCC(=O)N/N=C/c1ccc[nH]1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 F15 compound treatment 10.545 1.0895 0.2923 11.4762 2.0186 0.4783 0.5449 0.9721 3214436 Ald1-H_000705 Oc1ccccc1NC(=O)CCCCCC(=O)N/N=C/c2ccc(cc2)N3CCCC3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 F16 compound treatment 244.002 234.55 62.9348 256.418 246.96 58.5136 85.877 0.9993 3214438 Ald1-H_000706 ONC(=O)CCCCCC(=O)N/N=C/c1ccc(cc1)N2CCCC2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 F17 mock treatment 7.4438 -2.0117 -0.5398 9.9721 0.5145 0.1219 -0.2955 -0.534 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 F18 mock treatment 10.0406 0.58503 0.157 9.3257 -0.13187 -0.0312 0.0889 0.5555 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 F19 compound treatment 14.9629 5.5073 1.4778 12.8313 3.3737 0.7993 1.6102 0.9584 3214440 Ald1-H_000707 Oc1ccccc1NC(=O)CCCCCC(=O)N/N=C/c2ccccc2O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 F20 compound treatment 13.9542 4.4986 1.2071 16.1683 6.7107 1.59 1.9778 0.9908 3214442 Ald1-H_000708 ONC(=O)CCCCCC(=O)N/N=C/c1ccccc1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 F21 compound treatment 9.0989 -0.35668 -0.0957 12.5466 3.089 0.7319 0.4499 0.6095 3214444 Ald1-H_000709 CCCCCCC/C=N/NC(=O)CCCCCC(=O)Nc1ccccc1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 F22 compound treatment 11.9771 2.5216 0.6766 10.1841 0.72652 0.1721 0.6001 0.8596 3214446 Ald1-H_000710 CCCCCCC/C=N/NC(=O)CCCCCC(=O)NO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 F23 compound treatment 14.8094 5.3538 1.4366 15.0588 5.6012 1.3271 1.9542 0.9992 3214448 Ald1-H_000711 Oc1ccccc1NC(=O)CCCCCC(=O)N/N=C/c2nccs2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 F24 compound treatment 26.2167 16.761 4.4974 30.9539 21.496 5.0932 6.7816 0.9981 3214450 Ald1-H_000712 ONC(=O)CCCCCC(=O)N/N=C/c1nccs1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 G01 compound treatment 88.4406 78.985 21.1937 103.5658 94.108 22.2976 30.753 0.9997 3214452 Ald1-H_000713 ONC(=O)CCCCCC(=O)N/N=C/c1ccccc1Cl 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 G02 compound treatment 17.9906 8.5351 2.2902 21.0876 11.63 2.7556 3.5679 0.9958 3214454 Ald1-H_000714 Oc1ccccc1NC(=O)CCCCCC(=O)N/N=C/c2ccccc2Cl 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 G03 mock treatment 7.9107 -1.5449 -0.4145 8.0571 -1.4005 -0.3318 -0.5278 -0.9939 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 G04 mock treatment 8.984 -0.47155 -0.1265 9.0583 -0.39924 -0.0946 -0.1564 -0.9897 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 G05 compound treatment 12.7295 3.2739 0.8785 13.3753 3.9178 0.9283 1.2776 0.9996 3214456 Ald1-H_000715 ONC(=O)CCCCCC(=O)N/N=C/c1cccnc1Cl 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 G06 compound treatment 90.6911 81.236 21.7976 103.6533 94.196 22.3183 31.1946 0.9999 3214458 Ald1-H_000716 Oc1ccccc1NC(=O)CCCCCC(=O)N/N=C/c2cccnc2Cl 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 G07 compound treatment 248.4913 239.04 64.1394 293.2948 283.84 67.2511 92.9071 0.9997 3214460 Ald1-H_000717 ONC(=O)CCCCCC(=O)N/N=C/C=C/c1ccccc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 G08 compound treatment 14.5283 5.0727 1.3611 12.9019 3.4443 0.8161 1.5395 0.9701 3214462 Ald1-H_000718 Oc1ccccc1NC(=O)CCCCCC(=O)N/N=C/C=C/c2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 G09 compound treatment 80.3328 70.877 19.0182 49.9234 40.466 9.5878 20.2275 0.9497 3214464 Ald1-H_000719 C[C@H](CCC=C(C)C)C/C=N/NC(=O)CCCCCC(=O)NO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 G10 compound treatment 10.9114 1.4558 0.3906 10.492 1.0344 0.2451 0.4495 0.9748 3214466 Ald1-H_000720 C[C@H](CCC=C(C)C)C/C=N/NC(=O)CCCCCC(=O)Nc1ccccc1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 G11 compound treatment 89.579 80.123 21.4992 81.2197 71.762 17.003 27.2251 0.9933 3214468 Ald1-H_000721 C[C@@H](CCC=C(C)C)C/C=N/NC(=O)CCCCCC(=O)NO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 G12 compound treatment 10.8177 1.3621 0.3655 8.9419 -0.51571 -0.1222 0.172 0.4464 3214469 Ald1-H_000722 C[C@@H](CCC=C(C)C)C/C=N/NC(=O)CCCCCC(=O)Nc1ccccc1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 G13 compound treatment 94.1918 84.736 22.7369 125.963 116.51 27.6042 35.5966 0.9954 3214470 Ald1-H_000723 ONC(=O)CCCCCC(=O)N/N=C/c1ccc(C#N)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 G14 compound treatment 37.2853 27.83 7.4674 34.2868 24.829 5.8829 9.4401 0.993 3214472 Ald1-H_000724 Oc1ccccc1NC(=O)CCCCCC(=O)N/N=C/c2ccc(C#N)cc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 G15 compound treatment 14.7138 5.2582 1.4109 20.2556 10.798 2.5584 2.8067 0.9607 3214474 Ald1-H_000725 ONC(=O)CCCCCC(=O)N/N=C/C1CCCCC1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 G16 compound treatment 9.9226 0.46702 0.1253 11.3685 1.9109 0.4528 0.4088 0.8701 3214476 Ald1-H_000726 Oc1ccccc1NC(=O)CCCCCC(=O)N/N=C/C2CCCCC2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 G17 compound treatment 67.4748 58.019 15.5681 80.9495 71.492 16.939 22.9859 0.9991 3214478 Ald1-H_000727 COc1ccc(/C=N/NC(=O)CCCCCC(=O)NO)cc1Br 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 G18 compound treatment 16.8937 7.4381 1.9958 13.5252 4.0676 0.9638 2.0928 0.9442 3214480 Ald1-H_000728 COc1ccc(/C=N/NC(=O)CCCCCC(=O)Nc2ccccc2O)cc1Br 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 G19 mock treatment 9.9507 0.49509 0.1328 8.575 -0.8826 -0.2091 -0.0539 -0.2177 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 G20 mock treatment 8.5496 -0.906 -0.2431 9.2888 -0.16877 -0.04 -0.2002 -0.8125 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 G21 compound treatment 15.703 6.2474 1.6763 11.5735 2.1159 0.5013 1.5399 0.8801 3214482 Ald1-H_000729 ONC(=O)CCCCCC(=O)N/N=C/c1cc(Br)cc(Br)c1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 G22 compound treatment 9.0675 -0.3881 -0.1041 8.4313 -1.0263 -0.2432 -0.2456 -0.9284 3214484 Ald1-H_000730 Oc1ccccc1NC(=O)CCCCCC(=O)N/N=C/c2cc(Br)cc(Br)c2O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 G23 compound treatment 77.8256 68.37 18.3454 76.6507 67.193 15.9204 24.2296 0.9975 3214486 Ald1-H_000731 CCCCN(CCCC)c1ccc(/C=N/NC(=O)CCCCCC(=O)NO)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 G24 compound treatment 9.4995 0.043943 0.0118 10.204 0.74645 0.1769 0.1334 0.7526 3214488 Ald1-H_000732 CCCCN(CCCC)c1ccc(/C=N/NC(=O)CCCCCC(=O)Nc2ccccc2O)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 H01 compound treatment 24.8367 15.381 4.1272 21.9034 12.446 2.9489 5.0035 0.9864 3214490 Ald1-H_000733 Oc1ccccc1NC(=O)CCCCCC(=O)N/N=C/c2cccs2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 H02 compound treatment 227.4818 218.03 58.502 224.7033 215.25 50.9993 77.4291 0.9977 3214492 Ald1-H_000734 ONC(=O)CCCCCC(=O)N/N=C/c1cccs1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 H03 mock treatment 8.789 -0.66658 -0.1789 9.8081 0.35055 0.0831 -0.0677 -0.3435 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 H04 mock treatment 10.381 0.92546 0.2483 11.0423 1.5847 0.3755 0.4411 0.9799 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 H05 compound treatment 15.4129 5.9573 1.5985 12.892 3.4345 0.8137 1.7057 0.9509 3214494 Ald1-H_000735 Oc1ccccc1NC(=O)CCCCCC(=O)N/N=C/c2ccc(cc2)C(F)(F)F 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 H06 compound treatment 18.1029 8.6473 2.3203 24.3073 14.85 3.5184 4.1286 0.9796 3214496 Ald1-H_000736 ONC(=O)CCCCCC(=O)N/N=C/c1ccc(cc1)C(F)(F)F 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 H07 compound treatment 9.9589 0.50329 0.135 10.3563 0.89867 0.2129 0.2461 0.9759 3214498 Ald1-H_000737 Oc1ccc(/C=N/NC(=O)CCCCCC(=O)Nc2ccccc2O)c(O)c1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 H08 compound treatment 11.5649 2.1093 0.566 10.1886 0.73102 0.1732 0.5227 0.8831 3214500 Ald1-H_000738 ONC(=O)CCCCCC(=O)N/N=C/c1ccc(O)c(O)c1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 H09 compound treatment 9.5451 0.089511 0.024 8.6768 -0.78077 -0.185 -0.1138 -0.6102 3214502 Ald1-H_000739 Oc1cc(O)c(/C=N/NC(=O)CCCCCC(=O)Nc2ccccc2O)c(O)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 H10 compound treatment 10.7053 1.2497 0.3353 10.0919 0.63431 0.1503 0.3434 0.9345 3214504 Ald1-H_000740 ONC(=O)CCCCCC(=O)N/N=C/c1c(O)cc(O)cc1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 H11 compound treatment 9.5776 0.12202 0.0327 9.4939 0.036305 0.0086 0.0292 0.8636 3214506 Ald1-H_000741 COc1cc(OC)c(/C=N/NC(=O)CCCCCC(=O)Nc2ccccc2O)c(OC)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 H12 compound treatment 9.0742 -0.38136 -0.1023 9.7728 0.3152 0.0747 -0.0195 -0.1543 3214508 Ald1-H_000742 COc1cc(OC)c(/C=N/NC(=O)CCCCCC(=O)NO)c(OC)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 H13 compound treatment 12.1181 2.6625 0.7144 13.1522 3.6946 0.8754 1.1242 0.9949 3214510 Ald1-H_000743 COc1cc(/C=N/NC(=O)CCCCCC(=O)Nc2ccccc2O)cc(OC)c1OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 H14 compound treatment 9.5105 0.054896 0.0147 10.3742 0.91664 0.2172 0.164 0.7533 3214512 Ald1-H_000744 COc1cc(/C=N/NC(=O)CCCCCC(=O)NO)cc(OC)c1OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 H15 compound treatment 8.9806 -0.47497 -0.1274 10.7288 1.2712 0.3012 0.1229 0.3757 3214514 Ald1-H_000745 CC(C)(C)/C=N/NC(=O)CCCCCC(=O)Nc1ccccc1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 H16 compound treatment 11.6406 2.185 0.5863 12.7355 3.2779 0.7766 0.9637 0.9904 3214516 Ald1-H_000746 CC(C)(C)/C=N/NC(=O)CCCCCC(=O)NO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 H17 compound treatment 11.906 2.4505 0.6575 10.298 0.84036 0.1991 0.6057 0.8817 3214518 Ald1-H_000747 CC1=C(C/C=N/NC(=O)CCCCCC(=O)Nc2ccccc2O)C(C)(C)CCC1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 H18 compound treatment 14.2417 4.7861 1.2842 11.7652 2.3076 0.5467 1.2947 0.9276 3214520 Ald1-H_000748 CC1=C(C/C=N/NC(=O)CCCCCC(=O)NO)C(C)(C)CCC1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 H19 mock treatment 8.8383 -0.61732 -0.1656 10.2886 0.83102 0.1969 0.0221 0.0859 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 H20 mock treatment 8.3766 -1.079 -0.2895 9.8806 0.42298 0.1002 -0.1339 -0.4369 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 H21 compound treatment 12.3892 2.9336 0.7872 11.9038 2.4462 0.5796 0.9664 0.9887 3214522 Ald1-H_000749 NC(=O)COc1ccccc1/C=N/NC(=O)CCCCCC(=O)Nc2ccccc2O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 H22 compound treatment 9.2718 -0.18374 -0.0493 10.5972 1.1396 0.27 0.1561 0.5686 3214524 Ald1-H_000750 NC(=O)COc1ccccc1/C=N/NC(=O)CCCCCC(=O)NO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 H23 compound treatment 10.8471 1.3916 0.3734 12.4815 3.0239 0.7165 0.7707 0.9539 3214526 Ald1-H_000751 NC(=O)COc1ccc(/C=N/NC(=O)CCCCCC(=O)Nc2ccccc2O)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 H24 compound treatment 10.113 0.65742 0.1764 12.1825 2.7249 0.6456 0.5813 0.8685 3214528 Ald1-H_000752 NC(=O)COc1ccc(/C=N/NC(=O)CCCCCC(=O)NO)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 I01 compound treatment 134.11 124.65 33.448 168.391 158.93 37.6569 50.2788 0.9983 3214530 Ald1-H_000753 COc1cc(Cl)c(/C=N/NC(=O)CCCCCC(=O)NO)c(Cl)c1OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 I02 compound treatment 11.4066 1.951 0.5235 8.5723 -0.8853 -0.2098 0.2219 0.3934 3214532 Ald1-H_000754 COc1cc(Cl)c(/C=N/NC(=O)CCCCCC(=O)Nc2ccccc2O)c(Cl)c1OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 I03 compound treatment 12.3784 2.9228 0.7843 11.7472 2.2897 0.5425 0.9382 0.9838 3214534 Ald1-H_000755 ONC(=O)CCCCCC(=O)N/N=C/c1cc(Cl)cc(Cl)c1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 I04 compound treatment 10.9283 1.4727 0.3952 11.2017 1.7441 0.4132 0.5716 0.9998 3214536 Ald1-H_000756 Oc1ccccc1NC(=O)CCCCCC(=O)N/N=C/c2cc(Cl)cc(Cl)c2O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 I05 mock treatment 9.4227 -0.032877 -0.0088 10.0632 0.60558 0.1435 0.0952 0.6624 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 I06 mock treatment 10.7736 1.318 0.3537 9.5148 0.057215 0.0136 0.2597 0.7337 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 I07 compound treatment 9.2324 -0.22322 -0.0599 25.5415 16.084 3.8108 2.6523 0.6959 3214538 Ald1-H_000757 ONC(=O)CCCCCC(=O)N/N=C/c1cc(Br)cc([N+](=O)[O-])c1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 I08 compound treatment 8.8669 -0.58864 -0.1579 9.4979 0.040295 0.0095 -0.1049 -0.6632 3214540 Ald1-H_000758 Oc1ccccc1NC(=O)CCCCCC(=O)N/N=C/c2cc(Br)cc([N+](=O)[O-])c2O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 I09 compound treatment 16.015 6.5594 1.7601 17.5483 8.0908 1.917 2.6001 0.9991 3214542 Ald1-H_000759 CCN(CC)c1ccc(/C=N/NC(=O)CCCCCC(=O)NO)c(O)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 I10 compound treatment 13.249 3.7934 1.0179 11.9657 2.5081 0.5943 1.14 0.9672 3214544 Ald1-H_000760 CCN(CC)c1ccc(/C=N/NC(=O)CCCCCC(=O)Nc2ccccc2O)c(O)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 I11 compound treatment 198.0532 188.6 50.6056 196.3305 186.87 44.2768 67.092 0.9978 3214546 Ald1-H_000761 ONC(=O)CCCCCC(=O)N/N=C/c1ccc2OCCc2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 I12 compound treatment 32.2618 22.806 6.1195 36.8109 27.353 6.481 8.9099 0.9996 3214548 Ald1-H_000762 Oc1ccccc1NC(=O)CCCCCC(=O)N/N=C/c2ccc3OCCc3c2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 I13 compound treatment 9.0077 -0.44789 -0.1202 9.6156 0.15805 0.0374 -0.0585 -0.4647 3214550 Ald1-H_000763 ONC(=O)CCCCCC(=O)N/N=C/c1cccc(O)c1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 I14 compound treatment 11.1886 1.733 0.465 9.9278 0.47026 0.1114 0.4076 0.8524 3214552 Ald1-H_000764 Oc1cccc(/C=N/NC(=O)CCCCCC(=O)Nc2ccccc2O)c1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 I15 compound treatment 11.0985 1.643 0.4409 10.5257 1.0682 0.2531 0.4907 0.9653 3214554 Ald1-H_000765 ONC(=O)CCCCCC(=O)N/N=C/c1ccc(O)cc1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 I16 compound treatment 12.5065 3.0509 0.8186 10.8479 1.3903 0.3294 0.8118 0.9199 3214556 Ald1-H_000766 Oc1ccc(/C=N/NC(=O)CCCCCC(=O)Nc2ccccc2O)c(O)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 I17 compound treatment 10.6225 1.167 0.3131 9.4049 -0.05266 -0.0125 0.2126 0.6784 3214558 Ald1-H_000767 ONC(=O)CCCCCC(=O)N/N=C/c1cc(O)ccc1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 I18 compound treatment 16.0376 6.582 1.7661 17.5269 8.0693 1.9119 2.6008 0.9992 3214560 Ald1-H_000768 Oc1ccc(O)c(/C=N/NC(=O)CCCCCC(=O)Nc2ccccc2O)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 I19 compound treatment 10.9754 1.5198 0.4078 10.6065 1.1489 0.2722 0.4808 0.9807 3214562 Ald1-H_000769 ONC(=O)CCCCCC(=O)N/N=C/c1ccc(O)c(O)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 I20 compound treatment 9.2799 -0.1757 -0.0471 8.9506 -0.50699 -0.1201 -0.1183 -0.9166 3214564 Ald1-H_000770 Oc1ccc(/C=N/NC(=O)CCCCCC(=O)Nc2ccccc2O)cc1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 I21 mock treatment 8.5603 -0.89527 -0.2402 8.7656 -0.69198 -0.164 -0.2858 -0.9827 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 I22 mock treatment 9.7868 0.3312 0.0889 8.6654 -0.79214 -0.1877 -0.0699 -0.3365 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 I23 compound treatment 43.1975 33.742 9.0538 41.0553 31.598 7.4866 11.6959 0.9955 3214566 Ald1-H_000771 COc1ccc(/C=N/NC(=O)CCCCCC(=O)NO)c(OC)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 I24 compound treatment 13.6722 4.2166 1.1314 15.4133 5.9558 1.4111 1.7979 0.994 3214568 Ald1-H_000772 COc1ccc(/C=N/NC(=O)CCCCCC(=O)Nc2ccccc2O)c(OC)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 J01 compound treatment 10.8354 1.3799 0.3703 9.4802 0.02261 0.0054 0.2656 0.7173 3214570 Ald1-H_000773 Oc1ccccc1NC(=O)CCCCCC(=O)NN=C2CCCCCCC2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 J02 compound treatment 15.1591 5.7035 1.5304 16.5038 7.0462 1.6695 2.2627 0.9991 3214571 Ald1-H_000774 ONC(=O)CCCCCC(=O)NN=C1CCCCCCC1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 J03 compound treatment 8.6016 -0.85401 -0.2292 10.1506 0.69306 0.1642 -0.0459 -0.1629 3214572 Ald1-H_000775 Oc1ccccc1NC(=O)CCCCCC(=O)NN=C2CCCCCC2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 J04 compound treatment 13.7239 4.2683 1.1453 13.1667 3.7091 0.8788 1.4313 0.9914 3214573 Ald1-H_000776 ONC(=O)CCCCCC(=O)NN=C1CCCCCC1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 J05 mock treatment 11.2468 1.7912 0.4806 8.8823 -0.57524 -0.1363 0.2435 0.4874 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 J06 mock treatment 10.3106 0.85506 0.2294 10.1938 0.73625 0.1744 0.2856 0.9909 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 J07 compound treatment 11.9614 2.5058 0.6724 7.2583 -2.1992 -0.5211 0.107 0.1258 3214574 Ald1-H_000777 Oc1ccccc1NC(=O)CCCCCC(=O)NN=C2CCCC2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 J08 compound treatment 13.6045 4.1489 1.1133 8.785 -0.67257 -0.1594 0.6745 0.5998 3214575 Ald1-H_000778 ONC(=O)CCCCCC(=O)NN=C1CCCC1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 J09 compound treatment 10.5395 1.0839 0.2908 8.882 -0.57561 -0.1364 0.1092 0.34 3214215 Ald1-H_000779 NNC(=O)CCCCCC(=O)Nc1ccccc1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 J10 mock treatment 8.0636 -1.392 -0.3735 8.7359 -0.72167 -0.171 -0.385 -0.9373 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 J11 compound treatment 65.472 56.016 15.0307 76.8007 67.343 15.956 21.9109 0.9996 3214576 Ald1-H_000780 COc1cc(Br)c(/C=N/NC(=O)CCCCCC(=O)Nc2ccccc2O)cc1OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 J12 compound treatment 10.9812 1.5256 0.4093 11.207 1.7494 0.4145 0.5825 1.0 3214578 Ald1-H_000781 COc1cc(Br)c(/C=N/NC(=O)CCCCCC(=O)NO)cc1OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 J13 compound treatment 10.8813 1.4257 0.3825 8.7211 -0.7365 -0.1745 0.1471 0.3499 3214580 Ald1-H_000782 Oc1ccccc1NC(=O)CCCCCC(=O)N/N=C/CCC2CCCCC2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 J14 compound treatment 18.1557 8.7001 2.3345 19.9906 10.533 2.4956 3.4154 0.9994 3214582 Ald1-H_000783 ONC(=O)CCCCCC(=O)N/N=C/CCC1CCCCC1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 J15 compound treatment 13.0705 3.6149 0.97 11.9173 2.4597 0.5828 1.098 0.9703 3214584 Ald1-H_000784 Oc1ccccc1NC(=O)CCCCCC(=O)N/N=C/c2ccc(cc2)N(c3ccccc3)c4ccccc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 J16 compound treatment 81.507 72.051 19.3333 99.7721 90.315 21.3987 28.8018 0.9987 3214586 Ald1-H_000785 ONC(=O)CCCCCC(=O)N/N=C/c1ccc(cc1)N(c2ccccc2)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 J17 compound treatment 7.8195 -1.6361 -0.439 9.598 0.14044 0.0333 -0.2869 -0.6516 3214588 Ald1-H_000786 Oc1ccccc1NC(=O)CCCCCC(=O)N/N=C/C[P+](c2ccccc2)(c3ccccc3)c4ccccc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 J18 compound treatment 11.3181 1.8625 0.4998 9.1007 -0.35685 -0.0845 0.2936 0.5792 3214590 Ald1-H_000787 ONC(=O)CCCCCC(=O)N/N=C/C[P+](c1ccccc1)(c2ccccc2)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 J19 compound treatment 10.4069 0.95127 0.2553 8.9003 -0.55733 -0.1321 0.0871 0.3031 3214215 Ald1-H_000788 NNC(=O)CCCCCC(=O)Nc1ccccc1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 J20 mock treatment 10.6168 1.1612 0.3116 9.5547 0.097082 0.023 0.2366 0.7572 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 J21 mock treatment 10.4685 1.013 0.2718 10.0183 0.56068 0.1328 0.2861 0.9458 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 J22 mock treatment 10.4181 0.96253 0.2583 7.6282 -1.8294 -0.4335 -0.1239 -0.2455 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 J23 compound treatment 8.7867 -0.66889 -0.1795 10.3747 0.91707 0.2173 0.0267 0.0949 3214215 Ald1-H_000789 NNC(=O)CCCCCC(=O)Nc1ccccc1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 J24 mock treatment 9.6121 0.15656 0.042 8.5579 -0.89965 -0.2132 -0.121 -0.557 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 K01 compound treatment 10.5503 1.0948 0.2938 11.4931 2.0355 0.4823 0.5487 0.9717 3214592 Ald1-H_000790 COc1cccc(OC)c1/C=N/NC(=O)CCCCCC(=O)NO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 K02 compound treatment 11.131 1.6754 0.4495 14.1268 4.6693 1.1063 1.1002 0.9213 3214594 Ald1-H_000791 COc1cccc(OC)c1/C=N/NC(=O)CCCCCC(=O)Nc2ccccc2O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 K03 compound treatment 12.3801 2.9245 0.7847 14.111 4.6534 1.1026 1.3345 0.9861 3214596 Ald1-H_000792 COc1ccc(/C=N/NC(=O)CCCCCC(=O)NO)cc1OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 K04 compound treatment 14.8783 5.4227 1.455 15.2879 5.8303 1.3814 2.0057 0.9997 3214598 Ald1-H_000793 COc1ccc(/C=N/NC(=O)CCCCCC(=O)Nc2ccccc2O)cc1OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 K05 compound treatment 11.2394 1.7838 0.4786 9.6962 0.23858 0.0565 0.3784 0.7852 3214600 Ald1-H_000794 COc1cc(O)cc(OC)c1/C=N/NC(=O)CCCCCC(=O)NO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 K06 compound treatment 8.5083 -0.94728 -0.2542 8.496 -0.96154 -0.2278 -0.3408 -0.9985 3214602 Ald1-H_000795 COc1cc(O)cc(OC)c1/C=N/NC(=O)CCCCCC(=O)Nc2ccccc2O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 K07 mock treatment 8.0972 -1.3584 -0.3645 8.202 -1.2555 -0.2975 -0.4681 -0.9949 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 K08 mock treatment 9.4748 0.019246 0.0052 8.7921 -0.6655 -0.1577 -0.1078 -0.6836 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 K09 compound treatment 12.5126 3.057 0.8203 20.0525 10.595 2.5103 2.3551 0.8918 3214604 Ald1-H_000796 CC1(C)COC(CCC/C=N/NC(=O)CCCCCC(=O)NO)OC1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 K10 compound treatment 9.6394 0.18377 0.0493 9.8973 0.43972 0.1042 0.1085 0.9416 3214606 Ald1-H_000797 CC1(C)COC(CCC/C=N/NC(=O)CCCCCC(=O)Nc2ccccc2O)OC1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 K11 compound treatment 9.567 0.11146 0.0299 9.7924 0.33485 0.0793 0.0772 0.9111 3214608 Ald1-H_000798 Cc1nnc(Sc2ccc(/C=N/NC(=O)CCCCCC(=O)NO)o2)n1C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 K12 compound treatment 10.8365 1.3809 0.3705 9.5693 0.11167 0.0265 0.2807 0.7557 3214610 Ald1-H_000799 Cc1nnc(Sc2ccc(/C=N/NC(=O)CCCCCC(=O)Nc3ccccc3O)o2)n1C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 K13 compound treatment 185.914 176.46 47.3483 191.324 181.87 43.0906 63.95 0.9989 3214612 Ald1-H_000800 ONC(=O)CCCCCC(=O)N/N=C/c1cc(Br)cs1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 K14 compound treatment 28.9666 19.511 5.2353 35.5795 26.122 6.1892 8.0784 0.9965 3214614 Ald1-H_000801 Oc1ccccc1NC(=O)CCCCCC(=O)N/N=C/c2cc(Br)cs2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 K15 mock treatment 10.1791 0.72352 0.1941 8.1671 -1.2905 -0.3058 -0.0789 -0.2179 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 K16 mock treatment 7.9826 -1.473 -0.3952 10.16 0.70236 0.1664 -0.1618 -0.3773 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 K17 compound treatment 12.3295 2.8739 0.7711 9.8456 0.38804 0.0919 0.6103 0.7858 3214616 Ald1-H_000802 CC(C)(C)OC(=O)NC/C=N/NC(=O)CCCCCC(=O)NO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 K18 compound treatment 9.8109 0.35528 0.0953 9.7165 0.2589 0.0613 0.1108 0.9773 3214618 Ald1-H_000803 CC(C)(C)OC(=O)NC/C=N/NC(=O)CCCCCC(=O)Nc1ccccc1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 K19 compound treatment 255.007 245.55 65.8878 250.6678 241.21 57.1512 87.0017 0.9975 3214620 Ald1-H_000804 ONC(=O)CCCCCC(=O)N/N=C/c1ccc-2c(Cc3ccccc32)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 K20 compound treatment 10.2605 0.80488 0.216 11.2601 1.8025 0.4271 0.4547 0.9501 3214622 Ald1-H_000805 Oc1ccccc1NC(=O)CCCCCC(=O)N/N=C/c2ccc-3c(Cc4ccccc43)c2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 K21 compound treatment 222.0313 212.58 57.0395 242.768 233.31 55.2795 79.4215 0.9999 3214624 Ald1-H_000806 ONC(=O)CCCCCC(=O)N/N=C/c1ccc(F)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 K22 compound treatment 15.5181 6.0625 1.6267 16.8164 7.3588 1.7436 2.3831 0.9994 3214626 Ald1-H_000807 Oc1ccccc1NC(=O)CCCCCC(=O)N/N=C/c2ccc(F)cc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 K23 mock treatment 9.6399 0.18436 0.0495 9.052 -0.4056 -0.0961 -0.033 -0.3051 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 K24 mock treatment 9.5836 0.12805 0.0344 11.3751 1.9175 0.4543 0.3456 0.7584 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 L01 compound treatment 10.1597 0.70409 0.1889 10.2756 0.81804 0.1938 0.2706 0.9999 3214628 Ald1-H_000808 OC[C@@H](O)[C@@H](O)[C@H](O)/C=N/NC(=O)CCCCCC(=O)Nc1ccccc1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 L02 compound treatment 11.1172 1.6616 0.4459 11.2229 1.7654 0.4183 0.611 0.9995 3214630 Ald1-H_000809 OC[C@@H](O)[C@@H](O)[C@H](O)/C=N/NC(=O)CCCCCC(=O)NO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 L03 compound treatment 9.7463 0.29077 0.078 11.2649 1.8073 0.4282 0.358 0.8224 3214632 Ald1-H_000810 C[C@@H](O)[C@@H](O)[C@@H](O)C/C=N/NC(=O)CCCCCC(=O)Nc1ccccc1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 L04 compound treatment 10.9521 1.4965 0.4015 9.1938 -0.26379 -0.0625 0.2397 0.5899 3214634 Ald1-H_000811 C[C@@H](O)[C@@H](O)[C@@H](O)C/C=N/NC(=O)CCCCCC(=O)NO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 L05 compound treatment 9.0931 -0.36247 -0.0973 11.7411 2.2836 0.5411 0.3138 0.5708 3214636 Ald1-H_000812 OC[C@@H](O)[C@H](O)[C@H](O)[C@@H](O)/C=N/NC(=O)CCCCCC(=O)Nc1ccccc1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 L06 compound treatment 9.6148 0.15921 0.0427 11.6497 2.1921 0.5194 0.3975 0.7627 3214638 Ald1-H_000813 OC[C@@H](O)[C@H](O)[C@H](O)[C@@H](O)/C=N/NC(=O)CCCCCC(=O)NO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 L07 mock treatment 9.7089 0.25334 0.068 8.6332 -0.8244 -0.1953 -0.0901 -0.4354 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 L08 mock treatment 10.2655 0.80997 0.2173 10.5594 1.1018 0.261 0.3383 0.9959 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 L09 compound treatment 10.6996 1.244 0.3338 9.9859 0.52827 0.1252 0.3245 0.9104 3214640 Ald1-H_000814 OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)/C=N/NC(=O)CCCCCC(=O)Nc1ccccc1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 L10 compound treatment 11.6321 2.1766 0.584 10.3269 0.86934 0.206 0.5586 0.902 3214641 Ald1-H_000815 OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)/C=N/NC(=O)CCCCCC(=O)NO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 L11 compound treatment 10.0152 0.55962 0.1502 9.1124 -0.34518 -0.0818 0.0483 0.2828 3214642 Ald1-H_000816 OC[C@H](O)[C@H](O)[C@@H](O)[C@@H](O)/C=N/NC(=O)CCCCCC(=O)Nc1ccccc1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 L12 compound treatment 9.6136 0.15806 0.0424 9.7318 0.27425 0.065 0.0759 0.9786 3214643 Ald1-H_000817 OC[C@H](O)[C@H](O)[C@@H](O)[C@@H](O)/C=N/NC(=O)CCCCCC(=O)NO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 L13 compound treatment 10.9009 1.4454 0.3878 8.0333 -1.4243 -0.3375 0.0356 0.0693 3214644 Ald1-H_000818 C[C@H](O)[C@H](O)[C@@H](O)[C@@H](O)/C=N/NC(=O)CCCCCC(=O)Nc1ccccc1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 L14 compound treatment 10.5941 1.1385 0.3055 9.6022 0.14458 0.0343 0.2402 0.7815 3214646 Ald1-H_000819 C[C@H](O)[C@H](O)[C@@H](O)[C@@H](O)/C=N/NC(=O)CCCCCC(=O)NO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 L15 mock treatment 10.117 0.66139 0.1775 7.6211 -1.8365 -0.4351 -0.1822 -0.3877 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 L16 mock treatment 10.5568 1.1012 0.2955 9.3103 -0.14724 -0.0349 0.1843 0.6193 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 L17 compound treatment 10.453 0.99743 0.2676 9.878 0.42038 0.0996 0.2597 0.9093 3214648 Ald1-H_000820 Oc1ccccc1NC(=O)CCCCCC(=O)N/N=C/c2ccc(Oc3ccccc3)cc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 L18 compound treatment 147.8498 138.39 37.1347 168.3823 158.92 37.6549 52.8842 1.0 3214650 Ald1-H_000821 ONC(=O)CCCCCC(=O)N/N=C/c1ccc(Oc2ccccc2)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 L19 compound treatment 10.2864 0.83082 0.2229 8.9602 -0.49739 -0.1178 0.0743 0.2947 3214652 Ald1-H_000822 Oc1ccccc1NC(=O)CCCCCC(=O)N/N=C/c2cc[n+]([O-])cc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 L20 compound treatment 8.9793 -0.4763 -0.1278 10.7442 1.2866 0.3049 0.1252 0.3787 3214654 Ald1-H_000823 ONC(=O)CCCCCC(=O)N/N=C/c1cc[n+]([O-])cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 L21 compound treatment 15.2911 5.8355 1.5658 13.5411 4.0835 0.9675 1.7914 0.9732 3214656 Ald1-H_000824 Oc1ccccc1NC(=O)CCCCCC(=O)N/N=C/c2ccc3ccccc3n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 L22 compound treatment 259.501 250.05 67.0936 282.3628 272.91 64.6609 93.1645 0.9998 3214658 Ald1-H_000825 ONC(=O)CCCCCC(=O)N/N=C/c1ccc2ccccc2n1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 L23 mock treatment 10.7762 1.3206 0.3543 10.5158 1.0582 0.2507 0.4279 0.9857 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 L24 mock treatment 11.7802 2.3246 0.6238 8.8349 -0.6227 -0.1475 0.3367 0.5254 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 M01 compound treatment 9.581 0.12544 0.0337 9.7634 0.30581 0.0725 0.075 0.9392 3214660 Ald1-H_000826 ONC(=O)CCCCCC(=O)N/N=C/c1ccc(O)c(F)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 M02 compound treatment 10.5927 1.1371 0.3051 11.9476 2.49 0.59 0.6329 0.9529 3214662 Ald1-H_000827 Oc1ccc(/C=N/NC(=O)CCCCCC(=O)Nc2ccccc2O)cc1F 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 M03 compound treatment 26.9494 17.494 4.694 40.5634 31.106 7.3701 8.5306 0.9763 3214664 Ald1-H_000828 ONC(=O)CCCCCC(=O)N/N=C/c1ccc(F)c(Oc2ccccc2)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 M04 compound treatment 11.4443 1.9887 0.5336 9.9545 0.49687 0.1177 0.4606 0.8428 3214666 Ald1-H_000829 Oc1ccccc1NC(=O)CCCCCC(=O)N/N=C/c2ccc(F)c(Oc3ccccc3)c2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 M05 compound treatment 68.0942 58.639 15.7342 15.3891 5.9315 1.4054 12.1195 0.7672 3214668 Ald1-H_000830 ONC(=O)CCCCCC(=O)N/N=C/c1cc(F)ccc1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 M06 compound treatment 11.3083 1.8528 0.4971 13.4796 4.022 0.953 1.0254 0.954 3214670 Ald1-H_000831 Oc1ccccc1NC(=O)CCCCCC(=O)N/N=C/c2cc(F)ccc2O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 M07 compound treatment 9.5017 0.046146 0.0124 10.5865 1.1289 0.2675 0.1979 0.739 3214672 Ald1-H_000832 ONC(=O)CCCCCC(=O)N/N=C/c1coc2ccccc2c1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 M08 compound treatment 9.42 -0.035557 -0.0095 8.4941 -0.96348 -0.2283 -0.1682 -0.736 3214674 Ald1-H_000833 Oc1ccccc1NC(=O)CCCCCC(=O)N/N=C/c2coc3ccccc3c2=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 M09 mock treatment 10.1334 0.67782 0.1819 9.4657 0.0081423 0.0019 0.13 0.7146 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 M10 mock treatment 7.0966 -2.3589 -0.633 8.6582 -0.79939 -0.1894 -0.5815 -0.8801 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 M11 compound treatment 194.3395 184.88 49.6091 189.093 179.64 42.562 65.1748 0.9971 3214676 Ald1-H_000834 CC(C)(C)OC(=O)Nc1ccc(/C=N/NC(=O)CCCCCC(=O)NO)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 M12 compound treatment 71.6366 62.181 16.6848 71.861 62.403 14.7856 22.2529 0.9982 3214678 Ald1-H_000835 CC(C)(C)OC(=O)Nc1ccc(/C=N/NC(=O)CCCCCC(=O)Nc2ccccc2O)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 M13 mock treatment 9.2434 -0.21214 -0.0569 10.2789 0.82128 0.1946 0.0973 0.4801 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 M14 mock treatment 8.7179 -0.73764 -0.1979 11.0044 1.5468 0.3665 0.1192 0.2862 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 M15 compound treatment 10.2559 0.80036 0.2148 8.2927 -1.1649 -0.276 -0.0433 -0.1238 3214680 Ald1-H_000836 ONC(=O)CCCCCC(=O)N/N=C/c1cccc(c1)B(O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 M16 compound treatment 10.6461 1.1906 0.3195 9.3706 -0.086995 -0.0206 0.2113 0.6601 3214682 Ald1-H_000837 OB(O)c1cccc(/C=N/NC(=O)CCCCCC(=O)Nc2ccccc2O)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 M17 compound treatment 110.0235 100.57 26.985 123.2345 113.78 26.9578 38.1433 1.0 3214684 Ald1-H_000838 ONC(=O)CCCCCC(=O)N/N=C/c1ccco1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 M18 compound treatment 16.6817 7.2261 1.9389 14.1192 4.6616 1.1045 2.152 0.9644 3214686 Ald1-H_000839 Oc1ccccc1NC(=O)CCCCCC(=O)N/N=C/c2ccco2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 M19 compound treatment 55.9181 46.463 12.4671 57.903 48.445 11.4784 16.932 0.9991 3214688 Ald1-H_000840 ONC(=O)CCCCCC(=O)N/N=C/c1ccoc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 M20 compound treatment 14.3017 4.8461 1.3003 12.8761 3.4185 0.81 1.4922 0.974 3214690 Ald1-H_000841 Oc1ccccc1NC(=O)CCCCCC(=O)N/N=C/c2ccoc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 M21 compound treatment 11.1762 1.7206 0.4617 10.9525 1.4949 0.3542 0.5769 0.9914 3214692 Ald1-H_000842 ONC(=O)CCCCCC(=O)N/N=C/c1cccc(O)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 M22 compound treatment 28.6504 19.195 5.1505 28.5156 19.058 4.5155 6.8349 0.9978 3214694 Ald1-H_000843 Oc1cccc(/C=N/NC(=O)CCCCCC(=O)Nc2ccccc2O)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 M23 compound treatment 12.9964 3.5408 0.9501 12.957 3.4994 0.8291 1.2581 0.9977 3214696 Ald1-H_000844 ONC(=O)CCCCCC(=O)N/N=C/c1ccc(O)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 M24 compound treatment 13.0165 3.5609 0.9555 13.384 3.9264 0.9303 1.3335 0.9999 3214698 Ald1-H_000845 Oc1ccc(/C=N/NC(=O)CCCCCC(=O)Nc2ccccc2O)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 N01 compound treatment 33.0024 23.547 6.3182 26.6111 17.154 4.0643 7.3415 0.9772 3214700 Ald1-H_000846 Cc1ccccc1/C=N/NC(=O)CCCCCC(=O)Nc2ccccc2O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 N02 compound treatment 274.7795 265.32 71.1932 321.965 312.51 74.044 102.6983 0.9998 3214702 Ald1-H_000847 Cc1ccccc1/C=N/NC(=O)CCCCCC(=O)NO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 N03 compound treatment 15.3123 5.8567 1.5715 11.6074 2.1498 0.5094 1.4714 0.8907 3214704 Ald1-H_000848 COc1cc(/C=N/NC(=O)CCCCCC(=O)Nc2ccccc2O)ccc1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 N04 compound treatment 11.2363 1.7807 0.4778 9.9069 0.44927 0.1064 0.4131 0.8439 3214706 Ald1-H_000849 COc1cc(/C=N/NC(=O)CCCCCC(=O)NO)ccc1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 N05 compound treatment 9.534 0.078378 0.021 9.3786 -0.078998 -0.0187 0.0016 0.0581 3214708 Ald1-H_000850 O[C@@H](/C=N/NC(=O)CCCCCC(=O)Nc1ccccc1O)[C@@H](O)[C@@H](O)[C@H](O)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 N06 compound treatment 11.9975 2.5419 0.6821 9.7546 0.29698 0.0704 0.5321 0.7759 3214710 Ald1-H_000851 ONC(=O)CCCCCC(=O)N/N=C/[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 N07 compound treatment 9.412 -0.043622 -0.0117 8.6404 -0.81717 -0.1936 -0.1452 -0.7485 3214712 Ald1-H_000852 OC[C@@H](O)[C@H](O)[C@@H](O)/C=N/NC(=O)CCCCCC(=O)Nc1ccccc1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 N08 compound treatment 10.7697 1.3141 0.3526 11.8149 2.3573 0.5585 0.6443 0.9754 3214713 Ald1-H_000853 OC[C@@H](O)[C@H](O)[C@@H](O)/C=N/NC(=O)CCCCCC(=O)NO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 N09 mock treatment 9.1673 -0.28823 -0.0773 8.4509 -1.0067 -0.2385 -0.2233 -0.8907 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 N10 mock treatment 10.2634 0.80783 0.2168 7.5317 -1.9259 -0.4563 -0.1694 -0.3353 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 N11 compound treatment 22.7223 13.267 3.5598 21.7089 12.251 2.9028 4.5697 0.9949 3214714 Ald1-H_000854 COc1ccc(/C=N/NC(=O)CCCCCC(=O)Nc2ccccc2O)cc1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 N12 compound treatment 10.0652 0.6096 0.1636 10.6645 1.2069 0.2859 0.3179 0.9649 3214716 Ald1-H_000855 COc1ccc(/C=N/NC(=O)CCCCCC(=O)NO)cc1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 N13 mock treatment 8.2019 -1.2537 -0.3364 10.4895 1.0319 0.2445 -0.065 -0.1563 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 N14 mock treatment 8.6783 -0.77732 -0.2086 9.3982 -0.05939 -0.0141 -0.1574 -0.7531 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 N15 compound treatment 16.9991 7.5435 2.0241 19.1577 9.7001 2.2983 3.0564 0.998 3214718 Ald1-H_000856 CCOc1cccc(/C=N/NC(=O)CCCCCC(=O)Nc2ccccc2O)c1OCC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 N16 compound treatment 264.0278 254.57 68.3083 260.5732 251.12 59.4982 90.3728 0.9976 3214720 Ald1-H_000857 CCOc1cccc(/C=N/NC(=O)CCCCCC(=O)NO)c1OCC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 N17 compound treatment 8.8091 -0.64645 -0.1735 9.1531 -0.30444 -0.0721 -0.1737 -0.9244 3214722 Ald1-H_000858 Oc1ccccc1NC(=O)CCCCCC(=O)N/N=C/c2cc(I)cc(I)c2O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 N18 compound treatment 16.5399 7.0843 1.9009 12.0168 2.5592 0.6064 1.7729 0.8886 3214724 Ald1-H_000859 ONC(=O)CCCCCC(=O)N/N=C/c1cc(I)cc(I)c1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 N19 compound treatment 13.7075 4.252 1.1409 19.4585 10.001 2.3696 2.4823 0.9439 3214726 Ald1-H_000860 CN(C)c1ccc(/C=N/NC(=O)CCCCCC(=O)Nc2ccccc2O)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 N20 compound treatment 262.037 252.58 67.7741 261.3555 251.9 59.6835 90.1261 0.998 3214728 Ald1-H_000861 CN(C)c1ccc(/C=N/NC(=O)CCCCCC(=O)NO)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 N21 compound treatment 9.7587 0.30316 0.0813 9.3705 -0.087085 -0.0206 0.0429 0.5115 3214730 Ald1-H_000862 CCn1c2ccccc2c3cc(/C=N/NC(=O)CCCCCC(=O)Nc4ccccc4O)ccc13 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 N22 compound treatment 123.0273 113.57 30.4742 132.293 122.84 29.104 42.1282 0.9997 3214732 Ald1-H_000863 CCn1c2ccccc2c3cc(/C=N/NC(=O)CCCCCC(=O)NO)ccc13 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 N23 compound treatment 11.4398 1.9842 0.5324 11.6235 2.1659 0.5132 0.7393 0.9998 3214734 Ald1-H_000864 Oc1ccccc1NC(=O)CCCCCC(=O)N/N=C/c2ccc(c(F)c2)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 N24 compound treatment 256.4103 246.95 66.2643 305.7945 296.34 70.2127 96.5038 0.9996 3214736 Ald1-H_000865 ONC(=O)CCCCCC(=O)N/N=C/c1ccc(c(F)c1)c2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 O01 compound treatment 13.8798 4.4242 1.1871 14.9496 5.492 1.3013 1.7595 0.9989 3214738 Ald1-H_000866 OCCOc1ccccc1/C=N/NC(=O)CCCCCC(=O)NO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 O02 compound treatment 33.3053 23.85 6.3995 41.5331 32.075 7.5998 9.899 0.9963 3214740 Ald1-H_000867 OCCOc1ccccc1/C=N/NC(=O)CCCCCC(=O)Nc2ccccc2O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 O03 compound treatment 12.0724 2.6168 0.7022 10.652 1.1944 0.283 0.6966 0.9202 3214742 Ald1-H_000868 OCCOc1cccc(/C=N/NC(=O)CCCCCC(=O)NO)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 O04 compound treatment 24.8769 15.421 4.1379 27.1369 17.679 4.1889 5.8879 1.0 3214744 Ald1-H_000869 OCCOc1cccc(/C=N/NC(=O)CCCCCC(=O)Nc2ccccc2O)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 O05 compound treatment 15.6653 6.2097 1.6662 15.683 6.2254 1.475 2.2212 0.9982 3214746 Ald1-H_000870 OCCOc1ccc(/C=N/NC(=O)CCCCCC(=O)NO)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 O06 compound treatment 13.6128 4.1572 1.1155 19.6335 10.176 2.411 2.4936 0.9387 3214748 Ald1-H_000871 OCCOc1ccc(/C=N/NC(=O)CCCCCC(=O)Nc2ccccc2O)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 O07 compound treatment 17.0783 7.6227 2.0454 17.7075 8.2499 1.9547 2.8285 0.9997 3214750 Ald1-H_000872 COc1ccc(/C=N/NC(=O)CCCCCC(=O)NO)c(O)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 O08 compound treatment 12.0266 2.571 0.6899 10.0864 0.62882 0.149 0.5932 0.8404 3214752 Ald1-H_000873 COc1ccc(/C=N/NC(=O)CCCCCC(=O)Nc2ccccc2O)c(O)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 O09 compound treatment 11.6067 2.1511 0.5772 8.3947 -1.0629 -0.2518 0.2301 0.3653 3214754 Ald1-H_000874 COc1ccc(O)c(/C=N/NC(=O)CCCCCC(=O)NO)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 O10 compound treatment 20.5659 11.11 2.9812 19.2745 9.8169 2.326 3.7527 0.9925 3214756 Ald1-H_000875 COc1ccc(O)c(/C=N/NC(=O)CCCCCC(=O)Nc2ccccc2O)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 O11 mock treatment 9.0156 -0.43997 -0.1181 8.4377 -1.0199 -0.2416 -0.2543 -0.9457 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 O12 mock treatment 10.2832 0.82761 0.2221 11.3085 1.8509 0.4386 0.4671 0.9503 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 O13 compound treatment 10.4993 1.0438 0.2801 10.8968 1.4392 0.341 0.4392 0.9952 3214758 Ald1-H_000876 COc1cc(/C=C/C=N/NC(=O)CCCCCC(=O)NO)ccc1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 O14 compound treatment 13.7077 4.2521 1.141 15.8828 6.4253 1.5224 1.8833 0.9899 3214760 Ald1-H_000877 COc1cc(/C=C/C=N/NC(=O)CCCCCC(=O)Nc2ccccc2O)ccc1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 O15 compound treatment 17.4249 7.9693 2.1384 20.0041 10.547 2.4988 3.279 0.997 3214762 Ald1-H_000878 Cc1ccc(O)c(/C=N/NC(=O)CCCCCC(=O)NO)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 O16 compound treatment 16.0201 6.5645 1.7614 15.0764 5.6188 1.3313 2.1869 0.9905 3214764 Ald1-H_000879 Cc1ccc(O)c(/C=N/NC(=O)CCCCCC(=O)Nc2ccccc2O)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 O17 compound treatment 9.9055 0.44988 0.1207 10.7763 1.3187 0.3124 0.3063 0.9144 3214766 Ald1-H_000880 OCc1ccc(/C=N/NC(=O)CCCCCC(=O)NO)o1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 O18 compound treatment 9.4419 -0.013697 -0.0037 11.5557 2.0982 0.4971 0.3489 0.7019 3214768 Ald1-H_000881 OCc1ccc(/C=N/NC(=O)CCCCCC(=O)Nc2ccccc2O)o1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 O19 compound treatment 10.304 0.84842 0.2277 10.0726 0.61499 0.1457 0.264 0.9768 3214770 Ald1-H_000882 ONC(=O)CCCCCC(=O)N/N=C/c1ccc2ccccc2c1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 O20 compound treatment 10.2054 0.74983 0.2012 9.7714 0.31378 0.0743 0.1948 0.9084 3214772 Ald1-H_000883 Oc1ccccc1NC(=O)CCCCCC(=O)N/N=C/c2ccc3ccccc3c2O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 O21 compound treatment 167.8823 158.43 42.51 181.354 171.9 40.7283 58.8584 0.9998 3214774 Ald1-H_000884 ONC(=O)CCCCCC(=O)N/N=C/c1ccc(o1)c2cccc(Cl)c2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 O22 compound treatment 15.8612 6.4056 1.7188 19.6778 10.22 2.4215 2.9276 0.9859 3214776 Ald1-H_000885 Oc1ccccc1NC(=O)CCCCCC(=O)N/N=C/c2ccc(o2)c3cccc(Cl)c3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 O23 compound treatment 9.4849 0.029346 0.0079 9.9378 0.4802 0.1138 0.086 0.7542 3214778 Ald1-H_000886 ONC(=O)CCCCCC(=O)N/N=C/c1cc(Br)c(O)c(Br)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 O24 compound treatment 9.5439 0.088323 0.0237 10.1789 0.72136 0.1709 0.1376 0.7975 3214780 Ald1-H_000887 Oc1ccccc1NC(=O)CCCCCC(=O)N/N=C/c2cc(Br)c(O)c(Br)c2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 P01 compound treatment 10.5084 1.0528 0.2825 10.95 1.4924 0.3536 0.4498 0.9938 3214782 Ald1-H_000888 Oc1ccccc1NC(=O)CCCCCC(=O)N/N=C/c2ccc(o2)S(=O)(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 P02 compound treatment 7.6742 -1.7814 -0.478 11.7134 2.2558 0.5345 0.04 0.0557 3214784 Ald1-H_000889 ONC(=O)CCCCCC(=O)N/N=C/c1ccc(o1)S(=O)(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 P03 compound treatment 23.3432 13.888 3.7264 27.2476 17.79 4.2151 5.6155 0.9981 3214786 Ald1-H_000890 Cn1cc(/C=N/NC(=O)CCCCCC(=O)Nc2ccccc2O)c3ccccc13 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 P04 compound treatment 102.8338 93.378 25.0558 111.1223 101.66 24.088 34.7499 0.9998 3214788 Ald1-H_000891 Cn1cc(/C=N/NC(=O)CCCCCC(=O)NO)c2ccccc12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 P05 compound treatment 12.0262 2.5706 0.6898 11.9786 2.521 0.5973 0.9101 0.9974 3214790 Ald1-H_000892 Oc1ccccc1NC(=O)CCCCCC(=O)N/N=C/c2cn(Cc3ccccc3)c4ccccc24 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 P06 compound treatment 31.2111 21.756 5.8376 41.7571 32.3 7.6529 9.5392 0.9911 3214792 Ald1-H_000893 ONC(=O)CCCCCC(=O)N/N=C/c1cn(Cc2ccccc2)c3ccccc13 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 P07 compound treatment 14.0835 4.6279 1.2418 11.5027 2.0451 0.4846 1.2207 0.9158 3214794 Ald1-H_000894 Oc1ccccc1NC(=O)CCCCCC(=O)N/N=C/C2=CCCCC2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 P08 compound treatment 143.4295 133.97 35.9486 159.5645 150.11 35.5656 50.5682 1.0 3214796 Ald1-H_000895 ONC(=O)CCCCCC(=O)N/N=C/C1=CCCCC1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 P09 compound treatment 12.9641 3.5085 0.9414 8.903 -0.55464 -0.1314 0.5728 0.6026 3214798 Ald1-H_000896 OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)/C=N/NC(=O)CCCCCC(=O)Nc1ccccc1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 P10 compound treatment 10.99 1.5344 0.4117 10.3184 0.86086 0.204 0.4354 0.9475 3214799 Ald1-H_000897 OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)/C=N/NC(=O)CCCCCC(=O)NO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 P11 mock treatment 11.2897 1.8341 0.4921 10.5288 1.0713 0.2538 0.5275 0.9526 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 P12 mock treatment 8.6641 -0.79153 -0.2124 7.1424 -2.3152 -0.5485 -0.5381 -0.9147 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 P13 compound treatment 8.9999 -0.45564 -0.1223 9.3249 -0.13265 -0.0314 -0.1087 -0.8609 3214800 Ald1-H_000898 OC[C@@H](O)[C@@H](O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O)[C@H](O)[C@@H](O)/C=N/NC(=O)CCCCCC(=O)Nc2ccccc2O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 P14 compound treatment 9.891 0.43547 0.1168 9.8071 0.34951 0.0828 0.1412 0.9858 3214802 Ald1-H_000899 OC[C@@H](O)[C@@H](O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O)[C@H](O)[C@@H](O)/C=N/NC(=O)CCCCCC(=O)NO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 P15 compound treatment 11.7155 2.2599 0.6064 9.8432 0.38563 0.0914 0.4934 0.8046 3214804 Ald1-H_000900 OC[C@H]1O[C@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)/C=N/NC(=O)CCCCCC(=O)Nc2ccccc2O)[C@H](O)[C@@H](O)[C@H]1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 P16 compound treatment 10.0104 0.55482 0.1489 9.5104 0.052855 0.0125 0.1141 0.7639 3214806 Ald1-H_000901 OC[C@H]1O[C@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)/C=N/NC(=O)CCCCCC(=O)NO)[C@H](O)[C@@H](O)[C@H]1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 P17 compound treatment 10.3333 0.8777 0.2355 9.3684 -0.089195 -0.0211 0.1516 0.6411 3214808 Ald1-H_000902 C/C(=N\NC(=O)CCCCCC(=O)Nc1ccccc1O)/C[P+](c2ccccc2)(c3ccccc3)c4ccccc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 P18 compound treatment 9.5183 0.062713 0.0168 9.0342 -0.42339 -0.1003 -0.059 -0.5804 3214810 Ald1-H_000903 C/C(=N\NC(=O)CCCCCC(=O)NO)/C[P+](c1ccccc1)(c2ccccc2)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 P19 compound treatment 67.0837 57.628 15.4631 68.4738 59.016 13.983 20.8216 0.9987 3214812 Ald1-H_000904 CN(C)CCCOc1ccc(/C=N/NC(=O)CCCCCC(=O)Nc2ccccc2O)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 P20 compound treatment 74.8182 65.363 17.5385 72.8798 63.422 15.027 23.0272 0.997 3214814 Ald1-H_000905 CN(C)CCCOc1ccc(/C=N/NC(=O)CCCCCC(=O)NO)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 P21 compound treatment 19.8297 10.374 2.7836 29.1169 19.659 4.658 5.262 0.9697 3214816 Ald1-H_000906 CCOc1cc(/C=N/NC(=O)CCCCCC(=O)Nc2ccccc2O)ccc1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 P22 compound treatment 8.3173 -1.1383 -0.3054 10.6824 1.2248 0.2902 -0.0108 -0.0256 3214818 Ald1-H_000907 CCOc1cc(/C=N/NC(=O)CCCCCC(=O)NO)ccc1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 P23 compound treatment 12.7448 3.2892 0.8826 14.0288 4.5712 1.0831 1.3899 0.9948 3214820 Ald1-H_000908 CN(CCO)c1ccc(/C=N/NC(=O)CCCCCC(=O)Nc2ccccc2O)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2133 P24 compound treatment 13.9899 4.5343 1.2167 13.9371 4.4795 1.0614 1.6108 0.9977 3214822 Ald1-H_000909 CN(CCO)c1ccc(/C=N/NC(=O)CCCCCC(=O)NO)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 A01 compound treatment 10.0585 0.50707 0.1361 9.9072 0.14019 0.0332 0.1197 0.8546 3214824 Ald1-H_000910 NNC(=O)CCCCC(=O)NO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 A02 compound treatment 10.895 1.3436 0.3605 9.7731 0.0061594 0.0015 0.256 0.71 3214825 Ald1-H_000911 COC(=O)CCCCCCC(=O)NN 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 A03 compound treatment 251.26 241.71 64.8566 269.3877 259.62 61.5133 89.3571 0.9997 3214826 Ald1-H_000912 ONC(=O)CCCCC(=O)N/N=C/c1ccccc1OCC=C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 A04 compound treatment 11.2936 1.7422 0.4675 9.5243 -0.24271 -0.0575 0.2899 0.6155 3214828 Ald1-H_000913 COC(=O)CCCCCCC(=O)N/N=C/c1ccccc1OCC=C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 A05 compound treatment 17.2001 7.6487 2.0523 20.3953 10.628 2.5182 3.2319 0.9948 3214830 Ald1-H_000914 COc1ccc(/C=N/NC(=O)CCCCC(=O)NO)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 A06 compound treatment 11.3389 1.7875 0.4796 10.4775 0.71055 0.1684 0.4582 0.9014 3214832 Ald1-H_000915 COC(=O)CCCCCCC(=O)N/N=C/c1ccc(OC)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 A07 compound treatment 65.9826 56.431 15.1419 70.5731 60.806 14.4071 20.8943 0.9997 3214834 Ald1-H_000916 ONC(=O)CCCCC(=O)N/N=C/c1ccccc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 A08 compound treatment 10.8861 1.3346 0.3581 14.6413 4.8743 1.1549 1.0699 0.8848 3214836 Ald1-H_000917 COC(=O)CCCCCCC(=O)N/N=C/c1ccccc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 A09 compound treatment 17.481 7.9296 2.1277 25.6627 15.896 3.7663 4.1677 0.9635 3214838 Ald1-H_000918 ONC(=O)CCCCC(=O)N/N=C/c1ccc2OCCOc2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 A10 compound treatment 11.8585 2.3071 0.6191 9.6736 -0.093403 -0.0221 0.4221 0.6814 3214840 Ald1-H_000919 COC(=O)CCCCCCC(=O)N/N=C/c1ccc2OCCOc2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 A11 compound treatment 11.4717 1.9202 0.5152 9.7371 -0.029908 -0.0071 0.3593 0.6973 3214842 Ald1-H_000920 ONC(=O)CCCCC(=O)N/N=C/COCc1ccccc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 A12 compound treatment 10.2903 0.73887 0.1983 10.3653 0.59835 0.1418 0.2404 0.9865 3214844 Ald1-H_000921 COC(=O)CCCCCCC(=O)N/N=C/COCc1ccccc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 A13 mock treatment 9.3832 -0.16829 -0.0452 9.7119 -0.055051 -0.013 -0.0412 -0.8756 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 A14 mock treatment 10.3663 0.81488 0.2187 8.9531 -0.81391 -0.1928 0.0182 0.0626 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 A15 compound treatment 124.669 115.12 30.889 145.105 135.34 32.0664 44.5162 0.9998 3214846 Ald1-H_000922 ONC(=O)CCCCC(=O)N/N=C/c1ccc(cc1)c2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 A16 compound treatment 9.4141 -0.13739 -0.0369 10.4688 0.70184 0.1663 0.0915 0.5373 3214848 Ald1-H_000923 COC(=O)CCCCCCC(=O)N/N=C/c1ccc(cc1)c2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 A17 compound treatment 302.8835 293.33 78.7085 294.268 284.5 67.4083 103.3202 0.997 3214850 Ald1-H_000924 ONC(=O)CCCCC(=O)N/N=C/c1ccccc1Br 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 A18 compound treatment 11.5076 1.9562 0.5249 9.9962 0.22922 0.0543 0.4096 0.7761 3214852 Ald1-H_000925 COC(=O)CCCCCCC(=O)N/N=C/c1ccccc1Br 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 A19 compound treatment 28.9951 19.444 5.2172 28.8274 19.06 4.5161 6.8825 0.9974 3214854 Ald1-H_000926 ONC(=O)CCCCC(=O)N/N=C/c1cccc(Br)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 A20 compound treatment 12.5215 2.9701 0.7969 10.5853 0.81835 0.1939 0.7006 0.8542 3214856 Ald1-H_000927 COC(=O)CCCCCCC(=O)N/N=C/c1cccc(Br)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 A21 compound treatment 47.3731 37.822 10.1485 40.8703 31.103 7.3695 12.3871 0.9876 3214858 Ald1-H_000928 ONC(=O)CCCCC(=O)N/N=C/c1ccc(Br)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 A22 compound treatment 10.5097 0.9583 0.2571 10.2694 0.50241 0.119 0.266 0.9387 3214860 Ald1-H_000929 COC(=O)CCCCCCC(=O)N/N=C/c1ccc(Br)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 A23 compound treatment 12.7338 3.1823 0.8539 9.5632 -0.20382 -0.0483 0.5696 0.6661 3214862 Ald1-H_000930 ONC(=O)CCCCC(=O)N/N=C/C(=C/c1ccccc1)/Br 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 A24 compound treatment 12.5812 3.0298 0.813 10.7581 0.99113 0.2348 0.7409 0.8756 3214864 Ald1-H_000931 COC(=O)CCCCCCC(=O)N/N=C/C(=C/c1ccccc1)/Br 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 B01 compound treatment 9.5003 -0.051142 -0.0137 9.7644 -0.0025606 -6.0E-4 -0.0101 -0.7376 3214866 Ald1-H_000932 COC(=O)CCCCCCC(=O)N/N=C/c1c(O)ccc2ccccc12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 B02 compound treatment 50.4193 40.868 10.9659 74.0314 64.264 15.2265 18.5208 0.987 3214868 Ald1-H_000933 ONC(=O)CCCCC(=O)N/N=C/c1c(O)ccc2ccccc12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 B03 compound treatment 8.1567 -1.3947 -0.3742 10.3898 0.6228 0.1476 -0.1603 -0.3984 3214870 Ald1-H_000934 COC(=O)CCCCCCC(=O)N/N=C/c1ccc(O)c2ccccc12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 B04 compound treatment 12.3852 2.8338 0.7604 13.439 3.672 0.87 1.1529 0.9977 3214872 Ald1-H_000935 ONC(=O)CCCCC(=O)N/N=C/c1ccc(O)c2ccccc12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 B05 compound treatment 7.4516 -2.0999 -0.5634 9.3414 -0.42556 -0.1008 -0.4697 -0.8206 3214874 Ald1-H_000936 COC(=O)CCCCCCC(=O)N/N=C/c1ccc([N+](=O)[O-])c(O)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 B06 compound treatment 9.625 0.073516 0.0197 10.6691 0.90209 0.2137 0.1651 0.7691 3214876 Ald1-H_000937 ONC(=O)CCCCC(=O)N/N=C/c1ccc([N+](=O)[O-])c(O)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 B07 compound treatment 9.6574 0.10592 0.0284 8.842 -0.92497 -0.2192 -0.1349 -0.6103 3214878 Ald1-H_000938 COC(=O)CCCCCCC(=O)N/N=C/c1cc(O)ccc1[N+](=O)[O-] 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 B08 compound treatment 8.8663 -0.68515 -0.1838 10.0089 0.24193 0.0573 -0.0895 -0.4646 3214880 Ald1-H_000939 ONC(=O)CCCCC(=O)N/N=C/c1cc(O)ccc1[N+](=O)[O-] 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 B09 compound treatment 9.0493 -0.50218 -0.1347 10.7086 0.94162 0.2231 0.0625 0.2397 3214882 Ald1-H_000940 COC(=O)CCCCCCC(=O)N/N=C/c1ccc(cc1)n2ccnc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 B10 compound treatment 10.3692 0.81779 0.2194 11.372 1.605 0.3803 0.4241 0.9659 3214884 Ald1-H_000941 ONC(=O)CCCCC(=O)N/N=C/c1ccc(cc1)n2ccnc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 B11 compound treatment 10.1717 0.62024 0.1664 10.4568 0.68977 0.1634 0.2332 1.0 3214886 Ald1-H_000942 COC(=O)CCCCCCC(=O)N/N=C/c1c[nH]c2ccccc12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 B12 compound treatment 12.3553 2.8038 0.7523 14.3011 4.5341 1.0743 1.2916 0.9848 3214888 Ald1-H_000943 ONC(=O)CCCCC(=O)N/N=C/c1c[nH]c2ccccc12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 B13 mock treatment 8.6712 -0.88028 -0.2362 8.0451 -1.7219 -0.408 -0.4555 -0.9662 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 B14 mock treatment 10.7741 1.2226 0.3281 9.5555 -0.21144 -0.0501 0.1965 0.5923 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 B15 compound treatment 10.1 0.54851 0.1472 9.013 -0.75394 -0.1786 -0.0222 -0.0961 3214890 Ald1-H_000944 COC(=O)CCCCCCC(=O)N/N=C/c1ccc(I)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 B16 compound treatment 90.7524 81.201 21.7883 110.9716 101.2 23.979 32.3623 0.9989 3214892 Ald1-H_000945 ONC(=O)CCCCC(=O)N/N=C/c1ccc(I)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 B17 compound treatment 9.6508 0.099306 0.0266 12.1801 2.4131 0.5717 0.4231 0.7393 3214894 Ald1-H_000946 COC(=O)CCCCCCC(=O)N/N=C/C(=C\C)/C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 B18 compound treatment 12.192 2.6406 0.7085 10.9136 1.1467 0.2717 0.6931 0.9134 3214896 Ald1-H_000947 C/C=C(/C)\C=N\NC(=O)CCCCC(=O)NO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 B19 compound treatment 10.0936 0.54218 0.1455 10.3088 0.54178 0.1284 0.1936 0.9981 3214898 Ald1-H_000948 COC(=O)CCCCCCC(=O)N/N=C/c1ccccc1[N+](=O)[O-] 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 B20 compound treatment 13.0418 3.4904 0.9366 12.6926 2.9256 0.6932 1.1524 0.989 3214900 Ald1-H_000949 ONC(=O)CCCCC(=O)N/N=C/c1ccccc1[N+](=O)[O-] 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 B21 compound treatment 8.8474 -0.70402 -0.1889 9.8023 0.035344 0.0084 -0.1277 -0.6751 3214902 Ald1-H_000950 COC(=O)CCCCCCC(=O)N/N=C/c1ccc(C)o1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 B22 compound treatment 30.5027 20.951 5.6218 30.4511 20.684 4.9008 7.4406 0.9977 3214904 Ald1-H_000951 Cc1ccc(/C=N/NC(=O)CCCCC(=O)NO)o1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 B23 compound treatment 8.975 -0.57643 -0.1547 10.2724 0.50538 0.1197 -0.0247 -0.1263 3214906 Ald1-H_000952 COC(=O)CCCCCCC(=O)N/N=C/c1nc[nH]c1C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 B24 compound treatment 11.585 2.0336 0.5457 9.628 -0.13898 -0.0329 0.3626 0.6632 3214908 Ald1-H_000953 Cc1[nH]cnc1/C=N/NC(=O)CCCCC(=O)NO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 C01 compound treatment 9.5306 -0.020857 -0.0056 10.4517 0.68472 0.1622 0.1108 0.6823 3214910 Ald1-H_000954 ONC(=O)CCCCC(=O)N/N=C/c1ccc(Br)o1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 C02 compound treatment 10.0278 0.4764 0.1278 9.2175 -0.54951 -0.1302 -0.0017 -0.0092 3214912 Ald1-H_000955 COC(=O)CCCCCCC(=O)N/N=C/c1ccc(Br)o1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 C03 compound treatment 63.0794 53.528 14.3629 69.544 59.777 14.1633 20.1711 1.0 3214914 Ald1-H_000956 ONC(=O)CCCCC(=O)N/N=C/c1ccc(O)cc1Br 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 C04 compound treatment 9.5232 -0.028222 -0.0076 11.1124 1.3454 0.3188 0.2201 0.6901 3214916 Ald1-H_000957 COC(=O)CCCCCCC(=O)N/N=C/c1ccc(O)cc1Br 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 C05 compound treatment 44.0592 34.508 9.2593 43.1757 33.409 7.9157 12.1446 0.997 3214918 Ald1-H_000958 ONC(=O)CCCCC(=O)N/N=C/c1cc(O)ccc1Br 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 C06 compound treatment 8.1553 -1.3962 -0.3746 12.7319 2.965 0.7025 0.2318 0.2912 3214920 Ald1-H_000959 COC(=O)CCCCCCC(=O)N/N=C/c1cc(O)ccc1Br 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 C07 compound treatment 9.156 -0.39546 -0.1061 9.2763 -0.4907 -0.1163 -0.1572 -0.999 3214922 Ald1-H_000960 COc1cc(Br)cc(/C=N/NC(=O)CCCCC(=O)NO)c1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 C08 compound treatment 7.3656 -2.1858 -0.5865 9.998 0.23106 0.0547 -0.376 -0.6383 3214924 Ald1-H_000961 COC(=O)CCCCCCC(=O)N/N=C/c1cc(Br)cc(OC)c1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 C09 compound treatment 367.6338 358.08 96.0827 322.968 313.2 74.2084 120.414 0.9919 3214926 Ald1-H_000962 COc1ccc(Br)c(/C=N/NC(=O)CCCCC(=O)NO)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 C10 compound treatment 9.1624 -0.38903 -0.1044 11.0618 1.2948 0.3068 0.1431 0.4416 3214928 Ald1-H_000963 COC(=O)CCCCCCC(=O)N/N=C/c1cc(OC)ccc1Br 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 C11 mock treatment 9.716 0.16452 0.0441 10.4421 0.67515 0.16 0.1443 0.8697 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 C12 mock treatment 9.0302 -0.52129 -0.1399 9.7405 -0.026508 -0.0063 -0.1033 -0.7381 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 C13 compound treatment 347.6723 338.12 90.7265 303.1 293.33 69.501 113.2979 0.9913 3214930 Ald1-H_000964 COc1ccc(Br)cc1/C=N/NC(=O)CCCCC(=O)NO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 C14 compound treatment 9.6875 0.13602 0.0365 9.3406 -0.42636 -0.101 -0.0456 -0.4248 3214932 Ald1-H_000965 COC(=O)CCCCCCC(=O)N/N=C/c1cc(Br)ccc1OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 C15 mock treatment 10.028 0.4766 0.1279 9.3309 -0.43613 -0.1033 0.0174 0.1056 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 C16 mock treatment 9.8213 0.2699 0.0724 12.1888 2.4218 0.5738 0.457 0.7901 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 C17 compound treatment 290.5813 281.03 75.4075 295.5933 285.83 67.7223 101.2081 0.9986 3214934 Ald1-H_000966 ONC(=O)CCCCC(=O)N/N=C/c1cc2OCOc2cc1Br 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 C18 compound treatment 10.284 0.73252 0.1966 9.6932 -0.073793 -0.0175 0.1266 0.6417 3214936 Ald1-H_000967 COC(=O)CCCCCCC(=O)N/N=C/c1cc2OCOc2cc1Br 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 C19 compound treatment 28.5685 19.017 5.1028 35.9803 26.213 6.2109 8.0 0.9952 3214938 Ald1-H_000968 ONC(=O)CCCCC(=O)N/N=C/c1cccnc1Br 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 C20 compound treatment 8.9032 -0.64825 -0.1739 8.9642 -0.80277 -0.1902 -0.2575 -0.999 3214940 Ald1-H_000969 COC(=O)CCCCCCC(=O)N/N=C/c1cccnc1Br 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 C21 compound treatment 63.0292 53.478 14.3495 61.7836 52.017 12.3246 18.8614 0.9971 3214942 Ald1-H_000970 ONC(=O)CCCCC(=O)N/N=C/c1ccncc1Br 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 C22 compound treatment 9.2382 -0.31321 -0.084 8.9175 -0.84953 -0.2013 -0.2018 -0.925 3214944 Ald1-H_000971 COC(=O)CCCCCCC(=O)N/N=C/c1ccncc1Br 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 C23 compound treatment 9.7359 0.18448 0.0495 10.7043 0.93732 0.2221 0.192 0.844 3214946 Ald1-H_000972 ONC(=O)CCCCC(=O)N/N=C/c1cc(Br)ccc1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 C24 compound treatment 9.0269 -0.52449 -0.1407 10.2364 0.46943 0.1112 -0.0209 -0.1163 3214948 Ald1-H_000973 COC(=O)CCCCCCC(=O)N/N=C/c1cc(Br)ccc1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 D01 compound treatment 9.4351 -0.11634 -0.0312 8.2873 -1.4797 -0.3506 -0.27 -0.767 3214950 Ald1-H_000974 COC(=O)CCCCCCC(=O)N/N=C/c1sccc1C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 D02 compound treatment 202.5462 192.99 51.7855 244.486 234.72 55.6132 75.9423 0.9994 3214952 Ald1-H_000975 Cc1ccsc1/C=N/NC(=O)CCCCC(=O)NO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 D03 compound treatment 10.128 0.5766 0.1547 9.8791 0.11213 0.0266 0.1282 0.8166 3214954 Ald1-H_000976 COC(=O)CCCCCCC(=O)N/N=C/C1=CC[C@H]2C[C@@H]1C2(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 D04 compound treatment 21.6408 12.089 3.2439 26.0545 16.288 3.8591 5.0226 0.9963 3214956 Ald1-H_000977 CC1(C)[C@@H]2C[C@H]1C(=CC2)/C=N/NC(=O)CCCCC(=O)NO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 D05 compound treatment 8.796 -0.75542 -0.2027 9.9446 0.17759 0.0421 -0.1136 -0.5486 3214958 Ald1-H_000978 COC(=O)CCCCCCC(=O)N/N=C/c1cccc2ccccc12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 D06 compound treatment 299.6405 290.09 77.8384 310.9978 301.23 71.3722 105.5078 0.9991 3214960 Ald1-H_000979 ONC(=O)CCCCC(=O)N/N=C/c1cccc2ccccc12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 D07 compound treatment 8.7674 -0.78406 -0.2104 8.5849 -1.1821 -0.2801 -0.3468 -0.9901 3214962 Ald1-H_000980 COC(=O)CCCCCCC(=O)N/N=C/c1cc(OC)c(OC)cc1[N+](=O)[O-] 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 D08 compound treatment 102.4276 92.876 24.9211 120.4448 110.68 26.2235 36.1647 0.9997 3214964 Ald1-H_000981 COc1cc(/C=N/NC(=O)CCCCC(=O)NO)c(cc1OC)[N+](=O)[O-] 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 D09 compound treatment 9.1301 -0.4213 -0.113 10.5228 0.7558 0.1791 0.0467 0.2205 3214966 Ald1-H_000982 COC(=O)CCCCCCC(=O)N/N=C/c1ccc2ccccc2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 D10 compound treatment 46.2915 36.74 9.8583 42.6206 32.854 7.7842 12.4751 0.9932 3214968 Ald1-H_000983 ONC(=O)CCCCC(=O)N/N=C/c1ccc2ccccc2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 D11 mock treatment 8.5495 -1.0019 -0.2688 8.8121 -0.95493 -0.2263 -0.3501 -0.9963 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 D12 mock treatment 9.6195 0.068023 0.0183 8.0804 -1.6866 -0.3996 -0.2697 -0.6741 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 D13 compound treatment 8.7021 -0.84934 -0.2279 9.2704 -0.49655 -0.1177 -0.2443 -0.9527 3214970 Ald1-H_000984 COC(=O)CCCCCCC(=O)N/N=C/c1ccc(s1)[N+](=O)[O-] 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 D14 compound treatment 13.105 3.5535 0.9535 13.91 4.143 0.9816 1.3683 0.9999 3214972 Ald1-H_000985 ONC(=O)CCCCC(=O)N/N=C/c1ccc(s1)[N+](=O)[O-] 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 D15 mock treatment 8.5832 -0.96823 -0.2598 7.8807 -1.8863 -0.4469 -0.4997 -0.9667 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 D16 mock treatment 8.3183 -1.2331 -0.3309 10.369 0.60205 0.1426 -0.1331 -0.3694 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 D17 compound treatment 7.8195 -1.7319 -0.4647 10.561 0.79401 0.1881 -0.1956 -0.3901 3214974 Ald1-H_000986 COC(=O)CCCCCCC(=O)N/N=C/c1c(F)c(F)c(F)c(F)c1F 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 D18 compound treatment 12.4056 2.8541 0.7658 13.3605 3.5935 0.8514 1.1436 0.9986 3214976 Ald1-H_000987 ONC(=O)CCCCC(=O)N/N=C/c1c(F)c(F)c(F)c(F)c1F 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 D19 compound treatment 9.1535 -0.39794 -0.1068 8.7706 -0.9964 -0.2361 -0.2424 -0.9357 3214978 Ald1-H_000988 COC(=O)CCCCCCC(=O)N/N=C/CCC=C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 D20 compound treatment 10.5096 0.95811 0.2571 12.1394 2.3724 0.5621 0.5793 0.9371 3214980 Ald1-H_000989 ONC(=O)CCCCC(=O)N/N=C/CCC=C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 D21 compound treatment 8.0565 -1.4949 -0.4011 10.8951 1.1281 0.2673 -0.0946 -0.1963 3214982 Ald1-H_000990 COC(=O)CCCCCCC(=O)N/N=C/C1=CC[C@H](CC1)C(=C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 D22 compound treatment 19.8684 10.317 2.7683 20.2365 10.469 2.4806 3.7115 0.9985 3214984 Ald1-H_000991 CC(=C)[C@H]1CCC(=CC1)/C=N/NC(=O)CCCCC(=O)NO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 D23 compound treatment 7.9002 -1.6513 -0.4431 7.9529 -1.8141 -0.4298 -0.6172 -0.9999 3214986 Ald1-H_000992 COC(=O)CCCCCCC(=O)N/N=C/c1cccc(Oc2ccccc2)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 D24 compound treatment 130.1955 120.64 32.3719 152.5288 142.76 33.8253 46.8085 0.9998 3214988 Ald1-H_000993 ONC(=O)CCCCC(=O)N/N=C/c1cccc(Oc2ccccc2)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 E01 mock treatment 11.916 2.3646 0.6345 8.5389 -1.2281 -0.291 0.2429 0.348 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 E02 mock treatment 9.7855 0.23405 0.0628 9.1576 -0.60941 -0.1444 -0.0577 -0.3664 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 E03 compound treatment 166.26 156.71 42.0489 150.0785 140.31 33.2448 53.2407 0.9932 3214990 Ald1-H_000994 ONC(=O)CCCCC(=O)N/N=C/c1ccc(Br)s1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 E04 compound treatment 9.2503 -0.30114 -0.0808 10.4966 0.72963 0.1729 0.0651 0.3412 3214992 Ald1-H_000995 COC(=O)CCCCCCC(=O)N/N=C/c1ccc(Br)s1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 E05 compound treatment 9.9227 0.37126 0.0996 10.5061 0.73909 0.1751 0.1943 0.9643 3214994 Ald1-H_000996 COc1cc(/C=N/NC(=O)CCCCC(=O)NO)c(Br)cc1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 E06 compound treatment 8.2409 -1.3105 -0.3517 7.6563 -2.1106 -0.5001 -0.6023 -0.9852 3214996 Ald1-H_000997 COC(=O)CCCCCCC(=O)N/N=C/c1cc(OC)c(O)cc1Br 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 E07 compound treatment 8.9313 -0.62018 -0.1664 8.574 -1.193 -0.2827 -0.3175 -0.9681 3214998 Ald1-H_000998 ONC(=O)CCCCC(=O)N/N=C/c1ccc(OCc2ccccc2)cc1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 E08 compound treatment 8.9621 -0.58932 -0.1581 8.7788 -0.98814 -0.2341 -0.2774 -0.9817 3215000 Ald1-H_000999 COC(=O)CCCCCCC(=O)N/N=C/c1ccc(OCc2ccccc2)cc1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 E09 mock treatment 12.7807 3.2292 0.8665 9.5108 -0.25614 -0.0607 0.5698 0.656 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 E10 mock treatment 8.9771 -0.57439 -0.1541 8.952 -0.81499 -0.1931 -0.2455 -0.9938 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 E11 compound treatment 10.6496 1.0981 0.2947 10.632 0.865 0.2049 0.3533 0.9843 3215002 Ald1-H_001000 CC(C)(C)OC(=O)NC1(CCCC1)/C=N/NC(=O)CCCCC(=O)NO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 E12 compound treatment 8.698 -0.85346 -0.229 10.6553 0.88834 0.2105 -0.0131 -0.0421 3215004 Ald1-H_001001 COC(=O)CCCCCCC(=O)N/N=C/C1(CCCC1)NC(=O)OC(C)(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 E13 compound treatment 11.41 1.8585 0.4987 12.5762 2.8092 0.6656 0.8233 0.9899 3215006 Ald1-H_001002 CC(C)(C)OC(=O)N1CCC[C@H]1/C=N/NC(=O)CCCCC(=O)NO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 E14 compound treatment 9.3189 -0.23252 -0.0624 8.5101 -1.2569 -0.2978 -0.2547 -0.8371 3215008 Ald1-H_001003 COC(=O)CCCCCCC(=O)N/N=C/[C@@H]1CCCN1C(=O)OC(C)(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 E15 compound treatment 10.3698 0.81839 0.2196 10.5197 0.75272 0.1783 0.2814 0.9947 3215010 Ald1-H_001004 CC(C)(C)OC(=O)Nc1cccc(/C=N/NC(=O)CCCCC(=O)NO)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 E16 compound treatment 8.7687 -0.78273 -0.21 9.1738 -0.59318 -0.1405 -0.2479 -0.9809 3215012 Ald1-H_001005 COC(=O)CCCCCCC(=O)N/N=C/c1cccc(NC(=O)OC(C)(C)C)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 E17 mock treatment 9.2681 -0.28333 -0.076 9.4717 -0.29524 -0.07 -0.1032 -0.9991 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 E18 mock treatment 7.9531 -1.5983 -0.4289 9.2866 -0.48038 -0.1138 -0.3837 -0.8648 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 E19 compound treatment 9.0906 -0.46088 -0.1237 7.1251 -2.6419 -0.626 -0.5301 -0.8307 3215014 Ald1-H_001006 ONC(=O)CCCCC(=O)N/N=C/c1cccc(c1)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 E20 compound treatment 9.249 -0.30248 -0.0812 10.4223 0.65531 0.1553 0.0524 0.2991 3215016 Ald1-H_001007 COC(=O)CCCCCCC(=O)N/N=C/c1cccc(c1)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 E21 compound treatment 10.8233 1.2719 0.3413 8.8578 -0.90917 -0.2154 0.089 0.2205 3215018 Ald1-H_001008 ONC(=O)CCCCC(=O)N/N=C/c1ccccc1C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 E22 compound treatment 9.7538 0.20232 0.0543 9.9871 0.22016 0.0522 0.0753 0.9998 3215020 Ald1-H_001009 COC(=O)CCCCCCC(=O)N/N=C/c1ccccc1C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 E23 compound treatment 10.3884 0.83694 0.2246 9.0405 -0.72652 -0.1721 0.0371 0.131 3215022 Ald1-H_001010 ONC(=O)CCCCC(=O)N/N=C/c1ccc(cc1)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 E24 compound treatment 9.464 -0.087474 -0.0235 8.9663 -0.80067 -0.1897 -0.1507 -0.7886 3215024 Ald1-H_001011 COC(=O)CCCCCCC(=O)N/N=C/c1ccc(cc1)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 F01 mock treatment 9.7503 0.19889 0.0534 7.9589 -1.8081 -0.4284 -0.2652 -0.6143 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 F02 mock treatment 11.8235 2.2721 0.6097 8.3276 -1.4394 -0.341 0.1899 0.2719 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 F03 compound treatment 9.7813 0.22983 0.0617 8.3843 -1.3826 -0.3276 -0.188 -0.5641 3215026 Ald1-H_001012 COC(=O)CCCCCCC(=O)N/N=C/c1cn(c2ccccc12)S(=O)(=O)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 F04 compound treatment 61.7306 52.179 14.001 72.5157 62.749 14.8674 20.413 0.9995 3215028 Ald1-H_001013 ONC(=O)CCCCC(=O)N/N=C/c1cn(c2ccccc12)S(=O)(=O)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 F05 compound treatment 9.0872 -0.46424 -0.1246 8.3183 -1.4487 -0.3432 -0.3308 -0.9059 3215030 Ald1-H_001014 COC(=O)CCCCCCC(=O)N/N=C/c1ccccn1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 F06 compound treatment 11.7226 2.1712 0.5826 11.161 1.394 0.3303 0.6455 0.9639 3215032 Ald1-H_001015 ONC(=O)CCCCC(=O)N/N=C/c1ccccn1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 F07 compound treatment 10.5656 1.0142 0.2721 10.5552 0.78825 0.1868 0.3245 0.9831 3215034 Ald1-H_001016 COC(=O)CCCCCCC(=O)N/N=C/c1cccnc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 F08 compound treatment 12.7827 3.2312 0.867 10.0399 0.27289 0.0647 0.6588 0.7577 3215036 Ald1-H_001017 ONC(=O)CCCCC(=O)N/N=C/c1cccnc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 F09 mock treatment 7.9001 -1.6514 -0.4431 9.0608 -0.70615 -0.1673 -0.4316 -0.9113 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 F10 mock treatment 10.7391 1.1877 0.3187 10.865 1.098 0.2602 0.4093 0.9949 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 F11 compound treatment 8.9857 -0.5657 -0.1518 10.9468 1.1798 0.2795 0.0903 0.284 3215038 Ald1-H_001018 COC(=O)CCCCCCC(=O)N/N=C/c1c(O)c(C)ncc1CO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 F12 compound treatment 10.1452 0.5938 0.1593 9.6778 -0.089151 -0.0211 0.0977 0.608 3215040 Ald1-H_001019 Cc1ncc(CO)c(/C=N/NC(=O)CCCCC(=O)NO)c1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 F13 compound treatment 8.7039 -0.84752 -0.2274 9.7037 -0.063273 -0.015 -0.1714 -0.7521 3215042 Ald1-H_001020 COC(=O)CCCCCCC(=O)N/N=C/c1ccc[nH]1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 F14 compound treatment 11.8221 2.2706 0.6093 10.3888 0.62186 0.1473 0.535 0.8535 3215044 Ald1-H_001021 ONC(=O)CCCCC(=O)N/N=C/c1ccc[nH]1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 F15 compound treatment 10.011 0.45959 0.1233 11.6255 1.8585 0.4403 0.3986 0.8716 3215046 Ald1-H_001022 COC(=O)CCCCCCC(=O)N/N=C/c1ccc(cc1)N2CCCC2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 F16 compound treatment 43.9969 34.446 9.2426 47.2059 37.439 8.8706 12.808 0.9998 3215048 Ald1-H_001023 ONC(=O)CCCCC(=O)N/N=C/c1ccc(cc1)N2CCCC2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 F17 mock treatment 10.3664 0.81494 0.2187 7.8121 -1.9548 -0.4632 -0.1729 -0.3375 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 F18 mock treatment 9.6332 0.081776 0.0219 8.7402 -1.0268 -0.2433 -0.1565 -0.6407 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 F19 compound treatment 8.8835 -0.66791 -0.1792 10.8702 1.1032 0.2614 0.0581 0.1833 3215050 Ald1-H_001024 COC(=O)CCCCCCC(=O)N/N=C/c1ccccc1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 F20 compound treatment 9.6004 0.048938 0.0131 10.5591 0.79212 0.1877 0.142 0.7547 3215052 Ald1-H_001025 ONC(=O)CCCCC(=O)N/N=C/c1ccccc1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 F21 compound treatment 9.3375 -0.21399 -0.0574 10.4336 0.66661 0.1579 0.0711 0.423 3215054 Ald1-H_001026 CCCCCCC/C=N/NC(=O)CCCCCCC(=O)OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 F22 compound treatment 10.1827 0.63126 0.1694 10.212 0.44502 0.1054 0.1943 0.974 3215056 Ald1-H_001027 CCCCCCC/C=N/NC(=O)CCCCC(=O)NO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 F23 compound treatment 8.2157 -1.3358 -0.3584 10.7244 0.95737 0.2268 -0.093 -0.2194 3215058 Ald1-H_001028 COC(=O)CCCCCCC(=O)N/N=C/c1nccs1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 F24 compound treatment 10.5942 1.0427 0.2798 11.8498 2.0828 0.4935 0.5468 0.9639 3215060 Ald1-H_001029 ONC(=O)CCCCC(=O)N/N=C/c1nccs1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 G01 compound treatment 243.7955 234.24 62.8537 248.3127 238.55 56.5199 84.4099 0.9986 3215062 Ald1-H_001030 ONC(=O)CCCCC(=O)N/N=C/c1ccccc1Cl 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 G02 compound treatment 10.091 0.53955 0.1448 10.8297 1.0627 0.2518 0.2804 0.9655 3215064 Ald1-H_001031 COC(=O)CCCCCCC(=O)N/N=C/c1ccccc1Cl 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 G03 mock treatment 9.7758 0.2244 0.0602 9.9839 0.21696 0.0514 0.0789 0.9969 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 G04 mock treatment 9.1039 -0.44755 -0.1201 10.2229 0.4559 0.108 -0.0085 -0.0528 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 G05 compound treatment 13.6976 4.1461 1.1125 13.5894 3.8225 0.9057 1.4271 0.9948 3215066 Ald1-H_001032 ONC(=O)CCCCC(=O)N/N=C/c1cccnc1Cl 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 G06 compound treatment 9.8757 0.32427 0.087 13.3939 3.6269 0.8593 0.6692 0.7747 3215068 Ald1-H_001033 COC(=O)CCCCCCC(=O)N/N=C/c1cccnc1Cl 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 G07 compound treatment 36.1348 26.583 7.133 50.6501 40.883 9.6866 11.8933 0.9887 3215070 Ald1-H_001034 ONC(=O)CCCCC(=O)N/N=C/C=C/c1ccccc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 G08 compound treatment 9.6807 0.12931 0.0347 11.9213 2.1543 0.5104 0.3855 0.7534 3215072 Ald1-H_001035 COC(=O)CCCCCCC(=O)N/N=C/C=C/c1ccccc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 G09 compound treatment 10.1185 0.56702 0.1521 8.7968 -0.97021 -0.2299 -0.055 -0.1994 3215074 Ald1-H_001036 C[C@H](CCC=C(C)C)C/C=N/NC(=O)CCCCC(=O)NO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 G10 compound treatment 8.838 -0.71341 -0.1914 9.7383 -0.028678 -0.0068 -0.1402 -0.7317 3215076 Ald1-H_001037 COC(=O)CCCCCCC(=O)N/N=C/C[C@H](C)CCC=C(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 G11 compound treatment 8.3451 -1.2064 -0.3237 11.138 1.371 0.3248 8.0E-4 0.0018 3215078 Ald1-H_001038 C[C@@H](CCC=C(C)C)C/C=N/NC(=O)CCCCC(=O)NO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 G12 compound treatment 8.9725 -0.57893 -0.1553 10.9273 1.1603 0.2749 0.0846 0.2678 3215079 Ald1-H_001039 COC(=O)CCCCCCC(=O)N/N=C/C[C@@H](C)CCC=C(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 G13 compound treatment 10.4476 0.89613 0.2405 9.3534 -0.41363 -0.098 0.1007 0.3879 3215080 Ald1-H_001040 ONC(=O)CCCCC(=O)N/N=C/c1ccc(C#N)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 G14 compound treatment 9.1757 -0.37577 -0.1008 11.154 1.387 0.3286 0.1611 0.4686 3215082 Ald1-H_001041 COC(=O)CCCCCCC(=O)N/N=C/c1ccc(C#N)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 G15 compound treatment 10.8819 1.3305 0.357 12.1016 2.3346 0.5532 0.6436 0.9776 3215084 Ald1-H_001042 ONC(=O)CCCCC(=O)N/N=C/C1CCCCC1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 G16 compound treatment 9.6592 0.10775 0.0289 8.6315 -1.1355 -0.269 -0.1698 -0.6275 3215086 Ald1-H_001043 COC(=O)CCCCCCC(=O)N/N=C/C1CCCCC1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 G17 compound treatment 23.2123 13.661 3.6656 23.6828 13.916 3.2971 4.9234 0.9986 3215088 Ald1-H_001044 COc1ccc(/C=N/NC(=O)CCCCC(=O)NO)cc1Br 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 G18 compound treatment 9.4728 -0.078609 -0.0211 10.9644 1.1974 0.2837 0.1857 0.6527 3215090 Ald1-H_001045 COC(=O)CCCCCCC(=O)N/N=C/c1ccc(OC)c(Br)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 G19 mock treatment 9.196 -0.35543 -0.0954 9.1624 -0.6046 -0.1433 -0.1687 -0.9805 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 G20 mock treatment 9.0589 -0.49249 -0.1321 7.6587 -2.1082 -0.4995 -0.4467 -0.8644 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 G21 compound treatment 9.6363 0.084866 0.0228 8.571 -1.1959 -0.2834 -0.1843 -0.6482 3215092 Ald1-H_001046 ONC(=O)CCCCC(=O)N/N=C/c1cc(Br)cc(Br)c1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 G22 compound treatment 10.4256 0.87417 0.2346 7.9559 -1.8111 -0.4291 -0.1376 -0.2813 3215094 Ald1-H_001047 COC(=O)CCCCCCC(=O)N/N=C/c1cc(Br)cc(Br)c1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 G23 compound treatment 12.2469 2.6954 0.7232 9.2807 -0.48627 -0.1152 0.4299 0.5871 3215096 Ald1-H_001048 CCCCN(CCCC)c1ccc(/C=N/NC(=O)CCCCC(=O)NO)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 G24 compound treatment 10.2009 0.64949 0.1743 12.1964 2.4295 0.5756 0.5303 0.8817 3215098 Ald1-H_001049 CCCCN(CCCC)c1ccc(/C=N/NC(=O)CCCCCCC(=O)OC)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 H01 compound treatment 8.618 -0.93343 -0.2505 9.4053 -0.36166 -0.0857 -0.2377 -0.8979 3215100 Ald1-H_001050 COC(=O)CCCCCCC(=O)N/N=C/c1cccs1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 H02 compound treatment 14.3016 4.7502 1.2746 15.9 6.133 1.4531 1.9288 0.9979 3215102 Ald1-H_001051 ONC(=O)CCCCC(=O)N/N=C/c1cccs1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 H03 mock treatment 8.6847 -0.86675 -0.2326 11.3184 1.5514 0.3676 0.0955 0.2195 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 H04 mock treatment 9.4701 -0.081322 -0.0218 10.3544 0.58746 0.1392 0.083 0.5891 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 H05 compound treatment 10.5047 0.95325 0.2558 10.8151 1.0482 0.2483 0.3565 0.9999 3215104 Ald1-H_001052 COC(=O)CCCCCCC(=O)N/N=C/c1ccc(cc1)C(F)(F)F 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 H06 compound treatment 30.5702 21.019 5.6399 29.691 19.924 4.7207 7.326 0.9961 3215106 Ald1-H_001053 ONC(=O)CCCCC(=O)N/N=C/c1ccc(cc1)C(F)(F)F 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 H07 compound treatment 8.9333 -0.61819 -0.1659 8.2429 -1.5241 -0.3611 -0.3726 -0.9377 3215108 Ald1-H_001054 COC(=O)CCCCCCC(=O)N/N=C/c1ccc(O)c(O)c1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 H08 compound treatment 11.0349 1.4834 0.398 11.7229 1.9559 0.4634 0.6092 0.9971 3215110 Ald1-H_001055 ONC(=O)CCCCC(=O)N/N=C/c1ccc(O)c(O)c1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 H09 compound treatment 9.7897 0.23823 0.0639 12.0328 2.2658 0.5369 0.4248 0.7858 3215112 Ald1-H_001056 COC(=O)CCCCCCC(=O)N/N=C/c1c(O)cc(O)cc1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 H10 compound treatment 10.2299 0.67841 0.182 11.602 1.8351 0.4348 0.4362 0.9253 3215114 Ald1-H_001057 ONC(=O)CCCCC(=O)N/N=C/c1c(O)cc(O)cc1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 H11 compound treatment 7.3888 -2.1627 -0.5803 11.3395 1.5725 0.3726 -0.1469 -0.213 3215116 Ald1-H_001058 COC(=O)CCCCCCC(=O)N/N=C/c1c(OC)cc(OC)cc1OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 H12 compound treatment 11.2272 1.6757 0.4496 9.4843 -0.28273 -0.067 0.2706 0.5952 3215118 Ald1-H_001059 COc1cc(OC)c(/C=N/NC(=O)CCCCC(=O)NO)c(OC)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 H13 compound treatment 14.6646 5.1131 1.372 10.7282 0.96121 0.2277 1.1312 0.8134 3215120 Ald1-H_001060 COC(=O)CCCCCCC(=O)N/N=C/c1cc(OC)c(OC)c(OC)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 H14 compound treatment 9.2699 -0.28158 -0.0756 10.3252 0.55817 0.1322 0.0401 0.2632 3215122 Ald1-H_001061 COc1cc(/C=N/NC(=O)CCCCC(=O)NO)cc(OC)c1OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 H15 compound treatment 10.7674 1.216 0.3263 9.73 -0.036948 -0.0088 0.2245 0.6879 3215124 Ald1-H_001062 COC(=O)CCCCCCC(=O)N/N=C/C(C)(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 H16 compound treatment 10.0965 0.54506 0.1463 11.3476 1.5807 0.3745 0.3682 0.9159 3215126 Ald1-H_001063 CC(C)(C)/C=N/NC(=O)CCCCC(=O)NO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 H17 compound treatment 9.1581 -0.39334 -0.1055 11.7083 1.9413 0.46 0.2506 0.531 3215128 Ald1-H_001064 COC(=O)CCCCCCC(=O)N/N=C/CC1=C(C)CCCC1(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 H18 compound treatment 14.0889 4.5374 1.2175 14.816 5.049 1.1963 1.7068 1.0 3215130 Ald1-H_001065 CC1=C(C/C=N/NC(=O)CCCCC(=O)NO)C(C)(C)CCC1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 H19 mock treatment 9.417 -0.13442 -0.0361 10.6326 0.86557 0.2051 0.1195 0.5739 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 H20 mock treatment 7.4292 -2.1223 -0.5695 10.3438 0.57686 0.1367 -0.306 -0.5225 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 H21 compound treatment 9.8338 0.28232 0.0758 9.2235 -0.54349 -0.1288 -0.0375 -0.2509 3215132 Ald1-H_001066 COC(=O)CCCCCCC(=O)N/N=C/c1ccccc1OCC(=O)N 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 H22 compound treatment 9.8146 0.26319 0.0706 11.1762 1.4092 0.3339 0.286 0.8381 3215134 Ald1-H_001067 NC(=O)COc1ccccc1/C=N/NC(=O)CCCCC(=O)NO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 H23 compound treatment 9.0396 -0.51186 -0.1373 9.4107 -0.35624 -0.0844 -0.1568 -0.9727 3215136 Ald1-H_001068 COC(=O)CCCCCCC(=O)N/N=C/c1ccc(OCC(=O)N)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 H24 compound treatment 10.2507 0.69921 0.1876 9.948 0.18102 0.0429 0.163 0.8469 3215138 Ald1-H_001069 NC(=O)COc1ccc(/C=N/NC(=O)CCCCC(=O)NO)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 I01 compound treatment 129.7873 120.24 32.2624 135.44 125.67 29.7764 43.868 0.9992 3215140 Ald1-H_001070 COc1cc(Cl)c(/C=N/NC(=O)CCCCC(=O)NO)c(Cl)c1OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 I02 compound treatment 9.3499 -0.20153 -0.0541 12.548 2.7811 0.6589 0.4277 0.6469 3215142 Ald1-H_001071 COC(=O)CCCCCCC(=O)N/N=C/c1c(Cl)cc(OC)c(OC)c1Cl 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 I03 compound treatment 10.1299 0.57848 0.1552 10.5741 0.80708 0.1912 0.245 0.9946 3215144 Ald1-H_001072 ONC(=O)CCCCC(=O)N/N=C/c1cc(Cl)cc(Cl)c1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 I04 compound treatment 8.9646 -0.5868 -0.1575 10.255 0.48803 0.1156 -0.0296 -0.1514 3215146 Ald1-H_001073 COC(=O)CCCCCCC(=O)N/N=C/c1cc(Cl)cc(Cl)c1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 I05 mock treatment 12.1963 2.6448 0.7097 9.4233 -0.3437 -0.0814 0.4442 0.6219 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 I06 mock treatment 9.8413 0.28984 0.0778 11.135 1.368 0.3241 0.2842 0.8526 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 I07 compound treatment 10.0534 0.502 0.1347 10.3776 0.61061 0.1447 0.1975 0.9994 3215148 Ald1-H_001074 ONC(=O)CCCCC(=O)N/N=C/c1cc(Br)cc([N+](=O)[O-])c1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 I08 compound treatment 11.3298 1.7784 0.4772 9.6062 -0.16077 -0.0381 0.3105 0.6486 3215150 Ald1-H_001075 COC(=O)CCCCCCC(=O)N/N=C/c1cc(Br)cc([N+](=O)[O-])c1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 I09 compound treatment 14.2217 4.6702 1.2531 14.6884 4.9214 1.1661 1.7106 0.9994 3215152 Ald1-H_001076 CCN(CC)c1ccc(/C=N/NC(=O)CCCCC(=O)NO)c(O)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 I10 compound treatment 10.7879 1.2365 0.3318 11.5984 1.8314 0.4339 0.5414 0.9912 3215154 Ald1-H_001077 CCN(CC)c1ccc(/C=N/NC(=O)CCCCCCC(=O)OC)c(O)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 I11 compound treatment 16.5379 6.9864 1.8746 22.5686 12.802 3.0332 3.4703 0.9733 3215156 Ald1-H_001078 ONC(=O)CCCCC(=O)N/N=C/c1ccc2OCCc2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 I12 compound treatment 10.5773 1.0259 0.2753 8.6039 -1.1631 -0.2756 -2.0E-4 -6.0E-4 3215158 Ald1-H_001079 COC(=O)CCCCCCC(=O)N/N=C/c1ccc2OCCc2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 I13 compound treatment 10.9317 1.3802 0.3704 8.8703 -0.8967 -0.2125 0.1116 0.2615 3215160 Ald1-H_001080 ONC(=O)CCCCC(=O)N/N=C/c1cccc(O)c1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 I14 compound treatment 9.0812 -0.47023 -0.1262 10.9285 1.1615 0.2752 0.1054 0.3481 3215162 Ald1-H_001081 COC(=O)CCCCCCC(=O)N/N=C/c1cccc(O)c1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 I15 compound treatment 10.2507 0.69924 0.1876 9.9228 0.15579 0.0369 0.1588 0.8303 3215164 Ald1-H_001082 ONC(=O)CCCCC(=O)N/N=C/c1ccc(O)cc1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 I16 compound treatment 10.7141 1.1626 0.312 9.9776 0.21058 0.0499 0.2559 0.8099 3215166 Ald1-H_001083 COC(=O)CCCCCCC(=O)N/N=C/c1ccc(O)cc1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 I17 compound treatment 9.3811 -0.17034 -0.0457 10.04 0.27299 0.0647 0.0134 0.1694 3215168 Ald1-H_001084 ONC(=O)CCCCC(=O)N/N=C/c1cc(O)ccc1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 I18 compound treatment 13.5994 4.048 1.0862 11.9505 2.1835 0.5174 1.1339 0.9425 3215170 Ald1-H_001085 COC(=O)CCCCCCC(=O)N/N=C/c1cc(O)ccc1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 I19 compound treatment 9.4266 -0.12484 -0.0335 10.0302 0.26319 0.0624 0.0204 0.2883 3215172 Ald1-H_001086 ONC(=O)CCCCC(=O)N/N=C/c1ccc(O)c(O)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 I20 compound treatment 11.2646 1.7132 0.4597 12.9185 3.1515 0.7467 0.853 0.9728 3215174 Ald1-H_001087 COC(=O)CCCCCCC(=O)N/N=C/c1ccc(O)c(O)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 I21 mock treatment 9.511 -0.040424 -0.0108 11.7404 1.9734 0.4676 0.323 0.6905 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 I22 mock treatment 8.8708 -0.68067 -0.1826 9.118 -0.64895 -0.1538 -0.2379 -0.9963 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 I23 compound treatment 25.793 16.242 4.358 25.3067 15.54 3.6819 5.6851 0.9965 3215176 Ald1-H_001088 COc1ccc(/C=N/NC(=O)CCCCC(=O)NO)c(OC)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 I24 compound treatment 9.2048 -0.34662 -0.093 10.9626 1.1956 0.2833 0.1345 0.4512 3215178 Ald1-H_001089 COC(=O)CCCCCCC(=O)N/N=C/c1ccc(OC)cc1OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 J01 compound treatment 8.9338 -0.61768 -0.1657 11.1197 1.3527 0.3205 0.1094 0.3033 3215180 Ald1-H_001090 COC(=O)CCCCCCC(=O)NN=C1CCCCCCC1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 J02 compound treatment 10.7018 1.1504 0.3087 12.0996 2.3327 0.5527 0.6091 0.9621 3215181 Ald1-H_001091 ONC(=O)CCCCC(=O)NN=C1CCCCCCC1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 J03 compound treatment 11.0426 1.4912 0.4001 11.1331 1.3661 0.3237 0.5118 0.9945 3215182 Ald1-H_001092 COC(=O)CCCCCCC(=O)NN=C1CCCCCC1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 J04 compound treatment 10.0067 0.45524 0.1222 10.5182 0.75125 0.178 0.2122 0.9831 3215183 Ald1-H_001093 ONC(=O)CCCCC(=O)NN=C1CCCCCC1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 J05 mock treatment 9.231 -0.32047 -0.086 11.7577 1.9907 0.4717 0.2727 0.5688 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 J06 mock treatment 16.6668 7.1153 1.9092 8.094 -1.673 -0.3964 1.0697 0.5486 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 J07 compound treatment 9.714 0.16251 0.0436 9.7822 0.015229 0.0036 0.0334 0.763 3215184 Ald1-H_001094 COC(=O)CCCCCCC(=O)NN=C1CCCC1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 J08 compound treatment 8.0314 -1.52 -0.4079 9.4071 -0.35988 -0.0853 -0.3487 -0.8368 3215185 Ald1-H_001095 ONC(=O)CCCCC(=O)NN=C1CCCC1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 J09 compound treatment 8.8581 -0.69334 -0.186 10.1125 0.3455 0.0819 -0.0737 -0.3624 3214825 Ald1-H_001096 COC(=O)CCCCCCC(=O)NN 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 J10 compound treatment 9.9821 0.43062 0.1155 9.1091 -0.65784 -0.1559 -0.0285 -0.1469 3214824 Ald1-H_001097 NNC(=O)CCCCC(=O)NO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 J11 compound treatment 9.9147 0.36327 0.0975 10.677 0.91004 0.2156 0.2214 0.9356 3215186 Ald1-H_001098 COC(=O)CCCCCCC(=O)N/N=C/c1cc(OC)c(OC)cc1Br 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 J12 compound treatment 197.7115 188.16 50.4882 188.0223 178.26 42.235 65.5652 0.9961 3215188 Ald1-H_001099 COc1cc(Br)c(/C=N/NC(=O)CCCCC(=O)NO)cc1OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 J13 compound treatment 9.2993 -0.25218 -0.0677 10.8474 1.0804 0.256 0.1332 0.5029 3215190 Ald1-H_001100 COC(=O)CCCCCCC(=O)N/N=C/CCC1CCCCC1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 J14 compound treatment 10.1361 0.58468 0.1569 13.1406 3.3736 0.7993 0.6761 0.8301 3215192 Ald1-H_001101 ONC(=O)CCCCC(=O)N/N=C/CCC1CCCCC1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 J15 compound treatment 13.5231 3.9716 1.0657 13.5308 3.7639 0.8918 1.3841 0.9961 3215194 Ald1-H_001102 COC(=O)CCCCCCC(=O)N/N=C/c1ccc(cc1)N(c2ccccc2)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 J16 compound treatment 14.0592 4.5078 1.2095 16.5428 6.7758 1.6054 1.9905 0.9903 3215196 Ald1-H_001103 ONC(=O)CCCCC(=O)N/N=C/c1ccc(cc1)N(c2ccccc2)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 J17 compound treatment 8.2198 -1.3316 -0.3573 9.9528 0.1858 0.044 -0.2215 -0.6153 3215198 Ald1-H_001104 COC(=O)CCCCCCC(=O)N/N=C/C[P+](c1ccccc1)(c2ccccc2)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 J18 compound treatment 8.3959 -1.1555 -0.3101 10.2614 0.49441 0.1171 -0.1364 -0.4116 3215200 Ald1-H_001105 ONC(=O)CCCCC(=O)N/N=C/C[P+](c1ccccc1)(c2ccccc2)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 J19 compound treatment 9.3383 -0.21315 -0.0572 10.6553 0.88836 0.2105 0.1084 0.4969 3214825 Ald1-H_001106 COC(=O)CCCCCCC(=O)NN 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 J20 compound treatment 9.3505 -0.20095 -0.0539 9.7163 -0.050703 -0.012 -0.0466 -0.844 3214824 Ald1-H_001107 NNC(=O)CCCCC(=O)NO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 J21 mock treatment 9.443 -0.10845 -0.0291 12.0204 2.2534 0.5339 0.357 0.6676 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 J22 mock treatment 8.9935 -0.55794 -0.1497 8.7738 -0.99322 -0.2353 -0.2723 -0.9762 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 J23 compound treatment 8.6317 -0.9197 -0.2468 7.8773 -1.8897 -0.4477 -0.4911 -0.9606 3214825 Ald1-H_001108 COC(=O)CCCCCCC(=O)NN 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 J24 compound treatment 10.3914 0.83997 0.2254 10.1353 0.36832 0.0873 0.2211 0.9147 3214824 Ald1-H_001109 NNC(=O)CCCCC(=O)NO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 K01 compound treatment 10.0962 0.54478 0.1462 9.3369 -0.43009 -0.1019 0.0313 0.1757 3215202 Ald1-H_001110 COc1cccc(OC)c1/C=N/NC(=O)CCCCC(=O)NO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 K02 compound treatment 10.4664 0.91491 0.2455 11.54 1.773 0.4201 0.4706 0.9673 3215204 Ald1-H_001111 COC(=O)CCCCCCC(=O)N/N=C/c1c(OC)cccc1OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 K03 compound treatment 9.3296 -0.22189 -0.0595 10.6735 0.90647 0.2148 0.1098 0.4925 3215206 Ald1-H_001112 COc1ccc(/C=N/NC(=O)CCCCC(=O)NO)cc1OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 K04 compound treatment 12.0447 2.4933 0.669 9.3844 -0.38258 -0.0906 0.409 0.6058 3215208 Ald1-H_001113 COC(=O)CCCCCCC(=O)N/N=C/c1ccc(OC)c(OC)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 K05 compound treatment 11.5152 1.9637 0.5269 11.3397 1.5727 0.3726 0.6361 0.9856 3215210 Ald1-H_001114 COc1cc(O)cc(OC)c1/C=N/NC(=O)CCCCC(=O)NO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 K06 compound treatment 9.7193 0.16786 0.045 10.6691 0.90214 0.2137 0.183 0.8377 3215212 Ald1-H_001115 COC(=O)CCCCCCC(=O)N/N=C/c1c(OC)cc(O)cc1OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 K07 mock treatment 9.6698 0.11835 0.0318 9.8872 0.12017 0.0285 0.0426 0.9985 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 K08 mock treatment 8.2239 -1.3275 -0.3562 9.0692 -0.69782 -0.1653 -0.3688 -0.9391 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 K09 compound treatment 8.4111 -1.1403 -0.306 10.5421 0.77507 0.1836 -0.0865 -0.2424 3215214 Ald1-H_001116 CC1(C)COC(CCC/C=N/NC(=O)CCCCC(=O)NO)OC1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 K10 compound treatment 10.0333 0.48188 0.1293 11.9672 2.2002 0.5213 0.46 0.8565 3215216 Ald1-H_001117 COC(=O)CCCCCCC(=O)N/N=C/CCCC1OCC(C)(C)CO1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 K11 compound treatment 9.8904 0.33892 0.0909 9.673 -0.093933 -0.0223 0.0486 0.5187 3215218 Ald1-H_001118 Cc1nnc(Sc2ccc(/C=N/NC(=O)CCCCC(=O)NO)o2)n1C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 K12 compound treatment 10.1762 0.62472 0.1676 9.1737 -0.59333 -0.1406 0.0191 0.0874 3215220 Ald1-H_001119 COC(=O)CCCCCCC(=O)N/N=C/c1ccc(Sc2nnc(C)n2C)o1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 K13 compound treatment 15.7821 6.2306 1.6718 18.1158 8.3488 1.9781 2.5809 0.9965 3215222 Ald1-H_001120 ONC(=O)CCCCC(=O)N/N=C/c1cc(Br)cs1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 K14 compound treatment 10.0936 0.54215 0.1455 11.9009 2.134 0.5056 0.4604 0.8751 3215224 Ald1-H_001121 COC(=O)CCCCCCC(=O)N/N=C/c1cc(Br)cs1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 K15 mock treatment 7.8201 -1.7313 -0.4646 8.1607 -1.6063 -0.3806 -0.5976 -0.9951 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 K16 mock treatment 11.3895 1.8381 0.4932 9.4981 -0.26886 -0.0637 0.3037 0.6107 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 K17 compound treatment 8.5268 -1.0246 -0.2749 10.8149 1.0479 0.2483 -0.0188 -0.0509 3215226 Ald1-H_001122 CC(C)(C)OC(=O)NC/C=N/NC(=O)CCCCC(=O)NO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 K18 compound treatment 9.2508 -0.30061 -0.0807 9.8525 0.085527 0.0203 -0.0427 -0.5135 3215228 Ald1-H_001123 COC(=O)CCCCCCC(=O)N/N=C/CNC(=O)OC(C)(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 K19 compound treatment 195.82 186.27 49.9806 206.9458 197.18 46.7186 68.3767 0.9994 3215230 Ald1-H_001124 ONC(=O)CCCCC(=O)N/N=C/c1ccc-2c(Cc3ccccc32)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 K20 compound treatment 11.1702 1.6188 0.4344 12.4678 2.7008 0.6399 0.7596 0.9822 3215232 Ald1-H_001125 COC(=O)CCCCCCC(=O)N/N=C/c1ccc-2c(Cc3ccccc32)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 K21 compound treatment 13.0717 3.5202 0.9446 12.1047 2.3377 0.5539 1.0596 0.9677 3215234 Ald1-H_001126 ONC(=O)CCCCC(=O)N/N=C/c1ccc(F)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 K22 compound treatment 8.6915 -0.85993 -0.2307 8.441 -1.326 -0.3142 -0.3853 -0.9885 3215236 Ald1-H_001127 COC(=O)CCCCCCC(=O)N/N=C/c1ccc(F)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 K23 mock treatment 9.9599 0.40844 0.1096 12.386 2.619 0.6205 0.5163 0.8193 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 K24 mock treatment 11.1081 1.5567 0.4177 11.3614 1.5944 0.3778 0.5625 0.9987 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 L01 compound treatment 9.0449 -0.5065 -0.1359 9.9695 0.20248 0.048 -0.0622 -0.4314 3215238 Ald1-H_001128 COC(=O)CCCCCCC(=O)N/N=C/[C@@H](O)[C@H](O)[C@H](O)CO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 L02 compound treatment 10.9723 1.4209 0.3813 11.3135 1.5465 0.3664 0.5287 0.9998 3215240 Ald1-H_001129 OC[C@@H](O)[C@@H](O)[C@H](O)/C=N/NC(=O)CCCCC(=O)NO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 L03 compound treatment 8.0803 -1.4711 -0.3947 9.8488 0.081774 0.0194 -0.2654 -0.6716 3215242 Ald1-H_001130 COC(=O)CCCCCCC(=O)N/N=C/C[C@H](O)[C@H](O)[C@@H](C)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 L04 compound treatment 9.7939 0.24247 0.0651 11.0706 1.3036 0.3089 0.2644 0.8377 3215244 Ald1-H_001131 C[C@@H](O)[C@@H](O)[C@@H](O)C/C=N/NC(=O)CCCCC(=O)NO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 L05 compound treatment 8.3246 -1.2268 -0.3292 9.8211 0.054167 0.0128 -0.2237 -0.679 3215246 Ald1-H_001132 COC(=O)CCCCCCC(=O)N/N=C/[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)CO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 L06 compound treatment 10.6466 1.0951 0.2939 10.6828 0.91581 0.217 0.3612 0.9889 3215248 Ald1-H_001133 OC[C@@H](O)[C@H](O)[C@H](O)[C@@H](O)/C=N/NC(=O)CCCCC(=O)NO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 L07 mock treatment 9.1611 -0.39039 -0.1048 10.5665 0.79955 0.1894 0.0599 0.2766 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 L08 mock treatment 7.6865 -1.8649 -0.5004 12.0503 2.2833 0.541 0.0287 0.0389 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 L09 compound treatment 9.7543 0.20282 0.0544 9.9411 0.17415 0.0413 0.0677 0.9907 3215250 Ald1-H_001134 COC(=O)CCCCCCC(=O)N/N=C/[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 L10 compound treatment 9.4328 -0.11862 -0.0318 12.928 3.1611 0.749 0.5071 0.6764 3215251 Ald1-H_001135 OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)/C=N/NC(=O)CCCCC(=O)NO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 L11 compound treatment 8.9972 -0.55421 -0.1487 10.2005 0.43354 0.1027 -0.0325 -0.1799 3215252 Ald1-H_001136 COC(=O)CCCCCCC(=O)N/N=C/[C@H](O)[C@H](O)[C@@H](O)[C@@H](O)CO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 L12 compound treatment 8.2556 -1.2958 -0.3477 10.4682 0.70119 0.1661 -0.1284 -0.3332 3215253 Ald1-H_001137 OC[C@H](O)[C@H](O)[C@@H](O)[C@@H](O)/C=N/NC(=O)CCCCC(=O)NO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 L13 compound treatment 9.2814 -0.27001 -0.0725 13.2163 3.4493 0.8173 0.5267 0.6419 3215254 Ald1-H_001138 COC(=O)CCCCCCC(=O)N/N=C/[C@H](O)[C@H](O)[C@@H](O)[C@H](C)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 L14 compound treatment 8.8552 -0.69629 -0.1868 11.1277 1.3607 0.3224 0.0959 0.2573 3215256 Ald1-H_001139 C[C@H](O)[C@H](O)[C@@H](O)[C@@H](O)/C=N/NC(=O)CCCCC(=O)NO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 L15 mock treatment 7.8345 -1.7169 -0.4607 11.2255 1.4586 0.3456 -0.0814 -0.1413 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 L16 mock treatment 10.2748 0.72335 0.1941 10.1055 0.3385 0.0802 0.194 0.9236 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 L17 compound treatment 9.3113 -0.24015 -0.0644 9.2372 -0.52982 -0.1255 -0.1343 -0.952 3215258 Ald1-H_001140 COC(=O)CCCCCCC(=O)N/N=C/c1ccc(Oc2ccccc2)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 L18 compound treatment 11.8453 2.2939 0.6155 15.3255 5.5585 1.317 1.3665 0.94 3215260 Ald1-H_001141 ONC(=O)CCCCC(=O)N/N=C/c1ccc(Oc2ccccc2)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 L19 compound treatment 9.6442 0.092756 0.0249 8.2327 -1.5342 -0.3635 -0.2394 -0.6572 3215262 Ald1-H_001142 COC(=O)CCCCCCC(=O)N/N=C/c1cc[n+]([O-])cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 L20 compound treatment 9.9456 0.39417 0.1058 10.972 1.205 0.2855 0.2767 0.9087 3215264 Ald1-H_001143 ONC(=O)CCCCC(=O)N/N=C/c1cc[n+]([O-])cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 L21 compound treatment 10.6119 1.0604 0.2845 10.0474 0.28037 0.0664 0.2482 0.8494 3215266 Ald1-H_001144 COC(=O)CCCCCCC(=O)N/N=C/c1ccc2ccccc2n1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 L22 compound treatment 12.4822 2.9307 0.7864 14.7971 5.0301 1.1918 1.3988 0.9796 3215268 Ald1-H_001145 ONC(=O)CCCCC(=O)N/N=C/c1ccc2ccccc2n1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 L23 mock treatment 8.927 -0.62442 -0.1675 10.4542 0.68718 0.1628 -0.0033 -0.0143 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 L24 mock treatment 8.6507 -0.90074 -0.2417 8.9099 -0.85713 -0.2031 -0.3145 -0.9963 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 M01 compound treatment 8.9512 -0.60027 -0.1611 9.7971 0.030067 0.0071 -0.1089 -0.6752 3215270 Ald1-H_001146 ONC(=O)CCCCC(=O)N/N=C/c1ccc(O)c(F)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 M02 compound treatment 11.311 1.7595 0.4721 8.7703 -0.99672 -0.2362 0.1669 0.3161 3215272 Ald1-H_001147 COC(=O)CCCCCCC(=O)N/N=C/c1ccc(O)c(F)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 M03 compound treatment 31.5773 22.026 5.9101 42.9109 33.144 7.853 9.732 0.9902 3215274 Ald1-H_001148 ONC(=O)CCCCC(=O)N/N=C/c1ccc(F)c(Oc2ccccc2)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 M04 compound treatment 8.9151 -0.63638 -0.1708 9.2537 -0.51329 -0.1216 -0.2067 -0.9862 3215276 Ald1-H_001149 COC(=O)CCCCCCC(=O)N/N=C/c1ccc(F)c(Oc2ccccc2)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 M05 compound treatment 9.301 -0.25046 -0.0672 10.0144 0.24741 0.0586 -0.0061 -0.0681 3215278 Ald1-H_001150 ONC(=O)CCCCC(=O)N/N=C/c1cc(F)ccc1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 M06 compound treatment 8.9574 -0.59407 -0.1594 14.0351 4.2681 1.0113 0.6024 0.5884 3215280 Ald1-H_001151 COC(=O)CCCCCCC(=O)N/N=C/c1cc(F)ccc1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 M07 compound treatment 9.1188 -0.4326 -0.1161 10.5852 0.81821 0.1939 0.055 0.2434 3215282 Ald1-H_001152 ONC(=O)CCCCC(=O)N/N=C/c1coc2ccccc2c1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 M08 compound treatment 8.2539 -1.2975 -0.3482 10.8911 1.1241 0.2663 -0.0579 -0.132 3215284 Ald1-H_001153 COC(=O)CCCCCCC(=O)N/N=C/c1coc2ccccc2c1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 M09 mock treatment 8.2306 -1.3209 -0.3544 11.0968 1.3298 0.3151 -0.0278 -0.0587 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 M10 mock treatment 9.1117 -0.43971 -0.118 8.4825 -1.2845 -0.3043 -0.2986 -0.9149 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 M11 compound treatment 42.3178 32.766 8.7921 53.2956 43.529 10.3135 13.5096 0.9968 3215286 Ald1-H_001154 CC(C)(C)OC(=O)Nc1ccc(/C=N/NC(=O)CCCCC(=O)NO)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 M12 compound treatment 8.1242 -1.4272 -0.383 11.0142 1.2472 0.2955 -0.0618 -0.1278 3215288 Ald1-H_001155 COC(=O)CCCCCCC(=O)N/N=C/c1ccc(NC(=O)OC(C)(C)C)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 M13 mock treatment 8.7421 -0.80934 -0.2172 11.0886 1.3217 0.3131 0.0679 0.1781 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 M14 mock treatment 10.356 0.80458 0.2159 8.7431 -1.0239 -0.2426 -0.0189 -0.0581 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 M15 compound treatment 8.3679 -1.1835 -0.3176 11.0295 1.2625 0.2991 -0.013 -0.0299 3215290 Ald1-H_001156 ONC(=O)CCCCC(=O)N/N=C/c1cccc(c1)B(O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 M16 compound treatment 8.6518 -0.89961 -0.2414 9.2469 -0.5201 -0.1232 -0.2578 -0.9513 3215292 Ald1-H_001157 COC(=O)CCCCCCC(=O)N/N=C/c1cccc(c1)B(O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 M17 compound treatment 11.4148 1.8633 0.5 11.9092 2.1422 0.5076 0.7124 1.0 3215294 Ald1-H_001158 ONC(=O)CCCCC(=O)N/N=C/c1ccco1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 M18 compound treatment 8.7529 -0.79851 -0.2143 11.2006 1.4336 0.3397 0.0887 0.2208 3215296 Ald1-H_001159 COC(=O)CCCCCCC(=O)N/N=C/c1ccco1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 M19 compound treatment 9.8839 0.3325 0.0892 11.477 1.71 0.4052 0.3496 0.8426 3215298 Ald1-H_001160 ONC(=O)CCCCC(=O)N/N=C/c1ccoc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 M20 compound treatment 10.5513 0.99989 0.2683 8.9388 -0.82819 -0.1962 0.051 0.1533 3215300 Ald1-H_001161 COC(=O)CCCCCCC(=O)N/N=C/c1ccoc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 M21 compound treatment 9.6016 0.050188 0.0135 11.3215 1.5545 0.3683 0.27 0.7325 3215302 Ald1-H_001162 ONC(=O)CCCCC(=O)N/N=C/c1cccc(O)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 M22 compound treatment 11.2222 1.6707 0.4483 11.0438 1.2768 0.3025 0.5309 0.9817 3215304 Ald1-H_001163 COC(=O)CCCCCCC(=O)N/N=C/c1cccc(O)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 M23 compound treatment 9.0696 -0.48188 -0.1293 9.9067 0.13973 0.0331 -0.068 -0.5096 3215306 Ald1-H_001164 ONC(=O)CCCCC(=O)N/N=C/c1ccc(O)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 M24 compound treatment 11.3461 1.7947 0.4816 10.6248 0.85783 0.2033 0.4842 0.9264 3215308 Ald1-H_001165 COC(=O)CCCCCCC(=O)N/N=C/c1ccc(O)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 N01 compound treatment 10.157 0.60551 0.1625 10.3974 0.6304 0.1494 0.2205 0.9991 3215310 Ald1-H_001166 COC(=O)CCCCCCC(=O)N/N=C/c1ccccc1C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 N02 compound treatment 235.214 225.66 60.5511 279.7145 269.95 63.9601 88.0427 0.9996 3215312 Ald1-H_001167 Cc1ccccc1/C=N/NC(=O)CCCCC(=O)NO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 N03 compound treatment 7.6396 -1.9118 -0.513 9.9307 0.16371 0.0388 -0.3353 -0.6518 3215314 Ald1-H_001168 COC(=O)CCCCCCC(=O)N/N=C/c1ccc(O)c(OC)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 N04 compound treatment 9.6955 0.14405 0.0387 11.7038 1.9369 0.4589 0.3518 0.764 3215316 Ald1-H_001169 COc1cc(/C=N/NC(=O)CCCCC(=O)NO)ccc1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 N05 compound treatment 8.3163 -1.2351 -0.3314 10.1839 0.41688 0.0988 -0.1645 -0.4757 3215318 Ald1-H_001170 COC(=O)CCCCCCC(=O)N/N=C/[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 N06 compound treatment 9.629 0.077511 0.0208 11.4623 1.6953 0.4017 0.2987 0.7427 3215320 Ald1-H_001171 ONC(=O)CCCCC(=O)N/N=C/[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 N07 compound treatment 7.9174 -1.634 -0.4384 11.2487 1.4817 0.3511 -0.0618 -0.11 3215322 Ald1-H_001172 COC(=O)CCCCCCC(=O)N/N=C/[C@H](O)[C@@H](O)[C@H](O)CO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 N08 compound treatment 11.2854 1.734 0.4653 10.3725 0.60549 0.1435 0.4304 0.8841 3215323 Ald1-H_001173 OC[C@@H](O)[C@H](O)[C@@H](O)/C=N/NC(=O)CCCCC(=O)NO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 N09 mock treatment 7.5755 -1.976 -0.5302 11.5981 1.8311 0.4339 -0.0681 -0.0995 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 N10 mock treatment 9.3084 -0.24303 -0.0652 9.6513 -0.1157 -0.0274 -0.0655 -0.9259 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 N11 compound treatment 9.2002 -0.35127 -0.0943 9.6239 -0.14308 -0.0339 -0.0906 -0.9047 3215324 Ald1-H_001174 COC(=O)CCCCCCC(=O)N/N=C/c1ccc(OC)c(O)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 N12 compound treatment 8.4231 -1.1284 -0.3028 9.771 0.0040369 0.001 -0.2134 -0.7049 3215326 Ald1-H_001175 COc1ccc(/C=N/NC(=O)CCCCC(=O)NO)cc1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 N13 mock treatment 8.7395 -0.81192 -0.2179 10.5525 0.78547 0.1861 -0.0225 -0.0784 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 N14 mock treatment 9.724 0.17256 0.0463 9.5216 -0.24536 -0.0581 -0.0084 -0.1126 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 N15 compound treatment 9.1572 -0.39421 -0.1058 8.6471 -1.1199 -0.2653 -0.2624 -0.9187 3215328 Ald1-H_001176 CCOc1cccc(/C=N/NC(=O)CCCCCCC(=O)OC)c1OCC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 N16 compound treatment 174.1853 164.63 44.1755 187.595 177.83 42.1337 61.0298 0.9997 3215330 Ald1-H_001177 CCOc1cccc(/C=N/NC(=O)CCCCC(=O)NO)c1OCC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 N17 compound treatment 7.7013 -1.8502 -0.4965 8.925 -0.84197 -0.1995 -0.4921 -0.9198 3215332 Ald1-H_001178 COC(=O)CCCCCCC(=O)N/N=C/c1cc(I)cc(I)c1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 N18 compound treatment 9.4624 -0.089074 -0.0239 10.2247 0.4577 0.1084 0.0598 0.5383 3215334 Ald1-H_001179 ONC(=O)CCCCC(=O)N/N=C/c1cc(I)cc(I)c1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 N19 compound treatment 15.113 5.5616 1.4923 9.8665 0.099552 0.0236 1.0719 0.7182 3215336 Ald1-H_001180 COC(=O)CCCCCCC(=O)N/N=C/c1ccc(cc1)N(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 N20 compound treatment 20.9558 11.404 3.0601 27.614 17.847 4.2286 5.1539 0.9874 3215338 Ald1-H_001181 CN(C)c1ccc(/C=N/NC(=O)CCCCC(=O)NO)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 N21 compound treatment 8.3134 -1.2381 -0.3322 10.7019 0.93493 0.2215 -0.0783 -0.196 3215340 Ald1-H_001182 CCn1c2ccccc2c3cc(/C=N/NC(=O)CCCCCCC(=O)OC)ccc13 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 N22 compound treatment 75.0847 65.533 17.5843 91.0427 81.276 19.2571 26.0508 0.999 3215342 Ald1-H_001183 CCn1c2ccccc2c3cc(/C=N/NC(=O)CCCCC(=O)NO)ccc13 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 N23 compound treatment 7.5841 -1.9674 -0.5279 10.4251 0.65814 0.1559 -0.263 -0.4778 3215344 Ald1-H_001184 COC(=O)CCCCCCC(=O)N/N=C/c1ccc(c(F)c1)c2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 N24 compound treatment 95.6099 86.059 23.0917 110.1284 100.36 23.7792 33.1427 0.9999 3215346 Ald1-H_001185 ONC(=O)CCCCC(=O)N/N=C/c1ccc(c(F)c1)c2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 O01 compound treatment 12.3093 2.7579 0.74 10.8822 1.1152 0.2642 0.7101 0.9037 3215348 Ald1-H_001186 OCCOc1ccccc1/C=N/NC(=O)CCCCC(=O)NO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 O02 compound treatment 10.2263 0.67488 0.1811 10.586 0.81906 0.1941 0.2653 0.9994 3215350 Ald1-H_001187 COC(=O)CCCCCCC(=O)N/N=C/c1ccccc1OCCO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 O03 compound treatment 10.1163 0.56487 0.1516 12.4431 2.6762 0.6341 0.5555 0.8521 3215352 Ald1-H_001188 OCCOc1cccc(/C=N/NC(=O)CCCCC(=O)NO)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 O04 compound treatment 10.0012 0.4498 0.1207 11.4186 1.6516 0.3913 0.3621 0.8841 3215354 Ald1-H_001189 COC(=O)CCCCCCC(=O)N/N=C/c1cccc(OCCO)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 O05 compound treatment 8.1403 -1.4112 -0.3787 12.1522 2.3852 0.5651 0.1319 0.1938 3215356 Ald1-H_001190 OCCOc1ccc(/C=N/NC(=O)CCCCC(=O)NO)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 O06 compound treatment 8.3721 -1.1794 -0.3165 12.3161 2.5491 0.604 0.2033 0.2982 3215358 Ald1-H_001191 COC(=O)CCCCCCC(=O)N/N=C/c1ccc(OCCO)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 O07 compound treatment 9.8404 0.289 0.0775 12.4565 2.6895 0.6372 0.5054 0.7873 3215360 Ald1-H_001192 COc1ccc(/C=N/NC(=O)CCCCC(=O)NO)c(O)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 O08 compound treatment 10.6196 1.0682 0.2866 8.2043 -1.5627 -0.3703 -0.0591 -0.1263 3215362 Ald1-H_001193 COC(=O)CCCCCCC(=O)N/N=C/c1ccc(OC)cc1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 O09 compound treatment 11.1981 1.6466 0.4418 13.0243 3.2573 0.7718 0.8581 0.965 3215364 Ald1-H_001194 COc1ccc(O)c(/C=N/NC(=O)CCCCC(=O)NO)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 O10 compound treatment 9.6155 0.064096 0.0172 8.7981 -0.96891 -0.2296 -0.1502 -0.6523 3215366 Ald1-H_001195 COC(=O)CCCCCCC(=O)N/N=C/c1cc(OC)ccc1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 O11 mock treatment 10.3221 0.77068 0.2068 9.1672 -0.59979 -0.1421 0.0457 0.1823 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 O12 mock treatment 7.9953 -1.5561 -0.4175 8.8806 -0.88638 -0.21 -0.4438 -0.9494 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 O13 compound treatment 9.0674 -0.48401 -0.1299 9.6515 -0.11544 -0.0274 -0.1112 -0.8377 3215368 Ald1-H_001196 COc1cc(/C=C/C=N/NC(=O)CCCCC(=O)NO)ccc1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 O14 compound treatment 8.9239 -0.62756 -0.1684 10.5098 0.74286 0.176 0.0054 0.0221 3215370 Ald1-H_001197 COC(=O)CCCCCCC(=O)N/N=C/C=C/c1ccc(O)c(OC)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 O15 compound treatment 23.4827 13.931 3.7381 36.1076 26.341 6.241 7.0563 0.97 3215372 Ald1-H_001198 Cc1ccc(O)c(/C=N/NC(=O)CCCCC(=O)NO)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 O16 compound treatment 7.7474 -1.8041 -0.4841 8.4199 -1.3471 -0.3192 -0.568 -0.9796 3215374 Ald1-H_001199 COC(=O)CCCCCCC(=O)N/N=C/c1cc(C)ccc1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 O17 compound treatment 12.0265 2.4751 0.6641 10.7161 0.94913 0.2249 0.6286 0.8965 3215376 Ald1-H_001200 OCc1ccc(/C=N/NC(=O)CCCCC(=O)NO)o1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 O18 compound treatment 8.0378 -1.5136 -0.4061 8.1685 -1.5985 -0.3787 -0.555 -0.9994 3215378 Ald1-H_001201 COC(=O)CCCCCCC(=O)N/N=C/c1ccc(CO)o1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 O19 compound treatment 12.1144 2.563 0.6877 11.6594 1.8924 0.4484 0.8033 0.9785 3215380 Ald1-H_001202 ONC(=O)CCCCC(=O)N/N=C/c1ccc2ccccc2c1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 O20 compound treatment 8.2712 -1.2802 -0.3435 9.6634 -0.10357 -0.0245 -0.2603 -0.7557 3215382 Ald1-H_001203 COC(=O)CCCCCCC(=O)N/N=C/c1ccc2ccccc2c1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 O21 compound treatment 250.0017 240.45 64.519 277.8908 268.12 63.528 90.5429 1.0 3215384 Ald1-H_001204 ONC(=O)CCCCC(=O)N/N=C/c1ccc(o1)c2cccc(Cl)c2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 O22 compound treatment 10.0675 0.51607 0.1385 10.3479 0.58096 0.1377 0.1952 1.0 3215386 Ald1-H_001205 COC(=O)CCCCCCC(=O)N/N=C/c1ccc(o1)c2cccc(Cl)c2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 O23 compound treatment 8.8276 -0.72382 -0.1942 11.4038 1.6368 0.3878 0.1369 0.3156 3215388 Ald1-H_001206 ONC(=O)CCCCC(=O)N/N=C/c1cc(Br)c(O)c(Br)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 O24 compound treatment 9.915 0.36355 0.0975 10.492 0.72504 0.1718 0.1904 0.964 3215390 Ald1-H_001207 COC(=O)CCCCCCC(=O)N/N=C/c1cc(Br)c(O)c(Br)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 P01 compound treatment 11.7868 2.2354 0.5998 8.955 -0.81199 -0.1924 0.2881 0.4574 3215392 Ald1-H_001208 COC(=O)CCCCCCC(=O)N/N=C/c1ccc(o1)S(=O)(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 P02 compound treatment 8.7856 -0.76588 -0.2055 9.2315 -0.5355 -0.1269 -0.235 -0.9731 3215394 Ald1-H_001209 ONC(=O)CCCCC(=O)N/N=C/c1ccc(o1)S(=O)(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 P03 compound treatment 8.9538 -0.59762 -0.1604 9.1073 -0.65968 -0.1563 -0.2239 -0.9999 3215396 Ald1-H_001210 COC(=O)CCCCCCC(=O)N/N=C/c1cn(C)c2ccccc12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 P04 compound treatment 123.849 114.3 30.669 127.5813 117.81 27.9144 41.4247 0.9989 3215398 Ald1-H_001211 Cn1cc(/C=N/NC(=O)CCCCC(=O)NO)c2ccccc12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 P05 compound treatment 14.2729 4.7214 1.2669 20.2031 10.436 2.4727 2.6443 0.9517 3215400 Ald1-H_001212 COC(=O)CCCCCCC(=O)N/N=C/c1cn(Cc2ccccc2)c3ccccc13 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 P06 compound treatment 225.6023 216.05 57.972 236.7095 226.94 53.7707 79.014 0.9993 3215402 Ald1-H_001213 ONC(=O)CCCCC(=O)N/N=C/c1cn(Cc2ccccc2)c3ccccc13 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 P07 compound treatment 10.9034 1.3519 0.3628 11.8591 2.0921 0.4957 0.607 0.9882 3215404 Ald1-H_001214 COC(=O)CCCCCCC(=O)N/N=C/C1=CCCCC1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 P08 compound treatment 17.0029 7.4515 1.9994 23.387 13.62 3.2271 3.6957 0.9735 3215406 Ald1-H_001215 ONC(=O)CCCCC(=O)N/N=C/C1=CCCCC1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 P09 compound treatment 8.0558 -1.4956 -0.4013 10.5426 0.77563 0.1838 -0.1538 -0.3485 3215408 Ald1-H_001216 COC(=O)CCCCCCC(=O)N/N=C/[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 P10 compound treatment 9.9584 0.40695 0.1092 12.2201 2.4531 0.5812 0.4882 0.8255 3215409 Ald1-H_001217 OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)/C=N/NC(=O)CCCCC(=O)NO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 P11 mock treatment 9.1998 -0.35168 -0.0944 8.8872 -0.87976 -0.2084 -0.2141 -0.9358 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 P12 mock treatment 10.6382 1.0868 0.2916 11.2108 1.4438 0.3421 0.4481 0.9968 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 P13 compound treatment 9.9243 0.37287 0.1001 10.4291 0.66213 0.1569 0.1817 0.9764 3215410 Ald1-H_001218 COC(=O)CCCCCCC(=O)N/N=C/[C@H](O)[C@@H](O)[C@H](O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O)[C@H](O)CO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 P14 compound treatment 8.8457 -0.70573 -0.1894 12.0489 2.282 0.5407 0.2484 0.4336 3215412 Ald1-H_001219 OC[C@@H](O)[C@@H](O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O)[C@H](O)[C@@H](O)/C=N/NC(=O)CCCCC(=O)NO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 P15 compound treatment 11.2434 1.692 0.454 10.8488 1.0818 0.2563 0.5023 0.9634 3215414 Ald1-H_001220 COC(=O)CCCCCCC(=O)N/N=C/[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO[C@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 P16 compound treatment 9.1887 -0.36276 -0.0973 11.2017 1.4347 0.3399 0.1715 0.4851 3215416 Ald1-H_001221 OC[C@H]1O[C@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)/C=N/NC(=O)CCCCC(=O)NO)[C@H](O)[C@@H](O)[C@H]1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 P17 compound treatment 9.2 -0.35141 -0.0943 10.0165 0.24947 0.0591 -0.0249 -0.2236 3215418 Ald1-H_001222 COC(=O)CCCCCCC(=O)N/N=C(\C)/C[P+](c1ccccc1)(c2ccccc2)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 P18 compound treatment 9.5533 0.001863 5.0E-4 10.6837 0.91672 0.2172 0.1539 0.7087 3215420 Ald1-H_001223 C/C(=N\NC(=O)CCCCC(=O)NO)/C[P+](c1ccccc1)(c2ccccc2)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 P19 compound treatment 7.2216 -2.3299 -0.6252 9.5602 -0.20683 -0.049 -0.4767 -0.7602 3215422 Ald1-H_001224 COC(=O)CCCCCCC(=O)N/N=C/c1ccc(OCCCN(C)C)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 P20 compound treatment 11.3059 1.7544 0.4708 12.4606 2.6936 0.6382 0.7842 0.9888 3215424 Ald1-H_001225 CN(C)CCCOc1ccc(/C=N/NC(=O)CCCCC(=O)NO)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 P21 compound treatment 8.1196 -1.4319 -0.3842 9.281 -0.48595 -0.1151 -0.3531 -0.8803 3215426 Ald1-H_001226 CCOc1cc(/C=N/NC(=O)CCCCCCC(=O)OC)ccc1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 P22 compound treatment 8.608 -0.94349 -0.2532 9.4305 -0.33644 -0.0797 -0.2354 -0.8868 3215428 Ald1-H_001227 CCOc1cc(/C=N/NC(=O)CCCCC(=O)NO)ccc1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 P23 compound treatment 7.0985 -2.453 -0.6582 9.4912 -0.27579 -0.0653 -0.5116 -0.7735 3215430 Ald1-H_001228 COC(=O)CCCCCCC(=O)N/N=C/c1ccc(cc1)N(C)CCO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2134 P24 compound treatment 8.6135 -0.93795 -0.2517 11.2521 1.4851 0.3519 0.0708 0.1638 3215432 Ald1-H_001229 CN(CCO)c1ccc(/C=N/NC(=O)CCCCC(=O)NO)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 A01 compound treatment 14.9244 1.7302 0.4643 18.0249 4.6271 1.0963 1.1035 0.9269 3561417 BPBio1_000001 CS(=O)(=O)Nc1ccc(Cc2noc(n2)c3ccc4[nH]cc(CCN)c4c3)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 A02 compound treatment 20.9862 7.7921 2.0908 21.8648 8.467 2.0061 2.897 0.9998 3614564 BPBio1_000002 CN(C)CCCc1cc(ccc1O)C(=O)Nc2ccc(cc2)c3ccncc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 A03 compound treatment 31.1678 17.974 4.8228 27.0492 13.651 3.2345 5.6974 0.9811 1164875 BPBio1_000003 Nc1nc2[nH]nnc2c(=O)[nH]1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 A04 compound treatment 12.045 -1.1492 -0.3084 13.6979 0.30013 0.0711 -0.1678 -0.5301 683 BPBio1_000004 Cc1ncc([N+](=O)[O-])n1CCO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 A05 compound treatment 15.6013 2.4072 0.6459 19.4161 6.0183 1.4259 1.465 0.9359 923 BPBio1_000005 NC(=O)NC1NC(=O)NC1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 A06 compound treatment 29.9971 16.803 4.5087 16.065 2.6672 0.632 3.635 0.7984 1449 BPBio1_000006 CN1[C@@H](CCC1=O)c2cccnc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 A07 compound treatment 14.3866 1.1924 0.3199 13.246 -0.15179 -0.036 0.2008 0.6237 692 BPBio1_000007 CC(=O)Nc1nnc(s1)S(=O)(=O)N 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 A08 compound treatment 0.1689 -13.025 -3.495 13.8841 0.48634 0.1152 -2.3899 -0.6834 1402 BPBio1_000008 CC[N+](C)(C)c1cccc(O)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 A09 compound treatment 14.6281 1.4339 0.3847 18.6955 5.2977 1.2552 1.1596 0.8833 1714 BPBio1_000009 CN(C)C(=N)NC(=N)N 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 A10 compound treatment 12.504 -0.6902 -0.1852 4.715 -8.6828 -2.0573 -1.5857 -0.7677 1029858 BPBio1_000010 NC(=N)NC(=N)N1CCOCC1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 A11 compound treatment 12.6491 -0.5451 -0.1463 12.8065 -0.59131 -0.1401 -0.2025 -0.9998 3221455 BPBio1_000011 COc1ccc(CC2c3cc(OC)c(OC)cc3CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]4(C)CCc5cc(OC)c(OC)cc5C4Cc6ccc(OC)c(OC)c6)cc1OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 A12 compound treatment 15.1488 1.9546 0.5245 16.2709 2.8732 0.6808 0.8522 0.9917 678 BPBio1_000012 NCC(CC(=O)O)c1ccc(Cl)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 A13 compound treatment 20.4094 7.2152 1.936 17.7789 4.3811 1.038 2.103 0.9573 3064163 BPBio1_000013 CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 A14 compound treatment 16.4539 3.2598 0.8747 16.858 3.4602 0.8199 1.1982 0.9995 839 BPBio1_000014 Nc1nc2n(COCCO)cnc2c(=O)[nH]1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 A15 compound treatment 13.6187 0.42455 0.1139 13.0411 -0.35667 -0.0845 0.0208 0.1466 1000042 BPBio1_000015 NC(=N)NC(=O)c1nc(Cl)c(N)nc1N 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 A16 compound treatment 11.6727 -1.5215 -0.4083 15.8371 2.4393 0.5779 0.12 0.1696 35 BPBio1_000016 CC1=Nc2ccc(Cl)cc2S(=O)(=O)N1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 A17 compound treatment 12.5309 -0.66332 -0.178 22.8039 9.4061 2.2286 1.45 0.6486 807 BPBio1_000017 CCCc1ncc(C[n+]2ccccc2C)c(N)n1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 A18 compound treatment 14.1317 0.93755 0.2516 14.0794 0.68156 0.1615 0.2921 0.977 1090166 BPBio1_000018 CN(C)c1c(C)n(C)n(c2ccccc2)c1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 A19 compound treatment 14.1618 0.96763 0.2596 13.045 -0.35277 -0.0836 0.1245 0.4564 931 BPBio1_000019 NS(=O)(=O)c1cc2c(NCNS2(=O)=O)cc1Cl 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 A20 compound treatment 20.2197 7.0255 1.8851 21.8991 8.5014 2.0143 2.7573 0.9995 3616486 BPBio1_000020 C[C@@H]1CC[C@@]2(CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]2[C@H]1C)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 A21 compound treatment 15.3215 2.1274 0.5708 12.0954 -1.3024 -0.3086 0.1854 0.2858 1241 BPBio1_000021 NC(=N)NS(=O)(=O)c1ccc(N)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 A22 compound treatment 14.0536 0.8594 0.2306 14.1709 0.77314 0.1832 0.2926 0.9935 1428 BPBio1_000022 CC(C)NCC(O)COc1cccc2[nH]ccc12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 A23 mock treatment 12.5271 -0.6671 -0.179 16.0606 2.6628 0.6309 0.3196 0.4873 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 A24 mock treatment 14.2113 1.0171 0.2729 16.4991 3.1013 0.7348 0.7126 0.9091 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 B01 compound treatment 28.477 15.283 4.1008 17.9412 4.5434 1.0765 3.6609 0.8635 3176924 BPBio1_000023 CC(N)Cc1c[nH]c2ccc(OCc3cccs3)cc12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 B02 compound treatment 13.5734 0.3792 0.1017 13.3957 -0.0021352 -5.0E-4 0.0716 0.7036 3614583 BPBio1_000024 CN1CC[C@@H]2CN3CCc4cccc([C@@H]2C1)c34 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 B03 compound treatment 18.4064 5.2122 1.3986 15.4441 2.0463 0.4848 1.3318 0.8997 735 BPBio1_000025 NNC(=O)c1ccncc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 B04 compound treatment 11.8998 -1.2944 -0.3473 14.7668 1.369 0.3244 -0.0162 -0.0341 1425 BPBio1_000026 CC(N)COc1c(C)cccc1C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 B05 compound treatment 15.7888 2.5946 0.6962 18.9938 5.596 1.3259 1.4298 0.9548 1008060 BPBio1_000027 C1CCc2nnnn2CC1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 B06 compound treatment 11.5858 -1.6084 -0.4316 17.2785 3.8807 0.9195 0.345 0.3397 3101 BPBio1_000028 Cc1c(oc2c(cccc2c1=O)C(=O)OCCN3CCCCC3)c4ccccc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 B07 compound treatment 15.0482 1.854 0.4975 7.9352 -5.4625 -1.2943 -0.5634 -0.4063 1480 BPBio1_000029 Clc1ccc2oc(=O)[nH]c2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 B08 compound treatment 11.8594 -1.3348 -0.3582 13.1203 -0.27754 -0.0658 -0.2998 -0.8232 769 BPBio1_000030 CCCCOc1ccc(CC(=O)NO)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 B09 compound treatment 13.6785 0.48436 0.13 15.0975 1.6998 0.4027 0.3767 0.8901 1054660 BPBio1_000031 Cc1ncc([N+](=O)[O-])n1CC(O)CCl 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 B10 compound treatment 10.5949 -2.5992 -0.6974 14.47 1.0722 0.254 -0.3135 -0.4224 1469 BPBio1_000032 CCC1(CCC(=O)NC1=O)c2ccc(N)cc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 B11 compound treatment 13.3335 0.13935 0.0374 15.5221 2.1243 0.5033 0.3823 0.7575 869 BPBio1_000033 CCC1(C)CC(=O)NC1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 B12 compound treatment 13.3868 0.19262 0.0517 13.4998 0.10204 0.0242 0.0536 0.9401 858 BPBio1_000034 OCC(O)CN1CCN(CC1)c2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 B13 compound treatment 16.9373 3.7432 1.0044 14.4166 1.0188 0.2414 0.8809 0.8528 997 BPBio1_000035 NCc1ccc(cc1)S(=O)(=O)N 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 B14 compound treatment 13.3321 0.13793 0.037 14.55 1.1522 0.273 0.2192 0.7957 3173239 BPBio1_000036 CC(N/C(=N/C#N)/Nc1ccncc1)C(C)(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 B15 compound treatment 14.9207 1.7265 0.4633 13.7078 0.30996 0.0734 0.3795 0.8091 399 BPBio1_000037 Nc1nc2ccc(OC(F)(F)F)cc2s1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 B16 compound treatment 282.0038 268.81 72.1285 277.984 264.59 62.6898 95.331 0.9976 1185085 BPBio1_000038 CCCSc1ccc2[nH]c(NC(=O)OC)nc2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 B17 compound treatment 13.381 0.1868 0.0501 10.8519 -2.5458 -0.6032 -0.3911 -0.6461 3173466 BPBio1_000039 [O-][N+](=O)c1ccc(/C=N/N2CC(=O)NC2=O)o1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 B18 compound treatment 11.7626 -1.4316 -0.3841 15.4201 2.0223 0.4792 0.0672 0.1094 3616606 BPBio1_000040 Clc1cccc(Cl)c1NC2=NCCN2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 B19 compound treatment 14.8669 1.6728 0.4488 14.5725 1.1747 0.2783 0.5142 0.9736 3616534 BPBio1_000041 N/N=C/1\N=NC=C2C=CC=CC12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 B20 compound treatment 14.5895 1.3953 0.3744 12.5026 -0.89514 -0.2121 0.1148 0.2667 1101055 BPBio1_000042 CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 B21 compound treatment 13.684 0.48983 0.1314 15.1799 1.7821 0.4222 0.3915 0.8853 3273 BPBio1_000043 NNCCc1ccccc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 B22 compound treatment 14.8115 1.6173 0.434 15.0291 1.6313 0.3865 0.5802 0.9983 690 BPBio1_000044 CC(C)NCC(O)COc1ccccc1CC=C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 B23 mock treatment 12.9486 -0.24557 -0.0659 15.7383 2.3405 0.5545 0.3455 0.6187 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 B24 mock treatment 14.3486 1.1544 0.3098 12.8985 -0.49929 -0.1183 0.1354 0.4083 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 C01 compound treatment 16.6245 3.4304 0.9205 17.4369 4.0391 0.957 1.3276 0.9998 3560538 BPBio1_000045 O=C1CC2(CCCC2)CC(=O)N1CCNCC3COc4ccccc4O3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 C02 compound treatment 14.019 0.82485 0.2213 15.8354 2.4376 0.5776 0.5649 0.9133 3559954 BPBio1_000046 CC(C)NCC(O)COc1ccccc1n2cccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 C03 compound treatment 13.2403 0.046127 0.0124 15.0628 1.665 0.3945 0.2877 0.7289 2898 BPBio1_000047 Cc1cc2CCCS(=O)(=O)c2cc1S(=O)(=O)N 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 C04 compound treatment 12.4884 -0.7058 -0.1894 14.6543 1.2565 0.2977 0.0766 0.2171 715 BPBio1_000048 COc1c2ccoc2c(OC)c3oc(C)cc(=O)c13 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 C05 compound treatment 13.509 0.31478 0.0845 11.9694 -1.4284 -0.3384 -0.1796 -0.5148 3188932 BPBio1_000049 CCCCNc1ccc(cc1)C(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 C06 compound treatment 17.0597 3.8655 1.0372 17.1582 3.7604 0.891 1.3634 0.9971 3616489 BPBio1_000050 CN(C)C/C=C(\c1ccc(Br)cc1)/c2cccnc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 C07 compound treatment 11.8246 -1.3696 -0.3675 15.0643 1.6665 0.3949 0.0194 0.0359 1131 BPBio1_000051 NS(=O)(=O)c1cc2c(NCNS2(=O)=O)cc1C(F)(F)F 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 C08 compound treatment 13.984 0.78978 0.2119 13.2881 -0.10972 -0.026 0.1315 0.6157 1451360 BPBio1_000052 OC(C1CCNCC1)(c2ccccc2)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 C09 compound treatment 11.6728 -1.5214 -0.4082 15.8247 2.4269 0.575 0.1179 0.1672 878 BPBio1_000053 CC(=O)NS(=O)(=O)c1ccc(N)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 C10 compound treatment 15.1374 1.9432 0.5214 18.2062 4.8084 1.1393 1.1743 0.9372 1865021 BPBio1_000054 Cn1cnc([N+](=O)[O-])c1Sc2ncnc3[nH]cnc23 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 C11 compound treatment 12.4415 -0.75271 -0.202 10.2265 -3.1713 -0.7514 -0.6741 -0.8664 1507 BPBio1_000055 CC(N)CCCC(C)(C)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 C12 compound treatment 23.6954 10.501 2.8177 23.6931 10.295 2.4393 3.7173 0.9974 3069004 BPBio1_000056 C[C@@]12CC[C@H]3[C@@H](CCC4=CCCC[C@H]34)[C@@H]2CC[C@@]1(O)C#C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 C13 compound treatment 14.926 1.7318 0.4647 16.2303 2.8325 0.6711 0.8031 0.9839 1175 BPBio1_000057 Nc1ccc(cc1)S(=O)(=O)Nc2nccs2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 C14 compound treatment 11.8394 -1.3548 -0.3635 13.3085 -0.08931 -0.0212 -0.272 -0.747 3060090 BPBio1_000058 NC(=N)N/N=C/c1c(Cl)cccc1Cl 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 C15 compound treatment 12.5991 -0.59508 -0.1597 14.5626 1.1648 0.276 0.0822 0.2579 1079 BPBio1_000059 N[C@@H](Cc1ccc(O)c(O)c1)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 C16 compound treatment 73.3269 60.133 16.1352 55.1137 41.716 9.884 18.3983 0.9723 2038 BPBio1_000060 CCN(CC)C(=S)SSC(=S)N(CC)CC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 C17 compound treatment 12.276 -0.91822 -0.2464 18.2202 4.8224 1.1426 0.6337 0.5422 2651 BPBio1_000061 OC[C@H]1O[C@H](C[C@@H]1O)n2cc(I)c(=O)[nH]c2=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 C18 compound treatment 15.2695 2.0753 0.5569 14.8746 1.4768 0.3499 0.6412 0.9749 2060486 BPBio1_000062 CC(=O)Oc1ccccc1C(=O)Oc2ccccc2C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 C19 compound treatment 17.0686 3.8744 1.0396 11.4482 -1.9496 -0.4619 0.4085 0.3591 861 BPBio1_000063 C[C@H](CS)C(=O)N1CCC[C@H]1C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 C20 compound treatment 17.6834 4.4893 1.2046 15.7758 2.378 0.5634 1.2502 0.9401 1434 BPBio1_000064 CN1CCN2C(C1)c3ccccc3Cc4ccccc24 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 C21 compound treatment 14.1301 0.93595 0.2511 14.9152 1.5174 0.3595 0.4318 0.9846 3616456 BPBio1_000065 Nc1cc(nc(=N)n1O)N2CCCCC2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 C22 compound treatment 154.858 141.66 38.012 189.093 175.7 41.6284 56.3143 0.999 440 BPBio1_000066 COC(=O)Nc1nc2cc(ccc2[nH]1)C(=O)c3cccs3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 C23 mock treatment 13.7121 0.5179 0.139 12.4815 -0.91625 -0.2171 -0.0552 -0.2143 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 C24 mock treatment 13.8113 0.61715 0.1656 13.4022 0.0043898 0.001 0.1178 0.7115 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 D01 compound treatment 17.167 3.9728 1.066 14.4864 1.0886 0.2579 0.9362 0.8536 836181 BPBio1_000067 Clc1cccc(c1)N2CCNCC2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 D02 compound treatment 23.7284 10.534 2.8266 30.2416 16.844 3.9909 4.8207 0.9857 3614588 BPBio1_000068 COc1ccc2[nH]cc(CCNCc3ccc(Br)cc3)c2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 D03 compound treatment 14.4189 1.2247 0.3286 14.0297 0.63194 0.1497 0.3382 0.9366 1262 BPBio1_000069 NC[C@H]1CC[C@@H](CC1)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 D04 compound treatment 12.4461 -0.74809 -0.2007 14.5427 1.1449 0.2713 0.0499 0.1478 1282 BPBio1_000070 NS(=O)(=O)c1cc2c(N=CNS2(=O)=O)cc1Cl 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 D05 compound treatment 12.5886 -0.60562 -0.1625 11.8371 -1.5607 -0.3698 -0.3764 -0.9318 718 BPBio1_000071 Cn1c(=O)n(C)c2ncn(CCO)c2c1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 D06 compound treatment 12.3482 -0.84602 -0.227 11.4886 -1.9091 -0.4523 -0.4804 -0.9492 3036 BPBio1_000072 OC(CCCN1CCCCC1)(c2ccccc2)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 D07 compound treatment 15.0689 1.8748 0.5031 14.0476 0.64984 0.154 0.4646 0.8831 3616541 BPBio1_000073 N[C@H]1C[C@@H]1c2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 D08 compound treatment 14.4339 1.2397 0.3326 12.3243 -1.0735 -0.2544 0.0554 0.1322 1000286 BPBio1_000074 C[C@@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@@H]2CC[C@@]1(O)C#C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 D09 compound treatment 11.9109 -1.2833 -0.3443 12.6113 -0.78648 -0.1863 -0.3752 -0.9584 3256 BPBio1_000075 CCN(CCCc1ccccc1)CCCc2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 D10 compound treatment 16.4577 3.2636 0.8757 14.4332 1.0354 0.2453 0.7927 0.8716 809 BPBio1_000076 CNCCC=C1c2ccccc2CCc3ccccc13 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 D11 compound treatment 12.7562 -0.43797 -0.1175 15.6665 2.2687 0.5375 0.297 0.5398 3069075 BPBio1_000077 OC(=O)COC(=O)Cc1ccccc1Nc2c(Cl)cccc2Cl 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 D12 compound treatment 20.5343 7.3402 1.9696 13.8882 0.49041 0.1162 1.4748 0.7475 112 BPBio1_000078 OC(=O)c1cccnc1Nc2cccc(c2)C(F)(F)F 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 D13 compound treatment 13.0691 -0.12505 -0.0336 13.4532 0.055365 0.0131 -0.0145 -0.4011 780 BPBio1_000079 CC(C)NNC(=O)c1ccncc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 D14 compound treatment 20.619 7.4249 1.9923 16.0938 2.696 0.6388 1.8604 0.8892 1000009 BPBio1_000080 C/C(=C\C=C\C(=C/C(=O)O)\C)/C=C/C1=C(C)CCCC1(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 D15 compound treatment 16.836 3.6418 0.9772 14.4243 1.0265 0.2432 0.863 0.857 1256 BPBio1_000081 Cc1cc(NS(=O)(=O)c2ccc(N)cc2)no1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 D16 compound treatment 13.4828 0.28868 0.0775 12.6173 -0.78054 -0.1849 -0.076 -0.379 104 BPBio1_000082 C/C(=C\C=C\C(=C\C(=O)O)\C)/C=C/C1=C(C)CCCC1(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 D17 compound treatment 12.7499 -0.4443 -0.1192 17.1205 3.7227 0.882 0.5394 0.606 741 BPBio1_000083 Cc1ccccc1OCC(O)CO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 D18 compound treatment 12.3942 -0.79995 -0.2146 12.5683 -0.82951 -0.1965 -0.2908 -0.999 746 BPBio1_000084 C(N(Cc1ccccc1)c2ccccc2)C3=NCCN3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 D19 compound treatment 12.2473 -0.94685 -0.2541 11.2663 -2.1315 -0.505 -0.5368 -0.9495 1018627 BPBio1_000085 NC(=N)NC(=N)NCCc1ccccc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 D20 compound treatment 16.8526 3.6584 0.9817 15.5952 2.1974 0.5206 1.0623 0.956 1485 BPBio1_000086 CCC(=C)C(=O)c1ccc(OCC(=O)O)c(Cl)c1Cl 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 D21 compound treatment 48.6256 35.431 9.5072 13.6442 0.24636 0.0584 6.7639 0.7114 1086 BPBio1_000087 CC(C)C(=O)Nc1ccc([N+](=O)[O-])c(c1)C(F)(F)F 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 D22 compound treatment 13.6474 0.45323 0.1216 12.5685 -0.82926 -0.1965 -0.0529 -0.2291 1000106 BPBio1_000088 O=C(C1CCCCC1)N2CC3N(CCc4ccccc34)C(=O)C2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 D23 mock treatment 15.3663 2.1721 0.5828 13.0539 -0.34394 -0.0815 0.3545 0.6024 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 D24 mock treatment 15.4634 2.2692 0.6089 11.9629 -1.4349 -0.34 0.1901 0.2727 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 E01 compound treatment 14.0154 0.82125 0.2204 21.4991 8.1013 1.9195 1.5131 0.7831 3614557 BPBio1_000089 CN1C2CCC(Cn3ccnc3C)C(=O)C2c4ccccc14 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 E02 compound treatment 10.6401 -2.5541 -0.6853 15.8855 2.4877 0.5894 -0.0678 -0.075 3614567 BPBio1_000090 COc1ccccc1N2CCN(CCCCN3C(=O)CCC3=O)CC2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 E03 compound treatment 12.7432 -0.45102 -0.121 11.4265 -1.9713 -0.4671 -0.4158 -0.8619 944 BPBio1_000091 Nc1ccc(cc1)S(=O)(=O)Nc2ccnn2c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 E04 compound treatment 11.0328 -2.1614 -0.58 12.2673 -1.1305 -0.2678 -0.5995 -0.9384 899 BPBio1_000092 CN1CCc2cccc-3c2[C@H]1Cc4ccc(O)c(O)c43 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 E05 compound treatment 10.7801 -2.4141 -0.6478 11.1626 -2.2352 -0.5296 -0.8325 -0.995 3060 BPBio1_000093 CC(C)(CO)[C@@H](O)C(=O)NCCCO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 E06 compound treatment 15.4213 2.2271 0.5976 14.6805 1.2827 0.3039 0.6375 0.9508 885 BPBio1_000094 Clc1ccc2Oc3ccccc3N=C(N4CCNCC4)c2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 E07 compound treatment 12.5595 -0.63463 -0.1703 14.4894 1.0916 0.2586 0.0625 0.2017 1159 BPBio1_000095 Nc1ccc(cc1)S(=O)(=O)Nc2ncccn2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 E08 compound treatment 12.7231 -0.47109 -0.1264 12.6409 -0.75691 -0.1793 -0.2162 -0.9853 3326 BPBio1_000096 CN1CCC(=C2c3ccccc3C=Cc4ccccc24)CC1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 E09 compound treatment 18.1104 4.9162 1.3191 14.0419 0.64414 0.1526 1.0407 0.7837 3188934 BPBio1_000097 C[C@@]12CC[C@H]3[C@@H](CCC4=C3CCC(=O)C4)[C@@H]2CC[C@@]1(O)C#C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 E10 compound treatment 11.09 -2.1042 -0.5646 13.4483 0.050467 0.012 -0.3908 -0.692 3616496 BPBio1_000098 NC(=Nc1nc(CSCCC(=N)NS(=O)(=O)N)cs1)N 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 E11 compound treatment 11.5473 -1.6468 -0.4419 14.8328 1.435 0.34 -0.072 -0.1292 1433 BPBio1_000099 CS(=O)(=O)c1ccc(cc1)[C@@H](O)[C@@H](CO)NC(=O)C(Cl)Cl 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 E12 compound treatment 11.2901 -1.9041 -0.5109 12.961 -0.43681 -0.1035 -0.4345 -0.8334 3189048 BPBio1_000100 C[C@@]12CC[C@H]3[C@@H](CCC4=Cc5oncc5C[C@]34C)[C@@H]2CC[C@@]1(O)C#C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 E13 compound treatment 12.8802 -0.31397 -0.0842 13.52 0.12219 0.029 -0.0391 -0.4389 3616459 BPBio1_000101 CN/C(=N/CCSCc1nc[nH]c1C)/NC#N 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 E14 compound treatment 15.4578 2.2637 0.6074 14.3345 0.93676 0.222 0.5864 0.9068 3169 BPBio1_000102 CCN(CC)C(=O)N[C@@H]1CN(C)[C@@H]2Cc3c[nH]c4cccc(C2=C1)c34 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 E15 compound treatment 14.3456 1.1514 0.309 12.4705 -0.92729 -0.2197 0.0631 0.1665 1432 BPBio1_000103 CN(C)CCOC(C)(c1ccccc1)c2ccccn2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 E16 compound treatment 18.3594 5.1653 1.386 13.6835 0.28569 0.0677 1.0279 0.7408 3616497 BPBio1_000104 C[C@H]1[C@H]2[C@H](C[C@H]3[C@@H]4CC[C@H]5C[C@H](CC[C@]5(C)[C@H]4CC[C@]23C)O[C@@H]6O[C@H](CO)[C@H](O[C@@H]7O[C@H](CO)[C@@H](O)[C@H](O[C@@H]8OC[C@@H](O)[C@H](O)[C@H]8O)[C@H]7O[C@@H]9O[C@H](CO)[C@@H](O)[C@H](O)[C@H]9O)[C@H](O)[C@H]6O)OC%101CC[C@H](C)CN%10 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 E17 compound treatment 13.9256 0.73145 0.1963 12.674 -0.72379 -0.1715 0.0175 0.0672 1000260 BPBio1_000105 CC[C@H](CO)NCCN[C@H](CC)CO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 E18 compound treatment 11.1413 -2.0529 -0.5509 12.9384 -0.45941 -0.1088 -0.4665 -0.8308 1386 BPBio1_000106 CN1CC(c2ccccc2)c3cccc(N)c3C1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 E19 compound treatment 12.6958 -0.49837 -0.1337 11.314 -2.0838 -0.4937 -0.4437 -0.8674 1108 BPBio1_000107 Cc1cc(=O)n(c2ccccc2)n1C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 E20 compound treatment 13.4514 0.2572 0.069 14.3513 0.95354 0.2259 0.2086 0.8828 907387 BPBio1_000108 C[C@@]1(N[C@@H]2Cc3ccccc31)c4ccccc24 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 E21 compound treatment 13.1429 -0.051318 -0.0138 13.3921 -0.0056502 -0.0013 -0.0107 -0.7722 1079457 BPBio1_000109 Cc1c(O)c(=O)n(c2ccccc2)n1C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 E22 compound treatment 11.8412 -1.353 -0.363 11.2961 -2.1017 -0.498 -0.6088 -0.9879 3069006 BPBio1_000110 CC(=O)CC(c1ccc(cc1)[N+](=O)[O-])c2c(O)c3ccccc3oc2=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 E23 mock treatment 12.3456 -0.8486 -0.2277 13.3974 -3.8516E-4 -1.0E-4 -0.1611 -0.7074 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 E24 mock treatment 11.9903 -1.2039 -0.323 14.7849 1.3871 0.3287 0.004 0.0086 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 F01 compound treatment 12.3809 -0.81323 -0.2182 12.9138 -0.48396 -0.1147 -0.2354 -0.9549 1101182 BPBio1_000111 Clc1cncc(n1)N2CCNCC2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 F02 compound treatment 15.0206 1.8264 0.4901 11.9456 -1.4521 -0.3441 0.1032 0.1724 885651 BPBio1_000112 NC(=N)NC(=N)Nc1cccc(Cl)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 F03 compound treatment 12.3137 -0.88045 -0.2362 14.9571 1.5593 0.3695 0.0942 0.2148 1081 BPBio1_000113 Cc1c(N)c(=O)n(c2ccccc2)n1C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 F04 compound treatment 38.8151 25.621 6.8747 20.9257 7.5279 1.7836 6.1224 0.862 3616617 BPBio1_000114 C[C@@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@]34C)[C@@H]2CC[C@@]1(O)C#C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 F05 compound treatment 12.6178 -0.5764 -0.1547 14.1992 0.80141 0.1899 0.0249 0.1017 1000096 BPBio1_000115 C1CN2CC(N=C2S1)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 F06 compound treatment 11.6841 -1.5101 -0.4052 17.1032 3.7054 0.8779 0.3343 0.3457 938 BPBio1_000116 Cc1ccc(cc1)/C(=C\CN2CCCC2)/c3ccccn3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 F07 compound treatment 12.7786 -0.41556 -0.1115 24.9591 11.561 2.7393 1.8581 0.6778 719 BPBio1_000117 CN(CC#C)Cc1ccccc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 F08 compound treatment 12.3202 -0.874 -0.2345 10.4908 -2.907 -0.6888 -0.6529 -0.8973 3060494 BPBio1_000118 CN(C)CC/C=C/1\c2ccccc2COc3ccccc13 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 F09 compound treatment 13.7266 0.53246 0.1429 12.6826 -0.71524 -0.1695 -0.0188 -0.0848 1062 BPBio1_000119 COc1ccccc1OCC(O)COC(=O)N 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 F10 compound treatment 23.0657 9.8715 2.6488 16.0878 2.69 0.6374 2.3237 0.8529 1240 BPBio1_000120 CCCCOc1ccc(cc1)C(=O)CCN2CCCCC2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 F11 compound treatment 12.1925 -1.0017 -0.2688 13.338 -0.059793 -0.0142 -0.2001 -0.7433 3189063 BPBio1_000121 C[C@H]1[C@H](NC(=O)/C(=N\OC(C)(C)C(=O)O)/c2csc(N)n2)C(=O)N1S(=O)(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 F12 compound treatment 16.8018 3.6077 0.968 13.33 -0.067753 -0.0161 0.6731 0.6953 3173092 BPBio1_000122 CN(C)CCOC(c1ccccc1)c2ccccc2.Cn1c(=O)n(C)c2nc(Cl)[nH]c2c1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 F13 compound treatment 18.6198 5.4257 1.4558 12.7592 -0.63863 -0.1513 0.9224 0.6302 1337 BPBio1_000123 Cc1onc(c1C(=O)N[C@H]2[C@H]3SC(C)(C)[C@@H](N3C2=O)C(=O)O)c4ccccc4Cl 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 F14 compound treatment 12.3908 -0.80334 -0.2156 9.3461 -4.0517 -0.96 -0.8312 -0.8448 1112 BPBio1_000124 CC(C)N(CCC(C(=O)N)(c1ccccc1)c2ccccn2)C(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 F15 compound treatment 11.6734 -1.5208 -0.4081 12.0901 -1.3077 -0.3098 -0.5076 -0.9908 724 BPBio1_000125 CCn1cc(C(=O)O)c(=O)c2ccc(C)nc12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 F16 compound treatment 11.7127 -1.4815 -0.3975 9.6942 -3.7036 -0.8775 -0.9016 -0.9359 1272 BPBio1_000126 Clc1ccccc1C(c2ccccc2)(c3ccccc3)n4ccnc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 F17 compound treatment 15.1653 1.9712 0.5289 14.1892 0.79146 0.1875 0.5066 0.9028 3061416 BPBio1_000127 C[N+]1(CCCCC[N+]2(C)CCCC2)CCCC1.O[C@H]([C@@H](O)C(=O)O)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 F18 compound treatment 13.4514 0.2572 0.069 10.6228 -2.775 -0.6575 -0.4161 -0.6294 2359 BPBio1_000128 CCOC(=O)C1=C[C@]2(CC)CCCN3CCc4c([C@@H]32)n1c5ccccc45 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 F19 compound treatment 13.2437 0.04957 0.0133 11.9575 -1.4403 -0.3412 -0.2319 -0.679 1300191 BPBio1_000129 C(Nc1ncnc2nc[nH]c12)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 F20 compound treatment 15.6077 2.4135 0.6476 15.1755 1.7777 0.4212 0.7558 0.9783 1393 BPBio1_000130 CN(C)CCCN1c2ccccc2CCc3ccc(Cl)cc13 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 F21 compound treatment 13.7032 0.509 0.1366 13.6286 0.23084 0.0547 0.1353 0.9193 198 BPBio1_000131 CCCCNC(=O)NS(=O)(=O)c1ccc(C)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 F22 compound treatment 22.8317 9.6375 2.586 18.2154 4.8176 1.1415 2.6357 0.9324 1215 BPBio1_000132 CC(NCCC(c1ccccc1)c2ccccc2)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 F23 mock treatment 11.4591 -1.735 -0.4656 13.1838 -0.21404 -0.0507 -0.3651 -0.7795 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 F24 mock treatment 16.7483 3.5541 0.9537 12.3912 -1.0065 -0.2385 0.5057 0.5144 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 G01 compound treatment 38.8397 25.646 6.8814 62.8847 49.487 11.7252 13.1568 0.9677 907439 BPBio1_000133 CCCCCCCCCOc1ccc2[nH]cc(CCN)c2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 G02 compound treatment 35.3964 22.202 5.9574 61.8991 48.501 11.4917 12.3384 0.9532 3560511 BPBio1_000134 COc1ccc(NC(=O)c2ccc(cc2)c3ccc(cc3C)c4noc(C)n4)cc1OCCN(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 G03 compound treatment 13.8148 0.62065 0.1665 11.1251 -2.2727 -0.5385 -0.263 -0.4666 1160 BPBio1_000135 OC[C@@H](NC(=O)C(Cl)Cl)[C@H](O)c1ccc(cc1)[N+](=O)[O-] 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 G04 compound treatment 15.8476 2.6535 0.712 15.3846 1.9869 0.4708 0.8363 0.9798 929 BPBio1_000136 Oc1ccc2C[C@H]3N(CC=C)CC[C@]4([C@H]5Oc1c24)[C@@]3(O)CCC5=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 G05 compound treatment 11.7518 -1.4424 -0.387 14.0402 0.64237 0.1522 -0.166 -0.3993 2702 BPBio1_000137 COc1cc(C)nn1c2nc(C)cc(OC)n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 G06 compound treatment 10.7576 -2.4366 -0.6538 15.244 1.8462 0.4374 -0.153 -0.1945 918 BPBio1_000138 CC1Nc2cc(Cl)c(cc2C(=O)N1c3ccccc3C)S(=O)(=O)N 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 G07 compound treatment 11.2775 -1.9167 -0.5143 13.4618 0.06399 0.0152 -0.3529 -0.686 697 BPBio1_000139 Cn1c(=O)n(C)c2ncn(CC(O)CO)c2c1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 G08 compound treatment 10.9213 -2.2728 -0.6099 15.7017 2.3039 0.5459 -0.0452 -0.0553 757 BPBio1_000140 OC(=O)c1cn(C2CC2)c3cc(N4CCNCC4)c(F)cc3c1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 G09 compound treatment 12.7745 -0.41967 -0.1126 14.5675 1.1697 0.2772 0.1163 0.3889 1061 BPBio1_000141 Nc1nc(N)c2nc(c(N)nc2n1)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 G10 compound treatment 12.3205 -0.87364 -0.2344 11.1433 -2.2545 -0.5342 -0.5435 -0.9317 1092 BPBio1_000142 CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccccc3)C(=O)N2[C@H]1C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 G11 compound treatment 12.6214 -0.57277 -0.1537 14.9722 1.5744 0.373 0.1551 0.3844 1186 BPBio1_000143 Nc1ccc(cc1)S(=O)(=O)c2ccc(N)cc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 G12 compound treatment 24.8199 11.626 3.1195 13.0374 -0.36042 -0.0854 2.1454 0.6875 1261 BPBio1_000144 OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 G13 compound treatment 15.892 2.6978 0.7239 12.8346 -0.56314 -0.1334 0.4175 0.5672 3616468 BPBio1_000145 CO[C@H]1C[C@H](O[C@H]2[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3OC(=O)C)N(C)C)[C@@H](C)C[C@@]4(CO4)C(=O)[C@H](C)[C@@H](OC(=O)C)[C@@H](C)[C@@H](C)OC(=O)[C@@H]2C)O[C@@H](C)[C@@H]1OC(=O)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 G14 compound treatment 14.0443 0.85008 0.2281 15.9016 2.5038 0.5932 0.5808 0.9138 3189051 BPBio1_000146 Oc1ccc2C[C@H]3N(CC4CC4)CC[C@]5([C@H]6Oc1c25)[C@@]3(O)CCC6=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 G15 compound treatment 9.3613 -3.8329 -1.0285 10.636 -2.7618 -0.6544 -1.1899 -0.9762 1259 BPBio1_000147 CCc1nc(N)nc(N)c1c2ccc(Cl)cc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 G16 compound treatment 11.5455 -1.6487 -0.4424 15.9236 2.5258 0.5984 0.1104 0.1483 1207 BPBio1_000148 CN(C)CCC(c1ccc(Cl)cc1)c2ccccn2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 G17 compound treatment 10.9985 -2.1957 -0.5892 14.5934 1.1956 0.2833 -0.2163 -0.3309 1270 BPBio1_000149 C[N+](C)(C)CCCCCC[N+](C)(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 G18 compound treatment 13.1749 -0.019228 -0.0052 14.9713 1.5735 0.3728 0.26 0.6973 1027 BPBio1_000150 O[C@H]1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5O[C@@H]1[C@]2(CCN3CC6CCC6)c54 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 G19 compound treatment 13.0496 -0.1446 -0.0388 14.1388 0.74101 0.1756 0.0967 0.5379 1518 BPBio1_000151 OC(=O)c1cc(ccc1O)c2ccc(F)cc2F 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 G20 compound treatment 13.8622 0.66801 0.1792 12.0974 -1.3004 -0.3081 -0.0911 -0.2556 2241 BPBio1_000152 COc1ccc(cc1C(=O)NCc2cccnc2)C(=O)NCc3cccnc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 G21 compound treatment 31.1214 17.927 4.8103 32.427 19.029 4.5087 6.5895 0.9995 1313 BPBio1_000153 Oc1ccc(Cl)cc1C(=O)Nc2ccc(cc2Cl)[N+](=O)[O-] 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 G22 compound treatment 17.3658 4.1717 1.1194 19.1033 5.7055 1.3518 1.7474 0.9956 1002008 BPBio1_000154 C[C@@]12C[C@H](O)[C@@]3(F)[C@@H](CCC4=CC(=O)C=C[C@@]43C)[C@@H]2C[C@@H](O)[C@]1(O)C(=O)CO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 G23 mock treatment 14.6539 1.4597 0.3917 14.6537 1.2559 0.2976 0.4874 0.9908 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 G24 mock treatment 12.1938 -1.0004 -0.2684 13.4113 0.013515 0.0032 -0.1875 -0.6986 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 H01 compound treatment 12.5285 -0.66564 -0.1786 15.8809 2.4831 0.5883 0.2897 0.4712 3326 BPBio1_000155 CN1CCC(=C2c3ccccc3C=Cc4ccccc24)CC1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 H02 compound treatment 13.2509 0.056752 0.0152 0.0 -13.398 -3.1744 -2.2339 -0.7037 924 BPBio1_000156 NC(=N)NC(=N)Nc1ccccc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 H03 compound treatment 13.6927 0.49854 0.1338 13.1972 -0.20064 -0.0475 0.061 0.4295 1535 BPBio1_000157 COc1ccc(OC)c(c1)C(O)CNC(=O)CN 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 H04 compound treatment 15.403 2.2088 0.5927 14.9691 1.5713 0.3723 0.6823 0.9749 3069234 BPBio1_000158 CC[C@]1(CCCN2CCc3c4[C@@H]21)C[C@](O)(C(=O)OC)n4c5ccccc35 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 H05 compound treatment 14.6394 1.4453 0.3878 13.9214 0.52359 0.1241 0.3619 0.8889 370 BPBio1_000159 O=C1N(C2CCC(=O)NC2=O)C(=O)c3ccccc13 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 H06 compound treatment 12.408 -0.7862 -0.211 13.681 0.28324 0.0671 -0.1017 -0.4595 2797 BPBio1_000160 COc1ccc2n(C(=O)c3ccc(Cl)cc3)c(C)c(CC(=O)O)c2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 H07 compound treatment 14.7603 1.5661 0.4202 18.1419 4.7441 1.124 1.092 0.91 1266 BPBio1_000161 CCn1cc(C(=O)O)c(=O)c2cc3OCOc3cc12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 H08 compound treatment 13.9324 0.7382 0.1981 13.3155 -0.082295 -0.0195 0.1263 0.6344 3176928 BPBio1_000162 C[C@@]12CC(=O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@]34C)[C@@H]2CC[C@]1(O)C(=O)CO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 H09 compound treatment 12.8515 -0.34268 -0.0919 13.8058 0.40804 0.0967 0.0033 0.0251 1298 BPBio1_000163 CS(=O)(=O)Nc1ccc(cc1Oc2ccccc2)[N+](=O)[O-] 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 H10 compound treatment 17.7387 4.5445 1.2194 16.4774 3.0796 0.7297 1.3782 0.9699 3189180 BPBio1_000164 C[C@@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]2CC[C@]1(O)C(=O)CO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 H11 compound treatment 10.6354 -2.5588 -0.6866 14.3395 0.94169 0.2231 -0.3277 -0.454 3616559 BPBio1_000165 C[N+]1=Cc2cc3OCOc3cc2CC1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 H12 compound treatment 14.0939 0.89968 0.2414 13.6427 0.24496 0.058 0.2117 0.8528 1172 BPBio1_000166 CC(C)OC(=O)C(C)(C)Oc1ccc(cc1)C(=O)c2ccc(Cl)cc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 H13 compound treatment 13.3918 0.19767 0.053 14.6487 1.2509 0.2964 0.2471 0.8206 1331 BPBio1_000167 CC(=O)CCCCn1c(=O)n(C)c2ncn(C)c2c1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 H14 compound treatment 12.2049 -0.98931 -0.2655 12.9031 -0.49469 -0.1172 -0.2706 -0.9325 404 BPBio1_000168 CCCCNc1cc(cc(c1Oc2ccccc2)S(=O)(=O)N)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 H15 compound treatment 17.3657 4.1716 1.1193 12.0818 -1.316 -0.3118 0.571 0.4914 3616563 BPBio1_000169 C[C@H](N)[C@H](O)c1cccc(O)c1.O[C@H]([C@@H](O)C(=O)O)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 H16 compound treatment 12.4711 -0.72308 -0.194 11.4171 -1.9807 -0.4693 -0.469 -0.9236 1100 BPBio1_000170 CC(CCc1ccccc1)NCC(O)c2ccc(O)c(c2)C(=O)N 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 H17 compound treatment 15.1033 1.9092 0.5123 10.8067 -2.5911 -0.6139 -0.0719 -0.0899 1523 BPBio1_000171 CC(C)(C)NCC(O)c1ccc(O)c(CO)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 H18 compound treatment 14.332 1.1378 0.3053 10.6695 -2.7283 -0.6464 -0.2412 -0.3374 3172 BPBio1_000172 C(/C=C/c1ccccc1)N2CCN(CC2)C(c3ccccc3)c4ccccc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 H19 compound treatment 14.4638 1.2696 0.3407 14.112 0.71421 0.1692 0.3605 0.9479 1436 BPBio1_000173 CCCNC(C)C(=O)Nc1ccccc1C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 H20 compound treatment 16.9915 3.7973 1.0189 14.0649 0.66706 0.1581 0.8322 0.8071 1001967 BPBio1_000174 C[C@H]1C[C@H]2[C@@H]3CC[C@](O)(C(=O)CO)[C@@]3(C)C[C@H](O)[C@@H]2[C@@]4(C)C=CC(=O)C=C14 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 H21 compound treatment 30.0886 16.894 4.5332 39.6957 26.298 6.2309 7.6114 0.9878 383 BPBio1_000175 CC[C@@]1(O)C(=O)OCc2c1cc3-c4nc5ccccc5cc4Cn3c2=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 H22 compound treatment 12.8525 -0.34167 -0.0917 12.558 -0.83982 -0.199 -0.2055 -0.9381 1000268 BPBio1_000176 COc1ccc2nccc([C@H](O)[C@H]3C[C@@H]4CCN3C[C@@H]4C=C)c2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 H23 mock treatment 15.4153 2.2211 0.596 10.9261 -2.4716 -0.5856 0.0073 0.0088 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 H24 mock treatment 9.563 -3.6311 -0.9743 10.5049 -2.8929 -0.6854 -1.1736 -0.9852 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 I01 compound treatment 222.282 209.09 56.1036 167.0062 153.61 36.3953 65.4066 0.978 3561626 BPBio1_000177 COc1ccc2[nH]cc(C3=CCNCC3)c2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 I02 compound treatment 15.195 2.0008 0.5369 15.0615 1.6637 0.3942 0.6584 0.9885 3614569 BPBio1_000178 CCCCN(CC)CCOc1cccc2ccccc12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 I03 compound treatment 14.3171 1.1229 0.3013 13.0076 -0.39017 -0.0924 0.1477 0.4686 779 BPBio1_000179 CCN(CC)CCOC(=O)c1ccc(N)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 I04 compound treatment 14.508 1.3138 0.3525 8.5034 -4.8943 -1.1596 -0.5707 -0.4709 3616505 BPBio1_000180 CC(C)C[C@@H]1N2C(=O)[C@](NC(=O)[C@H]3CN(C)C4Cc5c(Br)[nH]c6cccc(C4=C3)c56)(O[C@@]2(O)[C@@H]7CCCN7C1=O)C(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 I05 compound treatment 11.8422 -1.352 -0.3628 14.4052 1.0074 0.2387 -0.0877 -0.202 2847 BPBio1_000181 CC(C)c1cc(OC(=O)C)c(C)cc1OCCN(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 I06 compound treatment 10.5279 -2.6663 -0.7154 13.6142 0.21639 0.0513 -0.4696 -0.6548 3069040 BPBio1_000182 CNCC(O)c1ccc(O)c(OC)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 I07 compound treatment 13.1229 -0.071223 -0.0191 15.9056 2.5078 0.5942 0.4066 0.684 3068964 BPBio1_000183 NCCc1cc[nH]n1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 I08 compound treatment 12.6212 -0.57299 -0.1537 12.7975 -0.60026 -0.1422 -0.2093 -0.9992 2858 BPBio1_000184 C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@H]3[C@H](CC(=O)[C@]12C)[C@@]4(C)CCC(=O)C[C@H]4CC3=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 I09 compound treatment 10.7377 -2.4565 -0.6591 13.4077 0.0099398 0.0024 -0.4644 -0.7046 1268 BPBio1_000185 CN1C(=C(O)c2ccccc2S1(=O)=O)C(=O)Nc3cc(C)on3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 I10 compound treatment 12.9635 -0.23068 -0.0619 12.7342 -0.66358 -0.1572 -0.1549 -0.917 1610 BPBio1_000186 COc1ccc(cc1O)[C@@H]2CC(=O)c3c(O)cc(O)cc3O2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 I11 compound treatment 12.5632 -0.63102 -0.1693 12.6793 -0.71846 -0.1702 -0.2401 -1.0 907391 BPBio1_000187 COc1ccc2cc(ccc2c1)C(C)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 I12 compound treatment 15.9161 2.7219 0.7304 20.3886 6.9908 1.6564 1.6877 0.9323 1465 BPBio1_000188 OCCN1CCN(CCCN2c3ccccc3Sc4ccc(Cl)cc24)CC1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 I13 compound treatment 12.6836 -0.51057 -0.137 15.7132 2.3154 0.5486 0.2911 0.5147 1083 BPBio1_000189 C(C1=NCCN1)c2cccc3ccccc23 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 I14 compound treatment 29.8962 16.702 4.4816 31.6993 18.302 4.3363 6.2352 0.9999 1387 BPBio1_000190 OC(C1CCCCN1)c2cc(nc3c(cccc23)C(F)(F)F)C(F)(F)F 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 I15 compound treatment 21.8804 8.6862 2.3307 23.2167 9.8189 2.3264 3.2931 1.0 1821 BPBio1_000191 Clc1ccccc1CN2CCc3sccc3C2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 I16 compound treatment 31.0506 17.856 4.7913 15.6458 2.248 0.5326 3.7646 0.7809 3487389 BPBio1_000192 Clc1ccc(C(Cn2ccnc2)OCc3c(Cl)cccc3Cl)c(Cl)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 I17 compound treatment 27.7396 14.545 3.9029 25.5172 12.119 2.8715 4.7902 0.9886 819 BPBio1_000193 CCN(CC)CCOC(=O)C1(CCCCC1)C2CCCCC2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 I18 compound treatment 16.6778 3.4836 0.9347 12.6329 -0.76486 -0.1812 0.5328 0.5596 3189054 BPBio1_000194 CC(=O)S[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@H]3CC[C@@]4(C)[C@@H](CC[C@]54CCC(=O)O5)[C@H]13 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 I19 compound treatment 12.9309 -0.26332 -0.0707 12.9278 -0.46994 -0.1113 -0.1287 -0.9759 3188937 BPBio1_000195 CCC(C)(CN(C)C)OC(=O)c1ccccc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 I20 compound treatment 13.9587 0.76454 0.2051 14.3605 0.96269 0.2281 0.3063 0.9986 786 BPBio1_000196 CN1CCN(CC(=O)N2c3ccccc3C(=O)Nc4cccnc24)CC1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 I21 compound treatment 13.0709 -0.12331 -0.0331 13.6653 0.26749 0.0634 0.0214 0.2996 362 BPBio1_000197 CCN(CC)CC(=O)Nc1c(C)cccc1C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 I22 compound treatment 18.154 4.9599 1.3309 21.1238 7.726 1.8306 2.2355 0.9877 1000246 BPBio1_000198 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 I23 mock treatment 12.6935 -0.50064 -0.1343 12.5146 -0.88316 -0.2093 -0.243 -0.977 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 I24 mock treatment 13.7501 0.5559 0.1492 12.4665 -0.93124 -0.2206 -0.0505 -0.1898 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 J01 compound treatment 15.0961 1.9019 0.5103 15.3629 1.9651 0.4656 0.6901 0.999 907239 BPBio1_000199 Clc1ccc2Nc3ccccc3C(=Nc2c1)N4CCNCC4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 J02 compound treatment 12.4472 -0.74697 -0.2004 14.6866 1.2888 0.3054 0.0742 0.2031 3614592 BPBio1_000200 Cn1cc(C(=O)C(=O)N[C@H]2CN3CCC2CC3)c4ccccc14 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 J03 compound treatment 13.0025 -0.19165 -0.0514 13.1045 -0.29333 -0.0695 -0.0855 -0.989 3616567 BPBio1_000201 CN/C(=C/[N+](=O)[O-])/NCCSCc1ccc(CN(C)C)o1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 J04 compound treatment 19.6224 6.4282 1.7249 20.158 6.7602 1.6017 2.3522 0.9993 3616626 BPBio1_000202 CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)C3(F)C(=O)C[C@@]21C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 J05 compound treatment 11.3383 -1.8559 -0.498 14.7258 1.3281 0.3147 -0.1296 -0.22 3069077 BPBio1_000203 OC(=O)Cc1cc(I)c(Oc2ccc(O)c(I)c2)c(I)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 J06 compound treatment 13.2512 0.056977 0.0153 13.62 0.22221 0.0527 0.048 0.8762 1033 BPBio1_000204 CC(Cc1ccc(O)cc1)NCC(O)c2cc(O)cc(O)c2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 J07 compound treatment 13.4823 0.2881 0.0773 12.0989 -1.2989 -0.3078 -0.163 -0.5135 41 BPBio1_000205 OC(=O)c1ccccc1Nc2cccc(c2)C(F)(F)F 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 J08 compound treatment 16.7733 3.5791 0.9604 14.3594 0.96164 0.2278 0.8402 0.8512 1019722 BPBio1_000206 CN1CCCN(CC1)C(c2ccccc2)c3ccc(Cl)cc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 J09 compound treatment 12.2599 -0.93427 -0.2507 17.3575 3.9597 0.9382 0.4861 0.5006 752 BPBio1_000207 CC1CCc2cc(F)cc3c(=O)c(cn1c23)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 J10 compound treatment 16.1377 2.9435 0.7898 12.8398 -0.55796 -0.1322 0.465 0.5807 1164 BPBio1_000208 CCN(CC)C(=O)N1CCN(C)CC1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 J11 compound treatment 10.1431 -3.0511 -0.8187 14.8609 1.4631 0.3467 -0.3338 -0.3754 1258696 BPBio1_000209 Cc1c(Cl)cccc1Nc2ccccc2C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 J12 compound treatment 11.6149 -1.5793 -0.4238 13.2212 -0.17661 -0.0418 -0.3292 -0.7732 1000071 BPBio1_000210 C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 J13 compound treatment 16.8912 3.6971 0.992 17.1897 3.7919 0.8984 1.3368 0.9988 1123 BPBio1_000211 Cc1ccc(Cl)c(Nc2ccccc2C(=O)O)c1Cl 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 J14 compound treatment 46.8069 33.613 9.0192 21.4673 8.0695 1.9119 7.7295 0.8384 1158 BPBio1_000212 C(C(C1CCCCC1)C2CCCCC2)C3CCCCN3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 J15 compound treatment 15.3134 2.1192 0.5686 14.4091 1.0113 0.2396 0.5715 0.9262 3189175 BPBio1_000213 COC1=CC(=O)O[C@H](C1)/C=C/c2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 J16 compound treatment 20.2736 7.0795 1.8996 15.1895 1.7917 0.4245 1.6434 0.8443 3480597 BPBio1_000214 CCN(CC)CC#CCOC(=O)C(O)(C1CCCCC1)c2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 J17 compound treatment 15.3537 2.1595 0.5795 14.006 0.6082 0.1441 0.5116 0.8569 1201 BPBio1_000215 COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 J18 compound treatment 15.3184 2.1242 0.57 17.7291 4.3313 1.0262 1.1287 0.9615 1180 BPBio1_000216 Fc1ccc(cc1)C(=O)CCCN2CCC3(CC2)N(CNC3=O)c4ccccc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 J19 compound treatment 11.7491 -1.445 -0.3877 13.6674 0.26961 0.0639 -0.229 -0.5828 734 BPBio1_000217 CCN(CC)CCNC(=O)c1cc(Cl)c(N)cc1OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 J20 compound treatment 13.2891 0.094927 0.0255 12.6175 -0.78031 -0.1849 -0.1127 -0.604 830 BPBio1_000218 COc1ccc(CN(CCN(C)C)c2ccccn2)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 J21 compound treatment 256.8615 243.67 65.3822 218.509 205.11 48.5981 80.5962 0.9893 1281686 BPBio1_000219 COC(=O)Nc1nc2cc(Sc3ccccc3)ccc2[nH]1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 J22 compound treatment 12.4217 -0.77249 -0.2073 13.3017 -0.09611 -0.0228 -0.1627 -0.7801 753 BPBio1_000220 O=C1C(CCS(=O)c2ccccc2)C(=O)N(N1c3ccccc3)c4ccccc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 J23 mock treatment 12.2775 -0.91671 -0.246 13.3291 -0.068735 -0.0163 -0.1854 -0.7523 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 J24 mock treatment 14.7729 1.5787 0.4236 13.3165 -0.081235 -0.0192 0.2859 0.6743 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 K01 compound treatment 13.3066 0.11242 0.0302 12.0889 -1.3089 -0.3101 -0.198 -0.6353 1415 BPBio1_000221 FC(F)(F)c1cccc(c1)N2CCNCC2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 K02 compound treatment 12.5133 -0.68086 -0.1827 5.2366 -8.1612 -1.9337 -1.4965 -0.7705 3560659 BPBio1_000222 O=C1CC2(CCCC2)CC(=O)N1CCCCNCC3COc4ccccc4O3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 K03 compound treatment 14.6507 1.4565 0.3908 17.8257 4.4279 1.0491 1.0182 0.9095 1010605 BPBio1_000223 COP(=O)(OC)C(O)C(Cl)(Cl)Cl 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 K04 compound treatment 16.2773 3.0831 0.8273 13.7246 0.32679 0.0774 0.6397 0.7699 72 BPBio1_000224 Cc1cnc(cn1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 K05 compound treatment 13.8426 0.64845 0.174 13.8474 0.44956 0.1065 0.1984 0.9723 1019 BPBio1_000225 NC(=O)N1c2ccccc2C=Cc3ccccc13 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 K06 compound treatment 24.5845 11.39 3.0563 18.56 5.1622 1.2231 3.026 0.9192 4362 BPBio1_000226 CN1CCN(CC1)C2=Nc3ccccc3Oc4ccc(Cl)cc24 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 K07 compound treatment 38.1073 24.913 6.6848 30.9514 17.554 4.1591 7.6678 0.9739 1401 BPBio1_000227 CN(C)CCCN1c2ccccc2Sc3ccc(cc13)C(F)(F)F 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 K08 compound treatment 13.5408 0.34664 0.093 15.5493 2.1515 0.5098 0.4262 0.8225 3487390 BPBio1_000228 OCCOCCN1CCN(CC1)C(c2ccccc2)c3ccc(Cl)cc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 K09 compound treatment 12.2118 -0.98236 -0.2636 14.0835 0.68571 0.1625 -0.0715 -0.2309 939 BPBio1_000229 Cc1cccc(Nc2ccccc2C(=O)O)c1C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 K10 compound treatment 14.0407 0.84658 0.2272 14.007 0.60923 0.1443 0.2627 0.976 355 BPBio1_000230 COc1ccc(cc1)[C@@H]2Sc3ccccc3N(CCN(C)C)C(=O)[C@@H]2OC(=O)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 K11 compound treatment 14.1428 0.94865 0.2545 12.6122 -0.78556 -0.1861 0.0484 0.1534 3186 BPBio1_000231 CC(=O)c1ccc(cc1)S(=O)(=O)NC(=O)NC2CCCCC2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 K12 compound treatment 12.8642 -0.32995 -0.0885 13.0537 -0.34409 -0.0815 -0.1203 -0.9992 1000064 BPBio1_000232 CN(Cc1cnc2nc(N)nc(N)c2n1)c3ccc(cc3)C(=O)NC(CCC(=O)O)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 K13 compound treatment 11.3651 -1.8291 -0.4908 13.8691 0.47129 0.1117 -0.2681 -0.5326 920 BPBio1_000233 CCN1CCCC1CNC(=O)c2cc(ccc2OC)S(=O)(=O)N 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 K14 compound treatment 20.037 6.8429 1.8361 26.9796 13.582 3.218 3.5738 0.9646 709 BPBio1_000234 COc1ccc(CCN2CCC(CC2)Nc3nc4ccccc4n3Cc5ccc(F)cc5)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 K15 compound treatment 11.3857 -1.8084 -0.4853 13.1572 -0.24059 -0.057 -0.3834 -0.7848 3127 BPBio1_000235 CCCCOc1cc(ccc1N)C(=O)OCCN(CC)CC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 K16 compound treatment 15.7719 2.5777 0.6917 11.2698 -2.128 -0.5042 0.1326 0.1549 3189055 BPBio1_000236 CCC[C@@H]1C[C@H](N(C)C1)C(=O)N[C@H]([C@H](C)Cl)C2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 K17 compound treatment 19.0413 5.8471 1.5689 16.8756 3.4778 0.824 1.6921 0.9548 1318 BPBio1_000237 CN(C(=O)CN(CCO)CC(=O)N(C)C(C)(C)Cc1ccccc1)C(C)(C)Cc2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 K18 compound treatment 19.1721 5.9779 1.604 16.8141 3.4163 0.8095 1.7066 0.9498 1590 BPBio1_000238 CC(C)(C)c1ccc(cc1)C(O)CCCN2CCC(CC2)C(O)(c3ccccc3)c4ccccc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 K19 compound treatment 17.2688 4.0746 1.0933 12.4867 -0.91105 -0.2159 0.6205 0.5568 884 BPBio1_000239 CN(C)CCC(c1ccccc1)c2ccccn2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 K20 compound treatment 12.8238 -0.37035 -0.0994 15.5183 2.1205 0.5024 0.285 0.5565 3060388 BPBio1_000240 CO/N=C(\C(=O)N[C@H]1[C@H]2SCC(=C(N2C1=O)C(=O)O)COC(=O)C)/c3csc(N)n3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 K21 compound treatment 16.2959 3.1017 0.8323 14.1257 0.72789 0.1725 0.7105 0.8359 965 BPBio1_000241 C(C1=NCCN1)c2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 K22 compound treatment 14.3602 1.166 0.3129 12.8219 -0.57586 -0.1364 0.1248 0.3655 1418 BPBio1_000242 CN(C)[C@H]1[C@@H]2C[C@H]3C(=C(O)[C@]2(O)C(=O)C(=C1O)C(=O)N)C(=O)c4c(O)cccc4[C@@]3(C)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 K23 mock treatment 10.448 -2.7461 -0.7369 12.9224 -0.47536 -0.1126 -0.6007 -0.8058 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 K24 mock treatment 10.4563 -2.7379 -0.7346 11.9981 -1.3997 -0.3316 -0.754 -0.9354 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 L01 compound treatment 35.7125 22.518 6.0422 23.1764 9.7786 2.3169 5.9108 0.9134 3561646 BPBio1_000243 COc1cc(OC)c(cc1NS(=O)(=O)c2ccc(cc2)C(F)(F)F)C(=O)CCCCN3CCC4(CC3)NC(=O)NC4=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 L02 compound treatment 11.7697 -1.4245 -0.3822 12.8035 -0.59426 -0.1408 -0.3698 -0.9079 3177469 BPBio1_000244 NC1CCN(CC1)c2cccc(Cl)n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 L03 compound treatment 14.9783 1.7842 0.4787 13.2959 -0.10184 -0.0241 0.3215 0.6706 347 BPBio1_000245 CN1C(=C(O)c2ccccc2S1(=O)=O)C(=O)Nc3ccccn3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 L04 compound treatment 12.6966 -0.49755 -0.1335 11.9941 -1.4037 -0.3326 -0.3296 -0.9196 3068677 BPBio1_000246 OC1=NC(=O)CN1/N=C/c2ccc(o2)c3ccc(cc3)[N+](=O)[O-] 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 L05 compound treatment 13.9401 0.74593 0.2002 14.5898 1.192 0.2824 0.3412 0.9858 3616578 BPBio1_000247 CN1CCCN=C1/C=C/c2cccs2.O[C@H]([C@@H](O)C(=O)O)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 L06 compound treatment 12.4806 -0.71355 -0.1915 14.5188 1.121 0.2656 0.0524 0.1601 850 BPBio1_000248 Clc1cccc(c1)N2CCN(CCCn3nc4ccccn4c3=O)CC2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 L07 compound treatment 13.0024 -0.19177 -0.0515 12.3204 -1.0774 -0.2553 -0.2169 -0.8329 1144 BPBio1_000249 O=C1NCC2(CCN(CCc3ccccc3)CC2)O1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 L08 compound treatment 28.4832 15.289 4.1024 17.5813 4.1835 0.9912 3.6018 0.8534 936 BPBio1_000250 OCC(O)COC(=O)c1ccccc1Nc2ccnc3cc(Cl)ccc23 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 L09 compound treatment 14.5541 1.3599 0.3649 14.5968 1.199 0.2841 0.4589 0.9923 796 BPBio1_000251 Cc1ccc(C)c(OCCCC(C)(C)C(=O)O)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 L10 compound treatment 15.9543 2.7602 0.7406 16.6079 3.2101 0.7606 1.0615 0.9999 1060 BPBio1_000252 CN1CCC(=C2c3ccccc3Sc4ccccc24)CC1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 L11 compound treatment 11.7586 -1.4356 -0.3852 17.4311 4.0334 0.9556 0.4034 0.3915 1346 BPBio1_000253 CCN(CC)CCNC(=O)COc1ccc(OC)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 L12 compound treatment 13.6131 0.41895 0.1124 13.7307 0.33286 0.0789 0.1353 0.985 1069 BPBio1_000254 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc3c[nH]c4cccc2c34 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 L13 compound treatment 11.9659 -1.2282 -0.3296 13.4574 0.05959 0.0141 -0.2231 -0.6762 1339 BPBio1_000255 CCN(CC)CCNC(=O)c1cc(ccc1OC)S(=O)(=O)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 L14 compound treatment 15.9614 2.7673 0.7425 10.2909 -3.1069 -0.7361 0.0045 0.0043 1113 BPBio1_000256 COc1ccc2n(C(=O)c3ccc(Cl)cc3)c(C)c(CC(=O)OCC(=O)O)c2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 L15 compound treatment 132.7995 119.61 32.0932 130.3844 116.99 27.7183 42.2931 0.9973 1350 BPBio1_000257 COC(=O)Nc1nc2cc(ccc2[nH]1)C(=O)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 L16 compound treatment 13.9577 0.7635 0.2049 12.2723 -1.1255 -0.2667 -0.0437 -0.1299 3068682 BPBio1_000258 CN(C)CCCOc1nn(Cc2ccccc2)c3ccccc13 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 L17 compound treatment 13.1116 -0.082548 -0.0221 13.9063 0.50854 0.1205 0.0695 0.5676 699 BPBio1_000259 OC(=O)CCC(=O)c1ccc(cc1)c2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 L18 compound treatment 12.5102 -0.68392 -0.1835 13.8695 0.47169 0.1118 -0.0507 -0.2361 1348 BPBio1_000260 Clc1ccc(OCC(=O)N2CCN(Cc3ccc4OCOc4c3)CC2)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 L19 compound treatment 14.3505 1.1563 0.3103 14.9529 1.5551 0.3685 0.4799 0.9963 1209 BPBio1_000261 CC(C(=O)O)c1cccc(c1)C(=O)c2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 L20 compound treatment 12.4135 -0.78069 -0.2095 13.5719 0.17414 0.0413 -0.1189 -0.5571 3055129 BPBio1_000262 CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@H](C[C@@]21C)c5ccc(cc5)N(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 L21 compound treatment 14.7506 1.5565 0.4176 13.6704 0.27261 0.0646 0.341 0.8069 1127 BPBio1_000263 CC1Cc2ccccc2N1NC(=O)c3ccc(Cl)c(c3)S(=O)(=O)N 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 L22 compound treatment 15.0387 1.8445 0.4949 12.7474 -0.65039 -0.1541 0.241 0.4649 1045066 BPBio1_000264 O=C(Nc1ccccc1)OCC(CN2CCCCC2)OC(=O)Nc3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 L23 mock treatment 13.661 0.4668 0.1253 14.9145 1.5167 0.3594 0.3427 0.9004 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 L24 mock treatment 12.3116 -0.88255 -0.2368 11.2603 -2.1375 -0.5064 -0.5256 -0.9401 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 M01 compound treatment 12.3723 -0.82184 -0.2205 10.722 -2.6758 -0.634 -0.6042 -0.9002 3060152 BPBio1_000265 OC(CN1CCN(CC1)c2cccc(Cl)c2)C(c3ccccc3)c4ccccc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 M02 compound treatment 14.8908 1.6966 0.4552 12.7545 -0.64326 -0.1524 0.2141 0.446 3614572 BPBio1_000266 COc1ccccc1N2CCN(CCn3c(=O)n(C)c4c5ccccc5n(C)c4c3=O)CC2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 M03 compound treatment 11.6359 -1.5583 -0.4181 11.9266 -1.4712 -0.3486 -0.5421 -0.9959 3188938 BPBio1_000267 CN1CCCN=C1/C=C/c2sccc2C.OC(C(O)C(=O)O)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 M04 compound treatment 11.1751 -2.0191 -0.5418 11.4918 -1.906 -0.4516 -0.7024 -0.9959 1000056 BPBio1_000268 COc1ccc(CCN(C)CCCC(C#N)(C(C)C)c2ccc(OC)c(OC)c2)cc1OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 M05 compound treatment 9.2248 -3.9694 -1.0651 13.1304 -0.26736 -0.0633 -0.7979 -0.7478 3559747 BPBio1_000269 CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)C(O)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 M06 compound treatment 18.0897 4.8956 1.3136 17.8869 4.4891 1.0636 1.681 0.9945 1301 BPBio1_000270 OCCN(CCO)c1nc(N2CCCCC2)c3nc(nc(N4CCCCC4)c3n1)N(CCO)CCO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 M07 compound treatment 125.2048 112.01 30.0553 69.3564 55.959 13.2586 30.6276 0.9324 110 BPBio1_000271 COC(=O)C1=C(C)NC(=C(C1c2ccccc2[N+](=O)[O-])C(=O)OC)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 M08 compound treatment 17.2693 4.0751 1.0935 18.2912 4.8934 1.1594 1.593 0.9996 1360 BPBio1_000272 Clc1ccc(NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)Nc2ccc(Cl)cc2)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 M09 compound treatment 29.2351 16.041 4.3042 25.5844 12.187 2.8874 5.0852 0.9811 436 BPBio1_000273 CN(C)CCCN1c2ccccc2Sc3ccc(Cl)cc13 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 M10 compound treatment 16.6538 3.4597 0.9283 21.2415 7.8437 1.8584 1.9705 0.9486 80 BPBio1_000274 CN(C)C(=O)C(CCN1CCC(O)(CC1)c2ccc(Cl)cc2)(c3ccccc3)c4ccccc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 M11 compound treatment 14.4368 1.2427 0.3334 13.2878 -0.11001 -0.0261 0.2173 0.6498 1002 BPBio1_000275 CN(C)CCOC(c1ccccc1)c2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 M12 compound treatment 10.2817 -2.9125 -0.7815 12.026 -1.3718 -0.325 -0.7824 -0.9244 3198950 BPBio1_000276 CN(C)[C@H]1[C@@H]2CC3C(=C(O)[C@]2(O)C(=O)C(=C1O)C(=O)N)C(=O)c4c(O)ccc(Cl)c4[C@@]3(C)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 M13 compound treatment 9.7631 -3.4311 -0.9207 14.0638 0.66604 0.1578 -0.5394 -0.5775 728 BPBio1_000277 Cc1cc(nnc1NCCN2CCOCC2)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 M14 compound treatment 26.7457 13.552 3.6362 39.0517 25.654 6.0783 6.8692 0.9698 368 BPBio1_000278 CC/C(=C(\c1ccccc1)/c2ccc(OCCN(C)C)cc2)/c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 M15 compound treatment 36.2671 23.073 6.1911 23.2288 9.831 2.3293 6.0248 0.9108 814 BPBio1_000279 Clc1ccc(COC(Cn2ccnc2)c3ccc(Cl)cc3Cl)c(Cl)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 M16 compound treatment 14.7116 1.5174 0.4072 11.5592 -1.8386 -0.4356 -0.0201 -0.0338 783 BPBio1_000280 CO[C@@]12C[C@@H](COC(=O)c3cncc(Br)c3)CN(C)[C@@H]2Cc4cn(C)c5cccc1c45 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 M17 compound treatment 10.8489 -2.3453 -0.6293 13.7517 0.35386 0.0838 -0.3857 -0.6075 3471598 BPBio1_000281 CC(COc1ccccc1)NC(C)C(O)c2ccc(O)cc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 M18 compound treatment 13.1244 -0.069823 -0.0187 13.0582 -0.3396 -0.0805 -0.0701 -0.849 2784 BPBio1_000282 C[C@@]12CC[C@H]3[C@@H](C=CC4=CC(=O)CC[C@]34C)[C@@H]2CC[C@@]1(O)CCC(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 M19 compound treatment 12.9279 -0.26632 -0.0715 11.2269 -2.1709 -0.5144 -0.4142 -0.7977 1223 BPBio1_000283 CCCC(=O)Nc1ccc(OCC(O)CNC(C)C)c(c1)C(=O)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 M20 compound treatment 15.1623 1.9682 0.5281 18.2531 4.8553 1.1504 1.1869 0.9376 3189056 BPBio1_000284 CN(C)S(=O)(=O)c1ccc2Sc3ccccc3N(CCCN4CCN(C)CC4)c2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 M21 compound treatment 11.0081 -2.186 -0.5866 10.5321 -2.8657 -0.679 -0.8949 -0.9973 971 BPBio1_000285 CN(C(=S)Oc1ccc2ccccc2c1)c3cccc(C)c3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 M22 compound treatment 13.5692 0.37498 0.1006 13.071 -0.32681 -0.0774 0.0164 0.1291 3616513 BPBio1_000286 CN1C[C@@H](CC2[C@H]1Cc3c[nH]c4cccc2c34)C(=O)N[C@]5(C)O[C@@]6(O)[C@@H]7CCCN7C(=O)[C@H](Cc8ccccc8)N6C5=O.OC(C(O)C(=O)O)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 M23 mock treatment 11.6789 -1.5153 -0.4066 13.6098 0.21199 0.0502 -0.252 -0.6151 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 M24 mock treatment 15.154 1.9598 0.5259 13.7692 0.37136 0.088 0.4341 0.8141 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 N01 compound treatment 23.2574 10.063 2.7002 37.5039 24.106 5.7116 5.948 0.9415 3177235 BPBio1_000287 CN1C[C@H](CNC(=O)OCc2ccccc2)C[C@H]3[C@H]1Cc4cn(C)c5cccc3c45 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 N02 compound treatment 13.2831 0.08897 0.0239 11.5849 -1.8129 -0.4295 -0.2868 -0.6668 3614595 BPBio1_000288 CN(C)Cc1nc(no1)c2cn(C)c3ccccc23 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 N03 compound treatment 12.7882 -0.40602 -0.1089 14.9884 1.5906 0.3769 0.1895 0.4829 747 BPBio1_000289 CCn1cc(C(=O)O)c(=O)c2cc(F)c(cc12)N3CCNCC3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 N04 compound treatment 13.1575 -0.03671 -0.0099 12.0907 -1.3071 -0.3097 -0.226 -0.7292 1608 BPBio1_000290 NCCCC[C@H](N[C@@H](CCc1ccccc1)C(=O)O)C(=O)N2CCC[C@H]2C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 N05 compound treatment 11.6905 -1.5037 -0.4035 11.7023 -1.6954 -0.4017 -0.5694 -1.0 3189176 BPBio1_000291 CCCCCC[C@@H]1[C@@H](OC(=O)CC(C)C)[C@H](C)OC(=O)C(NC(=O)c2cccc(NC=O)c2O)[C@@H](C)OC1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 N06 compound treatment 10.2658 -2.9283 -0.7857 10.8048 -2.593 -0.6144 -0.99 -0.9926 3068878 BPBio1_000292 CCC[C@@H]1C[C@H](N(C)C1)C(=O)N[C@H]([C@@H](C)O)[C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@@H]2O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 N07 compound treatment 13.0066 -0.18759 -0.0503 13.1102 -0.28761 -0.0681 -0.0838 -0.9889 816 BPBio1_000293 Cc1cc(cc(C)c1CC2=NCCN2)C(C)(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 N08 compound treatment 11.3421 -1.8521 -0.497 13.8933 0.49551 0.1174 -0.2684 -0.5256 907526 BPBio1_000294 CN1CCN(CC(=O)N2c3c(C)scc3C(=O)Nc4ccccc24)CC1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 N09 compound treatment 8.3076 -4.8866 -1.3112 12.3222 -1.0756 -0.2549 -1.1074 -0.829 1181 BPBio1_000295 Cc1cc(c(O)c(C)c1CC2=NCCN2)C(C)(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 N10 compound treatment 36.6045 23.41 6.2816 30.9541 17.556 4.1597 7.3831 0.98 773 BPBio1_000296 Clc1ccc(COC(Cn2ccnc2)c3ccc(Cl)cc3Cl)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 N11 compound treatment 15.8111 2.617 0.7022 12.7193 -0.67844 -0.1607 0.3829 0.5315 1162 BPBio1_000297 Cc1c(NC(=O)c2cccnc2)c(=O)n(c3ccccc3)n1C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 N12 compound treatment 15.1933 1.9991 0.5364 13.4361 0.03834 0.0091 0.3857 0.719 1357 BPBio1_000298 CCCCN1CCCCC1C(=O)Nc2c(C)cccc2C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 N13 compound treatment 21.0081 7.8139 2.0967 19.5304 6.1326 1.453 2.51 0.984 812 BPBio1_000299 COC1=CC(=O)C[C@@H](C)[C@@]21Oc3c(C2=O)c(OC)cc(OC)c3Cl 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 N14 compound treatment 17.4972 4.3031 1.1546 18.8243 5.4265 1.2857 1.7256 0.9986 927 BPBio1_000300 CN1CCC[C@@H]1CCO[C@](C)(c2ccccc2)c3ccc(Cl)cc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 N15 compound treatment 23.4539 10.26 2.753 18.9877 5.5899 1.3245 2.8832 0.9438 386963 BPBio1_000301 Clc1ccc(Cn2c(CN3CCCC3)nc4ccccc24)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 N16 compound treatment 11.8018 -1.3923 -0.3736 12.9402 -0.4576 -0.1084 -0.3408 -0.8762 876 BPBio1_000302 CN(C)[C@H]1[C@@H]2[C@@H](O)[C@H]3C(=C(O)[C@]2(O)C(=O)C(=C1O)C(=O)N)C(=O)c4c(O)cccc4[C@@]3(C)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 N17 compound treatment 11.1199 -2.0743 -0.5566 12.6747 -0.72313 -0.1713 -0.5147 -0.8838 1075 BPBio1_000303 CCN(Cc1ccncc1)C(=O)C(CO)c2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 N18 compound treatment 18.6829 5.4888 1.4728 19.5142 6.1164 1.4492 2.0661 1.0 2117626 BPBio1_000304 Fc1ccc(cc1)C(CCCN2CCC(CC2)n3c(=O)[nH]c4ccccc34)c5ccc(F)cc5 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 N19 compound treatment 12.859 -0.33517 -0.0899 13.8171 0.41931 0.0993 0.0067 0.0497 1016 BPBio1_000305 CN1CCOC(c2ccccc2)c3ccccc3C1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 N20 compound treatment 14.9099 1.7157 0.4604 16.8041 3.4063 0.8071 0.8962 0.9646 467359 BPBio1_000306 CCN(CC)Cc1cc(Nc2ccnc3cc(Cl)ccc23)ccc1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 N21 compound treatment 16.361 3.1668 0.8497 18.674 5.2762 1.2501 1.4848 0.9823 3046406 BPBio1_000307 Cc1ccc(cc1)N(CC2=NCCN2)c3cccc(O)c3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 N22 compound treatment 13.2599 0.065697 0.0176 13.0425 -0.35529 -0.0842 -0.0471 -0.5472 714 BPBio1_000308 CCN(CCCCOC(=O)c1ccc(OC)c(OC)c1)C(C)Cc2ccc(OC)cc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 N23 mock treatment 13.5504 0.3562 0.0956 12.0158 -1.382 -0.3275 -0.164 -0.4807 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 N24 mock treatment 12.7999 -0.39427 -0.1058 12.0878 -1.31 -0.3104 -0.2943 -0.8974 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 O01 compound treatment 11.7122 -1.482 -0.3976 12.8157 -0.58212 -0.1379 -0.3787 -0.8998 3561713 BPBio1_000309 CC(C)(C)NC[C@H](O)COc1cccc2[nH]c(C#N)cc12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 O02 compound treatment 16.0083 2.8141 0.7551 17.9223 4.5245 1.072 1.292 0.9853 3614574 BPBio1_000310 COc1ccccc1N2CCN(CCn3c(=O)[nH]c4c5ccccc5[nH]c4c3=O)CC2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 O03 compound treatment 13.4295 0.23535 0.0632 11.3983 -1.9995 -0.4737 -0.2903 -0.6075 1125 BPBio1_000311 CCOC(=O)NNc1nncc2ccccc12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 O04 compound treatment 12.4843 -0.70989 -0.1905 14.3747 0.97686 0.2315 0.029 0.0966 935 BPBio1_000312 CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 O05 compound treatment 12.6592 -0.53495 -0.1435 14.9538 1.556 0.3687 0.1592 0.4024 1174 BPBio1_000313 CN(C)CCCN1c2ccccc2CCc3ccccc13 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 O06 compound treatment 14.1401 0.94594 0.2538 14.5356 1.1378 0.2696 0.3701 0.9995 3616516 BPBio1_000314 CO[C@H]1C[C@H](O[C@H]2[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C)[C@@H](C)C[C@@]4(CO4)C(=O)[C@H](C)[C@@H](O)[C@@H](C)[C@@H](C)OC(=O)[C@@H]2C)O[C@@H](C)[C@@H]1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 O07 compound treatment 13.4202 0.22598 0.0606 11.7239 -1.6739 -0.3966 -0.2376 -0.5921 1212 BPBio1_000315 CC/1=C(CC(=O)O)c2cc(F)ccc2\C1=C/c3ccc(cc3)S(=O)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 O08 compound treatment 10.5747 -2.6194 -0.7029 11.5966 -1.8012 -0.4268 -0.7988 -0.9714 3616519 BPBio1_000316 CCC(=O)O[C@H]1[C@H](C)O[C@H](C[C@@]1(C)O)O[C@@H]2[C@@H](C)O[C@@H](O[C@H]3[C@@H](CC=O)C[C@@H](C)[C@H](O)/C=C/C=C/C[C@@H](C)OC(=O)C[C@@H](OC(=O)CC)[C@@H]3OC)[C@H](O)[C@H]2N(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 O09 compound treatment 14.064 0.86983 0.2334 15.6176 2.2199 0.526 0.5369 0.9331 1365 BPBio1_000317 CN(C)CCC=C1c2ccccc2CCc3ccccc13 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 O10 compound treatment 15.0856 1.8914 0.5075 13.8138 0.41604 0.0986 0.4286 0.829 3616520 BPBio1_000318 CO[C@H]1[C@@H](CC(=O)O[C@H](C)C/C=C/C=C/[C@H](O)[C@H](C)C[C@H](CC=O)[C@@H]1O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(OC(=O)CC(C)C)[C@@H](O)[C@H](C)O3)[C@@H]([C@H]2O)N(C)C)OC(=O)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 O11 compound treatment 11.3073 -1.8869 -0.5063 16.1975 2.7997 0.6633 0.1111 0.1331 872 BPBio1_000319 CCN(CC)CCOC(=O)C(c1ccccc1)c2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 O12 compound treatment 92.0335 78.839 21.1546 98.4666 85.069 20.1558 29.2109 0.9997 346 BPBio1_000320 CC(=O)O[C@@H]1C2=C(C)[C@H](C[C@@](O)([C@@H](OC(=O)c3ccccc3)[C@@H]4[C@@]5(CO[C@@H]5C[C@H](O)[C@@]4(C)C1=O)OC(=O)C)C2(C)C)OC(=O)[C@H](O)[C@@H](NC(=O)c6ccccc6)c7ccccc7 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 O13 compound treatment 11.7732 -1.421 -0.3813 14.9896 1.5918 0.3772 -0.0029 -0.0055 969 BPBio1_000321 CCCCOc1cc(C(=O)NCCN(CC)CC)c2ccccc2n1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 O14 compound treatment 12.6245 -0.56972 -0.1529 13.9511 0.55329 0.1311 -0.0154 -0.0765 3616524 BPBio1_000322 CC[C@H](C)[C@H]1O[C@]2(CC[C@@H]1C)C[C@@H]3C[C@@H](C/C=C(\C)/[C@@H](O[C@H]4C[C@H](OC)[C@@H](O[C@H]5C[C@H](OC)[C@@H](O)[C@H](C)O5)[C@H](C)O4)[C@@H](C)/C=C/C=C/6\CO[C@@H]7[C@H](O)C(=C[C@@H](C(=O)O3)[C@@]76O)C)O2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 O15 compound treatment 14.8859 1.6918 0.4539 19.2553 5.8575 1.3878 1.3023 0.8919 2080073 BPBio1_000323 C[C@@]12CC(=O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]2CC[C@]1(O)C(=O)CO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 O16 compound treatment 11.1736 -2.0205 -0.5422 14.6333 1.2355 0.2927 -0.1764 -0.2863 1257 BPBio1_000324 CC[N+](CC)(CC)CCOc1cccc(OCC[N+](CC)(CC)CC)c1OCC[N+](CC)(CC)CC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 O17 compound treatment 25.2084 12.014 3.2237 29.813 16.415 3.8893 5.0297 0.9957 731 BPBio1_000325 CSc1ccc2Sc3ccccc3N(CCC4CCCCN4C)c2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 O18 compound treatment 11.8124 -1.3818 -0.3708 13.8929 0.49509 0.1173 -0.1792 -0.4609 1000317 BPBio1_000326 NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]4O[C@H](CN)[C@@H](O)[C@H](O)[C@H]4N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 O19 compound treatment 13.4689 0.27468 0.0737 11.9774 -1.4204 -0.3365 -0.1858 -0.5395 1001312 BPBio1_000327 C[N+]1(C)CCC(=C(c2ccccc2)c3ccccc3)CC1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 O20 compound treatment 12.9185 -0.27572 -0.074 14.8573 1.4595 0.3458 0.1922 0.5435 3069047 BPBio1_000328 CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@H]2[C@H](O[C@@H]3[C@@H](O)[C@H](O)[C@@H](NC(=N)N)[C@H](O)[C@H]3NC(=N)N)O[C@@H](C)[C@]2(O)CO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 O21 compound treatment 12.3783 -0.81588 -0.2189 11.9172 -1.4806 -0.3508 -0.4029 -0.9742 1053 BPBio1_000329 COc1cc(cc(OC)c1OC)C(=O)NCc2ccc(OCCN(C)C)cc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 O22 compound treatment 12.8705 -0.32367 -0.0868 14.1362 0.73841 0.175 0.0623 0.319 3189062 BPBio1_000330 CN[C@H](C)[C@@H]1CC[C@@H](N)[C@@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3OC[C@](C)(O)[C@H](NC)[C@H]3O)[C@H]2O)O1.CN[C@@H]1[C@@H](O)[C@@H](O[C@H]2[C@H](N)C[C@H](N)[C@@H](O[C@H]3O[C@H](CN)CC[C@H]3N)[C@@H]2O)OC[C@]1(C)O.CN[C@@H]1[C@@H](O)[C@@H](O[C@H]2[C@H](N)C[C@H](N)[C@@H](O[C@H]3O[C@@H](CC[C@H]3N)[C@@H](C)N)[C@@H]2O)OC[C@]1(C)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 O23 mock treatment 11.0033 -2.1908 -0.5879 14.2201 0.82231 0.1948 -0.2779 -0.4487 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 O24 mock treatment 15.1326 1.9384 0.5201 15.9417 2.5439 0.6027 0.794 0.9973 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 P01 compound treatment 7.7841 -5.41 -1.4517 15.118 1.7202 0.4076 -0.7383 -0.4896 1434 BPBio1_000331 CN1CCN2C(C1)c3ccccc3Cc4ccccc24 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 P02 compound treatment 12.9932 -0.20095 -0.0539 14.0529 0.65509 0.1552 0.0716 0.4359 1315226 BPBio1_000332 CN1C2CCC1CC(C2)OC(=O)c3cc(C)cc(C)c3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 P03 compound treatment 15.0592 1.865 0.5004 18.7342 5.3364 1.2644 1.2479 0.9177 805 BPBio1_000333 CCc1cccc2c3CCOC(CC)(CC(=O)O)c3[nH]c12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 P04 compound treatment 13.2571 0.06289 0.0169 13.1519 -0.24584 -0.0582 -0.0293 -0.4824 3177204 BPBio1_000334 CC(C(O)c1ccc(O)cc1)N2CCC(Cc3ccccc3)CC2.OC(C(O)C(=O)O)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 P05 compound treatment 65.4376 52.243 14.0183 13.4679 0.070115 0.0166 9.9241 0.7079 3069144 BPBio1_000335 C[N+]1([O-])[C@H]2C[C@@H](C[C@@H]1[C@H]3O[C@H]32)OC(=O)[C@H](CO)c4ccccc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 P06 compound treatment 13.5173 0.32313 0.0867 63.1461 49.748 11.7871 8.3961 0.7123 43 BPBio1_000336 Fc1ccc(cc1)C(N2CCN(C/C=C/c3ccccc3)CC2)c4ccc(F)cc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 P07 compound treatment 15.263 2.0688 0.5551 15.5655 2.1677 0.5136 0.7557 0.9992 3616593 BPBio1_000337 CN1[C@H]2CC[C@@H]1C[C@@H](C2)OC(=O)[C@H](CO)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 P08 compound treatment 23.6515 10.457 2.806 38.8926 25.495 6.0406 6.2555 0.9392 437 BPBio1_000338 CN1CCN(CCCN2c3ccccc3Sc4ccc(cc24)C(F)(F)F)CC1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 P09 compound treatment 12.1532 -1.041 -0.2793 13.95 0.55219 0.1308 -0.105 -0.3404 3487401 BPBio1_000339 NC(=O)OCC(O)COc1ccc(Cl)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 P10 compound treatment 12.5973 -0.5969 -0.1602 16.2085 2.8107 0.666 0.3577 0.5222 1036 BPBio1_000340 CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N2CCC[C@H]2C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 P11 compound treatment 13.6087 0.41448 0.1112 12.1453 -1.2525 -0.2968 -0.1312 -0.414 3189177 BPBio1_000341 CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N=C)c3ccccc3)C(=O)N2[C@H]1C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 P12 compound treatment 12.8236 -0.37057 -0.0994 12.6458 -0.75203 -0.1782 -0.1963 -0.962 3616642 BPBio1_000342 CN(C)[C@@H]1C2CC3Cc4c(ccc(O)c4C(=O)C3=C(O)[C@@]2(O)C(=O)C(=C1O)C(=O)N)N(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 P13 compound treatment 15.5852 2.391 0.6416 15.6759 2.2781 0.5398 0.8353 0.9963 2997 BPBio1_000343 COc1cc(cc(OC)c1OC)C(=O)OCCCN2CCCN(CCCOC(=O)c3cc(OC)c(OC)c(OC)c3)CC2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 P14 compound treatment 12.6364 -0.5578 -0.1497 13.8844 0.48656 0.1153 -0.0243 -0.1287 74 BPBio1_000344 COc1ccc(Cl)cc1C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 P15 compound treatment 16.7246 3.5305 0.9473 10.9203 -2.4775 -0.587 0.2548 0.2286 1323 BPBio1_000345 CC1COc2c(N3CCN(C)CC3)c(F)cc4c(=O)c(cn1c24)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 P16 compound treatment 12.9916 -0.20255 -0.0543 14.6327 1.2349 0.2926 0.1685 0.5661 3055 BPBio1_000346 NC(=N)NCCN1CCCCCCC1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 P17 compound treatment 12.996 -0.19818 -0.0532 12.2585 -1.1393 -0.2699 -0.2285 -0.8304 999 BPBio1_000347 CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNC(C)C3)c(F)c12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 P18 compound treatment 0.0 -13.194 -3.5403 58.2656 44.868 10.6308 5.0137 0.4475 763 BPBio1_000348 CCN(CC)CCCC(C)Nc1c2ccc(Cl)cc2nc3ccc(OC)cc13 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 P19 compound treatment 13.1054 -0.088723 -0.0238 13.9748 0.57698 0.1367 0.0798 0.5753 1443 BPBio1_000349 CN(C)CCOC(c1ccccc1)c2ccccc2C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 P20 compound treatment 15.1053 1.9111 0.5128 14.0398 0.64196 0.1521 0.4702 0.879 907228 BPBio1_000350 CCCCCCC[N+](CC)(CC)CCCCc1ccc(Cl)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 P21 compound treatment 16.9812 3.787 1.0162 15.098 1.7002 0.4028 1.0034 0.9179 1291 BPBio1_000351 CCCN(CCC)C(=O)C(CCC(=O)O)NC(=O)c1ccccc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 P22 compound treatment 17.6014 4.4072 1.1826 26.6973 13.299 3.1511 3.0644 0.9105 1130 BPBio1_000352 OCCN1CCN(CCCN2c3ccccc3Sc4ccc(cc24)C(F)(F)F)CC1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 P23 mock treatment 13.2374 0.043185 0.0116 14.3539 0.95609 0.2265 0.1684 0.7423 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2320 P24 mock treatment 12.5283 -0.66585 -0.1787 14.6588 1.261 0.2988 0.0849 0.244 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 A01 compound treatment 12.4521 -0.55343 -0.1485 17.2106 3.8539 0.9131 0.5407 0.5844 3614601 BPBio1_000353 CC(C)n1cnc2c(cc(Cl)cc12)C(=O)N[C@H]3CN4CCC3CC4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 A02 compound treatment 21.5622 8.5566 2.296 26.6523 13.296 3.1502 3.851 0.9879 1095093 BPBio1_000354 CNCCC(Oc1ccc(cc1)C(F)(F)F)c2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 A03 compound treatment 13.7433 0.73775 0.198 16.9618 3.6052 0.8542 0.744 0.8485 3189183 BPBio1_000355 CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@H]2[C@H](O[C@@H]3[C@@H](O)[C@H](O)[C@@H](NC(=N)N)[C@H](O)[C@H]3NC(=N)N)O[C@@H](C)[C@]2(O)C=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 A04 compound treatment 13.2957 0.2902 0.0779 13.1132 -0.24346 -0.0577 0.0143 0.1473 2717 BPBio1_000356 CCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 A05 compound treatment 15.7069 2.7014 0.7249 14.4972 1.1406 0.2702 0.7036 0.9096 3480229 BPBio1_000357 COc1cc2nc(nc(N)c2cc1OC)N(C)CCCNC(=O)C3CCCO3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 A06 compound treatment 15.0645 2.059 0.5525 15.5987 2.2421 0.5312 0.7663 0.9998 1403 BPBio1_000358 COC(=O)C1=CCCN(C)C1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 A07 compound treatment 16.5544 3.5489 0.9523 21.7417 8.3851 1.9867 2.0782 0.9433 1132 BPBio1_000359 CCCNC(=O)NS(=O)(=O)c1ccc(Cl)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 A08 compound treatment 13.9352 0.9297 0.2495 12.0846 -1.2721 -0.3014 -0.0367 -0.0939 1000219 BPBio1_000360 N[C@@H](Cc1cc(I)c(Oc2cc(I)c(O)c(I)c2)c(I)c1)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 A09 compound treatment 13.6897 0.68418 0.1836 14.7324 1.3757 0.326 0.3603 0.9631 1001994 BPBio1_000361 C[C@@H](N)[C@@H](O)c1ccccc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 A10 compound treatment 15.0134 2.0078 0.5388 15.9687 2.612 0.6189 0.8186 0.9976 1000243 BPBio1_000362 CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC[C@]1(C)CCc2c(C)c(O)c(C)c(C)c2O1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 A11 compound treatment 15.5429 2.5374 0.6808 16.1337 2.777 0.658 0.9467 0.9999 1000341 BPBio1_000363 OC[C@H](O)[C@H]1OC(=O)C(=C1O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 A12 compound treatment 16.8639 3.8584 1.0353 20.3512 6.9945 1.6572 1.9039 0.9743 387 BPBio1_000364 CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)C[C@H](O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CC(C)C)C(C)C)C(C)C)[C@@H](O)CC(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 A13 compound treatment 15.9462 2.9407 0.7891 14.7188 1.3622 0.3227 0.7862 0.9222 800 BPBio1_000365 C[C@](N)(Cc1ccc(O)c(O)c1)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 A14 compound treatment 13.8843 0.87877 0.2358 16.1015 2.7449 0.6504 0.6266 0.9058 3068973 BPBio1_000366 C(CN1CCOCC1)Nc2cc3CCCc4ccccc4-c3nn2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 A15 compound treatment 15.5495 2.5439 0.6826 15.3682 2.0115 0.4766 0.8197 0.9846 3063 BPBio1_000367 CCN1CCN(C(=O)N[C@@H](C(=O)N[C@H]2[C@H]3SCC(=C(N3C2=O)C(=O)O)CSc4nnnn4C)c5ccc(O)cc5)C(=O)C1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 A16 compound treatment 15.2465 2.2409 0.6013 14.3031 0.94649 0.2243 0.5838 0.9096 1000308 BPBio1_000368 N[C@]1(C[C@@H]2C[C@H]3C[C@@H](C2)C1)C3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 A17 compound treatment 11.1481 -1.8574 -0.4984 16.9898 3.6331 0.8608 0.2563 0.2576 3173242 BPBio1_000369 Nc1nc2cc(Cl)ccc2o1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 A18 compound treatment 13.713 0.7075 0.1898 15.3971 2.0405 0.4835 0.4761 0.9166 3068976 BPBio1_000370 Clc1ccc(CCC(Cn2ccnc2)Sc3c(Cl)cccc3Cl)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 A19 compound treatment 12.6716 -0.33388 -0.0896 15.7423 2.3857 0.5652 0.3363 0.5877 1516 BPBio1_000371 Nc1c2CCCCc2nc3ccccc13 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 A20 compound treatment 16.1175 3.1119 0.835 20.3747 7.018 1.6628 1.7662 0.9492 26 BPBio1_000372 CCCCc1oc2ccccc2c1C(=O)c3cc(I)c(OCCN(CC)CC)c(I)c3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 A21 compound treatment 14.2684 1.2629 0.3389 12.9591 -0.39754 -0.0942 0.173 0.4919 3487402 BPBio1_000373 CC(C)NCC(O)COc1ccc(COCCOC(C)C)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 A22 compound treatment 15.1087 2.1031 0.5643 12.7342 -0.62246 -0.1475 0.2947 0.5053 3616687 BPBio1_000374 C[C@H]1O[C@@H](O[C@@H]/2C[C@@H]3O[C@@](O)(C[C@H](O)[C@H]3C(=O)O)C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@@H](C)[C@H](C)[C@H](O)[C@@H](C)\C=C\C=C\C=C\C=C\C=C\C=C\C=C2)[C@@H](O)[C@@H](N)[C@@H]1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 A23 mock treatment 13.2493 0.24375 0.0654 13.2573 -0.099364 -0.0235 0.0296 0.4258 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 A24 mock treatment 17.6029 4.5974 1.2336 16.2909 2.9343 0.6952 1.3639 0.9632 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 B01 compound treatment 19.4307 6.4252 1.724 20.6103 7.2536 1.7186 2.4343 1.0 1001998 BPBio1_000375 Nc1ccc(CCN2CCN(CC2)c3cccc(c3)C(F)(F)F)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 B02 compound treatment 12.8217 -0.18379 -0.0493 15.7122 2.3555 0.5581 0.3598 0.6421 907126 BPBio1_000376 NC/C=C\C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 B03 compound treatment 14.331 1.3255 0.3557 15.0252 1.6685 0.3953 0.531 0.9986 429 BPBio1_000377 NCCc1c[nH]c2ccc(O)cc12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 B04 compound treatment 13.0323 0.026799 0.0072 15.4333 2.0767 0.492 0.353 0.7174 3189566 BPBio1_000378 COc1cc2CC[N+](C)(C)[C@@H]3Cc4ccc(O)c(Oc5cc6[C@H](Cc7cccc(Oc(c1O)c32)c7)N(C)CCc6cc5OC)c4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 B05 compound treatment 14.3604 1.3549 0.3636 13.5426 0.186 0.0441 0.2882 0.7871 1000242 BPBio1_000379 CN(C)CCn1nnnc1SCC2=C(N3[C@H](SC2)[C@H](NC(=O)Cc4csc(N)n4)C3=O)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 B06 compound treatment 13.2336 0.22807 0.0612 15.0732 1.7166 0.4067 0.3309 0.8044 907285 BPBio1_000380 CC(C)[C@@]1(NC(=O)[C@@H]2C[C@H]3[C@@H](Cc4c[nH]c5cccc3c45)N(C)C2)O[C@@]6(O)[C@@H]7CCCN7C(=O)[C@H](Cc8ccccc8)N6C1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 B07 compound treatment 16.0527 3.0472 0.8176 16.0193 2.6626 0.6309 1.0243 0.9918 3189438 BPBio1_000381 Cc1n[nH]c(=O)[nH]c1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 B08 compound treatment 17.6007 4.5951 1.233 21.0432 7.6866 1.8212 2.1597 0.982 961 BPBio1_000382 COc1ccc2[C@H](OC(=O)c2c1OC)[C@@H]3N(C)CCc4cc5OCOc5c(OC)c34 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 B09 compound treatment 14.2293 1.2237 0.3284 18.5757 5.219 1.2366 1.1066 0.8649 1077918 BPBio1_000383 Fc1ccc(cc1)C(=O)CCCN2CCC(CC2)n3c(=O)[nH]c4ccccc34 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 B10 compound treatment 21.1803 8.1748 2.1935 24.4428 11.086 2.6267 3.4084 0.996 3616747 BPBio1_000384 CCOC(=O)Oc1c(OC)cc(cc1OC)C(=O)O[C@@H]2C[C@@H]3CN4CCc5c([nH]c6cc(OC)ccc56)[C@H]4C[C@@H]3[C@@H]([C@H]2OC)C(=O)OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 B11 compound treatment 13.346 0.34047 0.0914 16.6795 3.3229 0.7873 0.6213 0.7839 3173761 BPBio1_000385 N[C@@H](C(=O)N[C@H]1[C@H]2SCC(=C(N2C1=O)C(=O)O)Cl)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 B12 compound treatment 12.3937 -0.61185 -0.1642 13.1217 -0.23491 -0.0557 -0.1554 -0.8967 1000124 BPBio1_000386 CN1C2CCC1CC(C2)OC(=O)C(CO)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 B13 compound treatment 15.2186 2.213 0.5938 15.8702 2.5136 0.5956 0.841 1.0 3189439 BPBio1_000387 CC(C)CCCCC(=O)N[C@H](CCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](CCN)C(=O)N[C@@H]1CCNC(=O)[C@@H](NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@@H](CNC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O)C(C)C)[C@@H](C)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 B14 compound treatment 16.1622 3.1567 0.847 16.5499 3.1933 0.7566 1.1339 0.9984 976 BPBio1_000388 CNC(=O)Oc1ccc2N(C)[C@H]3N(C)CC[C@@]3(C)c2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 B15 compound treatment 40.752 27.746 7.4451 33.464 20.107 4.7642 8.6332 0.9767 3587 BPBio1_000389 COc1cccc2C(=O)c3c(O)c4C[C@](O)(C[C@H](O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)c4c(O)c3C(=O)c12)C(=O)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 B16 compound treatment 13.3474 0.34182 0.0917 13.5942 0.23751 0.0563 0.1046 0.9725 3189567 BPBio1_000390 CCN1C[C@@]2(COC)C3[C@@H](OC)[C@H]4[C@@H]1[C@@]3(C5C[C@@]6(O)[C@H](OC(=O)c7ccccc7)C5[C@]4(OC(=O)C)[C@@H](O)[C@H]6OC)[C@H](C[C@H]2O)OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 B17 compound treatment 12.6971 -0.30841 -0.0828 14.118 0.76134 0.1804 0.069 0.3479 3616733 BPBio1_000391 CN(C)CC/C=C/1\c2ccccc2CSc3ccccc13 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 B18 compound treatment 16.2938 3.2883 0.8823 16.5745 3.2178 0.7624 1.163 0.9974 3141 BPBio1_000392 CO[C@H]1[C@@H](C[C@@H]2CN3CCc4c([nH]c5cc(OC)ccc45)[C@H]3C[C@@H]2[C@@H]1C(=O)OC)OC(=O)/C=C/c6cc(OC)c(OC)c(OC)c6 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 B19 compound treatment 11.4659 -1.5396 -0.4131 15.3706 2.014 0.4772 0.0453 0.0718 3616734 BPBio1_000393 CC(C)(O/N=C(\C(=O)N[C@H]1[C@H]2SCC(=C(N2C1=O)C(=O)O)C[n+]3ccccc3)/c4csc(N)n4)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 B20 compound treatment 12.3122 -0.69335 -0.186 12.1494 -1.2073 -0.286 -0.3338 -0.9783 3068781 BPBio1_000394 CC(C)[C@@H]1N2C(=O)[C@](NC(=O)[C@@H]3C[C@H]4[C@@H](Cc5c[nH]c6cccc4c56)N(C)C3)(O[C@@]2(O)[C@@H]7CCCN7C1=O)C(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 B21 compound treatment 14.7345 1.729 0.4639 13.6196 0.26296 0.0623 0.3721 0.7949 3060173 BPBio1_000395 NC(=N)NCc1cccc(I)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 B22 compound treatment 20.4729 7.4673 2.0037 19.0141 5.6575 1.3405 2.3647 0.9809 2081037 BPBio1_000396 CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]4NCCc5cc(OC)c(OC)cc45 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 B23 mock treatment 10.6087 -2.3969 -0.6431 13.9893 0.63266 0.1499 -0.3488 -0.5281 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 B24 mock treatment 16.7771 3.7716 1.012 14.5046 1.1479 0.272 0.9079 0.8664 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 C01 compound treatment 15.4746 2.469 0.6625 17.3388 3.9822 0.9435 1.1356 0.985 1444554 BPBio1_000397 C(N1CCN(CC1)c2nc3ccccc3s2)c4ccc5OCOc5c4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 C02 compound treatment 20.4246 7.4191 1.9907 14.8888 1.5321 0.363 1.6643 0.8225 417 BPBio1_000398 CN1CCN(CC1)C2=Nc3cc(Cl)ccc3Nc4ccccc24 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 C03 compound treatment 13.6282 0.62267 0.1671 14.6062 1.2496 0.2961 0.3275 0.9633 907527 BPBio1_000399 C(C#CCN1CCCC1)N2CCCC2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 C04 compound treatment 12.9307 -0.074851 -0.0201 15.0532 1.6965 0.402 0.27 0.6709 3189308 BPBio1_000400 C[C@@]12CC[C@H]3[C@@H](CC[C@H]4C[C@H](O)CC[C@@]43C)[C@@H]2CCC1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 C05 compound treatment 17.8466 4.8411 1.299 14.426 1.0694 0.2534 1.0977 0.8294 1486 BPBio1_000401 CC(C)NCC(O)COc1ccc(NC(=O)C)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 C06 compound treatment 25.9777 12.972 3.4808 26.8365 13.48 3.1939 4.7197 0.9991 336 BPBio1_000402 COc1ccc(C[C@H]2NC[C@H](O)[C@H]2OC(=O)C)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 C07 compound treatment 15.2864 2.2809 0.612 16.2387 2.8821 0.6829 0.9156 0.9985 1142 BPBio1_000403 Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)[nH]c1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 C08 compound treatment 17.6237 4.6181 1.2392 17.1369 3.7802 0.8957 1.5096 0.9873 1023517 BPBio1_000404 NC(=O)Nc1ccc(cc1)[As](=O)(O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 C09 compound treatment 13.5994 0.59392 0.1594 20.3071 6.9504 1.6468 1.2772 0.7719 1192 BPBio1_000405 Cc1noc(NS(=O)(=O)c2ccc(N)cc2)c1C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 C10 compound treatment 18.3035 5.2979 1.4216 27.66 14.303 3.389 3.4016 0.9256 360 BPBio1_000406 Oc1ccc(cc1)c2cc(=O)c3c(O)cc(O)cc3o2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 C11 compound treatment 20.1955 7.19 1.9293 17.719 4.3624 1.0336 2.0951 0.9572 3068881 BPBio1_000407 CCCOc1ccccc1c2nc(=O)c3[nH]nnc3[nH]2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 C12 compound treatment 16.9203 3.9148 1.0504 13.9399 0.58326 0.1382 0.8405 0.7933 2060483 BPBio1_000408 CC(=O)N[C@@H](CC(=O)O)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 C13 compound treatment 13.5986 0.59309 0.1591 20.0157 6.6591 1.5778 1.2282 0.7745 1471 BPBio1_000409 CN1C(c2ccc(Cl)cc2)S(=O)(=O)CCC1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 C14 compound treatment 11.2654 -1.7401 -0.4669 12.5492 -0.80744 -0.1913 -0.4654 -0.9224 3189309 BPBio1_000410 CCOC(=O)OC(C)OC(=O)[C@@H]1N2[C@H](SC1(C)C)[C@H](NC(=O)[C@H](N)c3ccccc3)C2=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 C15 compound treatment 21.1769 8.1713 2.1926 17.0124 3.6558 0.8662 2.1629 0.9175 2431 BPBio1_000411 CCN(CC)CCNC(=O)c1ccc(N)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 C16 compound treatment 13.8371 0.83155 0.2231 25.883 12.526 2.9679 2.2564 0.7581 1960 BPBio1_000412 CC(=C)[C@@H]1CC[C@@]2(CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 C17 compound treatment 20.5669 7.5614 2.0289 20.6011 7.2445 1.7165 2.6484 0.9965 3189186 BPBio1_000413 CNc1ncnc2n(cnc12)[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 C18 compound treatment 9.6027 -3.4028 -0.9131 12.9857 -0.37096 -0.0879 -0.7078 -0.7716 951 BPBio1_000414 OC(=O)CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@H]12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 C19 compound treatment 11.2419 -1.7636 -0.4732 12.2182 -1.1384 -0.2697 -0.5254 -0.9645 3368 BPBio1_000415 NC(=N)NC(=O)Cc1c(Cl)cccc1Cl 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 C20 compound treatment 14.4009 1.3953 0.3744 14.5117 1.155 0.2737 0.4583 0.9881 982 BPBio1_000416 CC(=O)Oc1ccc(cc1)C(c2ccc(OC(=O)C)cc2)c3ccccn3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 C21 compound treatment 17.7247 4.7192 1.2663 19.0157 5.659 1.3408 1.8435 0.9996 1001939 BPBio1_000417 OCCN1CCN(CC/C=C\2/c3ccccc3Sc4ccc(cc24)C(F)(F)F)CC1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 C22 compound treatment 14.1649 1.1593 0.3111 15.3701 2.0135 0.4771 0.5573 0.9785 3557442 BPBio1_000418 CC(C)[C@@H](C)/C=C/[C@@H](C)[C@H]1CC[C@H]2\C(=C\C=C/3\C[C@@H](O)CCC3=C)\CCC[C@]12C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 C23 mock treatment 15.9618 2.9563 0.7933 12.4305 -0.92614 -0.2194 0.4057 0.493 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 C24 mock treatment 13.2354 0.22985 0.0617 8.1255 -5.2311 -1.2394 -0.8328 -0.6711 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 D01 compound treatment 16.6086 3.603 0.9668 17.2886 3.932 0.9316 1.3424 0.9998 1181 BPBio1_000419 Cc1cc(c(O)c(C)c1CC2=NCCN2)C(C)(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 D02 compound treatment 11.0131 -1.9924 -0.5346 14.7782 1.4216 0.3368 -0.1399 -0.2213 864 BPBio1_000420 Oc1noc2CNCCc12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 D03 compound treatment 18.1677 5.1622 1.3851 13.669 0.31239 0.074 1.0318 0.7438 2120971 BPBio1_000421 CN1CCCC(CC2c3ccccc3Sc4ccccc24)C1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 D04 compound treatment 15.3556 2.35 0.6306 17.023 3.6664 0.8687 1.0601 0.9876 1218 BPBio1_000422 CCCCNc1ccc(cc1)C(=O)OCCN(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 D05 compound treatment 16.0851 3.0796 0.8263 16.8791 3.5225 0.8346 1.1745 1.0 3172716 BPBio1_000423 NC(=O)N/N=C/c1ccc(o1)[N+](=O)[O-] 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 D06 compound treatment 24.5878 11.582 3.1078 28.2072 14.851 3.5186 4.6856 0.9981 1000293 BPBio1_000424 C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]2(C)[C@@]1(OC(=O)c5ccco5)C(=O)CCl 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 D07 compound treatment 14.5776 1.5721 0.4218 15.8947 2.538 0.6014 0.7235 0.985 1782 BPBio1_000425 COc1ccc2[nH]c(nc2c1)S(=O)Cc3ncc(C)c(OC)c3C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 D08 compound treatment 14.7578 1.7523 0.4702 18.0627 4.7061 1.115 1.1209 0.9263 3198963 BPBio1_000426 C[C@H]1[C@H]2[C@H](C[C@H]3[C@@H]4CC[C@H]5C[C@@H](O)CC[C@]5(C)[C@H]4CC[C@]23C)O[C@]61CC[C@H](C)CN6 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 D09 compound treatment 14.932 1.9264 0.5169 22.2398 8.8831 2.1047 1.8538 0.8554 912 BPBio1_000427 CCCc1cc(=O)[nH]c(=S)[nH]1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 D10 compound treatment 11.301 -1.7046 -0.4574 15.3821 2.0255 0.4799 0.0159 0.024 964 BPBio1_000428 CN(C)N=Nc1[nH]cnc1C(=O)N 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 D11 compound treatment 16.5242 3.5187 0.9442 17.9689 4.6122 1.0928 1.4404 0.9973 3616735 BPBio1_000429 CC(C)N1CCN(CC1)c2ccc(OC[C@H]3CO[C@@](Cn4cncn4)(O3)c5ccc(Cl)cc5Cl)cc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 D12 compound treatment 11.222 -1.7835 -0.4786 15.7606 2.404 0.5696 0.0644 0.0865 3616748 BPBio1_000430 CC(C)[N+]1(C)[C@@H]2CC[C@@H]1CC(C2)OC(=O)C(CO)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 D13 compound treatment 13.7553 0.74978 0.2012 12.4641 -0.89255 -0.2115 -0.0073 -0.0249 3487464 BPBio1_000431 CC(C(=O)O)c1ccc(s1)C(=O)c2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 D14 compound treatment 14.5787 1.5732 0.4221 13.926 0.56931 0.1349 0.3939 0.8888 1092107 BPBio1_000432 CN(C)CCCN1c2ccccc2Sc3ccc(cc13)C(=O)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 D15 compound treatment 11.3797 -1.6258 -0.4363 12.7894 -0.56726 -0.1344 -0.4035 -0.884 3616736 BPBio1_000433 CN[C@H](CC(C)C)C(=O)N[C@@H]1[C@H](O)c2ccc(Oc3cc4cc(Oc5ccc(cc5Cl)[C@@H](O)[C@@H]6NC(=O)[C@H](NC(=O)[C@@H]4NC(=O)[C@H](CC(=O)N)NC1=O)c7ccc(O)c(c7)-c8c(O)cc(O)cc8[C@H](NC6=O)C(=O)O)c3O[C@@H]9OC(CO)[C@@H](O)[C@H](O)[C@H]9O[C@H]%10C[C@](C)(N)[C@H](O)[C@H](C)O%10)c(Cl)c2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 D16 compound treatment 14.9332 1.9277 0.5173 15.574 2.2173 0.5254 0.7372 1.0 1000115 BPBio1_000434 COC(=O)[C@@H]1[C@@H](O)CC[C@@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@H]12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 D17 compound treatment 13.5143 0.50872 0.1365 18.2624 4.9057 1.1623 0.9184 0.7848 1263 BPBio1_000435 C[C@@H]1CC[C@H]2[C@@H](C)C(=O)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@@]23OO4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 D18 compound treatment 11.5993 -1.4062 -0.3773 12.0228 -1.3339 -0.316 -0.4903 -0.9961 450 BPBio1_000436 COC(=O)[C@@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@H]12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 D19 compound treatment 12.3713 -0.63424 -0.1702 12.9442 -0.41248 -0.0977 -0.1894 -0.9653 1489 BPBio1_000437 CCCNCC(O)COc1ccccc1C(=O)CCc2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 D20 compound treatment 15.3744 2.3689 0.6356 11.7644 -1.5922 -0.3773 0.1827 0.2472 1084508 BPBio1_000438 COc1ccc2cc3-c4cc(OC)c(OC)cc4CC[n+]3cc2c1OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 D21 compound treatment 13.5617 0.55615 0.1492 11.1921 -2.1645 -0.5129 -0.2571 -0.4814 1113307 BPBio1_000439 CCN(CC)C(=O)c1ccc(O)c(OC)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 D22 compound treatment 12.7013 -0.3042 -0.0816 13.0459 -0.31072 -0.0736 -0.1098 -0.9987 3616749 BPBio1_000440 COc1cc2CC[C@H](N)c3cc(=O)c(O)ccc3-c2c(OC)c1OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 D23 mock treatment 12.003 -1.0025 -0.269 15.1992 1.8425 0.4366 0.1185 0.2311 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 D24 mock treatment 14.3117 1.3061 0.3505 11.7255 -1.6311 -0.3865 -0.0255 -0.0488 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 E01 compound treatment 12.4494 -0.55608 -0.1492 15.3767 2.02 0.4786 0.2329 0.4646 3561656 BPBio1_000441 CCCCN1CCC(CCC(=O)c2cc(Cl)c(N)cc2OC)CC1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 E02 compound treatment 13.0535 0.047999 0.0129 14.1122 0.75554 0.179 0.1357 0.756 991 BPBio1_000442 CC[C@@H](CO)NC(=O)[C@H]1CN(C)[C@@H]2Cc3c[nH]c4cccc(C2=C1)c34 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 E03 compound treatment 11.0267 -1.9789 -0.531 15.2732 1.9166 0.4541 -0.0544 -0.0778 1188 BPBio1_000443 NS(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 E04 compound treatment 23.8946 10.889 2.9218 26.7338 13.377 3.1695 4.3072 0.9992 3616694 BPBio1_000444 CCCCCCCCN[C@H](C)[C@@H](O)c1ccc(SC(C)C)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 E05 compound treatment 11.0535 -1.9521 -0.5238 14.1182 0.76154 0.1804 -0.2428 -0.4382 1510 BPBio1_000445 CN(C)CCN(Cc1cccs1)c2ccccn2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 E06 compound treatment 12.2069 -0.79858 -0.2143 15.9284 2.5718 0.6093 0.2794 0.4325 3069011 BPBio1_000446 NCCC(=O)NCCc1c[nH]cn1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 E07 compound treatment 12.0152 -0.99033 -0.2657 12.4301 -0.92652 -0.2195 -0.3431 -0.9955 844 BPBio1_000447 CNCCCN1c2ccccc2CCc3ccccc13 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 E08 compound treatment 14.4292 1.4236 0.382 15.8224 2.4658 0.5842 0.6832 0.9788 1409 BPBio1_000448 CCCC(C)(COC(=O)N)COC(=O)NC(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 E09 compound treatment 21.2997 8.2941 2.2255 23.4362 10.08 2.3882 3.2624 0.9994 2203 BPBio1_000449 CN(CCCOc1ccc(Cl)cc1Cl)CC#C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 E10 compound treatment 13.283 0.27748 0.0745 17.4843 4.1277 0.978 0.7442 0.7587 3189311 BPBio1_000450 CC(=O)OCC1=C(N2[C@H](SC1)[C@H](N)C2=O)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 E11 compound treatment 15.8203 2.8147 0.7553 14.0484 0.69174 0.1639 0.6499 0.841 1390 BPBio1_000451 CC(C)(C)NCC(O)c1cc(Cl)c(N)c(Cl)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 E12 compound treatment 12.6031 -0.4024 -0.108 13.2574 -0.099239 -0.0235 -0.093 -0.8414 2117409 BPBio1_000452 COc1cc(ccc1N=Nc2ccc3c(cc(c(N)c3c2O)S(=O)(=O)O)S(=O)(=O)O)c4ccc(N=Nc5ccc6c(cc(c(N)c6c5O)S(=O)(=O)O)S(=O)(=O)O)c(OC)c4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 E13 compound treatment 13.1017 0.096224 0.0258 13.7839 0.42724 0.1012 0.0898 0.8599 1000329 BPBio1_000453 CNCCC[C@]1(CC[C@H]2c3ccccc31)c4ccccc24 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 E14 compound treatment 12.9781 -0.027463 -0.0074 13.2364 -0.12021 -0.0285 -0.0254 -0.8617 907205 BPBio1_000454 COc1cc(OC)c(C(=O)CCCN2CCCC2)c(OC)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 E15 compound treatment 25.2266 12.221 3.2792 35.1099 21.753 5.1541 5.9633 0.9762 3189187 BPBio1_000455 Nc1nc(S)c2ncn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c2n1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 E16 compound treatment 12.1279 -0.87763 -0.2355 13.065 -0.29165 -0.0691 -0.2154 -0.8776 3173763 BPBio1_000456 O[C@@H]1C[C@](O)(C[C@@H](OC(=O)/C=C/c2ccc(O)c(O)c2)[C@@H]1O)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 E17 compound treatment 13.781 0.7755 0.2081 17.8202 4.4635 1.0576 0.895 0.8303 801 BPBio1_000457 CN(C)CC/C=C/1\c2ccccc2Sc3ccc(Cl)cc13 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 E18 compound treatment 18.8641 5.8586 1.572 17.9414 4.5847 1.0863 1.8797 0.9837 3180147 BPBio1_000458 CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]4NCCc5cc(O)c(OC)cc45 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 E19 compound treatment 12.3538 -0.65174 -0.1749 12.8767 -0.47994 -0.1137 -0.2041 -0.9783 1000292 BPBio1_000459 C[C@H](NCCc1ccc(O)cc1)[C@H](O)c2ccc(O)cc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 E20 compound treatment 11.2225 -1.783 -0.4784 13.9842 0.62756 0.1487 -0.2332 -0.4654 2838 BPBio1_000460 CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2/C(=C/C=C\3/C[C@@H](O)CCC3=C)/CCC[C@]12C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 E21 compound treatment 9.4231 -3.5825 -0.9613 14.9293 1.5727 0.3726 -0.4162 -0.4037 417 BPBio1_000461 CN1CCN(CC1)C2=Nc3cc(Cl)ccc3Nc4ccccc24 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 E22 compound treatment 10.3024 -2.7031 -0.7253 11.417 -1.9396 -0.4596 -0.8378 -0.9758 3616697 BPBio1_000462 CO[C@@H]1CN(CCCOc2ccc(F)cc2)CC[C@@H]1NC(=O)c3cc(Cl)c(N)cc3OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 E23 mock treatment 12.4411 -0.56443 -0.1514 14.1926 0.83596 0.1981 0.033 0.1322 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 E24 mock treatment 12.3477 -0.65778 -0.1765 12.804 -0.55266 -0.1309 -0.2174 -0.9892 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 F01 compound treatment 14.2948 1.2893 0.3459 15.5529 2.1963 0.5204 0.6126 0.9803 920 BPBio1_000463 CCN1CCCC1CNC(=O)c2cc(ccc2OC)S(=O)(=O)N 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 F02 compound treatment 11.8447 -1.1609 -0.3115 11.904 -1.4526 -0.3442 -0.4636 -0.9988 907532 BPBio1_000464 CP(=O)(O)C1=CCNCC1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 F03 compound treatment 11.7999 -1.2056 -0.3235 15.9085 2.5518 0.6046 0.1988 0.2899 1002022 BPBio1_000465 NC(CCC(=O)O)C=C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 F04 compound treatment 12.0432 -0.96235 -0.2582 16.2013 2.8446 0.674 0.294 0.4073 3180327 BPBio1_000466 COc1ccc2[C@H](OC(=O)c2c1OC)[C@@H]3N(C)CCc4cc5OCOc5cc34 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 F05 compound treatment 15.9449 2.9394 0.7887 15.8221 2.4655 0.5842 0.9708 0.9891 3616738 BPBio1_000467 OC(CCN1CCCCC1)(C2C[C@H]3C[C@@H]2C=C3)c4ccccc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 F06 compound treatment 12.1542 -0.85131 -0.2284 14.9074 1.5508 0.3674 0.0983 0.2272 1054667 BPBio1_000468 CN1C(CC(O)c2ccccc2)CCCC1CC(O)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 F07 compound treatment 12.0017 -1.0038 -0.2693 17.2227 3.866 0.916 0.4573 0.4789 3487465 BPBio1_000469 OC(=O)COCCN1CCN(CC1)C(c2ccccc2)c3ccc(Cl)cc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 F08 compound treatment 12.9158 -0.089751 -0.0241 12.985 -0.37164 -0.0881 -0.0793 -0.8686 959 BPBio1_000470 COc1ccc(Cc2nccc3cc(OC)c(OC)cc23)cc1OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 F09 compound treatment 11.4773 -1.5283 -0.4101 13.1725 -0.1841 -0.0436 -0.3208 -0.7779 3189442 BPBio1_000471 CCc1cccc(CC)c1NC(=O)CN(CC(=O)O)CC(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 F10 compound treatment 17.5216 4.5161 1.2118 14.8913 1.5347 0.3636 1.114 0.8805 3000363 BPBio1_000472 COC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@H]12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 F11 compound treatment 11.0097 -1.9958 -0.5355 14.5017 1.1451 0.2713 -0.1868 -0.3112 1252 BPBio1_000473 CC(C)NCC(O)c1cc(O)cc(O)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 F12 compound treatment 13.0696 0.064099 0.0172 14.2053 0.84866 0.2011 0.1543 0.7648 3061052 BPBio1_000474 CN1[C@H](C[C@H](O)c2ccccc2)CCC[C@@H]1CC(=O)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 F13 compound treatment 11.9612 -1.0444 -0.2802 13.5374 0.18074 0.0428 -0.1679 -0.5922 3616739 BPBio1_000475 CN[C@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](OC3OC(=CCC3N)CN)[C@@H]2O)OC[C@@]1(C)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 F14 compound treatment 11.833 -1.1725 -0.3146 11.1679 -2.1888 -0.5186 -0.5892 -0.9713 909 BPBio1_000476 COc1ccc2cc3-c4cc5OCOc5cc4CC[n+]3cc2c1OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 F15 compound treatment 11.7966 -1.209 -0.3244 14.3242 0.96759 0.2293 -0.0673 -0.1694 353 BPBio1_000477 Oc1cc(O)c2c(=O)c(O)c(oc2c1)c3ccc(O)c(O)c3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 F16 compound treatment 138.2245 125.22 33.5995 105.1131 91.756 21.7403 39.1312 0.9778 3189572 BPBio1_000478 CN1Cc2c3OCOc3ccc2[C@H]4[C@@H](O)Cc5cc6OCOc6cc5[C@H]41 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 F17 compound treatment 14.5046 1.4991 0.4022 14.2199 0.86329 0.2045 0.4291 0.9508 2269 BPBio1_000479 Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 F18 compound treatment 10.0389 -2.9667 -0.796 14.7134 1.3567 0.3215 -0.3356 -0.3909 1202 BPBio1_000480 COc1ccc2CN(C)CC[C@]34C=C[C@H](O)C[C@@H]4Oc1c23 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 F19 compound treatment 17.0603 4.0547 1.088 13.9888 0.63221 0.1498 0.8752 0.7969 2922 BPBio1_000481 OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Br)cc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 F20 compound treatment 13.2871 0.2816 0.0756 12.4441 -0.91251 -0.2162 -0.0995 -0.4342 1220 BPBio1_000482 CN1CCc2cc3OCOc3cc2[C@H]1[C@@H]4OC(=O)c5c6OCOc6ccc45 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 F21 compound treatment 12.8779 -0.1276 -0.0342 15.2362 1.8796 0.4453 0.2907 0.6508 1000807 BPBio1_000483 CN1CCN(CC1)C(c2ccccc2)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 F22 compound treatment 9.2986 -3.7069 -0.9947 15.332 1.9754 0.468 -0.3724 -0.3388 3173993 BPBio1_000484 O[C@H]1CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]2[C@H]1C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 F23 mock treatment 13.7087 0.70317 0.1887 11.5578 -1.7988 -0.4262 -0.168 -0.3603 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 F24 mock treatment 10.0483 -2.9573 -0.7935 12.2787 -1.0779 -0.2554 -0.7417 -0.8897 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 G01 compound treatment 11.6758 -1.3297 -0.3568 13.3586 0.0019862 5.0E-4 -0.252 -0.7062 3561657 BPBio1_000485 COc1cc(N)c(Cl)cc1C(=O)CCC2CCN(CCNS(=O)(=O)C)CC2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 G02 compound treatment 15.6613 2.6558 0.7126 12.1496 -1.2071 -0.286 0.3017 0.3929 3314 BPBio1_000486 CC[C@@H](CO)NC(=O)[C@H]1CN(C)[C@@H]2Cc3cn(C)c4cccc(C2=C1)c34 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 G03 compound treatment 11.3832 -1.6223 -0.4353 13.1332 -0.22341 -0.0529 -0.3452 -0.7873 1332 BPBio1_000487 NS(=O)(=O)c1cc(ccc1Cl)C2(O)NC(=O)c3ccccc32 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 G04 compound treatment 12.5194 -0.48614 -0.1304 11.3867 -1.9699 -0.4667 -0.4223 -0.8713 1055132 BPBio1_000488 COc1cc2cc[n+]3c(C)c4cc(OC)c(OC)cc4cc3c2cc1OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 G05 compound treatment 11.4969 -1.5087 -0.4048 15.0663 1.7097 0.4051 2.0E-4 3.0E-4 3480458 BPBio1_000489 CC(CCc1ccc(O)cc1)NCCc2ccc(O)c(O)c2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 G06 compound treatment 18.0952 5.0896 1.3657 15.2163 1.8597 0.4406 1.2773 0.8901 3054850 BPBio1_000490 C[C@@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@]34C)[C@@H]2CC[C@@H]1C(=O)CO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 G07 compound treatment 12.9695 -0.036051 -0.0097 12.7085 -0.64809 -0.1536 -0.1154 -0.7502 1048 BPBio1_000491 CCn1cc(C(=O)O)c(=O)c2cc(F)c(nc12)N3CCNCC3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 G08 compound treatment 14.8712 1.8656 0.5006 12.2607 -1.096 -0.2597 0.1704 0.3021 3189313 BPBio1_000492 C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(=O)N)[C@H]2N=C1/C(=C/3\N=C(/C=C/4\N=C(/C(=C\5/[C@@H](CCC(=O)N)[C@](C)(CC(=O)N)[C@@]2(C)N5[Co+]C#N)/C)\[C@@](C)(CC(=O)N)[C@@H]4CCC(=O)N)\C(C)(C)[C@@H]3CCC(=O)N)/C)OP(=O)(O)O[C@H]6[C@@H](O)[C@H](O[C@@H]6CO)n7cnc8cc(C)c(C)cc78 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 G09 compound treatment 12.4456 -0.55998 -0.1503 15.1892 1.8326 0.4342 0.2008 0.437 3616658 BPBio1_000493 C[C@H]1CCC[C@@H](C)N1NC(=O)c2ccc(Cl)c(c2)S(=O)(=O)N 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 G10 compound treatment 12.2312 -0.77428 -0.2078 13.91 0.55339 0.1311 -0.0542 -0.2206 1037 BPBio1_000494 CC1=C(N2[C@H](SC1)[C@H](NC(=O)[C@H](N)c3ccc(O)cc3)C2=O)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 G11 compound treatment 15.7668 2.7612 0.7409 16.5811 3.2244 0.764 1.0641 0.9999 1105 BPBio1_000495 CCN(CC)CCNc1ccc(CO)c2sc3ccccc3c(=O)c12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 G12 compound treatment 13.1092 0.10363 0.0278 13.6885 0.33183 0.0786 0.0753 0.9024 3069049 BPBio1_000496 CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C/C=C/C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O)C(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 G13 compound treatment 11.5361 -1.4694 -0.3943 15.9709 2.6143 0.6194 0.1592 0.2168 3068883 BPBio1_000497 Nc1ncnc2n(cnc12)[C@@H]3O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]3O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 G14 compound treatment 22.9866 9.981 2.6782 20.7796 7.423 1.7588 3.1374 0.9792 3189314 BPBio1_000498 C[C@@]12CC[C@H]3[C@@H](CC[C@@H]4C[C@@H](O)CC[C@@]43C)[C@@]2(O)CC[C@@H]1C5=CC(=O)OC5 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 G15 compound treatment 12.0892 -0.91633 -0.2459 13.3947 0.038061 0.009 -0.1675 -0.6807 3189189 BPBio1_000499 CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccc(O)cc3)C(=O)N2[C@H]1C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 G16 compound treatment 22.7945 9.7889 2.6266 21.6083 8.2516 1.9551 3.2398 0.9894 3189315 BPBio1_000500 C[C@H]1O[C@H](C[C@H](O)[C@@H]1O)O[C@@H]2[C@@H](C)O[C@H](C[C@@H]2O)O[C@@H]3[C@@H](C)O[C@H](C[C@@H]3O)O[C@H]4CC[C@@]5(C)[C@H](CC[C@@H]6[C@@H]5C[C@@H](O)[C@]7(C)[C@H](CC[C@]67O)C8=CC(=O)OC8)C4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 G17 compound treatment 11.5571 -1.4484 -0.3887 11.7964 -1.5602 -0.3697 -0.5362 -0.9997 1000342 BPBio1_000501 CC1=C(N2[C@H](SC1)[C@H](NC(=O)[C@H](N)c3ccccc3)C2=O)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 G18 compound treatment 30.235 17.229 4.6231 30.8091 17.452 4.1351 6.193 0.9985 1000279 BPBio1_000502 COc1cccc2C(=O)c3c(O)c4C[C@](O)(C[C@H](O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)c4c(O)c3C(=O)c12)C(=O)CO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 G19 compound treatment 13.48 0.47442 0.1273 16.0356 2.679 0.6347 0.5388 0.8323 1000343 BPBio1_000503 COc1ccc2C[C@H]3[C@H]4CCCC[C@@]4(CCN3C)c2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 G20 compound treatment 11.6972 -1.3083 -0.3511 14.0853 0.72864 0.1726 -0.1262 -0.3225 3069053 BPBio1_000504 CCOC(=O)n1ccn(C)c1=S 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 G21 compound treatment 12.581 -0.42455 -0.1139 12.6278 -0.72884 -0.1727 -0.2027 -0.9796 764 BPBio1_000505 Fc1ccc(cc1)C(=O)CCCN2CCC(=CC2)n3c(=O)[nH]c4ccccc34 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 G22 compound treatment 10.7366 -2.2689 -0.6088 15.7414 2.3848 0.565 -0.031 -0.0373 1001924 BPBio1_000506 C[C@@]12CC[C@H]3[C@@H](CC[C@H]4C[C@@H](O)CC[C@@]43C)[C@@H]2CCC1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 G23 mock treatment 13.0316 0.026119 0.007 15.5338 2.1772 0.5158 0.3697 0.7166 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 G24 mock treatment 12.5348 -0.47068 -0.1263 13.5173 0.16069 0.0381 -0.0624 -0.4729 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 H01 compound treatment 11.4927 -1.5129 -0.4059 14.8637 1.5071 0.3571 -0.0346 -0.0639 907371 BPBio1_000507 CN1C2CCC1CC(C2)NC(=O)c3nn(C)c4ccccc34 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 H02 compound treatment 11.5708 -1.4347 -0.385 11.6309 -1.7257 -0.4089 -0.5613 -0.9995 3560375 BPBio1_000508 CCOC(OCC)P(=O)(O)CCCN 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 H03 compound treatment 24.6503 11.645 3.1246 27.5681 14.211 3.3672 4.5904 0.9993 1095093 BPBio1_000509 CNCCC(Oc1ccc(cc1)C(F)(F)F)c2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 H04 compound treatment 12.7992 -0.20633 -0.0554 12.0697 -1.2869 -0.3049 -0.2548 -0.8221 1000946 BPBio1_000510 COc1ccc(CC2N(C)CCc3cc(OC)c(OC)cc23)cc1OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 H05 compound treatment 12.8826 -0.12293 -0.033 12.3733 -0.98331 -0.233 -0.1881 -0.7992 2141046 BPBio1_000511 CC(=O)N(CC(O)CO)c1c(I)c(C(=O)NCC(O)CO)c(I)c(C(=O)NCC(O)CO)c1I 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 H06 compound treatment 12.8933 -0.11227 -0.0301 12.378 -0.97866 -0.2319 -0.1853 -0.7923 3054974 BPBio1_000512 COC(=O)C1=CO[C@@H](C)[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 H07 compound treatment 16.0895 3.084 0.8275 11.6989 -1.6577 -0.3928 0.3074 0.3356 3068692 BPBio1_000513 CNCCC=C1c2ccccc2C=Cc3ccccc13 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 H08 compound treatment 11.7011 -1.3044 -0.35 17.142 3.7853 0.8969 0.3867 0.4017 4895 BPBio1_000514 C[n+]1cccc(c1)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 H09 compound treatment 12.2736 -0.73192 -0.1964 16.3591 3.0025 0.7114 0.3642 0.4934 889 BPBio1_000515 NC(=O)c1cnccn1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 H10 compound treatment 13.2528 0.24731 0.0664 13.781 0.42434 0.1005 0.118 0.9797 915 BPBio1_000516 OC(=O)Cc1ccccc1Nc2c(Cl)cccc2Cl 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 H11 compound treatment 14.2181 1.2125 0.3254 15.8111 2.4544 0.5815 0.6413 0.9623 2900 BPBio1_000517 CN1C(=O)OC(C)(C)C1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 H12 compound treatment 13.3575 0.35195 0.0944 12.4868 -0.86984 -0.2061 -0.079 -0.3483 3616751 BPBio1_000518 CN1CC[C@]23[C@@H]4Nc5ccccc5[C@]3(CCN4C)[C@@H]1Nc6ccccc62 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 H13 compound treatment 18.842 5.8364 1.5661 16.1634 2.8067 0.665 1.5776 0.9272 1607 BPBio1_000519 CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 H14 compound treatment 10.3048 -2.7007 -0.7247 16.215 2.8584 0.6773 -0.0335 -0.0338 3616752 BPBio1_000520 COc1ccc(cc1OC)C(=O)OC2C[C@H]3CC[C@H](C2)N3C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 H15 compound treatment 11.2333 -1.7723 -0.4755 13.8001 0.44349 0.1051 -0.262 -0.5379 3616740 BPBio1_000521 C[C@H]1O[C@@H](OC/2CC(O)C(C(O)CC(=O)CC(O)C(O)CCC(O)CC(O)CC(O)CC(=O)OC(C)C(C)C(O)C(C)/C=C/C=C/CC\C=C\C=C\C=C\C=C2)C(=O)O)[C@@H](O)[C@@H](N)[C@@H]1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 H16 compound treatment 10.6765 -2.3291 -0.625 14.3875 1.0309 0.2442 -0.2692 -0.4012 2060325 BPBio1_000522 COc1ccc2C[C@@H]3N(C)CCc4cc(OC)c(OC)c(c34)-c2c1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 H17 compound treatment 15.5624 2.5569 0.6861 16.3671 3.0105 0.7133 0.9895 0.9998 3060147 BPBio1_000523 CCCC1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 H18 compound treatment 12.7714 -0.23408 -0.0628 11.9054 -1.4513 -0.3439 -0.2876 -0.8227 1076 BPBio1_000524 Cc1cccc(C)c1NC2=NCCCS2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 H19 compound treatment 11.4372 -1.5683 -0.4208 13.3305 -0.026171 -0.0062 -0.3019 -0.7174 3068724 BPBio1_000525 C[C@@H](O)[C@@H]1[C@H]2CC(=C(N2C1=O)C(=O)O)SCCNC=N 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 H20 compound treatment 11.4288 -1.5767 -0.4231 12.7921 -0.56456 -0.1338 -0.3937 -0.8874 3179848 BPBio1_000526 C/C=C\1/CC(=C)[C@@](C)(O)C(=O)OCC2=CCN3CC[C@@H](OC1=O)[C@H]32 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 H21 compound treatment 17.1426 4.1371 1.1101 14.7756 1.419 0.3362 1.0227 0.8817 1448 BPBio1_000527 OC(=O)c1cc(N=Nc2ccc(cc2)S(=O)(=O)Nc3ccccn3)ccc1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 H22 compound treatment 10.3649 -2.6406 -0.7085 11.6964 -1.6603 -0.3934 -0.7792 -0.9614 1001889 BPBio1_000528 COc1cc-2c(C[C@@H]3N(C)CCc4cc(O)c(OC)c2c34)cc1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 H23 mock treatment 15.0364 2.0309 0.5449 13.3965 0.039811 0.0094 0.392 0.7192 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 H24 mock treatment 10.2867 -2.7189 -0.7295 10.4649 -2.8918 -0.6852 -1.0004 -0.9995 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 I01 compound treatment 11.5613 -1.4443 -0.3875 17.2604 3.9037 0.9249 0.38 0.3789 3614608 BPBio1_000529 COc1cc(N)c(Cl)cc1C(=O)OCCCN2CCCCC2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 I02 compound treatment 9.6485 -3.3571 -0.9008 13.7565 0.3999 0.0948 -0.57 -0.6293 52159 BPBio1_000530 COc1ccc2[nH]cc(CCN)c2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 I03 compound treatment 13.7462 0.74071 0.1988 14.3476 0.99091 0.2348 0.3066 0.9966 3189191 BPBio1_000531 CN(C)C(=O)Oc1cc(OC(=O)N(C)C)cc(c1)C(O)CNC(C)(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 I04 compound treatment 13.743 0.73742 0.1979 12.8223 -0.53432 -0.1266 0.0504 0.2145 386 BPBio1_000532 C[C@@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]2CC[C@@H]1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 I05 compound treatment 14.182 1.1764 0.3157 24.3837 11.027 2.6127 2.0707 0.7868 3068885 BPBio1_000533 C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 I06 compound treatment 10.2532 -2.7523 -0.7385 14.0179 0.66122 0.1567 -0.4114 -0.545 2078 BPBio1_000534 CCCCc1ccc(nc1)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 I07 compound treatment 236.0793 223.07 59.8564 72.2503 58.894 13.954 52.1918 0.8492 1352 BPBio1_000535 COc1cc2CC[C@H](NC(=O)C)c3cc(=O)c(OC)ccc3-c2c(OC)c1OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 I08 compound treatment 11.8105 -1.195 -0.3206 12.9823 -0.37431 -0.0887 -0.2894 -0.87 907497 BPBio1_000536 COc1ccc(cc1)c2ccc(N)[n+](CCCC(=O)O)n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 I09 compound treatment 26.1121 13.107 3.5168 24.0412 10.685 2.5316 4.2769 0.987 3177235 BPBio1_000537 CN1C[C@H](CNC(=O)OCc2ccccc2)C[C@H]3[C@H]1Cc4cn(C)c5cccc3c45 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 I10 compound treatment 10.7909 -2.2146 -0.5942 13.6311 0.27449 0.065 -0.3742 -0.626 3616701 BPBio1_000538 C[C@@H]1C(=O)O[C@H]2CC34[C@H]5C[C@@H](C(C)(C)C)[C@@]46[C@@H](O)C(=O)O[C@H]6O[C@@]3(C(=O)O5)[C@@]12O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 I11 compound treatment 13.5799 0.5744 0.1541 13.229 -0.12768 -0.0303 0.0876 0.5577 3189192 BPBio1_000539 CCN[C@H]1CN(CCCOC)S(=O)(=O)c2sc(cc12)S(=O)(=O)N 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 I12 compound treatment 16.1612 3.1557 0.8467 14.9102 1.5535 0.3681 0.859 0.9304 716 BPBio1_000540 CN(C)CCC=C1c2ccccc2C=Cc3ccccc13 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 I13 compound treatment 14.0582 1.0527 0.2825 15.1916 1.835 0.4348 0.5072 0.9782 1000229 BPBio1_000541 Nc1c(Br)cc(Br)cc1CN[C@H]2CC[C@H](O)CC2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 I14 compound treatment 10.7403 -2.2652 -0.6078 12.4633 -0.89338 -0.2117 -0.5795 -0.9003 1300555 BPBio1_000542 CC(C)(C)NCC(O)COc1cccc2NC(=O)CCc12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 I15 compound treatment 20.2032 7.1977 1.9313 33.126 19.769 4.6841 4.6778 0.9233 705 BPBio1_000543 CC(Cc1cccc(c1)C(F)(F)F)NCCOC(=O)c2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 I16 compound treatment 16.0438 3.0382 0.8152 18.7177 5.361 1.2702 1.4746 0.977 2080102 BPBio1_000544 C[C@@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@]34C)[C@@H]2CC[C@]1(O)C(=O)CO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 I17 compound treatment 35.7387 22.733 6.0999 34.9934 21.637 5.1265 7.9383 0.9963 1000048 BPBio1_000545 CC(C)COCC(CN(Cc1ccccc1)c2ccccc2)N3CCCC3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 I18 compound treatment 18.1675 5.162 1.3851 13.3842 0.027564 0.0065 0.984 0.7104 1190 BPBio1_000546 Nc1c2C(O)CCCc2nc3ccccc13 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 I19 compound treatment 10.9388 -2.0667 -0.5546 22.188 8.8313 2.0924 1.0875 0.5024 1504 BPBio1_000547 O=C1CC2(CCCC2)CC(=O)N1CCCCN3CCN(CC3)c4ncccn4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 I20 compound treatment 12.3158 -0.68974 -0.1851 15.3637 2.007 0.4755 0.2054 0.4025 992 BPBio1_000548 CC[C@H]1[C@@H](Cc2cncn2C)COC1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 I21 compound treatment 12.8633 -0.14225 -0.0382 15.3987 2.042 0.4838 0.3151 0.6493 2873 BPBio1_000549 CCc1oc2ccccc2c1C(=O)c3cc(Br)c(O)c(Br)c3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 I22 compound treatment 14.5621 1.5566 0.4177 14.9369 1.5802 0.3744 0.5601 0.9985 1265 BPBio1_000550 Cc1onc(c1C(=O)N[C@H]2[C@H]3SC(C)(C)[C@@H](N3C2=O)C(=O)O)c4c(Cl)cccc4Cl 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 I23 mock treatment 12.8807 -0.12483 -0.0335 14.9258 1.5691 0.3718 0.2392 0.6408 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 I24 mock treatment 11.3325 -1.673 -0.4489 11.5482 -1.8085 -0.4285 -0.6204 -0.9997 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 J01 compound treatment 12.4228 -0.5827 -0.1564 11.6464 -1.7102 -0.4052 -0.3971 -0.9143 3177404 BPBio1_000551 CNc1cc(NS(=O)(=O)c2ccc(N)cc2)nc(NC)n1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 J02 compound treatment 23.7439 10.738 2.8814 15.2828 1.9262 0.4564 2.3602 0.809 3560381 BPBio1_000552 NCCCP(=O)(O)CC1CCCCC1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 J03 compound treatment 13.3078 0.30222 0.0811 15.3562 1.9996 0.4738 0.3923 0.8163 821975 BPBio1_000553 C[C@H](CCC(=O)NCC(=O)O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3C[C@H](O)[C@]12C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 J04 compound treatment 102.7284 89.723 24.075 119.7418 106.39 25.2064 34.8472 0.9997 3616753 BPBio1_000554 COc1ccc2C[C@@H]3N(CCc4cc(OC)c(O)cc34)Cc2c1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 J05 compound treatment 94.8524 81.847 21.9616 20.2339 6.8773 1.6295 16.6814 0.7575 3616742 BPBio1_000555 CCC(C)[C@@H]1N[C@@H]2C=Cc3c(cc(nc3[C@H]2O)C(=O)O[C@H](C)[C@@H]4NC(=O)c5csc(n5)[C@@H](NC(=O)[C@H]6CSC(=N6)/C(=C\C)/NC(=O)[C@@H](NC(=O)c7csc(n7)[C@]8(CCC(=N[C@H]8c9csc4n9)c%10nc(cs%10)C(=O)NC(=C)C(=O)NC(=C)C(=O)N)NC(=O)[C@H](C)NC(=O)C(=C)NC(=O)[C@H](C)NC1=O)[C@@H](C)O)[C@@](C)(O)[C@@H](C)O)[C@H](C)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 J06 compound treatment 15.8307 2.8252 0.7581 11.5934 -1.7632 -0.4178 0.2406 0.278 3616754 BPBio1_000556 CC[C@@H]1[C@@H](O)N2[C@@H]3CC45[C@H](O)C3C1C[C@H]2[C@@H]5N(C)c6ccccc64 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 J07 compound treatment 15.0897 2.0842 0.5592 12.6159 -0.74071 -0.1755 0.2713 0.4629 3177255 BPBio1_000557 CS(=N)(=O)CC[C@H](N)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 J08 compound treatment 13.7477 0.74215 0.1991 21.6933 8.3367 1.9753 1.5375 0.7745 1539 BPBio1_000558 C[C@H]1C(=O)O[C@@H]2CCN3CC=C(COC(=O)[C@](C)(O)[C@]1(C)O)[C@H]23 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 J09 compound treatment 13.318 0.31252 0.0839 13.6957 0.33904 0.0803 0.1161 0.9998 737 BPBio1_000559 c1nc(cs1)c2nc3ccccc3[nH]2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 J10 compound treatment 42.6528 29.647 7.9551 30.2068 16.85 3.9924 8.4482 0.9492 3069522 BPBio1_000560 COc1cc(/C=C/C(=O)N2CCC=CC2=O)cc(OC)c1OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 J11 compound treatment 12.8169 -0.18863 -0.0506 14.708 1.3513 0.3202 0.1906 0.588 3189445 BPBio1_000561 CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C2=O)c4c(O)c(/C=N/N5CCN(C)CC5)c(NC(=O)/C(=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(=O)C)[C@@H]1C)/C)c(O)c4c(O)c3C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 J12 compound treatment 14.3256 1.32 0.3542 14.3428 0.98614 0.2337 0.4157 0.9796 3100 BPBio1_000562 COc1c2OCOc2cc3CCN(C)Cc13 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 J13 compound treatment 11.3255 -1.68 -0.4508 14.5197 1.1631 0.2756 -0.1239 -0.2345 803 BPBio1_000563 CCc1cc(ccn1)C(=S)N 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 J14 compound treatment 14.9646 1.959 0.5257 14.0067 0.65001 0.154 0.4806 0.8774 1000122 BPBio1_000564 O[C@@H]([C@@H]1C[C@@H]2CCN1C[C@@H]2C=C)c3ccnc4ccccc34 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 J15 compound treatment 10.2925 -2.713 -0.728 15.1081 1.7515 0.415 -0.2213 -0.2641 900 BPBio1_000565 CN1C(=C(O)c2sccc2S1(=O)=O)C(=O)Nc3ccccn3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 J16 compound treatment 41.5029 28.497 7.6466 23.0387 9.6821 2.294 7.0291 0.8805 1039 BPBio1_000566 CC[C@]1(CCCN2CCc3c4[C@@H]21)CC(=O)n4c5ccccc35 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 J17 compound treatment 11.9899 -1.0156 -0.2725 12.9988 -0.35781 -0.0848 -0.2526 -0.8852 3068731 BPBio1_000567 CC(=O)Oc1cc(ccc1C(=O)O)C(F)(F)F 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 J18 compound treatment 12.923 -0.082576 -0.0222 17.114 3.7574 0.8903 0.6138 0.6893 2082296 BPBio1_000568 O[C@H]([C@H]1C[C@@H]2CCN1C[C@@H]2C=C)c3ccnc4ccccc34 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 J19 compound treatment 13.0952 0.089642 0.0241 14.4055 1.0488 0.2485 0.1927 0.7719 4379 BPBio1_000569 CN1CCCCC1CCN2c3ccccc3Sc4ccc(cc24)S(=O)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 J20 compound treatment 11.8358 -1.1698 -0.3139 15.401 2.0444 0.4844 0.1206 0.2089 994 BPBio1_000570 N[C@@H](CCONC(=N)N)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 J21 compound treatment 14.1024 1.0968 0.2943 13.8302 0.47356 0.1122 0.2875 0.9126 1470254 BPBio1_000571 Cc1c(C)c2OC(C)(CCc2c(C)c1O)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 J22 compound treatment 14.9258 1.9203 0.5153 17.4756 4.119 0.9759 1.0544 0.9554 1530 BPBio1_000572 COc1ccc2c3CCN=C(C)c3[nH]c2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 J23 mock treatment 13.2043 0.19877 0.0533 14.7966 1.4399 0.3412 0.279 0.8078 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 J24 mock treatment 14.7171 1.7116 0.4593 14.8925 1.5358 0.3639 0.5821 0.9934 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 K01 compound treatment 13.2954 0.2899 0.0778 18.5369 5.1802 1.2274 0.9229 0.7504 3561678 BPBio1_000573 COc1cc(COc2cc(N)c(Cl)cc2C(=O)CCC3CCN(CCNS(=O)(=O)C)CC3)cc(OC)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 K02 compound treatment 13.4836 0.47808 0.1283 21.5049 8.1483 1.9306 1.4559 0.7524 907505 BPBio1_000574 CCN(CC)CCOC(=O)c1cc(Cl)c(N)cc1OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 K03 compound treatment 11.4696 -1.5359 -0.4121 12.6309 -0.72579 -0.172 -0.413 -0.9249 771 BPBio1_000575 CN1CCC(=C2c3ccsc3C(=O)Cc4ccccc24)CC1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 K04 compound treatment 12.9642 -0.041341 -0.0111 17.0653 3.7087 0.8787 0.6135 0.6981 1055159 BPBio1_000576 NC(CC(=O)c1cccc(O)c1N)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 K05 compound treatment 11.0625 -1.9431 -0.5214 14.3954 1.0388 0.2461 -0.1946 -0.3376 907283 BPBio1_000577 NC(=N)N1CCc2ccccc2C1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 K06 compound treatment 10.8588 -2.1468 -0.576 10.6372 -2.7195 -0.6443 -0.8629 -0.9984 3189433 BPBio1_000578 OC[C@@H](O)[C@@H](O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O)[C@H](O)[C@@H](O)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 K07 compound treatment 13.7501 0.74452 0.1998 11.3652 -1.9914 -0.4718 -0.1924 -0.3755 1000064 BPBio1_000579 CN(Cc1cnc2nc(N)nc(N)c2n1)c3ccc(cc3)C(=O)NC(CCC(=O)O)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 K08 compound treatment 13.1019 0.096399 0.0259 14.1945 0.83784 0.1985 0.1587 0.7925 3616708 BPBio1_000580 COC1=C[C@H]2[C@H](C3=C2c4c(OC)c(OC)c(OC)cc4CC[C@@H]3NC(=O)C)C1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 K09 compound treatment 13.2631 0.25757 0.0691 13.1105 -0.24611 -0.0583 0.0076 0.0845 991 BPBio1_000581 CC[C@@H](CO)NC(=O)[C@H]1CN(C)[C@@H]2Cc3c[nH]c4cccc(C2=C1)c34 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 K10 compound treatment 12.5734 -0.43218 -0.116 15.3695 2.0128 0.4769 0.2552 0.52 1134 BPBio1_000582 CN1C[C@H](CO)C=C2[C@H]1Cc3c[nH]c4cccc2c34 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 K11 compound treatment 34.5363 21.531 5.7773 29.1413 15.785 3.7399 6.7297 0.9778 1496 BPBio1_000583 CSc1ccc2Sc3ccccc3CC(N4CCN(C)CC4)c2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 K12 compound treatment 18.1657 5.1602 1.3846 14.4445 1.0878 0.2577 1.1613 0.8246 3174101 BPBio1_000584 CN1CCc2c(C1)c3ccccc3n2Cc4ccccc4.OS(=O)(=O)c1cccc2c(cccc12)S(=O)(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 K13 compound treatment 15.7531 2.7475 0.7372 14.7747 1.418 0.336 0.7589 0.9367 3068886 BPBio1_000585 CC(C)/N=c/1\cc2n(c3ccc(Cl)cc3)c4ccccc4nc2cc1Nc5ccc(Cl)cc5 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 K14 compound treatment 13.1755 0.16997 0.0456 12.4873 -0.86931 -0.206 -0.1134 -0.5375 3616712 BPBio1_000586 CN(C)[C@H]1[C@@H]2[C@@H](O)C3C(=C)c4c(Cl)ccc(O)c4C(=O)C3=C(O)[C@]2(O)C(=O)C(=C1O)C(=O)N.OC(=O)c1cc(ccc1O)S(=O)(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 K15 compound treatment 12.5245 -0.48103 -0.1291 14.9667 1.6101 0.3815 0.1785 0.4432 975 BPBio1_000587 CCN(CC)CCOC(=O)C(CC1CCCO1)Cc2cccc3ccccc23 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 K16 compound treatment 15.1116 2.106 0.5651 12.6883 -0.66836 -0.1584 0.2876 0.4901 1035 BPBio1_000588 Cc1cccc(CN2CCN(CC2)C(c3ccccc3)c4ccc(Cl)cc4)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 K17 compound treatment 11.2524 -1.7531 -0.4704 11.2554 -2.1012 -0.4978 -0.6847 -0.9996 1000105 BPBio1_000589 CC(C)(Oc1ccc(CCNC(=O)c2ccc(Cl)cc2)cc1)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 K18 compound treatment 13.2515 0.246 0.066 15.2895 1.9328 0.458 0.3705 0.8008 988 BPBio1_000590 COc1ccc2[nH]cc(CCNC(=O)C)c2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 K19 compound treatment 11.1063 -1.8993 -0.5096 14.1335 0.77689 0.1841 -0.2302 -0.4248 341 BPBio1_000591 N[C@@H](Cn1ccc(=O)c(O)c1)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 K20 compound treatment 65.6589 52.653 14.1283 62.3606 49.004 11.6108 18.2002 0.9953 449 BPBio1_000592 CC1=CC(=O)c2ccccc2C1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 K21 compound treatment 13.1054 0.099924 0.0268 13.2791 -0.077539 -0.0184 0.006 0.1836 2777 BPBio1_000593 COc1cc(N)c(Cl)cc1C(=O)NC2CCN(Cc3ccccc3)CC2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 K22 compound treatment 12.26 -0.74548 -0.2 14.7459 1.3892 0.3292 0.0913 0.237 3069122 BPBio1_000594 CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)C[C@H](O)[C@@H]1C/C=C\CCCC(=O)O.COC(N)(CO)CO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 K23 mock treatment 11.4309 -1.5746 -0.4225 16.3751 3.0184 0.7152 0.2069 0.2491 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 K24 mock treatment 14.3952 1.3896 0.3729 15.1004 1.7438 0.4132 0.5558 0.9987 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 L01 compound treatment 14.8629 1.8573 0.4984 15.2763 1.9196 0.4548 0.674 0.999 907368 BPBio1_000595 CC(C)n1cc2C[C@@H]3[C@H](C[C@H](CN3C)C(=O)OC(C)C(C)O)c4cccc1c24 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 L02 compound treatment 21.2179 8.2123 2.2036 12.2813 -1.0753 -0.2548 1.378 0.6212 3614707 BPBio1_000596 CCOC(OCC)P(=O)(O)CCCNCc1ccc(Cl)c(Cl)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 L03 compound treatment 15.0741 2.0685 0.555 16.8638 3.5072 0.831 0.9801 0.9808 907463 BPBio1_000597 Cc1nc2ccccn2c(=O)c1CCN3CCC(CC3)C(=O)c4ccc(F)cc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 L04 compound treatment 63.1942 50.189 13.4669 57.0156 43.659 10.3443 16.8371 0.9915 1578 BPBio1_000598 CC1=NCCc2c1[nH]c3cc(O)ccc23 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 L05 compound treatment 16.28 3.2745 0.8786 12.2891 -1.0675 -0.2529 0.4424 0.4839 1024517 BPBio1_000599 COc1cc2CCNC(C)c2cc1OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 L06 compound treatment 9.5433 -3.4622 -0.929 11.5564 -1.8003 -0.4265 -0.9585 -0.9377 1043296 BPBio1_000600 Cc1nccc2c3ccc(O)cc3[nH]c12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 L07 compound treatment 14.8871 1.8816 0.5049 11.3876 -1.9691 -0.4665 0.0271 0.0394 1193 BPBio1_000601 CCOc1ccc(NC(=O)C)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 L08 compound treatment 10.7168 -2.2887 -0.6141 14.0558 0.69911 0.1656 -0.3171 -0.4986 297849 BPBio1_000602 COc1ccc2c(c1)[nH]c3c(C)nccc23 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 L09 compound treatment 34.7542 21.749 5.8357 19.4751 6.1184 1.4497 5.1515 0.8567 3474094 BPBio1_000603 OC1=C(C2CCC(CC2)c3ccc(Cl)cc3)C(=O)c4ccccc4C1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 L10 compound treatment 285.236 272.23 73.0464 121.3132 107.96 25.5787 69.7385 0.9011 2057 BPBio1_000604 Cc1c2[nH]c3ccccc3c2c(C)c4cnccc14 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 L11 compound treatment 11.5563 -1.4492 -0.3889 14.892 1.5353 0.3638 -0.0177 -0.0333 3058468 BPBio1_000605 COc1ccc(OC)c(c1)C(O)C(C)N 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 L12 compound treatment 116.6825 103.68 27.8192 28.4094 15.053 3.5665 22.1931 0.7913 3069524 BPBio1_000606 O=C1C=CC(=O)c2c1ccc3c2ccc4ccccc43 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 L13 compound treatment 12.5063 -0.49923 -0.134 15.7566 2.4 0.5686 0.3074 0.5261 1001857 BPBio1_000607 CC(C)NC[C@@H](O)COc1ccc(CC(=O)N)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 L14 compound treatment 10.7824 -2.2232 -0.5965 13.1535 -0.20316 -0.0481 -0.4558 -0.7617 3616759 BPBio1_000608 CN(CCCCCCCCCCN(C)C(=O)Oc1cccc(c1)[N+](C)(C)C)C(=O)Oc2cccc(c2)[N+](C)(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 L15 compound treatment 12.0722 -0.93336 -0.2504 13.0068 -0.34987 -0.0829 -0.2357 -0.8935 904 BPBio1_000609 NC(=O)CN1CCCC1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 L16 compound treatment 10.9796 -2.026 -0.5436 13.2739 -0.082741 -0.0196 -0.3983 -0.7321 1494 BPBio1_000610 C1CN(CCN1)c2ccc3ccccc3n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 L17 compound treatment 11.0851 -1.9204 -0.5153 16.8263 3.4697 0.8221 0.2169 0.2236 948 BPBio1_000611 O=C1C(C(=O)c2ccccc12)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 L18 compound treatment 14.4821 1.4765 0.3962 14.6766 1.32 0.3128 0.5013 0.9931 3616761 BPBio1_000612 C1CCN2C[C@@H]3C[C@@H](CN4CCCC[C@H]34)[C@@H]2C1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 L19 compound treatment 12.9057 -0.099876 -0.0268 12.4766 -0.88004 -0.2085 -0.1664 -0.7915 3189446 BPBio1_000613 COc1c(O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)cc3CCC(NC(=O)C)c4cc(=O)c(SC)ccc4-c3c1OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 L20 compound treatment 17.0296 4.0241 1.0798 17.5894 4.2327 1.0029 1.4727 0.9993 3043 BPBio1_000614 C[C@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(OC(=O)C)C(=O)COC(=O)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 L21 compound treatment 14.2157 1.2102 0.3247 12.5591 -0.79754 -0.189 0.096 0.2555 3068774 BPBio1_000615 Nc1cc(C(=C(Cl)Cl)Cl)c(cc1S(=O)(=O)N)S(=O)(=O)N 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 L22 compound treatment 14.5805 1.5749 0.4226 13.6122 0.25556 0.0606 0.3416 0.8003 1035065 BPBio1_000616 Cc1nccc2c3ccccc3[nH]c12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 L23 mock treatment 14.6133 1.6078 0.4314 12.1983 -1.1584 -0.2745 0.111 0.2171 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 L24 mock treatment 8.9531 -4.0524 -1.0874 12.884 -0.47267 -0.112 -0.8481 -0.7758 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 M01 compound treatment 12.2305 -0.77502 -0.208 11.6264 -1.7303 -0.41 -0.4369 -0.9505 3060500 BPBio1_000617 O=C(OCCN1CCCCC1)c2c[nH]c3ccccc23 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 M02 compound treatment 15.2077 2.2022 0.5909 14.0243 0.66761 0.1582 0.5297 0.8659 1761 BPBio1_000618 CN1C2CCC1CC(C2)OC(=O)c3c[nH]c4ccccc34 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 M03 compound treatment 21.5526 8.5471 2.2934 28.1702 14.814 3.5099 4.1035 0.9787 907366 BPBio1_000619 Cc1cccc(C)c1NC(=O)CN2CCN(CCCC(c3ccc(F)cc3)c4ccc(F)cc4)CC2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 M04 compound treatment 14.31 1.3044 0.35 14.3848 1.0281 0.2436 0.4197 0.9843 2830 BPBio1_000620 Clc1ccc2n(C3CCN(CCCn4c(=O)[nH]c5ccccc45)CC3)c(=O)[nH]c2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 M05 compound treatment 10.5748 -2.4307 -0.6522 21.4112 8.0546 1.9084 0.8883 0.4404 3480396 BPBio1_000621 CC(C)NCC(O)COc1ccc(CCOCC2CC2)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 M06 compound treatment 14.7356 1.73 0.4642 14.2383 0.88164 0.2089 0.476 0.935 3616717 BPBio1_000622 Nc1nc(cs1)/C(=N/OCC(=O)O)/C(=O)N[C@H]2[C@H]3SCC(=C(N3C2=O)C(=O)O)C=C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 M07 compound treatment 10.0405 -2.9651 -0.7956 10.8054 -2.5513 -0.6045 -0.99 -0.9908 86 BPBio1_000623 COC(=O)C1=C(C)NC(=C(C1c2cccc(c2)[N+](=O)[O-])C(=O)OCCN(C)Cc3ccccc3)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 M08 compound treatment 12.0387 -0.96683 -0.2594 12.4669 -0.88971 -0.2108 -0.3325 -0.9947 3616719 BPBio1_000624 CN(C(=O)C)c1c(I)c(NC(=O)C)c(I)c(C(=O)N[C@H]2C(O)O[C@H](CO)[C@@H](O)[C@@H]2O)c1I 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 M09 compound treatment 13.053 0.047449 0.0127 11.8264 -1.5302 -0.3626 -0.2474 -0.6819 1210 BPBio1_000625 CC(C)(C)c1cc(SC(C)(C)Sc2cc(c(O)c(c2)C(C)(C)C)C(C)(C)C)cc(c1O)C(C)(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 M10 compound treatment 12.6958 -0.30972 -0.0831 13.5009 0.14426 0.0342 -0.0346 -0.385 3616721 BPBio1_000626 C[C@@H](O[C@H]1[C@H](O)[C@@H](CO)O[C@H](O)[C@@H]1NC(=O)C)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 M11 compound treatment 15.2949 2.2893 0.6143 22.7599 9.4032 2.228 2.0098 0.8696 1135 BPBio1_000627 OCCNCCNc1ccc(NCCNCCO)c2C(=O)c3c(O)ccc(O)c3C(=O)c12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 M12 compound treatment 11.8555 -1.1501 -0.3086 17.53 4.1733 0.9888 0.481 0.4643 2181 BPBio1_000628 Oc1cc(O)c2c(=O)c(O)c(oc2c1)c3cc(O)c(O)c(O)c3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 M13 compound treatment 45.166 32.16 8.6295 29.8774 16.521 3.9143 8.8698 0.9361 907273 BPBio1_000629 Fc1ccc(cc1)C(OCCN2CCN(CCCc3ccccc3)CC2)c4ccc(F)cc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 M14 compound treatment 12.2591 -0.74645 -0.2003 16.4981 3.1414 0.7443 0.3847 0.4991 1733214 BPBio1_000630 Oc1ccc(cc1)C2CC(=O)c3c(O)cc(O)cc3O2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 M15 compound treatment 13.3679 0.3624 0.0972 13.5816 0.22494 0.0533 0.1064 0.9599 990 BPBio1_000631 CCN(CC)CCOCCOC(=O)C1(CCCC1)c2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 M16 compound treatment 11.1566 -1.8489 -0.4961 16.747 3.3904 0.8033 0.2172 0.2301 895 BPBio1_000632 C[C@@H]1O[C@@H](O[C@@H]2[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]2Oc3cc(O)c4C(=O)C[C@H](Oc4c3)c5ccc(O)cc5)[C@H](O)[C@H](O)[C@H]1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 M17 compound treatment 19.6074 6.6018 1.7714 12.3431 -1.0136 -0.2402 1.0828 0.6057 1351 BPBio1_000633 Cc1cc(N)c2ccccc2[n+]1CCCCCCCCCC[n+]3c(C)cc(N)c4ccccc34 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 M18 compound treatment 13.247 0.24147 0.0648 12.1212 -1.2354 -0.2927 -0.1612 -0.5376 822 BPBio1_000634 CN(C)C(=O)Oc1cccc(c1)[N+](C)(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 M19 compound treatment 12.6016 -0.4039 -0.1084 13.3495 -0.0071138 -0.0017 -0.0778 -0.718 3060108 BPBio1_000635 CC(=O)N1CCN(CC1)c2ccc(OC[C@H]3CO[C@@](Cn4ccnc4)(O3)c5ccc(Cl)cc5Cl)cc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 M20 compound treatment 15.7527 2.7471 0.7371 13.0612 -0.29546 -0.07 0.4717 0.6371 1067495 BPBio1_000636 [O-][N+](=O)c1cnc(s1)N2CCNC2=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 M21 compound treatment 13.0542 0.048674 0.0131 13.6515 0.29484 0.0699 0.0586 0.825 3616670 BPBio1_000637 C[C@@H]1[C@H](O)CC[C@@]2(C)C1CC[C@@]3(C)[C@H]2[C@H](O)C[C@H]4/C(=C(\CCC=C(C)C)/C(=O)O)/[C@H](C[C@@]43C)OC(=O)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 M22 compound treatment 11.6582 -1.3473 -0.3615 14.1832 0.82659 0.1958 -0.1171 -0.2849 3069161 BPBio1_000638 NCc1ccccc1CC(=O)N[C@H]2[C@H]3SCC(=C(N3C2=O)C(=O)O)CSc4nnnn4CC(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 M23 mock treatment 12.7881 -0.21748 -0.0584 14.8957 1.539 0.3647 0.2166 0.5865 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 M24 mock treatment 10.7503 -2.2552 -0.6051 10.261 -3.0957 -0.7335 -0.9465 -0.9954 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 N01 compound treatment 13.3702 0.3647 0.0979 14.2147 0.85801 0.2033 0.2129 0.9438 2079 BPBio1_000639 NC1CC(=CC=C1)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 N02 compound treatment 13.8762 0.8707 0.2336 14.7265 1.3699 0.3246 0.3947 0.987 3614708 BPBio1_000640 C[C@H](NC[C@H](O)CP(=O)(O)CC1CCCCC1)c2ccc(Cl)c(Cl)c2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 N03 compound treatment 17.592 4.5864 1.2307 16.7567 3.4001 0.8056 1.4399 0.9789 1309 BPBio1_000641 Cc1cc(C2CCCCC2)n(O)c(=O)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 N04 compound treatment 17.0278 4.0222 1.0793 14.0159 0.65926 0.1562 0.8736 0.8011 1048750 BPBio1_000642 COc1ccc2[nH]c3C(=NCCc3c2c1)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 N05 compound treatment 16.7299 3.7244 0.9994 17.3134 3.9567 0.9375 1.3696 0.9995 722 BPBio1_000643 CCCN(CCC)S(=O)(=O)c1ccc(cc1)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 N06 compound treatment 17.4298 4.4243 1.1872 17.226 3.8693 0.9168 1.4877 0.9918 3069526 BPBio1_000644 C[N+]1(C)CCC[C@H]1C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 N07 compound treatment 17.0779 4.0723 1.0927 15.2498 1.8932 0.4486 1.0898 0.9227 1213 BPBio1_000645 CNCCc1ccccn1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 N08 compound treatment 11.8206 -1.1849 -0.3179 16.8855 3.5288 0.8361 0.3664 0.4096 2709 BPBio1_000646 Cc1ncc(CO)c(CO)c1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 N09 compound treatment 14.2581 1.2525 0.3361 17.1875 3.8308 0.9077 0.8795 0.9086 3177389 BPBio1_000647 NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](N)C[C@@H]1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 N10 compound treatment 12.328 -0.67752 -0.1818 15.1082 1.7516 0.415 0.1649 0.364 3560436 BPBio1_000648 O=c1cccc2[C@H]3CNC[C@H](C3)Cn21 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 N11 compound treatment 13.007 0.0014493 4.0E-4 14.5729 1.2163 0.2882 0.204 0.7081 1000096 BPBio1_000649 C1CN2CC(N=C2S1)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 N12 compound treatment 12.3324 -0.67313 -0.1806 13.8901 0.53341 0.1264 -0.0383 -0.174 1039072 BPBio1_000650 CN1C2CCCC1CC(=O)C2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 N13 compound treatment 12.5385 -0.46706 -0.1253 15.5673 2.2106 0.5238 0.2817 0.5231 3068775 BPBio1_000651 CC(=O)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 N14 compound treatment 13.455 0.44942 0.1206 18.8424 5.4857 1.2998 1.0043 0.7694 3189579 BPBio1_000652 CC(=O)SCC(Cc1ccccc1)C(=O)NCC(=O)OCc2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 N15 compound treatment 10.2265 -2.7791 -0.7457 12.4749 -0.88176 -0.2089 -0.675 -0.8717 3616743 BPBio1_000653 CCOC(=O)/N=c\1/c[n+]([n-]o1)N2CCOCC2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 N16 compound treatment 11.42 -1.5855 -0.4254 11.9336 -1.423 -0.3372 -0.5392 -0.9934 1117 BPBio1_000654 Nc1nc(=O)c2nc(CNc3ccc(cc3)C(=O)N[C@@H](CCC(=O)O)C(=O)O)cnc2[nH]1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 N17 compound treatment 13.3651 0.35952 0.0965 19.1284 5.7717 1.3675 1.0352 0.7551 1000114 BPBio1_000655 CCN(CC)CCCC(C)Nc1ccnc2cc(Cl)ccc12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 N18 compound treatment 14.2324 1.2269 0.3292 14.9159 1.5592 0.3694 0.494 0.9983 3189580 BPBio1_000656 C[C@@H]1NCCc2cc(O)c(O)cc12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 N19 compound treatment 12.3557 -0.64986 -0.1744 12.3923 -0.96439 -0.2285 -0.2849 -0.9911 1365793 BPBio1_000657 COc1ccc(CN2CCNCC2)c(OC)c1OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 N20 compound treatment 15.3316 2.326 0.6241 13.797 0.44036 0.1043 0.5151 0.814 1014994 BPBio1_000658 CN(C)Cc1c[nH]c2ccccc12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 N21 compound treatment 45.4382 32.433 8.7025 41.5316 28.175 6.6757 10.874 0.9914 3103826 BPBio1_000659 C/C/1=C\CC[C@@]2(C)O[C@@H]2[C@H]3OC(=O)C(=C)[C@@H]3CC1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 N22 compound treatment 17.5366 4.531 1.2158 16.1414 2.7847 0.6598 1.3262 0.9588 3189581 BPBio1_000660 CCCCc1cc2ccccc2c(OCCN(C)C)n1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 N23 mock treatment 13.9708 0.96531 0.259 14.1923 0.83564 0.198 0.3232 0.9912 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 N24 mock treatment 14.6597 1.6542 0.4439 12.8409 -0.51579 -0.1222 0.2274 0.494 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 O01 compound treatment 33.5809 20.575 5.5209 24.1019 10.745 2.5459 5.7041 0.9382 1393 BPBio1_000661 CN(C)CCCN1c2ccccc2CCc3ccc(Cl)cc13 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 O02 compound treatment 13.6152 0.60967 0.1636 12.8549 -0.50174 -0.1189 0.0316 0.1563 3177047 BPBio1_000662 CCCN(CCC)CCc1c[nH]c2ccc(cc12)C(=O)N 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 O03 compound treatment 15.8766 2.8711 0.7704 17.2404 3.8838 0.9202 1.1954 0.9961 743 BPBio1_000663 CC(C)(C)NCC(O)c1cc(O)cc(O)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 O04 compound treatment 23.4186 10.413 2.7941 25.0473 11.691 2.7699 3.9343 1.0 1000325 BPBio1_000664 C[C@@H]1O[C@@H](O[C@H]2C[C@@H](O)[C@]3(CO)[C@H]4[C@H](O)C[C@]5(C)[C@H](CC[C@]5(O)[C@@H]4CC[C@]3(O)C2)C6=CC(=O)OC6)[C@H](O)[C@H](O)[C@H]1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 O05 compound treatment 18.1555 5.15 1.3819 15.352 1.9954 0.4728 1.3114 0.8979 3616672 BPBio1_000665 O[C@H]([C@@H](O)C(=O)O)C(=O)O.Fc1ccc(cc1)C(=O)C2CCN(CCn3c(=O)[nH]c4ccccc4c3=O)CC2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 O06 compound treatment 14.1859 1.1804 0.3167 16.1707 2.8141 0.6668 0.6954 0.9421 3616726 BPBio1_000666 CC(C)(CO)C(O)C(=O)NCCC(=O)O[Ca]OC(=O)CCNC(=O)C(O)C(C)(C)CO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 O07 compound treatment 13.2931 0.28754 0.0772 18.3501 4.9935 1.1831 0.8912 0.7516 907335 BPBio1_000667 C[N+]1(C)CCOC(O)(C1)c2ccc(cc2)c3ccc(cc3)C4(O)C[N+](C)(C)CCO4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 O08 compound treatment 11.9035 -1.102 -0.2957 16.142 2.7853 0.6599 0.2576 0.3561 3189436 BPBio1_000668 CO[C@]1(NC(=O)C2SC(=C(C(=O)N)C(=O)O)S2)[C@H]3SCC(=C(N3C1=O)C(=O)O)CSc4nnnn4C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 O09 compound treatment 15.0319 2.0264 0.5437 15.4395 2.0829 0.4935 0.7334 0.9988 698 BPBio1_000669 NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 O10 compound treatment 19.3512 6.3457 1.7027 13.3231 -0.033526 -0.0079 1.1984 0.7038 1534 BPBio1_000670 O=C(/C=C/C=C/c1ccc2OCOc2c1)N3CCCCC3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 O11 compound treatment 12.9937 -0.011876 -0.0032 13.2826 -0.074039 -0.0175 -0.0147 -0.8221 3616675 BPBio1_000671 NCC[C@H](O)C(=O)N[C@@H]1C[C@H](N)[C@@H](O[C@H]2O[C@H](CN)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 O12 compound treatment 12.3874 -0.61812 -0.1659 16.1424 2.7858 0.66 0.3494 0.5135 1537011 BPBio1_000672 CN(C)CCC(c1ccc(Br)cc1)c2ccccn2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 O13 compound treatment 22.2642 9.2587 2.4843 27.7214 14.365 3.4035 4.1633 0.988 3616678 BPBio1_000673 COc1cc(cc(OC)c1O)[C@H]2[C@@H]3[C@H](COC3=O)[C@H](O[C@@H]4O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]4O)c6cc7OCOc7cc26 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 O14 compound treatment 16.4388 3.4333 0.9212 16.4655 3.1089 0.7366 1.1723 0.9939 2551 BPBio1_000674 COc1cc(NC(C)CCCN)c2ncccc2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 O15 compound treatment 36.9699 23.964 6.4303 25.8167 12.46 2.9522 6.6344 0.9376 3068926 BPBio1_000675 CCN(CC)CCOc1ccc(cc1)/C(=C(/Cl)\c2ccccc2)/c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 O16 compound treatment 12.1927 -0.81279 -0.2181 14.1594 0.80274 0.1902 -0.0197 -0.0682 1072 BPBio1_000676 CC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 O17 compound treatment 13.1235 0.11797 0.0317 13.1078 -0.24884 -0.059 -0.0193 -0.2885 3616680 BPBio1_000677 CN1CCCN=C1/C=C/c2cccc(O)c2.OC(=O)c1c(O)cc2ccccc2c1Cc3c(C(=O)O)c(O)cc4ccccc34 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 O18 compound treatment 21.9392 8.9336 2.3971 26.4308 13.074 3.0977 3.8855 0.992 3480329 BPBio1_000678 CCOC(=O)C1=C(C)NC(=C(C1c2cccc(Cl)c2Cl)C(=O)OC)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 O19 compound treatment 13.5084 0.50287 0.1349 14.9968 1.6402 0.3886 0.3702 0.8999 1041 BPBio1_000679 CN1CCN(CCCN2c3ccccc3Sc4ccc(Cl)cc24)CC1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 O20 compound treatment 12.0387 -0.96687 -0.2594 15.4977 2.1411 0.5073 0.1753 0.3076 1362 BPBio1_000680 COc1c2occc2cc3ccc(=O)oc13 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 O21 compound treatment 11.4231 -1.5824 -0.4246 14.5467 1.1901 0.282 -0.1009 -0.1979 3075213 BPBio1_000681 COc1ccc(cc1O)[C@@H]2CC(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3O2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 O22 compound treatment 40.5229 27.517 7.3836 39.2832 25.927 6.1429 9.5647 0.9958 3616730 BPBio1_000682 COc1ccc(C[C@H](N)C(=O)N[C@H]2[C@@H](O)[C@@H](O[C@@H]2CO)n3cnc4c(ncnc34)N(C)C)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 O23 mock treatment 11.6081 -1.3975 -0.375 12.8292 -0.52746 -0.125 -0.3535 -0.8944 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 O24 mock treatment 17.0001 3.9945 1.0718 15.968 2.6114 0.6187 1.1954 0.9659 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 P01 compound treatment 16.8454 3.8399 1.0303 16.6049 3.2483 0.7696 1.2728 0.9897 3061087 BPBio1_000683 NC/C=C/C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 P02 compound treatment 17.416 4.4105 1.1835 14.0915 0.73486 0.1741 0.9599 0.8025 3614710 BPBio1_000684 C[C@H](NC[C@H](O)CP(=O)(O)Cc1ccccc1)c2ccc(Cl)c(Cl)c2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 P03 compound treatment 34.3383 21.333 5.7241 32.9966 19.64 4.6534 7.338 0.9947 922 BPBio1_000685 CCCCC(CC)CN1CN(CC(CC)CCCC)CC(C)(N)C1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 P04 compound treatment 15.0175 2.012 0.5399 17.9073 4.5506 1.0782 1.1442 0.9489 3382 BPBio1_000686 Cc1c(CCO)sc[n+]1Cc2cnc(C)nc2N 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 P05 compound treatment 14.5785 1.573 0.4221 20.5526 7.1959 1.705 1.504 0.8563 2284 BPBio1_000687 C[C@H](Cc1ccccc1)N(C)CC#C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 P06 compound treatment 19.3331 6.3275 1.6978 17.4753 4.1187 0.9759 1.8906 0.9654 3487152 BPBio1_000688 CNCC(O)c1ccc(OC(=O)C(C)(C)C)c(OC(=O)C(C)(C)C)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 P07 compound treatment 13.6685 0.66295 0.1779 14.5355 1.1789 0.2793 0.3233 0.9763 1020 BPBio1_000689 NC(=N)c1ccc(OCCCCCOc2ccc(cc2)C(=N)N)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 P08 compound treatment 13.7456 0.74002 0.1986 15.317 1.9604 0.4645 0.4688 0.9281 2041 BPBio1_000690 OC(=O)CNC(=O)C(CS)Cc1ccccc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 P09 compound treatment 13.0915 0.085949 0.0231 14.2929 0.93626 0.2218 0.1732 0.7764 196 BPBio1_000691 Cc1ccc(cc1)S(=O)(=O)NC(=O)NN2CCCCCC2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 P10 compound treatment 14.9028 1.8972 0.5091 13.8527 0.49604 0.1175 0.4431 0.848 3211 BPBio1_000692 Cc1cc2nc3c(=O)[nH]c(=O)nc3n(C[C@H](O)[C@H](O)[C@H](O)CO)c2cc1C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 P11 compound treatment 12.962 -0.043498 -0.0117 15.0734 1.7168 0.4068 0.2794 0.6865 1931603 BPBio1_000693 Oc1ccc(cc1)C(=O)N/N=C/c2ccc(o2)[N+](=O)[O-] 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 P12 compound treatment 14.5393 1.5337 0.4115 21.4847 8.1281 1.9258 1.6528 0.8393 3189582 BPBio1_000694 CC[C@H]1CN2CCC1C[C@H]2[C@H](O)c3ccnc4ccc(OC)cc34 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 P13 compound treatment 14.7442 1.7387 0.4665 13.3392 -0.017439 -0.0041 0.327 0.7008 804 BPBio1_000695 COc1c(C)c2COC(=O)c2c(O)c1C/C=C(\C)/CCC(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 P14 compound treatment 10.8745 -2.131 -0.5718 15.0892 1.7325 0.4105 -0.1141 -0.162 824 BPBio1_000696 CC[C@]1(CCCN2CCc3c4[C@@H]21)C[C@@](O)(C(=O)OC)n4c5ccccc35 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 P15 compound treatment 9.9295 -3.0761 -0.8254 13.5052 0.14856 0.0352 -0.5587 -0.6763 1001314 BPBio1_000697 CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C)[C@](C)(O)C[C@@H](C)[C@@H]4N[C@@H](COCCOC)O[C@H]([C@H]4C)[C@]1(C)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 P16 compound treatment 11.0274 -1.9781 -0.5308 14.1889 0.8323 0.1972 -0.2359 -0.4166 3069528 BPBio1_000698 C/C=C\1/C[C@@H](C)[C@](O)(CO)C(=O)OCC2=CCN3CC[C@@H](OC1=O)[C@H]32 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 P17 compound treatment 12.4453 -0.56026 -0.1503 15.5761 2.2194 0.5259 0.2655 0.4855 3474312 BPBio1_000699 Cc1ccc(cc1)S(=O)(=O)NC(=O)NN2CC3CCCC3C2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 P18 compound treatment 15.5902 2.5846 0.6935 14.5098 1.1531 0.2732 0.6836 0.9171 3187609 BPBio1_000700 C[C@H]1[C@H]2CC[C@H]3[C@@H]4CC=C5C[C@H](CC[C@]5(C)[C@H]4CC[C@]23CN1C)N(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 P19 compound treatment 14.4329 1.4273 0.383 17.6172 4.2606 1.0095 0.9846 0.912 3060137 BPBio1_000701 COc1ccccc1N2CCN(CCCCNC(=O)c3ccc4ccccc4c3)CC2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 P20 compound treatment 11.8799 -1.1256 -0.302 16.451 3.0943 0.7332 0.3049 0.3845 3616767 BPBio1_000702 CC[C@@H](C)C(=O)O[C@H]1[C@H](O)[C@H]2[C@@H](CN3C[C@@H](C)CC[C@H]3[C@@]2(C)O)C4C[C@]5(O[C@]6(O)[C@H]7[C@@H](OC(=O)C)[C@@H](OC(=O)C)[C@H]5[C@@]41O)[C@@]7(C)CC[C@@H]6OC(=O)[C@](C)(O)CC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 P21 compound treatment 30.8779 17.872 4.7956 46.7368 33.38 7.9089 8.9835 0.9713 3616746 BPBio1_000703 CC(O)C(=O)C.CC(Cc1ccccc1)NCCC(c2ccccc2)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 P22 compound treatment 168.3326 155.33 41.6782 165.1089 151.75 35.9555 54.8953 0.9973 3616768 BPBio1_000704 C[C@H]1[C@H]2[C@H](C[C@H]3[C@@H]4CC=C5C[C@H](CC[C@]5(C)[C@H]4CC[C@]23C)O[C@@H]6O[C@H](CO)[C@H](O)[C@H](O[C@@H]7O[C@H](CO)[C@@H](O)[C@H](O)[C@H]7O)[C@H]6O[C@@H]8O[C@@H](C)[C@H](O)[C@@H](O)[C@H]8O)N9C[C@@H](C)CC[C@H]19 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 P23 mock treatment 10.1193 -2.8862 -0.7744 11.5795 -1.7771 -0.4211 -0.8454 -0.959 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2321 P24 mock treatment 10.5681 -2.4375 -0.654 12.857 -0.49968 -0.1184 -0.5462 -0.8218 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 A01 compound treatment 21.7623 7.9257 2.1267 14.2587 -0.23912 -0.0567 1.4637 0.688 3614712 BPBio1_000705 NCC(CS(=O)(=O)O)c1ccc(Cl)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 A02 compound treatment 16.5151 2.6785 0.7187 13.49 -1.0078 -0.2388 0.3393 0.4481 3198426 BPBio1_000706 NCC(CC(=O)O)c1ccc(Cl)s1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 A03 compound treatment 18.2938 4.4572 1.196 10.4744 -4.0234 -0.9533 0.1716 0.1122 3187611 BPBio1_000707 COc1cc(ccc1c2nc3ncccc3[nH]2)S(=O)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 A04 compound treatment 18.9384 5.1018 1.3689 13.8577 -0.64012 -0.1517 0.8607 0.6249 1606 BPBio1_000708 NS(=O)(=O)c1cc2c(NC(CSCC=C)NS2(=O)=O)cc1Cl 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 A05 compound treatment 17.0082 3.1716 0.851 15.7979 1.3001 0.308 0.8196 0.9056 1254 BPBio1_000709 O[C@H]1Cc2c(O)cc(O)cc2O[C@@H]1c3ccc(O)c(O)c3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 A06 compound treatment 15.0094 1.1728 0.3147 13.5979 -0.89989 -0.2132 0.0718 0.1888 1524 BPBio1_000710 CC(C)Nc1c(C)n(C)n(c2ccccc2)c1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 A07 compound treatment 25.1285 11.292 3.0299 20.0413 5.5435 1.3135 3.0712 0.93 3187612 BPBio1_000711 CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 A08 compound treatment 18.6728 4.8362 1.2977 13.8974 -0.60037 -0.1422 0.817 0.6258 883 BPBio1_000712 CC(Oc1ccccc1)C(=O)N[C@H]2[C@H]3SC(C)(C)[C@@H](N3C2=O)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 A09 compound treatment 15.8645 2.0279 0.5441 16.4041 1.9063 0.4517 0.7041 0.9957 3069530 BPBio1_000713 CC(=O)NC1CCSC1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 A10 compound treatment 17.3738 3.5372 0.9491 17.2996 2.8018 0.6639 1.1405 0.9847 887 BPBio1_000714 COc1ccc(NS(=O)(=O)c2ccc(N)cc2)nn1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 A11 compound treatment 21.2801 7.4435 1.9973 18.64 4.1422 0.9814 2.1063 0.9465 1000240 BPBio1_000715 CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)CC[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 A12 compound treatment 13.8536 0.017016 0.0046 10.8664 -3.6314 -0.8604 -0.6052 -0.7033 745 BPBio1_000716 CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 A13 compound treatment 23.7873 9.9507 2.67 25.1207 10.623 2.5169 3.6677 0.9996 3616769 BPBio1_000717 C[C@H]1O[C@H](C[C@H](O)[C@@H]1O)OC2CC[C@]3(C=O)[C@H]4CC[C@]5(C)[C@H](CC[C@]5(O)[C@@H]4CC[C@]3(O)C2)C6=CC(=O)OC6 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 A14 compound treatment 18.4012 4.5646 1.2248 14.1991 -0.29867 -0.0708 0.816 0.6651 3263 BPBio1_000718 CNC(C)(C)Cc1ccccc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 A15 compound treatment 17.7156 3.879 1.0408 15.4397 0.94191 0.2232 0.8938 0.8396 2060360 BPBio1_000719 C1CN=C(C1)c2cccnc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 A16 compound treatment 11.7232 -2.1134 -0.5671 12.717 -1.7808 -0.4219 -0.6993 -0.9894 3187750 BPBio1_000720 CC(C)C[C@@H]1N2C(=O)[C@](NC(=O)[C@H]3CN(C)[C@@H]4Cc5c[nH]c6cccc(C4=C3)c56)(O[C@@]2(O)[C@@H]7CCCN7C1=O)C(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 A17 compound treatment 16.6899 2.8533 0.7656 13.7734 -0.72439 -0.1716 0.42 0.5353 3069532 BPBio1_000721 C[N+]1(C)C[C@@H](O)C[C@H]1C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 A18 compound treatment 18.7164 4.8798 1.3094 17.6889 3.1911 0.7561 1.4605 0.9659 751 BPBio1_000722 COc1cc(NS(=O)(=O)c2ccc(N)cc2)nc(OC)n1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 A19 compound treatment 15.5925 1.7559 0.4712 18.4419 3.9441 0.9345 0.994 0.9497 946 BPBio1_000723 OCCNC(=O)Cn1ccnc1[N+](=O)[O-] 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 A20 compound treatment 16.4574 2.6208 0.7032 13.221 -1.2768 -0.3025 0.2833 0.3701 1146 BPBio1_000724 Nc1ccc(cc1)S(=O)(=O)N 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 A21 compound treatment 34.1846 20.348 5.4599 14.7879 0.29011 0.0687 3.9093 0.716 3616770 BPBio1_000725 NCCC(O)C(=O)N[C@@H]1C[C@H](N)[C@@H](OC2O[C@H](CN)[C@@H](O)[C@H](O)[C@H]2N)[C@H](OC3O[C@H](CO)C(O)[C@H]3O)[C@H]1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 A22 compound treatment 14.4115 0.57489 0.1543 17.8561 3.3583 0.7957 0.6717 0.8288 3616809 BPBio1_000726 C[C@H]1[C@H]2[C@H](C[C@H]3[C@@H]4CC[C@H]5C[C@@H](O)CC[C@]5(C)[C@H]4CC(=O)[C@]23C)O[C@@]61CC[C@@H](C)CO6 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 A23 mock treatment 16.5068 2.6702 0.7165 14.3269 -0.1709 -0.0405 0.478 0.6661 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 A24 mock treatment 18.9564 5.1198 1.3738 13.6375 -0.86032 -0.2038 0.8273 0.5957 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 B01 compound treatment 16.4358 2.5992 0.6974 15.9567 1.4589 0.3457 0.7376 0.9476 3614714 BPBio1_000727 NC(=N)S/C=C\C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 B02 compound treatment 13.5342 -0.30238 -0.0811 14.6765 0.17873 0.0423 -0.0274 -0.2997 3614718 BPBio1_000728 CC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 B03 compound treatment 13.7819 -0.054684 -0.0147 15.7319 1.2341 0.2924 0.1964 0.6708 1412 BPBio1_000729 CN(C)CCOC(c1ccc(Cl)cc1)c2ccccn2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 B04 compound treatment 13.2409 -0.59568 -0.1598 11.1176 -3.3802 -0.8009 -0.6793 -0.8318 1300 BPBio1_000730 OC(=O)c1cccnc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 B05 compound treatment 15.4554 1.6188 0.4344 14.6784 0.18056 0.0428 0.3374 0.773 3069629 BPBio1_000731 CC(=O)/N=c/1\sc(nn1C)S(=O)(=O)N 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 B06 compound treatment 14.0653 0.22866 0.0614 15.274 0.77621 0.1839 0.1734 0.8945 2819 BPBio1_000732 CCC1(C)CC(=O)NC(=O)C1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 B07 compound treatment 14.7612 0.92459 0.2481 18.016 3.5182 0.8336 0.7649 0.8794 818 BPBio1_000733 CCC1(CC)C(=O)NC=CC1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 B08 compound treatment 24.7878 10.951 2.9385 29.6986 15.201 3.6016 4.6246 0.9949 3187897 BPBio1_000734 C[C@]12[C@H](CC[C@]2(O)[C@@H]3CC[C@@H]4C[C@@H](O)CC[C@]4(C)[C@H]3C[C@H]1O)C5=CC(=O)OC5 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 B09 compound treatment 17.0824 3.2458 0.8709 16.2958 1.798 0.426 0.9171 0.9459 795 BPBio1_000735 CN[C@@H]1[C@H](O)[C@H](NC)[C@H]2O[C@]3(O)[C@@H](O[C@H](C)CC3=O)O[C@@H]2[C@H]1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 B10 compound treatment 20.0522 6.2156 1.6678 12.2068 -2.2909 -0.5428 0.7955 0.4536 4370 BPBio1_000736 CNCC(O)C(O)C(O)C(O)CO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 B11 compound treatment 14.7676 0.93102 0.2498 15.1359 0.63816 0.1512 0.2836 0.9711 1129 BPBio1_000737 CCn1cc(C(=O)O)c(=O)c2cnc(nc12)N3CCCC3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 B12 compound treatment 40.7937 26.957 7.2333 31.738 17.24 4.0848 8.0031 0.9634 2117591 BPBio1_000738 C[C@]12[C@H]3CC[C@H](O3)[C@]2(C)C(=O)OC1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 B13 compound treatment 21.9179 8.0812 2.1684 17.9129 3.4152 0.8092 2.1055 0.9097 755 BPBio1_000739 CC(CN(C)C)CN1c2ccccc2CCc3ccccc13 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 B14 compound treatment 20.31 6.4734 1.737 19.6922 5.1944 1.2307 2.0985 0.9858 1999 BPBio1_000740 Oc1c(I)cc(Cl)c2cccnc12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 B15 compound treatment 16.3927 2.5561 0.6859 13.8139 -0.68392 -0.162 0.3704 0.5256 1088922 BPBio1_000741 CN(C)CCN(Cc1ccc(Cl)cc1)c2ccccn2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 B16 compound treatment 13.8197 -0.016909 -0.0045 10.3597 -4.138 -0.9804 -0.6965 -0.7104 838 BPBio1_000742 COc1ccc(C(=O)c2ccccc2)c(O)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 B17 compound treatment 15.2869 1.4503 0.3892 13.9504 -0.54736 -0.1297 0.1835 0.4473 3043753 BPBio1_000743 [O-][N+](=O)c1ccc(/C=N/N2CCOC2=O)o1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 B18 compound treatment 18.11 4.2734 1.1467 15.4946 0.99676 0.2362 0.9778 0.8352 681 BPBio1_000744 CC(CN1c2ccccc2Sc3ccccc13)N(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 B19 compound treatment 14.8916 1.055 0.2831 1.3629 -13.135 -3.1121 -2.0004 -0.6401 2570 BPBio1_000745 NS(=O)(=O)c1cc(Cl)c(Cl)c(c1)S(=O)(=O)N 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 B20 compound treatment 15.5633 1.7266 0.4633 20.2704 5.7726 1.3677 1.2947 0.8966 1225 BPBio1_000746 Oc1cc(O)c2c(=O)cc(oc2c1)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 B21 compound treatment 16.7241 2.8875 0.7748 14.19 -0.30782 -0.0729 0.4963 0.6377 871 BPBio1_000747 Clc1ccc(CSC(Cn2ccnc2)c3ccc(Cl)cc3Cl)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 B22 compound treatment 13.6781 -0.15848 -0.0425 18.3478 3.85 0.9122 0.615 0.6734 3487233 BPBio1_000748 CC(O)Cn1cnc2n(C)c(=O)n(C)c(=O)c12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 B23 mock treatment 13.3897 -0.44688 -0.1199 26.1906 11.693 2.7704 1.8742 0.6759 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 B24 mock treatment 11.8125 -2.0241 -0.5431 11.558 -2.9398 -0.6965 -0.8766 -0.9924 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 C01 compound treatment 14.761 0.92437 0.248 12.2 -2.2978 -0.5444 -0.2096 -0.3503 2069299 BPBio1_000749 CC1(C)CO[C@@H](CC(=O)O)CN1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 C02 compound treatment 11.724 -2.1126 -0.5669 13.7315 -0.76632 -0.1816 -0.5292 -0.8891 678 BPBio1_000750 NCC(CC(=O)O)c1ccc(Cl)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 C03 compound treatment 14.5658 0.72917 0.1957 24.5151 10.017 2.3735 1.8166 0.7628 1624 BPBio1_000751 CCC1=C(C)CN(C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)N[C@H]3CC[C@H](C)CC3)C1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 C04 compound treatment 13.6782 -0.15846 -0.0425 12.7936 -1.7042 -0.4038 -0.3156 -0.7773 706 BPBio1_000752 Nc1ccc(cc1)S(=O)(=O)Nc2cnc3ccccc3n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 C05 compound treatment 17.6767 3.8401 1.0304 22.5257 8.0279 1.9021 2.0736 0.9585 3616771 BPBio1_000753 CC(=C)[C@H]1[C@H]2OC(=O)C1[C@]3(O)CC4O[C@]45C(=O)O[C@H]2[C@@]53C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 C06 compound treatment 12.3152 -1.5214 -0.4082 17.5623 3.0646 0.7261 0.2248 0.2698 1149 BPBio1_000754 CN(N=O)C(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 C07 compound treatment 14.422 0.58539 0.1571 12.7888 -1.709 -0.4049 -0.1753 -0.4035 1244 BPBio1_000755 C[N+]1(C)CCCC(C1)OC(=O)C(O)(c2ccccc2)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 C08 compound treatment 12.384 -1.4526 -0.3898 15.8475 1.3497 0.3198 -0.0495 -0.0981 3616810 BPBio1_000756 COCCc1ccc(OCC(O)CNC(C)C)cc1.O[C@H]([C@@H](O)C(=O)O)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 C09 compound treatment 15.5806 1.744 0.468 18.4529 3.9551 0.9371 0.9935 0.9485 3187616 BPBio1_000757 C/C(=C(\CCOP(=O)(O)O)/SC(=O)c1ccccc1)/N(Cc2cnc(C)nc2N)C=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 C10 compound treatment 17.0995 3.2628 0.8755 18.6714 4.1736 0.9889 1.3183 0.9982 3187752 BPBio1_000758 C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 C11 compound treatment 19.3992 5.5626 1.4926 15.2599 0.76213 0.1806 1.1831 0.7869 3069534 BPBio1_000759 CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)CC[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CCl 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 C12 compound treatment 14.8106 0.97396 0.2613 15.3957 0.89786 0.2127 0.3352 0.9948 359 BPBio1_000760 FC(F)(F)COc1ccc(OCC(F)(F)F)c(c1)C(=O)NCC2CCCCN2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 C13 compound treatment 29.3081 15.472 4.1514 23.385 8.8872 2.1057 4.4244 0.9505 3616772 BPBio1_000761 C[C@H]1O[C@H](C[C@H](O)[C@@H]1O[C@H]2C[C@H](O)[C@H](O[C@H]3C[C@H](OC(=O)C)[C@H](O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)[C@@H](C)O3)[C@@H](C)O2)O[C@H]5CC[C@@]6(C)[C@H](CC[C@@]7(C)[C@@]8(O)CC[C@H](C9=CC(=O)OC9)[C@@]8(C)[C@H](O)C[C@]67C)C5 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 C14 compound treatment 13.7423 -0.094334 -0.0253 15.639 1.1412 0.2704 0.1733 0.6381 689 BPBio1_000762 Cc1nnc(SCC2=C(N3[C@H](SC2)[C@H](NC(=O)Cn4cnnn4)C3=O)C(=O)O)s1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 C15 compound treatment 11.2813 -2.5553 -0.6856 11.973 -2.5248 -0.5982 -0.9078 -0.9977 3103678 BPBio1_000763 N/C(=N\C(=O)c1nc(Cl)c(N)nc1N)/NCc2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 C16 compound treatment 14.2377 0.40104 0.1076 17.1403 2.6425 0.6261 0.5188 0.8167 3616811 BPBio1_000764 CC(C)CC(=O)O[C@H]1[C@@H](O[C@@H]2C[C@H]([C@H]3CC[C@]4(C[C@H]5CC[C@H]4[C@]3(C)C2)[C@@H](O)C5=C)C(=O)O)O[C@H](CO)[C@@H](OS(=O)(=O)O)[C@@H]1OS(=O)(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 C17 compound treatment 16.423 2.5864 0.694 15.5081 1.0103 0.2394 0.66 0.899 827 BPBio1_000765 CCCCC1(COC(=O)CCC(=O)O)C(=O)N(N(C1=O)c2ccccc2)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 C18 compound treatment 14.8231 0.98652 0.2647 14.9647 0.46693 0.1106 0.2654 0.9251 873 BPBio1_000766 Nc1nc(=O)c2N(C=O)C(CNc3ccc(cc3)C(=O)N[C@@H](CCC(=O)O)C(=O)O)CNc2[nH]1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 C19 compound treatment 14.9682 1.1316 0.3036 13.7082 -0.78962 -0.1871 0.0824 0.2311 3069535 BPBio1_000767 C(Nc1ncnc2nc[nH]c12)c3ccco3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 C20 compound treatment 12.4067 -1.4299 -0.3837 16.1127 1.6149 0.3826 -7.0E-4 -0.0014 953 BPBio1_000768 C[C@H](N)[C@H](O)c1ccc(O)c(O)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 C21 compound treatment 16.2677 2.4311 0.6523 15.6892 1.1914 0.2823 0.6609 0.9298 3616773 BPBio1_000769 CC[C@H](C)[C@H]1O[C@@]2(C[C@@H]3C[C@H](C/C=C(\C)/C(O[C@H]4C[C@H](OC)C(O[C@H]5C[C@H](OC)[C@@H](O)[C@H](C)O5)[C@H](C)O4)[C@@H](C)\C=C\C=C/6\CO[C@@H]7[C@H](O)C(=C[C@@H](C(=O)O3)[C@@]76O)C)O2)C=C[C@@H]1C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 C22 compound treatment 28.4731 14.636 3.9273 33.2424 18.745 4.4413 5.9175 0.9981 1531 BPBio1_000770 O=c1n([se]c2ccccc12)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 C23 mock treatment 15.1608 1.3242 0.3553 13.5119 -0.98589 -0.2336 0.0861 0.2024 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 C24 mock treatment 15.7404 1.9038 0.5108 16.6812 2.1834 0.5173 0.727 1.0 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 D01 compound treatment 14.6215 0.78487 0.2106 11.7742 -2.7236 -0.6453 -0.3074 -0.4528 3189316 BPBio1_000771 COc1ccc(cc1)c2ccc(=N)n(CCCC(=O)O)n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 D02 compound treatment 11.936 -1.9006 -0.51 13.5459 -0.95189 -0.2255 -0.5201 -0.9327 3614719 BPBio1_000772 C[C@@]12CC[C@H]3[C@@H](CC[C@H]4C[C@H](O)CC[C@@]43C)[C@@H]2CC[C@@H]1C(=O)CO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 D03 compound treatment 12.1024 -1.7342 -0.4653 13.4783 -1.0194 -0.2415 -0.4998 -0.9534 3472295 BPBio1_000773 COc1c(O)cc2C(=O)OC3C(O)C(O)C(CO)OC3c2c1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 D04 compound treatment 12.8237 -1.0129 -0.2718 13.0975 -1.4003 -0.3318 -0.4268 -0.9951 1022907 BPBio1_000774 CC(=O)c1cc2ccccc2oc1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 D05 compound treatment 14.6267 0.79004 0.212 13.254 -1.2438 -0.2947 -0.0585 -0.1611 1446 BPBio1_000775 OC(COc1cccc2oc(cc(=O)c12)C(=O)O)COc3cccc4oc(cc(=O)c34)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 D06 compound treatment 14.5862 0.74958 0.2011 15.4229 0.92506 0.2192 0.2972 0.9991 3616845 BPBio1_000776 OC[C@H]1OC(Oc2cc3ccc(=O)oc3cc2O)[C@H](O)[C@@H](O)[C@@H]1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 D07 compound treatment 15.2606 1.424 0.3821 15.8728 1.375 0.3258 0.5005 0.9969 3616827 BPBio1_000777 CCCC(=O)Nc1ncnc2n(cnc12)[C@@H]3O[C@@H]4OP(=O)(O)OC[C@H]4[C@H]3OC(=O)CCC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 D08 compound treatment 13.3385 -0.49813 -0.1337 12.0856 -2.4122 -0.5715 -0.4987 -0.8496 2776 BPBio1_000778 OC(=O)Cc1ccc(cc1)c2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 D09 compound treatment 13.772 -0.064589 -0.0173 17.2771 2.7794 0.6585 0.4534 0.6883 3176931 BPBio1_000779 NC(=O)c1cc[n+](CC2=C(N3[C@H](SC2)[C@H](NC(=O)[C@@H](c4ccccc4)S(=O)(=O)O)C3=O)C(=O)O)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 D10 compound treatment 15.0851 1.2485 0.335 14.8924 0.39461 0.0935 0.303 0.8712 1012530 BPBio1_000780 CCCCOC(=O)c1ccc(O)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 D11 compound treatment 12.3148 -1.5218 -0.4083 13.7173 -0.78047 -0.1849 -0.4195 -0.9358 717 BPBio1_000781 OC(=O)c1ccccc1OP(=O)(O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 D12 compound treatment 23.7159 9.8793 2.6509 15.6406 1.1428 0.2708 2.0659 0.7753 1299 BPBio1_000782 Nc1ccc(cc1)C(=O)NCC(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 D13 compound treatment 16.1352 2.2986 0.6168 10.8928 -3.605 -0.8542 -0.1679 -0.1593 1102 BPBio1_000783 CC(C(=O)O)c1ccc(cc1)C(=O)c2cccs2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 D14 compound treatment 12.7977 -1.0389 -0.2788 11.8038 -2.6939 -0.6383 -0.6485 -0.931 1231 BPBio1_000784 CC(C)C[C@H](NC(=O)C)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 D15 compound treatment 22.4104 8.5738 2.3006 17.1846 2.6868 0.6366 2.0769 0.8701 1047041 BPBio1_000785 OC1Cc2c(O)cc(O)cc2OC1c3ccc(O)c(O)c3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 D16 compound treatment 13.7528 -0.083859 -0.0225 14.6452 0.14741 0.0349 0.0088 0.2115 1258 BPBio1_000786 CCn1cc(C(=O)O)c(=O)c2cnc(nc12)N3CCNCC3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 D17 compound treatment 12.1352 -1.7014 -0.4565 13.2026 -1.2952 -0.3069 -0.5398 -0.9813 1555091 BPBio1_000787 CC(C)(C)NCC(O)COc1cccc2CC(O)C(O)Cc12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 D18 compound treatment 14.1767 0.34012 0.0913 11.5663 -2.9315 -0.6946 -0.4266 -0.609 3059213 BPBio1_000788 COc1ccc(C(=O)c2ccccc2O)c(O)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 D19 compound treatment 12.6468 -1.1898 -0.3193 17.1592 2.6614 0.6306 0.2201 0.3114 3066 BPBio1_000789 CO[C@]1(NC(=O)[C@H](C(=O)O)c2ccc(O)cc2)[C@H]3OCC(=C(N3C1=O)C(=O)O)CSc4nnnn4C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 D20 compound treatment 12.4998 -1.3368 -0.3587 14.3534 -0.14442 -0.0342 -0.2778 -0.7711 3187899 BPBio1_000790 C[C@@]12CC(=O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@]34C)[C@@H]2CCC1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 D21 compound treatment 12.2508 -1.5858 -0.4255 15.067 0.56918 0.1349 -0.2055 -0.4604 856 BPBio1_000791 Cn1c(=O)n(C)c2nc[nH]c2c1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 D22 compound treatment 12.107 -1.7296 -0.4641 15.481 0.98321 0.233 -0.1634 -0.3147 3616847 BPBio1_000792 C[N+]1(C)C2CC[C@H]1C[C@H](C2)OC(=O)C(CO)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 D23 mock treatment 14.0168 0.18015 0.0483 13.7756 -0.72224 -0.1711 -0.0868 -0.4883 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 D24 mock treatment 14.0031 0.16652 0.0447 13.9043 -0.59347 -0.1406 -0.0678 -0.4598 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 E01 compound treatment 15.1594 1.3228 0.3549 12.1767 -2.3211 -0.55 -0.1379 -0.2107 2060389 BPBio1_000793 OC(=O)Cc1c[nH]cn1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 E02 compound treatment 13.893 0.056341 0.0151 11.6308 -2.867 -0.6793 -0.4697 -0.6912 1220 BPBio1_000794 CN1CCc2cc3OCOc3cc2[C@H]1[C@@H]4OC(=O)c5c6OCOc6ccc45 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 E03 compound treatment 13.8119 -0.024709 -0.0066 10.873 -3.6248 -0.8588 -0.612 -0.7125 3069536 BPBio1_000795 OC[C@H]1OC([C@H](O)[C@@H](O)[C@@H]1O)c2c(O)cc(O)c3c(=O)cc(oc23)c4ccc(O)cc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 E04 compound treatment 12.418 -1.4186 -0.3807 11.3962 -3.1016 -0.7349 -0.7888 -0.9531 1000108 BPBio1_000796 NC(=O)c1ccc[n+](c1)[C@@H]2O[C@H](COP(=O)(O)OP(=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc5c(N)ncnc45)[C@@H](O)[C@H]2O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 E05 compound treatment 15.3288 1.4922 0.4004 13.3727 -1.1251 -0.2666 0.0946 0.1967 3616774 BPBio1_000797 CN1C[C@@]2(C=C)C3CC4OC[C@@H]3[C@@H]1[C@H]2[C@@]45C(=O)Nc6ccccc65 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 E06 compound treatment 13.9352 0.098541 0.0264 16.5472 2.0495 0.4856 0.3621 0.7445 799 BPBio1_000798 Cc1nnc(NS(=O)(=O)c2ccc(N)cc2)s1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 E07 compound treatment 15.5143 1.6777 0.4502 14.4687 -0.029087 -0.0069 0.3134 0.6962 3616775 BPBio1_000799 C[C@H]1[C@H]2[C@H](C[C@H]3[C@@H]4CC=C5C[C@@H](O)CC[C@]5(C)[C@H]4CC[C@]23C)O[C@@]61CC[C@@H](C)CN6 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 E08 compound treatment 13.4541 -0.38251 -0.1026 14.9431 0.44531 0.1055 0.002 0.0138 3187753 BPBio1_000800 C[C@H]1C[C@H]2[C@@H]3CC[C@H](C(=O)C)[C@@]3(C)C[C@H](O)[C@@H]2[C@@]4(C)CCC(=O)C=C14 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 E09 compound treatment 11.7731 -2.0635 -0.5537 12.1844 -2.3134 -0.5481 -0.7791 -1.0 3616777 BPBio1_000801 CCN1C[C@]2(COC)CC[C@H](OC)[C@]3([C@@H]4C[C@H]5[C@H](OC)[C@@H]4[C@@]6(C[C@@H]5OC)OCO[C@]76[C@@H](O)[C@@H]32)C17 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 E10 compound treatment 13.9131 0.076441 0.0205 12.0538 -2.444 -0.5791 -0.395 -0.6816 3187754 BPBio1_000802 CNCC(O)C(O)C(O)C(O)CO.Cc1c(Nc2ncccc2C(=O)O)cccc1C(F)(F)F 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 E11 compound treatment 10.3724 -3.4642 -0.9295 23.8526 9.3548 2.2165 0.91 0.3786 3616778 BPBio1_000803 COc1c(OC[C@@H](O)C(C)(C)O)ccc2c(OC)c3ccoc3nc12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 E12 compound treatment 13.4088 -0.42783 -0.1148 14.0777 -0.42007 -0.0995 -0.1516 -0.9975 3187755 BPBio1_000804 CO[C@H]1[C@H](O)CC(=O)O[C@H](C)C/C=C/C=C/[C@H](OC2CCC(C(C)O2)N(C)C)[C@H](C)C[C@H](CC=O)[C@@H]1OC3OC(C)C(OC4CC(C)(O)C(O)C(C)O4)C(C3O)N(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 E13 compound treatment 14.3244 0.48777 0.1309 11.9023 -2.5955 -0.615 -0.3423 -0.5444 3187620 BPBio1_000805 C[C@H]1CCC[C@@H](C)N1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 E14 compound treatment 11.922 -1.9146 -0.5137 12.4449 -2.0529 -0.4864 -0.7072 -0.9996 3069580 BPBio1_000806 C[N+]1(C)CCC(C1)OC(=O)C(O)(C2CCCC2)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 E15 compound treatment 15.5734 1.7368 0.466 12.8192 -1.6786 -0.3977 0.0483 0.0789 1540789 BPBio1_000807 COc1cc(=O)n(C)c2c(OCC(O)C(C)(C)O)cccc12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 E16 compound treatment 14.2828 0.44619 0.1197 15.8541 1.3563 0.3214 0.3119 0.9095 3069581 BPBio1_000808 Cn1nnnc1SCC2=C(N3[C@H](SC2)[C@H](NC(=O)[C@H](O)c4ccccc4)C3=O)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 E17 compound treatment 15.8204 1.9838 0.5323 12.9194 -1.5784 -0.374 0.1119 0.1721 1054505 BPBio1_000809 COc1ccc2c(OC)c3ccoc3nc2c1OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 E18 compound treatment 21.2785 7.4419 1.9969 19.6206 5.1228 1.2138 2.2703 0.9715 3616814 BPBio1_000810 CC[C@]1(CC[C@@H](O1)[C@]2(C)CC[C@]3(C[C@H](O)[C@@H](C)[C@H](O3)[C@@H](C)[C@@H](OC)[C@H](C)C(=O)O)O2)[C@@H]4O[C@H](C[C@@H]4C)[C@H]5O[C@@](O)(CO)[C@H](C)C[C@@H]5C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 E19 compound treatment 12.1142 -1.7224 -0.4622 12.7198 -1.778 -0.4213 -0.6247 -0.9989 3616780 BPBio1_000811 C1CC[C@@H](NC1)c2cccnc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 E20 compound treatment 14.4896 0.65302 0.1752 14.779 0.28121 0.0666 0.171 0.9123 4338 BPBio1_000812 CCC(NC(C)C)C(O)c1ccc(O)c(O)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 E21 compound treatment 22.3398 8.5032 2.2816 26.2565 11.759 2.786 3.5834 0.9951 193 BPBio1_000813 COc1cc2CCN(C)[C@H]3Cc4ccc(OC)c(Oc5ccc(C[C@@H]6N(C)CCc7cc(OC)c(Oc(c1OC)c32)cc67)cc5)c4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 E22 compound treatment 12.2092 -1.6274 -0.4367 12.7098 -1.7879 -0.4236 -0.6083 -0.9999 1050972 BPBio1_000814 CC1(O)CCOC(=O)C1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 E23 mock treatment 14.2865 0.44987 0.1207 15.176 0.67818 0.1607 0.199 0.9901 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 E24 mock treatment 14.7713 0.93467 0.2508 14.8601 0.36231 0.0858 0.238 0.898 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 F01 compound treatment 16.3698 2.5332 0.6797 14.86 0.36226 0.0858 0.5413 0.7901 3614716 BPBio1_000815 Cc1ncsc1CCCl 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 F02 compound treatment 14.1981 0.36147 0.097 14.7081 0.21028 0.0498 0.1038 0.9521 3614720 BPBio1_000816 CC(C)(C)C1(COP2(=S)OC1)CO2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 F03 compound treatment 12.5086 -1.328 -0.3563 15.6609 1.1631 0.2756 -0.0571 -0.1268 3616829 BPBio1_000817 CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](NC(=O)N3CCNC3=O)c4ccccc4)C(=O)N2[C@H]1C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 F04 compound treatment 14.2738 0.43714 0.1173 13.2794 -1.2184 -0.2887 -0.1212 -0.3889 2732 BPBio1_000818 Cc1cc(=O)oc2cc(O)ccc12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 F05 compound treatment 16.7655 2.9289 0.7859 14.5405 0.042708 0.0101 0.5629 0.7162 1303 BPBio1_000819 C[N+]1(CCC2CC1)CC2OC(=O)C(O)(c3ccccc3)c4ccccc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 F06 compound treatment 17.9663 4.1297 1.1081 13.7311 -0.76672 -0.1817 0.6551 0.5834 1978 BPBio1_000820 OC(=O)/C=C/c1ccc(O)c(O)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 F07 compound treatment 14.0306 0.19399 0.0521 17.4567 2.9589 0.7011 0.5325 0.7575 1529 BPBio1_000821 COc1cc(NS(=O)(=O)c2ccc(N)cc2)ncn1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 F08 compound treatment 13.88 0.043346 0.0116 12.236 -2.2618 -0.5359 -0.3707 -0.6916 3069737 BPBio1_000822 CN(C(=O)C(Cl)Cl)c1ccc(OC(=O)c2ccco2)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 F09 compound treatment 15.1392 1.3026 0.3495 14.5272 0.029358 0.007 0.2521 0.721 1114 BPBio1_000823 NS(=O)(=O)c1cc2c(N=C(CSCc3ccccc3)NS2(=O)=O)cc1Cl 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 F10 compound treatment 13.9593 0.12264 0.0329 13.9121 -0.58569 -0.1388 -0.0749 -0.5249 2743 BPBio1_000824 CC(C)(C(=O)c1cccnc1)c2cccnc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 F11 compound treatment 11.3852 -2.4514 -0.6578 13.8084 -0.68942 -0.1633 -0.5806 -0.8567 1000 BPBio1_000825 NS(=O)(=O)c1cc2c(NC(NS2(=O)=O)C(Cl)Cl)cc1Cl 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 F12 compound treatment 16.1047 2.2681 0.6086 12.6615 -1.8363 -0.4351 0.1227 0.164 3202 BPBio1_000826 COc1ccccc1N2CCN(CCCNc3cc(=O)n(C)c(=O)n3C)CC2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 F13 compound treatment 12.2431 -1.5935 -0.4276 11.4604 -3.0374 -0.7197 -0.8112 -0.9691 1052436 BPBio1_000827 CCN(CC)CCc1nc(no1)c2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 F14 compound treatment 19.2132 5.3766 1.4427 29.0729 14.575 3.4534 3.462 0.925 23081 BPBio1_000828 Fc1ccc(cc1)C(CCCN2CCC3(CC2)N(CNC3=O)c4ccccc4)c5ccc(F)cc5 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 F15 compound treatment 12.3549 -1.4818 -0.3976 12.7653 -1.7325 -0.4105 -0.5714 -0.9999 1397 BPBio1_000829 CC(C)[N+](C)(CCOC(=O)C1c2ccccc2Oc3ccccc13)C(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 F16 compound treatment 13.8257 -0.010909 -0.0029 18.4858 3.988 0.9449 0.6661 0.7049 1472 BPBio1_000830 CC(C)Cc1ccc(cc1)[C@H](C)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 F17 compound treatment 22.0802 8.2436 2.212 31.9337 17.436 4.1312 4.4853 0.9571 3187885 BPBio1_000831 CC[C@H]([C@H]1O[C@@](CC)(C[C@@H]1C)[C@H]2CC[C@](O)(CC)[C@H](C)O2)C(=O)[C@@H](C)[C@@H](O)[C@H](C)CCc3ccc(C)c(O)c3C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 F18 compound treatment 15.4756 1.6389 0.4398 11.297 -3.2008 -0.7584 -0.2253 -0.257 3187900 BPBio1_000832 CC(=O)O[C@H]1CC[C@@H]2[C@H]3CC[C@@]4(C)[C@@H](CC[C@@]4(OC(=O)C)C#C)[C@@H]3CCC2=C1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 F19 compound treatment 14.4139 0.57724 0.1549 13.2273 -1.2705 -0.301 -0.1033 -0.3052 1519 BPBio1_000833 CC1(C)OC(=O)NC1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 F20 compound treatment 13.3775 -0.45916 -0.1232 15.1922 0.69441 0.1645 0.0292 0.1422 1440 BPBio1_000834 COc1ccc2cc(CCC(=O)C)ccc2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 F21 compound treatment 14.1913 0.35467 0.0952 14.1172 -0.38057 -0.0902 0.0035 0.0269 852 BPBio1_000835 CCOc1ccc(Cc2nccc3cc(OCC)c(OCC)cc23)cc1OCC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 F22 compound treatment 10.9504 -2.8862 -0.7745 13.1073 -1.3905 -0.3295 -0.7806 -0.9275 907434 BPBio1_000836 CNCCC(Oc1ccccc1OC)c2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 F23 mock treatment 11.9875 -1.8491 -0.4962 14.7604 0.26261 0.0622 -0.3068 -0.6136 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 F24 mock treatment 16.5143 2.6777 0.7185 12.7968 -1.7009 -0.403 0.2231 0.2708 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 G01 compound treatment 23.0866 9.25 2.482 15.6825 1.1847 0.2807 1.9535 0.7821 399 BPBio1_000837 Nc1nc2ccc(OC(F)(F)F)cc2s1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 G02 compound treatment 14.2669 0.43032 0.1155 13.0469 -1.4509 -0.3438 -0.1614 -0.4452 3684 BPBio1_000838 OC(=O)C1=CCCNC1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 G03 compound treatment 14.778 0.94142 0.2526 12.0992 -2.3986 -0.5683 -0.2232 -0.3589 3129 BPBio1_000839 CC(=O)[C@H]1CC[C@H]2[C@@H]3C=CC4=CC(=O)CC[C@@]4(C)[C@@H]3CC[C@]12C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 G04 compound treatment 12.9603 -0.87627 -0.2351 12.8967 -1.6011 -0.3794 -0.4345 -0.9735 3480633 BPBio1_000840 COc1cc2nc(nc(N)c2cc1OC)N3CCN(CC3)C(=O)C4CCCO4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 G05 compound treatment 18.4044 4.5678 1.2257 13.865 -0.63277 -0.1499 0.7607 0.616 1025381 BPBio1_000841 COc1ccc2CC3N(CCc4cc5OCOc5cc34)Cc2c1OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 G06 compound treatment 16.2767 2.4401 0.6547 15.1713 0.67346 0.1596 0.5758 0.8544 1404 BPBio1_000842 Nc1ccc(N=Nc2ccccc2)c(N)n1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 G07 compound treatment 13.2 -0.63658 -0.1708 11.0942 -3.4036 -0.8064 -0.691 -0.8383 3616781 BPBio1_000843 CCN1C[C@]2(C)CC[C@H](OC)[C@@]34[C@@H]2[C@H](OC(=O)C)[C@@]5(OCO[C@]65C[C@H](OC)[C@H]7C[C@]4(O)[C@@H]6[C@H]7OC)C13 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 G08 compound treatment 16.4362 2.5996 0.6975 15.7693 1.2716 0.3013 0.7063 0.9295 1451 BPBio1_000844 CN(C)[C@H]1[C@@H]2C[C@@H]3[C@H](O)c4c(Cl)ccc(O)c4C(=O)C3=C(O)[C@]2(O)C(=O)C(=C1O)C(=O)N 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 G09 compound treatment 14.8871 1.0505 0.2819 11.983 -2.5148 -0.5959 -0.222 -0.3368 1182082 BPBio1_000845 Cn1c(cc(=O)c2ccccc12)c3ccc4OCOc4c3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 G10 compound treatment 12.7448 -1.0918 -0.293 14.2142 -0.28357 -0.0672 -0.2547 -0.8473 1438 BPBio1_000846 CC(C(=O)O)c1cccc(Oc2ccccc2)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 G11 compound treatment 14.0963 0.25969 0.0697 14.177 -0.32074 -0.076 -0.0045 -0.0433 3616783 BPBio1_000847 CN1CCC2=C[C@H](O)[C@H]3OC(=O)c4cc5OCOc5cc4[C@H]3[C@H]12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 G12 compound treatment 12.6513 -1.1853 -0.318 11.5219 -2.9759 -0.7051 -0.7235 -0.9353 963 BPBio1_000848 CCN1CCN(C(=O)N[C@@H](C(=O)N[C@H]2[C@H]3SC(C)(C)[C@@H](N3C2=O)C(=O)O)c4ccccc4)C(=O)C1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 G13 compound treatment 12.4348 -1.4019 -0.3762 33.884 19.386 4.5933 2.982 0.647 3187623 BPBio1_000849 CC=C(C)C(=O)OC1[C@H](OC(=O)C)C2(CO)[C@H](O)C[C@]3(C)C(=CCC4C5(C)CCC(OC6OC([C@H](O[C@H]7OC(CO)[C@H](O)[C@H](O)C7O)[C@H](O)C6O[C@H]8OC(CO)[C@H](O)[C@H](O)C8O)C(=O)O)[C@](C)(CO)C5CCC43C)C2CC1(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 G14 compound treatment 47.9703 34.134 9.1589 44.1126 29.615 7.0168 11.438 0.9913 1138 BPBio1_000850 CC/C(=C(/CC)\c1ccc(O)cc1)/c2ccc(O)cc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 G15 compound treatment 21.2694 7.4328 1.9944 20.5833 6.0855 1.4419 2.4298 0.9873 829 BPBio1_000851 CC(C)c1c(O)c(O)c(C=O)c2c(O)c(c(C)cc12)c3c(C)cc4c(C(C)C)c(O)c(O)c(C=O)c4c3O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 G16 compound treatment 14.3629 0.52632 0.1412 13.0667 -1.4311 -0.3391 -0.1399 -0.3809 3057880 BPBio1_000852 COc1ccc(cc1)C(=C(c2ccc(OC)cc2)c3ccc(OC)cc3)Cl 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 G17 compound treatment 14.3861 0.54952 0.1475 13.268 -1.2298 -0.2914 -0.1018 -0.3117 1115322 BPBio1_000853 COc1ccn(C)c(=O)c1C#N 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 G18 compound treatment 14.9431 1.1065 0.2969 12.7589 -1.7389 -0.412 -0.0814 -0.1603 3616815 BPBio1_000854 NC[C@H]1O[C@H](OC2[C@@H](N)C[C@@H](N)[C@H](O)[C@H]2O[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)[C@H](N)[C@@H](O)[C@@H]1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 G19 compound treatment 15.0808 1.2442 0.3338 15.2572 0.75938 0.1799 0.3633 0.9579 3616785 BPBio1_000855 CCN1C[C@]2(COC)CC[C@H](O)[C@]3([C@@H]4C[C@H]5[C@H](OC)[C@@H]4[C@](O)(C[C@@H]5OC)[C@@]6(O)[C@@H](OC)[C@@H]32)C16 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 G20 compound treatment 10.8007 -3.0359 -0.8146 12.8661 -1.6317 -0.3866 -0.8494 -0.942 1094620 BPBio1_000856 CC(C[N+](C)(C)C)OC(=O)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 G21 compound treatment 12.5596 -1.2771 -0.3427 12.9893 -1.5085 -0.3574 -0.495 -0.9998 3616786 BPBio1_000857 C/C=C\1/C[N+]2(C)CCC34[C@@H]2C[C@@H]1C(=C4Nc5ccccc53)C=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 G22 compound treatment 14.114 0.27739 0.0744 12.9153 -1.5825 -0.3749 -0.2125 -0.5559 1246 BPBio1_000858 CC[N+]1(C)CCCC(C1)OC(=O)C(O)(c2ccccc2)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 G23 mock treatment 12.4929 -1.3437 -0.3606 11.7657 -2.7321 -0.6473 -0.7127 -0.9618 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 G24 mock treatment 15.7097 1.873 0.5026 13.1725 -1.3253 -0.314 0.1333 0.225 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 H01 compound treatment 15.5833 1.7466 0.4687 15.1638 0.66598 0.1578 0.443 0.8958 962 BPBio1_000859 CCC1(C(=O)NCNC1=O)c2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 H02 compound treatment 10.8546 -2.982 -0.8002 9.914 -4.5838 -1.0861 -1.3338 -0.9887 1008060 BPBio1_000860 C1CCc2nnnn2CC1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 H03 compound treatment 14.0525 0.21587 0.0579 11.0788 -3.419 -0.8101 -0.5319 -0.6549 1452 BPBio1_000861 CCCCN(CCCC)CCCOC(=O)c1ccc(N)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 H04 compound treatment 12.5654 -1.2712 -0.3411 11.565 -2.9328 -0.6949 -0.7325 -0.9463 3616848 BPBio1_000862 CC(C)NC[C@@H](O)c1ccc(O)c(O)c1.O[C@H]([C@@H](O)C(=O)O)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 H05 compound treatment 15.3283 1.4917 0.4003 13.9089 -0.58889 -0.1395 0.1844 0.4349 1189 BPBio1_000863 CO[C@]1(NC(=O)Cc2cccs2)[C@H]3SCC(=C(N3C1=O)C(=O)O)COC(=O)N 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 H06 compound treatment 12.0002 -1.8364 -0.4927 14.2604 -0.23744 -0.0563 -0.3882 -0.7828 1001471 BPBio1_000864 Oc1ccc(OCc2ccccc2)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 H07 compound treatment 12.5747 -1.2619 -0.3386 13.222 -1.2758 -0.3023 -0.4532 -0.9984 1000080 BPBio1_000865 ClCCNP1(=O)OCCCN1CCCl 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 H08 compound treatment 14.0801 0.24352 0.0653 14.4681 -0.029692 -0.007 0.0412 0.6274 1025776 BPBio1_000866 Nc1ccccc1S(=O)(=O)N 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 H09 compound treatment 13.0388 -0.79783 -0.2141 11.4361 -3.0617 -0.7254 -0.6643 -0.8783 3616830 BPBio1_000867 CO[C@@H]1[C@@H](OC(=O)N)[C@@H](O)C(Oc2ccc3c(O)c(NC(=O)c4ccc(O)c(CC=C(C)C)c4)c(=O)oc3c2C)OC1(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 H10 compound treatment 17.1935 3.3569 0.9007 16.6023 2.1045 0.4986 0.9895 0.9611 3060043 BPBio1_000868 C[C@@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]2CCC1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 H11 compound treatment 13.629 -0.20766 -0.0557 12.9137 -1.5841 -0.3753 -0.3048 -0.8033 1232 BPBio1_000869 OC1=C(O)C(=O)C(=C(O)C1=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 H12 compound treatment 17.0978 3.2611 0.875 12.6292 -1.8686 -0.4427 0.3057 0.3117 907370 BPBio1_000870 CCCCCN(CCCCC)C(=O)C(CCC(=O)O)NC(=O)c1ccc(Cl)c(Cl)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 H13 compound treatment 14.0416 0.20497 0.055 14.0233 -0.47454 -0.1124 -0.0406 -0.3245 1029 BPBio1_000871 CC(C(=O)O)c1ccc(cc1)N2Cc3ccccc3C2=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 H14 compound treatment 17.8272 3.9905 1.0708 22.3203 7.8225 1.8534 2.0677 0.966 117 BPBio1_000872 CCOC(=O)C1=C(C)NC(=C(C1c2cccc(c2)[N+](=O)[O-])C(=O)OC)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 H15 compound treatment 11.531 -2.3056 -0.6187 12.2677 -2.2301 -0.5284 -0.8111 -0.9969 1276 BPBio1_000873 CC1(C)[C@H](CC[C@@]2(C)[C@H]1CC[C@]3(C)[C@@H]2C(=O)C=C4[C@@H]5C[C@](C)(CC[C@]5(C)CC[C@]43C)C(=O)O)OC(=O)CCC(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 H16 compound treatment 12.6506 -1.186 -0.3182 10.908 -3.5898 -0.8506 -0.8265 -0.9101 1000135 BPBio1_000874 CC(C(=O)O)c1ccc(c(F)c1)c2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 H17 compound treatment 13.0895 -0.74713 -0.2005 12.1306 -2.3672 -0.5609 -0.5384 -0.9038 3187887 BPBio1_000875 CC(CN(C(=O)C)c1c(I)cc(I)c(N)c1I)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 H18 compound treatment 12.672 -1.1646 -0.3125 13.3299 -1.1679 -0.2767 -0.4166 -0.9982 115 BPBio1_000876 COCCOC(=O)C1=C(C)NC(=C(C1c2cccc(c2)[N+](=O)[O-])C(=O)OC(C)C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 H19 compound treatment 10.9614 -2.8752 -0.7715 14.4475 -0.050317 -0.0119 -0.554 -0.7179 1670 BPBio1_000877 Nc1nc2n(COC(CO)CO)cnc2c(=O)[nH]1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 H20 compound treatment 13.9261 0.089489 0.024 12.079 -2.4188 -0.5731 -0.3883 -0.6769 3221506 BPBio1_000878 CCC(C)C(N)C1=NC(CS1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H]2CCCCNC(=O)[C@H](CC(=O)N)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@H](Cc3cnc[nH]3)NC(=O)[C@@H](Cc4ccccc4)NC(=O)[C@@H](NC(=O)[C@@H](CCCN)NC2=O)[C@@H](C)CC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 H21 compound treatment 15.9856 2.1489 0.5766 16.8907 2.3929 0.567 0.8086 1.0 727 BPBio1_000879 CCN(CC)C(C)CN1c2ccccc2Sc3ccccc13 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 H22 compound treatment 12.7723 -1.0644 -0.2856 13.8951 -0.60266 -0.1428 -0.3029 -0.9487 3616849 BPBio1_000880 O[C@@H]1CCCC[C@H]1N2CCC(CC2)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 H23 mock treatment 13.0712 -0.76537 -0.2054 12.8814 -1.6164 -0.383 -0.416 -0.9573 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 H24 mock treatment 13.8336 -0.0030339 -8.0E-4 14.0416 -0.45622 -0.1081 -0.077 -0.7124 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 I01 compound treatment 14.3566 0.52001 0.1395 13.9465 -0.55127 -0.1306 0.0063 0.033 3061090 BPBio1_000881 OC(=O)C1CCCN(CCC=C(c2ccccc2)c3ccccc3)C1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 I02 compound treatment 13.7522 -0.084409 -0.0226 13.2823 -1.2155 -0.288 -0.2197 -0.7604 774 BPBio1_000882 OC(=O)C1=CCNCC1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 I03 compound treatment 15.3982 1.5616 0.419 12.4253 -2.0725 -0.491 -0.0509 -0.0789 3069541 BPBio1_000883 C[C@H]1[C@H]2[C@H](OC1=O)[C@H]3C(=CC(=O)C3=C(C)C[C@@H]2O)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 I04 compound treatment 13.3093 -0.52731 -0.1415 11.959 -2.5388 -0.6015 -0.5254 -0.8502 1429 BPBio1_000884 CCCCOC(=O)c1ccc(N)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 I05 compound treatment 13.3215 -0.51511 -0.1382 14.6171 0.11931 0.0283 -0.0777 -0.5511 3616789 BPBio1_000885 CC[N+]1(C)[C@H]2CC[C@@H]1CC(C2)OC(=O)[C@H]3CCC(C(=O)OC4C[C@@H]5CC[C@H](C4)[N+]5(C)CC)(c6ccccc6)c7ccccc37 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 I06 compound treatment 13.659 -0.17758 -0.0477 12.3208 -2.177 -0.5158 -0.3984 -0.7692 867 BPBio1_000886 Nc1ccc(cc1)S(=O)(=O)Nc2ccccn2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 I07 compound treatment 14.0702 0.23362 0.0627 11.8777 -2.6201 -0.6208 -0.3946 -0.6325 3173628 BPBio1_000887 CN1C(C)(C)CCCC1(C)C.OC(C(O)C(=O)O)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 I08 compound treatment 14.245 0.40839 0.1096 11.9019 -2.5959 -0.6151 -0.3574 -0.5721 1001 BPBio1_000888 CN(C)CCOC(=O)COc1ccc(Cl)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 I09 compound treatment 15.7213 1.8847 0.5057 9.8699 -4.6279 -1.0965 -0.4177 -0.346 3616793 BPBio1_000889 CO[C@H](C)C(O)(C(C)C)C(=O)OCC1=CCN2CC[C@H](O)[C@H]21 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 I10 compound treatment 12.4159 -1.4207 -0.3812 12.5713 -1.9265 -0.4565 -0.5923 -0.996 3069584 BPBio1_000890 [O-][N+](=O)c1ccc(/C=N/N2CC(CN3CCOCC3)OC2=O)o1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 I11 compound treatment 15.9526 2.116 0.5678 15.2759 0.77811 0.1844 0.5318 0.8909 3616795 BPBio1_000891 C1CN[C@H]2[C@@H](C1)C3CCC2[C@H]4N3CCc5c4[nH]c6ccccc56 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 I12 compound treatment 41.994 28.157 7.5554 20.7949 6.2971 1.492 6.3974 0.8307 837 BPBio1_000892 CCOc1ccc2NC(C)(C)C=C(C)c2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 I13 compound treatment 23.2348 9.3982 2.5218 22.6663 8.1685 1.9354 3.1517 0.9915 3069543 BPBio1_000893 O[C@H]1C=C2CCN3Cc4cc5OCOc5cc4[C@@H](C32)[C@@H]1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 I14 compound treatment 13.3565 -0.48011 -0.1288 13.2753 -1.2225 -0.2896 -0.2959 -0.9334 2575 BPBio1_000894 CCS(=O)(=O)CCn1c(C)ncc1[N+](=O)[O-] 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 I15 compound treatment 14.5907 0.75409 0.2023 15.1871 0.68928 0.1633 0.2586 0.9944 3616797 BPBio1_000895 CCN1C[C@]2(C)CC[C@H](O)[C@]3([C@@H]4C[C@H]5C(O)[C@@H]4[C@](O)(C[C@@H]5OC)[C@H]6C[C@@H]32)C61 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 I16 compound treatment 14.0585 0.22192 0.0595 13.4833 -1.0145 -0.2404 -0.1279 -0.5163 3187758 BPBio1_000896 NC(=N)NCC1COC2(CCCCC2)O1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 I17 compound treatment 13.4159 -0.42073 -0.1129 14.291 -0.20682 -0.049 -0.1145 -0.9302 3187745 BPBio1_000897 C[C@@]12CC[C@H]3[C@@H](CCc4cc(OS(=O)(=O)O)ccc34)[C@@H]2CCC1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 I18 compound treatment 14.411 0.57439 0.1541 15.7031 1.2053 0.2856 0.3109 0.9581 3616817 BPBio1_000898 Nc1ncnc2n(cnc12)C3O[C@H](CO)[C@@H](O)[C@@H]3O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 I19 compound treatment 16.295 2.4584 0.6596 14.1908 -0.30697 -0.0727 0.415 0.6254 3616800 BPBio1_000899 CO[C@H]1C=C2CCN(C)[C@H]2C3[C@@H]1OC(=O)c4cc5OCOc5cc34 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 I20 compound treatment 14.6015 0.7649 0.2052 14.0763 -0.42147 -0.0999 0.0745 0.3265 1094 BPBio1_000900 COc1cnc(NS(=O)(=O)c2ccc(N)cc2)nc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 I21 compound treatment 14.4899 0.65328 0.1753 30.3248 15.827 3.75 2.7756 0.7394 3616802 BPBio1_000901 CCN1C[C@]2(C)CC[C@H](O)[C@]3([C@@H]2C[C@H]4C13)[C@@H]5C[C@H](O)[C@H]6C[C@]45[C@H](O)C6=C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 I22 compound treatment 15.8475 2.0109 0.5396 14.466 -0.031742 -0.0075 0.3762 0.6972 888 BPBio1_000902 CC(C)[N+](C)(CCC(C(=O)N)(c1ccccc1)c2ccccc2)C(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 I23 mock treatment 15.8714 2.0347 0.546 16.9293 2.4316 0.5761 0.7934 0.9996 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 I24 mock treatment 13.0641 -0.77251 -0.2073 12.655 -1.8428 -0.4366 -0.4553 -0.942 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 J01 compound treatment 17.4832 3.6466 0.9785 13.7248 -0.77296 -0.1831 0.5624 0.5649 3614717 BPBio1_000903 NCCn1oc(=O)[nH]c1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 J02 compound treatment 16.6225 2.7859 0.7475 9.9503 -4.5475 -1.0775 -0.2333 -0.1779 3614721 BPBio1_000904 OC/C=C/C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 J03 compound treatment 42.8962 29.06 7.7974 40.5851 26.087 6.181 9.8843 0.9934 3187888 BPBio1_000905 O=C1OC2(C[C@H]3C=CC2=C1)[C@H]4CCCCN34 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 J04 compound treatment 14.3608 0.52424 0.1407 14.5073 0.0095082 0.0023 0.1011 0.7183 1637 BPBio1_000906 CN/C(=C/[N+](=O)[O-])/NCCSCc1csc(CN(C)C)n1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 J05 compound treatment 10.8964 -2.9402 -0.7889 11.5931 -2.9047 -0.6882 -1.0445 -0.9977 3044756 BPBio1_000907 CC(CN(C)C)CN1c2ccccc2Sc3ccccc13.OC(C(O)C(=O)O)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 J06 compound treatment 14.2019 0.36532 0.098 13.3961 -1.1017 -0.261 -0.1153 -0.4134 3188017 BPBio1_000908 S=C(NC1CCCCC1)N2CCC(CC2)C3C=NC=N3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 J07 compound treatment 12.2766 -1.5601 -0.4186 15.224 0.72623 0.1721 -0.1743 -0.3852 3187889 BPBio1_000909 CCOc1ccc2ccccc2c1C(=O)N[C@H]3[C@H]4SC(C)(C)[C@@H](N4C3=O)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 J08 compound treatment 16.0739 2.2373 0.6003 12.1052 -2.3926 -0.5669 0.0236 0.0286 3061617 BPBio1_000910 OC(CNCCNC(=O)N1CCOCC1)COc2ccc(O)cc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 J09 compound treatment 14.4073 0.57074 0.1531 13.6763 -0.82147 -0.1946 -0.0293 -0.1185 1057 BPBio1_000911 OC(CCN1CCCC1)(C2CCCCC2)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 J10 compound treatment 14.7749 0.93827 0.2518 13.9955 -0.50227 -0.119 0.0939 0.3371 1000092 BPBio1_000912 COc1ccc(cc1OC2CCCC2)C3CNC(=O)C3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 J11 compound treatment 11.6585 -2.1781 -0.5844 13.2442 -1.2536 -0.297 -0.6233 -0.9507 3074401 BPBio1_000913 CN(C)CCCO[C@H]1[C@H](O[C@@H]2OC(C)(C)O[C@H]12)[C@H](O)CO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 J12 compound treatment 44.375 30.538 8.1942 36.7705 22.273 5.2772 9.5257 0.9773 1007994 BPBio1_000914 CCCCCCCCCCCCCCCC[N+](C)(C)CCN(Cc1ccc(OC)cc1)c2ncccn2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 J13 compound treatment 26.5284 12.692 3.4055 31.6809 17.183 4.0713 5.2869 0.9961 2710 BPBio1_000915 COc1ccc2[C@H]3CC[C@@]4(C)[C@@H](CC[C@@]4(O)C#C)[C@@H]3CCc2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 J14 compound treatment 17.9415 4.1049 1.1015 14.0272 -0.47057 -0.1115 0.7 0.6323 3060036 BPBio1_000916 C1CN=C(N1)C2COc3ccccc3O2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 J15 compound treatment 17.3737 3.5371 0.9491 12.298 -2.1998 -0.5212 0.3026 0.2794 3452 BPBio1_000917 CC(C)(C)NC[C@H](O)COc1cccc2C(=O)CCCc12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 J16 compound treatment 15.6082 1.7716 0.4754 11.5522 -2.9456 -0.6979 -0.1574 -0.1864 2844 BPBio1_000918 CCN(CC)C(=O)N[C@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(C)C1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 J17 compound treatment 12.635 -1.2016 -0.3224 14.0229 -0.47487 -0.1125 -0.3075 -0.9006 3487254 BPBio1_000919 CC(=O)N(CC(O)CN(C(=O)C)c1c(I)c(C(=O)NCC(O)CO)c(I)c(C(=O)NCC(O)CO)c1I)c2c(I)c(C(=O)NCC(O)CO)c(I)c(C(=O)NCC(O)CO)c2I 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 J18 compound treatment 12.4306 -1.406 -0.3773 12.3648 -2.133 -0.5054 -0.6241 -0.9896 1765 BPBio1_000920 CC1(C)NC(=O)N(C1=O)c2ccc([N+](=O)[O-])c(c2)C(F)(F)F 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 J19 compound treatment 15.0487 1.212 0.3252 16.7877 2.29 0.5426 0.6136 0.97 3069696 BPBio1_000921 CN(C)[C@H]1C2CC3C(=C(O)[C@]2(O)C(=O)C(=C1O)C(=O)NCN4CCCC4)C(=O)c5c(O)cccc5[C@@]3(C)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 J20 compound treatment 15.4482 1.6116 0.4324 11.106 -3.3918 -0.8036 -0.2625 -0.2876 3172846 BPBio1_000922 NC(CO)(CO)CO.OC(=O)C1CCn2c(ccc12)C(=O)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 J21 compound treatment 16.2526 2.416 0.6483 15.6076 1.1098 0.2629 0.6443 0.921 1405 BPBio1_000923 C[C@@]12CC[C@H]3C(=CCc4cc(O)ccc34)[C@@H]2CCC1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 J22 compound treatment 14.0986 0.26197 0.0703 16.4727 1.9749 0.4679 0.3806 0.8043 4487 BPBio1_000924 CNCCCC1c2ccccc2C=Cc3ccccc13 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 J23 mock treatment 14.6143 0.77769 0.2087 15.9114 1.4136 0.3349 0.3844 0.9741 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 J24 mock treatment 13.3653 -0.47131 -0.1265 13.4494 -1.0483 -0.2484 -0.2651 -0.951 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 K01 compound treatment 13.8688 0.032141 0.0086 12.548 -1.9498 -0.462 -0.3206 -0.6938 1002022 BPBio1_000925 NC(CCC(=O)O)C=C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 K02 compound treatment 12.7652 -1.0714 -0.2875 13.2598 -1.238 -0.2933 -0.4107 -0.9999 2178 BPBio1_000926 NCc1cc(O)no1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 K03 compound treatment 12.7038 -1.1328 -0.304 14.3971 -0.10067 -0.0239 -0.2318 -0.7603 3616804 BPBio1_000927 COc1cc(ccc1O)C(=O)O[C@@H]2C[C@@H]3CC[C@H](C2)N3C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 K04 compound treatment 14.1094 0.27282 0.0732 19.937 5.4392 1.2887 0.963 0.7461 3187759 BPBio1_000928 CCC(=O)OCC(=O)C1(OC(=O)CC)[C@H](C)C[C@H]2[C@@H]3[C@H](Cl)CC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 K05 compound treatment 12.8744 -0.96226 -0.2582 15.1104 0.61261 0.1451 -0.0799 -0.2699 3480066 BPBio1_000929 CN(C)CCCC1(OCc2cc(C#N)ccc21)c3ccc(F)cc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 K06 compound treatment 18.5589 4.7222 1.2671 11.8843 -2.6135 -0.6192 0.4581 0.3248 1499 BPBio1_000930 Cc1oncc1C(=O)Nc2ccc(cc2)C(F)(F)F 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 K07 compound treatment 12.0311 -1.8055 -0.4845 11.5188 -2.979 -0.7058 -0.8417 -0.9831 1047 BPBio1_000931 CN(C)CCCN1c2ccccc2Sc3ccccc13 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 K08 compound treatment 15.2443 1.4077 0.3777 18.5796 4.0818 0.9671 0.9509 0.9159 3069624 BPBio1_000932 CC[C@@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@H]34)[C@@H]2CC[C@@]1(O)C#C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 K09 compound treatment 15.8841 2.0474 0.5494 14.073 -0.42477 -0.1006 0.3173 0.5681 1177 BPBio1_000933 Cc1ccnc(NS(=O)(=O)c2ccc(N)cc2)n1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 K10 compound treatment 24.4659 10.629 2.8521 23.8097 9.3119 2.2063 3.5768 0.9919 3187760 BPBio1_000934 CC(=O)OCC(=O)[C@]12OC(C)(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@@]31C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 K11 compound treatment 11.7707 -2.0659 -0.5543 16.065 1.5672 0.3713 -0.1294 -0.194 1463 BPBio1_000935 COc1ccc(cc1)c2cc(=O)c3c(O)cc(O)cc3o2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 K12 compound treatment 15.8733 2.0367 0.5465 12.3309 -2.1669 -0.5134 0.0234 0.0312 934 BPBio1_000936 Cc1cc(C)nc(NS(=O)(=O)c2ccc(N)cc2)n1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 K13 compound treatment 16.1575 2.3208 0.6227 13.8127 -0.68507 -0.1623 0.3256 0.5059 1424515 BPBio1_000937 CCN1C(=O)NC(C1=O)c2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 K14 compound treatment 12.7257 -1.1109 -0.2981 14.0299 -0.46786 -0.1109 -0.2892 -0.9092 896 BPBio1_000938 COc1ccccc1OCC(O)CO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 K15 compound treatment 19.5138 5.6772 1.5233 15.9138 1.416 0.3355 1.3144 0.8426 3069570 BPBio1_000939 C[C@@]12CCC3[C@@H](CC[C@@H]4C[C@H](O)CC[C@@]43C)[C@@H]2CCC1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 K16 compound treatment 6.4943 -7.3423 -1.9701 28.2133 13.716 3.2497 0.9048 0.2381 1324 BPBio1_000940 CCCCC(CC)CNC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NCC(CC)CCCC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 K17 compound treatment 14.1308 0.29419 0.0789 14.06 -0.43782 -0.1037 -0.0175 -0.1345 1444 BPBio1_000941 C1CN=C(N1)C2CCCc3ccccc23 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 K18 compound treatment 37.89 24.053 6.4541 40.8554 26.358 6.245 8.9797 0.9999 1338 BPBio1_000942 CCCC(C(=O)OCCN(CC)CC)(c1ccccc1)c2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 K19 compound treatment 27.4507 13.614 3.653 21.3287 6.8309 1.6185 3.7275 0.9329 1070 BPBio1_000943 CCC(C(CC)c1ccc(O)cc1)c2ccc(O)cc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 K20 compound treatment 14.3599 0.52324 0.1404 15.2981 0.80026 0.1896 0.2334 0.9891 1533 BPBio1_000944 Cc1cc(CC(=O)O)n(C)c1C(=O)c2ccc(Cl)cc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 K21 compound treatment 13.7204 -0.11621 -0.0312 16.0866 1.5888 0.3764 0.2441 0.6463 1000312 BPBio1_000945 CO[C@]1(NC(=O)CSCC#N)[C@H]2SCC(=C(N2C1=O)C(=O)O)CSc3nnnn3C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 K22 compound treatment 16.409 2.5724 0.6902 12.993 -1.5048 -0.3565 0.236 0.3037 956 BPBio1_000946 CCn1nc(C(=O)O)c(=O)c2cc3OCOc3cc12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 K23 mock treatment 14.9172 1.0806 0.29 16.3792 1.8814 0.4458 0.5202 0.9783 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 K24 mock treatment 12.1188 -1.7178 -0.4609 14.0271 -0.47067 -0.1115 -0.4048 -0.8536 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 L01 compound treatment 15.2923 1.4557 0.3906 11.6882 -2.8096 -0.6657 -0.1945 -0.252 2060391 BPBio1_000947 OC1/C(=C/C(=O)O)/CCCc2ccccc12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 L02 compound treatment 11.7181 -2.1186 -0.5685 12.5847 -1.9131 -0.4533 -0.7225 -0.9937 907433 BPBio1_000948 OC(=O)C1=CCCN(CCON=C(c2ccccc2)c3ccccc3)C1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 L03 compound treatment 13.8303 -0.0062589 -0.0017 12.1124 -2.3854 -0.5652 -0.4008 -0.7092 3197 BPBio1_000949 Fc1ccc(cc1)[C@@H]2CCNC[C@H]2COc3ccc4OCOc4c3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 L04 compound treatment 21.9594 8.1228 2.1795 22.7359 8.2382 1.9519 2.9214 0.9985 1677 BPBio1_000950 CC(C)c1cccc(C(C)C)c1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 L05 compound treatment 14.2029 0.36627 0.0983 11.7717 -2.7261 -0.6459 -0.3872 -0.5927 3187892 BPBio1_000951 C[C@@H]1[C@H]2[C@H](O)[C@H]3[C@H](N(C)C)C(=C(C(=O)N)C(=O)C3(O)C(=C2C(=O)c4c(O)cccc14)O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 L06 compound treatment 15.7362 1.8996 0.5097 13.2313 -1.2665 -0.3001 0.1482 0.2506 3560914 BPBio1_000952 CCN1CCC[C@H]1CNC(=O)c2c(O)c(CC)cc(Cl)c2OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 L07 compound treatment 12.0668 -1.7699 -0.4749 14.9554 0.45761 0.1084 -0.2591 -0.532 1000323 BPBio1_000953 N[C@@H](Cc1cc(I)c(Oc2ccc(O)c(I)c2)c(I)c1)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 L08 compound treatment 13.3355 -0.50113 -0.1345 11.4245 -3.0733 -0.7282 -0.61 -0.8238 962 BPBio1_000954 CCC1(C(=O)NCNC1=O)c2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 L09 compound treatment 16.632 2.7954 0.7501 12.5067 -1.9911 -0.4718 0.1968 0.2221 3616837 BPBio1_000955 CC[C@H]1OC(=O)[C@H](C)[C@@H](OC2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C)[C@](C)(O)C[C@@H](C)/C(=N\OCOCCOC)/[C@H](C)[C@@H](O)[C@]1(C)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 L10 compound treatment 15.6076 1.771 0.4752 13.8272 -0.67054 -0.1589 0.2237 0.4464 1910 BPBio1_000956 Nc1nc(=O)[nH]cc1F 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 L11 compound treatment 19.9526 6.116 1.6411 20.2071 5.7093 1.3527 2.1169 0.9954 1000270 BPBio1_000957 CCC(=O)OCC(=O)[C@@]1(OC(=O)CC)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@@]21C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 L12 compound treatment 12.0357 -1.8009 -0.4832 12.9282 -1.5696 -0.3719 -0.6047 -0.9916 3069740 BPBio1_000958 C[C@]1(N[C@H]2Cc3ccccc31)c4ccccc24 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 L13 compound treatment 14.2024 0.36577 0.0981 15.3298 0.83196 0.1971 0.2088 0.9481 865 BPBio1_000959 Cc1ccc(cc1)C(=O)c2ccc(CC(=O)O)n2C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 L14 compound treatment 11.6626 -2.174 -0.5833 13.5812 -0.91661 -0.2172 -0.5661 -0.9094 3616850 BPBio1_000960 C[N+](C)(CCOc1ccccc1)Cc2ccccc2.OC(=O)c1cc2ccccc2cc1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 L15 compound treatment 14.7365 0.89987 0.2415 12.2986 -2.1991 -0.5211 -0.1977 -0.3443 3069698 BPBio1_000961 CC(C)(C)NC[C@@H](O)COc1cccc2C(=O)CCCc12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 L16 compound treatment 29.4106 15.574 4.1789 27.1436 12.646 2.9962 5.0736 0.9867 3069741 BPBio1_000962 CC(=O)O[C@H]1CC[C@]2(C)[C@H]3CC[C@@]4(C)[C@@H](CCC4=O)[C@@H]3CC=C2C1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 L17 compound treatment 13.2237 -0.61292 -0.1645 13.3002 -1.1976 -0.2837 -0.3169 -0.9664 1215118 BPBio1_000963 COc1cc2nc(nc(N)c2cc1OC)N3CCN(CC3)C(=O)C4COc5ccccc5O4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 L18 compound treatment 18.0651 4.2285 1.1346 16.6173 2.1195 0.5022 1.1574 0.9328 1095 BPBio1_000964 NC(CO)C(=O)NNCc1ccc(O)c(O)c1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 L19 compound treatment 15.9094 2.0728 0.5562 15.4379 0.94008 0.2227 0.5508 0.9193 3616839 BPBio1_000965 CC(C)n1c(/C=C/[C@H](O)C[C@H](O)CC(=O)O)c(c2ccc(F)cc2)c3ccccc13 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 L20 compound treatment 15.0886 1.252 0.3359 14.8244 0.32658 0.0774 0.2923 0.8478 2685 BPBio1_000966 OC(=O)c1c(I)cc(I)c(NC(=O)CCCCC(=O)Nc2c(I)cc(I)c(C(=O)O)c2I)c1I 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 L21 compound treatment 13.2861 -0.55046 -0.1477 15.9946 1.4968 0.3546 0.1463 0.3809 3069699 BPBio1_000967 C[C@@H]1NC(=O)NC1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 L22 compound treatment 12.5461 -1.2905 -0.3463 11.3357 -3.1621 -0.7492 -0.7746 -0.9385 1020463 BPBio1_000968 Oc1cc2ccc(=O)oc2cc1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 L23 mock treatment 10.7668 -3.0698 -0.8237 15.1262 0.62841 0.1489 -0.4772 -0.5701 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 L24 mock treatment 13.6619 -0.17466 -0.0469 12.9187 -1.5791 -0.3741 -0.2977 -0.7895 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 M01 compound treatment 13.9005 0.063916 0.0172 12.1936 -2.3042 -0.546 -0.3739 -0.6846 1677 BPBio1_000969 CC(C)c1cccc(C(C)C)c1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 M02 compound treatment 12.1944 -1.6422 -0.4407 10.8437 -3.6541 -0.8658 -0.9238 -0.9509 907141 BPBio1_000970 NCC(CP(=O)(O)O)c1ccc(Cl)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 M03 compound treatment 10.9412 -2.8954 -0.7769 16.5748 2.077 0.4921 -0.2014 -0.219 1005 BPBio1_000971 OC(CCN1CCCCC1)(C2CCCCC2)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 M04 compound treatment 17.1886 3.352 0.8994 19.0131 4.5153 1.0698 1.3925 0.9963 3069627 BPBio1_000972 CCC(=O)OC1([C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C)C(=O)CCl 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 M05 compound treatment 12.5477 -1.2889 -0.3458 13.2541 -1.2437 -0.2947 -0.4529 -0.9968 1603 BPBio1_000973 OC(=O)CCC(=O)Nc1ccc(cc1)S(=O)(=O)Nc2nccs2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 M06 compound treatment 240.7838 226.95 60.8958 230.26 215.76 51.1217 79.2083 0.9962 1001531 BPBio1_000974 COc1cc(cc(OC)c1OC)[C@H]2[C@@H]3[C@H](COC3=O)[C@@H](O)c4cc5OCOc5cc24 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 M07 compound treatment 12.4212 -1.4154 -0.3798 14.5462 0.048383 0.0115 -0.2605 -0.6855 907320 BPBio1_000975 CC(C)c1c(CN(C)C(C)Cc2ccccc2)n(C)n(c3ccccc3)c1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 M08 compound treatment 12.9949 -0.84166 -0.2258 11.2507 -3.2471 -0.7694 -0.7037 -0.8776 877 BPBio1_000976 CC(C)(Oc1ccc(Cl)cc1)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 M09 compound treatment 13.4599 -0.37673 -0.1011 10.0089 -4.4889 -1.0636 -0.8235 -0.7708 955 BPBio1_000977 CCN(CC)CCNC(=O)c1cc(Br)c(N)cc1OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 M10 compound treatment 14.3376 0.50094 0.1344 11.2249 -3.2729 -0.7755 -0.4533 -0.576 917 BPBio1_000978 NS(=O)(=O)c1cc2c(NC(Cc3ccccc3)NS2(=O)=O)cc1C(F)(F)F 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 M11 compound treatment 70.8444 57.008 15.2967 100.9053 86.408 20.473 25.293 0.9897 1286 BPBio1_000979 Cc1cc(ccc1OCCOCC[N+](C)(C)Cc2ccccc2)C(C)(C)CC(C)(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 M12 compound treatment 12.51 -1.3267 -0.356 13.8858 -0.61199 -0.145 -0.3542 -0.9216 1481 BPBio1_000980 Oc1c(Cc2c(O)c3ccccc3oc2=O)c(=O)oc4ccccc14 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 M13 compound treatment 22.8797 9.0431 2.4265 24.0192 9.5214 2.256 3.311 0.9993 863 BPBio1_000981 CN1CCN(CC1)C(c2ccccc2)c3ccc(Cl)cc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 M14 compound treatment 10.2657 -3.5709 -0.9582 13.3676 -1.1302 -0.2678 -0.8669 -0.8713 3092 BPBio1_000982 Cn1ccnc1S 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 M15 compound treatment 13.6069 -0.22968 -0.0616 16.8461 2.3483 0.5564 0.3498 0.625 1441 BPBio1_000983 CN1CCC(CC1)OC(c2ccccc2)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 M16 compound treatment 32.2038 18.367 4.9284 34.5798 20.082 4.7581 6.8494 0.9998 3616821 BPBio1_000984 O[Hg]c1c(O)c(Br)cc2c1Oc3cc(O)c(Br)cc3C42OC(=O)c5ccccc54 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 M17 compound treatment 40.1232 26.287 7.0534 20.769 6.2712 1.4859 6.0381 0.8377 1373 BPBio1_000985 CC(C)(C)CC(C)(C)c1ccc(OCCOCC[N+](C)(C)Cc2ccccc2)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 M18 compound treatment 13.7477 -0.088934 -0.0239 13.2061 -1.2917 -0.306 -0.2333 -0.7599 3187761 BPBio1_000986 CC(CNC1CCCCC1)OC(=O)c2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 M19 compound treatment 12.5678 -1.2688 -0.3404 10.5795 -3.9183 -0.9284 -0.8972 -0.9073 1012 BPBio1_000987 Cc1cc2cc3c(C)cc(=O)oc3c(C)c2o1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 M20 compound treatment 24.8885 11.052 2.9655 28.4873 13.99 3.3146 4.4407 0.9985 793 BPBio1_000988 CCN(CC)CCOC(=O)C(C1CCCCC1)c2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 M21 compound treatment 23.7678 9.9312 2.6648 25.0249 10.527 2.4942 3.648 0.9995 2117332 BPBio1_000989 C[C@@]12CC[C@H]3[C@@H](CC[C@]4(O)C[C@@H](O)CC[C@]34C=O)[C@@]2(O)CC[C@@H]1C5=CC(=O)OC5 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 M22 compound treatment 15.2858 1.4492 0.3889 16.5901 2.0923 0.4957 0.6255 0.9928 2080598 BPBio1_000990 C[C@H]1C[C@H](C)C(=O)[C@@H](C1)[C@H](O)CC2CC(=O)NC(=O)C2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 M23 mock treatment 13.5667 -0.26991 -0.0724 12.5325 -1.9653 -0.4656 -0.3805 -0.8074 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 M24 mock treatment 10.9832 -2.8535 -0.7657 12.7699 -1.7279 -0.4094 -0.8309 -0.957 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 N01 compound treatment 12.5646 -1.272 -0.3413 30.7341 16.236 3.847 2.4789 0.6418 1001950 BPBio1_000991 COc1ccc2[C@@H](OC(=O)c2c1OC)[C@H]3N(C)CCc4cc5OCOc5cc34 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 N02 compound treatment 14.134 0.29744 0.0798 13.6606 -0.83717 -0.1984 -0.0838 -0.392 3614723 BPBio1_000992 Nn1cc(Br)c(=O)[nH]c1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 N03 compound treatment 19.3183 5.4817 1.4709 15.7633 1.2655 0.2998 1.2521 0.8341 1764 BPBio1_000993 NCC1(CC(=O)O)CCCCC1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 N04 compound treatment 15.4228 1.5862 0.4256 12.1547 -2.3431 -0.5552 -0.0916 -0.1309 2030 BPBio1_000994 OC(=O)CN(CCN(CC(=O)O)CC(=O)O)CCN(CC(=O)O)CC(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 N05 compound treatment 15.8462 2.0096 0.5392 12.301 -2.1968 -0.5205 0.0132 0.0177 1694 BPBio1_000995 Oc1ccc(cc1)c2sc3cc(O)ccc3c2C(=O)c4ccc(OCCN5CCCCC5)cc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 N06 compound treatment 22.0968 8.2602 2.2164 12.8161 -1.6817 -0.3985 1.2855 0.5708 907192 BPBio1_000996 CC[N+](C)(C)Cc1ccccc1Br 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 N07 compound treatment 16.1417 2.3051 0.6185 12.4511 -2.0467 -0.4849 0.0944 0.1202 2764 BPBio1_000997 CC(O)(P(=O)(O)O)P(=O)(O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 N08 compound treatment 14.0722 0.23555 0.0632 14.1171 -0.38069 -0.0902 -0.0191 -0.1733 3172714 BPBio1_000998 C[n+]1ccccc1/C=N/O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 N09 compound treatment 12.1659 -1.6708 -0.4483 12.5895 -1.9083 -0.4522 -0.6367 -1.0 3069699 BPBio1_000999 C[C@@H]1NC(=O)NC1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 N10 compound treatment 29.3242 15.488 4.1557 31.2329 16.735 3.9652 5.7423 0.9997 1395 BPBio1_001000 CC(COc1ccccc1)N(CCCl)Cc2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 N11 compound treatment 19.5727 5.7361 1.5391 29.423 14.925 3.5363 3.5889 0.9305 1000094 BPBio1_001001 CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 N12 compound treatment 21.8142 7.9776 2.1406 18.0943 3.5965 0.8521 2.1162 0.9185 3480629 BPBio1_001002 OCc1cc(ccc1O)C(O)CNCCCCCCOCCCCc2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 N13 compound treatment 63.5968 49.76 13.3519 56.4881 41.99 9.949 16.4762 0.9895 3616840 BPBio1_001003 Nc1ncn(C2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)n1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 N14 compound treatment 16.2592 2.4225 0.65 14.1428 -0.35499 -0.0841 0.4002 0.6105 1371 BPBio1_001004 CN(C)c1nc(nc(n1)N(C)C)N(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 N15 compound treatment 14.9469 1.1103 0.2979 14.231 -0.26684 -0.0632 0.166 0.5449 3616841 BPBio1_001005 NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3OC4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 N16 compound treatment 30.8465 17.01 4.5642 19.0826 4.5848 1.0863 3.9955 0.8516 349 BPBio1_001006 COc1cc2nc(nc(N)c2cc1OC)N3CCN(CC3)C(=O)c4ccco4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 N17 compound treatment 14.3302 0.49364 0.1325 12.8469 -1.6509 -0.3912 -0.1829 -0.443 1267 BPBio1_001007 CC(=O)Nc1ccc(O)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 N18 compound treatment 11.7895 -2.0472 -0.5493 13.5038 -0.99404 -0.2355 -0.555 -0.9285 1428570 BPBio1_001008 CC(C)(C)NC[C@H](O)COc1nsnc1N2CCOCC2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 N19 compound treatment 14.5094 0.67274 0.1805 13.4302 -1.0676 -0.253 -0.0512 -0.1648 1604 BPBio1_001009 OC(=O)c1ccccc1C(=O)Nc2ccc(cc2)S(=O)(=O)Nc3nccs3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 N20 compound treatment 12.427 -1.4096 -0.3782 19.0348 4.537 1.075 0.4927 0.4323 893 BPBio1_001010 NCC(O)c1ccc(O)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 N21 compound treatment 13.819 -0.017584 -0.0047 13.7913 -0.70649 -0.1674 -0.1217 -0.7267 2137 BPBio1_001011 Oc1cc(O)c2c(=O)cc(oc2c1)c3ccc(O)c(O)c3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 N22 compound treatment 12.1173 -1.7193 -0.4613 17.8641 3.3663 0.7976 0.2378 0.2581 806 BPBio1_001012 OC(=O)C1CCCNC1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 N23 mock treatment 12.6109 -1.2257 -0.3289 16.7825 2.2847 0.5413 0.1502 0.2371 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 N24 mock treatment 16.1398 2.3032 0.618 12.1411 -2.3567 -0.5584 0.0422 0.0506 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 O01 compound treatment 13.4997 -0.33696 -0.0904 18.344 3.8462 0.9113 0.5805 0.6338 3060125 BPBio1_001013 CCc1c(ncc2[nH]c3cc(OC)c(OC)cc3c12)C(=O)OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 O02 compound treatment 14.3643 0.52772 0.1416 11.5257 -2.9721 -0.7042 -0.3978 -0.5538 2292 BPBio1_001014 CP(=O)(O)CCCN 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 O03 compound treatment 11.709 -2.1277 -0.5709 13.9184 -0.57942 -0.1373 -0.5008 -0.8528 1155 BPBio1_001015 Nc1ccc(cc1)S(=O)(=O)NC(=O)c2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 O04 compound treatment 13.5592 -0.27741 -0.0744 12.5328 -1.965 -0.4656 -0.3819 -0.8099 1000165 BPBio1_001016 COc1ccc2cc(ccc2c1)[C@@H](C)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 O05 compound treatment 15.0519 1.2153 0.3261 11.4066 -3.0911 -0.7324 -0.2873 -0.3584 1513 BPBio1_001017 CCOC(=O)c1ccc(N)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 O06 compound treatment 14.3669 0.53032 0.1423 9.219 -5.2788 -1.2507 -0.7838 -0.6226 244 BPBio1_001018 CC[N+](C)(CC)CCC[n+]1c(c2ccccc2)c3cc(N)ccc3c4ccc(N)cc14 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 O07 compound treatment 11.8919 -1.9447 -0.5218 12.4547 -2.0431 -0.4841 -0.7113 -0.9993 1242 BPBio1_001019 CN(CS(=O)(=O)O)c1c(C)n(C)n(c2ccccc2)c1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 O08 compound treatment 30.3659 16.529 4.4352 17.6987 3.2009 0.7584 3.6725 0.8162 1431 BPBio1_001020 Clc1ccc(cc1)C(OCCN2CCCCC2)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 O09 compound treatment 15.3642 1.5276 0.4099 12.6781 -1.8197 -0.4311 -0.015 -0.0253 1064 BPBio1_001021 [O-][N+](=O)O[C@@H]1CO[C@@H]2[C@H](CO[C@H]12)O[N+](=O)[O-] 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 O10 compound treatment 14.378 0.54135 0.1453 11.1441 -3.3536 -0.7946 -0.4592 -0.5684 3187762 BPBio1_001022 CC1CC(CC(C)(C)N1C)OC(=O)C(O)c2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 O11 compound treatment 15.6151 1.7785 0.4772 12.1972 -2.3006 -0.5451 -0.048 -0.0663 1668673 BPBio1_001023 Nc1ccc(cc1)S(=O)(=O)Nc2ccc(Cl)nn2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 O12 compound treatment 14.8169 0.98032 0.263 10.7114 -3.7864 -0.8971 -0.4484 -0.4796 3383 BPBio1_001024 Cc1cc(no1)C(=O)NNCc2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 O13 compound treatment 16.3088 2.4722 0.6633 12.8657 -1.6321 -0.3867 0.1956 0.2548 1467 BPBio1_001025 CCCCOc1ccc(OCCCN2CCOCC2)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 O14 compound treatment 16.3116 2.475 0.6641 12.7304 -1.7673 -0.4187 0.1735 0.221 2105063 BPBio1_001026 C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 O15 compound treatment 12.4711 -1.3655 -0.3664 14.1487 -0.34912 -0.0827 -0.3176 -0.8455 3069574 BPBio1_001027 CC(C)(C)NC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4NC(=O)C=C[C@]4(C)[C@H]3CC[C@]12C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 O16 compound treatment 15.938 2.1014 0.5639 15.5378 1.04 0.2464 0.573 0.9311 2752 BPBio1_001028 COc1ccc2Sc3ccccc3N(C[C@H](C)CN(C)C)c2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 O17 compound treatment 14.5508 0.71418 0.1916 18.2896 3.7918 0.8984 0.7708 0.8391 2081008 BPBio1_001029 C[C@H]1C[C@H]2[C@@H]3CC[C@](O)(C(=O)C)[C@@]3(C)C[C@H](O)[C@]2(F)[C@@]4(C)C=CC(=O)C=C14 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 O18 compound treatment 32.0238 18.187 4.8801 30.1626 15.665 3.7115 6.0752 0.9909 1370 BPBio1_001030 C/C=C(/C(=C/C)/c1ccc(O)cc1)\c2ccc(O)cc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 O19 compound treatment 14.5345 0.69792 0.1873 14.1597 -0.33809 -0.0801 0.0758 0.372 759 BPBio1_001031 CC(=O)OCC1=C(N2[C@H](SC1)[C@H](NC(=O)Cc3cccs3)C2=O)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 O20 compound treatment 15.8436 2.0069 0.5385 13.4625 -1.0353 -0.2453 0.2073 0.3504 1328 BPBio1_001032 OC(CCN1CCCCC1)(c2ccccc2)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 O21 compound treatment 13.2379 -0.59874 -0.1607 14.1279 -0.36989 -0.0876 -0.1756 -0.9594 3616807 BPBio1_001033 CO/N=C(\C(=O)N[C@H]1[C@H]2SCC(=C(N2C1=O)C(=O)O)COC(=O)N)/c3ccco3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 O22 compound treatment 11.607 -2.2297 -0.5983 12.7165 -1.7813 -0.4221 -0.7215 -0.9854 794 BPBio1_001034 Nc1cc(c[nH]c1=O)c2ccncc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 O23 mock treatment 12.7874 -1.0492 -0.2815 13.2943 -1.2035 -0.2852 -0.4007 -1.0 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 O24 mock treatment 12.9154 -0.92118 -0.2472 15.0533 0.55546 0.1316 -0.0817 -0.2918 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 P01 compound treatment 12.6014 -1.2352 -0.3314 12.5681 -1.9297 -0.4572 -0.5577 -0.9875 1206 BPBio1_001035 CC(=C)[C@@H]1[C@H]2OC(=O)[C@@H]1[C@]3(O)C[C@H]4O[C@]45C(=O)O[C@H]2[C@@]53C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 P02 compound treatment 11.8736 -1.963 -0.5267 12.2144 -2.2833 -0.541 -0.755 -0.9999 3060051 BPBio1_001036 COC(=O)c1cc2c(cn1)[nH]c3ccccc32 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 P03 compound treatment 13.9037 0.067091 0.018 17.8577 3.3599 0.7961 0.5756 0.7229 3069701 BPBio1_001037 C[C@H](O)C(=O)Nc1c(I)c(C(=O)NC(CO)CO)c(I)c(C(=O)NC(CO)CO)c1I 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 P04 compound treatment 13.9126 0.075991 0.0204 12.6483 -1.8495 -0.4382 -0.2954 -0.6735 2660 BPBio1_001038 CCN(C(=O)/C=C/C)c1ccccc1C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 P05 compound treatment 16.1796 2.343 0.6287 14.1927 -0.30506 -0.0723 0.3934 0.6217 3487261 BPBio1_001039 COCC(=O)Nc1c(I)c(C(=O)NCC(O)CO)c(I)c(C(=O)N(C)CC(O)CO)c1I 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 P06 compound treatment 15.1007 1.2641 0.3392 13.1084 -1.3894 -0.3292 0.0071 0.015 351 BPBio1_001040 CC(C)NCC(O)COc1cccc2ccccc12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 P07 compound treatment 15.0482 1.2116 0.3251 13.4905 -1.0073 -0.2387 0.0611 0.1515 856 BPBio1_001041 Cn1c(=O)n(C)c2nc[nH]c2c1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 P08 compound treatment 12.499 -1.3376 -0.3589 15.0284 0.53056 0.1257 -0.1649 -0.4336 1001858 BPBio1_001042 CC(C)NC[C@H](O)COc1ccc(CC(=O)N)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 P09 compound treatment 13.3324 -0.50426 -0.1353 12.5252 -1.9726 -0.4674 -0.4262 -0.8759 1222 BPBio1_001043 Cn1cnc2n(C)c(=O)[nH]c(=O)c12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 P10 compound treatment 13.4713 -0.36536 -0.098 17.5523 3.0545 0.7237 0.4424 0.6058 3188022 BPBio1_001044 CC(C)(C)CC(C)(C)c1ccc(OCOCCOCCO)c(Cc2cc(cc(Cc3cc(ccc3OCOCCOCCO)C(C)(C)CC(C)(C)C)c2OCOCCOCCO)C(C)(C)CC(C)(C)C)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 P11 compound treatment 20.1737 6.3371 1.7004 17.3233 2.8255 0.6695 1.6757 0.917 687 BPBio1_001045 CO[C@H]1[C@@H](C[C@@H]2CN3CCc4c([nH]c5cc(OC)ccc45)[C@H]3C[C@@H]2[C@@H]1C(=O)OC)OC(=O)c6cc(OC)c(OC)c(OC)c6 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 P12 compound treatment 12.5639 -1.2727 -0.3415 11.3013 -3.1965 -0.7574 -0.777 -0.9353 3069742 BPBio1_001046 CS(=O)(=O)c1ccc(cc1)[C@@H](O)[C@@H](CF)NC(=O)C(Cl)Cl 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 P13 compound treatment 15.0567 1.2201 0.3274 10.5768 -3.921 -0.929 -0.4254 -0.4319 989 BPBio1_001047 NC(=N)NCCCCNC(=N)N 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 P14 compound treatment 16.8382 3.0016 0.8054 18.2647 3.7669 0.8925 1.2006 0.9987 4369 BPBio1_001048 CC(=O)O[C@@]1(CC[C@H]2[C@@H]3C=C(C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C)C(=O)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 P15 compound treatment 15.9758 2.1392 0.574 14.0439 -0.45387 -0.1075 0.3298 0.5648 3075421 BPBio1_001049 CN1[C@H]2C[C@@H](C[C@@H]1[C@H]3O[C@H]32)OC(=O)[C@H](CO)c4ccccc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 P16 compound treatment 14.3212 0.48459 0.13 13.2212 -1.2766 -0.3025 -0.1219 -0.3704 3069771 BPBio1_001050 C[C@@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@]34C)[C@@H]2CC[C@@H]1C(=O)CO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 P17 compound treatment 14.7429 0.90627 0.2432 15.0566 0.55886 0.1324 0.2656 0.9592 3487262 BPBio1_001051 OCCN(C(=O)CO)c1c(I)c(C(=O)NCC(O)CO)c(I)c(C(=O)NCC(O)CO)c1I 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 P18 compound treatment 13.7067 -0.12992 -0.0349 16.0213 1.5235 0.361 0.2306 0.6359 1000212 BPBio1_001052 C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3[C@@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 P19 compound treatment 18.5943 4.7577 1.2766 13.0585 -1.4393 -0.341 0.6616 0.5007 446 BPBio1_001053 COc1cc(CNC(=O)CCCC/C=C/C(C)C)ccc1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 P20 compound treatment 13.3382 -0.49846 -0.1337 14.6628 0.16504 0.0391 -0.0669 -0.4803 4481 BPBio1_001054 CCCOc1ccc(cc1N)C(=O)OCCN(CC)CC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 P21 compound treatment 16.4494 2.6128 0.7011 15.9901 1.4923 0.3536 0.7458 0.9498 1327 BPBio1_001055 C[N+](C)(C)CCOC(=O)N 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 P22 compound treatment 12.501 -1.3356 -0.3584 11.8863 -2.6115 -0.6188 -0.6909 -0.9663 1167 BPBio1_001056 NCCCCCC(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 P23 mock treatment 11.8992 -1.9374 -0.5198 15.2682 0.77043 0.1825 -0.2385 -0.4329 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2322 P24 mock treatment 11.2356 -2.601 -0.6979 15.6508 1.153 0.2732 -0.3003 -0.4007 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 A01 compound treatment 27.5889 13.56 3.6385 24.6489 11.335 2.6856 4.4718 0.9888 3614724 BPBio1_001057 CCCCOC(=O)c1cc2c(cn1)[nH]c3ccccc32 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 A02 compound treatment 19.5797 5.5506 1.4894 18.6788 5.3647 1.2711 1.9519 0.9969 3614728 BPBio1_001058 COc1ccc(CCNC(=O)C(=O)c2c[nH]c3ccccc23)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 A03 compound treatment 11.9782 -2.0508 -0.5503 13.0997 -0.21442 -0.0508 -0.425 -0.7691 1073908 BPBio1_001059 CC[N+](CC)(CC(=O)Nc1c(C)cccc1C)Cc2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 A04 compound treatment 17.1646 3.1355 0.8413 17.2718 3.9577 0.9377 1.258 0.9985 3616869 BPBio1_001060 CCOC(=O)c1cncn1[C@@H](C)c2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 A05 compound treatment 12.8887 -1.1403 -0.306 15.1792 1.8651 0.4419 0.0961 0.1788 1322 BPBio1_001061 COc1cc2ccc(=O)oc2cc1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 A06 compound treatment 15.6052 1.5762 0.4229 13.559 0.24492 0.058 0.3401 0.7967 3188157 BPBio1_001062 CC[N+](CC)(CC)CCC(O)(C1CCCCC1)c2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 A07 compound treatment 15.5799 1.5508 0.4161 16.1315 2.8174 0.6675 0.7663 0.9741 1081653 BPBio1_001063 Clc1ccc(C(Cn2ccnc2)OCC=C)c(Cl)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 A08 compound treatment 17.6808 3.6517 0.9799 35.7514 22.437 5.3162 4.452 0.8236 3487585 BPBio1_001064 CC(C)(C)NCC(O)COc1ccccc1C2CCCC2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 A09 compound treatment 17.5606 3.5316 0.9476 16.2826 2.9685 0.7033 1.1674 0.9892 1203 BPBio1_001065 CN(C)[C@H]1[C@@H]2[C@@H](O)[C@@H]3C(=C)c4cccc(O)c4C(=O)C3=C(O)[C@]2(O)C(=O)C(=C1O)C(=O)N 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 A10 compound treatment 0.0 -14.029 -3.7644 15.232 1.9179 0.4544 -2.3405 -0.6173 3188158 BPBio1_001066 CCOC(=O)O[C@@]1(CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C)C(=O)COC(=O)CC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 A11 compound treatment 13.3064 -0.72267 -0.1939 16.5661 3.252 0.7705 0.4077 0.5132 2060138 BPBio1_001067 C[C@]1([C@H]2[C@H](C(=O)O)[C@]3(CC(=C)[C@@]4(O)C3)[C@@H](CC4)[C@]52OC1=O)[C@@H](O)C=C5 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 A12 compound treatment 16.002 1.973 0.5294 18.0681 4.754 1.1264 1.1708 0.9407 3069813 BPBio1_001068 Clc1ccc(C(Cn2ccnc2)OCc3csc4c(Cl)cccc34)c(Cl)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 A13 compound treatment 14.054 0.024956 0.0067 34.2676 20.953 4.9646 3.5153 0.7081 3480627 BPBio1_001069 CC(C)NCC(O)c1ccc(NS(=O)(=O)C)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 A14 compound treatment 13.4179 -0.61115 -0.164 17.5659 4.2518 1.0074 0.5964 0.5843 3188159 BPBio1_001070 CCOc1cc(CC(=O)N[C@@H](CC(C)C)c2ccccc2N3CCCCC3)ccc1C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 A15 compound treatment 12.8706 -1.1585 -0.3108 14.339 1.0249 0.2428 -0.0481 -0.1219 3616851 BPBio1_001071 CN1[C@H]2C[C@@H](O)[C@@H]1CC(=O)C2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 A16 compound treatment 16.6235 2.5945 0.6962 15.5737 2.2596 0.5354 0.8708 0.9916 3168 BPBio1_001072 NS(=O)(=O)c1cc(cc(N2CCCC2)c1Oc3ccccc3)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 A17 compound treatment 15.9718 1.9427 0.5213 12.7371 -0.57696 -0.1367 0.2719 0.5046 3855 BPBio1_001073 C[N+](C)(C)CCCCCCCCCC[N+](C)(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 A18 compound treatment 18.357 4.3279 1.1613 20.4907 7.1767 1.7004 2.0235 0.9827 3188160 BPBio1_001074 CC(=O)c1ccc2Sc3ccccc3N(CCCN4CCC(CCO)CC4)c2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 A19 compound treatment 13.5293 -0.49977 -0.1341 14.0617 0.74759 0.1771 0.0304 0.1369 1040327 BPBio1_001075 CC(=O)Nc1cc2ccccc2oc1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 A20 compound treatment 113.2699 99.241 26.6289 136.8495 123.54 29.2699 39.5264 0.9989 943 BPBio1_001076 CCCCC1C(=O)N(N(C1=O)c2ccc(O)cc2)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 A21 compound treatment 17.1358 3.1067 0.8336 19.9326 6.6185 1.5682 1.6983 0.9563 1120 BPBio1_001077 Oc1ccc(cc1[N+](=O)[O-])[As](=O)(O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 A22 compound treatment 21.6885 7.6594 2.0552 16.125 2.8109 0.666 1.9242 0.8907 3069814 BPBio1_001078 CCC1NC(=O)c2cc(c(Cl)cc2N1)S(=O)(=O)N 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 A23 mock treatment 16.0781 2.0491 0.5498 13.3608 0.04676 0.0111 0.3966 0.7212 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 A24 mock treatment 13.6331 -0.39595 -0.1062 15.1593 1.8452 0.4372 0.234 0.5201 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 B01 compound treatment 26.6282 12.599 3.3807 16.4399 3.1258 0.7406 2.9142 0.842 429 BPBio1_001079 NCCc1c[nH]c2ccc(O)cc12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 B02 compound treatment 14.1209 0.091803 0.0246 16.5983 3.2842 0.7781 0.5676 0.7291 3614640 BPBio1_001080 C[C@@H](N)CCCP(=O)(O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 B03 compound treatment 15.0353 1.0063 0.27 14.9367 1.6226 0.3844 0.4628 0.9851 309349 BPBio1_001081 CN1CCN(CC1)c2ccc3ccccc3n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 B04 compound treatment 12.4178 -1.6112 -0.4323 14.2793 0.96524 0.2287 -0.144 -0.2944 3614665 BPBio1_001082 N[C@@]1(CC[C@@H](C1)C(=O)O)C(=O)O.N[C@]1(CC[C@H](C1)C(=O)O)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 B05 compound treatment 13.8295 -0.19952 -0.0535 12.246 -1.0681 -0.2531 -0.2168 -0.8381 907389 BPBio1_001083 CC(N)Cc1c[nH]c2ccc(O)cc12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 B06 compound treatment 15.4731 1.4441 0.3875 13.7241 0.41 0.0971 0.3427 0.8578 1325 BPBio1_001084 NC1(CCCC1)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 B07 compound treatment 14.2619 0.23285 0.0625 14.7606 1.4465 0.3427 0.2865 0.8225 3614527 BPBio1_001085 C=CCN1CCN(CC1)c2nc3ccccc3nc2C#N 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 B08 compound treatment 35.5616 21.533 5.7777 36.2666 22.952 5.4382 7.9309 0.9995 831767 BPBio1_001086 NCCCNCCCCNCCCN 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 B09 compound treatment 28.2146 14.186 3.8064 28.9974 15.683 3.7159 5.3191 0.9999 3614475 BPBio1_001087 Fc1ccc(OCCCN2CCC3(CC2)N(CNC3=O)c4ccccc4)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 B10 compound treatment 10.1704 -3.8587 -1.0354 13.7822 0.46811 0.1109 -0.6537 -0.6278 2105 BPBio1_001088 CC1Nc2ccc(Cl)cc2S(=O)(=O)N1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 B11 compound treatment 14.7159 0.68685 0.1843 15.534 2.2199 0.526 0.5022 0.9012 3561419 BPBio1_001089 Clc1cccc(SC2CCNCC2)n1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 B12 compound treatment 23.7266 9.6976 2.6021 25.236 11.922 2.8247 3.8374 0.9992 3614454 BPBio1_001090 CCCN(C/C=C/I)C1CCc2ccc(O)cc2C1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 B13 compound treatment 20.7309 6.7018 1.7983 23.1958 9.8817 2.3413 2.9271 0.9915 907222 BPBio1_001091 CN1CCN(CC1)c2nc3cc(ccc3n4cccc24)C(F)(F)F 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 B14 compound treatment 15.2324 1.2034 0.3229 17.1379 3.8238 0.906 0.869 0.9035 3061067 BPBio1_001092 CCN(CC)C(=O)N[C@H]1CN(C)[C@@H]2Cc3c[nH]c4cccc(C2=C1)c34 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 B15 compound treatment 12.3785 -1.6505 -0.4429 14.8552 1.5411 0.3651 -0.055 -0.0958 1077753 BPBio1_001093 CN(C)CCN1C(=O)c2ccccc2N(C)c3ccccc13 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 B16 compound treatment 27.7365 13.707 3.6781 26.1293 12.815 3.0364 4.7478 0.9955 3177240 BPBio1_001094 OC1(CCN(Cc2c[nH]c3ccccc23)CC1)c4ccc(Cl)cc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 B17 compound treatment 16.038 2.009 0.5391 15.3059 1.9919 0.4719 0.7149 0.9978 3614505 BPBio1_001095 CC(C)[C@@]1(NC(=O)[C@@H]2CC3[C@@H](Cc4c[nH]c5cccc3c45)N(C)C2)O[C@@]6(O)[C@@H]7CCCN7C(=O)[C@H](Cc8ccccc8)N6C1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 B18 compound treatment 13.8266 -0.20244 -0.0543 13.0496 -0.26446 -0.0627 -0.0827 -0.9975 3614486 BPBio1_001096 Cc1c(noc1c2ccc(Cl)cc2)C3CCN(CCc4ccccc4)CC3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 B19 compound treatment 12.958 -1.0711 -0.2874 11.2537 -2.0604 -0.4882 -0.5484 -0.9681 1001895 BPBio1_001097 CN(C)CCCSc1ccccc1NC(=O)/C=C/c2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 B20 compound treatment 10.7988 -3.2302 -0.8667 12.7121 -0.60199 -0.1426 -0.7137 -0.8125 1001903 BPBio1_001098 COc1ccc2C[C@H]3N(C)CCc4cc(O)cc(c34)-c2c1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 B21 compound treatment 10.4655 -3.5636 -0.9562 12.4887 -0.82538 -0.1956 -0.8144 -0.8345 3560446 BPBio1_001099 CN1CCN(CC1)C2=Nc3cc(F)ccc3Cc4ccccc24 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 B22 compound treatment 12.8324 -1.1966 -0.3211 13.9716 0.65751 0.1558 -0.1169 -0.3275 734 BPBio1_001100 CCN(CC)CCNC(=O)c1cc(Cl)c(N)cc1OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 B23 mock treatment 11.066 -2.963 -0.7951 12.9458 -0.36829 -0.0873 -0.6239 -0.78 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 B24 mock treatment 15.3739 1.3448 0.3609 14.4304 1.1163 0.2645 0.4422 0.9883 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 C01 compound treatment 19.1866 5.1575 1.3839 20.0225 6.7084 1.5895 2.1025 0.9976 3561772 BPBio1_001101 CCCOC(=O)c1cc2c(cn1)[nH]c3ccccc32 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 C02 compound treatment 12.5925 -1.4366 -0.3855 14.4514 1.1374 0.2695 -0.082 -0.1744 907300 BPBio1_001102 CNC(=O)c1cc2c(cn1)[nH]c3ccccc32 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 C03 compound treatment 16.0788 2.0498 0.55 15.1196 1.8055 0.4278 0.6914 0.9923 3188026 BPBio1_001103 CCN1CCC[C@H]1CNC(=O)c2c(OC)ccc(Br)c2OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 C04 compound treatment 14.7598 0.73078 0.1961 15.2899 1.9759 0.4682 0.4697 0.9254 1267101 BPBio1_001104 CCOC(=O)Nc1ccc2Sc3ccccc3N(C(=O)CCN4CCOCC4)c2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 C05 compound treatment 13.2497 -0.7794 -0.2091 15.408 2.0939 0.4961 0.2029 0.3769 864 BPBio1_001105 Oc1noc2CNCCc12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 C06 compound treatment 13.9116 -0.1174 -0.0315 22.3509 9.0368 2.1411 1.4917 0.6966 1487 BPBio1_001106 CCC(Cc1c(I)cc(I)c(N)c1I)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 C07 compound treatment 15.3425 1.3135 0.3524 14.5824 1.2683 0.3005 0.4617 0.9969 1134931 BPBio1_001107 Cc1ccc2n3CCNC4CCCc(c43)c2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 C08 compound treatment 15.0621 1.0331 0.2772 13.4111 0.09706 0.023 0.2123 0.7631 3188161 BPBio1_001108 CC(C)(C)C(=O)OCOC(=O)[C@@H]1N2[C@H](SC1(C)C)[C@H](/N=C/N3CCCCCC3)C2=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 C09 compound treatment 18.3799 4.3509 1.1674 13.6735 0.35941 0.0852 0.8857 0.7567 1512 BPBio1_001109 CC(C)NCC(O)c1ccc2ccccc2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 C10 compound treatment 14.232 0.203 0.0545 14.3793 1.0652 0.2524 0.217 0.8404 3188162 BPBio1_001110 CCC(=O)OC(Cc1ccccc1)(C(C)CN(C)C)c2ccccc2.OS(=O)(=O)c1ccc2ccccc2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 C11 compound treatment 11.4575 -2.5716 -0.69 14.8206 1.5065 0.3569 -0.2355 -0.3032 3480607 BPBio1_001111 COc1ccccc1N2CCN(CC(O)COc3cccc4ccccc34)CC2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 C12 compound treatment 14.3115 0.28243 0.0758 57.9136 44.6 10.5672 7.5257 0.7122 772 BPBio1_001112 CCN1CCCC(C1)OC(=O)C(c2ccccc2)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 C13 compound treatment 17.0948 3.0657 0.8226 24.4636 11.15 2.6417 2.4496 0.8854 907524 BPBio1_001113 CCCCNc1c(C(=O)OCC)c(C)nc2n(CC)ncc12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 C14 compound treatment 16.6078 2.5788 0.692 19.5575 6.2435 1.4793 1.5353 0.9401 1001642 BPBio1_001114 OC[C@H]1OC(C[C@@H]1O)n2cc(c(=O)[nH]c2=O)C(F)(F)F 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 C15 compound treatment 14.6739 0.64485 0.173 15.3643 2.0502 0.4858 0.4658 0.9034 2372 BPBio1_001115 COc1cc(ccc1OC(F)F)c2ccc(=O)[nH]n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 C16 compound treatment 13.0136 -1.0154 -0.2725 14.3538 1.0397 0.2463 -0.0185 -0.0503 1001977 BPBio1_001116 CC(C)NCC(O)COc1ccccc1OCC=C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 C17 compound treatment 12.21 -1.819 -0.4881 16.6423 3.3282 0.7886 0.2125 0.2291 733 BPBio1_001117 CC1(CC2CC3(C)C1)CC(N)(C2)C3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 C18 compound treatment 7.9094 -6.1196 -1.6421 13.9311 0.61699 0.1462 -1.0577 -0.6416 1434439 BPBio1_001118 Cc1nccn1CC2CCc3c(C2=O)c4ccccc4n3C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 C19 compound treatment 11.6855 -2.3435 -0.6288 15.7176 2.4035 0.5695 -0.042 -0.0495 2742 BPBio1_001119 OC(=O)/C=C/c1ccc(Cn2ccnc2)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 C20 compound treatment 14.1956 0.16654 0.0447 12.8648 -0.44926 -0.1064 -0.0437 -0.3783 3069816 BPBio1_001120 CCCOc1cc(N)ccc1C(=O)OCCN(CC)CC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 C21 compound treatment 12.4841 -1.5449 -0.4145 42.241 28.927 6.8538 4.5533 0.6631 2245 BPBio1_001121 C(N1CCN(CC1)c2ncccn2)c3ccc4OCOc4c3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 C22 compound treatment 13.5235 -0.50552 -0.1356 16.103 2.7889 0.6608 0.3713 0.5505 1672 BPBio1_001122 OC(=O)CCc1nc(c(o1)c2ccccc2)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 C23 mock treatment 12.3697 -1.6593 -0.4452 13.0021 -0.31195 -0.0739 -0.3671 -0.8134 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 C24 mock treatment 11.825 -2.2041 -0.5914 13.5448 0.23072 0.0547 -0.3795 -0.639 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 D01 compound treatment 13.257 -0.77202 -0.2072 12.2835 -1.0306 -0.2442 -0.3191 -0.9967 1378 BPBio1_001123 NCCc1ccc(O)c(O)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 D02 compound treatment 12.228 -1.8011 -0.4833 22.262 8.9479 2.1201 1.1574 0.5323 3614617 BPBio1_001124 CC[C@@H](NC)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 D03 compound treatment 13.8313 -0.19777 -0.0531 12.6195 -0.69455 -0.1646 -0.1539 -0.89 864860 BPBio1_001125 CNCCc1ccc(O)c(O)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 D04 compound treatment 13.215 -0.8141 -0.2184 12.5254 -0.78874 -0.1869 -0.2866 -0.997 3561549 BPBio1_001126 N[C@H](CC(=O)O)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 D05 compound treatment 25.4221 11.393 3.0571 17.6282 4.3141 1.0222 2.8845 0.8948 2048 BPBio1_001127 NC1CCc2cc(O)c(O)cc2C1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 D06 compound treatment 13.2312 -0.7978 -0.2141 13.2072 -0.1069 -0.0253 -0.1693 -0.7853 1001854 BPBio1_001128 N[C@@H](CC(=O)O)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 D07 compound treatment 14.1592 0.1301 0.0349 12.2276 -1.0865 -0.2574 -0.1574 -0.6057 3614445 BPBio1_001129 CCCN[C@@H]1CCc2c(OC)cccc2[C@@H]1C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 D08 compound treatment 14.4625 0.4334 0.1163 11.5248 -1.7893 -0.424 -0.2175 -0.4949 3560077 BPBio1_001130 N[C@H](CCC(=O)O)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 D09 compound treatment 13.1473 -0.88175 -0.2366 13.4842 0.17014 0.0403 -0.1388 -0.5783 1000273 BPBio1_001131 CC(C)C[C@@H]1N2C(=O)[C@](NC(=O)[C@H]3CN(C)[C@@H]4Cc5c(Br)[nH]c6cccc(C4=C3)c56)(O[C@@]2(O)[C@@H]7CCCN7C1=O)C(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 D10 compound treatment 9.1178 -4.9113 -1.3178 13.6238 0.30974 0.0734 -0.8799 -0.6667 2674 BPBio1_001132 N[C@@H](CCC(=O)O)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 D11 compound treatment 18.3313 4.3023 1.1544 15.3917 2.0776 0.4923 1.1644 0.9278 3614449 BPBio1_001133 CC(C)[C@@H]1N2C(=O)[C@](NC(=O)[C@H]3CN(C)[C@@H]4Cc5c[nH]c6cccc(C4=C3)c56)(O[C@@]2(O)[C@@H]7CCCN7C1=O)C(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 D12 compound treatment 14.1638 0.1347 0.0361 13.3996 0.085468 0.0203 0.0399 0.9625 3614623 BPBio1_001134 C[C@H]1C[C@](N)(C1)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 D13 compound treatment 33.1298 19.101 5.1252 30.9962 17.682 4.1895 6.5865 0.995 3176926 BPBio1_001135 C1CCN(CC1)C2(CCCCC2)c3cc4ccccc4s3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 D14 compound treatment 10.3559 -3.6731 -0.9856 14.6229 1.3088 0.3101 -0.4777 -0.4623 3614626 BPBio1_001136 N[C@]1(C[C@H](C1)C(=O)O)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 D15 compound treatment 17.264 3.2349 0.868 20.5473 7.2332 1.7138 1.8256 0.9503 3560442 BPBio1_001137 CN1CCN(CC1)C2=Nc3ccccc3Sc4ccc(Cl)cc24 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 D16 compound treatment 11.2569 -2.7721 -0.7438 11.1281 -2.186 -0.5179 -0.8922 -0.9844 3614630 BPBio1_001138 C[C@H](N)CCP(=O)(O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 D17 compound treatment 12.238 -1.7911 -0.4806 14.0424 0.72834 0.1726 -0.2178 -0.4265 417 BPBio1_001139 CN1CCN(CC1)C2=Nc3cc(Cl)ccc3Nc4ccccc24 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 D18 compound treatment 12.5215 -1.5075 -0.4045 12.7054 -0.60868 -0.1442 -0.388 -0.9035 3614635 BPBio1_001140 C[C@@H](N)CCP(=O)(O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 D19 compound treatment 10.3858 -3.6432 -0.9776 11.9795 -1.3346 -0.3162 -0.9148 -0.8904 907273 BPBio1_001141 Fc1ccc(cc1)C(OCCN2CCN(CCCc3ccccc3)CC2)c4ccc(F)cc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 D20 compound treatment 13.1296 -0.89942 -0.2413 19.3623 6.0482 1.433 0.8427 0.5799 3614637 BPBio1_001142 C[C@H](N)CCCP(=O)(O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 D21 compound treatment 13.0051 -1.0239 -0.2747 11.9781 -1.336 -0.3165 -0.4181 -0.9975 907341 BPBio1_001143 CCCN(CCC)C1CCc2ccc(O)cc2C1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 D22 compound treatment 9.8265 -4.2025 -1.1276 13.5316 0.21751 0.0515 -0.7609 -0.6741 3614639 BPBio1_001144 CC(N)CCCP(=O)(O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 D23 mock treatment 15.183 1.1539 0.3096 14.9597 1.6456 0.3899 0.4946 0.9935 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 D24 mock treatment 11.923 -2.1061 -0.5651 12.6 -0.71411 -0.1692 -0.5192 -0.8802 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 E01 compound treatment 12.3394 -1.6896 -0.4534 15.0854 1.7713 0.4197 -0.0238 -0.0386 1486810 BPBio1_001145 CCOC(=O)c1cc2c(cn1)[nH]c3ccccc32 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 E02 compound treatment 14.3329 0.30383 0.0815 14.8918 1.5777 0.3738 0.322 0.8415 3480658 BPBio1_001146 CN1CCN(CC1)C(=O)OC2N(C(=O)c3nccnc23)c4ccc(Cl)cn4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 E03 compound treatment 15.2176 1.1885 0.3189 12.511 -0.80311 -0.1903 0.091 0.2449 3188027 BPBio1_001147 CCN(CC)CCOC(=O)C1(CCCC1)c2ccc(cc2)[N+](=O)[O-] 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 E04 compound treatment 10.0475 -3.9815 -1.0683 14.1729 0.85881 0.2035 -0.6115 -0.5623 3188163 BPBio1_001148 CN1C(=O)CC(C1=O)c2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 E05 compound treatment 19.3104 5.2814 1.4171 18.8281 5.514 1.3065 1.9259 0.9992 2098610 BPBio1_001149 C1CC1C(NC2=NCCO2)C3CC3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 E06 compound treatment 13.8666 -0.16243 -0.0436 14.449 1.1349 0.2689 0.1593 0.5849 2957 BPBio1_001150 CNC(=O)c1c(I)c(N(C)C(=O)C)c(I)c(C(=O)NCC(=O)Nc2c(I)c(C(=O)O)c(I)c(C(=O)NCCO)c2I)c1I 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 E07 compound treatment 17.5498 3.5207 0.9447 15.9674 2.6533 0.6287 1.1125 0.9804 3723 BPBio1_001151 CN(C)CCCSC(=N)N 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 E08 compound treatment 11.5466 -2.4824 -0.6661 12.8654 -0.44866 -0.1063 -0.5462 -0.8097 3069817 BPBio1_001152 CN(C/C=C/c1ccccc1)Cc2cccc3ccccc23 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 E09 compound treatment 13.3735 -0.65557 -0.1759 14.0554 0.74127 0.1756 -2.0E-4 -8.0E-4 3069774 BPBio1_001153 CO[C@H]1[C@H](O)C[C@@H]2CN3CCc4c([nH]c5cc(OC)ccc45)[C@H]3C[C@@H]2[C@@H]1C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 E10 compound treatment 9.5924 -4.4366 -1.1905 13.3357 0.021635 0.0051 -0.8382 -0.7041 907413 BPBio1_001154 CCCNC(C)(C)COC(=O)c1ccccc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 E11 compound treatment 12.1698 -1.8592 -0.4989 13.4117 0.097633 0.0231 -0.3364 -0.6736 3069775 BPBio1_001155 CC[C@H](CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 E12 compound treatment 12.9251 -1.1039 -0.2962 15.2064 1.8923 0.4484 0.1076 0.2002 1666 BPBio1_001156 Cc1[nH]c(=O)c(C#N)cc1c2ccncc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 E13 compound treatment 20.043 6.0139 1.6137 20.8861 7.572 1.7941 2.4097 0.9986 3616854 BPBio1_001157 C[C@@H]1O[C@@H](O[C@H]2CC[C@]3(C)C4CC[C@]5(C)[C@H](CC[C@]5(O)C4CCC3=C2)c6ccc(=O)oc6)[C@H](O)[C@H](O)[C@H]1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 E14 compound treatment 14.2609 0.2319 0.0622 13.0658 -0.24829 -0.0588 0.0024 0.0281 4382 BPBio1_001158 CC[N+](C)(CC)CCOC(=O)C1c2ccccc2Oc3ccccc13 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 E15 compound treatment 27.9502 13.921 3.7354 28.8014 15.487 3.6695 5.2361 1.0 2549 BPBio1_001159 C[n+]1cc2c3OCOc3ccc2c4ccc5cc6OCOc6cc5c14 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 E16 compound treatment 12.9859 -1.0431 -0.2799 13.1048 -0.20925 -0.0496 -0.233 -0.8196 3616870 BPBio1_001160 CC1(C)S[C@@H]2[C@H](NC(=O)C(C(=O)O)c3ccsc3)C(=O)N2[C@H]1C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 E17 compound treatment 12.096 -1.9331 -0.5187 12.4077 -0.90641 -0.2148 -0.5186 -0.9238 3552120 BPBio1_001161 C[C@@]1(C[C@@H](O)[C@]2(O)C=CO[C@@H](O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)[C@H]12)OC(=O)/C=C/c4ccccc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 E18 compound treatment 15.0364 1.0074 0.2703 15.1394 1.8253 0.4325 0.4969 0.9744 3188276 BPBio1_001162 CCSc1ccc2Sc3ccccc3N(CCCN4CCN(C)CC4)c2c1.OC(CC(=O)O)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 E19 compound treatment 10.4218 -3.6072 -0.9679 18.1874 4.8733 1.1547 0.132 0.0876 3616856 BPBio1_001163 C[C@@H]1CC[C@@]2(CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)C[C@@H](O)[C@H](O)[C@@](C)(CO)C5CC[C@]43C)[C@@H]2[C@H]1C)C(=O)O[C@@H]6O[C@H](COC7O[C@H](CO)[C@@H](OC8O[C@@H](C)[C@H](O)[C@@H](O)[C@H]8O)[C@H](O)[C@H]7O)[C@@H](O)[C@H](O)[C@H]6O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 E20 compound treatment 12.1331 -1.8959 -0.5087 12.6645 -0.64957 -0.1539 -0.4686 -0.8816 1778 BPBio1_001164 Nc1ccc(O)c(c1)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 E21 compound treatment 14.4491 0.42005 0.1127 18.0512 4.7371 1.1224 0.8733 0.7742 3559616 BPBio1_001165 CC(=C)[C@@H]1CC[C@]2(CO)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 E22 compound treatment 12.4451 -1.5839 -0.425 10.9605 -2.3536 -0.5577 -0.6948 -0.991 3047 BPBio1_001166 C[C@H]1[C@@H]2CC[C@@]3(C)C=CC(=O)C(=C3[C@H]2OC1=O)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 E23 mock treatment 14.3538 0.32473 0.0871 22.5688 9.2547 2.1928 1.6121 0.7346 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 E24 mock treatment 12.2322 -1.7969 -0.4821 13.1349 -0.17916 -0.0425 -0.3709 -0.7664 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 F01 compound treatment 18.3278 4.2988 1.1535 13.4081 0.09406 0.0223 0.8314 0.7206 4379 BPBio1_001167 CN1CCCCC1CCN2c3ccccc3Sc4ccc(cc24)S(=O)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 F02 compound treatment 12.1367 -1.8923 -0.5078 13.4402 0.12611 0.0299 -0.3379 -0.6643 989 BPBio1_001168 NC(=N)NCCCCNC(=N)N 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 F03 compound treatment 14.4464 0.41733 0.112 10.6373 -2.6768 -0.6342 -0.3693 -0.5734 907479 BPBio1_001169 CCCN1CCC[C@@H]2Cc3n[nH]cc3C[C@H]21 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 F04 compound treatment 39.8948 25.866 6.9404 30.7404 17.426 4.1289 7.8272 0.9692 3614643 BPBio1_001170 COc1cc2CC(=O)NN=C(c3ccc(N)cc3)c2cc1OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 F05 compound treatment 11.2156 -2.8134 -0.7549 11.5593 -1.7548 -0.4158 -0.8278 -0.9605 3188026 BPBio1_001171 CCN1CCC[C@H]1CNC(=O)c2c(OC)ccc(Br)c2OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 F06 compound treatment 13.207 -0.82203 -0.2206 11.4609 -1.8532 -0.4391 -0.4665 -0.9493 89599 BPBio1_001172 OC(=O)c1cc(O)c2c(Cl)cc(Cl)cc2n1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 F07 compound treatment 12.7857 -1.2433 -0.3336 14.1338 0.81974 0.1942 -0.0986 -0.2553 907274 BPBio1_001173 CN1CCc2cc(Cl)c(O)cc2[C@H](C1)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 F08 compound treatment 14.1121 0.083078 0.0223 10.6718 -2.6423 -0.626 -0.4269 -0.6815 907282 BPBio1_001174 Clc1cc2[nH]c(=O)c(=O)[nH]c2cc1Cl 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 F09 compound treatment 25.8614 11.832 3.1749 36.7965 23.482 5.5638 6.1792 0.9646 731 BPBio1_001175 CSc1ccc2Sc3ccccc3N(CCC4CCCCN4C)c2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 F10 compound treatment 13.4774 -0.55163 -0.148 13.2547 -0.059387 -0.0141 -0.1146 -0.7709 907275 BPBio1_001176 [O-][N+](=O)c1cc2[nH]c(=O)c(=O)[nH]c2cc1[N+](=O)[O-] 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 F11 compound treatment 22.2424 8.2134 2.2039 22.5766 9.2625 2.1946 3.1102 1.0 907200 BPBio1_001177 CC(C)(C)[C@]1(O)CCN2C[C@@H]3c4c(cccc4CCc5ccccc35)[C@@H]2C1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 F12 compound treatment 11.0482 -2.9809 -0.7998 11.6245 -1.6896 -0.4003 -0.8486 -0.9488 3614648 BPBio1_001178 C[C@H](N)CCC(=O)NCS(=O)(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 F13 compound treatment 11.3287 -2.7004 -0.7246 9.3079 -4.0062 -0.9492 -1.1836 -0.9911 899 BPBio1_001179 CN1CCc2cccc-3c2[C@H]1Cc4ccc(O)c(O)c43 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 F14 compound treatment 12.7514 -1.2777 -0.3428 11.6146 -1.6995 -0.4027 -0.5271 -0.9968 3614651 BPBio1_001180 Oc1c(C(=O)C2CC2)c(=O)[nH]c3cc(Cl)ccc13 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 F15 compound treatment 53.1673 39.138 10.5018 21.7848 8.4707 2.007 8.8451 0.8273 436 BPBio1_001181 CN(C)CCCN1c2ccccc2Sc3ccc(Cl)cc13 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 F16 compound treatment 13.6515 -0.37752 -0.1013 15.2325 1.9184 0.4545 0.2498 0.5364 1020954 BPBio1_001182 NC(=N)NCCCCCCCCCCNC(=N)N 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 F17 compound treatment 28.2013 14.172 3.8028 19.0688 5.7547 1.3635 3.6531 0.9043 1001939 BPBio1_001183 OCCN1CCN(CC/C=C\2/c3ccccc3Sc4ccc(cc24)C(F)(F)F)CC1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 F18 compound treatment 11.3455 -2.6836 -0.7201 18.8138 5.4997 1.3031 0.4122 0.2769 3614655 BPBio1_001184 OC(=O)Cc1cccnc1C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 F19 compound treatment 11.4575 -2.5716 -0.69 11.889 -1.4251 -0.3377 -0.7267 -0.9459 2830 BPBio1_001185 Clc1ccc2n(C3CCN(CCCn4c(=O)[nH]c5ccccc45)CC3)c(=O)[nH]c2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 F20 compound treatment 10.3459 -3.6831 -0.9883 17.4148 4.1007 0.9716 -0.0118 -0.0085 3614658 BPBio1_001186 CN([C@@H]1CCCC[C@@H]1N2CCCC2)C(=O)c3ccc(Cl)c(Cl)c3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 F21 compound treatment 11.8007 -2.2284 -0.5979 15.3707 2.0567 0.4873 -0.0782 -0.1014 1130 BPBio1_001187 OCCN1CCN(CCCN2c3ccccc3Sc4ccc(cc24)C(F)(F)F)CC1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 F22 compound treatment 12.5293 -1.4997 -0.4024 14.4278 1.1137 0.2639 -0.098 -0.2036 3614662 BPBio1_001188 N[C@@]1(CC[C@H](C1)C(=O)O)C(=O)O.N[C@]1(CC[C@@H](C1)C(=O)O)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 F23 mock treatment 12.7164 -1.3126 -0.3522 13.4631 0.14899 0.0353 -0.2241 -0.6331 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 F24 mock treatment 15.6168 1.5878 0.426 16.8455 3.5314 0.8367 0.8929 0.951 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 G01 compound treatment 15.2951 1.266 0.3397 15.8272 2.5132 0.5955 0.6613 0.9646 1471 BPBio1_001189 CN1C(c2ccc(Cl)cc2)S(=O)(=O)CCC1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 G02 compound treatment 15.0106 0.98158 0.2634 13.0138 -0.3003 -0.0712 0.1359 0.4982 3183 BPBio1_001190 CCOC(=O)c1ncn-2c1CN(C)C(=O)c3cc(F)ccc32 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 G03 compound treatment 14.2262 0.19713 0.0529 17.1748 3.8607 0.9147 0.6842 0.7467 1327636 BPBio1_001191 COc1ccc2c(c1)C(=O)N(CCc3ccc(cc3)S(=O)(=O)NC(=O)NC4CCCCC4)C(=O)C2(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 G04 compound treatment 13.9288 -0.1003 -0.0269 12.293 -1.0211 -0.2419 -0.1901 -0.7809 3069853 BPBio1_001192 OCN1C(NC(=O)NCNC(=O)NC2N(CO)C(=O)NC2=O)C(=O)NC1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 G05 compound treatment 14.926 0.8969 0.2407 12.7389 -0.57516 -0.1363 0.0738 0.2669 3069778 BPBio1_001193 CN1CCC(=C2c3ccsc3CCc4ccccc24)CC1.OC(CC(=O)O)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 G06 compound treatment 12.0146 -2.0144 -0.5405 14.0936 0.77949 0.1847 -0.2516 -0.4405 1503 BPBio1_001194 Cc1c(CS(=O)c2nc3ccccc3[nH]2)nccc1OCC(F)(F)F 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 G07 compound treatment 11.2287 -2.8003 -0.7514 17.1824 3.8683 0.9165 0.1168 0.0985 1380 BPBio1_001195 NC(=O)c1ncn(n1)[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 G08 compound treatment 12.6006 -1.4285 -0.3833 12.6533 -0.66076 -0.1566 -0.3817 -0.922 834 BPBio1_001196 CC(C[N+](C)(C)C)OC(=O)N 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 G09 compound treatment 12.8659 -1.1631 -0.3121 15.9418 2.6277 0.6226 0.2196 0.3153 1057366 BPBio1_001197 NS(=O)(=O)c1cc2c(NC(CC3CCCC3)NS2(=O)=O)cc1Cl 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 G10 compound treatment 13.9756 -0.053477 -0.0143 12.8718 -0.44234 -0.1048 -0.0843 -0.7965 3188277 BPBio1_001198 CC(=O)O[C@@]1(CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)C5CC5[C@]4(C)[C@H]3CC[C@@]21C)C(=O)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 G11 compound treatment 12.2164 -1.8126 -0.4864 12.3032 -1.0109 -0.2395 -0.5133 -0.9468 3177109 BPBio1_001199 COCCCC/C(=N\OCCN)/c1ccc(cc1)C(F)(F)F 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 G12 compound treatment 10.897 -3.132 -0.8404 11.7165 -1.5976 -0.3785 -0.8619 -0.9351 3002368 BPBio1_001200 CC(C)NC[C@H](O)COc1cccc2ccccc12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 G13 compound treatment 15.169 1.1399 0.3059 14.6955 1.3814 0.3273 0.4477 0.9994 3069779 BPBio1_001201 NC(=O)c1cc[n+](CC2=C(N3[C@H](SC2)[C@H](NC(=O)Cc4cccs4)C3=O)C(=O)O)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 G14 compound treatment 11.9431 -2.086 -0.5597 13.4653 0.15124 0.0358 -0.3704 -0.6605 3903 BPBio1_001202 CC(C)(Oc1ccc(cc1)C2CC2(Cl)Cl)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 G15 compound treatment 19.6916 5.6625 1.5194 15.8973 2.5832 0.6121 1.5072 0.9201 1000221 BPBio1_001203 CCC(=O)O[C@@]1([C@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C)C(=O)SCF 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 G16 compound treatment 12.2495 -1.7795 -0.4775 16.3789 3.0648 0.7262 0.1758 0.2023 1029881 BPBio1_001204 CN1C2CCC1CC(O)C2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 G17 compound treatment 12.5045 -1.5245 -0.4091 12.9357 -0.37842 -0.0897 -0.3527 -0.8421 3069780 BPBio1_001205 OCCN1CCN(CC/C=C\2/c3ccccc3Sc4ccc(Cl)cc24)CC1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 G18 compound treatment 11.5139 -2.5151 -0.6749 13.3507 0.03661 0.0087 -0.4711 -0.698 954 BPBio1_001206 CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 G19 compound treatment 11.141 -2.8881 -0.7749 11.6465 -1.6676 -0.3951 -0.8273 -0.9511 4480 BPBio1_001207 CC(C)NC(=N)NC(=N)Nc1ccc(Cl)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 G20 compound treatment 16.7295 2.7005 0.7246 10.9696 -2.3445 -0.5555 0.1196 0.131 1295 BPBio1_001208 OC(=O)CCCc1ccc(cc1)N(CCCl)CCCl 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 G21 compound treatment 10.5617 -3.4674 -0.9304 15.3659 2.0518 0.4861 -0.3141 -0.2992 3188032 BPBio1_001209 CN(C)[C@H]1[C@@H]2C[C@H]3C(=C(O)[C@]2(O)C(=O)C(=C1O)C(=O)NCNC(CCCCN)C(=O)O)C(=O)c4c(O)cccc4[C@@]3(C)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 G22 compound treatment 118.6817 104.65 28.081 146.8587 133.54 31.6414 42.2301 0.9982 3188278 BPBio1_001210 COC(=O)Nc1nc2cc(SC(C)C)ccc2[nH]1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 G23 mock treatment 12.7256 -1.3034 -0.3497 12.2553 -1.0588 -0.2509 -0.4247 -0.9867 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 G24 mock treatment 13.1641 -0.86492 -0.2321 11.8373 -1.4768 -0.3499 -0.4115 -0.9801 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 H01 compound treatment 12.2209 -1.8082 -0.4852 13.0833 -0.23076 -0.0547 -0.3817 -0.7818 1069 BPBio1_001211 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc3c[nH]c4cccc2c34 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 H02 compound treatment 12.8333 -1.1957 -0.3209 13.3801 0.065985 0.0156 -0.2158 -0.6719 3060333 BPBio1_001212 N[C@@H](CS(=O)O)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 H03 compound treatment 13.1807 -0.8484 -0.2276 12.0351 -1.279 -0.303 -0.3753 -0.9901 3061673 BPBio1_001213 CCCN1CCC[C@@H]2Cc3nc(N)ncc3C[C@H]21 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 H04 compound treatment 12.4104 -1.6187 -0.4343 12.1716 -1.1425 -0.2707 -0.4985 -0.9741 3614667 BPBio1_001214 NC(C(=O)O)c1nnn[nH]1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 H05 compound treatment 13.2541 -0.77495 -0.2079 13.647 0.33294 0.0789 -0.0913 -0.4103 907487 BPBio1_001215 CCN1CCC[C@H]1CNC(=O)c2c(O)c(Cl)cc(Cl)c2OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 H06 compound treatment 10.8769 -3.1521 -0.8458 10.6496 -2.6645 -0.6313 -1.0445 -0.9896 3614670 BPBio1_001216 OC(=O)[C@@H]1C[C@H]2C[C@@H](CP(=O)(O)O)CC[C@H]2CN1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 H07 compound treatment 10.9866 -3.0425 -0.8164 12.6056 -0.70845 -0.1679 -0.696 -0.835 1795 BPBio1_001217 Cc1nc2CCCCn2c(=O)c1CCN3CCC(CC3)c4noc5cc(F)ccc45 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 H08 compound treatment 13.1128 -0.91622 -0.2458 10.357 -2.9571 -0.7006 -0.6693 -0.9013 3614675 BPBio1_001218 N[C@@H](Cc1cc(CP(=O)(O)O)cc(c1)c2ccccc2Cl)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 H09 compound treatment 16.757 2.728 0.732 15.0096 1.6955 0.4017 0.8017 0.9601 3614469 BPBio1_001219 Oc1cc2[C@H](CNCCc2c(Cl)c1O)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 H10 compound treatment 11.225 -2.8041 -0.7524 11.7011 -1.613 -0.3822 -0.8023 -0.9507 1923 BPBio1_001220 NC1(CC1)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 H11 compound treatment 12.2516 -1.7774 -0.4769 9.8177 -3.4964 -0.8284 -0.923 -0.9656 1002005 BPBio1_001221 CCN1CCC[C@H]1CNC(=O)c2cc(ccc2OC)S(=O)(=O)N 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 H12 compound treatment 12.9888 -1.0402 -0.2791 14.118 0.80394 0.1905 -0.0627 -0.1855 4295 BPBio1_001222 NCC(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 H13 compound treatment 11.6466 -2.3824 -0.6393 13.0021 -0.31199 -0.0739 -0.5043 -0.7837 2351 BPBio1_001223 CCCN(CCC)C1Cc2cc(OC)c(OC)cc2C1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 H14 compound treatment 8.6363 -5.3928 -1.447 14.0455 0.73144 0.1733 -0.9007 -0.618 3614679 BPBio1_001224 N[C@@H]1CCN(O)C1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 H15 compound treatment 26.5266 12.498 3.3534 27.6706 14.357 3.4016 4.7765 1.0 3614470 BPBio1_001225 CN1Cc2ccccc2[C@H]3[C@H]1Cc4c[nH]c5cccc3c45 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 H16 compound treatment 8.8815 -5.1475 -1.3812 13.4201 0.10597 0.0251 -0.9589 -0.6941 1000790 BPBio1_001226 N[C@H](CO)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 H17 compound treatment 15.9052 1.8761 0.5034 11.2909 -2.0232 -0.4794 0.017 0.0245 3177000 BPBio1_001227 Oc1cc2CC[C@H]3NCc4ccccc4[C@@H]3c2cc1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 H18 compound treatment 12.8675 -1.1616 -0.3117 12.5906 -0.72348 -0.1714 -0.3416 -0.9603 1044852 BPBio1_001228 OC(=O)c1cc2cc(Cl)ccc2[nH]1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 H19 compound treatment 9.1613 -4.8678 -1.3062 12.8047 -0.50939 -0.1207 -1.0089 -0.7692 907272 BPBio1_001229 Oc1cc2CCNCC(c3ccccc3)c2cc1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 H20 compound treatment 11.8498 -2.1793 -0.5848 13.7098 0.39576 0.0938 -0.3472 -0.5862 873168 BPBio1_001230 OC(=O)c1cc(O)c2ccc(Cl)cc2n1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 H21 compound treatment 11.3016 -2.7275 -0.7319 14.0438 0.72971 0.1729 -0.3952 -0.5256 1261 BPBio1_001231 OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 H22 compound treatment 13.9918 -0.037297 -0.01 10.4316 -2.8825 -0.683 -0.49 -0.7174 907227 BPBio1_001232 [O-][N+](=O)c1cc2[nH]c(=O)c(=O)[nH]c2cc1C#N 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 H23 mock treatment 15.5493 1.5203 0.4079 12.0303 -1.2838 -0.3042 0.0734 0.1442 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 H24 mock treatment 14.5552 0.52618 0.1412 13.722 0.40786 0.0966 0.1682 0.9829 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 I01 compound treatment 13.7277 -0.30133 -0.0809 14.5946 1.2805 0.3034 0.1574 0.5012 3614725 BPBio1_001233 CN(C)C(=O)OC1=C(Sc2ccccc2-n3cccc13)c4ccccc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 I02 compound treatment 12.4481 -1.581 -0.4242 16.2357 2.9216 0.6922 0.1895 0.2334 1236 BPBio1_001234 OCc1cc2c(cn1)[nH]c3ccccc32 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 I03 compound treatment 16.3097 2.2806 0.612 13.1244 -0.18969 -0.0449 0.4009 0.6534 3069781 BPBio1_001235 CC(=O)OCC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@H](O)CC[C@]4(C)[C@H]3C(=O)C[C@]12C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 I04 compound treatment 10.6003 -3.4288 -0.92 16.3381 3.0241 0.7165 -0.1439 -0.1234 3002368 BPBio1_001236 CC(C)NC[C@H](O)COc1cccc2ccccc12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 I05 compound treatment 14.3398 0.31078 0.0834 13.43 0.11588 0.0275 0.0784 0.8928 3177333 BPBio1_001237 CC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@H](O)CC[C@]4(C)[C@H]3C(=O)C[C@]12C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 I06 compound treatment 23.8156 9.7865 2.626 18.3553 5.0412 1.1944 2.7014 0.9364 3616871 BPBio1_001238 CN1CC[C@]2(C)[C@@H]1N(C)c3ccc(O)cc32 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 I07 compound treatment 13.5741 -0.45497 -0.1221 16.8353 3.5213 0.8343 0.5036 0.5973 1053328 BPBio1_001239 CCCC1C(=O)N2N(C1=O)c3cc(C)ccc3N=C2N(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 I08 compound treatment 10.6389 -3.3902 -0.9097 14.6203 1.3062 0.3095 -0.4244 -0.4417 3616872 BPBio1_001240 CCN1C[C@]2(COC)CC[C@H](O)[C@]3([C@@H]4C[C@H]5[C@H](OC(=O)C)[C@@H]4[C@](O)(C[C@@H]5OC)[C@H]6C[C@@H]32)C61 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 I09 compound treatment 14.1579 0.12888 0.0346 16.782 3.4679 0.8217 0.6055 0.7362 3188033 BPBio1_001241 CCC1(CCCCN(C)C1)c2cccc(O)c2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 I10 compound treatment 15.4169 1.3878 0.3724 10.9782 -2.3359 -0.5535 -0.128 -0.1919 2060476 BPBio1_001242 C[C@H]1[C@@H]2CCC(=C3[C@@H]([C@H]2OC1=O)C(=CC3=O)C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 I11 compound treatment 12.4176 -1.6115 -0.4324 12.2012 -1.1129 -0.2637 -0.4922 -0.9719 3616858 BPBio1_001243 CN[C@H]1[C@@H](O)C2O[C@H](O[C@@H]3[C@@H](N)C[C@@H](N)[C@H](O)[C@H]3O)[C@H](N)C[C@@H]2OC1O[C@H]4O[C@H](CO)[C@@H](N)[C@H](O)[C@H]4O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 I12 compound treatment 9.396 -4.633 -1.2432 12.6106 -0.70354 -0.1667 -0.9969 -0.7948 1336284 BPBio1_001244 COc1c2CC(Oc2nc3ccccc13)C(C)(O)CO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 I13 compound treatment 33.716 19.687 5.2825 19.9918 6.6777 1.5822 4.8541 0.8803 3069782 BPBio1_001245 C[C@@]12CC[C@H]3[C@@H](CC[C@H]4CC5SC5C[C@@]43C)[C@@H]2CC[C@@H]1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 I14 compound treatment 10.0005 -4.0285 -1.081 12.6857 -0.62839 -0.1489 -0.8696 -0.797 3176921 BPBio1_001246 N[C@H]1CONC1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 I15 compound treatment 11.7126 -2.3165 -0.6216 15.1132 1.7991 0.4263 -0.1381 -0.1832 3188035 BPBio1_001247 C/C(=C(/CCO)\SSCC1CCCO1)/N(Cc2cnc(C)nc2N)C=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 I16 compound treatment 13.1811 -0.84796 -0.2275 16.9911 3.677 0.8712 0.4552 0.5055 3069855 BPBio1_001248 Clc1cnccn1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 I17 compound treatment 13.2648 -0.76422 -0.2051 12.4218 -0.89233 -0.2114 -0.2945 -0.9999 2080 BPBio1_001249 CCOC(=O)c1ccc(OC(=O)CCCCCNC(=N)N)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 I18 compound treatment 11.9696 -2.0594 -0.5526 13.1841 -0.12996 -0.0308 -0.4125 -0.7454 1076620 BPBio1_001250 CNCC(O)c1ccc(O)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 I19 compound treatment 12.9269 -1.1022 -0.2957 15.4339 2.1198 0.5023 0.146 0.2505 3188145 BPBio1_001251 CC(C)(C)C(=O)OCOC(=O)[C@@H]1N2[C@H](SC1(C)C)[C@H](NC(=O)[C@H](N)c3ccccc3)C2=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 I20 compound treatment 12.586 -1.4431 -0.3872 12.9114 -0.40267 -0.0954 -0.3413 -0.8557 760 BPBio1_001252 N[C@@H]1CONC1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 I21 compound treatment 14.4464 0.41738 0.112 15.9701 2.656 0.6293 0.5242 0.8201 3188146 BPBio1_001253 CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccccc3)C(=O)N2[C@H]1C(=O)OC4OC(=O)c5ccccc45 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 I22 compound treatment 13.9422 -0.086872 -0.0233 13.3823 0.068235 0.0162 -0.0051 -0.178 1076027 BPBio1_001254 CC1CC(CC(C)(C)C1)OC(=O)c2ccccc2O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 I23 mock treatment 11.5164 -2.5126 -0.6742 12.8671 -0.44701 -0.1059 -0.5516 -0.8083 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 I24 mock treatment 14.3926 0.36358 0.0976 13.6773 0.36319 0.0861 0.1298 0.998 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 J01 compound treatment 12.5773 -1.4517 -0.3895 12.5598 -0.75429 -0.1787 -0.4018 -0.9376 920 BPBio1_001255 CCN1CCCC1CNC(=O)c2cc(ccc2OC)S(=O)(=O)N 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 J02 compound treatment 14.5136 0.48455 0.13 14.3347 1.0206 0.2418 0.2629 0.9576 3614683 BPBio1_001256 OC(=O)[C@H]1C[C@@H](CP(=O)(O)O)CCN1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 J03 compound treatment 12.9281 -1.1009 -0.2954 14.679 1.3649 0.3234 0.0198 0.0452 2955 BPBio1_001257 Nc1nc2CCN(CC=C)CCc2s1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 J04 compound treatment 14.5592 0.53018 0.1423 2.8783 -10.436 -2.4726 -1.6478 -0.6653 3694 BPBio1_001258 NC(=O)OCC(COC(=O)N)c1ccccc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 J05 compound treatment 27.4172 13.388 3.5924 30.3892 17.075 4.0457 5.4009 0.9982 3614475 BPBio1_001259 Fc1ccc(OCCCN2CCC3(CC2)N(CNC3=O)c4ccccc4)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 J06 compound treatment 12.1355 -1.8935 -0.5081 10.9816 -2.3325 -0.5527 -0.7501 -0.9991 3614684 BPBio1_001260 N[C@H]1CCN(O)C1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 J07 compound treatment 46.0201 31.991 8.584 49.0384 35.724 8.4644 12.055 1.0 3614476 BPBio1_001261 Fc1ccc(cc1)C(=O)CCCN2CCC3(CC2)N(CN(Cc4cccc(F)c4)C3=O)c5ccccc5 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 J08 compound treatment 15.063 1.034 0.2774 10.85 -2.4641 -0.5838 -0.2167 -0.3352 3614685 BPBio1_001262 OC(=O)[C@H]1C[C@H](NC(=O)Nc2ccccc2)c3c(Cl)cc(Cl)cc3N1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 J09 compound treatment 13.7933 -0.23577 -0.0633 14.2364 0.92231 0.2185 0.1098 0.4826 3614477 BPBio1_001263 COc1ccccc1N2CCN(CCCCNC(=O)c3ccc(cc3)c4ccc(cc4)C(=O)C)CC2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 J10 compound treatment 10.7573 -3.2718 -0.8779 13.2103 -0.10379 -0.0246 -0.6382 -0.7266 3614687 BPBio1_001264 Oc1c(c2cccc(Oc3ccccc3)c2)c(=O)[nH]c4cc(Cl)ccc14 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 J11 compound treatment 11.2018 -2.8273 -0.7586 13.2837 -0.03039 -0.0072 -0.5415 -0.7138 2405 BPBio1_001265 Oc1ccc(cc1)C2CNCCc3c(Cl)c(O)c(O)cc23 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 J12 compound treatment 14.0198 -0.0092468 -0.0025 15.0947 1.7807 0.4219 0.2966 0.7029 1357939 BPBio1_001266 OC(=O)CCc1c([nH]c2cc(Cl)cc(Cl)c12)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 J13 compound treatment 15.1485 1.1194 0.3004 16.1181 2.804 0.6644 0.6822 0.9356 907466 BPBio1_001267 CCCN1CCO[C@H]2[C@H]1COc3ccc(O)cc23 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 J14 compound treatment 10.9737 -3.0554 -0.8198 17.8601 4.546 1.0771 0.1819 0.1344 3614689 BPBio1_001268 [O-][N+](=O)c1cc([N+](=O)[O-])c2[nH]c(=O)c(=O)[nH]c2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 J15 compound treatment 12.9477 -1.0814 -0.2902 11.5655 -1.7486 -0.4143 -0.4981 -0.9848 2245 BPBio1_001269 C(N1CCN(CC1)c2ncccn2)c3ccc4OCOc4c3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 J16 compound treatment 13.0964 -0.93265 -0.2503 12.2491 -1.065 -0.2523 -0.3554 -1.0 733 BPBio1_001270 CC1(CC2CC3(C)C1)CC(N)(C2)C3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 J17 compound treatment 26.911 12.882 3.4566 23.3596 10.046 2.3801 4.1272 0.9834 3614480 BPBio1_001271 CCCN(CCC)[C@@H]1CCc2c(OC)cccc2[C@@H]1C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 J18 compound treatment 13.0586 -0.97042 -0.2604 12.7827 -0.53139 -0.1259 -0.2732 -0.9444 907387 BPBio1_001272 C[C@@]1(N[C@@H]2Cc3ccccc31)c4ccccc24 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 J19 compound treatment 25.6593 11.63 3.1207 38.9316 25.617 6.0697 6.4986 0.9522 3614482 BPBio1_001273 CN1CCN(CC1)C2=Cc3ccccc3Oc4ccc(Cl)cc24 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 J20 compound treatment 19.1017 5.0727 1.3611 14.4222 1.1081 0.2626 1.1481 0.8282 3614694 BPBio1_001274 NCCCCCCCCCCNCCCN 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 J21 compound treatment 13.7293 -0.29977 -0.0804 16.4315 3.1174 0.7386 0.4654 0.6264 3614484 BPBio1_001275 Cc1c(noc1C2CCN(CCc3ccccc3)CC2)c4ccc(Cl)cc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 J22 compound treatment 43.3376 29.309 7.8643 35.6016 22.287 5.2807 9.2949 0.9812 1586 BPBio1_001276 NCCCCNCCCN 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 J23 mock treatment 14.0365 0.0074782 0.002 12.8547 -0.45939 -0.1088 -0.0755 -0.694 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 J24 mock treatment 13.1439 -0.8852 -0.2375 12.5416 -0.77246 -0.183 -0.2974 -0.9917 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 K01 compound treatment 14.1025 0.073428 0.0197 14.2263 0.91216 0.2161 0.1668 0.7684 3177059 BPBio1_001277 CCCCCCN(CCCCCC)C(=O)Cc1c([nH]c2ccccc12)c3ccc(F)cc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 K02 compound treatment 17.2478 3.2188 0.8637 18.4245 5.1104 1.2108 1.4669 0.9863 907215 BPBio1_001278 CCC(C)N(C)C(=O)c1cc2ccccc2c(n1)c3ccccc3Cl 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 K03 compound treatment 12.9649 -1.0641 -0.2855 14.2232 0.90909 0.2154 -0.0496 -0.1387 3188147 BPBio1_001279 Cc1onc(c1C(=O)N[C@H]2[C@H]3SC(C)(C)C(N3C2=O)C(=O)O)c4c(F)cccc4Cl 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 K04 compound treatment 11.2286 -2.8004 -0.7514 11.4952 -1.8189 -0.431 -0.8361 -0.9652 3616874 BPBio1_001280 CC(=O)N[C@@H](CC(=O)N[C@H](CCC(=O)O)C(=O)O)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 K05 compound treatment 14.9653 0.93628 0.2512 11.7924 -1.5217 -0.3605 -0.0773 -0.1759 2920 BPBio1_001281 CCN(CC)c1cc(C)nc2ncnn12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 K06 compound treatment 11.6374 -2.3917 -0.6418 15.7242 2.4101 0.571 -0.05 -0.0582 3616879 BPBio1_001282 Nc1ncnc2n(cnc12)[C@@H]3O[C@@H]4COP(=O)(O)OC4C3O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 K07 compound treatment 11.2438 -2.7853 -0.7474 15.1436 1.8295 0.4335 -0.222 -0.2569 3616859 BPBio1_001283 CN(C)[C@@H]1CCCCC(C1)OC2c3ccccc3CCc4ccccc24 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 K08 compound treatment 12.7535 -1.2755 -0.3423 13.4851 0.17101 0.0405 -0.2134 -0.6191 907479 BPBio1_001284 CCCN1CCC[C@@H]2Cc3n[nH]cc3C[C@H]21 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 K09 compound treatment 34.339 20.31 5.4497 32.0232 18.709 4.4328 6.988 0.9947 3078457 BPBio1_001285 CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c3ccccc13 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 K10 compound treatment 12.1324 -1.8967 -0.5089 11.7296 -1.5845 -0.3754 -0.6253 -0.9888 3188280 BPBio1_001286 COc1ncnc(NS(=O)(=O)c2ccc(N)cc2)c1OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 K11 compound treatment 12.952 -1.077 -0.289 10.0051 -3.309 -0.784 -0.7587 -0.908 1022844 BPBio1_001287 Oc1ccc(O)c(c1)S(=O)(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 K12 compound treatment 13.2094 -0.8196 -0.2199 10.8275 -2.4865 -0.5892 -0.5721 -0.9097 1221 BPBio1_001288 CN(C)CCOC(=O)C(c1ccccc1)C2(O)CCCC2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 K13 compound treatment 11.4201 -2.6089 -0.7 13.9323 0.61823 0.1465 -0.3914 -0.5473 1779 BPBio1_001289 COc1nc(C)nc(Cl)c1NC2=NCCN2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 K14 compound treatment 11.3146 -2.7144 -0.7283 8.8467 -4.4674 -1.0585 -1.2635 -0.9834 3188281 BPBio1_001290 C[C@@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]2C[C@@H](O)[C@@H]1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 K15 compound treatment 10.7033 -3.3257 -0.8924 9.8157 -3.4984 -0.8289 -1.2171 -0.9993 1326779 BPBio1_001291 CCNCC(O)c1cccc(O)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 K16 compound treatment 12.3045 -1.7245 -0.4627 12.455 -0.85911 -0.2036 -0.4711 -0.932 1000336 BPBio1_001292 CC(C)NC[C@H](O)c1ccc(O)c(O)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 K17 compound treatment 11.8393 -2.1897 -0.5876 14.1858 0.87169 0.2065 -0.2694 -0.4326 220 BPBio1_001293 CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 K18 compound treatment 10.7652 -3.2639 -0.8758 11.431 -1.8831 -0.4462 -0.9348 -0.951 2121 BPBio1_001294 Oc1ccc(cc1)c2oc3cc(O)cc(O)c3c(=O)c2O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 K19 compound treatment 13.0297 -0.99937 -0.2682 15.2536 1.9395 0.4595 0.1353 0.2543 3616862 BPBio1_001295 CCOC1O[C@H]([C@@H](COCc2ccccc2)OCc3ccccc3)[C@H](OCc4ccccc4)[C@H]1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 K20 compound treatment 15.2074 1.1783 0.3162 14.6575 1.3434 0.3183 0.4486 1.0 865102 BPBio1_001296 O=C(CCNNC(=O)c1ccncc1)NCc2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 K21 compound treatment 17.644 3.6149 0.97 22.5051 9.191 2.1777 2.2257 0.9336 3188150 BPBio1_001297 CCC(=O)[C@@]1(C)[C@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 K22 compound treatment 16.2176 2.1886 0.5873 15.424 2.11 0.4999 0.7687 0.9968 3616885 BPBio1_001298 CC(=CCC/C(=C/CC1=C(C)C(=O)c2ccccc2C1=O)/C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 K23 mock treatment 18.3937 4.3646 1.1711 13.6121 0.29804 0.0706 0.8781 0.7484 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 K24 mock treatment 34.9363 20.907 5.61 11.8384 -1.4757 -0.3496 3.7196 0.6618 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 L01 compound treatment 24.2244 10.195 2.7357 14.5284 1.2143 0.2877 2.1379 0.7772 3544 BPBio1_001299 Clc1ccc(cc1)N2CCN(Cc3c[nH]c4ncccc34)CC2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 L02 compound treatment 9.8278 -4.2013 -1.1273 12.0891 -1.225 -0.2902 -1.0024 -0.8611 1001868 BPBio1_001300 OC(=O)[C@H]1C[C@H](N1)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 L03 compound treatment 11.0096 -3.0195 -0.8102 12.0672 -1.2469 -0.2954 -0.7818 -0.9066 3061599 BPBio1_001301 Cc1cccc(c1)C(=O)NCN2CCN(CC2)c3ccccc3C#N 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 L04 compound treatment 13.5134 -0.51565 -0.1384 12.6457 -0.66839 -0.1584 -0.2098 -0.9977 3614696 BPBio1_001302 Cc1onc(O)c1C[C@@H](N)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 L05 compound treatment 24.5615 10.532 2.8261 43.5192 30.205 7.1566 7.0589 0.9174 3614551 BPBio1_001303 CCCN(C/C=C/I)C1CCc2cccc(O)c2C1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 L06 compound treatment 15.5876 1.5586 0.4182 11.7249 -1.5892 -0.3765 0.0295 0.0523 832310 BPBio1_001304 Cc1onc(O)c1C[C@H](N)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 L07 compound treatment 24.5501 10.521 2.8231 31.146 17.832 4.225 4.9837 0.9808 3614489 BPBio1_001305 C1CCN(C1)C2(CCCCC2)c3cc4ccccc4s3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 L08 compound treatment 9.5916 -4.4375 -1.1907 13.0637 -0.25044 -0.0593 -0.8839 -0.7414 2122 BPBio1_001306 CC(=C)[C@H]1CN[C@@H]([C@H]1CC(=O)O)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 L09 compound treatment 21.0259 6.9969 1.8774 25.818 12.504 2.9626 3.4224 0.9758 3614491 BPBio1_001307 C(NC1(CCCCC1)c2cc3ccccc3s2)C4CC4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 L10 compound treatment 14.0299 8.5568E-4 2.0E-4 12.4587 -0.85541 -0.2027 -0.1432 -0.7063 2310 BPBio1_001308 C[C@H](C[C@H](N)C(=O)O)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 L11 compound treatment 12.5894 -1.4396 -0.3863 10.9504 -2.3637 -0.5601 -0.6692 -0.9836 3177054 BPBio1_001309 CN1C2CCC1CC(C2)OC(c3ccc(F)cc3)c4ccc(F)cc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 L12 compound treatment 8.2814 -5.7476 -1.5422 11.043 -2.2711 -0.5381 -1.471 -0.9006 1111508 BPBio1_001310 OC(=O)c1cc(O)c2cc(Cl)ccc2n1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 L13 compound treatment 27.3308 13.302 3.5692 23.8634 10.549 2.4995 4.2912 0.9848 907242 BPBio1_001311 CN1C2CCC1CC(C2)OC(c3ccccc3)c4ccc(Cl)cc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 L14 compound treatment 14.2966 0.26754 0.0718 10.3166 -2.9975 -0.7102 -0.4514 -0.6324 2191 BPBio1_001312 NS(=O)(=O)c1cccc2c3[nH]c(=O)c(=O)[nH]c3cc([N+](=O)[O-])c12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 L15 compound treatment 10.3817 -3.6473 -0.9787 13.15 -0.16414 -0.0389 -0.7195 -0.7346 3614496 BPBio1_001313 C(CN1CCN(C/C=C/c2ccccc2)CC1)OC(c3ccccc3)c4ccccc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 L16 compound treatment 20.2484 6.2193 1.6688 16.1549 2.8408 0.6731 1.656 0.9203 3614699 BPBio1_001314 CCCNC(=O)N1N=C(c2ccc(N)cc2)c3cc4OCOc4cc3C1C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 L17 compound treatment 18.7857 4.7566 1.2763 22.3439 9.0298 2.1395 2.4153 0.9695 3393 BPBio1_001315 C(CN1CCN(CCOC(c2ccccc2)c3ccccc3)CC1)Cc4ccccc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 L18 compound treatment 12.7953 -1.2337 -0.331 11.3994 -1.9147 -0.4536 -0.5549 -0.988 1031 BPBio1_001316 COc1ccc(cc1)C(=O)N2CCCC2=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 L19 compound treatment 23.3211 9.2921 2.4933 30.4668 17.153 4.0641 4.6368 0.9725 3614500 BPBio1_001317 Fc1ccc(cc1)C(OCCN2CCN(C/C=C/c3ccccc3)CC2)c4ccc(F)cc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 L20 compound treatment 11.6484 -2.3806 -0.6388 11.7299 -1.5842 -0.3753 -0.7171 -0.9679 68561 BPBio1_001318 O=C(N1CCCCC1)c2ccc3OCOc3c2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 L21 compound treatment 13.5174 -0.51162 -0.1373 10.0699 -3.2442 -0.7687 -0.6406 -0.8204 3614504 BPBio1_001319 C1NCc2ccccc2C1c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 L22 compound treatment 11.9351 -2.0939 -0.5619 14.0171 0.70299 0.1666 -0.2795 -0.477 1488 BPBio1_001320 NS(=O)(=O)c1cc2c(NC(NS2(=O)=O)C3CC4CC3C=C4)cc1Cl 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 L23 mock treatment 12.5741 -1.4549 -0.3904 9.8241 -3.49 -0.8269 -0.8608 -0.9413 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 L24 mock treatment 14.4086 0.37959 0.1019 11.3299 -1.9842 -0.4701 -0.2604 -0.5414 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 M01 compound treatment 12.7082 -1.3209 -0.3544 17.7229 4.4088 1.0446 0.488 0.4424 3614726 BPBio1_001321 CCCCCCN(CCCCCC)C(=O)Cc1c([nH]c2ccc(Cl)cc12)c3ccc(Cl)cc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 M02 compound treatment 13.7477 -0.28132 -0.0755 12.8341 -0.48004 -0.1137 -0.1338 -0.9802 735 BPBio1_001322 NNC(=O)c1ccncc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 M03 compound treatment 9.7194 -4.3097 -1.1564 12.1165 -1.1976 -0.2838 -1.0183 -0.8552 3480040 BPBio1_001323 COC(=O)C1=C(C)NC(=C(C1c2cccc3nonc23)C(=O)OC(C)C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 M04 compound treatment 15.6155 1.5865 0.4257 10.8393 -2.4748 -0.5864 -0.1136 -0.1568 2929 BPBio1_001324 CCN[C@@H]1C[C@H](N)[C@@H](O[C@H]2OC(=CC[C@H]2N)CN)[C@H](O)[C@H]1O[C@H]3OC[C@](C)(O)[C@H](NC)[C@H]3O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 M05 compound treatment 13.1431 -0.88595 -0.2377 11.8921 -1.422 -0.3369 -0.4063 -0.9854 1077199 BPBio1_001325 CCNC1(CCCCC1=O)c2cccs2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 M06 compound treatment 15.0742 1.0451 0.2804 15.5437 2.2296 0.5283 0.5718 0.9561 3173761 BPBio1_001326 N[C@@H](C(=O)N[C@H]1[C@H]2SCC(=C(N2C1=O)C(=O)O)Cl)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 M07 compound treatment 14.154 0.12493 0.0335 13.0357 -0.27841 -0.066 -0.0229 -0.31 3069807 BPBio1_001327 CNC(C)CCC=C(C)C.OC(C(O)C(O)C(=O)O)C(O)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 M08 compound treatment 14.6204 0.59135 0.1587 13.8398 0.52566 0.1245 0.2003 0.9928 3616891 BPBio1_001328 O[C@H]1C[C@](O)(C[C@H](O)[C@@H]1O)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 M09 compound treatment 13.7396 -0.28947 -0.0777 11.2906 -2.0235 -0.4794 -0.3939 -0.8111 3188151 BPBio1_001329 CC1CS(=O)(=O)CCN1/N=C/c2ccc(o2)[N+](=O)[O-] 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 M10 compound treatment 13.0134 -1.0156 -0.2725 13.8573 0.54319 0.1287 -0.1017 -0.3374 3616894 BPBio1_001330 C[C@H]1O[C@@H](O[C@@H]/2C[C@@H]3O[C@@](O)(C[C@H](O)[C@H]3C(=O)O)C[C@@H](O)C[C@H]4OC4\C=C\C(=O)O[C@H](C)C\C=C\C=C\C=C\C=C2)[C@@H](O)[C@@H](N)[C@@H]1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 M11 compound treatment 12.0077 -2.0214 -0.5424 9.1848 -4.1293 -0.9784 -1.0753 -0.9613 1698 BPBio1_001331 N#Cc1ccc(cc1)C(c2ccc(C#N)cc2)n3cncn3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 M12 compound treatment 17.6892 3.6602 0.9821 16.8583 3.5442 0.8397 1.2882 0.997 3616896 BPBio1_001332 COC(=O)C1C(=CC=C2c3cc4[nH]c(cc5nc(cc6[nH]c(cc(n3)[C@]12C)c(C)c6CCC(=O)O)c(CCC(=O)O)c5C)c(C=C)c4C)C(=O)OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 M13 compound treatment 12.1206 -1.9085 -0.5121 11.0116 -2.3025 -0.5455 -0.7479 -0.9995 3174242 BPBio1_001333 OC[C@H]1O[C@@H](Oc2ccc(O)cc2)[C@H](O)[C@@H](O)[C@@H]1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 M14 compound treatment 11.0237 -3.0053 -0.8064 13.1023 -0.21184 -0.0502 -0.6057 -0.7497 1000348 BPBio1_001334 C[C@@H](O)[C@@H]1[C@H]2[C@@H](C)C(=C(N2C1=O)C(=O)O)S[C@@H]3CN[C@@H](C3)C(=O)N(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 M15 compound treatment 13.7427 -0.2863 -0.0768 11.8394 -1.4746 -0.3494 -0.3014 -0.8425 3188152 BPBio1_001335 CC(N)C(=O)Nc1c(C)cccc1C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 M16 compound treatment 10.9228 -3.1062 -0.8335 14.5154 1.2013 0.2846 -0.3881 -0.4407 3069861 BPBio1_001336 CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N2C(C[C@@H]3CCC[C@@H]32)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 M17 compound treatment 13.2448 -0.7843 -0.2104 12.6874 -0.62668 -0.1485 -0.2538 -0.9854 3188153 BPBio1_001337 CC1(C)S[C@@H]2[C@H](NC(=O)COc3ccccc3)C(=O)N2C1C(=O)O.C(CNCc1ccccc1)NCc2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 M18 compound treatment 11.3474 -2.6817 -0.7196 11.4379 -1.8762 -0.4445 -0.8231 -0.9732 1517 BPBio1_001338 CCC1(NC(=O)N(C)C1=O)c2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 M19 compound treatment 12.1215 -1.9075 -0.5118 11.226 -2.0881 -0.4947 -0.7118 -0.9999 1795 BPBio1_001339 Cc1nc2CCCCn2c(=O)c1CCN3CCC(CC3)c4noc5cc(F)ccc45 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 M20 compound treatment 12.9257 -1.1034 -0.2961 11.8637 -1.4504 -0.3436 -0.4523 -0.9972 3616904 BPBio1_001340 CCC(C)N1CCC2(CC1)NC3=C4NC(=O)/C(=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(=O)C)[C@H](C)[C@@H](OC)/C=C/O[C@@]5(C)Oc6c(C5=O)c(C3=N2)c(C4=O)c(O)c6C)/C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 M21 compound treatment 13.9013 -0.12775 -0.0343 12.0495 -1.2646 -0.2996 -0.2361 -0.7829 1001638 BPBio1_001341 CC(C)NC(=O)NS(=O)(=O)c1cnccc1Nc2cccc(C)c2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 M22 compound treatment 167.0303 153.0 41.0542 176.0988 162.78 38.5694 56.3024 0.9995 3069862 BPBio1_001342 CCCCc1ccc2[nH]c(NC(=O)OC)nc2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 M23 mock treatment 12.9798 -1.0493 -0.2815 13.2003 -0.11384 -0.027 -0.2182 -0.7713 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 M24 mock treatment 9.9335 -4.0956 -1.0989 9.9656 -3.3485 -0.7934 -1.3381 -0.9872 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 N01 compound treatment 13.005 -1.0241 -0.2748 13.0919 -0.22219 -0.0526 -0.2315 -0.8275 3614505 BPBio1_001343 CC(C)[C@@]1(NC(=O)[C@@H]2CC3[C@@H](Cc4c[nH]c5cccc3c45)N(C)C2)O[C@@]6(O)[C@@H]7CCCN7C(=O)[C@H](Cc8ccccc8)N6C1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 N02 compound treatment 11.6361 -2.393 -0.6421 10.3838 -2.9303 -0.6943 -0.945 -0.9992 3614700 BPBio1_001344 NC(=O)C[C@H](NC(=O)Cc1ccc(O)cc1O)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 N03 compound treatment 15.6627 1.6337 0.4384 13.141 -0.17309 -0.041 0.281 0.6382 437 BPBio1_001345 CN1CCN(CCCN2c3ccccc3Sc4ccc(cc24)C(F)(F)F)CC1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 N04 compound treatment 13.5872 -0.44187 -0.1186 16.6219 3.3078 0.7837 0.4703 0.5934 3614702 BPBio1_001346 N[C@@H](C(=O)O)c1ccc(O)c(c1)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 N05 compound treatment 16.9944 2.9654 0.7957 15.6669 2.3528 0.5575 0.9568 0.9849 907498 BPBio1_001347 CN1CCc2cc(Br)c(O)cc2C(C1)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 N06 compound treatment 9.8517 -4.1774 -1.1209 13.9641 0.65004 0.154 -0.6837 -0.6043 3614705 BPBio1_001348 N[C@H](CCC(=O)NCC(=O)O)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 N07 compound treatment 65.3116 51.283 13.7604 90.4558 77.142 18.2776 22.6543 0.9902 3061056 BPBio1_001349 Ic1ccc(cc1)N2CCN(Cc3c[nH]c4ncccc34)CC2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 N08 compound treatment 11.6801 -2.3489 -0.6303 13.6014 0.28726 0.0681 -0.3975 -0.6271 949 BPBio1_001350 OC(=O)c1cc(O)c2ccccc2n1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 N09 compound treatment 21.5688 7.5398 2.0231 19.2878 5.9737 1.4154 2.4314 0.9847 1001908 BPBio1_001351 Oc1ccc2C[C@H]3N(CC=C)CCc4cccc(c34)-c2c1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 N10 compound treatment 20.6024 6.5733 1.7638 36.086 22.772 5.3955 5.0624 0.8918 1496 BPBio1_001352 CSc1ccc2Sc3ccccc3CC(N4CCN(C)CC4)c2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 N11 compound treatment 25.0021 10.973 2.9443 26.226 12.912 3.0593 4.2452 0.9998 907195 BPBio1_001353 Oc1cc2[C@H](CN(CC=C)CCc2c(Br)c1O)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 N12 compound treatment 12.0431 -1.9859 -0.5329 10.6044 -2.7097 -0.642 -0.8308 -0.9957 907494 BPBio1_001354 CCCN(CCC)C1CCc2cccc(O)c2C1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 N13 compound treatment 46.2945 32.265 8.6576 7.149 -6.1651 -1.4607 5.089 0.5796 907136 BPBio1_001355 NC[C@@H]1O[C@@H](Cc2c(O)c(O)ccc12)C3(CC4CC5CC(C4)C3)C5 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 N14 compound treatment 12.0782 -1.9509 -0.5235 11.9052 -1.4089 -0.3338 -0.6062 -0.9764 3304 BPBio1_001356 Fc1ccc(cc1)C(=O)C2CCN(CCn3c(=O)[nH]c4ccccc4c3=O)CC2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 N15 compound treatment 15.1143 1.0853 0.2912 17.9213 4.6072 1.0916 0.9778 0.8655 1001864 BPBio1_001357 CN1CC(=C[C@H]2[C@H]1Cc3c[nH]c4cccc2c34)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 N16 compound treatment 14.6593 0.6302 0.1691 12.3611 -0.953 -0.2258 -0.0401 -0.1421 614200 BPBio1_001358 CN1C2CCC1CC(C2)OC(=O)c3cc(Cl)cc(Cl)c3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 N17 compound treatment 10.9112 -3.1179 -0.8366 12.3794 -0.93472 -0.2215 -0.7482 -0.8645 1438259 BPBio1_001359 CC(CO)NC(=O)C1CN(C)C2Cc3c[nH]c4cccc(C2=C1)c34 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 N18 mock treatment 11.7527 -2.2764 -0.6108 12.5096 -0.80449 -0.1906 -0.5667 -0.8856 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 N19 compound treatment 14.455 0.42593 0.1143 15.4006 2.0865 0.4944 0.4304 0.8482 3187750 BPBio1_001360 CC(C)C[C@@H]1N2C(=O)[C@](NC(=O)[C@H]3CN(C)[C@@H]4Cc5c[nH]c6cccc(C4=C3)c56)(O[C@@]2(O)[C@@H]7CCCN7C1=O)C(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 N20 compound treatment 15.8682 1.8392 0.4935 14.7815 1.4674 0.3477 0.5948 0.9853 907388 BPBio1_001361 Cc1[nH]c2ccc(O)cc2c1CCN 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 N21 compound treatment 11.1874 -2.8417 -0.7625 11.3088 -2.0053 -0.4751 -0.8751 -0.9741 907229 BPBio1_001362 Oc1cc2C(CN(CC=C)CCc2c(Cl)c1O)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 N22 compound treatment 12.1837 -1.8453 -0.4951 11.8557 -1.4584 -0.3456 -0.5945 -0.9845 3294 BPBio1_001363 COc1ccccc1N2CCN(CCCCN3C(=O)c4ccccc4C3=O)CC2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 N23 mock treatment 13.1159 -0.91316 -0.245 12.1238 -1.1903 -0.282 -0.3727 -0.9975 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 N24 mock treatment 11.7237 -2.3053 -0.6186 16.5087 3.1946 0.7569 0.0978 0.1001 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 O01 compound treatment 18.7771 4.7481 1.274 12.9482 -0.36593 -0.0867 0.8396 0.6575 3614727 BPBio1_001364 COc1c(nc2ccc(NCc3cccc(OC)c3)nn12)c4ccc(N)cc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 O02 compound treatment 13.9172 -0.11183 -0.03 11.7953 -1.5188 -0.3599 -0.2757 -0.7634 1002512 BPBio1_001365 OC(=O)c1ccncc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 O03 compound treatment 14.462 0.43295 0.1162 17.7707 4.4566 1.0559 0.8288 0.7802 2080909 BPBio1_001366 CCCCN(CCCC)CCC(O)c1cc2c(Cl)cc(Cl)cc2c3cc(ccc13)C(F)(F)F 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 O04 compound treatment 15.259 1.2299 0.33 13.0131 -0.30101 -0.0713 0.1829 0.5418 3856 BPBio1_001367 CNC1(C)C2CCC(C2)C1(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 O05 compound treatment 13.7556 -0.2734 -0.0734 13.0638 -0.25031 -0.0593 -0.0938 -0.9944 3069809 BPBio1_001368 CCCNC(C)C(=O)Nc1c(C)csc1C(=O)OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 O06 compound treatment 14.7058 0.67675 0.1816 17.4309 4.1168 0.9754 0.8181 0.8246 3199 BPBio1_001369 CNNCc1ccc(cc1)C(=O)NC(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 O07 compound treatment 15.8296 1.8005 0.4831 16.3257 3.0116 0.7136 0.8462 0.982 3616863 BPBio1_001370 CC(=O)O[C@@]1(CC[C@H]2[C@@H]3C=C(C)C4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21C)C(=O)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 O08 compound treatment 12.6768 -1.3522 -0.3628 15.0132 1.6991 0.4026 0.0281 0.0519 3616911 BPBio1_001371 NCCC[C@H](N)CC(=O)N[C@H]1CNC(=O)[C@@H](NC(=O)/C(=C/NC(=O)N)/NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC1=O)[C@H]2C[C@H](O)N=C(N)N2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 O09 compound treatment 16.981 2.9519 0.7921 11.6792 -1.6349 -0.3874 0.2862 0.3246 3177327 BPBio1_001372 CC(=O)O[C@H]1[C@H](C[C@H]2[C@@H]3CC[C@H]4C[C@H](OC(=O)C)[C@H](C[C@]4(C)[C@H]3CC[C@]12C)[N+]5(C)CCCCC5)[N+]6(C)CCCCC6 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 O10 compound treatment 14.0786 0.049578 0.0133 10.9603 -2.3538 -0.5577 -0.3849 -0.69 3069863 BPBio1_001373 CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc3ccccc3)NC(=O)[C@H](CC(=O)N)NC(=O)c4ccc5ccccc5n4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 O11 compound treatment 11.8364 -2.1927 -0.5883 15.1802 1.8662 0.4422 -0.1034 -0.1405 1511611 BPBio1_001374 CCc1c(C)[nH]c2CCC(CN3CCOCC3)C(=O)c12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 O12 compound treatment 11.2291 -2.8 -0.7513 17.3348 4.0207 0.9526 0.1424 0.1173 1509 BPBio1_001375 Cn1c(COC(=O)N)ncc1[N+](=O)[O-] 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 O13 compound treatment 11.3305 -2.6985 -0.7241 15.4938 2.1797 0.5164 -0.1468 -0.1651 3616868 BPBio1_001376 OC/C=C/1\C[N@+]2(CC=C)CC[C@]3([C@@H]2C[C@@H]1C4=CN5C6C(=CN7C43)[C@H]\8C[C@H]9[C@@]6(CC[N@@+]9(CC=C)C/C8=C\CO)c%10ccccc5%10)c%11ccccc7%11 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 O14 compound treatment 10.3534 -3.6757 -0.9863 15.1851 1.871 0.4433 -0.3839 -0.3551 1829 BPBio1_001377 CCN[C@H]1C[C@H](C)S(=O)(=O)c2sc(cc12)S(=O)(=O)N 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 O15 compound treatment 15.2395 1.2105 0.3248 14.0043 0.69019 0.1635 0.3453 0.9496 2747 BPBio1_001378 Nc1ccn([C@H]2CC[C@@H](CO)O2)c(=O)n1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 O16 compound treatment 13.0016 -1.0274 -0.2757 14.7395 1.4254 0.3377 0.0439 0.1006 1078453 BPBio1_001379 Fc1ccc(cc1)C(=O)CCCN2CCN(CC2)c3ccccn3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 O17 compound treatment 11.2824 -2.7466 -0.737 12.7485 -0.56563 -0.134 -0.6159 -0.8222 3069810 BPBio1_001380 COc1ccc(C[C@](C)(N)C(=O)O)cc1OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 O18 compound treatment 12.6326 -1.3964 -0.3747 14.7334 1.4193 0.3363 -0.0272 -0.054 3616914 BPBio1_001381 CO/N=C(\C(=O)N[C@H]1[C@H]2SCC(=C(N2C1=O)C(=O)O)C[N+]3(C)CCCC3)/c4csc(N)n4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 O19 compound treatment 10.8629 -3.1662 -0.8496 11.8621 -1.452 -0.344 -0.844 -0.9208 3069811 BPBio1_001382 C[C@@H]1CN(CC[C@]1(C(=O)O)c2ccccc2)[C@H]3CC[C@](CC3)(C#N)c4ccc(F)cc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 O20 compound treatment 22.8938 8.8648 2.3786 14.9506 1.6365 0.3878 1.9561 0.8117 3188289 BPBio1_001383 C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]2(C)[C@H]1C(=O)COC(=O)C(C)(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 O21 compound treatment 51.5949 37.566 10.0799 101.4608 88.147 20.8851 21.8955 0.9442 3188156 BPBio1_001384 CN(C)c1ccc2[n+](C)c(/C=C\c3cc(C)n(c3C)c4ccccc4)ccc2c1.OC(=O)c1cc2ccccc2c(Cc3c(O)c(cc4ccccc34)C(=O)O)c1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 O22 compound treatment 14.8301 0.80105 0.2149 12.2242 -1.0899 -0.2582 -0.0306 -0.0911 2884 BPBio1_001385 CC1(C)S[C@@H]2[C@H](NC(=O)C3(N)CCCCC3)C(=O)N2[C@H]1C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 O23 mock treatment 14.0033 -0.025762 -0.0069 13.5297 0.21564 0.0511 0.0312 0.6059 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 O24 mock treatment 11.0558 -2.9733 -0.7978 11.1467 -2.1674 -0.5135 -0.9273 -0.9773 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 P01 compound treatment 11.0703 -2.9588 -0.7939 13.6049 0.29079 0.0689 -0.5127 -0.6433 3614511 BPBio1_001386 CCCN(CCC)C1CCc2cc(O)c(O)cc2C1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 P02 compound treatment 20.5063 6.4773 1.738 13.1263 -0.18779 -0.0445 1.1975 0.6888 539732 BPBio1_001387 C1CN(CCN1)c2cccc3ccccc23 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 P03 compound treatment 16.826 2.797 0.7505 14.6749 1.3608 0.3224 0.7587 0.9288 907269 BPBio1_001388 CCCN(CCC)CCc1ccc(O)c(O)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 P04 compound treatment 14.2157 0.18665 0.0501 16.2244 2.9103 0.6896 0.523 0.7565 907481 BPBio1_001389 [O-][N+](=O)c1ccc2nc(ccc2c1)N3CCNCC3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 P05 compound treatment 20.9955 6.9664 1.8693 13.2753 -0.03879 -0.0092 1.3153 0.7036 907267 BPBio1_001390 CN1CCc2cc(O)cc-3c2[C@H]1Cc4ccc(O)c(O)c43 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 P06 compound treatment 27.4407 13.412 3.5987 20.1613 6.8472 1.6223 3.6918 0.9352 1096365 BPBio1_001391 CN1CCC(=C2c3ccsc3CCc4ccccc24)CC1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 P07 compound treatment 166.7065 152.68 40.9673 76.4553 63.141 14.9604 39.5468 0.9068 907268 BPBio1_001392 CCCN1CCc2cc(O)cc-3c2[C@H]1Cc4ccc(O)c(O)c43 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 P08 compound treatment 25.5929 11.564 3.1029 12.4817 -0.83238 -0.1972 2.0546 0.6608 1494 BPBio1_001393 C1CN(CCN1)c2ccc3ccccc3n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 P09 compound treatment 12.9519 -1.0772 -0.289 18.6026 5.2885 1.253 0.6816 0.5301 1501 BPBio1_001394 NCCc1ccc(O)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 P10 compound treatment 18.6564 4.6273 1.2416 31.6331 18.319 4.3404 3.9471 0.8743 907496 BPBio1_001395 O=C1NCN(c2ccccc2)C31CCN(CC4COc5ccccc5O4)CC3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 P11 compound treatment 12.2694 -1.7597 -0.4722 17.373 4.0589 0.9617 0.3461 0.3231 2060500 BPBio1_001396 NCCc1cccc(O)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 P12 compound treatment 10.395 -3.6341 -0.9751 13.9354 0.62129 0.1472 -0.5854 -0.5936 3614541 BPBio1_001397 CN1C(=O)COc2c(cc(Cl)cc12)C(=O)NC3CN4CCC3CC4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 P13 compound treatment 9.2735 -4.7556 -1.276 16.3358 3.0217 0.7159 -0.396 -0.2707 3614515 BPBio1_001398 CN(C)S(=O)(=O)N[C@H]1C[C@H]2[C@@H](Cc3cn(C)c4cccc2c34)N(C)C1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 P14 compound treatment 13.8007 -0.22835 -0.0613 13.7479 0.43379 0.1028 0.0294 0.2453 3614543 BPBio1_001399 C(COc1ccc2OCOc2c1)CN3CCN(CC3)c4ccccc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 P15 compound treatment 12.0966 -1.9325 -0.5185 13.8337 0.51964 0.1231 -0.2796 -0.5246 907466 BPBio1_001400 CCCN1CCO[C@H]2[C@H]1COc3ccc(O)cc23 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 P16 compound treatment 11.636 -2.393 -0.6421 12.6574 -0.65667 -0.1556 -0.5641 -0.8537 907201 BPBio1_001401 CN1CCC(CC1)c2c[nH]c3ccc(O)cc23 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 P17 compound treatment 26.7596 12.731 3.4159 40.9472 27.633 6.5473 7.045 0.954 907456 BPBio1_001402 CCCN(CCc1ccccc1)C2CCc3c(O)cccc3C2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 P18 compound treatment 12.051 -1.9781 -0.5308 16.8203 3.5062 0.8307 0.2121 0.2152 1504 BPBio1_001403 O=C1CC2(CCCC2)CC(=O)N1CCCCN3CCN(CC3)c4ncccn4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 P19 compound treatment 21.2912 7.2621 1.9486 16.5237 3.2096 0.7605 1.9156 0.9158 1001905 BPBio1_001404 CCCN1CCc2cccc-3c2[C@H]1Cc4ccc(O)c(O)c43 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 P20 compound treatment 12.4645 -1.5646 -0.4198 13.2632 -0.050915 -0.0121 -0.3054 -0.7271 907224 BPBio1_001405 NCCc1c[nH]c2ccc(cc12)C(=O)N 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 P21 compound treatment 17.4119 3.3828 0.9077 16.4047 3.0906 0.7323 1.1596 0.9943 1002009 BPBio1_001406 CCN(CC)C(=O)N[C@@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(C)C1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 P22 compound treatment 13.4753 -0.55374 -0.1486 12.513 -0.80114 -0.1898 -0.2393 -0.9927 3614549 BPBio1_001407 OCc1ccccc1N2CCN(CCN(C(=O)C3CCCCC3)c4ccccn4)CC2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 P23 mock treatment 14.474 0.4449 0.1194 12.4825 -0.83155 -0.197 -0.0549 -0.2383 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2323 P24 mock treatment 12.1525 -1.8765 -0.5035 13.4927 0.17864 0.0423 -0.3261 -0.6454 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 A01 compound treatment 36.0029 22.461 6.0269 18.3211 4.7743 1.1312 5.0615 0.8254 1913656 CBChromo1_000001 COc1ccc(/C=N/NC(=O)c2ccccc2O)cc1OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 A02 compound treatment 22.427 8.8851 2.3841 43.0837 29.537 6.9983 6.6344 0.8974 1920364 CBChromo1_000002 C1CCc2c(C1)sc3ncnc(N/N=C\c4ccc(cc4)c5ccccc5)c23 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 A03 compound treatment 21.618 8.0761 2.167 25.7605 12.214 2.8939 3.5786 0.9898 1912983 CBChromo1_000003 O=C(Cc1ccccc1)NNc2ccc3ccccc3c2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 A04 compound treatment 12.932 -0.60991 -0.1637 18.0598 4.5131 1.0693 0.6404 0.592 538 CBChromo1_000004 CC(CCc1ccccc1)C(=O)NO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 A05 compound treatment 54.4541 40.912 10.9778 58.1831 44.636 10.5759 15.2408 0.9998 1912573 CBChromo1_000005 NC(=N)SCc1ccccc1F 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 A06 compound treatment 20.9946 7.4527 1.9998 37.2373 23.691 5.6131 5.3831 0.9034 1244471 CBChromo1_000006 CCN(CC)CC(O)COc1ccc(cc1)C2(CC3CC4CC(C3)C2)C4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 A07 compound treatment 13.1891 -0.35279 -0.0947 19.7441 6.1973 1.4684 0.9714 0.6602 1913686 CBChromo1_000007 OC(=O)/C=C/C(=O)Nc1cccc2c(NC(=O)\C=C\C(=O)O)cccc12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 A08 compound treatment 12.5714 -0.97054 -0.2604 17.1339 3.5872 0.8499 0.4168 0.4689 1699574 CBChromo1_000008 CN1C(N(C)c2ccccc12)c3cccs3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 A09 compound treatment 32.4705 18.929 5.079 24.0469 10.5 2.4878 5.3506 0.9461 1918598 CBChromo1_000009 COc1cccc(/C=N\Nc2ccccn2)c1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 A10 compound treatment 10.7734 -2.7685 -0.7429 16.7511 3.2043 0.7592 0.0116 0.0109 1917942 CBChromo1_000010 CCOC(=O)c1c(C)c(C)sc1NC(=O)C(F)(F)F 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 A11 compound treatment 12.8818 -0.66014 -0.1771 17.8177 4.2709 1.0119 0.5903 0.5746 1913101 CBChromo1_000011 N=c1ccn(CC(=O)c2ccc(cc2)c3ccccc3)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 A12 compound treatment 13.872 0.33014 0.0886 13.219 -0.32778 -0.0777 0.0077 0.0656 1002707 CBChromo1_000012 Oc1cc(cc2cc(NC(=O)Nc3ccc4c(O)cc(cc4c3)S(=O)(=O)O)ccc12)S(=O)(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 A13 compound treatment 14.9562 1.4143 0.3795 18.5967 5.0499 1.1965 1.1144 0.8878 1917324 CBChromo1_000013 Cc1cc(Br)cc(C)c1OCC(=O)N/N=C/c2cc(Br)c(O)c(Br)c2O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 A14 compound treatment 149.1349 135.59 36.3831 103.9152 90.368 21.4115 40.8669 0.968 1392413 CBChromo1_000014 CN(C)c1cccc(c1)C(=O)n2nnc3ccccc23 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 A15 compound treatment 12.6953 -0.84657 -0.2272 24.8108 11.264 2.6689 1.7265 0.6446 1914233 CBChromo1_000015 Oc1c(Br)cc(cc1Br)S(=O)(=O)c2cc(Br)c(OCC=C)c(Br)c2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 A16 compound treatment 32.7203 19.178 5.1461 28.7941 15.247 3.6126 6.1933 0.985 1924027 CBChromo1_000016 COc1ccc(OC)c(/C=C/C(=O)c2c(c3ccccc3)c4cc(Br)ccc4[nH]c2=O)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 A17 compound treatment 17.488 3.9461 1.0588 13.6465 0.099696 0.0236 0.7654 0.7227 1031871 CBChromo1_000017 Oc1ccc(Cl)cc1Cc2cc(Cl)cc(Cc3cc(Cl)ccc3O)c2O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 A18 compound treatment 109.6475 96.106 25.7876 35.5245 21.978 5.2073 21.9167 0.8331 1933148 CBChromo1_000018 Cc1ccc(cc1NS(=O)(=O)c2ccccc2)c3nc4cc(Cl)ccc4o3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 A19 compound treatment 39.0029 25.461 6.8318 39.8646 26.318 6.2356 9.2401 0.999 1916017 CBChromo1_000019 Nc1ccc(cc1)c2cnc(nc2)c3ccc(N)cc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 A20 compound treatment 23.0966 9.5547 2.5638 23.7825 10.236 2.4252 3.5277 0.9996 1308836 CBChromo1_000020 Cc1cc(C)c(NC(=O)COc2cccc(Br)c2)c(C)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 A21 compound treatment 16.7689 3.227 0.8659 22.1014 8.5546 2.0269 2.0455 0.928 1918845 CBChromo1_000021 Oc1ccccc1C(=O)N/N=C/c2cc3OCOc3cc2[N+](=O)[O-] 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 A22 compound treatment 65.3329 51.791 13.8969 56.7199 43.173 10.2292 17.0597 0.9886 1428952 CBChromo1_000022 COc1ccc(Cl)cc1C(=O)n2nnc3ccccc23 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 A23 mock treatment 3.8603 -9.6816 -2.5978 16.9369 3.3901 0.8032 -1.269 -0.4667 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 A24 mock treatment 15.5066 1.9647 0.5272 17.4166 3.8698 0.9169 1.0211 0.9655 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 B01 compound treatment 15.8968 2.3549 0.6319 33.3956 19.849 4.7029 3.7722 0.795 1913438 CBChromo1_000023 [O-][N+](=O)c1ccc(/C=N/NC(=O)c2ccncc2)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 B02 compound treatment 19.2649 5.723 1.5356 18.8988 5.3521 1.2681 1.9825 0.9955 1192620 CBChromo1_000024 Clc1ccc(OCC(=O)N2CC(CC2=O)c3ccccc3)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 B03 compound treatment 21.9809 8.439 2.2644 28.7399 15.193 3.5998 4.1466 0.975 1920508 CBChromo1_000025 Cc1ccc(cc1)S(=O)(=O)NC2=C(C(=O)c3ccccc3C2=O)[n+]4ccccc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 B04 compound treatment 16.1303 2.5884 0.6945 15.6385 2.0917 0.4956 0.8415 0.9863 1923167 CBChromo1_000026 CC1(C)CC(=O)C2=C(C1)OC3=C(C2c4ccc(I)cc4)C(=O)CC(C)(C)C3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 B05 compound treatment 13.4541 -0.08779 -0.0236 14.9194 1.3726 0.3252 0.2133 0.6542 1041351 CBChromo1_000027 CN(C)Cc1c[nH]c2cc(ccc12)[N+](=O)[O-] 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 B06 compound treatment 3.3808 -10.161 -2.7265 28.7629 15.216 3.6052 0.6214 0.1375 1921966 CBChromo1_000028 Brc1ccccc1C(=O)n2nnc3ccccc23 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 B07 compound treatment 13.2335 -0.30836 -0.0827 23.9033 10.357 2.4538 1.6766 0.6829 1913597 CBChromo1_000029 COc1ccccc1C2CC(=NN2c3ccccc3)c4ccccc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 B08 compound treatment 96.4562 82.914 22.2481 63.8723 50.326 11.9239 24.1632 0.9573 1128878 CBChromo1_000030 COc1ccc(cc1OC)C(=O)n2nnc3ccccc23 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 B09 compound treatment 19.8965 6.3546 1.7051 20.302 6.7553 1.6006 2.3375 0.9995 1918866 CBChromo1_000031 [O-][N+](=O)c1ccc(OC(=O)CN2C(=O)c3ccccc3C2=O)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 B10 compound treatment 14.5071 0.96524 0.259 18.6246 5.0779 1.2031 1.0339 0.8401 1496608 CBChromo1_000032 CCOc1ccc(cc1OC)C2C3=C(CC(C)(C)CC3=O)OC4=C2C(=O)CC(C)(C)C4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 B11 compound treatment 40.495 26.953 7.2322 36.9151 23.368 5.5368 9.029 0.9913 1086418 CBChromo1_000033 ClCC(=O)Nc1ccc(Br)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 B12 compound treatment 15.1169 1.575 0.4226 11.1696 -2.3772 -0.5632 -0.0994 -0.1412 1207865 CBChromo1_000034 Cc1ccc(o1)C2C3=C(CC(C)(C)CC3=O)OC4=C2C(=O)CC(C)(C)C4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 B13 compound treatment 13.3331 -0.20879 -0.056 13.4571 -0.089609 -0.0212 -0.0546 -0.9118 1626895 CBChromo1_000035 CC1(C)CC(=O)C2=C(C1)OC3=C(C2c4ccc(OCc5ccc(F)cc5)cc4)C(=O)CC(C)(C)C3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 B14 compound treatment 13.1222 -0.41966 -0.1126 17.6187 4.072 0.9648 0.6026 0.6204 1931161 CBChromo1_000036 CC1(C)CC(=O)C2=C(C1)OC3=C(C2c4c(O)ccc5ccccc45)C(=O)CC(C)(C)C3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 B15 compound treatment 39.0374 25.495 6.8411 51.124 37.577 8.9034 11.133 0.9915 1140129 CBChromo1_000037 Cc1ccc(C)c(OCC(=O)Nc2c(C)cc(C)cc2C)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 B16 compound treatment 44.4881 30.946 8.3037 23.3663 9.8195 2.3266 7.5167 0.8717 1918161 CBChromo1_000038 CCCCCC(=O)N/N=C/c1ccc2cc(OC)ccc2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 B17 compound treatment 16.73 3.1881 0.8555 12.5939 -0.95288 -0.2258 0.4453 0.5033 3624409 CBChromo1_000039 Cc1cccc(COc2ccc(cc2)C3C4=C(CC(C)(C)CC4=O)OC5=C3C(=O)CC(C)(C)C5)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 B18 compound treatment 35.4919 21.95 5.8898 32.5335 18.987 4.4986 7.3457 0.9912 1152708 CBChromo1_000040 Cc1ccc(cc1)S(=O)(=O)Nc2ccccc2c3nc4ccccc4[nH]c3=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 B19 compound treatment 13.1707 -0.37116 -0.0996 30.1808 16.634 3.9412 2.7164 0.689 3624410 CBChromo1_000041 CC(=O)Nc1ccc(cc1)S(=O)(=O)Nc2ccc(cc2)c3nc4ccccc4o3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 B20 compound treatment 20.8672 7.3253 1.9656 31.0102 17.463 4.1377 4.3157 0.9421 1589883 CBChromo1_000042 Cc1cccc(c1)c2nc3cc(NS(=O)(=O)c4ccccc4)ccc3o2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 B21 compound treatment 24.7512 11.209 3.0078 21.129 7.5822 1.7965 3.3971 0.9697 3624411 CBChromo1_000043 COc1ccc(NC(CC(=O)c2ccc(Br)cc2)c3ccccc3)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 B22 compound treatment 11.4225 -2.1194 -0.5687 15.616 2.0693 0.4903 -0.0554 -0.0738 3624412 CBChromo1_000044 C[C@@H](O)[C@@H]1OC1/C=C/[C@@H]2O[C@H]2[C@H](O)C=C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 B23 mock treatment 13.0947 -0.44719 -0.12 15.8536 2.3068 0.5466 0.3016 0.539 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 B24 mock treatment 15.8697 2.3278 0.6246 12.4149 -1.1319 -0.2682 0.252 0.3708 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 C01 compound treatment 24.4775 10.936 2.9343 23.0782 9.5315 2.2583 3.6718 0.9916 1921774 CBChromo1_000045 CC/C(=C/c1sc2ccc3ccccc3c2[n+]1C)/SC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 C02 compound treatment 22.8898 9.3479 2.5083 24.0285 10.482 2.4835 3.5297 1.0 1920309 CBChromo1_000046 Oc1ccc(/C=N/Nc2ncnc3sc4CCCCc4c23)c(O)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 C03 compound treatment 24.634 11.092 2.9763 33.5573 20.011 4.7412 5.4571 0.9748 1010154 CBChromo1_000047 CC(NC(=O)CCl)c1ccccc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 C04 compound treatment 19.0429 5.501 1.4761 14.9451 1.3983 0.3313 1.278 0.8448 1121247 CBChromo1_000048 Cc1cc(C)c(NC(=O)CCc2ccccc2)c(C)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 C05 compound treatment 31.3492 17.807 4.7782 38.7371 25.19 5.9685 7.599 0.9939 1003597 CBChromo1_000049 Oc1cc2oc3cc(=O)c(O)cc3c(c4ccccc4)c2cc1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 C06 compound treatment 325.7635 312.22 83.7771 293.3533 279.81 66.296 106.1177 0.9933 536 CBChromo1_000050 ONC(=O)CCCCCN1C(=O)c2cccc3cccc(C1=O)c23 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 C07 compound treatment 15.9298 2.3879 0.6407 13.7844 0.23765 0.0563 0.4929 0.7663 1913709 CBChromo1_000051 COc1ccc(/C=N/NC(=O)c2cc3ccccc3cc2O)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 C08 compound treatment 44.6217 31.08 8.3395 80.9975 67.451 15.9815 17.1975 0.954 1918023 CBChromo1_000052 CC[n+]1c(/C=C/N(C)c2ccccc2)n(c3ccccc3)c4ccc(cc14)c5nc6ccccc6s5 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 C09 compound treatment 13.5916 0.049685 0.0133 16.0878 2.5411 0.6021 0.4352 0.7226 1919799 CBChromo1_000053 CCOc1c(OCC)c2oc(C(=O)N3CCOCC3)c(C)c2cc1[N+](=O)[O-] 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 C10 compound treatment 15.6365 2.0946 0.562 15.871 2.3242 0.5507 0.7868 0.9999 1919796 CBChromo1_000054 C/C(=N\NC(=O)c1ccccc1O)/Cn2nnc(n2)[N+](=O)[O-] 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 C11 compound treatment 14.8224 1.2805 0.3436 13.4164 -0.13038 -0.0309 0.2211 0.6409 1727701 CBChromo1_000055 Clc1ccc(cc1)C(=O)NCc2ccccn2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 C12 compound treatment 12.1524 -1.3895 -0.3728 14.105 0.55827 0.1323 -0.1701 -0.43 1921358 CBChromo1_000056 Oc1nc(cc(n1)c2ccccc2)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 C13 compound treatment 22.9299 9.388 2.519 25.5395 11.993 2.8415 3.7905 0.9982 1035314 CBChromo1_000057 Nc1ccc(NC(=O)c2ccc(cc2)C(=O)Nc3ccc(N)cc3)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 C14 compound treatment 17.8769 4.335 1.1632 14.6744 1.1276 0.2672 1.0114 0.8475 1350276 CBChromo1_000058 CC(=O)Nc1ccc(cc1)S(=O)(=O)Nc2cccc(c2)c3nc4ccccc4o3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 C15 compound treatment 18.5447 5.0028 1.3424 16.3022 2.7554 0.6529 1.4108 0.9452 535 CBChromo1_000059 ONC(=O)CCCN1C(=O)c2cccc3cccc(C1=O)c23 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 C16 compound treatment 26.281 12.739 3.4182 18.901 5.3542 1.2686 3.3141 0.909 1593689 CBChromo1_000060 Ic1ccc(cc1)c2nc3cc(NS(=O)(=O)c4ccccc4)ccc3o2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 C17 compound treatment 47.5806 34.039 9.1335 32.1157 18.569 4.3996 9.5693 0.9439 1915616 CBChromo1_000061 [O-][N+](=O)c1cc(ccc1Cl)S(=O)(=O)Nc2ccc(Br)cc2C(=O)Nc3cc(Cl)ccc3Cl 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 C18 compound treatment 15.2911 1.7492 0.4694 11.9945 -1.5523 -0.3678 0.0718 0.1205 1931455 CBChromo1_000062 Fc1ccc(C(=O)n2nnc3ccccc23)c(F)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 C19 compound treatment 13.6913 0.14941 0.0401 18.4017 4.855 1.1503 0.8417 0.7313 1133700 CBChromo1_000063 CC(Oc1cccc(Cl)c1)C(=O)NN 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 C20 compound treatment 12.2662 -1.2757 -0.3423 13.5636 0.016871 0.004 -0.2392 -0.6988 1129917 CBChromo1_000064 CCOC(=O)C(C)Oc1ccc2c(C)c(C)c(=O)oc2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 C21 compound treatment 15.9787 2.4368 0.6539 13.6694 0.12267 0.0291 0.4829 0.7378 1920217 CBChromo1_000065 Cc1ccc(/C=N/NC(=O)c2ccccc2O)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 C22 compound treatment 14.0032 0.46134 0.1238 13.4121 -0.13461 -0.0319 0.065 0.5083 1291152 CBChromo1_000066 COc1ccc(cc1)N(CC(=O)N2CCOCC2)S(=O)(=O)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 C23 mock treatment 14.1883 0.64641 0.1734 13.8167 0.26992 0.064 0.1679 0.9081 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 C24 mock treatment 16.387 2.8452 0.7634 14.9261 1.3794 0.3268 0.7709 0.9283 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 D01 compound treatment 58.5915 45.05 12.088 63.8322 50.285 11.9144 16.9722 1.0 1523100 CBChromo1_000067 Nc1cc2cccnc2c3ncccc13 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 D02 compound treatment 12.6689 -0.87299 -0.2342 15.4587 1.9119 0.453 0.1547 0.3033 3017585 CBChromo1_000068 CN1CCc2c1nc3CCCc3c2N.OC(=O)c1cncc(O)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 D03 compound treatment 16.6487 3.1068 0.8336 15.8533 2.3065 0.5465 0.9759 0.979 1157157 CBChromo1_000069 Cc1ccc(C)n1c2cccc(c2)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 D04 compound treatment 20.4593 6.9174 1.8561 92.5759 79.029 18.7248 14.5529 0.7734 1716722 CBChromo1_000070 Cc1ccc2[nH]c3C(CCCc3c2c1)NCC4(CC5CC6CC(C5)C4)C6 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 D05 compound treatment 16.5378 2.996 0.8039 17.8622 4.3154 1.0225 1.2914 0.9929 1913502 CBChromo1_000071 CN(C)c1ccc(/C=N/NC(=N)N[N+](=O)[O-])cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 D06 compound treatment 52.4539 38.912 10.4411 64.5577 51.011 12.0863 15.9293 0.9973 1920938 CBChromo1_000072 Brc1ccc(cc1)C(=O)n2nnc3ccccc23 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 D07 compound treatment 14.7732 1.2313 0.3304 19.2745 5.7277 1.3571 1.1932 0.8543 1010375 CBChromo1_000073 Oc1cc(cc2ccc(Nc3ccccc3)cc12)S(=O)(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 D08 compound treatment 29.1783 15.636 4.1957 26.6108 13.064 3.0953 5.1555 0.9888 1218659 CBChromo1_000074 O=C(c1ccc(cc1)c2ccccc2)n3nnc4ccccc34 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 D09 compound treatment 13.7439 0.20202 0.0542 11.8877 -1.6591 -0.3931 -0.2396 -0.6039 1026485 CBChromo1_000075 Cc1ccc(cc1)S(=O)(=O)NCCCCCC(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 D10 compound treatment 25.5112 11.969 3.2117 30.2643 16.718 3.961 5.0718 0.9946 1524778 CBChromo1_000076 CCOc1ccc(cc1)C(CC(=O)c2ccccc2)Nc3ccc(Cl)cc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 D11 compound treatment 16.1989 2.657 0.7129 13.074 -0.47278 -0.112 0.4249 0.5888 1914356 CBChromo1_000077 CCc1nnc(NS(=O)(=O)c2ccc(NC(=S)NC(=O)/C=C/c3ccco3)cc2)s1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 D12 compound treatment 11.8891 -1.6528 -0.4435 12.8051 -0.74163 -0.1757 -0.4378 -0.9179 1630350 CBChromo1_000078 CC1(C)CC(=O)C2=C(C1)OC3=C(C2c4ccc(o4)c5ccc(Cl)cc5)C(=O)CC(C)(C)C3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 D13 compound treatment 22.7809 9.239 2.4791 22.3063 8.7595 2.0754 3.2205 0.9961 1215060 CBChromo1_000079 Brc1cccc(c1)c2nc3cc(NS(=O)(=O)c4ccccc4)ccc3o2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 D14 compound treatment 37.8956 24.354 6.5347 56.8054 43.259 10.2495 11.8682 0.9764 1917473 CBChromo1_000080 Cc1ccc(o1)c2cc3C(=O)c4ccccc4-c3nn2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 D15 compound treatment 18.4084 4.8665 1.3058 15.5875 2.0407 0.4835 1.2652 0.9086 1337439 CBChromo1_000081 CCc1ccc(OCC(=O)Nc2c(C)cc(C)cc2C)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 D16 compound treatment 13.8599 0.31801 0.0853 14.3118 0.76507 0.1813 0.1885 0.9409 1918640 CBChromo1_000082 Nc1cc(c2ccccc2c1)S(=O)(=O)N 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 D17 compound treatment 32.5883 19.046 5.1106 30.3876 16.841 3.9902 6.4353 0.9925 3624413 CBChromo1_000083 Clc1ccc(cc1)S(=O)(=O)Nc2ccc(cc2)c3nc4ccccc4o3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 D18 compound treatment 32.8772 19.335 5.1881 39.9067 26.36 6.2456 8.0849 0.9958 1374975 CBChromo1_000084 Oc1ccc(NS(=O)(=O)c2ccccc2)cc1c3nc4ccccc4o3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 D19 compound treatment 71.5861 58.044 15.5747 54.2799 40.733 9.6511 17.8374 0.9735 3624414 CBChromo1_000085 O=C(Nc1cccc(c1)C(=O)n2nnc3ccccc23)c4ccccc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 D20 compound treatment 14.9305 1.3886 0.3726 14.112 0.56522 0.1339 0.3582 0.9046 1241852 CBChromo1_000086 O=S(=O)(Nc1ccc2oc(nc2c1)c3cccnc3)c4ccccc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 D21 compound treatment 17.1968 3.6549 0.9807 12.6758 -0.87092 -0.2064 0.5476 0.5464 3624415 CBChromo1_000087 Cc1ccc(NC(=O)COc2ccc(C)c(C)c2)c(N)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 D22 compound treatment 12.1023 -1.4396 -0.3863 13.0037 -0.54303 -0.1287 -0.3641 -0.8943 471 CBChromo1_000088 CCCC(CCC)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 D23 mock treatment 15.0064 1.4645 0.393 13.8506 0.30385 0.072 0.3288 0.823 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 D24 mock treatment 11.1618 -2.3801 -0.6386 12.0305 -1.5163 -0.3593 -0.7056 -0.963 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 E01 compound treatment 13.6466 0.10469 0.0281 11.5316 -2.0152 -0.4775 -0.3178 -0.6644 1427482 CBChromo1_000089 Cc1c(oc2c3OCCOc3ccc12)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 E02 compound treatment 11.4213 -2.1206 -0.569 14.4676 0.92082 0.2182 -0.2481 -0.4071 1921826 CBChromo1_000090 Oc1ccc(Br)cc1/C=N/c2cccc(Nc3nc(nc(n3)N4CCOCC4)N(c5ccccc5)c6ccccc6)c2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 E03 compound treatment 11.2135 -2.3284 -0.6248 13.2694 -0.27735 -0.0657 -0.4882 -0.7772 1913491 CBChromo1_000091 Ic1ccccc1C(=O)OCC(=O)c2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 E04 compound treatment 11.7891 -1.7528 -0.4703 11.3086 -2.2382 -0.5303 -0.7076 -0.9982 1919107 CBChromo1_000092 Cc1cc(NCCCN2CCOCC2)nc(n1)c3ccccc3O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 E05 compound treatment 13.4254 -0.1165 -0.0313 11.6845 -1.8623 -0.4412 -0.3341 -0.7553 1118121 CBChromo1_000093 CC1(C)CC(=C(CC2C(=O)CC(C)(C)CC2=O)C(=O)C1)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 E06 compound treatment 16.8189 3.277 0.8793 13.8901 0.34332 0.0813 0.6793 0.7692 1921947 CBChromo1_000094 CC1(C)CC(=O)C2=C(C1)OC3=C(C2c4ccccc4)C(=O)CC(C)(C)C3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 E07 compound treatment 12.6424 -0.89946 -0.2413 13.0883 -0.45845 -0.1086 -0.2475 -0.935 1913769 CBChromo1_000095 Oc1cc2ccccc2cc1C(=O)N/N=C/c3ccccc3F 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 E08 compound treatment 13.0083 -0.53356 -0.1432 14.0376 0.49085 0.1163 -0.019 -0.103 1919356 CBChromo1_000096 COc1ccc(cc1)c2n(C)c3ccccc3[n+]2C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 E09 compound treatment 31.5033 17.961 4.8195 29.0289 15.482 3.6683 6.0018 0.9909 1912827 CBChromo1_000097 CCN(CC)c1ccc(/C=N\NC(=O)c2cccc(Br)c2)c(O)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 E10 compound treatment 17.1014 3.5595 0.9551 13.8067 0.25992 0.0616 0.7189 0.7511 1918577 CBChromo1_000098 O=S(=O)(c1ccccc1)n2nnc3ccccc23 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 E11 compound treatment 31.6118 18.07 4.8486 15.9152 2.3685 0.5612 3.8253 0.7837 1003076 CBChromo1_000099 OC(=O)c1ccccc1c2c3cc(Br)c(O)c(Br)c3oc4c(Br)c(=O)c(Br)cc24 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 E12 compound treatment 12.9032 -0.63874 -0.1714 16.25 2.7032 0.6405 0.3317 0.5003 1917753 CBChromo1_000100 COc1ccc2C(=O)N(C)C(=O)c3cccc1c32 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 E13 compound treatment 18.5218 4.9799 1.3362 16.7969 3.2501 0.7701 1.4894 0.9657 1470918 CBChromo1_000101 Cc1cc(C)cc(NCC(=O)Nc2c(C)cccc2C)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 E14 compound treatment 15.7091 2.1672 0.5815 20.086 6.5392 1.5494 1.5068 0.9105 1941017 CBChromo1_000102 Cc1cc(Cl)ccc1OCCCC(=O)NO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 E15 compound treatment 16.2774 2.7355 0.734 16.6594 3.1126 0.7375 1.0405 1.0 1914841 CBChromo1_000103 [O-][N+](=O)c1ccccc1NC(=S)NC(NC(=O)Cc2cccc3ccccc23)C(Cl)(Cl)Cl 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 E16 compound treatment 18.2739 4.7321 1.2697 21.2475 7.7007 1.8246 2.188 0.9843 1275344 CBChromo1_000104 CCc1ccc2oc(nc2c1)c3ccc(C)c(NS(=O)(=O)c4ccccc4)c3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 E17 compound treatment 23.6095 10.068 2.7014 18.7266 5.1799 1.2273 2.778 0.9363 1915720 CBChromo1_000105 [O-][N+](=O)c1cc(ccc1Cl)S(=O)(=O)Nc2ccc(Cl)cc2C(=O)Nc3cc(Cl)ccc3Cl 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 E18 compound treatment 12.0595 -1.4824 -0.3978 16.3097 2.7629 0.6546 0.1816 0.2371 1931570 CBChromo1_000106 [O-][N+](=O)c1ccc(F)c(c1)C(=O)n2nnc3ccccc23 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 E19 compound treatment 127.2168 113.67 30.5019 96.1016 82.555 19.5602 35.3992 0.9769 1920218 CBChromo1_000107 Clc1c(Cl)c(Cl)c(C(=O)OCC#C)c(C(=O)OCC#C)c1Cl 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 E20 compound treatment 27.0998 13.558 3.6379 18.1055 4.5587 1.0801 3.3362 0.8791 1291287 CBChromo1_000108 Cc1cc(C)c(NC(=O)COc2cccc(Cl)c2)c(C)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 E21 compound treatment 18.7062 5.1643 1.3857 16.303 2.7562 0.653 1.4416 0.9411 1919426 CBChromo1_000109 COc1ccc(/C=N/NC(=O)c2ccccc2O)cc1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 E22 compound treatment 17.4676 3.9257 1.0534 19.1492 5.6024 1.3274 1.6835 0.9934 1166615 CBChromo1_000110 COc1ccc(N(CC(=O)Nc2ccccc2Br)S(=O)(=O)c3ccc(C)cc3)c(OC)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 E23 mock treatment 17.52 3.9781 1.0674 11.2778 -2.2689 -0.5376 0.3746 0.3135 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 E24 mock treatment 13.9397 0.39781 0.1067 13.0533 -0.4935 -0.1169 -0.0072 -0.0455 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 F01 compound treatment 18.4355 4.8936 1.3131 11.0912 -2.4556 -0.5818 0.5171 0.36 1913508 CBChromo1_000111 Nc1scc[n+]1CC(=O)c2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 F02 compound treatment 15.4845 1.9426 0.5212 11.7011 -1.8456 -0.4373 0.0594 0.0873 1915702 CBChromo1_000112 Oc1c(I)cc(I)cc1C(=O)Nc2cc(ccc2Cl)S(=O)(=O)c3ccc(Cl)cc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 F03 compound treatment 16.8126 3.2707 0.8776 16.4738 2.927 0.6935 1.1109 0.9932 1774290 CBChromo1_000113 [O-][N+](=O)c1ccc(cc1)C(=O)Nc2sc3CCCCc3c2C(=O)c4ccccc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 F04 compound treatment 20.5196 6.9778 1.8723 30.1839 16.637 3.9419 4.1113 0.9421 1251647 CBChromo1_000114 Fc1ccccc1CN2CCN(CC2)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 F05 compound treatment 16.9629 3.421 0.918 14.5896 1.0428 0.2471 0.8238 0.8666 1628747 CBChromo1_000115 COc1ccc(cc1OC)C(=O)Nc2ccccc2C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 F06 compound treatment 12.0395 -1.5023 -0.4031 11.9808 -1.5659 -0.371 -0.5474 -0.9991 1921581 CBChromo1_000116 CCN(C(=O)c1ccc(cc1)c2ccccc2)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 F07 compound treatment 131.6078 118.07 31.6801 127.342 113.8 26.9621 41.4663 0.9968 1049687 CBChromo1_000117 Cc1ccc(cc1)S(=O)(=O)Nc2cccc3cccnc23 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 F08 compound treatment 37.6848 24.143 6.4782 28.2935 14.747 3.494 7.0514 0.958 541 CBChromo1_000118 Cc1c(C)c(CONC(=O)c2ccccc2)c(C)c(C)c1Br 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 F09 compound treatment 23.1333 9.5914 2.5736 19.5809 6.0341 1.4297 2.8308 0.9615 1565273 CBChromo1_000119 Oc1ccc(Oc2ccc(Oc3ccc(O)cc3)cc2)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 F10 compound treatment 51.8489 38.307 10.2788 38.3366 24.79 5.8736 11.4214 0.9648 1176912 CBChromo1_000120 Cc1cc(C)c(NC(=O)COc2ccc(Cl)cc2)c(C)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 F11 compound treatment 14.4193 0.87739 0.2354 12.9021 -0.64468 -0.1527 0.0585 0.2083 1914302 CBChromo1_000121 O=C(NC(=S)Nc1ccc(cc1)S(=O)(=O)Nc2nccs2)/C=C/c3ccco3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 F12 compound treatment 14.3324 0.7905 0.2121 16.9374 3.3906 0.8034 0.718 0.8642 1613055 CBChromo1_000122 Cc1ccccc1C2C3=C(CC(C)(C)CC3=O)OC4=C2C(=O)CC(C)(C)C4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 F13 compound treatment 58.9164 45.375 12.1752 47.5417 33.995 8.0546 14.3046 0.9799 1359699 CBChromo1_000123 Brc1ccccc1c2nc3cc(NS(=O)(=O)c4ccccc4)ccc3o2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 F14 compound treatment 12.731 -0.81091 -0.2176 13.7473 0.20052 0.0475 -0.1203 -0.54 1918058 CBChromo1_000124 Oc1ccccc1C(=O)NNC(=S)NC(=O)c2ccc(cc2)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 F15 compound treatment 19.8958 6.3539 1.7049 17.4879 3.9411 0.9338 1.8658 0.9599 1175946 CBChromo1_000125 Cc1cc(C)c(NC(=O)COc2ccc(C)c(C)c2)c(C)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 F16 compound treatment 163.7612 150.22 40.3077 132.8057 119.26 28.2567 48.4823 0.9849 1708885 CBChromo1_000126 Cc1ccc(cc1)S(=O)(=O)Nc2ccccc2c3nc4ccccc4o3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 F17 compound treatment 29.8881 16.346 4.3861 26.0314 12.485 2.9581 5.1931 0.9816 3624416 CBChromo1_000127 Clc1ccc(cc1)S(=O)(=O)Nc2cccc(c2)c3nc4ccccc4o3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 F18 compound treatment 23.8458 10.304 2.7648 20.8102 7.2634 1.721 3.1719 0.974 1525986 CBChromo1_000128 Cc1ccc2oc(nc2c1)c3cccc(NS(=O)(=O)c4ccccc4)c3C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 F19 compound treatment 11.7124 -1.8295 -0.4909 14.957 1.4102 0.3341 -0.1109 -0.1867 1451943 CBChromo1_000129 Cc1ccc(NC(=O)c2ccc(OCC(=O)Nc3ccccc3)cc2)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 F20 compound treatment 24.1299 10.588 2.841 27.7199 14.173 3.3581 4.3835 0.9965 1577769 CBChromo1_000130 CCc1ccc2oc(nc2c1)c3ccc(NS(=O)(=O)c4ccccc4)cc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 F21 compound treatment 30.1524 16.611 4.457 26.9845 13.438 3.1839 5.4029 0.9864 3624417 CBChromo1_000131 Cc1ccc(C(=O)n2nnc3ccccc23)c(F)c1F 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 F22 compound treatment 15.7661 2.2242 0.5968 11.2343 -2.3125 -0.5479 0.0346 0.0427 3069074 CBChromo1_000132 N[C@@H]1C[C@H]1c2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 F23 mock treatment 17.1266 3.5847 0.9619 12.799 -0.74774 -0.1772 0.5549 0.5673 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 F24 mock treatment 12.9689 -0.57296 -0.1537 9.3729 -4.1739 -0.9889 -0.808 -0.8073 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 G01 compound treatment 16.1888 2.6469 0.7102 15.0934 1.5467 0.3665 0.7613 0.9526 1912757 CBChromo1_000133 Cc1cc2/C(=C/c3ccco3)/OC(=O)c2c(=O)[nH]1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 G02 compound treatment 34.0615 20.52 5.5059 31.0111 17.464 4.1379 6.8192 0.9901 1915749 CBChromo1_000134 Oc1ccc(/N=C/c2ccc(o2)[N+](=O)[O-])cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 G03 compound treatment 31.4547 17.913 4.8065 39.0559 25.509 6.044 7.6725 0.9936 1913613 CBChromo1_000135 CCc1c(cn2CCn3c(C)ccc3-c12)c4ccccc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 G04 compound treatment 21.2575 7.7156 2.0703 32.6458 19.099 4.5252 4.6637 0.9372 1367680 CBChromo1_000136 Cc1ccc(cc1)c2cc(nc(n2)N3CCOCC3)c4ccccc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 G05 compound treatment 64.6003 51.058 13.7003 57.5182 43.971 10.4184 17.0545 0.9909 1913753 CBChromo1_000137 C/C(=N\NC(=O)c1ccccc1O)/c2ccc3ccccc3c2O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 G06 compound treatment 12.3247 -1.2172 -0.3266 12.4066 -1.1402 -0.2702 -0.422 -0.9956 540 CBChromo1_000138 CC1(CC2CC3(C)C1)CC(C2)(C3)C(=O)NO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 G07 compound treatment 46.1148 32.573 8.7402 46.6816 33.135 7.8508 11.7316 0.9986 1913831 CBChromo1_000139 CCN1/C(=C/c2ccc3cc(C)ccc3[n+]2CC)/C=Cc4cc(C)ccc14 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 G08 compound treatment 15.9617 2.4198 0.6493 13.2169 -0.32985 -0.0782 0.4039 0.6175 1919068 CBChromo1_000140 Clc1ccc(nn1)N2CCCCC2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 G09 compound treatment 16.0957 2.5538 0.6853 16.2115 2.6647 0.6314 0.931 0.9992 1919035 CBChromo1_000141 [O-][N+](=O)c1ccc(cc1)C(=O)Oc2c(Cl)cc(Cl)c(Cl)c2CNC(=O)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 G10 compound treatment 74.5823 61.04 16.3787 84.159 70.612 16.7305 23.4118 0.9999 1918768 CBChromo1_000142 Clc1ccc(C(=O)n2nnc3ccccc23)c(Cl)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 G11 compound treatment 109.707 96.165 25.8036 151.2993 137.75 32.6384 41.3247 0.9932 1001846 CBChromo1_000143 CCNc1cc2oc3cc(=NCC)c(C)cc3c(c4ccccc4C(=O)OCC)c2cc1C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 G12 compound treatment 45.3891 31.847 8.5454 29.2491 15.702 3.7204 8.6733 0.9306 1294988 CBChromo1_000144 Fc1ccccc1C(=O)n2nnc3ccccc23 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 G13 compound treatment 14.1043 0.56236 0.1509 13.0288 -0.518 -0.1227 0.0199 0.1024 1499150 CBChromo1_000145 Cc1ccccc1NCC(=O)Nc2c(C)cccc2C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 G14 compound treatment 28.1154 14.574 3.9105 30.8227 17.276 4.0933 5.6595 0.9997 1256375 CBChromo1_000146 COc1ccc(cc1)C(=O)CC(Nc2ccc(Cl)cc2)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 G15 compound treatment 12.3172 -1.2247 -0.3286 13.5255 -0.021229 -0.005 -0.2359 -0.7178 1352496 CBChromo1_000147 Nc1ccc(C(=O)Nc2ccc(cc2)C(=O)O)c(c1)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 G16 compound treatment 37.2407 23.699 6.359 32.0075 18.461 4.374 7.5894 0.9833 1707305 CBChromo1_000148 O=S(=O)(Nc1ccc(cc1)c2nc3ccccc3o2)c4ccccc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 G17 compound treatment 28.7383 15.196 4.0776 29.5993 16.052 3.8034 5.5727 0.9994 1916635 CBChromo1_000149 Nc1ccc(cc1)c2nc3ccc(cc3[nH]2)c4nc5ccc(N)cc5[nH]4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 G18 compound treatment 49.7164 36.175 9.7066 36.6903 23.144 5.4835 10.741 0.9635 1931472 CBChromo1_000150 Cc1cc(F)c(F)cc1C(=O)n2nnc3ccccc23 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 G19 compound treatment 74.2833 60.741 16.2985 64.151 50.604 11.9899 20.0029 0.9886 3624419 CBChromo1_000151 Clc1ccc(cc1)C(=O)n2nnc3ccccc23 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 G20 compound treatment 18.2976 4.7557 1.2761 21.0165 7.4698 1.7699 2.1538 0.9871 1924714 CBChromo1_000152 COc1ccc(cc1Br)C2C3=C(CC(C)(C)CC3=O)OC4=C2C(=O)CC(C)(C)C4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 G21 compound treatment 50.3233 36.781 9.8694 31.9296 18.383 4.3556 10.0585 0.9324 1919298 CBChromo1_000153 Cc1cc(C)c(/C=N/NC(=O)c2ccccc2[N+](=O)[O-])c(C)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 G22 compound treatment 13.4216 -0.12025 -0.0323 12.8395 -0.70728 -0.1676 -0.1413 -0.828 1924575 CBChromo1_000154 COC(=O)c1ccc(cc1)C2C(=C(C)NC(=C2C(=O)OCC=C)C)C(=O)OCC=C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 G23 mock treatment 14.1979 0.65596 0.176 15.3871 1.8403 0.436 0.4328 0.9204 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 G24 mock treatment 11.7323 -1.8096 -0.4856 12.709 -0.83778 -0.1985 -0.4837 -0.9221 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 H01 compound treatment 18.6425 5.1006 1.3686 14.0131 0.46639 0.1105 1.0459 0.7617 1913510 CBChromo1_000155 NC1=[N+](Cc2ccccc12)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 H02 compound treatment 13.9469 0.40498 0.1087 14.9847 1.438 0.3407 0.3178 0.8885 1410511 CBChromo1_000156 Cc1ccc(cc1)S(=O)(=O)Nc2ccc(Cc3ccc(NS(=O)(=O)c4ccc(C)cc4)c(c3)C(=O)O)cc2C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 H03 compound treatment 14.8157 1.2738 0.3418 14.2915 0.74477 0.1765 0.3665 0.9527 1913412 CBChromo1_000157 OCCSc1nnnn1c2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 H04 compound treatment 48.0632 34.521 9.263 31.611 18.064 4.2801 9.5764 0.9385 1156418 CBChromo1_000158 Cc1ccc(CN2CCN(CC2)c3ccccc3)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 H05 compound treatment 15.0174 1.4755 0.3959 17.2024 3.6556 0.8661 0.8924 0.9371 1380267 CBChromo1_000159 COc1ccc(cc1OC)C(=O)OCCN2CCOCC2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 H06 compound treatment 12.4172 -1.1247 -0.3018 13.8766 0.32988 0.0782 -0.1581 -0.5072 1920603 CBChromo1_000160 CC1CCN(CC1)C(=O)Nc2ccccc2C(F)(F)F 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 H07 compound treatment 127.4186 113.88 30.556 62.5289 48.982 11.6056 29.8128 0.9121 1917951 CBChromo1_000161 Oc1ccc2ccccc2c1/C=N/NC(=O)c3ccn[nH]3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 H08 compound treatment 12.1779 -1.364 -0.366 16.7055 3.1588 0.7484 0.2704 0.3246 3624420 CBChromo1_000162 CC1(C)CC(=O)C2=C(C1)OC3=C(C2)C(=O)CC(C)(C)C3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 H09 compound treatment 50.4616 36.92 9.9065 37.2276 23.681 5.6108 10.9724 0.9638 1913459 CBChromo1_000163 COc1ccc(NC(=S)NC(NC(=O)/C=C/c2ccccc2)C(Cl)(Cl)Cl)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 H10 compound treatment 64.7363 51.194 13.7368 47.5807 34.034 8.0639 15.4154 0.9678 3624421 CBChromo1_000164 [O-][N+](=O)c1ccc(C(=O)n2nnc3ccccc23)c(Cl)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 H11 compound treatment 12.9369 -0.60496 -0.1623 16.9364 3.3897 0.8031 0.4531 0.553 3624422 CBChromo1_000165 Brc1cc(Br)c(OC(=O)CCCC(=O)OCC#C)c(Br)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 H12 compound treatment 44.435 30.893 8.2894 73.8311 60.284 14.2835 15.9615 0.9665 1720239 CBChromo1_000166 CCOc1ccc(cc1)C(=O)n2nnc3ccccc23 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 H13 compound treatment 44.9288 31.387 8.4219 18.3702 4.8235 1.1429 6.7633 0.7958 1604810 CBChromo1_000167 COc1ccc(cc1Br)c2nc3cc(NS(=O)(=O)c4ccccc4)ccc3o2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 H14 compound treatment 13.1011 -0.44077 -0.1183 14.6051 1.0584 0.2508 0.0937 0.3379 1029030 CBChromo1_000168 OC(Cc1cccnc1)c2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 H15 compound treatment 46.5559 33.014 8.8585 45.4181 31.871 7.5514 11.6036 0.9968 3624423 CBChromo1_000169 Fc1cccc(c1)C(=O)n2nnc3ccccc23 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 H16 compound treatment 14.5793 1.0374 0.2784 14.2172 0.67042 0.1588 0.3092 0.9646 1777712 CBChromo1_000170 CCc1ccc(cc1)c2nc3cc(NC(=O)c4cccc(c4)[N+](=O)[O-])ccc3o2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 H17 compound treatment 23.937 10.395 2.7893 27.0782 13.531 3.2061 4.2394 0.9976 3624424 CBChromo1_000171 Cc1cc(F)c(F)c(C(=O)n2nnc3ccccc23)c1Cl 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 H18 compound treatment 20.237 6.6951 1.7965 18.6192 5.0724 1.2018 2.1201 0.9809 1369668 CBChromo1_000172 Fc1ccccc1c2nc3cc(NS(=O)(=O)c4ccccc4)ccc3o2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 H19 compound treatment 86.0253 72.483 19.4492 60.3068 46.76 11.0791 21.5868 0.9644 3624425 CBChromo1_000173 COc1ccc(cc1Br)C(=O)n2nnc3ccccc23 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 H20 compound treatment 27.5327 13.991 3.7541 21.929 8.3822 1.986 4.0589 0.9557 1494517 CBChromo1_000174 Clc1ccc(cc1)c2nc3cc(NS(=O)(=O)c4ccccc4)ccc3o2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 H21 compound treatment 48.517 34.975 9.3847 34.8807 21.334 5.0548 10.2103 0.9579 3624426 CBChromo1_000175 Cc1ccc(cc1)S(=O)(=O)Nc2ccc(cc2)c3nc4cc(C)ccc4o3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 H22 compound treatment 13.3975 -0.14436 -0.0387 14.8958 1.3491 0.3196 0.1986 0.6169 3273 CBChromo1_000176 NNCCc1ccccc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 H23 mock treatment 13.536 -0.0058898 -0.0016 14.4719 0.92512 0.2192 0.1539 0.702 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 H24 mock treatment 14.1758 0.63386 0.1701 12.2403 -1.3065 -0.3096 -0.0986 -0.2792 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 I01 compound treatment 16.7942 3.2523 0.8727 21.2699 7.7232 1.8299 1.911 0.9426 1912759 CBChromo1_000177 Cc1ccc(/C=C/2\OC(=O)c3c2cc(C)[nH]c3=O)o1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 I02 compound treatment 13.4873 -0.05464 -0.0147 19.9679 6.4211 1.5214 1.0654 0.7003 1004614 CBChromo1_000178 OC(=O)CNS(=O)(=O)c1ccccc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 I03 compound treatment 14.7538 1.2119 0.3252 14.9352 1.3884 0.329 0.4626 1.0 1913667 CBChromo1_000179 CCOC(=O)C/C(=N/c1cnn(c1)c2ccccc2)/C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 I04 compound treatment 15.6702 2.1283 0.5711 11.4132 -2.1336 -0.5055 0.0464 0.0608 878 CBChromo1_000180 CC(=O)NS(=O)(=O)c1ccc(N)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 I05 compound treatment 11.4446 -2.0973 -0.5628 16.1046 2.5579 0.6061 0.0306 0.037 1921399 CBChromo1_000181 [O-][N+](=O)c1ccc(Nc2ccccc2Cl)c(c1)[N+](=O)[O-] 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 I06 compound treatment 13.737 0.1951 0.0524 11.9847 -1.562 -0.3701 -0.2247 -0.6011 1283442 CBChromo1_000182 O=C(Nc1ccc2OCOc2c1)C3(CC4CC5CC(C4)C3)C5 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 I07 compound treatment 120.7472 107.21 28.766 111.3853 97.839 23.1814 36.7323 0.9943 1921209 CBChromo1_000183 CC[n+]1c(/C=C/N(C)c2ccccc2)oc3ccc(cc13)c4ccccc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 I08 compound treatment 96.7867 83.245 22.3367 97.7617 84.215 19.9535 29.9037 0.9984 1918103 CBChromo1_000184 CCN(CC)CCn1c2ccccc2c3nc4ccc(cc4cc13)[N+](=O)[O-] 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 I09 compound treatment 57.1797 43.638 11.7091 60.5095 46.963 11.1271 16.1477 0.9997 1913121 CBChromo1_000185 CCCN1C/C(=C\c2cccc(c2)[N+](=O)[O-])/C(=O)\C(=C\c3cccc(c3)[N+](=O)[O-])\C1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 I10 compound treatment 61.0564 47.515 12.7494 53.6566 40.11 9.5035 15.7351 0.9895 1920019 CBChromo1_000186 Cc1cc(O)c(C(=O)O)c(/C=C/c2cccc(Br)c2)n1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 I11 compound treatment 14.7922 1.2504 0.3355 14.4703 0.92352 0.2188 0.392 0.9786 1913249 CBChromo1_000187 CN(C)c1ccc(/C=C\2/C(=O)N(N=C2c3ccccc3)c4ccc(Br)cc4)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 I12 compound treatment 26.6914 13.149 3.5283 24.7227 11.176 2.648 4.3673 0.99 1921765 CBChromo1_000188 [O-][N+](=O)c1cccc(/C=C/C(=O)Nc2cccc(Cl)c2)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 I13 compound treatment 12.3128 -1.229 -0.3298 12.192 -1.3547 -0.321 -0.4602 -0.9999 1558952 CBChromo1_000189 Cc1cccc(C)c1NC(=O)CNc2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 I14 compound treatment 12.701 -0.84094 -0.2256 14.1286 0.58182 0.1379 -0.0621 -0.2348 1661743 CBChromo1_000190 COc1ccc(cc1)C(=O)CC(Nc2ccc(Br)cc2)c3ccc(F)cc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 I15 compound treatment 14.7932 1.2513 0.3357 13.5508 0.0040461 0.001 0.2381 0.7091 1786058 CBChromo1_000191 [O-][N+](=O)c1ccc(cc1)C(=O)Oc2ccc(C(=O)c3ccccc3)c(OC(=O)c4ccc(cc4)[N+](=O)[O-])c2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 I16 compound treatment 42.7931 29.251 7.8489 25.3855 11.839 2.805 7.5334 0.9038 1642758 CBChromo1_000192 Cc1cc(C)c2oc(nc2c1)c3ccc(NS(=O)(=O)c4ccccc4)cc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 I17 compound treatment 13.8805 0.33866 0.0909 31.7163 18.17 4.305 3.1084 0.7219 1580129 CBChromo1_000193 Nc1ccccc1C(=O)Nc2ccc(cc2C(=O)O)c3ccc(NC(=O)c4ccccc4N)c(c3)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 I18 compound treatment 75.7764 62.235 16.6991 43.2794 29.733 7.0447 16.7894 0.9264 3624427 CBChromo1_000194 Fc1ccc(cc1F)C(=O)n2nnc3ccccc23 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 I19 compound treatment 10.7102 -2.8317 -0.7598 11.3328 -2.214 -0.5246 -0.9082 -0.9836 1919066 CBChromo1_000195 Brc1cccc(c1)C(=O)n2nnc3ccccc23 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 I20 compound treatment 15.6536 2.1117 0.5666 13.6711 0.12437 0.0295 0.4215 0.7429 1378967 CBChromo1_000196 CCc1ccccc1N2C(=O)CC(Sc3nc(C)cc(C)n3)C2=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 I21 compound treatment 23.3198 9.7779 2.6237 19.8223 6.2755 1.4869 2.9066 0.9638 1919338 CBChromo1_000197 COc1cc(/C=N/NC(=O)c2ccccc2O)c(cc1OC)[N+](=O)[O-] 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 I22 compound treatment 61.16 47.618 12.7772 51.2343 37.688 8.9295 15.3489 0.9847 3624428 CBChromo1_000198 Cc1ccc(cc1)S(=O)(=O)Nc2cccc(c2)c3nc4ccccc4o3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 I23 mock treatment 12.566 -0.97591 -0.2619 14.0968 0.55002 0.1303 -0.093 -0.318 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 I24 mock treatment 12.3634 -1.1784 -0.3162 14.9822 1.4354 0.3401 0.0169 0.0364 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 J01 compound treatment 19.7307 6.1888 1.6606 21.9502 8.4034 1.9911 2.5821 0.9959 1002045 CBChromo1_000199 Oc1c(ccc2cccnc12)C(Nc3ccc(cc3)[N+](=O)[O-])c4ccccc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 J02 compound treatment 17.2101 3.6683 0.9843 20.0173 6.4706 1.5331 1.7801 0.9771 1043460 CBChromo1_000200 COC(=O)c1ccccc1NC(c2ccccc2)c3ccc4cccnc4c3O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 J03 compound treatment 59.4803 45.938 12.3265 54.7787 41.232 9.7693 15.6241 0.9934 1920592 CBChromo1_000201 O=c1c(=NNc2nnn[nH]2)c(=O)c3ccccc13 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 J04 compound treatment 16.4622 2.9203 0.7836 13.9983 0.4515 0.107 0.6297 0.7963 1681672 CBChromo1_000202 CCOc1ccc(cc1)C2C3=C(CC(C)(C)CC3=O)OC4=C2C(=O)CC(C)(C)C4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 J05 compound treatment 13.6301 0.08821 0.0237 15.0981 1.5514 0.3676 0.2767 0.7511 1916346 CBChromo1_000203 CCOC(=O)C1=C(C)C2C3C(C(=O)N(C3=O)c4ccc(cc4)C(=O)O)C1(C)C5C2C(=O)N(C5=O)c6ccc(cc6)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 J06 compound treatment 9.7538 -3.7881 -1.0165 159.6832 146.14 34.6249 23.7648 0.6861 1382399 CBChromo1_000204 C(Cc1ccccc1)NC2CCCc3c2[nH]c4ccc(cc34)C5CCCCC5 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 J07 compound treatment 178.1685 164.63 44.1736 182.2682 168.72 39.9761 59.5028 0.9988 1353277 CBChromo1_000205 CCOC(=O)c1[nH]c2CCC(=C(Sc3ccccc3)c2c1C)C=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 J08 compound treatment 14.2205 0.67863 0.1821 12.253 -1.2937 -0.3065 -0.088 -0.2468 1094556 CBChromo1_000206 CC1C2=C(CC(C)(C)CC2=O)OC3=C1C(=O)CC(C)(C)C3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 J09 compound treatment 81.3384 67.796 18.1915 73.4649 59.918 14.1967 22.902 0.9925 1913469 CBChromo1_000207 ClC(Cl)(Cl)C(NC(=O)/C=C/c1ccccc1)NC(=S)Nc2ccc(N=Nc3ccccc3)cc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 J10 compound treatment 16.137 2.5951 0.6963 19.141 5.5942 1.3255 1.4296 0.9548 1676891 CBChromo1_000208 COc1cccc(OC)c1C(=O)n2nnc3ccccc23 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 J11 compound treatment 14.124 0.58206 0.1562 14.5641 1.0173 0.241 0.2809 0.9779 1918471 CBChromo1_000209 Brc1cc(Br)c(OC(=O)c2ccccc2C(=O)OCC#C)c(Br)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 J12 compound treatment 14.657 1.1151 0.2992 14.2803 0.7335 0.1738 0.3345 0.9666 1262121 CBChromo1_000210 COc1cc(cc(OC)c1O)C2C3=C(CC(C)(C)CC3=O)OC4=C2C(=O)CC(C)(C)C4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 J13 compound treatment 35.3587 21.817 5.854 24.3718 10.825 2.5648 5.953 0.9314 3624429 CBChromo1_000211 O=S(=O)(Nc1cccc(c1)c2nc3ccccc3o2)c4ccccc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 J14 compound treatment 25.5559 12.014 3.2237 43.0911 29.544 7.0001 7.2293 0.9381 1918243 CBChromo1_000212 CC(=O)N(CCCn1c2ccccc2c3nc4ccc(cc4cc13)[N+](=O)[O-])C(=O)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 J15 compound treatment 10.9313 -2.6106 -0.7005 9.9038 -3.643 -0.8631 -1.1057 -0.9946 3624430 CBChromo1_000213 COc1ccc(Cl)cc1C2C3=C(CC(C)(C)CC3=O)OC4=C2C(=O)CC(C)(C)C4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 J16 compound treatment 19.3486 5.8067 1.5581 21.7482 8.2015 1.9432 2.4758 0.994 1921580 CBChromo1_000214 Oc1ccc(/N=C/C=C/c2ccccc2[N+](=O)[O-])cc1c3nc4ccccc4o3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 J17 compound treatment 14.5993 1.0574 0.2837 18.5498 5.003 1.1854 1.0388 0.8523 3624431 CBChromo1_000215 CC1(C)CC(=O)C2=C(C1)OC3=C(C2c4ccc(cc4)C(=O)O)C(=O)CC(C)(C)C3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 J18 compound treatment 14.6315 1.0896 0.2924 20.7232 7.1764 1.7004 1.4091 0.8167 3624432 CBChromo1_000216 Fc1cccc(C(=O)n2nnc3ccccc23)c1F 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 J19 compound treatment 44.1168 30.575 8.204 46.2646 32.718 7.752 11.2826 0.9996 1860866 CBChromo1_000217 Cc1ccc(cc1I)C(=O)n2nnc3ccccc23 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 J20 compound treatment 13.864 0.32209 0.0864 16.0938 2.547 0.6035 0.4878 0.8002 199 CBChromo1_000218 C[C@H](/C=C(\C)/C=C/C(=O)NO)C(=O)c1ccc(cc1)N(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 J21 compound treatment 14.897 1.3551 0.3636 19.8406 6.2938 1.4912 1.3116 0.8545 3624433 CBChromo1_000219 Cc1ccc(cc1NS(=O)(=O)c2ccc(Cl)cc2)c3nc4ccccc4[nH]3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 J22 compound treatment 13.0838 -0.45805 -0.1229 107.7605 94.214 22.3226 15.6975 0.7032 865102 CBChromo1_000220 O=C(CCNNC(=O)c1ccncc1)NCc2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 J23 mock treatment 12.8815 -0.66043 -0.1772 15.5355 1.9888 0.4712 0.2079 0.4129 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 J24 mock treatment 13.2212 -0.32073 -0.0861 14.5285 0.98177 0.2326 0.1036 0.4178 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 K01 compound treatment 13.7575 0.21564 0.0579 12.7664 -0.78035 -0.1849 -0.0898 -0.4637 1912767 CBChromo1_000221 COc1ccc(/C=C/2\OC(=O)c3c2cc(C)[nH]c3=O)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 K02 compound treatment 37.5564 24.014 6.4437 24.7129 11.166 2.6457 6.4272 0.9227 1913149 CBChromo1_000222 CC(C)(C)c1cc(Br)cc(/C=N/NC(=O)c2ccccc2O)c1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 K03 compound treatment 13.1588 -0.38311 -0.1028 13.9639 0.4171 0.0988 -0.0028 -0.0197 1914261 CBChromo1_000223 CC/C(=N\N=C(/CC)\c1ccccc1)/c2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 K04 compound treatment 16.6262 3.0843 0.8276 12.0426 -1.5042 -0.3564 0.3332 0.3698 1917298 CBChromo1_000224 C/C(=N\NC(=O)c1ccc(cc1)c2ccccc2)/c3cccc(N)c3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 K05 compound treatment 31.3119 17.77 4.7682 35.944 22.397 5.3067 7.124 0.9986 1912543 CBChromo1_000225 O=C(Oc1ccc(/C=N/Nc2ccccc2)cc1)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 K06 compound treatment 19.2018 5.6599 1.5187 18.9965 5.4498 1.2912 1.9869 0.9967 1661768 CBChromo1_000226 Cc1ccc(cc1)C(=O)c2coc3ccc(O)c(Cl)c23 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 K07 compound treatment 56.8061 43.264 11.6089 39.9358 26.389 6.2525 12.6299 0.9579 1913935 CBChromo1_000227 Oc1ccccc1C(=O)N/N=C\c2ccc(Cl)cc2Cl 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 K08 compound treatment 13.8357 0.29381 0.0788 17.6865 4.1397 0.9808 0.7493 0.7615 1917883 CBChromo1_000228 O/N=C/1\C2(CCCCC2)C(=O)N(O)C31CCCC=C3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 K09 compound treatment 66.8586 53.317 14.3063 33.0028 19.456 4.6098 13.3757 0.8899 1498599 CBChromo1_000229 CCOC(=O)C1(CCCC1=O)C2(O)C(=O)c3ccccc3C2=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 K10 compound treatment 14.2555 0.71364 0.1915 13.9252 0.37847 0.0897 0.1988 0.9403 1919798 CBChromo1_000230 Oc1ccc(cc1/C=N/c2cccc3ccccc23)[N+](=O)[O-] 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 K11 compound treatment 13.7141 0.17216 0.0462 15.0258 1.479 0.3504 0.2805 0.7935 1920545 CBChromo1_000231 O=c1cc([nH]c(=S)[nH]1)c2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 K12 compound treatment 24.7068 11.165 2.9958 22.6988 9.152 2.1684 3.6517 0.9874 1975241 CBChromo1_000232 CC1(C)CC(=O)C2=C(C1)OC3=C(C2c4ccc(Cl)cc4)C(=O)CC(C)(C)C3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 K13 compound treatment 23.0139 9.472 2.5416 25.0222 11.475 2.7189 3.7198 0.9994 1918634 CBChromo1_000233 [O-][n+]1ccc(N/N=C/c2ccc(F)cc2)c3ccccc13 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 K14 compound treatment 13.4531 -0.088767 -0.0238 15.6882 2.1414 0.5074 0.3419 0.6732 1188672 CBChromo1_000234 COc1ccc(cc1)C(=O)CC(Nc2ccc(Cl)cc2)c3ccc(Cl)cc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 K15 compound treatment 13.3434 -0.19846 -0.0533 14.1964 0.64962 0.1539 0.0712 0.437 1425867 CBChromo1_000235 Oc1ccccc1C(CC(=O)N2CCCCC2)N3CCCCC3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 K16 compound treatment 19.1517 5.6098 1.5053 32.7107 19.164 4.5406 4.2751 0.8937 1393634 CBChromo1_000236 CCc1ccc(cc1)c2nc3cc(NS(=O)(=O)c4ccccc4)ccc3o2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 K17 compound treatment 11.5833 -1.9586 -0.5255 13.2203 -0.32648 -0.0774 -0.4263 -0.8025 1709481 CBChromo1_000237 Cc1ccc(cc1)S(=O)(=O)Nc2cc(C(=O)O)c(NS(=O)(=O)c3ccc(C)cc3)cc2C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 K18 compound treatment 51.9371 38.395 10.3024 35.3097 21.763 5.1564 10.931 0.9488 1931583 CBChromo1_000238 Fc1cc(Cl)c(cc1F)C(=O)n2nnc3ccccc23 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 K19 compound treatment 12.2965 -1.2454 -0.3342 14.3839 0.83714 0.1983 -0.096 -0.2472 1473494 CBChromo1_000239 Cc1ccc(C)c(NCC(=O)Nc2c(C)cccc2C)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 K20 compound treatment 12.1048 -1.4371 -0.3856 13.9425 0.3957 0.0938 -0.2064 -0.52 1229469 CBChromo1_000240 CCCOc1ccc(cc1OCC)C2C3=C(CC(C)(C)CC3=O)OC4=C2C(=O)CC(C)(C)C4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 K21 compound treatment 84.6945 71.153 19.0921 70.2488 56.702 13.4347 22.9999 0.9852 1920306 CBChromo1_000241 CCn1c2ccccc2c3cc(/C=N/NC(=O)COc4ccccc4)ccc13 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 K22 compound treatment 161.0525 147.51 39.5809 149.6002 136.05 32.2359 50.7821 0.9948 1564910 CBChromo1_000242 Cc1cc(C)c(OCC(=O)Nc2c(C)cccc2C)c(C)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 K23 mock treatment 28.6176 15.076 4.0452 11.1248 -2.4219 -0.5738 2.4546 0.6008 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 K24 mock treatment 15.6687 2.1269 0.5707 9.905 -3.6417 -0.8629 -0.2066 -0.1997 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 L01 compound treatment 13.7696 0.22772 0.0611 17.389 3.8423 0.9104 0.6869 0.7529 1913570 CBChromo1_000243 CCC(=O)OCC1OC(C(Br)C1OC(=O)CC)n2cc(F)c(=O)[nH]c2=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 L02 compound treatment 12.19 -1.3519 -0.3627 12.898 -0.64875 -0.1537 -0.3652 -0.927 1917264 CBChromo1_000244 [O-][N+](=O)c1ccccc1NC(=O)c2cc(ccc2Cl)S(=O)(=O)N3CCCCC3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 L03 compound treatment 13.1226 -0.41934 -0.1125 14.6923 1.1455 0.2714 0.1124 0.3824 1913436 CBChromo1_000245 O=C(N/N=C\c1ccco1)c2ccncc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 L04 compound treatment 98.8111 85.269 22.8799 158.007 144.46 34.2277 40.3812 0.9808 1706491 CBChromo1_000246 Fc1ccc(cc1)C(=O)n2nnc3ccccc23 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 L05 compound treatment 26.6013 13.059 3.5042 28.2327 14.686 3.4796 4.9383 1.0 1027977 CBChromo1_000247 O=C1C=CC(=O)N1c2cccc3ccccc23 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 L06 compound treatment 30.5735 17.032 4.57 36.6761 23.129 5.4802 7.1065 0.9959 1921008 CBChromo1_000248 Clc1ccccc1C(=O)n2nnc3ccccc23 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 L07 compound treatment 14.0405 0.49859 0.1338 16.9079 3.3612 0.7964 0.6577 0.8145 1914929 CBChromo1_000249 CC1(C)C(N(O)C(=O)Nc2cccc3ccccc23)N(C(=O)N1CC(=O)N/N=C/c4cc(Br)ccc4O)c5cccc6ccccc56 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 L08 compound treatment 13.6661 0.12424 0.0333 14.5573 1.0105 0.2394 0.1929 0.7979 1970309 CBChromo1_000250 CC1(C)CC(=O)C2=C(C1)OC3=C(C(=O)CC(C)(C)C3)C2(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 L09 compound treatment 14.3548 0.81291 0.2181 17.3863 3.8396 0.9097 0.7975 0.8525 1913581 CBChromo1_000251 COc1ccc(cc1)C(=O)NC(NC(=S)Nc2ccc(N=Nc3ccccc3)cc2)C(Cl)(Cl)Cl 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 L10 compound treatment 11.3254 -2.2165 -0.5947 14.2432 0.69643 0.165 -0.3039 -0.4923 1375710 CBChromo1_000252 CC1(C)CC(=O)C2=C(C1)OC3=C(C2c4ccc(o4)c5cccc(Cl)c5)C(=O)CC(C)(C)C3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 L11 compound treatment 14.4899 0.94796 0.2544 12.8544 -0.69235 -0.164 0.0639 0.211 1914613 CBChromo1_000253 O=C(COc1ccccc1)NN=C2CCCCC2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 L12 compound treatment 53.1022 39.56 10.6151 52.9486 39.402 9.3357 14.1073 0.998 1413142 CBChromo1_000254 Clc1ccc(cc1)C(=O)c2ccccc2C(=O)n3nnc4ccccc34 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 L13 compound treatment 43.6616 30.12 8.0819 56.5092 42.962 10.1793 12.9126 0.9935 3624434 CBChromo1_000255 Cc1ccc(cc1Br)C(=O)n2nnc3ccccc23 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 L14 compound treatment 58.0782 44.536 11.9502 24.3725 10.826 2.565 10.2638 0.8398 1919882 CBChromo1_000256 CN1C(=O)N(C(=O)/C(=C/c2ccc3OCOc3c2)/C1=O)c4ccccc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 L15 compound treatment 20.616 7.0741 1.8982 20.2015 6.6548 1.5768 2.4571 0.9957 1147680 CBChromo1_000257 CCc1cccc(C)c1NC(=O)COc2cc(C)cc(C)c2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 L16 compound treatment 62.5271 48.985 13.144 28.1728 14.626 3.4654 11.7446 0.864 1921275 CBChromo1_000258 Cc1[nH]c2ccccc2c1C(=O)/C=C/c3cccnc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 L17 compound treatment 41.7771 28.235 7.5762 27.4976 13.951 3.3054 7.6945 0.9309 1136335 CBChromo1_000259 COc1ccc(cc1)C(CC(=O)c2ccccc2)Nc3ccc(F)cc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 L18 compound treatment 204.8678 191.33 51.3376 207.8812 194.33 46.0447 68.8597 0.9985 3624435 CBChromo1_000260 Cc1ccc(cc1)S(=O)(=O)Nc2ccccc2c3nc4ccccc4s3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 L19 compound treatment 45.5785 32.037 8.5962 41.7661 28.219 6.6862 10.8063 0.9923 1860865 CBChromo1_000261 COc1ccc(cc1I)C(=O)n2nnc3ccccc23 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 L20 compound treatment 15.3182 1.7763 0.4766 14.5079 0.9612 0.2277 0.4981 0.9429 541 CBChromo1_000262 Cc1c(C)c(CONC(=O)c2ccccc2)c(C)c(C)c1Br 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 L21 compound treatment 11.8874 -1.6545 -0.444 15.4694 1.9226 0.4555 0.0082 0.0129 3624436 CBChromo1_000263 O=C(Nc1ccc2OCOc2c1)c3ccccc3NS(=O)(=O)c4ccccc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 L22 compound treatment 12.9774 -0.56449 -0.1515 13.3575 -0.18928 -0.0448 -0.1388 -0.8788 2027357 CBChromo1_000264 OCc1ccc(cc1)[C@@H]2C[C@H](CSc3nc(c(o3)c4ccccc4)c5ccccc5)O[C@@H](O2)c6ccc(NC(=O)CCCCCCC(=O)NO)cc6 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 L23 mock treatment 16.2011 2.6592 0.7135 11.3788 -2.168 -0.5137 0.1413 0.1607 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 L24 mock treatment 6.0458 -7.496 -2.0114 14.5679 1.0211 0.2419 -1.2512 -0.6176 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 M01 compound treatment 19.4354 5.8936 1.5814 22.7456 9.1988 2.1795 2.6594 0.9876 1432230 CBChromo1_000265 Cc1sc2ncnc(Nc3ccc(C)c(C)c3)c2c1C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 M02 compound treatment 28.8495 15.308 4.1074 32.7758 19.229 4.556 6.126 0.9987 1921141 CBChromo1_000266 CCN1/C(=C/C=C/C=C/c2sc3ccccc3[n+]2CC(=O)O)/Sc4ccccc14 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 M03 compound treatment 13.4823 -0.059637 -0.016 12.3195 -1.2272 -0.2908 -0.2169 -0.7449 1914421 CBChromo1_000267 C/C(=N\Nc1ccccc1)/c2cc3ccccc3oc2=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 M04 compound treatment 24.8077 11.266 3.0229 28.4652 14.918 3.5347 4.6369 0.997 1915319 CBChromo1_000268 Nc1ccc2oc3ccc(N)cc3c(=O)c2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 M05 compound treatment 14.9353 1.3934 0.3739 10.6642 -2.8825 -0.683 -0.2186 -0.2807 1913842 CBChromo1_000269 Oc1cc2ccccc2cc1C(=O)N/N=C/c3ccccc3[N+](=O)[O-] 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 M06 compound treatment 93.3192 79.777 21.4063 87.506 73.959 17.5236 27.5276 0.9951 1917785 CBChromo1_000270 O=C(Nc1ccc(/C=C/C(=O)c2ccccc2)cc1)C(c3ccccc3)c4ccccc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 M07 compound treatment 11.6749 -1.867 -0.501 20.6118 7.065 1.674 0.8294 0.4747 1445757 CBChromo1_000271 COc1ccc(OC)c(c1)C2C3=C(CC(C)(C)CC3=O)OC4=C2C(=O)CC(C)(C)C4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 M08 compound treatment 13.3552 -0.18671 -0.0501 12.1601 -1.3866 -0.3285 -0.2677 -0.8056 1919359 CBChromo1_000272 COc1cc(/C=N/c2ccc(NC(=O)C)cc2)cc(Br)c1OCc3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 M09 compound treatment 15.6086 2.0667 0.5545 13.13 -0.41673 -0.0987 0.3223 0.5722 1179853 CBChromo1_000273 Clc1ccc(NC(=O)c2ccccc2C(=O)OCC#C)c(Cl)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 M10 compound treatment 19.7108 6.1689 1.6553 15.5955 2.0487 0.4854 1.5137 0.8775 1463503 CBChromo1_000274 N(C(c1ccccc1)c2ccncc2)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 M11 compound treatment 55.1366 41.595 11.1609 30.7727 17.226 4.0814 10.778 0.9069 1913206 CBChromo1_000275 OC(=O)c1ccc(/N=C/c2ccc(O)cc2O)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 M12 compound treatment 13.0532 -0.48866 -0.1311 15.411 1.8642 0.4417 0.2196 0.4766 1241870 CBChromo1_000276 COc1cccc(c1)C2C3=C(CC(C)(C)CC3=O)OC4=C2C(=O)CC(C)(C)C4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 M13 compound treatment 18.8274 5.2855 1.4182 17.0446 3.4978 0.8288 1.5889 0.9673 1307245 CBChromo1_000277 CCN(CC)c1ccc(cc1)C2C3=C(CC(C)(C)CC3=O)OC4=C2C(=O)CC(C)(C)C4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 M14 compound treatment 12.2693 -1.2726 -0.3415 13.7928 0.24605 0.0583 -0.2002 -0.578 1218208 CBChromo1_000278 COc1ccc(cc1)C(CC(=O)c2ccc(C)cc2)Nc3ccc(Br)cc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 M15 compound treatment 15.4987 1.9568 0.525 16.6155 3.0687 0.7271 0.8854 0.9872 1919544 CBChromo1_000279 [O-][N+](=O)c1cc(ccc1Br)C(=O)Oc2ccc(OC(=O)c3ccc(Br)c(c3)[N+](=O)[O-])c(c2)C(=O)c4ccccc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 M16 compound treatment 32.0621 18.52 4.9695 36.2191 22.672 5.3719 7.3124 0.9992 1935088 CBChromo1_000280 Clc1ccc2oc(nc2c1)c3cccc(NS(=O)(=O)c4ccccc4)c3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 M17 compound treatment 17.8519 4.31 1.1565 14.0015 0.45472 0.1077 0.8939 0.7696 1915136 CBChromo1_000281 C/C(=N\NC(=O)N)/c1cc(CNC(=O)CCl)cs1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 M18 compound treatment 15.1636 1.6217 0.4351 10.96 -2.5867 -0.6129 -0.1257 -0.1672 3624437 CBChromo1_000282 CC1(C)CC(=O)C2=C(C1)OC3=C(C2c4ccc(Cl)c(Cl)c4)C(=O)CC(C)(C)C3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 M19 compound treatment 15.4537 1.9118 0.513 12.2514 -1.2954 -0.3069 0.1457 0.2438 1915304 CBChromo1_000283 CC1C=CC(=C(O)C1C(=O)O)N=Nc2ccc(cc2)c3ccc(N=Nc4ccc(C)c(C(=O)O)c4O)cc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 M20 compound treatment 14.4998 0.95791 0.257 15.7921 2.2453 0.532 0.5579 0.9443 1614005 CBChromo1_000284 CCc1ccccc1NC(=O)CN(c2ccc(C)cc2)S(=O)(=O)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 M21 compound treatment 33.2307 19.689 5.283 33.5156 19.969 4.7313 7.0812 0.9985 1919995 CBChromo1_000285 CCn1c2ccccc2c3cc(/C=N/NC(=O)c4ccccc4O)ccc13 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 M22 compound treatment 68.1782 54.636 14.6603 53.3831 39.836 9.4386 17.0405 0.9773 1925163 CBChromo1_000286 COC(=O)C(=O)/C(=C\c1ccc(o1)c2ccccc2[N+](=O)[O-])/C(=O)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 M23 mock treatment 12.9652 -0.57671 -0.1547 14.4253 0.87855 0.2082 0.0378 0.1456 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 M24 mock treatment 12.1602 -1.3817 -0.3707 13.8235 0.27672 0.0656 -0.2158 -0.5732 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 N01 compound treatment 13.2694 -0.27246 -0.0731 21.3567 7.8099 1.8505 1.2568 0.6786 1369355 CBChromo1_000287 Cc1cc(=O)oc2cc(OC(=O)COc3ccc4c(=O)c(c(C)oc4c3)c5ccc6OCCOc6c5)ccc12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 N02 compound treatment 35.7881 22.246 5.9692 38.7874 25.241 5.9804 8.4497 1.0 1917291 CBChromo1_000288 O=S1(=O)Nc2cc3nc4ccccc4nc3c5cccc1c25 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 N03 compound treatment 14.1042 0.56229 0.1509 17.8337 4.2869 1.0157 0.8249 0.8033 1035127 CBChromo1_000289 O=C(NN=c1c(=O)c2ccccc2c1=O)c3ccncc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 N04 compound treatment 11.06 -2.4818 -0.6659 13.2451 -0.30168 -0.0715 -0.5214 -0.7785 1975127 CBChromo1_000290 CC1(C)CC(=O)C2=C(C1)OC3=C(C2c4cccc5ccccc45)C(=O)CC(C)(C)C3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 N05 compound treatment 17.8518 4.3099 1.1565 20.5938 7.0471 1.6697 1.9984 0.9839 1914450 CBChromo1_000291 OC(=O)c1ccc(Nc2nc(Cl)nc(Cl)n2)cc1c3c4ccc(O)cc4oc5cc(=O)ccc35 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 N06 compound treatment 10.5209 -3.021 -0.8106 12.6708 -0.87594 -0.2075 -0.7199 -0.8604 1734841 CBChromo1_000292 COc1cc(ccc1O)C2C3=C(CC(C)(C)CC3=O)OC4=C2C(=O)CC(C)(C)C4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 N07 compound treatment 16.0283 2.4864 0.6672 14.081 0.53425 0.1266 0.5613 0.8265 1085540 CBChromo1_000293 O=C(COc1ccccc1)NCc2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 N08 compound treatment 24.2143 10.672 2.8637 16.6161 3.0693 0.7272 2.5392 0.8594 1361475 CBChromo1_000294 CC1(C)CC(=O)C2=C(C1)OC3=C(C2c4cccc(O)c4)C(=O)CC(C)(C)C3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 N09 compound treatment 13.9643 0.42244 0.1134 13.8886 0.34185 0.081 0.1374 0.9864 1920541 CBChromo1_000295 CC(=O)Cc1ccccc1OC(=O)c2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 N10 compound treatment 34.2082 20.666 5.5453 20.6854 7.1386 1.6914 5.1171 0.8826 3624438 CBChromo1_000296 Fc1cccc(Cl)c1C(=O)n2nnc3ccccc23 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 N11 compound treatment 22.0129 8.471 2.273 18.9608 5.414 1.2828 2.5143 0.9633 1918269 CBChromo1_000297 O=C(N/N=C\c1c[nH]c2ccccc12)c3cccs3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 N12 compound treatment 92.5886 79.047 21.2103 68.1935 54.647 12.9477 24.1534 0.972 1135840 CBChromo1_000298 CCN(CC)c1ccc(cc1)C(=O)n2nnc3ccccc23 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 N13 compound treatment 18.5877 5.0458 1.3539 20.0658 6.519 1.5446 2.0496 0.9978 1335771 CBChromo1_000299 CC1(C)CC(=O)C2=C(C1)OC3=C(C2c4cccc(F)c4)C(=O)CC(C)(C)C3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 N14 compound treatment 18.0145 4.4726 1.2001 18.0031 4.4563 1.0559 1.5952 0.998 1919988 CBChromo1_000300 Oc1[nH]c(SCC(=O)N2CCCCC2)nc(=O)c1C(c3ccccc3)c4ccccc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 N15 compound treatment 12.8706 -0.67134 -0.1801 15.6031 2.0563 0.4872 0.2171 0.418 3624439 CBChromo1_000301 Cc1ccc(COc2cccc(c2)C3C4=C(CC(C)(C)CC4=O)OC5=C3C(=O)CC(C)(C)C5)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 N16 compound treatment 13.5742 0.032285 0.0087 10.7924 -2.7544 -0.6526 -0.4553 -0.6977 1154816 CBChromo1_000302 CC(NC(=S)c1cccnc1)c2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 N17 compound treatment 11.1329 -2.409 -0.6464 12.8198 -0.72693 -0.1722 -0.5789 -0.8653 1552144 CBChromo1_000303 CN(c1ccccc1)c2ccc(cc2)C3C4=C(CC(C)(C)CC4=O)OC5=C3C(=O)CC(C)(C)C5 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 N18 compound treatment 14.4051 0.86319 0.2316 13.3973 -0.1494 -0.0354 0.1387 0.5922 1924578 CBChromo1_000304 COCCCNC(=O)C(=O)Nc1ccc(Cl)cc1C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 N19 compound treatment 11.8524 -1.6895 -0.4533 17.9944 4.4476 1.0538 0.4246 0.3701 1165782 CBChromo1_000305 CCOc1ccc(NCC(=O)Nc2ccc(C)cc2C)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 N20 compound treatment 11.7549 -1.787 -0.4795 11.8593 -1.6875 -0.3998 -0.6218 -0.9959 529 CBChromo1_000306 Nc1ccccc1NC(=O)c2ccc(CNC(=O)OCc3cccnc3)cc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 N21 compound treatment 11.693 -1.8489 -0.4961 15.4798 1.933 0.458 -0.027 -0.0399 3624440 CBChromo1_000307 COc1ccc(OC)c(NC(=O)CNc2cccc(C)c2)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 N22 compound treatment 15.8509 2.3091 0.6196 13.5236 -0.023179 -0.0055 0.4342 0.7008 719 CBChromo1_000308 CN(CC#C)Cc1ccccc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 N23 mock treatment 12.4383 -1.1036 -0.2961 13.8256 0.27889 0.0661 -0.1627 -0.5361 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 N24 mock treatment 13.1675 -0.37441 -0.1005 14.6537 1.1069 0.2623 0.1144 0.4074 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 O01 compound treatment 211.4066 197.86 53.0922 145.8821 132.34 31.3549 59.7131 0.9684 1921786 CBChromo1_000309 Cc1ccc(/C=N/C(=N\NC(=O)c2ccccc2)/c3ccccc3)o1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 O02 compound treatment 18.9445 5.4026 1.4496 13.9404 0.39362 0.0933 1.091 0.751 1913281 CBChromo1_000310 CN(N=c1c(=O)c2ccccc2c1=O)C(=N)N 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 O03 compound treatment 20.0864 6.5446 1.7561 13.9892 0.44247 0.1048 1.3159 0.748 1914260 CBChromo1_000311 CCOc1ccc(cc1)C(Nc2ccc(Br)cc2)P3(=O)OCCCO3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 O04 compound treatment 16.8242 3.2824 0.8807 18.7406 5.1939 1.2306 1.493 0.9865 1920814 CBChromo1_000312 [O-][N+](=O)c1ccc(NC(NC(=O)c2ccccc2Cl)C(Cl)(Cl)Cl)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 O05 compound treatment 0.0 -13.542 -3.6336 15.7261 2.1793 0.5164 -2.2042 -0.6006 1913661 CBChromo1_000313 Oc1ccccc1C(=O)N/N=C/c2ccco2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 O06 compound treatment 20.3726 6.8307 1.8329 31.9493 18.403 4.3602 4.3792 0.9259 1921127 CBChromo1_000314 C/C(=N\NC(=O)COc1c(C)cc(cc1C)[N+](=O)[O-])/c2cccs2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 O07 compound treatment 38.5003 24.958 6.697 28.7193 15.173 3.5949 7.2775 0.9575 1921659 CBChromo1_000315 CC(OS(=O)(=O)c1ccccc1)C(F)(F)[N+](=O)[O-] 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 O08 compound treatment 15.1395 1.5976 0.4287 15.0718 1.525 0.3613 0.5586 0.9964 1474431 CBChromo1_000316 CN1CCN(CC1)C(=O)c2sc3ccccc3c2Cl 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 O09 compound treatment 16.0155 2.4736 0.6637 15.626 2.0793 0.4927 0.8177 0.9892 1036003 CBChromo1_000317 NC(Cc1c[nH]c2ccc(OCc3ccccc3)cc12)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 O10 compound treatment 24.0445 10.503 2.8181 20.9531 7.4063 1.7548 3.2336 0.974 1919255 CBChromo1_000318 Cc1cc(C)c(C(=O)/C=C/c2ccccc2)c(=O)[nH]1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 O11 compound treatment 30.9068 17.365 4.6594 18.9398 5.393 1.2778 4.1983 0.8689 1920522 CBChromo1_000319 O=C1C(=C(C(=O)c2ccccc12)[n+]3ccc4ccccc4c3)NS(=O)(=O)c5ccccc5 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 O12 compound treatment 44.536 30.994 8.3165 59.2888 45.742 10.8379 13.5442 0.9914 3624441 CBChromo1_000320 CCOc1cccc(c1)C(=O)n2nnc3ccccc23 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 O13 compound treatment 15.2161 1.6742 0.4492 11.8799 -1.6669 -0.3949 0.0384 0.0642 1696710 CBChromo1_000321 CC1(C)CC(=O)C2=C(C1)OC3=C(C2c4ccccc4O)C(=O)CC(C)(C)C3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 O14 compound treatment 21.9478 8.4059 2.2555 21.3882 7.8414 1.8579 2.9086 0.9954 1440513 CBChromo1_000322 COc1ccc(cc1)C(CC(=O)c2ccc(Cl)cc2)Nc3ccc(Br)cc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 O15 compound treatment 32.1721 18.63 4.999 26.4595 12.913 3.0595 5.6982 0.9722 1919154 CBChromo1_000323 Cc1cc(c2cccnc2c1O)C3(OC(=O)c4ccccc43)c5cc(C)c(O)c6ncccc56 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 O16 compound treatment 30.4763 16.934 4.5439 36.0368 22.49 5.3287 6.981 0.9969 1262202 CBChromo1_000324 Clc1ccc(Br)cc1c2nc3cc(NS(=O)(=O)c4ccccc4)ccc3o2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 O17 compound treatment 18.2945 4.7526 1.2752 17.7022 4.1554 0.9846 1.5979 0.9918 1569049 CBChromo1_000325 COc1ccc(cc1)C(CC(=O)c2ccccc2)Nc3ccc(Br)cc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 O18 compound treatment 14.8222 1.2803 0.3435 12.5456 -1.0011 -0.2372 0.0752 0.1801 1924572 CBChromo1_000326 COc1ccc(C/C(=N/OC(=O)c2cccs2)/N)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 O19 compound treatment 13.5691 0.02721 0.0073 12.6908 -0.85594 -0.2028 -0.1382 -0.6812 1918841 CBChromo1_000327 [O-][N+](=O)c1cc2OCOc2cc1/C=N/NC(=O)C3CC3(c4ccccc4)c5ccccc5 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 O20 compound treatment 12.0307 -1.5112 -0.4055 11.4596 -2.0871 -0.4945 -0.6364 -0.9951 1386229 CBChromo1_000328 CCOc1cc(ccc1OCC=C)C2C3=C(CC(C)(C)CC3=O)OC4=C2C(=O)CC(C)(C)C4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 O21 compound treatment 20.4008 6.8589 1.8404 28.3575 14.811 3.5092 3.7828 0.9546 1919956 CBChromo1_000329 CCn1c2ccccc2c3cc(/C=N/N=C/c4ccc5n(CC)c6ccccc6c5c4)ccc13 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 O22 compound treatment 14.6222 1.0803 0.2899 14.1388 0.59207 0.1403 0.3042 0.9445 1973247 CBChromo1_000330 CC1(C)CC(=O)C2=C(C1)OC3=C(C2c4cc(Cl)ccc4O)C(=O)CC(C)(C)C3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 O23 mock treatment 10.698 -2.8439 -0.7631 12.854 -0.69275 -0.1641 -0.6556 -0.84 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 O24 mock treatment 12.6042 -0.93774 -0.2516 10.0568 -3.4899 -0.8269 -0.7626 -0.8823 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 P01 compound treatment 16.2672 2.7253 0.7313 18.528 4.9813 1.1802 1.3516 0.9735 1915000 CBChromo1_000331 CCc1nnc(NS(=O)(=O)c2ccc(NC(=S)NC(=O)/C=C/c3ccc(OC)c(OC)c3)cc2)s1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 P02 compound treatment 53.5468 40.005 10.7343 22.9716 9.4248 2.2331 9.1694 0.8363 1918260 CBChromo1_000332 [O-][n+]1ccc(N/N=C/c2ccccc2)c3ccccc13 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 P03 compound treatment 19.5871 6.0452 1.6221 21.9014 8.3546 1.9795 2.5467 0.9951 1913472 CBChromo1_000333 [O-][N+](=O)c1ccc(cc1)S(=O)(=O)NNC(=O)c2ccncc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 P04 compound treatment 17.1525 3.6106 0.9688 16.2131 2.6663 0.6317 1.1318 0.9785 1604763 CBChromo1_000334 CC1(C)CC(=O)C2=C(C1)OC3=C(C2c4ccc(O)cc4)C(=O)CC(C)(C)C3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 P05 compound treatment 14.8551 1.3132 0.3524 18.3572 4.8105 1.1398 1.0551 0.8844 1016032 CBChromo1_000335 COC(=O)C1CC2(CC(CC(C(=O)OC)C2=O)(C(=O)OC)C1=O)C(=O)OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 P06 compound treatment 27.2004 13.658 3.6649 22.7308 9.184 2.176 4.1302 0.969 1921369 CBChromo1_000336 C/C(=N\NC(=S)N1CCOCC1)/c2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 P07 compound treatment 19.6111 6.0692 1.6285 22.8682 9.3215 2.2086 2.7132 0.9888 1362155 CBChromo1_000337 Cc1cccc(OCC(=O)Nc2cccc(O)c2)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 P08 compound treatment 20.3726 6.8307 1.8328 11.7874 -1.7594 -0.4169 1.0012 0.5327 1726183 CBChromo1_000338 Cc1cccc(OCC(=O)Nc2c(C)cccc2C)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 P09 compound treatment 14.2385 0.69664 0.1869 12.9007 -0.64609 -0.1531 0.0239 0.099 1729379 CBChromo1_000339 ONC(=O)C1(CCCC2CCC1)C2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 P10 compound treatment 39.7953 26.253 7.0445 37.0534 23.507 5.5695 8.9195 0.9932 3624442 CBChromo1_000340 Fc1cccc(F)c1C(=O)n2nnc3ccccc23 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 P11 compound treatment 13.413 -0.12894 -0.0346 14.6288 1.082 0.2564 0.1568 0.6062 3624443 CBChromo1_000341 CC1(C)CC(=O)C2=C(C1)OC3=C(C2C=C(Cl)Cl)C(=O)CC(C)(C)C3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 P12 compound treatment 120.888 107.35 28.8037 124.0137 110.47 26.1735 38.8748 0.9989 1928477 CBChromo1_000342 Clc1ccc(Cl)c(c1)C(=O)n2nnc3ccccc23 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 P13 compound treatment 31.1274 17.585 4.7186 31.84 18.293 4.3343 6.4014 0.9991 3624444 CBChromo1_000343 Cc1ccc2oc(nc2c1)c3cccc(NS(=O)(=O)c4ccc(Cl)cc4)c3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 P14 compound treatment 15.1247 1.5828 0.4247 12.996 -0.55073 -0.1305 0.208 0.4683 1920301 CBChromo1_000344 C/C(=C/1\C(=NN(C1=O)c2ccc(Br)cc2Br)C)/NCc3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 P15 compound treatment 13.6204 0.07855 0.0211 15.4867 1.9399 0.4596 0.3399 0.7388 3624445 CBChromo1_000345 CCOc1ccc(cc1Cl)C2C3=C(CC(C)(C)CC3=O)OC4=C2C(=O)CC(C)(C)C4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 P16 compound treatment 11.4329 -2.109 -0.5659 14.9587 1.4119 0.3345 -0.1636 -0.2489 1287603 CBChromo1_000346 ONC(=O)CCn1c2ccccc2c3ccccc13 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 P17 compound treatment 65.3304 51.789 13.8962 68.4876 54.941 13.0174 19.0308 0.9995 3624446 CBChromo1_000347 COc1ccccc1C(=O)n2nnc3ccccc23 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 P18 compound treatment 22.3039 8.762 2.3511 20.4494 6.9027 1.6355 2.8189 0.9843 1735115 CBChromo1_000348 Cc1ccc2oc(nc2c1)c3cccc(NS(=O)(=O)c4ccccc4)c3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 P19 compound treatment 16.0197 2.4779 0.6649 17.4125 3.8658 0.9159 1.1178 0.9876 3624447 CBChromo1_000349 COc1ccc(NC(CC(=O)c2ccc(Cl)cc2)c3ccccc3)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 P20 compound treatment 13.7864 0.24453 0.0656 18.9407 5.3939 1.278 0.9501 0.7424 1019 CBChromo1_000350 NC(=O)N1c2ccccc2C=Cc3ccccc13 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 P21 compound treatment 16.817 3.2751 0.8788 17.0377 3.4909 0.8271 1.2063 0.9995 3624448 CBChromo1_000351 CC(=O)Nc1ccc(cc1)S(=O)(=O)Nc2cccc(c2)c3nc4cc(C)ccc4o3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 P22 compound treatment 11.521 -2.0209 -0.5423 27.5891 14.042 3.3271 1.9692 0.5842 3198425 CBChromo1_000352 CC1(C)O[C@@H]2CO[C@@]3(COS(=O)(=O)N)OC(C)(C)O[C@H]3[C@@H]2O1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 P23 mock treatment 10.612 -2.9299 -0.7862 13.3483 -0.1985 -0.047 -0.5892 -0.7481 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2417 P24 mock treatment 10.8579 -2.684 -0.7202 15.8325 2.2858 0.5416 -0.1263 -0.1401 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 A01 compound treatment 75.066 75.066 20.1421 16.5126 3.4025 0.8062 14.8127 0.7348 3652636 Neuro1_000001 [O-][N+](=O)c1cccc(c1)c2nc(NCc3ccccc3)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 A02 compound treatment 11.0192 11.019 2.9567 17.4472 4.337 1.0276 2.8173 0.9 1542244 Neuro1_000002 CCCOc1ccc(cc1)c2nc(N(CC)CC)c3ccccc3n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 A03 compound treatment 0.0 0.0 0.0 14.6895 1.5793 0.3742 0.2646 0.7071 3652637 Neuro1_000003 [O-][N+](=O)c1cccc(c1)c2nc(Nc3ccccc3F)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 A04 compound treatment 0.0 0.0 0.0 14.5013 1.3911 0.3296 0.2331 0.7071 3652638 Neuro1_000004 CC1CCN(CC1)c2nc(nc3ccccc23)N4CCOCC4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 A05 compound treatment 0.0 0.0 0.0 16.4115 3.3014 0.7822 0.5531 0.7071 1701346 Neuro1_000005 Cc1ccc(Nc2nc(NCc3ccco3)c4ccccc4n2)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 A06 compound treatment 2380.7177 2380.7 638.8078 46.8147 33.704 7.9858 457.3521 0.7159 3652639 Neuro1_000006 Oc1ccccc1/C=N/Nc2nc(nc3ccccc23)c4cccnc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 A07 compound treatment 0.0 0.0 0.0 16.5792 3.469 0.8219 0.5812 0.7071 1677893 Neuro1_000007 Fc1ccc(Nc2nc(NCc3ccco3)c4ccccc4n2)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 A08 compound treatment 0.0 0.0 0.0 19.6823 6.5721 1.5572 1.1011 0.7071 3652641 Neuro1_000008 COc1cccc2c(NCCCN3CCCC3=O)nc(nc12)C(Cl)(Cl)Cl 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 A09 compound treatment 0.0 0.0 0.0 15.8141 2.7039 0.6406 0.453 0.7071 1486822 Neuro1_000009 Cc1ccc(Nc2nc(nc3ccccc23)c4ccc(Cl)cc4)c(C)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 A10 compound treatment 0.0 0.0 0.0 15.1962 2.086 0.4943 0.3495 0.7071 3652642 Neuro1_000010 COc1ccc(Cl)cc1Nc2nc(N)c3ccccc3n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 A11 compound treatment 0.0 0.0 0.0 19.4998 6.3896 1.5139 1.0705 0.7071 1143772 Neuro1_000011 COc1ccc(Nc2nc(NCc3ccco3)c4ccccc4n2)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 A12 compound treatment 0.0 0.0 0.0 20.2073 7.0971 1.6816 1.189 0.7071 3652643 Neuro1_000012 C(N1CCN(CC1)c2nc(NC3CCCCC3)c4ccccc4n2)c5ccccc5 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 A13 compound treatment 0.0 0.0 0.0 15.7991 2.689 0.6371 0.4505 0.7071 1462125 Neuro1_000013 C(Nc1nc(nc2ccccc12)N3CCOCC3)c4ccco4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 A14 compound treatment 0.0 0.0 0.0 18.9354 5.8252 1.3802 0.9759 0.7071 3652644 Neuro1_000014 COc1ccc(Cl)cc1Nc2nc(NCC3CCCO3)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 A15 compound treatment 0.0 0.0 0.0 12.3157 -0.79451 -0.1882 -0.1331 -0.7071 1523378 Neuro1_000015 CCN(CC)c1ccc(Nc2ncnc3ccc(Br)cc23)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 A16 compound treatment 0.0 0.0 0.0 18.0533 4.9432 1.1712 0.8282 0.7071 3652645 Neuro1_000016 Oc1ccccc1Nc2nc(NC3CCCC3)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 A17 compound treatment 183.169 183.17 49.149 14.1858 1.0757 0.2549 34.9338 0.7108 1312582 Neuro1_000017 Oc1cccc(Nc2ncnc3ccc(Br)cc23)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 A18 compound treatment 0.0 0.0 0.0 16.748 3.6378 0.8619 0.6095 0.7071 3652646 Neuro1_000018 Fc1ccccc1c2nc(NCc3ccccc3)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 A19 compound treatment 0.0 0.0 0.0 15.571 2.4608 0.5831 0.4123 0.7071 1480295 Neuro1_000019 CN(C)c1ccc(Nc2ncnc3ccc(Br)cc23)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 A20 compound treatment 0.0 0.0 0.0 15.3621 2.2519 0.5336 0.3773 0.7071 3652647 Neuro1_000020 CN1CCN(CC1)c2nc(Nc3ccc(Br)cc3)nc4ccccc24 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 A21 compound treatment 0.0 0.0 0.0 12.848 -0.26214 -0.0621 -0.0439 -0.7071 1670841 Neuro1_000021 COc1cccc(Nc2ncnc3ccc(Br)cc23)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 A22 compound treatment 0.0 0.0 0.0 16.9204 3.8103 0.9028 0.6384 0.7071 3652648 Neuro1_000022 [O-][N+](=O)c1cccc(c1)c2nc(Nc3cccc(Cl)c3)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 A23 mock treatment 0.0 0.0 0.0 13.6863 0.57611 0.1365 0.0965 0.7071 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 A24 mock treatment 0.0 0.0 0.0 13.6419 0.5317 0.126 0.0891 0.7071 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 B01 compound treatment 0.0 0.0 0.0 24.6013 11.491 2.7227 1.9252 0.7071 3652649 Neuro1_000023 CCN(CC)CCNc1nc(nc2ccccc12)c3cccc(c3)[N+](=O)[O-] 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 B02 compound treatment 0.0 0.0 0.0 20.2765 7.1664 1.698 1.2006 0.7071 1202518 Neuro1_000024 COc1ccc(cc1)C(=O)Oc2ccc(Nc3ncnc4ccccc34)cc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 B03 compound treatment 0.0 0.0 0.0 14.5152 1.405 0.3329 0.2354 0.7071 3652650 Neuro1_000025 [O-][N+](=O)c1cccc(c1)c2nc(NCC3CCCO3)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 B04 compound treatment 7.2824 7.2824 1.9541 17.0802 3.9701 0.9406 2.0469 0.9438 3652651 Neuro1_000026 Fc1ccccc1c2nc(NCCCN3CCOCC3)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 B05 compound treatment 0.0 0.0 0.0 12.9433 -0.16686 -0.0395 -0.028 -0.7071 3652652 Neuro1_000027 Cc1cc(C)c2nc(nc(N3CCc4ccccc4C3)c2c1)C(F)(F)F 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 B06 compound treatment 305.627 305.63 82.0076 32.0504 18.94 4.4876 61.1613 0.7447 1362256 Neuro1_000028 CCOc1ccccc1Nc2ncnc3ccc(I)cc23 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 B07 compound treatment 0.0 0.0 0.0 15.0041 1.8939 0.4487 0.3173 0.7071 3652653 Neuro1_000029 Oc1ccc(Nc2nc(NCC3CCCO3)c4ccccc4n2)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 B08 compound treatment 0.0 0.0 0.0 13.6279 0.51776 0.1227 0.0867 0.7071 1446183 Neuro1_000030 COc1ccc(CCNc2ncnc3ccc(I)cc23)cc1OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 B09 compound treatment 56.816 56.816 15.2452 13.7329 0.62277 0.1476 10.8843 0.7139 3652654 Neuro1_000031 COc1ccc(CCNc2nc(nc3c(C)cc(C)cc23)C(F)(F)F)cc1OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 B10 compound treatment 0.0 0.0 0.0 13.0805 -0.029637 -0.007 -0.005 -0.7071 3652655 Neuro1_000032 Oc1ccc(cc1Nc2ncnc3ccc(Br)cc23)[N+](=O)[O-] 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 B11 compound treatment 0.0 0.0 0.0 17.8361 4.726 1.1197 0.7918 0.7071 3652656 Neuro1_000033 CC(Nc1nc(nc2ccccc12)N3CCCCC3)c4ccccc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 B12 compound treatment 0.0 0.0 0.0 16.3578 3.2476 0.7695 0.5441 0.7071 3652657 Neuro1_000034 CC(Nc1nc(nc2ccccc12)N3CCN(CCO)CC3)c4ccccc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 B13 compound treatment 0.0 0.0 0.0 14.5907 1.4805 0.3508 0.248 0.7071 3652658 Neuro1_000035 Clc1cccc(c1)c2nc(NCCCN3CCOCC3)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 B14 compound treatment 0.0 0.0 0.0 28.1229 15.013 3.5571 2.5152 0.7071 1494734 Neuro1_000036 Fc1ccc(cc1)C(=O)Oc2ccc(Nc3ncnc4ccccc34)cc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 B15 compound treatment 0.0 0.0 0.0 15.4257 2.3155 0.5486 0.3879 0.7071 3652659 Neuro1_000037 [O-][N+](=O)c1cccc(Nc2ncnc3ccc(I)cc23)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 B16 compound treatment 0.0 0.0 0.0 14.3969 1.2868 0.3049 0.2156 0.7071 3652660 Neuro1_000038 CC(C)OCCCNc1ncnc2ccc(Br)cc12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 B17 compound treatment 14.5423 14.542 3.9021 14.2372 1.127 0.267 2.948 0.7537 1539522 Neuro1_000039 CN(C)c1ccc(Nc2ncnc3ccc(I)cc23)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 B18 compound treatment 0.0 0.0 0.0 15.5442 2.434 0.5767 0.4078 0.7071 3652661 Neuro1_000040 [O-][N+](=O)c1ccc(NCCNc2nc(nc3ccccc23)N4CCOCC4)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 B19 compound treatment 0.0 0.0 0.0 16.3148 3.2046 0.7593 0.5369 0.7071 3652662 Neuro1_000041 CCOC(=O)c1nc(Nc2ccc(cc2)S(=O)(=O)Nc3ncccn3)c4ccccc4n1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 B20 compound treatment 0.0 0.0 0.0 20.6915 7.5813 1.7963 1.2702 0.7071 3652663 Neuro1_000042 OCCNc1nc(Nc2ccc(O)cc2)nc3ccccc13 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 B21 compound treatment 0.0 0.0 0.0 35.2863 22.176 5.2543 3.7154 0.7071 1395503 Neuro1_000043 Cc1ccc(cc1)C(=O)Oc2ccc(Nc3ncnc4ccccc34)cc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 B22 compound treatment 0.0 0.0 0.0 14.9721 1.8619 0.4412 0.3119 0.7071 3652664 Neuro1_000044 CC1CN(CC(C)O1)c2nc(nc3c(C)cc(C)cc23)C(F)(F)F 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 B23 mock treatment 0.0 0.0 0.0 15.5673 2.4571 0.5822 0.4117 0.7071 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 B24 mock treatment 0.0 0.0 0.0 14.062 0.95186 0.2255 0.1595 0.7071 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 C01 compound treatment 0.0 0.0 0.0 14.9557 1.8455 0.4373 0.3092 0.7071 3652665 Neuro1_000045 Fc1ccccc1c2nc(NCc3ccco3)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 C02 compound treatment 0.0 0.0 0.0 14.0504 0.94021 0.2228 0.1575 0.7071 1476428 Neuro1_000046 Cc1ccc(cc1Nc2ncnc3ccc(Br)cc23)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 C03 compound treatment 0.0 0.0 0.0 16.8555 3.7453 0.8874 0.6275 0.7071 3652666 Neuro1_000047 CCOc1ccc(Nc2nc(nc3ccccc23)c4cccc(c4)[N+](=O)[O-])cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 C04 compound treatment 0.0 0.0 0.0 13.182 0.071788 0.017 0.012 0.7071 3652667 Neuro1_000048 CCN(CC)c1nc(nc2ccccc12)N3CCN(CCO)CC3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 C05 compound treatment 0.0 0.0 0.0 12.6112 -0.49901 -0.1182 -0.0836 -0.7071 1183267 Neuro1_000049 Cc1cccc(Nc2nc(nc3ccccc23)c4ccc(Cl)cc4)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 C06 compound treatment 0.0 0.0 0.0 13.5841 0.47397 0.1123 0.0794 0.7071 3652668 Neuro1_000050 Oc1ccccc1/C=N/Nc2nc(nc3ccccc23)c4ccc(Br)cc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 C07 compound treatment 144.2883 144.29 38.7162 20.4298 7.3197 1.7343 28.6029 0.738 1407411 Neuro1_000051 CCOC(=O)c1ccc(Nc2nc(nc3ccccc23)c4cccnc4)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 C08 compound treatment 5.5178 5.5178 1.4806 14.1015 0.99129 0.2349 1.213 0.8092 3652670 Neuro1_000052 Cc1cc(N2CCN(CC2)c3nc(nc4ccccc34)N5CCOCC5)c6ccccc6n1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 C09 compound treatment 0.0 0.0 0.0 14.4463 1.3361 0.3166 0.2239 0.7071 1627656 Neuro1_000053 Brc1ccc(Nc2nc(N3CCOCC3)c4ccccc4n2)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 C10 compound treatment 0.0 0.0 0.0 14.8572 1.7471 0.4139 0.2927 0.7071 3652671 Neuro1_000054 CN(C)c1ccc(Nc2nc(N)c3ccccc3n2)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 C11 compound treatment 0.0 0.0 0.0 16.4067 3.2965 0.7811 0.5523 0.7071 1165826 Neuro1_000055 Fc1ccc(Nc2nc(NCc3ccccc3)c4ccccc4n2)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 C12 compound treatment 0.0 0.0 0.0 13.3635 0.25329 0.06 0.0424 0.7071 3652672 Neuro1_000056 COc1ccc(Cl)cc1Nc2nc(NCCO)c3ccccc3n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 C13 compound treatment 0.0 0.0 0.0 14.6668 1.5566 0.3688 0.2608 0.7071 1447299 Neuro1_000057 CCc1ccccc1Nc2nc(nc3ccccc23)c4ccc(Cl)cc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 C14 compound treatment 0.0 0.0 0.0 13.1251 0.014913 0.0035 0.0025 0.7071 3652673 Neuro1_000058 CN1CCN(CC1)c2nc(NC3CCCC3)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 C15 compound treatment 9.9823 9.9823 2.6785 13.705 0.59489 0.1409 1.9937 0.7433 1577515 Neuro1_000059 Fc1ccc(Nc2ncnc3ccc(Br)cc23)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 C16 compound treatment 0.0 0.0 0.0 16.2268 3.1167 0.7385 0.5222 0.7071 3652674 Neuro1_000060 COc1ccc(OC)c(Nc2nc(NCC3CCCO3)c4ccccc4n2)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 C17 compound treatment 0.0 0.0 0.0 14.0728 0.96267 0.2281 0.1613 0.7071 1633041 Neuro1_000061 CCc1ccc(Nc2ncnc3ccc(Br)cc23)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 C18 compound treatment 0.0 0.0 0.0 12.4062 -0.70396 -0.1668 -0.1179 -0.7071 1170803 Neuro1_000062 CCN1CCN(CC1)c2nc(nc3ccccc23)c4ccc(OC)cc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 C19 compound treatment 0.0 0.0 0.0 11.5811 -1.529 -0.3623 -0.2562 -0.7071 1481237 Neuro1_000063 COc1ccc(C)cc1Nc2ncnc3ccc(Br)cc23 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 C20 compound treatment 0.0 0.0 0.0 14.9645 1.8543 0.4394 0.3107 0.7071 3652675 Neuro1_000064 [O-][N+](=O)c1cccc(c1)c2nc(NC3CCCC3)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 C21 compound treatment 0.0 0.0 0.0 12.9245 -0.18571 -0.044 -0.0311 -0.7071 1141507 Neuro1_000065 CCN(CC)CCNc1ncnc2ccc(Br)cc12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 C22 compound treatment 0.0 0.0 0.0 13.0461 -0.064087 -0.0152 -0.0107 -0.7071 3652676 Neuro1_000066 [O-][N+](=O)c1cccc(c1)c2nc(N3CCN(Cc4ccccc4)CC3)c5ccccc5n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 C23 mock treatment 0.0 0.0 0.0 14.6468 1.5366 0.3641 0.2574 0.7071 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 C24 mock treatment 0.0 0.0 0.0 12.0016 -1.1086 -0.2627 -0.1857 -0.7071 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 D01 compound treatment 0.0 0.0 0.0 13.2555 0.14539 0.0344 0.0244 0.7071 3652677 Neuro1_000067 COC(=O)c1cccc(Nc2nc(nc3ccccc23)c4ccccc4F)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 D02 compound treatment 0.0 0.0 0.0 13.3086 0.19841 0.047 0.0332 0.7071 1128505 Neuro1_000068 CC(C)Oc1ccc(Nc2ncnc3ccccc23)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 D03 compound treatment 0.0 0.0 0.0 15.025 1.9148 0.4537 0.3208 0.7071 3652678 Neuro1_000069 Oc1cccc(Nc2nc(NCc3ccco3)c4ccccc4n2)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 D04 compound treatment 0.0 0.0 0.0 17.2498 4.1397 0.9808 0.6936 0.7071 3652679 Neuro1_000070 OCCN1CCN(CC1)c2nc(N3CCN(CC3)c4ccc(cc4)[N+](=O)[O-])c5ccccc5n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 D05 compound treatment 0.0 0.0 0.0 16.3215 3.2114 0.7609 0.538 0.7071 3086865 Neuro1_000071 OCCNc1nc(nc2ccccc12)N3CCN(CC3)c4ccccc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 D06 compound treatment 0.0 0.0 0.0 11.0472 -2.0629 -0.4888 -0.3456 -0.7071 1371864 Neuro1_000072 CC(=O)Nc1ccc(Nc2ncnc3ccc(I)cc23)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 D07 compound treatment 0.0 0.0 0.0 17.5632 4.453 1.0551 0.7461 0.7071 3652680 Neuro1_000073 CCOC(=O)N1CCN(CC1)c2nc(nc3c(C)cc(C)cc23)C(F)(F)F 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 D08 compound treatment 0.0 0.0 0.0 11.4137 -1.6965 -0.402 -0.2842 -0.7071 3652681 Neuro1_000074 Ic1ccc2ncnc(NCCCN3CCOCC3)c2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 D09 compound treatment 0.0 0.0 0.0 15.0033 1.8931 0.4485 0.3172 0.7071 3652682 Neuro1_000075 CN1CCN(CC1)c2nc(NCCO)c3ccccc3n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 D10 compound treatment 0.0 0.0 0.0 12.4309 -0.67921 -0.1609 -0.1138 -0.7071 1228851 Neuro1_000076 Cc1ccc(O)c(Nc2ncnc3ccc(Br)cc23)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 D11 compound treatment 0.0 0.0 0.0 19.1618 6.0516 1.4338 1.0139 0.7071 3652683 Neuro1_000077 CC(Nc1nc(nc2ccccc12)N3CCN(CC3)S(=O)(=O)c4ccccc4)c5ccccc5 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 D12 compound treatment 0.0 0.0 0.0 16.434 3.3239 0.7875 0.5569 0.7071 3652684 Neuro1_000078 OC(=O)c1cccc(Nc2nc(nc3ccccc23)C(F)(F)F)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 D13 compound treatment 0.0 0.0 0.0 10.8579 -2.2523 -0.5337 -0.3773 -0.7071 3652685 Neuro1_000079 Clc1cccc(c1)c2nc(NCc3cccnc3)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 D14 compound treatment 0.0 0.0 0.0 14.8514 1.7412 0.4125 0.2917 0.7071 1555545 Neuro1_000080 N(c1ccccc1)c2ccc(Nc3ncnc4ccccc34)cc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 D15 compound treatment 0.0 0.0 0.0 11.1627 -1.9475 -0.4614 -0.3263 -0.7071 1326651 Neuro1_000081 Oc1ccc(Nc2ncnc3ccc(I)cc23)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 D16 compound treatment 0.0 0.0 0.0 14.3904 1.2802 0.3033 0.2145 0.7071 1553618 Neuro1_000082 O=S(=O)(Nc1ncccn1)c2ccc(Nc3ncnc4ccccc34)cc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 D17 compound treatment 81.3412 81.341 21.8259 10.7728 -2.3374 -0.5538 15.0417 0.6889 1414439 Neuro1_000083 Fc1ccc(Nc2ncnc3ccc(I)cc23)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 D18 compound treatment 0.0 0.0 0.0 14.8383 1.7282 0.4095 0.2895 0.7071 3652686 Neuro1_000084 CC(Nc1nc(nc2ccccc12)N3CCN(CC3)S(=O)(=O)c4ccc(C)cc4)c5ccccc5 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 D19 compound treatment 0.0 0.0 0.0 13.8703 0.76016 0.1801 0.1274 0.7071 3652687 Neuro1_000085 CCOC(=O)c1nc(Nc2cc(Cl)ccc2O)c3ccccc3n1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 D20 compound treatment 0.0 0.0 0.0 10.8826 -2.2276 -0.5278 -0.3732 -0.7071 3652688 Neuro1_000086 Cc1cc(C)c2nc(nc(N3CCN(CC3)c4ccccc4F)c2c1)C(F)(F)F 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 D21 compound treatment 121.023 121.02 32.4736 12.9561 -0.15406 -0.0365 22.9365 0.7063 3652689 Neuro1_000087 CC(=O)c1ccc(Nc2nc(nc3ccccc23)c4ccccc4)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 D22 compound treatment 0.0 0.0 0.0 17.5397 4.4296 1.0495 0.7421 0.7071 3652690 Neuro1_000088 Oc1ccccc1Nc2nc(NCc3ccccc3)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 D23 mock treatment 0.0 0.0 0.0 11.7857 -1.3244 -0.3138 -0.2219 -0.7071 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 D24 mock treatment 0.0 0.0 0.0 14.1766 1.0664 0.2527 0.1787 0.7071 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 E01 compound treatment 0.0 0.0 0.0 12.9201 -0.19011 -0.045 -0.0319 -0.7071 1623881 Neuro1_000089 COc1ccc(cc1)c2nc(NCCO)c3ccccc3n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 E02 compound treatment 10.9894 10.989 2.9487 13.5398 0.42969 0.1018 2.1571 0.7311 3652691 Neuro1_000090 OC(=O)C(Nc1nc(nc2ccccc12)C(F)(F)F)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 E03 compound treatment 0.0 0.0 0.0 15.1259 2.0157 0.4776 0.3377 0.7071 1647041 Neuro1_000091 Cc1ccccc1Nc2nc(NCc3ccco3)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 E04 compound treatment 0.0 0.0 0.0 13.4535 0.34335 0.0814 0.0575 0.7071 1935369 Neuro1_000092 CCOc1ccc(/C=N/Nc2nc(nc3ccccc23)c4ccc(C)cc4)c(O)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 E05 compound treatment 0.0 0.0 0.0 12.7567 -0.35347 -0.0838 -0.0592 -0.7071 1127286 Neuro1_000093 CCOc1ccccc1Nc2nc(nc3ccccc23)c4cccnc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 E06 compound treatment 0.0 0.0 0.0 10.3549 -2.7553 -0.6528 -0.4616 -0.7071 3652692 Neuro1_000094 COc1cccc(/C=N/Nc2nc(nc3ccccc23)c4ccc(Br)cc4)c1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 E07 compound treatment 0.0 0.0 0.0 35.1072 21.997 5.2119 3.6853 0.7071 1515436 Neuro1_000095 C(Nc1nc(nc2ccccc12)N3CCCCC3)c4ccccc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 E08 compound treatment 69.0537 69.054 18.5289 14.7917 1.6815 0.3984 13.3836 0.7221 3652694 Neuro1_000096 COc1cccc2c(nc(nc12)C(Cl)(Cl)Cl)N3CC(C)OC(C)C3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 E09 compound treatment 0.0 0.0 0.0 12.5794 -0.53076 -0.1258 -0.0889 -0.7071 1609740 Neuro1_000097 Cc1cccc(Nc2nc(N3CCOCC3)c4ccccc4n2)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 E10 compound treatment 0.0 0.0 0.0 14.8555 1.7453 0.4135 0.2924 0.7071 3652695 Neuro1_000098 COc1ccc(OC)c(Nc2nc(NCc3ccco3)c4ccccc4n2)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 E11 compound treatment 0.0 0.0 0.0 11.6325 -1.4777 -0.3501 -0.2476 -0.7071 1181771 Neuro1_000099 C(Nc1nc(nc2ccccc12)N3CCN(CC3)c4ccccc4)c5ccccc5 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 E12 compound treatment 0.0 0.0 0.0 11.2096 -1.9006 -0.4503 -0.3184 -0.7071 3652696 Neuro1_000100 COc1ccc(C)cc1Nc2nc(NCCO)c3ccccc3n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 E13 compound treatment 0.0 0.0 0.0 12.6845 -0.42564 -0.1008 -0.0713 -0.7071 1643938 Neuro1_000101 Oc1ccccc1c2nc(Nc3ccc(Cl)c(Cl)c3)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 E14 compound treatment 0.0 0.0 0.0 12.6272 -0.48298 -0.1144 -0.0809 -0.7071 3652697 Neuro1_000102 Cc1ccc(Nc2nc(N3CCOCC3)c4ccccc4n2)cc1C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 E15 compound treatment 0.0 0.0 0.0 13.1997 0.089563 0.0212 0.015 0.7071 3652698 Neuro1_000103 COc1ccccc1N2CCN(CC2)c3nc(nc4ccccc34)c5ccccc5O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 E16 compound treatment 0.0 0.0 0.0 13.7272 0.61699 0.1462 0.1034 0.7071 3652699 Neuro1_000104 COc1ccc(OC)c(Nc2nc(N)c3ccccc3n2)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 E17 compound treatment 676.3632 676.36 181.4857 114.098 100.99 23.9276 145.2491 0.7935 3652700 Neuro1_000105 CC(=O)c1ccc(Nc2ncnc3ccc(Br)cc23)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 E18 compound treatment 0.0 0.0 0.0 13.2482 0.13804 0.0327 0.0231 0.7071 3652701 Neuro1_000106 [O-][N+](=O)c1cccc(c1)c2nc(NCc3cccnc3)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 E19 compound treatment 0.0 0.0 0.0 13.3961 0.28593 0.0677 0.0479 0.7071 1714181 Neuro1_000107 Cc1cc(C)cc(Nc2ncnc3ccc(Br)cc23)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 E20 compound treatment 79.5 79.5 21.3319 12.8511 -0.25906 -0.0614 15.0405 0.7051 3652702 Neuro1_000108 CN1CCN(CC1)c2nc(Nc3cccc(Cl)c3)nc4ccccc24 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 E21 compound treatment 0.0 0.0 0.0 12.3403 -0.76986 -0.1824 -0.129 -0.7071 1208363 Neuro1_000109 Brc1ccc2ncnc(N(CC=C)CC=C)c2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 E22 compound treatment 0.0 0.0 0.0 13.5033 0.39311 0.0931 0.0659 0.7071 1578547 Neuro1_000110 CN(C1CCCCC1)c2nc(nc3ccccc23)c4ccccc4F 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 E23 mock treatment 0.0 0.0 0.0 12.7164 -0.39374 -0.0933 -0.066 -0.7071 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 E24 mock treatment 0.0 0.0 0.0 14.2326 1.1224 0.2659 0.188 0.7071 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 F01 compound treatment 0.0 0.0 0.0 18.5054 5.3953 1.2783 0.9039 0.7071 3652703 Neuro1_000111 COc1ccccc1Nc2nc(nc3ccccc23)c4cccc(c4)[N+](=O)[O-] 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 F02 compound treatment 0.0 0.0 0.0 12.1462 -0.96394 -0.2284 -0.1615 -0.7071 3652704 Neuro1_000112 OCCCNc1nc(nc2ccccc12)c3ccc(Cl)cc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 F03 compound treatment 6.0313 6.0313 1.6183 19.4138 6.3036 1.4935 2.2004 0.9992 3652705 Neuro1_000113 COC(=O)c1ccc(Nc2nc(NCc3ccccc3)c4ccccc4n2)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 F04 compound treatment 0.0 0.0 0.0 12.2428 -0.86735 -0.2055 -0.1453 -0.7071 3652706 Neuro1_000114 COc1ccc(Nc2nc(nc3ccccc23)N4CCOCC4)c(OC)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 F05 compound treatment 0.0 0.0 0.0 11.5539 -1.5562 -0.3687 -0.2607 -0.7071 3652707 Neuro1_000115 COc1ccccc1N2CCN(CC2)c3nc(nc4c(C)cc(C)cc34)C(F)(F)F 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 F06 compound treatment 0.0 0.0 0.0 12.9049 -0.20526 -0.0486 -0.0344 -0.7071 1568958 Neuro1_000116 Ic1ccc2ncnc(NCC3CCCO3)c2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 F07 compound treatment 0.0 0.0 0.0 12.7568 -0.35339 -0.0837 -0.0592 -0.7071 3652708 Neuro1_000117 C1CCN(CC1)c2nc(Nc3ccccc3)nc4ccccc24 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 F08 compound treatment 11.0183 11.018 2.9565 10.6855 -2.4247 -0.5745 1.6843 0.5592 1676459 Neuro1_000118 COC(=O)c1ccc(Nc2ncnc3ccc(I)cc23)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 F09 compound treatment 0.0 0.0 0.0 11.4717 -1.6384 -0.3882 -0.2745 -0.7071 1986166 Neuro1_000119 CC(Nc1nc(nc2ccccc12)N3CCN(CC3)S(=O)(=O)C)c4ccccc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 F10 compound treatment 27.5645 27.564 7.3963 13.7103 0.60009 0.1422 5.3305 0.7206 3652709 Neuro1_000120 Brc1cccc(Nc2ncnc3ccccc23)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 F11 compound treatment 0.0 0.0 0.0 12.7687 -0.34149 -0.0809 -0.0572 -0.7071 3652710 Neuro1_000121 Clc1cccc(c1)c2nc(NCC3CCCO3)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 F12 compound treatment 0.0 0.0 0.0 10.3734 -2.7368 -0.6484 -0.4585 -0.7071 3652711 Neuro1_000122 O=S(=O)(Nc1nccs1)c2ccc(Nc3ncnc4ccccc34)cc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 F13 compound treatment 0.0 0.0 0.0 12.3634 -0.74675 -0.1769 -0.1251 -0.7071 3652712 Neuro1_000123 O=C(NCc1ccccc1)c2nc(NCc3ccccc3)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 F14 compound treatment 0.0 0.0 0.0 33.8554 20.745 4.9153 3.4756 0.7071 1179362 Neuro1_000124 Cc1ccc(O)c(Nc2nc(nc3ccccc23)c4ccccc4)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 F15 compound treatment 0.0 0.0 0.0 9.7731 -3.3371 -0.7907 -0.5591 -0.7071 3652713 Neuro1_000125 COCCCNc1ncnc2ccc(I)cc12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 F16 compound treatment 0.0 0.0 0.0 13.5223 0.41219 0.0977 0.0691 0.7071 3652714 Neuro1_000126 COc1ccc(cc1Nc2ncnc3ccc(Br)cc23)[N+](=O)[O-] 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 F17 compound treatment 24.8246 24.825 6.6611 15.5719 2.4618 0.5833 5.1225 0.7661 1600380 Neuro1_000127 CCOC(=O)c1nc(Nc2ccc(C)c(Cl)c2)c3ccccc3n1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 F18 compound treatment 3.5821 3.5821 0.9612 18.6419 5.5317 1.3107 1.6064 0.9884 3652715 Neuro1_000128 CC(Nc1nc(nc2ccccc12)N3CCCC3)c4ccccc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 F19 compound treatment 0.0 0.0 0.0 12.1997 -0.91047 -0.2157 -0.1525 -0.7071 3652716 Neuro1_000129 CCOC(=O)c1nc(Nc2ccc(cc2)N3CCOCC3)c4ccccc4n1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 F20 compound treatment 0.0 0.0 0.0 15.317 2.2069 0.5229 0.3697 0.7071 3652717 Neuro1_000130 COc1cccc(Nc2nc(NCC3CCCO3)c4ccccc4n2)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 F21 compound treatment 0.0 0.0 0.0 20.5732 7.463 1.7683 1.2503 0.7071 3652718 Neuro1_000131 COc1ccc(cc1Nc2nc(nc3ccccc23)c4ccccc4)[N+](=O)[O-] 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 F22 compound treatment 0.0 0.0 0.0 11.6029 -1.5073 -0.3571 -0.2525 -0.7071 3652719 Neuro1_000132 OCCN1CCN(CC1)c2nc(NCC3CCCO3)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 F23 mock treatment 0.0 0.0 0.0 11.1064 -2.0037 -0.4748 -0.3357 -0.7071 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 F24 mock treatment 0.0 0.0 0.0 13.3468 0.23661 0.0561 0.0396 0.7071 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 G01 compound treatment 0.0 0.0 0.0 16.1444 3.0343 0.7189 0.5084 0.7071 1201768 Neuro1_000133 CCCNc1nc(nc2ccccc12)c3ccc(OC)cc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 G02 compound treatment 0.0 0.0 0.0 16.2855 3.1753 0.7523 0.532 0.7071 3652720 Neuro1_000134 CCN(CC)c1nc(nc2ccccc12)N3CCOCC3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 G03 compound treatment 0.0 0.0 0.0 12.4521 -0.65806 -0.1559 -0.1103 -0.7071 1236128 Neuro1_000135 CCOc1ccc(Nc2nc(N3CCOCC3)c4ccccc4n2)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 G04 compound treatment 0.0 0.0 0.0 10.9849 -2.1253 -0.5036 -0.3561 -0.7071 1935323 Neuro1_000136 Cc1ccc(cc1)c2nc(N/N=C/c3ccccc3O)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 G05 compound treatment 0.0 0.0 0.0 11.2558 -1.8543 -0.4394 -0.3107 -0.7071 1614179 Neuro1_000137 CCOc1ccc(Nc2nc(nc3ccccc23)c4ccc(Cl)cc4)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 G06 compound treatment 0.0 0.0 0.0 13.9176 0.80746 0.1913 0.1353 0.7071 3652721 Neuro1_000138 CCOc1ccc(/C=N/Nc2nc(nc3ccccc23)c4ccc(Br)cc4)c(O)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 G07 compound treatment 0.0 0.0 0.0 11.4998 -1.6104 -0.3816 -0.2698 -0.7071 1257914 Neuro1_000139 COc1cccc(Nc2nc(nc3ccccc23)c4cccnc4)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 G08 compound treatment 0.0 0.0 0.0 11.9836 -1.1266 -0.2669 -0.1887 -0.7071 3652723 Neuro1_000140 COc1cccc2c(nc(nc12)C(Cl)(Cl)Cl)N3CCN(Cc4ccccc4)CC3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 G09 compound treatment 0.0 0.0 0.0 13.4933 0.38309 0.0908 0.0642 0.7071 1954230 Neuro1_000141 FC(F)(F)c1cccc(Nc2nc(nc3ccccc23)c4cccnc4)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 G10 compound treatment 0.0 0.0 0.0 11.2247 -1.8855 -0.4467 -0.3159 -0.7071 3652724 Neuro1_000142 CCN1CCN(CC1)c2nc(NCc3ccco3)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 G11 compound treatment 5.7996 5.7996 1.5562 9.9559 -3.1542 -0.7473 0.5719 0.3313 1243756 Neuro1_000143 CCOc1ccc(Nc2nc(nc3ccccc23)c4cccnc4)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 G12 compound treatment 0.0 0.0 0.0 13.5513 0.44111 0.1045 0.0739 0.7071 3652725 Neuro1_000144 COc1ccc(C)cc1Nc2nc(N)c3ccccc3n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 G13 compound treatment 0.0 0.0 0.0 11.1377 -1.9725 -0.4674 -0.3305 -0.7071 1154520 Neuro1_000145 CCN(Cc1ccccc1)c2ncnc3ccc(Br)cc23 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 G14 compound treatment 0.0 0.0 0.0 12.7479 -0.36226 -0.0858 -0.0607 -0.7071 3652726 Neuro1_000146 OCCNc1nc(Nc2ccc(Cl)c(Cl)c2)nc3ccccc13 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 G15 compound treatment 0.0 0.0 0.0 11.8996 -1.2106 -0.2868 -0.2028 -0.7071 1361807 Neuro1_000147 Cc1ccc(C)c(Nc2nc(nc3ccccc23)c4ccccc4O)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 G16 compound treatment 0.0 0.0 0.0 12.8733 -0.23689 -0.0561 -0.0397 -0.7071 3652727 Neuro1_000148 CCN1CCN(CC1)c2nc(N3CCOCC3)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 G17 compound treatment 0.0 0.0 0.0 10.7774 -2.3327 -0.5527 -0.3908 -0.7071 1383741 Neuro1_000149 CC(=O)Nc1ccc(Nc2ncnc3ccc(Br)cc23)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 G18 compound treatment 0.0 0.0 0.0 11.786 -1.3241 -0.3137 -0.2218 -0.7071 3652728 Neuro1_000150 COC(=O)c1ccc(Nc2nc(N3CCOCC3)c4ccccc4n2)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 G19 compound treatment 0.0 0.0 0.0 15.0597 1.9496 0.4619 0.3266 0.7071 1379452 Neuro1_000151 CC(C)OC(=O)c1ccc(Nc2ncnc3ccc(Br)cc23)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 G20 compound treatment 0.0 0.0 0.0 11.6523 -1.4578 -0.3454 -0.2442 -0.7071 3652729 Neuro1_000152 COc1ccc(Cc2nc(NCC3CCCO3)c4ccccc4n2)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 G21 compound treatment 0.0 0.0 0.0 13.1743 0.064138 0.0152 0.0107 0.7071 1580613 Neuro1_000153 COc1ccc(CCNc2ncnc3ccc(Br)cc23)cc1OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 G22 compound treatment 0.0 0.0 0.0 13.374 0.26381 0.0625 0.0442 0.7071 3652730 Neuro1_000154 Oc1cccc(Nc2nc(N3CCOCC3)c4ccccc4n2)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 G23 mock treatment 0.0 0.0 0.0 13.0017 -0.10846 -0.0257 -0.0182 -0.7071 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 G24 mock treatment 0.0 0.0 0.0 15.6703 2.5601 0.6066 0.4289 0.7071 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 H01 compound treatment 18.946 18.946 5.0837 12.3727 -0.73744 -0.1747 3.4712 0.6824 1141229 Neuro1_000155 Fc1ccccc1c2nc(N3CCN(Cc4ccccc4)CC3)c5ccccc5n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 H02 compound treatment 0.0 0.0 0.0 13.5782 0.46799 0.1109 0.0784 0.7071 1523458 Neuro1_000156 O=C(Oc1ccc(Nc2ncnc3ccccc23)cc1)c4ccncc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 H03 compound treatment 0.0 0.0 0.0 13.3135 0.20339 0.0482 0.0341 0.7071 3652731 Neuro1_000157 Cc1ccc(OCCN2CCN(CC2)c3nc(NCc4ccccc4)c5ccccc5n3)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 H04 compound treatment 0.0 0.0 0.0 19.3071 6.1969 1.4683 1.0382 0.7071 3652732 Neuro1_000158 COc1ccc(Nc2nc(nc3ccccc23)N4CCN(CC4)c5ccc(cc5)[N+](=O)[O-])cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 H05 compound treatment 0.0 0.0 0.0 10.6465 -2.4637 -0.5837 -0.4128 -0.7071 3652733 Neuro1_000159 Oc1ccccc1Nc2nc(N3CCOCC3)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 H06 compound treatment 0.0 0.0 0.0 13.4645 0.35436 0.084 0.0594 0.7071 1329695 Neuro1_000160 Ic1ccc2ncnc(Nc3ccccc3)c2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 H07 compound treatment 0.0 0.0 0.0 9.5401 -3.5701 -0.8459 -0.5981 -0.7071 1487640 Neuro1_000161 Oc1ccc(Cl)cc1Nc2ncnc3ccc(Br)cc23 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 H08 compound treatment 0.0 0.0 0.0 12.4953 -0.61486 -0.1457 -0.103 -0.7071 3652734 Neuro1_000162 CN1CCN(CC1)c2nc(NC3CCCCC3)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 H09 compound treatment 0.0 0.0 0.0 16.4535 3.3434 0.7922 0.5601 0.7071 3652735 Neuro1_000163 [O-][N+](=O)c1ccc2ncnc(N(Cc3ccccc3)Cc4ccccc4)c2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 H10 compound treatment 0.0 0.0 0.0 12.1026 -1.0075 -0.2387 -0.1688 -0.7071 3652736 Neuro1_000164 Ic1cccc(Nc2ncnc3ccccc23)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 H11 compound treatment 0.0 0.0 0.0 11.1876 -1.9226 -0.4555 -0.3221 -0.7071 3652737 Neuro1_000165 Clc1cccc(c1)c2nc(NCc3ccco3)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 H12 compound treatment 0.0 0.0 0.0 14.6458 1.5356 0.3638 0.2573 0.7071 3652738 Neuro1_000166 Cc1c(Nc2nc(nc3ccccc23)C(F)(F)F)c(=O)n(c4ccccc4)n1C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 H13 compound treatment 0.0 0.0 0.0 10.9014 -2.2088 -0.5233 -0.3701 -0.7071 1433926 Neuro1_000167 Ic1ccc2ncnc(NC3CCCCC3)c2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 H14 compound treatment 0.0 0.0 0.0 12.0841 -1.0261 -0.2431 -0.1719 -0.7071 3652739 Neuro1_000168 [O-][N+](=O)c1ccc(cc1)C(=O)Oc2ccc(Nc3ncnc4ccccc34)cc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 H15 compound treatment 0.0 0.0 0.0 13.5718 0.46161 0.1094 0.0773 0.7071 1274605 Neuro1_000169 OC(=O)c1cccc(Nc2ncnc3ccc(I)cc23)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 H16 compound treatment 0.0 0.0 0.0 11.1786 -1.9316 -0.4577 -0.3236 -0.7071 1469064 Neuro1_000170 Fc1ccc(Nc2ncnc3ccc(Br)cc23)cc1Cl 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 H17 compound treatment 15.4712 15.471 4.1513 15.2045 2.0944 0.4962 3.2863 0.786 1262527 Neuro1_000171 CCOC(=O)c1nc(Nc2cc(C)cc(C)c2)c3ccccc3n1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 H18 compound treatment 0.0 0.0 0.0 13.7215 0.61135 0.1448 0.1024 0.7071 3119176 Neuro1_000172 CC(Nc1nc(nc2ccccc12)N3CCNCC3)c4ccccc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 H19 compound treatment 52.0945 52.094 13.9783 12.4616 -0.64858 -0.1537 9.7755 0.6993 1413519 Neuro1_000173 CCOC(=O)c1nc(Nc2cc(Cl)ccc2OC)c3ccccc3n1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 H20 compound treatment 0.0 0.0 0.0 10.7856 -2.3246 -0.5508 -0.3895 -0.7071 3652740 Neuro1_000174 Cc1cc(C)c2nc(nc(N3CCN(CCO)CC3)c2c1)C(F)(F)F 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 H21 compound treatment 0.0 0.0 0.0 14.6396 1.5294 0.3624 0.2562 0.7071 1557489 Neuro1_000175 C(N1CCN(CC1)c2ncnc3ccccc23)c4ccccc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 H22 compound treatment 0.0 0.0 0.0 11.9089 -1.2012 -0.2846 -0.2013 -0.7071 3652741 Neuro1_000176 COc1ccc(Nc2nc(nc3ccccc23)N4CCN(CC4)S(=O)(=O)C)c(OC)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 H23 mock treatment 0.0 0.0 0.0 12.5739 -0.53631 -0.1271 -0.0899 -0.7071 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 H24 mock treatment 0.0 0.0 0.0 12.9349 -0.1753 -0.0415 -0.0294 -0.7071 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 I01 compound treatment 0.0 0.0 0.0 17.1981 4.0879 0.9686 0.6849 0.7071 1985684 Neuro1_000177 COC(=O)c1ccc(Nc2nc(N3CCN(C)CC3)c4ccccc4n2)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 I02 compound treatment 0.0 0.0 0.0 11.6153 -1.4949 -0.3542 -0.2505 -0.7071 3652742 Neuro1_000178 CCN(CC)c1nc(Nc2ccncc2)nc3ccccc13 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 I03 compound treatment 0.0 0.0 0.0 11.3089 -1.8013 -0.4268 -0.3018 -0.7071 1983321 Neuro1_000179 C(CNc1nc(nc2ccccc12)c3ccccc3)CN4CCOCC4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 I04 compound treatment 0.0 0.0 0.0 10.3422 -2.768 -0.6558 -0.4637 -0.7071 1935653 Neuro1_000180 COc1cccc(/C=N/Nc2nc(nc3ccccc23)c4ccc(C)cc4)c1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 I05 compound treatment 0.0 0.0 0.0 11.1695 -1.9407 -0.4598 -0.3251 -0.7071 1674338 Neuro1_000181 C1CN(CCO1)c2nc(Nc3ccccc3)nc4ccccc24 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 I06 compound treatment 0.0 0.0 0.0 14.3934 1.2832 0.304 0.215 0.7071 3652743 Neuro1_000182 Cc1c(O)ccc(/C=N/Nc2nc(nc3ccccc23)c4ccc(Br)cc4)c1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 I07 compound treatment 0.0 0.0 0.0 13.2365 0.12631 0.0299 0.0212 0.7071 1141952 Neuro1_000183 Cc1ccccc1Nc2nc(nc3ccccc23)c4ccc(Cl)cc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 I08 compound treatment 0.0 0.0 0.0 14.4107 1.3005 0.3081 0.2179 0.7071 3652745 Neuro1_000184 CN1CCN(CC1)c2nc(NCCc3ccccc3)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 I09 compound treatment 0.0 0.0 0.0 14.2689 1.1587 0.2745 0.1941 0.7071 1313914 Neuro1_000185 CCOc1ccc(Nc2nc(NCc3ccco3)c4ccccc4n2)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 I10 compound treatment 0.0 0.0 0.0 11.6982 -1.412 -0.3346 -0.2366 -0.7071 3652746 Neuro1_000186 CN(C)c1ccc(Nc2nc(N3CCOCC3)c4ccccc4n2)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 I11 compound treatment 0.0 0.0 0.0 12.6317 -0.47844 -0.1134 -0.0802 -0.7071 1591665 Neuro1_000187 OCCN1CCN(CC1)c2nc(NCc3ccccc3)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 I12 compound treatment 0.0 0.0 0.0 13.4483 0.33816 0.0801 0.0567 0.7071 3652747 Neuro1_000188 C(Cc1ccccc1)Nc2nc(nc3ccccc23)N4CCOCC4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 I13 compound treatment 0.0 0.0 0.0 12.0918 -1.0184 -0.2413 -0.1706 -0.7071 1382464 Neuro1_000189 CC1CC(C)CN(C1)c2nc(nc3ccccc23)c4ccccc4O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 I14 compound treatment 11.1981 11.198 3.0047 11.7237 -1.3865 -0.3285 1.8924 0.6261 3652748 Neuro1_000190 Cc1ccc(Nc2nc(N3CCOCC3)c4ccccc4n2)cc1Cl 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 I15 compound treatment 0.0 0.0 0.0 10.6178 -2.4924 -0.5905 -0.4176 -0.7071 3652749 Neuro1_000191 Oc1ccccc1c2nc(Nc3cccc(c3)C(F)(F)F)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 I16 compound treatment 0.0 0.0 0.0 11.9666 -1.1436 -0.271 -0.1916 -0.7071 3652750 Neuro1_000192 COc1ccc(OC)c(Nc2nc(N3CCOCC3)c4ccccc4n2)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 I17 compound treatment 0.0 0.0 0.0 21.4516 8.3415 1.9764 1.3975 0.7071 1620739 Neuro1_000193 Clc1ccc(Nc2ncnc3ccc(Br)cc23)cc1Cl 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 I18 compound treatment 0.0 0.0 0.0 13.2267 0.11654 0.0276 0.0195 0.7071 3652751 Neuro1_000194 CC(Nc1nc(nc2ccccc12)c3cccc(c3)[N+](=O)[O-])c4ccccc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 I19 compound treatment 0.0 0.0 0.0 14.2016 1.0914 0.2586 0.1829 0.7071 3652752 Neuro1_000195 CC1CCCN(C1)c2nc(nc3ccccc23)c4ccccc4O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 I20 compound treatment 0.0 0.0 0.0 11.2255 -1.8847 -0.4466 -0.3158 -0.7071 3652753 Neuro1_000196 COc1ccccc1N2CCN(CC2)c3nc(nc4ccccc34)c5cccc(c5)[N+](=O)[O-] 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 I21 compound treatment 0.0 0.0 0.0 13.6756 0.56539 0.134 0.0947 0.7071 3652754 Neuro1_000197 CCN1CCN(CC1)c2nc(nc3ccccc23)c4ccccc4O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 I22 compound treatment 0.0 0.0 0.0 12.6848 -0.42536 -0.1008 -0.0713 -0.7071 3652755 Neuro1_000198 CN1CCN(CC1)c2nc(nc3ccccc23)c4ccccc4F 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 I23 mock treatment 0.0 0.0 0.0 10.8014 -2.3087 -0.547 -0.3868 -0.7071 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 I24 mock treatment 0.0 0.0 0.0 15.2304 2.1202 0.5023 0.3552 0.7071 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 J01 compound treatment 0.0 0.0 0.0 9.8623 -3.2478 -0.7695 -0.5441 -0.7071 3652756 Neuro1_000199 Fc1ccccc1Nc2nc(NCC3CCCO3)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 J02 compound treatment 0.0 0.0 0.0 14.42 1.3098 0.3103 0.2194 0.7071 3652757 Neuro1_000200 CN1CCN(CC1)c2nc(nc3ccccc23)N4CCN(CC4)c5ccccc5 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 J03 compound treatment 0.0 0.0 0.0 13.9586 0.84839 0.201 0.1421 0.7071 3652758 Neuro1_000201 CC(C)(C)Nc1nc(nc2ccccc12)c3cccc(c3)[N+](=O)[O-] 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 J04 compound treatment 6.4355 6.4355 1.7268 13.9915 0.88131 0.2088 1.3687 0.7869 3209382 Neuro1_000202 Cc1ccc(cc1)S(=O)(=O)N2CCN(CC2)c3nc(NC4CCCC4)c5ccccc5n3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 J05 compound treatment 0.0 0.0 0.0 11.7947 -1.3155 -0.3117 -0.2204 -0.7071 3652759 Neuro1_000203 Oc1ccccc1Nc2nc(NCc3ccco3)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 J06 compound treatment 0.0 0.0 0.0 12.1521 -0.95806 -0.227 -0.1605 -0.7071 1353170 Neuro1_000204 COc1ccc(Nc2ncnc3ccc(I)cc23)cc1OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 J07 compound treatment 0.0 0.0 0.0 13.0369 -0.073237 -0.0174 -0.0123 -0.7071 3086809 Neuro1_000205 CN1CCN(CC1)c2nc(NCC3CCCO3)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 J08 compound treatment 0.0 0.0 0.0 11.923 -1.1872 -0.2813 -0.1989 -0.7071 3652760 Neuro1_000206 Cc1c(Cl)cccc1Nc2nc(NCCO)c3ccccc3n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 J09 compound treatment 8.8402 8.8402 2.3721 12.91 -0.20019 -0.0474 1.6438 0.6928 3652761 Neuro1_000207 COc1ccc(Nc2nc(nc3ccccc23)N4CCN(CC4)S(=O)(=O)c5ccc(C)cc5)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 J10 compound treatment 0.0 0.0 0.0 12.9898 -0.12036 -0.0285 -0.0202 -0.7071 3652762 Neuro1_000208 CC1CN(CC(C)N1)c2nc(nc3ccccc23)N4CCCC4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 J11 compound treatment 0.0 0.0 0.0 12.6778 -0.43239 -0.1024 -0.0724 -0.7071 3652763 Neuro1_000209 Clc1cccc(c1)c2nc(NCCN3CCOCC3)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 J12 compound treatment 128.6248 128.62 34.5133 13.7082 0.59806 0.1417 24.5048 0.71 1170239 Neuro1_000210 Brc1ccc2ncnc(Nc3cccc(OC(=O)c4cccs4)c3)c2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 J13 compound treatment 0.0 0.0 0.0 11.1161 -1.9941 -0.4725 -0.3341 -0.7071 1617762 Neuro1_000211 Ic1ccc2ncnc(NCCN3CCOCC3)c2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 J14 compound treatment 0.0 0.0 0.0 22.3452 9.235 2.1881 1.5472 0.7071 1523583 Neuro1_000212 Oc1cccc(Nc2nc(nc3ccccc23)c4ccccc4)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 J15 compound treatment 0.0 0.0 0.0 10.6818 -2.4284 -0.5754 -0.4068 -0.7071 1234275 Neuro1_000213 Ic1ccc2ncnc(Nc3ccc4OCCOc4c3)c2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 J16 compound treatment 0.0 0.0 0.0 14.3635 1.2534 0.297 0.21 0.7071 1985883 Neuro1_000214 COc1ccc(Nc2nc(nc3ccccc23)N4CCCC4)c(OC)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 J17 compound treatment 0.0 0.0 0.0 11.1808 -1.9293 -0.4571 -0.3232 -0.7071 3652764 Neuro1_000215 CCCOc1ccccc1Nc2nc(nc3ccccc23)C(=O)OCC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 J18 compound treatment 0.0 0.0 0.0 11.8709 -1.2392 -0.2936 -0.2076 -0.7071 3652765 Neuro1_000216 C1CN(CCO1)c2nc(NC3C4CC5CC(C4)CC3C5)c6ccccc6n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 J19 compound treatment 0.0 0.0 0.0 10.6608 -2.4493 -0.5803 -0.4104 -0.7071 1424113 Neuro1_000217 CC(C)Oc1ccccc1Nc2ncnc3ccccc23 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 J20 compound treatment 0.0 0.0 0.0 13.0806 -0.029537 -0.007 -0.0049 -0.7071 3652766 Neuro1_000218 OCCNc1nc(Nc2ccc(Cl)cc2)nc3ccccc13 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 J21 compound treatment 0.0 0.0 0.0 12.9804 -0.12973 -0.0307 -0.0217 -0.7071 1120309 Neuro1_000219 COc1ccc(OC)c(Nc2ncnc3ccccc23)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 J22 compound treatment 0.0 0.0 0.0 12.9807 -0.12949 -0.0307 -0.0217 -0.7071 1661495 Neuro1_000220 CC(C)CC(Nc1ncnc2ccc(C)cc12)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 J23 mock treatment 0.0 0.0 0.0 15.7634 2.6532 0.6286 0.4445 0.7071 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 J24 mock treatment 0.0 0.0 0.0 14.2797 1.1695 0.2771 0.1959 0.7071 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 K01 compound treatment 0.0 0.0 0.0 14.2583 1.1481 0.272 0.1924 0.7071 3652767 Neuro1_000221 CC1CCCCN1c2nc(nc3ccccc23)c4cccc(c4)[N+](=O)[O-] 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 K02 compound treatment 0.0 0.0 0.0 10.3008 -2.8094 -0.6656 -0.4707 -0.7071 3652768 Neuro1_000222 CCN1CCN(CC1)c2nc(N3CCCC(C)C3)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 K03 compound treatment 553.1 553.1 148.411 13.5186 0.40839 0.0968 105.0108 0.7076 1698023 Neuro1_000223 Clc1ccc(cc1)c2nc(Nc3ccc(I)cc3)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 K04 compound treatment 0.0 0.0 0.0 57.8008 44.691 10.5888 7.4874 0.7071 3652769 Neuro1_000224 Cc1ccc(cc1)c2nc(N/N=C/c3cc(Br)ccc3O)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 K05 compound treatment 5.7896 5.7896 1.5535 10.9097 -2.2005 -0.5214 0.7298 0.4454 1623340 Neuro1_000225 Brc1ccc(Nc2nc(NCc3ccco3)c4ccccc4n2)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 K06 compound treatment 0.0 0.0 0.0 21.0776 7.9674 1.8878 1.3348 0.7071 3652771 Neuro1_000226 Oc1ccc(/C=N/Nc2nc(nc3ccccc23)c4ccc(Br)cc4)c(O)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 K07 compound treatment 0.0 0.0 0.0 12.772 -0.33815 -0.0801 -0.0567 -0.7071 1447318 Neuro1_000227 COc1cccc(Nc2nc(nc3ccccc23)c4ccc(Cl)cc4)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 K08 compound treatment 0.0 0.0 0.0 21.3463 8.2361 1.9514 1.3799 0.7071 3652773 Neuro1_000228 C1CCC(C1)Nc2nc(Nc3ccc4OCOc4c3)nc5ccccc25 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 K09 compound treatment 0.0 0.0 0.0 11.1536 -1.9565 -0.4636 -0.3278 -0.7071 1143902 Neuro1_000229 Clc1cccc(Nc2nc(NCc3ccco3)c4ccccc4n2)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 K10 compound treatment 0.0 0.0 0.0 12.048 -1.0622 -0.2517 -0.178 -0.7071 3652774 Neuro1_000230 CN(C)c1ccc(Nc2nc(NCC3CCCO3)c4ccccc4n2)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 K11 compound treatment 0.0 0.0 0.0 23.8952 10.785 2.5554 1.8069 0.7071 1465833 Neuro1_000231 C(Nc1nc(Nc2ccccc2)nc3ccccc13)c4ccccc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 K12 compound treatment 0.0 0.0 0.0 11.969 -1.1412 -0.2704 -0.1912 -0.7071 3652775 Neuro1_000232 Nc1nc(Nc2ccc(Cl)c(Cl)c2)nc3ccccc13 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 K13 compound treatment 327.6175 327.62 87.9082 8.8409 -4.2693 -1.0115 61.4452 0.6989 1154723 Neuro1_000233 Cc1ccc(Nc2ncnc3ccc(Br)cc23)c(C)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 K14 compound treatment 0.0 0.0 0.0 10.6279 -2.4822 -0.5881 -0.4159 -0.7071 3652776 Neuro1_000234 CN(C)c1ccc(Nc2nc(NCCO)c3ccccc3n2)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 K15 compound treatment 0.0 0.0 0.0 48.7935 35.683 8.4546 5.9783 0.7071 1458204 Neuro1_000235 Oc1ccccc1c2nc(Nc3ccc(F)cc3)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 K16 compound treatment 0.0 0.0 0.0 12.6361 -0.47406 -0.1123 -0.0794 -0.7071 3652777 Neuro1_000236 COc1ccc(Cl)cc1Nc2nc(N3CCOCC3)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 K17 compound treatment 0.0 0.0 0.0 10.2188 -2.8914 -0.6851 -0.4844 -0.7071 1601387 Neuro1_000237 Oc1ccccc1c2nc(Nc3ccccc3Cl)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 K18 compound treatment 1770.7625 1770.8 475.1411 12.8675 -0.24269 -0.0575 335.9349 0.707 1495821 Neuro1_000238 COc1ccc(cc1)c2nc(N3CCCC3)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 K19 compound treatment 0.0 0.0 0.0 42.5339 29.424 6.9715 4.9296 0.7071 1322048 Neuro1_000239 COC(=O)c1cccc(Nc2nc(nc3ccccc23)c4ccccc4O)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 K20 compound treatment 0.0 0.0 0.0 12.8978 -0.21236 -0.0503 -0.0356 -0.7071 1153244 Neuro1_000240 COc1ccc(cc1)c2nc(NCC=C)c3ccccc3n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 K21 compound treatment 0.0 0.0 0.0 36.6501 23.54 5.5774 3.9439 0.7071 1320708 Neuro1_000241 Brc1ccc2ncnc(Nc3ccc(cc3)N4CCCC4)c2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 K22 compound treatment 0.0 0.0 0.0 12.1241 -0.98609 -0.2336 -0.1652 -0.7071 3652778 Neuro1_000242 COc1ccccc1Nc2nc(NCC3CCCO3)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 K23 mock treatment 0.0 0.0 0.0 9.0847 -4.0254 -0.9538 -0.6744 -0.7071 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 K24 mock treatment 0.0 0.0 0.0 14.6283 1.5181 0.3597 0.2543 0.7071 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 L01 compound treatment 0.0 0.0 0.0 13.9324 0.82226 0.1948 0.1378 0.7071 3652779 Neuro1_000243 CN1CCN(CC1)c2nc(Nc3ccc(O)cc3)nc4ccccc24 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 L02 compound treatment 0.0 0.0 0.0 16.2605 3.1504 0.7464 0.5278 0.7071 3652780 Neuro1_000244 Oc1cccc(Nc2nc(NCc3ccccc3)c4ccccc4n2)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 L03 compound treatment 0.0 0.0 0.0 10.822 -2.2882 -0.5422 -0.3834 -0.7071 3652781 Neuro1_000245 CN(Cc1ccccc1)c2nc(nc3ccccc23)c4cccc(c4)[N+](=O)[O-] 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 L04 compound treatment 0.0 0.0 0.0 12.2171 -0.89304 -0.2116 -0.1496 -0.7071 3652782 Neuro1_000246 COc1ccc(Nc2nc(nc3ccccc23)N4CCN(CCO)CC4)c(OC)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 L05 compound treatment 0.0 0.0 0.0 12.1059 -1.0042 -0.2379 -0.1682 -0.7071 3652783 Neuro1_000247 Fc1cccc(Nc2nc(NCC3CCCO3)c4ccccc4n2)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 L06 compound treatment 772.25 772.25 207.2145 12.1424 -0.96781 -0.2293 146.3607 0.7063 3652784 Neuro1_000248 CC(=O)c1cccc(Nc2ncnc3ccc(I)cc23)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 L07 compound treatment 0.0 0.0 0.0 14.2575 1.1474 0.2719 0.1922 0.7071 3652785 Neuro1_000249 COc1ccc(cc1)N2CCN(CC2)c3nc(nc4c(C)cc(C)cc34)C(F)(F)F 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 L08 compound treatment 0.0 0.0 0.0 12.4011 -0.70911 -0.168 -0.1188 -0.7071 3652786 Neuro1_000250 CCN1CCN(CC1)c2nc(NCc3ccccc3)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 L09 compound treatment 0.0 0.0 0.0 27.4012 14.291 3.3861 2.3943 0.7071 3652787 Neuro1_000251 CN1CCN(CC1)c2nc(NCCNc3ccc(cc3)[N+](=O)[O-])c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 L10 compound treatment 331.3125 331.31 88.8997 13.531 0.42084 0.0997 62.9321 0.7079 3652788 Neuro1_000252 Cc1ccc2ncnc(Nc3cccc(c3)C(=O)O)c2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 L11 compound treatment 0.0 0.0 0.0 12.1109 -0.99922 -0.2368 -0.1674 -0.7071 3652789 Neuro1_000253 COCCNc1nc(nc2ccccc12)c3cccc(Cl)c3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 L12 compound treatment 0.0 0.0 0.0 11.2166 -1.8936 -0.4487 -0.3172 -0.7071 1418789 Neuro1_000254 CC1CCN(CC1)c2ccc(Nc3ncnc4ccccc34)cc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 L13 compound treatment 0.0 0.0 0.0 12.1676 -0.94254 -0.2233 -0.1579 -0.7071 1599005 Neuro1_000255 COc1ccccc1Nc2ncnc3ccc(I)cc23 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 L14 compound treatment 0.0 0.0 0.0 12.5152 -0.59493 -0.141 -0.0997 -0.7071 1165430 Neuro1_000256 CC(=O)Nc1ccc(Nc2nc(nc3ccccc23)c4ccccc4)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 L15 compound treatment 0.0 0.0 0.0 9.8604 -3.2497 -0.77 -0.5445 -0.7071 1624986 Neuro1_000257 Oc1cccc(Nc2ncnc3ccc(I)cc23)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 L16 compound treatment 0.0 0.0 0.0 12.5398 -0.57041 -0.1352 -0.0956 -0.7071 1706455 Neuro1_000258 O=C(CCc1ccccc1)Oc2ccc(Nc3ncnc4ccccc34)cc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 L17 compound treatment 0.0 0.0 0.0 13.5013 0.39116 0.0927 0.0655 0.7071 3652790 Neuro1_000259 CCOC(=O)c1nc(Nc2cc(ccc2O)[N+](=O)[O-])c3ccccc3n1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 L18 compound treatment 0.0 0.0 0.0 12.559 -0.55119 -0.1306 -0.0923 -0.7071 3211569 Neuro1_000260 CC(Nc1nc(nc2ccccc12)N3CCOCC3)c4ccccc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 L19 compound treatment 0.0 0.0 0.0 10.3942 -2.7159 -0.6435 -0.455 -0.7071 1534926 Neuro1_000261 CC(C)C(Nc1ncnc2ccc(Br)cc12)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 L20 compound treatment 0.0 0.0 0.0 10.6536 -2.4566 -0.5821 -0.4116 -0.7071 3652791 Neuro1_000262 C(Nc1nc(nc2ccccc12)N3CCOCC3)C4CCCO4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 L21 compound treatment 8.1141 8.1141 2.1772 12.7053 -0.40485 -0.0959 1.4717 0.6753 1624571 Neuro1_000263 O=C(Oc1ccc(Nc2ncnc3ccccc23)cc1)c4cccs4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 L22 compound treatment 0.0 0.0 0.0 10.3531 -2.757 -0.6532 -0.4619 -0.7071 1447467 Neuro1_000264 COc1ccc(CCNc2ncnc3ccccc23)cc1OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 L23 mock treatment 0.0 0.0 0.0 11.7029 -1.4072 -0.3334 -0.2358 -0.7071 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 L24 mock treatment 0.0 0.0 0.0 14.0726 0.96246 0.228 0.1612 0.7071 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 M01 compound treatment 3.0557 3.0557 0.8199 11.1299 -1.9803 -0.4692 0.248 0.2625 3652792 Neuro1_000265 Oc1ccc(Nc2nc(NCc3ccco3)c4ccccc4n2)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 M02 compound treatment 0.0 0.0 0.0 13.0702 -0.039962 -0.0095 -0.0067 -0.7071 3652793 Neuro1_000266 CCN(CC)c1nc(nc2ccccc12)N3CCN(C)CC3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 M03 compound treatment 0.0 0.0 0.0 10.464 -2.6462 -0.627 -0.4433 -0.7071 1304107 Neuro1_000267 CCOC(=O)c1cccc(Nc2nc(nc3ccccc23)c4cccnc4)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 M04 compound treatment 0.0 0.0 0.0 14.0975 0.98731 0.2339 0.1654 0.7071 3652794 Neuro1_000268 Cc1ccc(cc1)c2nc(N/N=C/c3c(O)ccc4ccccc34)c5ccccc5n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 M05 compound treatment 0.0 0.0 0.0 12.6363 -0.47383 -0.1123 -0.0794 -0.7071 1282699 Neuro1_000269 CC(Nc1nc(nc2ccccc12)c3cccnc3)c4ccccc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 M06 compound treatment 0.0 0.0 0.0 11.9573 -1.1528 -0.2731 -0.1931 -0.7071 3652796 Neuro1_000270 COc1cc2ncnc(Nc3c(C)n(C)n(c4ccccc4)c3=O)c2cc1OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 M07 compound treatment 0.0 0.0 0.0 10.2009 -2.9093 -0.6893 -0.4874 -0.7071 1294207 Neuro1_000271 Clc1cccc(Nc2nc(N3CCOCC3)c4ccccc4n2)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 M08 compound treatment 1859.0175 1859.0 498.8222 11.6493 -1.4609 -0.3461 352.4758 0.7066 3652797 Neuro1_000272 Cc1ccc(Nc2nc(NCCO)c3ccccc3n2)cc1C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 M09 compound treatment 0.0 0.0 0.0 9.9488 -3.1613 -0.749 -0.5296 -0.7071 1726085 Neuro1_000273 OCCN1CCN(CC1)c2nc(N3CCOCC3)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 M10 compound treatment 0.0 0.0 0.0 11.1577 -1.9525 -0.4626 -0.3271 -0.7071 3652798 Neuro1_000274 COc1ccc(OC)c(Nc2nc(N3CCCCC3)c4ccccc4n2)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 M11 compound treatment 0.0 0.0 0.0 11.9129 -1.1972 -0.2837 -0.2006 -0.7071 1627384 Neuro1_000275 C(CN1CCOCC1)Nc2nc(nc3ccccc23)c4cccnc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 M12 compound treatment 0.0 0.0 0.0 13.2113 0.10109 0.024 0.0169 0.7071 3652799 Neuro1_000276 COc1ccc(OC)c(Nc2nc(NCCO)c3ccccc3n2)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 M13 compound treatment 17.8925 17.892 4.801 14.7969 1.6867 0.3996 3.6774 0.7633 1298176 Neuro1_000277 CCCOc1ccccc1Nc2ncnc3ccc(Br)cc23 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 M14 compound treatment 0.0 0.0 0.0 11.2264 -1.8838 -0.4463 -0.3156 -0.7071 3652800 Neuro1_000278 CCN1CCN(CC1)c2nc(NCCO)c3ccccc3n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 M15 compound treatment 0.0 0.0 0.0 9.943 -3.1672 -0.7504 -0.5306 -0.7071 1359384 Neuro1_000279 CC(Nc1ncnc2ccc(Br)cc12)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 M16 compound treatment 0.0 0.0 0.0 12.0224 -1.0877 -0.2577 -0.1822 -0.7071 3652801 Neuro1_000280 Cc1ccccc1Nc2nc(nc3ccccc23)c4cccc(c4)[N+](=O)[O-] 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 M17 compound treatment 0.0 0.0 0.0 16.118 3.0079 0.7127 0.5039 0.7071 3652802 Neuro1_000281 Oc1ccccc1Nc2nc(nc3ccccc23)c4ccccc4O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 M18 compound treatment 0.0 0.0 0.0 9.7582 -3.3519 -0.7942 -0.5616 -0.7071 3652803 Neuro1_000282 Clc1ccc2nc(nc(N3CCCCC3)c2c1)c4ccccc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 M19 compound treatment 64.072 64.072 17.1922 12.4821 -0.62804 -0.1488 12.0515 0.701 1533661 Neuro1_000283 CCCOc1ccc(cc1)c2nc(N3CCOCC3)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 M20 compound treatment 0.0 0.0 0.0 13.0007 -0.10944 -0.0259 -0.0183 -0.7071 3652804 Neuro1_000284 [O-][N+](=O)c1cccc(c1)c2nc(N3CCN(CC3)c4ccccc4)c5ccccc5n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 M21 compound treatment 256.5766 256.58 68.8461 10.2104 -2.8998 -0.6871 48.1957 0.7 1672231 Neuro1_000285 CCOc1ccccc1Nc2ncnc3ccc(Br)cc23 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 M22 compound treatment 0.0 0.0 0.0 12.1329 -0.97721 -0.2315 -0.1637 -0.7071 3652805 Neuro1_000286 [O-][N+](=O)c1cccc(c1)c2nc(N3CCCC3)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 M23 mock treatment 0.0 0.0 0.0 12.5884 -0.52181 -0.1236 -0.0874 -0.7071 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 M24 mock treatment 0.0 0.0 0.0 11.4858 -1.6244 -0.3849 -0.2721 -0.7071 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 N01 compound treatment 0.0 0.0 0.0 12.5671 -0.54309 -0.1287 -0.091 -0.7071 3652806 Neuro1_000287 [O-][N+](=O)c1cccc(c1)c2nc(Nc3ccc(F)c(F)c3)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 N02 compound treatment 0.0 0.0 0.0 15.6573 2.5472 0.6035 0.4267 0.7071 3652807 Neuro1_000288 CCN(CC)CCCNc1nc(nc2ccccc12)c3ccc(OC)cc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 N03 compound treatment 0.0 0.0 0.0 13.3078 0.19761 0.0468 0.0331 0.7071 3652808 Neuro1_000289 OCCNc1nc(nc2ccccc12)N3CCN(Cc4ccccc4)CC3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 N04 compound treatment 8.4149 8.4149 2.2579 12.8507 -0.2595 -0.0615 1.5531 0.6876 3652809 Neuro1_000290 CC(=O)Nc1ccc(cc1)S(=O)(=O)N2CCN(CC2)c3nc(NC4CCCC4)c5ccccc5n3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 N05 compound treatment 0.0 0.0 0.0 13.0404 -0.069812 -0.0165 -0.0117 -0.7071 3652810 Neuro1_000291 Cc1cc(C)c2nc(nc(NCc3ccc4OCOc4c3)c2c1)C(F)(F)F 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 N06 compound treatment 0.0 0.0 0.0 10.3244 -2.7857 -0.66 -0.4667 -0.7071 3652811 Neuro1_000292 OCCOCCNc1ncnc2ccc(I)cc12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 N07 compound treatment 0.0 0.0 0.0 11.2186 -1.8915 -0.4482 -0.3169 -0.7071 3652812 Neuro1_000293 Cc1cc(C)c2nc(nc(NCCCN3CCOCC3)c2c1)C(F)(F)F 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 N08 compound treatment 0.0 0.0 0.0 20.2365 7.1263 1.6885 1.1939 0.7071 1144684 Neuro1_000294 Cc1ccc(O)c(Nc2nc(nc3ccccc23)c4ccc(Cl)cc4)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 N09 compound treatment 0.0 0.0 0.0 12.0901 -1.0201 -0.2417 -0.1709 -0.7071 3652813 Neuro1_000295 C1CN(CCO1)c2ccc(Nc3nc(nc4ccccc34)N5CCOCC5)cc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 N10 compound treatment 0.0 0.0 0.0 10.3991 -2.7111 -0.6423 -0.4542 -0.7071 3652814 Neuro1_000296 OC(=O)C1CCCN1c2nc(nc3ccccc23)C(F)(F)F 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 N11 compound treatment 0.0 0.0 0.0 15.7026 2.5924 0.6142 0.4343 0.7071 3652815 Neuro1_000297 CCN(CC)CCNc1nc(nc2ccccc12)c3cccc(Cl)c3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 N12 compound treatment 0.0 0.0 0.0 9.6322 -3.478 -0.8241 -0.5827 -0.7071 1650814 Neuro1_000298 N(c1ccc(Oc2ccccc2)cc1)c3ncnc4ccccc34 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 N13 compound treatment 0.0 0.0 0.0 12.8816 -0.22853 -0.0541 -0.0383 -0.7071 3652816 Neuro1_000299 CC(=O)c1ccc(Nc2ncnc3ccc(I)cc23)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 N14 compound treatment 0.0 0.0 0.0 13.2827 0.17252 0.0409 0.0289 0.7071 3652817 Neuro1_000300 COc1ccc(Nc2nc(nc3ccccc23)N4CCCCC4)c(OC)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 N15 compound treatment 0.0 0.0 0.0 12.7652 -0.34499 -0.0817 -0.0578 -0.7071 3652818 Neuro1_000301 CC(Nc1nc(nc2ccccc12)N3CCN(CC3)C(=O)c4ccc(Cl)cc4)c5ccccc5 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 N16 compound treatment 52.5278 52.528 14.0946 11.6725 -1.4377 -0.3406 9.7255 0.6898 1426920 Neuro1_000302 CN(C1CCN(C)CC1)c2nc(nc3ccccc23)c4ccccc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 N17 compound treatment 9.8599 9.8599 2.6457 11.6616 -1.4485 -0.3432 1.6281 0.6103 1368755 Neuro1_000303 CCOC(=O)c1nc(Nc2ccc(F)cc2)c3ccccc3n1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 N18 compound treatment 0.0 0.0 0.0 11.9341 -1.176 -0.2786 -0.197 -0.7071 3652819 Neuro1_000304 [O-][N+](=O)c1cc(ccc1NCCCNc2nc(nc3ccccc23)N4CCOCC4)C(F)(F)F 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 N19 compound treatment 0.0 0.0 0.0 12.6493 -0.46088 -0.1092 -0.0772 -0.7071 1549121 Neuro1_000305 COc1ccc(Cl)cc1Nc2ncnc3ccccc23 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 N20 compound treatment 0.0 0.0 0.0 15.5625 2.4524 0.5811 0.4109 0.7071 3652820 Neuro1_000306 Cc1cc(C)c2nc(nc(N3CCN(Cc4ccccc4)CC3)c2c1)C(F)(F)F 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 N21 compound treatment 0.0 0.0 0.0 9.9279 -3.1822 -0.754 -0.5331 -0.7071 1173401 Neuro1_000307 O=C(Oc1ccc(Nc2ncnc3ccccc23)cc1)C4CCCCC4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 N22 compound treatment 0.0 0.0 0.0 15.2565 2.1464 0.5085 0.3596 0.7071 1191667 Neuro1_000308 Fc1ccccc1c2nc(N3CCOCC3)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 N23 mock treatment 0.0 0.0 0.0 13.0537 -0.056415 -0.0134 -0.0095 -0.7071 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 N24 mock treatment 0.0 0.0 0.0 13.126 0.015858 0.0038 0.0027 0.7071 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 O01 compound treatment 0.0 0.0 0.0 10.7756 -2.3346 -0.5531 -0.3911 -0.7071 1510828 Neuro1_000309 Fc1ccccc1c2nc(NCC3CCCO3)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 O02 compound treatment 0.0 0.0 0.0 14.2045 1.0944 0.2593 0.1834 0.7071 3652821 Neuro1_000310 CC(Nc1nc(nc2ccccc12)N3CCN(C)CC3)c4ccccc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 O03 compound treatment 0.0 0.0 0.0 11.3795 -1.7307 -0.4101 -0.29 -0.7071 1168079 Neuro1_000311 C1CN(CCO1)c2nc(nc3ccccc23)N4CCN(CC4)c5ccccc5 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 O04 compound treatment 0.0 0.0 0.0 10.588 -2.5221 -0.5976 -0.4226 -0.7071 3652822 Neuro1_000312 COc1cccc(/C=N/Nc2nc(nc3ccccc23)c4cccnc4)c1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 O05 compound treatment 70.58 70.58 18.9384 13.2518 0.1416 0.0336 13.4152 0.7084 1975084 Neuro1_000313 CC(C)(C)c1ccc(cc1)c2nc(NCCCN3CCOCC3)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 O06 compound treatment 0.0 0.0 0.0 10.4287 -2.6814 -0.6353 -0.4492 -0.7071 3652824 Neuro1_000314 COc1ccc(CNc2nc(nc3c(OC)cccc23)C(Cl)(Cl)Cl)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 O07 compound treatment 0.0 0.0 0.0 11.8891 -1.2211 -0.2893 -0.2046 -0.7071 1535722 Neuro1_000315 CN(C)c1ccc(Nc2nc(nc3ccccc23)c4cccnc4)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 O08 compound treatment 0.0 0.0 0.0 11.6455 -1.4647 -0.347 -0.2454 -0.7071 3652825 Neuro1_000316 CCN1CCN(CC1)c2nc(NCC3CCCO3)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 O09 compound treatment 0.0 0.0 0.0 14.4497 1.3395 0.3174 0.2244 0.7071 1201288 Neuro1_000317 Cc1c(Cl)cccc1Nc2nc(nc3ccccc23)c4ccc(Cl)cc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 O10 compound treatment 0.0 0.0 0.0 12.7496 -0.36056 -0.0854 -0.0604 -0.7071 3652826 Neuro1_000318 Cc1ccc(Nc2nc(N)c3ccccc3n2)cc1Cl 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 O11 compound treatment 0.0 0.0 0.0 11.477 -1.6331 -0.3869 -0.2736 -0.7071 1556983 Neuro1_000319 OCCN1CCN(CC1)c2nc(NCc3ccco3)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 O12 compound treatment 0.0 0.0 0.0 12.4735 -0.63669 -0.1509 -0.1067 -0.7071 3652827 Neuro1_000320 C1CCC(CC1)Nc2nc(nc3ccccc23)N4CCOCC4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 O13 compound treatment 0.0 0.0 0.0 10.9769 -2.1333 -0.5054 -0.3574 -0.7071 1641717 Neuro1_000321 COc1ccc(OC)c(Nc2ncnc3ccc(Br)cc23)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 O14 compound treatment 0.0 0.0 0.0 19.5446 6.4344 1.5245 1.078 0.7071 3652828 Neuro1_000322 CN(C)c1ccc(Nc2nc(NCc3ccco3)c4ccccc4n2)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 O15 compound treatment 12.0078 12.008 3.222 13.2727 0.16254 0.0385 2.3055 0.7155 3652829 Neuro1_000323 CCCOc1ccc(cc1)c2nc(N3CCN(Cc4ccccc4)CC3)c5ccccc5n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 O16 compound treatment 6.5892 6.5892 1.7681 11.869 -1.2411 -0.2941 1.0423 0.5815 3652830 Neuro1_000324 Cc1ccc(OCCN2CCN(CC2)c3nc(NCc4ccco4)c5ccccc5n3)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 O17 compound treatment 0.0 0.0 0.0 15.5223 2.4122 0.5715 0.4041 0.7071 1330225 Neuro1_000325 CCCN(CCC)c1ncnc2ccc(Br)cc12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 O18 compound treatment 0.0 0.0 0.0 13.584 0.47381 0.1123 0.0794 0.7071 3652831 Neuro1_000326 COc1ccc(OC)c(Nc2nc(nc3ccccc23)c4cccc(c4)[N+](=O)[O-])c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 O19 compound treatment 0.0 0.0 0.0 15.9738 2.8636 0.6785 0.4798 0.7071 1494026 Neuro1_000327 CC1CCCCN1c2nc(nc3ccccc23)c4ccccc4O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 O20 compound treatment 0.0 0.0 0.0 11.3643 -1.7458 -0.4136 -0.2925 -0.7071 1736348 Neuro1_000328 COc1ccc(OC)c(Nc2nc(nc3ccccc23)c4ccccc4F)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 O21 compound treatment 0.0 0.0 0.0 12.8084 -0.30181 -0.0715 -0.0506 -0.7071 1492306 Neuro1_000329 COc1ccc(Cl)cc1Nc2ncnc3ccc(Br)cc23 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 O22 compound treatment 0.0 0.0 0.0 10.5995 -2.5107 -0.5949 -0.4206 -0.7071 3652832 Neuro1_000330 Fc1ccc(Nc2nc(nc3ccccc23)c4ccccc4)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 O23 mock treatment 0.0 0.0 0.0 10.755 -2.3551 -0.558 -0.3946 -0.7071 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 O24 mock treatment 0.0 0.0 0.0 10.7231 -2.387 -0.5656 -0.3999 -0.7071 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 P01 compound treatment 0.0 0.0 0.0 12.137 -0.97314 -0.2306 -0.163 -0.7071 3652833 Neuro1_000331 [O-][N+](=O)c1cccc(c1)c2nc(N3CCOCC3)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 P02 compound treatment 0.0 0.0 0.0 15.9171 2.8069 0.6651 0.4703 0.7071 3652834 Neuro1_000332 Oc1ccccc1Nc2nc(nc3ccccc23)c4ccccc4F 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 P03 compound treatment 0.0 0.0 0.0 12.2997 -0.81049 -0.192 -0.1358 -0.7071 3652835 Neuro1_000333 Cc1cc(C)c2nc(nc(NCCCN3CCCC3=O)c2c1)C(F)(F)F 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 P04 compound treatment 0.0 0.0 0.0 12.2411 -0.86911 -0.2059 -0.1456 -0.7071 3652836 Neuro1_000334 COc1ccc(Nc2nc(nc3ccccc23)N4CCN(CC4)S(=O)(=O)C)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 P05 compound treatment 0.0 0.0 0.0 10.322 -2.7882 -0.6606 -0.4671 -0.7071 3652837 Neuro1_000335 OCCNc1nc(Nc2ccc(Br)cc2)nc3ccccc13 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 P06 compound treatment 0.0 0.0 0.0 12.0189 -1.0913 -0.2586 -0.1828 -0.7071 1442987 Neuro1_000336 CC(O)CNc1ncnc2ccc(I)cc12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 P07 compound treatment 0.0 0.0 0.0 14.6336 1.5235 0.361 0.2552 0.7071 3652838 Neuro1_000337 Cc1cc(C)c2nc(nc(N3CCN(CC3)C(=O)c4ccco4)c2c1)C(F)(F)F 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 P08 compound treatment 0.0 0.0 0.0 12.2901 -0.82008 -0.1943 -0.1374 -0.7071 1685272 Neuro1_000338 Oc1ccc(Cl)cc1Nc2nc(nc3ccccc23)c4ccc(Cl)cc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 P09 compound treatment 0.0 0.0 0.0 19.0823 5.9721 1.415 1.0006 0.7071 3652839 Neuro1_000339 [O-][N+](=O)c1ccc(NCCNc2nc(nc3ccccc23)N4CCCC4)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 P10 compound treatment 0.0 0.0 0.0 13.1095 -6.6211E-4 -2.0E-4 -1.0E-4 -0.7071 3652840 Neuro1_000340 OC(=O)C1CCN(CC1)c2nc(nc3ccccc23)C(F)(F)F 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 P11 compound treatment 0.0 0.0 0.0 11.88 -1.2302 -0.2915 -0.2061 -0.7071 3652841 Neuro1_000341 CN(C)CCCNc1nc(nc2ccccc12)c3cccc(Cl)c3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 P12 compound treatment 0.0 0.0 0.0 11.658 -1.4522 -0.3441 -0.2433 -0.7071 3652842 Neuro1_000342 CCCCOc1ccccc1Nc2ncnc3ccccc23 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 P13 compound treatment 0.0 0.0 0.0 12.155 -0.95513 -0.2263 -0.16 -0.7071 1617765 Neuro1_000343 Ic1ccc2ncnc(NCc3ccco3)c2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 P14 compound treatment 0.0 0.0 0.0 9.5768 -3.5334 -0.8372 -0.592 -0.7071 1544623 Neuro1_000344 O=C(Oc1ccc(Nc2ncnc3ccccc23)cc1)c4cccnc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 P15 compound treatment 0.0 0.0 0.0 10.5613 -2.5489 -0.6039 -0.427 -0.7071 1134738 Neuro1_000345 Ic1ccc2ncnc(NCCc3ccccc3)c2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 P16 compound treatment 412.9875 412.99 110.8152 12.1929 -0.91726 -0.2173 78.2045 0.7057 1366684 Neuro1_000346 C1CN(CCN1c2ncnc3ccccc23)c4ncnc5ccccc45 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 P17 compound treatment 0.0 0.0 0.0 11.2269 -1.8833 -0.4462 -0.3155 -0.7071 3652843 Neuro1_000347 CCOC(=O)c1cccc(Nc2nc(nc3ccccc23)C(=O)OCC)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 P18 compound treatment 0.0 0.0 0.0 12.0492 -1.061 -0.2514 -0.1778 -0.7071 3652844 Neuro1_000348 Cc1ccc(C)c(Nc2nc(NCCO)c3ccccc3n2)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 P19 compound treatment 0.0 0.0 0.0 10.9276 -2.1826 -0.5171 -0.3657 -0.7071 1361396 Neuro1_000349 C(N1CCN(CC1)c2nc(nc3ccccc23)c4ccccc4)c5ccccc5 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 P20 compound treatment 0.0 0.0 0.0 11.8756 -1.2345 -0.2925 -0.2068 -0.7071 3652845 Neuro1_000350 COc1ccc(Nc2nc(NCC3CCCO3)c4ccccc4n2)c(OC)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 P21 compound treatment 0.0 0.0 0.0 11.8726 -1.2376 -0.2932 -0.2073 -0.7071 1450719 Neuro1_000351 CCCCC(Nc1ncnc2ccc(Br)cc12)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 P22 compound treatment 0.0 0.0 0.0 13.277 0.16686 0.0395 0.028 0.7071 3652846 Neuro1_000352 CN(C)CCCNc1ncnc2ccc(Br)cc12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 P23 mock treatment 0.0 0.0 0.0 11.7394 -1.3708 -0.3248 -0.2297 -0.7071 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2435 P24 mock treatment 0.0 0.0 0.0 15.3393 2.2291 0.5282 0.3735 0.7071 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 A01 compound treatment 17.0532 3.5756 0.9594 14.7154 2.1457 0.5084 1.0379 0.9559 3652847 Neuro1_000353 COc1ccc(cc1OC)/C(=N/Nc2nc(nc3ccccc23)c4cccnc4)/C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 A02 compound treatment 16.2594 2.7817 0.7464 15.0794 2.5097 0.5946 0.9483 0.9937 1407528 Neuro1_000354 Oc1ccccc1c2nc(N3CCN(CC3)c4ccccc4)c5ccccc5n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 A03 compound treatment 66.7251 53.247 14.2877 12.5995 0.029895 0.0071 10.1079 0.7075 3652849 Neuro1_000355 Brc1ccc(cc1)c2nc(N/N=C/c3cccnc3)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 A04 compound treatment 14.1998 0.72208 0.1938 15.885 3.3153 0.7855 0.6925 0.8559 3652851 Neuro1_000356 C/C(=N\Nc1nc(nc2ccccc12)c3ccc(C)cc3)/c4ccc(Br)cc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 A05 compound treatment 15.1485 1.6708 0.4483 12.2156 -0.35404 -0.0839 0.2577 0.565 3652853 Neuro1_000357 Cc1cc(C)n(n1)c2nc(nc3ccccc23)c4ccc(Br)cc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 A06 compound treatment 21.0356 7.5579 2.028 23.3558 10.786 2.5556 3.2411 0.9934 3652854 Neuro1_000358 Cc1ccc(cc1)c2nc(N/N=C/c3ccccc3[N+](=O)[O-])c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 A07 compound treatment 16.932 3.4543 0.9269 12.8369 0.26728 0.0633 0.7002 0.7537 1558498 Neuro1_000359 COC(=O)c1ccc(Nc2nc(nc3ccccc23)c4ccc(Br)cc4)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 A08 compound treatment 17.1501 3.6724 0.9854 26.9218 14.352 3.4005 3.1013 0.876 3652856 Neuro1_000360 C/C(=N\Nc1nc(nc2ccccc12)c3ccc(C)cc3)/c4ccc(I)cc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 A09 compound treatment 27.7692 14.291 3.8348 14.985 2.4154 0.5723 3.1163 0.8037 1168208 Neuro1_000361 CC(C)Nc1nc(nc2ccccc12)c3ccc(Br)cc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 A10 compound treatment 12.1885 -1.2892 -0.3459 12.4011 -0.16849 -0.0399 -0.2728 -0.7835 1935975 Neuro1_000362 C/C(=N\Nc1nc(nc2ccccc12)c3ccc(C)cc3)/c4ccccc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 A11 compound treatment 15.5345 2.0569 0.5519 15.2178 2.6482 0.6274 0.8339 0.998 1506528 Neuro1_000363 Clc1ccc(cc1Cl)c2nc(N3CCOCC3)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 A12 compound treatment 12.902 -0.57572 -0.1545 13.3075 0.73783 0.1748 0.0144 0.0616 1321517 Neuro1_000364 Clc1cccc(Nc2ncnc3ccc(Br)cc23)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 A13 compound treatment 18.2547 4.777 1.2818 13.2282 0.65858 0.156 1.0167 0.7874 1653294 Neuro1_000365 Clc1ccccc1c2nc(N3CCOCC3)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 A14 compound treatment 13.7978 0.32011 0.0859 11.7498 -0.81981 -0.1942 -0.0766 -0.3607 1226926 Neuro1_000366 OC(=O)CCNc1ncnc2ccc(Br)cc12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 A15 compound treatment 14.0457 0.56803 0.1524 18.1397 5.5701 1.3197 1.041 0.7836 1318548 Neuro1_000367 COc1ccc(Nc2nc(nc3ccccc23)c4ccccc4O)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 A16 compound treatment 14.6662 1.1885 0.3189 13.1224 0.55276 0.131 0.3181 0.9227 1974909 Neuro1_000368 COCCN(CCOC)c1nc(nc2ccccc12)c3ccc(Cl)cc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 A17 compound treatment 14.5924 1.1147 0.2991 14.2394 1.6697 0.3956 0.4912 0.9905 1706867 Neuro1_000369 CC1CCN(CC1)c2nc(nc3ccccc23)c4ccccc4O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 A18 compound treatment 17.6655 4.1878 1.1237 13.1214 0.55181 0.1307 0.887 0.7841 3652858 Neuro1_000370 Fc1ccc(Nc2nc(/C=C/c3ccccc3)nc4ccccc24)cc1F 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 A19 compound treatment 14.756 1.2783 0.343 13.7202 1.1506 0.2726 0.4353 0.9935 3652860 Neuro1_000371 OC(=O)CCCCCNc1ncnc2ccc(Br)cc12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 A20 compound treatment 17.4649 3.9872 1.0699 13.0688 0.49911 0.1183 0.8401 0.7805 3652861 Neuro1_000372 C1CCC(CC1)Nc2nc(/C=C/c3ccccc3)nc4ccccc24 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 A21 compound treatment 32.7225 19.245 5.1639 19.3276 6.758 1.6012 4.7836 0.8848 1917968 Neuro1_000373 CCN(CC)CCCC(C)Nc1nc(/C=C/c2ccc(Br)cc2)nc3cc(Cl)ccc13 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 A22 compound treatment 15.906 2.4283 0.6516 14.9592 2.3896 0.5662 0.8611 0.9976 1415981 Neuro1_000374 CCN1CCN(CC1)c2nc(nc3ccccc23)c4ccccc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 A23 mock treatment 17.641 4.1633 1.1171 14.884 2.3144 0.5484 1.1777 0.9463 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 A24 mock treatment 13.024 -0.45371 -0.1217 15.1624 2.5927 0.6143 0.3483 0.5562 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 B01 compound treatment 12.3216 -1.1561 -0.3102 14.465 1.8954 0.4491 0.0982 0.1799 1974596 Neuro1_000375 [O-][N+](=O)c1ccc(cc1)c2nc(NCCCN3CCOCC3)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 B02 compound treatment 110.9179 97.44 26.1457 13.5027 0.93303 0.2211 18.6441 0.7131 1532266 Neuro1_000376 Oc1ccc(Nc2nc(nc3ccccc23)c4ccccc4Cl)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 B03 compound treatment 16.2816 2.8039 0.7524 13.5168 0.94711 0.2244 0.6907 0.8797 1864017 Neuro1_000377 [O-][N+](=O)c1ccc(cc1)c2nc(Nc3ccccc3)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 B04 compound treatment 13.4335 -0.044215 -0.0119 15.2205 2.6509 0.6281 0.4357 0.6936 1337812 Neuro1_000378 OC(=O)c1ccc(Nc2nc(nc3ccccc23)c4ccc(Cl)cc4)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 B05 compound treatment 12.2395 -1.2382 -0.3322 13.3713 0.80168 0.1899 -0.1006 -0.2629 1974637 Neuro1_000379 COCCN(CCOC)c1nc(nc2ccccc12)c3ccc(cc3)[N+](=O)[O-] 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 B06 compound treatment 23.1454 9.6677 2.5941 13.0324 0.46273 0.1096 1.9118 0.7363 1606595 Neuro1_000380 Cc1ccc(C)c(Nc2nc(NCc3ccco3)c4ccccc4n2)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 B07 compound treatment 13.7096 0.23193 0.0622 14.026 1.4563 0.3451 0.288 0.8214 1864021 Neuro1_000381 Cc1ccc(Nc2nc(nc3ccccc23)c4ccc(cc4)[N+](=O)[O-])c(C)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 B08 compound treatment 99.0777 85.6 22.9687 47.7752 35.206 8.3414 22.1396 0.906 1472713 Neuro1_000382 Cc1cccc(c1)c2nc(Nc3ccc(cc3)N4CCOCC4)c5ccccc5n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 B09 compound treatment 13.704 0.22628 0.0607 15.3319 2.7623 0.6545 0.5057 0.7694 1628280 Neuro1_000383 Clc1ccc(Nc2nc(NCc3ccco3)c4ccccc4n2)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 B10 compound treatment 13.5822 0.1045 0.028 10.792 -1.7777 -0.4212 -0.278 -0.6586 1326862 Neuro1_000384 Cc1ccccc1C(=O)Oc2cccc(Nc3ncnc4ccccc34)c2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 B11 compound treatment 14.0963 0.61859 0.166 11.1661 -1.4036 -0.3326 -0.1178 -0.3169 1864058 Neuro1_000385 CCN(CC)c1nc(nc2ccccc12)c3ccc(cc3)[N+](=O)[O-] 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 B12 compound treatment 15.1881 1.7104 0.459 11.7454 -0.82421 -0.1953 0.1864 0.3738 1482064 Neuro1_000386 Cc1ccc(cc1)c2nc(NCCN3CCOCC3)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 B13 compound treatment 22.6398 9.1622 2.4584 63.742 51.172 12.1245 10.3117 0.8335 1418455 Neuro1_000387 Clc1ccc(c(Cl)c1)c2nc(NCc3cccnc3)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 B14 compound treatment 15.0203 1.5426 0.4139 14.1369 1.5673 0.3713 0.5553 0.9985 3652863 Neuro1_000388 [O-][N+](=O)c1ccc(cc1)C(=O)Oc2cccc(Nc3ncnc4ccccc34)c2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 B15 compound treatment 13.7353 0.25758 0.0691 13.0256 0.45597 0.108 0.1253 0.9767 1974602 Neuro1_000389 COCCN(CCOC)c1nc(nc2ccccc12)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 B16 compound treatment 17.378 3.9003 1.0466 12.8861 0.31648 0.075 0.793 0.7558 1348023 Neuro1_000390 Brc1ccc2ncnc(Nc3ccc(cc3)N4CCCCC4)c2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 B17 compound treatment 14.2921 0.81436 0.2185 12.6334 0.06371 0.0151 0.1652 0.7542 1864057 Neuro1_000391 OCCNc1nc(nc2ccccc12)c3ccc(cc3)[N+](=O)[O-] 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 B18 compound treatment 14.2131 0.73538 0.1973 12.5495 -0.020148 -0.0048 0.1362 0.6898 1384325 Neuro1_000392 Oc1ccccc1c2nc(Nc3ccccc3F)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 B19 compound treatment 12.1027 -1.375 -0.3689 15.2557 2.686 0.6364 0.1891 0.2571 1223663 Neuro1_000393 Clc1ccccc1c2nc(Nc3ccc4OCCOc4c3)c5ccccc5n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 B20 compound treatment 13.6787 0.20103 0.0539 10.4335 -2.1361 -0.5061 -0.3197 -0.6282 1123336 Neuro1_000394 Cc1cc(Cl)ccc1Nc2ncnc3ccc(Br)cc23 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 B21 compound treatment 15.2877 1.81 0.4857 12.9242 0.35453 0.084 0.4028 0.8173 1238844 Neuro1_000395 Cc1ccc(Nc2nc(nc3ccccc23)c4ccccc4Cl)c(C)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 B22 compound treatment 13.6925 0.21478 0.0576 13.6907 1.121 0.2656 0.2286 0.841 1561925 Neuro1_000396 CC1CCCN(C1)c2nc(nc3ccccc23)c4ccccc4F 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 B23 mock treatment 12.7904 -0.68727 -0.1844 11.1935 -1.3761 -0.326 -0.3609 -0.9636 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 B24 mock treatment 12.6499 -0.82778 -0.2221 13.6689 1.0992 0.2604 0.0271 0.0792 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 C01 compound treatment 14.1853 0.70758 0.1899 12.0298 -0.53981 -0.1279 0.0438 0.1914 3652864 Neuro1_000397 N(/N=C/c1cccnc1)c2nc(nc3ccccc23)c4cccnc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 C02 compound treatment 15.1563 1.6786 0.4504 14.1581 1.5885 0.3764 0.5846 0.996 3652866 Neuro1_000398 Oc1ccccc1c2nc(N/N=C/c3ccccc3Cl)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 C03 compound treatment 14.3578 0.88016 0.2362 14.4596 1.89 0.4478 0.4836 0.9553 3652868 Neuro1_000399 C/C(=N\Nc1nc(nc2ccccc12)c3ccc(Br)cc3)/c4cccnc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 C04 compound treatment 18.0494 4.5717 1.2267 11.0773 -1.4923 -0.3536 0.6174 0.4836 2115809 Neuro1_000400 Cc1ccc(cc1)c2nc(N/N=C/c3ccc(O)cc3)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 C05 compound treatment 13.1687 -0.30902 -0.0829 11.3947 -1.1749 -0.2784 -0.2555 -0.8795 1691530 Neuro1_000401 CC1CCN(CC1)c2nc(nc3ccccc23)c4ccc(Br)cc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 C06 compound treatment 16.5989 3.1213 0.8375 14.6461 2.0765 0.492 0.9401 0.9678 1935368 Neuro1_000402 C/C(=N\Nc1nc(nc2ccccc12)c3ccc(C)cc3)/c4ccc(N)cc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 C07 compound treatment 12.6968 -0.7809 -0.2095 15.2878 2.7182 0.644 0.3072 0.4536 1673689 Neuro1_000403 Brc1ccc(Nc2nc(nc3ccccc23)c4ccc(Br)cc4)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 C08 compound treatment 15.368 1.8903 0.5072 12.5261 -0.04359 -0.0103 0.3514 0.6926 1935618 Neuro1_000404 Cc1ccc(cc1)c2nc(N/N=C/c3cccc(F)c3)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 C09 compound treatment 14.2856 0.80793 0.2168 11.4584 -1.1112 -0.2633 -0.0329 -0.0964 3652870 Neuro1_000405 C/C(=N\Nc1nc(nc2ccccc12)c3ccc(Br)cc3)/c4ccc(F)cc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 C10 compound treatment 38.511 25.033 6.7171 29.663 17.093 4.05 7.6135 0.9707 3652872 Neuro1_000406 COc1ccccc1/C=N/Nc2nc(nc3ccccc23)c4cccnc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 C11 compound treatment 13.7844 0.30666 0.0823 10.445 -2.1246 -0.5034 -0.2978 -0.5838 1460559 Neuro1_000407 Clc1ccc(cc1)c2nc(N3CCCC3)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 C12 compound treatment 12.0819 -1.3958 -0.3745 10.4819 -2.0878 -0.4947 -0.6146 -0.9906 1438608 Neuro1_000408 Brc1ccc2ncnc(Nc3cccc4ccccc34)c2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 C13 compound treatment 13.6808 0.20311 0.0545 11.8861 -0.68352 -0.1619 -0.076 -0.4446 1174599 Neuro1_000409 CCN(CC)c1nc(nc2ccccc12)c3ccccc3Cl 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 C14 compound treatment 13.4906 0.01291 0.0035 10.7506 -1.8191 -0.431 -0.3023 -0.7014 1677801 Neuro1_000410 CN(Cc1ccccc1)c2ncnc3ccc(Br)cc23 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 C15 compound treatment 13.1467 -0.33099 -0.0888 13.5263 0.95663 0.2267 0.0975 0.4004 1492426 Neuro1_000411 CC(Nc1nc(nc2ccccc12)c3ccccc3O)c4ccccc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 C16 compound treatment 16.4905 3.0128 0.8084 16.3143 3.7446 0.8872 1.199 0.9989 1324336 Neuro1_000412 CN(C)CCNc1nc(nc2ccccc12)c3ccc(Cl)cc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 C17 compound treatment 12.3951 -1.0826 -0.2905 11.1227 -1.4469 -0.3428 -0.4478 -0.9966 1335943 Neuro1_000413 Cc1ccc2ncnc(Nc3ccc(I)cc3)c2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 C18 compound treatment 14.3789 0.90116 0.2418 12.5192 -0.050475 -0.012 0.1625 0.6713 3652874 Neuro1_000414 Fc1ccc(Nc2nc(/C=C/c3ccccc3)nc4ccccc24)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 C19 compound treatment 13.5814 0.10371 0.0278 11.8713 -0.69837 -0.1655 -0.0973 -0.58 1254761 Neuro1_000415 COc1ccc(Nc2ncnc3ccc(Br)cc23)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 C20 compound treatment 14.8473 1.3696 0.3675 10.3181 -2.2515 -0.5335 -0.1174 -0.1812 3652876 Neuro1_000416 CC(=O)c1cccc(Nc2nc(nc3ccccc23)c4ccc(cc4)C(C)(C)C)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 C21 compound treatment 13.9937 0.51598 0.1385 9.4447 -3.1249 -0.7404 -0.4256 -0.5651 1915748 Neuro1_000417 CCN(CC)CCCC(C)Nc1nc(C)nc2cc(Cl)ccc12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 C22 compound treatment 13.5912 0.11348 0.0305 14.5287 1.959 0.4642 0.3497 0.7519 1864052 Neuro1_000418 [O-][N+](=O)c1ccc(cc1)c2nc(NCC3CCCO3)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 C23 mock treatment 13.1413 -0.33636 -0.0903 12.7092 0.13953 0.0331 -0.0404 -0.4208 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 C24 mock treatment 17.0044 3.5268 0.9463 13.8319 1.2623 0.2991 0.8806 0.8873 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 D01 compound treatment 15.1672 1.6895 0.4533 16.8 4.2304 1.0023 1.0293 0.9357 1864024 Neuro1_000419 [O-][N+](=O)c1ccc(cc1)c2nc(Nc3ccc(cc3)N4CCOCC4)c5ccccc5n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 D02 compound treatment 13.3441 -0.13357 -0.0358 14.8417 2.272 0.5383 0.3553 0.6586 1736515 Neuro1_000420 C(Nc1nc(nc2ccccc12)N3CCOCC3)c4ccccc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 D03 compound treatment 12.4658 -1.0119 -0.2715 13.8542 1.2846 0.3044 0.0232 0.0569 1403547 Neuro1_000421 Clc1ccc(cc1)c2nc(N(CC=C)CC=C)c3ccccc3n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 D04 compound treatment 44.658 31.18 8.3665 12.0719 -0.49779 -0.1179 5.8326 0.6971 3652877 Neuro1_000422 Ic1ccc(Nc2nc(nc3ccccc23)c4cccnc4)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 D05 compound treatment 13.6083 0.13063 0.0351 12.5113 -0.05839 -0.0138 0.015 0.3981 3652878 Neuro1_000423 COCCNc1nc(nc2ccccc12)c3ccc(cc3)[N+](=O)[O-] 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 D06 compound treatment 15.1364 1.6587 0.4451 13.2577 0.68808 0.163 0.43 0.9072 1382426 Neuro1_000424 C(Nc1nc(nc2ccccc12)N3CCN(CC3)c4ccccc4)c5ccco5 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 D07 compound treatment 11.8271 -1.6506 -0.4429 13.7981 1.2284 0.2911 -0.1074 -0.2026 3652879 Neuro1_000425 [O-][N+](=O)c1ccc(cc1)c2nc(Nc3cccc(c3)C(F)(F)F)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 D08 compound treatment 16.2645 2.7868 0.7478 13.0115 0.44191 0.1047 0.6028 0.7983 1875932 Neuro1_000426 Cc1ccc(cc1)c2nc(Nc3cccc(c3)[N+](=O)[O-])c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 D09 compound treatment 15.3797 1.902 0.5104 11.6394 -0.93024 -0.2204 0.205 0.3688 3652880 Neuro1_000427 CC(=O)c1cccc(Nc2nc(nc3ccccc23)c4ccc(Cl)cc4)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 D10 compound treatment 16.5002 3.0225 0.811 13.3681 0.79848 0.1892 0.7072 0.8493 3652881 Neuro1_000428 CC(=O)c1cccc(Nc2nc(nc3ccccc23)c4ccc(C)cc4)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 D11 compound treatment 14.2873 0.80958 0.2172 12.8828 0.31318 0.0742 0.2061 0.8977 1864075 Neuro1_000429 CCN1CCN(CC1)c2nc(nc3ccccc23)c4ccc(cc4)[N+](=O)[O-] 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 D12 compound treatment 15.4443 1.9666 0.5277 11.9783 -0.59132 -0.1401 0.2741 0.502 1698173 Neuro1_000430 Cc1cccc(c1)c2nc(Nc3ccccc3)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 D13 compound treatment 14.9842 1.5065 0.4042 13.2539 0.68426 0.1621 0.4005 0.9195 1864064 Neuro1_000431 CN(Cc1ccccc1)c2nc(nc3ccccc23)c4ccc(cc4)[N+](=O)[O-] 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 D14 compound treatment 14.0237 0.54598 0.1465 12.1354 -0.43421 -0.1029 0.0308 0.1723 1722222 Neuro1_000432 Cc1ccc(cc1)c2nc(NCc3ccco3)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 D15 compound treatment 15.514 2.0364 0.5464 13.7714 1.2018 0.2847 0.5877 0.9538 1864048 Neuro1_000433 CC(Nc1nc(nc2ccccc12)c3ccc(cc3)[N+](=O)[O-])c4ccccc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 D16 compound treatment 12.7512 -0.72654 -0.1949 13.5011 0.93143 0.2207 0.0182 0.0618 1346578 Neuro1_000434 CC(C)Oc1ccc(Nc2ncnc3ccc(Br)cc23)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 D17 compound treatment 11.0378 -2.4399 -0.6547 10.5338 -2.0359 -0.4824 -0.804 -0.9887 1864074 Neuro1_000435 CN1CCN(CC1)c2nc(nc3ccccc23)c4ccc(cc4)[N+](=O)[O-] 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 D18 compound treatment 11.6014 -1.8763 -0.5035 10.8105 -1.7591 -0.4168 -0.6507 -0.9956 3652882 Neuro1_000436 CCCCOc1ccccc1Nc2ncnc3ccc(Br)cc23 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 D19 compound treatment 11.2988 -2.1789 -0.5847 12.6763 0.10667 0.0253 -0.3955 -0.6759 1698013 Neuro1_000437 COC(=O)c1ccc(Nc2nc(nc3ccccc23)c4ccccc4Cl)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 D20 compound treatment 14.2365 0.75886 0.2036 14.0322 1.4625 0.3465 0.389 0.9679 3652883 Neuro1_000438 CCCCOc1ccc(Nc2ncnc3ccc(Br)cc23)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 D21 compound treatment 10.632 -2.8457 -0.7636 10.9872 -1.5825 -0.3749 -0.8051 -0.9464 3652884 Neuro1_000439 CC(=O)c1cccc(Nc2nc(nc3ccccc23)c4ccccc4Cl)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 D22 compound treatment 12.0492 -1.4285 -0.3833 14.2334 1.6637 0.3942 0.0077 0.014 3652885 Neuro1_000440 CCOc1ccc(Nc2nc(N3CCN(C)CC3)c4ccccc4n2)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 D23 mock treatment 12.998 -0.47973 -0.1287 13.6446 1.075 0.2547 0.0891 0.3121 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 D24 mock treatment 13.2507 -0.22697 -0.0609 11.8577 -0.71199 -0.1687 -0.1623 -0.9052 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 E01 compound treatment 11.6358 -1.8419 -0.4942 10.3518 -2.2179 -0.5255 -0.721 -0.9995 1476399 Neuro1_000441 COc1ccc(Nc2nc(nc3ccccc23)c4cccnc4)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 E02 compound treatment 12.9148 -0.56289 -0.151 13.1466 0.57701 0.1367 -0.0101 -0.0497 1934925 Neuro1_000442 C/C(=N\Nc1nc(nc2ccccc12)c3ccc(C)cc3)/c4cccc(c4)[N+](=O)[O-] 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 E03 compound treatment 12.2702 -1.2075 -0.324 14.0048 1.4352 0.34 0.0113 0.0241 1331650 Neuro1_000443 Brc1ccc(cc1)c2nc(NCc3ccccc3)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 E04 compound treatment 11.4934 -1.9843 -0.5324 11.3888 -1.1809 -0.2798 -0.5743 -0.9549 3652886 Neuro1_000444 C/C(=N\Nc1nc(nc2ccccc12)c3ccc(C)cc3)/c4ccc(Cl)c(Cl)c4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 E05 compound treatment 11.4255 -2.0522 -0.5506 9.9135 -2.6561 -0.6293 -0.8344 -0.9978 3652888 Neuro1_000445 Oc1ccc(/C=N/Nc2nc(nc3ccccc23)c4ccc(Br)cc4)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 E06 compound treatment 13.9399 0.46218 0.124 10.0344 -2.5352 -0.6007 -0.3371 -0.5495 3652890 Neuro1_000446 Cc1ccc(cc1)c2nc(Nc3cccc(F)c3)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 E07 compound treatment 12.344 -1.1337 -0.3042 11.7355 -0.83416 -0.1976 -0.3548 -0.9782 1651398 Neuro1_000447 Fc1ccc(Nc2nc(nc3ccccc23)c4ccc(Br)cc4)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 E08 compound treatment 12.2274 -1.2503 -0.3355 11.7573 -0.81237 -0.1925 -0.3733 -0.9652 1935777 Neuro1_000448 Cc1ccc(cc1)c2nc(N/N=C/c3ccccc3)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 E09 compound treatment 12.1998 -1.2779 -0.3429 11.0013 -1.5683 -0.3716 -0.5052 -0.9992 3652891 Neuro1_000449 NNc1nc(nc2ccccc12)c3ccc(Br)cc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 E10 compound treatment 12.2396 -1.2381 -0.3322 12.1222 -0.44749 -0.106 -0.3099 -0.8886 1431459 Neuro1_000450 Clc1ccccc1Nc2ncnc3ccc(Br)cc23 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 E11 compound treatment 13.1107 -0.36702 -0.0985 14.0371 1.4675 0.3477 0.1762 0.4876 1523927 Neuro1_000451 Clc1ccccc1c2nc(NCc3ccccc3)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 E12 compound treatment 21.6332 8.1555 2.1883 12.779 0.20933 0.0496 1.5825 0.7229 1941178 Neuro1_000452 [O-][N+](=O)c1cccc(Nc2ncnc3ccc(Br)cc23)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 E13 compound treatment 11.3174 -2.1603 -0.5797 11.1903 -1.3793 -0.3268 -0.641 -0.9632 1565218 Neuro1_000453 Clc1ccccc1c2nc(N3CCCC3)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 E14 compound treatment 13.7281 0.25041 0.0672 11.4053 -1.1643 -0.2759 -0.1476 -0.5197 1305930 Neuro1_000454 OCC(Nc1ncnc2ccc(Br)cc12)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 E15 compound treatment 16.2592 2.7815 0.7464 18.0154 5.4458 1.2903 1.4401 0.9661 1345839 Neuro1_000455 Oc1ccccc1c2nc(N3CCCCCC3)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 E16 compound treatment 11.9835 -1.4942 -0.4009 11.7133 -0.85632 -0.2029 -0.427 -0.9502 1137633 Neuro1_000456 CCN1CCN(CC1)c2nc(nc3ccccc23)c4ccc(Cl)cc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 E17 compound treatment 16.0095 2.5318 0.6794 18.2482 5.6786 1.3455 1.4318 0.9499 1164201 Neuro1_000457 Clc1ccc(Nc2ncnc3ccc(Br)cc23)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 E18 compound treatment 10.891 -2.5867 -0.6941 11.2257 -1.344 -0.3184 -0.7159 -0.9376 3652892 Neuro1_000458 C1CCCN(CC1)c2nc(/C=C/c3ccccc3)nc4ccccc24 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 E19 compound treatment 11.156 -2.3217 -0.623 11.6822 -0.88741 -0.2103 -0.5892 -0.8961 1711587 Neuro1_000459 Cc1c(Cl)cccc1Nc2ncnc3ccc(Br)cc23 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 E20 compound treatment 51.6046 38.127 10.2304 16.2007 3.6311 0.8603 7.8424 0.7639 3652894 Neuro1_000460 CCC1CCCCN1c2nc(nc3ccccc23)c4ccc(cc4)[N+](=O)[O-] 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 E21 compound treatment 13.4138 -0.06389 -0.0171 12.6056 0.035987 0.0085 -0.0061 -0.3182 1358947 Neuro1_000461 Cc1ccc(Nc2nc(nc3ccccc23)c4ccccc4O)c(C)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 E22 compound treatment 12.1578 -1.3199 -0.3542 12.5276 -0.04209 -0.01 -0.2575 -0.7267 1316921 Neuro1_000462 CC(C)(C)c1ccc(cc1)c2nc(N3CCOCC3)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 E23 mock treatment 12.6766 -0.80109 -0.215 12.901 0.33138 0.0785 -0.0965 -0.4216 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 E24 mock treatment 14.1386 0.66093 0.1773 14.3286 1.759 0.4168 0.4201 0.9275 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 F01 compound treatment 33.5061 20.028 5.3742 15.9131 3.3435 0.7922 4.3603 0.8027 1667500 Neuro1_000463 COc1ccc(Cl)cc1Nc2nc(nc3ccccc23)c4ccc(Cl)cc4Cl 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 F02 compound treatment 12.852 -0.62572 -0.1679 12.9488 0.37916 0.0898 -0.0552 -0.2899 1461219 Neuro1_000464 Fc1ccccc1Nc2nc(N3CCOCC3)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 F03 compound treatment 10.9996 -2.4781 -0.6649 8.9895 -3.5802 -0.8483 -1.07 -0.9927 1864063 Neuro1_000465 CN(C1CCCCC1)c2nc(nc3ccccc23)c4ccc(cc4)[N+](=O)[O-] 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 F04 compound treatment 14.6788 1.2011 0.3223 11.4817 -1.0879 -0.2578 0.0456 0.1105 1609272 Neuro1_000466 COc1ccc(Nc2nc(N3CCOCC3)c4ccccc4n2)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 F05 compound treatment 11.947 -1.5307 -0.4107 12.4643 -0.10537 -0.025 -0.3081 -0.7487 1731031 Neuro1_000467 C(Cc1ccccc1)Nc2nc(nc3ccccc23)c4ccccc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 F06 compound treatment 12.9831 -0.49457 -0.1327 12.9053 0.33564 0.0795 -0.0376 -0.2431 1165915 Neuro1_000468 CCOC(=O)c1cccc(Nc2ncnc3ccccc23)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 F07 compound treatment 13.3315 -0.14623 -0.0392 10.9394 -1.6303 -0.3863 -0.3009 -0.7749 1654363 Neuro1_000469 Cc1ccc(Nc2nc(N3CCOCC3)c4ccccc4n2)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 F08 compound treatment 22.7961 9.3184 2.5004 24.2491 11.679 2.7673 3.7248 0.9987 1875933 Neuro1_000470 Cc1cccc(c1)c2nc(Nc3cccc(c3)[N+](=O)[O-])c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 F09 compound treatment 20.1238 6.6461 1.7833 14.808 2.2384 0.5303 1.636 0.8793 1692238 Neuro1_000471 CCOc1ccc(Nc2nc(NCc3ccccc3)c4ccccc4n2)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 F10 compound treatment 19.6249 6.1473 1.6495 12.1823 -0.38737 -0.0918 1.1015 0.6667 1663781 Neuro1_000472 CC1CN(CC(C)O1)c2nc(nc3ccccc23)c4ccc(C)cc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 F11 compound treatment 12.4613 -1.0164 -0.2727 15.739 3.1693 0.7509 0.3381 0.4233 1864073 Neuro1_000473 CC1CN(CC(C)O1)c2nc(nc3ccccc23)c4ccc(cc4)[N+](=O)[O-] 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 F12 compound treatment 12.3896 -1.0881 -0.292 9.2909 -3.2787 -0.7768 -0.7558 -0.9107 1197549 Neuro1_000474 Cc1cccc(c1)c2nc(NCCN3CCOCC3)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 F13 compound treatment 9.1733 -4.3044 -1.155 11.139 -1.4306 -0.339 -1.0564 -0.8776 1864050 Neuro1_000475 [O-][N+](=O)c1ccc(cc1)c2nc(NCCc3ccccc3)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 F14 compound treatment 13.4309 -0.04674 -0.0125 10.9079 -1.6617 -0.3937 -0.2873 -0.7293 1123686 Neuro1_000476 O=C(Oc1cccc(Nc2ncnc3ccccc23)c1)c4cccnc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 F15 compound treatment 12.442 -1.0357 -0.2779 12.9387 0.36906 0.0874 -0.1347 -0.4623 1863996 Neuro1_000477 [O-][N+](=O)c1cccc(Nc2nc(nc3ccccc23)c4ccc(Cl)cc4Cl)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 F16 compound treatment 12.1268 -1.3509 -0.3625 14.0439 1.4743 0.3493 -0.0093 -0.0185 1983310 Neuro1_000478 C(CNc1ncnc2ccccc12)CNc3ncnc4ccccc34 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 F17 compound treatment 12.8188 -0.65889 -0.1768 12.6527 0.083085 0.0197 -0.1111 -0.6245 1974998 Neuro1_000479 COCCNc1nc(nc2ccccc12)c3ccc(cc3)C(C)(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 F18 compound treatment 11.6802 -1.7975 -0.4823 11.732 -0.8376 -0.1985 -0.4814 -0.923 1209891 Neuro1_000480 CN(C1CCN(C)CC1)c2ncnc3ccc(Br)cc23 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 F19 compound treatment 11.3055 -2.1722 -0.5829 11.7933 -0.77634 -0.1839 -0.5422 -0.8871 1420188 Neuro1_000481 Cc1ccccc1Nc2nc(nc3ccccc23)c4ccccc4Cl 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 F20 compound treatment 11.2616 -2.2161 -0.5946 11.7878 -0.78181 -0.1852 -0.5514 -0.8854 1637647 Neuro1_000482 Cc1ccc(Nc2ncnc3ccc(Br)cc23)cc1Cl 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 F21 compound treatment 14.2924 0.81468 0.2186 10.7699 -1.7998 -0.4264 -0.147 -0.3067 1665278 Neuro1_000483 Clc1ccccc1c2nc(Nc3ccc(I)cc3)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 F22 compound treatment 13.1621 -0.31559 -0.0847 13.1029 0.53321 0.1263 0.0295 0.1937 3652895 Neuro1_000484 CC(=C)CN1CCN(CC1)c2nc(NCc3ccco3)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 F23 mock treatment 13.3036 -0.17414 -0.0467 13.9194 1.3498 0.3198 0.1931 0.5975 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 F24 mock treatment 11.4586 -2.0191 -0.5418 11.6328 -0.93682 -0.222 -0.5401 -0.9224 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 G01 compound treatment 19.3297 5.852 1.5702 14.8664 2.2967 0.5442 1.4951 0.8997 3652896 Neuro1_000485 COc1ccc(/C=N/Nc2nc(nc3ccccc23)c4cccnc4)c(OC)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 G02 compound treatment 22.6023 9.1246 2.4484 13.0 0.43033 0.102 1.8033 0.7359 1935032 Neuro1_000486 Cc1ccc(cc1)c2nc(N/N=C/c3ccncc3)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 G03 compound treatment 12.276 -1.2017 -0.3224 9.562 -3.0076 -0.7126 -0.7319 -0.9357 1580403 Neuro1_000487 OCCNc1nc(nc2ccccc12)c3ccc(Br)cc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 G04 compound treatment 13.7295 0.25176 0.0676 10.655 -1.9146 -0.4536 -0.273 -0.5952 1487118 Neuro1_000488 Cc1cc(C)n(n1)c2nc(nc3ccccc23)c4ccc(C)cc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 G05 compound treatment 12.8602 -0.61754 -0.1657 11.534 -1.0356 -0.2454 -0.2907 -0.9817 3652898 Neuro1_000489 COc1cc(/C=N/Nc2nc(nc3ccccc23)c4ccc(Br)cc4)ccc1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 G06 compound treatment 53.7251 40.247 10.7994 17.2058 4.6361 1.0985 8.4131 0.775 1935415 Neuro1_000490 CN(C)c1ccc(/C=N/Nc2nc(nc3ccccc23)c4ccc(C)cc4)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 G07 compound treatment 13.6083 0.13061 0.035 12.0962 -0.47342 -0.1122 -0.0545 -0.4641 1639473 Neuro1_000491 Clc1cccc(Nc2nc(nc3ccccc23)c4ccc(Br)cc4)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 G08 compound treatment 10.7216 -2.7561 -0.7395 12.0656 -0.50407 -0.1194 -0.6074 -0.8108 1935724 Neuro1_000492 COc1ccc(/C=N/Nc2nc(nc3ccccc23)c4ccc(C)cc4)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 G09 compound treatment 21.6039 8.1262 2.1805 10.545 -2.0246 -0.4797 1.2026 0.5387 1626806 Neuro1_000493 CCN(CC)c1nc(nc2ccccc12)c3ccc(Br)cc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 G10 compound treatment 11.8292 -1.6485 -0.4423 12.1127 -0.45697 -0.1083 -0.3893 -0.8549 1617513 Neuro1_000494 CSCCC(Nc1ncnc2ccc(Br)cc12)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 G11 compound treatment 14.9246 1.4469 0.3882 11.6897 -0.8799 -0.2085 0.1271 0.2884 1726213 Neuro1_000495 Clc1ccccc1Nc2nc(nc3ccccc23)c4ccccc4Cl 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 G12 compound treatment 12.0755 -1.4022 -0.3763 10.4053 -2.1644 -0.5128 -0.6287 -0.9884 1171304 Neuro1_000496 CCOC(=O)c1ccc(Nc2ncnc3ccc(Br)cc23)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 G13 compound treatment 12.4251 -1.0526 -0.2825 10.5355 -2.0342 -0.482 -0.5405 -0.9676 1733773 Neuro1_000497 COc1ccc(Nc2nc(nc3ccccc23)c4ccncc4)c(OC)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 G14 compound treatment 10.8782 -2.5995 -0.6975 10.7265 -1.8432 -0.4367 -0.802 -0.9746 1263689 Neuro1_000498 Brc1ccc2ncnc(NCc3ccccc3)c2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 G15 compound treatment 12.4555 -1.0222 -0.2743 12.7823 0.21262 0.0504 -0.1583 -0.5677 1925712 Neuro1_000499 Brc1ccc(cc1)c2nc(NCCCN3CCOCC3)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 G16 compound treatment 11.3843 -2.0934 -0.5617 14.0064 1.4367 0.3404 -0.1565 -0.2383 1233473 Neuro1_000500 Clc1ccc(cc1)c2nc(NCc3ccco3)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 G17 compound treatment 13.5723 0.094575 0.0254 12.2467 -0.32294 -0.0765 -0.0362 -0.4486 1203567 Neuro1_000501 CC(C)CC(Nc1ncnc2ccc(Br)cc12)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 G18 compound treatment 14.8062 1.3285 0.3565 12.2933 -0.27632 -0.0655 0.2058 0.5677 3652900 Neuro1_000502 CC1CCN(CC1)c2nc(/C=C/c3ccccc3)nc4ccccc24 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 G19 compound treatment 11.9237 -1.5539 -0.417 9.6854 -2.8842 -0.6834 -0.7781 -0.9719 1941232 Neuro1_000503 FC(F)(F)c1cccc(Nc2ncnc3ccc(Br)cc23)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 G20 compound treatment 12.8286 -0.64905 -0.1742 11.2645 -1.3051 -0.3092 -0.3418 -0.9631 1558452 Neuro1_000504 Clc1ccc(c(Cl)c1)c2nc(NCc3ccco3)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 G21 compound treatment 13.3506 -0.12709 -0.0341 12.3582 -0.21142 -0.0501 -0.0595 -0.9824 1278774 Neuro1_000505 Oc1ccccc1c2nc(Nc3cccc(F)c3)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 G22 compound treatment 12.9629 -0.51482 -0.1381 12.2586 -0.31107 -0.0737 -0.1498 -0.9567 1864051 Neuro1_000506 [O-][N+](=O)c1ccc(cc1)c2nc(NCc3cccnc3)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 G23 mock treatment 12.3459 -1.1318 -0.3037 12.5021 -0.06759 -0.016 -0.2261 -0.7434 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 G24 mock treatment 16.7762 3.2985 0.8851 14.0305 1.4609 0.3461 0.8706 0.9161 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 H01 compound treatment 16.3784 2.9007 0.7783 18.8636 6.2939 1.4913 1.6048 0.954 3652902 Neuro1_000507 CC(=O)c1cccc(Nc2nc(nc3ccccc23)c4ccc(cc4)[N+](=O)[O-])c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 H02 compound treatment 15.3529 1.8752 0.5032 12.4498 -0.11984 -0.0284 0.3357 0.6661 1413336 Neuro1_000508 Clc1ccccc1Nc2nc(NCc3ccco3)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 H03 compound treatment 17.5402 4.0625 1.0901 13.5172 0.94753 0.2245 0.9295 0.8352 1155824 Neuro1_000509 CC1CN(CC(C)O1)c2nc(nc3ccccc23)c4ccccc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 H04 compound treatment 13.5295 0.051825 0.0139 10.9457 -1.6239 -0.3848 -0.2622 -0.6811 1392884 Neuro1_000510 CN1CCN(CC1)c2nc(N3CCOCC3)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 H05 compound treatment 11.2134 -2.2643 -0.6076 13.1351 0.56541 0.134 -0.3349 -0.5383 1864023 Neuro1_000511 Cc1cc(Cl)ccc1Nc2nc(nc3ccccc23)c4ccc(cc4)[N+](=O)[O-] 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 H06 compound treatment 11.7305 -1.7472 -0.4688 12.2149 -0.35477 -0.0841 -0.3909 -0.8208 1864032 Neuro1_000512 COc1ccccc1Nc2nc(nc3ccccc23)c4ccc(cc4)[N+](=O)[O-] 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 H07 compound treatment 12.9763 -0.50135 -0.1345 12.1056 -0.46408 -0.11 -0.1729 -0.995 1411828 Neuro1_000513 Clc1ccc(cc1)c2nc(Nc3ccc4OCCOc4c3)c5ccccc5n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 H08 compound treatment 13.6661 0.18838 0.0505 16.8995 4.3299 1.0259 0.7612 0.741 1556370 Neuro1_000514 CN(C1CCN(C)CC1)c2nc(nc3ccccc23)c4ccc(C)cc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 H09 compound treatment 20.3497 6.872 1.8439 18.3163 5.7467 1.3616 2.2667 0.9889 1224552 Neuro1_000515 Cc1cccc(Nc2nc(NCc3ccco3)c4ccccc4n2)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 H10 compound treatment 10.9198 -2.5579 -0.6864 12.5588 -0.0108 -0.0026 -0.4871 -0.7097 3118214 Neuro1_000516 Cc1cccc(c1)c2nc(NCCCN3CCOCC3)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 H11 compound treatment 10.1421 -3.3356 -0.895 11.4907 -1.0789 -0.2556 -0.8136 -0.8741 1864067 Neuro1_000517 [O-][N+](=O)c1ccc(cc1)c2nc(N3CCCCCC3)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 H12 compound treatment 14.2351 0.75738 0.2032 11.0448 -1.5248 -0.3613 -0.1118 -0.2696 1166424 Neuro1_000518 Cc1cccc(c1)c2nc(NCc3ccco3)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 H13 compound treatment 11.3956 -2.0821 -0.5587 11.6451 -0.9245 -0.219 -0.5499 -0.9164 1864035 Neuro1_000519 CCOc1ccccc1Nc2nc(nc3ccccc23)c4ccc(cc4)[N+](=O)[O-] 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 H14 compound treatment 13.8554 0.37771 0.1013 11.1451 -1.4246 -0.3375 -0.167 -0.4739 1440212 Neuro1_000520 Clc1ccccc1C(=O)Oc2cccc(Nc3ncnc4ccccc34)c2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 H15 compound treatment 13.2274 -0.25032 -0.0672 10.6186 -1.951 -0.4623 -0.3744 -0.8014 1864072 Neuro1_000521 [O-][N+](=O)c1ccc(cc1)c2nc(N3CCOCC3)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 H16 compound treatment 11.9197 -1.558 -0.4181 12.7982 0.22853 0.0541 -0.2573 -0.6104 1317715 Neuro1_000522 Cc1ccccc1Nc2nc(N3CCOCC3)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 H17 compound treatment 11.95 -1.5277 -0.4099 13.5673 0.99763 0.2364 -0.1227 -0.2593 1718575 Neuro1_000523 CC(C)(C)c1ccc(cc1)c2nc(NCc3ccco3)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 H18 compound treatment 12.6466 -0.83114 -0.223 12.1476 -0.42202 -0.1 -0.2284 -0.9345 1423155 Neuro1_000524 CCCOC(=O)c1cccc(Nc2ncnc3ccc(Br)cc23)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 H19 compound treatment 15.5886 2.1109 0.5664 11.0757 -1.4939 -0.354 0.1502 0.2249 3652903 Neuro1_000525 CCC(CC)c1nc(Nc2cccc(c2)C(=O)C)c3ccccc3n1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 H20 compound treatment 13.3591 -0.11859 -0.0318 14.8764 2.3067 0.5465 0.364 0.6648 3652904 Neuro1_000526 Oc1ccccc1c2nc(Nc3cccc(Cl)c3)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 H21 compound treatment 104.7076 91.23 24.4793 48.785 36.215 8.5807 23.377 0.9012 1520301 Neuro1_000527 CCCOC(=O)c1ccc(Nc2nc(nc3ccccc23)c4ccccc4Cl)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 H22 compound treatment 14.979 1.5013 0.4028 11.1263 -1.4433 -0.342 0.043 0.0815 3652905 Neuro1_000528 Cc1ccc(C)c(Nc2nc(NCC3CCCO3)c4ccccc4n2)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 H23 mock treatment 16.193 2.7154 0.7286 11.0283 -1.5413 -0.3652 0.257 0.3153 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 H24 mock treatment 13.1596 -0.31804 -0.0853 11.1374 -1.4322 -0.3393 -0.3003 -0.8582 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 I01 compound treatment 21.7075 8.2298 2.2083 259.6009 247.03 58.5304 42.9488 0.7333 1333707 Neuro1_000529 CCN1CCN(CC1)c2ccc(Nc3nc(C)nc4cc(Cl)ccc34)cc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 I02 compound treatment 12.0847 -1.393 -0.3738 13.1204 0.55076 0.1305 -0.172 -0.4345 1304777 Neuro1_000530 COc1ccc(Nc2nc(nc3ccccc23)c4ccc(C)cc4)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 I03 compound treatment 14.0202 0.54248 0.1456 11.9289 -0.64073 -0.1518 -0.0044 -0.021 3652906 Neuro1_000531 Clc1ccccc1Nc2nc(nc3ccccc23)c4ccc(Br)cc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 I04 compound treatment 19.6383 6.1606 1.6531 11.0439 -1.5257 -0.3615 0.9133 0.5397 3652907 Neuro1_000532 CCCCCOc1ccc(/C=N/Nc2nc(nc3ccccc23)c4ccc(C)cc4)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 I05 compound treatment 16.4593 2.9816 0.8 12.6999 0.13028 0.0309 0.5875 0.7338 3652909 Neuro1_000533 COc1cccc(/C=N/Nc2nc(nc3ccccc23)c4ccc(Br)cc4)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 I06 compound treatment 12.6506 -0.82714 -0.2219 15.7223 3.1527 0.747 0.3713 0.4764 1935362 Neuro1_000534 Cc1ccc(cc1)c2nc(N/N=C/c3cccc(c3)[N+](=O)[O-])c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 I07 compound treatment 14.7624 1.2847 0.3447 9.2524 -3.3172 -0.786 -0.312 -0.3635 1724591 Neuro1_000535 Brc1ccc(cc1)c2nc(Nc3ccccc3)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 I08 compound treatment 12.2229 -1.2548 -0.3367 12.933 0.3634 0.0861 -0.1772 -0.5099 1935729 Neuro1_000536 COc1ccc(/C=N/Nc2nc(nc3ccccc23)c4ccc(C)cc4)cc1OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 I09 compound treatment 11.0207 -2.457 -0.6593 11.8801 -0.68954 -0.1634 -0.5817 -0.8564 3652911 Neuro1_000537 Fc1ccc(/C=N/Nc2nc(nc3ccccc23)c4ccc(Br)cc4)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 I10 compound treatment 11.2297 -2.248 -0.6032 10.5519 -2.0178 -0.4781 -0.7646 -0.9934 1473263 Neuro1_000538 Cc1ccccc1Nc2ncnc3ccc(Br)cc23 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 I11 compound treatment 12.4872 -0.99045 -0.2658 11.0808 -1.4888 -0.3527 -0.4374 -0.9903 1589310 Neuro1_000539 CN1CCN(CC1)c2nc(nc3ccccc23)c4ccc(Cl)cc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 I12 compound treatment 12.3096 -1.1681 -0.3134 10.8732 -1.6965 -0.402 -0.5059 -0.9924 1411301 Neuro1_000540 Cc1cccc(Nc2ncnc3ccc(Br)cc23)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 I13 compound treatment 10.3479 -3.1298 -0.8398 11.1779 -1.3917 -0.3298 -0.827 -0.9166 1928846 Neuro1_000541 FC(F)(F)c1cccc(Nc2nc(nc3ccccc23)c4ccncc4)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 I14 compound treatment 12.176 -1.3017 -0.3493 12.1163 -0.45336 -0.1074 -0.3229 -0.8837 1560672 Neuro1_000542 COc1ccccc1Nc2ncnc3ccc(Br)cc23 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 I15 compound treatment 12.0037 -1.474 -0.3955 12.0402 -0.52946 -0.1254 -0.3684 -0.8878 1553258 Neuro1_000543 CN1CCN(CC1)c2nc(nc3ccccc23)c4ccccc4O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 I16 compound treatment 10.6868 -2.7909 -0.7489 11.6166 -0.95307 -0.2258 -0.6892 -0.8811 1219300 Neuro1_000544 CC1CN(CC(C)O1)c2nc(nc3ccccc23)c4ccc(Cl)cc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 I17 compound treatment 11.2884 -2.1893 -0.5874 10.6182 -1.9514 -0.4624 -0.7423 -0.993 1566980 Neuro1_000545 Cc1cccc(C)c1Nc2ncnc3ccc(Br)cc23 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 I18 compound treatment 12.3703 -1.1073 -0.2971 11.0277 -1.5419 -0.3653 -0.4684 -0.9947 3652913 Neuro1_000546 C1CN(CCO1)c2nc(/C=C/c3ccccc3)nc4ccccc24 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 I19 compound treatment 9.9209 -3.5568 -0.9544 10.3058 -2.2638 -0.5364 -1.0541 -0.9629 1715482 Neuro1_000547 COC(=O)c1ccc(Nc2ncnc3ccc(Br)cc23)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 I20 compound treatment 13.071 -0.40674 -0.1091 10.4157 -2.1539 -0.5103 -0.438 -0.8393 1864065 Neuro1_000548 [O-][N+](=O)c1ccc(cc1)c2nc(N3CCCC3)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 I21 compound treatment 13.0847 -0.39304 -0.1055 12.4807 -0.08895 -0.0211 -0.0895 -0.832 3652915 Neuro1_000549 CCOc1ccc(Nc2nc(N)c3ccccc3n2)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 I22 compound treatment 10.9049 -2.5728 -0.6904 11.2158 -1.3539 -0.3208 -0.715 -0.9392 1864070 Neuro1_000550 CC1CCN(CC1)c2nc(nc3ccccc23)c4ccc(cc4)[N+](=O)[O-] 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 I23 mock treatment 13.2392 -0.23853 -0.064 10.0398 -2.5298 -0.5994 -0.4691 -0.7782 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 I24 mock treatment 13.0926 -0.38509 -0.1033 12.7517 0.18209 0.0431 -0.0426 -0.3801 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 J01 compound treatment 13.0337 -0.44397 -0.1191 10.9935 -1.5762 -0.3734 -0.3483 -0.8886 3652916 Neuro1_000551 COCCCNc1nc(nc2ccccc12)c3ccc(Cl)cc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 J02 compound treatment 13.8361 0.35836 0.0962 12.8479 0.27823 0.0659 0.1146 0.983 1610139 Neuro1_000552 C(Nc1nc(nc2ccccc12)N3CCN(Cc4ccccc4)CC3)c5ccccc5 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 J03 compound treatment 12.5805 -0.89719 -0.2407 10.6184 -1.9512 -0.4623 -0.4971 -0.9538 1864038 Neuro1_000553 CN(C)c1ccc(Nc2nc(nc3ccccc23)c4ccc(cc4)[N+](=O)[O-])cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 J04 compound treatment 12.6527 -0.82502 -0.2214 11.8269 -0.74274 -0.176 -0.281 -0.9935 1691758 Neuro1_000554 Fc1ccc(Nc2nc(N3CCOCC3)c4ccccc4n2)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 J05 compound treatment 12.0763 -1.4014 -0.376 12.3336 -0.23609 -0.0559 -0.3054 -0.8035 3652917 Neuro1_000555 OCCCNc1nc(nc2ccccc12)c3ccc(cc3)[N+](=O)[O-] 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 J06 compound treatment 12.6683 -0.80942 -0.2172 9.923 -2.6466 -0.6271 -0.597 -0.8996 1347171 Neuro1_000556 Cc1ccc(cc1)c2nc(Nc3ccc(cc3)C(=O)O)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 J07 compound treatment 15.8241 2.3464 0.6296 11.3984 -1.1712 -0.2775 0.249 0.3619 1387715 Neuro1_000557 C(Nc1nc(nc2ccccc12)N3CCN(Cc4ccccc4)CC3)c5ccco5 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 J08 compound treatment 13.9466 0.46891 0.1258 9.9992 -2.5704 -0.609 -0.3417 -0.5494 1259981 Neuro1_000558 Cc1ccc(cc1)c2nc(Nc3ccc(O)cc3)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 J09 compound treatment 16.0084 2.5307 0.6791 15.319 2.7494 0.6514 0.9408 0.9998 1864055 Neuro1_000559 CN(C)CCNc1nc(nc2ccccc12)c3ccc(cc3)[N+](=O)[O-] 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 J10 compound treatment 14.4015 0.92376 0.2479 15.2165 2.6468 0.6271 0.6187 0.9175 1386535 Neuro1_000560 Cc1cccc(c1)c2nc(Nc3ccc(O)cc3)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 J11 compound treatment 14.0366 0.55891 0.15 11.7336 -0.83609 -0.1981 -0.034 -0.137 1864019 Neuro1_000561 Cc1ccc(Nc2nc(nc3ccccc23)c4ccc(cc4)[N+](=O)[O-])cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 J12 compound treatment 15.0173 1.5396 0.4131 15.8016 3.232 0.7658 0.8336 0.9581 1252547 Neuro1_000562 Cc1ccc(cc1)c2nc(Nc3cccc(O)c3)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 J13 compound treatment 10.3109 -3.1668 -0.8497 11.8596 -0.71007 -0.1682 -0.7198 -0.831 1864062 Neuro1_000563 [O-][N+](=O)c1ccc(cc1)c2nc(N(CC=C)CC=C)c3ccccc3n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 J14 compound treatment 9.9026 -3.5751 -0.9593 9.1582 -3.4115 -0.8083 -1.2499 -0.9964 1517067 Neuro1_000564 Oc1ccc(Nc2ncnc3ccc(Br)cc23)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 J15 compound treatment 10.4808 -2.9969 -0.8041 15.0827 2.5131 0.5954 -0.1476 -0.1475 1864042 Neuro1_000565 OC(=O)c1ccc(Nc2nc(nc3ccccc23)c4ccc(cc4)[N+](=O)[O-])cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 J16 compound treatment 15.4129 1.9352 0.5193 15.035 2.4654 0.5841 0.7802 0.9983 1121498 Neuro1_000566 COc1ccc(Nc2nc(NCc3ccccc3)c4ccccc4n2)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 J17 compound treatment 11.8632 -1.6145 -0.4332 12.8378 0.26813 0.0635 -0.2614 -0.597 1444843 Neuro1_000567 CC(C)(C)c1ccc(cc1)c2nc(NCc3cccnc3)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 J18 compound treatment 12.0103 -1.4674 -0.3937 11.472 -1.0977 -0.2601 -0.4623 -0.9797 1176544 Neuro1_000568 Oc1ccccc1c2nc(NCCc3ccccc3)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 J19 compound treatment 17.6377 4.16 1.1162 14.4246 1.8549 0.4395 1.1001 0.917 1233327 Neuro1_000569 CCC(CC)c1nc(Nc2cccc(OC)c2)c3ccccc3n1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 J20 compound treatment 24.6093 11.132 2.9869 21.911 9.3413 2.2133 3.6771 0.9891 1274473 Neuro1_000570 Oc1ccccc1c2nc(Nc3ccc(Br)cc3)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 J21 compound treatment 12.3625 -1.1152 -0.2992 12.5584 -0.011215 -0.0027 -0.2135 -0.7134 1193123 Neuro1_000571 COc1cccc(Nc2nc(nc3ccccc23)c4ccccc4Cl)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 J22 compound treatment 12.164 -1.3137 -0.3525 10.1062 -2.4634 -0.5837 -0.662 -0.9708 1261607 Neuro1_000572 Fc1ccccc1c2nc(N3CCN(CC3)c4ccccc4)c5ccccc5n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 J23 mock treatment 13.5106 0.032865 0.0088 10.1745 -2.3951 -0.5675 -0.395 -0.696 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 J24 mock treatment 14.0274 0.54968 0.1475 13.23 0.66033 0.1565 0.2149 0.9996 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 K01 compound treatment 14.1762 0.69851 0.1874 20.6023 8.0326 1.9032 1.4783 0.773 3652918 Neuro1_000573 COc1ccc(/C=N/Nc2nc(nc3ccccc23)c4ccc(Br)cc4)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 K02 compound treatment 13.3935 -0.084215 -0.0226 12.175 -0.39464 -0.0935 -0.0821 -0.8534 3652920 Neuro1_000574 Cc1ccc(cc1)c2nc(N/N=C/c3ccccc3Cl)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 K03 compound treatment 13.4822 0.0045348 0.0012 11.3635 -1.2061 -0.2858 -0.2012 -0.7041 1554183 Neuro1_000575 Clc1ccc(Nc2nc(nc3ccccc23)c4ccc(Br)cc4)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 K04 compound treatment 14.4576 0.97993 0.2629 11.2809 -1.2887 -0.3053 -0.03 -0.0744 1935257 Neuro1_000576 Cc1ccc(cc1)c2nc(N/N=C/c3cccnc3)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 K05 compound treatment 16.4664 2.9888 0.802 10.832 -1.7376 -0.4117 0.276 0.3061 1246914 Neuro1_000577 COc1ccc(Nc2nc(nc3ccccc23)c4ccc(Br)cc4)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 K06 compound treatment 11.7907 -1.687 -0.4527 10.1228 -2.4469 -0.5797 -0.73 -0.9925 1935637 Neuro1_000578 C/C(=N\Nc1nc(nc2ccccc12)c3ccc(C)cc3)/c4ccc(cc4)[N+](=O)[O-] 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 K07 compound treatment 13.0484 -0.42927 -0.1152 9.5308 -3.0388 -0.72 -0.5906 -0.8099 1271420 Neuro1_000579 CN1CCN(CC1)c2nc(nc3ccccc23)c4ccc(Br)cc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 K08 compound treatment 13.8549 0.37716 0.1012 12.6388 0.069185 0.0164 0.0832 0.8111 3652922 Neuro1_000580 C/C(=N\Nc1nc(nc2ccccc12)c3ccc(C)cc3)/c4ccc(C)cc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 K09 compound treatment 12.4627 -1.015 -0.2723 10.5033 -2.0664 -0.4896 -0.5388 -0.9617 1434003 Neuro1_000581 COc1ccc(CNc2nc(nc3ccccc23)c4ccccc4)cc1OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 K10 compound treatment 11.8554 -1.6223 -0.4353 12.394 -0.17564 -0.0416 -0.3372 -0.7712 1941166 Neuro1_000582 Brc1ccc2ncnc(NCCCN3CCOCC3)c2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 K11 compound treatment 12.7517 -0.72594 -0.1948 11.645 -0.92467 -0.2191 -0.2927 -0.9983 1372612 Neuro1_000583 Clc1ccc(c(Cl)c1)c2nc(N3CCOCC3)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 K12 compound treatment 11.435 -2.0427 -0.5481 9.7342 -2.8354 -0.6718 -0.8626 -0.9949 1941168 Neuro1_000584 CC(=O)c1cccc(Nc2ncnc3ccc(Br)cc23)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 K13 compound treatment 14.3788 0.90111 0.2418 11.2085 -1.3611 -0.3225 -0.0571 -0.1416 1267611 Neuro1_000585 Clc1ccc(Nc2nc(nc3ccccc23)c4ccncc4)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 K14 compound treatment 13.4073 -0.07034 -0.0189 12.6947 0.12505 0.0296 0.0076 0.2165 1659533 Neuro1_000586 Cc1ccc2ncnc(NC(CC(=O)O)C(=O)O)c2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 K15 compound treatment 12.4093 -1.0684 -0.2867 11.1241 -1.4455 -0.3425 -0.4449 -0.9961 1172751 Neuro1_000587 Brc1ccc(Nc2nc(nc3ccccc23)c4ccncc4)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 K16 compound treatment 11.7541 -1.7236 -0.4625 12.5563 -0.013315 -0.0032 -0.3293 -0.7119 1941548 Neuro1_000588 COCCNc1nc(nc2ccccc12)c3ccc(Cl)cc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 K17 compound treatment 13.7664 0.28875 0.0775 10.4552 -2.1144 -0.501 -0.2995 -0.5907 3652924 Neuro1_000589 CCN(CC)CCCNc1ncnc2ccc(Br)cc12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 K18 compound treatment 14.4845 1.0068 0.2701 12.2204 -0.34922 -0.0827 0.1325 0.469 3652925 Neuro1_000590 C(Cc1ccccc1)Nc2nc(/C=C/c3ccccc3)nc4ccccc24 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 K19 compound treatment 11.6536 -1.8241 -0.4894 10.9638 -1.6058 -0.3805 -0.6151 -0.9922 1401934 Neuro1_000591 Brc1ccc2ncnc(NCCc3ccccc3)c2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 K20 compound treatment 14.6642 1.1865 0.3184 11.249 -1.3206 -0.3129 0.0039 0.0087 1864031 Neuro1_000592 Oc1ccc(Nc2nc(nc3ccccc23)c4ccc(cc4)[N+](=O)[O-])cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 K21 compound treatment 13.2818 -0.19585 -0.0526 12.0195 -0.55016 -0.1304 -0.1293 -0.9202 3027313 Neuro1_000593 COc1ccc(Nc2nc(nc3ccccc23)N4CCN(C)CC4)c(OC)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 K22 compound treatment 19.726 6.2484 1.6766 18.6223 6.0526 1.4341 2.1996 0.997 1184905 Neuro1_000594 COC(=O)c1ccc(Nc2ncnc3ccccc23)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 K23 mock treatment 12.2828 -1.1949 -0.3206 11.9453 -0.62438 -0.1479 -0.3313 -0.9383 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 K24 mock treatment 13.3037 -0.174 -0.0467 11.4115 -1.1582 -0.2744 -0.2271 -0.8157 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 L01 compound treatment 20.1389 6.6612 1.7874 14.8208 2.2511 0.5334 1.641 0.8798 3652927 Neuro1_000595 Clc1ccc(c(Cl)c1)c2nc(Nc3ccc(I)cc3)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 L02 compound treatment 13.1676 -0.31013 -0.0832 12.6369 0.06726 0.0159 -0.0476 -0.5615 1201460 Neuro1_000596 CN1CCN(CC1)c2nc(NCc3ccccc3)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 L03 compound treatment 12.7125 -0.76519 -0.2053 9.5652 -3.0045 -0.7119 -0.6486 -0.8754 1155180 Neuro1_000597 Oc1ccc(Nc2nc(nc3ccccc23)c4ccc(Cl)cc4Cl)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 L04 compound treatment 17.312 3.8343 1.0288 21.6371 9.0675 2.1484 2.2466 0.9432 1356650 Neuro1_000598 Fc1ccccc1Nc2nc(NCc3ccccc3)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 L05 compound treatment 31.0908 17.613 4.726 26.987 14.417 3.416 5.7573 0.9873 1589346 Neuro1_000599 Clc1ccc(c(Cl)c1)c2nc(Nc3ccc4OCCOc4c3)c5ccccc5n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 L06 compound treatment 10.5521 -2.9256 -0.785 11.7042 -0.86541 -0.205 -0.7001 -0.8629 1371105 Neuro1_000600 Fc1ccc(cc1)C(=O)Oc2cccc(Nc3ncnc4ccccc34)c2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 L07 compound treatment 13.7506 0.27291 0.0732 10.4007 -2.1689 -0.5139 -0.3116 -0.6003 1441651 Neuro1_000601 Fc1ccccc1Nc2nc(NCc3ccco3)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 L08 compound treatment 14.5222 1.0446 0.2803 9.3697 -3.1999 -0.7582 -0.3379 -0.4181 1491367 Neuro1_000602 COc1cccc(Nc2nc(nc3ccccc23)c4ccc(C)cc4)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 L09 compound treatment 11.7013 -1.7764 -0.4766 11.4056 -1.1641 -0.2758 -0.5321 -0.9662 1864056 Neuro1_000603 [O-][N+](=O)c1ccc(cc1)c2nc(NCCN3CCOCC3)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 L10 compound treatment 11.3196 -2.1581 -0.5791 13.3344 0.76473 0.1812 -0.2813 -0.4637 1488897 Neuro1_000604 Cc1ccc(cc1)c2nc(NCc3cccnc3)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 L11 compound treatment 13.4901 0.01241 0.0033 12.2337 -0.33595 -0.0796 -0.0539 -0.6769 1864069 Neuro1_000605 CC1CCCN(C1)c2nc(nc3ccccc23)c4ccc(cc4)[N+](=O)[O-] 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 L12 compound treatment 11.529 -1.9487 -0.5229 12.175 -0.39469 -0.0935 -0.4359 -0.8205 1589550 Neuro1_000606 COc1ccccc1Nc2nc(nc3ccccc23)c4ccc(C)cc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 L13 compound treatment 11.8938 -1.5839 -0.425 12.4134 -0.15627 -0.037 -0.3267 -0.7658 1864030 Neuro1_000607 Oc1cccc(Nc2nc(nc3ccccc23)c4ccc(cc4)[N+](=O)[O-])c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 L14 compound treatment 10.6465 -2.8312 -0.7597 11.2087 -1.3609 -0.3225 -0.7652 -0.9272 1438155 Neuro1_000608 CCCOc1ccc(Nc2ncnc3ccc(Br)cc23)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 L15 compound treatment 11.5735 -1.9042 -0.5109 12.1355 -0.43419 -0.1029 -0.434 -0.8328 1228044 Neuro1_000609 CN(C)CCNc1nc(nc2ccccc12)c3ccc(cc3)C(C)(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 L16 compound treatment 9.7968 -3.6809 -0.9877 9.409 -3.1607 -0.7489 -1.2279 -0.9907 1241988 Neuro1_000610 Clc1ccc(Nc2nc(N3CCOCC3)c4ccccc4n2)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 L17 compound treatment 12.0023 -1.4754 -0.3959 12.0018 -0.5678 -0.1345 -0.3751 -0.897 1650752 Neuro1_000611 CC(C)(C)c1ccc(cc1)c2nc(Nc3ccc(cc3)C(=O)O)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 L18 compound treatment 13.9097 0.43204 0.1159 15.0978 2.5282 0.599 0.5055 0.8286 3652928 Neuro1_000612 Oc1ccccc1c2nc(NCC3CCOC3)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 L19 compound treatment 10.8034 -2.6743 -0.7176 11.4475 -1.1221 -0.2659 -0.6954 -0.9087 1615698 Neuro1_000613 CCOC(=O)c1cccc(Nc2nc(nc3ccccc23)c4ccccc4Cl)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 L20 compound treatment 12.4487 -1.029 -0.2761 11.3318 -1.2379 -0.2933 -0.4026 -0.9995 1457150 Neuro1_000614 COc1ccccc1Nc2nc(nc3ccccc23)c4ccccc4O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 L21 compound treatment 11.2167 -2.2609 -0.6067 11.1538 -1.4159 -0.3355 -0.6662 -0.961 1608866 Neuro1_000615 CCOc1ccccc1Nc2nc(nc3ccccc23)c4ccccc4Cl 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 L22 compound treatment 12.2117 -1.266 -0.3397 10.3406 -2.2291 -0.5281 -0.6137 -0.9772 1445378 Neuro1_000616 COc1ccccc1Nc2nc(nc3ccccc23)c4ccccc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 L23 mock treatment 13.1214 -0.35632 -0.0956 15.2516 2.682 0.6355 0.3817 0.594 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 L24 mock treatment 13.4853 0.0075848 0.002 12.1836 -0.38604 -0.0915 -0.0632 -0.6912 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 M01 compound treatment 13.1946 -0.28309 -0.076 13.1592 0.58955 0.1397 0.0451 0.2834 3652929 Neuro1_000617 Fc1ccccc1/C=N/Nc2nc(nc3ccccc23)c4ccc(Br)cc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 M02 compound treatment 14.3314 0.85368 0.2291 13.841 1.2714 0.3012 0.375 0.9909 3652931 Neuro1_000618 C/C(=N\Nc1nc(nc2ccccc12)c3ccc(C)cc3)/c4ccc(F)cc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 M03 compound treatment 13.591 0.11333 0.0304 13.9438 1.3741 0.3256 0.2517 0.7698 3652933 Neuro1_000619 COc1ccc(/C=N/Nc2nc(nc3ccccc23)c4ccc(Br)cc4)c(OC)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 M04 compound treatment 77.9828 64.505 17.3084 83.4851 70.915 16.8024 24.1199 0.9999 1935343 Neuro1_000620 COc1ccc(/C=N/Nc2nc(nc3ccccc23)c4ccc(C)cc4)c(OC)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 M05 compound treatment 12.9835 -0.49418 -0.1326 9.5337 -3.0359 -0.7193 -0.6024 -0.8236 1590843 Neuro1_000621 Brc1ccc(cc1)c2nc(N3CCCC3)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 M06 compound treatment 11.5753 -1.9024 -0.5105 11.5734 -0.9962 -0.236 -0.5278 -0.9386 3652935 Neuro1_000622 CCCCCc1ccc(cc1)/C(=N/Nc2nc(nc3ccccc23)c4ccc(C)cc4)/C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 M07 compound treatment 12.4972 -0.98052 -0.2631 11.3148 -1.2548 -0.2973 -0.3963 -0.9981 3652937 Neuro1_000623 COc1ccccc1/C=N/Nc2nc(nc3ccccc23)c4ccc(Br)cc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 M08 compound treatment 29.1636 15.686 4.2089 18.5671 5.9974 1.421 3.981 0.8961 1935891 Neuro1_000624 Cc1ccc(cc1)c2nc(N/N=C/c3ccc(cc3)[N+](=O)[O-])c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 M09 compound treatment 11.0239 -2.4537 -0.6584 10.5496 -2.0201 -0.4786 -0.804 -0.9877 1505815 Neuro1_000625 CCOC(=O)C1CCN(CC1)c2nc(nc3ccccc23)c4ccccc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 M10 compound treatment 9.9534 -3.5243 -0.9457 11.5233 -1.0464 -0.2479 -0.844 -0.8633 1578334 Neuro1_000626 OC(=O)CC(Nc1ncnc2ccc(Br)cc12)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 M11 compound treatment 10.8807 -2.597 -0.6969 12.35 -0.2196 -0.052 -0.5295 -0.7578 1608315 Neuro1_000627 CC(C)Nc1nc(nc2ccccc12)c3ccc(Cl)cc3Cl 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 M12 compound treatment 10.98 -2.4977 -0.6702 10.3602 -2.2094 -0.5235 -0.8441 -0.9925 1597755 Neuro1_000628 Cc1ccc(Nc2ncnc3ccc(Br)cc23)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 M13 compound treatment 15.3978 1.9201 0.5152 11.0076 -1.562 -0.3701 0.1026 0.1618 1195961 Neuro1_000629 Cc1ccc(C)c(Nc2nc(nc3ccccc23)c4ccncc4)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 M14 compound treatment 11.4662 -2.0115 -0.5397 11.6376 -0.93202 -0.2208 -0.5378 -0.9222 1466687 Neuro1_000630 CC(C)CNc1nc(nc2ccccc12)c3ccc(Cl)cc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 M15 compound treatment 9.6199 -3.8578 -1.0352 11.7096 -0.86008 -0.2038 -0.8761 -0.8304 1483149 Neuro1_000631 COC(=O)CCNc1nc(nc2ccccc12)c3ccc(Br)cc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 M16 compound treatment 12.617 -0.86072 -0.231 11.327 -1.2427 -0.2944 -0.3715 -0.9928 1738379 Neuro1_000632 CCOC(=O)c1ccc(Nc2nc(nc3ccccc23)c4ccc(Cl)cc4)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 M17 compound treatment 11.1739 -2.3038 -0.6182 12.245 -0.32463 -0.0769 -0.4915 -0.789 1164820 Neuro1_000633 CC1CCCCC1Nc2ncnc3ccc(Br)cc23 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 M18 compound treatment 10.1749 -3.3028 -0.8862 10.4098 -2.1599 -0.5118 -0.9885 -0.9659 3652939 Neuro1_000634 COC(=O)c1cccc(Nc2nc(/C=C/c3ccccc3)nc4ccccc24)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 M19 compound treatment 9.0211 -4.4566 -1.1958 9.0195 -3.5501 -0.8412 -1.4404 -0.9852 1330942 Neuro1_000635 Brc1ccc2ncnc(Nc3ccc4OCCOc4c3)c2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 M20 compound treatment 13.6891 0.21138 0.0567 11.1833 -1.3864 -0.3285 -0.1922 -0.5765 1864046 Neuro1_000636 [O-][N+](=O)c1ccc(cc1)c2nc(NC3CCCCC3)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 M21 compound treatment 12.8522 -0.62553 -0.1678 11.7836 -0.78609 -0.1863 -0.2504 -0.9987 1681263 Neuro1_000637 Cc1ccc(Nc2nc(nc3ccccc23)c4ccccc4O)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 M22 compound treatment 48.9065 35.429 9.5065 18.3613 5.7917 1.3722 7.6924 0.8009 1864071 Neuro1_000638 CC1(CC2CC(C)(C)C1)CN2c3nc(nc4ccccc34)c5ccc(cc5)[N+](=O)[O-] 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 M23 mock treatment 12.2496 -1.2281 -0.3295 13.3614 0.79173 0.1876 -0.1004 -0.2647 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 M24 mock treatment 11.2059 -2.2717 -0.6096 12.0975 -0.47216 -0.1119 -0.5101 -0.8231 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 N01 compound treatment 13.5248 0.047085 0.0126 15.8627 3.293 0.7802 0.5606 0.7185 1864018 Neuro1_000639 Cc1ccccc1Nc2nc(nc3ccccc23)c4ccc(cc4)[N+](=O)[O-] 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 N02 compound treatment 14.4026 0.92488 0.2482 12.8301 0.26045 0.0617 0.2191 0.8568 1118945 Neuro1_000640 C(N1CCN(CC1)c2nc(N3CCOCC3)c4ccccc4n2)c5ccccc5 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 N03 compound treatment 18.585 5.1073 1.3704 10.4948 -2.0748 -0.4916 0.6214 0.4268 1864029 Neuro1_000641 COc1ccc(Cl)cc1Nc2nc(nc3ccccc23)c4ccc(cc4)[N+](=O)[O-] 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 N04 compound treatment 14.2826 0.80493 0.216 11.4823 -1.0874 -0.2576 -0.0295 -0.0876 1677576 Neuro1_000642 CN(C)CCNc1nc(nc2ccccc12)c3cccnc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 N05 compound treatment 11.6861 -1.7916 -0.4807 13.4193 0.84963 0.2013 -0.1976 -0.3791 1864025 Neuro1_000643 [O-][N+](=O)c1ccc(cc1)c2nc(Nc3cccc(Cl)c3)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 N06 compound treatment 37.1291 23.651 6.3463 37.2826 24.713 5.8554 8.6279 0.9992 1573616 Neuro1_000644 Cc1cccc(c1)c2nc(N3CC4(C)CC3CC(C)(C)C4)c5ccccc5n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 N07 compound treatment 11.2094 -2.2683 -0.6086 16.2421 3.6725 0.8701 0.1849 0.1741 1432761 Neuro1_000645 CCOc1ccccc1Nc2nc(nc3ccccc23)c4ccc(Cl)cc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 N08 compound treatment 12.4829 -0.99482 -0.2669 9.3377 -3.2319 -0.7658 -0.7302 -0.9005 1314067 Neuro1_000646 Cc1ccc(cc1)c2nc(Nc3cccc(c3)C(=O)O)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 N09 compound treatment 12.4884 -0.98925 -0.2654 11.3313 -1.2384 -0.2934 -0.3952 -0.9987 1560212 Neuro1_000647 CC(C)(C)c1ccc(cc1)c2nc(N3CCCC3)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 N10 compound treatment 13.0548 -0.42289 -0.1135 12.2337 -0.33597 -0.0796 -0.1365 -0.985 1393428 Neuro1_000648 COc1ccccc1Nc2nc(nc3ccccc23)c4cccc(C)c4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 N11 compound treatment 11.4891 -1.9886 -0.5336 10.4284 -2.1412 -0.5073 -0.7361 -0.9997 1874117 Neuro1_000649 COC(=O)c1ccc(Nc2nc(nc3ccccc23)c4ccc(cc4)[N+](=O)[O-])cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 N12 compound treatment 13.0371 -0.44058 -0.1182 11.7919 -0.77777 -0.1843 -0.2139 -0.977 1309268 Neuro1_000650 COC(=O)c1cccc(Nc2nc(nc3ccccc23)c4cccc(C)c4)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 N13 compound treatment 11.8844 -1.5933 -0.4275 11.4701 -1.0995 -0.2605 -0.4865 -0.9718 1864036 Neuro1_000651 CCOc1ccc(Nc2nc(nc3ccccc23)c4ccc(cc4)[N+](=O)[O-])cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 N14 compound treatment 10.2318 -3.2459 -0.871 11.7592 -0.81042 -0.192 -0.7516 -0.8428 1368813 Neuro1_000652 COc1ccc(Nc2ncnc3ccc(Br)cc23)c(OC)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 N15 compound treatment 14.8968 1.4191 0.3808 15.5754 3.0057 0.7122 0.7728 0.957 1864039 Neuro1_000653 COC(=O)c1cccc(Nc2nc(nc3ccccc23)c4ccc(cc4)[N+](=O)[O-])c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 N16 compound treatment 11.988 -1.4897 -0.3997 11.6662 -0.90344 -0.2141 -0.434 -0.9572 1523724 Neuro1_000654 COc1ccc(OC)c(Nc2nc(nc3ccccc23)c4ccccc4O)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 N17 compound treatment 58.8638 45.386 12.1782 10.5949 -1.9747 -0.4679 8.2805 0.6794 1975030 Neuro1_000655 COCCCNc1nc(nc2ccccc12)c3ccc(cc3)C(C)(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 N18 compound treatment 10.69 -2.7877 -0.748 11.6393 -0.93034 -0.2204 -0.6848 -0.8781 3652941 Neuro1_000656 Oc1ccccc1c2nc(N3CCN(CC3)C(c4ccccc4)c5ccccc5)c6ccccc6n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 N19 compound treatment 10.3418 -3.1359 -0.8414 10.7398 -1.8299 -0.4336 -0.9016 -0.9525 1421575 Neuro1_000657 OC(=O)c1ccc(Nc2nc(nc3ccccc23)c4ccccc4Cl)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 N20 compound treatment 11.9253 -1.5524 -0.4165 11.1994 -1.3702 -0.3246 -0.5241 -0.9924 1371006 Neuro1_000658 Cc1cccc(Nc2ncnc3ccc(Br)cc23)c1C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 N21 compound treatment 11.6828 -1.7949 -0.4816 10.8201 -1.7495 -0.4145 -0.6337 -0.9972 1371117 Neuro1_000659 Oc1cccc(Nc2nc(nc3ccccc23)c4ccccc4Cl)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 N22 compound treatment 12.1574 -1.3203 -0.3543 13.1875 0.61781 0.1464 -0.147 -0.3835 3652942 Neuro1_000660 Fc1ccc(Nc2nc(NCC3CCCO3)c4ccccc4n2)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 N23 mock treatment 14.6438 1.1661 0.3129 11.4794 -1.0903 -0.2583 0.0386 0.0951 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 N24 mock treatment 13.6405 0.16286 0.0437 11.0486 -1.521 -0.3604 -0.2239 -0.6168 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 O01 compound treatment 21.2789 7.8013 2.0933 23.7003 11.131 2.6372 3.345 0.9935 3652943 Neuro1_000661 COc1ccc(/C=N/Nc2nc(nc3ccccc23)c4ccc(Br)cc4)cc1OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 O02 compound treatment 15.382 1.9043 0.511 17.207 4.6373 1.0987 1.1382 0.9393 3652945 Neuro1_000662 CCCCc1ccc(cc1)/C(=N/Nc2nc(nc3ccccc23)c4ccc(C)cc4)/C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 O03 compound treatment 12.7842 -0.69352 -0.1861 12.0184 -0.55121 -0.1306 -0.2239 -0.985 1145689 Neuro1_000663 COC(=O)c1cccc(Nc2nc(nc3ccccc23)c4ccc(Br)cc4)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 O04 compound treatment 14.3739 0.89621 0.2405 10.609 -1.9607 -0.4645 -0.1584 -0.3029 3652947 Neuro1_000664 Cc1ccc(cc1)c2nc(N/N=C/c3c(F)c(F)c(F)c(F)c3F)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 O05 compound treatment 14.0435 0.56578 0.1518 10.6798 -1.8898 -0.4478 -0.2093 -0.4426 3652949 Neuro1_000665 Fc1ccc(Nc2nc(nc3ccccc23)c4ccc(Br)cc4)cc1F 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 O06 compound treatment 14.2325 0.75478 0.2025 13.1228 0.55313 0.1311 0.2359 0.9778 1458048 Neuro1_000666 Cc1ccc(Nc2nc(nc3ccccc23)c4ccc(C)cc4)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 O07 compound treatment 11.0072 -2.4705 -0.6629 11.6515 -0.91813 -0.2175 -0.6226 -0.8923 1191448 Neuro1_000667 Brc1ccc(cc1)c2nc(N3CCCCC3)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 O08 compound treatment 10.1554 -3.3223 -0.8915 12.2346 -0.33502 -0.0794 -0.6865 -0.767 3652950 Neuro1_000668 Cc1ccc(cc1)c2nc(N/N=C/c3ccc(Br)cc3)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 O09 compound treatment 22.5204 9.0427 2.4264 11.702 -0.86764 -0.2056 1.5704 0.6449 3652952 Neuro1_000669 CC(=O)c1ccc(cc1)N2CCN(CC2)c3nc(nc4ccccc34)c5ccccc5 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 O10 compound treatment 11.2939 -2.1838 -0.586 12.0223 -0.54736 -0.1297 -0.506 -0.8432 1476095 Neuro1_000670 COC(=O)c1cccc(Nc2ncnc3ccc(Br)cc23)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 O11 compound treatment 13.307 -0.17067 -0.0458 12.2753 -0.29437 -0.0697 -0.0817 -0.9792 1384871 Neuro1_000671 CN1CCN(CC1)c2nc(nc3ccccc23)c4ccc(Cl)c(Cl)c4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 O12 compound treatment 10.7023 -2.7754 -0.7447 11.5446 -1.025 -0.2429 -0.6983 -0.8915 1260329 Neuro1_000672 CCC(Nc1ncnc2ccc(Br)cc12)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 O13 compound treatment 15.4216 1.9439 0.5216 26.6617 14.092 3.3389 2.7298 0.8078 1616520 Neuro1_000673 COc1ccc(Nc2nc(nc3ccccc23)c4ccncc4)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 O14 compound treatment 13.0722 -0.40552 -0.1088 9.2417 -3.328 -0.7885 -0.6345 -0.7971 1565343 Neuro1_000674 OC(=O)c1cccc(Nc2nc(nc3ccccc23)c4ccccc4)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 O15 compound treatment 11.2418 -2.2359 -0.5999 10.1875 -2.3821 -0.5644 -0.8233 -0.9995 1630999 Neuro1_000675 C(Cc1ccccc1)Nc2nc(nc3ccccc23)c4cccnc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 O16 compound treatment 12.0081 -1.4696 -0.3943 12.0116 -0.55808 -0.1322 -0.3723 -0.8952 1141931 Neuro1_000676 Clc1ccc(cc1)c2nc(NCCN3CCOCC3)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 O17 compound treatment 10.2096 -3.2681 -0.8769 8.836 -3.7336 -0.8846 -1.2456 -1.0 1165000 Neuro1_000677 Cc1ccc(Nc2ncnc3ccc(Br)cc23)cc1C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 O18 compound treatment 11.8771 -1.6006 -0.4295 12.1449 -0.42472 -0.1006 -0.3748 -0.8498 3652953 Neuro1_000678 CN1CCN(CC1)c2nc(/C=C/c3ccccc3)nc4ccccc24 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 O19 compound treatment 9.3304 -4.1473 -1.1128 8.2495 -4.3201 -1.0236 -1.5107 -0.9991 1194253 Neuro1_000679 CCN1CCN(CC1)c2ncnc3ccc(Br)cc23 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 O20 compound treatment 10.9873 -2.4903 -0.6682 10.9105 -1.6592 -0.3931 -0.7505 -0.968 1974698 Neuro1_000680 COCCCNc1nc(nc2ccccc12)c3ccc(cc3)[N+](=O)[O-] 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 O21 compound treatment 12.2577 -1.22 -0.3273 9.7389 -2.8308 -0.6707 -0.7057 -0.9456 1933893 Neuro1_000681 CC(=O)c1ccc(Nc2nc(nc3ccccc23)c4ccccc4O)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 O22 compound treatment 24.3618 10.884 2.9205 12.1956 -0.37408 -0.0886 2.0024 0.6853 1864034 Neuro1_000682 COc1ccc(Nc2nc(nc3ccccc23)c4ccc(cc4)[N+](=O)[O-])cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 O23 mock treatment 11.802 -1.6757 -0.4496 11.29 -1.2796 -0.3032 -0.5323 -0.9816 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 O24 mock treatment 13.448 -0.02969 -0.008 12.0018 -0.56784 -0.1345 -0.1008 -0.7477 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 P01 compound treatment 22.6792 9.2015 2.469 17.0637 4.4941 1.0648 2.4988 0.9293 3652955 Neuro1_000683 CC(=O)c1cccc(Nc2nc(nc3ccccc23)c4ccc(Cl)cc4Cl)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 P02 compound treatment 26.5823 13.105 3.5163 21.6061 9.0364 2.141 4.0004 0.9717 1419363 Neuro1_000684 CCOC(=O)c1cccc(Nc2nc(nc3ccccc23)c4ccc(Cl)cc4)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 P03 compound treatment 25.3208 11.843 3.1778 12.2069 -0.36277 -0.086 2.1863 0.6877 1618578 Neuro1_000685 COC(=O)c1ccc(Nc2nc(nc3ccccc23)c4ccc(Cl)cc4Cl)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 P04 compound treatment 11.4041 -2.0736 -0.5564 11.5909 -0.97869 -0.2319 -0.5574 -0.9247 1276280 Neuro1_000686 Cc1cccc(Nc2nc(nc3ccccc23)c4ccc(Cl)cc4)c1C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 P05 compound treatment 12.3813 -1.0964 -0.2942 11.3117 -1.258 -0.2981 -0.4188 -1.0 1864053 Neuro1_000687 [O-][N+](=O)c1ccc(cc1)c2nc(NCc3ccco3)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 P06 compound treatment 12.9176 -0.56005 -0.1503 11.0093 -1.5603 -0.3697 -0.3677 -0.9213 1334348 Neuro1_000688 O=C(Oc1cccc(Nc2ncnc3ccccc23)c1)c4cccs4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 P07 compound treatment 12.8332 -0.64447 -0.1729 12.0737 -0.49591 -0.1175 -0.2054 -0.9823 1287828 Neuro1_000689 CN1CCN(CC1)c2nc(NCc3ccco3)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 P08 compound treatment 12.677 -0.80072 -0.2149 11.3522 -1.2174 -0.2885 -0.3559 -0.9895 1652815 Neuro1_000690 CN(Cc1ccccc1)c2nc(nc3ccccc23)c4cccc(C)c4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 P09 compound treatment 13.5157 0.038035 0.0102 13.2129 0.64321 0.1524 0.115 0.7528 1864049 Neuro1_000691 [O-][N+](=O)c1ccc(cc1)c2nc(NCc3ccccc3)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 P10 compound treatment 10.9536 -2.5241 -0.6773 10.4568 -2.1129 -0.5006 -0.8329 -0.9889 1329450 Neuro1_000692 COc1cc(cc(OC)c1OC)C(=O)Oc2cccc(Nc3ncnc4ccccc34)c2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 P11 compound treatment 11.5787 -1.899 -0.5096 12.9099 0.34024 0.0806 -0.3033 -0.5879 3652956 Neuro1_000693 [O-][N+](=O)c1ccc(cc1)c2nc(Nc3ccc4OCCOc4c3)c5ccccc5n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 P12 compound treatment 12.5913 -0.88637 -0.2378 12.0336 -0.53604 -0.127 -0.258 -0.9568 1481183 Neuro1_000694 Cc1cccc(c1)c2nc(NCc3cccnc3)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 P13 compound treatment 14.3488 0.87106 0.2337 11.8856 -0.68402 -0.1621 0.0507 0.1782 1974536 Neuro1_000695 CCN(CC)CCCNc1nc(nc2ccccc12)c3ccc(Cl)cc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 P14 compound treatment 22.3977 8.9201 2.3935 19.5612 6.9915 1.6565 2.8638 0.9838 3652957 Neuro1_000696 CN(C)CCCNc1nc(nc2ccccc12)c3ccccc3O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 P15 compound treatment 12.5883 -0.88937 -0.2386 12.1646 -0.40509 -0.096 -0.2366 -0.9199 1864026 Neuro1_000697 [O-][N+](=O)c1ccc(cc1)c2nc(Nc3ccc(Cl)cc3)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 P16 compound treatment 12.3346 -1.1431 -0.3067 9.7983 -2.7714 -0.6566 -0.6812 -0.9399 1227490 Neuro1_000698 COc1ccc(Nc2nc(nc3ccccc23)c4ccccc4O)c(OC)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 P17 compound treatment 12.4317 -1.046 -0.2807 13.0134 0.44377 0.1051 -0.1241 -0.4141 1672057 Neuro1_000699 CC(C)(C)c1ccc(cc1)c2nc(NCCN3CCOCC3)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 P18 compound treatment 11.4844 -1.9933 -0.5348 9.9984 -2.5712 -0.6092 -0.809 -0.9979 1204793 Neuro1_000700 COc1ccc(Nc2ncnc3ccc(Br)cc23)cc1OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 P19 compound treatment 18.9703 5.4926 1.4738 17.4125 4.8428 1.1474 1.8535 0.9923 1864298 Neuro1_000701 [O-][N+](=O)c1cccc(Nc2nc(nc3ccccc23)c4ccccc4Cl)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 P20 compound treatment 13.5718 0.094072 0.0252 10.4694 -2.1003 -0.4976 -0.334 -0.6704 1679198 Neuro1_000702 CC(C)(C)c1ccc(cc1)c2nc(Nc3cccc(c3)C(=O)O)c4ccccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 P21 compound treatment 10.9089 -2.5688 -0.6893 10.8016 -1.768 -0.4189 -0.7836 -0.9715 1267483 Neuro1_000703 Cc1c(Cl)cccc1Nc2nc(nc3ccccc23)c4ccccc4Cl 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 P22 compound treatment 10.8722 -2.6055 -0.6991 12.018 -0.55162 -0.1307 -0.5868 -0.825 3652958 Neuro1_000704 COC(=O)c1ccc(Nc2nc(nc3ccccc23)c4ccccc4F)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 P23 mock treatment 10.6231 -2.8546 -0.766 13.0997 0.53009 0.1256 -0.4528 -0.5834 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2436 P24 mock treatment 15.0583 1.5806 0.4241 12.4297 -0.13994 -0.0332 0.2764 0.6498 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 A01 compound treatment 35.804 25.177 6.7555 15.7365 9.9874 2.3664 6.4502 0.9011 3636025 DAlc3.1-H_000321 CO[C@H]1O[C@H](COC(=O)NCCCCCC(=O)NO)[C@@H](OC(=O)Nc2ccccc2c3ccccc3)[C@H](OC(=O)Nc4ccccc4)[C@@H]1OC(=O)Nc5ccccc5 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 A02 compound treatment 13.5205 2.8931 0.7763 13.2307 7.4815 1.7726 1.8024 0.9314 3636027 DAlc3.1-H_000322 CO[C@H]1O[C@H](COC(=O)NCCCCCC(=O)NO)[C@@H](OC(=O)c2ccc(Br)cc2)[C@H](OC(=O)c3cc4ccccc4[nH]3)[C@H]1OC(=O)c5cc6ccccc6[nH]5 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 A03 compound treatment 11.8049 1.1774 0.3159 12.4716 6.7224 1.5928 1.3497 0.8312 3636029 DAlc3.1-H_000323 CO[C@H]1O[C@H](COC(=O)NCCCCCC(=O)NO)[C@@H](OC(=O)c2ccc(Br)cc2)[C@@H]3OC(=O)[C@@H](Cc4ccccc4)C/C=C/C[C@H](Cc5ccccc5)C(=O)O[C@@H]13 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 A04 compound treatment 13.5221 2.8947 0.7767 12.7549 7.0058 1.6599 1.723 0.9401 3636031 DAlc3.1-H_000324 CO[C@H]1O[C@H](COC(=O)NCCCCCC(=O)NO)[C@@H](OC(=O)c2c(OC)cccc2OC)[C@H](OC(=O)c3cc4ccccc4[nH]3)[C@H]1OC(=O)c5cc6ccccc6[nH]5 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 A05 compound treatment 15.5358 4.9084 1.317 10.7859 5.0367 1.1934 1.7751 0.9988 3636033 DAlc3.1-H_000325 CO[C@H]1O[C@H](COC(=O)NCCCCCC(=O)NO)[C@@H](OC(=O)c2c(OC)cccc2OC)[C@@H]3OC(=O)[C@@H](Cc4ccccc4)C/C=C/C[C@H](Cc5ccccc5)C(=O)O[C@@H]13 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 A06 compound treatment 12.9184 2.291 0.6147 12.235 6.4859 1.5367 1.5213 0.9192 3636035 DAlc3.1-H_000326 COC(=O)[C@]1(CC=C)N=C(O[C@@H]1c2ccccc2)c3ccc(OCCCOC(=O)NCCCCCC(=O)NO)cc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 A07 compound treatment 12.9779 2.3505 0.6307 10.8053 5.0561 1.198 1.2931 0.9551 3636037 DAlc3.1-H_000327 CO[C@H]1O[C@H](COC(=O)NCCCCCC(=O)NO)[C@@H](OC(=O)Nc2cccc(F)c2)[C@@H]3OC(=O)[C@@H](Cc4ccccc4)C/C=C/C[C@H](Cc5ccccc5)C(=O)O[C@@H]13 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 A08 compound treatment 13.7891 3.1617 0.8484 12.2464 6.4972 1.5394 1.6884 0.9606 3636039 DAlc3.1-H_000328 COC(=O)[C@@]1(CC=C)COC(=N1)c2ccc(OCCCOC(=O)NCCCCCC(=O)NO)cc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 A09 compound treatment 47.5436 36.916 9.9056 23.7841 18.035 4.2731 10.0258 0.9294 3636041 DAlc3.1-H_000329 CO[C@H]1O[C@H](COC(=O)NCCCCCC(=O)NO)[C@@H](OC(=O)Nc2ccc(OC)cc2)[C@@H]3OC(=O)[C@@H](Cc4ccccc4)C/C=C/C[C@H](Cc5ccccc5)C(=O)O[C@@H]13 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 A10 compound treatment 11.915 1.2876 0.3455 9.9367 4.1875 0.9922 0.9459 0.9003 3636043 DAlc3.1-H_000330 COC(=O)[C@@]1(Cc2ccccc2)COC(=N1)c3ccc(OCCCOC(=O)NCCCCCC(=O)NO)cc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 A11 compound treatment 14.6329 4.0055 1.0748 15.664 9.9148 2.3492 2.4211 0.9372 3636045 DAlc3.1-H_000331 CO[C@H]1O[C@H](COC(=O)NCCCCCC(=O)NO)[C@@H](OC(=O)Nc2ccc(C#N)cc2)[C@@H]3OC(=O)[C@@H](Cc4ccccc4)C/C=C/C[C@H](Cc5ccccc5)C(=O)O[C@@H]13 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 A12 compound treatment 16.6688 6.0414 1.6211 13.1729 7.4237 1.7589 2.39 0.9992 3636047 DAlc3.1-H_000332 COC(=O)[C@@]1(CCS(=O)(=O)c2ccccc2)COC(=N1)c3ccc(OCCCOC(=O)NCCCCCC(=O)NO)cc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 A13 mock treatment 9.1653 -1.4621 -0.3923 10.0471 4.2979 1.0183 0.4427 0.4056 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 A14 mock treatment 11.2961 0.66864 0.1794 10.2182 4.469 1.0589 0.8756 0.8153 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 A15 compound treatment 15.3141 4.6866 1.2575 12.132 6.3828 1.5123 1.9586 0.9958 3636049 DAlc3.1-H_000333 CO[C@H]1O[C@H](COC(=O)NCCCCCC(=O)NO)[C@@H](OC(=O)c2c(OC)cccc2OC)[C@@H]3OC(=O)[C@H](Cc4ccccc4)C/C=C/C[C@@H](Cc5ccccc5)C(=O)O[C@@H]13 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 A16 compound treatment 16.0255 5.3981 1.4485 12.2264 6.4772 1.5347 2.1094 0.9996 3556558 DAlc3.1-H_000334 COC(=O)[C@]1(CCS(=O)(=O)c2ccccc2)N=C(O[C@@H]1c3ccccc3)c4ccc(OCCCOC(=O)NCCCCCC(=O)NO)cc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 A17 compound treatment 13.8107 3.1833 0.8541 11.5434 5.7942 1.3729 1.5747 0.9739 3636050 DAlc3.1-H_000335 CO[C@H]1O[C@H](COC(=O)NCCCCCC(=O)NO)[C@@H](OC(=O)Nc2ccc(OC)cc2)[C@@H]3OC(=O)[C@H](Cc4ccccc4)C/C=C/C[C@@H](Cc5ccccc5)C(=O)O[C@@H]13 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 A18 compound treatment 17.3649 6.7374 1.8078 18.7227 12.974 3.0739 3.4519 0.968 3636051 DAlc3.1-H_000336 NC(=O)[C@]1(CCS(=O)(=O)c2ccccc2)N=C(O[C@@H]1c3ccccc3)c4ccc(OCCCOC(=O)NCCCCCC(=O)NO)cc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 A19 compound treatment 17.0306 6.4032 1.7181 13.3593 7.6101 1.8031 2.4899 0.9997 3636053 DAlc3.1-H_000337 CO[C@H]1O[C@H](COC(=O)NCCCCCC(=O)NO)[C@@H](OC(=O)Nc2ccc3OCOc3c2)[C@@H]4OC(=O)[C@H](Cc5ccccc5)C/C=C/C[C@@H](Cc6ccccc6)C(=O)O[C@@H]14 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 A20 compound treatment 14.0619 3.4345 0.9216 15.4727 9.7235 2.3038 2.2807 0.9191 3636055 DAlc3.1-H_000338 ONC(=O)CCCCCNC(=O)OCCCOc1ccc(cc1)C2=N[C@@](CCS(=O)(=O)c3ccccc3)([C@@H](O2)c4ccccc4)C(=O)NCCN5CCOCC5 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 A21 compound treatment 14.4013 3.7739 1.0126 13.8568 8.1076 1.921 2.0744 0.9553 3636057 DAlc3.1-H_000339 CO[C@H]1O[C@H](COC(=O)NCCCCCC(=O)NO)[C@@H](OC(=O)c2c(OC)cccc2OC)[C@@H]3OC(=O)[C@@H](Cc4ccc5ccccc5c4)C/C=C/C[C@H](Cc6ccc7ccccc7c6)C(=O)O[C@@H]13 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 A22 compound treatment 31.3401 20.713 5.5577 22.2814 16.532 3.9171 6.6997 0.9853 3636059 DAlc3.1-H_000340 ONC(=O)CCCCCNC(=O)OCCCOc1ccc(cc1)C2=N[C@@](Cc3ccccc3)([C@@H](O2)c4ccccc4)C(=O)N5CCOCC5 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 A23 compound treatment 11.8113 1.1839 0.3177 14.1451 8.3959 1.9893 1.6313 0.8098 3636061 DAlc3.1-H_000341 CO[C@H]1O[C@H](COC(=O)NCCCCCC(=O)NO)[C@@H](OC(=O)Nc2ccc(OC)cc2)[C@@H]3OC(=O)[C@@H](Cc4ccc5ccccc5c4)C/C=C/C[C@H](Cc6ccc7ccccc7c6)C(=O)O[C@@H]13 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 A24 compound treatment 13.8704 3.243 0.8702 16.383 10.634 2.5195 2.3969 0.8992 3636063 DAlc3.1-H_000342 ONC(=O)CCCCCNC(=O)OCCCOc1ccc(cc1)C2=N[C@@](Cc3ccccc3)([C@@H](O2)c4ccccc4)C(=O)NCCN5CCOCC5 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 B01 compound treatment 12.9717 2.3443 0.629 10.3321 4.5829 1.0859 1.2126 0.9663 3636065 DAlc3.1-H_000343 CC(C)CNC(=O)[C@]1(Cc2ccccc2I)[C@@H](N(Cc3ccccc3Cl)C(=O)c4ccccc41)c5ccc(COC(=O)NCCCCCC(=O)NO)cc5 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 B02 compound treatment 29.6128 18.985 5.0943 22.7921 17.043 4.0381 6.4575 0.9934 3636067 DAlc3.1-H_000344 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CCn4cc(CCOC(=O)NCCCCCC(=O)NO)nn4)C(=O)N(CC=C)c5ccc(cc53)N6CCC6=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 B03 compound treatment 9.229 -1.3984 -0.3752 10.5068 4.7576 1.1272 0.5317 0.4476 3636069 DAlc3.1-H_000345 CCCNC(=O)[C@]1(CC(=O)N(C2Cc3ccccc3C2)[C@@H]1c4ccc(COC(=O)NCCCCCC(=O)NO)cc4)Sc5ccc(C)cc5 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 B04 compound treatment 14.0879 3.4604 0.9285 13.4323 7.6831 1.8204 1.9438 0.9512 3636071 DAlc3.1-H_000346 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CCOC(=O)NCCCCCC(=O)NO)C(=O)N(Cc4ccccc4)c5ccc(cc53)N6CCC6=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 B05 compound treatment 11.6661 1.0386 0.2787 11.5951 5.8459 1.3851 1.1765 0.8327 3636073 DAlc3.1-H_000347 CC(C)CN1C(=O)[C@]2(Cc3ccccc13)[C@@H](N(Cc4ccccc4Cl)C(=O)c5ccccc52)c6ccc(COC(=O)NCCCCCC(=O)NO)cc6 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 B06 compound treatment 24.082 13.455 3.6102 20.4862 14.737 3.4917 5.0218 0.9999 3636075 DAlc3.1-H_000348 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CCn4cc(CCOC(=O)NCCCCCC(=O)NO)nn4)C(=O)N(Cc5cccc(c5)N6CCC6=O)c7ccccc73 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 B07 compound treatment 15.2223 4.5949 1.2329 13.6905 7.9413 1.8816 2.2023 0.979 3636077 DAlc3.1-H_000349 CC(C)CNC(=O)[C@]1(Cc2ccccc2I)[C@@H](N(Cc3ccccc3)C(=O)c4ccccc41)c5ccc(COC(=O)NCCCCCC(=O)NO)cc5 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 B08 compound treatment 14.9746 4.3472 1.1665 14.0596 8.3104 1.969 2.2171 0.9688 3636079 DAlc3.1-H_000350 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CCOC(=O)NCCCCCC(=O)NO)C(=O)N(Cc4cccc(c4)N5CCC5=O)c6ccccc63 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 B09 compound treatment 12.9713 2.3438 0.6289 13.2659 7.5167 1.781 1.704 0.9022 3636081 DAlc3.1-H_000351 CC(C)CNC(=O)[C@]1(CC(=O)N(C2Cc3ccccc3C2)[C@@H]1c4ccc(COC(=O)NCCCCCC(=O)NO)cc4)Sc5ccc(C)cc5 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 B10 compound treatment 18.0084 7.3809 1.9805 16.4348 10.686 2.5318 3.1907 0.9926 3636083 DAlc3.1-H_000352 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CCOC(=O)NCCCCCC(=O)NO)C(=O)N(CC=C)c4ccc(cc43)N5CCC5=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 B11 compound treatment 10.3223 -0.30515 -0.0819 11.4052 5.656 1.3401 0.8897 0.6627 3636084 DAlc3.1-H_000353 Cc1ccc(S[C@@]2(CC(=O)N([C@@H]2c3ccc(COC(=O)NCCCCCC(=O)NO)cc3)C4CCCCC4)C(=O)NCc5ccccc5)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 B12 compound treatment 11.7967 1.1693 0.3137 10.9414 5.1922 1.2302 1.0917 0.8599 3636086 DAlc3.1-H_000354 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CC(=O)N4CCC[C@H]4COC(=O)NCCCCCC(=O)NO)C(=O)N(Cc5cccc(c5)N6CCOC6=O)c7ccccc73 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 B13 mock treatment 11.8908 1.2634 0.339 12.4278 6.6786 1.5824 1.3586 0.8395 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 B14 mock treatment 10.3067 -0.32077 -0.0861 11.2502 5.501 1.3034 0.8608 0.659 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 B15 compound treatment 10.8824 0.25497 0.0684 12.2015 6.4523 1.5288 1.1294 0.738 3636088 DAlc3.1-H_000355 CC(C)N1[C@H](c2ccc(COC(=O)NCCCCCC(=O)NO)cc2)[C@@](CC1=O)(Sc3ccc(C)cc3)C(=O)NCC(F)(F)F 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 B16 compound treatment 26.9891 16.362 4.3903 26.7652 21.016 4.9794 6.6254 0.998 3636090 DAlc3.1-H_000356 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CCn4cc(CCOC(=O)NCCCCCC(=O)NO)nn4)C(=O)N(Cc5ccc(cc5)N6CCC6=O)c7ccccc73 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 B17 compound treatment 10.1562 -0.47127 -0.1265 10.8725 5.1233 1.2139 0.7689 0.63 3636092 DAlc3.1-H_000357 COCCCN1C(=O)[C@]2(Cc3ccccc13)[C@@H](N(Cc4ccccc4)C(=O)c5ccccc52)c6ccc(COC(=O)NCCCCCC(=O)NO)cc6 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 B18 compound treatment 11.3958 0.76833 0.2062 13.8573 8.1081 1.9211 1.5042 0.7785 3636094 DAlc3.1-H_000358 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CCn4cc(CCOC(=O)NCCCCCC(=O)NO)nn4)C(=O)N(CC=C)c5ccc(cc53)N6CCC6=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 B19 compound treatment 12.9059 2.2785 0.6114 11.5489 5.7997 1.3742 1.404 0.9335 3636095 DAlc3.1-H_000359 CCCNC(=O)[C@]1(CC(=O)N(Cc2ccccc2)[C@@H]1c3ccc(COC(=O)NCCCCCC(=O)NO)cc3)Sc4ccc(C)cc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 B20 compound treatment 12.5131 1.8857 0.506 13.7492 8.0 1.8955 1.6981 0.8656 3636097 DAlc3.1-H_000360 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CCOC(=O)NCCCCCC(=O)NO)C(=O)N(Cc4cccc(c4)N5CCC5=O)c6ccccc63 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 B21 compound treatment 11.7721 1.1446 0.3071 10.7829 5.0337 1.1927 1.0605 0.8611 3636098 DAlc3.1-H_000361 ONC(=O)CCCCCNC(=O)OCc1ccc(cc1)[C@@H]2N(Cc3ccccc3)C(=O)c4ccccc4[C@]52Cc6ccccc6N(C7CC7)C5=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 B22 compound treatment 17.9203 7.2929 1.9569 19.1245 13.375 3.1691 3.6246 0.9732 3636100 DAlc3.1-H_000362 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CCn4cc(CCOC(=O)NCCCCCC(=O)NO)nn4)C(=O)N(Cc5ccc(cc5)N6CCC6=O)c7ccccc73 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 B23 compound treatment 12.724 2.0966 0.5626 13.0152 7.266 1.7216 1.6151 0.8918 3636101 DAlc3.1-H_000363 CCCNC(=O)[C@]1(CC(=O)N(C(C)C)[C@@H]1c2ccc(COC(=O)NCCCCCC(=O)NO)cc2)Sc3ccc(C)cc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 B24 compound treatment 20.8964 10.269 2.7554 19.8716 14.122 3.3461 4.3144 0.9953 3636103 DAlc3.1-H_000364 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CCn4cc(CCOC(=O)NCCCCCC(=O)NO)nn4)C(=O)N(C)c5c3cc(C)cc5Br 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 C01 compound treatment 13.5044 2.8769 0.772 12.0214 6.2722 1.4861 1.5967 0.9535 3636105 DAlc3.1-H_000365 NC(=O)NCC#Cc1ccc2NC(=O)[C@]3([C@@H]([C@@H]4N([C@@H]3c5ccc(OCCOC(=O)NCCCCCC(=O)NO)cc5)[C@H]([C@H](OC4=O)c6ccccc6)c7ccccc7)C(=O)N)c2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 C02 compound treatment 43.3513 32.724 8.7806 39.2732 33.524 7.943 11.8254 0.9987 3636107 DAlc3.1-H_000366 NC(=O)[C@]1(CC=C)N=C(O[C@@H]1c2ccccc2)c3ccc(OCCCOC(=O)NCCCCCC(=O)NO)cc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 C03 compound treatment 11.7225 1.0951 0.2938 10.974 5.2248 1.2379 1.0831 0.8513 3636109 DAlc3.1-H_000367 ONC(=O)CCCCCNC(=O)OCCOc1ccccc1[C@@H]2N3[C@H]([C@H](C(=O)NCC=C)[C@@]24C(=O)Nc5ccccc54)C(=O)O[C@H]([C@H]3c6ccccc6)c7ccccc7 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 C04 compound treatment 23.736 13.109 3.5174 25.7339 19.985 4.7351 5.8354 0.9893 3636111 DAlc3.1-H_000368 COC(=O)[C@@]1(CC=C)N=C(O[C@H]1c2ccccc2)c3ccc(OCCCOC(=O)NCCCCCC(=O)NO)cc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 C05 compound treatment 12.188 1.5605 0.4187 13.0983 7.3491 1.7413 1.5274 0.8528 3636112 DAlc3.1-H_000369 ONC(=O)CCCCCNC(=O)OCCOc1ccc(cc1)[C@@H]2N3[C@H]([C@H](C(=O)N4CCN(CC4)c5ncccn5)[C@@]26C(=O)Nc7ccc(C#CC8=CCCCC8)cc76)C(=O)O[C@H]([C@H]3c9ccccc9)c%10ccccc%10 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 C06 compound treatment 12.172 1.5445 0.4144 12.4136 6.6644 1.579 1.4096 0.8635 3556560 DAlc3.1-H_000370 COC(=O)[C@]1(Cc2ccccc2)N=C(O[C@@H]1c3ccccc3)c4ccc(OCCCOC(=O)NCCCCCC(=O)NO)cc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 C07 compound treatment 10.7657 0.13828 0.0371 9.2208 3.4716 0.8225 0.6079 0.7383 3636114 DAlc3.1-H_000371 ONC(=O)CCCCCNC(=O)OCCOc1ccccc1[C@@H]2N3[C@H]([C@H](C(=O)NCC=C)[C@@]24C(=O)Nc5ccc(C#CC6(O)CCCCCC6)cc54)C(=O)O[C@H]([C@H]3c7ccccc7)c8ccccc8 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 C08 compound treatment 32.498 21.871 5.8684 30.8806 25.131 5.9545 8.3601 1.0 3636116 DAlc3.1-H_000372 COC(=O)[C@@]1(CCS(=O)(=O)c2ccccc2)N=C(O[C@H]1c3ccccc3)c4ccc(OCCCOC(=O)NCCCCCC(=O)NO)cc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 C09 compound treatment 18.5171 7.8897 2.117 16.8864 11.137 2.6388 3.3629 0.994 3636117 DAlc3.1-H_000373 ONC(=O)CCCCCNC(=O)OCCOc1ccccc1[C@@H]2N3[C@H]([C@H](C(=O)N4CCCCCCC4)[C@@]25C(=O)Nc6ccccc65)C(=O)O[C@H]([C@H]3c7ccccc7)c8ccccc8 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 C10 compound treatment 10.6817 0.054314 0.0146 12.0238 6.2747 1.4867 1.0616 0.714 3636119 DAlc3.1-H_000374 CC(C)(C)OC(=O)CC[C@]12N=C(O[C@@H]2c3ccccc3CN(CCS(=O)(=O)c4ccccc4)C1=O)c5ccc(OCCCOC(=O)NCCCCCC(=O)NO)cc5 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 C11 mock treatment 12.175 1.5475 0.4152 9.326 3.5769 0.8475 0.8929 0.9461 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 C12 mock treatment 11.873 1.2456 0.3342 10.0888 4.3396 1.0282 0.9634 0.8911 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 C13 compound treatment 8.2533 -2.3741 -0.637 12.3433 6.5942 1.5624 0.6543 0.3878 3636121 DAlc3.1-H_000375 COc1cc2CCN(Cc2cc1OC)C(=O)[C@H]3[C@H]4N([C@@H](c5ccc(OCCOC(=O)NCCCCCC(=O)NO)cc5)[C@]36C(=O)Nc7ccccc76)[C@@H]([C@@H](OC4=O)c8ccccc8)c9ccccc9 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 C14 compound treatment 12.6871 2.0597 0.5527 10.6555 4.9063 1.1625 1.2128 0.9422 3636123 DAlc3.1-H_000376 ONC(=O)CCCCCNC(=O)OCCCOc1ccc(cc1)C2=N[C@]3(Cc4ccccc4)[C@H](O2)c5ccccc5CN(CCS(=O)(=O)c6ccccc6)C3=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 C15 mock treatment 9.8984 -0.72904 -0.1956 9.4536 3.7044 0.8777 0.4823 0.5363 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 C16 mock treatment 9.8061 -0.82128 -0.2204 10.6389 4.8897 1.1585 0.6634 0.5625 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 C17 compound treatment 10.1868 -0.44065 -0.1182 8.6779 2.9287 0.6939 0.4071 0.5783 3636125 DAlc3.1-H_000377 ONC(=O)CCCCCNC(=O)OCCOc1ccc(cc1)[C@H]2N3[C@@H]([C@@H](C(=O)N4CCN(CC4)c5ncccn5)[C@]26C(=O)Nc7ccc(C#CC8=CCCCC8)cc76)C(=O)O[C@@H]([C@@H]3c9ccccc9)c%10ccccc%10 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 C18 compound treatment 13.4761 2.8486 0.7644 10.7633 5.0141 1.188 1.3805 0.9773 3636126 DAlc3.1-H_000378 CC(C)(C)OC(=O)CC[C@@]12N=C(O[C@H]2c3ccccc3CN(CC=C)C1=O)c4ccc(OCCCOC(=O)NCCCCCC(=O)NO)cc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 C19 compound treatment 11.0703 0.44288 0.1188 10.9354 5.1862 1.2288 0.9529 0.7719 3636128 DAlc3.1-H_000379 ONC(=O)CCCCCNC(=O)OCCOc1ccccc1[C@H]2N3[C@@H]([C@@H](C(=O)NCC=C)[C@]24C(=O)Nc5ccc(C#CC6(O)CCCCCC6)cc54)C(=O)O[C@@H]([C@@H]3c7ccccc7)c8ccccc8 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 C20 compound treatment 10.3152 -0.31218 -0.0838 10.774 5.0248 1.1906 0.7826 0.6557 3636129 DAlc3.1-H_000380 ONC(=O)CCCCCNC(=O)OCCCOc1ccc(cc1)C2=N[C@]3(CC=C)[C@H](O2)c4ccccc4CN(CCS(=O)(=O)c5ccccc5)C3=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 C21 compound treatment 10.0769 -0.55056 -0.1477 12.3885 6.6393 1.5731 1.0079 0.6379 3636131 DAlc3.1-H_000381 COc1ccc(C#Cc2ccc3NC(=O)[C@@]4([C@H]([C@H]5N([C@H]4c6ccccc6OCCOC(=O)NCCCCCC(=O)NO)[C@@H]([C@@H](OC5=O)c7ccccc7)c8ccccc8)C(=O)N9CCN(CC9)c%10ncccn%10)c3c2)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 C22 compound treatment 13.5105 2.8831 0.7736 14.0022 8.253 1.9554 1.9297 0.9176 3636133 DAlc3.1-H_000382 ONC(=O)CCCCCNC(=O)OCCCOc1ccc(cc1)C2=N[C@@]3(Cc4ccccc4CN(CCS(=O)(=O)c5ccccc5)C3=O)[C@@H](O2)c6ccccc6 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 C23 compound treatment 12.4575 1.8301 0.4911 12.7355 6.9863 1.6553 1.5177 0.879 3636135 DAlc3.1-H_000383 ONC(=O)CCCCCNC(=O)OCCOc1ccccc1[C@H]2N3[C@@H]([C@@H](C(=O)N4CCN(CC4)c5ncccn5)[C@]26C(=O)Nc7ccc(C#CC8(O)CCCCCC8)cc76)C(=O)O[C@@H]([C@@H]3c9ccccc9)c%10ccccc%10 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 C24 compound treatment 18.0687 7.4413 1.9967 14.2654 8.5162 2.0178 2.8387 1.0 3636137 DAlc3.1-H_000384 ONC(=O)CCCCCNC(=O)OCCCOc1ccc(cc1)C2=N[C@@]3(Cc4ccccc4CN(Cc5ccccc5)C3=O)[C@@H](O2)c6ccccc6 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 D01 compound treatment 13.356 2.7286 0.7321 12.5593 6.8101 1.6136 1.6587 0.9361 3636139 DAlc3.1-H_000385 Cc1ccc(S[C@@]2(CC(=O)N([C@@H]2c3ccc(COC(=O)NCCCCCC(=O)NO)cc3)C4CCCCC4)C(=O)NC5CC5)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 D02 compound treatment 15.4135 4.7861 1.2842 14.3363 8.5871 2.0346 2.3468 0.9754 3636141 DAlc3.1-H_000386 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CCOC(=O)NCCCCCC(=O)NO)C(=O)N(Cc4ccccc4)c5ccc(cc53)N6CCC6=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 D03 compound treatment 12.7848 2.1574 0.5789 12.7433 6.9941 1.6572 1.5811 0.9007 3636142 DAlc3.1-H_000387 Cc1ccc(S[C@@]2(CC(=O)N(Cc3ccccc3C(F)(F)F)[C@@H]2c4ccc(COC(=O)NCCCCCC(=O)NO)cc4)C(=O)NCCN5CCOCC5)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 D04 compound treatment 10.6049 -0.022473 -0.006 10.6792 4.93 1.1681 0.8217 0.7034 3636144 DAlc3.1-H_000388 C[N+](C)(C)CCCC[C@@H]1NC(=O)[C@@H]2C[C@@H]([C@@H](N2C1=O)c3cccc(OCCOC(=O)NCCCCCC(=O)NO)c3)C(=O)NCc4ccc(F)cc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 D05 compound treatment 11.5664 0.93894 0.2519 11.0663 5.3172 1.2598 1.069 0.832 3636146 DAlc3.1-H_000389 COc1ccc(CCNC(=O)[C@]2(CC(=O)N(Cc3ccccc3Cl)[C@@H]2c4ccc(COC(=O)NCCCCCC(=O)NO)cc4)Sc5ccc(C)cc5)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 D06 compound treatment 9.7844 -0.84297 -0.2262 9.4574 3.7082 0.8786 0.4613 0.5085 3636148 DAlc3.1-H_000390 ONC(=O)CCCCCNC(=O)OCCOc1cccc(c1)[C@H]2[C@H](C[C@@H]3N2C(=O)CNC3=O)C(=O)NCc4ccc(F)cc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 D07 compound treatment 11.9741 1.3467 0.3614 10.0216 4.2724 1.0123 0.9713 0.9037 3636150 DAlc3.1-H_000391 Cc1ccc(S[C@@]2(CC(=O)N(C3Cc4ccccc4C3)[C@@H]2c5ccc(COC(=O)NCCCCCC(=O)NO)cc5)C(=O)NCC(F)(F)F)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 D08 compound treatment 11.1069 0.47947 0.1287 10.4642 4.715 1.1172 0.8809 0.7834 3636152 DAlc3.1-H_000392 ONC(=O)CCCCCNC(=O)OCCOc1cccc(c1)[C@H]2[C@H](C[C@@H]3N2C(=O)[C@@H]4CCCN4C3=O)C(=O)NCc5ccc(F)cc5 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 D09 compound treatment 9.947 -0.68044 -0.1826 9.7329 3.9837 0.9439 0.5383 0.5599 3636154 DAlc3.1-H_000393 COc1ccc(CCNC(=O)[C@]2(CC(=O)N(Cc3ccccc3)[C@@H]2c4ccc(COC(=O)NCCCCCC(=O)NO)cc4)Sc5ccc(C)cc5)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 D10 compound treatment 11.6656 1.0382 0.2786 9.3336 3.5844 0.8493 0.7975 0.8923 3636156 DAlc3.1-H_000394 C[N+](C)(C)CCCCCCNC(=O)[C@@H]1C[C@H]2N([C@@H]1c3cccc(OCCOC(=O)NCCCCCC(=O)NO)c3)C(=O)[C@H](CCCC[N+](C)(C)C)NC2=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 D11 mock treatment 11.3177 0.69023 0.1852 8.7276 2.9784 0.7057 0.63 0.8634 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 D12 mock treatment 10.8362 0.20877 0.056 10.7835 5.0343 1.1928 0.883 0.7395 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 D13 compound treatment 12.2179 1.5905 0.4268 10.2087 4.4596 1.0566 1.0489 0.9205 3636158 DAlc3.1-H_000395 CC(C)NC(=O)[C@]1(CC(=O)N(C(C)C)[C@@H]1c2ccc(COC(=O)NCCCCCC(=O)NO)cc2)Sc3ccc(C)cc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 D14 compound treatment 10.2625 -0.36495 -0.0979 10.58 4.8308 1.1446 0.7401 0.6443 3636160 DAlc3.1-H_000396 ONC(=O)CCCCCNC(=O)OCCOc1cccc(c1)[C@H]2[C@H](C[C@@H]3N2C(=O)[C@H](Cc4ccccc4)NC3=O)C(=O)NCc5ccc(F)cc5 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 D15 mock treatment 11.0728 0.44535 0.1195 10.1917 4.4425 1.0526 0.8288 0.7824 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 D16 mock treatment 8.8832 -1.7442 -0.468 10.5948 4.8456 1.1481 0.4809 0.3879 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 D17 compound treatment 11.095 0.46762 0.1255 8.6924 2.9432 0.6974 0.5818 0.8212 3636162 DAlc3.1-H_000397 COc1ccccc1CN2[C@@H](c3ccc(COC(=O)NCCCCCC(=O)NO)cc3)[C@]4(Cc5ccccc5N(CCN6CCOCC6)C4=O)c7ccccc7C2=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 D18 compound treatment 11.2009 0.57349 0.1539 8.6736 2.9244 0.6929 0.5988 0.8436 3636164 DAlc3.1-H_000398 C[N+](C)(C)CCCC[C@@H]1NC(=O)[C@@H]2C[C@@H]([C@@H](N2C1=O)c3cccc(OCCOC(=O)NCCCCCC(=O)NO)c3)C(=O)OCCOc4ccc(cc4)[C@@H]5N6[C@H]([C@H](C(=O)OCC=C)[C@@]57C(=O)Nc8ccccc87)C(=O)O[C@H]([C@H]6c9ccccc9)c%10ccccc%10 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 D19 compound treatment 10.8522 0.22478 0.0603 10.0106 4.2614 1.0097 0.7566 0.748 3636166 DAlc3.1-H_000399 COc1ccc(CCN2C(=O)[C@]3(Cc4ccccc24)[C@@H](N(C5CCCCC5)C(=O)c6ccccc63)c7ccc(COC(=O)NCCCCCC(=O)NO)cc7)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 D20 compound treatment 11.654 1.0266 0.2755 8.9571 3.2079 0.7601 0.7322 0.9057 3636168 DAlc3.1-H_000400 ONC(=O)CCCCCNC(=O)OCCOc1cccc(c1)[C@H]2[C@H](C[C@@H]3N2C(=O)CNC3=O)C(=O)OCCOc4ccc(cc4)[C@@H]5N6[C@H]([C@H](C(=O)OCC=C)[C@@]57C(=O)Nc8ccccc87)C(=O)O[C@H]([C@H]6c9ccccc9)c%10ccccc%10 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 D21 compound treatment 10.3899 -0.23754 -0.0637 11.0518 5.3026 1.2564 0.8433 0.6704 3636170 DAlc3.1-H_000401 COCCCN1C(=O)[C@]2(Cc3ccccc13)[C@@H](N(C4CCCCC4)C(=O)c5ccccc52)c6ccc(COC(=O)NCCCCCC(=O)NO)cc6 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 D22 compound treatment 10.5525 -0.074873 -0.0201 12.6834 6.9342 1.643 1.1475 0.6984 3636172 DAlc3.1-H_000402 CN(C)CCCC[C@@H]1NC(=O)[C@@H]2C[C@@H]([C@@H](N2C1=O)c3cccc(OCCOC(=O)NCCCCCC(=O)NO)c3)C(=O)OCCOc4ccc(cc4)[C@@H]5N6[C@H]([C@H](C(=O)OCC=C)[C@@]57C(=O)Nc8ccccc87)C(=O)O[C@H]([C@H]6c9ccccc9)c%10ccccc%10 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 D23 compound treatment 12.1688 1.5414 0.4136 11.7203 5.9711 1.4148 1.2929 0.8771 3636174 DAlc3.1-H_000403 CC(C)NC(=O)[C@]1(CC(=O)N(Cc2ccccc2C(F)(F)F)[C@@H]1c3ccc(COC(=O)NCCCCCC(=O)NO)cc3)Sc4ccc(C)cc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 D24 compound treatment 11.4914 0.86393 0.2318 13.0783 7.3291 1.7365 1.3918 0.7945 3636176 DAlc3.1-H_000404 C[N+](C)(C)CCCC[C@@H]1NC(=O)[C@H]2C[C@H]([C@H](N2C1=O)c3cccc(OCCOC(=O)NCCCCCC(=O)NO)c3)C(=O)OCCOc4ccc(cc4)[C@@H]5N6[C@H]([C@H](C(=O)OCC=C)[C@@]57C(=O)Nc8ccccc87)C(=O)O[C@H]([C@H]6c9ccccc9)c%10ccccc%10 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 E01 mock treatment 12.2698 1.6424 0.4407 10.2793 4.5301 1.0733 1.0706 0.9227 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 E02 mock treatment 10.3707 -0.25671 -0.0689 10.1559 4.4067 1.0441 0.6896 0.659 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 E03 compound treatment 11.6914 1.064 0.2855 11.8047 6.0555 1.4348 1.2164 0.8315 3636177 DAlc3.1-H_000405 COc1ccc(C#Cc2ccc3NC(=O)[C@]4([C@@H]([C@@H]5N([C@@H]4c6ccccc6OCCOC(=O)NCCCCCC(=O)NO)[C@H]([C@H](OC5=O)c7ccccc7)c8ccccc8)C(=O)N9CCc%10cc(OC)c(OC)cc%10C9)c3c2)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 E04 compound treatment 10.4319 -0.1955 -0.0525 9.7719 4.0228 0.9531 0.6369 0.6672 3636179 DAlc3.1-H_000406 ONC(=O)CCCCCNC(=O)OCCCOc1ccc(cc1)C2=N[C@]3(Cc4ccccc4CN(Cc5ccccc5)C3=O)[C@H](O2)c6ccccc6 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 E05 compound treatment 9.4303 -1.1971 -0.3212 9.2303 3.4811 0.8248 0.3561 0.4023 3636180 DAlc3.1-H_000407 ONC(=O)CCCCCNC(=O)OCCOc1ccc(cc1)[C@H]2N3[C@@H]([C@@H](C(=O)N4CCCCCCC4)[C@]25C(=O)Nc6ccc(C#CC7(O)CCCCCC7)cc65)C(=O)O[C@@H]([C@@H]3c8ccccc8)c9ccccc9 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 E06 compound treatment 12.887 2.2595 0.6063 11.1736 5.4244 1.2852 1.3375 0.9412 3636182 DAlc3.1-H_000408 CC(C)(C)OC(=O)CC[C@@]12N=C(O[C@H]2c3ccccc3CN(CCS(=O)(=O)c4ccccc4)C1=O)c5ccc(OCCCOC(=O)NCCCCCC(=O)NO)cc5 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 E07 compound treatment 10.7246 0.097179 0.0261 20.8179 15.069 3.5703 2.543 0.7123 3636183 DAlc3.1-H_000409 ONC(=O)CCCCCNC(=O)OCCOc1ccccc1[C@@H]2N3[C@H]([C@H](C(=O)N4CCN(CC4)c5ncccn5)[C@@]26C(=O)Nc7ccc(C#CC8=CCCCC8)cc76)C(=O)O[C@H]([C@H]3c9ccccc9)c%10ccccc%10 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 E08 compound treatment 10.5668 -0.060603 -0.0163 0.0 -5.7492 -1.3622 -0.9747 -0.7155 3636185 DAlc3.1-H_000410 CC(C)(C)OC(=O)CC[C@]12N=C(O[C@@H]2c3ccccc3CN(CC=C)C1=O)c4ccc(OCCCOC(=O)NCCCCCC(=O)NO)cc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 E09 mock treatment 9.8818 -0.74561 -0.2001 11.2578 5.5086 1.3052 0.7814 0.5918 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 E10 mock treatment 10.5557 -0.071726 -0.0192 12.1009 6.3517 1.5049 1.0505 0.698 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 E11 compound treatment 10.816 0.18862 0.0506 4.4443 -1.3049 -0.3092 -0.1828 -0.5836 3636186 DAlc3.1-H_000411 NC(=O)NCC#Cc1ccc2NC(=O)[C@@]3([C@H]([C@H]4N([C@H]3c5ccc(OCCOC(=O)NCCCCCC(=O)NO)cc5)[C@@H]([C@@H](OC4=O)c6ccccc6)c7ccccc7)C(=O)N)c2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 E12 compound treatment 12.8646 2.2372 0.6003 0.0 -5.7492 -1.3622 -0.5387 -0.3619 3636187 DAlc3.1-H_000412 ONC(=O)CCCCCNC(=O)OCCCOc1ccc(cc1)C2=N[C@@]3(CC=C)[C@@H](O2)c4ccccc4CN(CCS(=O)(=O)c5ccccc5)C3=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 E13 compound treatment 10.3539 -0.27348 -0.0734 8.6472 2.898 0.6866 0.4336 0.628 3636188 DAlc3.1-H_000413 NC(=O)[C@H]1[C@H]2N([C@@H](c3ccccc3OCCOC(=O)NCCCCCC(=O)NO)[C@]14C(=O)Nc5ccc(C#CC6=CCCCC6)cc54)[C@@H]([C@@H](OC2=O)c7ccccc7)c8ccccc8 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 E14 compound treatment 11.2619 0.6345 0.1703 11.6877 5.9385 1.407 1.1153 0.7869 3636190 DAlc3.1-H_000414 ONC(=O)CCCCCNC(=O)OCCCOc1ccc(cc1)C2=N[C@@]3(Cc4ccccc4)[C@@H](O2)c5ccccc5CN(CC=C)C3=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 E15 compound treatment 11.0293 0.40186 0.1078 1.8534 -3.8958 -0.9231 -0.5765 -0.6203 3636192 DAlc3.1-H_000415 COc1cc2CCN(Cc2cc1OC)C(=O)[C@@H]3[C@@H]4N([C@H](c5ccccc5OCCOC(=O)NCCCCCC(=O)NO)[C@@]36C(=O)Nc7ccc(C#CC8=CCCCC8)cc76)[C@H]([C@H](OC4=O)c9ccccc9)c%10ccccc%10 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 E16 compound treatment 11.5252 0.89775 0.2409 0.0 -5.7492 -1.3622 -0.7929 -0.5732 3636194 DAlc3.1-H_000416 ONC(=O)CCCCCNC(=O)OCCCOc1ccc(cc1)C2=N[C@]3(Cc4ccccc4)[C@H](O2)c5ccccc5CN(CC=C)C3=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 E17 mock treatment 9.8349 -0.79249 -0.2126 5.155 -0.59415 -0.1408 -0.2499 -0.9799 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 E18 mock treatment 10.9492 0.32183 0.0864 0.0 -5.7492 -1.3622 -0.9021 -0.661 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 E19 compound treatment 11.3137 0.68628 0.1841 9.7638 4.0146 0.9512 0.8028 0.8286 3636195 DAlc3.1-H_000417 ONC(=O)CCCCCNC(=O)OCCOc1ccc(cc1)[C@@H]2N3[C@H]([C@H](C(=O)N4CCCCCCC4)[C@@]25C(=O)Nc6ccccc65)C(=O)O[C@H]([C@H]3c7ccccc7)c8ccccc8 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 E20 compound treatment 14.0126 3.3852 0.9083 14.884 9.1348 2.1644 2.1727 0.9256 3636197 DAlc3.1-H_000418 ONC(=O)CCCCCNC(=O)OCCCOc1ccc(cc1)C2=N[C@](CCS(=O)(=O)c3ccccc3)([C@H](O2)c4ccccc4)C(=O)NCCN5CCOCC5 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 E21 compound treatment 11.3909 0.76347 0.2049 10.1973 4.4482 1.0539 0.8901 0.829 3636198 DAlc3.1-H_000419 NC(=O)[C@@H]1[C@@H]2N([C@H](c3ccccc3OCCOC(=O)NCCCCCC(=O)NO)[C@@]14C(=O)Nc5ccc(C#CC6(O)CCCCCC6)cc54)[C@H]([C@H](OC2=O)c7ccccc7)c8ccccc8 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 E22 compound treatment 13.0528 2.4254 0.6508 11.9268 6.1777 1.4637 1.4952 0.9334 3636200 DAlc3.1-H_000420 ONC(=O)CCCCCNC(=O)OCCCOc1ccc(cc1)C2=N[C@](CCS(=O)(=O)c3ccccc3)(CO2)C(=O)NCCN4CCOCC4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 E23 compound treatment 12.3836 1.7562 0.4712 9.3934 3.6442 0.8634 0.9438 0.9594 3636202 DAlc3.1-H_000421 COc1ccc(C#Cc2ccc3NC(=O)[C@]4([C@@H]([C@@H]5N([C@@H]4c6ccc(OCCOC(=O)NCCCCCC(=O)NO)cc6)[C@H]([C@H](OC5=O)c7ccccc7)c8ccccc8)C(=O)N)c3c2)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 E24 compound treatment 28.0895 17.462 4.6855 0.0 -5.7492 -1.3622 2.35 0.4816 3636204 DAlc3.1-H_000422 COCCCNC(=O)[C@@]1(CC=C)COC(=N1)c2ccc(OCCCOC(=O)NCCCCCC(=O)NO)cc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 F01 mock treatment 12.9189 2.2915 0.6149 9.7217 3.9725 0.9412 1.1003 0.9787 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 F02 mock treatment 12.1204 1.493 0.4006 11.2164 5.4672 1.2954 1.1992 0.8845 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 F03 compound treatment 14.2941 3.6667 0.9839 12.2864 6.5372 1.5489 1.7909 0.976 3636206 DAlc3.1-H_000423 CN(C)CCCNC(=O)[C@H]1[C@@H](N(Cc2cc(cc(c2)C(F)(F)F)C(F)(F)F)C(=O)c3ccccc13)c4ccc(COC(=O)NCCCCCC(=O)NO)cc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 F04 compound treatment 9.8148 -0.81263 -0.2181 11.284 5.5348 1.3114 0.7731 0.5815 3636208 DAlc3.1-H_000424 CC(C)C[C@@H]1NC(=O)[C@H]2C[C@H]([C@H](N2C1=O)c3cccc(OCCOC(=O)NCCCCCC(=O)NO)c3)C(=O)OCCOc4ccc(cc4)[C@@H]5N6[C@H]([C@H](C(=O)OCC=C)[C@@]57C(=O)Nc8ccccc87)C(=O)O[C@H]([C@H]6c9ccccc9)c%10ccccc%10 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 F05 compound treatment 14.6981 4.0706 1.0923 14.934 9.1848 2.1762 2.3111 0.9492 3636210 DAlc3.1-H_000425 C[C@]1([C@@H](N(Cc2cc(cc(c2)C(F)(F)F)C(F)(F)F)C(=O)c3ccccc31)c4ccc(COC(=O)NCCCCCC(=O)NO)cc4)C(=O)NCCN5CCOCC5 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 F06 compound treatment 11.2898 0.66242 0.1777 9.5497 3.8006 0.9005 0.7624 0.8307 3636212 DAlc3.1-H_000426 ONC(=O)CCCCCNC(=O)OCCOc1cccc(c1)[C@@H]2[C@@H](C[C@H]3N2C(=O)[C@H](Cc4ccccc4)NC3=O)C(=O)OCCOc5ccc(cc5)[C@@H]6N7[C@H]([C@H](C(=O)OCC=C)[C@@]68C(=O)Nc9ccccc98)C(=O)O[C@H]([C@H]7c%10ccccc%10)c%11ccccc%11 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 F07 compound treatment 10.9105 0.28305 0.0759 0.0 -5.7492 -1.3622 -0.9095 -0.6666 3636214 DAlc3.1-H_000427 CCCNC(=O)[C@H]1[C@@H](N(C2Cc3ccccc3C2)C(=O)c4ccccc14)c5ccc(COC(=O)NCCCCCC(=O)NO)cc5 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 F08 compound treatment 10.6065 -0.020926 -0.0056 0.0 -5.7492 -1.3622 -0.9672 -0.71 3636216 DAlc3.1-H_000428 CC(C)C[C@@H]1NC(=O)[C@@H]2C[C@@H]([C@@H](N2C1=O)c3cccc(OCCOC(=O)NCCCCCC(=O)NO)c3)C(=O)OCCOc4ccc(cc4)[C@@H]5N6[C@H]([C@H](C(=O)OCC=C)[C@@]57C(=O)Nc8ccccc87)C(=O)O[C@H]([C@H]6c9ccccc9)c%10ccccc%10 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 F09 mock treatment 9.621 -1.0064 -0.2701 7.933 2.1838 0.5174 0.1749 0.2997 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 F10 mock treatment 12.3218 1.6944 0.4547 10.2912 4.542 1.0762 1.0825 0.9265 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 F11 compound treatment 12.7756 2.1482 0.5764 0.0 -5.7492 -1.3622 -0.5556 -0.3756 3636217 DAlc3.1-H_000429 CCCNC(=O)[C@H]1[C@@H](N(Cc2ccccc2C(F)(F)F)C(=O)c3ccccc13)c4ccc(COC(=O)NCCCCCC(=O)NO)cc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 F12 compound treatment 10.6547 0.027229 0.0073 0.0 -5.7492 -1.3622 -0.958 -0.7033 3636219 DAlc3.1-H_000430 CN(C)CCCC[C@@H]1NC(=O)[C@H]2C[C@H]([C@H](N2C1=O)c3cccc(OCCOC(=O)NCCCCCC(=O)NO)c3)C(=O)OCCOc4ccc(cc4)[C@@H]5N6[C@H]([C@H](C(=O)OCC=C)[C@@]57C(=O)Nc8ccccc87)C(=O)O[C@H]([C@H]6c9ccccc9)c%10ccccc%10 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 F13 compound treatment 10.5591 -0.068336 -0.0183 0.0 -5.7492 -1.3622 -0.9762 -0.7166 3636220 DAlc3.1-H_000431 CC(C)CNC(=O)[C@H]1[C@@H](N(Cc2ccccc2C(F)(F)F)C(=O)c3ccccc13)c4ccc(COC(=O)NCCCCCC(=O)NO)cc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 F14 compound treatment 16.017 5.3896 1.4462 0.0 -5.7492 -1.3622 0.0594 0.0299 3636222 DAlc3.1-H_000432 ONC(=O)CCCCCNC(=O)OCCOc1cccc(c1)[C@@H]2[C@@H](C[C@H]3N2C(=O)CNC3=O)C(=O)OCCOc4ccc(cc4)[C@@H]5N6[C@H]([C@H](C(=O)OCC=C)[C@@]57C(=O)Nc8ccccc87)C(=O)O[C@H]([C@H]6c9ccccc9)c%10ccccc%10 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 F15 compound treatment 10.0976 -0.52978 -0.1422 0.0 -5.7492 -1.3622 -1.0637 -0.7767 3636223 DAlc3.1-H_000433 ONC(=O)CCCCCNC(=O)OCc1ccc(cc1)[C@@H]2N(Cc3ccccc3Cl)C(=O)c4ccccc4[C@]52Cc6ccccc6N(CCN7CCOCC7)C5=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 F16 compound treatment 8.9323 -1.6951 -0.4548 0.0 -5.7492 -1.3622 -1.2848 -0.8947 3636225 DAlc3.1-H_000434 ONC(=O)CCCCCNC(=O)OCCOc1cccc(c1)[C@H]2[C@H](C[C@@H]3N2C(=O)[C@H](Cc4ccccc4)NC3=O)C(=O)OCCOc5ccc(cc5)[C@@H]6N7[C@H]([C@H](C(=O)OCC=C)[C@@]68C(=O)Nc9ccccc98)C(=O)O[C@H]([C@H]7c%10ccccc%10)c%11ccccc%11 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 F17 mock treatment 10.3861 -0.24132 -0.0648 0.0 -5.7492 -1.3622 -1.009 -0.7399 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 F18 mock treatment 8.8923 -1.7351 -0.4656 0.0 -5.7492 -1.3622 -1.2924 -0.8978 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 F19 compound treatment 9.9709 -0.65652 -0.1762 0.0 -5.7492 -1.3622 -1.0878 -0.792 3636226 DAlc3.1-H_000435 CC(C)CN1C(=O)[C@]2(CC(=O)N(CC3C4CC5CC(C4)CC3C5)[C@@H]2c6ccc(COC(=O)NCCCCCC(=O)NO)cc16)c7ccc(cc7)[N+](=O)[O-] 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 F20 compound treatment 11.346 0.71858 0.1928 0.0 -5.7492 -1.3622 -0.8269 -0.601 3636228 DAlc3.1-H_000436 C[N+](C)(C)CCCC[C@@H]1NC(=O)[C@H]2C[C@H]([C@H](N2C1=O)c3cccc(OCCOC(=O)NCCCCCC(=O)NO)c3)C(=O)OCCOc4ccc(cc4)[C@@H]5N6[C@H]([C@H](C(=O)OCC=C)[C@@]57C(=O)Nc8ccc(I)cc87)C(=O)O[C@H]([C@H]6c9ccccc9)c%10ccccc%10 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 F21 compound treatment 12.5435 1.9161 0.5141 11.2188 5.4696 1.2959 1.2799 0.918 3636230 DAlc3.1-H_000437 CN1C(=O)C2C(C3C(N(Cc4cccc(OC(F)(F)F)c4)C2C=C3CCCOC(=O)NCCCCCC(=O)NO)c5ccc(CN6CCCC6)cc5)C1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 F22 compound treatment 9.9975 -0.62988 -0.169 9.7797 4.0305 0.955 0.5558 0.5731 3636231 DAlc3.1-H_000438 ONC(=O)CCCCCNC(=O)OCCOc1cccc(c1)[C@@H]2[C@@H](C[C@H]3N2C(=O)CNC3=O)C(=O)OCCOc4ccc(cc4)[C@@H]5N6[C@H]([C@H](C(=O)OCC=C)[C@@]57C(=O)Nc8ccc(I)cc87)C(=O)O[C@H]([C@H]6c9ccccc9)c%10ccccc%10 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 F23 compound treatment 13.2024 2.575 0.6909 0.0 -5.7492 -1.3622 -0.4746 -0.3108 3636233 DAlc3.1-H_000439 ONC(=O)CCCCCNC(=O)OCc1ccc(cc1)c2cc[n+](Cc3sc4ccccc4c3Cl)cc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 F24 compound treatment 12.3968 1.7694 0.4748 0.0 -5.7492 -1.3622 -0.6275 -0.435 3636234 DAlc3.1-H_000440 CC(C)C[C@@H]1NC(=O)[C@H]2C[C@H]([C@H](N2C1=O)c3cccc(OCCOC(=O)NCCCCCC(=O)NO)c3)C(=O)OCCOc4ccc(cc4)[C@H]5N6[C@@H]([C@@H](C(=O)OCC=C)[C@]57C(=O)Nc8ccc(I)cc87)C(=O)O[C@@H]([C@@H]6c9ccccc9)c%10ccccc%10 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 G01 compound treatment 12.8516 2.2242 0.5968 10.708 4.9589 1.1749 1.2528 0.9507 3636236 DAlc3.1-H_000441 COc1ccc(C#Cc2ccc3NC(=O)[C@]4([C@@H]([C@@H]5N([C@@H]4c6ccccc6OCCOC(=O)NCCCCCC(=O)NO)[C@H]([C@H](OC5=O)c7ccccc7)c8ccccc8)C(=O)N)c3c2)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 G02 compound treatment 11.458 0.83057 0.2229 11.8923 6.1431 1.4555 1.1868 0.806 3636238 DAlc3.1-H_000442 ONC(=O)CCCCCNC(=O)OCCCOc1ccc(cc1)C2=N[C@](Cc3ccccc3)([C@H](O2)c4ccccc4)C(=O)NCCN5CCOCC5 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 G03 mock treatment 8.6463 -1.9811 -0.5316 8.43 2.6808 0.6352 0.0733 0.0885 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 G04 mock treatment 10.6488 0.021397 0.0057 9.0266 3.2775 0.7765 0.5532 0.7123 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 G05 compound treatment 11.5813 0.95386 0.2559 11.9198 6.1706 1.462 1.2148 0.8184 3636239 DAlc3.1-H_000443 COc1ccc(C#Cc2ccc3NC(=O)[C@@]4([C@H]([C@H]5N([C@H]4c6ccccc6OCCOC(=O)NCCCCCC(=O)NO)[C@@H]([C@@H](OC5=O)c7ccccc7)c8ccccc8)C(=O)NCC=C)c3c2)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 G06 compound treatment 9.9638 -0.66358 -0.1781 9.8221 4.0729 0.965 0.5565 0.5671 3636241 DAlc3.1-H_000444 ONC(=O)CCCCCNC(=O)OCCCOc1ccc(cc1)C2=N[C@](CC=C)(CO2)C(=O)NCCN3CCOCC3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 G07 compound treatment 9.69 -0.9374 -0.2515 0.0 -5.7492 -1.3622 -1.1411 -0.8237 3636243 DAlc3.1-H_000445 COc1cc2CCN(Cc2cc1OC)C(=O)[C@@H]3[C@@H]4N([C@H](c5ccc(OCCOC(=O)NCCCCCC(=O)NO)cc5)[C@@]36C(=O)Nc7ccc(C#CC8=CCCCC8)cc76)[C@H]([C@H](OC4=O)c9ccccc9)c%10ccccc%10 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 G08 compound treatment 11.4575 0.83006 0.2227 0.0 -5.7492 -1.3622 -0.8057 -0.5837 3636245 DAlc3.1-H_000446 ONC(=O)CCCCCNC(=O)OCCCOc1ccc(cc1)C2=N[C@](Cc3ccccc3)(CO2)C(=O)NCCN4CCOCC4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 G09 compound treatment 11.9914 1.364 0.366 12.2613 6.5121 1.543 1.3498 0.8512 3636247 DAlc3.1-H_000447 ONC(=O)CCCCCNC(=O)OCCOc1ccccc1[C@H]2N3[C@@H]([C@@H](C(=O)N4CCN(CC4)c5ncccn5)[C@]26C(=O)Nc7ccccc76)C(=O)O[C@@H]([C@@H]3c8ccccc8)c9ccccc9 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 G10 compound treatment 11.6909 1.0635 0.2854 10.021 4.2718 1.0121 0.9175 0.8725 3636249 DAlc3.1-H_000448 ONC(=O)CCCCCNC(=O)OCCCOc1ccc(cc1)C2=N[C@](Cc3ccccc3)([C@H](O2)c4ccccc4)C(=O)N5CCOCC5 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 G11 compound treatment 10.3154 -0.31201 -0.0837 0.0 -5.7492 -1.3622 -1.0224 -0.7492 3636250 DAlc3.1-H_000449 COc1ccc(C#Cc2ccc3NC(=O)[C@@]4([C@H]([C@H]5N([C@H]4c6ccc(OCCOC(=O)NCCCCCC(=O)NO)cc6)[C@@H]([C@@H](OC5=O)c7ccccc7)c8ccccc8)C(=O)N)c3c2)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 G12 compound treatment 13.6956 3.0681 0.8233 0.0 -5.7492 -1.3622 -0.3811 -0.2394 3636251 DAlc3.1-H_000450 ONC(=O)CCCCCNC(=O)OCCCOc1ccc(cc1)C2=N[C@]3(CCS(=O)(=O)c4ccccc4)[C@H](O2)c5ccccc5CN(Cc6ccccc6)C3=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 G13 compound treatment 11.2278 0.60035 0.1611 0.0 -5.7492 -1.3622 -0.8493 -0.6192 3636253 DAlc3.1-H_000451 ONC(=O)CCCCCNC(=O)OCCOc1ccccc1[C@H]2N3[C@@H]([C@@H](C(=O)N4CCCCCCC4)[C@]25C(=O)Nc6ccccc65)C(=O)O[C@@H]([C@@H]3c7ccccc7)c8ccccc8 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 G14 compound treatment 13.0313 2.4039 0.645 0.0 -5.7492 -1.3622 -0.5071 -0.3365 3556554 DAlc3.1-H_000452 ONC(=O)CCCCCNC(=O)OCCCOc1ccc(cc1)C2=N[C@@]3(Cc4ccccc4)[C@@H](O2)c5ccccc5CN(Cc6ccccc6)C3=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 G15 compound treatment 11.0021 0.37468 0.1005 0.0 -5.7492 -1.3622 -0.8921 -0.6531 3636254 DAlc3.1-H_000453 COc1ccc(C#Cc2ccc3NC(=O)[C@]4([C@@H]([C@@H]5N([C@@H]4c6ccccc6OCCOC(=O)NCCCCCC(=O)NO)[C@H]([C@H](OC5=O)c7ccccc7)c8ccccc8)C(=O)N9CCCCCCC9)c3c2)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 G16 compound treatment 124.7489 114.12 30.6217 0.0 -5.7492 -1.3622 20.6896 0.675 3636256 DAlc3.1-H_000454 ONC(=O)CCCCCNC(=O)OCCCOc1ccc(cc1)C2=N[C@]3(Cc4ccccc4CN(C(=O)c5ccccc5)C3=O)[C@H](O2)c6ccccc6 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 G17 compound treatment 9.8485 -0.77892 -0.209 0.0 -5.7492 -1.3622 -1.111 -0.8062 3636258 DAlc3.1-H_000455 ONC(=O)CCCCCNC(=O)OCCOc1ccccc1[C@H]2N3[C@@H]([C@@H](C(=O)N4CCCCCCC4)[C@]25C(=O)Nc6ccc(C#CC7=CCCCC7)cc65)C(=O)O[C@@H]([C@@H]3c8ccccc8)c9ccccc9 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 G18 compound treatment 114.8755 104.25 27.9724 0.0 -5.7492 -1.3622 18.8163 0.6719 3636260 DAlc3.1-H_000456 CC(C)(C)OC(=O)CC[C@@]12N=C(O[C@H]2c3ccccc3CN(C(=O)c4ccccc4)C1=O)c5ccc(OCCCOC(=O)NCCCCCC(=O)NO)cc5 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 G19 mock treatment 10.3758 -0.25158 -0.0675 0.0 -5.7492 -1.3622 -1.0109 -0.7412 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 G20 mock treatment 10.3138 -0.31366 -0.0842 0.0 -5.7492 -1.3622 -1.0227 -0.7494 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 G21 compound treatment 13.9055 3.2781 0.8796 10.2738 4.5246 1.072 1.38 0.9952 3636262 DAlc3.1-H_000457 COc1ccc(C#Cc2ccc3NC(=O)[C@@]4([C@H]([C@H]5N([C@H]4c6ccccc6OCCOC(=O)NCCCCCC(=O)NO)[C@@H]([C@@H](OC5=O)c7ccccc7)c8ccccc8)C(=O)N)c3c2)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 G22 compound treatment 99.0721 88.445 23.732 83.9 78.151 18.5167 29.8743 0.9925 3636263 DAlc3.1-H_000458 ONC(=O)CCCCCNC(=O)OCCCOc1ccc(cc1)C2=N[C@@]3(CC=C)[C@@H](O2)c4ccccc4CN(C(=O)c5ccccc5)C3=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 G23 compound treatment 10.716 0.088574 0.0238 0.0 -5.7492 -1.3622 -0.9464 -0.6947 3636265 DAlc3.1-H_000459 NC(=O)[C@@H]1[C@@H]2N([C@H](c3ccc(OCCOC(=O)NCCCCCC(=O)NO)cc3)[C@@]14C(=O)Nc5ccccc54)[C@H]([C@H](OC2=O)c6ccccc6)c7ccccc7 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 G24 compound treatment 12.9528 2.3253 0.6239 0.0 -5.7492 -1.3622 -0.522 -0.3484 3636267 DAlc3.1-H_000460 ONC(=O)CCCCCNC(=O)OCCCOc1ccc(cc1)C2=N[C@]3(Cc4ccccc4)[C@H](O2)c5ccccc5CN(Cc6ccccc6)C3=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 H01 compound treatment 11.5068 0.87936 0.236 13.0014 7.2522 1.7183 1.3819 0.7967 3636268 DAlc3.1-H_000461 ONC(=O)CCCCCNC(=O)OCc1ccc(cc1)c2cc[n+](Cc3cc4OCOc4cc3Br)cc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 H02 compound treatment 10.4249 -0.20253 -0.0543 9.2846 3.5355 0.8377 0.5539 0.6598 3636269 DAlc3.1-H_000462 CN(C)CCCC[C@@H]1NC(=O)[C@H]2C[C@H]([C@H](N2C1=O)c3cccc(OCCOC(=O)NCCCCCC(=O)NO)c3)C(=O)OCCOc4ccc(cc4)[C@@H]5N6[C@H]([C@H](C(=O)OCC=C)[C@@]57C(=O)Nc8ccc(I)cc87)C(=O)O[C@H]([C@H]6c9ccccc9)c%10ccccc%10 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 H03 mock treatment 8.85 -1.7775 -0.4769 10.4138 4.6646 1.1052 0.4443 0.3691 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 H04 mock treatment 11.6792 1.0518 0.2822 11.5981 5.8489 1.3858 1.1795 0.834 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 H05 compound treatment 11.9254 1.298 0.3483 13.6479 7.8987 1.8715 1.5696 0.8245 3636271 DAlc3.1-H_000463 CN1C(=O)C2C(C3C(N(Cc4cccc(OC(F)(F)F)c4)C2C=C3CCCOC(=O)NCCCCCC(=O)NO)c5cccs5)C1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 H06 compound treatment 10.6621 0.034672 0.0093 9.735 3.9858 0.9444 0.6743 0.714 3636272 DAlc3.1-H_000464 CC(=O)NCCCC[C@@H]1NC(=O)[C@H]2C[C@H]([C@H](N2C1=O)c3cccc(OCCOC(=O)NCCCCCC(=O)NO)c3)C(=O)OCCOc4ccc(cc4)[C@@H]5N6[C@H]([C@H](C(=O)OCC=C)[C@@]57C(=O)Nc8ccc(I)cc87)C(=O)O[C@H]([C@H]6c9ccccc9)c%10ccccc%10 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 H07 compound treatment 10.6384 0.011027 0.003 0.0 -5.7492 -1.3622 -0.9611 -0.7056 3636274 DAlc3.1-H_000465 CN1C(=O)C2C(C3C(N(Cc4cc5OCOc5cc4Br)C2C=C3CCCOC(=O)NCCCCCC(=O)NO)c6ccc(CN7CCCC7)cc6)C1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 H08 compound treatment 10.3751 -0.25234 -0.0677 0.0 -5.7492 -1.3622 -1.0111 -0.7413 3636275 DAlc3.1-H_000466 ONC(=O)CCCCCNC(=O)OCCOc1cccc(c1)[C@@H]2[C@@H](C[C@H]3N2C(=O)[C@H](Cc4ccccc4)NC3=O)C(=O)OCCOc5ccc(cc5)[C@@H]6N7[C@H]([C@H](C(=O)OCC=C)[C@@]68C(=O)Nc9ccc(I)cc98)C(=O)O[C@H]([C@H]7c%10ccccc%10)c%11ccccc%11 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 H09 compound treatment 10.2287 -0.39869 -0.107 11.0924 5.3432 1.266 0.8196 0.6451 3636277 DAlc3.1-H_000467 ONC(=O)CCCCCNC(=O)OCCCc1cc[n+](Cc2sc3ccccc3c2Cl)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 H10 compound treatment 10.0512 -0.57619 -0.1546 9.1465 3.3973 0.8049 0.4599 0.561 3636278 DAlc3.1-H_000468 CC(C)C[C@@H]1NC(=O)[C@H]2C[C@H]([C@H](N2C1=O)c3cccc(OCCOC(=O)NCCCCCC(=O)NO)c3)C(=O)OCCOc4ccc(cc4)[C@@H]5N6[C@H]([C@H](C(=O)OCC=C)[C@@]57C(=O)Nc8ccc(I)cc87)C(=O)O[C@H]([C@H]6c9ccccc9)c%10ccccc%10 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 H11 compound treatment 10.9236 0.29616 0.0795 0.0 -5.7492 -1.3622 -0.907 -0.6647 3636279 DAlc3.1-H_000469 CN1C(=O)C2C(C3C(N(Cc4sc5ccccc5c4Cl)C2C=C3CCCOC(=O)NCCCCCC(=O)NO)c6ccc(CN7CCCC7)cc6)C1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 H12 compound treatment 10.3853 -0.24213 -0.065 0.0 -5.7492 -1.3622 -1.0092 -0.74 3636280 DAlc3.1-H_000470 CN(C)CCCCNC(=O)[C@@H]1C[C@H]2N([C@@H]1c3cccc(OCCOC(=O)NCCCCCC(=O)NO)c3)C(=O)[C@@H]4CCCN4C2=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 H13 compound treatment 12.1525 1.5251 0.4092 0.0 -5.7492 -1.3622 -0.6739 -0.4738 3636282 DAlc3.1-H_000471 CN1C(=O)C2C(C3C(C4CC4)N(Cc5sc6ccccc6c5Cl)C2C=C3CCCOC(=O)NCCCCCC(=O)NO)C1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 H14 compound treatment 13.1432 2.5158 0.675 0.0 -5.7492 -1.3622 -0.4859 -0.3196 3636283 DAlc3.1-H_000472 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CCOC(=O)NCCCCCC(=O)NO)C(=O)N(Cc4ccc(cc4)N5CCC5=O)c6ccccc63 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 H15 compound treatment 11.0189 0.39144 0.105 0.0 -5.7492 -1.3622 -0.8889 -0.6507 3636285 DAlc3.1-H_000473 ONC(=O)CCCCCNC(=O)OCCCC1=CC(N(Cc2cccc(OC(F)(F)F)c2)/C(=N\P(=O)(Oc3ccccc3)Oc4ccccc4)/C1)c5ccc(CN6CCCC6)cc5 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 H16 compound treatment 11.0031 0.37568 0.1008 0.0 -5.7492 -1.3622 -0.8919 -0.653 3636287 DAlc3.1-H_000474 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CC(=O)N(CCOC(=O)NCCCCCC(=O)NO)Cc4ccccc4)C(=O)N(Cc5cccc(I)c5)c6ccccc63 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 H17 compound treatment 10.94 0.31256 0.0839 0.0 -5.7492 -1.3622 -0.9039 -0.6623 3636289 DAlc3.1-H_000475 ONC(=O)CCCCCNC(=O)OCCCC1=CC(C2CC2)N(Cc3cc4OCOc4cc3Br)CC1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 H18 compound treatment 11.1097 0.48225 0.1294 0.0 -5.7492 -1.3622 -0.8717 -0.6371 3636290 DAlc3.1-H_000476 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CCn4cc(CCOC(=O)NCCCCCC(=O)NO)nn4)C(=O)N(Cc5cccc(c5)N6CCC6=O)c7ccccc73 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 H19 mock treatment 9.722 -0.90539 -0.2429 0.0 -5.7492 -1.3622 -1.135 -0.8203 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 H20 mock treatment 10.173 -0.45443 -0.1219 0.0 -5.7492 -1.3622 -1.0494 -0.7673 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 H21 compound treatment 12.3071 1.6796 0.4507 12.6931 6.9439 1.6453 1.4821 0.8688 3636291 DAlc3.1-H_000477 CC1C=C(CCCOC(=O)NCCCCCC(=O)NO)CCN1Cc2cccc(OC(F)(F)F)c2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 H22 compound treatment 39.7377 29.11 7.811 40.4506 34.701 8.222 11.3371 0.9997 3556685 DAlc3.1-H_000478 COc1ccc(NC(=O)O[C@H]([C@@H](C)C=C)c2ccc(OCCOC(=O)NCCCCCC(=O)NO)cc2)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 H23 compound treatment 13.0698 2.4424 0.6553 0.0 -5.7492 -1.3622 -0.4998 -0.3306 3636292 DAlc3.1-H_000479 ONC(=O)CCCCCNC(=O)OCCCC1=CC(C2CC2)N(Cc3sc4ccccc4c3Cl)CC1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 H24 compound treatment 16.4198 5.7924 1.5542 0.0 -5.7492 -1.3622 0.1358 0.0657 3636293 DAlc3.1-H_000480 CO[C@H](C=C)[C@H](OC(=O)Nc1ccc(OC)cc1)c2ccc(OCCOC(=O)NCCCCCC(=O)NO)cc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 I01 compound treatment 14.469 3.8415 1.0308 9.5793 3.8302 0.9075 1.3706 0.998 3636295 DAlc3.1-H_000481 ONC(=O)CCCCCNC(=O)OCCOc1ccc(cc1)[C@H]2N3[C@@H]([C@@H](C(=O)N4CCCCCCC4)[C@]25C(=O)Nc6ccccc65)C(=O)O[C@@H]([C@@H]3c7ccccc7)c8ccccc8 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 I02 compound treatment 71.4353 60.808 16.3163 58.2811 52.532 12.4467 20.3385 0.9911 3636296 DAlc3.1-H_000482 CC(C)(C)OC(=O)CC[C@]12N=C(O[C@@H]2c3ccccc3CN(C(=O)c4ccccc4)C1=O)c5ccc(OCCCOC(=O)NCCCCCC(=O)NO)cc5 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 I03 compound treatment 12.6603 2.0329 0.5455 11.739 5.9898 1.4192 1.3892 0.9137 3636297 DAlc3.1-H_000483 ONC(=O)CCCCCNC(=O)OCCOc1ccccc1[C@@H]2N3[C@H]([C@H](C(=O)N4CCN(CC4)c5ncccn5)[C@@]26C(=O)Nc7ccccc76)C(=O)O[C@H]([C@H]3c8ccccc8)c9ccccc9 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 I04 compound treatment 64.9808 54.353 14.5844 70.1934 64.444 15.2691 21.1096 0.9997 3636298 DAlc3.1-H_000484 ONC(=O)CCCCCNC(=O)OCCCOc1ccc(cc1)C2=N[C@]3(CC=C)[C@H](O2)c4ccccc4CN(C(=O)c5ccccc5)C3=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 I05 mock treatment 10.798 0.17054 0.0458 9.2044 3.4553 0.8187 0.6112 0.7455 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 I06 mock treatment 11.9522 1.3248 0.3555 10.7072 4.958 1.1747 1.082 0.8816 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 I07 compound treatment 10.1564 -0.47103 -0.1264 0.0 -5.7492 -1.3622 -1.0526 -0.7694 3636299 DAlc3.1-H_000485 COc1ccc(C#Cc2ccc3NC(=O)[C@]4([C@@H]([C@@H]5N([C@@H]4c6ccccc6OCCOC(=O)NCCCCCC(=O)NO)[C@H]([C@H](OC5=O)c7ccccc7)c8ccccc8)C(=O)N9CCN(CC9)c%10ncccn%10)c3c2)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 I08 compound treatment 59.8472 49.22 13.2069 0.0 -5.7492 -1.3622 8.3755 0.6308 3636300 DAlc3.1-H_000486 ONC(=O)CCCCCNC(=O)OCCCOc1ccc(cc1)C2=N[C@@]3(CCS(=O)(=O)c4ccccc4)[C@@H](O2)c5ccccc5CN(C(=O)c6ccccc6)C3=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 I09 compound treatment 11.8183 1.1909 0.3196 10.4503 4.7011 1.1139 1.0136 0.8747 3636302 DAlc3.1-H_000487 COc1ccc(C#Cc2ccc3NC(=O)[C@@]4([C@H]([C@H]5N([C@H]4c6ccccc6OCCOC(=O)NCCCCCC(=O)NO)[C@@H]([C@@H](OC5=O)c7ccccc7)c8ccccc8)C(=O)N9CCc%10cc(OC)c(OC)cc%10C9)c3c2)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 I10 compound treatment 11.6421 1.0147 0.2723 11.8028 6.0537 1.4343 1.2067 0.8266 3636303 DAlc3.1-H_000488 ONC(=O)CCCCCNC(=O)OCCCOc1ccc(cc1)C2=N[C@@]3(CC=C)[C@@H](O2)c4ccccc4CN(Cc5ccccc5)C3=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 I11 compound treatment 13.4772 2.8497 0.7647 0.0 -5.7492 -1.3622 -0.4225 -0.2705 3636305 DAlc3.1-H_000489 NC(=O)[C@H]1[C@H]2N([C@@H](c3ccccc3OCCOC(=O)NCCCCCC(=O)NO)[C@]14C(=O)Nc5ccccc54)[C@@H]([C@@H](OC2=O)c6ccccc6)c7ccccc7 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 I12 compound treatment 92.5283 81.901 21.9761 0.0 -5.7492 -1.3622 14.5762 0.662 3636307 DAlc3.1-H_000490 ONC(=O)CCCCCNC(=O)OCCCOc1ccc(cc1)C2=N[C@]3(CCS(=O)(=O)c4ccccc4)[C@H](O2)c5ccccc5CN(C(=O)c6ccccc6)C3=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 I13 compound treatment 11.1575 0.53003 0.1422 0.0 -5.7492 -1.3622 -0.8626 -0.6299 3636308 DAlc3.1-H_000491 COc1cc2CCN(Cc2cc1OC)C(=O)[C@H]3[C@H]4N([C@@H](c5ccc(OCCOC(=O)NCCCCCC(=O)NO)cc5)[C@]36C(=O)Nc7ccc(C#CC8=CCCCC8)cc76)[C@@H]([C@@H](OC4=O)c9ccccc9)c%10ccccc%10 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 I14 compound treatment 14.3196 3.6922 0.9907 0.0 -5.7492 -1.3622 -0.2627 -0.156 3636309 DAlc3.1-H_000492 CC(C)(C)OC(=O)CC[C@@]12N=C(O[C@H]2c3ccccc3CN(Cc4ccccc4)C1=O)c5ccc(OCCCOC(=O)NCCCCCC(=O)NO)cc5 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 I15 compound treatment 11.0988 0.47139 0.1265 0.0 -5.7492 -1.3622 -0.8738 -0.6387 3636311 DAlc3.1-H_000493 NC(=O)[C@@H]1[C@@H]2N([C@H](c3ccccc3OCCOC(=O)NCCCCCC(=O)NO)[C@@]14C(=O)Nc5ccc(C#CC6=CCCCC6)cc54)[C@H]([C@H](OC2=O)c7ccccc7)c8ccccc8 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 I16 compound treatment 82.1538 71.526 19.1924 0.0 -5.7492 -1.3622 12.6078 0.6553 3636312 DAlc3.1-H_000494 ONC(=O)CCCCCNC(=O)OCCCOc1ccc(cc1)C2=N[C@]3(Cc4ccccc4)[C@H](O2)c5ccccc5CN(C(=O)c6ccccc6)C3=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 I17 compound treatment 12.3751 1.7477 0.469 0.0 -5.7492 -1.3622 -0.6316 -0.4384 3636314 DAlc3.1-H_000495 COc1cc2CCN(Cc2cc1OC)C(=O)[C@H]3[C@H]4N([C@@H](c5ccccc5OCCOC(=O)NCCCCCC(=O)NO)[C@]36C(=O)Nc7ccc(C#CC8=CCCCC8)cc76)[C@@H]([C@@H](OC4=O)c9ccccc9)c%10ccccc%10 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 I18 compound treatment 11.1177 0.49027 0.1316 0.0 -5.7492 -1.3622 -0.8702 -0.6359 3636315 DAlc3.1-H_000496 ONC(=O)CCCCCNC(=O)OCCCOc1ccc(cc1)C2=NC(ON2c3ccccc3)C(=O)NCc4ccccc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 I19 compound treatment 10.4736 -0.15379 -0.0413 0.0 -5.7492 -1.3622 -0.9924 -0.7282 3636316 DAlc3.1-H_000497 NC(=O)[C@H]1[C@H]2N([C@@H](c3ccc(OCCOC(=O)NCCCCCC(=O)NO)cc3)[C@]14C(=O)Nc5ccc(C#CC6=CCCCC6)cc54)[C@@H]([C@@H](OC2=O)c7ccccc7)c8ccccc8 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 I20 compound treatment 9.6658 -0.96164 -0.258 0.0 -5.7492 -1.3622 -1.1457 -0.8264 3636318 DAlc3.1-H_000498 COc1ccc(CCNC(=O)[C@]2(CC(=O)N(Cc3ccccc3C(F)(F)F)[C@@H]2c4ccc(COC(=O)NCCCCCC(=O)NO)cc4)Sc5ccc(C)cc5)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 I21 mock treatment 13.3858 2.7584 0.7402 9.3888 3.6396 0.8623 1.1331 0.9971 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 I22 mock treatment 10.9896 0.36213 0.0972 9.9898 4.2406 1.0048 0.7792 0.7719 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 I23 compound treatment 10.5726 -0.054848 -0.0147 0.0 -5.7492 -1.3622 -0.9736 -0.7147 3636320 DAlc3.1-H_000499 NC(=O)[C@H]1[C@H]2N([C@@H](c3ccccc3OCCOC(=O)NCCCCCC(=O)NO)[C@]14C(=O)Nc5ccc(C#CC6(O)CCCCCC6)cc54)[C@@H]([C@@H](OC2=O)c7ccccc7)c8ccccc8 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 I24 compound treatment 12.9653 2.3379 0.6273 0.0 -5.7492 -1.3622 -0.5196 -0.3465 3636321 DAlc3.1-H_000500 COc1ccc(CCNC(=O)[C@]2(Cc3ccccc3I)[C@@H](N(Cc4ccccc4C(F)(F)F)C(=O)c5ccccc52)c6ccc(COC(=O)NCCCCCC(=O)NO)cc6)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 J01 compound treatment 14.9057 4.2783 1.148 12.3168 6.5676 1.5561 1.9121 0.9888 3636323 DAlc3.1-H_000501 ONC(=O)CCCCCNC(=O)OCc1ccc(cc1)C2=CC(C3CC3)N(Cc4cc5OCOc5cc4Br)CC2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 J02 compound treatment 11.0195 0.39212 0.1052 12.1574 6.4082 1.5183 1.148 0.7543 3636324 DAlc3.1-H_000502 CO[C@@H](C=C)[C@@H](OC(=O)Nc1ccc(OC)cc1)c2ccc(OCCOC(=O)NCCCCCC(=O)NO)cc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 J03 compound treatment 16.7295 6.1021 1.6373 13.4507 7.7015 1.8247 2.4481 0.9985 3636325 DAlc3.1-H_000503 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CCn4cc(CCOC(=O)NCCCCCC(=O)NO)nn4)C(=O)N(CC=C)c5ccccc53 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 J04 compound treatment 15.9148 5.2874 1.4188 14.4801 8.7309 2.0687 2.466 0.9831 3636327 DAlc3.1-H_000504 COc1ccc(NC(=O)O[C@@H]([C@H](C)C=C)c2ccc(OCCOC(=O)NCCCCCC(=O)NO)cc2)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 J05 mock treatment 10.5422 -0.085246 -0.0229 11.9218 6.1726 1.4625 1.018 0.696 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 J06 mock treatment 16.4887 5.8613 1.5727 8.929 3.1798 0.7534 1.6448 0.9432 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 J07 compound treatment 12.0439 1.4164 0.3801 0.0 -5.7492 -1.3622 -0.6945 -0.4911 3636328 DAlc3.1-H_000505 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CCOC(=O)NCCCCCC(=O)NO)C(=O)N(CC=C)c4ccccc43 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 J08 compound treatment 9.7534 -0.874 -0.2345 0.0 -5.7492 -1.3622 -1.129 -0.8168 3636330 DAlc3.1-H_000506 ONC(=O)CCCCCNC(=O)OCCCCO[C@H]1C[C@H](C=C(O1)C(=O)NCc2ccccc2F)c3coc4ccccc4c3=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 J09 compound treatment 12.7793 2.1519 0.5774 11.0632 5.314 1.2591 1.2986 0.9375 3556636 DAlc3.1-H_000507 COc1ccc(cc1)[Si](C)(C)[C@H](CC(=O)N2CCC[C@H]2COC(=O)NCCCCCC(=O)NO)/C=C/C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 J10 compound treatment 9.0166 -1.6109 -0.4322 8.1648 2.4156 0.5723 0.0991 0.1381 3636332 DAlc3.1-H_000508 COC(CN(C)C(=O)C1=C[C@@H](C[C@H](OCCCCOC(=O)NCCCCCC(=O)NO)O1)c2coc3ccccc3c2=O)OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 J11 compound treatment 13.6577 3.0303 0.8131 0.0 -5.7492 -1.3622 -0.3883 -0.2447 3636334 DAlc3.1-H_000509 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CCn4cc(CCOC(=O)NCCCCCC(=O)NO)nn4)C(=O)N(c5ccccc53)c6ccccc6 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 J12 compound treatment 9.9747 -0.65276 -0.1752 0.0 -5.7492 -1.3622 -1.0871 -0.7915 3636336 DAlc3.1-H_000510 ONC(=O)CCCCCNC(=O)OCCCCO[C@H]1C[C@H](C=C(O1)C(=O)N2CCOCCOCCOCCOCC2)c3coc4ccccc4c3=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 J13 compound treatment 14.1188 3.4914 0.9368 0.0 -5.7492 -1.3622 -0.3008 -0.1819 3636338 DAlc3.1-H_000511 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CCOC(=O)NCCCCCC(=O)NO)C(=O)N(c4ccccc43)c5ccccc5 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 J14 compound treatment 10.4935 -0.13394 -0.0359 0.0 -5.7492 -1.3622 -0.9886 -0.7255 3636340 DAlc3.1-H_000512 CN(C)CCCCCCNC(=O)[C@H]1C[C@@H]2N([C@H]1c3cccc(OCCOC(=O)NCCCCCC(=O)NO)c3)C(=O)[C@H](Cc4ccccc4)NC2=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 J15 compound treatment 14.4256 3.7982 1.0191 0.0 -5.7492 -1.3622 -0.2426 -0.1426 3636342 DAlc3.1-H_000513 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CCn4cc(CCOC(=O)NCCCCCC(=O)NO)nn4)C(=O)N(c5ccccc53)c6ccccc6 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 J16 compound treatment 9.8478 -0.77965 -0.2092 0.0 -5.7492 -1.3622 -1.1111 -0.8062 3636343 DAlc3.1-H_000514 CC(C)C[C@@H]1NC(=O)[C@H]2C[C@H]([C@H](N2C1=O)c3cccc(OCCOC(=O)NCCCCCC(=O)NO)c3)C(=O)OCCOc4ccc(cc4)[C@H]5N6[C@@H]([C@@H](C(=O)OCC=C)[C@]57C(=O)Nc8ccccc87)C(=O)O[C@@H]([C@@H]6c9ccccc9)c%10ccccc%10 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 J17 compound treatment 16.0887 5.4613 1.4654 0.0 -5.7492 -1.3622 0.073 0.0365 3636344 DAlc3.1-H_000515 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CCOC(=O)NCCCCCC(=O)NO)C(=O)N(Cc4ccc(cc4)N5CCOC5=O)c6ccccc63 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 J18 compound treatment 8.3331 -2.2944 -0.6156 0.0 -5.7492 -1.3622 -1.3985 -0.9356 3636346 DAlc3.1-H_000516 CC(C)C[C@@H]1NC(=O)[C@H]2C[C@H]([C@H](N2C1=O)c3cccc(OCCOC(=O)NCCCCCC(=O)NO)c3)C(=O)NCCCCN(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 J19 compound treatment 18.4114 7.784 2.0886 0.0 -5.7492 -1.3622 0.5137 0.206 3556624 DAlc3.1-H_000517 COc1ccc(cc1)[Si](C)(C)[C@H](CCn2cc(CCOC(=O)NCCCCCC(=O)NO)nn2)/C=C/C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 J20 compound treatment 9.5905 -1.0369 -0.2782 0.0 -5.7492 -1.3622 -1.1599 -0.8343 3636348 DAlc3.1-H_000518 CC(=O)NCCCC[C@@H]1NC(=O)[C@H]2C[C@H]([C@H](N2C1=O)c3cccc(OCCOC(=O)NCCCCCC(=O)NO)c3)C(=O)NCc4ccc(F)cc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 J21 mock treatment 10.285 -0.34238 -0.0919 9.667 3.9178 0.9283 0.5914 0.634 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 J22 mock treatment 10.2346 -0.39282 -0.1054 10.9288 5.1796 1.2272 0.7933 0.644 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 J23 compound treatment 11.3338 0.70641 0.1895 0.0 -5.7492 -1.3622 -0.8292 -0.6029 3556632 DAlc3.1-H_000519 COc1ccc(cc1)[Si](C)(C)[C@H](CC(=O)N2Cc3ccccc3C[C@H]2COC(=O)NCCCCCC(=O)NO)/C=C/C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 J24 compound treatment 10.118 -0.50943 -0.1367 0.0 -5.7492 -1.3622 -1.0599 -0.7742 3636350 DAlc3.1-H_000520 ONC(=O)CCCCCNC(=O)OCCOc1cccc(c1)[C@H]2[C@H](C[C@@H]3N2C(=O)[C@H](Cc4ccccc4)NC3=O)C(=O)OCCOc5ccc(cc5)[C@H]6N7[C@@H]([C@@H](C(=O)OCC=C)[C@]68C(=O)Nc9ccccc98)C(=O)O[C@@H]([C@@H]7c%10ccccc%10)c%11ccccc%11 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 K01 compound treatment 9.1992 -1.4282 -0.3832 11.6591 5.91 1.4003 0.7192 0.4954 3636351 DAlc3.1-H_000521 COc1ccc(C#Cc2ccc3NC(=O)[C@@]4([C@H]([C@H]5N([C@H]4c6ccc(OCCOC(=O)NCCCCCC(=O)NO)cc6)[C@@H]([C@@H](OC5=O)c7ccccc7)c8ccccc8)C(=O)N9CCCCCCC9)c3c2)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 K02 compound treatment 10.1274 -0.50002 -0.1342 11.6419 5.8927 1.3962 0.8924 0.6362 3636353 DAlc3.1-H_000522 Cc1ccc(S[C@@]2(CC(=O)N(Cc3ccccc3Cl)[C@@H]2c4ccc(COC(=O)NCCCCCC(=O)NO)cc4)C(=O)NCC(F)(F)F)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 K03 compound treatment 14.7275 4.1001 1.1002 13.3813 7.6322 1.8083 2.0566 0.9716 3636355 DAlc3.1-H_000523 COCCOC(=O)N1C(=O)[C@]2([C@@H]([C@@H]3N([C@@H]2c4ccccc4OCCOC(=O)NCCCCCC(=O)NO)[C@H]([C@H](OC3=O)c5ccccc5)c6ccccc6)C(=O)NCC=C)c7cc(C#Cc8ccc(OC)cc8)ccc17 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 K04 compound treatment 10.7854 0.15802 0.0424 10.9907 5.2415 1.2419 0.9081 0.7308 3636357 DAlc3.1-H_000524 Cc1ccc(S[C@@]2(CC(=O)N(Cc3ccccc3)[C@@H]2c4ccc(COC(=O)NCCCCCC(=O)NO)cc4)C(=O)NCCN5CCOCC5)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 K05 compound treatment 15.0821 4.4547 1.1953 13.1974 7.4482 1.7647 2.0931 0.982 3636359 DAlc3.1-H_000525 COCCOC(=O)N1C(=O)[C@@]2([C@H]([C@H]3N([C@H]2c4ccc(OCCOC(=O)NCCCCCC(=O)NO)cc4)[C@@H]([C@@H](OC3=O)c5ccccc5)c6ccccc6)C(=O)N)c7ccccc17 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 K06 compound treatment 9.8195 -0.80793 -0.2168 10.6278 4.8786 1.1559 0.6641 0.5646 3636361 DAlc3.1-H_000526 CC(C)CNC(=O)[C@]1(CC(=O)N(Cc2ccccc2C(F)(F)F)[C@@H]1c3ccc(COC(=O)NCCCCCC(=O)NO)cc3I)Sc4ccc(C)cc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 K07 mock treatment 10.1549 -0.47256 -0.1268 0.0 -5.7492 -1.3622 -1.0529 -0.7696 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 K08 mock treatment 9.1322 -1.4952 -0.4012 0.0 -5.7492 -1.3622 -1.2469 -0.8781 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 K09 compound treatment 8.0258 -2.6016 -0.6981 9.63 3.8808 0.9195 0.1566 0.1356 3636363 DAlc3.1-H_000527 NC(=O)NCC#Cc1ccc2NC(=O)[C@]3([C@@H]([C@@H]4N([C@@H]3c5ccccc5OCCOC(=O)NCCCCCC(=O)NO)[C@H]([C@H](OC4=O)c6ccccc6)c7ccccc7)C(=O)N8CCN(CC8)c9ncccn9)c2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 K10 compound treatment 11.6644 1.037 0.2783 10.0607 4.3115 1.0215 0.9191 0.8681 3636365 DAlc3.1-H_000528 CC(C)N1[C@H](c2ccc(COC(=O)NCCCCCC(=O)NO)cc2)[C@@](CC1=O)(Sc3ccc(C)cc3)C(=O)NCCN4CCOCC4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 K11 compound treatment 10.4883 -0.13914 -0.0373 0.0 -5.7492 -1.3622 -0.9896 -0.7262 3636367 DAlc3.1-H_000529 ONC(=O)CCCCCNC(=O)OCCOc1ccccc1[C@H]2N3[C@@H]([C@@H](C(=O)O)[C@]24C(=O)Nc5ccccc54)C(=O)O[C@@H]([C@@H]3c6ccccc6)c7ccccc7 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 K12 compound treatment 10.8396 0.2122 0.0569 0.0 -5.7492 -1.3622 -0.9229 -0.677 3636369 DAlc3.1-H_000530 CN(C)CCCNC(=O)[C@]1(CC(=O)N(C2Cc3ccccc3C2)[C@@H]1c4ccc(COC(=O)NCCCCCC(=O)NO)cc4)Sc5ccc(C)cc5 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 K13 compound treatment 12.0342 1.4067 0.3775 0.0 -5.7492 -1.3622 -0.6963 -0.4926 3636371 DAlc3.1-H_000531 NC(=O)NCC#Cc1ccc2NC(=O)[C@@]3([C@H]([C@H]4N([C@H]3c5ccccc5OCCOC(=O)NCCCCCC(=O)NO)[C@@H]([C@@H](OC4=O)c6ccccc6)c7ccccc7)C(=O)NCC=C)c2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 K14 compound treatment 11.4297 0.80223 0.2153 0.0 -5.7492 -1.3622 -0.811 -0.5881 3636373 DAlc3.1-H_000532 COCCCNC(=O)[C@]1(CC(=O)N(C(C)C)[C@@H]1c2ccc(COC(=O)NCCCCCC(=O)NO)cc2)Sc3ccc(C)cc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 K15 mock treatment 8.5956 -2.0319 -0.5452 0.0 -5.7492 -1.3622 -1.3487 -0.9192 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 K16 mock treatment 11.6947 1.0673 0.2864 0.0 -5.7492 -1.3622 -0.7607 -0.5465 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 K17 compound treatment 9.2196 -1.4078 -0.3778 0.0 -5.7492 -1.3622 -1.2303 -0.8703 3636375 DAlc3.1-H_000533 ONC(=O)CCCCCNC(=O)OCCOc1ccccc1[C@H]2N3[C@@H]([C@@H](C(=O)NCC=C)[C@]24C(=O)Nc5ccccc54)C(=O)O[C@@H]([C@@H]3c6ccccc6)c7ccccc7 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 K18 compound treatment 9.2992 -1.3283 -0.3564 0.0 -5.7492 -1.3622 -1.2152 -0.8631 3636376 DAlc3.1-H_000534 CC(C)CNC(=O)[C@]1(CC(=O)N([C@@H]1c2ccc(COC(=O)NCCCCCC(=O)NO)cc2)C3CCCCC3)Sc4ccc(C)cc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 K19 compound treatment 9.7754 -0.85205 -0.2286 0.0 -5.7492 -1.3622 -1.1249 -0.8144 3636378 DAlc3.1-H_000535 ONC(=O)CCCCCNC(=O)OCCOc1ccccc1[C@@H]2N3[C@H]([C@H](C(=O)O)[C@@]24C(=O)Nc5ccc(C#CC6(O)CCCCCC6)cc54)C(=O)O[C@H]([C@H]3c7ccccc7)c8ccccc8 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 K20 compound treatment 11.1091 0.4817 0.1293 0.0 -5.7492 -1.3622 -0.8718 -0.6372 3636380 DAlc3.1-H_000536 CN(C)CCCN1C(=O)[C@]2(Cc3ccccc13)[C@@H](N(C4CCCCC4)C(=O)c5ccccc52)c6ccc(COC(=O)NCCCCCC(=O)NO)cc6 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 K21 compound treatment 10.6095 -0.017956 -0.0048 11.502 5.7528 1.3631 0.9604 0.7046 3636382 DAlc3.1-H_000537 NC(=O)[C@@H]1[C@@H]2N([C@H](c3ccc(O)cc3)[C@@]14C(=O)Nc5ccc(C#CCCOC(=O)NCCCCCC(=O)NO)cc54)[C@H]([C@H](OC2=O)c6ccccc6)c7ccccc7 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 K22 compound treatment 10.8454 0.21794 0.0585 10.761 5.0118 1.1875 0.881 0.741 3636384 DAlc3.1-H_000538 Cc1ccc(S[C@@]2(CC(=O)N(Cc3ccccc3C(F)(F)F)[C@@H]2c4ccc(COC(=O)NCCCCCC(=O)NO)cc4)C(=O)NC5CC5)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 K23 mock treatment 7.9412 -2.6862 -0.7208 0.0 -5.7492 -1.3622 -1.4729 -0.9557 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 K24 mock treatment 11.952 1.3245 0.3554 0.0 -5.7492 -1.3622 -0.7119 -0.5057 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 L01 compound treatment 12.7606 2.1332 0.5724 13.8084 8.0592 1.9095 1.755 0.8804 3636386 DAlc3.1-H_000539 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CCOC(=O)NCCCCCC(=O)NO)C(=O)N(C)c4ccccc43 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 L02 compound treatment 10.4433 -0.18411 -0.0494 10.8353 5.0861 1.2051 0.8172 0.6776 3636387 DAlc3.1-H_000540 CN(C)CCCCNC(=O)[C@@H]1C[C@H]2N([C@@H]1c3cccc(OCCOC(=O)NCCCCCC(=O)NO)c3)C(=O)[C@H](CCCCN(C)C)NC2=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 L03 compound treatment 12.4044 1.7769 0.4768 12.8031 7.0539 1.6713 1.5189 0.874 3636389 DAlc3.1-H_000541 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CCOC(=O)NCCCCCC(=O)NO)C(=O)N(CC=C)c4ccc(I)cc43 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 L04 compound treatment 11.418 0.7906 0.2121 12.7658 7.0166 1.6625 1.3256 0.7909 3636390 DAlc3.1-H_000542 ONC(=O)CCCCCNC(=O)OCCOc1cccc(c1)[C@@H]2[C@@H](C[C@H]3N2C(=O)CNC3=O)C(=O)NCc4ccc(F)cc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 L05 compound treatment 12.2338 1.6063 0.431 10.9224 5.1732 1.2257 1.1715 0.9016 3636391 DAlc3.1-H_000543 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CCOC(=O)NCCCCCC(=O)NO)C(=O)N(C)c4c3cc(C)cc4Br 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 L06 compound treatment 8.4137 -2.2137 -0.594 10.751 5.0018 1.1851 0.418 0.3153 3636393 DAlc3.1-H_000544 ONC(=O)CCCCCNC(=O)OCCOc1cccc(c1)[C@@H]2[C@@H](C[C@H]3N2C(=O)[C@H](Cc4ccccc4)NC3=O)C(=O)NCc5ccc(F)cc5 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 L07 mock treatment 9.7284 -0.89905 -0.2412 0.0 -5.7492 -1.3622 -1.1338 -0.8196 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 L08 mock treatment 8.9742 -1.6532 -0.4436 0.0 -5.7492 -1.3622 -1.2769 -0.8913 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 L09 compound treatment 12.0699 1.4424 0.387 11.9825 6.2333 1.4769 1.318 0.8633 3556635 DAlc3.1-H_000545 COc1ccc(cc1)[Si](C)(C)[C@@H](CC(=O)N2Cc3ccccc3C[C@H]2COC(=O)NCCCCCC(=O)NO)/C=C/C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 L10 compound treatment 10.1861 -0.44135 -0.1184 9.8062 4.0571 0.9613 0.596 0.6153 3636394 DAlc3.1-H_000546 ONC(=O)CCCCCNC(=O)OCCOc1cccc(c1)[C@H]2[C@H](C[C@@H]3N2C(=O)[C@@H]4CCCN4C3=O)C(=O)OCCOc5ccc(cc5)[C@H]6N7[C@@H]([C@@H](C(=O)OCC=C)[C@]68C(=O)Nc9ccccc98)C(=O)O[C@@H]([C@@H]7c%10ccccc%10)c%11ccccc%11 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 L11 compound treatment 13.229 2.6016 0.6981 0.0 -5.7492 -1.3622 -0.4696 -0.3068 3636396 DAlc3.1-H_000547 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CCOC(=O)NCCCCCC(=O)NO)C(=O)N(CC=C)c4ccc(I)cc43 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 L12 compound treatment 11.2066 0.5792 0.1554 0.0 -5.7492 -1.3622 -0.8533 -0.6224 3636397 DAlc3.1-H_000548 CC(C)C[C@@H]1NC(=O)[C@H]2C[C@H]([C@H](N2C1=O)c3cccc(OCCOC(=O)NCCCCCC(=O)NO)c3)C(=O)NCc4ccc(F)cc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 L13 compound treatment 12.4264 1.799 0.4827 0.0 -5.7492 -1.3622 -0.6219 -0.4303 3636399 DAlc3.1-H_000549 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CCOC(=O)NCCCCCC(=O)NO)C(=O)N(CC=C)c4ccc(NC(=O)C)cc43 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 L14 compound treatment 9.3552 -1.2722 -0.3414 0.0 -5.7492 -1.3622 -1.2046 -0.8578 3636401 DAlc3.1-H_000550 CN(C)CCCCCCNC(=O)[C@H]1C[C@@H]2N([C@H]1c3cccc(OCCOC(=O)NCCCCCC(=O)NO)c3)C(=O)[C@H](CCCC[N+](C)(C)C)NC2=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 L15 mock treatment 10.6621 0.034662 0.0093 0.0 -5.7492 -1.3622 -0.9566 -0.7023 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 L16 mock treatment 11.6226 0.99518 0.267 0.0 -5.7492 -1.3622 -0.7744 -0.5579 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 L17 compound treatment 13.0053 2.3778 0.638 0.0 -5.7492 -1.3622 -0.5121 -0.3404 3556627 DAlc3.1-H_000551 COc1ccc(cc1)[Si](C)(C)[C@@H](CCn2cc(CCOC(=O)NCCCCCC(=O)NO)nn2)/C=C/C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 L18 compound treatment 8.7073 -1.9202 -0.5152 0.0 -5.7492 -1.3622 -1.3275 -0.9115 3636403 DAlc3.1-H_000552 ONC(=O)CCCCCNC(=O)OCCOc1cccc(c1)[C@H]2[C@H](C[C@@H]3N2C(=O)CNC3=O)C(=O)OCCOc4ccc(cc4)[C@H]5N6[C@@H]([C@@H](C(=O)OCC=C)[C@]57C(=O)Nc8ccccc87)C(=O)O[C@@H]([C@@H]6c9ccccc9)c%10ccccc%10 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 L19 compound treatment 10.703 0.075564 0.0203 0.0 -5.7492 -1.3622 -0.9489 -0.6965 3636404 DAlc3.1-H_000553 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CCOC(=O)NCCCCCC(=O)NO)C(=O)N4c5c3cc(OC)cc5C(=CC4(C)C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 L20 compound treatment 11.3376 0.71015 0.1906 0.0 -5.7492 -1.3622 -0.8285 -0.6023 3636406 DAlc3.1-H_000554 ONC(=O)CCCCCNC(=O)OCCOc1cccc(c1)[C@@H]2[C@@H](C[C@H]3N2C(=O)[C@@H]4CCCN4C3=O)C(=O)OCCOc5ccc(cc5)[C@H]6N7[C@@H]([C@@H](C(=O)OCC=C)[C@]68C(=O)Nc9ccccc98)C(=O)O[C@@H]([C@@H]7c%10ccccc%10)c%11ccccc%11 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 L21 compound treatment 11.236 0.60853 0.1633 12.379 6.6298 1.5708 1.2262 0.7764 3556631 DAlc3.1-H_000555 COc1ccc(cc1)[Si](C)(C)[C@@H](CC(=O)N(CCOC(=O)NCCCCCC(=O)NO)Cc2ccccc2)/C=C/C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 L22 compound treatment 12.5341 1.9067 0.5116 10.623 4.8738 1.1548 1.1783 0.9329 3636407 DAlc3.1-H_000556 CN(C)CCCCNC(=O)[C@@H]1C[C@H]2N([C@@H]1c3cccc(OCCOC(=O)NCCCCCC(=O)NO)c3)C(=O)[C@H](CCCCNC(=O)C)NC2=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 L23 mock treatment 9.7851 -0.84236 -0.226 0.0 -5.7492 -1.3622 -1.123 -0.8133 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 L24 mock treatment 10.013 -0.61443 -0.1649 0.0 -5.7492 -1.3622 -1.0798 -0.7869 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 M01 compound treatment 11.8828 1.2554 0.3369 12.0023 6.2531 1.4816 1.2858 0.8463 3636409 DAlc3.1-H_000557 NC(=O)[C@@H]1[C@@H]2N([C@H](c3ccc(OCCOC(=O)NCCCCCC(=O)NO)cc3)[C@@]14C(=O)Nc5ccc(C#CC6(O)CCCCCC6)cc54)[C@H]([C@H](OC2=O)c7ccccc7)c8ccccc8 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 M02 compound treatment 12.4365 1.809 0.4854 10.8206 5.0714 1.2016 1.1929 0.9205 3636411 DAlc3.1-H_000558 ONC(=O)CCCCCNC(=O)OCc1ccc(cc1)[C@@H]2N(C3CCCCC3)C(=O)c4ccccc4[C@]52Cc6ccccc6N(CCN7CCOCC7)C5=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 M03 compound treatment 12.9058 2.2784 0.6114 10.1404 4.3912 1.0404 1.168 0.9679 3636413 DAlc3.1-H_000559 COc1ccc(C#Cc2ccc3NC(=O)[C@@]4([C@H]([C@H]5N([C@H]4c6ccccc6OCCOC(=O)NCCCCCC(=O)NO)[C@@H]([C@@H](OC5=O)c7ccccc7)c8ccccc8)C(=O)N9CCCCCCC9)c3c2)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 M04 compound treatment 9.8661 -0.76129 -0.2043 11.159 5.4098 1.2818 0.7619 0.587 3636414 DAlc3.1-H_000560 COc1ccccc1CN2[C@@H](c3ccc(COC(=O)NCCCCCC(=O)NO)cc3)[C@]4(Cc5ccccc5N(Cc6ccccc6)C4=O)c7ccccc7C2=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 M05 compound treatment 13.8128 3.1854 0.8547 11.4849 5.7357 1.359 1.5653 0.975 3636416 DAlc3.1-H_000561 COc1cc2CCN(Cc2cc1OC)C(=O)[C@H]3[C@H]4N([C@@H](c5ccccc5OCCOC(=O)NCCCCCC(=O)NO)[C@]36C(=O)Nc7ccccc76)[C@@H]([C@@H](OC4=O)c8ccccc8)c9ccccc9 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 M06 compound treatment 11.0826 0.45514 0.1221 10.1438 4.3946 1.0412 0.8226 0.7847 3636418 DAlc3.1-H_000562 CC(C)N1[C@H](c2ccc(COC(=O)NCCCCCC(=O)NO)cc2)[C@@](CC1=O)(Sc3ccc(C)cc3)C(=O)NC4CC4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 M07 compound treatment 9.8976 -0.72979 -0.1958 0.0 -5.7492 -1.3622 -1.1017 -0.8005 3636420 DAlc3.1-H_000563 COc1cc2CCN(Cc2cc1OC)C(=O)[C@H]3[C@H]4N([C@@H](c5ccccc5OCCOC(=O)NCCCCCC(=O)NO)[C@]36C(=O)Nc7ccc(C#CCNC(=O)N)cc76)[C@@H]([C@@H](OC4=O)c8ccccc8)c9ccccc9 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 M08 compound treatment 10.546 -0.081461 -0.0219 0.0 -5.7492 -1.3622 -0.9787 -0.7184 3636422 DAlc3.1-H_000564 COc1ccc(CCNC(=O)[C@]2(CC(=O)N([C@@H]2c3ccc(COC(=O)NCCCCCC(=O)NO)cc3)C4CCCCC4)Sc5ccc(C)cc5)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 M09 mock treatment 9.4102 -1.2172 -0.3266 9.1921 3.4429 0.8158 0.3459 0.3936 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 M10 mock treatment 8.5269 -2.1005 -0.5636 8.3482 2.5991 0.6158 0.0369 0.0442 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 M11 compound treatment 9.4365 -1.1909 -0.3195 0.0 -5.7492 -1.3622 -1.1892 -0.8499 3636424 DAlc3.1-H_000565 COc1cc2CCN(Cc2cc1OC)C(=O)[C@@H]3[C@@H]4N([C@H](c5ccc(OCCOC(=O)NCCCCCC(=O)NO)cc5)[C@@]36C(=O)Nc7ccc(C#CCNC(=O)N)cc76)[C@H]([C@H](OC4=O)c8ccccc8)c9ccccc9 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 M12 compound treatment 9.7092 -0.91821 -0.2464 0.0 -5.7492 -1.3622 -1.1374 -0.8217 3636426 DAlc3.1-H_000566 CC(C)NC(=O)[C@]1(CC(=O)N([C@@H]1c2ccc(COC(=O)NCCCCCC(=O)NO)cc2)C3CCCCC3)Sc4ccc(C)cc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 M13 mock treatment 12.4782 1.8508 0.4966 0.0 -5.7492 -1.3622 -0.612 -0.4221 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 M14 mock treatment 9.4784 -1.149 -0.3083 0.0 -5.7492 -1.3622 -1.1812 -0.8458 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 M15 compound treatment 10.4965 -0.13096 -0.0351 0.0 -5.7492 -1.3622 -0.9881 -0.7251 3636428 DAlc3.1-H_000567 NC(=O)[C@@H]1[C@@H]2N([C@H](c3ccccc3OCCOC(=O)NCCCCCC(=O)NO)[C@@]14C(=O)Nc5ccccc54)[C@H]([C@H](OC2=O)c6ccccc6)c7ccccc7 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 M16 compound treatment 9.0457 -1.5817 -0.4244 0.0 -5.7492 -1.3622 -1.2633 -0.8854 3636429 DAlc3.1-H_000568 ONC(=O)CCCCCNC(=O)OCc1ccc(cc1)[C@@H]2N(Cc3ccccc3Cl)C(=O)c4ccccc4[C@]2(Cc5ccccc5I)C(=O)NCc6ccccc6 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 M17 compound treatment 10.4062 -0.22127 -0.0594 0.0 -5.7492 -1.3622 -1.0052 -0.7372 3636431 DAlc3.1-H_000569 COCCOC(=O)N1C(=O)[C@@]2([C@H]([C@H]3N([C@H]2c4ccccc4OCCOC(=O)NCCCCCC(=O)NO)[C@@H]([C@@H](OC3=O)c5ccccc5)c6ccccc6)C(=O)N)c7cc(C#Cc8ccc(OC)cc8)ccc17 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 M18 compound treatment 10.2045 -0.42291 -0.1135 0.0 -5.7492 -1.3622 -1.0435 -0.7634 3636433 DAlc3.1-H_000570 COCCCNC(=O)[C@]1(CC(=O)N(Cc2ccccc2C(F)(F)F)[C@@H]1c3ccc(COC(=O)NCCCCCC(=O)NO)cc3)Sc4ccc(C)cc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 M19 compound treatment 12.8685 2.2411 0.6013 0.0 -5.7492 -1.3622 -0.538 -0.3613 3636435 DAlc3.1-H_000571 COCCOC(=O)N1C(=O)[C@]2([C@@H]([C@@H]3N([C@@H]2c4ccccc4OCCOC(=O)NCCCCCC(=O)NO)[C@H]([C@H](OC3=O)c5ccccc5)c6ccccc6)C(=O)N7CCc8cc(OC)c(OC)cc8C7)c9cc(C#Cc%10ccc(OC)cc%10)ccc19 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 M20 compound treatment 11.3231 0.69565 0.1867 0.0 -5.7492 -1.3622 -0.8312 -0.6046 3636437 DAlc3.1-H_000572 COc1ccc(CCNC(=O)[C@]2(Cc3ccccc3I)[C@@H](N(Cc4ccccc4OC)C(=O)c5ccccc52)c6ccc(COC(=O)NCCCCCC(=O)NO)cc6)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 M21 compound treatment 13.7498 3.1224 0.8378 10.7224 4.9732 1.1783 1.4256 0.986 3636439 DAlc3.1-H_000573 COCCOC(=O)N1C(=O)[C@@]2([C@H]([C@H]3N([C@H]2c4ccccc4OCCOC(=O)NCCCCCC(=O)NO)[C@@H]([C@@H](OC3=O)c5ccccc5)c6ccccc6)C(=O)N7CCc8cc(OC)c(OC)cc8C7)c9cc(C#Cc%10ccc(OC)cc%10)ccc19 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 M22 compound treatment 9.5554 -1.072 -0.2877 12.8059 7.0567 1.672 0.9789 0.577 3636440 DAlc3.1-H_000574 ONC(=O)CCCCCNC(=O)OCc1ccc(cc1)[C@@H]2N(Cc3ccccc3)C(=O)c4ccccc4[C@]2(Cc5ccccc5I)C(=O)NCc6ccccc6 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 M23 compound treatment 11.5409 0.91343 0.2451 0.0 -5.7492 -1.3622 -0.7899 -0.5707 3636442 DAlc3.1-H_000575 COCCOC(=O)N1C(=O)[C@@]2([C@H]([C@H]3N([C@H]2c4ccccc4OCCOC(=O)NCCCCCC(=O)NO)[C@@H]([C@@H](OC3=O)c5ccccc5)c6ccccc6)C(=O)N7CCc8cc(OC)c(OC)cc8C7)c9cc(C#CCNC(=O)N)ccc19 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 M24 compound treatment 12.5251 1.8977 0.5092 0.0 -5.7492 -1.3622 -0.6032 -0.4148 3636444 DAlc3.1-H_000576 Cc1ccc(S[C@@]2(CC(=O)N(Cc3ccccc3Cl)[C@@H]2c4ccc(COC(=O)NCCCCCC(=O)NO)cc4)C(=O)NC5CC5)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 N01 compound treatment 11.866 1.2386 0.3323 11.7034 5.9542 1.4108 1.2326 0.8504 3636446 DAlc3.1-H_000577 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CCOC(=O)NCCCCCC(=O)NO)C(=O)N4c5c3cc(OC)cc5C(=CC4(C)C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 N02 compound treatment 11.2483 0.62091 0.1666 9.9916 4.2424 1.0052 0.8286 0.8132 3636447 DAlc3.1-H_000578 CN(C)CCCC[C@@H]1NC(=O)[C@H]2C[C@H]([C@H](N2C1=O)c3cccc(OCCOC(=O)NCCCCCC(=O)NO)c3)C(=O)NCc4ccc(F)cc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 N03 compound treatment 10.9763 0.34886 0.0936 9.945 4.1958 0.9941 0.7692 0.7703 3636449 DAlc3.1-H_000579 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CC(=O)N4CCC[C@H]4COC(=O)NCCCCCC(=O)NO)C(=O)N(C)c5ccccc53 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 N04 compound treatment 10.8072 0.17982 0.0483 11.6257 5.8765 1.3924 1.0187 0.7312 3636451 DAlc3.1-H_000580 CCCCc1cn(C[C@@H]2CCCN2C(=O)N[C@@H](CCc3oc(C(=O)C)c(C(=O)OC)c3C(=O)OC)COC(=O)NCCCCCC(=O)NO)nn1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 N05 compound treatment 12.5909 1.9635 0.5269 15.191 9.4418 2.2371 1.9544 0.8504 3636453 DAlc3.1-H_000581 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CCn4cc(CCOC(=O)NCCCCCC(=O)NO)nn4)C(=O)N(CC=C)c5ccccc53 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 N06 compound treatment 11.3684 0.74101 0.1988 11.9817 6.2325 1.4767 1.1848 0.7951 3636454 DAlc3.1-H_000582 COC(=O)c1c(CC[C@@H](COC(=O)NCCCCCC(=O)NO)NC(=O)N[C@@H](Cc2ccccc2)Cn3cc(nn3)C4(O)CCCC4)oc(C(=O)N5CCOCC5)c1C(=O)OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 N07 compound treatment 12.0077 1.3803 0.3704 0.0 -5.7492 -1.3622 -0.7013 -0.4968 3636456 DAlc3.1-H_000583 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CCOC(=O)NCCCCCC(=O)NO)C(=O)N(Cc4ccccc4)c5ccc(NC(=O)C)cc53 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 N08 compound treatment 12.4443 1.8169 0.4875 0.0 -5.7492 -1.3622 -0.6185 -0.4275 3636458 DAlc3.1-H_000584 COCc1cn(C[C@H](Cc2ccccc2)NC(=O)N[C@@H](CCc3oc(C(=O)N4CCOCC4)c(C(=O)OC)c3C(=O)OC)COC(=O)NCCCCCC(=O)NO)nn1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 N09 mock treatment 11.877 1.2496 0.3353 9.1687 3.4195 0.8102 0.81 0.9238 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 N10 mock treatment 8.4155 -2.2119 -0.5935 9.1742 3.425 0.8115 0.1541 0.1533 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 N11 compound treatment 11.6207 0.9933 0.2665 0.0 -5.7492 -1.3622 -0.7747 -0.5582 3556639 DAlc3.1-H_000585 COc1ccc(cc1)[Si](C)(C)[C@@H](CC(=O)N2CCC[C@H]2COC(=O)NCCCCCC(=O)NO)/C=C/C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 N12 compound treatment 9.1638 -1.4636 -0.3927 0.0 -5.7492 -1.3622 -1.2409 -0.8753 3556538 DAlc3.1-H_000586 COC(=O)c1c(C(=O)OC)c2oc1CC[C@@H](COC(=O)NCCCCCC(=O)NO)NC(=O)N[C@H](C)Cn3cc(CN(C)C2=O)nn3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 N13 mock treatment 13.007 2.3796 0.6385 0.0 -5.7492 -1.3622 -0.5117 -0.3401 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 N14 mock treatment 12.6662 2.0388 0.5471 0.0 -5.7492 -1.3622 -0.5764 -0.3926 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 N15 compound treatment 12.3928 1.7654 0.4737 0.0 -5.7492 -1.3622 -0.6283 -0.4356 3556628 DAlc3.1-H_000587 COc1ccc(cc1)[Si](C)(C)[C@H](CC(=O)N(CCOC(=O)NCCCCCC(=O)NO)Cc2ccccc2)/C=C/C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 N16 compound treatment 9.5442 -1.0832 -0.2906 0.0 -5.7492 -1.3622 -1.1687 -0.8391 3636460 DAlc3.1-H_000588 COC(=O)c1c(CC[C@@H](COC(=O)NCCCCCC(=O)NO)NC(=O)N2CCCC2)oc(C(=O)Cc3ccccc3)c1C(=O)OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 N17 compound treatment 22.6872 12.06 3.2359 0.0 -5.7492 -1.3622 1.3249 0.3774 3556640 DAlc3.1-H_000589 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CCOC(=O)NCCCCCC(=O)NO)C(=O)N(C)c4ccccc43 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 N18 compound treatment 10.4932 -0.13426 -0.036 0.0 -5.7492 -1.3622 -0.9887 -0.7256 3636462 DAlc3.1-H_000590 COC(=O)c1c(CC[C@@H](COC(=O)NCCCCCC(=O)NO)NC(=O)NCC(C)C)oc(C(=O)Cc2ccccc2)c1C(=O)OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 N19 compound treatment 12.5539 1.9264 0.5169 0.0 -5.7492 -1.3622 -0.5977 -0.4102 3636464 DAlc3.1-H_000591 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CCOC(=O)NCCCCCC(=O)NO)C(=O)N(c4ccccc43)c5ccccc5 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 N20 compound treatment 9.7969 -0.83054 -0.2229 0.0 -5.7492 -1.3622 -1.1208 -0.812 3636465 DAlc3.1-H_000592 COc1cccc(C[C@H]2C[C@@H](COC(=O)NCCCCCC(=O)NO)NC2=O)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 N21 compound treatment 12.0745 1.4471 0.3883 10.2659 4.5167 1.0702 1.0313 0.9059 3636467 DAlc3.1-H_000593 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CCn4cc(CCOC(=O)NCCCCCC(=O)NO)nn4)C(=O)N(CC=C)c5ccc(cc53)N6CCOC6=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 N22 compound treatment 10.219 -0.40843 -0.1096 38.8159 33.067 7.8347 5.4625 0.6971 3636469 DAlc3.1-H_000594 COC(=O)c1c(CC[C@@H](COC(=O)NCCCCCC(=O)NO)NC(=O)N(C)Cc2ccccc2)oc(C(=O)OCC=C)c1C(=O)OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 N23 compound treatment 17.2843 6.6568 1.7862 0.0 -5.7492 -1.3622 0.2998 0.1335 3636471 DAlc3.1-H_000595 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CCOC(=O)NCCCCCC(=O)NO)C(=O)N(Cc4cccc(NC(=O)C)c4)c5ccccc53 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 N24 compound treatment 11.0858 0.45835 0.123 0.0 -5.7492 -1.3622 -0.8762 -0.6407 3636473 DAlc3.1-H_000596 COC(=O)c1c(C(=O)OC)c2oc1CC[C@@H](COC(=O)NCCCCCC(=O)NO)NC(=O)N[C@@H](Cc3ccccc3)Cn4cc(COC2=O)nn4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 O01 compound treatment 12.4805 1.8531 0.4972 10.7864 5.0372 1.1935 1.1955 0.9247 3636475 DAlc3.1-H_000597 NC(=O)[C@H]1[C@H]2N([C@@H](c3ccc(OCCOC(=O)NCCCCCC(=O)NO)cc3)[C@]14C(=O)Nc5ccccc54)[C@@H]([C@@H](OC2=O)c6ccccc6)c7ccccc7 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 O02 compound treatment 10.1003 -0.52709 -0.1414 10.9134 5.1642 1.2236 0.7652 0.6212 3636476 DAlc3.1-H_000598 ONC(=O)CCCCCNC(=O)OCc1ccc(cc1)[C@@H]2N(Cc3ccccc3C(F)(F)F)C(=O)c4ccccc4[C@]52Cc6ccccc6N(CCN7CCOCC7)C5=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 O03 compound treatment 8.5473 -2.0802 -0.5582 11.3644 5.6152 1.3304 0.5461 0.3785 3636478 DAlc3.1-H_000599 COC(=O)C(CC#Cc1ccc2NC(=O)[C@]3([C@@H]([C@@H]4N([C@@H]3c5ccc(OCCOC(=O)NCCCCCC(=O)NO)cc5)[C@H]([C@H](OC4=O)c6ccccc6)c7ccccc7)C(=O)N)c2c1)C(=O)OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 O04 compound treatment 9.5976 -1.0298 -0.2763 10.5232 4.774 1.1311 0.6044 0.5191 3636480 DAlc3.1-H_000600 CC(C)N1[C@H](c2ccc(COC(=O)NCCCCCC(=O)NO)cc2)[C@@](CC1=O)(Sc3ccc(C)cc3)C(=O)NCc4ccccc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 O05 compound treatment 14.0333 3.4059 0.9139 11.7594 6.0103 1.424 1.6532 0.977 3636482 DAlc3.1-H_000601 COCCOC(=O)N1C(=O)[C@@]2([C@H]([C@H]3N([C@H]2c4ccccc4OCCOC(=O)NCCCCCC(=O)NO)[C@@H]([C@@H](OC3=O)c5ccccc5)c6ccccc6)C(=O)NCC(OC(=O)NCCCCCC(=O)NO)c7ccccc7)c8ccccc18 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 O06 compound treatment 8.9173 -1.7101 -0.4589 10.7929 5.0437 1.195 0.5206 0.4067 3636484 DAlc3.1-H_000602 CC(C)CNC(=O)[C@]1(CC(=O)N(Cc2ccccc2C(F)(F)F)[C@@H]1c3ccc(COC(=O)NCCCCCC(=O)NO)cc3)Sc4ccc(C)cc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 O07 compound treatment 11.7115 1.0841 0.2909 0.0 -5.7492 -1.3622 -0.7575 -0.5439 3636486 DAlc3.1-H_000603 COc1ccc(C#Cc2ccc3NC(=O)[C@]4([C@@H]([C@@H]5N([C@@H]4c6ccc(OCCOC(=O)NCCCCCC(=O)NO)cc6)[C@H]([C@H](OC5=O)c7ccccc7)c8ccccc8)C(=O)N9CCN(CC9)c%10ncccn%10)c3c2)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 O08 compound treatment 12.1586 1.5312 0.4109 0.0 -5.7492 -1.3622 -0.6727 -0.4728 3636488 DAlc3.1-H_000604 ONC(=O)CCCCCNC(=O)OCc1ccc(cc1)[C@@H]2N(Cc3ccccc3Cl)C(=O)c4ccccc4[C@]52Cc6ccccc6N(C7CC7)C5=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 O09 compound treatment 11.6814 1.0539 0.2828 9.8024 4.0532 0.9603 0.879 0.8781 3636490 DAlc3.1-H_000605 NC(=O)NCC#Cc1ccc2NC(=O)[C@@]3([C@H]([C@H]4N([C@H]3c5ccccc5OCCOC(=O)NCCCCCC(=O)NO)[C@@H]([C@@H](OC4=O)c6ccccc6)c7ccccc7)C(=O)N)c2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 O10 compound treatment 15.0245 4.397 1.1798 10.406 4.6569 1.1034 1.6145 0.9994 3636492 DAlc3.1-H_000606 Cc1ccc(S[C@@]2(CC(=O)N(C3Cc4ccccc4C3)[C@@H]2c5ccc(COC(=O)NCCCCCC(=O)NO)cc5)C(=O)NCc6ccccc6)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 O11 mock treatment 10.5396 -0.087871 -0.0236 0.0 -5.7492 -1.3622 -0.9799 -0.7192 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 O12 mock treatment 10.3057 -0.32174 -0.0863 0.0 -5.7492 -1.3622 -1.0243 -0.7504 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 O13 compound treatment 11.2907 0.66333 0.178 0.0 -5.7492 -1.3622 -0.8374 -0.6095 3636494 DAlc3.1-H_000607 NC(=O)[C@H]1[C@H]2N([C@@H](c3ccc(OCCOC(=O)NCCCCCC(=O)NO)cc3)[C@]14C(=O)Nc5ccc(C#CC6(O)CCCCCC6)cc54)[C@@H]([C@@H](OC2=O)c7ccccc7)c8ccccc8 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 O14 compound treatment 12.3073 1.6799 0.4508 0.0 -5.7492 -1.3622 -0.6445 -0.4492 3636495 DAlc3.1-H_000608 CC(C)N1[C@H](c2ccc(COC(=O)NCCCCCC(=O)NO)cc2)[C@@](CC1=O)(Sc3ccc(C)cc3)C(=O)NCCCN(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 O15 compound treatment 10.774 0.14655 0.0393 0.0 -5.7492 -1.3622 -0.9354 -0.6864 3636497 DAlc3.1-H_000609 NC(=O)NCC#Cc1ccc2NC(=O)[C@]3([C@@H]([C@@H]4N([C@@H]3c5ccccc5OCCOC(=O)NCCCCCC(=O)NO)[C@H]([C@H](OC4=O)c6ccccc6)c7ccccc7)C(=O)NCC=C)c2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 O16 compound treatment 12.812 2.1846 0.5862 0.0 -5.7492 -1.3622 -0.5487 -0.37 3636498 DAlc3.1-H_000610 CN(C)CCCNC(=O)[C@]1(CC(=O)N(Cc2ccccc2Cl)[C@@H]1c3ccc(COC(=O)NCCCCCC(=O)NO)cc3)Sc4ccc(C)cc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 O17 compound treatment 10.7277 0.1003 0.0269 0.0 -5.7492 -1.3622 -0.9442 -0.693 3636500 DAlc3.1-H_000611 COc1ccc(C#Cc2ccc3NC(=O)[C@]4([C@@H]([C@@H]5N([C@@H]4c6ccccc6OCCOC(=O)NCCCCCC(=O)NO)[C@H]([C@H](OC5=O)c7ccccc7)c8ccccc8)C(=O)NCC=C)c3c2)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 O18 compound treatment 9.8711 -0.75634 -0.2029 0.0 -5.7492 -1.3622 -1.1067 -0.8036 3636501 DAlc3.1-H_000612 CN(C)CCCN1C(=O)[C@]2(Cc3ccccc13)[C@@H](N(Cc4ccccc4Cl)C(=O)c5ccccc52)c6ccc(COC(=O)NCCCCCC(=O)NO)cc6 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 O19 compound treatment 10.2258 -0.40162 -0.1078 0.0 -5.7492 -1.3622 -1.0394 -0.7607 3636503 DAlc3.1-H_000613 ONC(=O)CCCCCNC(=O)OCCOc1ccc(cc1)[C@@H]2N3[C@H]([C@H](C(=O)N4CCCCCCC4)[C@@]25C(=O)Nc6ccc(C#CC7(O)CCCCCC7)cc65)C(=O)O[C@H]([C@H]3c8ccccc8)c9ccccc9 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 O20 compound treatment 11.0831 0.4557 0.1223 0.0 -5.7492 -1.3622 -0.8767 -0.6411 3636504 DAlc3.1-H_000614 CCCNC(=O)[C@]1(CC(=O)N(Cc2ccccc2C(F)(F)F)[C@@H]1c3ccc(COC(=O)NCCCCCC(=O)NO)cc3)Sc4ccc(C)cc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 O21 compound treatment 13.9325 3.3051 0.8868 10.3688 4.6196 1.0945 1.401 0.9945 3636506 DAlc3.1-H_000615 CO[C@H]1O[C@H](COC(=O)NCCCCCC(=O)NO)[C@@H](OC(=O)Nc2cccc(F)c2)[C@@H]3OC(=O)[C@H](Cc4cccc(Br)c4)C/C=C/C[C@@H](Cc5cccc(Br)c5)C(=O)O[C@@H]13 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 O22 compound treatment 11.8131 1.1857 0.3182 12.204 6.4548 1.5294 1.3064 0.8363 3636508 DAlc3.1-H_000616 CN(C)CCCN1C(=O)[C@]2(Cc3ccccc13)[C@@H](N(Cc4ccccc4C(F)(F)F)C(=O)c5ccccc52)c6ccc(COC(=O)NCCCCCC(=O)NO)cc6 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 O23 compound treatment 11.7171 1.0897 0.2924 0.0 -5.7492 -1.3622 -0.7565 -0.543 3636510 DAlc3.1-H_000617 CO[C@H]1O[C@H](COC(=O)NCCCCCC(=O)NO)[C@@H](OC(=O)Nc2ccc3OCOc3c2)[C@@H]4OC(=O)[C@H](Cc5cccc(Br)c5)C/C=C/C[C@@H](Cc6cccc(Br)c6)C(=O)O[C@@H]14 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 O24 compound treatment 12.4397 1.8122 0.4863 0.0 -5.7492 -1.3622 -0.6194 -0.4282 3636512 DAlc3.1-H_000618 CCCNC(=O)[C@]1(CC(=O)N([C@@H]1c2ccc(COC(=O)NCCCCCC(=O)NO)cc2)C3CCCCC3)Sc4ccc(C)cc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 P01 compound treatment 43.0084 32.381 8.6886 47.2292 41.48 9.8281 13.0933 0.9981 3636514 DAlc3.1-H_000619 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CCn4cc(CCOC(=O)NCCCCCC(=O)NO)nn4)C(=O)N(Cc5cccc(c5)N6CCOC6=O)c7ccccc73 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 P02 compound treatment 10.1758 -0.45164 -0.1212 12.5378 6.7886 1.6085 1.0517 0.652 3636516 DAlc3.1-H_000620 COc1cccc(C[C@]2(C[C@@H](COC(=O)NCCCCCC(=O)NO)NC2=O)C(=O)OCc3ccccc3)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 P03 compound treatment 18.749 8.1216 2.1792 19.2536 13.504 3.1997 3.8034 0.9825 3636518 DAlc3.1-H_000621 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CCOC(=O)NCCCCCC(=O)NO)C(=O)N(Cc4cccc(NC(=O)C)c4)c5ccccc53 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 P04 compound treatment 12.2712 1.6438 0.4411 11.862 6.1128 1.4483 1.336 0.8824 3636519 DAlc3.1-H_000622 COc1cccc(C[C@@]2(C[C@@H](COC(=O)NCCCCCC(=O)NO)NC2=O)C(=O)OCc3ccccc3)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 P05 compound treatment 12.3626 1.7352 0.4656 13.4979 7.7487 1.8359 1.6274 0.8592 3636520 DAlc3.1-H_000623 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CCOC(=O)NCCCCCC(=O)NO)C(=O)N(Cc4ccccc4)c5ccc(NC(=O)C)cc53 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 P06 compound treatment 9.7395 -0.88797 -0.2383 10.3156 4.5664 1.0819 0.5966 0.5385 3636521 DAlc3.1-H_000624 COC(=O)c1c(C(=O)OC)c2oc1CC[C@@H](COC(=O)NCCCCCC(=O)NO)NC(=O)N(C)Cc3cn(C[C@H](Cc4ccccc4)NC2=O)nn3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 P07 compound treatment 14.8389 4.2114 1.13 0.0 -5.7492 -1.3622 -0.1642 -0.0927 3636523 DAlc3.1-H_000625 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CCOC(=O)NCCCCCC(=O)NO)C(=O)N(CC=C)c4ccc(cc43)N5CCOC5=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 P08 compound treatment 8.7127 -1.9147 -0.5138 0.0 -5.7492 -1.3622 -1.3265 -0.9111 3636525 DAlc3.1-H_000626 COC(=O)c1c(C(=O)OC)c2oc1CC[C@@H](COC(=O)NCCCCCC(=O)NO)NC(=O)N(Cc3ccccc3)Cc4cn(C[C@H](Cc5ccccc5)NC2=O)nn4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 P09 compound treatment 26.2555 15.628 4.1934 23.6072 17.858 4.2312 5.9571 1.0 3636527 DAlc3.1-H_000627 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CCn4cc(CCOC(=O)NCCCCCC(=O)NO)nn4)C(=O)N(Cc5ccc(cc5)N6CCOC6=O)c7ccccc73 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 P10 compound treatment 10.2209 -0.40655 -0.1091 9.854 4.1048 0.9726 0.6106 0.6239 3636529 DAlc3.1-H_000628 COC(=O)c1c(C(=O)OC)c2oc1CC[C@@H](COC(=O)NCCCCCC(=O)NO)NC(=O)N(Cc3ccccc3)Cc4cn(C[C@@H](Cc5ccccc5)NC2=O)nn4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 P11 mock treatment 10.3569 -0.27051 -0.0726 0.0 -5.7492 -1.3622 -1.0145 -0.7437 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 P12 mock treatment 9.1085 -1.5189 -0.4076 0.0 -5.7492 -1.3622 -1.2514 -0.8801 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 P13 compound treatment 30.5363 19.909 5.3421 0.0 -5.7492 -1.3622 2.8142 0.5105 3636530 DAlc3.1-H_000629 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CCOC(=O)NCCCCCC(=O)NO)C(=O)N(Cc4ccc(NC(=O)C)cc4)c5ccccc53 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 P14 compound treatment 9.9349 -0.69253 -0.1858 0.0 -5.7492 -1.3622 -1.0946 -0.7962 3636532 DAlc3.1-H_000630 COC(=O)c1c(C(=O)OC)c2oc1CC[C@@H](COC(=O)NCCCCCC(=O)NO)NC(=O)N(Cc3ccccc3)Cc4cnnn4C[C@@H](Cc5ccccc5)NC2=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 P15 compound treatment 18.3846 7.7571 2.0814 0.0 -5.7492 -1.3622 0.5086 0.2045 3636534 DAlc3.1-H_000631 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CCOC(=O)NCCCCCC(=O)NO)C(=O)N(CC=C)c4ccc(cc43)N5CCC5=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 P16 compound treatment 9.9565 -0.67088 -0.18 0.0 -5.7492 -1.3622 -1.0905 -0.7937 3636535 DAlc3.1-H_000632 COC(=O)c1c(C(=O)OC)c2oc1CC[C@@H](COC(=O)NCCCCCC(=O)NO)NC(=O)N(Cc3ccccc3)Cc4cn(C[C@@H]5CCCN5C2=O)nn4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 P17 compound treatment 11.1715 0.54407 0.146 0.0 -5.7492 -1.3622 -0.86 -0.6277 3636094 DAlc3.1-H_000633 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CCn4cc(CCOC(=O)NCCCCCC(=O)NO)nn4)C(=O)N(CC=C)c5ccc(cc53)N6CCC6=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 P18 compound treatment 10.3926 -0.23484 -0.063 0.0 -5.7492 -1.3622 -1.0078 -0.739 3636537 DAlc3.1-H_000634 COC(=O)c1c(C(=O)OC)c2oc1CC[C@@H](COC(=O)NCCCCCC(=O)NO)NC(=O)NC3(CCCCC3)c4cn(C[C@H](C)NC2=O)nn4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 P19 compound treatment 21.1186 10.491 2.8151 0.0 -5.7492 -1.3622 1.0273 0.3285 3636539 DAlc3.1-H_000635 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CCOC(=O)NCCCCCC(=O)NO)C(=O)N(Cc4ccc(cc4)N5CCC5=O)c6ccccc63 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 P20 compound treatment 117.5717 106.94 28.6959 0.0 -5.7492 -1.3622 19.3279 0.6728 3636540 DAlc3.1-H_000636 CC(=CCN(CC#Cc1ccccc1)[C@H](COC(=O)NCCCCCC(=O)NO)c2ccccc2)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 P21 compound treatment 17.7356 7.1082 1.9073 17.4407 11.691 2.7701 3.3074 0.9834 3636542 DAlc3.1-H_000637 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CCn4cc(CCOC(=O)NCCCCCC(=O)NO)nn4)C(=O)N(C)c5c3cc(C)cc5Br 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 P22 compound treatment 30.2783 19.651 5.2728 36.0311 30.282 7.1748 8.8018 0.9885 3636543 DAlc3.1-H_000638 C/C=C/CN([C@H](COC(=O)NCCCCCC(=O)NO)c1ccccc1)C(=O)C#Cc2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 P23 compound treatment 13.4789 2.8515 0.7651 0.0 -5.7492 -1.3622 -0.4222 -0.2702 3636545 DAlc3.1-H_000639 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CCn4cc(CCOC(=O)NCCCCCC(=O)NO)nn4)C(=O)N(Cc5cccc(c5)N6CCOC6=O)c7ccccc73 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2438 P24 compound treatment 8.2004 -2.427 -0.6512 0.0 -5.7492 -1.3622 -1.4237 -0.9429 3636546 DAlc3.1-H_000640 CCOC(=O)[C@@H]1[C@H]2O[C@@]3(C=C2)[C@@H](N(CCCCCCOC(=O)NCCCCCC(=O)NO)C(=O)[C@@H]13)C(=O)NCc4ccccc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 A01 compound treatment 14.3739 3.8402 1.0304 13.9995 3.4815 0.8249 1.3119 0.9939 3652012 DAlcMix-H_000001 CC(C)(C)[C@@H]1C[C@H](OCc2ccc(COC(=O)NCCCCCC(=O)NO)cc2)OC(=C1)C(=O)N3CCCCCCC3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 A02 compound treatment 15.0051 4.4714 1.1998 14.5047 3.9867 0.9446 1.5163 0.993 3652155 DAlcMix-H_000002 CCO[C@@H]1OC(=C[C@@H]([C@H]1CCCOC(=O)NCCCCCC(=O)NO)c2csc3ccccc23)C(=O)N4CCN(Cc5ccc6OCOc6c5)CC4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 A03 compound treatment 17.9921 7.4584 2.0013 14.3003 3.7823 0.8962 2.0488 0.9343 3652014 DAlcMix-H_000003 CC(C)(C)[C@@H]1C[C@H](OCc2ccc(COC(=O)NCCCCCC(=O)NO)cc2)OC(=C1)C(=O)N3CCOCC3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 A04 compound treatment 12.0444 1.5107 0.4054 10.9049 0.38691 0.0917 0.3515 0.8457 3652157 DAlcMix-H_000004 CCO[C@@H]1OC(=C[C@@H]([C@H]1CCCOC(=O)NCCCCCC(=O)NO)c2cn(C(=O)C)c3ccccc23)C(=O)N4CCOCC4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 A05 compound treatment 12.8698 2.336 0.6268 15.3424 4.8244 1.1431 1.2515 0.96 3652016 DAlcMix-H_000005 CC(C)(C)[C@@H]1C[C@H](OCc2ccc(COC(=O)NCCCCCC(=O)NO)cc2)OC(=C1)C(=O)N3CCN(Cc4ccc5OCOc5c4)CC3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 A06 compound treatment 12.7416 2.2079 0.5924 11.2234 0.70539 0.1671 0.5371 0.8725 3652159 DAlcMix-H_000006 CCO[C@@H]1OC(=C[C@@H]([C@H]1CCCOC(=O)NCCCCCC(=O)NO)c2cn(C(=O)C)c3ccccc23)C(=O)N4CCN(C)CC4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 A07 compound treatment 16.5879 6.0542 1.6245 22.9853 12.467 2.9539 3.2375 0.9603 3652018 DAlcMix-H_000007 ONC(=O)CCCCCNC(=O)OCc1ccc(CO[C@H]2C[C@H](C=C(O2)C(=O)N3CCOCC3)C4CCCCC4)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 A08 compound treatment 12.4602 1.9265 0.5169 11.7806 1.2626 0.2991 0.5771 0.9662 3652161 DAlcMix-H_000008 CCO[C@@H]1OC(=C[C@@H]([C@H]1CCCOC(=O)NCCCCCC(=O)NO)c2cn(C(=O)C)c3ccccc23)C(=O)N4CCN(Cc5ccc6OCOc6c5)CC4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 A09 compound treatment 25.2216 14.688 3.9411 20.033 9.515 2.2544 4.3809 0.9649 3652020 DAlcMix-H_000009 ONC(=O)CCCCCNC(=O)OCc1ccc(CO[C@H]2C[C@H](C=C(O2)C(=O)N3CCN(Cc4ccc5OCOc5c4)CC3)C6CCCCC6)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 A10 compound treatment 13.5884 3.0547 0.8196 10.6112 0.093215 0.0221 0.5952 0.7259 3652163 DAlcMix-H_000010 CCO[C@@H]1OC(=C[C@@H]([C@H]1CCCOC(=O)NCCCCCC(=O)NO)c2cn(C(=O)C)c3ccccc23)C(=O)OCC=C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 A11 compound treatment 23.0557 12.522 3.36 27.5799 17.062 4.0426 5.2344 0.9958 3652022 DAlcMix-H_000011 ONC(=O)CCCCCNC(=O)OCc1ccc(CO[C@H]2C[C@H](C=C(O2)C(=O)N3CCOCC3)c4ccccc4)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 A12 compound treatment 12.4021 1.8683 0.5013 10.4296 -0.088418 -0.0209 0.3397 0.677 3652165 DAlcMix-H_000012 CCO[C@@H]1OC(=C[C@@H]([C@H]1CCCOC(=O)NCCCCCC(=O)NO)c2coc3ccccc3c2=O)C(=O)N4CCCCCCC4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 A13 mock treatment 9.771 -0.76274 -0.2047 10.2102 -0.30781 -0.0729 -0.1963 -0.9034 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 A14 mock treatment 11.6828 1.1491 0.3083 10.9819 0.46391 0.1099 0.2957 0.9035 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 A15 compound treatment 12.9522 2.4185 0.6489 14.2777 3.7598 0.8908 1.0888 0.9879 3652024 DAlcMix-H_000013 ONC(=O)CCCCCNC(=O)OCc1ccc(CO[C@H]2C[C@H](C=C(O2)C(=O)N3CCN(Cc4ccc5OCOc5c4)CC3)c6ccccc6)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 A16 compound treatment 11.7181 1.1844 0.3178 11.7476 1.2296 0.2913 0.4307 0.9991 3652167 DAlcMix-H_000014 CCO[C@@H]1OC(=C[C@@H]([C@H]1CCCOC(=O)NCCCCCC(=O)NO)c2coc3ccccc3c2=O)C(=O)N4CCOCC4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 A17 compound treatment 15.0456 4.5119 1.2107 13.9136 3.3956 0.8045 1.425 0.9803 3652026 DAlcMix-H_000015 ONC(=O)CCCCCNC(=O)OCc1ccc(CO[C@H]2C[C@H](C=C(O2)C(=O)N3CCOCC3)c4ccc5OCOc5c4)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 A18 compound treatment 11.1737 0.63998 0.1717 12.671 2.153 0.5101 0.4821 0.8957 3652169 DAlcMix-H_000016 CCO[C@@H]1OC(=C[C@@H]([C@H]1CCCOC(=O)NCCCCCC(=O)NO)c2coc3ccccc3c2=O)C(=O)N4CCN(Cc5ccc6OCOc6c5)CC4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 A19 compound treatment 29.6595 19.126 5.1319 26.6133 16.095 3.8136 6.3254 0.9893 3652028 DAlcMix-H_000017 ONC(=O)CCCCCNC(=O)OCc1ccc(CO[C@H]2C[C@H](C=C(O2)C(=O)N3CCN(Cc4ccc5OCOc5c4)CC3)c6ccc7OCOc7c6)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 A20 compound treatment 10.5515 0.017764 0.0048 13.7115 3.1935 0.7567 0.5384 0.7115 3652171 DAlcMix-H_000018 CCO[C@@H]1OC(=C[C@@H]([C@H]1CCCOC(=O)NCCCCCC(=O)NO)c2coc3ccccc3c2=O)C(=O)OCC=C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 A21 compound treatment 12.7348 2.2011 0.5906 12.1829 1.665 0.3945 0.6966 0.9808 3652030 DAlcMix-H_000019 ONC(=O)CCCCCNC(=O)OCc1ccc(CO[C@H]2C[C@H](C=C(O2)C(=O)N3CCOCC3)c4ccc(cc4)C(F)(F)F)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 A22 compound treatment 14.1498 3.6161 0.9703 14.1481 3.6301 0.8601 1.2943 0.9982 3652173 DAlcMix-H_000020 CCO[C@H]1OC(=C[C@@H](C)[C@@H]1CCCOC(=O)NCCCCCC(=O)NO)C(=O)N2CCOCC2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 A23 compound treatment 20.6977 10.164 2.7273 20.7099 10.192 2.4148 3.636 0.9982 3652032 DAlcMix-H_000021 ONC(=O)CCCCCNC(=O)OCc1ccc(CO[C@H]2C[C@H](C=C(O2)C(=O)N3CCN(Cc4ccc5OCOc5c4)CC3)c6ccc(cc6)C(F)(F)F)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 A24 compound treatment 14.1312 3.5975 0.9653 14.7386 4.2206 1.0 1.3897 0.9998 3652174 DAlcMix-H_000022 CCO[C@H]1OC(=C[C@@H](C)[C@@H]1CCCOC(=O)NCCCCCC(=O)NO)C(=O)N2CCN(Cc3ccc4OCOc4c3)CC2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 B01 compound treatment 11.5076 0.97384 0.2613 9.8152 -0.7028 -0.1665 0.067 0.2163 3556439 DAlcMix-H_000023 ONC(=O)CCCCCNC(=O)OCCOc1ccc(cc1)[C@@H]2N3[C@H]([C@H](C(=O)OCC=C)[C@]24C(=O)Nc5ccccc54)C(=O)O[C@H]([C@H]3c6ccccc6)c7ccccc7 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 B02 compound treatment 10.6834 0.14972 0.0402 11.9413 1.4233 0.3372 0.2669 0.7858 3652278 DAlcMix-H_000024 C[C@@]1(Oc2ccccc2[C@H]3NC(=S)N1CC=C)[C@@H]3COC(=O)NCCCCCC(=O)NO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 B03 compound treatment 10.3785 -0.15521 -0.0416 10.6837 0.16575 0.0393 -0.0017 -0.0293 3556442 DAlcMix-H_000025 ONC(=O)CCCCCNC(=O)OCCOc1ccc(cc1)[C@H]2N3[C@@H]([C@@H](C(=O)OCC=C)[C@@]24C(=O)Nc5ccccc54)C(=O)O[C@@H]([C@@H]3c6ccccc6)c7ccccc7 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 B04 compound treatment 9.4197 -1.114 -0.2989 10.7936 0.27558 0.0653 -0.1652 -0.5399 3652280 DAlcMix-H_000026 COc1ccc(COC[C@]2(Oc3ccccc3[C@H]4NC(=O)N2CC=C)[C@@H]4COC(=O)NCCCCCC(=O)NO)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 B05 compound treatment 10.3945 -0.13922 -0.0374 9.6523 -0.86563 -0.2051 -0.1714 -0.8224 3556444 DAlcMix-H_000027 ONC(=O)CCCCCNC(=O)OCCOc1ccc(cc1)[C@@H]2N3[C@H]([C@H](C(=O)OCC=C)[C@]24C(=O)Nc5ccc(I)cc54)C(=O)O[C@H]([C@H]3c6ccccc6)c7ccccc7 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 B06 compound treatment 9.967 -0.56669 -0.1521 10.6022 0.084262 0.02 -0.0934 -0.609 3652282 DAlcMix-H_000028 COc1ccc(COC[C@]2(NC(=O)N[C@H]3[C@H]2COC(=O)NCCCCCC(=O)NO)Oc4ccccc34)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 B07 compound treatment 10.7707 0.237 0.0636 10.6495 0.13156 0.0312 0.067 0.9462 3556446 DAlcMix-H_000029 ONC(=O)CCCCCNC(=O)OCCOc1ccc(cc1)[C@H]2N3[C@@H]([C@@H](C(=O)OCC=C)[C@@]24C(=O)Nc5ccc(I)cc54)C(=O)O[C@@H]([C@@H]3c6ccccc6)c7ccccc7 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 B08 compound treatment 8.9583 -1.5754 -0.4227 9.1929 -1.3251 -0.314 -0.5209 -0.9893 3652284 DAlcMix-H_000030 C[C@@]1(NC(=S)N[C@H]2[C@H]1COC(=O)NCCCCCC(=O)NO)Oc3ccccc23 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 B09 compound treatment 11.5303 0.99656 0.2674 12.1359 1.6179 0.3833 0.4601 0.9845 3556448 DAlcMix-H_000031 ONC(=O)CCCCCNC(=O)OCCOc1cccc(c1)[C@@H]2N3[C@H]([C@H](C(=O)OCC=C)[C@]24C(=O)Nc5ccc(I)cc54)C(=O)O[C@H]([C@H]3c6ccccc6)c7ccccc7 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 B10 compound treatment 13.0622 2.5285 0.6785 10.1171 -0.40085 -0.095 0.4126 0.6022 3652286 DAlcMix-H_000032 COc1ccc(COC[C@]2(NC(=S)N[C@H]3[C@H]2COC(=O)NCCCCCC(=O)NO)Oc4ccccc34)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 B11 compound treatment 13.3417 2.808 0.7535 10.9278 0.40977 0.0971 0.6014 0.7917 3556451 DAlcMix-H_000033 CN1C(=O)[C@@H]2C[C@]/3(C)OC[C@H]([C@@H]2C1=O)\C3=C/c4cccc(COC(=O)NCCCCCC(=O)NO)c4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 B12 compound treatment 11.1671 0.6334 0.17 10.317 -0.20098 -0.0476 0.0865 0.4901 3652288 DAlcMix-H_000034 C[C@@]1(NC(=O)N[C@H]2[C@H]1COC(=O)NCCCCCC(=O)NO)Oc3ccccc23 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 B13 mock treatment 12.3418 1.808 0.4851 10.2258 -0.29216 -0.0692 0.2941 0.6001 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 B14 mock treatment 8.9346 -1.5991 -0.4291 10.0446 -0.47337 -0.1122 -0.3827 -0.8629 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 B15 compound treatment 11.6253 1.0916 0.2929 8.7189 -1.7991 -0.4263 -0.0943 -0.1823 3556455 DAlcMix-H_000035 CCO[C@@H]1OC(=C[C@@H]([C@H]1CCOCCOCCOC(=O)NCCCCCC(=O)NO)c2ccc(cc2)C(=O)OC)C(=O)N3CCC(CC3)N4CCCCC4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 B16 compound treatment 11.181 0.64731 0.1737 11.1576 0.63959 0.1515 0.23 0.9977 3652290 DAlcMix-H_000036 C[C@]1(Oc2ccccc2[C@@H]3[C@H]1COC(=O)NCCCCCC(=O)NO)N=C4SCc5ccccc5CN34 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 B17 compound treatment 12.9452 2.4115 0.6471 18.9996 8.4816 2.0096 1.8785 0.8898 3556457 DAlcMix-H_000037 COc1cc2CCN3CCC[C@H]4C(=NO[C@]43c2cc1OC)c5ccc(OCCOC(=O)NCCCCCC(=O)NO)cc5 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 B18 compound treatment 10.0759 -0.45785 -0.1229 11.6262 1.1083 0.2626 0.0988 0.3408 3652292 DAlcMix-H_000038 CC1(Oc2ccccc2C3C1COC(=O)NCCCCCC(=O)NO)N=C4SCC(=O)N34 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 B19 compound treatment 10.4543 -0.079431 -0.0213 9.9989 -0.51903 -0.123 -0.102 -0.8175 3556461 DAlcMix-H_000039 COc1cc2CCN3CC[C@H]4C(=NO[C@]43c2cc1OC)c5ccc(OCCOC(=O)NCCCCCC(=O)NO)cc5 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 B20 compound treatment 9.6082 -0.92551 -0.2483 12.1124 1.5944 0.3778 0.0915 0.2024 3652293 DAlcMix-H_000040 CN1C(=O)N[C@H]2[C@@H](COC(=O)NCCCCCC(=O)NO)[C@@]1(C)Oc3ccccc23 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 B21 compound treatment 10.0026 -0.53117 -0.1425 12.3496 1.8316 0.434 0.2061 0.4512 3556463 DAlcMix-H_000041 COc1cc2CCN(CC=C)CCc3c(noc3-c2cc1OC)c4ccc(OCCOC(=O)NCCCCCC(=O)NO)cc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 B22 compound treatment 10.7863 0.25263 0.0678 14.1421 3.6241 0.8587 0.6551 0.7606 3652295 DAlcMix-H_000042 CN1C(=S)N[C@H]2[C@@H](COC(=O)NCCCCCC(=O)NO)[C@@]1(C)Oc3ccccc23 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 B23 compound treatment 10.8527 0.31901 0.0856 11.5222 1.0042 0.2379 0.2288 0.9047 3556466 DAlcMix-H_000043 ONC(=O)CCCCCNC(=O)OC[C@@H]1N2CC(=C[C@@H]2[C@H](Cc3ccccc3)OC1=O)/C=C/C4CC4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 B24 compound treatment 11.7753 1.2416 0.3332 12.8476 2.3296 0.552 0.6259 0.9708 3652297 DAlcMix-H_000044 COc1ccc(COC[C@]2(Oc3ccccc3[C@H]4NC(=O)N2C)[C@@H]4COC(=O)NCCCCCC(=O)NO)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 C01 compound treatment 15.7874 5.2537 1.4097 15.5623 5.0443 1.1952 1.8419 0.9966 3652034 DAlcMix-H_000045 ONC(=O)CCCCCNC(=O)OCc1ccc(CO[C@H]2C[C@H](C=C(O2)C(=O)NC3CC3)c4ccc(cc4)C(F)(F)F)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 C02 compound treatment 12.7447 2.211 0.5933 13.7243 3.2063 0.7597 0.9567 0.9925 3652175 DAlcMix-H_000046 CCO[C@H]1OC(=C[C@@H](C2CC2)[C@@H]1CCCOC(=O)NCCCCCC(=O)NO)C(=O)N3CCN(Cc4ccc5OCOc5c4)CC3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 C03 compound treatment 11.446 0.91226 0.2448 11.2131 0.69508 0.1647 0.2895 0.9814 3652036 DAlcMix-H_000047 ONC(=O)CCCCCNC(=O)OCc1ccc(CO[C@H]2C[C@H](C=C(O2)C(=O)N3CCOCC3)c4ccc(Br)cc4)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 C04 compound treatment 13.2702 2.7364 0.7343 12.5169 1.9989 0.4736 0.8541 0.9775 3652176 DAlcMix-H_000048 CCO[C@H]1OC(=C[C@@H](C2CC2)[C@@H]1CCCOC(=O)NCCCCCC(=O)NO)C(=O)OCC=C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 C05 compound treatment 13.5987 3.065 0.8224 13.8635 3.3455 0.7927 1.142 0.9998 3652038 DAlcMix-H_000049 ONC(=O)CCCCCNC(=O)OCc1ccc(CO[C@H]2C[C@H](C=C(O2)C(=O)N3CCN(Cc4ccc5OCOc5c4)CC3)c6ccc(Br)cc6)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 C06 compound treatment 9.8587 -0.67503 -0.1811 10.5111 -0.0068803 -0.0016 -0.1292 -0.7134 3652178 DAlcMix-H_000050 CCO[C@H]1OC(=C[C@H]([C@@H]1CCCOC(=O)NCCCCCC(=O)NO)C2CCCCC2)C(=O)N3CCOCC3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 C07 compound treatment 11.2646 0.73088 0.1961 12.2401 1.7221 0.408 0.4272 0.9436 3652040 DAlcMix-H_000051 ONC(=O)CCCCCNC(=O)OCc1ccc(CO[C@H]2C[C@H](C=C(O2)C(=O)N3CCOCC3)c4csc5ccccc45)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 C08 compound treatment 12.4538 1.92 0.5152 13.0638 2.5458 0.6032 0.7908 0.9969 3652179 DAlcMix-H_000052 CCO[C@H]1OC(=C[C@H]([C@@H]1CCCOC(=O)NCCCCCC(=O)NO)C2CCCCC2)C(=O)N3CCN(Cc4ccc5OCOc5c4)CC3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 C09 compound treatment 12.4649 1.9312 0.5182 14.2275 3.7095 0.8789 0.9879 0.9682 3652042 DAlcMix-H_000053 ONC(=O)CCCCCNC(=O)OCc1ccc(CO[C@H]2C[C@H](C=C(O2)C(=O)N3CCN(Cc4ccc5OCOc5c4)CC3)c6csc7ccccc67)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 C10 compound treatment 10.5538 0.020087 0.0054 11.3079 0.78992 0.1872 0.1362 0.7272 3652181 DAlcMix-H_000054 CCO[C@H]1OC(=C[C@H]([C@@H]1CCCOC(=O)NCCCCCC(=O)NO)c2ccccc2)C(=O)N3CCOCC3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 C11 mock treatment 8.8387 -1.6951 -0.4548 10.4932 -0.024795 -0.0059 -0.3258 -0.7162 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 C12 mock treatment 9.2593 -1.2744 -0.342 10.4317 -0.08631 -0.0204 -0.2563 -0.7481 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 C13 compound treatment 13.385 2.8513 0.7651 10.313 -0.20502 -0.0486 0.5066 0.6609 3652044 DAlcMix-H_000055 CC(=O)n1cc([C@@H]2C[C@H](OCc3ccc(COC(=O)NCCCCCC(=O)NO)cc3)OC(=C2)C(=O)N4CCCCCCC4)c5ccccc15 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 C14 compound treatment 9.7054 -0.82834 -0.2223 10.6793 0.1613 0.0382 -0.1301 -0.5771 3652182 DAlcMix-H_000056 CCO[C@H]1OC(=C[C@H]([C@@H]1CCCOC(=O)NCCCCCC(=O)NO)c2ccccc2)C(=O)N3CCN(Cc4ccc5OCOc5c4)CC3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 C15 mock treatment 11.3636 0.82986 0.2227 11.6847 1.1668 0.2764 0.3529 0.9942 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 C16 mock treatment 9.3292 -1.2046 -0.3232 10.2825 -0.23552 -0.0558 -0.268 -0.8171 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 C17 compound treatment 10.6743 0.14053 0.0377 9.136 -1.382 -0.3274 -0.2049 -0.6216 3652046 DAlcMix-H_000057 CC(=O)n1cc([C@@H]2C[C@H](OCc3ccc(COC(=O)NCCCCCC(=O)NO)cc3)OC(=C2)C(=O)N4CCOCC4)c5ccccc15 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 C18 compound treatment 11.3919 0.85813 0.2303 11.3205 0.80252 0.1901 0.2973 0.9955 3652184 DAlcMix-H_000058 CCO[C@H]1OC(=C[C@H]([C@@H]1CCCOC(=O)NCCCCCC(=O)NO)c2ccccc2)C(=O)OCC=C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 C19 compound treatment 13.9927 3.459 0.9281 12.6725 2.1546 0.5105 1.0173 0.9604 3652048 DAlcMix-H_000059 ONC(=O)CCCCCNC(=O)OCc1ccc(CO[C@H]2C[C@H](C=C(O2)C(=O)N3CCOCC3)c4coc5ccccc5c4=O)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 C20 compound treatment 58.5011 47.967 12.8709 51.2905 40.773 9.6605 15.9321 0.99 3652185 DAlcMix-H_000060 CCO[C@H]1OC(=C[C@H]([C@@H]1CCCOC(=O)NCCCCCC(=O)NO)c2ccc3OCOc3c2)C(=O)N4CCOCC4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 C21 compound treatment 72.5575 62.024 16.6426 79.6132 69.095 16.3711 23.3442 1.0 3652050 DAlcMix-H_000061 C[C@@H]1C[C@H](OCCCCOC(=O)NCCCCCC(=O)NO)OC(=C1)C(=O)N2CCOCC2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 C22 compound treatment 10.4007 -0.133 -0.0357 9.8507 -0.66725 -0.1581 -0.137 -0.8455 3652187 DAlcMix-H_000062 CCO[C@H]1OC(=C[C@H]([C@@H]1CCCOC(=O)NCCCCCC(=O)NO)c2ccc3OCOc3c2)C(=O)N4CCN(C)CC4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 C23 compound treatment 11.8345 1.3008 0.349 15.2197 4.7018 1.114 1.0345 0.8862 3652052 DAlcMix-H_000063 ONC(=O)CCCCCNC(=O)OCCCCO[C@H]1C[C@H](C=C(O1)C(=O)N2CCOCC2)c3ccc4OCOc4c3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 C24 compound treatment 12.1849 1.6512 0.443 10.815 0.29697 0.0704 0.363 0.8093 3652189 DAlcMix-H_000064 CCO[C@H]1OC(=C[C@H]([C@@H]1CCCOC(=O)NCCCCCC(=O)NO)c2ccc3OCOc3c2)C(=O)N4CCN(Cc5ccc6OCOc6c5)CC4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 D01 compound treatment 11.1107 0.57703 0.1548 10.9228 0.40482 0.0959 0.1773 0.9735 3556470 DAlcMix-H_000065 Cn1c(=O)n2[C@H]3[C@@H]4[C@H](Cc5ccccc5)OC(=O)[C@H](COC(=O)NCCCCCC(=O)NO)N4CC3=C[C@@H](C6CC6)n2c1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 D02 compound treatment 11.5307 0.997 0.2675 10.7435 0.22555 0.0534 0.227 0.8319 3652299 DAlcMix-H_000066 CN1C(=O)N[C@H]2[C@@H](COC(=O)c3ccccc3)[C@]1(COC(=O)NCCCCCC(=O)NO)Oc4ccccc24 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 D03 compound treatment 11.547 1.0133 0.2719 9.7988 -0.71916 -0.1704 0.0718 0.2237 3556474 DAlcMix-H_000067 ONC(=O)CCCCCNC(=O)OC[C@@H]1N2CC3=CC(=O)[C@H](C4CC4)[C@H]3[C@@H]2[C@H](Cc5ccccc5)OC1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 D04 compound treatment 9.7464 -0.78736 -0.2113 9.8488 -0.6692 -0.1586 -0.2615 -0.99 3652301 DAlcMix-H_000068 COc1ccc(COC[C@@]2(Oc3ccccc3[C@@H]4[C@H]2COC(=O)NCCCCCC(=O)NO)N=C5SCc6ccccc6CN45)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 D05 compound treatment 11.7517 1.2179 0.3268 10.2997 -0.21826 -0.0517 0.1945 0.5879 3556478 DAlcMix-H_000069 ONC(=O)CCCCCNC(=O)OC[C@@H]1N2CC3=CCCC=C[C@H]3[C@@H]2[C@H](Cc4ccccc4)OC1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 D06 compound treatment 10.8959 0.36218 0.0972 14.3095 3.7915 0.8983 0.7039 0.7791 3652303 DAlcMix-H_000070 ONC(=O)CCCCCNC(=O)OC[C@@]1(Oc2ccccc2[C@@H]3[C@H]1COC(=O)c4ccccc4)N=C5SCc6ccccc6CN35 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 D07 compound treatment 12.174 1.6403 0.4401 13.734 3.216 0.762 0.85 0.966 3556482 DAlcMix-H_000071 CC(=CCN(C(COC(=O)NCCCCCC(=O)NO)c1ccccc1)C(=O)C#Cc2ccccc2)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 D08 compound treatment 11.8901 1.3564 0.364 11.9559 1.4379 0.3407 0.4983 0.9995 3652305 DAlcMix-H_000072 COc1ccc(COC[C@@]2(Oc3ccccc3[C@@H]4[C@H]2COC(=O)NCCCCCC(=O)NO)N=C5SCCCN45)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 D09 compound treatment 10.5744 0.040637 0.0109 9.7993 -0.71865 -0.1703 -0.1127 -0.6605 3556485 DAlcMix-H_000073 Cc1ccc(S[C@@]2(CC(=O)N(Cc3ccccc3)[C@@H]2c4ccc(COC(=O)NCCCCCC(=O)NO)cc4I)C(=O)NCc5ccccc5)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 D10 compound treatment 9.8603 -0.67347 -0.1807 9.5618 -0.95618 -0.2266 -0.288 -0.9937 3652307 DAlcMix-H_000074 COc1ccc(COC[C@@]2(Oc3ccccc3[C@@H]4[C@H]2COC(=O)NCCCCCC(=O)NO)N(C)c5c6C(=O)N(C)C(=O)c6c(C(=O)C)c(=O)n45)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 D11 mock treatment 10.9363 0.40259 0.108 18.2649 7.7469 1.8355 1.3743 0.7474 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 D12 mock treatment 8.5456 -1.9881 -0.5335 9.7638 -0.75417 -0.1787 -0.5036 -0.8951 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 D13 compound treatment 10.0687 -0.46502 -0.1248 9.8891 -0.62892 -0.149 -0.1936 -0.9961 3556522 DAlcMix-H_000075 COc1ccc(CCNC(=O)[C@]2(CC(=O)N(Cc3ccccc3)[C@@H]2c4ccc(COC(=O)NCCCCCC(=O)NO)cc4I)c5ccccc5)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 D14 compound treatment 10.782 0.2483 0.0666 11.927 1.409 0.3338 0.2832 0.8318 3652309 DAlcMix-H_000076 ONC(=O)CCCCCNC(=O)OC[C@@]1(Oc2ccccc2[C@@H]3[C@H]1COC(=O)c4ccccc4)N=C5SCCCN35 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 D15 mock treatment 10.723 0.18931 0.0508 9.6592 -0.85875 -0.2035 -0.108 -0.5148 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 D16 mock treatment 10.2788 -0.25489 -0.0684 11.523 1.005 0.2381 0.12 0.4844 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 D17 compound treatment 9.5683 -0.96545 -0.2591 11.4255 0.90757 0.215 -0.0311 -0.0925 3556524 DAlcMix-H_000077 ONC(=O)CCCCCNC(=O)OCc1ccc(cc1)[C@H]2[C@H](C(=O)NCc3ccccc3)c4ccccc4C(=O)N2Cc5ccccc5 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 D18 compound treatment 10.8664 0.33265 0.0893 10.1696 -0.34838 -0.0825 0.0047 0.0391 3652311 DAlcMix-H_000078 COc1ccc(COC[C@@]2(Oc3ccccc3[C@@H]4[C@H]2COC(=O)NCCCCCC(=O)NO)N=C5SCC(=O)N45)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 D19 compound treatment 11.309 0.77523 0.208 10.9851 0.46715 0.1107 0.2254 0.9564 3556526 DAlcMix-H_000079 C[C@]1([C@@H](N(Cc2ccccc2)C(=O)c3ccccc31)c4ccc(COC(=O)NCCCCCC(=O)NO)cc4)C(=O)NCc5ccccc5 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 D20 compound treatment 8.3896 -2.1441 -0.5753 11.4119 0.89389 0.2118 -0.2571 -0.4193 3652313 DAlcMix-H_000080 ONC(=O)CCCCCNC(=O)OC[C@@]1(Oc2ccccc2[C@@H]3[C@H]1COC(=O)c4ccccc4)N=C5SCC(=O)N35 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 D21 compound treatment 8.7861 -1.7477 -0.4689 10.5603 0.04232 0.01 -0.3245 -0.6918 3556528 DAlcMix-H_000081 COc1ccc(CCNC(=O)[C@]2(Cc3ccccc3I)[C@@H](N(Cc4ccccc4)C(=O)c5ccccc52)c6ccc(COC(=O)NCCCCCC(=O)NO)cc6)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 D22 compound treatment 10.6189 0.085182 0.0229 12.9618 2.4438 0.579 0.4256 0.7344 3652315 DAlcMix-H_000082 CCOC(=O)OC[C@@H]1[C@@H]2NC(=O)N(C)[C@@]1(COC(=O)NCCCCCC(=O)NO)Oc3ccccc23 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 D23 compound treatment 8.2996 -2.2341 -0.5995 9.1283 -1.3897 -0.3293 -0.6567 -0.9602 3556530 DAlcMix-H_000083 COc1ccc(CCN2C(=O)[C@]3(Cc4ccccc24)[C@@H](N(Cc5ccccc5)C(=O)c6ccccc63)c7ccc(COC(=O)NCCCCCC(=O)NO)cc7)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 D24 compound treatment 9.3739 -1.1598 -0.3112 11.6142 1.0962 0.2597 -0.0364 -0.0898 3652317 DAlcMix-H_000084 COc1ccc(COC[C@@]2(Oc3ccccc3[C@@H]4[C@H]2COC(=O)NCCCCCC(=O)NO)N=C5Sc6ccc(cc6C(=O)N45)[N+](=O)[O-])cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 E01 mock treatment 12.2262 1.6924 0.4541 11.8566 1.3386 0.3172 0.5454 0.9846 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 E02 mock treatment 13.1189 2.5852 0.6937 10.8522 0.33425 0.0792 0.5465 0.7828 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 E03 compound treatment 13.909 3.3753 0.9057 13.676 3.158 0.7482 1.1695 0.9955 3652054 DAlcMix-H_000085 ONC(=O)CCCCCNC(=O)OCCCCO[C@H]1C[C@H](C=C(O1)C(=O)N2CCOCC2)c3ccc(cc3)C(F)(F)F 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 E04 compound treatment 9.4056 -1.1282 -0.3027 12.1134 1.5954 0.378 0.0532 0.1099 3652190 DAlcMix-H_000086 CCO[C@H]1OC(=C[C@H]([C@@H]1CCCOC(=O)NCCCCCC(=O)NO)c2ccc(cc2)C(F)(F)F)C(=O)N3CCOCC3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 E05 compound treatment 10.2071 -0.32657 -0.0876 9.52 -0.99802 -0.2365 -0.2292 -0.9088 3652056 DAlcMix-H_000087 ONC(=O)CCCCCNC(=O)OCCCCO[C@H]1C[C@H](C=C(O1)C(=O)OCC=C)c2ccc(cc2)C(F)(F)F 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 E06 compound treatment 15.103 4.5693 1.2261 13.5771 3.0591 0.7248 1.3795 0.9685 3652191 DAlcMix-H_000088 CCO[C@H]1OC(=C[C@H]([C@@H]1CCCOC(=O)NCCCCCC(=O)NO)c2ccc(cc2)C(F)(F)F)C(=O)N3CCN(Cc4ccc5OCOc5c4)CC3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 E07 compound treatment 14.5578 4.0241 1.0798 12.6412 2.1232 0.5031 1.1192 0.9396 3652058 DAlcMix-H_000089 ONC(=O)CCCCCNC(=O)OCCCCO[C@H]1C[C@H](C=C(O1)C(=O)N2CCOCC2)c3ccc(C#C)cc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 E08 compound treatment 11.5265 0.99273 0.2664 9.6363 -0.88171 -0.2089 0.0406 0.12 3652192 DAlcMix-H_000090 CCO[C@H]1OC(=C[C@H]([C@@H]1CCCOC(=O)NCCCCCC(=O)NO)c2ccc(cc2)C(F)(F)F)C(=O)OCC=C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 E09 mock treatment 10.1211 -0.41262 -0.1107 11.3016 0.78365 0.1857 0.053 0.2452 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 E10 mock treatment 14.5259 3.9921 1.0712 11.5273 1.0094 0.2392 0.9266 0.8442 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 E11 compound treatment 10.3371 -0.19659 -0.0528 10.1937 -0.3243 -0.0768 -0.0916 -0.9832 3652060 DAlcMix-H_000091 ONC(=O)CCCCCNC(=O)OCCCCO[C@H]1C[C@H](C=C(O1)C(=O)OCC=C)c2csc3ccccc23 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 E12 compound treatment 9.7167 -0.81701 -0.2192 9.8943 -0.62365 -0.1478 -0.2595 -0.9816 3652193 DAlcMix-H_000092 CCO[C@H]1OC(=C[C@H]([C@@H]1CCCOC(=O)NCCCCCC(=O)NO)c2ccc(C#C)cc2)C(=O)OCC=C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 E13 compound treatment 12.7266 2.1929 0.5884 10.5729 0.05488 0.013 0.4253 0.7226 3652062 DAlcMix-H_000093 CC(=O)n1cc([C@@H]2C[C@H](OCCCCOC(=O)NCCCCCC(=O)NO)OC(=C2)C(=O)N3CCOCC3)c4ccccc14 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 E14 compound treatment 12.4569 1.9232 0.516 11.4572 0.93926 0.2225 0.5223 0.9293 3652194 DAlcMix-H_000094 CCO[C@H]1OC(=C[C@H]([C@@H]1CCCOC(=O)NCCCCCC(=O)NO)c2ccc(Br)cc2)C(=O)N3CCOCC3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 E15 compound treatment 12.7322 2.1985 0.5899 9.9688 -0.54921 -0.1301 0.3251 0.5382 3652064 DAlcMix-H_000095 CC(=O)n1cc([C@@H]2C[C@H](OCCCCOC(=O)NCCCCCC(=O)NO)OC(=C2)C(=O)OCC=C)c3ccccc13 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 E16 compound treatment 14.0896 3.5559 0.9541 20.7053 10.187 2.4137 2.3814 0.9175 3652195 DAlcMix-H_000096 CCO[C@H]1OC(=C[C@H]([C@@H]1CCCOC(=O)NCCCCCC(=O)NO)c2ccc(Br)cc2)C(=O)N3CCN(C)CC3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 E17 mock treatment 10.8245 0.29078 0.078 10.0263 -0.49165 -0.1165 -0.0272 -0.194 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 E18 mock treatment 10.3285 -0.20525 -0.0551 10.4705 -0.0475 -0.0113 -0.0469 -0.8344 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 E19 compound treatment 15.1849 4.6512 1.248 9.6709 -0.8471 -0.2007 0.7406 0.5859 3652066 DAlcMix-H_000097 ONC(=O)CCCCCNC(=O)OCCCCO[C@H]1C[C@H](C=C(O1)C(=O)N2CCOCC2)c3coc4ccccc4c3=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 E20 compound treatment 13.1674 2.6337 0.7067 12.406 1.888 0.4473 0.816 0.9757 3652196 DAlcMix-H_000098 CCO[C@H]1OC(=C[C@H]([C@@H]1CCCOC(=O)NCCCCCC(=O)NO)c2ccc(Br)cc2)C(=O)N3CCN(Cc4ccc5OCOc5c4)CC3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 E21 compound treatment 13.7709 3.2372 0.8686 15.945 5.427 1.2858 1.5234 0.9818 3652068 DAlcMix-H_000099 ONC(=O)CCCCCNC(=O)OCCCCO[C@H]1C[C@H](C=C(O1)C(=O)N2CCN(Cc3ccc4OCOc4c3)CC2)c5coc6ccccc6c5=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 E22 compound treatment 11.1203 0.58656 0.1574 10.459 -0.059025 -0.014 0.1014 0.6417 3652197 DAlcMix-H_000100 CCO[C@H]1OC(=C[C@H]([C@@H]1CCCOC(=O)NCCCCCC(=O)NO)c2ccc(Br)cc2)C(=O)OCC=C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 E23 compound treatment 11.7883 1.2546 0.3366 10.8539 0.33591 0.0796 0.2943 0.8508 3652070 DAlcMix-H_000101 ONC(=O)CCCCCNC(=O)OCc1ccc(CO[C@@H]2C[C@@H](C=C(O2)C(=O)N3CCCCCCC3)C4CCCCC4)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 E24 compound treatment 12.0785 1.5448 0.4145 11.0573 0.53935 0.1278 0.3835 0.884 3652198 DAlcMix-H_000102 CCO[C@H]1OC(=C[C@H]([C@@H]1CCCOC(=O)NCCCCCC(=O)NO)c2csc3ccccc23)C(=O)N4CCOCC4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 F01 mock treatment 8.8873 -1.6464 -0.4418 10.2072 -0.31083 -0.0736 -0.3645 -0.8138 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 F02 mock treatment 12.0543 1.5206 0.408 10.9825 0.46448 0.1101 0.3663 0.8669 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 F03 compound treatment 12.1782 1.6445 0.4413 14.632 4.114 0.9748 1.0013 0.9358 3556532 DAlcMix-H_000103 ONC(=O)CCCCCNC(=O)OCCCCOC1CC2C(=CC1C(=O)[C@@]32CCCO3)I 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 F04 compound treatment 9.5416 -0.99217 -0.2662 10.5826 0.064642 0.0153 -0.1774 -0.6653 3616059 DAlcMix-H_000104 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@@]3(O[C@@H]2CCOC(=O)NCCCCCC(=O)NO)C(=O)N(Cc4ccccc4)c5ccc(NC(=O)[C@@H](C)OC(=O)NCCCCCC(=O)NO)cc53 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 F05 compound treatment 10.617 0.083292 0.0223 10.0481 -0.46984 -0.1113 -0.0629 -0.5541 3556534 DAlcMix-H_000105 COC(=O)c1c(C(=O)OC)c2oc1CC[C@@H](COC(=O)NCCCCCC(=O)NO)NC(=O)N[C@H](Cc3ccccc3)Cn4cc(CN(C)C2=O)nn4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 F06 compound treatment 10.3973 -0.13645 -0.0366 9.6452 -0.87275 -0.2068 -0.1721 -0.8196 3616063 DAlcMix-H_000106 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@]3(O[C@H]2CCOC(=O)NCCCCCC(=O)NO)C(=O)N(Cc4ccccc4)c5ccc(NC(=O)[C@@H](C)OC(=O)NCCCCCC(=O)NO)cc53 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 F07 compound treatment 8.5827 -1.951 -0.5235 10.5622 0.044197 0.0105 -0.3628 -0.6928 3556536 DAlcMix-H_000107 COC(=O)c1c(CC[C@@H](COC(=O)NCCCCCC(=O)NO)NC(=O)N[C@@H](Cc2ccccc2)Cn3cc(nn3)c4ccccc4)oc(C(=O)N5CCOCC5)c1C(=O)OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 F08 compound treatment 14.5377 4.004 1.0744 14.1323 3.6143 0.8564 1.3652 0.9937 3616071 DAlcMix-H_000108 COc1cc2CCN(CC(C)OC(=O)NCCCCCC(=O)NO)CCCc3c(noc3-c2cc1OC)c4ccc(OCCO[Si](C(C)C)(C(C)C)C(C)C)cc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 F09 mock treatment 10.343 -0.19073 -0.0512 9.9435 -0.57444 -0.1361 -0.1324 -0.9107 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 F10 mock treatment 10.31 -0.22375 -0.06 9.3569 -1.1611 -0.2751 -0.237 -0.8416 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 F11 compound treatment 11.2623 0.72853 0.1955 9.6177 -0.90031 -0.2133 -0.0126 -0.0436 3556538 DAlcMix-H_000109 COC(=O)c1c(C(=O)OC)c2oc1CC[C@@H](COC(=O)NCCCCCC(=O)NO)NC(=O)N[C@H](C)Cn3cc(CN(C)C2=O)nn3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 F12 compound treatment 11.6586 1.1249 0.3018 11.896 1.378 0.3265 0.4443 0.9992 3616074 DAlcMix-H_000110 ONC(=O)CCCCCNC(=O)OCC(N(C/C=C/c1ccccc1)CC#C)c2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 F13 compound treatment 11.3626 0.82886 0.2224 9.9108 -0.60719 -0.1439 0.0555 0.2097 3556540 DAlcMix-H_000111 ONC(=O)CCCCCNC(=O)OCc1ccc(CN([C@@H](Cc2ccccc2)Cn3cc(nn3)c4ccccn4)C(=O)Nc5ccccc5)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 F14 compound treatment 16.6581 6.1244 1.6433 14.981 4.463 1.0574 1.9097 0.9773 3616079 DAlcMix-H_000112 ONC(=O)CCCCCNC(=O)OCCCCOC1CC2C(=CC1C(=O)[C@@]32CO3)Br 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 F15 compound treatment 11.0479 0.51419 0.138 11.9929 1.4749 0.3495 0.3447 0.9174 3556542 DAlcMix-H_000113 CC(=O)c1cc(c(CC[C@H](COC(=O)NCCCCCC(=O)NO)NC(=O)NCCc2c[nH]c3ccccc23)o1)S(=O)(=O)c4ccc(C)cc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 F16 compound treatment 12.5911 2.0574 0.5521 10.145 -0.37303 -0.0884 0.3279 0.5864 3616085 DAlcMix-H_000114 CC[C@@H](OC(=O)NCCCCCC(=O)NO)c1cc(nc(c1)c2ccc(OC)nc2)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 F17 mock treatment 9.8181 -0.71566 -0.192 12.292 1.774 0.4203 0.1614 0.3493 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 F18 mock treatment 9.7916 -0.74208 -0.1991 11.8044 1.2865 0.3048 0.0747 0.2053 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 F19 compound treatment 11.1794 0.64568 0.1733 10.8207 0.30273 0.0717 0.1732 0.9238 3556544 DAlcMix-H_000115 CC(=O)c1cc(c(CC[C@H](COC(=O)NCCCCCC(=O)NO)NC(=O)Nc2nc[nH]n2)o1)S(=O)(=O)c3ccc(C)cc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 F20 compound treatment 10.347 -0.18676 -0.0501 11.3193 0.80133 0.1899 0.0988 0.5032 3616090 DAlcMix-H_000116 COC(=O)c1c(C(=O)OC)c2oc1CC[C@H](COC(=O)NCCCCCC(=O)NO)NC(=O)N[C@H](Cc3ccccc3)C(=O)NCc4cn(C[C@H](Cc5ccccc5)NC(=O)c6oc(CC[C@H](COC(=O)NCCCCCC(=O)NO)NC(=O)N[C@H](Cc7ccccc7)C(=O)NCc8cn(C[C@H](Cc9ccccc9)NC2=O)nn8)c(C(=O)OC)c6C(=O)OC)nn4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 F21 compound treatment 10.1823 -0.3514 -0.0943 9.6647 -0.85333 -0.2022 -0.2096 -0.9397 3556546 DAlcMix-H_000117 ONC(=O)CCCCCNC(=O)OCCCOc1ccc(cc1)C2=N[C@@]3(Cc4ccccc4NC3=O)[C@@H](O2)c5ccccc5 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 F22 compound treatment 11.8972 1.3635 0.3659 9.1835 -1.3345 -0.3162 0.0351 0.0726 3616094 DAlcMix-H_000118 COC(=O)c1c(C(=O)OC)c2oc1CC[C@H](COC(=O)NCCCCCC(=O)NO)NC(=O)N[C@@H](Cc3ccccc3)C(=O)NCc4cn(C[C@@H](Cc5ccccc5)NC(=O)c6oc(CC[C@H](COC(=O)NCCCCCC(=O)NO)NC(=O)N[C@@H](Cc7ccccc7)C(=O)NCc8cn(C[C@@H](Cc9ccccc9)NC2=O)nn8)c(C(=O)OC)c6C(=O)OC)nn4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 F23 compound treatment 10.2132 -0.32054 -0.086 11.2483 0.73037 0.1731 0.0615 0.3185 3556548 DAlcMix-H_000119 COC(=O)[C@H]1N=C(O[C@H]1c2ccccc2)c3ccc(OCCCOC(=O)NCCCCCC(=O)NO)cc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 F24 compound treatment 8.7703 -1.7634 -0.4732 10.0016 -0.51633 -0.1223 -0.4211 -0.8616 3616095 DAlcMix-H_000120 COC(=O)c1c(C(=O)OC)c2oc1CC[C@H](COC(=O)NCCCCCC(=O)NO)NC(=O)N[C@H](Cc3ccccc3)C(=O)NCc4cn(C[C@@H](Cc5ccccc5)NC(=O)c6oc(CC[C@H](COC(=O)NCCCCCC(=O)NO)NC(=O)N[C@H](Cc7ccccc7)C(=O)NCc8cn(C[C@@H](Cc9ccccc9)NC2=O)nn8)c(C(=O)OC)c6C(=O)OC)nn4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 G01 compound treatment 13.5992 3.0655 0.8225 12.6141 2.0961 0.4966 0.9328 0.9708 3652072 DAlcMix-H_000121 ONC(=O)CCCCCNC(=O)OCc1ccc(CO[C@@H]2C[C@@H](C=C(O2)C(=O)N3CCOCC3)C4CCCCC4)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 G02 compound treatment 9.8683 -0.66541 -0.1785 10.7558 0.2378 0.0563 -0.0864 -0.4615 3652199 DAlcMix-H_000122 CCO[C@H]1OC(=C[C@H]([C@@H]1CCCOC(=O)NCCCCCC(=O)NO)c2csc3ccccc23)C(=O)N4CCN(C)CC4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 G03 mock treatment 12.4315 1.8977 0.5092 8.5203 -1.9977 -0.4733 0.0254 0.0365 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 G04 mock treatment 10.6906 0.15691 0.0421 9.3866 -1.1313 -0.2681 -0.1598 -0.5888 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 G05 compound treatment 10.8247 0.29102 0.0781 11.1144 0.59639 0.1413 0.1551 0.9609 3652073 DAlcMix-H_000123 ONC(=O)CCCCCNC(=O)OCc1ccc(CO[C@@H]2C[C@@H](C=C(O2)C(=O)N3CCN(Cc4ccc5OCOc5c4)CC3)C6CCCCC6)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 G06 compound treatment 10.0004 -0.53332 -0.1431 10.4726 -0.045363 -0.0107 -0.1088 -0.7581 3652201 DAlcMix-H_000124 CCO[C@H]1OC(=C[C@H]([C@@H]1CCCOC(=O)NCCCCCC(=O)NO)c2csc3ccccc23)C(=O)N4CCN(Cc5ccc6OCOc6c5)CC4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 G07 compound treatment 11.2787 0.74497 0.1999 10.9789 0.46091 0.1092 0.2186 0.9596 3652074 DAlcMix-H_000125 ONC(=O)CCCCCNC(=O)OCc1ccc(CO[C@@H]2C[C@@H](C=C(O2)C(=O)N3CCOCC3)c4ccccc4)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 G08 compound treatment 9.3673 -1.1664 -0.313 10.7448 0.22678 0.0537 -0.1833 -0.5773 3652202 DAlcMix-H_000126 CCO[C@H]1OC(=C[C@H]([C@@H]1CCCOC(=O)NCCCCCC(=O)NO)c2cn(C(=O)C)c3ccccc23)C(=O)N4CCOCC4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 G09 compound treatment 11.7666 1.2329 0.3308 11.1517 0.63374 0.1502 0.3401 0.9361 3652075 DAlcMix-H_000127 ONC(=O)CCCCCNC(=O)OCc1ccc(CO[C@@H]2C[C@@H](C=C(O2)C(=O)N3CCN(Cc4ccc5OCOc5c4)CC3)c6ccccc6)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 G10 compound treatment 9.6948 -0.83888 -0.2251 11.4894 0.97144 0.2302 0.0036 0.0112 3652203 DAlcMix-H_000128 CCO[C@H]1OC(=C[C@H]([C@@H]1CCCOC(=O)NCCCCCC(=O)NO)c2cn(C(=O)C)c3ccccc23)C(=O)N4CCN(C)CC4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 G11 compound treatment 11.343 0.80926 0.2171 14.403 3.885 0.9205 0.8044 0.8506 3652076 DAlcMix-H_000129 ONC(=O)CCCCCNC(=O)OCc1ccc(CO[C@@H]2C[C@@H](C=C(O2)C(=O)OCC=C)c3ccccc3)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 G12 compound treatment 9.5386 -0.99515 -0.267 14.5015 3.9835 0.9438 0.4786 0.4879 3652204 DAlcMix-H_000130 CCO[C@H]1OC(=C[C@H]([C@@H]1CCCOC(=O)NCCCCCC(=O)NO)c2cn(C(=O)C)c3ccccc23)C(=O)N4CCN(Cc5ccc6OCOc6c5)CC4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 G13 compound treatment 10.2584 -0.27532 -0.0739 11.6203 1.1023 0.2612 0.1324 0.4879 3652078 DAlcMix-H_000131 ONC(=O)CCCCCNC(=O)OCc1ccc(CO[C@@H]2C[C@@H](C=C(O2)C(=O)N3CCCCCCC3)c4ccc(cc4)C(F)(F)F)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 G14 compound treatment 12.1573 1.6236 0.4356 9.1477 -1.3703 -0.3247 0.0785 0.1444 3652205 DAlcMix-H_000132 CCO[C@H]1OC(=C[C@H]([C@@H]1CCCOC(=O)NCCCCCC(=O)NO)c2coc3ccccc3c2=O)C(=O)N4CCOCC4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 G15 compound treatment 10.3902 -0.14354 -0.0385 9.5559 -0.96212 -0.228 -0.1884 -0.815 3652080 DAlcMix-H_000133 ONC(=O)CCCCCNC(=O)OCc1ccc(CO[C@@H]2C[C@@H](C=C(O2)C(=O)N3CCOCC3)c4ccc(cc4)C(F)(F)F)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 G16 compound treatment 12.341 1.8073 0.4849 12.277 1.759 0.4168 0.6376 0.9972 3652206 DAlcMix-H_000134 CCO[C@H]1OC(=C[C@H]([C@@H]1CCCOC(=O)NCCCCCC(=O)NO)c2coc3ccccc3c2=O)C(=O)N4CCN(C)CC4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 G17 compound treatment 10.0107 -0.52305 -0.1403 12.5399 2.0219 0.4791 0.2395 0.4798 3652081 DAlcMix-H_000135 ONC(=O)CCCCCNC(=O)OCc1ccc(CO[C@@H]2C[C@@H](C=C(O2)C(=O)N3CCN(Cc4ccc5OCOc5c4)CC3)c6ccc(cc6)C(F)(F)F)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 G18 compound treatment 12.2177 1.6839 0.4518 9.0316 -1.4863 -0.3522 0.0705 0.123 3652208 DAlcMix-H_000136 CCO[C@H]1OC(=C[C@H]([C@@H]1CCCOC(=O)NCCCCCC(=O)NO)c2coc3ccccc3c2=O)C(=O)N4CCN(Cc5ccc6OCOc6c5)CC4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 G19 mock treatment 10.1553 -0.37841 -0.1015 10.9173 0.3993 0.0946 -0.0049 -0.0353 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 G20 mock treatment 9.3973 -1.1364 -0.3049 9.3592 -1.1588 -0.2746 -0.4097 -0.9986 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 G21 compound treatment 10.1883 -0.34539 -0.0927 10.8372 0.31925 0.0756 -0.012 -0.1007 3652082 DAlcMix-H_000137 ONC(=O)CCCCCNC(=O)OCc1ccc(CO[C@@H]2C[C@@H](C=C(O2)C(=O)OCC=C)c3ccc(C#C)cc3)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 G22 compound treatment 8.9576 -1.5762 -0.4229 9.1687 -1.3493 -0.3197 -0.5251 -0.9905 3652209 DAlcMix-H_000138 CCO[C@H]1OC(=C[C@H]([C@@H]1CCCOC(=O)NCCCCCC(=O)NO)c2coc3ccccc3c2=O)C(=O)OCC=C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 G23 compound treatment 9.4541 -1.0796 -0.2897 10.2823 -0.23566 -0.0558 -0.2443 -0.8282 3652084 DAlcMix-H_000139 ONC(=O)CCCCCNC(=O)OCc1ccc(CO[C@@H]2C[C@@H](C=C(O2)C(=O)N3CCCCCCC3)c4ccc(Br)cc4)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 G24 compound treatment 11.0818 0.54808 0.1471 12.2548 1.7368 0.4115 0.395 0.9038 3652210 DAlcMix-H_000140 CC(C)(C)[C@@H]1C[C@H](OCc2ccc(COC(=O)NCCCCCC(=O)NO)cc2)OC(=C1)C(=O)N3CCN(Cc4ccccc4)CC3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 H01 compound treatment 12.4879 1.9542 0.5244 12.0391 1.5211 0.3604 0.6256 0.9833 3556550 DAlcMix-H_000141 ONC(=O)CCCCCNC(=O)OCCCOc1ccc(cc1)C2=N[C@@]3(Cc4ccccc4N(CCS(=O)(=O)c5ccccc5)C3=O)[C@@H](O2)c6ccccc6 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 H02 compound treatment 11.5988 1.0651 0.2858 8.5227 -1.9953 -0.4728 -0.1322 -0.2393 3616097 DAlcMix-H_000142 COC(=O)c1c(C(=O)OC)c2oc1CC[C@H](COC(=O)NCCCCCC(=O)NO)NC(=O)N[C@@H](Cc3ccccc3)C(=O)NCc4cn(C[C@H](Cc5ccccc5)NC(=O)c6oc(CC[C@H](COC(=O)NCCCCCC(=O)NO)NC(=O)N[C@@H](Cc7ccccc7)C(=O)NCc8cn(C[C@H](Cc9ccccc9)NC2=O)nn8)c(C(=O)OC)c6C(=O)OC)nn4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 H03 mock treatment 9.5073 -1.0264 -0.2754 10.9046 0.3866 0.0916 -0.13 -0.4478 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 H04 mock treatment 10.6967 0.16298 0.0437 9.4602 -1.0578 -0.2506 -0.1463 -0.575 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 H05 compound treatment 10.1906 -0.34311 -0.0921 10.1388 -0.37922 -0.0899 -0.1286 -0.9999 3556552 DAlcMix-H_000143 CC(=O)N1Cc2ccccc2[C@@H]3OC(=N[C@]3(CCS(=O)(=O)c4ccccc4)C1=O)c5ccc(OCCCOC(=O)NCCCCCC(=O)NO)cc5 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 H06 compound treatment 10.657 0.12332 0.0331 10.4041 -0.11392 -0.027 0.0043 0.101 3616100 DAlcMix-H_000144 COC(=O)c1c(C(=O)OC)c2oc1CC[C@H](COC(=O)NCCCCCC(=O)NO)NC(=O)N[C@H](Cc3ccccc3)c4cn(C[C@@H](Cc5ccccc5)NC(=O)c6oc(CC[C@H](COC(=O)NCCCCCC(=O)NO)NC(=O)N[C@H](Cc7ccccc7)c8cn(C[C@@H](Cc9ccccc9)NC2=O)nn8)c(C(=O)OC)c6C(=O)OC)nn4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 H07 compound treatment 11.6129 1.0791 0.2896 11.6095 1.0915 0.2586 0.3876 0.9984 3556554 DAlcMix-H_000145 ONC(=O)CCCCCNC(=O)OCCCOc1ccc(cc1)C2=N[C@@]3(Cc4ccccc4)[C@@H](O2)c5ccccc5CN(Cc6ccccc6)C3=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 H08 compound treatment 10.386 -0.14775 -0.0396 13.0841 2.5661 0.608 0.4019 0.6596 3616104 DAlcMix-H_000146 COC(=O)c1c(C(=O)OC)c2oc1CC[C@H](COC(=O)NCCCCCC(=O)NO)NC(=O)N[C@@H](Cc3ccccc3)c4cn(C[C@@H](Cc5ccccc5)NC(=O)c6oc(CC[C@H](COC(=O)NCCCCCC(=O)NO)NC(=O)N[C@@H](Cc7ccccc7)c8cn(C[C@@H](Cc9ccccc9)NC2=O)nn8)c(C(=O)OC)c6C(=O)OC)nn4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 H09 compound treatment 11.1679 0.63419 0.1702 10.295 -0.223 -0.0528 0.083 0.4656 3556556 DAlcMix-H_000147 ONC(=O)CCCCCNC(=O)OCCCOc1ccc(cc1)C2=N[C@@]3(Cc4ccccc4)[C@@H](O2)c5ccccc5NC3=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 H10 compound treatment 9.0426 -1.4911 -0.4001 10.4231 -0.09484 -0.0225 -0.2988 -0.7456 3616108 DAlcMix-H_000148 COC(=O)c1c(C(=O)OC)c2oc1CC[C@@H](COC(=O)NCCCCCC(=O)NO)NC(=O)N[C@H](Cc3ccccc3)c4cn(C[C@H](Cc5ccccc5)NC(=O)c6oc(CC[C@@H](COC(=O)NCCCCCC(=O)NO)NC(=O)N[C@H](Cc7ccccc7)c8cn(C[C@H](Cc9ccccc9)NC2=O)nn8)c(C(=O)OC)c6C(=O)OC)nn4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 H11 compound treatment 8.8724 -1.6613 -0.4458 12.4922 1.9742 0.4678 0.0156 0.0241 3556558 DAlcMix-H_000149 COC(=O)[C@]1(CCS(=O)(=O)c2ccccc2)N=C(O[C@@H]1c3ccccc3)c4ccc(OCCCOC(=O)NCCCCCC(=O)NO)cc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 H12 compound treatment 11.1574 0.62372 0.1674 13.9411 3.4231 0.811 0.6918 0.8354 3652319 DAlcMix-H_000150 COc1ccc(cc1)N2[C@H](COC(=O)NCCCCCC(=O)NO)[C@H](Cc3ccccc3)[C@@H]4N(CCc5cc(OC)c(OC)cc45)C2=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 H13 compound treatment 11.8283 1.2946 0.3474 11.5518 1.0338 0.245 0.4188 0.9854 3556560 DAlcMix-H_000151 COC(=O)[C@]1(Cc2ccccc2)N=C(O[C@@H]1c3ccccc3)c4ccc(OCCCOC(=O)NCCCCCC(=O)NO)cc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 H14 compound treatment 30.7119 20.178 5.4143 29.8986 19.381 4.5919 7.0755 0.9966 3652321 DAlcMix-H_000152 CO[C@H]1O[C@H](COC(=O)NCCCCCC(=O)NO)[C@@H](OC(=O)c2ccccc2)[C@H](OC(=O)Nc3ccccc3c4ccccc4)[C@@H]1OC(=O)Nc5ccccc5c6ccccc6 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 H15 compound treatment 8.6579 -1.8758 -0.5033 8.329 -2.189 -0.5187 -0.7226 -0.9999 3556562 DAlcMix-H_000153 ONC(=O)CCCCCNC(=O)OCCCOc1ccc(cc1)C2=N[C@@]3(Cc4ccccc4CNC3=O)[C@@H](O2)c5ccccc5 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 H16 compound treatment 9.7922 -0.74156 -0.199 13.7737 3.2557 0.7714 0.4048 0.5081 3652323 DAlcMix-H_000154 CCOP(=O)(CC(=O)O[C@@H]1[C@@H](COC(=O)NCCCCCC(=O)NO)O[C@H](OC)[C@@H](OC(=O)Nc2ccccc2c3ccccc3)[C@H]1OC(=O)Nc4ccccc4c5ccccc5)OCC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 H17 compound treatment 10.4076 -0.12613 -0.0338 9.927 -0.59098 -0.14 -0.1229 -0.8534 3556564 DAlcMix-H_000155 C[C@H]1COC(=O)[C@H](CC/C=C/C[C@H](CC(=O)N(CCOC(=O)NCCCCCC(=O)NO)Cc2ccccc2)C(=O)N1)NC(=O)OCC3c4ccccc4-c5ccccc35 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 H18 compound treatment 15.4863 4.9526 1.3289 13.2177 2.6997 0.6396 1.392 0.9438 3652325 DAlcMix-H_000156 CCOP(=O)(CC(=O)O[C@@H]1[C@@H](COC(=O)NCCCCCC(=O)NO)O[C@H](OC)[C@@H]2OC(=O)[C@@H](Cc3ccc4ccccc4c3)C/C=C\C[C@H](Cc5ccc6ccccc6c5)C(=O)O[C@@H]12)OCC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 H19 mock treatment 12.2152 1.6815 0.4512 10.2773 -0.24063 -0.057 0.2787 0.6129 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 H20 mock treatment 10.7738 0.24009 0.0644 9.3738 -1.1441 -0.2711 -0.1461 -0.5245 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 H21 compound treatment 9.8074 -0.72631 -0.1949 13.1511 2.6331 0.6239 0.3033 0.4641 3556566 DAlcMix-H_000157 C[C@H]1CNC(=O)[C@@H](CC(=O)N(CCOC(=O)NCCCCCC(=O)NO)Cc2ccccc2)C/C=C/CC[C@H](NC(=O)OC(C)(C)C)C(=O)O1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 H22 compound treatment 9.7145 -0.81919 -0.2198 11.0916 0.5736 0.1359 -0.0593 -0.2296 3652327 DAlcMix-H_000158 CO[C@H]1O[C@H](COC(=O)NCCCCCC(=O)NO)[C@H](OC(=O)Nc2ccccc2)[C@H](OC(=O)Nc3ccccc3)[C@H]1OC(=O)Nc4ccccc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 H23 compound treatment 10.9123 0.37861 0.1016 9.5126 -1.0053 -0.2382 -0.0966 -0.373 3556568 DAlcMix-H_000159 CCOC(=O)C1=C(C)NC(=O)NC1c2ccc(OCCOC(=O)NCCCCCC(=O)NO)cc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 H24 compound treatment 12.1039 1.5702 0.4213 14.8928 4.3748 1.0366 1.0309 0.9213 3652329 DAlcMix-H_000160 ONC(=O)CCCCCNC(=O)OC[C@H]1OC=C[C@@H](OC(=O)Nc2ccccc2)[C@@H]1OC(=O)Nc3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 I01 compound treatment 13.3583 2.8246 0.7579 12.0165 1.4985 0.3551 0.787 0.9403 3652086 DAlcMix-H_000161 ONC(=O)CCCCCNC(=O)OCc1ccc(CO[C@@H]2C[C@@H](C=C(O2)C(=O)N3CCOCC3)c4ccc(Br)cc4)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 I02 compound treatment 132.4092 121.88 32.7023 112.3703 101.85 24.1324 40.1882 0.9888 3652212 DAlcMix-H_000162 ONC(=O)CCCCCNC(=O)OCc1ccc(CO[C@H]2C[C@H](C=C(O2)C(=O)N3CCN(Cc4ccccc4)CC3)C5CCCCC5)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 I03 compound treatment 12.5003 1.9666 0.5277 11.2865 0.76852 0.1821 0.5019 0.8991 3652087 DAlcMix-H_000163 ONC(=O)CCCCCNC(=O)OCc1ccc(CO[C@@H]2C[C@@H](C=C(O2)C(=O)N3CCN(Cc4ccc5OCOc5c4)CC3)c6ccc(Br)cc6)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 I04 compound treatment 12.4044 1.8706 0.5019 10.6294 0.11141 0.0264 0.3736 0.7433 3652214 DAlcMix-H_000164 ONC(=O)CCCCCNC(=O)OCc1ccc(CO[C@H]2C[C@H](C=C(O2)C(=O)N3CCN(Cc4ccccc4)CC3)c5ccccc5)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 I05 mock treatment 10.8567 0.32298 0.0867 9.0871 -1.4309 -0.339 -0.1785 -0.51 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 I06 mock treatment 8.5752 -1.9586 -0.5255 9.7155 -0.80252 -0.1901 -0.5061 -0.9055 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 I07 compound treatment 12.0871 1.5534 0.4168 12.1155 1.5975 0.3785 0.5624 0.9988 3652088 DAlcMix-H_000165 ONC(=O)CCCCCNC(=O)OCc1ccc(CO[C@@H]2C[C@@H](C=C(O2)C(=O)N3CCOCC3)c4csc5ccccc45)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 I08 compound treatment 11.0532 0.5195 0.1394 9.1115 -1.4064 -0.3332 -0.1371 -0.3795 3652216 DAlcMix-H_000166 ONC(=O)CCCCCNC(=O)OCc1ccc(CO[C@H]2C[C@H](C=C(O2)C(=O)N3CCN(Cc4ccccc4)CC3)c5ccc(cc5)C(F)(F)F)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 I09 compound treatment 9.3797 -1.154 -0.3096 10.6567 0.13873 0.0329 -0.1957 -0.6285 3652089 DAlcMix-H_000167 ONC(=O)CCCCCNC(=O)OCc1ccc(CO[C@@H]2C[C@@H](C=C(O2)C(=O)OCC=C)c3csc4ccccc34)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 I10 compound treatment 15.0304 4.4967 1.2066 11.243 0.72497 0.1718 0.9746 0.7997 3652218 DAlcMix-H_000168 ONC(=O)CCCCCNC(=O)OCc1ccc(CO[C@H]2C[C@H](C=C(O2)C(=O)N3CCN(Cc4ccccc4)CC3)c5csc6ccccc56)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 I11 compound treatment 12.5064 1.9727 0.5293 10.1812 -0.33677 -0.0798 0.3179 0.5938 3652091 DAlcMix-H_000169 CC(=O)n1cc([C@H]2C[C@@H](OCc3ccc(COC(=O)NCCCCCC(=O)NO)cc3)OC(=C2)C(=O)N4CCOCC4)c5ccccc15 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 I12 compound treatment 12.0634 1.5296 0.4104 12.1425 1.6245 0.3849 0.5624 0.9995 3652220 DAlcMix-H_000170 CC(=O)n1cc([C@@H]2C[C@H](OCc3ccc(COC(=O)NCCCCCC(=O)NO)cc3)OC(=C2)C(=O)N4CCN(Cc5ccccc5)CC4)c6ccccc16 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 I13 compound treatment 15.2427 4.709 1.2636 17.9732 7.4552 1.7664 2.1425 0.9865 3652092 DAlcMix-H_000171 CC(=O)n1cc([C@H]2C[C@@H](OCc3ccc(COC(=O)NCCCCCC(=O)NO)cc3)OC(=C2)C(=O)N4CCN(Cc5ccc6OCOc6c5)CC4)c7ccccc17 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 I14 compound treatment 9.4926 -1.0411 -0.2794 9.1649 -1.3531 -0.3206 -0.4242 -0.9976 3652222 DAlcMix-H_000172 ONC(=O)CCCCCNC(=O)OCc1ccc(CO[C@H]2C[C@H](C=C(O2)C(=O)N3CCN(Cc4ccccc4)CC3)c5coc6ccccc6c5=O)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 I15 compound treatment 8.9207 -1.613 -0.4328 9.8352 -0.68279 -0.1618 -0.4204 -0.9099 3652094 DAlcMix-H_000173 CC(=O)n1cc([C@H]2C[C@@H](OCc3ccc(COC(=O)NCCCCCC(=O)NO)cc3)OC(=C2)C(=O)OCC=C)c4ccccc14 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 I16 compound treatment 10.7576 0.2239 0.0601 11.0519 0.53397 0.1265 0.1319 0.9421 3652224 DAlcMix-H_000174 CC(C)(C)[C@@H]1C[C@H](OCCCCOC(=O)NCCCCCC(=O)NO)OC(=C1)C(=O)N2CCN(Cc3ccccc3)CC2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 I17 compound treatment 11.0235 0.48977 0.1314 12.0066 1.4886 0.3527 0.3423 0.9095 3652096 DAlcMix-H_000175 ONC(=O)CCCCCNC(=O)OCc1ccc(CO[C@@H]2C[C@@H](C=C(O2)C(=O)N3CCOCC3)c4coc5ccccc5c4=O)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 I18 compound treatment 13.199 2.6653 0.7152 9.3731 -1.1449 -0.2713 0.3139 0.4104 3652226 DAlcMix-H_000176 ONC(=O)CCCCCNC(=O)OCCCCO[C@H]1C[C@H](C=C(O1)C(=O)N2CCN(Cc3ccccc3)CC2)c4ccc(cc4)C(F)(F)F 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 I19 compound treatment 12.9695 2.4358 0.6536 11.53 1.012 0.2398 0.6317 0.9074 3652097 DAlcMix-H_000177 C[C@H]1C[C@@H](OCCCCOC(=O)NCCCCCC(=O)NO)OC(=C1)C(=O)N2CCOCC2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 I20 compound treatment 12.7681 2.2343 0.5995 11.0706 0.55265 0.1309 0.5165 0.8417 3652228 DAlcMix-H_000178 CC(=O)n1cc([C@@H]2C[C@H](OCCCCOC(=O)NCCCCCC(=O)NO)OC(=C2)C(=O)N3CCN(Cc4ccccc4)CC3)c5ccccc15 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 I21 mock treatment 9.5173 -1.0164 -0.2727 8.8497 -1.6682 -0.3953 -0.4723 -0.9836 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 I22 mock treatment 10.83 0.29633 0.0795 21.639 11.121 2.635 1.9194 0.7281 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 I23 compound treatment 10.7388 0.20506 0.055 11.2936 0.7756 0.1838 0.1688 0.8802 3652098 DAlcMix-H_000179 ONC(=O)CCCCCNC(=O)OCCCCO[C@@H]1C[C@@H](C=C(O1)C(=O)N2CCOCC2)C3CCCCC3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 I24 compound treatment 13.7708 3.2371 0.8686 15.5705 5.0525 1.1971 1.4607 0.9876 3652230 DAlcMix-H_000180 ONC(=O)CCCCCNC(=O)OCCCCO[C@H]1C[C@H](C=C(O1)C(=O)N2CCN(Cc3ccccc3)CC2)c4coc5ccccc5c4=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 J01 compound treatment 13.9001 3.3664 0.9033 12.8441 2.3261 0.5511 1.0284 0.9719 3556569 DAlcMix-H_000181 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CCn4cc(CCOC(=O)NCCCCCC(=O)NO)nn4)C(=O)N(C)c5ccccc53 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 J02 compound treatment 14.5511 4.0174 1.078 13.8041 3.2861 0.7786 1.3128 0.9872 3652331 DAlcMix-H_000182 CO[C@H]1O[C@H](COC(=O)NCCCCCC(=O)NO)[C@@H](OC(=O)Nc2ccc(OC)cc2)[C@H](OC(=O)Nc3ccccc3c4ccccc4)[C@H]1OC(=O)Nc5ccccc5c6ccccc6 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 J03 compound treatment 11.4839 0.95019 0.255 12.1562 1.6382 0.3882 0.4548 0.9792 3556571 DAlcMix-H_000183 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CCOC(=O)NCCCCCC(=O)NO)C(=O)N(Cc4ccccc4)c5ccc(I)cc53 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 J04 compound treatment 29.3227 18.789 5.0416 27.3024 16.784 3.9768 6.377 0.9931 3652333 DAlcMix-H_000184 CO[C@H]1O[C@H](COC(=O)NCCCCCC(=O)NO)[C@@H](OC(=O)Nc2ccc(OC)cc2)[C@H](OC(=O)Nc3ccccc3c4ccccc4)[C@@H]1OC(=O)Nc5ccccc5c6ccccc6 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 J05 mock treatment 11.8979 1.3642 0.366 9.3849 -1.133 -0.2685 0.069 0.152 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 J06 mock treatment 8.8643 -1.6694 -0.448 7.3933 -3.1246 -0.7403 -0.8402 -0.971 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 J07 compound treatment 12.2919 1.7581 0.4718 10.1277 -0.3903 -0.0925 0.2682 0.5579 3556573 DAlcMix-H_000185 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CCn4cc(CCOC(=O)NCCCCCC(=O)NO)nn4)C(=O)N(C)c5ccccc53 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 J08 compound treatment 12.9641 2.4304 0.6521 9.236 -1.282 -0.3037 0.2463 0.3424 3616254 DAlcMix-H_000186 ONC(=O)CCCCCNC(=O)OCC(NS(=O)(=O)c1ccc(Br)cc1)C=C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 J09 compound treatment 13.3071 2.7734 0.7442 9.5704 -0.94757 -0.2245 0.3675 0.4727 3556575 DAlcMix-H_000187 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CCOC(=O)NCCCCCC(=O)NO)C(=O)N(Cc4ccccc4)c5ccc(I)cc53 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 J10 compound treatment 11.5523 1.0186 0.2733 10.3701 -0.14789 -0.035 0.1685 0.6114 3616257 DAlcMix-H_000188 CC(C)(C)OC(=O)N[C@@H](COC(=O)NCCCCCC(=O)NO)C=C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 J11 compound treatment 11.7278 1.1941 0.3204 9.7462 -0.77175 -0.1829 0.0973 0.2636 3556577 DAlcMix-H_000189 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@]3(O[C@H]2CCOC(=O)NCCCCCC(=O)NO)C(=O)N(Cc4cccc(c4)N5CCCCC5=O)c6ccccc63 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 J12 compound treatment 11.0788 0.54508 0.1463 11.3668 0.8488 0.2011 0.2456 0.9878 3616262 DAlcMix-H_000190 ONC(=O)CCCCCNC(=O)OC[C@H](NS(=O)(=O)c1ccc(Br)cc1)C=C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 J13 compound treatment 13.2296 2.6959 0.7234 11.1989 0.68096 0.1613 0.6256 0.8441 3556580 DAlcMix-H_000191 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@]3(O[C@@H]2CCn4cc(CCOC(=O)NCCCCCC(=O)NO)nn4)C(=O)N(Cc5ccc(I)cc5)c6ccccc63 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 J14 compound treatment 12.4449 1.9111 0.5128 11.9063 1.3883 0.3289 0.5952 0.977 3616263 DAlcMix-H_000192 CC(C)(C)OC(=O)N[C@H](COC(=O)NCCCCCC(=O)NO)C=C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 J15 compound treatment 12.4107 1.877 0.5036 11.6502 1.1323 0.2683 0.5458 0.9565 3556583 DAlcMix-H_000193 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@]3(O[C@H]2CCOC(=O)NCCCCCC(=O)NO)C(=O)N(Cc4cccc(I)c4)c5ccccc53 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 J16 compound treatment 13.1828 2.6491 0.7108 10.5141 -0.0038378 -9.0E-4 0.502 0.7062 3616266 DAlcMix-H_000194 COc1cc(OC)c(CN(CC#CCOC(=O)NCCCCCC(=O)NO)S(=O)(=O)c2ccccc2[N+](=O)[O-])c(OC)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 J17 compound treatment 13.8618 3.3281 0.893 10.3428 -0.17518 -0.0415 0.6021 0.6735 3556585 DAlcMix-H_000195 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@]3(O[C@H]2CCOC(=O)NCCCCCC(=O)NO)C(=O)N(CC=C)c4ccc(cc43)N5CCC5=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 J18 compound treatment 12.6779 2.1442 0.5753 9.1879 -1.33 -0.3151 0.184 0.2805 3616259 DAlcMix-H_000196 CC(C)(C)OC(=O)NC(COC(=O)NCCCCCC(=O)NO)C=C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 J19 compound treatment 11.6671 1.1334 0.3041 10.6338 0.11579 0.0274 0.2344 0.7678 3556588 DAlcMix-H_000197 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@@]3(O[C@@H]2CCOC(=O)NCCCCCC(=O)NO)C(=O)N(CC=C)c4ccc(cc43)N5CCC5=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 J20 compound treatment 15.3931 4.8594 1.3039 16.2382 5.7202 1.3553 1.8804 0.9998 3616270 DAlcMix-H_000198 ONC(=O)CCCCCNC(=O)OCC#CCOC(=O)c1ccccc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 J21 mock treatment 10.8484 0.31464 0.0844 9.4821 -1.0359 -0.2454 -0.1138 -0.4386 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 J22 mock treatment 10.8888 0.35505 0.0953 12.2166 1.6986 0.4025 0.3519 0.851 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 J23 compound treatment 13.209 2.6753 0.7178 11.5551 1.0371 0.2457 0.6814 0.898 3556589 DAlcMix-H_000199 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@@]3(O[C@@H]2CCOC(=O)NCCCCCC(=O)NO)C(=O)N(Cc4cccc(I)c4)c5ccccc53 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 J24 compound treatment 9.4686 -1.0651 -0.2858 10.1772 -0.34076 -0.0807 -0.2592 -0.8727 3616228 DAlcMix-H_000200 CN(C)c1cccc(COC(=O)NCCCCCC(=O)NO)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 K01 compound treatment 12.3867 1.853 0.4972 10.7867 0.26868 0.0637 0.3966 0.7912 3652100 DAlcMix-H_000201 ONC(=O)CCCCCNC(=O)OCCCCO[C@@H]1C[C@@H](C=C(O1)C(=O)N2CCN(Cc3ccc4OCOc4c3)CC2)C5CCCCC5 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 K02 compound treatment 12.4487 1.915 0.5139 11.4045 0.88655 0.2101 0.5119 0.9221 3652232 DAlcMix-H_000202 ONC(=O)CCCCCNC(=O)OCc1ccc(CO[C@@H]2C[C@@H](C=C(O2)C(=O)N3CCN(Cc4ccccc4)CC3)C5CCCCC5)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 K03 compound treatment 10.5144 -0.019296 -0.0052 10.6853 0.16735 0.0397 0.0244 0.6096 3652102 DAlcMix-H_000203 ONC(=O)CCCCCNC(=O)OCCCCO[C@@H]1C[C@@H](C=C(O1)C(=O)N2CCOCC2)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 K04 compound treatment 9.7084 -0.82528 -0.2214 9.6872 -0.83079 -0.1968 -0.2958 -0.9983 3652233 DAlcMix-H_000204 ONC(=O)CCCCCNC(=O)OCc1ccc(CO[C@@H]2C[C@@H](C=C(O2)C(=O)N3CCN(Cc4ccccc4)CC3)c5ccccc5)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 K05 compound treatment 10.5844 0.050632 0.0136 10.2335 -0.28444 -0.0674 -0.038 -0.5534 3652104 DAlcMix-H_000205 ONC(=O)CCCCCNC(=O)OCCCCO[C@@H]1C[C@@H](C=C(O1)C(=O)N2CCOCC2)c3ccc4OCOc4c3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 K06 compound treatment 11.5959 1.0622 0.285 12.3474 1.8294 0.4335 0.508 0.9793 3652234 DAlcMix-H_000206 ONC(=O)CCCCCNC(=O)OCc1ccc(CO[C@@H]2C[C@@H](C=C(O2)C(=O)N3CCN(Cc4ccccc4)CC3)c5ccc(cc5)C(F)(F)F)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 K07 mock treatment 8.8306 -1.7031 -0.457 9.2225 -1.2955 -0.307 -0.5402 -0.9813 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 K08 mock treatment 9.9002 -0.63348 -0.17 9.9805 -0.53749 -0.1273 -0.2102 -0.9899 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 K09 compound treatment 9.9415 -0.59221 -0.1589 10.3708 -0.14721 -0.0349 -0.137 -0.8423 3652105 DAlcMix-H_000207 ONC(=O)CCCCCNC(=O)OCCCCO[C@@H]1C[C@@H](C=C(O1)C(=O)N2CCOCC2)c3ccc(cc3)C(F)(F)F 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 K10 compound treatment 11.412 0.87832 0.2357 12.7197 2.2017 0.5217 0.5355 0.9355 3652235 DAlcMix-H_000208 ONC(=O)CCCCCNC(=O)OCc1ccc(CO[C@@H]2C[C@@H](C=C(O2)C(=O)N3CCN(Cc4ccccc4)CC3)c5ccc(Br)cc5)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 K11 compound treatment 12.1278 1.5941 0.4277 10.3782 -0.13975 -0.0331 0.279 0.6504 3652106 DAlcMix-H_000209 ONC(=O)CCCCCNC(=O)OCCCCO[C@@H]1C[C@@H](C=C(O1)C(=O)N2CCN(Cc3ccc4OCOc4c3)CC2)c5ccc(cc5)C(F)(F)F 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 K12 compound treatment 11.0143 0.48055 0.1289 9.9383 -0.57971 -0.1374 -0.0059 -0.0316 3652237 DAlcMix-H_000210 ONC(=O)CCCCCNC(=O)OCc1ccc(CO[C@@H]2C[C@@H](C=C(O2)C(=O)N3CCN(Cc4ccccc4)CC3)c5csc6ccccc56)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 K13 compound treatment 11.2291 0.69534 0.1866 10.526 0.0079997 0.0019 0.1333 0.7143 3652108 DAlcMix-H_000211 ONC(=O)CCCCCNC(=O)OCCCCO[C@@H]1C[C@@H](C=C(O1)C(=O)N2CCOCC2)c3ccc(Br)cc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 K14 compound treatment 11.7613 1.2276 0.3294 10.2022 -0.31573 -0.0748 0.18 0.5329 3652238 DAlcMix-H_000212 CC(=O)n1cc([C@H]2C[C@@H](OCc3ccc(COC(=O)NCCCCCC(=O)NO)cc3)OC(=C2)C(=O)N4CCN(Cc5ccccc5)CC4)c6ccccc16 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 K15 mock treatment 10.6319 0.098142 0.0263 8.7004 -1.8175 -0.4306 -0.2859 -0.6626 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 K16 mock treatment 11.283 0.7493 0.2011 9.8111 -0.7069 -0.1675 0.0237 0.0907 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 K17 compound treatment 10.317 -0.21671 -0.0581 10.2438 -0.27416 -0.065 -0.0871 -0.9985 3652110 DAlcMix-H_000213 ONC(=O)CCCCCNC(=O)OCCCCO[C@@H]1C[C@@H](C=C(O1)C(=O)OCC=C)c2ccc(Br)cc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 K18 compound treatment 10.7726 0.23883 0.0641 10.9025 0.38457 0.0911 0.1097 0.9852 3652239 DAlcMix-H_000214 ONC(=O)CCCCCNC(=O)OCCCCO[C@@H]1C[C@@H](C=C(O1)C(=O)N2CCN(Cc3ccccc3)CC2)C4CCCCC4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 K19 compound treatment 9.4881 -1.0456 -0.2806 10.7485 0.23053 0.0546 -0.1598 -0.559 3652112 DAlcMix-H_000215 ONC(=O)CCCCCNC(=O)OCCCCO[C@@H]1C[C@@H](C=C(O1)C(=O)OCC=C)c2csc3ccccc23 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 K20 compound treatment 12.9398 2.4061 0.6456 13.0966 2.5786 0.611 0.8885 0.9996 3652241 DAlcMix-H_000216 ONC(=O)CCCCCNC(=O)OCCCCO[C@@H]1C[C@@H](C=C(O1)C(=O)N2CCN(Cc3ccccc3)CC2)c4ccccc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 K21 compound treatment 10.1163 -0.41746 -0.112 13.9633 3.4453 0.8163 0.498 0.6044 3652113 DAlcMix-H_000217 CC(=O)n1cc([C@H]2C[C@@H](OCCCCOC(=O)NCCCCCC(=O)NO)OC(=C2)C(=O)N3CCOCC3)c4ccccc14 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 K22 compound treatment 17.0926 6.5589 1.7599 19.1296 8.6116 2.0404 2.6872 0.9973 3652243 DAlcMix-H_000218 ONC(=O)CCCCCNC(=O)OCCCCO[C@@H]1C[C@@H](C=C(O1)C(=O)N2CCN(Cc3ccccc3)CC2)c4ccc5OCOc5c4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 K23 mock treatment 11.5816 1.0479 0.2812 9.6746 -0.8434 -0.1998 0.0575 0.1668 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 K24 mock treatment 10.528 -0.0057405 -0.0015 11.0733 0.55531 0.1316 0.0919 0.6988 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 L01 compound treatment 11.3341 0.80037 0.2148 10.9644 0.4464 0.1058 0.2266 0.9468 3556620 DAlcMix-H_000219 COc1ccc(cc1)[Si](C)(C)[C@H]2[C@H](C)[C@@]3(O[C@@H]2CCOC(=O)NCCCCCC(=O)NO)C(=O)N(CC=C)c4ccc(I)cc43 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 L02 compound treatment 26.5917 16.058 4.3088 21.3149 10.797 2.5582 4.8557 0.969 3616230 DAlcMix-H_000220 ONC(=O)CCCCCNC(=O)OCc1ccccc1CCc2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 L03 compound treatment 10.8708 0.33704 0.0904 11.5381 1.0201 0.2417 0.2349 0.9101 3556623 DAlcMix-H_000221 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@]3(O[C@H]2CCOC(=O)NCCCCCC(=O)NO)C(=O)N(CC=C)c4ccc(I)cc43 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 L04 compound treatment 22.2359 11.702 3.14 22.4673 11.949 2.8312 4.2223 0.9987 3616234 DAlcMix-H_000222 COc1cc2ccccc2cc1COC(=O)NCCCCCC(=O)NO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 L05 compound treatment 10.2506 -0.28309 -0.076 9.9129 -0.60509 -0.1434 -0.1551 -0.9559 3556624 DAlcMix-H_000223 COc1ccc(cc1)[Si](C)(C)[C@H](CCn2cc(CCOC(=O)NCCCCCC(=O)NO)nn2)/C=C/C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 L06 compound treatment 11.0257 0.49194 0.132 11.1756 0.6576 0.1558 0.2035 0.9966 3616236 DAlcMix-H_000224 ONC(=O)CCCCCNC(=O)OCc1cccc2ccccc12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 L07 mock treatment 12.1407 1.6069 0.4312 10.7196 0.20164 0.0478 0.3387 0.7807 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 L08 mock treatment 10.1163 -0.41745 -0.112 9.2137 -1.3042 -0.309 -0.2977 -0.9058 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 L09 compound treatment 11.4835 0.94978 0.2549 10.9157 0.39769 0.0942 0.2468 0.9084 3556627 DAlcMix-H_000225 COc1ccc(cc1)[Si](C)(C)[C@@H](CCn2cc(CCOC(=O)NCCCCCC(=O)NO)nn2)/C=C/C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 L10 compound treatment 177.691 167.16 44.8526 191.5772 181.06 42.8993 62.05 0.9998 3616239 DAlcMix-H_000226 ONC(=O)CCCCCNC(=O)OCc1ccc(Cl)c(c1)[N+](=O)[O-] 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 L11 compound treatment 11.363 0.82925 0.2225 9.9125 -0.60551 -0.1435 0.0559 0.2111 3556628 DAlcMix-H_000227 COc1ccc(cc1)[Si](C)(C)[C@H](CC(=O)N(CCOC(=O)NCCCCCC(=O)NO)Cc2ccccc2)/C=C/C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 L12 compound treatment 11.624 1.0903 0.2925 9.72 -0.79802 -0.1891 0.0732 0.21 3616241 DAlcMix-H_000228 ONC(=O)CCCCCNC(=O)OCCOc1ccc(Br)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 L13 compound treatment 10.7665 0.23274 0.0624 9.9076 -0.61036 -0.1446 -0.0581 -0.3688 3556631 DAlcMix-H_000229 COc1ccc(cc1)[Si](C)(C)[C@@H](CC(=O)N(CCOC(=O)NCCCCCC(=O)NO)Cc2ccccc2)/C=C/C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 L14 compound treatment 10.1929 -0.34083 -0.0915 10.4717 -0.046243 -0.011 -0.0724 -0.7862 3616244 DAlcMix-H_000230 ONC(=O)CCCCCNC(=O)OCc1cccc(Oc2ccccc2)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 L15 mock treatment 10.9274 0.39368 0.1056 10.4012 -0.11681 -0.0277 0.0551 0.5048 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 L16 mock treatment 8.8312 -1.7025 -0.4568 9.8566 -0.66136 -0.1567 -0.4338 -0.8983 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 L17 compound treatment 11.2184 0.68469 0.1837 10.8244 0.30646 0.0726 0.1813 0.9175 3556632 DAlcMix-H_000231 COc1ccc(cc1)[Si](C)(C)[C@H](CC(=O)N2Cc3ccccc3C[C@H]2COC(=O)NCCCCCC(=O)NO)/C=C/C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 L18 compound treatment 9.9336 -0.60012 -0.161 10.3129 -0.20509 -0.0486 -0.1482 -0.8812 3616247 DAlcMix-H_000232 COc1cc(COC(=O)NCCCCCC(=O)NO)ccc1OCc2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 L19 compound treatment 13.6107 3.077 0.8256 12.8527 2.3347 0.5532 0.975 0.981 3556635 DAlcMix-H_000233 COc1ccc(cc1)[Si](C)(C)[C@@H](CC(=O)N2Cc3ccccc3C[C@H]2COC(=O)NCCCCCC(=O)NO)/C=C/C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 L20 compound treatment 59.7327 49.199 13.2013 68.4605 57.943 13.7286 19.0424 0.9998 3616249 DAlcMix-H_000234 ONC(=O)CCCCCNC(=O)OCc1ccccc1c2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 L21 compound treatment 10.6288 0.095067 0.0255 11.3794 0.86139 0.2041 0.1624 0.7893 3556636 DAlcMix-H_000235 COc1ccc(cc1)[Si](C)(C)[C@H](CC(=O)N2CCC[C@H]2COC(=O)NCCCCCC(=O)NO)/C=C/C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 L22 compound treatment 27.8664 17.333 4.6508 29.3124 18.794 4.4531 6.4374 0.9998 3616252 DAlcMix-H_000236 Cc1c(COC(=O)NCCCCCC(=O)NO)cccc1[N+](=O)[O-] 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 L23 mock treatment 9.5808 -0.95288 -0.2557 11.8116 1.2936 0.3065 0.0359 0.09 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 L24 mock treatment 11.9183 1.3846 0.3715 11.2234 0.7054 0.1671 0.3809 0.935 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 M01 compound treatment 11.1376 0.60392 0.162 14.0161 3.4981 0.8288 0.7007 0.8296 3652114 DAlcMix-H_000237 CC(=O)n1cc([C@H]2C[C@@H](OCCCCOC(=O)NCCCCCC(=O)NO)OC(=C2)C(=O)OCC=C)c3ccccc13 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 M02 compound treatment 10.227 -0.30669 -0.0823 9.8789 -0.63907 -0.1514 -0.1653 -0.9589 3652245 DAlcMix-H_000238 ONC(=O)CCCCCNC(=O)OCCCCO[C@@H]1C[C@@H](C=C(O1)C(=O)N2CCN(Cc3ccccc3)CC2)c4ccc(cc4)C(F)(F)F 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 M03 compound treatment 9.4166 -1.1171 -0.2998 10.7192 0.20127 0.0477 -0.1782 -0.5872 3652115 DAlcMix-H_000239 ONC(=O)CCCCCNC(=O)OCCCCO[C@@H]1C[C@@H](C=C(O1)C(=O)OCC=C)c2coc3ccccc3c2=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 M04 compound treatment 12.2781 1.7443 0.468 11.3122 0.79422 0.1882 0.464 0.9198 3652246 DAlcMix-H_000240 ONC(=O)CCCCCNC(=O)OCCCCO[C@@H]1C[C@@H](C=C(O1)C(=O)N2CCN(Cc3ccccc3)CC2)c4ccc(Br)cc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 M05 compound treatment 12.3676 1.8339 0.4921 11.6763 1.1583 0.2744 0.542 0.962 3652117 DAlcMix-H_000241 CCO[C@@H]1OC(=C[C@H](C)[C@H]1CCCOC(=O)NCCCCCC(=O)NO)C(=O)N2CCOCC2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 M06 compound treatment 11.3794 0.84567 0.2269 8.9416 -1.5764 -0.3735 -0.1037 -0.2372 3652248 DAlcMix-H_000242 CC(=O)n1cc([C@H]2C[C@@H](OCCCCOC(=O)NCCCCCC(=O)NO)OC(=C2)C(=O)N3CCN(Cc4ccccc4)CC3)c5ccccc15 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 M07 compound treatment 10.6112 0.077469 0.0208 10.9529 0.43489 0.103 0.0876 0.833 3652119 DAlcMix-H_000243 CCO[C@@H]1OC(=C[C@H](C)[C@H]1CCCOC(=O)NCCCCCC(=O)NO)C(=O)N2CCN(Cc3ccc4OCOc4c3)CC2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 M08 compound treatment 13.6674 3.1337 0.8409 10.6535 0.13553 0.0321 0.6173 0.7336 3652249 DAlcMix-H_000244 ONC(=O)CCCCCNC(=O)OCCCCO[C@@H]1C[C@@H](C=C(O1)C(=O)N2CCN(Cc3ccccc3)CC2)c4coc5ccccc5c4=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 M09 mock treatment 10.0549 -0.47883 -0.1285 10.1894 -0.32857 -0.0778 -0.1459 -0.9712 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 M10 mock treatment 9.2444 -1.2893 -0.346 11.0119 0.49393 0.117 -0.1619 -0.4432 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 M11 compound treatment 9.9893 -0.54445 -0.1461 11.4607 0.9427 0.2234 0.0546 0.2047 3652121 DAlcMix-H_000245 CCO[C@@H]1OC(=C[C@H](C)[C@H]1CCCOC(=O)NCCCCCC(=O)NO)C(=O)OCC=C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 M12 compound treatment 9.1294 -1.4043 -0.3768 10.4289 -0.08909 -0.0211 -0.2814 -0.7455 3652250 DAlcMix-H_000246 CCO[C@@H]1OC(=C[C@H](C)[C@H]1CCCOC(=O)NCCCCCC(=O)NO)C(=O)N2CCN(Cc3ccccc3)CC2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 M13 mock treatment 10.2944 -0.23931 -0.0642 8.4841 -2.0339 -0.4819 -0.3862 -0.7943 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 M14 mock treatment 11.0123 0.47856 0.1284 11.7239 1.2059 0.2857 0.2928 0.9348 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 M15 compound treatment 11.5802 1.0465 0.2808 8.9515 -1.5665 -0.3712 -0.0639 -0.1373 3652123 DAlcMix-H_000247 CCO[C@@H]1OC(=C[C@H](C2CC2)[C@H]1CCCOC(=O)NCCCCCC(=O)NO)C(=O)N3CCOCC3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 M16 compound treatment 10.2735 -0.26019 -0.0698 11.249 0.73098 0.1732 0.0731 0.3915 3652252 DAlcMix-H_000248 CCO[C@@H]1OC(=C[C@H](C2CC2)[C@H]1CCCOC(=O)NCCCCCC(=O)NO)C(=O)N3CCN(Cc4ccccc4)CC3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 M17 compound treatment 11.1503 0.61655 0.1654 9.7773 -0.74071 -0.1755 -0.0071 -0.0295 3652125 DAlcMix-H_000249 CCO[C@@H]1OC(=C[C@H](C2CC2)[C@H]1CCCOC(=O)NCCCCCC(=O)NO)C(=O)N3CCN(Cc4ccc5OCOc5c4)CC3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 M18 compound treatment 10.7712 0.23751 0.0637 9.8492 -0.66877 -0.1585 -0.067 -0.3922 3652254 DAlcMix-H_000250 CCO[C@@H]1OC(=C[C@@H]([C@H]1CCCOC(=O)NCCCCCC(=O)NO)c2ccccc2)C(=O)N3CCN(Cc4ccccc4)CC3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 M19 compound treatment 0.0 -10.534 -2.8265 9.8931 -0.62489 -0.1481 -2.1033 -0.7431 3652127 DAlcMix-H_000251 CCO[C@@H]1OC(=C[C@@H]([C@H]1CCCOC(=O)NCCCCCC(=O)NO)C2CCCCC2)C(=O)N3CCOCC3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 M20 compound treatment 10.6348 0.10113 0.0271 12.0396 1.5216 0.3605 0.2741 0.7582 3652256 DAlcMix-H_000252 CCO[C@@H]1OC(=C[C@@H]([C@H]1CCCOC(=O)NCCCCCC(=O)NO)c2ccc3OCOc3c2)C(=O)N4CCN(Cc5ccccc5)CC4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 M21 compound treatment 11.1891 0.65537 0.1759 14.3843 3.8663 0.9161 0.7721 0.8277 3652129 DAlcMix-H_000253 CCO[C@@H]1OC(=C[C@@H]([C@H]1CCCOC(=O)NCCCCCC(=O)NO)C2CCCCC2)C(=O)OCC=C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 M22 compound treatment 38.8196 28.286 7.5898 43.2648 32.747 7.7589 10.8532 0.9999 3652258 DAlcMix-H_000254 CCO[C@@H]1OC(=C[C@@H]([C@H]1CCCOC(=O)NCCCCCC(=O)NO)c2ccc(cc2)C(F)(F)F)C(=O)N3CCN(Cc4ccccc4)CC3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 M23 compound treatment 10.9994 0.46568 0.125 12.2566 1.7386 0.4119 0.3796 0.8819 3652131 DAlcMix-H_000255 CCO[C@@H]1OC(=C[C@@H]([C@H]1CCCOC(=O)NCCCCCC(=O)NO)c2ccccc2)C(=O)N3CCOCC3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 M24 compound treatment 11.0008 0.46711 0.1253 11.8776 1.3596 0.3221 0.3164 0.9154 3652260 DAlcMix-H_000256 CCO[C@@H]1OC(=C[C@@H]([C@H]1CCCOC(=O)NCCCCCC(=O)NO)c2ccc(Br)cc2)C(=O)N3CCN(Cc4ccccc4)CC3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 N01 compound treatment 12.4191 1.8854 0.5059 12.6548 2.1368 0.5063 0.7157 1.0 3556639 DAlcMix-H_000257 COc1ccc(cc1)[Si](C)(C)[C@@H](CC(=O)N2CCC[C@H]2COC(=O)NCCCCCC(=O)NO)/C=C/C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 N02 compound treatment 253.3512 242.82 65.1542 247.7688 237.25 56.2131 85.8196 0.9973 3616219 DAlcMix-H_000258 COc1c(COC(=O)NCCCCCC(=O)NO)ccc2ccccc12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 N03 compound treatment 14.0555 3.5218 0.945 12.2616 1.7436 0.4131 0.9603 0.9311 3556640 DAlcMix-H_000259 COc1ccc(cc1)[Si](C)(C)[C@@H]2[C@@H](C)[C@@]3(O[C@H]2CCOC(=O)NCCCCCC(=O)NO)C(=O)N(C)c4ccccc43 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 N04 compound treatment 13.1315 2.5978 0.6971 10.6124 0.094442 0.0224 0.5087 0.7294 3616222 DAlcMix-H_000260 ONC(=O)CCCCCNC(=O)OCc1ccc(Cl)cc1Cl 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 N05 compound treatment 10.9327 0.39898 0.1071 10.3172 -0.20082 -0.0476 0.0421 0.359 3556643 DAlcMix-H_000261 ONC(=O)CCCCCNC(=O)OCc1ccc(CN2C[C@H](OC(=O)CC/C=C/CCC2=O)c3ccccc3)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 N06 compound treatment 11.0804 0.54664 0.1467 10.6344 0.1164 0.0276 0.1232 0.8256 3616225 DAlcMix-H_000262 ONC(=O)CCCCCNC(=O)OCc1ccc2OCOc2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 N07 compound treatment 11.7238 1.19 0.3193 12.6767 2.1587 0.5115 0.5875 0.9743 3556646 DAlcMix-H_000263 ONC(=O)CCCCCNC(=O)OCc1ccc(CN2[C@@H]3CCCC[C@H]3OC(=O)CC/C=C/CCC2=O)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 N08 compound treatment 307.5988 297.07 79.7102 322.4925 311.97 73.9178 108.6314 0.9993 199 DAlcMix-H_000264 C[C@H](/C=C(\C)/C=C/C(=O)NO)C(=O)c1ccc(cc1)N(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 N09 mock treatment 10.8943 0.36063 0.0968 12.0603 1.5424 0.3654 0.3268 0.8645 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 N10 mock treatment 10.5124 -0.021366 -0.0057 9.2115 -1.3064 -0.3095 -0.2229 -0.7201 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 N11 compound treatment 12.4965 1.9628 0.5267 8.9745 -1.5435 -0.3657 0.1138 0.1775 3556649 DAlcMix-H_000265 COC(=O)c1c(C(=O)OC)c2oc1CC[C@H](COC(=O)NCCCCCC(=O)NO)NC(=O)N[C@H](Cc3ccccc3)c4cn(C[C@@H](Cc5ccccc5)NC2=O)nn4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 N12 compound treatment 223.772 213.24 57.2173 212.0075 201.49 47.74 74.216 0.9959 468 DAlcMix-H_000266 ONC(=O)CCCCCCC(=O)Nc1ccccc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 N13 mock treatment 10.94 0.4063 0.109 9.7197 -0.79824 -0.1891 -0.0566 -0.2595 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 N14 mock treatment 10.2782 -0.25551 -0.0686 7.9884 -2.5296 -0.5994 -0.4723 -0.7829 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 N15 compound treatment 11.4482 0.91444 0.2454 8.3018 -2.2161 -0.5251 -0.1978 -0.3413 3556653 DAlcMix-H_000267 COC(=O)c1c(C(=O)OC)c2oc1CC[C@H](COC(=O)NCCCCCC(=O)NO)NC(=O)N[C@H](Cc3ccccc3)c4cn(C[C@H](Cc5ccccc5)NC2=O)nn4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 N16 compound treatment 380.3832 369.85 99.2401 342.713 332.2 78.7087 125.8289 0.9934 3068804 DAlcMix-H_000268 C[C@@H]1NC(=O)C2CCCN2C(=O)[C@H](CCCCCC(=O)[C@@H]3CO3)NC(=O)[C@H](C)NC1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 N17 compound treatment 10.4591 -0.074591 -0.02 9.3334 -1.1845 -0.2807 -0.2126 -0.7556 3556655 DAlcMix-H_000269 COC(=O)c1c(C(=O)OC)c2oc1CC[C@H](COC(=O)NCCCCCC(=O)NO)NC(=O)N[C@@H](Cc3ccccc3)c4cn(C[C@H](Cc5ccccc5)NC2=O)nn4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 N18 compound treatment 10.5035 -0.030213 -0.0081 9.9241 -0.59392 -0.1407 -0.1052 -0.7466 469 DAlcMix-H_000270 CCCC(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 N19 compound treatment 10.7861 0.25233 0.0677 9.3947 -1.1232 -0.2661 -0.1403 -0.5109 3556657 DAlcMix-H_000271 COC(=O)c1c(C(=O)OC)c2oc1CC[C@H](COC(=O)NCCCCCC(=O)NO)NC(=O)N[C@@H](Cc3ccccc3)c4cn(C[C@@H](Cc5ccccc5)NC2=O)nn4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 N20 compound treatment 10.2493 -0.28442 -0.0763 7.8052 -2.7128 -0.6428 -0.5085 -0.7855 2027357 DAlcMix-H_000272 OCc1ccc(cc1)[C@@H]2C[C@H](CSc3nc(c(o3)c4ccccc4)c5ccccc5)O[C@@H](O2)c6ccc(NC(=O)CCCCCCC(=O)NO)cc6 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 N21 compound treatment 10.3487 -0.18503 -0.0496 10.7543 0.23632 0.056 0.0045 0.0599 3556659 DAlcMix-H_000273 COC(=O)c1c(C(=O)OC)c2oc1CC[C@@H](COC(=O)NCCCCCC(=O)NO)NC(=O)N[C@@H](Cc3ccccc3)c4cn(C[C@@H](Cc5ccccc5)NC2=O)nn4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 N22 compound treatment 274.1135 263.58 70.7252 273.3135 262.8 62.2655 94.0387 0.998 536 DAlcMix-H_000274 ONC(=O)CCCCCN1C(=O)c2cccc3cccc(C1=O)c23 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 N23 compound treatment 11.1595 0.6258 0.1679 10.0141 -0.50386 -0.1194 0.0343 0.1666 3556661 DAlcMix-H_000275 COC(=O)c1c(C(=O)OC)c2oc1CC[C@@H](COC(=O)NCCCCCC(=O)NO)NC(=O)N[C@H](Cc3ccccc3)c4cn(C[C@@H](Cc5ccccc5)NC2=O)nn4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 N24 compound treatment 12.9475 2.4138 0.6477 22.424 11.906 2.8209 2.4527 0.8474 471 DAlcMix-H_000276 CCCC(CCC)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 O01 compound treatment 13.2769 2.7432 0.7361 10.3501 -0.16785 -0.0398 0.4924 0.6679 3652133 DAlcMix-H_000277 CCO[C@@H]1OC(=C[C@@H]([C@H]1CCCOC(=O)NCCCCCC(=O)NO)c2ccccc2)C(=O)OCC=C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 O02 compound treatment 11.6749 1.1411 0.3062 11.2894 0.77137 0.1828 0.3457 0.9696 3652262 DAlcMix-H_000278 CCO[C@@H]1OC(=C[C@@H]([C@H]1CCCOC(=O)NCCCCCC(=O)NO)c2csc3ccccc23)C(=O)N4CCN(Cc5ccccc5)CC4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 O03 compound treatment 12.2825 1.7488 0.4693 9.2272 -1.2908 -0.3058 0.1156 0.2063 3652135 DAlcMix-H_000279 CCO[C@@H]1OC(=C[C@@H]([C@H]1CCCOC(=O)NCCCCCC(=O)NO)c2ccc3OCOc3c2)C(=O)N4CCN(Cc5ccc6OCOc6c5)CC4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 O04 compound treatment 10.9498 0.41606 0.1116 11.0507 0.53268 0.1262 0.1682 0.9981 3652264 DAlcMix-H_000280 CCO[C@@H]1OC(=C[C@@H]([C@H]1CCCOC(=O)NCCCCCC(=O)NO)c2cn(C(=O)C)c3ccccc23)C(=O)N4CCN(Cc5ccccc5)CC4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 O05 compound treatment 16.0444 5.5107 1.4787 98.8486 88.331 20.9287 15.8444 0.7552 3652137 DAlcMix-H_000281 CCO[C@@H]1OC(=C[C@@H]([C@H]1CCCOC(=O)NCCCCCC(=O)NO)c2ccc(cc2)C(F)(F)F)C(=O)N3CCOCC3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 O06 compound treatment 13.4782 2.9445 0.7901 9.8815 -0.63648 -0.1508 0.452 0.562 3652266 DAlcMix-H_000282 CCO[C@@H]1OC(=C[C@@H]([C@H]1CCCOC(=O)NCCCCCC(=O)NO)c2coc3ccccc3c2=O)C(=O)N4CCN(Cc5ccccc5)CC4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 O07 compound treatment 12.7107 2.177 0.5841 11.9131 1.3951 0.3306 0.6468 0.9637 3652139 DAlcMix-H_000283 CCO[C@@H]1OC(=C[C@@H]([C@H]1CCCOC(=O)NCCCCCC(=O)NO)c2ccc(cc2)C(F)(F)F)C(=O)N3CCN(Cc4ccc5OCOc5c4)CC3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 O08 compound treatment 10.2104 -0.32328 -0.0867 11.9435 1.4255 0.3377 0.1775 0.509 3652268 DAlcMix-H_000284 CCO[C@H]1OC(=C[C@@H](C)[C@@H]1CCCOC(=O)NCCCCCC(=O)NO)C(=O)N2CCN(Cc3ccccc3)CC2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 O09 compound treatment 11.5311 0.99738 0.2676 11.0934 0.57546 0.1363 0.2857 0.951 3652141 DAlcMix-H_000285 CCO[C@@H]1OC(=C[C@@H]([C@H]1CCCOC(=O)NCCCCCC(=O)NO)c2ccc(cc2)C(F)(F)F)C(=O)OCC=C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 O10 compound treatment 12.2475 1.7138 0.4599 8.946 -1.572 -0.3725 0.0618 0.1044 3652269 DAlcMix-H_000286 CCO[C@H]1OC(=C[C@H]([C@@H]1CCCOC(=O)NCCCCCC(=O)NO)C(C)(C)C)C(=O)N2CCN(Cc3ccccc3)CC2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 O11 mock treatment 9.8313 -0.70243 -0.1885 8.3413 -2.1767 -0.5157 -0.498 -0.9069 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 O12 mock treatment 12.2958 1.7621 0.4728 10.96 0.44199 0.1047 0.4084 0.8433 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 O13 compound treatment 12.7456 2.2119 0.5935 12.9079 2.3899 0.5662 0.8201 0.9997 3652143 DAlcMix-H_000287 CCO[C@@H]1OC(=C[C@@H]([C@H]1CCCOC(=O)NCCCCCC(=O)NO)c2ccc(C#C)cc2)C(=O)OCC=C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 O14 compound treatment 9.772 -0.7617 -0.2044 9.5022 -1.0157 -0.2407 -0.3147 -0.9967 3652271 DAlcMix-H_000288 CCO[C@H]1OC(=C[C@H]([C@@H]1CCCOC(=O)NCCCCCC(=O)NO)C2CCCCC2)C(=O)N3CCN(Cc4ccccc4)CC3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 O15 compound treatment 13.7103 3.1766 0.8524 10.636 0.118 0.028 0.6225 0.7299 3652145 DAlcMix-H_000289 CCO[C@@H]1OC(=C[C@@H]([C@H]1CCCOC(=O)NCCCCCC(=O)NO)c2ccc(Br)cc2)C(=O)N3CCOCC3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 O16 compound treatment 10.7311 0.19737 0.053 10.411 -0.107 -0.0254 0.0195 0.3325 3652273 DAlcMix-H_000290 CCO[C@H]1OC(=C[C@H]([C@@H]1CCCOC(=O)NCCCCCC(=O)NO)c2ccccc2)C(=O)N3CCN(Cc4ccccc4)CC3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 O17 compound treatment 12.1567 1.623 0.4355 10.7924 0.27437 0.065 0.3539 0.8038 3652147 DAlcMix-H_000291 CCO[C@@H]1OC(=C[C@@H]([C@H]1CCCOC(=O)NCCCCCC(=O)NO)c2ccc(Br)cc2)C(=O)N3CCN(C)CC3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 O18 compound treatment 11.398 0.86429 0.2319 13.7509 3.2329 0.766 0.7056 0.8817 3652274 DAlcMix-H_000292 CCO[C@H]1OC(=C[C@H]([C@@H]1CCCOC(=O)NCCCCCC(=O)NO)c2ccc3OCOc3c2)C(=O)N4CCN(Cc5ccccc5)CC4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 O19 compound treatment 13.0251 2.4914 0.6685 13.0889 2.5709 0.6091 0.9034 0.9989 3652149 DAlcMix-H_000293 CCO[C@@H]1OC(=C[C@@H]([C@H]1CCCOC(=O)NCCCCCC(=O)NO)c2ccc(Br)cc2)C(=O)N3CCN(Cc4ccc5OCOc5c4)CC3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 O20 compound treatment 9.6569 -0.87683 -0.2353 12.593 2.075 0.4916 0.1813 0.3326 3652275 DAlcMix-H_000294 CCO[C@H]1OC(=C[C@H]([C@@H]1CCCOC(=O)NCCCCCC(=O)NO)c2csc3ccccc23)C(=O)N4CCN(Cc5ccccc5)CC4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 O21 compound treatment 11.4678 0.93407 0.2506 10.5105 -0.0074603 -0.0018 0.176 0.7021 3652151 DAlcMix-H_000295 CCO[C@@H]1OC(=C[C@@H]([C@H]1CCCOC(=O)NCCCCCC(=O)NO)c2ccc(Br)cc2)C(=O)OCC=C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 O22 compound treatment 11.1709 0.63719 0.171 10.9069 0.38893 0.0922 0.1861 0.9579 3652276 DAlcMix-H_000296 CCO[C@H]1OC(=C[C@H]([C@@H]1CCCOC(=O)NCCCCCC(=O)NO)c2cn(C(=O)C)c3ccccc23)C(=O)N4CCN(Cc5ccccc5)CC4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 O23 compound treatment 9.9774 -0.55633 -0.1493 9.7593 -0.75872 -0.1798 -0.2327 -0.9957 3652153 DAlcMix-H_000297 CCO[C@@H]1OC(=C[C@@H]([C@H]1CCCOC(=O)NCCCCCC(=O)NO)c2csc3ccccc23)C(=O)N4CCOCC4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 O24 compound treatment 12.3817 1.848 0.4959 9.726 -0.79193 -0.1876 0.2179 0.4111 3652277 DAlcMix-H_000298 CCO[C@H]1OC(=C[C@H]([C@@H]1CCCOC(=O)NCCCCCC(=O)NO)c2coc3ccccc3c2=O)C(=O)N4CCN(Cc5ccccc5)CC4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 P01 compound treatment 10.3697 -0.16405 -0.044 10.3138 -0.20418 -0.0484 -0.0653 -0.9989 3556663 DAlcMix-H_000299 COC(=O)c1c(C(=O)OC)c2oc1CC[C@@H](COC(=O)NCCCCCC(=O)NO)NC(=O)N[C@H](Cc3ccccc3)c4cn(C[C@H](Cc5ccccc5)NC2=O)nn4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 P02 compound treatment 12.7582 2.2245 0.5969 12.6384 2.1204 0.5024 0.7773 0.9963 483 DAlcMix-H_000300 CN(C)c1ccc(cc1)C(=O)NCCCCCCC(=O)NO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 P03 compound treatment 9.6981 -0.83559 -0.2242 10.3672 -0.15082 -0.0357 -0.1838 -0.8096 3556664 DAlcMix-H_000301 COC(=O)c1c(C(=O)OC)c2oc1CC[C@H](COC(=O)NCCCCCC(=O)NO)NC(=O)N[C@H](Cc3ccccc3)C(=O)NCc4cn(C[C@H](Cc5ccccc5)NC2=O)nn4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 P04 compound treatment 29.9831 19.449 5.2188 30.6956 20.178 4.7808 7.0708 0.999 478 DAlcMix-H_000302 ONC(=O)/C=C/C#Cc1cccc(NS(=O)(=O)c2ccccc2)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 P05 compound treatment 12.1516 1.6179 0.4341 9.7127 -0.80524 -0.1908 0.1721 0.3629 3556666 DAlcMix-H_000303 COC(=O)c1c(C(=O)OC)c2oc1CC[C@H](COC(=O)NCCCCCC(=O)NO)NC(=O)N[C@H](Cc3ccccc3)C(=O)NCc4cn(C[C@@H](Cc5ccccc5)NC2=O)nn4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 P06 compound treatment 53.7629 43.229 11.5995 53.1252 42.607 10.0952 15.3404 0.9976 529 DAlcMix-H_000304 Nc1ccccc1NC(=O)c2ccc(CNC(=O)OCc3cccnc3)cc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 P07 compound treatment 9.9102 -0.62356 -0.1673 10.3451 -0.1729 -0.041 -0.1473 -0.855 3556668 DAlcMix-H_000305 COC(=O)c1c(C(=O)OC)c2oc1CC[C@H](COC(=O)NCCCCCC(=O)NO)NC(=O)N[C@@H](Cc3ccccc3)C(=O)NCc4cn(C[C@H](Cc5ccccc5)NC2=O)nn4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 P08 compound treatment 13.0919 2.5581 0.6864 9.8444 -0.67359 -0.1596 0.3725 0.5286 506 DAlcMix-H_000306 CCC(C)C1NC(=O)[C@@H](NC(=O)[C@H](CCCCCC(=O)CC)NC(=O)[C@H]2CCCCN2C1=O)c3cn(OC)c4ccccc34 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 P09 compound treatment 10.2713 -0.26245 -0.0704 9.4069 -1.111 -0.2632 -0.2359 -0.8658 3556669 DAlcMix-H_000307 CO[C@H]1O[C@H](COC(=O)NCCCCCC(=O)NO)[C@@H](OC(=O)[C@H](CC=C)Cc2cccc(Br)c2)[C@H](OC(=O)[C@H](CC=C)Cc3ccccc3)[C@H]1OC(=O)OCC=C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 P10 compound treatment 32.2788 21.745 5.8348 40.6776 30.16 7.1459 9.1787 0.9949 3623005 DAlcMix-H_000308 CN(C)Cc1c(oc2ccccc12)C(=O)NCCOc3ccc(cc3)C(=O)NO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 P11 mock treatment 10.9639 0.43016 0.1154 10.6917 0.17377 0.0412 0.1107 0.9036 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 P12 mock treatment 9.0659 -1.4678 -0.3938 10.9257 0.4077 0.0966 -0.2102 -0.5183 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 P13 compound treatment 12.4358 1.902 0.5104 12.8976 2.3796 0.5638 0.7596 0.9988 3556672 DAlcMix-H_000309 CO[C@H]1O[C@H](COC(=O)NCCCCCC(=O)NO)[C@H]2OC(=O)[C@@H](Cc3cccc(Br)c3)C/C=C/C[C@H](Cc4ccccc4)C(=O)O[C@@H]2[C@H]1OC(=O)OCC=C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 P14 compound treatment 305.7557 295.22 79.2157 313.2942 302.78 71.7384 106.7406 0.9988 3623002 DAlcMix-H_000310 Cc1[nH]c2ccccc2c1CCNCc3ccc(/C=C/C(=O)NO)cc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 P15 compound treatment 29.2124 18.679 5.012 28.7765 18.258 4.3261 6.603 0.9973 3556674 DAlcMix-H_000311 CO[C@H]1O[C@H](COC(=O)NCCCCCC(=O)NO)[C@@H](OC(=O)Nc2ccccc2)[C@@H]3OC(=O)[C@H](Cc4cccc(Br)c4)C/C=C/C[C@@H](Cc5cccc(Br)c5)C(=O)O[C@@H]13 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 P16 compound treatment 21.6785 11.145 2.9904 19.6198 9.1018 2.1565 3.6395 0.9871 3622998 DAlcMix-H_000312 OCCN(CCc1c[nH]c2ccccc12)Cc3ccc(/C=C/C(=O)NO)cc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 P17 compound treatment 11.222 0.68833 0.1847 9.8314 -0.68655 -0.1627 0.0156 0.0633 3556677 DAlcMix-H_000313 CCOC(=O)[C@H]1C/C=C/C[C@H](C(=O)OCC)C(=O)O[C@H]2[C@H](OC(=O)Nc3ccccc3)[C@@H](COC(=O)NCCCCCC(=O)NO)O[C@H](OC)[C@@H]2OC1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 P18 compound treatment 16.9646 6.4309 1.7256 14.8653 4.3473 1.03 1.9485 0.9696 3622988 DAlcMix-H_000314 ONC(=O)/C=C/c1cccc(c1)S(=O)(=O)Nc2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 P19 compound treatment 9.033 -1.5007 -0.4027 10.9281 0.41013 0.0972 -0.216 -0.5215 3556680 DAlcMix-H_000315 ONC(=O)CCCCCNC(=O)OCC[C@@H]1OC(=O)C2(CCCC2)N3CC4=CCCC=C[C@H]4[C@H]13 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 P20 compound treatment 32.2788 21.745 5.8348 33.6589 23.141 5.4829 8.0028 0.9995 479 DAlcMix-H_000316 ONC(=O)CCCCCCC(=O)Nc1cccnc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 P21 compound treatment 9.5871 -0.9466 -0.254 11.9584 1.4404 0.3413 0.0617 0.1451 3556682 DAlcMix-H_000317 ONC(=O)CCCCCNC(=O)OCC[C@@H]1OC(=O)C2(CCCC2)N3CC(=C)[C@@H](/C=C/C=C)[C@H]13 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 P22 compound treatment 103.7179 93.184 25.0037 128.6678 118.15 27.9939 37.4749 0.9984 3622981 DAlcMix-H_000318 Nc1ccccc1NC(=O)c2ccc(CNc3nccc(n3)c4cccnc4)cc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 P23 compound treatment 9.449 -1.0847 -0.2911 12.6911 2.1731 0.5149 0.1583 0.2676 3616214 DAlcMix-H_000319 CC[C@@H](OC(=O)NCCCCCC(=O)NO)c1cc(C=C)nc(c1)c2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2447 P24 compound treatment 34.933 24.399 6.547 37.8833 27.365 6.4838 9.2142 1.0 525 DAlcMix-H_000320 CC(=O)Nc1ccc(cc1)C(=O)Nc2ccccc2N 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 A01 mock treatment 11.055 -0.63649 -0.1708 13.7657 1.8426 0.4366 0.188 0.4009 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 A02 mock treatment 11.2363 -0.45518 -0.1221 10.4561 -1.4669 -0.3476 -0.3321 -0.9015 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 A03 compound treatment 13.1136 1.4221 0.3816 32.8579 20.935 4.9602 3.7772 0.7593 3650167 BSPBio_001601 CC(=O)O[C@@H]1C[C@@]2(C)[C@@H](OC(=O)[C@H]3O[C@]32[C@]4(C)[C@@H](CC5C(C)(C)[C@@H](C[C@H](OC(=O)C)[C@]5(C)C14)OC(=O)C)OC(=O)C)c6ccoc6 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 A04 compound treatment 11.6704 -0.021096 -0.0057 14.1008 2.1777 0.516 0.3609 0.6993 3173352 BSPBio_001602 CC(=O)O[C@@H]1CC2C(C)(C)C(=O)C=C[C@]2(C)C3CC[C@@]4(C)[C@@H](OC(=O)C=C4[C@]13C)c5ccoc5 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 A05 compound treatment 13.7129 2.0214 0.5424 12.7345 0.81147 0.1923 0.5195 0.9027 3173997 BSPBio_001603 COC(=O)CC1C(C)(C)C(=O)C=CC1(C)C2CC[C@@]3(C)[C@@H](OC(=O)C4OC43C2=C)c5ccoc5 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 A06 compound treatment 12.9381 1.2466 0.3345 14.4577 2.5347 0.6006 0.6612 0.9618 2060232 BSPBio_001604 CC(=O)O[C@@H]1CC2C(C)(C)C(=O)CC[C@]2(C)C3CC[C@@]4(C)[C@@H](OC(=O)C=C4[C@]13C)c5ccoc5 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 A07 compound treatment 85.8364 74.145 19.895 89.9468 78.024 18.4866 27.1399 0.9993 3054122 BSPBio_001605 CC(=O)O[C@@H]1C[C@@]2(C)[C@@H](C[C@H]3O[C@]32[C@@]4(C)C1[C@@]5(C)C=CC(=O)C(C)(C)C5=C(O)C4=O)c6ccoc6 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 A08 compound treatment 12.661 0.96955 0.2602 11.0942 -0.82878 -0.1964 0.0451 0.1384 2060233 BSPBio_001606 COC(=O)C[C@H]1C(C)(C)[C@H](O)[C@@H]2CC3=C4CC(O)O[C@@H](c5ccoc5)[C@]4(C)CCC3[C@@]1(C)C2=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 A09 compound treatment 14.7295 3.038 0.8152 15.1136 3.1905 0.756 1.111 0.9993 2060028 BSPBio_001607 COC(=O)C[C@H]1C2(C)CC3(OC4(C)O[C@@]56[C@H](OC(=O)C)[C@@]3(O)C2OC(=O)C(C)C)[C@]1(C)[C@@]6(O4)[C@H](OC(=O)C)C(OC(=O)C)[C@@]7(C)[C@@H](OC(=O)/C(=C(\O)/C(C)C)/C57)c8ccoc8 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 A10 compound treatment 11.3912 -0.30023 -0.0806 9.2937 -2.6293 -0.623 -0.4975 -0.792 2060235 BSPBio_001608 CC(=O)O[C@@H]1CC2C(C)(C)C(=O)[C@@H]3O[C@@H]3[C@]2(C)C4CC[C@@]5(C)[C@@H](OC(=O)C=C5[C@]14C)c6ccoc6 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 A11 compound treatment 174.996 163.3 43.8188 166.3262 154.4 36.5836 56.8531 0.996 2060030 BSPBio_001609 COC(=O)C[C@H]1C(C)(C)C(=O)[C@@H]2CC3C(CC[C@@]4(C)[C@@H](OC(=O)C=C34)c5ccoc5)[C@@]1(C)C2=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 A12 compound treatment 11.5278 -0.16365 -0.0439 12.6255 0.70254 0.1665 0.0867 0.5034 2060237 BSPBio_001610 CC(=O)O[C@@H]1C[C@H](OC(=O)C)[C@@]2(C)C(CC(=O)[C@]3(C)C2CC[C@@]4(C)[C@@H](OC(=O)C5OC543)C(=O)O)C1(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 A13 compound treatment 40.0419 28.35 7.6071 40.4436 28.521 6.7575 10.1574 0.9983 2060031 BSPBio_001611 C[C@]12CCC3[C@@]4(C)C=CC(=O)C(C)(C)C4=C(O)C(=O)[C@@]3(C)[C@]25O[C@@H]5C[C@H]1c6ccoc6 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 A14 compound treatment 13.0571 1.3657 0.3664 13.568 1.645 0.3898 0.5347 0.9995 2060240 BSPBio_001612 CC1=C2C(O)C(=O)OC3CC4C(C)(C)C(=O)C=C[C@]4(C)C(CC1)[C@@]32C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 A15 compound treatment 14.9255 3.2341 0.8678 11.6089 -0.31415 -0.0744 0.561 0.6441 2060035 BSPBio_001613 CC1(C)C2C[C@@H](O)[C@]3(C)C(CC[C@@]4(C)[C@@H](OC(=O)[C@H]5O[C@]543)c6ccoc6)[C@@]2(C)C=CC1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 A16 compound treatment 13.4792 1.7877 0.4797 12.9734 1.0504 0.2489 0.5152 0.9533 2060241 BSPBio_001614 CC1(C)C2C[C@@H](O)[C@]3(C)C(CC[C@@]4(C)[C@@H](OC(=O)C=C43)c5ccoc5)[C@@]2(C)CCC1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 A17 compound treatment 13.5588 1.8674 0.5011 12.7068 0.78385 0.1857 0.4856 0.9088 2060230 BSPBio_001615 CC(=O)O[C@H]1C[C@@H](O)C(C)(C)C2C[C@@H](OC(=O)C)[C@]3(C)C(CC[C@@]4(C)[C@@H](OC(=O)C5OC543)c6ccoc6)[C@@]12C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 A18 compound treatment 13.8004 2.109 0.5659 11.5505 -0.3725 -0.0883 0.3377 0.5897 2060026 BSPBio_001616 COC(=O)C[C@H]1C(C)(C)[C@@H](OC(=O)C)[C@@H]2CC3C(CC[C@@]4(C)[C@@H](OC(=O)CC34)c5ccoc5)[C@@]1(C)C2=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 A19 compound treatment 12.1692 0.47773 0.1282 12.0083 0.085268 0.0202 0.1049 0.8086 2060147 BSPBio_001617 CC(=O)O[C@@H]1C[C@H](OC(=O)C)[C@@]2(C)C(C[C@@H](O)[C@]3(C)C2CC[C@@]4(C)[C@@H](OC(=O)[C@H]5O[C@]543)c6ccoc6)C1(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 A20 compound treatment 11.7142 0.022714 0.0061 14.9271 3.0041 0.7118 0.5076 0.7131 2060425 BSPBio_001618 COC(=O)[C@@H]1OC(=O)[C@H]2O[C@@]23[C@@]1(C)CCC4[C@@]5(C)CCC(=O)C(C)(C)C5C[C@@H](OC(=O)C)[C@]43C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 A21 compound treatment 13.7023 2.0108 0.5396 13.3791 1.4561 0.345 0.6255 0.9767 2060038 BSPBio_001619 COC(=O)C[C@H]1C(C)(C)C(=O)C=C[C@]1(C)C2CC[C@@]3(C)[C@@H](OC(=O)C=C3C2=C)c4ccoc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 A22 compound treatment 14.081 2.3896 0.6412 12.1123 0.18927 0.0448 0.4851 0.7547 2060027 BSPBio_001620 CC(=O)O[C@@H]1CC2C(C)(C)[C@@H](O)CC[C@]2(C)C3CC[C@@]4(C)[C@@H](OC(=O)[C@H]5O[C@]54[C@]13C)c6ccoc6 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 A23 mock treatment 11.3874 -0.30405 -0.0816 13.7244 1.8014 0.4268 0.2441 0.5618 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 A24 mock treatment 12.8 1.1086 0.2975 13.4674 1.5444 0.3659 0.4691 0.9947 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 B01 mock treatment 10.6451 -1.0463 -0.2808 9.5859 -2.3371 -0.5537 -0.5901 -0.9504 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 B02 mock treatment 11.1785 -0.51295 -0.1376 11.4034 -0.51956 -0.1231 -0.1844 -0.9984 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 B03 compound treatment 14.1832 2.4918 0.6686 15.4277 3.5046 0.8304 1.0599 0.9942 812 BSPBio_001621 COC1=CC(=O)C[C@@H](C)[C@@]21Oc3c(C2=O)c(OC)cc(OC)c3Cl 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 B04 compound treatment 17.5133 5.8219 1.5622 13.1329 1.2099 0.2867 1.3073 0.8231 2060218 BSPBio_001622 COc1c(CC(=O)c2cc3CC(O)C(C)(C)Oc3cc2O)ccc4OC(C)(C)C=Cc14 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 B05 compound treatment 11.3723 -0.31918 -0.0856 15.4568 3.5338 0.8373 0.5315 0.6315 1090422 BSPBio_001623 Cc1cc(O)cc(O)c1C(=O)Oc2cc(C)c(C(=O)O)c(O)c2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 B06 compound treatment 10.6088 -1.0827 -0.2905 11.6742 -0.24877 -0.0589 -0.2471 -0.8336 1254 BSPBio_001624 O[C@H]1Cc2c(O)cc(O)cc2O[C@@H]1c3ccc(O)c(O)c3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 B07 compound treatment 10.4042 -1.2872 -0.3454 11.6237 -0.29927 -0.0709 -0.2944 -0.8349 3177315 BSPBio_001625 CC1O[C@@H](Oc2c(oc3cc(O)cc(O)c3c2=O)c4ccc(O)c(O)c4)[C@H](O)[C@H](O)[C@H]1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 B08 compound treatment 13.0702 1.3787 0.3699 12.244 0.32097 0.076 0.3154 0.835 1001923 BSPBio_001626 O[C@@H]1Cc2c(O)cc(O)cc2O[C@@H]1c3ccc(O)c(O)c3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 B09 compound treatment 16.1478 4.4564 1.1958 12.4119 0.4889 0.1158 0.9274 0.772 2060433 BSPBio_001627 COc1ccc(cc1)c2cc(=O)c3c(O)cc(O[C@H]4O[C@H](CO[C@@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3o2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 B10 compound treatment 12.7674 1.0759 0.2887 11.9544 0.031345 0.0074 0.2094 0.7251 1859 BSPBio_001628 Oc1cc(O)c2C[C@@H](OC(=O)c3cc(O)c(O)c(O)c3)[C@H](Oc2c1)c4cc(O)c(O)c(O)c4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 B11 compound treatment 15.5616 3.8701 1.0385 18.5895 6.6665 1.5795 1.8512 0.9793 1057125 BSPBio_001629 CC(C)(C=C)c1c2OC(C)(C)C=Cc2c(O)c3c(=O)c4ccc(O)c(O)c4oc13 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 B12 compound treatment 11.029 -0.66247 -0.1778 13.4858 1.5628 0.3703 0.1361 0.3314 2060418 BSPBio_001630 COc1ccccc1c2cc(=O)c3cccc(OC)c3o2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 B13 compound treatment 10.9163 -0.77519 -0.208 11.6889 -0.23411 -0.0555 -0.1863 -0.8654 2060242 BSPBio_001631 COc1ccc(cc1)c2cc(=O)c3c(O)c(OC)c(O[C@H]4O[C@H](CO[C@@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3o2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 B14 compound treatment 11.5938 -0.097684 -0.0262 13.2232 1.3002 0.3081 0.1993 0.6446 2060224 BSPBio_001632 Oc1cc(O)c2C[C@@H](OC(=O)c3cc(O)c(O)c(O)c3)[C@H](Oc2c1)c4ccc(O)c(O)c4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 B15 compound treatment 14.2405 2.5491 0.684 11.4453 -0.47772 -0.1132 0.4036 0.5822 2060463 BSPBio_001633 COc1ccc(cc1)c2coc3c(OC)c(OC)cc(O)c3c2=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 B16 compound treatment 11.4126 -0.27882 -0.0748 12.5408 0.61777 0.1464 0.0506 0.3078 2060223 BSPBio_001634 COc1cc(OC)c2C[C@H](O)[C@H](Oc2c1)c3ccc(OC)c(OC)c3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 B17 compound treatment 12.8404 1.1489 0.3083 10.2824 -1.6406 -0.3887 -0.0569 -0.1147 2069243 BSPBio_001635 O/C(=C\C(=O)c1ccccc1O)/c2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 B18 compound treatment 14.6336 2.9421 0.7894 11.1229 -0.80007 -0.1896 0.4242 0.5225 907310 BSPBio_001636 O[C@@H]1Cc2c(O)cc(O)cc2O[C@@H]1c3cc(O)c(O)c(O)c3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 B19 compound treatment 11.65 -0.041504 -0.0111 12.2023 0.2793 0.0662 0.0389 0.58 2060040 BSPBio_001637 CCOC(=O)C1(O)Oc2cc(OC)cc(OC)c2C(=O)C1c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 B20 compound treatment 11.6652 -0.026276 -0.0071 12.6709 0.74791 0.1772 0.1203 0.6784 2060221 BSPBio_001638 COc1ccc(cc1)[C@H]2Oc3cc(OC)cc(OC)c3C[C@H]2O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 B21 compound treatment 10.9063 -0.78521 -0.2107 12.5831 0.6601 0.1564 -0.0384 -0.1463 1050335 BSPBio_001639 COc1cc(OC)c(C=O)cc1OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 B22 compound treatment 12.4818 0.79034 0.2121 12.1429 0.2199 0.0521 0.1868 0.8554 1210108 BSPBio_001640 Oc1ccc2cccc(O)c(=O)c2c1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 B23 mock treatment 10.2088 -1.4827 -0.3978 12.9991 1.076 0.255 -0.101 -0.2138 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 B24 mock treatment 15.4567 3.7652 1.0103 14.4769 2.5539 0.6051 1.1423 0.97 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 C01 mock treatment 10.9478 -0.74365 -0.1995 12.9592 1.0362 0.2455 0.0325 0.1028 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 C02 mock treatment 12.3034 0.61193 0.1642 10.8973 -1.0257 -0.243 -0.0557 -0.19 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 C03 compound treatment 10.606 -1.0855 -0.2913 10.9371 -0.98595 -0.2336 -0.3711 -0.994 2060055 BSPBio_001641 CC(=O)O[C@@H]1CC2C(C)(C)C(=O)CC[C@]2(C)C3CC[C@@]4(C)[C@@H](OC(=O)C5OC54[C@]13C)c6ccoc6 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 C04 compound treatment 11.8419 0.15044 0.0404 11.3947 -0.5283 -0.1252 -0.06 -0.456 2060029 BSPBio_001642 CC(=O)O[C@H]1CC[C@@]2(C)C(C[C@@H](OC(=O)C)[C@]3(C)C2CC[C@@]4(C)[C@@H](OC(=O)[C@H]5O[C@]543)c6ccoc6)C1(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 C05 compound treatment 12.5301 0.83859 0.225 15.5347 3.6117 0.8557 0.7642 0.8637 1609 BSPBio_001643 CC(=O)O[C@@H]1CC2C(C)(C)C(=O)C=C[C@]2(C)C3CC[C@@]4(C)[C@@H](OC(=O)[C@H]5O[C@]54[C@]13C)c6ccoc6 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 C06 compound treatment 16.438 4.7465 1.2736 11.3918 -0.5312 -0.1259 0.8116 0.6341 2060036 BSPBio_001644 CC1=CCc2c(O)c3c(=O)cc(C)oc3cc2OC1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 C07 compound treatment 13.5468 1.8553 0.4978 13.1199 1.1969 0.2836 0.5525 0.9644 2060059 BSPBio_001645 CC(=O)O[C@@H]1C[C@H](OC(=O)C)[C@@]2(C)C(C[C@@H](OC(=O)C)[C@]3(C)C2CC[C@@]4(C)[C@@H](C[C@H]5O[C@]543)c6ccoc6)C1(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 C08 compound treatment 12.5776 0.88611 0.2378 11.7322 -0.19083 -0.0452 0.1362 0.5626 2060086 BSPBio_001646 CCC(C)C(=O)O[C@@H]1C[C@@]2(C)[C@@H](OC(=O)CC32OC4(C)OC53[C@H](OC(=O)C(C)C)[C@@]6(O)[C@@H](OC(=O)C7(C)OC7C)[C@@]8(C)C[C@]6(O)[C@@](C)([C@H]8CC(=O)OC)C15O4)c9ccoc9 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 C09 compound treatment 11.794 0.10252 0.0275 12.7751 0.85212 0.2019 0.1622 0.7961 2060374 BSPBio_001647 CCC(C)C(OC(=O)C)C(=O)O[C@H]1[C@H](O)C2[C@@]3(C)C=CC(=O)C(C)(C)C3C[C@@H](OC(=O)C(O)C(C)C)[C@@]2(C)[C@]45O[C@@H]5C[C@@H](c6ccoc6)[C@]14C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 C10 compound treatment 11.4084 -0.28304 -0.0759 10.9625 -0.96048 -0.2276 -0.2146 -0.8946 3173368 BSPBio_001648 O=C1CC[C@]2(/C=C/C(=O)NCCCCNCCCNC(=O)\C=C\c3ccc4O[C@@H]2C1)c4c3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 C11 compound treatment 13.7267 2.0353 0.5461 12.3252 0.40222 0.0953 0.4536 0.8181 2060060 BSPBio_001649 CC1(C)C2CC(=O)[C@]3(C)C(CC[C@@]4(C)[C@@H](OC(=O)[C@H]5O[C@]543)c6ccoc6)[C@@]2(C)C=CC1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 C12 compound treatment 12.2704 0.57896 0.1553 13.0035 1.0805 0.256 0.2909 0.9713 2060039 BSPBio_001650 CC(=CCc1c(O)cc2oc(C)cc(=O)c2c1O)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 C13 compound treatment 11.3698 -0.32163 -0.0863 10.8307 -1.0923 -0.2588 -0.244 -0.8945 2060062 BSPBio_001651 CC(=O)O[C@@H]1C[C@H](OC(=O)C)[C@@]2(C)C(CC(=O)[C@]3(C)C2CC[C@@]4(C)[C@@H](OC(=O)[C@H]5O[C@]543)c6ccoc6)C1(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 C14 compound treatment 11.7519 0.060454 0.0162 11.7812 -0.14183 -0.0336 -0.0123 -0.3294 2060056 BSPBio_001652 COc1cc(O)c2c(=O)cc(C)oc2c1CC=C(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 C15 compound treatment 12.1526 0.46115 0.1237 12.7186 0.79562 0.1885 0.2208 0.9792 2060063 BSPBio_001653 CC(=O)O[C@@H]1C[C@H](OC(=O)C)[C@@]2(C)C(C[C@@H](OC(=O)C)[C@]3(C)C2CC[C@@]4(C)[C@@H](C(=O)[C@H]5O[C@]543)c6ccoc6)C1(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 C16 compound treatment 13.3889 1.6974 0.4555 10.0917 -1.8313 -0.4339 0.0152 0.0242 3054129 BSPBio_001654 CO[C@@H]1CC2N3CC(O)C2(C=C1)c4cc5OCOc5c(OC)c4C3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 C17 compound treatment 12.1751 0.48366 0.1298 12.0123 0.08928 0.0212 0.1067 0.8117 2060066 BSPBio_001655 COC(=O)CC1C(C)(C)C(=O)C[C@@H]2O[C@@]34CC(=O)O[C@@H](c5ccoc5)[C@]4(C)CCC(C3=C)[C@]12C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 C18 compound treatment 14.8294 3.138 0.842 12.6401 0.71713 0.1699 0.7155 0.833 2060061 BSPBio_001656 Cc1cc(=O)c2c(O)c3CCC(C)(C)Oc3cc2o1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 C19 compound treatment 14.4299 2.7384 0.7348 11.7829 -0.14007 -0.0332 0.4961 0.6745 3173867 BSPBio_001657 COC(=O)C[C@H]1C(C)(C)C(=O)[C@@H]2CC3=C4CC(=O)O[C@@H](c5ccoc5)[C@]4(C)CCC3[C@@]1(C)C2=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 C20 compound treatment 11.088 -0.60345 -0.1619 12.8407 0.91772 0.2174 0.0393 0.1448 3058621 BSPBio_001658 C[C@H]1C2[C@H](C[C@H]3C4CC=C5C[C@@H](O)CC[C@]5(C)C4CC[C@]23C)O[C@@]61CC[C@@H](C)CN6 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 C21 compound treatment 13.407 1.7155 0.4603 12.8716 0.94857 0.2247 0.4844 0.9457 2060435 BSPBio_001659 COC(=O)C(OC(=O)C)[C@H]1C(C)(C)C(=O)C[C@@H]2O[C@@]34CC(=O)O[C@@H](c5ccoc5)[C@]4(C)CCC(C3=C)[C@]12C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 C22 compound treatment 9.1144 -2.577 -0.6915 11.3578 -0.56518 -0.1339 -0.5836 -0.8286 2060161 BSPBio_001660 CC(=C)[C@H]1COc2cc3oc(=O)ccc3cc2O1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 C23 mock treatment 13.6284 1.9369 0.5197 13.8508 1.9278 0.4568 0.6905 0.9979 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 C24 mock treatment 12.3817 0.69027 0.1852 11.2816 -0.64143 -0.152 0.0235 0.0981 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 D01 mock treatment 10.3083 -1.3832 -0.3711 12.2681 0.34505 0.0818 -0.2046 -0.5384 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 D02 mock treatment 11.0935 -0.59801 -0.1605 14.9405 3.0175 0.7149 0.3921 0.5351 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 D03 compound treatment 11.7188 0.027361 0.0073 10.9476 -0.97545 -0.2311 -0.1582 -0.6843 2060043 BSPBio_001661 COc1cc(OC)c(Cl)c2OC3(C(C)CC(=O)C=C3O)C(=O)c21 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 D04 compound treatment 11.9537 0.26225 0.0704 13.0972 1.1742 0.2782 0.2465 0.8589 2060082 BSPBio_001662 COC(=O)c1cc(OC)c(=O)c2c(OC)c(OC)ccc2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 D05 compound treatment 10.7007 -0.99076 -0.2658 12.8394 0.91635 0.2171 -0.0345 -0.1004 2060396 BSPBio_001663 OC[C@H]1O[C@@H](Oc2ccc(C(=O)/C=C/c3ccccc3)c(O)c2)[C@H](O)[C@@H](O)[C@@H]1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 D06 compound treatment 13.1802 1.4888 0.3995 9.6671 -2.2559 -0.5345 -0.0955 -0.1431 2060226 BSPBio_001664 O[C@@H]1Cc2c(O)cc(O)cc2O[C@@H]1c3cc(O)c(O)c4c(=O)c(O)cc(cc34)[C@H]5Oc6cc(O)cc(O)c6C[C@H]5OC(=O)c7cc(O)c(O)c(O)c7 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 D07 compound treatment 12.1012 0.40975 0.1099 12.2793 0.35632 0.0844 0.1374 0.9915 3235 BSPBio_001665 OC(=O)c1ccccc1OC(=O)c2ccccc2O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 D08 compound treatment 14.2532 2.5617 0.6874 13.8515 1.9284 0.4569 0.8091 0.9803 2060444 BSPBio_001666 O[C@@H]1Cc2c(O)cc(O)cc2O[C@@H]1c3cc(O)c(O)c4c(=O)c(O)cccc34 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 D09 compound treatment 12.1133 0.42185 0.1132 12.5467 0.62367 0.1478 0.1845 0.9913 1032994 BSPBio_001667 O=C1CC(Oc2ccccc12)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 D10 compound treatment 11.9919 0.30043 0.0806 12.7618 0.8388 0.1987 0.1975 0.921 1016781 BSPBio_001668 OC(=O)c1cc(O)c(O)c(O)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 D11 compound treatment 18.5768 6.8853 1.8475 20.9899 9.0669 2.1483 2.8254 0.9972 3177381 BSPBio_001669 Oc1ccc(cc1)C(=O)/C=C/c2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 D12 compound treatment 13.3778 1.6864 0.4525 15.3369 3.4139 0.8089 0.8919 0.9623 1109169 BSPBio_001670 COc1ccc2c(=O)c(coc2c1)c3cc4OCOc4cc3OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 D13 compound treatment 13.6293 1.9378 0.52 11.314 -0.60904 -0.1443 0.2656 0.4923 2060263 BSPBio_001671 COc1ccc(C(=O)c2ccc(O)cc2)c(O)c1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 D14 compound treatment 12.6361 0.94459 0.2535 11.4304 -0.4926 -0.1167 0.0967 0.3465 2060407 BSPBio_001672 COc1ccc(/C=C/C(=O)O)cc1OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 D15 compound treatment 58.6561 46.965 12.6018 54.262 42.339 10.0316 16.0042 0.9936 1019365 BSPBio_001673 COC1=CC(=O)C=C(OC)C1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 D16 compound treatment 14.7026 3.0111 0.808 12.3586 0.43558 0.1032 0.6443 0.791 2060406 BSPBio_001674 COc1ccccc1/C=C\C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 D17 compound treatment 12.7993 1.1078 0.2973 10.5876 -1.3354 -0.3164 -0.0135 -0.0312 2069258 BSPBio_001675 COc1ccc(c(OC)c1O)c2coc3cc(O)ccc3c2=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 D18 compound treatment 15.4807 3.7892 1.0167 11.8261 -0.09693 -0.023 0.7027 0.691 2060422 BSPBio_001676 CCOc1ccc(cc1)C(=O)c2cc(O)c(OC)c(OC)c2O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 D19 compound treatment 11.9872 0.29575 0.0794 12.1718 0.24882 0.059 0.0978 0.9893 2060392 BSPBio_001677 CCOc1ccc(cc1)C(=O)c2ccc(O)c(O)c2O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 D20 compound treatment 13.8558 2.1643 0.5807 10.7461 -1.1769 -0.2789 0.2135 0.3314 2069226 BSPBio_001678 COc1ccc2-c3oc4cc(OC)ccc4c3COc2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 D21 compound treatment 11.7409 0.049464 0.0133 12.8145 0.8915 0.2112 0.1587 0.7501 3058620 BSPBio_001679 O[C@@H](C(=O)O)[C@@](O)(Cc1ccc(O)cc1)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 D22 compound treatment 14.0918 2.4004 0.6441 10.2132 -1.7098 -0.4051 0.169 0.2221 1003514 BSPBio_001680 COc1cc(cc(OC)c1OC)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 D23 mock treatment 10.828 -0.86348 -0.2317 10.3178 -1.6052 -0.3803 -0.4328 -0.9718 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 D24 mock treatment 11.3549 -0.33657 -0.0903 10.6133 -1.3097 -0.3103 -0.2833 -0.8765 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 E01 mock treatment 9.5044 -2.1871 -0.5868 12.3742 0.45118 0.1069 -0.3394 -0.5689 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 E02 mock treatment 12.7607 1.0693 0.2869 11.64 -0.28305 -0.0671 0.1555 0.5276 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 E03 compound treatment 11.4347 -0.25678 -0.0689 10.9813 -0.94169 -0.2231 -0.2065 -0.8843 2060083 BSPBio_001681 COC(=O)C(O)[C@H]1C(C)(C)C(=O)C[C@@H]2O[C@@]34CC(=O)O[C@@H](c5ccoc5)[C@]4(C)CCC(C3=C)[C@]12C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 E04 compound treatment 9.3304 -2.361 -0.6335 10.6117 -1.3113 -0.3107 -0.6677 -0.9462 1352641 BSPBio_001682 COc1c2ccoc2nc3ccccc13 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 E05 compound treatment 0.0 -11.691 -3.1371 19.6472 7.7242 1.8301 -0.9242 -0.2545 2060085 BSPBio_001683 C[C@]12CCC3[C@@](C)([C@H](O)CC4[C@]3(C)C=CC(=O)OC4(C)C)C25OC5C(=O)O[C@H]1c6ccoc6 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 E06 compound treatment 13.0709 1.3795 0.3701 10.0461 -1.8769 -0.4447 -0.0527 -0.0911 2060295 BSPBio_001684 CC(C)C1COc2cc3oc(=O)ccc3cc2O1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 E07 compound treatment 12.9856 1.2942 0.3473 13.2408 1.3178 0.3122 0.4663 0.9986 3085328 BSPBio_001685 Oc1cccc(c1)c2cc(=O)c3cc(O)ccc3o2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 E08 compound treatment 10.9299 -0.76153 -0.2043 9.9539 -1.9691 -0.4666 -0.4744 -0.9314 2060058 BSPBio_001686 CC1(C)CC[C@@]2(CC[C@]3(C)C(=CCC4[C@@]5(C)CC[C@@H](O)C(C)(C)C5CC[C@]43C)C2C1)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 E09 compound treatment 11.4622 -0.22927 -0.0615 12.7604 0.83741 0.1984 0.0968 0.466 2069252 BSPBio_001687 CCC(C)C(OC(=O)C)C(=O)O[C@H]1[C@H](OC=O)C(C(=C)C2(O)C(=O)C[C@@H](c3ccoc3)[C@]12C)[C@]4(C)C(CC(=O)OC)[C@@](C)(COC(=O)C)OC(=O)C[C@@H]4OC(=O)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 E10 compound treatment 11.2799 -0.4116 -0.1104 10.6659 -1.2571 -0.2978 -0.2887 -0.9088 3173478 BSPBio_001688 C[C@H]1C(=O)CCC2[C@]1(C)CCC3[C@@]2(C)CC[C@@]4(C)C5CC(C)(C)CC[C@]5(C)CC[C@]34C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 E11 compound treatment 12.1302 0.43875 0.1177 10.7318 -1.1912 -0.2822 -0.1163 -0.3804 2060087 BSPBio_001689 COC(=O)C(O)[C@H]1C(C)(C)C(OC(=O)/C(=C/C)/C)[C@@H]2C=C3C(CC[C@@]4(C)[C@@H](OC(=O)CC34)c5ccoc5)[C@@]1(C)C2=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 E12 compound treatment 8.8269 -2.8646 -0.7686 11.7632 -0.15978 -0.0379 -0.5703 -0.741 3054135 BSPBio_001690 CC(=O)O[C@H]1CC[C@@]2(C)C(CC[C@]3(C)C2CC=C4C5CC(C)(C)CC[C@]5(C)CC[C@]43C)C1(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 E13 compound treatment 11.5589 -0.1326 -0.0356 14.6384 2.7154 0.6434 0.4298 0.667 2060090 BSPBio_001691 COC(=O)C[C@H]1C(C)(C)C(OC(=O)C)[C@]2(O)C=C3C(CC[C@@]4(C)[C@@H](OC(=O)CC34)c5ccoc5)[C@@]1(C)C2=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 E14 compound treatment 12.6182 0.92668 0.2487 11.6374 -0.28557 -0.0677 0.128 0.4966 2060410 BSPBio_001692 CC1(C)[C@H](O)CC(=O)[C@@]2(C)C1C[C@@H](O)[C@]3(C)C2CC[C@@]4(C)[C@@H](OC(=O)C5OC543)c6ccoc6 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 E15 compound treatment 12.8823 1.1908 0.3195 13.3265 1.4035 0.3325 0.4611 0.9998 2060089 BSPBio_001693 CCC(C)C(=O)O[C@@H]1C[C@@]2(C)[C@@H](OC(=O)CC32OC4(C)O[C@]53[C@H](OC(=O)C)[C@@]6(O)C(OC(=O)C7(C)OC7C)C8(C)CC6(O)[C@@](C)([C@H]8CC(=O)OC)[C@@]15O4)c9ccoc9 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 E16 compound treatment 11.2516 -0.43985 -0.118 12.8751 0.9521 0.2256 0.0761 0.2987 2060065 BSPBio_001694 COC[C@@]12CN(C=O)C3[C@@H]4[C@H](OC)C2[C@]3(C5CC6(O)C(OC(=O)c7ccccc7)C5C4(OC(=O)C)C(O)C6OC)[C@H](C[C@H]1O)OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 E17 compound treatment 16.9945 5.303 1.4229 13.8827 1.9597 0.4643 1.3345 0.8916 2060091 BSPBio_001695 CC(CC(O)C1OC1(C)C)[C@@H]2CCC3(C)C4=CCC5C(C)(C)C(=O)CCC5(C)C4CC[C@@]23C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 E18 compound treatment 10.5659 -1.1256 -0.302 12.2095 0.28653 0.0679 -0.1656 -0.5348 3650168 BSPBio_001696 CC(=O)O[C@@H]1CC2C(C)(C)[C@H](O)CC[C@]2(C)C3CC[C@@]4(C)[C@@H](OC(=O)[C@H]5O[C@]54[C@]13C)c6ccoc6 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 E19 compound treatment 11.2365 -0.45495 -0.1221 10.8779 -1.0451 -0.2476 -0.2614 -0.9469 2060093 BSPBio_001697 CC([C@@H]1CC[C@]2(C)C3=CCC4C(C)(C)C(=O)CC[C@]4(C)C3CC[C@@]12C)C5OC(C)(C)C(O)C5O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 E20 compound treatment 13.9681 2.2766 0.6109 12.972 1.049 0.2485 0.6077 0.9215 2060068 BSPBio_001698 COC1C(O)C(O[C@H]2CC[C@]3(C=O)C4[C@@H](C[C@]5(C)[C@H](CC[C@]5(O)C4CC[C@]3(O)C2)C6=CC(=O)OC6)OC(=O)C)OC(C)C1OC(=O)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 E21 compound treatment 12.6579 0.96643 0.2593 14.3066 2.3835 0.5647 0.5827 0.9377 2060094 BSPBio_001699 COC(=O)C(O)[C@H]1C(C)(C)[C@@H](OC(=O)C)[C@@H]2CC3=C4CC(=O)O[C@@H](c5ccoc5)[C@]4(C)CCC3[C@@]1(C)C2=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 E22 compound treatment 11.3637 -0.32775 -0.0879 10.5173 -1.4057 -0.3331 -0.2977 -0.8642 3174249 BSPBio_001700 CC(CCC(=O)O)[C@H]1CCC2C3CC[C@@H]4C[C@H](O)CC[C@]4(C)C3C[C@H](O)[C@]12C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 E23 mock treatment 14.4309 2.7394 0.735 12.9399 1.0169 0.2409 0.6901 0.8922 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 E24 mock treatment 10.293 -1.3985 -0.3752 11.1731 -0.74993 -0.1777 -0.391 -0.9417 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 F01 mock treatment 12.2779 0.5864 0.1573 11.4596 -0.46341 -0.1098 0.0336 0.1752 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 F02 mock treatment 11.8259 0.1344 0.0361 12.5285 0.60549 0.1435 0.1269 0.8582 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 F03 compound treatment 10.7535 -0.93797 -0.2517 10.6789 -1.2441 -0.2948 -0.3864 -0.9969 1015281 BSPBio_001701 COc1cc(O)c(C(=O)C)c(OC)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 F04 compound treatment 10.4421 -1.2493 -0.3352 10.5576 -1.3654 -0.3235 -0.4658 -0.9998 2060452 BSPBio_001702 CC1(C)O[C@@H]2C[C@](O)(C[C@@H](O)[C@@H]2O1)C(=O)N 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 F05 compound treatment 9.8618 -1.8296 -0.4909 12.2408 0.31775 0.0753 -0.2939 -0.5918 3174120 BSPBio_001703 CCCCCCCCCCCC[C@@H]([C@@H](C)C(=O)O)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 F06 compound treatment 14.7184 3.0269 0.8122 12.3761 0.4531 0.1074 0.6502 0.7937 1009294 BSPBio_001704 Oc1ccc2C(=O)c3ccccc3C(=O)c2c1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 F07 compound treatment 11.2458 -0.44566 -0.1196 10.9207 -1.0023 -0.2375 -0.2525 -0.9496 2060049 BSPBio_001705 Cc1cc(=O)c2c(O)c(C)c(O)cc2o1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 F08 compound treatment 18.4244 6.7329 1.8066 11.3463 -0.57673 -0.1366 1.1808 0.6518 1112402 BSPBio_001706 COc1ccc2ccc(=O)oc2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 F09 compound treatment 13.0625 1.371 0.3679 11.302 -0.62101 -0.1471 0.1561 0.394 2060259 BSPBio_001707 COc1ccc2c(=O)c(CC(=O)O)coc2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 F10 compound treatment 12.0039 0.31245 0.0838 12.7476 0.8246 0.1954 0.1974 0.9286 3077346 BSPBio_001708 COC(=O)c1c(C)cc(OC)cc1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 F11 compound treatment 59.7508 48.059 12.8955 72.0103 60.087 14.2368 19.1855 0.9988 2060294 BSPBio_001709 COc1ccc2C(=O)C(Cc3ccc(OC)c(O)c3)COc2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 F12 compound treatment 13.1862 1.4947 0.4011 10.5963 -1.3267 -0.3143 0.0613 0.1204 2069267 BSPBio_001710 Oc1cc(O)c(C(=O)/C=C/c2ccccc2)c(O)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 F13 compound treatment 12.7998 1.1083 0.2974 12.5922 0.66915 0.1585 0.3224 0.9566 2060504 BSPBio_001711 Cc1cc(O)c(C)c(O)c1C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 F14 compound treatment 16.2946 4.6032 1.2351 14.0967 2.1737 0.515 1.2376 0.9248 3078463 BSPBio_001712 CCOC(=O)c1c(C)cc(OC)cc1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 F15 compound treatment 13.3025 1.611 0.4323 10.6666 -1.2565 -0.2977 0.0952 0.1813 2120750 BSPBio_001713 CC(C)C(C)/C=C/C(C)C1CCC2C3=CC=C4CC(O)CCC4(C)C3CCC12C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 F16 compound treatment 12.9673 1.2758 0.3423 13.5812 1.6582 0.3929 0.5199 0.9976 2060044 BSPBio_001714 CC(=O)Oc1cc(cc(OC(=O)C)c1OC(=O)C)c2coc3cc(OC(=O)C)c(OC(=O)C)c(OC(=O)C)c3c2=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 F17 compound treatment 11.8122 0.12073 0.0324 10.9698 -0.95315 -0.2258 -0.1368 -0.5995 3173626 BSPBio_001715 CC(C)C(C)/C=C/C(C)C1CCC2C3=CC=C4C(C)(C)C(CCC4(C)C3CCC12C)OC(=O)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 F18 compound treatment 12.6067 0.91518 0.2456 12.2498 0.3268 0.0774 0.2284 0.887 2060322 BSPBio_001716 COc1ccc2c(=O)c(OC)c(oc2c1)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 F19 compound treatment 11.4985 -0.19295 -0.0518 12.3983 0.47525 0.1126 0.043 0.3471 2060070 BSPBio_001717 COc1c(O)cc(O)cc1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 F20 compound treatment 11.1558 -0.5357 -0.1437 11.2149 -0.70814 -0.1678 -0.2203 -0.997 3173217 BSPBio_001718 CCN1C[C@@]2(COC)C3[C@@H](OC)[C@H]4[C@@H]1[C@@]3(C5C[C@@]6(O)[C@H](OC(=O)c7ccccc7)C5[C@]4(OC(=O)C)[C@@H](O)[C@@H]6OC)C(C[C@H]2O)OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 F21 compound treatment 13.593 1.9015 0.5102 9.9311 -1.9919 -0.472 0.0271 0.0389 2060069 BSPBio_001719 COc1cc(cc(O)c1OC)c2coc3cc(OCc4ccccc4)c(OC)c(O)c3c2=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 F22 compound treatment 11.291 -0.40045 -0.1074 10.1092 -1.8138 -0.4297 -0.3799 -0.8575 3553784 BSPBio_001720 CC[C@@H]1[C@@H](O)N2[C@H]3C[C@@]45C(O)C3C1CC2[C@@H]5N(C)c6ccccc64 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 F23 mock treatment 10.2984 -1.393 -0.3738 11.8559 -0.067077 -0.0159 -0.2755 -0.7365 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 F24 mock treatment 14.2365 2.545 0.6829 11.0727 -0.85026 -0.2015 0.3404 0.4781 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 G01 mock treatment 11.8317 0.1402 0.0376 11.5781 -0.3449 -0.0817 -0.0312 -0.3466 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 G02 mock treatment 10.4495 -1.242 -0.3333 12.4934 0.57042 0.1352 -0.1401 -0.3895 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 G03 compound treatment 10.3308 -1.3607 -0.3651 14.3669 2.4439 0.5791 0.1513 0.221 3079218 BSPBio_001721 COC(=O)C[C@H]1C(C)(C)[C@@H](O)C[C@@H]2O[C@@]34CC(=O)O[C@@H](c5ccoc5)[C@]4(C)CC[C@H](C3=C)[C@]12C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 G04 compound treatment 9.3648 -2.3267 -0.6243 12.2545 0.33147 0.0785 -0.3859 -0.6133 2060088 BSPBio_001722 COc1cc2ccc(=O)oc2c(OC)c1OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 G05 compound treatment 11.0532 -0.63825 -0.1713 10.311 -1.612 -0.3819 -0.3912 -0.9345 2060097 BSPBio_001723 C[C@]12CCC3C([C@H](O)CC4C(C)(C)C(=O)C=C[C@]34C)[C@]25O[C@@H]5C[C@H]1c6ccoc6 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 G06 compound treatment 13.6171 1.9256 0.5167 13.447 1.524 0.3611 0.6207 0.9846 1000946 BSPBio_001724 COc1ccc(CC2N(C)CCc3cc(OC)c(OC)cc23)cc1OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 G07 compound treatment 10.4898 -1.2017 -0.3225 11.7933 -0.12973 -0.0307 -0.2497 -0.771 1065 BSPBio_001725 CN1C(CC(O)c2ccccc2)CCCC1CC(=O)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 G08 compound treatment 11.8006 0.10908 0.0293 10.0753 -1.8477 -0.4378 -0.2889 -0.6584 1029487 BSPBio_001726 OCC(O)Cc1ccc2OCOc2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 G09 compound treatment 11.2793 -0.41219 -0.1106 9.1718 -2.7512 -0.6519 -0.5391 -0.8154 2060115 BSPBio_001727 CC(=CCOc1cc2oc(=O)ccc2cc1O)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 G10 compound treatment 11.0481 -0.6434 -0.1726 10.3557 -1.5673 -0.3713 -0.3847 -0.9393 2060292 BSPBio_001728 CC1(C)[C@H](O)C[C@H](O)[C@@]2(C)C1C[C@@H](O)[C@]3(C)C2CC[C@@]4(C)[C@@H](OC(=O)[C@H]5O[C@]543)c6ccoc6 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 G11 compound treatment 12.9494 1.258 0.3375 12.0368 0.1138 0.027 0.2577 0.7612 2060372 BSPBio_001729 COC(=O)C[C@H]1C(C)(C)C(=O)[C@@H]2CC3=C(CC[C@@]4(C)[C@@H](OC(=O)C=C34)c5ccoc5)[C@@]1(C)C2=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 G12 compound treatment 34.3006 22.609 6.0666 23.9263 12.003 2.844 6.3008 0.9404 2060092 BSPBio_001730 CC(=O)O[C@H]1CC[C@@]2(C)[C@@H](CCC3C4CC=C(C(=O)C)[C@@]4(C)C(=O)CC32)C1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 G13 compound treatment 11.6653 -0.026159 -0.007 11.3279 -0.59514 -0.141 -0.1047 -0.7414 2060371 BSPBio_001731 COC(=O)C[C@H]1C(C)(C)C2(O)OC34CC2C(=O)[C@]1(C)C4CC[C@@]5(C)[C@@H](OC(=O)C=C35)c6ccoc6 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 G14 compound treatment 13.2195 1.5281 0.41 9.2954 -2.6276 -0.6226 -0.1503 -0.2016 3557444 BSPBio_001732 C[C@@]12CCC3C(CC=C4C[C@@H](O)CC[C@]34C)C2CCC1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 G15 compound treatment 41.8959 30.204 8.1046 15.2297 3.3067 0.7835 6.2848 0.7719 2060118 BSPBio_001733 COC(=O)CC1C(C)(C)C(O)C[C@@H]2O[C@@]34CC(=O)O[C@@H](c5ccoc5)[C@]4(C)CCC(C3=C)[C@]12C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 G16 compound treatment 11.2548 -0.43672 -0.1172 9.8417 -2.0813 -0.4931 -0.4316 -0.8514 3054130 BSPBio_001734 CC(CCC=C(C)C)[C@@H]1CC[C@]2(C)C3=C(CC[C@@]12C)C4(C)CC[C@H](OC(=O)C)C(C)(C)C4CC3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 G17 compound treatment 15.403 3.7115 0.9959 15.6785 3.7555 0.8898 1.3334 0.9984 2069253 BSPBio_001735 CC(C)/C(=C/1\C2[C@@]34OC5(C)O[C@@]4([C@H](O)C(O)[C@@]2(C)[C@@H](OC1=O)c6ccoc6)[C@]7(C)[C@@H](CC(=O)O)C8(C)CC7(O5)[C@](O)(C8O)[C@H]3O)/O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 G18 compound treatment 17.4532 5.7617 1.546 17.6136 5.6906 1.3483 2.0466 0.9977 3173612 BSPBio_001736 CC(=O)OC1CC2(O)C3CCC4CC(CC[C@]4(C)C3CC[C@]2(C)C1C5=CC(=O)OC5)OC(=O)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 G19 compound treatment 12.2356 0.5441 0.146 8.7812 -3.1418 -0.7444 -0.4231 -0.5578 2060121 BSPBio_001737 COC(=O)C[C@H]1C(C)(C)C2(Cl)O[C@]34CC2C(=O)[C@]1(C)C4CC[C@@]5(C)[C@@H](OC(=O)C=C35)c6ccoc6 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 G20 compound treatment 11.3144 -0.37709 -0.1012 8.862 -3.061 -0.7253 -0.5844 -0.798 2060096 BSPBio_001738 CC(=O)O[C@@H]1CC(=O)[C@@]2(C)C(CC(=O)[C@]3(C)C2CC[C@@]4(C)[C@@H](OC(=O)C5OC543)c6ccoc6)C1(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 G21 compound treatment 11.6207 -0.070806 -0.019 11.4776 -0.4454 -0.1055 -0.0881 -0.8212 2060405 BSPBio_001739 CC1(C)[C@H](CC(=O)O)[C@@]2(C)C3CC[C@@]4(C)[C@@H](OC(=O)C=C4[C@]3(O)C[C@@H](C1=O)C2=O)c5ccoc5 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 G22 compound treatment 9.7786 -1.9129 -0.5133 9.7816 -2.1414 -0.5074 -0.7217 -1.0 2060098 BSPBio_001740 C[C@@]12CCC3C(CC[C@H]4C[C@@H](Cl)CC[C@@]43C)C2CCC1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 G23 mock treatment 10.5905 -1.101 -0.2954 12.1889 0.26586 0.063 -0.1644 -0.5441 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 G24 mock treatment 11.7493 0.057779 0.0155 13.2974 1.3743 0.3256 0.2412 0.7399 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 H01 mock treatment 11.147 -0.54448 -0.1461 13.5978 1.6748 0.3968 0.1773 0.4193 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 H02 mock treatment 10.3163 -1.3752 -0.369 13.8063 1.8832 0.4462 0.0546 0.0943 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 H03 compound treatment 10.8037 -0.88778 -0.2382 10.3077 -1.6153 -0.3827 -0.4391 -0.974 592 BSPBio_001741 Oc1ccc(cc1)c2coc3cc(O)ccc3c2=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 H04 compound treatment 20.6737 8.9822 2.4102 13.1183 1.1953 0.2832 1.9045 0.7848 922 BSPBio_001742 CCCCC(CC)CN1CN(CC(CC)CCCC)CC(C)(N)C1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 H05 compound treatment 11.2355 -0.45598 -0.1224 11.2012 -0.7218 -0.171 -0.2074 -0.9865 2060133 BSPBio_001743 COc1cc(cc(O)c1OC)c2coc3cc(O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)c(OC)c(O)c3c2=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 H06 compound treatment 11.0978 -0.59369 -0.1593 11.268 -0.65501 -0.1552 -0.2224 -0.9999 780 BSPBio_001744 CC(C)NNC(=O)c1ccncc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 H07 compound treatment 89.0992 77.408 20.7705 85.2945 73.371 17.3843 26.9795 0.9961 2060143 BSPBio_001745 COC1=CC(=O)C(=CC1=O)C(C=C)c2ccc(O)cc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 H08 compound treatment 13.0888 1.3974 0.3749 9.996 -1.927 -0.4566 -0.0577 -0.0977 736 BSPBio_001746 COC(=O)C(N)CS 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 H09 compound treatment 12.7657 1.0743 0.2883 10.0923 -1.8307 -0.4338 -0.1029 -0.1975 3054981 BSPBio_001747 COc1ccc(cc1)c2cc(=O)c3c(OC(=O)C)cc(OC(=O)C)cc3o2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 H10 compound treatment 41.7295 30.038 8.06 38.368 26.445 6.2658 10.1298 0.9922 1043 BSPBio_001748 O[Hg]c1c(O)c(Br)cc2c(c3ccccc3C(=O)O)c4cc(Br)c(=O)cc4oc12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 H11 compound treatment 11.0352 -0.65625 -0.1761 12.2962 0.37322 0.0884 -0.062 -0.3146 2060078 BSPBio_001749 COc1cc2OC[C@H]3Oc4c(CC=C(C)C)c(O)ccc4C(=O)[C@H]3c2cc1OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 H12 compound treatment 14.498 2.8066 0.7531 10.9212 -1.0018 -0.2374 0.3647 0.4618 893 BSPBio_001750 NCC(O)c1ccc(O)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 H13 compound treatment 11.1646 -0.52684 -0.1414 10.0337 -1.8893 -0.4477 -0.4165 -0.8872 2060106 BSPBio_001751 COc1cc(cc(OC)c1OC)c2coc3cc(OC)c(OC)c(OC)c3c2=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 H14 compound treatment 13.0949 1.4034 0.3766 10.2303 -1.6927 -0.4011 -0.0173 -0.0315 1020 BSPBio_001752 NC(=N)c1ccc(OCCCCCOc2ccc(cc2)C(=N)N)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 H15 compound treatment 11.3689 -0.3226 -0.0866 12.6032 0.68018 0.1612 0.0527 0.2883 3054030 BSPBio_001753 Oc1cc(O)cc(/C=C/c2ccccc2)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 H16 compound treatment 12.9379 1.2464 0.3345 9.702 -2.221 -0.5262 -0.1356 -0.2175 1052 BSPBio_001754 CC[C@H]1CN2CCC1C[C@@H]2[C@@H](O)c3ccnc4ccc(OC)cc34 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 H17 compound treatment 12.989 1.2975 0.3482 8.7723 -3.1507 -0.7465 -0.2817 -0.342 3055207 BSPBio_001755 COc1cc(O)cc(/C=C/c2ccccc2)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 H18 compound treatment 15.0398 3.3484 0.8985 11.4291 -0.49394 -0.117 0.5526 0.6098 1150 BSPBio_001756 OC(=O)CCCCCCCC(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 H19 compound treatment 12.4206 0.7291 0.1956 9.9152 -2.0078 -0.4757 -0.198 -0.385 3054032 BSPBio_001757 COc1cc(C/C=C/c2ccccc2)c(OC)cc1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 H20 compound treatment 10.5108 -1.1806 -0.3168 11.181 -0.742 -0.1758 -0.3483 -0.9614 1222 BSPBio_001758 Cn1cnc2n(C)c(=O)[nH]c(=O)c12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 H21 compound treatment 12.9797 1.2882 0.3457 11.8024 -0.1206 -0.0286 0.2242 0.6464 1059133 BSPBio_001759 COc1ccc(C(=O)c2ccccc2)c(O)c1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 H22 compound treatment 11.3777 -0.3138 -0.0842 9.8758 -2.0473 -0.4851 -0.4025 -0.8176 1154 BSPBio_001760 O=C1CC2OCC=C3CN4CC[C@]56C4C[C@@H]3[C@@H]2C6N1c7ccccc75 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 H23 mock treatment 12.5666 0.87512 0.2348 9.8069 -2.1162 -0.5014 -0.1885 -0.3405 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 H24 mock treatment 12.3992 0.7077 0.1899 10.6673 -1.2557 -0.2975 -0.0761 -0.2156 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 I01 mock treatment 11.7187 0.027254 0.0073 12.7125 0.78952 0.1871 0.1374 0.7342 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 I02 mock treatment 10.773 -0.91846 -0.2464 10.1966 -1.7264 -0.409 -0.4635 -0.9706 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 I03 compound treatment 12.1835 0.49198 0.132 157.793 145.87 34.5618 24.5322 0.7098 2060364 BSPBio_001761 CC(=O)O[C@@H]1C[C@H](OC(=O)C)[C@@]2(C)C(C[C@@H](OC(=O)C)[C@]3(C)C2CC[C@@]4(C)[C@@H](OC(=O)C=C43)c5ccoc5)C1(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 I04 compound treatment 10.9633 -0.72821 -0.1954 12.8867 0.96368 0.2283 0.0233 0.0775 1384788 BSPBio_001762 COc1c2OCOc2cc3CC[N+](=Cc13)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 I05 compound treatment 10.459 -1.2325 -0.3307 9.6628 -2.2602 -0.5355 -0.6125 -0.9732 2060145 BSPBio_001763 CC1(C)C2CC(=O)[C@]3(C)C(CC[C@@]4(C)[C@@H](OC(=O)C=C43)c5ccoc5)[C@@]2(C)C=CC1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 I06 compound treatment 11.4027 -0.2888 -0.0775 10.76 -1.163 -0.2755 -0.2496 -0.8721 1019607 BSPBio_001764 CN(C)Cc1c(C)[nH]c2ccccc12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 I07 compound treatment 150.7753 139.08 37.3198 190.8053 178.88 42.3835 56.3587 0.998 2060215 BSPBio_001765 CC1(C)C2C=C[C@]3(C)C(CC[C@@]4(C)[C@@H](OC(=O)C5OC543)c6ccoc6)[C@@]2(C)C=CC1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 I08 compound treatment 13.5646 1.8731 0.5026 9.9597 -1.9633 -0.4652 0.0265 0.0386 2060117 BSPBio_001766 Cc1ccc2c(CC[C@H]3CC(=O)CC[C@@]32C)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 I09 compound treatment 12.0588 0.36735 0.0986 10.7132 -1.2098 -0.2866 -0.133 -0.4387 2060127 BSPBio_001767 COC1CC2=C3C[C@H]4C(=O)C(C)(C)[C@H](CC(=O)OC)[C@@](C)(C3CC[C@@]2(C)[C@@H](O1)c5ccoc5)C4=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 I10 compound treatment 14.0022 2.3108 0.62 9.4996 -2.4234 -0.5742 0.0324 0.0384 2060122 BSPBio_001768 CC1(C)Oc2cc3oc(=O)ccc3cc2C=C1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 I11 compound treatment 10.7836 -0.90787 -0.2436 14.0841 2.1611 0.5121 0.1898 0.3348 2060125 BSPBio_001769 COC(=O)C[C@H]1C(C)(C)C(=O)[C@@H]2C[C@]3(O)C(CC[C@@]4(C)[C@@H](OC(=O)C=C43)c5ccoc5)[C@@]1(C)C2=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 I12 compound treatment 18.3346 6.6431 1.7825 26.3316 14.409 3.4139 3.6744 0.9541 2060124 BSPBio_001770 COC(=O)[C@@]1(C)CCC[C@@]2(C)C1CCc3c(C(C)C)c(O)ccc32 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 I13 compound treatment 11.5056 -0.18582 -0.0499 10.9532 -0.96982 -0.2298 -0.1977 -0.841 2060129 BSPBio_001771 CC(=O)O[C@@H]1C[C@H](OC(=O)C)[C@@]2(C)C(C[C@@H](OC(=O)C)[C@]3(C)C2CC[C@@]4(C)[C@@H](OC(=O)[C@H]5O[C@]543)c6ccoc6)C1(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 I14 compound treatment 12.3171 0.62563 0.1679 12.535 0.61195 0.145 0.2212 0.9973 2060128 BSPBio_001772 CO[C@@H]1C(OC(=O)C(C)C)[C@@]2(C)[C@@H](OC(=O)/C(=C(\OC)/C(C)C)/C2[C@@]34OC5(C)O[C@]14[C@]6(C)[C@@H](CC(=O)OC)C7(C)CC6(O5)[C@](OC)(C7OC(=O)C)[C@H]3OC)c8ccoc8 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 I15 compound treatment 11.7047 0.013231 0.0036 11.1568 -0.76625 -0.1816 -0.1259 -0.6931 2060365 BSPBio_001773 CC(=O)O[C@@H]1CC2C(C)(C)C(=O)C3OC3[C@]2(C)C4CC[C@@]5(C)[C@@H](OC(=O)C6OC65[C@]14C)c7ccoc7 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 I16 compound treatment 11.3329 -0.35855 -0.0962 10.1157 -1.8073 -0.4282 -0.3708 -0.8449 2060424 BSPBio_001774 C[C@@]12CC[C@@H](O)C[C@H]2CCc3ccccc31 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 I17 compound treatment 12.937 1.2456 0.3342 10.4744 -1.4486 -0.3432 -0.0064 -0.0133 2060350 BSPBio_001775 CC(=O)O[C@@H]1CC2C(C)(C)[C@H](O)C=C[C@]2(C)C3CC[C@@]4(C)[C@@H](OC(=O)C=C4[C@]13C)c5ccoc5 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 I18 compound treatment 12.1376 0.44615 0.1197 11.2694 -0.65364 -0.1549 -0.0249 -0.127 2060146 BSPBio_001776 C[C@@]12CCC(=O)C=C2CCc3ccc(O)cc31 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 I19 compound treatment 10.2854 -1.4061 -0.3773 11.8094 -0.11356 -0.0269 -0.2858 -0.7556 2060150 BSPBio_001777 CC1(C)[C@H](O)C=C[C@]2(C)C3CC[C@@]4(C)[C@@H](OC(=O)C=C4[C@]3(C)OC(=O)CC12)c5ccoc5 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 I20 compound treatment 11.4773 -0.21416 -0.0575 11.4823 -0.44072 -0.1044 -0.1145 -0.9604 2060410 BSPBio_001778 CC1(C)[C@H](O)CC(=O)[C@@]2(C)C1C[C@@H](O)[C@]3(C)C2CC[C@@]4(C)[C@@H](OC(=O)C5OC543)c6ccoc6 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 I21 compound treatment 14.7701 3.0786 0.8261 16.5233 4.6002 1.09 1.3548 0.9906 2060158 BSPBio_001779 CC(=O)O[C@@H]1CC2C(C)(C)[C@H](OC(=O)C)C=C[C@]2(C)C3CC[C@@]4(C)[C@@H](OC(=O)C=C4[C@]13C)c5ccoc5 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 I22 compound treatment 9.674 -2.0175 -0.5413 10.8682 -1.0548 -0.2499 -0.5595 -0.9384 2060151 BSPBio_001780 COC(=O)[C@@H]1OC(=O)C2OC23[C@@]1(C)CCC4[C@@]5(C)[C@H](C[C@@H](OC(=O)C)C(C)(C)C5C[C@H](O)[C@]43C)OC(=O)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 I23 mock treatment 11.2797 -0.41179 -0.1105 11.9441 0.021045 0.005 -0.0746 -0.6745 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 I24 mock treatment 10.7869 -0.90456 -0.2427 12.1526 0.22955 0.0544 -0.1332 -0.5354 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 J01 mock treatment 10.4682 -1.2233 -0.3282 12.3823 0.45934 0.1088 -0.1551 -0.4486 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 J02 mock treatment 12.7666 1.0751 0.2885 10.4498 -1.4732 -0.3491 -0.0428 -0.0946 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 J03 compound treatment 48.2244 36.533 9.8027 40.1193 28.196 6.6807 11.6556 0.9825 1092958 BSPBio_001781 COC1=CC(=O)C(=CC1=O)C(C=C)c2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 J04 compound treatment 12.3029 0.61144 0.1641 11.7744 -0.14861 -0.0352 0.0911 0.543 883 BSPBio_001782 CC(Oc1ccccc1)C(=O)N[C@H]2[C@H]3SC(C)(C)[C@@H](N3C2=O)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 J05 compound treatment 10.6757 -1.0157 -0.2725 12.3266 0.40361 0.0956 -0.1251 -0.4331 2060102 BSPBio_001783 COc1ccc2C(=O)c3cc(OC)c(OC)cc3CC(=O)COc2c1OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 J06 compound treatment 12.0814 0.38993 0.1046 12.4183 0.49526 0.1173 0.157 0.9984 811 BSPBio_001784 CC(=O)[C@H]1CCC2C3CC=C4C[C@@H](O)CC[C@]4(C)C3CC[C@]12C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 J07 compound treatment 26.7647 15.073 4.0445 29.0524 17.129 4.0586 5.7297 1.0 2060397 BSPBio_001785 COc1ccc2C(=O)/C(=C/c3ccc(OC)c(O)c3)/COc2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 J08 compound treatment 12.2734 0.58193 0.1561 14.5474 2.6244 0.6218 0.5501 0.858 1267 BSPBio_001786 CC(=O)Nc1ccc(O)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 J09 compound treatment 12.1059 0.4144 0.1112 11.8565 -0.06654 -0.0158 0.0675 0.6008 2069309 BSPBio_001787 COc1cc2OC[C@H]3Oc4c5CCC(C)(C)Oc5ccc4C(=O)[C@H]3c2cc1OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 J10 compound treatment 11.3155 -0.37597 -0.1009 10.7255 -1.1975 -0.2837 -0.272 -0.9031 692 BSPBio_001788 CC(=O)Nc1nnc(s1)S(=O)(=O)N 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 J11 compound treatment 12.7863 1.0949 0.2938 10.9437 -0.97929 -0.232 0.0437 0.1166 3198310 BSPBio_001789 COc1ccc([C@H]2COc3c(OC)c(O)ccc3C2)c(OC)c1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 J12 compound treatment 10.5393 -1.1522 -0.3092 13.428 1.505 0.3566 0.0335 0.0711 1414 BSPBio_001790 CC(=O)NO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 J13 compound treatment 11.8838 0.1923 0.0516 10.9891 -0.93394 -0.2213 -0.12 -0.5281 2069276 BSPBio_001791 COc1cc(cc(OCc2ccccc2)c1OC)c3coc4cc(OCc5ccccc5)c(OC)c(O)c4c3=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 J14 compound treatment 11.8602 0.16877 0.0453 12.2419 0.31887 0.0756 0.0854 0.97 1293 BSPBio_001792 CC(=O)OCC[N+](C)(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 J15 compound treatment 14.2385 2.547 0.6834 14.5264 2.6034 0.6168 0.9194 0.9987 2069255 BSPBio_001793 Oc1cc(cc(O)c1O)c2coc3cc(O)c(O)c(O)c3c2=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 J16 compound treatment 11.3658 -0.32569 -0.0874 10.9768 -0.9462 -0.2242 -0.2203 -0.9156 1001897 BSPBio_001794 CC(=O)N[C@@H](CS)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 J17 compound treatment 12.0258 0.33434 0.0897 10.6424 -1.2806 -0.3034 -0.1511 -0.4776 2060249 BSPBio_001795 COc1ccc(cc1)c2coc3c(OC)c(O)ccc3c2=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 J18 compound treatment 11.1384 -0.55307 -0.1484 10.8089 -1.1141 -0.264 -0.2916 -0.9629 418 BSPBio_001796 Nc1ncnc2n(cnc12)[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 J19 compound treatment 12.2482 0.55672 0.1494 13.0736 1.1506 0.2726 0.2984 0.9599 1050602 BSPBio_001797 COc1ccc(CC(=O)c2ccc(O)cc2O)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 J20 compound treatment 10.1792 -1.5122 -0.4058 10.4994 -1.4236 -0.3373 -0.5254 -0.9958 1292 BSPBio_001798 O=c1[nH]cnc2[nH]ncc12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 J21 compound treatment 68.7884 57.097 15.3206 60.5945 48.671 11.532 18.9876 0.9902 3055248 BSPBio_001799 C=CC(C1=CC(=O)C=CC1=O)c2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 J22 compound treatment 12.1365 0.445 0.1194 10.3467 -1.5763 -0.3735 -0.1797 -0.4582 3256 BSPBio_001800 CCN(CCCc1ccccc1)CCCc2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 J23 mock treatment 12.5631 0.87158 0.2339 10.8076 -1.1154 -0.2643 -0.0215 -0.0609 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 J24 mock treatment 12.3316 0.64011 0.1718 12.027 0.10402 0.0246 0.1389 0.8004 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 K01 mock treatment 14.305 2.6135 0.7013 12.6994 0.77642 0.184 0.626 0.8634 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 K02 mock treatment 12.5098 0.81833 0.2196 11.6407 -0.28233 -0.0669 0.108 0.4704 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 K03 compound treatment 13.9888 2.2973 0.6164 9.2453 -2.6777 -0.6344 -0.0127 -0.0144 2060154 BSPBio_001801 CC(=O)O[C@H]1CC[C@@]2(C)C(C[C@@H](OC(=O)C)[C@]3(C)C2CC[C@@]4(C)[C@@H](OC(=O)C=C43)c5ccoc5)C1(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 K04 compound treatment 9.577 -2.1145 -0.5674 12.15 0.227 0.0538 -0.3632 -0.6372 2060402 BSPBio_001802 COc1ccc2CC[C@H]3CC(=O)CC[C@]3(C)c2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 K05 compound treatment 11.138 -0.55345 -0.1485 12.4578 0.53477 0.1267 -0.0154 -0.079 2060037 BSPBio_001803 CC(=O)O[C@@H]1CC[C@@]2(C)C(C[C@@H](OC(=O)C)[C@]3(C)C2CC[C@@]4(C)[C@@H](OC(=O)C=C43)c5ccoc5)C1(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 K06 compound treatment 13.7634 2.0719 0.556 11.1681 -0.75494 -0.1789 0.2666 0.4566 2060153 BSPBio_001804 COc1cccc2c1CCC3=CC(=O)CC[C@@]32C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 K07 compound treatment 10.7078 -0.98366 -0.2639 11.9076 -0.015417 -0.0037 -0.1892 -0.7168 2060160 BSPBio_001805 CC(=O)O[C@@H]1CC2C(C)(C)CCC[C@]2(C)C3CC[C@@]4(C)[C@@H](OC(=O)C=C4[C@]13C)c5ccoc5 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 K08 compound treatment 10.8857 -0.80575 -0.2162 11.3736 -0.54938 -0.1302 -0.2449 -0.9705 2060408 BSPBio_001806 COC(=O)C[C@H]1C(C)(C)[C@H](C[C@@H]2O[C@@]34CC(=O)O[C@@H](c5ccoc5)[C@]4(C)CCC(C3=C)[C@]12C)OC(=O)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 K09 compound treatment 11.1685 -0.52299 -0.1403 10.9181 -1.0049 -0.2381 -0.2676 -0.9682 2060162 BSPBio_001807 COC(=O)C[C@H]1C(C)(C)[C@@H](O)[C@@H]2CC3=C4C=C(OC)O[C@@H](c5ccoc5)[C@]4(C)CCC3[C@@]1(C)C2=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 K10 compound treatment 10.7023 -0.98917 -0.2654 9.0035 -2.9195 -0.6917 -0.6768 -0.9135 2060157 BSPBio_001808 CC(=O)C1CCC2C3CCC4C[C@H](O)CCC4(C)C3C[C@H](O)C12C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 K11 compound treatment 11.3038 -0.38772 -0.104 11.095 -0.82798 -0.1962 -0.2123 -0.956 2060177 BSPBio_001809 CC1(C)C2C[C@@H](O)[C@]3(C)C(CC[C@@]4(C)[C@@H](OC(=O)C5OC543)c6ccoc6)[C@@]2(C)[C@H]7O[C@H]7C1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 K12 compound treatment 11.4431 -0.24836 -0.0666 12.6854 0.76245 0.1807 0.0806 0.4187 2060159 BSPBio_001810 COC(=O)[C@@H]1OC(=O)C2OC23[C@@]1(C)CCC4[C@@]5(C)CCC(=O)C(C)(C)C5C[C@@H](OC(=O)C)[C@]43C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 K13 compound treatment 11.0641 -0.62735 -0.1683 10.4239 -1.4991 -0.3552 -0.3702 -0.9418 2060179 BSPBio_001811 COc1cccc2c1CCC3CC(=O)CC[C@@]32C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 K14 compound treatment 11.657 -0.034486 -0.0093 16.588 4.665 1.1053 0.775 0.7012 3078271 BSPBio_001812 COC(=O)C[C@H]1C(C)(C)[C@H](O)C[C@@H]2O[C@@]34CC(=O)O[C@@H](c5ccoc5)[C@]4(C)CC[C@H](C3=C)[C@]12C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 K15 compound treatment 13.2779 1.5864 0.4257 12.0533 0.13027 0.0309 0.3228 0.7564 2060320 BSPBio_001813 COc1ccc2CC[C@@H]3CC(=O)CC[C@]3(C)c2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 K16 compound treatment 17.5565 5.865 1.5737 24.0382 12.115 2.8705 3.1426 0.96 2060429 BSPBio_001814 COC1CC(O[C@H]2CC[C@]3(C=O)C4CC[C@]5(C)C(CC[C@]5(O)C4CC[C@]3(O)C2)C6=CC(=O)OC6)OC(C)C1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 K17 compound treatment 28.6123 16.921 4.5403 10.9068 -1.0162 -0.2408 3.0402 0.6687 3173369 BSPBio_001815 CC(C)c1c(OC(=O)C)ccc2c1CCC3C(C)(C)CCC[C@@]32C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 K18 compound treatment 11.7598 0.068296 0.0183 10.1438 -1.7792 -0.4216 -0.2851 -0.6757 2060184 BSPBio_001816 CC1CCc2c(O)c3c(=O)cc(C)oc3cc2OC1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 K19 compound treatment 17.4692 5.7777 1.5503 17.3176 5.3946 1.2782 2.0 0.9954 3172856 BSPBio_001817 O[C@H]1C=C2CCN3Cc4cc5OCOc5cc4C(C32)[C@@H]1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 K20 compound treatment 9.6955 -1.996 -0.5356 9.6745 -2.2485 -0.5328 -0.7554 -1.0 2060185 BSPBio_001818 COc1ccc2[C@@H]3COc4cc(OC)ccc4[C@@H]3Oc2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 K21 compound treatment 15.0629 3.3714 0.9046 12.9886 1.0656 0.2525 0.8182 0.8712 2060034 BSPBio_001819 CC(C)c1c(O)ccc2c1CCC3[C@](C)(CCC[C@@]32C)C=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 K22 compound treatment 18.8827 7.1912 1.9296 17.5738 5.6508 1.3389 2.3111 0.9841 2060186 BSPBio_001820 CC(=O)OC1CCC2(C3CCC4(C)C(CCC54OC2=O)C6=CC(=O)OC6)C(O)(CCC35)C1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 K23 mock treatment 8.9083 -2.7832 -0.7468 11.4886 -0.43439 -0.1029 -0.6008 -0.797 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 K24 mock treatment 10.4465 -1.2449 -0.3341 13.6832 1.7602 0.4171 0.0587 0.1098 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 L01 mock treatment 10.1225 -1.5689 -0.421 11.1191 -0.80394 -0.1905 -0.4324 -0.9357 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 L02 mock treatment 11.8347 0.14318 0.0384 13.5287 1.6057 0.3805 0.2962 0.7746 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 L03 compound treatment 11.0323 -0.65913 -0.1769 9.3974 -2.5256 -0.5984 -0.5482 -0.8785 2060494 BSPBio_001821 COc1ccc2C(=O)C(Cc3ccc(OC)c(OC)c3)COc2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 L04 compound treatment 12.8249 1.1334 0.3041 11.1739 -0.74915 -0.1775 0.0895 0.2543 1408 BSPBio_001822 NC1(CC2CC3CC(C2)C1)C3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 L05 compound treatment 12.8025 1.1111 0.2981 9.956 -1.967 -0.4661 -0.1188 -0.2146 2060110 BSPBio_001823 COc1ccc(c(OC)c1)c2coc3cc(O)ccc3c2=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 L06 compound treatment 11.607 -0.084496 -0.0227 8.8114 -3.1116 -0.7372 -0.5373 -0.7285 3173722 BSPBio_001824 NCC[C@@H](O)C(=O)N[C@@H]1C[C@H](N)[C@@H](O[C@H]2O[C@H](CN)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)C3O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 L07 compound treatment 11.4087 -0.28273 -0.0759 9.7604 -2.1626 -0.5124 -0.416 -0.803 1004 BSPBio_001825 Oc1ccc2c(=O)cc(oc2c1O)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 L08 compound treatment 11.3257 -0.36581 -0.0982 11.8634 -0.059565 -0.0141 -0.0794 -0.8005 1000042 BSPBio_001826 NC(=N)NC(=O)c1nc(Cl)c(N)nc1N 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 L09 compound treatment 54.2801 42.589 11.4276 52.8852 40.962 9.7054 14.9433 0.9967 3054809 BSPBio_001827 COc1ccc2C(=O)C(Cc3ccc(OC)c(OC(=O)C)c3)COc2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 L10 compound treatment 11.0563 -0.63515 -0.1704 12.1981 0.27507 0.0652 -0.0744 -0.4079 1381 BSPBio_001828 Nc1ccc(cc1)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 L11 compound treatment 14.5697 2.8783 0.7723 12.3058 0.38282 0.0907 0.6102 0.7848 2060139 BSPBio_001829 COc1ccc([C@@H]2COc3c(OC)c(OC)ccc3C2)c(OC)c1OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 L12 compound treatment 10.6829 -1.0086 -0.2706 12.3668 0.44376 0.1051 -0.117 -0.403 1503 BSPBio_001830 Cc1c(CS(=O)c2nc3ccccc3[nH]2)nccc1OCC(F)(F)F 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 L13 compound treatment 35.7631 24.072 6.459 37.8288 25.906 6.138 8.9074 0.9997 3173749 BSPBio_001831 COc1cc2OC[C@H]3Oc4c5CC(Oc5ccc4C(=O)[C@H]3c2cc1OC)C(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 L14 compound treatment 11.7452 0.053766 0.0144 14.04 2.117 0.5016 0.3649 0.7271 1469 BSPBio_001832 CCC1(CCC(=O)NC1=O)c2ccc(N)cc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 L15 compound treatment 10.6053 -1.0862 -0.2915 11.6014 -0.32164 -0.0762 -0.26 -0.863 1008719 BSPBio_001833 COC(=O)C(O)c1ccccc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 L16 compound treatment 10.7188 -0.97266 -0.261 10.0502 -1.8728 -0.4437 -0.4983 -0.968 985 BSPBio_001834 Nc1ccc(C(=O)O)c(O)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 L17 compound treatment 14.0561 2.3646 0.6345 15.2975 3.3745 0.7995 1.014 0.9934 2060163 BSPBio_001835 COc1ccc2C(=O)[C@@H]3[C@@H](COc4cc(OC)c(OC)cc34)Oc2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 L18 compound treatment 11.2605 -0.43096 -0.1156 10.598 -1.325 -0.3139 -0.3038 -0.9079 1365 BSPBio_001836 CN(C)CCC=C1c2ccccc2CCc3ccccc13 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 L19 compound treatment 13.4933 1.8018 0.4835 12.699 0.77602 0.1839 0.4719 0.9123 2060165 BSPBio_001837 COc1cc2OCc3oc4c5CC(Oc5ccc4c(=O)c3-c2cc1OC)C(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 L20 compound treatment 8.6983 -2.9932 -0.8032 11.5188 -0.4042 -0.0958 -0.6356 -0.7859 1294 BSPBio_001838 CCN(CC)Cc1ccc(Nc2ccnc3cc(Cl)ccc23)cc1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 L21 compound treatment 9.7339 -1.9576 -0.5253 11.1804 -0.74259 -0.1759 -0.4958 -0.8951 2069225 BSPBio_001839 Oc1cc(O)c2C[C@@H](OC(=O)c3cc(O)c(O)c(O)c3)[C@H](Oc2c1)c4cc(O)c(O)c5c(=O)c(O)cc(cc45)[C@H]6Oc7cc(O)cc(O)c7C[C@H]6OC(=O)c8cc(O)c(O)c(O)c8 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 L22 compound treatment 9.1037 -2.5878 -0.6944 9.5741 -2.3489 -0.5565 -0.8845 -0.994 3045196 BSPBio_001840 CC1(C)S[C@@H]2[C@H](NC(=O)[C@@H](N)c3ccc(O)cc3)C(=O)N2[C@H]1C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 L23 mock treatment 12.4228 0.73137 0.1962 10.9171 -1.0059 -0.2383 -0.0298 -0.0964 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 L24 mock treatment 10.125 -1.5665 -0.4203 9.8798 -2.0432 -0.4841 -0.6395 -0.9975 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 M01 mock treatment 9.3132 -2.3783 -0.6382 12.3401 0.41714 0.0988 -0.3814 -0.5906 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 M02 mock treatment 24.1101 12.419 3.3322 16.1668 4.2437 1.0055 3.0672 0.8812 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 M03 compound treatment 28.9709 17.279 4.6365 32.4076 20.485 4.8535 6.7105 0.9997 2060126 BSPBio_001841 CC(C)c1c(O)ccc2c1CCC3[C@@](C)(CO)CCC[C@@]32C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 M04 compound treatment 12.2765 0.58499 0.157 10.0503 -1.8727 -0.4437 -0.2028 -0.4308 2060446 BSPBio_001842 CC1(C)[C@@H](O)C=C[C@@]2(C)C1CC(=O)[C@]3(C)C2CC[C@@]4(C)[C@@H](OC(=O)[C@H]5O[C@]543)c6ccoc6 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 M05 compound treatment 11.9564 0.26497 0.0711 11.5755 -0.34749 -0.0823 -0.0079 -0.073 3053987 BSPBio_001843 CC(=O)C1CC[C@H]2C3CC[C@H]4C[C@H](O)CC[C@]4(C)C3CC[C@]12C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 M06 compound treatment 11.2184 -0.47306 -0.1269 12.1805 0.25745 0.061 -0.0466 -0.3311 2060370 BSPBio_001844 COc1cc2OCOc2cc1c3coc4c5C=CC(C)(C)Oc5c(OC)cc4c3=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 M07 compound treatment 30.0192 18.328 4.9178 21.8039 9.8809 2.3411 5.1328 0.9424 3173992 BSPBio_001845 CC(C)c1c(O)ccc2c1CCC3C(C)(C)CCC[C@@]32C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 M08 compound treatment 11.7007 0.0092539 0.0025 9.9995 -1.9235 -0.4557 -0.3205 -0.7032 907 BSPBio_001846 OC(=O)c1cc(O)c2cccc(O)c2n1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 M09 compound treatment 10.1165 -1.575 -0.4226 10.9592 -0.96385 -0.2284 -0.4603 -0.9583 2060357 BSPBio_001847 CC(=O)O[C@@H]1CC2C(C)(C)CCC(=O)[C@]2(C)C3CC[C@@]4(C)[C@@H](OC(=O)C5OC54[C@]13C)c6ccoc6 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 M10 compound treatment 12.9611 1.2696 0.3407 10.4292 -1.4938 -0.3539 -0.0094 -0.0191 2060420 BSPBio_001848 CC(=O)O[C@@H]1CC2C(C)(C)[C@@H](O)CCC2(C)C3CC[C@@]4(C)[C@@H](OC(=O)C=C4C13C)c5ccoc5 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 M11 compound treatment 10.6106 -1.0809 -0.29 9.3855 -2.5375 -0.6012 -0.6302 -0.9441 2060280 BSPBio_001849 C[C@H]1C2C(CC3C4CC[C@H]5C[C@H](CC[C@]5(C)C4CC[C@]23C)OC(=O)C)O[C@]61CCC(C)CO6 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 M12 compound treatment 13.9422 2.2507 0.6039 9.3364 -2.5866 -0.6128 -0.0063 -0.0073 1111461 BSPBio_001850 CC(=CCOc1c2occc2cc3ccc(=O)oc13)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 M13 compound treatment 11.0649 -0.62657 -0.1681 12.0417 0.1187 0.0281 -0.099 -0.5808 3174366 BSPBio_001851 C[C@H]1C2C(CC3C4CC[C@@H]5C[C@H](CC[C@]5(C)C4CC[C@]23C)OC(=O)C)O[C@]61CCC(C)CO6 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 M14 compound treatment 13.2431 1.5517 0.4163 10.2658 -1.6572 -0.3927 0.0168 0.0293 3174000 BSPBio_001852 C[C@H]1[C@H]2[C@H](CC3C4CC[C@@H]5C[C@@H](O)CC[C@]5(C)C4CC[C@]23C)O[C@@]61CCC(C)CO6 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 M15 compound treatment 12.0352 0.34373 0.0922 12.7721 0.84905 0.2012 0.2075 0.9375 3173115 BSPBio_001853 C[C@H]1[C@H]2[C@H](CC3C4CC[C@H]5C[C@@H](O)CC[C@]5(C)C4CC[C@]23C)O[C@]61CCC(C)CN6 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 M16 compound treatment 9.5254 -2.1661 -0.5812 9.5341 -2.3889 -0.566 -0.8112 -0.9999 3173615 BSPBio_001854 CCC(CCC(C)[C@H]1CCC2C3CC=C4C[C@@H](O)CC[C@]4(C)C3CC[C@]12C)C(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 M17 compound treatment 10.5218 -1.1697 -0.3139 13.76 1.837 0.4352 0.0858 0.16 2060351 BSPBio_001855 C[C@H]1[C@H]2[C@H](CC3C4CC[C@H]5C[C@H](CC[C@]5(C)C4=CC(=O)[C@]23C)OC(=O)C)OC61OCC(C)CC6Br 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 M18 compound treatment 13.0603 1.3689 0.3673 11.1132 -0.80983 -0.1919 0.124 0.2993 2060206 BSPBio_001856 CCC(CCC(C)C1CCC2C3CC=C4C[C@H](CC[C@]4(C)C3CC[C@]12C)OC(=O)C)C(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 M19 compound treatment 13.6952 2.0037 0.5377 10.198 -1.725 -0.4087 0.0912 0.135 2060188 BSPBio_001857 C[C@H]1C2C(CC3C4CCC5C[C@@H](O)CCC5(C)C4=CCC23C)OC61CCC(C)CO6 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 M20 compound treatment 10.2103 -1.4812 -0.3974 11.9497 0.026673 0.0063 -0.2766 -0.6958 2069259 BSPBio_001858 C[C@@]12CCC3C(CC[C@H]4C[C@H](O)CC[C@@]43C)C2CC[C@@H]1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 M21 compound treatment 12.239 0.54751 0.1469 11.6217 -0.30135 -0.0714 0.0534 0.3269 3173999 BSPBio_001859 C[C@H]1C2C(CC3C4CC[C@H]5CC(CCC5(C)C4CC(=O)C23C)OC(=O)C)OC61CCC(C)CO6 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 M22 compound treatment 8.5061 -3.1854 -0.8547 10.7242 -1.1988 -0.284 -0.8052 -0.894 2069264 BSPBio_001860 C[C@@]12CCC3C(CC[C@H]4C[C@@H](O)CC[C@@]43C)C2CC[C@@H]1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 M23 mock treatment 11.4253 -0.26622 -0.0714 10.7634 -1.1596 -0.2747 -0.2448 -0.8623 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 M24 mock treatment 11.7703 0.078871 0.0212 11.0033 -0.91971 -0.2179 -0.1391 -0.6354 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 N01 mock treatment 12.1968 0.50537 0.1356 11.1508 -0.77222 -0.183 -0.0335 -0.1471 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 N02 mock treatment 9.1806 -2.5108 -0.6737 8.8415 -3.0815 -0.7301 -0.9927 -0.9992 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 N03 compound treatment 12.341 0.64953 0.1743 10.6232 -1.2998 -0.308 -0.0945 -0.2671 3173879 BSPBio_001861 CC(=CCc1c2OC(C)(C)C=Cc2c(OC(=O)C)c3c(=O)c(OC(=O)C)c(oc13)c4ccccc4)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 N04 compound treatment 11.1565 -0.53497 -0.1435 12.3587 0.43573 0.1032 -0.0285 -0.1612 1092 BSPBio_001862 CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccccc3)C(=O)N2[C@H]1C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 N05 compound treatment 11.4561 -0.23539 -0.0632 8.9982 -2.9248 -0.693 -0.5347 -0.7684 2060495 BSPBio_001863 O[C@@H]1Cc2c(O)cc(O)cc2O[C@@H]1c3cc(O)c(O)c(O)c3c4c(O)c(O)c(O)cc4[C@H]5Oc6cc(O)cc(O)c6C[C@H]5OC(=O)c7cc(O)c(O)c(O)c7 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 N06 compound treatment 11.8393 0.14779 0.0397 10.43 -1.493 -0.3537 -0.2221 -0.6239 807 BSPBio_001864 CCCc1ncc(C[n+]2ccccc2C)c(N)n1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 N07 compound treatment 11.9973 0.30585 0.0821 11.7099 -0.21313 -0.0505 0.0223 0.2317 2060167 BSPBio_001865 COC(=O)c1cc(O)c(=O)c2c(O)c(O)ccc2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 N08 compound treatment 10.5223 -1.1692 -0.3137 12.0374 0.11439 0.0271 -0.2027 -0.6436 746 BSPBio_001866 C(N(Cc1ccccc1)c2ccccc2)C3=NCCN3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 N09 compound treatment 10.9301 -0.76136 -0.2043 13.6277 1.7047 0.4039 0.1411 0.3118 3173852 BSPBio_001867 COc1ccc(CCC(=O)c2c(O)cc(O[C@@H]3O[C@H](CO)C(O)[C@H](O)C3O[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)cc2O)cc1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 N10 compound treatment 11.2336 -0.45785 -0.1229 10.8606 -1.0624 -0.2517 -0.2649 -0.9456 696 BSPBio_001868 Oc1cccc2Cc3cccc(O)c3C(=O)c12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 N11 compound treatment 25.4941 13.803 3.7036 18.8229 6.8999 1.6348 3.7748 0.9324 1017609 BSPBio_001869 CC(=CCc1c(O)c2c(=O)c(coc2c3C=CC(C)(C)Oc13)c4ccc(O)cc4)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 N12 compound treatment 10.2103 -1.4812 -0.3974 11.2076 -0.71539 -0.1695 -0.4009 -0.9278 1108 BSPBio_001870 Cc1cc(=O)n(c2ccccc2)n1C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 N13 compound treatment 13.3263 1.6349 0.4387 11.988 0.065045 0.0154 0.3211 0.7315 2069293 BSPBio_001871 CCc1ccc2c(O)c3C(=O)c4c(O)ccc(O)c4C(=O)c3cc2c1C(=O)OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 N14 compound treatment 9.9477 -1.7437 -0.4679 12.3599 0.43686 0.1035 -0.2577 -0.5377 1011303 BSPBio_001872 CN1CCc2cccc-3c2C1Cc4ccc(O)c(O)c43 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 N15 compound treatment 15.767 4.0755 1.0936 14.1616 2.2386 0.5304 1.1483 0.9448 2069330 BSPBio_001873 COc1cc(O)c(C(=O)/C=C/c2ccccc2)c(OC)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 N16 compound treatment 15.2941 3.6026 0.9667 11.5146 -0.40844 -0.0968 0.6151 0.6332 1000124 BSPBio_001874 CN1C2CCC1CC(C2)OC(=O)C(CO)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 N17 compound treatment 11.128 -0.56347 -0.1512 11.1754 -0.74765 -0.1771 -0.2322 -0.9969 3055218 BSPBio_001875 OCC(O)[C@H]1OC(=O)C(=C1O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 N18 compound treatment 11.3659 -0.32558 -0.0874 11.1105 -0.81252 -0.1925 -0.1979 -0.9361 1198 BSPBio_001876 Cn1cnc([N+](=O)[O-])c1Sc2[nH]cnc3ncnc23 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 N19 compound treatment 77.0694 65.378 17.5426 76.9504 65.027 15.4073 23.2991 0.9979 3177523 BSPBio_001877 CC[C@@]1(O)C[C@H](O[C@H]2C[C@@H]([C@H](O)[C@H](C)O2)N(C)C)c3c(O)c4C(=O)c5c(O)ccc(O)c5C(=O)c4cc3[C@H]1C(=O)OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 N20 compound treatment 9.9966 -1.6949 -0.4548 12.5307 0.6077 0.144 -0.2198 -0.4607 1368 BSPBio_001878 CCC(C)C(N)C1=NC(CS1)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)O)C(=O)NC(C(C)CC)C(=O)NCCCCC2NC(=O)C(CC(=O)N)NC(=O)C(CC(=O)O)NC(=O)C(Cc3c[nH]cn3)NC(=O)C(Cc4ccccc4)NC(=O)C(NC(=O)C(CCCN)NC2=O)C(C)CC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 N21 compound treatment 9.9999 -1.6916 -0.4539 11.218 -0.70499 -0.167 -0.4391 -0.9078 2069308 BSPBio_001879 CC(=CCc1c(O)cc2occ(c3ccc4OCOc4c3)c(=O)c2c1O)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 N22 compound treatment 11.6028 -0.088626 -0.0238 11.7822 -0.1408 -0.0334 -0.0404 -0.9862 678 BSPBio_001880 NCC(CC(=O)O)c1ccc(Cl)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 N23 mock treatment 12.6811 0.9896 0.2655 14.2461 2.323 0.5504 0.577 0.9441 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 N24 mock treatment 12.2901 0.5986 0.1606 10.4228 -1.5002 -0.3555 -0.1378 -0.3532 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 O01 mock treatment 11.5404 -0.1511 -0.0405 12.89 0.96697 0.2291 0.1333 0.5731 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 O02 mock treatment 12.6468 0.95528 0.2563 14.6429 2.7199 0.6444 0.6369 0.9184 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 O03 compound treatment 11.4831 -0.20837 -0.0559 13.3554 1.4324 0.3394 0.2004 0.5828 3054097 BSPBio_001881 C[C@H]1[C@H]2[C@H](CC3C4CC[C@H]5C[C@@H](O)CC[C@]5(C)C4CC[C@]23C)O[C@@]61CC[C@@H](C)CO6 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 O04 compound treatment 12.3964 0.70495 0.1892 14.0012 2.0782 0.4924 0.4819 0.9136 2069265 BSPBio_001882 C[C@@]12CCC3C(CC[C@H]4CC(=O)CC[C@@]43C)C2CCC1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 O05 compound treatment 56.2231 44.532 11.949 65.5329 53.61 12.7021 17.4309 0.9995 BSPBio_001883 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 O06 compound treatment 13.0972 1.4057 0.3772 15.2041 3.2811 0.7774 0.8164 0.9448 3058740 BSPBio_001884 CC(=O)O[C@@H]1CC[C@@]2(C)[C@@H](CCC3C4CCC(=O)[C@@]4(C)CCC32)C1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 O07 compound treatment 11.018 -0.67343 -0.1807 11.39 -0.53296 -0.1263 -0.2171 -0.9846 1355 BSPBio_001885 CC(C)(O)[C@@H]1[C@H]2OC(=O)[C@@H]1[C@]3(O)C[C@H]4O[C@]45C(=O)O[C@H]2[C@@]53C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 O08 compound treatment 18.1311 6.4396 1.7279 19.7025 7.7795 1.8432 2.5252 0.9995 2060178 BSPBio_001886 CC12C[C@@H](O)C3C(CCC4CC(O)CCC43C)C2(O)CCC1C5=CC(=O)OC5 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 O09 compound treatment 10.8248 -0.86669 -0.2326 12.3449 0.42187 0.1 -0.0938 -0.3704 2060207 BSPBio_001887 CC1(C)[C@H](O)C[C@H](O)[C@@]2(C)C1CC(=O)[C@]3(C)C2CC[C@@]4(C)[C@@H](OC(=O)C5OC543)c6ccoc6 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 O10 compound treatment 10.8322 -0.8593 -0.2306 11.7018 -0.22118 -0.0524 -0.2001 -0.8462 1010376 BSPBio_001888 Oc1ccc2C3c4cc(O)c(O)cc4CC3(O)COc2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 O11 compound treatment 13.628 1.9366 0.5196 9.2532 -2.6698 -0.6326 -0.0799 -0.0975 724 BSPBio_001889 CCn1cc(C(=O)O)c(=O)c2ccc(C)nc12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 O12 compound treatment 14.7229 3.0315 0.8134 20.6617 8.7387 2.0705 2.0392 0.9167 2060216 BSPBio_001890 COc1cc2OC[C@H]3Oc4c(ccc5oc(cc45)C(C)C)C(=O)[C@H]3c2cc1OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 O13 compound treatment 9.0957 -2.5958 -0.6965 9.6573 -2.2657 -0.5368 -0.8721 -0.9917 2060208 BSPBio_001891 COC(=O)C[C@H]1C(C)(C)[C@@H](O)[C@@H]2CC3=C4CC(O)O[C@@H](c5ccoc5)[C@]4(C)CCC3[C@@]1(C)C2=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 O14 compound treatment 117.8255 106.13 28.4785 134.1853 122.26 28.9682 40.621 1.0 1288 BSPBio_001892 CC[C@@]1(O)C[C@H](O[C@H]2C[C@@H]([C@H](O)[C@H](C)O2)N(C)C)c3c(O)c4C(=O)c5c(O)cccc5C(=O)c4cc3[C@H]1C(=O)OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 O15 compound treatment 12.1202 0.42875 0.115 12.9762 1.0531 0.2495 0.2578 0.9382 3054136 BSPBio_001893 CC1(C)CC[C@]2(C)CC[C@]3(C)C(=CCC4[C@@]5(C)CC[C@H](O)C(C)(C)C5CC[C@]43C)C2C1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 O16 compound treatment 12.5899 0.89846 0.2411 10.145 -1.778 -0.4213 -0.1274 -0.2625 3173106 BSPBio_001894 COC(=O)c1c(C)c2Oc3c(Cl)c(O)c(Cl)c(C)c3C(=O)Oc2c(C)c1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 O17 compound treatment 9.9161 -1.7754 -0.4764 8.1543 -3.7687 -0.8929 -0.9683 -0.9567 3650169 BSPBio_001895 CC1(C)C2CC(=O)[C@]3(C)C(CC[C@@]4(C)[C@@H](OC(=O)[C@H]5O[C@]543)c6ccoc6)[C@@]2(C)[C@H]7O[C@H]7C1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 O18 compound treatment 35.2011 23.51 6.3083 32.1223 20.199 4.7859 7.8448 0.9907 1527 BSPBio_001896 COc1cc2OC[C@H]3Oc4c5C[C@@H](Oc5ccc4C(=O)[C@H]3c2cc1OC)C(=C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 O19 compound treatment 11.5526 -0.13887 -0.0373 9.5139 -2.4091 -0.5708 -0.43 -0.7517 2069251 BSPBio_001897 CC(=O)O[C@@H]1CC2C(C)(C)[C@H](O)C[C@H](O)[C@]2(C)C3CC[C@@]4(C)[C@@H](OC(=O)[C@H]5O[C@]54[C@]13C)c6ccoc6 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 O20 compound treatment 8.9041 -2.7874 -0.7479 9.6186 -2.3044 -0.546 -0.9149 -0.988 2060234 BSPBio_001898 COC(=O)c1c(C)c2Oc3c(Cl)c(O)c(Cl)c(C)c3C(=O)Oc2cc1OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 O21 compound treatment 9.8912 -1.8003 -0.4831 9.5066 -2.4164 -0.5725 -0.7464 -0.9964 2060291 BSPBio_001899 CC(=O)O[C@@H]1CC2C(C)(C)[C@H](O)CC[C@]2(C)C3CC[C@@]4(C)[C@@H](OC(=O)C5OC54[C@]13C)c6ccoc6 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 O22 compound treatment 11.3295 -0.36192 -0.0971 10.5661 -1.3569 -0.3215 -0.296 -0.8814 1051460 BSPBio_001900 COc1cc(C(=O)O)c2Oc3c(C=O)c(O)cc(C)c3C(=O)Oc2c1C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 O23 mock treatment 11.009 -0.6825 -0.1831 10.3504 -1.5726 -0.3726 -0.393 -0.9465 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 O24 mock treatment 10.3606 -1.3309 -0.3571 10.4251 -1.4979 -0.3549 -0.5035 -1.0 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 P01 mock treatment 10.4132 -1.2783 -0.343 10.4447 -1.4783 -0.3503 -0.4902 -0.9999 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 P02 mock treatment 10.5888 -1.1027 -0.2959 10.5475 -1.3755 -0.3259 -0.4397 -0.9988 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 P03 compound treatment 12.3595 0.66807 0.1793 11.291 -0.63196 -0.1497 0.0209 0.0894 2060335 BSPBio_001901 Oc1ccc2C3Oc4cc5OCOc5cc4C3COc2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 P04 compound treatment 11.9039 0.21244 0.057 11.5862 -0.33682 -0.0798 -0.0161 -0.1644 834 BSPBio_001902 CC(C[N+](C)(C)C)OC(=O)N 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 P05 compound treatment 10.1215 -1.57 -0.4213 9.7196 -2.2034 -0.5221 -0.667 -0.9943 3173998 BSPBio_001903 CC(=O)O[C@@H]1C2CC[C@@H]3C1(C[C@@]2(C)O)C[C@@H](O)[C@@]4(O)[C@@H](C[C@H](O)C4(C)C)[C@]3(C)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 P06 compound treatment 12.3831 0.69158 0.1856 9.9821 -1.9409 -0.4599 -0.194 -0.3911 1095 BSPBio_001904 NC(CO)C(=O)NNCc1ccc(O)c(O)c1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 P07 compound treatment 56.9721 45.281 12.15 59.2895 47.367 11.2228 16.527 0.9992 2114344 BSPBio_001905 CC1=C(O)C(=O)C=C2C1=CC=C3[C@@]2(C)CC[C@@]4(C)[C@@H]5C[C@@](C)(CC[C@]5(C)CC[C@]34C)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 P08 compound treatment 12.3297 0.63818 0.1712 11.0558 -0.86718 -0.2055 -0.0242 -0.0905 1373 BSPBio_001906 CC(C)(C)CC(C)(C)c1ccc(OCCOCC[N+](C)(C)Cc2ccccc2)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 P09 compound treatment 12.2866 0.59513 0.1597 13.1196 1.1966 0.2835 0.3134 0.9631 3054028 BSPBio_001907 CC(CCC=C(C)C)[C@@H]1CC[C@]2(C)C3=C(CC[C@@]12C)C4(C)CC[C@H](O)C(C)(C)C4CC3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 P10 compound treatment 13.2627 1.5712 0.4216 13.843 1.92 0.4549 0.6198 0.9993 1513 BSPBio_001908 CCOC(=O)c1ccc(N)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 P11 compound treatment 11.3744 -0.3171 -0.0851 11.3252 -0.59778 -0.1416 -0.1603 -0.9703 2069246 BSPBio_001909 Cc1cc(O)c(C=O)c2Oc3c4C(O)OC(=O)c4c(O)c(C)c3OC(=O)c12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 P12 compound treatment 11.6365 -0.054946 -0.0147 11.6249 -0.29811 -0.0706 -0.0604 -0.8367 1114 BSPBio_001910 NS(=O)(=O)c1cc2c(N=C(CSCc3ccccc3)NS2(=O)=O)cc1Cl 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 P13 compound treatment 8.8902 -2.8013 -0.7517 10.6392 -1.2838 -0.3042 -0.7466 -0.9207 2060194 BSPBio_001911 COc1cc(O)c(C(=O)O)c(O)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 P14 compound treatment 11.8539 0.16244 0.0436 10.4398 -1.4832 -0.3514 -0.2177 -0.6147 1141 BSPBio_001912 CN1C2CCC1CC(C2)OC(c3ccccc3)c4ccccc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 P15 compound treatment 12.202 0.5105 0.137 10.6471 -1.2759 -0.3023 -0.1169 -0.3522 2060411 BSPBio_001913 O[C@H]1Cc2ccc(O)cc2O[C@@H]1c3ccc(O)c(O)c3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 P16 compound treatment 13.3965 1.705 0.4575 14.5439 2.6209 0.621 0.7626 0.9887 3177311 BSPBio_001914 C[C@H]1CC2C3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 P17 compound treatment 12.332 0.64057 0.1719 14.3155 2.3925 0.5669 0.5224 0.8819 3198309 BSPBio_001915 CC(=O)OCC(O)CC(O)CCCCCCCCCCCC=C.CC(=O)OCC(O)CC(O)CCCCCCCCCCCC#C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 P18 compound treatment 12.0953 0.40379 0.1083 11.8096 -0.11343 -0.0269 0.0576 0.5161 982 BSPBio_001916 CC(=O)Oc1ccc(cc1)C(c2ccc(OC(=O)C)cc2)c3ccccn3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 P19 compound treatment 9.8699 -1.8215 -0.4888 9.4886 -2.4344 -0.5768 -0.7535 -0.9966 2060203 BSPBio_001917 CCOC(=O)c1c(C)cc(O)c(C)c1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 P20 compound treatment 11.6068 -0.084686 -0.0227 9.7337 -2.1893 -0.5187 -0.3829 -0.7374 1247 BSPBio_001918 Oc1c(Cl)cc(Cl)cc1Sc2cc(Cl)cc(Cl)c2O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 P21 compound treatment 11.4268 -0.26467 -0.071 10.845 -1.078 -0.2554 -0.2308 -0.8707 1253 BSPBio_001919 C[C@H]1OC=C2C(=C(C(=O)O)C(=O)C(=C2[C@@H]1C)C)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 P22 compound treatment 9.4343 -2.2572 -0.6057 10.7628 -1.1602 -0.2749 -0.6226 -0.9361 1437 BSPBio_001920 CS(=O)(=O)OCCCCOS(=O)(=O)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 P23 mock treatment 10.4675 -1.224 -0.3284 11.9819 0.058865 0.0139 -0.2224 -0.6765 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2458 P24 mock treatment 11.4069 -0.28462 -0.0764 9.7386 -2.1844 -0.5176 -0.42 -0.8028 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 A01 mock treatment 12.3122 0.43885 0.1178 14.0454 2.2838 0.5411 0.4659 0.8413 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 A02 mock treatment 13.6847 1.8114 0.486 18.4528 6.6912 1.5854 1.4647 0.8833 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 A03 compound treatment 14.361 2.4877 0.6675 11.695 -0.066658 -0.0158 0.4608 0.6902 451 BSPBio_001921 Cn1cnc2n(C)c(=O)n(C)c(=O)c12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 A04 compound treatment 16.3533 4.48 1.2021 11.7634 0.0017522 4.0E-4 0.8503 0.7074 1441 BSPBio_001922 CN1CCC(CC1)OC(c2ccccc2)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 A05 compound treatment 12.6211 0.74782 0.2007 13.7493 1.9877 0.471 0.4749 0.9277 1326 BSPBio_001923 CC1(C)[C@@H]2CC[C@@]1(C)C(=O)C2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 A06 compound treatment 35.9858 24.113 6.47 20.5909 8.8293 2.092 6.0542 0.8904 1301 BSPBio_001924 OCCN(CCO)c1nc(N2CCCCC2)c3nc(nc(N4CCCCC4)c3n1)N(CCO)CCO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 A07 compound treatment 12.1251 0.25178 0.0676 11.6406 -0.12103 -0.0287 0.0275 0.3746 3177464 BSPBio_001925 NCCCC(N)CC(=O)NCC1NC(=O)C(CO)NC(=O)C(N)CNC(=O)C(NC(=O)/C(=C\NC(=O)N)/NC1=O)C2CCNC(=N)N2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 A08 compound treatment 87.0101 75.137 20.1611 83.3335 71.572 16.9579 26.2471 0.9963 979 BSPBio_001926 S=C1CC=CC=N1O[Zn]On2ccccc2=S 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 A09 compound treatment 12.8016 0.92827 0.2491 12.151 0.38934 0.0922 0.2414 0.9087 1327 BSPBio_001927 C[N+](C)(C)CCOC(=O)N 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 A10 compound treatment 11.8218 -0.051472 -0.0138 12.1439 0.3823 0.0906 0.0543 0.5924 1112 BSPBio_001928 CC(C)N(CCC(C(=O)N)(c1ccccc1)c2ccccn2)C(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 A11 compound treatment 12.3777 0.50437 0.1353 12.6322 0.87061 0.2063 0.2416 0.9791 1019 BSPBio_001929 NC(=O)N1c2ccccc2C=Cc3ccccc13 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 A12 compound treatment 14.8955 3.0221 0.8109 16.4316 4.67 1.1065 1.3558 0.9883 2038 BSPBio_001930 CCN(CC)C(=S)SSC(=S)N(CC)CC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 A13 compound treatment 14.4567 2.5834 0.6932 12.2289 0.46729 0.1107 0.5684 0.8098 1336 BSPBio_001931 CC1(C)S[C@@H]2[C@H](NC(=O)C(C(=O)O)c3ccccc3)C(=O)N2[C@H]1C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 A14 compound treatment 14.5318 2.6585 0.7134 11.5179 -0.24373 -0.0577 0.4636 0.6477 1378 BSPBio_001932 NCCc1ccc(O)c(O)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 A15 compound treatment 10.9454 -0.9279 -0.249 16.3946 4.633 1.0977 0.6002 0.5332 1412 BSPBio_001933 CN(C)CCOC(c1ccc(Cl)cc1)c2ccccn2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 A16 compound treatment 10.5486 -1.3247 -0.3555 10.6291 -1.1326 -0.2683 -0.4411 -0.9904 1059 BSPBio_001934 CN(C)CC/C=C\1/c2ccccc2COc3ccccc13 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 A17 compound treatment 14.1021 2.2288 0.598 9.785 -1.9766 -0.4683 0.0917 0.1207 1409 BSPBio_001935 CCCC(C)(COC(=O)N)COC(=O)NC(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 A18 compound treatment 11.7339 -0.13939 -0.0374 10.5626 -1.199 -0.2841 -0.2273 -0.7934 980 BSPBio_001936 C[C@@H]1[C@H]2[C@H](O)[C@H]3[C@H](N(C)C)C(=C(C(=O)N)C(=O)[C@@]3(O)C(=C2C(=O)c4c(O)cccc14)O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 A19 compound treatment 12.6478 0.77444 0.2078 9.7709 -1.9908 -0.4717 -0.1866 -0.362 3198549 BSPBio_001937 CC1=C(N2[C@H](SC1)[C@H](NC(=O)[C@@H](N)c3ccc(O)cc3)C2=O)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 A20 compound treatment 13.4044 1.5311 0.4108 12.5816 0.82001 0.1943 0.4279 0.9415 1432 BSPBio_001938 CN(C)CCOC(C)(c1ccccc1)c2ccccn2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 A21 compound treatment 11.8135 -0.059782 -0.016 13.1881 1.4265 0.338 0.2276 0.6728 689 BSPBio_001939 Cc1nnc(SCC2=C(N3[C@H](SC2)[C@H](NC(=O)Cn4cnnn4)C3=O)C(=O)O)s1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 A22 compound treatment 20.1721 8.2988 2.2268 15.4348 3.6732 0.8703 2.19 0.916 1240 BSPBio_001940 CCCCOc1ccc(cc1)C(=O)CCN2CCCCC2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 A23 mock treatment 10.6966 -1.1767 -0.3158 12.5033 0.74174 0.1757 -0.099 -0.274 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 A24 mock treatment 14.3567 2.4834 0.6664 14.3409 2.5793 0.6111 0.9033 0.9991 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 B01 mock treatment 12.0139 0.14064 0.0377 13.9438 2.1822 0.517 0.3923 0.7567 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 B02 mock treatment 13.8622 1.9889 0.5337 12.1546 0.39299 0.0931 0.4432 0.8181 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 B03 compound treatment 10.7216 -1.1517 -0.309 13.8321 2.0705 0.4906 0.1284 0.2214 995 BSPBio_001941 CCC[C@@H]1C[C@H](N(C)C1)C(=O)N[C@@H]([C@H](C)O)[C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 B04 compound treatment 10.9745 -0.89877 -0.2412 9.2126 -2.549 -0.6039 -0.5976 -0.9189 1000060 BSPBio_001942 COC(=O)C1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@H]12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 B05 compound treatment 12.7441 0.87076 0.2336 13.2631 1.5015 0.3558 0.4168 0.9792 997 BSPBio_001943 NCc1ccc(cc1)S(=O)(=O)N 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 B06 compound treatment 10.3329 -1.5404 -0.4133 12.4662 0.70464 0.167 -0.1742 -0.3908 1218 BSPBio_001944 CCCCNc1ccc(cc1)C(=O)OCCN(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 B07 compound treatment 14.3652 2.4919 0.6686 11.9366 0.17497 0.0415 0.5021 0.7495 1476 BSPBio_001945 CNCCCC1(CCC2c3ccccc31)c4ccccc24 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 B08 compound treatment 13.2585 1.3852 0.3717 11.8821 0.12046 0.0285 0.283 0.7592 836 BSPBio_001946 CNC(C)C(O)c1ccccc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 B09 compound treatment 17.5494 5.6761 1.523 16.6837 4.922 1.1662 1.9016 0.9913 1358 BSPBio_001947 CN(CCCl)CCCl 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 B10 compound treatment 11.9616 0.088268 0.0237 10.3652 -1.3965 -0.3309 -0.2172 -0.6548 1447 BSPBio_001948 NC(=O)c1ccccc1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 B11 compound treatment 9.7589 -2.1144 -0.5673 11.9221 0.16046 0.038 -0.3743 -0.6582 1035 BSPBio_001949 Cc1cccc(CN2CCN(CC2)C(c3ccccc3)c4ccc(Cl)cc4)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 B12 compound treatment 14.8753 3.002 0.8055 12.0415 0.27992 0.0663 0.6165 0.7627 1418 BSPBio_001950 CN(C)[C@H]1[C@@H]2C[C@H]3C(=C(O)[C@]2(O)C(=O)C(=C1O)C(=O)N)C(=O)c4c(O)cccc4[C@@]3(C)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 B13 compound treatment 12.9617 1.0884 0.292 9.417 -2.3446 -0.5555 -0.1863 -0.2969 1123 BSPBio_001951 Cc1ccc(Cl)c(Nc2ccccc2C(=O)O)c1Cl 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 B14 compound treatment 9.6356 -2.2377 -0.6004 11.0362 -0.72541 -0.1719 -0.5461 -0.8744 1120 BSPBio_001952 Oc1ccc(cc1[N+](=O)[O-])[As](=O)(O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 B15 compound treatment 13.698 1.8246 0.4896 12.7829 1.0213 0.242 0.5173 0.9472 1110 BSPBio_001953 C[C@H]1CC2C3CC[C@](OC(=O)C)(C(=O)C)[C@@]3(C)CCC2[C@@]4(C)CCC(=O)C=C14 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 B16 compound treatment 10.0499 -1.8234 -0.4893 10.5714 -1.1903 -0.282 -0.5454 -0.9657 777 BSPBio_001954 Oc1ccc(cc1)[C@@H]2CC(=O)c3c(O)cc(O)cc3O2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 B17 compound treatment 13.5561 1.6828 0.4515 15.8669 4.1053 0.9727 1.0071 0.9391 984 BSPBio_001955 C[C@H]1CC2C3CC[C@H](C(=O)C)[C@@]3(C)C[C@H](O)C2[C@@]4(C)CCC(=O)C=C14 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 B18 compound treatment 11.0978 -0.77555 -0.2081 11.953 0.19134 0.0453 -0.1151 -0.5404 750 BSPBio_001956 CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1OC2[C@H](O[C@H]3[C@H](O)[C@@H](O)[C@H](NC(=N)N)[C@@H](O)[C@@H]3NC(=N)N)O[C@@H](C)[C@]2(O)C=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 B19 compound treatment 14.5302 2.6569 0.7129 13.1681 1.4065 0.3332 0.7397 0.94 3198429 BSPBio_001957 CC(=O)O[C@@]1(CCC2C3C=C(C)C4=CC(=O)CCC4(C)C3CCC21C)C(=O)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 B20 compound treatment 14.6988 2.8255 0.7582 12.2937 0.53214 0.1261 0.6252 0.8135 1155 BSPBio_001958 Nc1ccc(cc1)S(=O)(=O)NC(=O)c2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 B21 compound treatment 14.3458 2.4724 0.6634 9.9815 -1.7801 -0.4218 0.1709 0.2174 1244 BSPBio_001959 C[N+]1(C)CCCC(C1)OC(=O)C(O)(c2ccccc2)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 B22 compound treatment 13.5137 1.6404 0.4402 11.6938 -0.067785 -0.0161 0.2999 0.6809 799 BSPBio_001960 Cc1nnc(NS(=O)(=O)c2ccc(N)cc2)s1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 B23 mock treatment 12.4828 0.60949 0.1635 11.7824 0.020822 0.0049 0.1191 0.7281 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 B24 mock treatment 13.8271 1.9538 0.5243 15.4979 3.7362 0.8852 0.9967 0.9687 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 C01 mock treatment 12.4262 0.55289 0.1484 14.6911 2.9295 0.6941 0.5957 0.8393 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 C02 mock treatment 10.1908 -1.6825 -0.4515 12.6628 0.90114 0.2135 -0.1683 -0.3369 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 C03 compound treatment 12.7222 0.84889 0.2278 12.438 0.67639 0.1603 0.2744 0.9852 3172713 BSPBio_001961 CO/N=C(/C(=O)N[C@H]1[C@H]2SCC(=C(N2C1=O)C(=O)O)COC(=O)C)\c3csc(N)n3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 C04 compound treatment 11.1139 -0.75936 -0.2038 10.3492 -1.4125 -0.3347 -0.3807 -0.9717 697 BSPBio_001962 Cn1c(=O)n(C)c2ncn(CC(O)CO)c2c1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 C05 compound treatment 10.537 -1.3363 -0.3586 11.3656 -0.39602 -0.0938 -0.3199 -0.8631 759 BSPBio_001963 CC(=O)OCC1=C(N2[C@H](SC1)[C@H](NC(=O)Cc3cccs3)C2=O)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 C06 compound treatment 11.1147 -0.75857 -0.2035 11.4394 -0.32223 -0.0763 -0.1979 -0.9104 1001324 BSPBio_001964 OC(=O)CN(CCN(CC(=O)O)CC(=O)O)CC(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 C07 compound treatment 12.9 1.0267 0.2755 10.5276 -1.234 -0.2924 -0.0119 -0.0297 712 BSPBio_001965 CC(=O)OCC1=C(N2[C@H](SC1)[C@H](NC(=O)CSc3ccncc3)C2=O)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 C08 compound treatment 13.8598 1.9865 0.533 14.3664 2.6048 0.6172 0.8133 0.9973 1000036 BSPBio_001966 CC[C@H]1CN2CCc3cc(OC)c(OC)cc3C2C[C@@H]1CC4NCCc5cc(OC)c(OC)cc45 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 C09 compound treatment 9.8674 -2.0059 -0.5382 10.4959 -1.2657 -0.2999 -0.5926 -0.9619 3177463 BSPBio_001967 CC1=C(N2C(SC1)[C@H](NC(=O)[C@H](N)C3=CCC=CC3)C2=O)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 C10 compound treatment 12.7288 0.85554 0.2296 10.5835 -1.1781 -0.2791 -0.035 -0.097 2069266 BSPBio_001968 CNC(C)[C@H](O)c1ccccc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 C11 compound treatment 21.0297 9.1564 2.4569 18.2361 6.4745 1.534 2.822 0.9743 981 BSPBio_001969 CCCCCCCCCCCCCCCC[n+]1ccccc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 C12 compound treatment 12.3308 0.45744 0.1227 10.2125 -1.5491 -0.367 -0.1727 -0.4463 3174481 BSPBio_001970 CNC[C@@H](O)c1ccc(O)c(O)c1.OC(C(O)C(=O)O)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 C13 compound treatment 9.8484 -2.0249 -0.5433 9.5201 -2.2415 -0.5311 -0.7597 -0.9999 1295 BSPBio_001971 OC(=O)CCCc1ccc(cc1)N(CCCl)CCCl 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 C14 compound treatment 9.4507 -2.4226 -0.65 10.5523 -1.2093 -0.2865 -0.6622 -0.9322 1000136 BSPBio_001972 CC12CCC3C(=CCc4cc(O)ccc34)C2CCC1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 C15 compound treatment 10.5118 -1.3615 -0.3653 8.9248 -2.8368 -0.6721 -0.7336 -0.9589 2550 BSPBio_001973 O[C@@H]([C@@H](COC(=O)CCC(=O)O)NC(=O)C(Cl)Cl)c1ccc(cc1)[N+](=O)[O-] 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 C16 compound treatment 12.8789 1.0056 0.2698 13.1241 1.3625 0.3228 0.4191 0.996 1400 BSPBio_001974 CC(C)[C@@H](C)/C=C/[C@@H](C)C1CC[C@H]2\C(=C\C=C/3\C[C@@H](O)CCC3=C)\CCC[C@]12C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 C17 compound treatment 12.7265 0.85317 0.2289 10.6317 -1.1299 -0.2677 -0.0274 -0.0779 3059437 BSPBio_001975 OC[C@H](NC(=O)C(Cl)Cl)[C@H](O)c1ccc(cc1)[N+](=O)[O-] 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 C18 compound treatment 11.0156 -0.8577 -0.2301 8.9409 -2.8207 -0.6683 -0.6353 -0.8988 3058614 BSPBio_001976 C[C@@H](CO)NC(=O)C1CN(C)[C@@H]2Cc3c[nH]c4cccc(C2=C1)c34 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 C19 compound treatment 12.1729 0.29959 0.0804 11.3811 -0.38056 -0.0902 -0.0069 -0.0572 1360 BSPBio_001977 Clc1ccc(NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)Nc2ccc(Cl)cc2)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 C20 compound treatment 11.9784 0.10514 0.0282 9.6047 -2.1569 -0.511 -0.3414 -0.6671 1363 BSPBio_001978 CCOC(=O)CCC(=O)O[C@@H]1[C@H](C[C@@H](C)O[C@H]1O[C@@H]2[C@@H](C)[C@H](O[C@H]3C[C@@](C)(OC)[C@@H](O)[C@H](C)O3)[C@@H](C)C(=O)O[C@H](CC)[C@@](C)(O)[C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@]2(C)O)N(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 C21 compound treatment 13.9845 2.1112 0.5665 10.9907 -0.77092 -0.1827 0.2714 0.456 2554 BSPBio_001979 C[C@H]1[C@H]2CCC3C4CC=C5C[C@H](CC[C@]5(C)C4CC[C@]23CN1C)N(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 C22 compound treatment 12.3294 0.45607 0.1224 10.7053 -1.0563 -0.2503 -0.0904 -0.3246 3173471 BSPBio_001980 C[C@@]12CCC3C(CCc4cc(O)ccc34)C2CC[C@@H]1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 C23 mock treatment 10.0974 -1.7759 -0.4765 13.0515 1.2899 0.3056 -0.1209 -0.2135 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 C24 mock treatment 13.2472 1.3739 0.3687 13.9515 2.1899 0.5189 0.6276 0.986 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 D01 mock treatment 11.6745 -0.19883 -0.0534 12.8804 1.1188 0.2651 0.1497 0.5537 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 D02 mock treatment 10.7849 -1.0884 -0.292 11.0742 -0.68743 -0.1629 -0.3217 -0.962 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 D03 compound treatment 16.1108 4.2375 1.137 16.5306 4.769 1.1299 1.603 1.0 1116 BSPBio_001981 S=c1[nH]cnc2nc[nH]c12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 D04 compound treatment 16.2846 4.4113 1.1837 18.2898 6.5282 1.5468 1.9307 0.9913 368 BSPBio_001982 CC/C(=C(\c1ccccc1)/c2ccc(OCCN(C)C)cc2)/c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 D05 compound treatment 11.4484 -0.42493 -0.114 11.3921 -0.36946 -0.0875 -0.1425 -0.9915 1252 BSPBio_001983 CC(C)NCC(O)c1cc(O)cc(O)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 D06 compound treatment 33.8738 22.0 5.9033 36.2475 24.486 5.8016 8.2766 1.0 1228 BSPBio_001984 CC[Hg]Sc1ccccc1C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 D07 compound treatment 10.8391 -1.0342 -0.2775 11.3366 -0.42501 -0.1007 -0.2674 -0.9059 1094620 BSPBio_001985 CC(C[N+](C)(C)C)OC(=O)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 D08 compound treatment 10.9786 -0.89473 -0.2401 11.0307 -0.73095 -0.1732 -0.2922 -0.9872 1223 BSPBio_001986 CCCC(=O)Nc1ccc(OCC(O)CNC(C)C)c(c1)C(=O)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 D09 compound treatment 14.2597 2.3864 0.6403 9.8683 -1.8933 -0.4486 0.1356 0.1734 762 BSPBio_001987 COc1cccc(OC)c1C(=O)N[C@H]2[C@H]3SC(C)(C)[C@@H](N3C2=O)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 D10 compound treatment 11.4272 -0.4461 -0.1197 11.8876 0.12601 0.0299 -0.0635 -0.515 1044 BSPBio_001988 C[C@H](CCC(=O)O)[C@H]1CCC2C3[C@@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)C3CC[C@]12C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 D11 compound treatment 10.6626 -1.2107 -0.3249 11.5979 -0.16373 -0.0388 -0.2571 -0.786 842 BSPBio_001989 Cn1cc[nH]c1=S 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 D12 compound treatment 11.5442 -0.3291 -0.0883 14.686 2.9243 0.6929 0.4275 0.612 1374 BSPBio_001990 Oc1c(Br)cc(Br)c2cccnc12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 D13 compound treatment 10.2881 -1.5852 -0.4253 11.3228 -0.43886 -0.104 -0.3743 -0.8548 1062 BSPBio_001991 COc1ccccc1OCC(O)COC(=O)N 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 D14 compound treatment 10.7094 -1.1639 -0.3123 9.9501 -1.8115 -0.4292 -0.5243 -0.9878 1096 BSPBio_001992 C[N+](C)(C)CC(O)CC(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 D15 compound treatment 9.6445 -2.2288 -0.598 12.5669 0.80526 0.1908 -0.288 -0.4587 1000064 BSPBio_001993 CN(Cc1cnc2nc(N)nc(N)c2n1)c3ccc(cc3)C(=O)NC(CCC(=O)O)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 D16 compound treatment 22.4416 10.568 2.8357 22.5025 10.741 2.5449 3.8047 0.9985 1056 BSPBio_001994 Nc1nc2nc[nH]c2c(=S)[nH]1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 D17 compound treatment 9.7324 -2.1409 -0.5745 8.9581 -2.8035 -0.6642 -0.8759 -0.9974 3058468 BSPBio_001995 COc1ccc(OC)c(c1)C(O)C(C)N 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 D18 compound treatment 10.2756 -1.5977 -0.4287 10.735 -1.0266 -0.2432 -0.4751 -0.964 BSPBio_001996 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 D19 compound treatment 10.2515 -1.6218 -0.4352 9.6246 -2.137 -0.5063 -0.6658 -0.9972 1362 BSPBio_001997 COc1c2occc2cc3ccc(=O)oc13 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 D20 compound treatment 12.885 1.0117 0.2715 10.3603 -1.4013 -0.332 -0.0428 -0.0998 1106 BSPBio_001998 CCC(=O)c1c(O)cc(O)cc1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 D21 compound treatment 12.1715 0.29816 0.08 9.591 -2.1706 -0.5143 -0.3071 -0.59 1009 BSPBio_001999 C[N+]1(C)C2CC(CC1C3OC32)OC(=O)[C@@H](CO)c4ccccc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 D22 compound treatment 9.8353 -2.038 -0.5468 10.7941 -0.96755 -0.2292 -0.5488 -0.9255 1000109 BSPBio_002000 Nc1ncnc2n(cnc12)[C@@H]3O[C@H](CO)[C@@H](O)[C@@H]3O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 D23 mock treatment 11.6778 -0.19554 -0.0525 8.5799 -3.1818 -0.7539 -0.5702 -0.7545 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 D24 mock treatment 12.5334 0.66009 0.1771 12.751 0.98942 0.2344 0.291 0.9904 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 E01 mock treatment 27.3963 15.523 4.1652 11.6963 -0.065358 -0.0155 2.9343 0.7045 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 E02 mock treatment 10.6617 -1.2116 -0.3251 11.6736 -0.088015 -0.0209 -0.2446 -0.7509 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 E03 compound treatment 9.1154 -2.7579 -0.74 11.0803 -0.68126 -0.1614 -0.6374 -0.8416 1000114 BSPBio_002001 CCN(CC)CCCC(C)Nc1ccnc2cc(Cl)ccc12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 E04 compound treatment 13.1515 1.2782 0.343 15.9673 4.2057 0.9965 0.9471 0.8987 1224 BSPBio_002002 C[C@@]12CCC3C(CCc4cc(O)ccc34)C2CC[C@@H]1OC(=O)CCC5CCCC5 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 E05 compound treatment 10.773 -1.1003 -0.2952 9.6179 -2.1437 -0.5079 -0.5679 -0.9667 1282 BSPBio_002003 NS(=O)(=O)c1cc2c(N=CNS2(=O)=O)cc1Cl 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 E06 compound treatment 16.6869 4.8136 1.2916 15.1292 3.3676 0.7979 1.4775 0.9732 1468 BSPBio_002004 CCCCC(=O)O[C@H]1CCC2C3CCc4cc(O)ccc4C3CC[C@]12C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 E07 compound treatment 11.791 -0.082307 -0.0221 9.6965 -2.0651 -0.4893 -0.3616 -0.7383 3057880 BSPBio_002005 COc1ccc(cc1)C(=C(c2ccc(OC)cc2)c3ccc(OC)cc3)Cl 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 E08 compound treatment 10.9044 -0.9689 -0.26 12.3106 0.54898 0.1301 -0.0919 -0.316 1216 BSPBio_002006 C[C@@]12CCC3C(CCc4cc(O)ccc34)C2C[C@@H](O)[C@@H]1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 E09 compound treatment 13.767 1.8937 0.5081 8.5815 -3.1801 -0.7535 -0.1735 -0.1909 1396 BSPBio_002007 Cc1cc(O)cc(C)c1Cl 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 E10 compound treatment 14.0022 2.1288 0.5712 13.7112 1.9496 0.4619 0.7305 0.9945 3058535 BSPBio_002008 C[C@@]12CCC3C(CCc4cc(O)ccc34)C2CCC1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 E11 compound treatment 10.2669 -1.6064 -0.431 10.1833 -1.5783 -0.3739 -0.5692 -0.9975 2069230 BSPBio_002009 CN(C)CC[C@H](c1ccc(Cl)cc1)c2ccccn2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 E12 compound treatment 12.2684 0.39512 0.106 13.2727 1.5111 0.358 0.3281 0.8788 1485 BSPBio_002010 CCC(=C)C(=O)c1ccc(OCC(=O)O)c(Cl)c1Cl 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 E13 compound treatment 15.0988 3.2255 0.8655 12.383 0.62143 0.1472 0.7161 0.8157 436 BSPBio_002011 CN(C)CCCN1c2ccccc2Sc3ccc(Cl)cc13 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 E14 compound treatment 9.0766 -2.7967 -0.7504 10.2317 -1.5299 -0.3625 -0.787 -0.9443 1176 BSPBio_002012 CC[C@@H](CO)NCCN[C@@H](CC)CO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 E15 compound treatment 9.0127 -2.8606 -0.7676 9.3477 -2.4139 -0.5719 -0.9472 -0.9895 1132 BSPBio_002013 CCCNC(=O)NS(=O)(=O)c1ccc(Cl)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 E16 compound treatment 15.9071 4.0337 1.0824 19.9801 8.2185 1.9473 2.1423 0.9616 1139 BSPBio_002014 C[C@@]12CCC3C(CCc4cc(O)ccc34)C2CC[C@@]1(O)C#C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 E17 compound treatment 33.2029 21.33 5.7233 35.7105 23.949 5.6743 8.0593 1.0 901 BSPBio_002015 CN(C)[C@H]1[C@@H]2C[C@H]3C(=C(O)[C@]2(O)C(=O)C(=C1O)C(=O)N)C(=O)c4c(O)ccc(Cl)c4[C@@]3(C)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 E18 compound treatment 12.1292 0.25589 0.0687 10.5495 -1.2121 -0.2872 -0.1545 -0.5233 803 BSPBio_002016 CCc1cc(ccn1)C(=S)N 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 E19 compound treatment 10.0549 -1.8184 -0.4879 9.0966 -2.665 -0.6314 -0.7915 -0.9919 1332 BSPBio_002017 NS(=O)(=O)c1cc(ccc1Cl)C2(O)NC(=O)c3ccccc32 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 E20 compound treatment 27.5474 15.674 4.2058 21.948 10.186 2.4135 4.6805 0.9652 727 BSPBio_002018 CCN(CC)C(C)CN1c2ccccc2Sc3ccccc13 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 E21 compound treatment 10.7693 -1.104 -0.2962 11.3934 -0.36824 -0.0872 -0.2712 -0.8781 1480 BSPBio_002019 Clc1ccc2oc(=O)[nH]c2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 E22 compound treatment 10.6811 -1.1923 -0.3199 13.349 1.5874 0.3761 0.0397 0.0805 3177451 BSPBio_002020 CC(=O)OCC(=O)[C@@]1(O)CCC2C3CCC4=CC(=O)CC[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 E23 mock treatment 10.6673 -1.206 -0.3236 10.7567 -1.0049 -0.2381 -0.3972 -0.9886 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 E24 mock treatment 11.2554 -0.61795 -0.1658 10.091 -1.6706 -0.3958 -0.3971 -0.9254 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 F01 mock treatment 10.5955 -1.2778 -0.3429 10.2005 -1.5612 -0.3699 -0.504 -0.9993 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 F02 mock treatment 12.4376 0.56429 0.1514 13.3773 1.6157 0.3828 0.3778 0.9176 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 F03 compound treatment 10.3235 -1.5498 -0.4158 11.9275 0.16591 0.0393 -0.2662 -0.6374 800 BSPBio_002021 C[C@](N)(Cc1ccc(O)c(O)c1)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 F04 compound treatment 12.9126 1.0393 0.2789 10.464 -1.2976 -0.3074 -0.0202 -0.0487 972 BSPBio_002022 CN(C)S(=O)(=O)c1ccc2Sc3ccccc3/C(=C\CCN4CCN(C)CC4)/c2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 F05 compound treatment 9.9345 -1.9388 -0.5202 15.3592 3.5975 0.8524 0.2349 0.2352 991 BSPBio_002023 CC[C@@H](CO)NC(=O)[C@H]1CN(C)[C@@H]2Cc3c[nH]c4cccc(C2=C1)c34 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 F06 compound treatment 11.6891 -0.18422 -0.0494 10.9128 -0.8488 -0.2011 -0.1772 -0.8554 1444 BSPBio_002024 C1CN=C(N1)C2CCCc3ccccc23 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 F07 compound treatment 12.5643 0.69099 0.1854 12.4759 0.71426 0.1692 0.2508 0.999 1234 BSPBio_002025 C[C@H]1CC2C3CC[C@](O)(C(=O)CO)[C@@]3(C)C[C@H](O)C2[C@@]4(C)C=CC(=O)C=C14 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 F08 compound treatment 12.1893 0.31602 0.0848 9.9078 -1.8538 -0.4392 -0.2506 -0.5603 1000116 BSPBio_002026 CC(=O)CC(c1ccccc1)c2c(O)c3ccccc3oc2=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 F09 compound treatment 11.3411 -0.53223 -0.1428 10.6385 -1.1232 -0.2661 -0.2892 -0.9574 734 BSPBio_002027 CCN(CC)CCNC(=O)c1cc(Cl)c(N)cc1OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 F10 compound treatment 10.8703 -1.003 -0.2691 11.4118 -0.34977 -0.0829 -0.2489 -0.8839 1256 BSPBio_002028 Cc1cc(NS(=O)(=O)c2ccc(N)cc2)no1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 F11 compound treatment 10.5807 -1.2926 -0.3468 11.6156 -0.146 -0.0346 -0.2697 -0.7738 3173081 BSPBio_002029 COCCc1ccc(OCC(O)CNC(C)C)cc1.OC(C(O)C(=O)O)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 F12 compound treatment 15.3746 3.5013 0.9395 16.2286 4.467 1.0584 1.4127 0.9982 731 BSPBio_002030 CSc1ccc2Sc3ccccc3N(CCC4CCCCN4C)c2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 F13 compound treatment 11.5827 -0.29059 -0.078 10.9314 -0.83026 -0.1967 -0.1942 -0.9179 683 BSPBio_002031 Cc1ncc([N+](=O)[O-])n1CCO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 F14 compound treatment 11.8184 -0.054905 -0.0147 8.8604 -2.9013 -0.6874 -0.4965 -0.7221 816 BSPBio_002032 Cc1cc(cc(C)c1CC2=NCCN2)C(C)(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 F15 compound treatment 18.3139 6.4406 1.7282 19.3679 7.6063 1.8022 2.4964 0.9998 814 BSPBio_002033 Clc1ccc(COC(Cn2ccnc2)c3ccc(Cl)cc3Cl)c(Cl)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 F16 compound treatment 9.3359 -2.5374 -0.6808 10.4139 -1.3478 -0.3193 -0.7072 -0.9405 2060475 BSPBio_002034 COc1cc(OC)c2C(=O)CC(Oc2c1)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 F17 compound treatment 10.3285 -1.5448 -0.4145 9.6864 -2.0752 -0.4917 -0.6408 -0.9964 1077 BSPBio_002035 CN(C)[C@H]1[C@@H]2C[C@@H]3Cc4c(ccc(O)c4C(=O)C3=C(O)[C@]2(O)C(=O)C(=C1O)C(=O)N)N(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 F18 compound treatment 10.8197 -1.0536 -0.2827 12.8452 1.0836 0.2567 -0.0184 -0.0481 3177389 BSPBio_002036 NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](N)C[C@@H]1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 F19 compound treatment 11.1863 -0.68696 -0.1843 8.6536 -3.108 -0.7364 -0.6511 -0.8576 82 BSPBio_002037 Nc1cc(nc(N)[n+]1[O-])N2CCCCC2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 F20 compound treatment 10.9063 -0.96704 -0.2595 10.7928 -0.96877 -0.2295 -0.3458 -0.9981 1533 BSPBio_002038 Cc1cc(CC(=O)O)n(C)c1C(=O)c2ccc(Cl)cc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 F21 compound treatment 10.6546 -1.2187 -0.327 12.7245 0.96291 0.2281 -0.0699 -0.1753 1000139 BSPBio_002039 CO[C@]1(NC(=O)C(C(=O)O)c2ccc(O)cc2)[C@H]3OCC(=C(N3C1=O)C(=O)O)CSc4nnnn4C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 F22 compound treatment 12.1424 0.2691 0.0722 12.0624 0.30083 0.0713 0.1015 1.0 753 BSPBio_002040 O=C1C(CCS(=O)c2ccccc2)C(=O)N(N1c3ccccc3)c4ccccc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 F23 mock treatment 9.5756 -2.2977 -0.6165 9.3223 -2.4393 -0.5779 -0.8446 -0.9995 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 F24 mock treatment 10.8444 -1.0289 -0.2761 10.603 -1.1586 -0.2745 -0.3893 -1.0 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 G01 mock treatment 11.9207 0.047393 0.0127 11.7889 0.02729 0.0065 0.0136 0.9508 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 G02 mock treatment 11.1649 -0.70841 -0.1901 10.7267 -1.0349 -0.2452 -0.3078 -0.9921 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 G03 compound treatment 12.458 0.58467 0.1569 14.1299 2.3683 0.5611 0.5077 0.8714 1309 BSPBio_002041 Cc1cc(C2CCCCC2)n(O)c(=O)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 G04 compound treatment 12.8814 1.0081 0.2705 12.4366 0.67499 0.1599 0.3044 0.9686 945 BSPBio_002042 C[C@@H]1CC2C3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)C(C)(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 G05 compound treatment 10.8646 -1.0087 -0.2707 10.3797 -1.3819 -0.3274 -0.4229 -0.9955 956 BSPBio_002043 CCn1nc(C(=O)O)c(=O)c2cc3OCOc3cc12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 G06 compound treatment 15.8616 3.9883 1.0702 11.7044 -0.05726 -0.0136 0.7471 0.6981 3177453 BSPBio_002044 CC(=O)OCC(=O)[C@]12OC(C)(C)O[C@@H]2CC3C4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@@]31C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 G07 compound treatment 11.5978 -0.27546 -0.0739 11.1502 -0.61144 -0.1449 -0.1547 -0.9512 927 BSPBio_002045 CN1CCC[C@@H]1CCO[C@](C)(c2ccccc2)c3ccc(Cl)cc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 G08 compound treatment 16.3251 4.4517 1.1945 12.3423 0.58064 0.1376 0.9419 0.7834 694 BSPBio_002046 C[C@H]1CC2C3CC[C@](O)(C(=O)C)[C@@]3(C)C[C@H](O)[C@]2(F)C4(C)C=CC(=O)C=C14 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 G09 compound treatment 11.6413 -0.23199 -0.0622 12.3697 0.60811 0.1441 0.0579 0.3687 1303 BSPBio_002047 C[N+]1(CCC2CC1)CC2OC(=O)C(O)(c3ccccc3)c4ccccc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 G10 compound treatment 15.1109 3.2376 0.8687 10.5166 -1.245 -0.295 0.4057 0.4422 720 BSPBio_002048 Fc1c[nH]c(=O)[nH]c1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 G11 compound treatment 10.4415 -1.4318 -0.3842 8.8162 -2.9454 -0.6979 -0.7651 -0.9605 1090 BSPBio_002049 CCC[C@@H]1C[C@H](N(C)C1)C(=O)NC(C(C)Cl)C2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 G12 compound treatment 11.7895 -0.083782 -0.0225 12.3716 0.60996 0.1445 0.0863 0.59 1000135 BSPBio_002050 CC(C(=O)O)c1ccc(c(F)c1)c2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 G13 compound treatment 11.6341 -0.23921 -0.0642 7.8211 -3.9405 -0.9336 -0.7056 -0.7539 877 BSPBio_002051 CC(C)(Oc1ccc(Cl)cc1)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 G14 compound treatment 8.9772 -2.8961 -0.7771 9.5738 -2.1878 -0.5184 -0.916 -0.9806 3043753 BSPBio_002052 [O-][N+](=O)c1ccc(/C=N/N2CCOC2=O)o1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 G15 compound treatment 12.6144 0.74112 0.1989 12.3753 0.61373 0.1454 0.2434 0.9882 1088 BSPBio_002053 CCN(CC)CCOc1ccc(cc1)/C(=C(\Cl)/c2ccccc2)/c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 G16 compound treatment 10.688 -1.1853 -0.318 10.023 -1.7386 -0.4119 -0.5162 -0.9918 1188 BSPBio_002054 NS(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 G17 compound treatment 10.3071 -1.5662 -0.4202 9.5554 -2.2062 -0.5227 -0.6668 -0.9941 448 BSPBio_002055 Clc1cccc(Cl)c1N=C2NCCN2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 G18 compound treatment 9.7557 -2.1176 -0.5682 11.6604 -0.1012 -0.024 -0.4187 -0.7363 742 BSPBio_002056 C[C@@H]1[C@H](O)CC[C@@]2(C)[C@H]1CC[C@@]3(C)C2[C@H](O)C[C@H]4/C(=C(/CCC=C(C)C)\C(=O)O)/[C@H](C[C@@]43C)OC(=O)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 G19 compound treatment 8.8786 -2.9947 -0.8036 11.2421 -0.51952 -0.1231 -0.6552 -0.806 1272 BSPBio_002057 Clc1ccccc1C(c2ccccc2)(c3ccccc3)n4ccnc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 G20 compound treatment 11.7103 -0.16303 -0.0437 8.8594 -2.9022 -0.6876 -0.5172 -0.7506 1257 BSPBio_002058 CC[N+](CC)(CC)CCOc1cccc(OCC[N+](CC)(CC)CC)c1OCC[N+](CC)(CC)CC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 G21 compound treatment 11.8411 -0.032187 -0.0086 9.9116 -1.85 -0.4383 -0.3161 -0.7209 1337 BSPBio_002059 Cc1onc(c1C(=O)N[C@H]2[C@H]3SC(C)(C)[C@@H](N3C2=O)C(=O)O)c4ccccc4Cl 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 G22 compound treatment 9.6149 -2.2584 -0.606 10.936 -0.82564 -0.1956 -0.5668 -0.8901 796 BSPBio_002060 Cc1ccc(C)c(OCCCC(C)(C)C(=O)O)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 G23 mock treatment 8.7693 -3.104 -0.8329 9.2807 -2.4809 -0.5878 -1.0046 -0.9854 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 G24 mock treatment 10.742 -1.1313 -0.3036 12.721 0.9594 0.2273 -0.0539 -0.1422 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 H01 mock treatment 12.2048 0.33144 0.0889 10.3445 -1.4171 -0.3358 -0.1745 -0.5025 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 H02 mock treatment 15.0614 3.1881 0.8554 12.0716 0.31001 0.0735 0.6568 0.765 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 H03 compound treatment 12.5467 0.67334 0.1807 14.8453 3.0837 0.7306 0.6444 0.8562 1000108 BSPBio_002061 NC(=O)c1ccc[n+](c1)[C@@H]2O[C@H](COP(=O)(O)OP(=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc5c(N)ncnc45)[C@@H](O)[C@H]2O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 H04 compound treatment 11.7177 -0.15561 -0.0418 11.8534 0.09177 0.0217 -0.0141 -0.3006 1552436 BSPBio_002062 COc1ccc(cc1)c2cc(=O)c3cc(OC)ccc3o2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 H05 compound treatment 13.0623 1.189 0.319 12.7845 1.0229 0.2424 0.397 0.9908 3173600 BSPBio_002063 Oc1ccc2C[C@H]3N(CC=C)CC[C@]4(C5Oc1c24)[C@@]3(O)CCC5=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 H06 compound treatment 10.762 -1.1113 -0.2982 10.2617 -1.4999 -0.3554 -0.4621 -0.9962 1011559 BSPBio_002064 Cc1cc(=O)oc2cc(O)c(O)cc12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 H07 compound treatment 11.7659 -0.10744 -0.0288 10.6876 -1.074 -0.2545 -0.2003 -0.7822 1083 BSPBio_002065 C(C1=NCCN1)c2cccc3ccccc23 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 H08 compound treatment 10.4983 -1.3751 -0.369 11.1201 -0.64155 -0.152 -0.3684 -0.9231 743 BSPBio_002066 CC(C)(C)NCC(O)c1cc(O)cc(O)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 H09 compound treatment 10.0813 -1.792 -0.4808 11.1279 -0.63373 -0.1502 -0.4462 -0.8857 890 BSPBio_002067 COc1ccc2cc(ccc2c1)[C@H](C)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 H10 compound treatment 14.1253 2.252 0.6043 10.9983 -0.76331 -0.1809 0.2994 0.4747 965 BSPBio_002068 C(C1=NCCN1)c2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 H11 compound treatment 12.264 0.39071 0.1048 10.9018 -0.85979 -0.2037 -0.0699 -0.3052 1300 BSPBio_002069 OC(=O)c1cccnc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 H12 compound treatment 11.1501 -0.72323 -0.1941 8.7357 -3.026 -0.717 -0.6442 -0.8673 679 BSPBio_002070 CC(=O)Nc1cc(ccc1O)[As](=O)(O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 H13 compound treatment 10.1901 -1.6832 -0.4516 10.2549 -1.5067 -0.357 -0.5718 -0.9932 110 BSPBio_002071 COC(=O)C1=C(C)NC(=C(C1c2ccccc2[N+](=O)[O-])C(=O)OC)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 H14 compound treatment 11.6052 -0.26808 -0.0719 10.616 -1.1456 -0.2714 -0.2428 -0.8647 1030891 BSPBio_002072 Cc1cc(=O)oc2c(O)c(O)ccc12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 H15 compound treatment 9.0559 -2.8174 -0.756 9.8654 -1.8962 -0.4493 -0.8522 -0.9691 3173466 BSPBio_002073 [O-][N+](=O)c1ccc(/C=N/N2CC(=O)NC2=O)o1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 H16 compound treatment 8.9294 -2.9439 -0.7899 11.3434 -0.41819 -0.0991 -0.6286 -0.7896 1499608 BSPBio_002074 COc1ccc2c(=O)cc(oc2c1)c3ccccc3OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 H17 compound treatment 10.6314 -1.242 -0.3332 9.2222 -2.5394 -0.6017 -0.6611 -0.9612 3172716 BSPBio_002075 NC(=O)N/N=C/c1ccc(o1)[N+](=O)[O-] 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 H18 compound treatment 630.3535 618.48 165.9541 586.4222 574.66 136.1574 213.6251 0.9952 892 BSPBio_002076 C[n+]1c2cc(N)ccc2cc3ccc(N)cc13 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 H19 compound treatment 14.315 2.4417 0.6552 10.8343 -0.92736 -0.2197 0.3079 0.4456 1406 BSPBio_002077 NC(=O)c1cc(cc(c1)[N+](=O)[O-])[N+](=O)[O-] 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 H20 compound treatment 10.0237 -1.8496 -0.4963 13.4494 1.6878 0.3999 -0.0682 -0.107 198 BSPBio_002078 CCCCNC(=O)NS(=O)(=O)c1ccc(C)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 H21 compound treatment 9.4534 -2.42 -0.6493 10.1164 -1.6452 -0.3898 -0.7348 -0.9702 879 BSPBio_002079 NC[C@H](O)c1ccc(O)c(O)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 H22 compound treatment 10.2757 -1.5977 -0.4287 10.9691 -0.79249 -0.1878 -0.4359 -0.9314 1064 BSPBio_002080 [O-][N+](=O)O[C@@H]1CO[C@@H]2[C@H](CO[C@H]12)O[N+](=O)[O-] 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 H23 mock treatment 9.201 -2.6723 -0.717 11.5063 -0.25529 -0.0605 -0.5498 -0.764 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 H24 mock treatment 9.5075 -2.3658 -0.6348 8.4308 -3.3308 -0.7892 -1.0069 -0.9942 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 I01 mock treatment 12.9727 1.0994 0.295 8.7476 -3.014 -0.7141 -0.2964 -0.3836 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 I02 mock treatment 12.4703 0.59699 0.1602 11.2891 -0.47247 -0.1119 0.0341 0.1746 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 I03 compound treatment 11.29 -0.58329 -0.1565 9.9237 -1.8379 -0.4355 -0.4186 -0.9046 820 BSPBio_002081 Oc1ccc(Cl)c2cccnc12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 I04 compound treatment 10.8016 -1.0717 -0.2876 11.4111 -0.35048 -0.083 -0.2621 -0.8755 3172720 BSPBio_002082 CNC(C)[C@@H]1CC[C@@H](N)[C@@H](OC2[C@@H](N)C[C@@H](N)[C@H](OC3OC[C@](C)(O)[C@H](NC)[C@H]3O)[C@H]2O)O1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 I05 compound treatment 149.3025 137.43 36.8758 140.3382 128.58 30.4643 47.6167 0.9955 1352 BSPBio_002083 COc1cc2CC[C@H](NC(=O)C)c3cc(=O)c(OC)ccc3-c2c(OC)c1OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 I06 compound treatment 56.7428 44.87 12.0396 54.7647 43.003 10.189 15.718 0.9966 704 BSPBio_002084 CN(C)c1ccc(cc1)C(=C2C=CC(=[N+](C)C)C=C2)c3ccc(cc3)N(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 I07 compound treatment 11.4532 -0.42013 -0.1127 13.7262 1.9645 0.4655 0.2494 0.5208 1111 BSPBio_002085 CCC(C)C1NC(=O)C(CCNCS(=O)(=O)O)NC(=O)C(CCNC(=O)C(NC(=O)C(CCNCS(=O)(=O)O)NC(=O)C(CCNCS(=O)(=O)O)NC(=O)C(NC1=O)C(C)CC)C(C)O)NC(=O)C(CCNCS(=O)(=O)O)NC(=O)C(NC(=O)C(CCNCS(=O)(=O)O)NC(=O)CCCCC(C)C)C(C)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 I08 compound treatment 11.8342 -0.039132 -0.0105 10.3558 -1.4058 -0.3331 -0.243 -0.729 906 BSPBio_002086 N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 I09 compound treatment 10.3073 -1.566 -0.4202 9.2672 -2.4945 -0.591 -0.715 -0.986 682 BSPBio_002087 CC(=O)OCC(=O)[C@@]1(O)CCC2C3CCC4=CC(=O)CC[C@]4(C)C3C(=O)C[C@@]21C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 I10 compound treatment 10.9947 -0.87859 -0.2357 9.6168 -2.1448 -0.5082 -0.526 -0.939 896 BSPBio_002088 COc1ccccc1OCC(O)CO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 I11 compound treatment 10.2772 -1.5961 -0.4283 13.0133 1.2517 0.2966 -0.0931 -0.1788 2060358 BSPBio_002089 C[C@@H]1CCC2[C@](C)(CO)[C@@H](O)CC[C@]2(C)[C@]31CC[C@@](CO)(CCO)O3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 I12 compound treatment 10.4682 -1.4051 -0.377 9.4666 -2.295 -0.5438 -0.6511 -0.984 3044526 BSPBio_002090 NC(=N)N/N=C\c1c(Cl)cccc1Cl 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 I13 compound treatment 8.3602 -3.5131 -0.9426 9.4542 -2.3074 -0.5467 -1.0531 -0.9664 964 BSPBio_002091 CN(C)N=Nc1[nH]cnc1C(=O)N 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 I14 compound treatment 13.6543 1.781 0.4779 10.8763 -0.8853 -0.2098 0.1896 0.3633 3055 BSPBio_002092 NC(=N)NCCN1CCCCCCC1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 I15 compound treatment 9.472 -2.4013 -0.6443 10.667 -1.0946 -0.2594 -0.639 -0.92 1446 BSPBio_002093 OC(COc1cccc2oc(cc(=O)c12)C(=O)O)COc3cccc4oc(cc(=O)c34)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 I16 compound treatment 10.0137 -1.8596 -0.499 8.6769 -3.0847 -0.7309 -0.8696 -0.9827 1290 BSPBio_002094 OC(=O)c1ccc(cc1)S(=O)(=O)N(Cl)Cl 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 I17 compound treatment 10.4712 -1.4021 -0.3762 11.0034 -0.75821 -0.1796 -0.3931 -0.9428 1000807 BSPBio_002095 CN1CCN(CC1)C(c2ccccc2)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 I18 compound treatment 10.8315 -1.0418 -0.2795 13.4554 1.6938 0.4013 0.0861 0.1761 1261 BSPBio_002096 OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 I19 compound treatment 13.016 1.1427 0.3066 11.1693 -0.59234 -0.1403 0.1176 0.3487 1221 BSPBio_002097 CN(C)CCOC(=O)C(c1ccccc1)C2(O)CCCC2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 I20 compound treatment 10.6294 -1.2439 -0.3338 10.5861 -1.1755 -0.2785 -0.433 -0.996 3173079 BSPBio_002098 CC1(C)N[C@@H](C(=O)N1C2[C@H]3SC(C)(C)[C@@H](N3C2=O)C(=O)O)c4ccccc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 I21 compound treatment 12.2454 0.37212 0.0998 10.4059 -1.3557 -0.3212 -0.1565 -0.4653 894 BSPBio_002099 ClCCN(CCCl)P1(=O)NCCCO1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 I22 compound treatment 10.8441 -1.0292 -0.2762 12.4444 0.68276 0.1618 -0.0809 -0.2527 1238 BSPBio_002100 Oc1c(Cl)cc(Cl)c(Cl)c1Cc2c(O)c(Cl)cc(Cl)c2Cl 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 I23 mock treatment 11.8021 -0.071197 -0.0191 11.608 -0.15357 -0.0364 -0.0392 -0.9548 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 I24 mock treatment 10.0119 -1.8614 -0.4995 12.5627 0.80111 0.1898 -0.2189 -0.4098 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 J01 mock treatment 12.5025 0.62922 0.1688 12.0441 0.2825 0.0669 0.1667 0.9179 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 J02 mock treatment 9.9768 -1.8965 -0.5089 8.2088 -3.5528 -0.8418 -0.9551 -0.9709 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 J03 compound treatment 10.8879 -0.98538 -0.2644 12.2689 0.50729 0.1202 -0.102 -0.3511 1169 BSPBio_002101 C[C@@]12CCC3C(CCC4=CC(=O)CC[C@H]34)C2CC[C@@]1(O)C#C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 J04 compound treatment 9.126 -2.7473 -0.7372 12.0048 0.24322 0.0576 -0.4805 -0.6498 2060323 BSPBio_002102 COc1ccccc1c2cc(=O)c3c(OC)cccc3o2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 J05 compound treatment 9.4448 -2.4285 -0.6516 10.5165 -1.2451 -0.295 -0.6694 -0.9358 1000107 BSPBio_002103 CC(=O)O[C@]1(CCC2C3CCC4=CC(=O)CC[C@@H]4C3CC[C@@]21C)C#C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 J06 compound treatment 13.7996 1.9263 0.5169 11.2951 -0.4665 -0.1105 0.2873 0.5436 1184 BSPBio_002104 Nc1ncnc2n(cnc12)C3O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]3O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 J07 compound treatment 12.7493 0.87594 0.235 10.4699 -1.2917 -0.3061 -0.0502 -0.1301 1115 BSPBio_002105 C[C@@]12CCC3C(CCC4=C3CCC(=O)C4)C2CC[C@@]1(O)C#C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 J08 compound treatment 10.0619 -1.8114 -0.4861 10.1854 -1.5762 -0.3735 -0.6078 -0.9915 865 BSPBio_002106 Cc1ccc(cc1)C(=O)c2ccc(CC(=O)O)n2C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 J09 compound treatment 11.9831 0.10979 0.0295 10.3187 -1.4429 -0.3419 -0.2209 -0.6438 747 BSPBio_002107 CCn1cc(C(=O)O)c(=O)c2cc(F)c(cc12)N3CCNCC3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 J10 compound treatment 10.8205 -1.0528 -0.2825 9.3035 -2.4582 -0.5824 -0.6116 -0.9448 1081 BSPBio_002108 Cc1c(N)c(=O)n(c2ccccc2)n1C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 J11 compound treatment 11.8005 -0.07285 -0.0195 9.3967 -2.3649 -0.5603 -0.41 -0.7313 1219 BSPBio_002109 CC[C@@]12CCC3C(CCC4=CC(=O)CC[C@H]34)C2CC[C@@]1(O)C#C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 J12 compound treatment 11.74 -0.13327 -0.0358 9.603 -2.1586 -0.5114 -0.3869 -0.7547 830 BSPBio_002110 COc1ccc(CN(CCN(C)C)c2ccccn2)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 J13 compound treatment 10.026 -1.8473 -0.4957 10.6694 -1.0922 -0.2588 -0.5335 -0.9541 809 BSPBio_002111 CNCCC=C1c2ccccc2CCc3ccccc13 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 J14 compound treatment 21.4586 9.5853 2.572 23.4537 11.692 2.7703 3.7775 0.9993 763 BSPBio_002112 CCN(CC)CCCC(C)Nc1c2ccc(Cl)cc2nc3ccc(OC)cc13 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 J15 compound treatment 12.2038 0.33051 0.0887 10.9522 -0.80944 -0.1918 -0.0729 -0.345 3177388 BSPBio_002113 COc1ccc2[C@@H](OC(=O)c2c1OC)[C@@H]3N(C)CCc4cc5OCOc5c(OC)c34 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 J16 compound treatment 11.4515 -0.4218 -0.1132 10.4391 -1.3225 -0.3133 -0.3016 -0.9053 1046 BSPBio_002114 CC1C2C(CC3C4CC[C@H]5C[C@@H](O)CC[C@]5(C)C4CC(=O)[C@]23C)OC61CCC(C)CO6 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 J17 compound treatment 10.6219 -1.2514 -0.3358 11.0814 -0.68016 -0.1612 -0.3514 -0.9434 905 BSPBio_002115 CO[C@@H]1[C@@H](OC(=O)N)[C@@H](O)[C@H](Oc2ccc3c(O)c(NC(=O)c4ccc(O)c(CC=C(C)C)c4)c(=O)oc3c2C)OC1(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 J18 compound treatment 12.8656 0.99232 0.2663 11.6855 -0.076153 -0.018 0.1755 0.6577 1284 BSPBio_002116 OC(=O)CN(CC(=O)O)Cc1cc2c(c3ccccc3C(=O)O)c4cc(CN(CC(=O)O)CC(=O)O)c(=O)cc4oc2cc1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 J19 compound treatment 9.5642 -2.3091 -0.6196 10.3688 -1.3929 -0.33 -0.6715 -0.9565 770 BSPBio_002117 CC(CCc1ccccc1)NC(C)C(O)c2ccc(O)cc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 J20 compound treatment 17.1367 5.2634 1.4123 17.3483 5.5866 1.3237 1.9346 0.9995 1028 BSPBio_002118 Oc1ccc(cc1)C(=C2C=CC(=O)C=C2)c3ccc(O)cc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 J21 compound treatment 10.5412 -1.3321 -0.3574 10.0088 -1.7528 -0.4153 -0.5464 -0.9972 3173595 BSPBio_002119 C[C@H]1OC(OC/2CC3O[C@@](O)(CC(O)C3C(=O)O)CC(O)C(O)CCC(O)CC(O)CC(O)CC(=O)O[C@@H](C)C(C)[C@H](O)[C@@H](C)/C=C/C=C/CC\C=C\C=C\C=C\C=C2)[C@@H](O)[C@@H](N)[C@@H]1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 J22 compound treatment 10.3982 -1.4751 -0.3958 9.1959 -2.5657 -0.6079 -0.7097 -0.9784 686 BSPBio_002120 C(Nc1ncnc2[nH]cnc12)c3ccco3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 J23 mock treatment 8.6806 -3.1927 -0.8567 11.1284 -0.6332 -0.15 -0.7118 -0.8185 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 J24 mock treatment 10.9146 -0.95868 -0.2572 9.5538 -2.2078 -0.5231 -0.5518 -0.9466 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 K01 mock treatment 10.9063 -0.96701 -0.2595 13.6171 1.8554 0.4396 0.1274 0.2495 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 K02 mock treatment 12.7487 0.87542 0.2349 13.044 1.2824 0.3038 0.3809 0.9919 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 K03 compound treatment 11.9624 0.089118 0.0239 9.4539 -2.3077 -0.5468 -0.3697 -0.6755 760 BSPBio_002121 N[C@@H]1CONC1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 K04 compound treatment 23.7777 11.904 3.1942 15.6149 3.8533 0.913 2.9042 0.8742 756 BSPBio_002122 CCCCCCc1ccc(O)cc1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 K05 compound treatment 9.5631 -2.3102 -0.6199 11.3651 -0.3965 -0.0939 -0.5047 -0.8051 859 BSPBio_002123 CC(=O)O[C@@]1(CCC2C3C=C(Cl)C4=CC(=O)[C@@H]5C[C@@H]5[C@]4(C)C3CC[C@@]21C)C(=O)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 K06 compound treatment 11.2712 -0.60216 -0.1616 10.7507 -1.0109 -0.2395 -0.2836 -0.9816 465 BSPBio_002124 NCCc1c[nH]cn1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 K07 compound treatment 11.0345 -0.83878 -0.2251 12.0702 0.30855 0.0731 -0.1075 -0.4541 1006 BSPBio_002125 Nc1ccn(C2O[C@H](CO)[C@@H](O)[C@@H]2O)c(=O)n1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 K08 compound treatment 9.6703 -2.2031 -0.5911 12.8291 1.0675 0.2529 -0.2392 -0.3719 700 BSPBio_002126 CN1C2CC[C@H]1C[C@H](C2)OC(=O)C(O)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 K09 compound treatment 10.5396 -1.3337 -0.3579 10.4229 -1.3387 -0.3172 -0.4773 -0.9982 1058 BSPBio_002127 C[C@@]12CCC3C(CCC4=Cc5oncc5C[C@]34C)C2CC[C@@]1(O)C#C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 K10 compound treatment 10.9522 -0.92106 -0.2471 9.6069 -2.1547 -0.5105 -0.5358 -0.9446 789 BSPBio_002128 C[N+]1(C)C2CC[C@H]1C[C@H](C2)OC(=O)C(O)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 K11 compound treatment 11.0076 -0.86571 -0.2323 9.3892 -2.3724 -0.5621 -0.5617 -0.9236 1186 BSPBio_002129 Nc1ccc(cc1)S(=O)(=O)c2ccc(N)cc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 K12 compound treatment 9.6544 -2.2189 -0.5954 11.2117 -0.54994 -0.1303 -0.5131 -0.8419 776 BSPBio_002130 NNc1nncc2ccccc12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 K13 compound treatment 8.5911 -3.2822 -0.8807 9.2762 -2.4854 -0.5889 -1.0391 -0.9808 745 BSPBio_002131 CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 K14 compound treatment 9.3033 -2.57 -0.6896 14.0625 2.3009 0.5452 -0.1021 -0.1162 931 BSPBio_002132 NS(=O)(=O)c1cc2c(NCNS2(=O)=O)cc1Cl 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 K15 compound treatment 9.5829 -2.2904 -0.6146 10.0498 -1.7118 -0.4056 -0.7214 -0.9797 1104 BSPBio_002133 C[C@H](CCC(=O)O)[C@H]1CCC2C3C(CC(=O)[C@]12C)[C@@]4(C)CCC(=O)CC4CC3=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 K16 compound treatment 12.2881 0.41479 0.1113 14.6786 2.917 0.6911 0.5674 0.8105 848 BSPBio_002134 CC(=O)OCC(=O)[C@@]1(O)CCC2C3CCC4=CC(=O)CC[C@]4(C)C3[C@@H](O)C[C@@]21C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 K17 compound treatment 11.9505 0.077203 0.0207 9.7518 -2.0098 -0.4762 -0.3221 -0.6757 1451 BSPBio_002135 CN(C)[C@H]1[C@@H]2C[C@@H]3[C@H](O)c4c(Cl)ccc(O)c4C(=O)C3=C(O)[C@]2(O)C(=O)C(=C1O)C(=O)N 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 K18 compound treatment 9.7033 -2.17 -0.5823 11.0536 -0.70805 -0.1678 -0.5303 -0.8752 1136 BSPBio_002136 C[C@@]12C[C@H](O)C3C(CCC4=CC(=O)CC[C@]34C)C2CC[C@]1(O)C(=O)COC(=O)CCC(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 K19 compound treatment 15.5504 3.6771 0.9867 9.064 -2.6976 -0.6392 0.2457 0.209 844 BSPBio_002137 CNCCCN1c2ccccc2CCc3ccccc13 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 K20 compound treatment 11.4051 -0.4682 -0.1256 10.7862 -0.97544 -0.2311 -0.2523 -0.959 881 BSPBio_002138 CC12C[C@H](O)C3C(CCC4=CC(=O)CCC34C)C2CC[C@]1(O)C(=O)COP(=O)(O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 K21 compound treatment 11.7312 -0.14211 -0.0381 10.5182 -1.2434 -0.2946 -0.2353 -0.792 3172851 BSPBio_002139 C[C@@H]1CC2C3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 K22 compound treatment 10.8233 -1.05 -0.2817 11.1094 -0.6522 -0.1545 -0.3085 -0.96 1131 BSPBio_002140 NS(=O)(=O)c1cc2c(NCNS2(=O)=O)cc1C(F)(F)F 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 K23 mock treatment 8.9033 -2.97 -0.7969 12.5528 0.79124 0.1875 -0.4309 -0.5264 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 K24 mock treatment 12.0235 0.15021 0.0403 9.4587 -2.3029 -0.5456 -0.3573 -0.6531 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 L01 mock treatment 11.2607 -0.61264 -0.1644 11.9962 0.23463 0.0556 -0.0769 -0.4433 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 L02 mock treatment 13.6824 1.8091 0.4854 13.1812 1.4196 0.3364 0.5811 0.9839 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 L03 compound treatment 12.1331 0.25977 0.0697 12.3965 0.63492 0.1504 0.1557 0.9389 1443 BSPBio_002141 CN(C)CCOC(c1ccccc1)c2ccccc2C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 L04 compound treatment 10.3258 -1.5475 -0.4152 12.3438 0.58223 0.138 -0.1961 -0.4481 1000219 BSPBio_002142 N[C@@H](Cc1cc(I)c(Oc2cc(I)c(O)c(I)c2)c(I)c1)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 L05 compound treatment 11.177 -0.69626 -0.1868 10.1971 -1.5646 -0.3707 -0.3942 -0.9497 3173215 BSPBio_002143 Cc1onc(c1C(=O)NC2[C@H]3SC(C)(C)[C@@H](N3C2=O)C(=O)O)c4ccccc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 L06 compound treatment 12.266 0.39268 0.1054 11.8996 0.13803 0.0327 0.0976 0.8849 2060466 BSPBio_002144 OC(=O)Cc1cc(I)c(Oc2cc(I)c(O)c(I)c2)c(I)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 L07 compound treatment 11.6399 -0.23341 -0.0626 10.2417 -1.5199 -0.3601 -0.2989 -0.8178 1181 BSPBio_002145 Cc1cc(c(O)c(C)c1CC2=NCCN2)C(C)(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 L08 compound treatment 11.9543 0.080993 0.0217 10.5914 -1.1702 -0.2773 -0.1807 -0.6497 2935 BSPBio_002146 CC(=O)NCc1c(I)c(NC(=O)C)c(I)c(C(=O)O)c1I 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 L09 compound treatment 19.5013 7.628 2.0468 16.5515 4.7899 1.1349 2.2498 0.9613 1356 BSPBio_002147 Oc1cccc2cccnc12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 L10 compound treatment 11.3504 -0.52296 -0.1403 10.5603 -1.2013 -0.2846 -0.3005 -0.9469 3077178 BSPBio_002148 CC1CCC2(C)C(CCC=C2C)C1(C)CC/C(=C/Cn3c[n+](C)c4c(N)ncnc34)/C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 L11 compound treatment 59.5276 47.654 12.7869 57.3541 45.593 10.8025 16.6802 0.9965 943 BSPBio_002149 CCCCC1C(=O)N(N(C1=O)c2ccc(O)cc2)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 L12 compound treatment 9.7801 -2.0932 -0.5617 12.2197 0.45811 0.1085 -0.3204 -0.5601 1009258 BSPBio_002150 O=C1NC(=O)C(=O)C(=O)N1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 L13 compound treatment 10.0436 -1.8297 -0.491 9.369 -2.3926 -0.5669 -0.748 -0.9974 876 BSPBio_002151 CN(C)[C@H]1[C@@H]2[C@@H](O)[C@H]3C(=C(O)[C@]2(O)C(=O)C(=C1O)C(=O)N)C(=O)c4c(O)cccc4[C@@]3(C)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 L14 compound treatment 9.9371 -1.9362 -0.5195 11.1641 -0.59751 -0.1416 -0.4675 -0.8681 1013195 BSPBio_002152 Nc1ncnc2[nH]cnc12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 L15 compound treatment 11.5777 -0.29558 -0.0793 11.4763 -0.28533 -0.0676 -0.1039 -0.9968 959 BSPBio_002153 COc1ccc(Cc2nccc3cc(OC)c(OC)cc23)cc1OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 L16 compound treatment 99.088 87.215 23.4019 75.818 64.056 15.1772 27.2796 0.978 1009556 BSPBio_002154 Nc1c2ccccc2nc3ccccc13 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 L17 compound treatment 12.6821 0.80882 0.217 14.1113 2.3497 0.5567 0.5471 0.9156 838 BSPBio_002155 COc1ccc(C(=O)c2ccccc2)c(O)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 L18 compound treatment 12.8834 1.0101 0.271 11.6855 -0.07613 -0.018 0.1789 0.6586 909 BSPBio_002156 COc1ccc2cc3-c4cc5OCOc5cc4CC[n+]3cc2c1OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 L19 compound treatment 10.7864 -1.0869 -0.2916 9.3855 -2.3761 -0.563 -0.6043 -0.9531 950 BSPBio_002157 Oc1ccc(Cl)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 L20 compound treatment 13.1769 1.3036 0.3498 8.6496 -3.112 -0.7373 -0.2741 -0.3358 1000253 BSPBio_002158 NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](N)[C@@H](O)[C@@H]1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 L21 compound treatment 10.7545 -1.1188 -0.3002 12.0403 0.27871 0.066 -0.1656 -0.5387 719 BSPBio_002159 CN(CC#C)Cc1ccccc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 L22 compound treatment 14.026 2.1527 0.5776 12.7163 0.95469 0.2262 0.5684 0.9163 1101 BSPBio_002160 CCCC1O[C@@H]2CC3C4CCC5=CC(=O)C=CC5(C)C4[C@@H](O)CC3(C)[C@@]2(O1)C(=O)CO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 L23 mock treatment 9.9222 -1.9511 -0.5235 9.3242 -2.4374 -0.5775 -0.7785 -0.9988 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 L24 mock treatment 13.2838 1.4105 0.3785 12.4632 0.70156 0.1662 0.3852 0.9318 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 M01 mock treatment 10.7494 -1.1239 -0.3016 11.8634 0.10179 0.0241 -0.1962 -0.6485 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 M02 mock treatment 9.8969 -1.9764 -0.5303 11.3166 -0.44503 -0.1054 -0.4496 -0.8314 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 M03 compound treatment 10.7079 -1.1655 -0.3127 10.0757 -1.686 -0.3995 -0.5036 -0.9927 1334 BSPBio_002161 C[C@@H]1CC2C3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COP(=O)(O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 M04 compound treatment 10.2969 -1.5764 -0.423 13.5334 1.7718 0.4198 -0.0023 -0.0038 702 BSPBio_002162 CCCCCC(=O)O[C@@]1(CCC2C3CCC4=CC(=O)CC[C@]4(C)C3CC[C@@]21C)C(=O)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 M05 compound treatment 10.8704 -1.0029 -0.2691 8.4279 -3.3337 -0.7899 -0.7488 -0.8974 1018 BSPBio_002163 COc1ccc2C[C@H]3[C@@H]4CCCC[C@@]4(CCN3C)c2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 M06 compound treatment 11.0091 -0.86418 -0.2319 9.5661 -2.1955 -0.5202 -0.5318 -0.9337 430 BSPBio_002164 NC(=O)NO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 M07 compound treatment 12.14 0.26667 0.0716 10.4412 -1.3204 -0.3129 -0.1706 -0.5317 1024 BSPBio_002165 c1ccc2c(c1)sc3ccccc32 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 M08 compound treatment 9.6711 -2.2022 -0.5909 12.8623 1.1007 0.2608 -0.2334 -0.3614 3174102 BSPBio_002166 OCCOCCN1CCN(CC1)C(c2ccccc2)c3ccc(Cl)cc3.OC(=O)c1cc2ccccc2c(Cc3c(O)c(cc4ccccc34)C(=O)O)c1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 M09 compound treatment 10.2572 -1.6161 -0.4336 9.7589 -2.0027 -0.4745 -0.6422 -0.999 969 BSPBio_002167 CCCCOc1cc(C(=O)NCCN(CC)CC)c2ccccc2n1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 M10 compound treatment 10.2297 -1.6436 -0.441 9.1706 -2.591 -0.6139 -0.7459 -0.9868 1124 BSPBio_002168 CN1C2CC[C@@H]1C[C@H](C2)OC(=O)[C@H](CO)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 M11 compound treatment 10.5922 -1.2811 -0.3438 10.4365 -1.3251 -0.314 -0.4651 -0.999 915 BSPBio_002169 OC(=O)Cc1ccccc1Nc2c(Cl)cccc2Cl 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 M12 compound treatment 10.6067 -1.2666 -0.3399 9.5446 -2.217 -0.5253 -0.6118 -0.9778 1000138 BSPBio_002170 CC(C)Cc1ccc(cc1)C(C)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 M13 compound treatment 12.145 0.27169 0.0729 8.8625 -2.8991 -0.6869 -0.4342 -0.6285 1265 BSPBio_002171 Cc1onc(c1C(=O)N[C@H]2[C@H]3SC(C)(C)[C@@H](N3C2=O)C(=O)O)c4c(Cl)cccc4Cl 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 M14 compound treatment 10.406 -1.4673 -0.3937 13.0197 1.258 0.2981 -0.0676 -0.137 1174 BSPBio_002172 CN(C)CCCN1c2ccccc2CCc3ccccc13 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 M15 compound treatment 11.6929 -0.18043 -0.0484 16.0275 4.2659 1.0107 0.6805 0.6725 1481 BSPBio_002173 Oc1c(Cc2c(O)c3ccccc3oc2=O)c(=O)oc4ccccc14 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 M16 compound treatment 9.7462 -2.1271 -0.5708 8.8407 -2.9209 -0.6921 -0.893 -0.9954 1127 BSPBio_002174 CC1Cc2ccccc2N1NC(=O)c3ccc(Cl)c(c3)S(=O)(=O)N 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 M17 compound treatment 17.0239 5.1506 1.382 18.771 7.0094 1.6608 2.1516 0.9958 819 BSPBio_002175 CCN(CC)CCOC(=O)C1(CCCCC1)C2CCCCC2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 M18 compound treatment 12.0947 0.22137 0.0594 13.638 1.8763 0.4446 0.3564 0.7945 2797 BSPBio_002176 COc1ccc2n(C(=O)c3ccc(Cl)cc3)c(C)c(CC(=O)O)c2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 M19 compound treatment 15.5674 3.6941 0.9912 15.1909 3.4293 0.8125 1.2754 0.9951 1370 BSPBio_002177 C/C=C(/C(=C/C)/c1ccc(O)cc1)\c2ccc(O)cc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 M20 compound treatment 11.2563 -0.61705 -0.1656 10.2965 -1.4651 -0.3471 -0.3625 -0.9426 1029 BSPBio_002178 CC(C(=O)O)c1ccc(cc1)N2Cc3ccccc3C2=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 M21 compound treatment 9.1477 -2.7256 -0.7314 11.6266 -0.13501 -0.032 -0.5398 -0.7373 1164 BSPBio_002179 CCN(CC)C(=O)N1CCN(C)CC1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 M22 compound treatment 11.451 -0.4223 -0.1133 15.834 4.0724 0.9649 0.6022 0.6198 778 BSPBio_002180 Oc1c(I)cc(I)c2cccnc12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 M23 mock treatment 11.0625 -0.81083 -0.2176 12.0863 0.32464 0.0769 -0.0995 -0.431 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 M24 mock treatment 9.2316 -2.6417 -0.7088 11.6858 -0.075835 -0.018 -0.5139 -0.7248 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 N01 mock treatment 11.4371 -0.43621 -0.117 11.1142 -0.64737 -0.1534 -0.1912 -0.9911 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 N02 mock treatment 12.2474 0.37407 0.1004 11.335 -0.4266 -0.1011 -5.0E-4 -0.0035 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 N03 compound treatment 10.4409 -1.4324 -0.3844 12.5361 0.77454 0.1835 -0.142 -0.3334 952 BSPBio_002181 CC(C)(S)[C@@H](N)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 N04 compound treatment 48.4363 36.563 9.8108 42.5288 30.767 7.2898 12.092 0.9893 3172726 BSPBio_002182 C[C@]12C3CCC(O3)[C@]2(C)C(=O)OC1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 N05 compound treatment 11.9531 0.079768 0.0214 9.5396 -2.222 -0.5265 -0.3571 -0.6778 954 BSPBio_002183 CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 N06 compound treatment 10.9582 -0.91513 -0.2456 11.2618 -0.49981 -0.1184 -0.2574 -0.9441 3172727 BSPBio_002184 CC(=C)[C@@H]1CC[C@]2(CO)CC[C@]3(C)[C@H](CCC4[C@@]5(C)CC[C@H](O)C(C)(C)C5CC[C@]43C)C12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 N07 compound treatment 13.458 1.5847 0.4252 11.1427 -0.61892 -0.1466 0.197 0.4379 1377 BSPBio_002185 CC1(C)S[C@@H]2[C@H](NC(=O)COc3ccccc3)C(=O)N2[C@H]1C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 N08 compound treatment 11.2764 -0.59686 -0.1602 13.0986 1.337 0.3168 0.1108 0.312 3055310 BSPBio_002186 COc1c(O)cc2C(=O)O[C@H]3[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]3c2c1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 N09 compound treatment 10.2464 -1.6269 -0.4365 12.1705 0.40884 0.0969 -0.2402 -0.5371 1404 BSPBio_002187 Nc1ccc(N=Nc2ccccc2)c(N)n1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 N10 compound treatment 9.9543 -1.919 -0.5149 13.2038 1.4422 0.3417 -0.1225 -0.1982 2060339 BSPBio_002188 COc1cc2N3C4[C@H]5[C@H]6C[C@@H]7N(CC[C@@]74c2cc1OC)CC6=CCOC5CC3=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 N11 compound treatment 10.2485 -1.6249 -0.436 12.6687 0.90714 0.2149 -0.1563 -0.3216 976 BSPBio_002189 CNC(=O)Oc1ccc2N(C)[C@H]3N(C)CC[C@@]3(C)c2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 N12 compound treatment 90.482 78.609 21.0927 104.8858 93.124 22.0644 30.5167 0.9997 1113269 BSPBio_002190 CN1Cc2c3OCOc3ccc2C4C(O)Cc5cc6OCOc6cc5C41 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 N13 compound treatment 12.1798 0.30644 0.0822 12.0595 0.29788 0.0706 0.108 0.9971 992 BSPBio_002191 CC[C@H]1[C@@H](Cc2cncn2C)COC1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 N14 compound treatment 10.9264 -0.94688 -0.2541 11.7893 0.02769 0.0066 -0.175 -0.6886 1064620 BSPBio_002192 COC1=CC23CCCN3CCc4cc5OCOc5cc4C2C1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 N15 compound treatment 10.3826 -1.4907 -0.4 11.5787 -0.18291 -0.0433 -0.3135 -0.7792 1428 BSPBio_002193 CC(C)NCC(O)COc1cccc2[nH]ccc12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 N16 compound treatment 12.0806 0.20724 0.0556 9.9499 -1.8117 -0.4293 -0.2642 -0.6104 2060472 BSPBio_002194 C[C@@]12CCC3C(C=CC4=CC(=O)CC[C@]34C)C2CC[C@@]1(O)CCC(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 N17 compound treatment 10.9908 -0.88251 -0.2368 11.8308 0.06921 0.0164 -0.1558 -0.6566 3173725 BSPBio_002195 CCN1CCN(C(=O)NC(C(=O)N[C@H]2[C@H]3SC(C)(C)[C@@H](N3C2=O)C(=O)O)c4ccccc4)C(=O)C1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 N18 compound treatment 11.1354 -0.73786 -0.198 9.4508 -2.3109 -0.5475 -0.5272 -0.9054 2060324 BSPBio_002196 CC12CC[C@@H]3[C@H](CC3(C)C)C(=C)CC2O1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 N19 compound treatment 11.978 0.10467 0.0281 9.3067 -2.4549 -0.5817 -0.3914 -0.6722 1333 BSPBio_002197 CCC(C)CCCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(NC(=O)C(CCN)NC(=O)C(CCN)NC(=O)C(CC(C)C)NC(=O)C(Cc2ccccc2)NC(=O)C(CCN)NC1=O)C(C)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 N20 compound treatment 10.7904 -1.0829 -0.2906 11.1363 -0.62528 -0.1482 -0.3102 -0.9511 3173360 BSPBio_002198 CC(CCC(=O)O)[C@H]1CCC2C3CC[C@@H]4CCCC[C@]4(C)C3CC[C@]12C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 N21 compound treatment 9.3224 -2.551 -0.6845 12.3766 0.61494 0.1457 -0.381 -0.5444 1000106 BSPBio_002199 O=C(C1CCCCC1)N2CC3N(CCc4ccccc34)C(=O)C2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 N22 compound treatment 10.7372 -1.1362 -0.3049 11.3997 -0.36187 -0.0857 -0.2762 -0.8721 710 BSPBio_002200 CC(=O)OCC1=C(N2C(SC1)[C@H](NC(=O)CCCC(N)C(=O)O)C2=O)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 N23 mock treatment 12.2946 0.42129 0.113 12.1463 0.38466 0.0911 0.1444 0.9943 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 N24 mock treatment 12.6643 0.79097 0.2122 11.6467 -0.11491 -0.0272 0.1308 0.6114 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 O01 mock treatment 13.0705 1.1972 0.3212 12.7865 1.0249 0.2428 0.3989 0.9905 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 O02 mock treatment 12.0876 0.21432 0.0575 13.026 1.2644 0.2996 0.2525 0.8277 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 O03 compound treatment 36.2533 24.38 6.5418 65.2021 53.44 12.6619 13.5791 0.9528 1138 BSPBio_002201 CC/C(=C(/CC)\c1ccc(O)cc1)/c2ccc(O)cc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 O04 compound treatment 10.9108 -0.96252 -0.2583 10.1291 -1.6325 -0.3868 -0.4561 -0.9807 3045140 BSPBio_002202 CC(C)[N+]1(C)C2CC[C@@H]1C[C@H](C2)OC(=O)C(CO)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 O05 compound treatment 11.8655 -0.0077646 -0.0021 12.3792 0.61756 0.1463 0.102 0.697 1518 BSPBio_002203 OC(=O)c1cc(ccc1O)c2ccc(F)cc2F 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 O06 compound treatment 15.7047 3.8314 1.0281 12.2026 0.44101 0.1045 0.8008 0.775 735 BSPBio_002204 NNC(=O)c1ccncc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 O07 compound treatment 16.4749 4.6015 1.2347 18.6961 6.9345 1.643 2.0349 0.9901 707 BSPBio_002205 C[C@H]1O[C@H](C[C@H](O)[C@@H]1O)O[C@@H]2[C@@H](C)O[C@H](C[C@@H]2O)O[C@@H]3[C@@H](C)O[C@H](C[C@@H]3O)O[C@H]4CC[C@@]5(C)[C@H](CCC6C5CC[C@]7(C)[C@H](CC[C@]67O)C8=CC(=O)OC8)C4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 O08 compound treatment 13.1533 1.2799 0.3434 12.2242 0.46259 0.1096 0.3204 0.8886 888 BSPBio_002206 CC(C)[N+](C)(CCC(C(=O)N)(c1ccccc1)c2ccccc2)C(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 O09 compound treatment 19.2668 7.3935 1.9839 19.7804 8.0188 1.8999 2.7463 0.9998 1454 BSPBio_002207 C[C@H]1O[C@H](C[C@H](O)[C@@H]1O)O[C@@H]2[C@@H](C)O[C@H](C[C@@H]2O)O[C@@H]3[C@@H](C)O[C@H](C[C@@H]3O)O[C@H]4CC[C@@]5(C)[C@H](CCC6C5C[C@@H](O)[C@]7(C)[C@H](CC[C@]67O)C8=CC(=O)OC8)C4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 O10 compound treatment 11.0231 -0.85022 -0.2281 12.2307 0.4691 0.1111 -0.0827 -0.326 1479 BSPBio_002208 CC(C)NCC(O)c1ccc(O)c(O)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 O11 compound treatment 12.1918 0.31851 0.0855 14.6974 2.9357 0.6956 0.5523 0.7881 1204 BSPBio_002209 CN1C[C@@H](C[C@H]2[C@H]1Cc3c[nH]c4cccc2c34)C(=O)N[C@]5(C)O[C@@]6(O)[C@@H]7CCCN7C(=O)[C@H](Cc8ccccc8)N6C5=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 O12 compound treatment 10.7541 -1.1192 -0.3003 9.2428 -2.5188 -0.5968 -0.6344 -0.9495 3650171 BSPBio_002210 C[C@H](COc1ccccc1)N[C@H](C)[C@H](O)c2ccc(O)cc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 O13 compound treatment 9.662 -2.2113 -0.5933 10.9872 -0.7744 -0.1835 -0.5493 -0.8844 3174228 BSPBio_002211 CN[C@H]1C(O)C(O)C(CO)OC1OC2[C@H](O[C@H]3[C@H](O)[C@@H](O)[C@H](NC(=N)N)[C@@H](O)[C@@H]3NC(=N)N)OC(C)[C@]2(O)CO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 O14 compound treatment 11.3622 -0.51107 -0.1371 11.3443 -0.41729 -0.0989 -0.1669 -0.9871 3177386 BSPBio_002212 NC[C@H]1O[C@H](OC2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 O15 compound treatment 9.6381 -2.2352 -0.5998 9.9482 -1.8134 -0.4297 -0.7279 -0.9866 3173092 BSPBio_002213 CN(C)CCOC(c1ccccc1)c2ccccc2.Cn1c(=O)n(C)c2nc(Cl)[nH]c2c1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 O16 compound treatment 10.6846 -1.1887 -0.319 12.1998 0.43821 0.1038 -0.1521 -0.4535 1157 BSPBio_002214 CC(=O)N1CCN(CC1)c2ccc(OCC3CO[C@@](Cn4ccnc4)(O3)c5ccc(Cl)cc5Cl)cc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 O17 compound treatment 11.5188 -0.35452 -0.0951 9.6987 -2.063 -0.4888 -0.4129 -0.8292 1519 BSPBio_002215 CC1(C)OC(=O)NC1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 O18 compound treatment 9.8401 -2.0332 -0.5456 9.1696 -2.592 -0.6141 -0.82 -0.9983 729 BSPBio_002216 OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 O19 compound treatment 9.8394 -2.0339 -0.5457 12.0325 0.27091 0.0642 -0.3405 -0.6197 3059213 BSPBio_002217 COc1ccc(C(=O)c2ccccc2O)c(O)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 O20 compound treatment 11.169 -0.70429 -0.189 12.0844 0.32279 0.0765 -0.0795 -0.3902 873 BSPBio_002218 Nc1nc(=O)c2N(C=O)C(CNc3ccc(cc3)C(=O)N[C@@H](CCC(=O)O)C(=O)O)CNc2[nH]1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 O21 compound treatment 12.9489 1.0756 0.2886 9.7584 -2.0032 -0.4746 -0.1315 -0.2368 1002 BSPBio_002219 CN(C)CCOC(c1ccccc1)c2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 O22 compound treatment 10.9923 -0.88103 -0.2364 11.115 -0.64664 -0.1532 -0.2755 -0.978 953 BSPBio_002220 C[C@H](N)[C@H](O)c1ccc(O)c(O)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 O23 mock treatment 12.9173 1.0439 0.2801 11.0435 -0.71814 -0.1702 0.0778 0.2372 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 O24 mock treatment 14.0469 2.1736 0.5832 10.9774 -0.78422 -0.1858 0.281 0.4591 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 P01 mock treatment 12.3921 0.51877 0.1392 11.4272 -0.33442 -0.0792 0.0424 0.2647 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 P02 mock treatment 10.7696 -1.1037 -0.2962 9.7511 -2.0105 -0.4764 -0.5463 -0.9739 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 P03 compound treatment 10.5764 -1.2969 -0.348 12.9462 1.1846 0.2807 -0.0476 -0.1065 349 BSPBio_002221 COc1cc2nc(nc(N)c2cc1OC)N3CCN(CC3)C(=O)c4ccco4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 P04 compound treatment 12.0235 0.15024 0.0403 15.0642 3.3026 0.7825 0.5818 0.7425 1000126 BSPBio_002222 C[C@H](CCC(=O)O)[C@H]1CCC2C3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)C3CC[C@]12C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 P05 compound treatment 10.3333 -1.54 -0.4132 21.6699 9.9083 2.3476 1.3678 0.5738 2551 BSPBio_002223 COc1cc(NC(C)CCCN)c2ncccc2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 P06 compound treatment 10.8395 -1.0338 -0.2774 10.4061 -1.3555 -0.3212 -0.4233 -0.9973 3055321 BSPBio_002224 CC(CCC(=O)O)[C@H]1CCC2C3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)C3C[C@H](O)[C@]12C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 P07 compound treatment 9.4205 -2.4528 -0.6581 13.7959 2.0343 0.482 -0.1246 -0.1527 962 BSPBio_002225 CCC1(C(=O)NCNC1=O)c2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 P08 compound treatment 9.3683 -2.505 -0.6722 12.0186 0.25696 0.0609 -0.4322 -0.6404 886 BSPBio_002226 O[C@@H]([C@H]1C[C@@H]2CCN1C[C@@H]2C=C)c3ccnc4ccccc34 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 P09 compound treatment 9.9773 -1.896 -0.5087 9.9434 -1.8182 -0.4308 -0.6644 -0.9966 722 BSPBio_002227 CCCN(CCC)S(=O)(=O)c1ccc(cc1)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 P10 compound treatment 11.6226 -0.25073 -0.0673 11.5873 -0.1743 -0.0413 -0.0768 -0.9725 2060331 BSPBio_002228 CC1=CCC(=C)[C@H]2CC(C)(C)[C@@H]2CC1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 P11 compound treatment 13.2206 1.3473 0.3615 11.2511 -0.51055 -0.121 0.1701 0.4462 2431 BSPBio_002229 CCN(CC)CCNC(=O)c1ccc(N)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 P12 compound treatment 11.9205 0.047168 0.0127 11.2805 -0.48109 -0.114 -0.0717 -0.6248 3177312 BSPBio_002230 CC(C)CCCC(C)C1CCC2C3=CC[C@H]4C[C@@H](O)CC[C@]4(C)C3CC[C@]12C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 P13 compound treatment 10.5217 -1.3516 -0.3627 8.9289 -2.8327 -0.6712 -0.731 -0.9582 779 BSPBio_002231 CCN(CC)CCOC(=O)c1ccc(N)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 P14 compound treatment 11.0769 -0.79638 -0.2137 13.9413 2.1797 0.5164 0.2141 0.383 BSPBio_002232 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 P15 compound treatment 8.4257 -3.4476 -0.9251 15.4998 3.7382 0.8857 -0.0278 -0.0217 1057 BSPBio_002233 OC(CCN1CCCC1)(C2CCCCC2)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 P16 compound treatment 11.6866 -0.18668 -0.0501 12.7086 0.94697 0.2244 0.1232 0.536 3177456 BSPBio_002234 CC(C)CCCC(C)[C@H]1CCC2C3CC=C4C[C@@H](O)CC[C@]4(C)C3CC[C@]12C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 P17 compound treatment 11.4416 -0.43174 -0.1158 16.9385 5.1769 1.2266 0.7854 0.6375 1000117 BSPBio_002235 CC(=O)[C@H]1CCC2C3CCC4=CC(=O)CC[C@]4(C)C3CC[C@]12C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 P18 compound treatment 11.7346 -0.13866 -0.0372 10.7413 -1.0203 -0.2417 -0.1973 -0.8064 3174615 BSPBio_002236 CC(C)CCCC(C)[C@H]1CCC2C3CC=C4CC(=O)CC[C@]4(C)C3CC[C@]12C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 P19 compound treatment 12.7986 0.92529 0.2483 10.6829 -1.0787 -0.2556 -0.0052 -0.0145 937 BSPBio_002237 CCC(=O)c1ccc2Sc3ccccc3N(CC(C)N(C)C)c2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 P20 compound treatment 15.3747 3.5014 0.9395 10.552 -1.2096 -0.2866 0.4617 0.47 2060399 BSPBio_002238 CC(C)CCCC(C)[C@H]1CCC2C3C[C@@H](O)[C@@]4(O)C[C@@H](O)CC[C@]4(C)C3CC[C@]12C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 P21 compound treatment 10.6188 -1.2545 -0.3366 14.6761 2.9145 0.6906 0.2503 0.3258 1070 BSPBio_002239 CCC(C(CC)c1ccc(O)cc1)c2ccc(O)cc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 P22 compound treatment 9.7175 -2.1558 -0.5785 11.5316 -0.22997 -0.0545 -0.4476 -0.7703 2060413 BSPBio_002240 CC(C)CCCC(C)[C@H]1CCC2C3CC[C@H]4CC(=O)CC[C@]4(C)C3CC[C@]12C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 P23 mock treatment 13.7435 1.8702 0.5018 61.8913 50.13 11.8775 8.7535 0.7363 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2459 P24 mock treatment 11.3442 -0.52915 -0.142 11.0409 -0.7207 -0.1708 -0.2211 -0.9958 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 A01 mock treatment 12.8929 1.6451 0.4414 167.4375 156.19 37.0067 26.4798 0.7155 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 A02 mock treatment 12.2418 0.99402 0.2667 12.5529 1.3045 0.3091 0.4072 0.9973 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 A03 compound treatment 13.0773 1.8296 0.4909 15.458 4.2095 0.9974 1.0524 0.9467 3177524 BSPBio_002241 CC(C)[C@H]1CC[C@@H](CC1)C(=O)N[C@@H](Cc2ccccc2)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 A04 compound treatment 33.1512 21.903 5.8772 33.8604 22.612 5.3576 7.9442 0.9989 1578 BSPBio_002242 CC1=NCCc2c1[nH]c3cc(O)ccc23 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 A05 compound treatment 13.6829 2.4351 0.6534 28.5241 17.276 4.0932 3.3564 0.8097 353 BSPBio_002243 Oc1cc(O)c2c(=O)c(O)c(oc2c1)c3ccc(O)c(O)c3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 A06 compound treatment 12.7503 1.5026 0.4032 14.7515 3.5031 0.83 0.872 0.945 1000143 BSPBio_002244 NC(Cn1ccc(=O)c(O)c1)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 A07 compound treatment 13.5566 2.3088 0.6195 11.702 0.45354 0.1075 0.514 0.8176 1201 BSPBio_002245 COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 A08 compound treatment 12.5959 1.3481 0.3617 12.4044 1.1559 0.2739 0.4494 0.9906 1587 BSPBio_002246 NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@@H]4O[C@H](CO)[C@@H](O)C[C@H]4N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O[C@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]5O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 A09 compound treatment 13.1038 1.856 0.498 10.5769 -0.67161 -0.1591 0.2396 0.4583 1101055 BSPBio_002247 CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 A10 compound treatment 14.0044 2.7566 0.7397 11.4695 0.22099 0.0524 0.56 0.7553 2308 BSPBio_002248 Cc1ccc(cc1NC(=O)c2cccc(NC(=O)Nc3cccc(c3)C(=O)Nc4cc(ccc4C)C(=O)Nc5ccc(c6cc(cc(c56)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)c2)C(=O)Nc7ccc(c8cc(cc(c78)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 A11 compound treatment 13.4543 2.2065 0.592 12.6507 1.4022 0.3322 0.6536 0.9627 3044756 BSPBio_002249 CC(CN(C)C)CN1c2ccccc2Sc3ccccc13.OC(C(O)C(=O)O)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 A12 compound treatment 14.285 3.0372 0.815 13.0109 1.7625 0.4176 0.8715 0.9518 2060486 BSPBio_002250 CC(=O)Oc1ccccc1C(=O)Oc2ccccc2C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 A13 compound treatment 13.0383 1.7905 0.4804 12.1862 0.93768 0.2222 0.4968 0.9386 1297 BSPBio_002251 COc1cc(CC=C)ccc1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 A14 compound treatment 13.0707 1.8229 0.4891 10.1201 -1.1284 -0.2673 0.1568 0.2813 1897 BSPBio_002252 NNCc1cccc(O)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 A15 compound treatment 36.3901 25.142 6.7463 44.8086 33.56 7.9516 10.393 0.9967 2060079 BSPBio_002253 CC(=CCCC1(C)Oc2c(CC=C(C)C)c3OC4(C5CC6C=C4C(=O)c3c(O)c2C=C1)C(C/C=C(/C)\C(=O)O)(OC5(C)C)C6O)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 A16 compound treatment 12.9045 1.6567 0.4445 11.4047 0.15618 0.037 0.3405 0.7633 1425 BSPBio_002254 CC(N)COc1c(C)cccc1C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 A17 compound treatment 13.9983 2.7505 0.738 13.0996 1.8511 0.4386 0.832 0.9691 938 BSPBio_002255 Cc1ccc(cc1)/C(=C\CN2CCCC2)/c3ccccn3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 A18 compound treatment 11.7255 0.47773 0.1282 13.4 2.1515 0.5098 0.4511 0.8582 864 BSPBio_002256 Oc1noc2CNCCc12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 A19 compound treatment 14.694 3.4462 0.9247 12.1979 0.94942 0.225 0.8129 0.8542 2407 BSPBio_002257 CN1C(=C(O)c2ccccc2S1(=O)=O)C(=O)Nc3ncc(C)s3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 A20 compound treatment 13.0853 1.8375 0.4931 11.067 -0.18152 -0.043 0.3182 0.643 1445 BSPBio_002258 C/C=C(/C)\C(=O)O[C@H]1CC[C@@]2(C)[C@@H]3CC[C@@H]4[C@@]2(C[C@@]5(O)[C@@H]6CN7C[C@@H](C)CC[C@H]7[C@@](C)(O)[C@@]6(O)[C@@H](O)C[C@@]45O)O[C@@]31O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 A21 compound treatment 16.5399 5.2921 1.42 12.9253 1.6769 0.3973 1.285 0.8715 926 BSPBio_002259 Oc1cccc2C(=O)c3cccc(O)c3C(=O)c12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 A22 compound treatment 13.7795 2.5317 0.6793 14.9085 3.66 0.8672 1.0935 0.9927 870 BSPBio_002260 OC(=O)/C(=C/c1ccc(O)cc1)/C#N 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 A23 mock treatment 11.8205 0.57268 0.1537 13.1428 1.8944 0.4488 0.426 0.898 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 A24 mock treatment 12.9166 1.6688 0.4478 13.5145 2.266 0.5369 0.6963 0.9959 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 B01 mock treatment 12.3913 1.1436 0.3068 13.1646 1.9162 0.454 0.538 0.9818 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 B02 mock treatment 9.7657 -1.4821 -0.3977 13.6402 2.3917 0.5667 0.1195 0.1726 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 B03 compound treatment 13.0052 1.7574 0.4715 14.5974 3.3489 0.7935 0.8945 0.9691 3059434 BSPBio_002261 C[C@]12CC[C@@H]3[C@H](CC3(C)C)C(=O)CC[C@H]2O1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 B04 compound treatment 13.6817 2.4339 0.6531 13.1445 1.896 0.4492 0.7795 0.9833 3650172 BSPBio_002262 N[C@@H](CC(=O)N1CCn2c(nnc2C1)C(F)(F)F)Cc3cc(F)c(F)cc3F 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 B05 compound treatment 11.5184 0.27058 0.0726 11.4335 0.18504 0.0438 0.0823 0.9708 2476 BSPBio_002263 CCOP(=S)(OCC)Oc1cc(C)nc(n1)C(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 B06 compound treatment 13.3955 2.1477 0.5763 11.3179 0.069402 0.0164 0.4191 0.727 2141061 BSPBio_002264 Cc1cc2nc3c(=O)[nH]c(=O)nc3n(C[C@@H](O)[C@@H](O)[C@@H](O)CO)c2cc1C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 B07 compound treatment 12.7662 1.5184 0.4074 11.7819 0.53345 0.1264 0.3775 0.8849 2477 BSPBio_002265 CCOP(=S)(OCC)SCSP(=S)(OCC)OCC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 B08 compound treatment 11.9591 0.71133 0.1909 11.804 0.55549 0.1316 0.228 0.9835 39 BSPBio_002266 Nc1c(S(=O)C(F)(F)F)c(C#N)nn1c2c(Cl)cc(cc2Cl)C(F)(F)F 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 B09 compound treatment 13.3738 2.126 0.5705 12.4935 1.245 0.295 0.612 0.9529 2478 BSPBio_002267 COP(=S)(OC)Oc1ccc(cc1)[N+](=O)[O-] 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 B10 compound treatment 11.1197 -0.12809 -0.0344 14.7292 3.4808 0.8247 0.5589 0.6771 3078460 BSPBio_002268 CO/N=C(\C(=O)NC1C2SCC(=C(N2C1=O)C(=O)OCOC(=O)C(C)(C)C)/C=C\c3scnc3C)/c4csc(N)n4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 B11 compound treatment 11.6794 0.43163 0.1158 10.8339 -0.4146 -0.0982 0.0124 0.0819 2479 BSPBio_002269 CCOP(=S)(OCC)Oc1ccc2c(C)c(Cl)c(=O)oc2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 B12 compound treatment 9.7896 -1.4582 -0.3913 11.0523 -0.19622 -0.0465 -0.3095 -0.7856 1788 BSPBio_002270 NC(=O)CS(=O)C(c1ccccc1)c2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 B13 compound treatment 11.2766 0.02878 0.0077 11.1593 -0.089143 -0.0211 -0.0095 -0.4213 2480 BSPBio_002271 COP(=S)(OC)SCn1nnc2ccccc2c1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 B14 compound treatment 11.1594 -0.088378 -0.0237 11.3703 0.12184 0.0289 0.0036 0.0976 3650174 BSPBio_002272 C/C=C\C1=C(N2C(SC1)C(NC(=O)C(N)c3ccc(O)cc3)C2=O)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 B15 compound treatment 12.5254 1.2776 0.3428 12.3891 1.1406 0.2703 0.4335 0.9931 2481 BSPBio_002273 CCOP(=S)(OCC)SCCSCC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 B16 compound treatment 11.4509 0.20309 0.0545 13.8567 2.6082 0.618 0.4755 0.7665 3650175 BSPBio_002274 CO/N=C(/C(=O)N[C@H]1[C@H]2SCC(=C(N2C1=O)C(=O)O)CSc3nc(=O)c(O)nn3C)\c4csc(N)n4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 B17 compound treatment 13.3939 2.1461 0.5759 11.9148 0.66628 0.1579 0.5188 0.8689 2482 BSPBio_002275 CCOC(=O)/C=C(\C)/OP(=O)(OC)OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 B18 compound treatment 11.4135 0.16573 0.0445 10.7508 -0.49763 -0.1179 -0.0519 -0.4121 3060866 BSPBio_002276 COc1ccccc1OCC(O)CN2CCN(CC(=O)Nc3c(C)cccc3C)CC2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 B19 compound treatment 13.6067 2.3589 0.6329 14.3665 3.1181 0.7388 0.97 0.997 2483 BSPBio_002277 COP(=O)(OC)OC(Br)C(Cl)(Cl)Br 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 B20 compound treatment 15.0061 3.7583 1.0085 12.2006 0.95209 0.2256 0.8726 0.8444 1625 BSPBio_002278 CN(C)C(=O)Cc1c(nc2ccc(C)cn12)c3ccc(C)cc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 B21 compound treatment 11.6299 0.38215 0.1025 12.9148 1.6664 0.3948 0.3517 0.8622 2484 BSPBio_002279 COP(=O)(OC)OC=C(Cl)Cl 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 B22 compound treatment 15.8939 4.6461 1.2467 13.2138 1.9653 0.4657 1.2108 0.9098 3650176 BSPBio_002280 CCC(=O)OCC(=O)[C@@]1(OC(=O)CC)[C@H](C)CC2C3[C@H](Cl)CC4=CC(=O)C=C[C@]4(C)C3[C@@H](O)C[C@@]21C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 B23 mock treatment 11.499 0.25122 0.0674 10.979 -0.26944 -0.0638 0.0025 0.0272 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 B24 mock treatment 11.1872 -0.06057 -0.0163 12.762 1.5135 0.3586 0.2421 0.6744 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 C01 mock treatment 13.1308 1.883 0.5052 11.7965 0.54799 0.1298 0.4491 0.8608 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 C02 mock treatment 11.7168 0.46905 0.1259 12.1778 0.92932 0.2202 0.2447 0.9648 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 C03 compound treatment 11.3105 0.062662 0.0168 10.0813 -1.1671 -0.2765 -0.1837 -0.6629 2069333 BSPBio_002281 CC[C@H](/C=C/C(C)C1CCC2C3CCC4=CC(=O)CC[C@]4(C)C3CC[C@]12C)C(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 C04 compound treatment 11.3498 0.10197 0.0274 14.8182 3.5697 0.8458 0.6174 0.7296 1000141 BSPBio_002282 OC[C@H]1O[C@@H](Oc2cc3ccc(=O)oc3cc2O)[C@H](O)[C@@H](O)[C@@H]1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 C05 compound treatment 10.0356 -1.2122 -0.3253 10.674 -0.57446 -0.1361 -0.3262 -0.9253 1002856 BSPBio_002283 CCC(C(=O)N)c1ccccc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 C06 compound treatment 12.0741 0.82628 0.2217 15.2189 3.9704 0.9407 0.822 0.8505 3173759 BSPBio_002284 COc1cc(cc(OC)c1O)[C@H]2[C@@H]3C(COC3=O)C(OC4O[C@@H]5COC(C)O[C@H]5[C@H](O)[C@H]4O)c6cc7OCOc7cc26 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 C07 compound treatment 12.3394 1.0916 0.2929 11.3303 0.081852 0.0194 0.2208 0.7523 882 BSPBio_002285 CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 C08 compound treatment 12.5391 1.2913 0.3465 9.452 -1.7965 -0.4256 -0.056 -0.102 919 BSPBio_002286 COc1cc(ccc1c2nc3cccnc3[nH]2)S(=O)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 C09 compound treatment 9.8903 -1.3575 -0.3643 12.0002 0.75174 0.1781 -0.1316 -0.3246 715 BSPBio_002287 COc1c2ccoc2c(OC)c3oc(C)cc(=O)c13 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 C10 compound treatment 14.9552 3.7075 0.9948 12.8078 1.5593 0.3694 0.9647 0.909 2060380 BSPBio_002288 CCC(=O)OCC(=O)[C@@]1(OC(=O)CC)[C@@H](C)CC2C3CCC4=CC(=O)C=C[C@]4(C)C3(F)[C@@H](O)C[C@@]21C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 C11 compound treatment 10.4219 -0.82586 -0.2216 10.3448 -0.90363 -0.2141 -0.3081 -0.9999 1075 BSPBio_002289 CCN(Cc1ccncc1)C(=O)C(CO)c2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 C12 compound treatment 11.0918 -0.15596 -0.0418 11.6123 0.36379 0.0862 0.0314 0.3273 35 BSPBio_002290 CC1=Nc2ccc(Cl)cc2S(=O)(=O)N1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 C13 compound treatment 11.2842 0.03643 0.0098 10.7596 -0.48891 -0.1158 -0.075 -0.6451 2101 BSPBio_002291 Oc1ccc(O)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 C14 compound treatment 11.3492 0.1014 0.0272 10.9605 -0.28802 -0.0682 -0.029 -0.3949 3856 BSPBio_002292 CNC1(C)C2CCC(C2)C1(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 C15 compound treatment 18.2085 6.9607 1.8677 16.5963 5.3479 1.2671 2.2167 0.9821 1195 BSPBio_002293 C[C@@]12CCC3C(CC[C@]4(O)C[C@@H](O)CC[C@]34C=O)[C@@]2(O)CCC1C5=CC(=O)OC5 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 C16 compound treatment 13.7745 2.5267 0.678 10.4839 -0.76456 -0.1812 0.3513 0.5006 3264 BSPBio_002294 Cn1nnnc1SCC2=C(N3C(SC2)C(NC(=O)C(OC=O)c4ccccc4)C3=O)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 C17 compound treatment 12.4953 1.2475 0.3347 12.1121 0.86361 0.2046 0.3814 0.9721 1416 BSPBio_002295 Cn1c(=O)n(C)c2[nH]c(nc2c1=O)C3CCCC3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 C18 compound treatment 10.8731 -0.37472 -0.1005 11.6051 0.35665 0.0845 -0.0113 -0.0864 3250 BSPBio_002296 CCCCCCCCCCCCCCCCCCOCC(O)CO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 C19 compound treatment 17.7489 6.5011 1.7444 31.6369 20.388 4.8308 4.6493 0.9052 193 BSPBio_002297 COc1cc2CCN(C)[C@H]3Cc4ccc(OC)c(Oc5ccc(C[C@@H]6N(C)CCc7cc(OC)c(Oc(c1OC)c32)cc67)cc5)c4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 C20 compound treatment 8.9854 -2.2624 -0.607 12.4284 1.1799 0.2796 -0.2316 -0.3465 1528 BSPBio_002298 NC(=O)c1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 C21 compound treatment 9.9699 -1.2779 -0.3429 13.8879 2.6395 0.6254 0.1997 0.2801 2070 BSPBio_002299 COc1ccc(cc1)c2coc3cc(O)ccc3c2=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 C22 compound treatment 11.6122 0.3644 0.0978 10.6699 -0.57859 -0.1371 -0.0278 -0.1651 1389 BSPBio_002300 CCOC(=O)N1CCC(=C2c3ccc(Cl)cc3CCc4cccnc24)CC1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 C23 mock treatment 12.464 1.2162 0.3263 13.7057 2.4572 0.5822 0.6424 0.9626 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 C24 mock treatment 9.2206 -2.0272 -0.5439 13.5244 2.2759 0.5393 -0.0033 -0.0043 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 D01 mock treatment 12.7725 1.5247 0.4091 11.9419 0.69338 0.1643 0.4055 0.9197 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 D02 mock treatment 11.6351 0.38728 0.1039 11.8923 0.64385 0.1525 0.1813 0.9825 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 D03 compound treatment 12.8778 1.63 0.4374 10.1557 -1.0928 -0.2589 0.1262 0.2483 2485 BSPBio_002301 CCS(=O)CCSP(=O)(OC)OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 D04 compound treatment 10.8459 -0.40186 -0.1078 11.027 -0.22147 -0.0525 -0.1134 -0.9452 3487465 BSPBio_002302 OC(=O)COCCN1CCN(CC1)C(c2ccccc2)c3ccc(Cl)cc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 D05 compound treatment 11.6797 0.43185 0.1159 12.7421 1.4936 0.3539 0.3322 0.892 2486 BSPBio_002303 CNC(=O)CSP(=S)(OC)OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 D06 compound treatment 12.0034 0.75564 0.2028 9.4619 -1.7866 -0.4233 -0.1559 -0.3323 1724 BSPBio_002304 CNS(=O)(=O)Cc1ccc2[nH]cc(CCN(C)C)c2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 D07 compound treatment 12.0113 0.76354 0.2049 10.1464 -1.1021 -0.2611 -0.0398 -0.1198 2487 BSPBio_002305 CCOC(=O)CC(SP(=S)(OC)OC)C(=O)OCC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 D08 compound treatment 13.9262 2.6784 0.7187 11.0348 -0.21369 -0.0506 0.4724 0.6557 3198425 BSPBio_002306 CC1(C)O[C@@H]2CO[C@@]3(COS(=O)(=O)N)OC(C)(C)O[C@H]3[C@@H]2O1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 D09 compound treatment 14.1434 2.8956 0.777 10.1622 -1.0863 -0.2574 0.3674 0.4489 2488 BSPBio_002307 CCOP(=S)(OCC)SCn1c(=O)oc2cc(Cl)ccc12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 D10 compound treatment 8.9596 -2.2882 -0.614 11.3816 0.13308 0.0315 -0.4119 -0.6699 3198423 BSPBio_002308 CO/N=C/1\CN(CC1CN)c2nc3n(cc(C(=O)O)c(=O)c3cc2F)C4CC4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 D11 compound treatment 11.425 0.17715 0.0475 9.6266 -1.6219 -0.3843 -0.2381 -0.615 2489 BSPBio_002309 COP(=O)(N)SC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 D12 compound treatment 11.91 0.66223 0.1777 10.1781 -1.0704 -0.2536 -0.0537 -0.1734 3198421 BSPBio_002310 CCC(C)C(=O)O[C@H]1C[C@H](O)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(=O)O)C12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 D13 compound treatment 11.2822 0.034407 0.0092 12.9592 1.7107 0.4053 0.2931 0.723 2490 BSPBio_002311 CCOP(=S)(OCC)SCSCC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 D14 compound treatment 10.8895 -0.35833 -0.0961 10.4786 -0.7699 -0.1824 -0.197 -0.9552 3650177 BSPBio_002312 NCC1CCCCC1CC(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 D15 compound treatment 9.776 -1.4718 -0.3949 11.0892 -0.1593 -0.0377 -0.3059 -0.7712 2491 BSPBio_002313 COC(=O)c1c(Cl)c(Cl)c(C(=O)OC)c(Cl)c1Cl 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 D16 compound treatment 10.5613 -0.68651 -0.1842 10.6227 -0.62577 -0.1483 -0.2351 -0.9942 1714 BSPBio_002314 CN(C)C(=N)NC(=N)N 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 D17 compound treatment 9.7671 -1.4807 -0.3973 9.6211 -1.6274 -0.3856 -0.5536 -0.9999 2492 BSPBio_002315 CC(C)Nc1nc(Cl)nc(NC(C)C)n1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 D18 compound treatment 12.9191 1.6713 0.4484 9.9652 -1.2832 -0.304 0.1021 0.1885 3650178 BSPBio_002316 CC(C)C[C@@H](CN)CC(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 D19 compound treatment 11.4453 0.19755 0.053 11.7065 0.45801 0.1085 0.1142 0.9457 2493 BSPBio_002317 CCC(=O)Nc1ccc(Cl)c(Cl)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 D20 compound treatment 10.543 -0.70477 -0.1891 9.7847 -1.4638 -0.3468 -0.379 -0.9593 3650180 BSPBio_002318 CCC(=O)NCC[C@@H]1CCc2ccc3OCCc3c12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 D21 compound treatment 12.445 1.1972 0.3212 10.7872 -0.46126 -0.1093 0.1499 0.4417 2494 BSPBio_002319 CCNc1nc(Cl)nc(NCC)n1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 D22 compound treatment 12.4486 1.2008 0.3222 10.9044 -0.34408 -0.0815 0.1702 0.5121 1787 BSPBio_002320 COc1ccnc(CS(=O)c2nc3cc(OC(F)F)ccc3[nH]2)c1OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 D23 mock treatment 9.8882 -1.3596 -0.3648 12.8496 1.6011 0.3794 0.0103 0.0196 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 D24 mock treatment 8.3034 -2.9444 -0.7901 13.4285 2.18 0.5165 -0.1934 -0.2049 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 E01 mock treatment 10.402 -0.84581 -0.227 10.969 -0.27948 -0.0662 -0.2073 -0.8769 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 E02 mock treatment 9.6567 -1.5911 -0.4269 11.6926 0.44416 0.1052 -0.2275 -0.5173 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 E03 compound treatment 9.4656 -1.7822 -0.4782 11.4471 0.19867 0.0471 -0.3049 -0.6344 2069231 BSPBio_002321 CC(=CCc1cc(ccc1O)C(=O)C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 E04 compound treatment 10.3617 -0.88611 -0.2378 11.3104 0.061912 0.0147 -0.1578 -0.6622 1048361 BSPBio_002322 c1ccc2c(c1)[nH]c3cnccc32 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 E05 compound treatment 61.3909 50.143 13.4547 58.1936 46.945 11.1229 17.379 0.9955 3177521 BSPBio_002323 COc1cc(cc(OC)c1OC)[C@H]2[C@H]3[C@H](COC3=O)[C@@H](OC(=O)C)c4cc5OCOc5cc24 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 E06 compound treatment 12.9387 1.6909 0.4537 11.9076 0.6591 0.1562 0.4313 0.8987 599 BSPBio_002324 Cc1cc(O)c2C(=O)c3c(O)cc(O)cc3C(=O)c2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 E07 compound treatment 9.3933 -1.8545 -0.4976 10.7269 -0.5216 -0.1236 -0.4392 -0.8567 1147 BSPBio_002325 COc1c2ccoc2cc3oc(=O)ccc13 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 E08 compound treatment 10.3293 -0.91848 -0.2465 11.9976 0.74913 0.1775 -0.0488 -0.1605 1111718 BSPBio_002326 NC1(CCC1)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 E09 compound treatment 11.589 0.34118 0.0915 8.2184 -3.03 -0.7179 -0.4429 -0.612 827 BSPBio_002327 CCCCC1(COC(=O)CCC(=O)O)C(=O)N(N(C1=O)c2ccccc2)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 E10 compound treatment 10.9561 -0.29168 -0.0783 10.7858 -0.46269 -0.1096 -0.1329 -0.9864 3173628 BSPBio_002328 CN1C(C)(C)CCCC1(C)C.OC(C(O)C(=O)O)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 E11 compound treatment 10.3761 -0.87172 -0.2339 10.1753 -1.0732 -0.2543 -0.3452 -0.9991 1000111 BSPBio_002329 OC(=O)CCCCC1SCC2NC(=O)NC12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 E12 compound treatment 10.4108 -0.83699 -0.2246 9.9719 -1.2766 -0.3025 -0.3727 -0.9893 907114 BSPBio_002330 CN1C2CCC1CC(C2)OC(c3ccccc3)c4ccccc4N 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 E13 compound treatment 12.7826 1.5348 0.4118 12.8752 1.6267 0.3854 0.5637 0.9995 792 BSPBio_002331 COc1ccc2nccc([C@@H](O)[C@H]3C[C@@H]4CCN3C[C@@H]4C=C)c2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 E14 compound treatment 11.4081 0.16027 0.043 11.0611 -0.18734 -0.0444 -0.001 -0.0158 1981222 BSPBio_002332 CCN1CCN(C(=O)NC(C(=O)NC2C3SCC(=C(N3C2=O)C(=O)O)CSc4nnnn4C)c5ccc(O)cc5)C(=O)C1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 E15 compound treatment 13.8671 2.6193 0.7028 10.8713 -0.37714 -0.0894 0.4338 0.6123 1313 BSPBio_002333 Oc1ccc(Cl)cc1C(=O)Nc2ccc(cc2Cl)[N+](=O)[O-] 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 E16 compound treatment 14.1431 2.8953 0.7769 11.5076 0.25913 0.0614 0.5928 0.7606 1000048 BSPBio_002334 CC(C)COCC(CN(Cc1ccccc1)c2ccccc2)N3CCCC3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 E17 compound treatment 9.7108 -1.537 -0.4124 10.7891 -0.45941 -0.1088 -0.3686 -0.8641 2060468 BSPBio_002335 CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OC(=O)c2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 E18 compound treatment 10.9137 -0.33407 -0.0896 10.0013 -1.2472 -0.2955 -0.2723 -0.8819 1459 BSPBio_002336 OC1CCN(CCCN2c3ccccc3Sc4ccc(C#N)cc24)CC1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 E19 compound treatment 14.8494 3.6016 0.9664 17.209 5.9605 1.4122 1.682 0.9829 1000094 BSPBio_002337 CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 E20 compound treatment 11.6716 0.4238 0.1137 12.7354 1.4869 0.3523 0.3295 0.8901 1117 BSPBio_002338 Nc1nc(=O)c2nc(CNc3ccc(cc3)C(=O)N[C@@H](CCC(=O)O)C(=O)O)cnc2[nH]1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 E21 compound treatment 11.8625 0.61473 0.1649 14.8356 3.5872 0.8499 0.7176 0.8289 1385 BSPBio_002339 C(/C=C/N1CCN(CC1)C(c2ccccc2)c3ccccc3)c4ccccc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 E22 compound treatment 11.6768 0.42903 0.1151 13.98 2.7315 0.6472 0.539 0.82 1232 BSPBio_002340 OC1=C(O)C(=O)C(=C(O)C1=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 E23 mock treatment 9.2902 -1.9576 -0.5253 11.128 -0.12043 -0.0285 -0.3916 -0.7444 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 E24 mock treatment 11.6491 0.40134 0.1077 9.8618 -1.3867 -0.3285 -0.1562 -0.4517 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 F01 mock treatment 11.6203 0.37247 0.0999 9.9833 -1.2652 -0.2998 -0.1413 -0.4472 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 F02 mock treatment 13.8568 2.609 0.7 10.9364 -0.31208 -0.0739 0.4427 0.6289 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 F03 compound treatment 11.9162 0.66844 0.1794 9.742 -1.5065 -0.3569 -0.1256 -0.3143 2495 BSPBio_002341 CCNc1nc(Cl)nc(NC(C)C)n1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 F04 compound treatment 11.3524 0.10457 0.0281 10.1492 -1.0993 -0.2605 -0.1643 -0.6273 3650182 BSPBio_002342 CCOC(=O)C1=C[C@@H](OC(CC)CC)[C@H](NC(=O)C)[C@@H](N)C1.OC(C(O)C(=O)O)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 F05 compound treatment 9.7331 -1.5147 -0.4064 11.2273 -0.021126 -0.005 -0.2909 -0.7158 2496 BSPBio_002343 CN(C)C(=O)Nc1ccc(Cl)c(Cl)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 F06 compound treatment 13.4648 2.217 0.5949 9.5286 -1.7199 -0.4075 0.1325 0.1837 1000411 BSPBio_002344 CCCCCNC(=N)N/N=C/c1c[nH]c2ccc(OC)cc12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 F07 compound treatment 11.1397 -0.1081 -0.029 11.7949 0.54646 0.1295 0.071 0.5354 2497 BSPBio_002345 CNC(=O)N(C)c1nnc(s1)C(C)(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 F08 compound treatment 10.0283 -1.2195 -0.3272 9.8151 -1.4334 -0.3396 -0.4715 -0.9998 1000299 BSPBio_002346 CCc1c2Cn3c(cc4c(COC(=O)[C@]4(O)CC)c3=O)-c2nc5ccc(OC(=O)N6CCC(CC6)N7CCCCC7)cc15 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 F09 compound treatment 10.7609 -0.48691 -0.1307 9.4473 -1.8012 -0.4268 -0.3942 -0.8831 2498 BSPBio_002347 COc1c(Cl)ccc(Cl)c1C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 F10 compound treatment 15.4848 4.237 1.1369 20.3949 9.1464 2.1671 2.3363 0.9547 2081802 BSPBio_002348 CC[C@@]1(O)C(=O)OCc2c1cc3-c4nc5ccc(O)c(CN(C)C)c5cc4Cn3c2=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 F11 compound treatment 11.4207 0.17288 0.0464 11.8214 0.57294 0.1357 0.1288 0.8978 2499 BSPBio_002349 CCCCN(CC)c1c(cc(cc1[N+](=O)[O-])C(F)(F)F)[N+](=O)[O-] 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 F12 compound treatment 9.9433 -1.3045 -0.35 10.7001 -0.5484 -0.1299 -0.3394 -0.909 2830 BSPBio_002350 Clc1ccc2n(C3CCN(CCCn4c(=O)[nH]c5ccccc45)CC3)c(=O)[nH]c2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 F13 compound treatment 11.3796 0.13183 0.0354 9.0688 -2.1797 -0.5165 -0.3402 -0.6571 2500 BSPBio_002351 COc1nc(NC(C)C)nc(NC(C)C)n1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 F14 compound treatment 115.455 104.21 27.9615 124.5657 113.32 26.8489 38.7568 0.9998 1001531 BSPBio_002352 COc1cc(cc(OC)c1OC)[C@H]2[C@@H]3[C@H](COC3=O)[C@@H](O)c4cc5OCOc5cc24 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 F15 compound treatment 12.0586 0.81084 0.2176 9.2698 -1.9787 -0.4688 -0.1777 -0.3437 2501 BSPBio_002353 CCc1cccc(C)c1N(C(C)COC)C(=O)CCl 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 F16 compound treatment 11.0808 -0.16696 -0.0448 9.6334 -1.6151 -0.3827 -0.3023 -0.7845 1079 BSPBio_002354 N[C@@H](Cc1ccc(O)c(O)c1)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 F17 compound treatment 11.438 0.19024 0.051 11.4291 0.1806 0.0428 0.0664 0.9962 2502 BSPBio_002355 Clc1cccc(Cl)c1C#N 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 F18 compound treatment 10.3173 -0.93051 -0.2497 11.7247 0.47625 0.1128 -0.0968 -0.3531 1395 BSPBio_002356 CC(COc1ccccc1)N(CCCl)Cc2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 F19 compound treatment 11.6045 0.35673 0.0957 11.1298 -0.11872 -0.0281 0.0478 0.4791 2503 BSPBio_002357 CSc1nc(NC(C)C)nc(NC(C)C)n1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 F20 compound treatment 10.3549 -0.89289 -0.2396 13.8701 2.6216 0.6212 0.2698 0.4053 1000056 BSPBio_002358 COc1ccc(CCN(C)CCCC(C#N)(C(C)C)c2ccc(OC)c(OC)c2)cc1OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 F21 compound treatment 9.8089 -1.4389 -0.3861 10.4461 -0.80241 -0.1901 -0.4074 -0.9467 2504 BSPBio_002359 CCCN(CCC)c1c(cc(cc1[N+](=O)[O-])C(F)(F)F)[N+](=O)[O-] 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 F22 compound treatment 10.8299 -0.41789 -0.1121 9.2351 -2.0134 -0.477 -0.4166 -0.8501 3173239 BSPBio_002360 CC(N/C(=N/C#N)/Nc1ccncc1)C(C)(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 F23 mock treatment 9.752 -1.4958 -0.4014 10.7388 -0.50966 -0.1208 -0.3692 -0.8809 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 F24 mock treatment 9.2791 -1.9687 -0.5283 11.4322 0.18368 0.0435 -0.3428 -0.6467 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 G01 mock treatment 10.8264 -0.42135 -0.1131 10.734 -0.51446 -0.1219 -0.1661 -0.9993 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 G02 mock treatment 11.7104 0.46263 0.1241 11.4455 0.19703 0.0467 0.1208 0.9108 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 G03 compound treatment 11.0509 -0.19687 -0.0528 10.7648 -0.48362 -0.1146 -0.1184 -0.9382 925 BSPBio_002361 C[C@@H]([C@H](O)c1ccccc1)N(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 G04 compound treatment 9.8265 -1.4213 -0.3814 13.4328 2.1843 0.5175 0.0963 0.1498 3526 BSPBio_002362 Oc1ccc2ccc(=O)oc2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 G05 compound treatment 9.2781 -1.9697 -0.5285 9.4998 -1.7487 -0.4143 -0.6667 -0.9927 856 BSPBio_002363 Cn1c(=O)n(C)c2nc[nH]c2c1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 G06 compound treatment 10.7653 -0.48254 -0.1295 12.2216 0.97314 0.2306 0.0715 0.2703 1020463 BSPBio_002364 Oc1cc2ccc(=O)oc2cc1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 G07 compound treatment 9.3651 -1.8827 -0.5052 12.1728 0.92428 0.219 -0.2024 -0.3675 1004713 BSPBio_002365 CNc1ccccc1C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 G08 compound treatment 12.7071 1.4593 0.3916 12.818 1.5695 0.3719 0.5398 0.9997 2060478 BSPBio_002366 CNc1ccc(cc1)C(=O)CC(O)CCC(C)C2OC(=O)CC(O)CC(=O)CC(O)CC(O)CC(O)CC(O)CC3(O)CC(O)C(C(CC(O[C@@H]4O[C@H](C)[C@@H](O)[C@H](N)[C@@H]4O)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/C2C)O3)C(=O)OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 G09 compound treatment 11.3184 0.070647 0.019 13.2021 1.9536 0.4629 0.3407 0.7354 2060101 BSPBio_002367 COc1ccc(cc1OC)[C@H]2Oc3c(I)c(OC)cc(OC)c3C[C@@H]2O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 G10 compound treatment 44.9997 33.752 9.0565 48.6873 37.439 8.8706 12.6764 0.9999 1011006 BSPBio_002368 O=C1C=CC(=O)c2ccccc12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 G11 compound treatment 11.026 -0.22177 -0.0595 10.8586 -0.3899 -0.0924 -0.1074 -0.9774 968 BSPBio_002369 CCCCC1C(=O)N(N(C1=O)c2ccccc2)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 G12 compound treatment 10.0746 -1.1732 -0.3148 9.2522 -1.9963 -0.473 -0.5571 -0.9804 3173627 BSPBio_002370 CCCCCC(O)C1C(O)CC(O)CC(O)CC(O)CC(O)CC(O)CC(O)/C(=C/C=C/C=C/C=C/C=C/C(O)C(C)OC1=O)/C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 G13 compound treatment 9.571 -1.6768 -0.4499 10.8363 -0.41213 -0.0976 -0.3872 -0.841 1321 BSPBio_002371 Cc1cc(=O)[nH]c(=S)[nH]1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 G14 compound treatment 11.0431 -0.20472 -0.0549 11.0832 -0.16531 -0.0392 -0.0665 -0.9863 1273 BSPBio_002372 C[C@@]12CC(=O)C3C(CCC4=CC(=O)C=C[C@]34C)C2CC[C@]1(O)C(=O)CO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 G15 compound treatment 12.7904 1.5426 0.4139 9.6444 -1.6041 -0.3801 0.0239 0.0426 3273 BSPBio_002373 NNCCc1ccccc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 G16 compound treatment 10.5052 -0.74262 -0.1993 12.5845 1.336 0.3165 0.0829 0.2217 1002775 BSPBio_002374 Cc1cccc(C(=O)O)c1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 G17 compound treatment 12.2646 1.0168 0.2728 10.9698 -0.27863 -0.066 0.1462 0.521 425 BSPBio_002375 Oc1ccc(cc1)c2coc3cc(O)cc(O)c3c2=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 G18 compound treatment 11.8259 0.57808 0.1551 13.2562 2.0077 0.4757 0.4461 0.8915 1465 BSPBio_002376 OCCN1CCN(CCCN2c3ccccc3Sc4ccc(Cl)cc24)CC1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 G19 compound treatment 9.0652 -2.1826 -0.5856 9.7972 -1.4513 -0.3439 -0.6573 -0.9678 958 BSPBio_002377 NC(=O)NC(=O)Cc1ccccc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 G20 compound treatment 11.9337 0.68588 0.184 12.7887 1.5402 0.3649 0.3882 0.9498 1269 BSPBio_002378 CC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 G21 compound treatment 11.1277 -0.12012 -0.0322 9.6355 -1.613 -0.3822 -0.293 -0.764 1600 BSPBio_002379 CCCCC[C@H](CC(=O)NO)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1CO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 G22 compound treatment 9.3438 -1.904 -0.5109 10.0067 -1.2417 -0.2942 -0.5693 -0.9656 884 BSPBio_002380 CN(C)CCC(c1ccccc1)c2ccccn2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 G23 mock treatment 11.1975 -0.050345 -0.0135 10.2349 -1.0135 -0.2401 -0.1794 -0.7457 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 G24 mock treatment 10.7704 -0.47743 -0.1281 13.317 2.0686 0.4901 0.256 0.5053 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 H01 mock treatment 13.9962 2.7484 0.7375 10.3083 -0.94021 -0.2228 0.3639 0.4724 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 H02 mock treatment 11.7682 0.52039 0.1396 12.3871 1.1386 0.2698 0.2895 0.953 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 H03 compound treatment 10.6081 -0.63974 -0.1717 10.5908 -0.6577 -0.1558 -0.2316 -0.9988 2505 BSPBio_002381 CC(C)N1C(=O)c2ccccc2NS1(=O)=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 H04 compound treatment 12.766 1.5182 0.4074 13.2567 2.0082 0.4758 0.6245 0.997 1072288 BSPBio_002382 CC(=C)C1CNC(C1CC(=O)O)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 H05 compound treatment 10.3264 -0.92144 -0.2472 11.5719 0.32345 0.0766 -0.1206 -0.4661 2506 BSPBio_002383 OC(=O)COc1ccc(Cl)cc1Cl 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 H06 compound treatment 10.3404 -0.90738 -0.2435 12.755 1.5065 0.3569 0.0802 0.1857 907272 BSPBio_002384 Oc1cc2CCNCC(c3ccccc3)c2cc1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 H07 compound treatment 12.51 1.2622 0.3387 11.2647 0.016239 0.0038 0.2422 0.7151 2507 BSPBio_002385 OC(=O)CCCOc1ccc(Cl)cc1Cl 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 H08 compound treatment 10.3921 -0.85574 -0.2296 9.6274 -1.6211 -0.3841 -0.434 -0.9698 1402 BSPBio_002386 CC[N+](C)(C)c1cccc(O)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 H09 compound treatment 10.5 -0.74777 -0.2006 9.0145 -2.234 -0.5293 -0.5162 -0.9118 2508 BSPBio_002387 OC(=O)COc1cc(Cl)c(Cl)cc1Cl 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 H10 compound treatment 12.5248 1.277 0.3427 12.4596 1.2111 0.287 0.4452 0.9961 3650184 BSPBio_002388 CC(C)[C@@H]1NC(=O)C(C)OC(=O)[C@H](NC(=O)C(OC(=O)[C@@H](NC(=O)C(C)OC(=O)[C@H](NC(=O)C(OC(=O)[C@@H](NC(=O)C(C)OC(=O)[C@H](NC(=O)C(OC1=O)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 H11 compound treatment 11.8293 0.58148 0.156 12.2709 1.0225 0.2423 0.2816 0.9774 2509 BSPBio_002389 CCc1cccc(CC)c1N(COC)C(=O)CCl 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 H12 compound treatment 12.5316 1.2838 0.3445 11.6229 0.37447 0.0887 0.3063 0.8611 1104463 BSPBio_002390 Oc1c2ccoc2cc3oc(=O)ccc13 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 H13 compound treatment 13.0441 1.7963 0.482 11.6894 0.44096 0.1045 0.4147 0.8409 2510 BSPBio_002391 COC(=O)COc1ccc(Cl)cc1Cl 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 H14 compound treatment 12.8612 1.6134 0.4329 10.8206 -0.4279 -0.1014 0.2344 0.5272 3650185 BSPBio_002392 CCCc1nc(C)c2c(=O)[nH]c(nn12)c3cc(ccc3OCC)S(=O)(=O)N4CCN(CC)CC4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 H15 compound treatment 9.1144 -2.1334 -0.5724 10.7622 -0.48632 -0.1152 -0.4862 -0.8327 2511 BSPBio_002393 COC(=O)CCCOc1ccc(Cl)cc1Cl 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 H16 compound treatment 11.1506 -0.09719 -0.0261 11.6892 0.44068 0.1044 0.0554 0.5147 1041 BSPBio_002394 CN1CCN(CCCN2c3ccccc3Sc4ccc(Cl)cc24)CC1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 H17 compound treatment 10.5066 -0.74121 -0.1989 11.1053 -0.14313 -0.0339 -0.1646 -0.8159 2512 BSPBio_002395 COC(=O)COc1cc(Cl)c(Cl)cc1Cl 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 H18 compound treatment 15.3615 4.1137 1.1038 44.3272 33.079 7.8375 6.3225 0.7988 3650186 BSPBio_002396 OC(=O)c1ccc(cc1)/C/2=C/3\C=C/C(=N3)/C(=c\4/cc\c\5=C(\C\6=N\C(=C(/c7ccc2n7[Mn+]n45)\c8ccc(cc8)C(=O)O)\C=C6)/c9ccc(cc9)C(=O)O)/c%10ccc(cc%10)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 H19 compound treatment 11.7842 0.53637 0.1439 10.9598 -0.28871 -0.0684 0.0534 0.3351 2513 BSPBio_002397 OC(=O)CNCP(=O)(O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 H20 compound treatment 12.8567 1.6089 0.4317 14.5421 3.2936 0.7804 0.8571 0.961 1587004 BSPBio_002398 COc1ccc(cc1)C2Sc3ccccc3N(CCN(C)C)C(=O)C2OC(=O)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 H21 compound treatment 9.8751 -1.3727 -0.3683 11.5877 0.33922 0.0804 -0.2036 -0.5401 2514 BSPBio_002399 CCCCCCC(C)OC(=O)COc1ccc(Cl)cc1Cl 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 H22 compound treatment 19.1602 7.9124 2.1231 18.5094 7.261 1.7204 2.7177 0.9946 3650188 BSPBio_002400 CC(=O)OC1OC(=O)c2c1c3Oc4c(C=O)c(OC(=O)C)cc(C)c4C(=O)Oc3c(C)c2OC(=O)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 H23 mock treatment 9.3179 -1.9299 -0.5178 10.2959 -0.95259 -0.2257 -0.5258 -0.9307 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 H24 mock treatment 9.6312 -1.6165 -0.4338 10.4175 -0.83095 -0.1969 -0.4459 -0.9361 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 I01 mock treatment 11.7694 0.52157 0.14 10.0162 -1.2323 -0.292 -0.1075 -0.332 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 I02 mock treatment 10.9422 -0.30557 -0.082 12.0158 0.76732 0.1818 0.0706 0.3539 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 I03 compound treatment 12.3304 1.0826 0.2905 9.2824 -1.966 -0.4658 -0.124 -0.2258 2060229 BSPBio_002401 Oc1cc(OC(=O)c2cc(O)c(O)c(O)c2)c3C[C@@H](OC(=O)c4cc(O)c(O)c(O)c4)[C@H](Oc3c1)c5cc(O)c(O)c(O)c5 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 I04 compound treatment 11.0445 -0.20326 -0.0545 11.1091 -0.13939 -0.033 -0.0619 -0.9711 3174244 BSPBio_002402 N=c1[nH]c(=O)c2[nH]c(=O)c(=O)[nH]c2[nH]1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 I05 compound treatment 39.8085 28.561 7.6636 46.7209 35.472 8.4047 11.362 0.9989 2060141 BSPBio_002403 COC1=CC(=O)C(=CC1=O)C(C=C)c2ccc(OC)cc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 I06 compound treatment 12.5439 1.2961 0.3478 10.6847 -0.56375 -0.1336 0.1515 0.4066 3173633 BSPBio_002404 CC1=C(N2[C@H](SC1)[C@H](NC(=O)C(N)c3ccccc3)C2=O)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 I07 compound treatment 10.8137 -0.43415 -0.1165 11.1123 -0.13622 -0.0323 -0.1052 -0.8702 970 BSPBio_002405 CC1(C)O[C@]2(C)CC[C@H]1CC2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 I08 compound treatment 11.5417 0.29393 0.0789 10.5359 -0.71259 -0.1688 -0.0636 -0.3414 832189 BSPBio_002406 CC(=O)CC(=O)CCC(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 I09 compound treatment 8.8897 -2.3581 -0.6327 9.0387 -2.2097 -0.5236 -0.8176 -0.9956 1260 BSPBio_002407 N[C@@H](Cc1ccc(cc1)N(CCCl)CCCl)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 I10 compound treatment 11.8387 0.59086 0.1585 12.0638 0.81528 0.1932 0.2487 0.9952 3054675 BSPBio_002408 CC(C)CCCC(C)C1CCC2/C(=C/C=C\3/C[C@@H](O)CCC3=C)/CCCC12C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 I11 compound treatment 13.8467 2.5989 0.6974 13.8485 2.6 0.616 0.9287 0.9981 1576 BSPBio_002409 CC(=CCc1c(O)c2c(=O)c(coc2c3C=CC(C)(C)Oc13)c4ccc(O)c(O)c4)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 I12 compound treatment 11.5469 0.29913 0.0803 10.8966 -0.35185 -0.0834 -0.0022 -0.019 1211 BSPBio_002410 CON 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 I13 compound treatment 8.9 -2.3478 -0.63 9.2199 -2.0286 -0.4806 -0.7853 -0.9911 1082584 BSPBio_002411 COc1cc2OCc3oc4c5CC(Oc5ccc4c(=O)c3-c2cc1OC)C(=C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 I14 compound treatment 12.7976 1.5498 0.4158 12.1205 0.872 0.2066 0.4401 0.9479 115 BSPBio_002412 COCCOC(=O)C1=C(C)NC(=C(C1c2cccc(c2)[N+](=O)[O-])C(=O)OC(C)C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 I15 compound treatment 10.0183 -1.2295 -0.3299 10.2284 -1.0201 -0.2417 -0.4042 -0.9883 2060051 BSPBio_002413 Cc1cc(=O)c2c(O)cc(O)c(C)c2o1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 I16 compound treatment 12.3175 1.0697 0.287 9.8062 -1.4423 -0.3417 -0.0387 -0.0867 BSPBio_002414 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 I17 compound treatment 10.3035 -0.94426 -0.2534 9.8239 -1.4246 -0.3375 -0.4178 -0.99 1539748 BSPBio_002415 COc1ccccc1c2coc3cc(O)ccc3c2=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 I18 compound treatment 11.3327 0.08495 0.0228 12.5762 1.3277 0.3146 0.2386 0.7564 1205 BSPBio_002416 CC(=CCC1=C(O)C(=O)c2ccccc2C1=O)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 I19 compound treatment 13.6052 2.3574 0.6326 13.1159 1.8674 0.4424 0.7601 0.9847 1010377 BSPBio_002417 Oc1ccc2C3c4cc(O)c(O)cc4CC3(O)COc2c1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 I20 compound treatment 11.3718 0.12395 0.0333 9.2147 -2.0338 -0.4819 -0.3172 -0.6567 932 BSPBio_002418 NCCCCC(N)C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(CCCCN)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 I21 compound treatment 12.5824 1.3346 0.3581 12.4681 1.2196 0.289 0.4576 0.9943 2060366 BSPBio_002419 CC1(C)C=CC(=O)[C@@]2(C)C1CC(=O)[C@]3(C)C2CC[C@@]4(C)[C@@H](OC(=O)C5OC543)c6ccoc6 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 I22 compound treatment 10.3299 -0.91792 -0.2463 9.7047 -1.5437 -0.3658 -0.4328 -0.9815 1208 BSPBio_002420 CNC[C@H](O)c1cccc(O)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 I23 mock treatment 9.8325 -1.4152 -0.3797 9.2073 -2.0411 -0.4836 -0.6105 -0.9928 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 I24 mock treatment 11.1692 -0.07859 -0.0211 9.5191 -1.7293 -0.4097 -0.3046 -0.7425 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 J01 mock treatment 11.684 0.43623 0.1171 11.8406 0.59211 0.1403 0.182 0.9959 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 J02 mock treatment 11.5418 0.29398 0.0789 12.8081 1.5596 0.3695 0.3171 0.8391 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 J03 compound treatment 13.2825 2.0347 0.546 9.0894 -2.1591 -0.5116 0.0243 0.0325 2515 BSPBio_002421 CCCCCCC(C)OC(=O)COc1cc(Cl)c(Cl)cc1Cl 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 J04 compound treatment 9.9992 -1.2486 -0.335 12.0895 0.84107 0.1993 -0.096 -0.2462 918 BSPBio_002422 CC1Nc2cc(Cl)c(cc2C(=O)N1c3ccccc3C)S(=O)(=O)N 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 J05 compound treatment 11.6706 0.42279 0.1134 9.3928 -1.8557 -0.4397 -0.2307 -0.508 2516 BSPBio_002423 CC(C)OC(=O)Nc1cccc(Cl)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 J06 compound treatment 9.9137 -1.3341 -0.358 9.7167 -1.5318 -0.3629 -0.5098 -1.0 3650189 BSPBio_002424 FC(C(F)(F)F)C(F)(F)Oc1cc(Cl)c(NC(=O)NC(=O)c2c(F)cccc2F)cc1Cl 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 J07 compound treatment 10.4232 -0.82459 -0.2213 12.6574 1.4089 0.3338 0.0796 0.1987 2517 BSPBio_002425 CC(C)N(C(=O)CCl)c1ccccc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 J08 compound treatment 11.0735 -0.17431 -0.0468 11.621 0.37257 0.0883 0.0293 0.2938 1907765 BSPBio_002426 Cc1coc-2c1C(=O)C(=O)c3c4CCCC(C)(C)c4ccc23 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 J09 compound treatment 10.9221 -0.32572 -0.0874 9.0791 -2.1694 -0.514 -0.4253 -0.8156 2518 BSPBio_002427 CCCCSP(=O)(SCCCC)SCCCC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 J10 compound treatment 10.7213 -0.52652 -0.1413 9.8065 -1.442 -0.3417 -0.3415 -0.9237 3650190 BSPBio_002428 CC(=O)OCC(=O)[C@H]1CCC2C3CC=C4C[C@@H](O)CC[C@]4(C)C3CC[C@]12C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 J11 compound treatment 10.302 -0.94578 -0.2538 10.5008 -0.74768 -0.1772 -0.3047 -0.9846 2519 BSPBio_002429 CC(C)N(C(C)C)C(=O)SCC(=C(Cl)Cl)Cl 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 J12 compound treatment 10.1419 -1.1059 -0.2967 10.6232 -0.62527 -0.1481 -0.3146 -0.9485 1000345 BSPBio_002430 OC/C=C/1\O[C@@H]2CC(=O)N2[C@H]1C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 J13 compound treatment 11.0681 -0.17972 -0.0482 10.1687 -1.0798 -0.2558 -0.215 -0.8259 2520 BSPBio_002431 Clc1ccc(Cl)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 J14 compound treatment 11.1502 -0.097643 -0.0262 11.4177 0.16919 0.0401 0.0098 0.205 3068774 BSPBio_002432 Nc1cc(C(=C(Cl)Cl)Cl)c(cc1S(=O)(=O)N)S(=O)(=O)N 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 J15 compound treatment 9.5091 -1.7387 -0.4665 11.4124 0.16395 0.0388 -0.3024 -0.646 2521 BSPBio_002433 Oc1c(Cl)c(Cl)c(Cl)c(Cl)c1Cl 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 J16 compound treatment 12.4696 1.2218 0.3278 10.9604 -0.2881 -0.0683 0.1835 0.5481 407 BSPBio_002434 [O-][N+](=O)c1cccc2c(Br)n[nH]c12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 J17 compound treatment 9.5921 -1.6557 -0.4443 8.7882 -2.4603 -0.5829 -0.7263 -0.991 2522 BSPBio_002435 CNC(=O)Oc1cccc2CC(C)(C)Oc21 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 J18 compound treatment 8.7079 -2.5399 -0.6815 9.002 -2.2465 -0.5323 -0.8583 -0.9925 1397 BSPBio_002436 CC(C)[N+](C)(CCOC(=O)C1c2ccccc2Oc3ccccc13)C(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 J19 compound treatment 11.4794 0.2316 0.0621 10.8193 -0.42917 -0.1017 -0.028 -0.2346 2523 BSPBio_002437 CCOP(=S)(OCC)Oc1nc(Cl)c(Cl)cc1Cl 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 J20 compound treatment 9.5772 -1.6706 -0.4483 10.0927 -1.1558 -0.2738 -0.5106 -0.972 1524104 BSPBio_002438 Oc1cc(O)c2C(=O)CC(Oc2c1)c3ccc(O)c(O)c3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 J21 compound treatment 12.0135 0.76574 0.2055 10.8551 -0.39335 -0.0932 0.0794 0.3519 2524 BSPBio_002439 COP(=O)(NC(=O)C)SC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 J22 compound treatment 9.8908 -1.357 -0.3641 9.4237 -1.8248 -0.4324 -0.5632 -0.9964 3650191 BSPBio_002440 CC1(C[C@@H](O)C2C3[C@H]1O)C2(C)CCCC3(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 J23 mock treatment 11.1971 -0.050663 -0.0136 8.9527 -2.2958 -0.544 -0.3942 -0.7246 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 J24 mock treatment 13.1491 1.9013 0.5102 11.9313 0.68284 0.1618 0.4751 0.8878 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 K01 mock treatment 10.681 -0.56683 -0.1521 10.2667 -0.98174 -0.2326 -0.272 -0.9788 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 K02 mock treatment 9.8377 -1.41 -0.3784 8.8768 -2.3716 -0.5619 -0.6649 -0.9815 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 K03 compound treatment 10.0881 -1.1597 -0.3112 8.8361 -2.4123 -0.5716 -0.6242 -0.9591 2060057 BSPBio_002441 COC(=O)C[C@H]1C(C)(C)[C@@H](OC(=O)C)[C@@H]2CC3=C4CC(=O)O[C@@H](c5ccoc5)[C@]4(C)CCC3[C@@]1(C)C2=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 K04 compound treatment 11.249 0.0012222 3.0E-4 10.1338 -1.1147 -0.2641 -0.1865 -0.7062 2060251 BSPBio_002442 NCC(N)C(=O)c1ccccc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 K05 compound treatment 12.9262 1.6784 0.4503 8.2279 -3.0205 -0.7157 -0.1876 -0.2219 653 BSPBio_002443 Oc1cc2cccc(O)c(=O)c2c(O)c1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 K06 compound treatment 11.0426 -0.20517 -0.0551 10.3173 -0.93117 -0.2206 -0.1949 -0.8573 797 BSPBio_002444 CC[C@]1(CC[C@@H](O1)[C@]2(C)CCC3(C[C@H](O)[C@@H](C)[C@H](O3)[C@H](C)[C@@H](OC)[C@H](C)C(=O)O)O2)C4O[C@H](C[C@@H]4C)C5O[C@@](O)(CC)[C@H](C)C[C@@H]5C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 K07 compound treatment 8.842 -2.4058 -0.6455 10.5874 -0.66104 -0.1566 -0.5672 -0.8539 1501 BSPBio_002445 NCCc1ccc(O)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 K08 compound treatment 10.4095 -0.83834 -0.2249 10.6584 -0.59008 -0.1398 -0.2579 -0.9738 2294 BSPBio_002446 CC(=O)NC(C(=O)O)C(C)(C)SN=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 K09 compound treatment 12.9192 1.6714 0.4485 10.4899 -0.7586 -0.1797 0.19 0.3933 1071570 BSPBio_002447 CCOC(=O)c1c(C)cc(O)cc1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 K10 compound treatment 11.1271 -0.12072 -0.0324 9.7917 -1.4567 -0.3452 -0.267 -0.7701 744 BSPBio_002448 Cn1cnc2[nH]c(=O)n(C)c(=O)c12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 K11 compound treatment 10.1791 -1.0687 -0.2868 10.5361 -0.71233 -0.1688 -0.3221 -0.9681 2060064 BSPBio_002449 CCC(C)C(=O)OC1[C@@H]2CC3=C4CC(=O)O[C@@H](c5ccoc5)[C@]4(C)CCC3[C@](C)([C@@H](CC(=O)OC)C1(C)C)C2=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 K12 compound treatment 10.8142 -0.43355 -0.1163 10.4045 -0.84402 -0.2 -0.2237 -0.9668 3173726 BSPBio_002450 NNC(=O)c1ccncc1.Nc1ccc(C(=O)O)c(O)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 K13 compound treatment 10.6205 -0.62732 -0.1683 10.4917 -0.7568 -0.1793 -0.2458 -0.9995 2060209 BSPBio_002451 COc1cc2OCC3Oc4c(C(=O)O)c(O)ccc4C(=O)C3(O)c2cc1OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 K14 compound treatment 11.4618 0.21395 0.0574 10.2195 -1.029 -0.2438 -0.1318 -0.5262 1129 BSPBio_002452 CCn1cc(C(=O)O)c(=O)c2cnc(nc12)N3CCCC3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 K15 compound treatment 11.6392 0.39138 0.105 9.8133 -1.4351 -0.34 -0.1662 -0.467 2060130 BSPBio_002453 COc1ccc(cc1)[C@@H](C)C(=O)c2ccc(O)cc2O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 K16 compound treatment 9.867 -1.3808 -0.3705 13.4333 2.1848 0.5177 0.1041 0.1635 3198550 BSPBio_002454 CCCCCCCCCCCCCC(O)CC(O)COC(=O)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 K17 compound treatment 11.0269 -0.22094 -0.0593 11.6526 0.40416 0.0958 0.0258 0.229 3174236 BSPBio_002455 O[C@@H]1Cc2c(O)cc(O)cc2O[C@@H]1c3cc(O)c(O)c4c(=O)c(O)cc(cc34)[C@H]5Oc6cc(O)cc(O)c6C[C@H]5O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 K18 compound treatment 9.6317 -1.6161 -0.4336 10.0572 -1.1912 -0.2822 -0.5062 -0.9784 802 BSPBio_002456 Oc1ccc2C(=O)c3c(O)ccc(O)c3C(=O)c2c1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 K19 compound treatment 10.0871 -1.1607 -0.3114 11.2342 -0.014233 -0.0034 -0.2226 -0.7147 2060137 BSPBio_002457 COc1ccc(cc1)c2coc3c(OC)c(OC)cc(OC)c3c2=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 K20 compound treatment 31.2739 20.026 5.3735 33.0323 21.784 5.1614 7.4493 0.9998 928 BSPBio_002458 CC(=O)O[Hg]c1ccccc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 K21 compound treatment 11.3247 0.076947 0.0206 11.769 0.52055 0.1233 0.1018 0.8141 1449 BSPBio_002459 CN1[C@@H](CCC1=O)c2cccnc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 K22 compound treatment 13.4539 2.2061 0.5919 11.3195 0.071074 0.0168 0.4305 0.7269 347 BSPBio_002460 CN1C(=C(O)c2ccccc2S1(=O)=O)C(=O)Nc3ccccn3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 K23 mock treatment 10.1811 -1.0667 -0.2862 10.3369 -0.9116 -0.216 -0.3551 -0.9904 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 K24 mock treatment 11.8765 0.62873 0.1687 12.1176 0.86911 0.2059 0.2649 0.9951 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 L01 mock treatment 11.8159 0.56814 0.1524 9.8578 -1.3907 -0.3295 -0.1252 -0.3448 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 L02 mock treatment 8.2718 -2.976 -0.7985 10.2163 -1.0322 -0.2446 -0.7376 -0.8832 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 L03 compound treatment 11.9643 0.71653 0.1923 9.0394 -2.2091 -0.5234 -0.2342 -0.4199 3172728 BSPBio_002461 CNC(=O)O/N=C(/C)\SC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 L04 compound treatment 10.1098 -1.138 -0.3053 9.2407 -2.0078 -0.4757 -0.5523 -0.977 3650192 BSPBio_002462 C[C@@]1(CC[C@@H]2[C@@](COC(=O)c3ccccc3)(O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)C5O[C@]2(O)C1)O5 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 L05 compound treatment 10.2264 -1.0214 -0.2741 8.9263 -2.3222 -0.5502 -0.5828 -0.9482 3055253 BSPBio_002463 CNC(=O)O/N=C/C(C)(C)SC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 L06 compound treatment 10.1702 -1.0776 -0.2891 9.3948 -1.8536 -0.4392 -0.515 -0.9794 1109110 BSPBio_002464 CCCCS(=N)(=O)CCC(N)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 L07 compound treatment 8.772 -2.4758 -0.6643 10.6801 -0.56839 -0.1347 -0.565 -0.8335 2527 BSPBio_002465 COP(=S)(OC)Oc1ccc(Sc2ccc(OP(=S)(OC)OC)cc2)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 L08 compound treatment 11.5264 0.27855 0.0747 11.738 0.48952 0.116 0.1349 0.9774 1999 BSPBio_002466 Oc1c(I)cc(Cl)c2cccnc12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 L09 compound treatment 10.6846 -0.56316 -0.1511 10.5064 -0.74209 -0.1758 -0.2312 -0.9972 2528 BSPBio_002467 CNC(=O)Oc1cccc2OC(C)(C)Oc21 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 L10 compound treatment 13.2263 1.9785 0.5309 10.7944 -0.45407 -0.1076 0.2993 0.5526 3189444 BSPBio_002468 CCC(C)C1NC2C=Cc3c(cc(nc3C2O)C(=O)OC(C)C4NC(=O)c5csc(n5)C(NC(=O)C6CSC(=N6)/C(=C\C)/NC(=O)C(NC(=O)c7csc(n7)C8(CCC(=NC8c9csc4n9)c%10nc(cs%10)C(=O)NC(=C)C(=O)NC(=C)C(=O)N)NC(=O)C(C)NC(=O)C(=C)NC(=O)C(C)NC1=O)C(C)O)C(C)(O)C(C)O)C(C)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 L11 compound treatment 11.4096 0.16176 0.0434 9.1394 -2.109 -0.4997 -0.3227 -0.6433 2529 BSPBio_002469 COP(=S)(OC)Oc1ccc(SC)c(C)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 L12 compound treatment 13.1 1.8522 0.497 11.773 0.52455 0.1243 0.4393 0.8575 3650194 BSPBio_002470 CC1COC2=C1C(=O)C(=O)c3c2ccc4c(C)cccc34 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 L13 compound treatment 9.1032 -2.1446 -0.5755 9.9702 -1.2783 -0.3029 -0.6211 -0.9551 2530 BSPBio_002471 CCCSP(=O)(OCC)SCCC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 L14 compound treatment 13.3492 2.1015 0.5639 8.8099 -2.4386 -0.5778 -0.0098 -0.0122 3650195 BSPBio_002472 C[C@@]12CCC3C(CCc4cc(OS(=O)(=O)O)ccc34)C2CCC1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 L15 compound treatment 8.3811 -2.8667 -0.7692 12.1741 0.92559 0.2193 -0.3888 -0.4861 2531 BSPBio_002473 CNC(=O)Oc1ccccc1OC(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 L16 compound treatment 10.5111 -0.73671 -0.1977 10.8197 -0.4288 -0.1016 -0.2116 -0.9521 1832 BSPBio_002474 CC(C)[C@H](N)C(=O)OCCOCn1cnc2c(=O)[nH]c(N)nc12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 L17 compound treatment 9.9507 -1.2971 -0.3481 7.9798 -3.2687 -0.7745 -0.7937 -0.9348 2532 BSPBio_002475 CC(C)(C)c1ccc(OC2CCCCC2OS(=O)OCC#C)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 L18 compound treatment 8.6325 -2.6153 -0.7017 9.0513 -2.1971 -0.5206 -0.8643 -0.9892 1875 BSPBio_002476 FC(F)(F)c1ccccc1n2ccnc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 L19 compound treatment 11.033 -0.21477 -0.0576 10.5287 -0.7198 -0.1705 -0.1613 -0.8963 2533 BSPBio_002477 Clc1ccc(cc1)C(c2ccc(Cl)cc2)C(Cl)(Cl)Cl 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 L20 compound treatment 10.6338 -0.61396 -0.1647 12.485 1.2365 0.293 0.0907 0.2698 3650196 BSPBio_002478 COc1ccc(/C=C/C(=O)c2cc(O)ccc2O)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 L21 compound treatment 11.595 0.34725 0.0932 11.3313 0.082852 0.0196 0.0798 0.8377 3046265 BSPBio_002479 Cl[C@H]1[C@H](Cl)[C@@H](Cl)[C@@H](Cl)[C@H](Cl)[C@H]1Cl 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 L22 compound treatment 15.2958 4.048 1.0862 12.4041 1.1557 0.2738 0.9617 0.8585 935 BSPBio_002480 CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 L23 mock treatment 11.1439 -0.10394 -0.0279 10.4045 -0.84394 -0.2 -0.1611 -0.798 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 L24 mock treatment 11.4033 0.1555 0.0417 10.7936 -0.45492 -0.1078 -0.0467 -0.4042 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 M01 mock treatment 12.1188 0.87096 0.2337 10.0889 -1.1596 -0.2747 -0.029 -0.0805 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 M02 mock treatment 11.5178 0.26999 0.0724 9.3489 -1.8995 -0.4501 -0.267 -0.5857 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 M03 compound treatment 30.3199 19.072 5.1175 27.3815 16.133 3.8225 6.3215 0.9897 2060045 BSPBio_002481 CC(=C)/C=C\1/C=CC(=O)C(=C1)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 M04 compound treatment 12.8333 1.5855 0.4254 10.7836 -0.46489 -0.1101 0.2229 0.5073 2060253 BSPBio_002482 NC(CC(=O)c1ccccc1N)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 M05 compound treatment 13.7757 2.5279 0.6783 8.618 -2.6305 -0.6233 0.0389 0.0422 2060196 BSPBio_002483 COc1cc2OCC3Oc4cc5OC(C)(C)C=Cc5c(O)c4C(=O)C3c2cc1OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 M06 compound treatment 10.1283 -1.1195 -0.3004 11.8299 0.5814 0.1378 -0.115 -0.348 470 BSPBio_002484 OC(=O)CCCc1ccccc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 M07 compound treatment 11.0951 -0.15266 -0.041 10.2718 -0.9767 -0.2314 -0.1926 -0.8195 3058622 BSPBio_002485 OC1=CC2=C3c4ccc(O)cc4OC[C@]3(O)CC2=CC1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 M08 compound treatment 8.661 -2.5867 -0.6941 10.1539 -1.0946 -0.2593 -0.6742 -0.9099 1044852 BSPBio_002486 OC(=O)c1cc2cc(Cl)ccc2[nH]1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 M09 compound treatment 10.9868 -0.26099 -0.07 10.1616 -1.0869 -0.2575 -0.2316 -0.8679 2060155 BSPBio_002487 COC(=O)[C@@H]1OC(=O)C2OC23[C@@]1(C)CCC4[C@@]5(C)[C@H](C[C@@H](OC(=O)C)C(C)(C)C5C[C@@H](O)[C@]43C)OC(=O)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 M10 compound treatment 9.0115 -2.2363 -0.6001 8.8947 -2.3538 -0.5577 -0.8187 -0.9993 593 BSPBio_002488 Oc1ccc2ccc(=O)oc2c1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 M11 compound treatment 9.0455 -2.2023 -0.5909 9.8826 -1.3659 -0.3236 -0.6467 -0.9598 2060228 BSPBio_002489 COC(=O)CC1[C@@]2(C)C3CC[C@@]4(C)[C@@H](OC(=O)C=C4[C@]53O[C@]2(O)[C@@H]([C@H]5OC(=O)C)C(OC(=O)C)C1(C)C)c6ccoc6 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 M12 compound treatment 13.2765 2.0287 0.5443 10.0829 -1.1656 -0.2762 0.1896 0.3107 907188 BSPBio_002490 COc1cccc(OC)c1OCCNCC2COc3ccccc3O2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 M13 compound treatment 11.1186 -0.12924 -0.0347 8.119 -3.1295 -0.7415 -0.5488 -0.7394 2060428 BSPBio_002491 CCOC(=O)C(=O)C1(Oc2cc(OC)cc(OC)c2C(=O)C1c3ccccc3)C(=O)OCC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 M14 compound treatment 11.5522 0.30443 0.0817 8.3257 -2.9228 -0.6925 -0.4319 -0.6194 902 BSPBio_002492 OC(=O)c1cc2cc(Cc3cccnc3)ccc2o1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 M15 compound treatment 25.097 13.849 3.7161 21.9498 10.701 2.5355 4.4206 0.9826 1597 BSPBio_002493 CC(=CCCC1(C)Oc2c(CC=C(C)C)c3OC4(C5CC6C=C4C(=O)c3c(O)c2C=C1)C(C/C=C(/C)\C(=O)O)(OC5(C)C)C6=O)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 M16 compound treatment 7.4272 -3.8206 -1.0252 11.0749 -0.17358 -0.0411 -0.754 -0.7349 1000133 BSPBio_002494 C[C@@]12CCC3C(CCC4=CC(=O)CC[C@]34C)C2CC[C@@H]1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 M17 compound treatment 9.6847 -1.5631 -0.4194 9.5863 -1.6622 -0.3938 -0.5751 -0.9995 1097 BSPBio_002495 OC(=O)c1cc(=O)c2ccccc2o1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 M18 compound treatment 11.6922 0.44438 0.1192 9.7552 -1.4933 -0.3538 -0.1659 -0.4442 3046406 BSPBio_002496 Cc1ccc(cc1)N(CC2=NCCN2)c3cccc(O)c3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 M19 compound treatment 11.1804 -0.067445 -0.0181 10.5851 -0.66336 -0.1572 -0.1239 -0.7833 3198311 BSPBio_002497 Cc1cc(O)c(C=O)c2Oc3c(C)c(C(=O)O)c(O)c(COC(=O)/C=C/C(=O)O)c3OC(=O)c12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 M20 compound treatment 9.0705 -2.1773 -0.5842 9.8892 -1.3593 -0.3221 -0.6408 -0.9606 2069343 BSPBio_002498 COc1ccc2[C@H](OC(=O)c2c1OC)[C@H]3N(C)CCc4cc5OCOc5cc34 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 M21 compound treatment 9.6421 -1.6057 -0.4309 10.0449 -1.2035 -0.2852 -0.5063 -0.9799 948 BSPBio_002499 O=C1C(C(=O)c2ccccc12)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 M22 compound treatment 15.1248 3.877 1.0403 12.3075 1.059 0.2509 0.913 0.8532 1289 BSPBio_002500 C[C@@]12C[C@H](O)C3C(CCC4=CC(=O)C=C[C@]34C)C2CC[C@]1(O)C(=O)CO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 M23 mock treatment 10.9438 -0.30395 -0.0816 9.5567 -1.6917 -0.4008 -0.3411 -0.8339 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 M24 mock treatment 10.6615 -0.58629 -0.1573 9.3523 -1.8962 -0.4493 -0.4289 -0.9011 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 N01 mock treatment 12.2867 1.0389 0.2788 11.256 0.007519 0.0018 0.1984 0.7116 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 N02 mock treatment 11.2613 0.01347 0.0036 10.859 -0.38947 -0.0923 -0.0627 -0.6789 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 N03 compound treatment 11.2302 -0.017645 -0.0047 9.5632 -1.6853 -0.3993 -0.2857 -0.7154 2534 BSPBio_002501 ClC(=C(c1ccc(Cl)cc1)c2ccc(Cl)cc2)Cl 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 N04 compound treatment 12.0059 0.75806 0.2034 10.8421 -0.40633 -0.0963 0.0758 0.3366 3650197 BSPBio_002502 CC(=O)O[C@@H]1C[C@]2(C)[C@H](CCC2C3CCC4=CC(=O)CC[C@]4(C)C13)C(=O)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 N05 compound treatment 11.8759 0.6281 0.1685 9.1007 -2.1478 -0.5089 -0.2407 -0.4489 2535 BSPBio_002503 CC1(C)C(C(Cl)Cl)C2(Cl)C(Cl)C(Cl)C1(Cl)C2(Cl)Cl 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 N06 compound treatment 12.3167 1.0689 0.2868 9.98 -1.2685 -0.3005 -0.0097 -0.0234 3100 BSPBio_002504 COc1c2OCOc2cc3CCN(C)Cc13 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 N07 compound treatment 12.7341 1.4863 0.3988 10.9586 -0.2899 -0.0687 0.2334 0.5768 2536 BSPBio_002505 ClC1CC2C(C1Cl)C3(Cl)C(Cl)C(Cl)C2(Cl)C3(Cl)Cl 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 N08 compound treatment 10.0328 -1.215 -0.326 11.4357 0.1872 0.0444 -0.1992 -0.6053 1886 BSPBio_002506 NCCOB(c1ccccc1)c2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 N09 compound treatment 11.4742 0.22635 0.0607 13.14 1.8916 0.4482 0.3599 0.7957 2537 BSPBio_002507 COc1ccc(cc1)C(c2ccc(OC)cc2)C(Cl)(Cl)Cl 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 N10 compound treatment 10.3406 -0.90716 -0.2434 11.5352 0.2867 0.0679 -0.1241 -0.491 BSPBio_002508 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 N11 compound treatment 10.2469 -1.0009 -0.2686 9.8522 -1.3963 -0.3308 -0.4238 -0.9946 2538 BSPBio_002509 ClC1C=CC2C1C3(Cl)C(=C(Cl)C2(Cl)C3(Cl)Cl)Cl 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 N12 compound treatment 11.1403 -0.10745 -0.0288 9.9276 -1.3209 -0.313 -0.2417 -0.769 1264 BSPBio_002510 OCc1ccccc1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 N13 compound treatment 11.2727 0.024895 0.0067 8.6128 -2.6357 -0.6245 -0.4369 -0.6995 2539 BSPBio_002511 CC1(C)C2(Cl)C(Cl)C1(Cl)C(Cl)(C(Cl)Cl)C(Cl)C2Cl 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 N14 compound treatment 13.1834 1.9356 0.5194 9.5533 -1.6952 -0.4016 0.0832 0.1268 3650198 BSPBio_002512 C[C@H]1[C@H](NC(=O)/C(=N/OC(C)(C)C(=O)O)/c2csc(N)n2)C(=O)N1S(=O)(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 N15 compound treatment 10.7369 -0.51093 -0.1371 8.2102 -3.0383 -0.7199 -0.606 -0.8269 2540 BSPBio_002513 ClC1=C(Cl)C2(Cl)C3C4CC(C=C4)C3C1(Cl)C2(Cl)Cl 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 N16 compound treatment 9.0719 -2.1759 -0.5839 9.7992 -1.4493 -0.3434 -0.6557 -0.968 1225 BSPBio_002514 Oc1cc(O)c2c(=O)cc(oc2c1)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 N17 compound treatment 9.455 -1.7928 -0.4811 11.2604 0.011902 0.0028 -0.3382 -0.7029 1534 BSPBio_002515 O=C(/C=C/C=C/c1ccc2OCOc2c1)N3CCCCC3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 N18 compound treatment 10.0216 -1.2262 -0.329 8.9891 -2.2594 -0.5353 -0.6112 -0.9727 3198422 BSPBio_002516 CN[C@H]1C[C@@H](N)[C@H](O)[C@@H](O[C@@H]2O[C@H](CO)[C@@H]3OC4(O[C@@H]3[C@@H]2O)O[C@H](C(N)CO)[C@H](O)[C@H](O)[C@H]4O)[C@@H]1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 N19 compound treatment 10.1156 -1.1322 -0.3038 8.7364 -2.5121 -0.5952 -0.6357 -0.9513 1307 BSPBio_002517 ClC(Cl)C(c1ccc(Cl)cc1)c2ccccc2Cl 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 N20 compound treatment 12.7031 1.4553 0.3905 10.7857 -0.46275 -0.1096 0.1986 0.4896 1511 BSPBio_002518 Oc1ccc(cc1)C2(OC(=O)c3ccccc32)c4ccc(O)cc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 N21 compound treatment 10.4423 -0.80553 -0.2161 9.917 -1.3315 -0.3155 -0.3759 -0.983 2541 BSPBio_002519 ClC1=C(Cl)C2(Cl)C3COS(=O)OCC3C1(Cl)C2(Cl)Cl 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 N22 compound treatment 10.5032 -0.74455 -0.1998 8.5841 -2.6644 -0.6313 -0.5877 -0.8875 1927 BSPBio_002520 NCCSC(=N)N 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 N23 mock treatment 12.4247 1.1769 0.3158 10.0412 -1.2073 -0.286 0.021 0.0494 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 N24 mock treatment 13.2377 1.9899 0.534 11.3013 0.052852 0.0125 0.3864 0.7235 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 O01 mock treatment 12.5896 1.3418 0.36 9.8927 -1.3558 -0.3212 0.0274 0.0569 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 O02 mock treatment 9.4596 -1.7882 -0.4798 12.8497 1.6012 0.3794 -0.071 -0.1161 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 O03 compound treatment 9.768 -1.4798 -0.3971 10.0811 -1.1674 -0.2766 -0.4764 -0.9844 1002679 BSPBio_002521 OCC(O)C(O)C(O)C(O)C(O)CO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 O04 compound treatment 10.9885 -0.25926 -0.0696 12.4705 1.2221 0.2895 0.1556 0.5224 4895 BSPBio_002522 C[n+]1cccc(c1)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 O05 compound treatment 10.2055 -1.0423 -0.2797 8.6294 -2.6191 -0.6206 -0.6366 -0.9352 2069325 BSPBio_002523 OC(=O)/C=C/C=C/c1ccccc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 O06 compound treatment 9.7821 -1.4657 -0.3933 11.2603 0.011872 0.0028 -0.2761 -0.702 1000142 BSPBio_002524 CC1(C)[C@@H](O)CC[C@@]2(C)C1CC[C@]3(C)C2C(=O)C=C4[C@H]5C[C@](C)(CC[C@]5(C)CC[C@]43C)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 O07 compound treatment 11.6406 0.39279 0.1054 9.9585 -1.29 -0.3056 -0.1416 -0.438 3177314 BSPBio_002525 CC(=CCCC1(C)Oc2c(CC=C(C)C)c3OC4(C5CCC=C4C(=O)c3c(O)c2C=C1)[C@@](C/C=C(\C)/C(=O)O)(OC5(C)C)C(=O)O)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 O08 compound treatment 126.9449 115.7 31.0445 100.9873 89.739 21.2623 36.9865 0.983 2576 BSPBio_002526 S=C=NCc1ccccc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 O09 compound treatment 10.4635 -0.78427 -0.2104 9.073 -2.1754 -0.5154 -0.5133 -0.9219 3059432 BSPBio_002527 CC(C)CCCC(C)[C@H]1CCC2C3C(CC[C@]12C)[C@@]4(C)CC[C@H](O)CC4=CC3=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 O10 compound treatment 12.7119 1.4641 0.3929 10.4523 -0.79622 -0.1887 0.1444 0.3313 3061087 BSPBio_002528 NC/C=C/C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 O11 compound treatment 10.7157 -0.53207 -0.1428 12.9208 1.6723 0.3962 0.1792 0.4255 2060311 BSPBio_002529 CC(CCC(=O)O)[C@H]1CCC2C3CC[C@@H]4CC(=O)CC[C@]4(C)C3C=C[C@]12C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 O12 compound treatment 12.639 1.3912 0.3733 9.3799 -1.8685 -0.4427 -0.0491 -0.0848 3174609 BSPBio_002530 CC(C)c1c(C(=O)c2ccccc2)c(c(c3ccc(F)cc3)n1CC[C@@H](O)C[C@@H](O)CC(=O)O)c4ccccc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 O13 compound treatment 10.3031 -0.94468 -0.2535 12.4377 1.1892 0.2818 0.02 0.0528 2060355 BSPBio_002531 CC1=C(C=C)/C(=C/c2[nH]c(Cc3[nH]c(\C=C\4/NC(=O)C(=C4C)C=C)c(C)c3CCC(=O)O)c(CCC(=O)O)c2C)/NC1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 O14 compound treatment 37.7828 26.535 7.12 35.2617 24.013 5.6896 9.0578 0.9938 1066 BSPBio_002532 OC1OCC=C2OC(=O)C=C12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 O15 compound treatment 10.4934 -0.75436 -0.2024 8.096 -3.1525 -0.7469 -0.6713 -0.8674 2060325 BSPBio_002533 COc1ccc2C[C@@H]3N(C)CCc4cc(OC)c(OC)c(c34)-c2c1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 O16 compound treatment 11.3502 0.10238 0.0275 8.9818 -2.2666 -0.537 -0.3603 -0.6701 804 BSPBio_002534 COc1c(C)c2COC(=O)c2c(O)c1C/C=C(\C)/CCC(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 O17 compound treatment 10.2143 -1.0335 -0.2773 9.6461 -1.6024 -0.3797 -0.4645 -0.9881 1055132 BSPBio_002535 COc1cc2cc[n+]3c(C)c4cc(OC)c(OC)cc4cc3c2cc1OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 O18 compound treatment 11.2169 -0.030905 -0.0083 11.4055 0.157 0.0372 0.0204 0.5363 3173859 BSPBio_002536 CC(C)CC(=O)OC1C(O[C@@H]2C[C@H]([C@H]3CC[C@]4(CC5CC[C@H]4[C@]3(C)C2)[C@@H](O)C5=C)C(=O)O)OC(CO)C(OS(=O)(=O)O)C1OS(=O)(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 O19 compound treatment 10.5246 -0.72322 -0.1941 10.2661 -0.9824 -0.2328 -0.3018 -0.9959 1737132 BSPBio_002537 COc1cc-2c(CC3N(C)CCc4cc(O)c(OC)c2c34)cc1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 O20 compound treatment 16.8616 5.6138 1.5063 13.201 1.9525 0.4626 1.3922 0.8835 1531 BSPBio_002538 O=c1n([se]c2ccccc12)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 O21 compound treatment 12.6622 1.4144 0.3795 8.9699 -2.2786 -0.5399 -0.1134 -0.1718 1530 BSPBio_002539 COc1ccc2c3CCN=C(C)c3[nH]c2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 O22 compound treatment 13.3133 2.0655 0.5542 9.5414 -1.7071 -0.4045 0.1059 0.1543 1455 BSPBio_002540 CC(=O)OCC(=O)[C@@]1(O)CCC2C3CCC4=CC(=O)C=CC4(C)C3[C@@H](O)C[C@@]21C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 O23 mock treatment 11.6583 0.41048 0.1101 12.6322 1.3838 0.3279 0.3097 0.8955 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 O24 mock treatment 12.1267 0.87895 0.2358 11.8784 0.62988 0.1492 0.2723 0.9756 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 P01 mock treatment 11.5564 0.30862 0.0828 9.5396 -1.7089 -0.4049 -0.2277 -0.5511 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 P02 mock treatment 10.9838 -0.26396 -0.0708 12.0784 0.82988 0.1966 0.089 0.4256 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 P03 compound treatment 9.9161 -1.3317 -0.3573 9.0322 -2.2162 -0.5251 -0.624 -0.9824 2542 BSPBio_002541 CCCCOC(=O)c1ccccc1C(=O)OCc2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 P04 compound treatment 12.42 1.1722 0.3145 11.0048 -0.24366 -0.0577 0.1816 0.5678 3650199 BSPBio_002542 CC[C@@H]1OC(=O)C[C@@H](O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@@H]([C@H]2O)N(C)C)[C@@H](CCN3C[C@@H](C)C[C@@H](C)C3)C[C@@H](C)C(=O)/C=C/C(=C\[C@@H]1CO[C@@H]4O[C@H](C)[C@@H](O)[C@@H](OC)[C@H]4OC)/C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 P05 compound treatment 10.6351 -0.61267 -0.1644 9.3537 -1.8948 -0.4489 -0.4337 -0.9071 2543 BSPBio_002543 CCCCCCCCCc1ccc(O)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 P06 compound treatment 11.9378 0.69003 0.1852 10.8017 -0.44677 -0.1059 0.0561 0.2629 3650201 BSPBio_002544 COc1cc(O)c(C(=O)/C=C/c2ccc(O)c(OC)c2)c(OC)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 P07 compound treatment 11.2284 -0.0194 -0.0052 21.7466 10.498 2.4874 1.7552 0.7056 2544 BSPBio_002545 CCOCN(C(=O)CCl)c1c(C)cccc1CC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 P08 compound treatment 34.4007 23.153 6.2125 34.4312 23.183 5.4928 8.2769 0.9981 1088391 BSPBio_002546 CC1=CC(=O)c2c(O)cccc2C1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 P09 compound treatment 12.2381 0.99027 0.2657 8.9095 -2.339 -0.5542 -0.204 -0.3319 2545 BSPBio_002547 CCCCOC(=O)c1ccccc1C(=O)OCCCC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 P10 compound treatment 57.8969 46.649 12.5172 65.2077 53.959 12.7849 17.8912 0.9999 1308 BSPBio_002548 CCCSc1ccc2nc(NC(=O)OC)[nH]c2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 P11 compound treatment 14.4672 3.2194 0.8638 14.3692 3.1208 0.7394 1.1337 0.997 1112405 BSPBio_002549 COc1cc2OCOc2cc1c3cc4cc5ccoc5cc4oc3=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 P12 compound treatment 13.108 1.8602 0.4991 9.1545 -2.0939 -0.4961 0.0021 0.003 1249 BSPBio_002550 C[N+](C)(C)CC(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 P13 compound treatment 11.7124 0.46461 0.1247 11.0353 -0.21322 -0.0505 0.0524 0.3898 923 BSPBio_002551 NC(=O)NC1NC(=O)NC1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 P14 compound treatment 9.7719 -1.4759 -0.396 9.5261 -1.7224 -0.4081 -0.5686 -0.9999 3650203 BSPBio_002552 Oc1ccc(cc1O)c2oc3c(O)c(O)cc(O)c3c(=O)c2O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 P15 compound treatment 9.2976 -1.9502 -0.5233 12.5517 1.3032 0.3088 -0.1517 -0.2496 1001523 BSPBio_002553 Nc1ccc(C(=O)Oc2ccccc2)c(O)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 P16 compound treatment 12.0235 0.77567 0.2081 11.8185 0.57006 0.1351 0.2427 0.9781 3650204 BSPBio_002554 CN(CCC(N)CC(=O)N[C@H]1C=CC(O[C@@H]1C(=O)O)n2ccc(N)nc2=O)C(=N)N 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 P17 compound treatment 12.3847 1.1369 0.3051 9.6449 -1.6035 -0.3799 -0.0529 -0.1086 3172973 BSPBio_002555 COC(=O)[C@@]1(O)OC[C@]2(C3[C@H]4OC[C@@]3([C@@H](C[C@@H]2OC(=O)/C(=C/C)/C)OC(=O)C)C(=O)OC)[C@@H]1[C@@](C)([C@@H]4O)C56O[C@@]6(C)[C@H]7C[C@@H]5OC8OC=C[C@]78O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 P18 compound treatment 10.0075 -1.2403 -0.3328 10.6908 -0.55765 -0.1321 -0.3287 -0.9181 3650205 BSPBio_002556 OC[C@H]1O[C@@H](Oc2c(O)cc(O)c3c(=O)c(O)c(oc23)c4ccc(O)c(O)c4)[C@H](O)[C@H](O)[C@H]1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 P19 compound treatment 9.3128 -1.935 -0.5192 12.381 1.1325 0.2683 -0.1774 -0.3035 3079227 BSPBio_002557 [O-][N+](=O)/N=C/1\NCCN1Cc2ccc(Cl)cc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 P20 compound treatment 10.3257 -0.92209 -0.2474 11.8498 0.60134 0.1425 -0.0742 -0.2599 3650207 BSPBio_002558 CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.Cc1c(Nc2ncccc2C(=O)O)cccc1C(F)(F)F 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 P21 compound treatment 10.365 -0.88279 -0.2369 9.7087 -1.5398 -0.3648 -0.4255 -0.9781 1304 BSPBio_002559 ClC1=C(Cl)C2(Cl)C3C4CC(C5OC54)C3C1(Cl)C2(Cl)Cl 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 P22 compound treatment 10.9651 -0.28269 -0.0759 9.586 -1.6625 -0.3939 -0.3322 -0.8281 2270 BSPBio_002560 CCCCOc1cc(CC2CNC(=O)N2)ccc1OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 P23 mock treatment 11.117 -0.13077 -0.0351 9.7421 -1.5063 -0.3569 -0.2772 -0.7729 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2460 P24 mock treatment 10.8478 -0.40002 -0.1073 12.12 0.87154 0.2065 0.0701 0.3013 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 A01 mock treatment 12.304 1.2735 0.3417 11.6989 0.55567 0.1317 0.3347 0.914 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 A02 mock treatment 15.1863 4.1558 1.1151 13.6485 2.5053 0.5936 1.2082 0.9564 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 A03 compound treatment 9.6118 -1.4187 -0.3807 12.5466 1.4034 0.3325 -0.034 -0.0674 2359 BSPBio_002561 CCOC(=O)C1=C[C@]2(CC)CCCN3CCc4c([C@@H]32)n1c5ccccc45 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 A04 compound treatment 11.7631 0.73262 0.1966 11.4049 0.26166 0.062 0.1828 0.887 2060285 BSPBio_002562 O=C1CCCCC/C=C/CCCCCCCCO1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 A05 compound treatment 11.1714 0.14089 0.0378 12.1938 1.0505 0.2489 0.2027 0.8053 1274 BSPBio_002563 C1CN2C[C@@H](N=C2S1)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 A06 compound treatment 12.4134 1.3829 0.3711 12.6159 1.4727 0.3489 0.5091 0.9995 1019872 BSPBio_002564 COc1cc2COC(=O)c2cc1OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 A07 compound treatment 12.1812 1.1507 0.3088 12.1173 0.97405 0.2308 0.3815 0.9897 1386 BSPBio_002565 CN1CC(c2ccccc2)c3cccc(N)c3C1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 A08 compound treatment 13.1905 2.1599 0.5796 12.467 1.3238 0.3137 0.6316 0.9584 348755 BSPBio_002566 OC(=O)c1cc2cc(F)ccc2[nH]1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 A09 compound treatment 14.1924 3.1619 0.8484 12.7 1.5568 0.3689 0.8608 0.9304 1270 BSPBio_002567 C[N+](C)(C)CCCCCC[N+](C)(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 A10 compound treatment 12.9008 1.8703 0.5019 13.3487 2.2055 0.5226 0.7244 0.9998 1094519 BSPBio_002568 CC(=O)N1CCCC1C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 A11 compound treatment 10.99 -0.040542 -0.0109 11.5569 0.4137 0.098 0.0616 0.6248 726 BSPBio_002569 CCOC(=O)N 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 A12 compound treatment 11.3902 0.35969 0.0965 11.3616 0.21843 0.0518 0.1048 0.9573 1031375 BSPBio_002570 NC(CCCNC(=O)N)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 A13 compound treatment 12.7739 1.7434 0.4678 16.2271 5.0839 1.2045 1.1825 0.9151 695 BSPBio_002571 CC1CCC(CC1)NC(=O)N(CCCl)N=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 A14 compound treatment 12.5607 1.5302 0.4106 10.8198 -0.32345 -0.0766 0.2361 0.5654 889 BSPBio_002572 NC(=O)c1cnccn1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 A15 compound treatment 12.375 1.3445 0.3608 11.305 0.16177 0.0383 0.2822 0.7779 941 BSPBio_002573 CC(=O)Oc1cccc(O)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 A16 compound treatment 11.8825 0.85199 0.2286 11.7587 0.61548 0.1458 0.2648 0.9764 1394 BSPBio_002574 BrCCC(=O)N1CCN(CC1)C(=O)CCBr 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 A17 compound treatment 12.2441 1.2136 0.3256 10.7731 -0.37017 -0.0877 0.1682 0.4989 117 BSPBio_002575 CCOC(=O)C1=C(C)NC(=C(C1c2cccc(c2)[N+](=O)[O-])C(=O)OC)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 A18 compound treatment 12.5511 1.5206 0.408 12.005 0.86176 0.2042 0.4329 0.9488 366 BSPBio_002576 OC(=O)Cc1nn(Cc2ccc(Br)cc2F)c(=O)c3ccccc13 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 A19 compound treatment 12.2853 1.2548 0.3367 13.1723 2.029 0.4807 0.578 0.9848 1512 BSPBio_002577 CC(C)NCC(O)c1ccc2ccccc2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 A20 compound treatment 14.7871 3.7565 1.008 13.5795 2.4363 0.5772 1.1209 0.965 2060108 BSPBio_002578 CC1=C(Cl)C(=O)C=C(O)C21Oc3cc(O)c(Cl)c(C)c3C2=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 A21 compound treatment 13.0071 1.9766 0.5304 11.8547 0.71152 0.1686 0.4942 0.8881 1415 BSPBio_002579 FC(F)(F)c1cccc(c1)N2CCNCC2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 A22 compound treatment 12.5493 1.5188 0.4075 12.5089 1.3657 0.3236 0.517 0.9935 26 BSPBio_002580 CCCCc1oc2ccccc2c1C(=O)c3cc(I)c(OCCN(CC)CC)c(I)c3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 A23 mock treatment 12.2461 1.2156 0.3262 11.6693 0.52603 0.1246 0.3188 0.9129 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 A24 mock treatment 12.3842 1.3537 0.3632 12.9769 1.8337 0.4345 0.5641 0.996 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 B01 mock treatment 13.2081 2.1776 0.5843 14.1875 3.0443 0.7213 0.9232 0.9945 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 B02 mock treatment 10.827 -0.20346 -0.0546 11.5499 0.40665 0.0964 0.0295 0.2666 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 B03 compound treatment 13.6136 2.5831 0.6931 11.0956 -0.047608 -0.0113 0.4821 0.6955 1061352 BSPBio_002581 COc1cc2Cc3cc(OC)c(OC)cc3Cc4cc(OC)c(OC)cc4Cc2cc1OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 B04 compound treatment 10.7282 -0.30232 -0.0811 9.5257 -1.6175 -0.3832 -0.3284 -0.8382 2069257 BSPBio_002582 CC1(C)CC2C1CCC(=C)C(O)CCC2=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 B05 compound treatment 14.6142 3.5837 0.9616 11.9543 0.81108 0.1922 0.8158 0.832 3058525 BSPBio_002583 COc1cc2OC[C@H]3Oc4c5C=CC(C)(C)Oc5ccc4C(=O)[C@H]3c2cc1OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 B06 compound treatment 60.1785 49.148 13.1877 42.917 31.774 7.5283 14.6484 0.9647 2560 BSPBio_002584 Cc1ccc2cc3c(ccc4ccccc43)c5CCc1c52 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 B07 compound treatment 12.1252 1.0947 0.2937 11.7552 0.61202 0.145 0.3102 0.9471 2325 BSPBio_002585 NC(C(O)C(=O)O)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 B08 compound treatment 28.3053 17.275 4.6353 26.0613 14.918 3.5346 5.777 0.991 383 BSPBio_002586 CC[C@@]1(O)C(=O)OCc2c1cc3-c4nc5ccccc5cc4Cn3c2=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 B09 compound treatment 14.893 3.8624 1.0364 10.2079 -0.93529 -0.2216 0.5761 0.5436 1026119 BSPBio_002587 COc1ccc(C(=O)O)c(O)c1OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 B10 compound treatment 11.1106 0.080138 0.0215 11.171 0.027797 0.0066 0.0199 0.8832 2547 BSPBio_002588 CC(=CC1C(C(=O)OCc2cccc(Oc3ccccc3)c2)C1(C)C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 B11 compound treatment 10.0228 -1.0077 -0.2704 11.4609 0.31772 0.0753 -0.138 -0.4916 2060313 BSPBio_002589 C/C/1=C/CC(C)(C)\C=C\C\C(=C\CC1)\C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 B12 compound treatment 10.9478 -0.082742 -0.0222 11.5844 0.44115 0.1045 0.0582 0.5448 3177379 BSPBio_002590 CC(=O)O[C@H]1CC(=C)C(CC[C@](C)(O)C=C)C2(C)CCCC(C)(C)C12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 B13 compound treatment 10.2027 -0.82776 -0.2221 11.2113 0.068115 0.0161 -0.1456 -0.654 BSPBio_002591 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 B14 compound treatment 11.9098 0.87932 0.2359 11.5463 0.4031 0.0955 0.2344 0.9208 994 BSPBio_002592 N[C@@H](CCONC(=N)N)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 B15 compound treatment 11.6082 0.57772 0.155 11.1037 -0.039505 -0.0094 0.103 0.6632 3055472 BSPBio_002593 CC(C)CCCC(C)[C@H]1CCC2C3CC[C@@H]4C[C@H](O)CC[C@]4(C)C3CC[C@]12C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 B16 compound treatment 21.503 10.473 2.81 13.7036 2.5604 0.6067 2.416 0.8404 3173364 BSPBio_002594 C[C@H]1[C@@]2(C)CCC3C(CCC4C[C@H](CC[C@@]43C)O[C@H]5O[C@H](CO)[C@H](O[C@H]6O[C@H](CO)[C@@H](O)[C@H](O[C@H]7OC[C@@H](O)[C@H](O)[C@H]7O[C@H]8O[C@H](CO)[C@@H](O)[C@H](O)[C@H]8O)[C@H]6O)[C@H](O)[C@H]5O)C2O[C@]91CC[C@H](C)CN9 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 B17 compound treatment 13.5714 2.5409 0.6818 12.755 1.6117 0.3819 0.7521 0.9625 2069272 BSPBio_002595 CC1C[C@H]2CC(=O)[C@H]3CCCN4CCC[C@H]2[C@]34C1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 B18 compound treatment 12.3745 1.3439 0.3606 13.3839 2.2407 0.5309 0.6304 0.9822 2060363 BSPBio_002596 COc1cc(O)cc(OC)c1OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 B19 compound treatment 10.7056 -0.32488 -0.0872 9.5641 -1.5791 -0.3742 -0.3262 -0.8491 2060441 BSPBio_002597 OC(=O)c1cc(O)c2C(=O)c3c(O)cc(O)cc3C(=O)c2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 B20 compound treatment 14.308 3.2775 0.8794 11.05 -0.093198 -0.0221 0.6062 0.6891 3198326 BSPBio_002598 O[C@@H]1O[C@H](COC(=O)CC[N+](=O)[O-])[C@@H](OC(=O)CC[N+](=O)[O-])[C@H](OC(=O)CC[N+](=O)[O-])[C@H]1OC(=O)CC[N+](=O)[O-] 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 B21 compound treatment 13.2083 2.1778 0.5844 9.5895 -1.5537 -0.3681 0.1529 0.2214 3198531 BSPBio_002599 COc1ccc(cc1)c2oc3c(CC=C(C)C)c(O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)cc(O)c3c(=O)c2O[C@@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 B22 compound treatment 13.3771 2.3465 0.6296 13.7672 2.624 0.6217 0.8848 1.0 3172845 BSPBio_002600 CCC(C)C(=O)O[C@H]1[C@H](O)C2C(CN3CC(C)CCC3[C@@]2(C)O)C4C[C@]5(O[C@@]6(O)C7C(OC(=O)C)[C@@H](OC(=O)C)C5[C@@]41O)[C@@]7(C)CCC6OC(=O)C(C)(O)CC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 B23 mock treatment 13.3518 2.3213 0.6229 12.24 1.0968 0.2599 0.6242 0.9249 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 B24 mock treatment 13.6757 2.6452 0.7098 10.5939 -0.54927 -0.1301 0.4099 0.568 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 C01 mock treatment 13.4766 2.446 0.6563 11.0463 -0.096945 -0.023 0.4479 0.6819 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 C02 mock treatment 9.6641 -1.3664 -0.3666 10.1836 -0.95962 -0.2274 -0.42 -0.9736 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 C03 compound treatment 12.5487 1.5182 0.4074 10.2142 -0.92898 -0.2201 0.1324 0.286 419 BSPBio_002601 CC1=NN(C(=O)C1)c2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 C04 compound treatment 14.256 3.2255 0.8655 10.8615 -0.28177 -0.0668 0.5648 0.6506 2069337 BSPBio_002602 COC(=O)C(C)c1ccc(cc1)C(=O)c2cccs2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 C05 compound treatment 10.1765 -0.854 -0.2292 10.7311 -0.41217 -0.0977 -0.2311 -0.9277 445 BSPBio_002603 NC(=O)c1cccc(N)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 C06 compound treatment 13.6055 2.575 0.6909 9.7982 -1.3451 -0.3187 0.2632 0.3459 1436 BSPBio_002604 CCCNC(C)C(=O)Nc1ccccc1C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 C07 compound treatment 10.9417 -0.088784 -0.0238 11.5995 0.45633 0.1081 0.0596 0.5384 2069284 BSPBio_002605 COc1ccc2cc(ccc2c1)[C@H](C)CO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 C08 compound treatment 11.6238 0.5933 0.1592 9.3534 -1.7898 -0.4241 -0.1873 -0.4135 3198551 BSPBio_002606 O[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)[C@H]1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 C09 compound treatment 14.4848 3.4543 0.9269 12.1577 1.0145 0.2404 0.8254 0.862 1357 BSPBio_002607 CCCCN1CCCCC1C(=O)Nc2c(C)cccc2C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 C10 compound treatment 12.285 1.2545 0.3366 11.3497 0.20651 0.0489 0.2726 0.8015 1119 BSPBio_002608 CSCCC(NC=O)C(=O)NC(Cc1ccccc1)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 C11 compound treatment 12.6265 1.596 0.4283 12.2477 1.1045 0.2617 0.4879 0.9721 1390 BSPBio_002609 CC(C)(C)NCC(O)c1cc(Cl)c(N)c(Cl)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 C12 compound treatment 20.6757 9.6452 2.5881 20.5636 9.4204 2.232 3.4083 0.9973 693 BSPBio_002610 CCN(CC)CCOc1ccc-2c(c1)C(=O)c3cc(OCCN(CC)CC)ccc32 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 C13 compound treatment 10.7127 -0.3178 -0.0853 10.4707 -0.67253 -0.1593 -0.173 -0.9571 1453 BSPBio_002611 CN1CCCN=C1/C=C/c2sccc2C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 C14 compound treatment 9.9274 -1.1031 -0.296 14.8528 3.7095 0.8789 0.4122 0.4445 2060414 BSPBio_002612 OC(=O)c1nc2cc(Cl)c(Cl)cc2nc1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 C15 compound treatment 12.7984 1.7679 0.4744 10.9655 -0.17773 -0.0421 0.3057 0.6418 1586 BSPBio_002613 NCCCCNCCCN 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 C16 compound treatment 54.8505 43.82 11.758 58.1206 46.977 11.1306 16.1847 0.9996 1000045 BSPBio_002614 CC(=O)O[C@@H]1C2=C(C)[C@H](C[C@@](O)([C@@H](OC(=O)c3ccccc3)C4[C@@]5(CO[C@@H]5C[C@H](O)[C@@]4(C)C1=O)OC(=O)C)C2(C)C)OC(=O)[C@H](O)[C@@H](NC(=O)c6ccccc6)c7ccccc7 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 C17 compound treatment 11.4718 0.44127 0.1184 11.6799 0.53667 0.1272 0.1736 0.9994 3172723 BSPBio_002615 CC(=O)OC[C@@]1(O)C[C@@]2(C[C@H]1CCC23)CCC4c5ccoc5CC[C@@]43C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 C18 compound treatment 10.2256 -0.80493 -0.216 16.6539 5.5107 1.3057 0.7705 0.5822 2060244 BSPBio_002616 COC1=CC(=O)OC(CCc2ccc(OC)c(OC)c2)C1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 C19 compound treatment 11.8187 0.78815 0.2115 12.2199 1.0767 0.2551 0.3299 0.9957 765 BSPBio_002617 Oc1ccnc(S)n1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 C20 compound treatment 12.3922 1.3617 0.3654 11.541 0.39777 0.0942 0.325 0.8613 3198312 BSPBio_002618 C[C@@]12CCC3C(C=CC4=CC(=O)CC[C@]34C)C2CC[C@]51CCC(=O)O5 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 C21 compound treatment 12.2601 1.2296 0.3299 13.4909 2.3477 0.5563 0.6266 0.9689 2060327 BSPBio_002619 COc1cc2CCN(C)[C@H]3Oc4ccc(O)c(Oc5cc6[C@H](Cc7ccc(Oc(c1O)c32)cc7)N(C)CCc6cc5OC)c4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 C22 compound treatment 10.5859 -0.44458 -0.1193 11.7687 0.62544 0.1482 0.0204 0.1074 3057756 BSPBio_002620 C1CCN2C[C@H]3C[C@@H](CN4CCCC[C@H]34)[C@@H]2C1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 C23 mock treatment 11.232 0.20151 0.0541 10.683 -0.46027 -0.1091 -0.0389 -0.3194 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 C24 mock treatment 13.2105 2.18 0.5849 9.5065 -1.6367 -0.3878 0.1394 0.1986 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 D01 mock treatment 11.1475 0.11699 0.0314 11.6764 0.53314 0.1263 0.1115 0.8568 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 D02 mock treatment 11.7566 0.72608 0.1948 10.4467 -0.69656 -0.165 0.0211 0.0825 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 D03 compound treatment 11.5598 0.52932 0.142 9.9707 -1.1725 -0.2778 -0.096 -0.3077 3198313 BSPBio_002621 C[C@@H]1CC[C@@]2(CC[C@]3(C)C(=CCC4[C@@]5(C)C[C@@H](O)[C@H](O)[C@@](C)(CO)C5[C@H](O)C[C@]43C)[C@@H]2[C@H]1C)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 D04 compound treatment 11.4312 0.40074 0.1075 10.8391 -0.30411 -0.0721 0.0251 0.1938 2546 BSPBio_002622 COC(=O)NC(=S)Nc1ccccc1NC(=S)NC(=O)OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 D05 compound treatment 9.4875 -1.543 -0.414 12.4193 1.2761 0.3024 -0.079 -0.154 3076175 BSPBio_002623 COc1cc(ccc1O)[C@H]2Oc3cc(ccc3O[C@@H]2CO)[C@H]4Oc5cc(O)cc(O)c5C(=O)[C@@H]4O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 D06 compound treatment 10.8645 -0.16601 -0.0445 10.0041 -1.1391 -0.2699 -0.2223 -0.8128 3174367 BSPBio_002624 NCCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 D07 compound treatment 11.4722 0.44168 0.1185 13.5084 2.3651 0.5604 0.4801 0.8381 3078458 BSPBio_002625 CCCCCC/C=C\CCCCCCCc1cccc(O)c1C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 D08 compound treatment 40.9961 29.966 8.0405 43.7226 32.579 7.7192 11.1438 0.9998 3055280 BSPBio_002626 CCCCCCc1ccc(O)cc1O.Nc1c2ccccc2nc3ccccc13 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 D09 compound treatment 13.1532 2.1227 0.5696 9.8791 -1.2641 -0.2995 0.191 0.2967 2141064 BSPBio_002627 COC1=C[C@@H]2[C@@H]3Cc4ccc(OC)c(O)c4[C@]2(CCN3C)CC1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 D10 compound treatment 11.5571 0.5266 0.1413 10.5282 -0.615 -0.1457 -0.0031 -0.0154 1082254 BSPBio_002628 OC(=O)CCNC(=O)c1ccccc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 D11 compound treatment 12.5803 1.5498 0.4159 11.8866 0.74333 0.1761 0.4186 0.9269 1084508 BSPBio_002629 COc1ccc2cc3-c4cc(OC)c(OC)cc4CC[n+]3cc2c1OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 D12 compound treatment 14.3525 3.322 0.8914 13.174 2.0308 0.4812 0.9705 0.9581 2060400 BSPBio_002630 CC(C)c1ccc2c(CCC3[C@](C)(CN)CCC[C@@]32C)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 D13 compound treatment 11.0378 0.0073182 0.002 13.033 1.8898 0.4477 0.318 0.7102 2069250 BSPBio_002631 OCC(O)CC(O)CCCCCCCCCCCC#C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 D14 compound treatment 11.1524 0.12184 0.0327 12.2449 1.1017 0.261 0.2077 0.7895 1473 BSPBio_002632 CC1(C)[C@@H](O)CC[C@@]2(C)C1CC[C@]3(C)C2C(=O)C=C4[C@@H]5C[C@](C)(CC[C@]5(C)CC[C@]43C)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 D15 compound treatment 11.7703 0.73976 0.1985 11.6579 0.51465 0.1219 0.2266 0.9726 3079228 BSPBio_002633 CCNC(=O)CC[C@H](N)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 D16 compound treatment 26.1941 15.164 4.0688 29.5259 18.383 4.3555 5.9569 0.9994 1001284 BSPBio_002634 CC(C)C1NC(=O)C(NC(=O)c2ccc(C)c3oc4c(C)c(=O)c(N)c(C(=O)NC5C(C)OC(=O)C(C(C)C)N(C)C(=O)CN(C)C(=O)C6CCCC6C(=O)C(NC5=O)C(C)C)c4nc23)C(C)OC(=O)C(C(C)C)N(C)C(=O)CN(C)C(=O)C7CCCC7C1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 D17 compound treatment 9.9651 -1.0654 -0.2859 10.4759 -0.66727 -0.1581 -0.3139 -0.961 1129781 BSPBio_002635 COc1ccc(cc1)c2cc(=O)c3c(OC)cc(OC)cc3o2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 D18 compound treatment 11.4553 0.42475 0.114 11.4418 0.29855 0.0707 0.1306 0.9737 2060421 BSPBio_002636 C[C@](O)(CCC1C(=C)C[C@H](O)C2C(C)(C)CCCC12C)C=C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 D19 compound treatment 13.3302 2.2997 0.6171 11.7054 0.56214 0.1332 0.5305 0.8404 3080393 BSPBio_002637 COc1ccc(cc1)c2c(O)c3c(OC)c4CCC(C)(C)Oc4cc3oc2=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 D20 compound treatment 11.2899 0.25942 0.0696 10.9153 -0.22793 -0.054 0.011 0.1252 2069338 BSPBio_002638 CC(=O)O[C@@H]1Cc2c(OC(=O)C)cc(OC(=O)C)cc2O[C@@H]1c3ccc(OC(=O)C)c(OC(=O)C)c3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 D21 compound treatment 12.3391 1.3086 0.3511 10.9904 -0.15284 -0.0362 0.2227 0.6308 3198546 BSPBio_002639 CC(=CCC/C(=C/COC(=O)\C=C\c1ccccc1)/C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 D22 compound treatment 10.99 -0.040497 -0.0109 9.9584 -1.1848 -0.2807 -0.2062 -0.7339 3263 BSPBio_002640 CNC(C)(C)Cc1ccccc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 D23 mock treatment 10.6016 -0.42888 -0.1151 9.399 -1.7442 -0.4133 -0.3736 -0.8709 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 D24 mock treatment 9.8944 -1.1361 -0.3049 11.1247 -0.018558 -0.0044 -0.2187 -0.7172 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 E01 mock treatment 11.3239 0.29341 0.0787 11.299 0.15583 0.0369 0.0818 0.9404 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 E02 mock treatment 10.6529 -0.37756 -0.1013 10.8702 -0.27301 -0.0647 -0.1174 -0.9765 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 E03 compound treatment 11.4346 0.40404 0.1084 10.76 -0.38319 -0.0908 0.0125 0.0881 1537011 BSPBio_002641 CN(C)CCC(c1ccc(Br)cc1)c2ccccn2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 E04 compound treatment 12.2521 1.2216 0.3278 12.4503 1.3071 0.3097 0.4508 0.9996 3198428 BSPBio_002642 CCOC(=O)[C@H](CCc1ccccc1)N[C@H](C)C(=O)N2[C@@H](CC3CCCCC32)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 E05 compound treatment 10.7748 -0.25572 -0.0686 11.2187 0.075452 0.0179 -0.0359 -0.506 2060330 BSPBio_002643 OC[C@H](O)[C@@H](O)[C@H](O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)[C@H](O)CO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 E06 compound treatment 12.2213 1.1908 0.3195 10.3722 -0.77098 -0.1827 0.0968 0.2629 1001332 BSPBio_002644 CN(C)CCC[C@]1(OCc2cc(C#N)ccc21)c3ccc(F)cc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 E07 compound treatment 13.5287 2.4982 0.6703 11.2726 0.12942 0.0307 0.4957 0.7387 691 BSPBio_002645 CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](NC(=O)N3CCNC3=O)c4ccccc4)C(=O)N2C1C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 E08 compound treatment 11.9949 0.96443 0.2588 12.9756 1.8323 0.4341 0.49 0.9694 3480229 BSPBio_002646 COc1cc2nc(nc(N)c2cc1OC)N(C)CCCNC(=O)C3CCCO3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 E09 compound treatment 11.3185 0.28802 0.0773 9.7149 -1.4283 -0.3384 -0.1847 -0.5319 2060340 BSPBio_002647 CC(=O)/C(=C\c1ccccc1)/CC(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 E10 compound treatment 24.7604 13.73 3.6841 24.6872 13.544 3.2091 4.8742 0.9976 3174103 BSPBio_002648 C/C/1=C\CC[C@@]2(C)OC2[C@H]3OC(=O)C(=C)[C@@H]3CC1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 E11 compound treatment 11.0078 -0.022719 -0.0061 11.485 0.34176 0.081 0.0529 0.652 1054504 BSPBio_002649 COc1c(OCC(O)C(C)(C)O)ccc2c(OC)c3ccoc3nc12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 E12 compound treatment 9.785 -1.2455 -0.3342 11.0549 -0.088353 -0.0209 -0.2511 -0.7499 1470 BSPBio_002650 N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](CCCNC(=N)N)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 E13 compound treatment 11.1767 0.14616 0.0392 12.0521 0.90891 0.2154 0.18 0.8224 2060307 BSPBio_002651 COc1ccc2[C@@H](O)[C@H](Cc3ccc(OC)c(OC)c3)COc2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 E14 compound treatment 10.5863 -0.44416 -0.1192 12.5348 1.3915 0.3297 0.1489 0.4246 690 BSPBio_002652 CC(C)NCC(O)COc1ccccc1CC=C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 E15 compound treatment 15.3117 4.2812 1.1488 13.3205 2.1773 0.5159 1.1771 0.9347 2060301 BSPBio_002653 COc1ccc(cc1O)c2cc(=O)c3c(O)cc(O)cc3o2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 E16 compound treatment 12.0898 1.0593 0.2842 12.2331 1.0899 0.2582 0.3836 0.9989 885 BSPBio_002654 Clc1ccc2Oc3ccccc3N=C(N4CCNCC4)c2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 E17 compound treatment 10.817 -0.21354 -0.0573 10.8847 -0.25853 -0.0613 -0.0838 -0.9994 2069298 BSPBio_002655 CC(=O)Nc1c(I)cc(I)c(C(=O)O)c1I 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 E18 compound treatment 12.4772 1.4467 0.3882 11.7446 0.60136 0.1425 0.3752 0.9075 1200 BSPBio_002656 NC1C[C@H]1c2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 E19 compound treatment 11.8433 0.81276 0.2181 10.2993 -0.84395 -0.2 0.0128 0.0433 3474304 BSPBio_002657 COc1ccc(cc1)C(CN(C)C)C2(O)CCCCC2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 E20 compound treatment 10.0573 -0.97323 -0.2611 11.4022 0.25898 0.0614 -0.1413 -0.5266 2060201 BSPBio_002658 CC(=O)OCC(O)CC(O)CCCCCCCCCCCC#C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 E21 compound treatment 10.7611 -0.26941 -0.0723 11.6708 0.52762 0.125 0.0373 0.2582 1001204 BSPBio_002659 COc1ccc(cc1)C(=O)CC(=O)c2ccc(cc2)C(C)(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 E22 compound treatment 11.8625 0.83202 0.2233 10.6773 -0.46594 -0.1104 0.0798 0.3204 2081691 BSPBio_002660 CC(=CCC/C(=C/CC/C(=C/CO)/C)/C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 E23 mock treatment 9.6392 -1.3913 -0.3733 12.0684 0.92513 0.2192 -0.109 -0.2517 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 E24 mock treatment 9.0993 -1.9313 -0.5182 10.8904 -0.25283 -0.0599 -0.4088 -0.7836 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 F01 mock treatment 10.9465 -0.084012 -0.0225 9.4819 -1.6614 -0.3936 -0.2943 -0.7464 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 F02 mock treatment 9.3598 -1.6707 -0.4483 11.8512 0.70796 0.1677 -0.1984 -0.4145 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 F03 compound treatment 12.4927 1.4622 0.3923 9.924 -1.2192 -0.2889 0.0732 0.1502 2069315 BSPBio_002661 COc1cc(OC)c2c(=O)c(coc2c1)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 F04 compound treatment 11.4409 0.41037 0.1101 11.5557 0.4125 0.0977 0.147 0.9982 1668673 BSPBio_002662 Nc1ccc(cc1)S(=O)(=O)Nc2ccc(Cl)nn2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 F05 compound treatment 11.0033 -0.027169 -0.0073 11.5412 0.39799 0.0943 0.0615 0.6505 3079229 BSPBio_002663 CC1(C)C2CC(O)C(C)(O)CC21 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 F06 compound treatment 12.9574 1.9269 0.517 12.0027 0.85949 0.2036 0.5096 0.917 2069240 BSPBio_002664 CC(=O)OCC(=O)[C@@]1(O)CCC2C3CC[C@@H]4C[C@@H](CC[C@]4(C)C3C(=O)C[C@@]21C)OC(=O)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 F07 compound treatment 9.2801 -1.7504 -0.4697 11.1672 0.023972 0.0057 -0.3281 -0.6985 2060187 BSPBio_002665 COc1cccc(/C=C/C(=O)O)c1C(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 F08 compound treatment 10.2907 -0.73982 -0.1985 12.3315 1.1883 0.2815 0.0587 0.1704 813 BSPBio_002666 CC(=O)O[C@H]1CCC2C3CCc4cc(OC(=O)C)ccc4C3CC[C@]12C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 F09 compound treatment 11.209 0.17845 0.0479 10.0295 -1.1137 -0.2639 -0.1527 -0.5695 3198535 BSPBio_002667 CC(=O)O[C@@H]1CC2C(C)(C)[C@H](O)C[C@H](O)[C@]2(C)C3CC[C@]4(C)[C@@H](OC(=O)C=C4[C@]13C)c5ccoc5 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 F10 compound treatment 8.7418 -2.2887 -0.6141 10.2477 -0.89556 -0.2122 -0.5843 -0.8993 3054072 BSPBio_002668 OC(=O)CCCCCCCCCCCCC1CCC=C1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 F11 compound treatment 9.9848 -1.0457 -0.2806 10.4574 -0.68585 -0.1625 -0.3133 -0.9663 1044258 BSPBio_002669 COc1cc2occ(c3ccc(O)cc3)c(=O)c2c(OC)c1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 F12 compound treatment 10.4348 -0.59574 -0.1599 10.8229 -0.32031 -0.0759 -0.1667 -0.942 2060132 BSPBio_002670 CC1=CC(=O)C2C(C)(C)CCC[C@]2(C)[C@@]1(O)CCc3ccoc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 F13 compound treatment 19.5287 8.4982 2.2803 17.8257 6.6825 1.5833 2.732 0.9841 3198552 BSPBio_002671 CO[C@H]1[C@@H](O)[C@@H](C)O[C@H](O[C@H]2CCC3(C)C4CCC5(C)[C@H](CC[C@]5(O)[C@@H]4CC[C@]3(O)C2)C6=CC(=O)OC6)[C@@H]1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 F14 compound treatment 10.8864 -0.14413 -0.0387 93.5151 82.372 19.5168 13.7731 0.7057 2060140 BSPBio_002672 COc1cc2occc2c3oc(=O)ccc13 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 F15 compound treatment 11.0877 0.057153 0.0153 11.2135 0.07032 0.0167 0.0226 0.9991 1020088 BSPBio_002673 NNCc1ccccc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 F16 compound treatment 13.1301 2.0996 0.5634 9.8739 -1.2693 -0.3008 0.1857 0.2908 3174245 BSPBio_002674 OC[C@H]1O[C@@H](Oc2cc(O)cc(O)c2C(=O)CCc3ccc(O)cc3)[C@H](O)[C@@H](O)[C@@H]1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 F17 compound treatment 45.1497 34.119 9.1551 42.2124 31.069 7.3614 11.6789 0.9942 2549 BSPBio_002675 C[n+]1cc2c3OCOc3ccc2c4ccc5cc6OCOc6cc5c14 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 F18 compound treatment 11.1598 0.12927 0.0347 10.7278 -0.41545 -0.0984 -0.0451 -0.4319 422 BSPBio_002676 Oc1cccc2C(=O)C=CC(=O)c12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 F19 compound treatment 11.6872 0.65665 0.1762 10.6157 -0.52748 -0.125 0.0362 0.1676 1482 BSPBio_002677 CN1CCc2cc3OCOc3cc2C1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 F20 compound treatment 11.4158 0.38527 0.1034 8.5655 -2.5777 -0.6107 -0.3588 -0.5792 2060136 BSPBio_002678 CC(=C)c1cc2cc(C(=O)C)c(O)cc2o1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 F21 compound treatment 10.4227 -0.60784 -0.1631 10.9488 -0.1944 -0.0461 -0.1479 -0.8727 3471036 BSPBio_002679 OC(=O)C1=C(C[n+]2ccccc2)CSC3C(NC(=O)Cc4cccs4)C(=O)N31 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 F22 compound treatment 10.9931 -0.037392 -0.01 12.2165 1.0733 0.2543 0.1727 0.6787 2060245 BSPBio_002680 OC[C@H]1O[C@@](CO)(O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)[C@@H]1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 F23 mock treatment 11.984 0.95347 0.2558 10.901 -0.24221 -0.0574 0.1403 0.5352 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 F24 mock treatment 9.4496 -1.5809 -0.4242 10.0009 -1.1424 -0.2707 -0.4913 -0.9765 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 G01 mock treatment 11.5858 0.55526 0.149 10.2773 -0.86591 -0.2052 -0.0397 -0.1567 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 G02 mock treatment 12.4941 1.4636 0.3927 11.1445 0.0012746 3.0E-4 0.2779 0.7077 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 G03 compound treatment 10.8849 -0.14558 -0.0391 10.6494 -0.49378 -0.117 -0.1103 -0.8947 1000656 BSPBio_002681 OC1=C([C@H]2CC[C@@H](CC2)c3ccc(Cl)cc3)C(=O)c4ccccc4C1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 G04 compound treatment 10.9904 -0.040109 -0.0108 10.0341 -1.1091 -0.2628 -0.1934 -0.7355 351 BSPBio_002682 CC(C)NCC(O)COc1cccc2ccccc12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 G05 compound treatment 11.339 0.30853 0.0828 10.148 -0.99522 -0.2358 -0.1082 -0.4329 BSPBio_002683 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 G06 compound treatment 15.1146 4.0841 1.0959 16.0597 4.9165 1.1649 1.5986 0.9995 709 BSPBio_002684 COc1ccc(CCN2CCC(CC2)Nc3nc4ccccc4n3Cc5ccc(F)cc5)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 G07 compound treatment 11.027 -0.0034568 -9.0E-4 11.1174 -0.025795 -0.0061 -0.005 -0.8052 1898 BSPBio_002685 OC(=O)CC[N+](=O)[O-] 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 G08 compound treatment 10.064 -0.96646 -0.2593 10.3441 -0.79911 -0.1893 -0.3173 -0.9881 832 BSPBio_002686 CCCn1c(=O)n(CCC)c2[nH]c(nc2c1=O)C3CCCC3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 G09 compound treatment 10.4114 -0.61915 -0.1661 15.1552 4.012 0.9506 0.5547 0.5748 1635 BSPBio_002687 CCCCC1=NC2(CCCC2)C(=O)N1Cc3ccc(cc3)c4ccccc4c5nnn[nH]5 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 G10 compound treatment 8.8293 -2.2012 -0.5907 10.9112 -0.23205 -0.055 -0.4565 -0.7696 1001954 BSPBio_002688 C/C=C/1\[C@@H]2Cc3[nH]c(=O)ccc3[C@@]1(N)CC(=C2)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 G11 compound treatment 10.4775 -0.553 -0.1484 9.5454 -1.5978 -0.3786 -0.3726 -0.9164 1000155 BSPBio_002689 C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc4c(=O)c(cn1c24)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 G12 compound treatment 11.7074 0.67692 0.1816 10.6688 -0.4744 -0.1124 0.049 0.2292 721 BSPBio_002690 CO[C@H]1C[C@H](O[C@H]2[C@H](C)[C@@H](OC3O[C@H](C)C[C@@H]([C@H]3O)N(C)C)[C@@H](C)C[C@]4(CO4)C(=O)[C@H](C)[C@@H](O)[C@@H](C)[C@@H](C)OC(=O)[C@@H]2C)O[C@@H](C)[C@@H]1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 G13 compound treatment 20.5988 9.5683 2.5674 11.5766 0.43334 0.1027 1.888 0.7348 2069295 BSPBio_002691 CCOc1nc2cccc(C(=O)OC(C)OC(=O)OC3CCCCC3)c2n1Cc4ccc(cc4)c5ccccc5c6nnn[nH]6 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 G14 compound treatment 10.953 -0.077532 -0.0208 12.0725 0.92923 0.2202 0.141 0.6375 3650208 BSPBio_002692 CCC1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](OC2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@@](C)(C[C@@H](C)C(=O)[C@H](C)[C@H]3N(CCCCn4cnc(c4)c5cccnc5)C(=O)O[C@]31C)OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 G15 compound treatment 10.518 -0.51246 -0.1375 8.9977 -2.1455 -0.5083 -0.4567 -0.8672 1000093 BSPBio_002693 CN(CCOc1ccc(CC2SC(=O)NC2=O)cc1)c3ccccn3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 G16 compound treatment 10.6758 -0.35472 -0.0952 11.3807 0.23748 0.0563 -0.0275 -0.2489 3078277 BSPBio_002694 CN[C@H]1[C@@H](O)[C@H]2O[C@@H](O[C@@H]3[C@@H](N)C[C@@H](N)[C@H](O)[C@H]3O)[C@H](N)C[C@@H]2O[C@@H]1O[C@H]4O[C@H](CO)[C@@H](N)[C@H](O)[C@H]4O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 G17 compound treatment 10.2464 -0.78406 -0.2104 10.6927 -0.45053 -0.1067 -0.2242 -0.9505 1606766 BSPBio_002695 CCCCc1nc(Cl)c(CO)n1Cc2ccc(cc2)c3ccccc3c4nnn[nH]4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 G18 compound treatment 13.8696 2.8391 0.7618 9.9239 -1.2193 -0.2889 0.3344 0.4104 1672 BSPBio_002696 OC(=O)CCc1nc(c(o1)c2ccccc2)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 G19 compound treatment 9.4538 -1.5767 -0.4231 9.6331 -1.5101 -0.3578 -0.5522 -0.9965 1001366 BSPBio_002697 COc1c(N2CCNC(C)C2)c(F)cc3c(=O)c(cn(C4CC4)c13)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 G20 compound treatment 18.968 7.9375 2.1298 16.5161 5.3729 1.273 2.4062 0.9697 3078457 BSPBio_002698 CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c3ccccc13 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 G21 compound treatment 10.5291 -0.50143 -0.1345 9.2141 -1.9292 -0.4571 -0.4183 -0.878 1000878 BSPBio_002699 OCCN1C[C@@H](O)[C@@H](O)C(O)C1CO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 G22 compound treatment 9.9696 -1.0609 -0.2847 11.487 0.34378 0.0815 -0.1437 -0.4853 3198316 BSPBio_002700 C[C@@H]1O[C@@H](OC[C@H]2OC(Oc3c(oc4cc(OCCO)cc(O)c4c3=O)c5ccc(OCCO)c(OCCO)c5)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 G23 mock treatment 12.0002 0.9697 0.2602 11.1716 0.028417 0.0067 0.1887 0.7252 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 G24 mock treatment 11.4748 0.44426 0.1192 11.2138 0.07055 0.0167 0.0961 0.7984 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 H01 mock treatment 11.1767 0.14622 0.0392 10.9754 -0.16781 -0.0398 -4.0E-4 -0.0067 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 H02 mock treatment 11.0206 -0.0099018 -0.0027 10.0763 -1.0669 -0.2528 -0.1806 -0.7145 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 H03 compound treatment 11.1847 0.15419 0.0414 9.8078 -1.3354 -0.3164 -0.1945 -0.6095 755 BSPBio_002701 CC(CN(C)C)CN1c2ccccc2CCc3ccccc13 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 H04 compound treatment 55.2417 44.211 11.863 68.2592 57.116 13.5328 17.9575 0.9978 1330 BSPBio_002702 ClCCN(CCCl)CCCl 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 H05 compound treatment 13.1697 2.1392 0.574 9.1954 -1.9478 -0.4615 0.0796 0.108 1082 BSPBio_002703 CN(Cc1cc(Br)cc(Br)c1N)C2CCCCC2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 H06 compound treatment 11.8746 0.84409 0.2265 12.3834 1.2401 0.2938 0.3679 0.9917 1086162 BSPBio_002704 COc1c2ccoc2c(OC)c3oc(=O)ccc13 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 H07 compound treatment 11.7145 0.68397 0.1835 9.3335 -1.8097 -0.4288 -0.1734 -0.3718 1837 BSPBio_002705 CS(=O)(=O)c1ccc(cc1)C2=C(C(=O)OC2)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 H08 compound treatment 10.0952 -0.93529 -0.251 11.1478 0.0045946 0.0011 -0.1767 -0.704 3174242 BSPBio_002706 OC[C@H]1O[C@@H](Oc2ccc(O)cc2)[C@H](O)[C@@H](O)[C@@H]1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 H09 compound treatment 10.0967 -0.93377 -0.2506 11.3124 0.16913 0.0401 -0.1488 -0.5866 3650210 BSPBio_002707 COC1C[C@H]2N3C[C@@H](O)C2(C=C1)c4cc5OCOc5cc4C3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 H10 compound treatment 10.6089 -0.42163 -0.1131 10.7374 -0.40583 -0.0962 -0.148 -0.9967 1601 BSPBio_002708 COc1c(OC)c2ccc(=O)oc2c3ccoc13 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 H11 compound treatment 10.8008 -0.22976 -0.0616 11.5083 0.36503 0.0865 0.0176 0.1654 2069260 BSPBio_002709 CC[C@@]1(O)C[C@H](O)c2c(O)c3C(=O)c4c(O)ccc(O)c4C(=O)c3cc2[C@H]1C(=O)OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 H12 compound treatment 20.7931 9.7626 2.6196 17.6621 6.5189 1.5446 2.9445 0.9683 2060142 BSPBio_002710 CC(=O)OC1C/C(=C/CC/C(=C/CC[C@](C)(O)C2CC1C(=C)C(=O)O2)/C)/C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 H13 compound treatment 9.8023 -1.2282 -0.3296 11.3238 0.18062 0.0428 -0.2028 -0.6102 1191 BSPBio_002711 Oc1c(Cl)cc(Cl)c2cccnc12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 H14 compound treatment 20.2252 9.1947 2.4672 20.3194 9.1761 2.1741 3.2819 0.998 1000110 BSPBio_002712 CO[C@H]1[C@@H](C[C@@H]2CN3CCc4c([nH]c5cc(OC)ccc45)[C@@H]3C[C@@H]2[C@@H]1C(=O)OC)OC(=O)c6cc(OC)c(OC)c(OC)c6 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 H15 compound treatment 11.13 0.099458 0.0267 10.4364 -0.70684 -0.1675 -0.0996 -0.587 862 BSPBio_002713 CCCCCCCCCCCCCCCC[N+](C)(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 H16 compound treatment 9.209 -1.8215 -0.4888 9.1816 -1.9617 -0.4648 -0.6743 -0.9997 2060264 BSPBio_002714 C[C@@H]1CC[C@]2(CCC3(C)[C@]4(OC2=O)C=CC5[C@@]6(C)CC[C@H](O)C(C)(C)C6CC[C@]53C)C4[C@H]1C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 H17 compound treatment 10.5927 -0.43782 -0.1175 11.9654 0.82215 0.1948 0.0547 0.2403 3079226 BSPBio_002715 C1CN2Cc3ccccc3N=C2C1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 H18 compound treatment 11.5881 0.55762 0.1496 11.7176 0.5744 0.1361 0.202 0.9989 2060134 BSPBio_002716 COc1cc2ccc(=O)oc2c3ccoc13 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 H19 compound treatment 11.5741 0.54362 0.1459 9.0227 -2.1205 -0.5024 -0.2521 -0.4819 3173855 BSPBio_002717 CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C)[C@](C)(O)C[C@@H](C)/C(=N\OCOCCOC)/[C@H](C)[C@@H](O)[C@]1(C)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 H20 compound treatment 12.9046 1.8741 0.5029 9.4936 -1.6497 -0.3909 0.0792 0.1243 2060080 BSPBio_002718 CC(=CCCC1(C)Oc2c(CC=C(C)C)c3OC4(C5CC6CC4C(=O)c3c(O)c2C=C1)C(C/C=C(/C)\C(=O)O)(OC5(C)C)C6O)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 H21 compound treatment 11.2017 0.17118 0.0459 10.2507 -0.89249 -0.2115 -0.117 -0.5409 3055573 BSPBio_002719 OC[C@H]1OC([C@H](O)[C@@H]1O)n2cnc3c(=O)[nH]cnc23 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 H22 compound treatment 9.9356 -1.0949 -0.2938 10.4635 -0.67967 -0.161 -0.3216 -0.9599 1913604 BSPBio_002720 OC(=O)CCCN1C(=O)c2cccc3cccc(C1=O)c23 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 H23 mock treatment 9.9124 -1.1181 -0.3 10.0859 -1.0573 -0.2505 -0.3893 -0.996 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 H24 mock treatment 12.2755 1.245 0.3341 11.0015 -0.14168 -0.0336 0.2125 0.6329 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 I01 mock treatment 12.0853 1.0548 0.283 14.7993 3.6561 0.8663 0.8127 0.8917 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 I02 mock treatment 10.3811 -0.64945 -0.1743 10.8341 -0.3091 -0.0732 -0.175 -0.9258 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 I03 compound treatment 10.5913 -0.43924 -0.1179 10.9543 -0.18897 -0.0448 -0.115 -0.9121 1001030 BSPBio_002721 Cc1onc(c1c2ccc(cc2)S(=O)(=O)N)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 I04 compound treatment 11.0702 0.039653 0.0106 12.9933 1.85 0.4383 0.3175 0.7241 2660 BSPBio_002722 CCN(C(=O)/C=C/C)c1ccccc1C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 I05 compound treatment 10.4667 -0.56377 -0.1513 12.0139 0.87073 0.2063 0.0389 0.1521 3480074 BSPBio_002723 CCc1ccc(CCOc2ccc(CC3SC(=O)NC3=O)cc2)nc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 I06 compound treatment 11.435 0.4045 0.1085 11.9232 0.78 0.1848 0.2074 0.9678 939 BSPBio_002724 Cc1cccc(Nc2ccccc2C(=O)O)c1C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 I07 compound treatment 12.014 0.98345 0.2639 12.2606 1.1174 0.2647 0.3738 1.0 3480078 BSPBio_002725 CC(C)N(CCC(c1ccccc1)c2cc(C)ccc2O)C(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 I08 compound treatment 9.4047 -1.6258 -0.4362 10.8312 -0.31206 -0.0739 -0.3608 -0.8153 1594 BSPBio_002726 N[C@@H](CCCNC(=N)N[N+](=O)[O-])C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 I09 compound treatment 10.1048 -0.92574 -0.2484 13.2028 2.0596 0.488 0.1694 0.3094 3480246 BSPBio_002727 CCOC(=O)C1=C(COCCN)NC(=C(C1c2ccccc2Cl)C(=O)OC)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 I10 compound treatment 11.1756 0.14513 0.0389 11.5821 0.4389 0.104 0.1011 0.9102 1471 BSPBio_002728 CN1C(c2ccc(Cl)cc2)S(=O)(=O)CCC1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 I11 compound treatment 9.4792 -1.5513 -0.4163 11.277 0.13379 0.0317 -0.2719 -0.6514 1001346 BSPBio_002729 OC(CC[C@@H]1[C@H](N(C1=O)c2ccc(F)cc2)c3ccc(O)cc3)c4ccc(F)cc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 I12 compound treatment 10.3529 -0.67762 -0.1818 12.255 1.1118 0.2634 0.0577 0.1803 3198323 BSPBio_002730 COc1cc(OC)c2c(=O)c(coc2c1)c3ccc4OCOc4c3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 I13 compound treatment 11.3038 0.27329 0.0733 11.3524 0.20922 0.0496 0.0869 0.9818 1000393 BSPBio_002731 CN(C)CCc1c[nH]c2ccc(CS(=O)(=O)N3CCCC3)cc12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 I14 compound treatment 10.4931 -0.53744 -0.1442 11.0612 -0.08197 -0.0194 -0.1157 -0.7952 2060317 BSPBio_002732 COc1cc(OC)c2c(OC)c(c3ccc4OCOc4c3)c(=O)oc2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 I15 compound treatment 11.0084 -0.022157 -0.0059 11.3111 0.16787 0.0398 0.0239 0.5948 3059791 BSPBio_002733 Nc1nc(cs1)/C(=C/CC(=O)O)/C(=O)N[C@H]2[C@H]3SCC=C(N3C2=O)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 I16 compound treatment 9.0613 -1.9692 -0.5284 10.838 -0.30518 -0.0723 -0.4248 -0.7964 1149 BSPBio_002734 CN(N=O)C(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 I17 compound treatment 11.4434 0.41293 0.1108 11.0206 -0.12263 -0.0291 0.0578 0.5046 3059465 BSPBio_002735 Nc1nc(cs1)/C(=N/O)/C(=O)N[C@H]2[C@H]3SCC(=C(N3C2=O)C(=O)O)C=C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 I18 compound treatment 17.4341 6.4036 1.7182 12.843 1.6998 0.4027 1.4998 0.8498 907179 BSPBio_002736 C/C(=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)C(=O)C(O)CC1(C)C)/C=C/C=C(\C)/C=C/C2=C(C)C(=O)C(O)CC2(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 I19 compound treatment 9.7368 -1.2937 -0.3471 12.5087 1.3655 0.3235 -0.0167 -0.0352 3480112 BSPBio_002737 CC(C)CC(N(C)C)C1(CCC1)c2ccc(Cl)cc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 I20 compound treatment 11.6139 0.58338 0.1565 13.6529 2.5097 0.5946 0.5312 0.8638 3198547 BSPBio_002738 CCCc1nc2c(C)cc(cc2n1Cc3ccc(cc3)c4ccccc4C(=O)O)c5nc6ccccc6n5C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 I21 compound treatment 13.4054 2.3749 0.6373 10.6504 -0.49278 -0.1168 0.368 0.5681 1045399 BSPBio_002739 CC(=O)C1CCC2C3CC(=O)C4=CC(=O)CCC4(C)C3CCC12C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 I22 compound treatment 17.6526 6.622 1.7769 19.4913 8.3481 1.978 2.6551 0.9986 1233 BSPBio_002740 CO[C@@H]1[C@@H](O)[C@H](C)O[C@H](O[C@H]2CC[C@@]3(C=O)[C@H](CCC4C3CC[C@]5(C)[C@H](CC[C@]45O)C6=CC(=O)OC6)C2)[C@H]1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 I23 mock treatment 11.317 0.28651 0.0769 11.3219 0.17864 0.0423 0.0843 0.9605 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 I24 mock treatment 10.1664 -0.86414 -0.2319 11.2273 0.084105 0.0199 -0.1499 -0.644 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 J01 mock treatment 11.9975 0.96699 0.2595 12.5098 1.3665 0.3238 0.4124 0.994 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 J02 mock treatment 9.9226 -1.1079 -0.2973 10.821 -0.32217 -0.0763 -0.2642 -0.8608 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 J03 compound treatment 74.2261 63.196 16.957 80.945 69.802 16.5385 23.6849 0.9999 3173492 BSPBio_002741 COc1cc2CC[C@H](NC(=O)C)c3cc(=O)c(O)ccc3-c2c(OC)c1OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 J04 compound treatment 9.8434 -1.1871 -0.3185 11.2528 0.10955 0.026 -0.2069 -0.6473 2060305 BSPBio_002742 CCCCC[C@H](CC(=O)O)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 J05 compound treatment 10.916 -0.11455 -0.0307 12.7955 1.6523 0.3915 0.2551 0.6496 2060503 BSPBio_002743 C1Oc2ccc(cc2O1)[C@H]3OC[C@@H]4[C@@H](OC[C@H]34)c5ccc6OCOc6c5 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 J06 compound treatment 12.0261 0.99556 0.2671 13.2646 2.1213 0.5026 0.5443 0.9563 3177461 BSPBio_002744 CN1C2C[C@H](O)[C@@H]1C[C@H](C2)OC(=O)[C@H](CO)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 J07 compound treatment 10.2051 -0.82537 -0.2215 9.965 -1.1782 -0.2792 -0.354 -0.9934 2060439 BSPBio_002745 COC1=C(OC)C(=O)C(=C(C)C1=O)C/C=C(\C)/CC/C=C(\C)/CC/C=C(\C)/CC\C=C(\C)/CC/C=C(\C)/CC/C=C(\C)/CC/C=C(\C)/CC/C=C(\C)/CC/C=C(\C)/CCC=C(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 J08 compound treatment 11.6038 0.57333 0.1538 12.7186 1.5754 0.3733 0.3727 0.9232 3057756 BSPBio_002746 C1CCN2C[C@H]3C[C@@H](CN4CCCC[C@H]34)[C@@H]2C1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 J09 compound treatment 9.103 -1.9275 -0.5172 8.583 -2.5602 -0.6066 -0.7947 -0.9969 2060248 BSPBio_002747 OC1=Cc2c(O)cc(O)cc2OC1(O)c3ccc(O)c(O)c3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 J10 compound treatment 13.3003 2.2698 0.609 11.8929 0.74965 0.1776 0.5563 0.8768 1098 BSPBio_002748 C[C@@]12C[C@H](O)C3C(CCC4=CC(=O)CC[C@]34C)C2CC[C@]1(O)C(=O)CO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 J11 compound treatment 9.1474 -1.8831 -0.5053 10.1804 -0.96286 -0.2281 -0.5186 -0.9354 2060042 BSPBio_002749 CCC(C)c1cnc(CC(C)C)c(=O)n1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 J12 compound treatment 12.369 1.3385 0.3592 11.8227 0.67944 0.161 0.3678 0.9345 3047 BSPBio_002750 C[C@H]1[C@@H]2CC[C@@]3(C)C=CC(=O)C(=C3[C@H]2OC1=O)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 J13 compound treatment 12.2643 1.2338 0.3311 12.9323 1.7891 0.4239 0.5338 0.9925 2557 BSPBio_002751 COS(=O)(=O)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 J14 compound treatment 11.1203 0.089766 0.0241 12.0059 0.86263 0.2044 0.1616 0.785 1107153 BSPBio_002752 CC(=O)c1cc2C=CC(C)(C)Oc2cc1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 J15 compound treatment 10.8205 -0.21004 -0.0564 11.2983 0.15505 0.0367 -0.0139 -0.2062 2069241 BSPBio_002753 COc1ccc2C3CC[C@]4(C)[C@@H](O)CCC4C3CCc2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 J16 compound treatment 13.7799 2.7494 0.7377 10.2017 -0.94156 -0.2231 0.3639 0.4722 2060197 BSPBio_002754 COC1(C)CCC2OC2(C)CCC3C1CC3(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 J17 compound treatment 11.1572 0.12672 0.034 13.0745 1.9313 0.4576 0.3476 0.7576 1661997 BSPBio_002755 CC12CCC3C(CCc4cc(OC(=O)c5ccccc5)ccc34)C2CCC1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 J18 compound treatment 11.1457 0.11521 0.0309 12.3483 1.2051 0.2855 0.2238 0.7791 2060191 BSPBio_002756 CC1(C)CC2C1CCC(=O)C(CCC2=C)C3CC(=O)OC3=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 J19 compound treatment 11.1752 0.14466 0.0388 10.9901 -0.15314 -0.0363 0.0018 0.0337 1007364 BSPBio_002757 CCOC(=O)C1C(C=C(C)C)C1(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 J20 compound treatment 10.6018 -0.42874 -0.115 8.973 -2.1702 -0.5142 -0.4449 -0.8444 3055391 BSPBio_002758 OC[C@H]1O[C@@H](Oc2cc(O)c3c(=O)cc(oc3c2)c4ccc(O)cc4)[C@H](O)[C@@H](O)[C@@H]1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 J21 compound treatment 12.2383 1.2078 0.3241 8.8607 -2.2826 -0.5408 -0.1533 -0.2431 2857 BSPBio_002759 O=C1CCc2cc(OCCCCc3nnnn3C4CCCCC4)ccc2N1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 J22 compound treatment 11.2115 0.18103 0.0486 11.9208 0.77757 0.1842 0.1646 0.864 3198645 BSPBio_002760 CC(C)CCCC(C)C1CCC2C3C[C@@H](O)[C@@]4(O)C[C@@H](O)CC[C@]4(C)C3CC[C@]12C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 J23 mock treatment 9.6428 -1.3877 -0.3724 11.4997 0.35643 0.0845 -0.2036 -0.5332 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 J24 mock treatment 11.7414 0.71089 0.1907 9.7782 -1.365 -0.3234 -0.0938 -0.2498 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 K01 mock treatment 8.8842 -2.1463 -0.5759 10.8942 -0.24903 -0.059 -0.4489 -0.7755 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 K02 mock treatment 11.194 0.1635 0.0439 10.5239 -0.61927 -0.1467 -0.0727 -0.4749 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 K03 compound treatment 9.9949 -1.0356 -0.2779 12.1528 1.0096 0.2392 -0.0274 -0.0746 3198536 BSPBio_002761 COc1ccc2C[C@H]3N(C)CC[C@]4([C@H]5Oc1c24)C3=CC[C@@H]5O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 K04 compound treatment 18.6862 7.6557 2.0542 21.8371 10.694 2.5338 3.2442 0.9946 1040 BSPBio_002762 CC(C)CC1NC(=O)C(CCCN)NC(=O)C(NC(=O)C(Cc2ccc(O)cc2)NC(=O)C(CCC(=O)O)NC(=O)C(CC(=O)O)NC(=O)C(Cc3ccccc3)NC(=O)C(Cc4ccccc4)NC(=O)C5CCCN5C(=O)C(Cc6ccccc6)NC1=O)C(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 K05 compound treatment 9.1071 -1.9234 -0.5161 11.4276 0.28435 0.0674 -0.3173 -0.6096 3079231 BSPBio_002763 CC1(C)O[C@H]2CC(=O)OC[C@@]23[C@H]1CC(=O)[C@]4(C)[C@@H]3CC[C@@]5(C)[C@@H](OC(=O)[C@H]6O[C@]654)c7ccoc7 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 K06 compound treatment 10.5527 -0.47782 -0.1282 11.8854 0.74215 0.1758 0.0337 0.1548 1449108 BSPBio_002764 Cc1ccc2c(Cl)cc(Cl)c(O)c2n1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 K07 compound treatment 14.986 3.9555 1.0614 12.7115 1.5683 0.3716 1.0132 0.901 1087705 BSPBio_002765 CCOC(=O)C1=C(O)C(=O)N(Cc2ccccc2)C1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 K08 compound treatment 9.9014 -1.1291 -0.303 11.1945 0.051292 0.0122 -0.2056 -0.6782 1402956 BSPBio_002766 CC(N)C(O)c1ccc(O)c(O)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 K09 compound treatment 10.1893 -0.84122 -0.2257 13.3671 2.2238 0.5269 0.213 0.3715 1492782 BSPBio_002767 OCNC(=O)c1cccnc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 K10 compound treatment 9.753 -1.2775 -0.3428 12.5697 1.4265 0.338 -0.0034 -0.007 3055414 BSPBio_002768 OC[C@@H]1CCCN2CCCC[C@H]12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 K11 compound treatment 12.4883 1.4578 0.3912 12.2682 1.1249 0.2665 0.4651 0.9825 80 BSPBio_002769 CN(C)C(=O)C(CCN1CCC(O)(CC1)c2ccc(Cl)cc2)(c3ccccc3)c4ccccc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 K12 compound treatment 11.5958 0.56524 0.1517 10.3356 -0.80761 -0.1914 -0.0281 -0.1149 2572 BSPBio_002770 COc1cc2CC[N+](C)(C)[C@@H]3Cc4ccc(O)c(Oc5cc6[C@H](Cc7ccc(Oc(c1O)c32)cc7)N(C)CCc6cc5OC)c4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 K13 compound treatment 11.9639 0.93339 0.2505 9.8351 -1.3081 -0.3099 -0.0421 -0.1056 2060166 BSPBio_002771 CC1(C)CC2C1CCC(=C)/C(=N\O)/CCC2=C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 K14 compound treatment 111.544 100.51 26.9704 123.3198 112.18 26.5786 37.8648 1.0 4624 BSPBio_002772 COc1cc(cc(OC)c1OC)[C@H]2[C@@H]3[C@H](COC3=O)Cc4c(O)c5OCOc5cc24 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 K15 compound treatment 12.165 1.1345 0.3044 10.8145 -0.3287 -0.0779 0.1602 0.5098 878 BSPBio_002773 CC(=O)NS(=O)(=O)c1ccc(N)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 K16 compound treatment 18.6892 7.6586 2.055 18.8761 7.7329 1.8322 2.7487 0.9984 3172974 BSPBio_002774 C[C@@H]1O[C@@H](O[C@H]2C[C@@H](O)[C@]3(CO)C4[C@H](O)C[C@]5(C)[C@H](CC[C@]5(O)C4CC[C@]3(O)C2)C6=CC(=O)OC6)[C@H](O)[C@H](O)[C@H]1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 K17 compound treatment 10.2035 -0.82703 -0.2219 8.7208 -2.4224 -0.574 -0.5628 -0.9145 1047 BSPBio_002775 CN(C)CCCN1c2ccccc2Sc3ccccc13 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 K18 compound treatment 11.1409 0.11035 0.0296 10.0164 -1.1268 -0.267 -0.1678 -0.6249 1602 BSPBio_002776 COc1ccc(cc1)c2coc3cc(O)cc(O)c3c2=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 K19 compound treatment 9.2393 -1.7913 -0.4806 10.441 -0.7022 -0.1664 -0.4575 -0.8995 681 BSPBio_002777 CC(CN1c2ccccc2Sc3ccccc13)N(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 K20 compound treatment 11.8489 0.81842 0.2196 13.7669 2.6236 0.6216 0.5948 0.9023 2060451 BSPBio_002778 CC(C)(O)CC[C@@H](O)[C@](C)(O)C1CC[C@@]2(O)C3=CC(=O)C4C[C@@H](O)[C@@H](O)C[C@]4(C)C3CC[C@]12C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 K21 compound treatment 9.8436 -1.1869 -0.3185 10.6347 -0.50853 -0.1205 -0.3104 -0.9116 907089 BSPBio_002779 Cn1c(=O)n(C)c2ncn(CCCl)c2c1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 K22 compound treatment 12.9566 1.9261 0.5168 11.6192 0.47596 0.1128 0.4452 0.8416 989 BSPBio_002780 NC(=N)NCCCCNC(=N)N 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 K23 mock treatment 12.5754 1.5449 0.4145 12.1602 1.0169 0.2409 0.4635 0.9667 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 K24 mock treatment 9.9671 -1.0634 -0.2853 12.6889 1.5457 0.3662 0.0572 0.1232 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 L01 mock treatment 13.2609 2.2304 0.5985 10.9296 -0.21358 -0.0506 0.3874 0.645 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 L02 mock treatment 9.4137 -1.6168 -0.4338 10.2719 -0.87127 -0.2064 -0.4527 -0.9423 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 L03 compound treatment 10.6153 -0.41521 -0.1114 13.1329 1.9897 0.4714 0.2546 0.5255 3055569 BSPBio_002781 OCc1cccnc1.OC(C(O)C(=O)O)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 L04 compound treatment 10.2275 -0.80301 -0.2155 12.2903 1.147 0.2718 0.0398 0.1148 3172979 BSPBio_002782 C[C@H]1C2C(CC3C4CC=C5C[C@@H](O)CC[C@]5(C)C4CC[C@]23C)O[C@@]61CC[C@@H](C)CO6 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 L05 compound treatment 9.1045 -1.926 -0.5168 13.0746 1.9314 0.4576 -0.0418 -0.0606 1338 BSPBio_002783 CCCC(C(=O)OCCN(CC)CC)(c1ccccc1)c2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 L06 compound treatment 10.7193 -0.31123 -0.0835 11.6767 0.53345 0.1264 0.0303 0.2002 3046390 BSPBio_002784 CCC(=O)O[C@H]1CCC2C3CCC4=CC(=O)CC[C@]4(C)C3CC[C@]12C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 L07 compound treatment 10.2874 -0.74309 -0.1994 12.0476 0.90435 0.2143 0.0105 0.036 2060488 BSPBio_002785 CC(=CCC[C@@](C)(O)C=C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 L08 compound treatment 10.9197 -0.1108 -0.0297 12.2422 1.099 0.2604 0.1631 0.6223 1053058 BSPBio_002786 COc1cc(OC)c2c(=O)c(O)c(oc2c1)c3ccc(OC)c(OC)c3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 L09 compound treatment 17.4827 6.4521 1.7313 16.1754 5.0322 1.1923 2.0673 0.9834 3177316 BSPBio_002787 C[C@@H]1O[C@@H](O[C@H]2CC[C@]3(C=O)C4CC[C@]5(C)[C@H](CC[C@]5(O)C4CC[C@]3(O)C2)C6=CC(=O)OC6)[C@H](O)[C@H](O)[C@H]1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 L10 compound treatment 10.9583 -0.072174 -0.0194 13.8251 2.6819 0.6354 0.4356 0.6852 910 BSPBio_002788 CN1CC(CNC(=O)OCc2ccccc2)C[C@@H]3C1Cc4cn(C)c5cccc3c45 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 L11 compound treatment 10.5436 -0.4869 -0.1306 11.8052 0.66201 0.1569 0.0185 0.0908 1591 BSPBio_002789 CC(C)C[C@@H](NC(=O)OCC1c2ccccc2-c3ccccc13)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 L12 compound treatment 9.621 -1.4095 -0.3782 9.3146 -1.8286 -0.4333 -0.5738 -0.9977 2060173 BSPBio_002790 CC(C)C1CCC(C)(O)C2CCC(=CC12)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 L13 compound treatment 16.5701 5.5396 1.4864 16.7167 5.5735 1.3206 1.9848 0.9983 3173991 BSPBio_002791 C[C@@]12CCC3C(CC[C@@H]4C[C@@H](O)CC[C@@]43C)[C@@]2(O)C[C@H](O)[C@@H]1C5=CC(=O)OC5 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 L14 compound treatment 9.2373 -1.7932 -0.4812 12.2562 1.113 0.2637 -0.1538 -0.2802 1952709 BSPBio_002792 COc1ccc2c(C)cc(=O)oc2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 L15 compound treatment 9.3564 -1.6741 -0.4492 12.5896 1.4464 0.3427 -0.0753 -0.1333 2069254 BSPBio_002793 CCCCCc1c(C(=O)O)c(O)cc2OC(=O)c3c(cc(OC)cc3Oc12)C(=O)CCCC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 L16 compound treatment 10.7993 -0.23121 -0.062 10.4409 -0.7023 -0.1664 -0.1615 -0.9096 2060362 BSPBio_002794 COc1ccc(cc1)c2c(OC)c3c(OC)c4C=CC(C)(C)Oc4cc3oc2=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 L17 compound treatment 9.4696 -1.5609 -0.4188 11.4508 0.30757 0.0729 -0.2446 -0.5754 1286 BSPBio_002795 Cc1cc(ccc1OCCOCC[N+](C)(C)Cc2ccccc2)C(C)(C)CC(C)(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 L18 compound treatment 11.042 0.011493 0.0031 9.1067 -2.0365 -0.4825 -0.339 -0.7026 2069324 BSPBio_002796 COc1cc(/C=C/C(=O)O)cc(OC)c1OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 L19 compound treatment 11.5669 0.53642 0.1439 14.3047 3.1614 0.7491 0.6314 0.8278 1317 BSPBio_002797 Fc1ccc(cc1)C(c2ccccc2)(c3ccccc3F)n4ccnc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 L20 compound treatment 9.6457 -1.3848 -0.3716 10.2568 -0.88641 -0.21 -0.4113 -0.9635 1099943 BSPBio_002798 COc1c2C=CC(C)(C)Oc2c(CC=C(C)C)c3oc(=O)c(c(O)c13)c4ccc(O)cc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 L21 compound treatment 11.1666 0.13609 0.0365 11.1961 0.0529 0.0125 0.0347 0.8984 2060426 BSPBio_002799 COc1c(O)cccc1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 L22 compound treatment 12.7101 1.6796 0.4507 10.642 -0.5012 -0.1188 0.2347 0.5036 2069297 BSPBio_002800 CC(C)CCCC(C)[C@H]1CCC2C3CC=C4C[C@H](CC[C@]4(C)C3CC[C@]12C)OC(=O)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 L23 mock treatment 11.4552 0.42467 0.114 11.0267 -0.11655 -0.0276 0.061 0.5207 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 L24 mock treatment 8.982 -2.0485 -0.5497 12.3557 1.2124 0.2873 -0.1855 -0.2992 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 M01 mock treatment 10.4994 -0.53114 -0.1425 10.7828 -0.36041 -0.0854 -0.1612 -0.97 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 M02 mock treatment 9.9202 -1.1103 -0.2979 9.6757 -1.4675 -0.3477 -0.4565 -0.997 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 M03 compound treatment 9.1616 -1.8689 -0.5015 12.6307 1.4875 0.3524 -0.1054 -0.1719 3079366 BSPBio_002801 O[C@@H]1[C@H]2COC(O2)[C@H](O)[C@H]1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 M04 compound treatment 57.3726 46.342 12.4348 72.824 61.681 14.6144 19.1266 0.9968 3172730 BSPBio_002802 OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc3c(NCc4ccco4)ncnc23 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 M05 compound treatment 9.2194 -1.8111 -0.486 10.3866 -0.75662 -0.1793 -0.4704 -0.9081 1006766 BSPBio_002803 OC(=O)c1ccc2OCOc2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 M06 compound treatment 8.4878 -2.5427 -0.6823 11.0707 -0.072553 -0.0172 -0.4946 -0.7247 829 BSPBio_002804 CC(C)c1c(O)c(O)c(C=O)c2c(O)c(c(C)cc12)c3c(C)cc4c(C(C)C)c(O)c(O)c(C=O)c4c3O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 M07 compound treatment 10.5176 -0.51291 -0.1376 12.6642 1.521 0.3604 0.1575 0.4083 846 BSPBio_002805 Cc1nc2sccn2c(=O)c1CCN3CCC(=C(c4ccc(F)cc4)c5ccc(F)cc5)CC3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 M08 compound treatment 10.5549 -0.47564 -0.1276 11.6752 0.53197 0.126 -0.0011 -0.0062 1008178 BSPBio_002806 COc1cc(C)c(C(=O)Oc2cc(C)c(C(=O)O)c(O)c2C)c(OC)c1C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 M09 compound treatment 12.2612 1.2307 0.3302 10.2475 -0.89568 -0.2122 0.0835 0.2126 2060286 BSPBio_002807 CC(C)CC(=O)c1c(O)c(CC=C(C)C)c(O)c2c(cc(=O)oc12)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 M10 compound treatment 8.7084 -2.3221 -0.6231 9.1896 -1.9536 -0.4629 -0.7679 -0.9893 1610 BSPBio_002808 COc1ccc(cc1O)[C@@H]2CC(=O)c3c(O)cc(O)cc3O2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 M11 compound treatment 12.7004 1.6699 0.4481 9.246 -1.8972 -0.4495 -0.001 -0.0016 3055336 BSPBio_002809 Oc1ccc2sc(=O)oc2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 M12 compound treatment 9.6367 -1.3938 -0.374 11.5428 0.39953 0.0947 -0.1975 -0.512 1599 BSPBio_002810 C=CCc1ccc2OCOc2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 M13 compound treatment 10.4013 -0.62916 -0.1688 14.6767 3.5335 0.8372 0.4726 0.5534 2060254 BSPBio_002811 CC(=O)CC1CCCCN1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 M14 compound treatment 10.0971 -0.93345 -0.2505 10.3475 -0.79571 -0.1885 -0.3104 -0.9902 1065857 BSPBio_002812 NC(CNC(=O)N)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 M15 compound treatment 10.5809 -0.4496 -0.1206 10.4 -0.74324 -0.1761 -0.2098 -0.983 1984013 BSPBio_002813 C/C=C/c1ccc2OCOc2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 M16 compound treatment 12.2645 1.234 0.3311 14.1872 3.0439 0.7212 0.7441 0.9376 2060361 BSPBio_002814 C/C=C(/C)\C(=O)O[C@@H]1[C@H](OC(=O)C)[C@]2(CO)[C@H](O)C[C@]3(C)C(=CCC4[C@@]5(C)CC[C@H](O[C@@H]6O[C@@H]([C@@H](O[C@@H]7O[C@H](CO)[C@@H](O)[C@H](O)[C@H]7O)[C@H](O)[C@H]6O[C@@H]8O[C@H](CO)[C@@H](O)[C@H](O)[C@H]8O)C(=O)O)[C@](C)(CO)C5CC[C@]43C)C2CC1(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 M17 compound treatment 10.5475 -0.48303 -0.1296 11.534 0.39078 0.0926 -0.0262 -0.1643 3079232 BSPBio_002815 COc1ccc2c(=O)ccoc2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 M18 compound treatment 10.7342 -0.29632 -0.0795 11.902 0.75875 0.1798 0.0709 0.3607 2069279 BSPBio_002816 CCC(C)C(NC)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 M19 compound treatment 9.9374 -1.0931 -0.2933 11.164 0.020755 0.0049 -0.2039 -0.6952 2069285 BSPBio_002817 CCCCCC(=O)Cc1cc(O)cc(O)c1C(=O)Oc2cc(CC(=O)CCCCC)c(C(=O)O)c(OC)c2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 M20 compound treatment 10.4689 -0.56165 -0.1507 12.2471 1.1039 0.2615 0.0784 0.2596 3055475 BSPBio_002818 COc1ccc(/C=C/C)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 M21 compound treatment 10.7041 -0.32643 -0.0876 8.8075 -2.3357 -0.5534 -0.4533 -0.809 1050711 BSPBio_002819 COc1cc(OC)cc(OC)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 M22 compound treatment 9.5345 -1.496 -0.4014 13.204 2.0607 0.4883 0.0614 0.0971 2069274 BSPBio_002820 CC(O)c1c(C)c2cc3[nH]c(cc4nc(cc5[nH]c(cc1n2)c(C)c5CCC(=O)O)c(CCC(=O)O)c4C)c(C)c3C(C)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 M23 mock treatment 9.227 -1.8035 -0.4839 9.5999 -1.5433 -0.3657 -0.6008 -0.9904 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 M24 mock treatment 11.3092 0.27864 0.0748 11.878 0.73474 0.1741 0.176 0.9288 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 N01 mock treatment 10.2843 -0.74623 -0.2002 10.1827 -0.96055 -0.2276 -0.3025 -0.998 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 N02 mock treatment 10.5371 -0.49345 -0.1324 13.0848 1.9416 0.46 0.2317 0.4839 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 N03 compound treatment 11.2083 0.17775 0.0477 11.936 0.79279 0.1878 0.1665 0.8594 1040795 BSPBio_002821 COc1cccc(O)c1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 N04 compound treatment 9.8171 -1.2134 -0.3256 10.1189 -1.0243 -0.2427 -0.4018 -0.9895 2060373 BSPBio_002822 COc1c(O)cc2c(cc(=O)oc2c1OC)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 N05 compound treatment 9.4659 -1.5646 -0.4198 11.0107 -0.13255 -0.0314 -0.3191 -0.7579 3650211 BSPBio_002823 COc1ccccc1OCCNCC(O)COc2cccc3[nH]c4ccccc4c23.OC(C(O)C(=O)O)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 N06 compound treatment 10.0902 -0.94031 -0.2523 11.6203 0.47704 0.113 -0.0985 -0.3562 1004889 BSPBio_002824 CC(=O)Nc1cccc(O)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 N07 compound treatment 11.1282 0.097656 0.0262 12.4092 1.266 0.2999 0.2306 0.766 1025940 BSPBio_002825 Cc1cc(O)c2C(=O)c3c(O)cccc3C(=O)c2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 N08 compound treatment 10.6885 -0.34203 -0.0918 12.1532 1.01 0.2393 0.1043 0.407 2069270 BSPBio_002826 CC(C)CCCC(C)C1CCC2C3CC(=O)[C@H]4C[C@@H](O)CC[C@]4(C)C3CC[C@]12C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 N09 compound treatment 11.0492 0.018696 0.005 11.0494 -0.093845 -0.0222 -0.0122 -0.5342 3198534 BSPBio_002827 OCC(O)CC(O)CCCCCCCCCCCC=C.OCC(O)CC(O)CCCCCCCCCCCC#C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 N10 compound treatment 9.7854 -1.2451 -0.3341 12.7094 1.5662 0.3711 0.0261 0.0524 2060214 BSPBio_002828 COc1c(ccc2OC(C)(C)C=Cc12)c3coc4cc5OC(C)(C)C(O)Cc5cc4c3=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 N11 compound treatment 9.2644 -1.7661 -0.4739 11.2281 0.084917 0.0201 -0.3209 -0.6765 1049466 BSPBio_002829 COc1cc(C)c2C(=O)Oc3c(C)c(O)c4C(=O)OC(O)c4c3Oc2c1C=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 N12 compound treatment 10.6938 -0.33668 -0.0903 10.136 -1.0072 -0.2386 -0.2326 -0.9116 2060174 BSPBio_002830 CC(=CCc1c2OC(C)(C)C=Cc2c(O)c3c(=O)c(O)c(oc13)c4ccccc4)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 N13 compound treatment 8.9846 -2.046 -0.549 10.7591 -0.38408 -0.091 -0.4525 -0.8132 2069233 BSPBio_002831 COc1ccc2C3CCC4(C)C(O)[C@H](O)CC4C3CCc2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 N14 compound treatment 9.6999 -1.3306 -0.357 12.6718 1.5286 0.3622 0.0036 0.0071 2069249 BSPBio_002832 COc1ccc(cc1)c2coc3c(O)c(OC)ccc3c2=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 N15 compound treatment 8.7523 -2.2782 -0.6113 10.2024 -0.94084 -0.2229 -0.5899 -0.9066 1140 BSPBio_002833 CC(=O)OC/C=C(\C)/C=C/C=C(\C)/C=C/C1=C(C)CCCC1(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 N16 compound treatment 10.4944 -0.53614 -0.1439 11.632 0.48875 0.1158 -0.0198 -0.1074 1044412 BSPBio_002834 Oc1cc2ccccc2oc1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 N17 compound treatment 9.9404 -1.0901 -0.2925 11.0192 -0.124 -0.0294 -0.2276 -0.7742 1495 BSPBio_002835 OC(=O)CCCCC1CCSS1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 N18 compound treatment 9.2287 -1.8018 -0.4835 11.9647 0.82152 0.1946 -0.2042 -0.3919 3059435 BSPBio_002836 CC[C@@H]1[C@@H](Cc2cncn2C)COC1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 N19 compound treatment 8.7575 -2.273 -0.6099 9.8236 -1.3196 -0.3127 -0.6524 -0.9518 1262 BSPBio_002837 NC[C@H]1CC[C@@H](CC1)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 N20 compound treatment 9.4669 -1.5636 -0.4196 11.5548 0.41162 0.0975 -0.2277 -0.5286 1308020 BSPBio_002838 COc1ccc(cc1)c2cc(=O)c3ccccc3o2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 N21 compound treatment 10.2683 -0.76221 -0.2045 14.5353 3.3921 0.8037 0.4237 0.5109 2069229 BSPBio_002839 Oc1ccc2oc3ccccc3c(=O)c2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 N22 compound treatment 11.2099 0.17944 0.0481 10.7165 -0.42674 -0.1011 -0.0374 -0.3344 3198325 BSPBio_002840 COc1ccc(cc1)c2cc(=O)c3c(OC)cc(O)cc3o2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 N23 mock treatment 10.3362 -0.69435 -0.1863 14.1159 2.9726 0.7043 0.3663 0.5028 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 N24 mock treatment 10.2663 -0.76418 -0.205 10.0426 -1.1006 -0.2608 -0.3294 -0.9929 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 O01 mock treatment 10.6569 -0.3736 -0.1002 10.4609 -0.68233 -0.1617 -0.1852 -0.9736 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 O02 mock treatment 11.3032 0.27264 0.0732 12.7903 1.6471 0.3902 0.3277 0.8253 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 O03 compound treatment 11.8531 0.82262 0.2207 12.1392 0.996 0.236 0.3229 0.9994 966 BSPBio_002841 OC[C@@H]1OC(=O)[C@@H](O)[C@H](O)[C@H]1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 O04 compound treatment 10.262 -0.76849 -0.2062 10.0977 -1.0455 -0.2477 -0.321 -0.9958 3058484 BSPBio_002842 CC(CCC(=O)O)[C@H]1CCC2C3C[C@H](O)[C@@H]4C[C@H](O)CC[C@]4(C)C3CC[C@]12C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 O05 compound treatment 9.2342 -1.7963 -0.482 12.1526 1.0093 0.2391 -0.1717 -0.3191 352677 BSPBio_002843 COc1ccccc1N2CCNCC2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 O06 compound treatment 10.134 -0.89649 -0.2406 11.8868 0.74362 0.1762 -0.0455 -0.1526 2060300 BSPBio_002844 COc1ccc(cc1)c2cc(=O)c3c(O)cc(O)c(c4cc(ccc4OC)c5cc(=O)c6c(O)cc(O)cc6o5)c3o2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 O07 compound treatment 9.8205 -1.21 -0.3247 8.4504 -2.6929 -0.638 -0.6807 -0.9509 1019888 BSPBio_002845 NCC(=O)c1ccccc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 O08 compound treatment 9.3896 -1.6409 -0.4403 11.2586 0.11533 0.0273 -0.292 -0.6619 1052338 BSPBio_002846 COc1cc2C(C)NCCc2cc1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 O09 compound treatment 9.8364 -1.1941 -0.3204 7.8617 -3.2815 -0.7775 -0.7763 -0.9232 1554635 BSPBio_002847 COc1cc(OC)c2c(=O)cc(oc2c1)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 O10 compound treatment 8.2017 -2.8288 -0.759 11.2737 0.13048 0.0309 -0.5149 -0.6777 401 BSPBio_002848 COc1cccc2c1cc([N+](=O)[O-])c3c(cc4OCOc4c23)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 O11 compound treatment 10.2336 -0.79691 -0.2138 8.4136 -2.7297 -0.6468 -0.6085 -0.8933 2069244 BSPBio_002849 CC(=O)OCC(O)/C=C/CCCCCCCCCCCC=C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 O12 compound treatment 10.3834 -0.64708 -0.1736 9.9669 -1.1763 -0.2787 -0.3198 -0.9741 2060502 BSPBio_002850 COc1cc(cc(OC)c1O)C(=O)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 O13 compound treatment 10.1685 -0.86199 -0.2313 10.1024 -1.0408 -0.2466 -0.3379 -0.9995 647 BSPBio_002851 Oc1ccc(CCC(=O)c2c(O)cc(O)cc2O)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 O14 compound treatment 11.4664 0.43587 0.117 8.7507 -2.3925 -0.5669 -0.3181 -0.5496 2069286 BSPBio_002852 CC(C)C(C)/C=C/C(C)[C@H]1CCC2C3=CCC4CC(=O)CC[C@]4(C)C3CC[C@]12C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 O15 compound treatment 9.6349 -1.3956 -0.3745 10.1664 -0.97682 -0.2314 -0.4284 -0.9733 4313 BSPBio_002853 CC(N)Cc1ccc(O)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 O16 compound treatment 15.6393 4.6088 1.2367 10.6998 -0.44342 -0.1051 0.8002 0.6447 3173993 BSPBio_002854 O[C@H]1CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]2[C@H]1C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 O17 compound treatment 9.1897 -1.8408 -0.4939 10.7009 -0.44235 -0.1048 -0.4234 -0.8385 2060176 BSPBio_002855 CC(=O)/C=C\[C@H]1[C@](C)(O)CCC2C(C)(C)CCC[C@]12C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 O18 compound treatment 10.8373 -0.19321 -0.0518 10.4376 -0.70565 -0.1672 -0.1549 -0.8848 2069278 BSPBio_002856 Cc1cc(O)c(C=O)c(O)c1C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 O19 compound treatment 10.7454 -0.28514 -0.0765 10.6254 -0.51782 -0.1227 -0.1409 -0.9742 3078269 BSPBio_002857 OCC(O)CC(O)CCCCCCCCCCCC=C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 O20 compound treatment 16.4928 5.4623 1.4657 17.6228 6.4795 1.5352 2.122 0.9997 2060427 BSPBio_002858 CO[C@@H]1C[C@H](O[C@H]2CC[C@]3(C)C4CC[C@]5(C)[C@H](CC[C@]5(O)[C@@H]4CC[C@]3(O)C2)C6=CC(=O)OC6)O[C@H](C)[C@@H]1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 O21 compound treatment 9.2706 -1.7599 -0.4722 8.308 -2.8352 -0.6718 -0.8089 -0.9851 3054108 BSPBio_002859 Nc1nc2ncc(=O)[nH]c2c(=O)[nH]1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 O22 compound treatment 10.392 -0.6385 -0.1713 12.2737 1.1305 0.2679 0.0683 0.2147 1353 BSPBio_002860 COC(=O)/C(=C/1\OC(=O)C(C1=O)c2ccccc2)/c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 O23 mock treatment 9.119 -1.9115 -0.5129 8.4915 -2.6517 -0.6283 -0.8069 -0.9949 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 O24 mock treatment 10.6411 -0.38943 -0.1045 10.1539 -0.98932 -0.2344 -0.2396 -0.9337 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 P01 mock treatment 10.1625 -0.86797 -0.2329 8.4611 -2.6821 -0.6355 -0.614 -0.9072 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 P02 mock treatment 11.1037 0.073153 0.0196 9.8069 -1.3363 -0.3166 -0.21 -0.662 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 P03 compound treatment 10.1375 -0.89302 -0.2396 9.473 -1.6703 -0.3957 -0.4493 -0.9711 1913676 BSPBio_002861 COc1ccc(cc1)C(=O)/C=C/c2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 P04 compound treatment 10.4837 -0.54682 -0.1467 11.9389 0.79572 0.1885 0.0296 0.1238 2060170 BSPBio_002862 CC(=O)OC1CCC2(O)CC1(C)CCC3C2CC3(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 P05 compound treatment 9.6415 -1.389 -0.3727 10.5035 -0.63976 -0.1516 -0.3707 -0.9214 3058489 BSPBio_002863 CC(C)CCCC(C)C1CCC2C3CC[C@H]4C[C@@H](O)CC[C@]4(C)C3CC[C@]12C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 P06 compound treatment 8.3421 -2.6884 -0.7214 10.2317 -0.91157 -0.216 -0.6628 -0.8802 3054976 BSPBio_002864 CC(C)[C@@H]1CC[C@@H](C)CC1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 P07 compound treatment 11.1058 0.075256 0.0202 9.7074 -1.4359 -0.3402 -0.2263 -0.664 3650212 BSPBio_002865 COC(=O)CCC(C)C1CCC2C3CC[C@@H]4C[C@H](O)CC[C@]4(C)C3C[C@H](O)[C@]12C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 P08 compound treatment 14.0049 2.9744 0.7981 11.1759 0.032705 0.0077 0.5698 0.7139 41 BSPBio_002866 OC(=O)c1ccccc1Nc2cccc(c2)C(F)(F)F 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 P09 compound treatment 13.614 2.5834 0.6932 12.327 1.1838 0.2805 0.6885 0.9207 3177462 BSPBio_002867 CCCCC(=O)O[C@@]1([C@@H](C)CC2C3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)C(O)C[C@@]21C)C(=O)CO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 P10 compound treatment 12.3541 1.3235 0.3551 9.6709 -1.4723 -0.3488 0.0045 0.0089 2060212 BSPBio_002868 CC1(C)[C@H](O)CC(=O)[C@@]2(C)C1CC(=O)[C@]3(C)C2CC[C@@]4(C)[C@@H](OC(=O)[C@H]5O[C@]543)c6ccoc6 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 P11 compound treatment 10.6691 -0.3614 -0.097 8.357 -2.7862 -0.6602 -0.5354 -0.8024 1588 BSPBio_002869 CC(=O)C1C(=O)C=C2Oc3c(c(O)c(C)c(O)c3C(=O)C)C2(C)C1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 P12 compound treatment 9.4355 -1.595 -0.428 9.0167 -2.1265 -0.5038 -0.6589 -0.9967 2060193 BSPBio_002870 CC1(C)C2CC1C(=C)C(N)C2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 P13 compound treatment 11.5433 0.51279 0.1376 10.4763 -0.66691 -0.158 -0.0144 -0.0689 1497 BSPBio_002871 NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O)C2O[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)[C@H](N)[C@@H](O)[C@@H]1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 P14 compound treatment 11.2877 0.25722 0.069 9.3336 -1.8097 -0.4288 -0.2544 -0.5857 3650213 BSPBio_002872 CC1(C)CC2C1CC[C@]3(CBr)CCC4C(CC(=O)O)C(=O)O[C@]24C3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 P15 compound treatment 9.5073 -1.5232 -0.4087 9.8845 -1.2587 -0.2982 -0.4999 -0.988 3046211 BSPBio_002873 CCC(C)[C@H]1O[C@@]2(C[C@@H]3C[C@@H](C/C=C(\C)/[C@@H](OC4C[C@H](OC)C(O[C@H]5C[C@H](OC)[C@@H](O)[C@H](C)O5)[C@H](C)O4)[C@@H](C)/C=C/C=C/6\CO[C@@H]7[C@H](O)C(=C[C@@H](C(=O)O3)[C@@]76O)C)O2)C=C[C@@H]1C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 P16 compound treatment 9.1323 -1.8982 -0.5093 11.6543 0.51108 0.1211 -0.2745 -0.5244 2060149 BSPBio_002874 Cc1cc(O)c2C(=O)c3c(O)cccc3Cc2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 P17 compound treatment 9.1143 -1.9162 -0.5142 9.5176 -1.6256 -0.3852 -0.6359 -0.9899 1319 BSPBio_002875 NCCCCN 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 P18 compound treatment 11.5895 0.55896 0.15 10.9424 -0.20087 -0.0476 0.0724 0.4601 3081416 BSPBio_002876 CC(CCC=C(C)C)C1CC[C@@]2(C)C3=C(CC[C@]12C)C4(C)CC[C@H](O)C(C)(C)C4CC3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 P19 compound treatment 9.4955 -1.535 -0.4119 12.8488 1.7056 0.4041 -0.0055 -0.0095 1039 BSPBio_002877 CC[C@]1(CCCN2CCc3c4[C@@H]21)CC(=O)n4c5ccccc35 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 P20 compound treatment 7.6788 -3.3517 -0.8993 10.8372 -0.30604 -0.0725 -0.6872 -0.7616 2060192 BSPBio_002878 CC1(C)CC2C1CCC3(C)CCCC2(O)C3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 P21 compound treatment 8.0355 -2.995 -0.8036 10.5933 -0.54987 -0.1303 -0.6604 -0.8112 790 BSPBio_002879 COc1ccc2[C@@H](OC(=O)c2c1OC)[C@@H]3N(C)CCc4cc5OCOc5cc34 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 P22 compound treatment 9.4994 -1.5311 -0.4108 8.8216 -2.3217 -0.5501 -0.6795 -0.9897 2069268 BSPBio_002880 CC(=O)O[C@H]1CC[C@]2(C)C3CC[C@@]4(C)C(CCC4=O)C3CC=C2C1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 P23 mock treatment 9.6757 -1.3548 -0.3635 11.6248 0.48156 0.1141 -0.1764 -0.4629 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2461 P24 mock treatment 9.3623 -1.6682 -0.4476 12.4317 1.2885 0.3053 -0.1006 -0.1857 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 A01 mock treatment 12.8482 1.1656 0.3128 19.138 9.0115 2.1351 1.7309 0.8021 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 A02 mock treatment 13.5786 1.896 0.5087 12.2204 2.0938 0.4961 0.7105 0.9999 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 A03 compound treatment 22.3067 10.624 2.8507 22.2904 12.164 2.882 4.0537 1.0 2060246 BSPBio_002881 C[C@@]1(CO)[C@H](O)CC[C@@]2(C)[C@H](C/C=C/3\[C@H](O)COC3=O)C(=C)CCC12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 A04 compound treatment 17.2303 5.5477 1.4886 13.3773 3.2507 0.7702 1.5972 0.953 3174107 BSPBio_002882 CN[C@@H]1C(O)[C@@H](O[C@H]2[C@H](N)C[C@H](N)[C@@H](O[C@H]3OC(=CC[C@H]3N)CN)[C@@H]2O)OC[C@]1(C)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 A05 compound treatment 25.5198 13.837 3.7129 14.5708 4.4442 1.053 3.37 0.8732 2060175 BSPBio_002883 C[C@](O)(CCC1C(=C)CCC2[C@@](C)(CO)CCC[C@]12C)C=C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 A06 compound treatment 12.5642 0.8817 0.2366 12.8332 2.7066 0.6413 0.6208 0.9081 1159 BSPBio_002884 Nc1ccc(cc1)S(=O)(=O)Nc2ncccn2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 A07 compound treatment 12.7495 1.067 0.2863 13.3295 3.2029 0.7589 0.7391 0.9112 1010689 BSPBio_002885 COc1cc(CC=C)c(OC)c2OCOc21 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 A08 compound treatment 14.3757 2.6931 0.7226 13.379 3.2524 0.7706 1.0559 0.9995 1177 BSPBio_002886 Cc1ccnc(NS(=O)(=O)c2ccc(N)cc2)n1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 A09 compound treatment 13.5436 1.861 0.4994 12.0339 1.9073 0.4519 0.6726 0.9988 2060113 BSPBio_002887 Cc1cc(O)cc(O)c1C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 A10 compound treatment 10.7215 -0.96108 -0.2579 20.7642 10.638 2.5204 1.5999 0.6315 1448 BSPBio_002888 OC(=O)c1cc(N=Nc2ccc(cc2)S(=O)(=O)Nc3ccccn3)ccc1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 A11 compound treatment 14.2501 2.5675 0.6889 12.8422 2.7156 0.6434 0.9421 0.9994 2060104 BSPBio_002889 COc1cc(C)c2c(=O)c3c(O)cc(O)cc3oc2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 A12 compound treatment 9.9051 -1.7774 -0.4769 13.9721 3.8455 0.9111 0.307 0.2985 1212 BSPBio_002890 CC/1=C(CC(=O)O)c2cc(F)ccc2\C1=C/c3ccc(cc3)S(=O)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 A13 compound treatment 15.0972 3.4147 0.9162 15.8675 5.7409 1.3602 1.6097 0.9815 2069262 BSPBio_002891 COc1cc(/C=C/C=O)cc(OC)c1OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 A14 compound treatment 12.0468 0.36423 0.0977 12.7219 2.5954 0.6149 0.5039 0.8093 833 BSPBio_002892 CC(C)(C)NC[C@@H](O)COc1nsnc1N2CCOCC2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 A15 compound treatment 12.4083 0.72576 0.1947 14.9159 4.7893 1.1348 0.9401 0.8165 3078273 BSPBio_002893 COc1cc(C)c(C(=O)Oc2cc(C)c(O)c(C(=O)O)c2C)c(O)c1C=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 A16 compound treatment 14.0196 2.337 0.6271 16.6564 6.5298 1.5471 1.5374 0.9209 977 BSPBio_002894 C[C@@]12C[C@H](O)[C@@]3(F)C(CCC4=CC(=O)C=C[C@@]43C)C2C[C@@H](O)[C@]1(O)C(=O)CO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 A17 compound treatment 11.9116 0.22904 0.0615 13.4473 3.3207 0.7868 0.5998 0.76 2060266 BSPBio_002895 C[C@@H]1CC[C@@]2(CC[C@]3(C)C(=CC(=O)C4[C@@]5(C)CC[C@H](OC(=O)C)C(C)(C)C5CC[C@]43C)C2[C@H]1C)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 A18 compound treatment 10.7353 -0.94721 -0.2542 12.8653 2.7387 0.6489 0.2791 0.4005 1341 BSPBio_002896 CC(=O)OCC(COC(=O)C)OC(=O)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 A19 compound treatment 13.1609 1.4784 0.3967 11.6695 1.5429 0.3656 0.539 0.9992 2060279 BSPBio_002897 CC(=O)OC1CC[C@@]2(C)C(CC[C@]3(C)C2CCC4C5CC(C)(C)CCC5(CC[C@]43C)C(=O)O)C1(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 A20 compound treatment 10.8887 -0.79382 -0.213 14.6893 4.5627 1.0811 0.6138 0.5571 1200 BSPBio_002898 NC1C[C@H]1c2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 A21 compound treatment 15.1488 3.4663 0.9301 13.9592 3.8326 0.9081 1.2998 0.9999 2060109 BSPBio_002899 CC(=O)Oc1ccc2C3c4cc(OC(=O)C)c(OC(=O)C)c(OC(=O)C)c4CC3(O)COc2c1OC(=O)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 A22 compound treatment 16.8389 5.1564 1.3836 16.2535 6.1269 1.4517 2.0048 0.9997 1000127 BSPBio_002900 CC1(C)O[C@@H]2CC3C4CCC5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 A23 mock treatment 12.3431 0.66059 0.1773 13.1662 3.0396 0.7202 0.6346 0.8556 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 A24 mock treatment 10.0485 -1.634 -0.4385 16.0474 5.9208 1.4028 0.6819 0.464 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 B01 mock treatment 11.5995 -0.083013 -0.0223 11.4767 1.3501 0.3199 0.2104 0.6563 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 B02 mock treatment 13.6585 1.976 0.5302 10.15 0.023421 0.0055 0.3788 0.7145 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 B03 compound treatment 15.5216 3.8391 1.0301 16.9669 6.8403 1.6207 1.8744 0.9761 1060 BSPBio_002901 CN1CCC(=C2c3ccccc3Sc4ccccc24)CC1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 B04 compound treatment 9.4176 -2.2649 -0.6077 11.2097 1.0831 0.2566 -0.2483 -0.3763 1589 BSPBio_002902 CC(C)CC(NC(=O)C(Cc1ccccc1)NC(=O)CNC(=O)CNC(=O)C(N)Cc2ccc(O)cc2)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 B05 compound treatment 12.471 0.78841 0.2116 10.4594 0.33279 0.0789 0.2053 0.9095 3173860 BSPBio_002903 O[C@H]1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5OC1[C@]2(CCN3CC6CCC6)c54 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 B06 compound treatment 13.8988 2.2162 0.5947 13.6291 3.5026 0.8299 1.0073 0.9866 1581 BSPBio_002904 CNC(=N)NCCCC(N)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 B07 compound treatment 12.8386 1.1561 0.3102 9.8852 -0.24143 -0.0572 0.1789 0.5671 3174101 BSPBio_002905 CN1CCc2c(C1)c3ccccc3n2Cc4ccccc4.OS(=O)(=O)c1cccc2c(cccc12)S(=O)(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 B08 compound treatment 12.0613 0.37874 0.1016 9.5429 -0.58368 -0.1383 -0.0259 -0.1511 904 BSPBio_002906 NC(=O)CN1CCCC1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 B09 compound treatment 10.84 -0.84251 -0.2261 11.3742 1.2476 0.2956 0.0492 0.1321 1291 BSPBio_002907 CCCN(CCC)C(=O)C(CCC(=O)O)NC(=O)c1ccccc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 B10 compound treatment 10.951 -0.73152 -0.1963 10.5907 0.46414 0.11 -0.061 -0.2713 772 BSPBio_002908 CCN1CCCC(C1)OC(=O)C(c2ccccc2)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 B11 compound treatment 12.2001 0.51755 0.1389 9.5441 -0.58246 -0.138 6.0E-4 0.0031 728 BSPBio_002909 Cc1cc(nnc1NCCN2CCOCC2)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 B12 compound treatment 11.161 -0.52159 -0.14 10.2611 0.13454 0.0319 -0.0764 -0.5324 973 BSPBio_002910 COc1ccc(cc1)C2C(=O)c3ccccc3C2=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 B13 compound treatment 11.1838 -0.49871 -0.1338 9.6583 -0.46833 -0.111 -0.1731 -0.9957 835 BSPBio_002911 CC(=O)OC1CN2CCC1CC2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 B14 compound treatment 13.0683 1.3858 0.3718 10.7067 0.58009 0.1374 0.3601 0.9084 3054972 BSPBio_002912 CC(C)C1=CC2=CCC3[C@](C)(CCC[C@]3(C)C2CC1)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 B15 compound treatment 12.6223 0.93975 0.2522 11.4651 1.3385 0.3171 0.4026 0.9935 840551 BSPBio_002913 NCCCCC(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 B16 compound treatment 13.8503 2.1677 0.5817 11.7009 1.5743 0.373 0.675 0.9769 2060304 BSPBio_002914 OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)[C@@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 B17 compound treatment 12.8338 1.1513 0.3089 12.1906 2.064 0.489 0.5642 0.9755 723 BSPBio_002915 CC(C)NCC(O)COc1ccc(CC(=O)N)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 B18 compound treatment 9.924 -1.7585 -0.4719 11.6488 1.5222 0.3607 -0.0786 -0.1324 2060308 BSPBio_002916 C/C(=C/C(=O)O)/C=C/C1(O)C(=CC(=O)CC1(C)C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 B19 compound treatment 12.3629 0.68034 0.1826 9.9209 -0.20571 -0.0487 0.0946 0.5008 446 BSPBio_002917 COc1cc(CNC(=O)CCCC/C=C/C(C)C)ccc1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 B20 compound treatment 12.4137 0.73115 0.1962 10.2093 0.082696 0.0196 0.1526 0.7739 2060368 BSPBio_002918 CNC(Cc1c[nH]c2ccccc12)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 B21 compound treatment 14.1468 2.4642 0.6612 12.6856 2.559 0.6063 0.8963 0.9991 847 BSPBio_002919 CC(=CCC/C(=C/CO)/C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 B22 compound treatment 10.2981 -1.3845 -0.3715 10.7296 0.60299 0.1429 -0.1617 -0.4062 3054980 BSPBio_002920 Nc1ncnc2n(cnc12)C3C[C@H](O)[C@@H](CO)O3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 B23 mock treatment 13.3652 1.6827 0.4515 14.107 3.9804 0.9431 0.9861 0.9431 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 B24 mock treatment 13.3788 1.6962 0.4551 13.1245 2.9979 0.7103 0.8241 0.9769 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 C01 mock treatment 11.8575 0.17499 0.047 11.4388 1.3122 0.3109 0.2531 0.8048 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 C02 mock treatment 11.0272 -0.65532 -0.1758 11.4126 1.286 0.3047 0.0911 0.259 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 C03 compound treatment 10.7489 -0.93367 -0.2505 12.8377 2.7111 0.6424 0.2771 0.4018 3078456 BSPBio_002921 CC(=CCC[C@](C)(O)C1CCC(=CC1)C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 C04 compound treatment 14.8173 3.1347 0.8411 12.9281 2.8015 0.6638 1.0641 0.9931 1000123 BSPBio_002922 CC(=O)OCC(=O)[C@@]1(O)[C@@H](CC2C3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C)OC(=O)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 C05 compound treatment 12.4738 0.79126 0.2123 11.0314 0.90484 0.2144 0.3017 1.0 2060492 BSPBio_002923 C[C@H]1C[C@@H](O)[C@]2(O)[C@@]31CC(=O)[C@@](C)(O)[C@]2(C)COC(=O)C3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 C06 compound treatment 12.2823 0.59975 0.1609 11.0903 0.96375 0.2283 0.2753 0.9853 1061 BSPBio_002924 Nc1nc(N)c2nc(c(N)nc2n1)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 C07 compound treatment 10.081 -1.6016 -0.4297 9.4501 -0.67651 -0.1603 -0.4172 -0.9096 2060268 BSPBio_002925 C[C@@H]1CC[C@]2(CCC3(C)[C@]4(OC2=O)C=CC5[C@@]6(C)CCC(=O)C(C)(C)C6CC[C@]53C)C4[C@H]1C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 C08 compound treatment 12.842 1.1595 0.3111 11.0654 0.9388 0.2224 0.3773 0.9865 1000 BSPBio_002926 NS(=O)(=O)c1cc2c(NC(NS2(=O)=O)C(Cl)Cl)cc1Cl 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 C09 compound treatment 11.6411 -0.041473 -0.0111 12.4755 2.3489 0.5565 0.3857 0.6928 2060202 BSPBio_002927 CC1(C)CC2C1CCC3(C)OC2(C)CCC3=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 C10 compound treatment 25.9306 14.248 3.8231 22.0639 11.937 2.8284 4.7033 0.989 437 BSPBio_002928 CN1CCN(CCCN2c3ccccc3Sc4ccc(cc24)C(F)(F)F)CC1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 C11 compound treatment 14.5891 2.9066 0.7799 11.3576 1.231 0.2917 0.7577 0.91 1050577 BSPBio_002929 COC(=O)Oc1ccccc1C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 C12 compound treatment 12.2604 0.57787 0.1551 13.826 3.6994 0.8765 0.7294 0.8195 1005 BSPBio_002930 OC(CCN1CCCCC1)(C2CCCCC2)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 C13 compound treatment 11.0142 -0.6683 -0.1793 11.9618 1.8353 0.4348 0.1807 0.3841 2060073 BSPBio_002931 CC(=O)OCC(OC(=O)C)C(OC(=O)C)C(OC(=O)C)C(OC(=O)C)C(COC(=O)C)OC(=O)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 C14 compound treatment 13.7142 2.0316 0.5451 11.6949 1.5683 0.3716 0.6482 0.9825 3079225 BSPBio_002932 OC(=O)CCC1NCC2CC1CN3CCCCC23 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 C15 compound treatment 21.5563 9.8737 2.6494 23.3342 13.208 3.1294 4.0862 0.9966 1020994 BSPBio_002933 COc1c(O)cc2oc3cc(O)c(CC=C(C)C)c(O)c3c(=O)c2c1CC=C(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 C16 compound treatment 17.4209 5.7383 1.5397 35.31 25.183 5.9668 5.308 0.8614 1053 BSPBio_002934 COc1cc(cc(OC)c1OC)C(=O)NCc2ccc(OCCN(C)C)cc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 C17 compound treatment 12.9417 1.2592 0.3379 12.7449 2.6183 0.6204 0.6776 0.9592 2069261 BSPBio_002935 COc1cc2OCC3Oc4c5C=CC(C)(C)Oc5cc(O)c4C(=O)C3c2cc1OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 C18 compound treatment 10.331 -1.3515 -0.3626 10.9636 0.83702 0.1983 -0.1162 -0.2811 1012 BSPBio_002936 Cc1cc2cc3c(C)cc(=O)oc3c(C)c2o1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 C19 compound treatment 11.2556 -0.42691 -0.1146 13.0644 2.9378 0.6961 0.4112 0.5829 2069239 BSPBio_002937 Cc1cc(O)c2C(=O)c3c(O)c(C)cc(O)c3C(=O)c2c1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 C20 compound treatment 9.958 -1.7245 -0.4627 12.6155 2.4889 0.5897 0.0898 0.1198 1012497 BSPBio_002938 NC(Cc1c[nH]c2ccccc12)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 C21 compound treatment 12.02 0.3375 0.0906 11.2105 1.0839 0.2568 0.2456 0.902 2060199 BSPBio_002939 CC1(C)CC2C1CCC3(C)OC2(C)CCC3O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 C22 compound treatment 12.9437 1.2612 0.3384 12.9769 2.8503 0.6753 0.7168 0.949 911 BSPBio_002940 CCCCCC(C)N 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 C23 mock treatment 12.9912 1.3087 0.3511 10.3337 0.20709 0.0491 0.283 0.7982 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 C24 mock treatment 12.75 1.0675 0.2864 0.0 -10.127 -2.3993 -1.4941 -0.6183 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 D01 mock treatment 10.8835 -0.79908 -0.2144 11.6795 1.553 0.3679 0.1086 0.2549 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 D02 mock treatment 11.7473 0.064802 0.0174 12.8484 2.7218 0.6449 0.4683 0.7259 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 D03 compound treatment 10.5759 -1.1066 -0.2969 9.9419 -0.18474 -0.0438 -0.2409 -0.8027 2117626 BSPBio_002941 Fc1ccc(cc1)C(CCCN2CCC(CC2)n3c(=O)[nH]c4ccccc34)c5ccc(F)cc5 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 D04 compound treatment 9.8378 -1.8447 -0.495 8.6497 -1.4769 -0.3499 -0.5974 -0.9856 1043296 BSPBio_002942 Cc1nccc2c3ccc(O)cc3[nH]c12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 D05 compound treatment 10.6793 -1.0033 -0.2692 9.4358 -0.69077 -0.1637 -0.3061 -0.9715 86 BSPBio_002943 COC(=O)C1=C(C)NC(=C(C1c2cccc(c2)[N+](=O)[O-])C(=O)OCCN(C)Cc3ccccc3)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 D06 compound treatment 13.0948 1.4122 0.3789 8.5938 -1.5328 -0.3632 0.0111 0.0212 1322 BSPBio_002944 COc1cc2ccc(=O)oc2cc1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 D07 compound treatment 10.7268 -0.95577 -0.2565 14.6206 4.4941 1.0648 0.5716 0.5219 786 BSPBio_002945 CN1CCN(CC(=O)N2c3ccccc3C(=O)Nc4cccnc24)CC1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 D08 compound treatment 9.6844 -1.9982 -0.5362 9.4593 -0.66734 -0.1581 -0.4909 -0.8782 1583 BSPBio_002946 COc1ccc(/C=C/c2cc(O)cc(O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)c2)cc1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 D09 compound treatment 9.8308 -1.8518 -0.4969 8.3996 -1.727 -0.4092 -0.6407 -0.9953 751 BSPBio_002947 COc1cc(NS(=O)(=O)c2ccc(N)cc2)nc(OC)n1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 D10 compound treatment 12.8426 1.1601 0.3113 11.1165 0.98993 0.2345 0.386 0.9903 767 BSPBio_002948 OC[C@H]1O[C@@H](OC[C@H]2O[C@@H](OC(C#N)c3ccccc3)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@@H](O)[C@@H]1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 D11 compound treatment 13.8241 2.1415 0.5746 8.2991 -1.8275 -0.433 0.1001 0.1392 706 BSPBio_002949 Nc1ccc(cc1)S(=O)(=O)Nc2cnc3ccccc3n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 D12 compound treatment 25.2861 13.604 3.6502 15.6237 5.4972 1.3025 3.5021 0.9036 598 BSPBio_002950 Oc1cc2c(=O)oc3c(O)c(O)cc4c(=O)oc(c1O)c2c43 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 D13 compound treatment 11.1863 -0.49628 -0.1332 8.5772 -1.5494 -0.3671 -0.3538 -0.9058 1241 BSPBio_002951 NC(=N)NS(=O)(=O)c1ccc(N)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 D14 compound treatment 11.4217 -0.26083 -0.07 8.671 -1.4556 -0.3449 -0.2934 -0.8336 1113841 BSPBio_002952 Oc1ccc2c(=O)c(O)c(oc2c1)c3ccc(O)c(O)c3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 D15 compound treatment 16.5332 4.8507 1.3016 13.5942 3.4676 0.8216 1.5013 0.9754 871 BSPBio_002953 Clc1ccc(CSC(Cn2ccnc2)c3ccc(Cl)cc3Cl)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 D16 compound treatment 13.3575 1.6749 0.4494 10.8642 0.73758 0.1748 0.4414 0.9153 1585 BSPBio_002954 CC(C)c1ccc(C)c2ccc(C)c2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 D17 compound treatment 9.8955 -1.7871 -0.4795 8.6736 -1.4529 -0.3443 -0.5825 -0.9868 3480067 BSPBio_002955 CC(NCCc1ccc(O)cc1)C(O)c2ccc(O)cc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 D18 compound treatment 23.2931 11.611 3.1154 8.2184 -1.9082 -0.4521 1.8832 0.5982 1010348 BSPBio_002956 OC1=CC(=O)c2ccccc2C1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 D19 compound treatment 11.2354 -0.44718 -0.12 10.1801 0.053524 0.0127 -0.0759 -0.6289 3058009 BSPBio_002957 CCN1CCC(CNC(=O)c2cc(ccc2OC)S(=O)(=O)N)C1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 D20 compound treatment 12.1073 0.42474 0.114 12.4452 2.3186 0.5494 0.469 0.836 3054057 BSPBio_002958 CC(=CCC/C(=C/CCC(C)(O)C=C)/C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 D21 compound treatment 12.3399 0.65731 0.1764 11.5868 1.4602 0.346 0.3693 0.9511 1180 BSPBio_002959 Fc1ccc(cc1)C(=O)CCCN2CCC3(CC2)N(CNC3=O)c4ccccc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 D22 compound treatment 13.6546 1.9721 0.5292 11.3583 1.2317 0.2918 0.5805 0.9607 1009367 BSPBio_002960 OC1=CC2=C3c4ccc(O)c(O)c4OCC3(O)CC2=CC1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 D23 mock treatment 13.2179 1.5354 0.412 12.1685 2.0419 0.4838 0.6334 0.9968 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 D24 mock treatment 11.5915 -0.091088 -0.0244 10.1068 -0.019796 -0.0047 -0.0206 -0.8277 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 E01 mock treatment 10.5436 -1.1389 -0.3056 13.2076 3.081 0.73 0.3001 0.3792 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 E02 mock treatment 11.7256 0.043012 0.0115 11.3381 1.2115 0.2871 0.2111 0.7349 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 E03 compound treatment 11.0092 -0.6733 -0.1807 24.1203 13.994 3.3156 2.2167 0.6676 2060138 BSPBio_002961 C[C@]1([C@H]2[C@H](C(=O)O)[C@]3(CC(=C)[C@@]4(O)C3)[C@@H](CC4)[C@]52OC1=O)[C@@H](O)C=C5 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 E04 compound treatment 11.517 -0.16557 -0.0444 9.8355 -0.29108 -0.069 -0.0802 -0.9774 824 BSPBio_002962 CC[C@]1(CCCN2CCc3c4[C@@H]21)C[C@@](O)(C(=O)OC)n4c5ccccc35 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 E05 compound treatment 10.819 -0.86351 -0.2317 12.078 1.9515 0.4624 0.1631 0.3154 2060336 BSPBio_002963 CCOc1cccc(c1)C(=O)c2ccc(O)c(O)c2O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 E06 compound treatment 12.869 1.1865 0.3184 11.5293 1.4027 0.3323 0.4601 0.9998 771 BSPBio_002964 CN1CCC(=C2c3ccsc3C(=O)Cc4ccccc24)CC1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 E07 compound treatment 9.9954 -1.6872 -0.4527 10.2205 0.093891 0.0222 -0.3044 -0.6715 2060220 BSPBio_002965 CC/1[C@H]2C[C@@H](C\C1=N/O)C2(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 E08 compound treatment 11.5342 -0.14839 -0.0398 9.749 -0.3776 -0.0895 -0.0914 -0.9335 705 BSPBio_002966 CC(Cc1cccc(c1)C(F)(F)F)NCCOC(=O)c2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 E09 compound treatment 12.0313 0.34871 0.0936 9.5906 -0.53595 -0.127 -0.0236 -0.1498 891 BSPBio_002967 CC(=O)OCC(=O)[C@H]1CCC2C3CCC4=CC(=O)CC[C@]4(C)C3CC[C@]12C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 E10 compound treatment 13.0454 1.3628 0.3657 11.638 1.5114 0.3581 0.5118 0.9999 1214 BSPBio_002968 CCOC(=O)Nc1c[n+](no1)N2CCOCC2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 E11 compound treatment 10.9143 -0.76826 -0.2061 11.5076 1.381 0.3272 0.0856 0.2214 2060111 BSPBio_002969 COc1cc(O)c(cc1O)C(=O)c2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 E12 compound treatment 9.7892 -1.8933 -0.508 12.3687 2.2421 0.5312 0.0164 0.0223 1227 BSPBio_002970 NCCCC(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 E13 compound treatment 10.7584 -0.92414 -0.248 11.2484 1.1218 0.2658 0.0126 0.0347 2060222 BSPBio_002971 C/C/1=C\CCC(=O)C2CC(C)(C)C2CC1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 E14 compound treatment 9.8922 -1.7904 -0.4804 9.1779 -0.94873 -0.2248 -0.4986 -0.9401 1091345 BSPBio_002972 Nc1nc(N)c2nc(CNc3ccc(cc3)C(=O)NC(CCC(=O)O)C(=O)O)cnc2n1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 E15 compound treatment 12.2412 0.55866 0.1499 10.1647 0.038071 0.009 0.1124 0.7483 3059164 BSPBio_002973 CC(C)CCCC(C)C1CCC2C3CC[C@H]4CC(=O)CC[C@]4(C)C3CC[C@]12C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 E16 compound treatment 12.0172 0.33464 0.0898 14.9519 4.8253 1.1433 0.8719 0.7603 1403 BSPBio_002974 COC(=O)C1=CCCN(C)C1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 E17 compound treatment 11.9488 0.26623 0.0714 10.829 0.70238 0.1664 0.1682 0.9287 2060195 BSPBio_002975 CC1(C)CC23C1CCC3(C)C(O)CCC2=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 E18 compound treatment 10.1542 -1.5284 -0.4101 8.8574 -1.2692 -0.3007 -0.5026 -0.9884 861 BSPBio_002976 C[C@H](CS)C(=O)N1CCC[C@H]1C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 E19 compound treatment 10.6157 -1.0668 -0.2863 13.9157 3.7891 0.8978 0.4324 0.4589 2060200 BSPBio_002977 CC12CCC3C(CC3(C)C)C(C)(O)CCC2O1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 E20 compound treatment 11.3276 -0.35499 -0.0953 9.1651 -0.96146 -0.2278 -0.2284 -0.9252 2081029 BSPBio_002978 CN/C(=N\C#N)/NCCSCc1nc[nH]c1C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 E21 compound treatment 15.1076 3.4251 0.919 9.4319 -0.69465 -0.1646 0.5335 0.5714 2060046 BSPBio_002979 C[C@H]1[C@@H]2CC[C@@]3(C)C=CC(=O)[C@@]4(C)O[C@]43[C@H]2OC1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 E22 compound treatment 10.4568 -1.2258 -0.3289 8.8781 -1.2485 -0.2958 -0.4417 -0.9986 949 BSPBio_002980 OC(=O)c1cc(O)c2ccccc2n1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 E23 mock treatment 10.2204 -1.4621 -0.3923 7.73 -2.3965 -0.5678 -0.6789 -0.9837 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 E24 mock treatment 10.3251 -1.3574 -0.3642 9.8467 -0.27989 -0.0663 -0.3044 -0.8223 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 F01 mock treatment 10.5051 -1.1774 -0.3159 10.7093 0.58275 0.1381 -0.1258 -0.3648 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 F02 mock treatment 8.9787 -2.7038 -0.7255 8.0147 -2.1119 -0.5004 -0.8668 -0.9836 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 F03 compound treatment 8.9195 -2.7631 -0.7414 7.2381 -2.8885 -0.6844 -1.0082 -0.9992 1509 BSPBio_002981 Cn1c(COC(=O)N)ncc1[N+](=O)[O-] 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 F04 compound treatment 9.4521 -2.2305 -0.5985 7.6355 -2.4911 -0.5902 -0.8405 -1.0 1002002 BSPBio_002982 O[C@@H]1CC(=C[C@@H](O)[C@H]1O)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 F05 compound treatment 8.6137 -3.0688 -0.8234 8.1967 -1.9299 -0.4573 -0.9056 -0.9615 887 BSPBio_002983 COc1ccc(NS(=O)(=O)c2ccc(N)cc2)nn1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 F06 compound treatment 10.1962 -1.4863 -0.3988 7.8933 -2.2333 -0.5291 -0.6562 -0.9903 3174608 BSPBio_002984 COC1C(O)C(O)C(O)[C@@H](O)C1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 F07 compound treatment 10.6459 -1.0366 -0.2781 8.7715 -1.3551 -0.3211 -0.4237 -0.9974 1094 BSPBio_002985 COc1cnc(NS(=O)(=O)c2ccc(N)cc2)nc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 F08 compound treatment 11.3611 -0.32146 -0.0863 7.6106 -2.516 -0.5961 -0.4825 -0.8011 2060409 BSPBio_002986 N[C@@H](CCCNC(=N)NC(CCC(=O)O)C(=O)O)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 F09 compound treatment 13.8037 2.1212 0.5692 11.7705 1.6439 0.3895 0.6779 0.9829 826 BSPBio_002987 CC1(C)O[C@@H]2CC3C4C[C@H](F)C5=CC(=O)CC[C@]5(C)C4[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 F10 compound treatment 10.6756 -1.007 -0.2702 9.8401 -0.2865 -0.0679 -0.2391 -0.8581 1255 BSPBio_002988 NC(=O)c1ccc(cc1Cl)[N+](=O)[O-] 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 F11 compound treatment 11.5816 -0.10099 -0.0271 8.4162 -1.7104 -0.4053 -0.3057 -0.7527 684 BSPBio_002989 CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3OC(=O)CC)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 F12 compound treatment 9.9935 -1.689 -0.4532 9.805 -0.32156 -0.0762 -0.3743 -0.8145 866 BSPBio_002990 Cc1c(cc(cc1[N+](=O)[O-])[N+](=O)[O-])C(=O)N 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 F13 compound treatment 20.9716 9.289 2.4925 12.4881 2.3615 0.5595 2.1581 0.8448 3059433 BSPBio_002991 CC(=O)OC1CCC2C3CCc4cc(O)ccc4C3CCC12C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 F14 compound treatment 10.7376 -0.94496 -0.2536 9.1044 -1.0222 -0.2422 -0.3505 -0.9997 1246 BSPBio_002992 CC[N+]1(C)CCCC(C1)OC(=O)C(O)(c2ccccc2)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 F15 compound treatment 18.2501 6.5675 1.7622 16.1836 6.057 1.4351 2.2609 0.9948 773 BSPBio_002993 Clc1ccc(COC(Cn2ccnc2)c3ccc(Cl)cc3Cl)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 F16 compound treatment 13.8573 2.1748 0.5835 8.4349 -1.6917 -0.4008 0.1292 0.1825 1424 BSPBio_002994 CCCC(=O)Nc1ncnc2n(cnc12)C3O[C@@H]4COP(=O)(O)O[C@H]4[C@H]3OC(=O)CCC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 F17 compound treatment 13.3871 1.7046 0.4574 10.3694 0.24285 0.0575 0.3641 0.7898 782 BSPBio_002995 CC1(C)O[C@@H]2CC3C4C[C@H](F)C5=CC(=O)C=CC5(C)C4C(O)CC3(C)[C@@]2(O1)C(=O)CO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 F18 compound treatment 12.3153 0.63276 0.1698 10.7506 0.62397 0.1478 0.2246 0.9976 775 BSPBio_002996 NCC(O)CC(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 F19 compound treatment 15.9317 4.2492 1.1402 10.0413 -0.085319 -0.0202 0.7919 0.6945 3078281 BSPBio_002997 C[C@H]1OC(C(O)[C@@H]1O)n2cc(F)c(=O)[nH]c2=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 F20 compound treatment 14.998 3.3155 0.8896 9.4185 -0.70812 -0.1678 0.5104 0.5638 1263 BSPBio_002998 C[C@@H]1CC[C@H]2[C@@H](C)C(=O)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@@]23OO4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 F21 compound treatment 13.3608 1.6783 0.4503 9.8818 -0.24478 -0.058 0.2774 0.611 1187 BSPBio_002999 C[C@@]12CCC3C(CCc4cc(OS(=O)(=O)O)ccc34)C2CC[C@H]1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 F22 compound treatment 8.1738 -3.5088 -0.9415 8.4203 -1.7063 -0.4043 -0.9516 -0.9287 1324 BSPBio_003000 CCCCC(CC)CNC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NCC(CC)CCCC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 F23 mock treatment 10.7014 -0.9811 -0.2633 10.2754 0.14882 0.0353 -0.1612 -0.607 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 F24 mock treatment 9.7767 -1.9058 -0.5114 11.5901 1.4635 0.3468 -0.1164 -0.1884 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 G01 mock treatment 10.6157 -1.0669 -0.2863 11.5192 1.3926 0.3299 0.0309 0.0707 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 G02 mock treatment 11.5753 -0.10724 -0.0288 10.8312 0.70466 0.167 0.0977 0.5767 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 G03 compound treatment 12.038 0.35551 0.0954 9.68 -0.44655 -0.1058 -0.0074 -0.0517 1031842 BSPBio_003001 CC(=O)Oc1ccc(O)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 G04 compound treatment 9.4779 -2.2046 -0.5916 14.4377 4.3111 1.0215 0.304 0.2575 3198646 BSPBio_003002 COc1c2occc2cc3c(=O)c-4c(COc5cc6OCOc6cc54)oc13 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 G05 compound treatment 13.4681 1.7856 0.4791 11.1102 0.98361 0.2331 0.5036 0.9452 3054634 BSPBio_003003 COc1c(CC=C(C)C)c2OC(C)(C)C=Cc2c3oc(=O)c(c(O)c13)c4ccc(O)cc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 G06 compound treatment 11.4135 -0.26901 -0.0722 10.5049 0.37829 0.0896 0.0123 0.1072 362 BSPBio_003004 CCN(CC)CC(=O)Nc1c(C)cccc1C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 G07 compound treatment 9.2692 -2.4133 -0.6476 10.8732 0.74657 0.1769 -0.3328 -0.4958 1114909 BSPBio_003005 COc1cc(CC=C)ccc1OC(=O)c2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 G08 compound treatment 11.5464 -0.1361 -0.0365 11.0479 0.92131 0.2183 0.1285 0.5807 988 BSPBio_003006 COc1ccc2[nH]cc(CCNC(=O)C)c2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 G09 compound treatment 11.069 -0.61353 -0.1646 11.07 0.94337 0.2235 0.0416 0.15 2060204 BSPBio_003007 CC(=O)OC1CC(C)(C)C2CCC3(C)CC12CCC3OC(=O)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 G10 compound treatment 12.4496 0.76708 0.2058 11.358 1.2314 0.2918 0.3518 0.9854 898 BSPBio_003008 CCOC(=O)C(Cc1ccc(O)cc1)NC(=O)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 G11 compound treatment 9.3935 -2.289 -0.6142 10.3405 0.21388 0.0507 -0.3985 -0.6466 2060053 BSPBio_003009 COc1c(CC=C(C)C)c2OC(C)(C)C=Cc2c3oc(=O)c(c(OC(=O)C)c13)c4ccc(OC(=O)C)cc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 G12 compound treatment 10.6848 -0.99774 -0.2677 10.8122 0.68557 0.1624 -0.0744 -0.2377 993 BSPBio_003010 CC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 G13 compound treatment 10.094 -1.5886 -0.4262 11.0842 0.95761 0.2269 -0.141 -0.2919 3055370 BSPBio_003011 COC(=O)c1c(C)c2Oc3c(Cl)c(OC(=O)C)c(Cl)c(C)c3C(=O)Oc2cc1OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 G14 compound treatment 11.3446 -0.33799 -0.0907 13.0073 2.8807 0.6825 0.4185 0.6078 1017 BSPBio_003012 CC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 G15 compound treatment 10.4555 -1.227 -0.3292 11.3411 1.2145 0.2878 -0.0293 -0.0671 2060314 BSPBio_003013 COC(=O)c1c(C)c2Oc3c(Cl)c(OC)c(Cl)c(C)c3C(=O)Oc2c(C)c1OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 G16 compound treatment 9.5272 -2.1553 -0.5783 11.1736 1.047 0.2481 -0.2335 -0.3711 1034 BSPBio_003014 CC(=O)N[C@@H](CCC(=O)O)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 G17 compound treatment 9.4685 -2.214 -0.5941 9.5117 -0.61484 -0.1457 -0.5231 -0.8552 2060119 BSPBio_003015 CC(C)c1c(O)c(cc2c1CCC3C(C)(C)CCC[C@@]32C)c4cc5c(CCC6C(C)(C)CCC[C@@]65C)c(C(C)C)c4O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 G18 compound treatment 11.7167 0.034187 0.0092 10.4198 0.29323 0.0695 0.0556 0.7936 1022 BSPBio_003016 COc1cc(OC)c2ccc(=O)oc2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 G19 compound treatment 10.8222 -0.86035 -0.2309 9.466 -0.66063 -0.1565 -0.2739 -0.9821 2060081 BSPBio_003017 CC(=CCc1c(O)cc(C)oc1=O)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 G20 compound treatment 9.5092 -2.1734 -0.5832 11.186 1.0595 0.251 -0.2349 -0.3699 1225 BSPBio_003018 Oc1cc(O)c2c(=O)cc(oc2c1)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 G21 compound treatment 9.7471 -1.9355 -0.5193 9.649 -0.47757 -0.1132 -0.4472 -0.8414 2060219 BSPBio_003019 CC(=O)OC/1CCC(=C)[C@H]2CC(C)(C)[C@@H]2C\C=C1/C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 G22 compound treatment 10.9727 -0.7098 -0.1905 9.3293 -0.79734 -0.1889 -0.2683 -1.0 987 BSPBio_003020 CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 G23 mock treatment 11.9252 0.24268 0.0651 10.7568 0.63023 0.1493 0.1516 0.9308 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 G24 mock treatment 9.1197 -2.5629 -0.6877 9.3759 -0.7507 -0.1779 -0.612 -0.8616 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 H01 mock treatment 15.427 3.7444 1.0047 8.7586 -1.368 -0.3241 0.4812 0.4559 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 H02 mock treatment 9.6451 -2.0374 -0.5467 8.4174 -1.7092 -0.405 -0.6729 -0.9891 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 H03 compound treatment 34.0675 22.385 6.0065 24.9168 14.79 3.5043 6.7251 0.9671 2060367 BSPBio_003021 CS(=O)(=O)CCCCN=C=S 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 H04 compound treatment 11.3638 -0.31869 -0.0855 7.8335 -2.293 -0.5433 -0.4446 -0.8084 1314 BSPBio_003022 CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N2Cc3ccccc3C[C@H]2C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 H05 compound treatment 9.3728 -2.3097 -0.6198 7.9956 -2.131 -0.5049 -0.7953 -0.9948 1076 BSPBio_003023 Cc1cccc(C)c1NC2=NCCCS2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 H06 compound treatment 11.6023 -0.080241 -0.0215 6.5631 -3.5635 -0.8443 -0.6122 -0.7249 1328 BSPBio_003024 OC(CCN1CCCCC1)(c2ccccc2)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 H07 compound treatment 10.6434 -1.0392 -0.2788 8.3462 -1.7804 -0.4218 -0.4955 -0.9798 196 BSPBio_003025 Cc1ccc(cc1)S(=O)(=O)NC(=O)NN2CCCCCC2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 H08 compound treatment 10.1851 -1.4974 -0.4018 6.6704 -3.4562 -0.8189 -0.8632 -0.9463 1031 BSPBio_003026 COc1ccc(cc1)C(=O)N2CCCC2=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 H09 compound treatment 20.0851 8.4026 2.2546 16.4873 6.3607 1.5071 2.6599 0.9808 1277 BSPBio_003027 C[C@H]1O[C@H](C[C@H](O)[C@@H]1O[C@H]2C[C@H](O)[C@H](O[C@H]3C[C@H](OC(=O)C)[C@H](O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)[C@@H](C)O3)[C@@H](C)O2)O[C@H]5CC[C@@]6(C)C(CCC7C6C[C@@H](O)[C@]8(C)[C@H](CC[C@]78O)C9=CC(=O)OC9)C5 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 H10 compound treatment 11.4243 -0.25829 -0.0693 8.8552 -1.2714 -0.3012 -0.262 -0.8476 3174106 BSPBio_003028 CN(C)CCCO[C@H]1[C@H](OC2OC(C)(C)O[C@H]12)C(O)CO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 H11 compound treatment 11.861 0.17846 0.0479 7.7321 -2.3945 -0.5673 -0.3673 -0.6451 821 BSPBio_003029 O=C1NS(=O)(=O)c2ccccc12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 H12 compound treatment 10.0621 -1.6205 -0.4348 6.9081 -3.2185 -0.7626 -0.8467 -0.9645 818 BSPBio_003030 CCC1(CC)C(=O)NC=CC1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 H13 compound treatment 8.9199 -2.7627 -0.7413 6.902 -3.2246 -0.764 -1.0644 -0.9999 1122 BSPBio_003031 N(=Nc1ccccc1)c2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 H14 compound treatment 10.6244 -1.0582 -0.2839 6.6158 -3.5108 -0.8318 -0.789 -0.8976 1339 BSPBio_003032 CCN(CC)CCNC(=O)c1cc(ccc1OC)S(=O)(=O)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 H15 compound treatment 8.9848 -2.6978 -0.7239 8.2463 -1.8803 -0.4455 -0.8269 -0.9728 3173631 BSPBio_003033 Oc1c(oc2ccc3occc3c2c1=O)c4ccccc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 H16 compound treatment 11.1275 -0.55506 -0.1489 8.0131 -2.1135 -0.5008 -0.4594 -0.8793 3202 BSPBio_003034 COc1ccccc1N2CCN(CCCNc3cc(=O)n(C)c(=O)n3C)CC2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 H17 compound treatment 11.089 -0.59354 -0.1593 8.1224 -2.0042 -0.4749 -0.4484 -0.8953 1036 BSPBio_003035 CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N2CCC[C@H]2C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 H18 compound treatment 10.8145 -0.86806 -0.2329 8.8516 -1.2749 -0.3021 -0.3783 -0.9917 917 BSPBio_003036 NS(=O)(=O)c1cc2c(NC(Cc3ccccc3)NS2(=O)=O)cc1C(F)(F)F 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 H19 compound treatment 12.4608 0.77826 0.2088 6.2147 -3.9119 -0.9269 -0.5077 -0.5344 1209 BSPBio_003037 CC(C(=O)O)c1cccc(c1)C(=O)c2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 H20 compound treatment 11.0939 -0.58865 -0.1579 7.3475 -2.7791 -0.6585 -0.5773 -0.8525 955 BSPBio_003038 CCN(CC)CCNC(=O)c1cc(Br)c(N)cc1OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 H21 compound treatment 12.3344 0.6519 0.1749 7.3412 -2.7854 -0.66 -0.343 -0.5023 1231 BSPBio_003039 CC(C)C[C@H](NC(=O)C)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 H22 compound treatment 11.713 0.030462 0.0082 7.7087 -2.4179 -0.5729 -0.3993 -0.6969 850 BSPBio_003040 Clc1cccc(c1)N2CCN(CCCn3nc4ccccn4c3=O)CC2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 H23 mock treatment 9.6682 -2.0143 -0.5405 6.5066 -3.62 -0.8577 -0.9887 -0.9752 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 H24 mock treatment 10.8956 -0.78694 -0.2112 14.2419 4.1153 0.9751 0.5402 0.5414 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 I01 mock treatment 11.9896 0.30706 0.0824 16.0247 5.8981 1.3975 1.0464 0.7475 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 I02 mock treatment 12.4012 0.71869 0.1928 12.3134 2.1868 0.5181 0.5027 0.9093 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 I03 compound treatment 9.9884 -1.6941 -0.4546 11.2273 1.1008 0.2608 -0.137 -0.2614 2069228 BSPBio_003041 COc1ccc2oc3ccccc3c(=O)c2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 I04 compound treatment 9.3672 -2.3154 -0.6213 10.12 -0.0066087 -0.0016 -0.4404 -0.7089 2060457 BSPBio_003042 COc1cc(O)c2c(=O)cc(oc2c1)c3ccc(O)cc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 I05 compound treatment 17.8064 6.1238 1.6432 14.7536 4.627 1.0963 1.9371 0.9807 2060270 BSPBio_003043 CC(C)c1ccc2c(CCC3C(C)(CCCC32C)C(=O)N)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 I06 compound treatment 10.0435 -1.639 -0.4398 11.2638 1.1372 0.2694 -0.1205 -0.2335 1651081 BSPBio_003044 COc1cc(O)c2c(=O)c(coc2c1)c3ccc(O)cc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 I07 compound treatment 11.0437 -0.63883 -0.1714 10.1751 0.048476 0.0115 -0.1131 -0.6583 2060116 BSPBio_003045 CCC(=O)OC1[C@@H]2CC3=C4CC(=O)O[C@@H](c5ccoc5)[C@]4(C)CCC3[C@](C)([C@@H](CC(=O)OC)C1(C)C)C2=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 I08 compound treatment 10.2887 -1.3939 -0.374 12.1368 2.0102 0.4763 0.0723 0.1194 3058615 BSPBio_003046 C[C@@H]1O[C@@H](O[C@@H]2[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]2Oc3cc(O)c4C(=O)C[C@H](Oc4c3)c5ccc(O)cc5)[C@H](O)[C@H](O)[C@H]1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 I09 compound treatment 10.6285 -1.054 -0.2828 10.6708 0.54423 0.1289 -0.1088 -0.35 3053889 BSPBio_003047 C[C@@H]1CC[C@H]2C(C)(C)C3CC12CC[C@@]3(C)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 I10 compound treatment 10.3276 -1.355 -0.3636 11.5125 1.3859 0.3284 -0.0249 -0.0508 1193 BSPBio_003048 CCOc1ccc(NC(=O)C)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 I11 compound treatment 9.3437 -2.3388 -0.6276 10.9023 0.77569 0.1838 -0.3138 -0.4799 2060382 BSPBio_003049 C/C/1=C\CC(C)(C)\C=C\CC2(C)OC2CC1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 I12 compound treatment 10.5214 -1.1611 -0.3116 9.7008 -0.42576 -0.1009 -0.2916 -0.8905 1087 BSPBio_003050 Oc1ccc(Cl)cc1Cc2cc(Cl)ccc2O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 I13 compound treatment 10.8588 -0.82374 -0.221 9.9349 -0.19169 -0.0454 -0.1884 -0.835 1156 BSPBio_003051 OC(=O)c1cc(O)ccc1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 I14 compound treatment 13.8048 2.1222 0.5695 12.2762 2.1496 0.5093 0.7628 0.9984 1146 BSPBio_003052 Nc1ccc(cc1)S(=O)(=O)N 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 I15 compound treatment 11.7486 0.066074 0.0177 9.8122 -0.31439 -0.0745 -0.0401 -0.5242 74 BSPBio_003053 COc1ccc(Cl)cc1C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 I16 compound treatment 11.6544 -0.028111 -0.0075 10.2063 0.079664 0.0189 0.008 0.3942 737 BSPBio_003054 c1nc(cs1)c2nc3ccccc3[nH]2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 I17 compound treatment 11.3451 -0.33743 -0.0905 10.6022 0.47557 0.1127 0.0157 0.1083 1010251 BSPBio_003055 O=C(Nc1ccccc1)Nc2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 I18 compound treatment 9.7591 -1.9235 -0.5161 11.6103 1.4837 0.3515 -0.1164 -0.1863 1008060 BSPBio_003056 C1CCc2nnnn2CC1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 I19 compound treatment 10.6713 -1.0112 -0.2713 10.9855 0.85891 0.2035 -0.048 -0.1414 2060272 BSPBio_003057 CC1CCC2C(CC2(C)C)C(=C)CCC1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 I20 compound treatment 12.6478 0.96524 0.259 12.0516 1.925 0.4561 0.5056 0.9641 2060265 BSPBio_003058 COC(=O)CCC(C)[C@H]1CCC2C3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)C3C[C@H](O)[C@]12C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 I21 compound treatment 11.4047 -0.27783 -0.0745 10.341 0.21436 0.0508 -0.0168 -0.1862 2060379 BSPBio_003059 COc1ccc(cc1)c2coc3c(OC)c(OC)ccc3c2=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 I22 compound treatment 12.0778 0.39525 0.1061 8.9429 -1.1837 -0.2805 -0.1233 -0.4113 2060267 BSPBio_003060 CC(CCC(=O)O)[C@H]1CCC2C3CC[C@@H]4C[C@H](O)CC[C@]4(C)C3CC[C@]12C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 I23 mock treatment 12.4705 0.78791 0.2114 8.5739 -1.5527 -0.3679 -0.1106 -0.2608 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 I24 mock treatment 11.2118 -0.47077 -0.1263 10.3856 0.25905 0.0614 -0.0459 -0.327 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 J01 mock treatment 11.3266 -0.35594 -0.0955 11.5986 1.472 0.3488 0.1791 0.4952 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 J02 mock treatment 11.5156 -0.16695 -0.0448 8.872 -1.2545 -0.2972 -0.2419 -0.8046 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 J03 compound treatment 12.1196 0.43701 0.1173 7.5915 -2.5351 -0.6006 -0.3418 -0.5585 404 BSPBio_003061 CCCCNc1cc(cc(c1Oc2ccccc2)S(=O)(=O)N)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 J04 compound treatment 11.6626 -0.019953 -0.0054 7.7658 -2.3608 -0.5594 -0.3993 -0.7138 1413 BSPBio_003062 CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 J05 compound treatment 9.0488 -2.6337 -0.7067 7.2649 -2.8617 -0.678 -0.9792 -0.9998 1000129 BSPBio_003063 CC1(C)[C@H](CC[C@@]2(C)C1CC[C@]3(C)C2C(=O)C=C4[C@@H]5C[C@](C)(CC[C@]5(C)CC[C@]43C)C(=O)O)OC(=O)CCC(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 J06 compound treatment 10.7387 -0.94385 -0.2533 8.0274 -2.0992 -0.4974 -0.5308 -0.951 1433 BSPBio_003064 CS(=O)(=O)c1ccc(cc1)[C@@H](O)[C@@H](CO)NC(=O)C(Cl)Cl 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 J07 compound treatment 12.478 0.79546 0.2134 7.1225 -3.0041 -0.7118 -0.3524 -0.4742 BSPBio_003065 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 J08 compound treatment 9.3284 -2.3542 -0.6317 9.3436 -0.783 -0.1855 -0.5778 -0.8777 900 BSPBio_003066 CN1C(=C(O)c2sccc2S1(=O)=O)C(=O)Nc3ccccn3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 J09 compound treatment 12.19 0.50746 0.1362 10.1983 0.071746 0.017 0.1083 0.7893 1498 BSPBio_003067 OC(=O)P(=O)(O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 J10 compound treatment 9.9357 -1.7468 -0.4687 8.0833 -2.0433 -0.4841 -0.6738 -0.9999 801 BSPBio_003068 CN(C)CC/C=C/1\c2ccccc2Sc3ccc(Cl)cc13 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 J11 compound treatment 10.7173 -0.96524 -0.259 7.9156 -2.211 -0.5239 -0.5536 -0.9473 112 BSPBio_003069 OC(=O)c1cccnc1Nc2cccc(c2)C(F)(F)F 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 J12 compound treatment 29.9735 18.291 4.9079 14.77 4.6434 1.1002 4.2484 0.8447 1054 BSPBio_003070 CC(C)(C)CC(C)(C)c1ccc(O)c(Cc2ccc(Cl)cc2Cl)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 J13 compound treatment 11.3412 -0.34138 -0.0916 7.4154 -2.7112 -0.6424 -0.519 -0.7998 1604 BSPBio_003071 OC(=O)c1ccccc1C(=O)Nc2ccc(cc2)S(=O)(=O)Nc3nccs3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 J14 compound treatment 12.1243 0.44175 0.1185 8.8661 -1.2604 -0.2986 -0.1274 -0.3964 716 BSPBio_003072 CN(C)CCC=C1c2ccccc2C=Cc3ccccc13 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 J15 compound treatment 12.2731 0.59059 0.1585 7.2927 -2.8339 -0.6715 -0.3627 -0.5258 1258 BSPBio_003073 CCn1cc(C(=O)O)c(=O)c2cnc(nc12)N3CCNCC3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 J16 compound treatment 10.553 -1.1296 -0.3031 10.315 0.18842 0.0446 -0.1828 -0.5965 3000787 BSPBio_003074 [O-][N+](=O)c1ccc(cc1)c2ccc(/C=N/N3CC(=O)NC3=O)o2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 J17 compound treatment 11.7584 0.075849 0.0204 8.4418 -1.6848 -0.3992 -0.2679 -0.6702 1603 BSPBio_003075 OC(=O)CCC(=O)Nc1ccc(cc1)S(=O)(=O)Nc2nccs2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 J18 compound treatment 10.7364 -0.94614 -0.2539 10.1527 0.026089 0.0062 -0.1751 -0.6897 1063 BSPBio_003076 CC(CNCCc1ccc(O)c(O)c1)Cc2cccc(O)c2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 J19 compound treatment 13.6273 1.9448 0.5218 8.696 -1.4306 -0.339 0.1293 0.2078 3471107 BSPBio_003077 NC(=O)c1cc[n+](CC2=C(N3C(SC2)C(NC(=O)C(c4ccccc4)S(=O)(=O)O)C3=O)C(=O)O)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 J20 compound treatment 9.2832 -2.3993 -0.6438 10.098 -0.028616 -0.0068 -0.46 -0.7145 1091 BSPBio_003078 CCc1cn(C2OCC(O)C2CO)c(=O)nc1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 J21 compound treatment 12.9623 1.2797 0.3434 9.7478 -0.37876 -0.0897 0.1794 0.5053 1266 BSPBio_003079 CCn1cc(C(=O)O)c(=O)c2cc3OCOc3cc12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 J22 compound treatment 10.6994 -0.98311 -0.2638 11.7462 1.6197 0.3838 0.0848 0.1822 1048 BSPBio_003080 CCn1cc(C(=O)O)c(=O)c2cc(F)c(nc12)N3CCNCC3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 J23 mock treatment 10.1976 -1.4849 -0.3984 10.8289 0.70232 0.1664 -0.1641 -0.38 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 J24 mock treatment 10.1757 -1.5069 -0.4043 10.9141 0.78755 0.1866 -0.154 -0.3457 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 K01 mock treatment 8.1353 -3.5473 -0.9518 11.4337 1.3071 0.3097 -0.4541 -0.4536 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 K02 mock treatment 11.6683 -0.014286 -0.0038 9.9318 -0.19475 -0.0461 -0.0353 -0.7632 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 K03 compound treatment 12.1346 0.45209 0.1213 10.6684 0.5418 0.1284 0.1765 0.9996 2060103 BSPBio_003081 COc1ccc2C(=O)[C@@H]3[C@@H](COc4cc(OC)c(OC)cc34)Oc2c1CC=C(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 K04 compound treatment 10.9214 -0.76112 -0.2042 9.5419 -0.58465 -0.1385 -0.2424 -0.9821 3177457 BSPBio_003082 CC(CCC(=O)O)[C@H]1CCC2C3C(CC(=O)[C@]12C)[C@@]4(C)CCC(=O)C[C@H]4CC3=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 K05 compound treatment 9.0624 -2.6202 -0.7031 10.6556 0.52906 0.1254 -0.4085 -0.572 2060256 BSPBio_003083 CC(=CC1C(CO)C1(C)C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 K06 compound treatment 12.1918 0.50926 0.1366 12.1109 1.9844 0.4702 0.4291 0.8764 3172708 BSPBio_003084 CCC(C)C(=O)O[C@H]1[C@H](O)C2C(CN3CC(C)CCC3[C@@]2(C)O)C4C[C@]5(O[C@@]6(O)C7C(OC(=O)C)[C@@H](OC(=O)C)C5[C@@]41O)[C@@]7(C)CCC6OC(=O)C(C)(O)C(C)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 K07 compound treatment 8.6052 -3.0774 -0.8257 9.5492 -0.57738 -0.1368 -0.6806 -0.8132 2060041 BSPBio_003085 COc1cc2CCN(C)C(Cc3ccc(O)cc3)c2cc1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 K08 compound treatment 12.8353 1.1528 0.3093 11.7801 1.6535 0.3918 0.4958 0.9932 1275107 BSPBio_003086 C1Cc2c(CN1)[nH]c3ccccc23 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 K09 compound treatment 10.4644 -1.2182 -0.3269 10.5882 0.46165 0.1094 -0.1538 -0.4462 2060099 BSPBio_003087 Oc1cc(O)c2c(=O)c(coc2c1)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 K10 compound treatment 10.4715 -1.211 -0.3249 10.2069 0.080334 0.019 -0.2163 -0.6645 2060276 BSPBio_003088 C[C@@H]1C(=O)OC2[C@H](O)C34[C@@H]5OC(=O)[C@@]4(O[C@@H]6OC(=O)[C@H](O)[C@@]63[C@@H]([C@H]5O)C(C)(C)C)[C@@]12O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 K11 compound treatment 9.9591 -1.7235 -0.4625 8.6848 -1.4418 -0.3416 -0.5686 -0.9889 3053888 BSPBio_003089 CC(=CCC[C@](C)(OC(=O)C)C1CCC(=CC1)C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 K12 compound treatment 19.5061 7.8236 2.0993 22.799 12.672 3.0025 3.6075 0.9847 3174369 BSPBio_003090 C[C@H]1OC(C[C@H](O)C1O)O[C@@H]2[C@@H](C)OC(C[C@@H]2O)O[C@@H]3[C@@H](C)O[C@H](C[C@@H]3O)O[C@H]4CC[C@@]5(C)[C@H](CC[C@@H]6C5CC[C@]7(C)[C@H]([C@@H](O)C[C@]67O)C8=CC(=O)OC8)C4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 K13 compound treatment 12.0767 0.39416 0.1058 17.0413 6.9147 1.6383 1.2333 0.7512 2060274 BSPBio_003091 CC(C)C1CC=C(C)C2CC(=O)C(=CC12)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 K14 compound treatment 9.9488 -1.7337 -0.4652 9.1665 -0.96005 -0.2275 -0.4898 -0.9458 2880 BSPBio_003092 N[C@@H](CCC(=O)N)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 K15 compound treatment 10.7051 -0.9774 -0.2623 8.8725 -1.2541 -0.2971 -0.3956 -0.9981 2060152 BSPBio_003093 CC(=O)O[C@@H]1CC2C(C)(C)C=CC(=O)[C@]2(C)C3CC[C@@]4(C)[C@@H](OC(=O)C5OC54[C@]13C)c6ccoc6 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 K16 compound treatment 11.0155 -0.667 -0.179 11.1872 1.0606 0.2513 0.0511 0.1658 752 BSPBio_003094 CC1CCc2cc(F)cc3c(=O)c(cn1c23)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 K17 compound treatment 9.7707 -1.9118 -0.513 9.7325 -0.39414 -0.0934 -0.4288 -0.8223 1151 BSPBio_003095 CC(C)CCCC(C)CCCC(C)CCCC1(C)CCc2c(C)c(O)c(C)c(C)c2O1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 K18 compound treatment 10.7232 -0.95939 -0.2574 7.9909 -2.1357 -0.506 -0.5398 -0.9509 43 BSPBio_003096 Fc1ccc(cc1)C(N2CCN(C/C=C/c3ccccc3)CC2)c4ccc(F)cc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 K19 compound treatment 10.9345 -0.74808 -0.2007 9.2085 -0.91807 -0.2175 -0.2957 -0.9992 1398 BSPBio_003097 CC(C)CCCC(C)CCCC(C)CCCC1(C)CCc2c(C)c(OC(=O)C)c(C)c(C)c2O1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 K20 compound treatment 12.1267 0.44416 0.1192 9.3457 -0.78086 -0.185 -0.0466 -0.2115 2069275 BSPBio_003098 CC1(C)[C@H](CC[C@@]2(C)C1CC[C@@]3(C)C4CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC(=O)C32)C(=O)O)O[C@@H]6O[C@@H]([C@@H](O[C@@H]7O[C@@H]([C@@H](O)[C@H](O)[C@H]7O)C(=O)O)[C@H](O)[C@H]6O)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 K21 compound treatment 10.3116 -1.371 -0.3679 9.7011 -0.4255 -0.1008 -0.3314 -0.8689 1052459 BSPBio_003099 COc1c2ccoc2cc3oc(C)cc(=O)c13 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 K22 compound treatment 13.2333 1.5507 0.4161 12.1319 2.0053 0.4751 0.6302 0.9978 1130 BSPBio_003100 OCCN1CCN(CCCN2c3ccccc3Sc4ccc(cc24)C(F)(F)F)CC1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 K23 mock treatment 9.7033 -1.9792 -0.5311 9.6663 -0.46032 -0.1091 -0.4526 -0.8349 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 K24 mock treatment 12.1293 0.44679 0.1199 11.5627 1.4361 0.3403 0.3254 0.9019 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 L01 mock treatment 11.128 -0.55454 -0.1488 8.5456 -1.5809 -0.3746 -0.3701 -0.9182 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 L02 mock treatment 11.2137 -0.46881 -0.1258 8.2365 -1.8901 -0.4478 -0.4056 -0.872 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 L03 compound treatment 11.3122 -0.37032 -0.0994 7.383 -2.7436 -0.6501 -0.5299 -0.8058 1189 BSPBio_003101 CO[C@]1(NC(=O)Cc2cccs2)[C@H]3SCC(=C(N3C1=O)C(=O)O)COC(=O)N 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 L04 compound treatment 12.3355 0.65293 0.1752 7.65 -2.4766 -0.5868 -0.291 -0.4753 1278 BSPBio_003102 COc1ccc(cc1O)c2cc(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@H]5O[C@H](C)[C@@H](O)[C@H](O)[C@@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3o2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 L05 compound treatment 11.4226 -0.25991 -0.0697 7.4307 -2.6959 -0.6387 -0.501 -0.7797 3173342 BSPBio_003103 CO/N=C(/C(=O)NC1C2SCC(=C(N2C1=O)C(=O)O)COC(=O)N)\c3ccco3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 L06 compound treatment 12.0734 0.39081 0.1049 7.4569 -2.6696 -0.6325 -0.3731 -0.5819 1348 BSPBio_003104 Clc1ccc(OCC(=O)N2CCN(Cc3ccc4OCOc4c3)CC2)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 L07 compound treatment 11.3916 -0.29098 -0.0781 8.0192 -2.1074 -0.4993 -0.4083 -0.8079 3471725 BSPBio_003105 CC1(C)SC2C(NC(=O)C(N=C)c3ccccc3)C(=O)N2C1C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 L08 compound treatment 12.4626 0.78001 0.2093 7.9216 -2.205 -0.5224 -0.2214 -0.3934 766 BSPBio_003106 CC12CCC3C(CCC4=CC(=O)CCC34C)C2CCC1(O)C#C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 L09 compound treatment 9.6261 -2.0564 -0.5518 6.907 -3.2196 -0.7628 -0.9296 -0.9874 999 BSPBio_003107 CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNC(C)C3)c(F)c12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 L10 compound treatment 13.3969 1.7144 0.46 8.9016 -1.225 -0.2903 0.12 0.2207 3177517 BSPBio_003108 NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)C(O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 L11 compound treatment 11.189 -0.49352 -0.1324 7.4977 -2.6289 -0.6229 -0.5341 -0.8387 1635952 BSPBio_003109 Cn1nnnc1SCC2=C(N3C(SC2)C(NC(=O)C(O)c4ccccc4)C3=O)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 L12 compound treatment 11.5466 -0.13599 -0.0365 13.2563 3.1297 0.7415 0.4985 0.6715 1162 BSPBio_003110 Cc1c(NC(=O)c2cccnc2)c(=O)n(c3ccccc3)n1C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 L13 compound treatment 11.0823 -0.60027 -0.1611 6.3444 -3.7822 -0.8961 -0.7476 -0.821 1514 BSPBio_003111 CC1OC1P(=O)(O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 L14 compound treatment 10.7237 -0.9588 -0.2573 7.7007 -2.4259 -0.5748 -0.5883 -0.9343 1298 BSPBio_003112 CS(=O)(=O)Nc1ccc(cc1Oc2ccccc2)[N+](=O)[O-] 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 L15 compound treatment 10.0361 -1.6464 -0.4418 8.0882 -2.0383 -0.483 -0.6539 -0.999 1067 BSPBio_003113 CO[C@]1(NC(=O)CSCC#N)C2SCC(=C(N2C1=O)C(=O)O)CSc3nnnn3C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 L16 compound treatment 11.9405 0.25796 0.0692 6.9829 -3.1437 -0.7449 -0.4777 -0.6386 3046112 BSPBio_003114 CC1(C)O[C@@H]2CC3C4CCC5=CC(=O)CCC5(C)C4(F)C(O)CC3(C)[C@@]2(O1)C(=O)CCl 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 L17 compound treatment 10.7963 -0.88626 -0.2378 6.6777 -3.4489 -0.8172 -0.746 -0.8765 3172714 BSPBio_003115 C[n+]1ccccc1/C=N/O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 L18 compound treatment 12.5414 0.85884 0.2304 8.6631 -1.4634 -0.3467 -0.0822 -0.1975 1105 BSPBio_003116 CCN(CC)CCNc1ccc(CO)c2sc3ccccc3c(=O)c12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 L19 compound treatment 10.4022 -1.2804 -0.3436 7.7686 -2.358 -0.5587 -0.638 -0.9727 1323 BSPBio_003117 CC1COc2c(N3CCN(C)CC3)c(F)cc4c(=O)c(cn1c24)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 L20 compound treatment 21.6418 9.9593 2.6723 14.19 4.0634 0.9628 2.5704 0.9049 1158 BSPBio_003118 C(C(C1CCCCC1)C2CCCCC2)C3CCCCN3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 L21 compound treatment 11.7106 0.028087 0.0075 8.0568 -2.0697 -0.4904 -0.3414 -0.6962 1000105 BSPBio_003119 CC(C)(Oc1ccc(CCNC(=O)c2ccc(Cl)cc2)cc1)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 L22 compound treatment 13.0288 1.3463 0.3612 8.508 -1.6186 -0.3835 -0.0157 -0.0299 1268 BSPBio_003120 CN1C(=C(O)c2ccccc2S1(=O)=O)C(=O)Nc3cc(C)on3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 L23 mock treatment 11.3004 -0.38219 -0.1026 8.5765 -1.5501 -0.3673 -0.3322 -0.8712 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 L24 mock treatment 11.9361 0.25361 0.068 10.8504 0.72379 0.1715 0.1694 0.9181 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 M01 mock treatment 10.8756 -0.80697 -0.2165 9.4408 -0.68575 -0.1625 -0.268 -0.99 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 M02 mock treatment 11.5003 -0.18227 -0.0489 10.7953 0.66868 0.1584 0.0774 0.4671 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 M03 compound treatment 8.9862 -2.6963 -0.7235 13.3539 3.2273 0.7647 0.0291 0.0277 1445 BSPBio_003121 C/C=C(/C)\C(=O)O[C@H]1CC[C@@]2(C)[C@@H]3CC[C@@H]4[C@@]2(C[C@@]5(O)[C@@H]6CN7C[C@@H](C)CC[C@H]7[C@@](C)(O)[C@@]6(O)[C@@H](O)C[C@@]45O)O[C@@]31O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 M04 compound treatment 10.035 -1.6475 -0.4421 12.0233 1.8967 0.4494 0.0052 0.0082 1086 BSPBio_003122 CC(C)C(=O)Nc1ccc([N+](=O)[O-])c(c1)C(F)(F)F 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 M05 compound treatment 12.4067 0.72419 0.1943 14.5798 4.4532 1.0551 0.8835 0.8235 1305 BSPBio_003123 CCOC(=O)O[C@H]([C@H]1C[C@@H]2CCN1C[C@@H]2C=C)c3ccnc4ccc(OC)cc34 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 M06 compound treatment 12.335 0.65248 0.1751 10.4691 0.34249 0.0811 0.1812 0.9389 936 BSPBio_003124 OCC(O)COC(=O)c1ccccc1Nc2ccnc3cc(Cl)ccc23 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 M07 compound treatment 10.0166 -1.6659 -0.447 11.8847 1.7581 0.4166 -0.0215 -0.0352 1016582 BSPBio_003125 COc1cc(O)c2c(=O)c(O)c(oc2c1)c3ccc(O)c(O)c3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 M08 compound treatment 9.4061 -2.2765 -0.6108 9.4402 -0.68636 -0.1626 -0.5469 -0.8652 837 BSPBio_003126 CCOc1ccc2NC(C)(C)C=C(C)c2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 M09 compound treatment 9.5278 -2.1547 -0.5782 8.9635 -1.1631 -0.2756 -0.6037 -0.9425 2060306 BSPBio_003127 C[C@@H](CCOC(=O)C)CCC=C(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 M10 compound treatment 12.7332 1.0506 0.2819 8.9209 -1.2057 -0.2857 -0.0027 -0.0066 793 BSPBio_003128 CCN(CC)CCOC(=O)C(C1CCCCC1)c2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 M11 compound treatment 45.5162 33.834 9.0784 40.7327 30.606 7.2517 11.5471 0.9938 1003215 BSPBio_003129 CC(C)C1=CC(=O)C(=CC1=O)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 M12 compound treatment 12.0886 0.40604 0.109 8.4632 -1.6634 -0.3941 -0.2016 -0.4931 852 BSPBio_003130 CCOc1ccc(Cc2nccc3cc(OCC)c(OCC)cc23)cc1OCC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 M13 compound treatment 10.6409 -1.0416 -0.2795 8.5398 -1.5868 -0.376 -0.4635 -0.9893 3174492 BSPBio_003131 CN1[C@H]2CC3CC1C(O)C2O3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 M14 compound treatment 10.086 -1.5965 -0.4284 9.8958 -0.23078 -0.0547 -0.3416 -0.7909 764 BSPBio_003132 Fc1ccc(cc1)C(=O)CCCN2CCC(=CC2)n3c(=O)[nH]c4ccccc34 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 M15 compound treatment 10.0693 -1.6133 -0.4329 9.0525 -1.0741 -0.2545 -0.486 -0.9679 3174493 BSPBio_003133 N[C@H]([C@@H](O)[C@H](O)[C@H](O)CO)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 M16 compound treatment 12.7012 1.0187 0.2733 8.0446 -2.082 -0.4933 -0.1555 -0.2758 3045799 BSPBio_003134 NC(=Nc1nc(CSCC/C(=N\S(=O)(=O)N)/N)cs1)N 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 M17 compound treatment 9.8972 -1.7854 -0.4791 10.4841 0.35749 0.0847 -0.2789 -0.5732 3053891 BSPBio_003135 OC(=O)C/C(=C\C(=O)O)/C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 M18 compound treatment 12.3203 0.63781 0.1711 8.3938 -1.7328 -0.4106 -0.1693 -0.3806 858 BSPBio_003136 OCC(O)CN1CCN(CC1)c2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 M19 compound treatment 10.8882 -0.79433 -0.2131 9.7554 -0.37119 -0.0879 -0.2129 -0.9234 3054971 BSPBio_003137 O[C@@H]1C[C@](O)(C[C@@H](O)[C@@H]1O)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 M20 compound treatment 11.1848 -0.49775 -0.1336 9.8452 -0.28137 -0.0667 -0.1416 -0.9485 805 BSPBio_003138 CCc1cccc2c3CCOC(CC)(CC(=O)O)c3[nH]c12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 M21 compound treatment 11.204 -0.47854 -0.1284 7.5317 -2.5949 -0.6148 -0.5255 -0.8367 1315 BSPBio_003139 COc1ccc(cc1O)[C@@H]2CC(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3O2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 M22 compound treatment 11.0722 -0.61037 -0.1638 10.5962 0.46961 0.1113 -0.0371 -0.1875 699 BSPBio_003140 OC(=O)CCC(=O)c1ccc(cc1)c2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 M23 mock treatment 11.2139 -0.46864 -0.1257 7.6962 -2.4304 -0.5758 -0.4961 -0.8417 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 M24 mock treatment 14.0811 2.3986 0.6436 8.145 -1.9816 -0.4695 0.1231 0.1545 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 N01 mock treatment 11.3632 -0.31933 -0.0857 6.8231 -3.3035 -0.7827 -0.614 -0.7799 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 N02 mock treatment 9.5537 -2.1289 -0.5712 7.0628 -3.0638 -0.7259 -0.9172 -0.993 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 N03 compound treatment 15.2052 3.5227 0.9452 6.9894 -3.1371 -0.7433 0.1428 0.1187 1009851 BSPBio_003141 O=C1c2ccccc2C(=O)c3ccccc13 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 N04 compound treatment 12.853 1.1704 0.3141 7.2099 -2.9166 -0.6911 -0.2666 -0.3512 1100 BSPBio_003142 CC(CCc1ccccc1)NCC(O)c2ccc(O)c(c2)C(=O)N 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 N05 compound treatment 13.0368 1.3543 0.3634 7.621 -2.5055 -0.5937 -0.1628 -0.2339 1372 BSPBio_003143 OC(=O)c1cccnc1C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 N06 compound treatment 13.9317 2.2492 0.6035 8.0379 -2.0887 -0.4949 0.0768 0.0984 3173346 BSPBio_003144 CC[C@H](C1OC(CC)(C[C@@H]1C)C2CC[C@](O)(CC)[C@H](C)O2)C(=O)C(C)[C@@H](O)[C@H](C)CCc3ccc(C)c(O)c3C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 N07 compound treatment 10.9615 -0.72107 -0.1935 6.9062 -3.2204 -0.763 -0.6764 -0.8592 1477 BSPBio_003145 O=C1O[Pt]OC(=O)C21CCC2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 N08 compound treatment 23.3106 11.628 3.1201 15.527 5.4004 1.2795 3.111 0.9225 3174099 BSPBio_003146 Nc1cccc(c1)C(=C2C=CC(=N)C=C2)c3cccc(N)c3.OC(=O)c1cc2ccccc2c(Cc3c(O)c(cc4ccccc34)C(=O)O)c1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 N09 compound treatment 13.6998 2.0172 0.5413 8.34 -1.7866 -0.4233 0.0834 0.1214 1475 BSPBio_003147 Cl[Pt]Cl 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 N10 compound treatment 13.0875 1.405 0.377 5.9398 -4.1868 -0.992 -0.4349 -0.4098 2060469 BSPBio_003148 C[C@H]1CC2C3CC[C@](O)(C(=O)COC(=O)C)C3(C)C[C@H](O)C2C4(C)C=CC(=O)C=C14 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 N11 compound treatment 11.1919 -0.49068 -0.1317 6.7664 -3.3601 -0.7961 -0.6561 -0.813 1364 BSPBio_003149 OC(=O)/C(=C/c1cccc(O)c1)/C#N 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 N12 compound treatment 10.5136 -1.169 -0.3137 6.3922 -3.7344 -0.8848 -0.8475 -0.9027 1535 BSPBio_003150 COc1ccc(OC)c(c1)C(O)CNC(=O)CN 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 N13 compound treatment 11.8595 0.17693 0.0475 6.6758 -3.4508 -0.8176 -0.5446 -0.6649 1107 BSPBio_003151 OC(=O)CN1CCNC1=N 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 N14 compound treatment 14.693 3.0104 0.8078 7.0862 -3.0404 -0.7204 0.0618 0.0571 1055 BSPBio_003152 CC(C)(C)NCC(O)COc1cccc2C[C@@H](O)[C@@H](O)Cc12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 N15 compound treatment 13.6265 1.944 0.5216 6.5678 -3.5587 -0.8432 -0.2274 -0.2293 1142 BSPBio_003153 Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)[nH]c1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 N16 compound treatment 12.3034 0.62087 0.1666 7.4167 -2.7099 -0.6421 -0.3362 -0.5069 1163 BSPBio_003154 Oc1ccc2C[C@H]3N(CC4CC4)CCC5([C@H]6Oc1c25)[C@@]3(O)CCC6=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 N17 compound treatment 13.5772 1.8946 0.5084 7.769 -2.3576 -0.5586 -0.0355 -0.047 3173625 BSPBio_003155 Nc1nc2n(cnc2c(=O)[nH]1)C3C[C@H](O)[C@@H](CO)O3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 N18 compound treatment 13.1156 1.4331 0.3845 7.8709 -2.2557 -0.5345 -0.106 -0.161 1069 BSPBio_003156 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc3c[nH]c4cccc2c34 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 N19 compound treatment 33.8385 22.156 5.945 30.9467 20.82 4.933 7.6919 0.9957 784 BSPBio_003157 Nc1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)n1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 N20 compound treatment 11.6352 -0.047313 -0.0127 6.49 -3.6366 -0.8616 -0.6182 -0.7174 1344 BSPBio_003158 CCCC(=O)O[C@@]1(CCC2[C@@H]3CCC4=CC(=O)CC[C@]4(C)C3[C@@H](O)C[C@@]21C)C(=O)CO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 N21 compound treatment 13.059 1.3765 0.3693 12.0699 1.9433 0.4604 0.5867 0.994 2080598 BSPBio_003159 C[C@H]1C[C@H](C)C(=O)[C@@H](C1)[C@H](O)CC2CC(=O)NC(=O)C2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 N22 compound treatment 22.8516 11.169 2.9969 18.7269 8.6003 2.0377 3.56 0.9823 1135 BSPBio_003160 OCCNCCNc1ccc(NCCNCCO)c2C(=O)c3c(O)ccc(O)c3C(=O)c12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 N23 mock treatment 12.4553 0.77281 0.2074 6.5029 -3.6236 -0.8586 -0.4605 -0.5213 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 N24 mock treatment 21.0409 9.3584 2.5111 10.0597 -0.066871 -0.0158 1.7644 0.7026 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 O01 mock treatment 11.2995 -0.38302 -0.1028 9.0156 -1.111 -0.2632 -0.2588 -0.9159 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 O02 mock treatment 13.1015 1.419 0.3808 11.8566 1.73 0.4099 0.5591 0.9993 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 O03 compound treatment 11.2486 -0.4339 -0.1164 10.3593 0.23276 0.0551 -0.0433 -0.3363 1003823 BSPBio_003161 Cc1occc(=O)c1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 O04 compound treatment 9.8376 -1.8449 -0.495 9.4764 -0.65023 -0.1541 -0.459 -0.8853 1172 BSPBio_003162 CC(C)OC(=O)C(C)(C)Oc1ccc(cc1)C(=O)c2ccc(Cl)cc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 O05 compound treatment 12.6924 1.0099 0.271 12.1558 2.0293 0.4808 0.5316 0.9632 3174602 BSPBio_003163 O=c1[nH]cnc2nc[nH]c12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 O06 compound treatment 18.1088 6.4263 1.7243 10.1361 0.0095438 0.0023 1.2209 0.708 1036721 BSPBio_003164 Oc1c(oc2ccccc2c1=O)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 O07 compound treatment 9.9267 -1.7559 -0.4711 10.0741 -0.052479 -0.0124 -0.3419 -0.7255 1014978 BSPBio_003165 OCC(O)C(O)C(O)CO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 O08 compound treatment 12.7343 1.0518 0.2822 10.9194 0.79279 0.1878 0.3324 0.9804 3100 BSPBio_003166 COc1c2OCOc2cc3CCN(C)Cc13 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 O09 compound treatment 10.6851 -0.99745 -0.2676 10.2787 0.15213 0.036 -0.1638 -0.6064 2060293 BSPBio_003167 C[C@@H]1CC[C@H]2C(C)(C)C3C[C@@]12CC[C@@]3(C)OC(=O)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 O10 compound treatment 11.5077 -0.17489 -0.0469 12.1582 2.0316 0.4814 0.3072 0.6352 802058 BSPBio_003168 COc1cc(/C=C/C(=O)O)ccc1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 O11 compound treatment 9.8906 -1.792 -0.4808 9.4029 -0.72367 -0.1715 -0.4612 -0.9035 1045072 BSPBio_003169 NC(CSCSCC(N)C(=O)O)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 O12 compound treatment 9.6893 -1.9932 -0.5348 10.3085 0.18194 0.0431 -0.3477 -0.648 1144 BSPBio_003170 O=C1NCC2(CCN(CCc3ccccc3)CC2)O1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 O13 compound treatment 9.9058 -1.7768 -0.4768 10.6052 0.4786 0.1134 -0.2569 -0.5243 852250 BSPBio_003171 C1CCC(NC1)c2cccnc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 O14 compound treatment 18.0436 6.361 1.7068 23.3943 13.268 3.1436 3.4298 0.9588 1215 BSPBio_003172 CC(NCCC(c1ccccc1)c2ccccc2)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 O15 compound treatment 9.614 -2.0686 -0.5551 8.3028 -1.8238 -0.4321 -0.698 -0.9923 1235 BSPBio_003173 CCOC(=O)CCCCCCCCCCCCC1CCC=C1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 O16 compound treatment 13.5116 1.8291 0.4908 11.0357 0.90914 0.2154 0.4994 0.9317 1206 BSPBio_003174 CC(=C)[C@@H]1[C@H]2OC(=O)[C@@H]1[C@]3(O)C[C@H]4O[C@]45C(=O)O[C@H]2[C@@]53C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 O17 compound treatment 12.6121 0.92954 0.2494 10.61 0.48338 0.1145 0.2573 0.9377 2081025 BSPBio_003175 C[C@H]1CCC[C@]2(C)C[C@H]3OC(=O)C(=C)[C@H]3C=C12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 O18 compound treatment 11.1576 -0.52499 -0.1409 10.2252 0.098591 0.0234 -0.0831 -0.5819 1210 BSPBio_003176 CC(C)(C)c1cc(SC(C)(C)Sc2cc(c(O)c(c2)C(C)(C)C)C(C)(C)C)cc(c1O)C(C)(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 O19 compound treatment 10.2888 -1.3937 -0.374 10.209 0.082391 0.0195 -0.2506 -0.6693 3174484 BSPBio_003177 C[C@@]12CCC3C(CC[C@H]4C[C@@H](O)CC[C@@]43C)C2CCC1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 O20 compound treatment 99.2562 87.574 23.4983 86.9286 76.802 18.1971 29.4831 0.992 1350 BSPBio_003178 COC(=O)Nc1nc2cc(ccc2[nH]1)C(=O)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 O21 compound treatment 12.5778 0.89523 0.2402 8.7006 -1.426 -0.3379 -0.0691 -0.1666 1343 BSPBio_003179 COC1=CC(C)[C@@H]2C[C@H]3OC(=O)C[C@H]4C(=C(OC)C(=O)C([C@@]34C)[C@@]2(C)C1=O)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 O22 compound treatment 12.6134 0.93089 0.2498 7.0195 -3.1071 -0.7362 -0.3439 -0.4424 1000104 BSPBio_003180 Cc1c(CCC(=O)O)c2cc3[nH]c(cc4nc(cc5[nH]c(cc1n2)c(C)c5C=C)c(C)c4C=C)c(C)c3CCC(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 O23 mock treatment 14.2915 2.6089 0.7 7.6398 -2.4868 -0.5892 0.0784 0.0857 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 O24 mock treatment 10.8308 -0.85178 -0.2286 6.0385 -4.0881 -0.9686 -0.8465 -0.8506 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 P01 mock treatment 11.3485 -0.33408 -0.0896 6.5861 -3.5405 -0.8389 -0.6566 -0.7782 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 P02 mock treatment 12.1532 0.47068 0.1263 6.8091 -3.3175 -0.786 -0.4665 -0.586 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 P03 compound treatment 12.1748 0.49224 0.1321 8.4267 -1.6999 -0.4028 -0.1914 -0.4516 3684 BSPBio_003181 OC(=O)C1=CCCNC1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 P04 compound treatment 11.7927 0.11018 0.0296 8.2882 -1.8384 -0.4356 -0.2871 -0.6576 1242 BSPBio_003182 CN(CS(=O)(=O)O)c1c(C)n(C)n(c2ccccc2)c1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 P05 compound treatment 11.189 -0.49352 -0.1324 6.4687 -3.6579 -0.8667 -0.7065 -0.8058 2575 BSPBio_003183 CCS(=O)(=O)CCn1c(C)ncc1[N+](=O)[O-] 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 P06 compound treatment 56.2272 44.545 11.9525 51.4402 41.314 9.7887 15.3733 0.9951 1342 BSPBio_003184 CN(C)C(=S)SSC(=S)N(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 P07 compound treatment 10.8867 -0.79589 -0.2136 6.9779 -3.1487 -0.746 -0.6785 -0.8744 725 BSPBio_003185 CC(=C)[C@@H]1CCC(=CC1)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 P08 compound treatment 12.9281 1.2455 0.3342 8.6927 -1.4339 -0.3397 -0.0039 -0.0082 3172968 BSPBio_003186 CCC1NC(=O)C(C(O)C(C)C/C=C/C)N(C)C(=O)C(C(C)C)N(C)C(=O)C(CC(C)C)N(C)C(=O)C(CC(C)C)N(C)C(=O)C(C)NC(=O)C(C)NC(=O)C(CC(C)C)N(C)C(=O)C(NC(=O)C(CC(C)C)N(C)C(=O)CN(C)C1=O)C(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 P09 compound treatment 17.8852 6.2026 1.6643 6.8648 -3.2618 -0.7728 0.6304 0.3435 1325 BSPBio_003187 NC1(CCCC1)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 P10 compound treatment 8.6234 -3.0591 -0.8208 7.4416 -2.685 -0.6362 -1.0303 -0.9921 1410 BSPBio_003188 S=P(N1CC1)(N2CC2)N3CC3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 P11 compound treatment 10.1347 -1.5479 -0.4153 7.5684 -2.5582 -0.6061 -0.7223 -0.983 1923 BSPBio_003189 NC1(CC1)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 P12 compound treatment 12.2206 0.53804 0.1444 9.0641 -1.0625 -0.2517 -0.0759 -0.2616 914 BSPBio_003190 OC[C@H]1O[C@@H](OC2c3cccc(O)c3C(=O)c4c(O)cc(CO)cc24)[C@H](O)[C@@H](O)[C@@H]1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 P13 compound treatment 10.7533 -0.9292 -0.2493 9.2227 -0.90385 -0.2142 -0.3277 -0.9971 829 BSPBio_003191 CC(C)c1c(O)c(O)c(C=O)c2c(O)c(c(C)cc12)c3c(C)cc4c(C(C)C)c(O)c(O)c(C=O)c4c3O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 P14 compound treatment 10.9631 -0.71948 -0.1931 7.1686 -2.958 -0.7008 -0.6321 -0.8695 913 BSPBio_003192 O[C@H]1[C@@H](O)[C@@H](O[C@@H]1COP(=O)(O)OP(=O)(O)OP(=O)(O)O)n2ccc(=O)[nH]c2=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 P15 compound treatment 13.8009 2.1184 0.5684 5.6602 -4.4664 -1.0583 -0.3464 -0.2883 825 BSPBio_003193 CC(Cc1ccc(O)c(O)c1)(NN)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 P16 compound treatment 10.3942 -1.2883 -0.3457 8.5593 -1.5673 -0.3714 -0.507 -0.9994 1417 BSPBio_003194 CCCCCCCCCCCCC[N+](C)(C)Cc1ccccc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 P17 compound treatment 10.6738 -1.0088 -0.2707 6.8388 -3.2878 -0.779 -0.7422 -0.9 121 BSPBio_003195 OC(=O)c1cc(ccc1NCCCc2ccccc2)[N+](=O)[O-] 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 P18 compound treatment 10.6195 -1.063 -0.2852 8.2262 -1.9004 -0.4503 -0.5201 -0.9757 975 BSPBio_003196 CCN(CC)CCOC(=O)C(CC1CCCO1)Cc2cccc3ccccc23 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 P19 compound treatment 10.1207 -1.5618 -0.4191 6.7377 -3.3888 -0.8029 -0.8641 -0.954 1508 BSPBio_003197 CSCCC(NC=O)C(=O)NC(C)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 P20 compound treatment 8.862 -2.8205 -0.7568 6.3948 -3.7318 -0.8842 -1.1604 -0.997 1038 BSPBio_003198 O=C1CCCN1CC#CCN2CCCC2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 P21 compound treatment 9.7269 -1.9557 -0.5248 6.5316 -3.595 -0.8518 -0.9734 -0.9729 1199 BSPBio_003199 CSCCC(NC=O)C(=O)NC(CC(C)C)C(=O)NC(Cc1ccccc1)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 P22 compound treatment 11.7155 0.032947 0.0088 7.1281 -2.9985 -0.7105 -0.4961 -0.6983 382 BSPBio_003200 NCCCCCCNS(=O)(=O)c1cccc2c(Cl)cccc12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 P23 mock treatment 12.5026 0.82006 0.22 6.748 -3.3786 -0.8005 -0.4104 -0.4944 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2462 P24 mock treatment 13.033 1.3505 0.3624 6.0293 -4.0973 -0.9708 -0.4302 -0.4152 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 A01 mock treatment 11.2371 1.4202 0.3811 10.8189 0.5781 0.137 0.3663 0.9046 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 A02 mock treatment 10.0017 0.18474 0.0496 11.9153 1.6745 0.3967 0.3156 0.7893 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 A03 compound treatment 10.0228 0.20584 0.0552 12.5366 2.2958 0.5439 0.4237 0.7749 1023 BSPBio_003201 CN[C@H](CC(=O)O)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 A04 compound treatment 10.3645 0.54753 0.1469 11.2311 0.99032 0.2346 0.2698 0.9746 1053060 BSPBio_003202 COc1ccc(cc1OC)c2oc3ccccc3c(=O)c2O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 A05 compound treatment 10.6792 0.86222 0.2314 13.6797 3.4389 0.8148 0.7397 0.8734 1496 BSPBio_003203 CSc1ccc2Sc3ccccc3CC(N4CCN(C)CC4)c2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 A06 compound treatment 10.9435 1.1265 0.3023 11.0564 0.8156 0.1932 0.3504 0.9766 3198541 BSPBio_003204 CC(CCC=C(C)C)C1CC[C@@]2(C)C3=C(CC[C@]12C)C4(C)CC[C@H](OC(=O)C)C(C)(C)C4CC3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 A07 compound treatment 12.2754 2.4584 0.6597 9.983 -0.25779 -0.0611 0.4233 0.6389 1280 BSPBio_003205 NCCNC(=O)c1ccc(Cl)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 A08 compound treatment 9.6925 -0.12452 -0.0334 10.3355 0.094719 0.0224 -0.0078 -0.1927 1001518 BSPBio_003206 CCC[C@H](N[C@@H](C)C(=O)N1[C@@H](C[C@@H]2CCCC[C@@H]21)C(=O)O)C(=O)OCC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 A09 compound treatment 10.2285 0.41154 0.1104 8.8413 -1.3995 -0.3316 -0.1564 -0.4475 924 BSPBio_003207 NC(=N)NC(=N)Nc1ccccc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 A10 compound treatment 8.7496 -1.0674 -0.2864 11.3865 1.1457 0.2715 -0.0106 -0.0268 1003535 BSPBio_003208 ONC(=O)Cc1ccccc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 A11 compound treatment 12.302 2.4851 0.6668 12.1974 1.9566 0.4636 0.7993 0.9842 3174610 BSPBio_003209 COc1cc(cc(OC)c1OC)C(=O)O[C@H]2CC[C@@]3(C)[C@@H]4CC[C@@H]5[C@@]3(C[C@@]6(O)[C@@H]7CN8C[C@@H](C)CC[C@H]8[C@@](C)(O)[C@@]7(O)[C@@H](O)C[C@@]56O)O[C@@]42O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 A12 compound treatment 10.2102 0.39319 0.1055 12.4716 2.2308 0.5286 0.4483 0.8318 3079280 BSPBio_003210 O[C@@H]1Cc2c(O)cc(O)cc2O[C@@H]1c3ccc(O)cc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 A13 compound treatment 10.2496 0.43261 0.1161 12.7497 2.5089 0.5944 0.5024 0.8295 1384 BSPBio_003211 COC(=O)[C@@H](N1CCc2sccc2C1)c3ccccc3Cl 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 A14 compound treatment 11.101 1.284 0.3445 10.0764 -0.16443 -0.039 0.2161 0.6232 1110410 BSPBio_003212 COc1ccc(C(=O)C)c(O)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 A15 compound treatment 11.2029 1.3859 0.3719 10.9628 0.72197 0.1711 0.3839 0.9379 3198436 BSPBio_003213 CO[C@H]1CC(O[C@H]/2[C@@H](C)\C=C\C=C\3/CO[C@@H]4\C(=N/O)\C(=C[C@@H](C(=O)O[C@H]5C[C@@H](C\C=C2/C)O[C@@]6(CC[C@H](C)[C@H](O6)C7CCCCC7)C5)[C@@]43O)C)O[C@@H](C)C1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 A16 compound treatment 10.4461 0.6291 0.1688 12.6831 2.4423 0.5787 0.5285 0.8768 3079389 BSPBio_003214 COc1cc(OC)c(C(=O)c2ccc(O)cc2)c(OC)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 A17 compound treatment 12.3594 2.5424 0.6822 10.5231 0.28229 0.0669 0.5297 0.7727 1950 BSPBio_003215 Oc1cc2oc(cc(=O)c2c(O)c1O)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 A18 compound treatment 28.3337 18.517 4.9685 26.8864 16.646 3.9439 6.3021 0.9935 2069327 BSPBio_003216 COC/1=CC(=O)C(=C\C1=C/C=C/c2ccccc2)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 A19 compound treatment 9.9876 0.17066 0.0458 11.6194 1.3786 0.3266 0.2633 0.7984 3172852 BSPBio_003217 CC1(C)CC[C@@]2(CC[C@]3(C)C(=CCC4[C@@]5(C)CC[C@H](O)[C@@](C)(CO)C5CC[C@]43C)C2C1)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 A20 compound treatment 10.6717 0.8547 0.2293 10.6225 0.38172 0.0904 0.2261 0.9172 3054572 BSPBio_003218 CC(=O)O[C@@H]1CC[C@@]2(C)C(CC[C@]3(C)C2CC=C4C5CC(C)(C)CC[C@@]5(CC[C@]43C)C(=O)O)C1(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 A21 compound treatment 10.4247 0.6077 0.1631 10.333 0.092209 0.0218 0.1308 0.7947 3650214 BSPBio_003219 C[C@H]1O[C@H](O[C@H]2[C@H](O)[C@H](O)CO[C@@H]2O[C@H]3CC[C@@]4(C)C(CC[C@]5(C)C4CC=C6[C@@H]7CC(C)(C)CC[C@@]7(CC[C@]65C)C(=O)O)[C@]3(C)CO)[C@@H](O)[C@H](O)[C@@H]1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 A22 compound treatment 11.5897 1.7727 0.4757 9.6481 -0.59269 -0.1404 0.2371 0.478 3081175 BSPBio_003220 CCOC(=O)c1c(C)c(Cl)c(O)c(Cl)c1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 A23 mock treatment 6.8242 -2.9928 -0.803 10.0314 -0.20942 -0.0496 -0.6029 -0.7494 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 A24 mock treatment 11.0175 1.2005 0.3221 10.3312 0.090374 0.0214 0.2429 0.7525 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 B01 mock treatment 10.755 0.93802 0.2517 13.5895 3.3487 0.7934 0.739 0.8878 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 B02 mock treatment 8.8828 -0.93419 -0.2507 11.4558 1.215 0.2879 0.0263 0.0689 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 B03 compound treatment 9.3812 -0.43582 -0.1169 11.7067 1.4659 0.3473 0.1629 0.4445 1000115 BSPBio_003221 COC(=O)[C@@H]1[C@@H](O)CC[C@@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@H]12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 B04 compound treatment 11.3259 1.5089 0.4049 8.6136 -1.6272 -0.3855 0.0137 0.0245 1864491 BSPBio_003222 COc1ccc(cc1)c2coc3cc(OC)cc(OC)c3c2=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 B05 compound treatment 9.555 -0.26199 -0.0703 11.0481 0.8073 0.1913 0.0855 0.4198 1258696 BSPBio_003223 Cc1c(Cl)cccc1Nc2ccccc2C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 B06 compound treatment 10.3924 0.57544 0.1544 10.1533 -0.087456 -0.0207 0.0945 0.6068 1119359 BSPBio_003224 COc1cc2ccc(=O)oc2c(O)c1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 B07 compound treatment 9.4456 -0.37143 -0.0997 10.3596 0.11881 0.0281 -0.0506 -0.4883 1865 BSPBio_003225 Clc1cccc(Nc2nnc(c3ccccc3)c4ccccc24)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 B08 compound treatment 10.0178 0.20077 0.0539 11.6408 1.3999 0.3317 0.2726 0.8113 907087 BSPBio_003226 CCN(CC)CCNC(=O)c1ccc(NC(=O)C)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 B09 compound treatment 8.8885 -0.92853 -0.2491 11.2527 1.0119 0.2397 -0.0066 -0.0192 1271 BSPBio_003227 CC(=O)OC(CC(=O)O)[N+](C)(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 B10 compound treatment 9.5847 -0.23226 -0.0623 12.1358 1.895 0.449 0.2734 0.6032 1329 BSPBio_003228 NC(Cc1cc(I)c(Oc2ccc(O)c(I)c2)c(I)c1)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 B11 compound treatment 9.8363 0.019326 0.0052 9.6109 -0.62995 -0.1493 -0.1019 -0.6821 3198548 BSPBio_003229 OC(=O)CCC/C=C\C[C@@H]1CO[C@@H](O[C@@H]1c2ccccc2O)C(F)(F)F 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 B12 compound treatment 11.7086 1.8917 0.5076 8.7625 -1.4783 -0.3503 0.1112 0.1804 1269 BSPBio_003230 CC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 B13 compound treatment 9.652 -0.16503 -0.0443 12.304 2.0632 0.4888 0.3144 0.6404 1458 BSPBio_003231 NC(Cc1ccc(Cl)cc1)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 B14 compound treatment 11.2967 1.4797 0.3971 11.1392 0.89837 0.2129 0.4313 0.9573 1001907 BSPBio_003232 C[C@](N)(Cc1ccc(O)cc1)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 B15 compound treatment 9.2092 -0.60777 -0.1631 11.4807 1.2399 0.2938 0.0924 0.275 1502 BSPBio_003233 OC(=O)c1c2ccccc2cc3ccccc13 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 B16 compound treatment 10.187 0.36999 0.0993 10.0406 -0.20018 -0.0474 0.0367 0.3332 2060343 BSPBio_003234 CCCc1occc(=O)c1/C=C/O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 B17 compound treatment 87.9394 78.122 20.9623 82.8662 72.625 17.2075 26.9901 0.9952 440 BSPBio_003235 COC(=O)Nc1nc2cc(ccc2[nH]1)C(=O)c3cccs3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 B18 compound treatment 11.7832 1.9662 0.5276 8.8289 -1.4119 -0.3345 0.1365 0.2185 1429 BSPBio_003236 CCCCOC(=O)c1ccc(N)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 B19 compound treatment 11.2294 1.4124 0.379 11.6525 1.4117 0.3345 0.5045 0.9981 2069318 BSPBio_003237 C[C@@H](NC(=O)/C(=C\c1ccc(O)c(O)c1)/C#N)c2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 B20 compound treatment 11.3084 1.4914 0.4002 8.653 -1.5879 -0.3762 0.0169 0.0309 1008566 BSPBio_003238 Cc1cc(c(O)c(c1)C(C)(C)C)C(C)(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 B21 compound treatment 9.1545 -0.66248 -0.1778 9.7261 -0.51475 -0.122 -0.2119 -0.9831 3480197 BSPBio_003239 CCC(NC(C)C)C(O)c1ccc(O)c2[nH]c(=O)ccc12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 B22 compound treatment 14.3514 4.5345 1.2167 8.8297 -1.4111 -0.3343 0.6239 0.4945 1000287 BSPBio_003240 OC(=O)CC(O)(CC(=O)O)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 B23 mock treatment 12.7249 2.9079 0.7803 11.7043 1.4635 0.3468 0.7969 0.9333 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 B24 mock treatment 9.6266 -0.19037 -0.0511 10.3467 0.10587 0.0251 -0.0184 -0.323 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 C01 mock treatment 9.7889 -0.028117 -0.0075 11.1411 0.90029 0.2133 0.1455 0.6817 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 C02 mock treatment 9.8811 0.064151 0.0172 9.5147 -0.72606 -0.172 -0.1095 -0.6332 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 C03 compound treatment 10.5405 0.72356 0.1941 9.0101 -1.2307 -0.2916 -0.0689 -0.1967 3172862 BSPBio_003241 O=c1cccc2C3CNC[C@@H](C3)Cn21 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 C04 compound treatment 10.8109 0.99394 0.2667 10.3242 0.083409 0.0198 0.2026 0.7574 3081176 BSPBio_003242 COc1ccccc1c2coc3cc(OC)c(OC)c(OC)c3c2=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 C05 compound treatment 10.4243 0.60729 0.163 12.7044 2.4636 0.5837 0.528 0.8712 1024517 BSPBio_003243 COc1cc2CCNC(C)c2cc1OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 C06 compound treatment 13.6171 3.8001 1.0197 14.0471 3.8063 0.9019 1.3587 0.9981 2559 BSPBio_003244 CC(=O)O[Cd]OC(=O)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 C07 compound treatment 8.7802 -1.0367 -0.2782 9.2813 -0.95955 -0.2274 -0.3575 -0.995 2060328 BSPBio_003245 CC(C)CC(=O)c1c(O)c(C)c(O)c2c1oc3c(C(=O)CC(C)C)c(O)c(C)c(O)c32 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 C08 compound treatment 10.421 0.60405 0.1621 9.988 -0.25277 -0.0599 0.0723 0.4182 BSPBio_003246 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 C09 compound treatment 8.1717 -1.6453 -0.4415 10.2884 0.047551 0.0113 -0.3042 -0.6888 2060287 BSPBio_003247 Cc1c(O)c(O)cc2c1CC=C3[C@@]2(C)CC[C@@]4(C)C5C[C@@](C)(CC[C@]5(C)CC[C@]34C)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 C10 compound treatment 13.0002 3.1832 0.8541 12.5319 2.2911 0.5429 0.9878 0.9761 2561 BSPBio_003248 Oc1ccc(cc1[N+](=O)[O-])[N+](=O)[O-] 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 C11 compound treatment 10.5408 0.72381 0.1942 10.8961 0.65528 0.1553 0.2471 0.9938 2060298 BSPBio_003249 CCCCCC1C(CC(=O)O)CCC1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 C12 compound treatment 9.4304 -0.38661 -0.1037 10.4941 0.25332 0.06 -0.0309 -0.2579 2558 BSPBio_003250 c1ccc2c(c1)cc3ccc4cccc5ccc2c3c45 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 C13 compound treatment 9.6724 -0.14456 -0.0388 11.3037 1.0629 0.2518 0.1506 0.5912 BSPBio_003251 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 C14 compound treatment 11.5432 1.7262 0.4632 10.5919 0.35105 0.0832 0.3863 0.821 1152 BSPBio_003252 CN(C)CCN(Cc1ccccc1)c2ccccn2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 C15 compound treatment 8.4115 -1.4055 -0.3771 9.394 -0.84683 -0.2006 -0.4085 -0.9564 2060454 BSPBio_003253 Oc1cc(O)c2c(=O)cc(oc2c1)c3cc(O)c(O)c(O)c3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 C16 compound treatment 9.6026 -0.2144 -0.0575 7.8158 -2.425 -0.5746 -0.447 -0.774 840 BSPBio_003254 CCOc1ccc2ccccc2c1NC(=O)[C@H]3[C@H]4SC(C)(C)C(N4C3=O)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 C17 compound treatment 12.3095 2.4925 0.6688 9.8764 -0.36437 -0.0863 0.4119 0.6108 3173493 BSPBio_003255 CC1=C2CCC3C4CCC(=O)[C@@]4(C)CCC3[C@@]2(C)CCC1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 C18 compound treatment 14.7133 4.8963 1.3138 14.4937 4.2528 1.0076 1.6415 0.9914 3174105 BSPBio_003256 CN(C)c1ccc2[n+](C)c(/C=C/c3cc(C)n(c3C)c4ccccc4)ccc2c1.OC(=O)c1cc2ccccc2c(Cc3c(O)c(cc4ccccc34)C(=O)O)c1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 C19 compound treatment 11.9489 2.1319 0.572 11.8265 1.5857 0.3757 0.6702 0.9792 2060271 BSPBio_003257 CCC(C)C(=O)c1c(O)c(C)c2oc3c(C)c(O)c(C(=O)C(C)CC)c(O)c3c2c1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 C20 compound treatment 12.4875 2.6705 0.7166 9.278 -0.96279 -0.2281 0.3454 0.4593 3173091 BSPBio_003258 NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)C(O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3OC4O[C@H](CN)[C@@H](O)[C@H](O)[C@H]4N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 C21 compound treatment 7.6283 -2.1887 -0.5873 9.5434 -0.69741 -0.1652 -0.5321 -0.8722 2060482 BSPBio_003259 CC(C)c1cc2CCC3C(C)(C)CCC[C@]3(C(=O)O)c2c(O)c1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 C22 compound treatment 10.106 0.28904 0.0776 9.0885 -1.1523 -0.273 -0.1382 -0.487 934 BSPBio_003260 Cc1cc(C)nc(NS(=O)(=O)c2ccc(N)cc2)n1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 C23 mock treatment 11.4267 1.6097 0.4319 9.7731 -0.46773 -0.1108 0.2271 0.5092 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 C24 mock treatment 9.2653 -0.55169 -0.148 8.3628 -1.878 -0.445 -0.4193 -0.8942 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 D01 mock treatment 8.7256 -1.0914 -0.2928 10.2396 -0.0012215 -3.0E-4 -0.2073 -0.7078 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 D02 mock treatment 10.0546 0.23761 0.0638 10.0741 -0.16672 -0.0395 0.0172 0.2287 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 D03 compound treatment 9.493 -0.32394 -0.0869 10.9369 0.69605 0.1649 0.0552 0.2958 1000118 BSPBio_003261 CN[C@@H](C)[C@@H](O)c1ccccc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 D04 compound treatment 8.8107 -1.0063 -0.27 11.8207 1.5798 0.3743 0.0738 0.1598 3198649 BSPBio_003262 COc1c(oc2c(CC=C(C)C)c3OC(C)(C)C=Cc3c(OC)c2c1=O)c4ccccc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 D05 compound treatment 10.0899 0.27291 0.0732 18.1819 7.9411 1.8815 1.3822 0.7341 1010471 BSPBio_003263 O=c1ccc2ccccc2o1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 D06 compound treatment 10.4215 0.60451 0.1622 10.1463 -0.094461 -0.0224 0.0989 0.6038 3055306 BSPBio_003264 C[C@@H]1CC[C@]2(CO)CC[C@]3(C)C(=CCC4[C@@]5(C)CC[C@H](O)C(C)(C)C5CC[C@]43C)[C@@H]2[C@H]1C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 D07 compound treatment 9.2971 -0.51987 -0.1395 11.0258 0.78499 0.186 0.0329 0.1414 867 BSPBio_003265 Nc1ccc(cc1)S(=O)(=O)Nc2ccccn2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 D08 compound treatment 9.439 -0.37797 -0.1014 9.8447 -0.39612 -0.0939 -0.1381 -0.9993 957 BSPBio_003266 NC(COC(=O)C=[N+]=[N-])C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 D09 compound treatment 10.325 0.50806 0.1363 11.371 1.1302 0.2678 0.2858 0.9509 1009654 BSPBio_003267 COc1ccc(cc1OC)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 D10 compound treatment 11.8989 2.0819 0.5586 11.4783 1.2375 0.2932 0.6023 0.9547 2577 BSPBio_003268 OC(=O)c1nn(Cc2ccc(Cl)c(Cl)c2)c3ccccc13 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 D11 compound treatment 11.6032 1.7862 0.4793 12.0361 1.7953 0.4254 0.6397 0.9982 2060316 BSPBio_003269 COc1c2C=CC(C)(C)Oc2cc3occ(c4ccc5OCOc5c4)c(=O)c13 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 D12 compound treatment 8.3226 -1.4944 -0.401 10.7151 0.47432 0.1124 -0.2041 -0.49 1000411 BSPBio_003270 CCCCCNC(=N)N/N=C/c1c[nH]c2ccc(OC)cc12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 D13 compound treatment 7.5179 -2.2991 -0.6169 10.0437 -0.19709 -0.0467 -0.4692 -0.7585 3650215 BSPBio_003271 CC1(C)CC2/C(=C/C=C/[C@@](C)(O)CC[C@]21O)/CO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 D14 compound treatment 9.5939 -0.22307 -0.0599 9.4931 -0.74775 -0.1772 -0.1676 -0.8962 3077177 BSPBio_003272 CC(=O)OCC(O)CC(=O)CCCCCCCCCCCC#C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 D15 compound treatment 11.1471 1.3301 0.3569 9.2085 -1.0323 -0.2446 0.0794 0.1836 1050602 BSPBio_003273 COc1ccc(CC(=O)c2ccc(O)cc2O)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 D16 compound treatment 14.6746 4.8576 1.3034 14.2596 4.0187 0.9522 1.5949 0.9881 1279 BSPBio_003274 N[C@@H]([C@@H]1CC(=NO1)Cl)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 D17 compound treatment 10.6862 0.86919 0.2332 11.5704 1.3296 0.315 0.3877 0.9891 1250 BSPBio_003275 COc1cc(C)c2c(=O)cc(oc2c1)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 D18 compound treatment 10.499 0.68205 0.183 9.3569 -0.88391 -0.2094 -0.0187 -0.0672 3173761 BSPBio_003276 N[C@@H](C(=O)N[C@H]1[C@H]2SCC(=C(N2C1=O)C(=O)O)Cl)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 D19 compound treatment 8.4336 -1.3834 -0.3712 8.9398 -1.301 -0.3082 -0.4804 -0.9957 1041649 BSPBio_003277 CC(C)c1ccc(C)c(C(=O)O)c1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 D20 compound treatment 7.9886 -1.8284 -0.4906 9.775 -0.46584 -0.1104 -0.425 -0.8451 2060315 BSPBio_003278 C[N+]1(C)C[C@H](O)[C@@H](C1)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 D21 compound treatment 9.9958 0.17879 0.048 9.9632 -0.27756 -0.0658 -0.0126 -0.1545 1547 BSPBio_003279 CN1C(=O)CN=C(c2ccccc2)c3cc(Cl)ccc13 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 D22 compound treatment 12.1408 2.3238 0.6235 10.3514 0.11061 0.0262 0.4594 0.7362 3198650 BSPBio_003280 COc1cc(NS(=O)(=O)C)ccc1Cc2c3ccccc3nc4ccccc24 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 D23 mock treatment 10.8997 1.0827 0.2905 10.7202 0.47942 0.1136 0.2857 0.9161 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 D24 mock treatment 10.6812 0.86425 0.2319 10.204 -0.036761 -0.0087 0.1578 0.6801 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 E01 mock treatment 8.7464 -1.0706 -0.2873 9.84 -0.40082 -0.095 -0.2703 -0.8933 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 E02 mock treatment 8.6226 -1.1944 -0.3205 10.1139 -0.12694 -0.0301 -0.2479 -0.7701 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 E03 compound treatment 13.9952 4.1782 1.1211 35.5321 25.291 5.9924 5.03 0.8251 2060432 BSPBio_003281 CC[C@@]1(O)C(=O)OCc2c1cc3-c4nc5ccc(O)cc5cc4Cn3c2=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 E04 compound treatment 10.2471 0.43007 0.1154 8.7312 -1.5096 -0.3577 -0.1713 -0.4558 1259 BSPBio_003282 CCc1nc(N)nc(N)c1c2ccc(Cl)cc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 E05 compound treatment 9.6256 -0.19136 -0.0513 11.2449 1.0041 0.2379 0.1319 0.542 2060497 BSPBio_003283 CC(C)(O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)C#N 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 E06 compound treatment 11.6997 1.8827 0.5052 14.7426 4.5018 1.0666 1.1114 0.9417 3054523 BSPBio_003284 C[C@@H]1CC[C@@]2(CC[C@]3(C)C(=CCC4[C@@]5(C)CC[C@H](O)C(C)(C)C5CC[C@]43C)C2[C@H]1C)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 E07 compound treatment 10.4057 0.58867 0.158 8.733 -1.5078 -0.3572 -0.1409 -0.3608 1386109 BSPBio_003285 Oc1ccc2c(=O)c(O)c(oc2c1)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 E08 compound treatment 9.4189 -0.39813 -0.1068 9.9745 -0.2663 -0.0631 -0.1202 -0.9684 2565 BSPBio_003286 COC1=CC(=O)OC1(O)C(=C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 E09 compound treatment 11.9123 2.0954 0.5622 13.4608 3.22 0.7629 0.937 0.9887 2060144 BSPBio_003287 COc1cccc(c1)c2cc(=O)c3cc(OC)ccc3o2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 E10 compound treatment 8.3481 -1.4688 -0.3941 10.3486 0.10782 0.0255 -0.2606 -0.6599 1506 BSPBio_003288 OCc1cc(=O)c(O)co1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 E11 compound treatment 9.6079 -0.2091 -0.0561 8.8032 -1.4376 -0.3406 -0.2805 -0.8126 2060456 BSPBio_003289 C[C@@H]1CC(Cl)CC[C@H]1C(=O)OC(C)(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 E12 compound treatment 10.0543 0.23735 0.0637 9.6989 -0.5419 -0.1284 -0.0458 -0.3192 2060349 BSPBio_003290 CCC[C@H]1CC2=C(C[C@@H](CC)CC3=C1C(=O)OC3=O)C(=O)OC2=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 E13 compound treatment 8.859 -0.95798 -0.257 9.8 -0.44078 -0.1044 -0.2556 -0.9213 907120 BSPBio_003291 CC(N)C(=O)OC(C)(C)Cc1ccc(Cl)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 E14 compound treatment 8.158 -1.659 -0.4451 12.4138 2.173 0.5149 0.0493 0.0724 1001994 BSPBio_003292 C[C@@H](N)[C@@H](O)c1ccccc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 E15 compound treatment 10.2747 0.45769 0.1228 9.7502 -0.49061 -0.1162 0.0046 0.0275 2060459 BSPBio_003293 OC[C@H]1OC2[C@@H](Oc3nc(=N)ccn23)[C@@H]1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 E16 compound treatment 8.917 -0.89995 -0.2415 9.3032 -0.93762 -0.2222 -0.3278 -0.9991 1393 BSPBio_003294 CN(C)CCCN1c2ccccc2CCc3ccc(Cl)cc13 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 E17 compound treatment 9.1279 -0.68908 -0.1849 8.8338 -1.407 -0.3334 -0.3665 -0.9613 2060471 BSPBio_003295 C[C@H]1[C@H]2[C@H](OC1=O)[C@@H]3C(=CC(=O)C3=C(C)C[C@@H]2O)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 E18 compound treatment 8.4911 -1.3259 -0.3558 11.8975 1.6567 0.3925 0.026 0.0491 1190 BSPBio_003296 Nc1c2C(O)CCCc2nc3ccccc13 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 E19 compound treatment 10.3634 0.54644 0.1466 8.4337 -1.8071 -0.4282 -0.1991 -0.4399 3474314 BSPBio_003297 CN1CCCCC1C(=O)Nc2c(C)cccc2C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 E20 compound treatment 9.3622 -0.45479 -0.122 9.1487 -1.0921 -0.2588 -0.2693 -0.9412 1516 BSPBio_003298 Nc1c2CCCCc2nc3ccccc13 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 E21 compound treatment 11.0618 1.2449 0.334 9.3277 -0.91307 -0.2163 0.0832 0.2091 1001314 BSPBio_003299 CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C)[C@](C)(O)C[C@@H](C)[C@@H]4N[C@@H](COCCOC)O[C@H]([C@H]4C)[C@]1(C)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 E22 compound treatment 9.7938 -0.023142 -0.0062 8.7603 -1.4805 -0.3508 -0.2524 -0.7195 3172849 BSPBio_003300 CN1CCC[C@H]1c2cccnc2.OC(C(O)C(=O)O)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 E23 mock treatment 12.8058 2.9888 0.802 8.4302 -1.8106 -0.429 0.2637 0.29 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 E24 mock treatment 11.2727 1.4557 0.3906 9.3119 -0.9289 -0.2201 0.1206 0.2689 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 F01 mock treatment 12.07 2.253 0.6046 11.2485 1.0076 0.2387 0.5963 0.9174 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 F02 mock treatment 8.9151 -0.90192 -0.242 12.5028 2.262 0.5359 0.2078 0.3534 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 F03 compound treatment 11.0377 1.2207 0.3275 11.0726 0.83183 0.1971 0.371 0.9704 1573 BSPBio_003301 CCCC(C)C1(CC)C(=O)NC(=NC1=O)S 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 F04 compound treatment 11.7903 1.9733 0.5295 12.1052 1.8644 0.4417 0.6868 0.9959 1008 BSPBio_003302 OC1CCCCC1N2CCC(CC2)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 F05 compound treatment 10.6382 0.82125 0.2204 10.7726 0.53176 0.126 0.2449 0.9648 1570 BSPBio_003303 CCCC(C)C1(CC=C)C(=O)NC(=NC1=O)S 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 F06 compound treatment 7.7081 -2.1089 -0.5659 10.9632 0.72236 0.1712 -0.2791 -0.4721 3474312 BSPBio_003304 Cc1ccc(cc1)S(=O)(=O)NC(=O)NN2CC3CCCC3C2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 F07 compound treatment 10.4229 0.60588 0.1626 11.3037 1.0629 0.2518 0.293 0.9776 1572 BSPBio_003305 CCCC(C)C1(CC)C(=O)NC(=NC1=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 F08 compound treatment 9.4539 -0.3631 -0.0974 10.9956 0.7548 0.1788 0.0576 0.2827 2069347 BSPBio_003306 CCC1(Cc2ccccc2O1)C3=NCCN3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 F09 compound treatment 9.7956 -0.021402 -0.0057 9.3406 -0.90021 -0.2133 -0.1549 -0.7259 3055245 BSPBio_003307 CCC[C@@H]1CCCCN1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 F10 compound treatment 10.8485 1.0315 0.2768 13.3911 3.1503 0.7464 0.7235 0.9088 2118912 BSPBio_003308 Oc1ccc(/C=C/C(=O)c2ccccc2O)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 F11 compound treatment 12.3805 2.5635 0.6879 10.0061 -0.23471 -0.0556 0.4471 0.6478 1304 BSPBio_003309 ClC1=C(Cl)C2(Cl)C3C4CC(C5OC54)C3C1(Cl)C2(Cl)Cl 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 F12 compound treatment 8.9036 -0.91335 -0.2451 10.4658 0.22502 0.0533 -0.1356 -0.5406 1014978 BSPBio_003310 OCC(O)C(O)C(O)CO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 F13 compound treatment 12.0246 2.2076 0.5924 9.5399 -0.70092 -0.1661 0.3014 0.49 2069281 BSPBio_003311 C[C@@]12CCC3C(CCc4cc(OC(=O)c5ccccc5)ccc34)C2CCC1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 F14 compound treatment 9.1935 -0.62354 -0.1673 10.7031 0.46234 0.1095 -0.0408 -0.2042 1003115 BSPBio_003312 COc1cc(cc(OC)c1O)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 F15 compound treatment 9.2602 -0.5568 -0.1494 10.9667 0.72591 0.172 0.016 0.0701 2060499 BSPBio_003313 OC[C@H]1O[C@@H](Oc2cc(O)c3c(=O)cc(oc3c2)c4ccc(O)cc4)[C@H](O[C@@H]5OC[C@](O)(CO)[C@H]5O)[C@@H](O)[C@@H]1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 F16 compound treatment 12.0626 2.2456 0.6025 10.5379 0.29714 0.0704 0.4758 0.7844 3104621 BSPBio_003314 CC[C@H]/1CC[C@H]2O[C@@]3(CC[C@@H](C)[C@@H](C[C@H](C)O)O3)[C@H](C)[C@@H](OC(=O)/C=C/[C@@H](C)[C@H](O)[C@@H](C)C(=O)[C@@H](C)[C@H](O)[C@@H](C)C(=O)[C@@](C)(O)[C@H](O)[C@@H](C)C\C=C\C=C1)[C@H]2C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 F17 compound treatment 9.1606 -0.65643 -0.1761 12.1694 1.9286 0.4569 0.1986 0.4055 1010 BSPBio_003315 COc1ccc(CN(CCN(C)C)c2ncccn2)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 F18 compound treatment 9.126 -0.69103 -0.1854 10.3392 0.098409 0.0233 -0.1146 -0.6134 1113 BSPBio_003316 COc1ccc2n(C(=O)c3ccc(Cl)cc3)c(C)c(CC(=O)OCC(=O)O)c2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 F19 compound treatment 12.781 2.964 0.7953 13.8123 3.5714 0.8462 1.1607 0.9995 3177324 BSPBio_003317 C[C@@]12CC(=O)C3C(CC[C@@H]4C[C@H](O)CC[C@@]43C)C2CC[C@]1(O)C(=O)CO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 F20 compound treatment 7.705 -2.112 -0.5667 9.8795 -0.36131 -0.0856 -0.4612 -0.8048 774 BSPBio_003318 OC(=O)C1=CCNCC1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 F21 compound treatment 8.3496 -1.4674 -0.3937 10.153 -0.087776 -0.0208 -0.2931 -0.7434 2069306 BSPBio_003319 C[C@@]12CCC3C(CCC4=CC(=O)C=C[C@]34C)C2CCC1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 F22 compound treatment 11.4247 1.6077 0.4314 11.1398 0.89905 0.213 0.4557 0.9471 3081181 BSPBio_003320 C[C@H]1CCC2=C1C[C@@H](CC[C@@H]2C)C(C)(C)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 F23 mock treatment 8.0146 -1.8024 -0.4836 8.4528 -1.788 -0.4236 -0.6415 -0.9978 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 F24 mock treatment 8.9453 -0.87173 -0.2339 8.8317 -1.4091 -0.3339 -0.4015 -0.9849 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 G01 mock treatment 16.0905 6.2735 1.6833 10.5185 0.27767 0.0658 1.2368 0.7342 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 G02 mock treatment 10.4488 0.63178 0.1695 9.9985 -0.24226 -0.0574 0.0793 0.443 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 G03 compound treatment 8.0337 -1.7833 -0.4785 10.6269 0.3861 0.0915 -0.2737 -0.5618 2060476 BSPBio_003321 C[C@H]1[C@@H]2CCC(=C3[C@@H]([C@H]2OC1=O)C(=CC3=O)C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 G04 compound treatment 10.2109 0.39396 0.1057 9.9351 -0.30569 -0.0724 0.0235 0.1836 718 BSPBio_003322 Cn1c(=O)n(C)c2ncn(CCO)c2c1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 G05 compound treatment 8.9691 -0.84789 -0.2275 9.0135 -1.2273 -0.2908 -0.3665 -0.9926 1089854 BSPBio_003323 Cc1ncc(CNC(=O)N(CCCl)N=O)c(N)n1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 G06 compound treatment 9.1159 -0.70106 -0.1881 9.7305 -0.51027 -0.1209 -0.2185 -0.9772 806 BSPBio_003324 OC(=O)C1CCCNC1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 G07 compound treatment 11.322 1.505 0.4038 10.9255 0.6847 0.1622 0.4003 0.9197 1765 BSPBio_003325 CC1(C)NC(=O)N(C1=O)c2ccc([N+](=O)[O-])c(c2)C(F)(F)F 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 G08 compound treatment 9.9771 0.16014 0.043 22.9384 12.698 3.0085 2.1577 0.7171 1055442 BSPBio_003326 Nc1nc(O)c2nc(cnc2n1)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 G09 compound treatment 11.1545 1.3375 0.3589 13.3665 3.1257 0.7406 0.7775 0.9447 1013144 BSPBio_003327 O=C1OC(=O)C2C3CCC(O3)C21 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 G10 compound treatment 9.0482 -0.76879 -0.2063 9.6585 -0.58234 -0.138 -0.2434 -0.9809 1464728 BSPBio_003328 Cn1c(=O)[nH]c2nc[nH]c2c1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 G11 compound treatment 8.1511 -1.6659 -0.447 10.2694 0.028554 0.0068 -0.3113 -0.6963 1734308 BSPBio_003329 Oc1cc(O)c2C(=O)C[C@H](Oc2c1)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 G12 compound treatment 9.3125 -0.50447 -0.1354 8.905 -1.3358 -0.3165 -0.3195 -0.9282 370 BSPBio_003330 O=C1N(C2CCC(=O)NC2=O)C(=O)c3ccccc13 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 G13 compound treatment 16.9069 7.0899 1.9024 10.5252 0.28436 0.0674 1.3929 0.7317 3059440 BSPBio_003331 OC(=O)C1CC(CN2CCCCC12)[C@@H]3CCCCN3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 G14 compound treatment 8.3823 -1.4347 -0.385 9.0364 -1.2044 -0.2854 -0.474 -0.9891 1049467 BSPBio_003332 COC(=O)c1c(C)cc(OC(=O)c2c(C)cc(O)c(C=O)c2O)c(C)c1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 G15 compound treatment 10.4032 0.58617 0.1573 9.9257 -0.31513 -0.0747 0.0584 0.3355 1307902 BSPBio_003333 CN1CCCCC1c2ccc(nc2)c3cccnc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 G16 compound treatment 9.2634 -0.55354 -0.1485 9.0734 -1.1674 -0.2766 -0.3006 -0.9575 986 BSPBio_003334 CN1CC(=O)NC1=N 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 G17 compound treatment 10.2304 0.41343 0.1109 10.3891 0.14829 0.0351 0.1033 0.8876 1216977 BSPBio_003335 CC1(C)Oc2ccc3ccc(=O)oc3c2CC1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 G18 compound treatment 9.1169 -0.70013 -0.1879 9.3017 -0.93907 -0.2225 -0.2902 -0.9965 1029490 BSPBio_003336 COc1cc(O)c(C)c(O)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 G19 compound treatment 8.519 -1.298 -0.3483 7.8648 -2.376 -0.563 -0.6443 -0.9734 2060489 BSPBio_003337 C/C=C(/C)\C(=O)O[C@@H]1Cc2c(OC1(C)C)ccc3ccc(=O)oc23 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 G20 compound treatment 10.0304 0.21343 0.0573 10.3819 0.14109 0.0334 0.0641 0.9671 1060118 BSPBio_003338 COc1cc(OC)c2c(=O)c(OC)c(oc2c1)c3ccc(OC)c(OC)c3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 G21 compound treatment 9.4736 -0.34336 -0.0921 10.1497 -0.091149 -0.0216 -0.0804 -0.8498 2060490 BSPBio_003339 C/C=C(\C)/C(=O)O[C@H]1[C@@H](OC(=O)C)C(C)(C)Oc2ccc3ccc(=O)oc3c12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 G22 compound treatment 10.3107 0.49371 0.1325 9.8246 -0.41617 -0.0986 0.0239 0.145 1024489 BSPBio_003340 Cc1cc(O)cc(=O)o1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 G23 mock treatment 9.3404 -0.4766 -0.1279 8.3851 -1.8557 -0.4397 -0.4013 -0.8765 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 G24 mock treatment 8.6156 -1.2014 -0.3224 9.2546 -0.98616 -0.2337 -0.3932 -0.9875 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 H01 mock treatment 9.022 -0.79495 -0.2133 10.1936 -0.047234 -0.0112 -0.1587 -0.7432 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 H02 mock treatment 9.1331 -0.68385 -0.1835 8.9127 -1.3281 -0.3147 -0.3523 -0.967 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 H03 compound treatment 9.7557 -0.061317 -0.0165 14.3257 4.0849 0.9679 0.6727 0.695 749 BSPBio_003341 NC(=O)N 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 H04 compound treatment 10.4433 0.62629 0.168 10.9942 0.75341 0.1785 0.2451 0.9995 1275 BSPBio_003342 CC(=O)NCCc1c[nH]c2ccc(O)cc12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 H05 compound treatment 10.7058 0.88884 0.2385 11.0427 0.80186 0.19 0.303 0.9937 3046992 BSPBio_003343 CO[C@]12[C@@H]3NC3CN2C4=C([C@@H]1COC(=O)N)C(=O)C(=C(C)C4=O)N 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 H06 compound treatment 11.8175 2.0005 0.5368 9.9748 -0.26597 -0.063 0.335 0.6198 757 BSPBio_003344 OC(=O)c1cn(C2CC2)c3cc(N4CCNCC4)c(F)cc3c1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 H07 compound treatment 8.7794 -1.0376 -0.2784 10.6857 0.44491 0.1054 -0.1223 -0.4109 1000009 BSPBio_003345 C/C(=C\C=C\C(=C/C(=O)O)\C)/C=C/C1=C(C)CCCC1(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 H08 compound treatment 10.703 0.88606 0.2378 7.5382 -2.7026 -0.6403 -0.2847 -0.4168 1607 BSPBio_003346 CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 H09 compound treatment 9.4933 -0.32369 -0.0869 11.9281 1.6873 0.3998 0.2213 0.5409 3177651 BSPBio_003347 CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N2[C@@H](C[C@@H]3CCC[C@@H]32)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 H10 compound treatment 8.8338 -0.98319 -0.2638 9.9198 -0.32099 -0.0761 -0.2403 -0.8753 839 BSPBio_003348 Nc1nc2n(COCCO)cnc2c(=O)[nH]1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 H11 compound treatment 9.7512 -0.065809 -0.0177 10.9308 0.69001 0.1635 0.1031 0.6271 2060352 BSPBio_003349 O=C(O[C@H]1Cc2c(OC(=O)c3ccccc3)cc(OC(=O)c4ccccc4)cc2O[C@@H]1c5ccc(OC(=O)c6ccccc6)c(OC(=O)c7ccccc7)c5)c8ccccc8 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 H12 compound treatment 9.9873 0.17027 0.0457 11.3481 1.1073 0.2624 0.2178 0.8179 3055308 BSPBio_003350 COC(=O)C1=CO[C@@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H]3[C@@H](C)[C@@H](O)C[C@@H]31 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 H13 compound treatment 8.2896 -1.5274 -0.4098 11.3971 1.1563 0.274 -0.0961 -0.1949 2060100 BSPBio_003351 OC(=O)c1cc(O)c(=O)c2c(O)c(O)ccc2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 H14 compound treatment 10.4428 0.62583 0.1679 10.7459 0.5051 0.1197 0.2034 0.9862 1380 BSPBio_003352 NC(=O)c1ncn(n1)[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 H15 compound treatment 8.73 -1.087 -0.2917 10.3577 0.11687 0.0277 -0.1867 -0.6371 3173763 BSPBio_003353 O[C@@H]1C[C@](O)(C[C@@H](OC(=O)/C=C/c2ccc(O)c(O)c2)[C@@H]1O)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 H16 compound treatment 11.31 1.493 0.4006 11.5399 1.299 0.3078 0.5009 0.9915 2080198 BSPBio_003354 CC(=O)C1=C(O)C2C3C(Cc4cccc5[nH]cc3c45)C(C)(C)N2C1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 H17 compound treatment 9.4302 -0.38683 -0.1038 11.575 1.3342 0.3161 0.1501 0.4512 2060377 BSPBio_003355 COc1c(ccc2OC(C)(C)CCc12)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 H18 compound treatment 10.1645 0.3475 0.0932 9.9307 -0.31013 -0.0735 0.014 0.1177 1537 BSPBio_003356 NC(Cc1ccc(F)cc1)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 H19 compound treatment 9.3579 -0.45908 -0.1232 10.0477 -0.19312 -0.0458 -0.1195 -0.9091 2060217 BSPBio_003357 COc1c(ccc2OC(C)(C)CCc12)C3COc4cc5OC(C)(C)C(O)Cc5cc4C3=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 H20 compound treatment 10.2036 0.38662 0.1037 12.3383 2.0975 0.497 0.4248 0.8367 1672652 BSPBio_003358 COc1ccc(cc1)c2cc(=O)c3ccc(OC)cc3o2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 H21 compound treatment 12.1583 2.3413 0.6282 10.3226 0.081771 0.0194 0.4579 0.7286 2060169 BSPBio_003359 Oc1cc(O)c2C[C@@H](OC(=O)c3cc(O)c(O)c(O)c3)[C@H](Oc2c1)c4cc(O)c(O)c(O)c4c5c(O)c(O)c(O)cc5[C@H]6Oc7cc(O)cc(O)c7C[C@H]6OC(=O)c8cc(O)c(O)c(O)c8 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 H22 compound treatment 9.3029 -0.5141 -0.1379 11.6355 1.3947 0.3304 0.1361 0.3801 790507 BSPBio_003360 OC(=O)CN1C(=O)c2cccc3cccc(C1=O)c23 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 H23 mock treatment 10.7223 0.90534 0.2429 10.886 0.64524 0.1529 0.2799 0.9751 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 H24 mock treatment 9.3916 -0.42539 -0.1141 10.448 0.20719 0.0491 -0.046 -0.3702 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 I01 mock treatment 7.8431 -1.9739 -0.5296 12.2389 1.9981 0.4734 -0.0398 -0.056 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 I02 mock treatment 8.7539 -1.0631 -0.2853 11.2141 0.97327 0.2306 -0.0387 -0.1054 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 I03 compound treatment 8.9961 -0.82088 -0.2203 12.0026 1.7618 0.4174 0.1394 0.2954 2060491 BSPBio_003361 CC(C)CC(=O)O[C@@H]1[C@H](OC(=O)C)c2c(OC1(C)C)ccc3ccc(=O)oc23 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 I04 compound treatment 12.1628 2.3458 0.6294 12.853 2.6122 0.6189 0.8827 1.0 2060467 BSPBio_003362 COc1ccc2C(=O)/C(=C\c3ccc(OC)c(OC)c3)/COc2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 I05 compound treatment 8.8431 -0.97387 -0.2613 10.2106 -0.030211 -0.0072 -0.1898 -0.7262 3055383 BSPBio_003363 CC(C)(O)[C@@H]1Cc2cc3ccc(=O)oc3cc2O1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 I06 compound treatment 9.3238 -0.49323 -0.1323 11.115 0.87417 0.2071 0.0529 0.2151 2060448 BSPBio_003364 COc1ccc2[C@H](O)[C@H](Cc3ccc(OC)c(OC)c3)COc2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 I07 compound treatment 13.1552 3.3382 0.8957 11.0663 0.82548 0.1956 0.7717 0.8417 3055445 BSPBio_003365 CC(=O)OC(C)(C)[C@@H]1Cc2cc3ccc(=O)oc3cc2O1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 I08 compound treatment 10.4434 0.62639 0.1681 10.3805 0.13966 0.0331 0.1422 0.8304 2060258 BSPBio_003366 CC(=O)O[C@H]1Cc2c(OC(=O)C)cc(OC(=O)C)cc2O[C@@H]1c3ccc(OC(=O)C)c(OC(=O)C)c3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 I09 compound treatment 8.9684 -0.84857 -0.2277 11.3502 1.1094 0.2629 0.0249 0.0715 2060501 BSPBio_003367 CC(C)(OC(=O)c1ccccc1)[C@@H]2Cc3cc4ccc(=O)oc4cc3O2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 I10 compound treatment 8.4482 -1.3688 -0.3673 10.4704 0.22959 0.0544 -0.2212 -0.5959 2060260 BSPBio_003368 COc1ccc(cc1)C2CC(=O)c3ccc(OC)cc3O2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 I11 compound treatment 9.5703 -0.24671 -0.0662 11.138 0.8972 0.2126 0.1035 0.4649 1023016 BSPBio_003369 COc1ccc2ccc(=O)oc2c1CC=C(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 I12 compound treatment 10.4505 0.63348 0.17 9.6968 -0.54402 -0.1289 0.029 0.1362 2060417 BSPBio_003370 CC(=C)C1Cc2c(O1)ccc(C(=O)O)c2O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 I13 compound treatment 9.426 -0.39101 -0.1049 10.9672 0.72641 0.1721 0.0475 0.2357 1296906 BSPBio_003371 COc1ccc(C(=O)CC(=O)O)c2OC(C)(C)C=Cc12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 I14 compound treatment 10.0586 0.24165 0.0648 9.8725 -0.36829 -0.0873 -0.0159 -0.1458 791 BSPBio_003372 CC(C)Oc1ccc2c(=O)cc(oc2c1)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 I15 compound treatment 8.1949 -1.6221 -0.4352 10.819 0.57816 0.137 -0.2109 -0.4622 1204574 BSPBio_003373 COc1c(oc2cc3oc(=O)ccc3cc12)C(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 I16 compound treatment 34.3653 24.548 6.587 33.0134 22.773 5.3956 8.473 0.9951 2069329 BSPBio_003374 COc1cc(O)c2c(=O)cc(oc2c1)c3ccc(OC)c(c3)c4c(O)cc(O)c5c(=O)cc(oc45)c6ccc(O)cc6 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 I17 compound treatment 12.734 2.917 0.7827 9.4836 -0.75719 -0.1794 0.4266 0.5313 1095093 BSPBio_003375 CNCCC(Oc1ccc(cc1)C(F)(F)F)c2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 I18 compound treatment 11.6082 1.7913 0.4806 10.252 0.011214 0.0027 0.3417 0.711 1192 BSPBio_003376 Cc1noc(NS(=O)(=O)c2ccc(N)cc2)c1C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 I19 compound treatment 10.4331 0.61609 0.1653 10.9738 0.73298 0.1737 0.2397 0.9997 1091368 BSPBio_003377 CNc1ccccc1C(=O)N2CCc3c([nH]c4ccccc34)C2=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 I20 compound treatment 10.1046 0.28758 0.0772 10.6874 0.44658 0.1058 0.1294 0.988 1175 BSPBio_003378 Nc1ccc(cc1)S(=O)(=O)Nc2nccs2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 I21 compound treatment 8.8273 -0.98968 -0.2656 8.635 -1.6058 -0.3805 -0.4568 -0.9845 2321 BSPBio_003379 COc1ccc2CC3N(CCc4cc(OC)c(OC)cc34)Cc2c1OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 I22 compound treatment 9.8999 0.082873 0.0222 9.5712 -0.66962 -0.1587 -0.0965 -0.6021 960 BSPBio_003380 C1N2CN3CN1CN(C2)C3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 I23 mock treatment 8.8249 -0.99206 -0.2662 11.7239 1.4831 0.3514 0.0602 0.1367 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 I24 mock treatment 10.8745 1.0576 0.2838 12.4729 2.2321 0.5289 0.5746 0.9574 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 J01 mock treatment 7.2775 -2.5395 -0.6814 16.8771 6.6363 1.5724 0.63 0.3676 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 J02 mock treatment 8.957 -0.86004 -0.2308 12.1642 1.9234 0.4557 0.1591 0.3114 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 J03 compound treatment 7.5057 -2.3112 -0.6202 11.357 1.1162 0.2645 -0.2515 -0.3731 3045136 BSPBio_003381 CC[C@H](C)C(=O)O[C@H]1CCC=C2C=C[C@H](C)C(CCC3C[C@@H](O)CC(=O)O3)[C@@H]12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 J04 compound treatment 9.923 0.10605 0.0285 13.9696 3.7288 0.8835 0.6448 0.7295 2060354 BSPBio_003382 COc1ccc(cc1)c2coc3cc(OC(=O)C)cc(OC(=O)C)c3c2=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 J05 compound treatment 8.2633 -1.5537 -0.4169 12.44 2.1992 0.5211 0.0737 0.1104 2060359 BSPBio_003383 COc1ccc(cc1)c2c(O)c3c(OC)c4C=CC(C)(C)Oc4cc3oc2=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 J06 compound treatment 9.5247 -0.2923 -0.0784 10.6318 0.39097 0.0926 0.01 0.0827 360 BSPBio_003384 Oc1ccc(cc1)c2cc(=O)c3c(O)cc(O)cc3o2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 J07 compound treatment 10.2875 0.47051 0.1262 9.31 -0.9308 -0.2205 -0.0667 -0.2624 2060284 BSPBio_003385 COc1cc(OC)c(c(OC)c1)c2c(OC)cc(OC)cc2OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 J08 compound treatment 12.0135 2.1965 0.5894 11.0926 0.8518 0.2018 0.5595 0.898 3077174 BSPBio_003386 CC(=O)Oc1ccc(cc1)c2cc(=O)c3c(OC(=O)C)cc(OC(=O)C)cc3o2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 J09 compound treatment 10.5226 0.70565 0.1893 11.0147 0.77389 0.1834 0.2635 0.9999 2060302 BSPBio_003387 CC(C)CCC[C@@H](C)CCC[C@@H](C)CC/C(=C/CO)/C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 J10 compound treatment 8.2726 -1.5444 -0.4144 12.5459 2.3051 0.5462 0.0932 0.1359 1013706 BSPBio_003388 O=c1c2ccccc2oc3ccccc13 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 J11 compound treatment 9.9746 0.15758 0.0423 11.4485 1.2077 0.2861 0.2322 0.8029 907381 BSPBio_003389 CC(=CCC/C(=C/C=C/C(=C/C=C/C(=C/C=C/C=C(\C)/C=C/C=C(\C)/C=C/C=C(\C)/CCC=C(C)C)/C)/C)/C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 J12 compound treatment 31.9996 22.183 5.9522 33.8911 23.65 5.6036 8.1711 0.9995 3077175 BSPBio_003390 COc1ccc2C(=O)/C(=C\c3ccc(O)c(O)c3)/COc2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 J13 compound treatment 9.468 -0.34896 -0.0936 9.4173 -0.82352 -0.1951 -0.2042 -0.9434 1461 BSPBio_003391 CN1CCCN=C1COC(=O)C(O)(C2CCCCC2)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 J14 compound treatment 12.7007 2.8837 0.7738 11.4853 1.2445 0.2949 0.7556 0.9126 1045 BSPBio_003392 C[C@@H]1CC2C3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 J15 compound treatment 9.2626 -0.55438 -0.1488 10.9388 0.698 0.1654 0.0118 0.0529 3080396 BSPBio_003393 CC(C)C[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)C(C)C)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 J16 compound treatment 11.3023 1.4853 0.3985 9.1163 -1.1245 -0.2664 0.0934 0.1948 1000323 BSPBio_003394 N[C@@H](Cc1cc(I)c(Oc2ccc(O)c(I)c2)c(I)c1)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 J17 compound treatment 8.0129 -1.8041 -0.4841 9.3197 -0.9211 -0.2182 -0.4966 -0.9352 1095029 BSPBio_003395 CCCCCCCCCCCCCCCCCCOP(=O)(O)OCC[N+](C)(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 J18 compound treatment 10.8117 0.99475 0.2669 9.0941 -1.1467 -0.2717 -0.0034 -0.0089 810 BSPBio_003396 CCCCC[C@@H]1[C@@H](OC(=O)CC(C)C)[C@H](C)OC(=O)[C@@H](NC(=O)c2cccc(NC=O)c2O)[C@@H](C)OC1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 J19 compound treatment 39.5007 29.684 7.9649 36.3243 26.084 6.1801 10.002 0.9921 3176939 BSPBio_003397 ClCC(=O)[C@H](Cc1ccccc1)NC(=O)OCc2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 J20 compound treatment 10.7607 0.94374 0.2532 9.0825 -1.1583 -0.2744 -0.015 -0.0401 3198426 BSPBio_003398 NCC(CC(=O)O)c1ccc(Cl)s1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 J21 compound treatment 10.9391 1.1221 0.3011 8.7665 -1.4743 -0.3493 -0.0341 -0.0739 3079212 BSPBio_003399 NCCCN.OC(C(O)C(=O)O)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 J22 compound treatment 11.7019 1.8849 0.5058 8.851 -1.3898 -0.3293 0.1248 0.2068 1450 BSPBio_003400 NCCc1c[nH]c2ccccc12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 J23 mock treatment 12.9416 3.1246 0.8384 9.8419 -0.39891 -0.0945 0.526 0.6234 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 J24 mock treatment 10.9914 1.1744 0.3151 9.324 -0.9168 -0.2172 0.0692 0.1809 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 K01 mock treatment 9.9606 0.14358 0.0385 10.9002 0.65937 0.1562 0.1377 0.8558 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 K02 mock treatment 10.1382 0.32117 0.0862 11.6765 1.4357 0.3402 0.3015 0.8591 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 K03 compound treatment 34.6014 24.784 6.6503 34.6569 24.416 5.785 8.7931 0.9976 3172984 BSPBio_003401 COC(=O)[C@]1(C)CC[C@]2(C)CC[C@]3(C)C4=CC=C5C(=C(O)C(=O)C=C5[C@]4(C)CC[C@@]3(C)[C@@H]2C1)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 K04 compound treatment 8.3623 -1.4547 -0.3903 12.783 2.5422 0.6023 0.1499 0.2089 912 BSPBio_003402 CCCc1cc(=O)[nH]c(=S)[nH]1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 K05 compound treatment 9.5278 -0.28915 -0.0776 10.0413 -0.19953 -0.0473 -0.0883 -0.9718 3173234 BSPBio_003403 Cn1c(=O)[nH]c(=O)c2nc[nH]c12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 K06 compound treatment 9.3071 -0.50993 -0.1368 9.1497 -1.0911 -0.2585 -0.2796 -0.9557 967 BSPBio_003404 C/C(=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C)/C=C/C=C(\C)/C=C/C2=C(C)CCCC2(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 K07 compound treatment 9.1025 -0.71446 -0.1917 9.8305 -0.41035 -0.0972 -0.2043 -0.9505 1001642 BSPBio_003405 OC[C@H]1OC(C[C@@H]1O)n2cc(c(=O)[nH]c2=O)C(F)(F)F 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 K08 compound treatment 9.9384 0.12142 0.0326 11.6558 1.415 0.3353 0.2601 0.7722 471 BSPBio_003406 CCCC(CCC)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 K09 compound treatment 9.2942 -0.52274 -0.1403 9.3986 -0.84216 -0.1995 -0.2403 -0.9851 1015899 BSPBio_003407 NCC(=O)CCC(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 K10 compound treatment 11.4663 1.6493 0.4426 10.6806 0.43975 0.1042 0.3866 0.8503 2060105 BSPBio_003408 CC1(C)Oc2cc3occ(c4ccc5OCOc5c4)c(=O)c3c(O)c2C=C1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 K11 compound treatment 9.4051 -0.41187 -0.1105 10.1416 -0.099186 -0.0235 -0.0948 -0.8387 907463 BSPBio_003409 Cc1nc2ccccn2c(=O)c1CCN3CCC(CC3)C(=O)c4ccc(F)cc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 K12 compound treatment 9.6025 -0.21446 -0.0575 10.5475 0.3067 0.0727 0.0107 0.1154 1213 BSPBio_003410 CNCCc1ccccn1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 K13 compound treatment 10.3884 0.57141 0.1533 9.9933 -0.24753 -0.0586 0.0669 0.4078 831758 BSPBio_003411 Oc1ccc(/C=C/C(=O)c2ccc(O)cc2O)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 K14 compound treatment 9.2668 -0.55021 -0.1476 8.2114 -2.0294 -0.4808 -0.4444 -0.8835 89599 BSPBio_003412 OC(=O)c1cc(O)c2c(Cl)cc(Cl)cc2n1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 K15 compound treatment 8.3129 -1.5041 -0.4036 11.0458 0.80502 0.1907 -0.1505 -0.3372 2060386 BSPBio_003413 CCN1C[C@]2(C)CC[C@H](OC)[C@@]34C2[C@H](O)[C@]5(OCO[C@]65C[C@H](OC)[C@H]7C[C@]4(O)C6[C@H]7O)C13 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 K16 compound treatment 10.1382 0.3212 0.0862 10.3835 0.14273 0.0338 0.0849 0.9165 831 BSPBio_003414 Nc1nccs1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 K17 compound treatment 9.9964 0.17939 0.0481 10.8882 0.64739 0.1534 0.1425 0.8864 3055171 BSPBio_003415 COC(=O)[C@]1(C)CC[C@]2(C)CC[C@]3(C)C4=CCc5c(C)c(O)c(O)cc5[C@]4(C)CC[C@@]3(C)C2C1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 K18 compound treatment 9.9589 0.14192 0.0381 9.3998 -0.84099 -0.1993 -0.114 -0.5618 1202 BSPBio_003416 COc1ccc2CN(C)CC[C@]34C=C[C@H](O)C[C@@H]4Oc1c23 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 K19 compound treatment 10.8855 1.0685 0.2867 10.0819 -0.15886 -0.0376 0.1761 0.609 4480 BSPBio_003417 CC(C)NC(=N)NC(=N)Nc1ccc(Cl)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 K20 compound treatment 9.4324 -0.38462 -0.1032 9.7201 -0.52073 -0.1234 -0.1602 -0.9961 3198647 BSPBio_003418 CC1(C)[C@H](O)C[C@H](O)[C@@]2(C)C1CC(=O)[C@]3(C)C2CC[C@@]4(C)[C@@H](OC(=O)C=C43)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 K21 compound treatment 20.641 10.824 2.9044 16.6033 6.3625 1.5075 3.1197 0.9534 1010201 BSPBio_003419 ClC1=C(Cl)C(=O)C(=C(Cl)C1=O)Cl 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 K22 compound treatment 10.8391 1.0221 0.2743 9.7431 -0.4977 -0.1179 0.1105 0.3703 3045298 BSPBio_003420 C[C@@H]1CC2C3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 K23 mock treatment 8.8714 -0.94559 -0.2537 8.1265 -2.1143 -0.5009 -0.5336 -0.9503 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 K24 mock treatment 10.8404 1.0234 0.2746 11.3926 1.1518 0.2729 0.3871 1.0 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 L01 mock treatment 10.8389 1.0219 0.2742 9.9925 -0.24826 -0.0588 0.1523 0.5431 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 L02 mock treatment 9.453 -0.36403 -0.0977 9.5192 -0.72157 -0.171 -0.19 -0.9647 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 L03 compound treatment 8.6376 -1.1794 -0.3165 10.5734 0.33265 0.0788 -0.168 -0.5153 3079213 BSPBio_003421 N[C@@H](CCC(=O)N[C@@H](CCSC(CC(=O)O)C(=O)O)C(=O)NCC(=O)O)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 L04 compound treatment 13.1436 3.3267 0.8926 10.0769 -0.16387 -0.0388 0.6037 0.6757 1526 BSPBio_003422 CC1CCCC(C)N1NC(=O)c2ccc(Cl)c(c2)S(=O)(=O)N 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 L05 compound treatment 10.6017 0.78474 0.2106 8.294 -1.9468 -0.4613 -0.1773 -0.3496 3198431 BSPBio_003423 CC(C)[C@H](N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 L06 compound treatment 11.1103 1.2933 0.347 9.0159 -1.2249 -0.2902 0.0402 0.0888 1835 BSPBio_003424 CCCc1nn(C)c2c(=O)[nH]c(nc12)c3cc(ccc3OCC)S(=O)(=O)N4CCN(C)CC4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 L07 compound treatment 11.0046 1.1876 0.3187 10.2947 0.053926 0.0128 0.2344 0.7349 3198435 BSPBio_003425 N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 L08 compound treatment 8.8634 -0.95361 -0.2559 8.935 -1.3058 -0.3094 -0.3997 -0.9955 3173357 BSPBio_003426 CC(=C)[C@@H]1CC[C@@]2(CCC3[C@H](CCC4[C@@]3(C)CCC5C(C)(C)[C@H](O)CC[C@@]54C)C12)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 L09 compound treatment 9.0886 -0.72842 -0.1955 13.1967 2.9559 0.7004 0.357 0.491 3198434 BSPBio_003427 NCCCC[C@H](N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 L10 compound treatment 11.5409 1.7239 0.4626 9.2822 -0.95862 -0.2271 0.1665 0.3231 1493 BSPBio_003428 CCC(=O)O[C@@]1([C@@H](C)CC2C3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C)C(=O)CCl 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 L11 compound treatment 8.1027 -1.7143 -0.46 8.9897 -1.2511 -0.2964 -0.5349 -0.9774 1000377 BSPBio_003429 CC(C)c1nc(nc(c1/C=C/[C@@H](O)C[C@@H](O)CC(=O)O)c2ccc(F)cc2)N(C)S(=O)(=O)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 L12 compound treatment 7.4225 -2.3945 -0.6425 10.3895 0.14868 0.0352 -0.4294 -0.6673 1431 BSPBio_003430 Clc1ccc(cc1)C(OCCN2CCCCC2)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 L13 compound treatment 9.859 0.041993 0.0113 9.3787 -0.86206 -0.2043 -0.1365 -0.6671 1032444 BSPBio_003431 CC(=O)Oc1c(C)cccc1C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 L14 compound treatment 33.1827 23.366 6.2696 34.6094 24.369 5.7738 8.516 0.9992 2060453 BSPBio_003432 Clc1c(Cl)c(C#N)c(Cl)c(C#N)c1Cl 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 L15 compound treatment 7.7951 -2.0219 -0.5425 11.6731 1.4323 0.3394 -0.1436 -0.2245 3079222 BSPBio_003433 CC(=O)OC[C@H]1O[C@@H](Oc2cc(OC(=O)C)c3c(=O)cc(oc3c2)c4ccc(OC(=O)C)cc4)[C@H](OC(=O)C)[C@@H](OC(=O)C)[C@@H]1OC(=O)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 L16 compound treatment 7.8718 -1.9452 -0.522 9.0001 -1.2407 -0.294 -0.577 -0.9631 1419 BSPBio_003434 NCCSSCCN 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 L17 compound treatment 9.6583 -0.15871 -0.0426 10.4005 0.15969 0.0378 -0.0034 -0.059 3079224 BSPBio_003435 COC1=C(O)C(=O)c2c(O)c3c(O)c(oc3cc2C1=O)C(=O)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 L18 compound treatment 80.9787 71.162 19.0945 82.7665 72.526 17.1839 25.6527 0.9986 1000697 BSPBio_003436 COc1cc(cc(OC)c1O)[C@H]2[C@@H]3C(COC3=O)C(O[C@@H]4O[C@@H]5CO[C@H](OC5[C@H](O)[C@H]4O)c6cccs6)c7cc8OCOc8cc27 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 L19 compound treatment 9.2783 -0.53871 -0.1446 7.8767 -2.3641 -0.5601 -0.4983 -0.8614 3078331 BSPBio_003437 OC(=O)c1cccc(O)c1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 L20 compound treatment 9.0642 -0.75281 -0.202 9.0377 -1.2031 -0.2851 -0.3444 -0.9858 2060442 BSPBio_003438 CCC(N)C(O)c1ccc(O)c(O)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 L21 compound treatment 6.9675 -2.8495 -0.7646 8.6765 -1.5643 -0.3706 -0.8027 -0.9447 1331 BSPBio_003439 CC(=O)CCCCn1c(=O)n(C)c2ncn(C)c2c1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 L22 compound treatment 10.6452 0.82817 0.2222 9.4389 -0.80192 -0.19 0.0228 0.0779 1316 BSPBio_003440 CC(C)(C)NCC(O)c1ccccc1Cl 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 L23 mock treatment 9.3229 -0.49406 -0.1326 7.3506 -2.8902 -0.6848 -0.578 -0.8286 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 L24 mock treatment 10.0842 0.26721 0.0717 7.4113 -2.8295 -0.6704 -0.4234 -0.6279 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 M01 mock treatment 9.6129 -0.20411 -0.0548 10.9848 0.744 0.1763 0.0859 0.4655 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 M02 mock treatment 7.9836 -1.8334 -0.492 8.8441 -1.3967 -0.3309 -0.5819 -0.9814 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 M03 compound treatment 7.5482 -2.2688 -0.6088 8.5299 -1.7109 -0.4054 -0.7171 -0.9805 2060483 BSPBio_003441 CC(=O)N[C@@H](CC(=O)O)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 M04 compound treatment 7.4554 -2.3615 -0.6337 9.6888 -0.552 -0.1308 -0.5405 -0.8354 944 BSPBio_003442 Nc1ccc(cc1)S(=O)(=O)Nc2ccnn2c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 M05 compound treatment 8.4333 -1.3837 -0.3713 11.5149 1.2741 0.3019 -0.0491 -0.1026 907181 BSPBio_003443 NC(=N)NC(=O)c1nc(Cl)c(nc1N)N2CCCCCC2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 M06 compound treatment 10.0936 0.27663 0.0742 8.8714 -1.3694 -0.3245 -0.1769 -0.5316 1401 BSPBio_003444 CN(C)CCCN1c2ccccc2Sc3ccc(cc13)C(F)(F)F 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 M07 compound treatment 9.5077 -0.30925 -0.083 10.4174 0.17658 0.0418 -0.0291 -0.3131 3173242 BSPBio_003445 Nc1nc2cc(Cl)ccc2o1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 M08 compound treatment 10.2154 0.39839 0.1069 11.5705 1.3297 0.3151 0.2984 0.8968 930 BSPBio_003446 CC(CN1CCCCC1)C(=O)c2ccc(C)cc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 M09 compound treatment 8.5067 -1.3102 -0.3516 8.6253 -1.6155 -0.3828 -0.5193 -0.9991 1002855 BSPBio_003447 CCC(C(=O)O)c1ccccc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 M10 compound treatment 77.827 68.01 18.2488 70.0709 59.83 14.1759 22.9277 0.9922 3173213 BSPBio_003448 COc1ccc(C[C@H](N)C(=O)N[C@H]2[C@@H](O)C(O[C@@H]2CO)n3cnc4c(ncnc34)N(C)C)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 M11 compound treatment 9.2283 -0.58873 -0.158 9.4329 -0.8079 -0.1914 -0.2471 -0.9954 2060416 BSPBio_003449 Sc1nc2ccccc2s1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 M12 compound treatment 9.5709 -0.24608 -0.066 9.3393 -0.9015 -0.2136 -0.1977 -0.8844 1000122 BSPBio_003450 O[C@@H]([C@@H]1C[C@@H]2CCN1C[C@@H]2C=C)c3ccnc4ccccc34 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 M13 compound treatment 9.0086 -0.80837 -0.2169 9.4875 -0.75333 -0.1785 -0.2796 -0.9953 1001451 BSPBio_003451 Cc1cc(C)cc(OCC2CNC(=O)O2)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 M14 compound treatment 10.8589 1.0419 0.2796 9.3773 -0.86347 -0.2046 0.053 0.1531 1462 BSPBio_003452 CC1C(CCC(C)(C)N1C)OC(=O)C(O)c2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 M15 compound treatment 9.7149 -0.10213 -0.0274 9.2684 -0.97238 -0.2304 -0.1823 -0.7857 3172732 BSPBio_003453 CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C)[C@@](C)(C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O)OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 M16 compound treatment 8.7726 -1.0444 -0.2802 11.5235 1.2827 0.3039 0.0168 0.0405 3177385 BSPBio_003454 CC1(C)O[C@@H]2CC3C4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 M17 compound treatment 8.3013 -1.5157 -0.4067 9.684 -0.55684 -0.1319 -0.3809 -0.8908 2060378 BSPBio_003455 Oc1nc2cc(Cl)c(Cl)cc2nc1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 M18 compound treatment 9.623 -0.19403 -0.0521 8.8016 -1.4393 -0.341 -0.2779 -0.8057 1302 BSPBio_003456 CC(C)CC1N2C(=O)[C@](NC(=O)C3CN(C)[C@@H]4Cc5c(Br)[nH]c6cccc(C4=C3)c56)(OC2(O)[C@@H]7CCCN7C1=O)C(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 M19 compound treatment 13.8897 4.0727 1.0928 14.2277 3.9868 0.9446 1.4407 0.9974 1001496 BSPBio_003457 NC(=O)N1c2ccccc2CC(=O)c3ccccc13 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 M20 compound treatment 38.5247 28.708 7.703 35.2249 24.984 5.9196 9.6327 0.9915 1000054 BSPBio_003458 CC(C)CC1NC(=O)C(CCCN)NC(=O)C(NC(=O)C2CCCN2C(=O)C(Cc3ccccc3)NC(=O)C(CC(C)C)NC(=O)C(CCCN)NC(=O)C(NC(=O)C4CCCN4C(=O)C(Cc5ccccc5)NC1=O)C(C)C)C(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 M21 compound treatment 9.3798 -0.43716 -0.1173 11.4547 1.2139 0.2876 0.1204 0.3877 3059445 BSPBio_003459 CCCCCCCCCCC[C@@H](C[C@H]1OC(=O)[C@H]1CCCCCC)OC(=O)[C@@H](CC(C)C)NC=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 M22 compound treatment 13.9648 4.1478 1.113 12.4289 2.1881 0.5184 1.1536 0.9396 1021 BSPBio_003460 CO[C@@H]1[C@@H](O)[C@H](C)O[C@@H](O[C@H]2CC[C@@]3(C)[C@H](CCC4C3CC[C@]5(C)C(CC[C@]45O)C6=CC(=O)OC6)C2)[C@H]1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 M23 mock treatment 10.0491 0.23209 0.0623 9.7777 -0.46311 -0.1097 -0.0336 -0.2659 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 M24 mock treatment 11.2569 1.44 0.3864 8.2265 -2.0143 -0.4773 -0.0643 -0.1047 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 N01 mock treatment 9.6159 -0.20107 -0.054 9.5847 -0.65611 -0.1555 -0.1481 -0.8999 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 N02 mock treatment 8.6318 -1.1852 -0.318 9.7097 -0.53108 -0.1258 -0.3138 -0.9177 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 N03 compound treatment 9.0003 -0.81666 -0.2191 8.7771 -1.4637 -0.3468 -0.4002 -0.9755 2269 BSPBio_003461 Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 N04 compound treatment 11.0287 1.2117 0.3251 8.8586 -1.3822 -0.3275 -0.0017 -0.0036 3045655 BSPBio_003462 CC(=O)[C@@]1(O)CCC2C3C=C(Cl)C4=CC(=O)[C@@H]5CC5[C@]4(C)C3CC[C@@]21C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 N05 compound treatment 9.8616 0.044653 0.012 8.4713 -1.7695 -0.4193 -0.288 -0.6866 2060255 BSPBio_003463 CC(=O)Oc1ccc(/C=C/c2cc(OC(=O)C)cc(OC(=O)C)c2)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 N06 compound treatment 8.378 -1.439 -0.3861 8.3996 -1.8412 -0.4363 -0.5815 -0.9981 1510 BSPBio_003464 CN(C)CCN(Cc1cccs1)c2ccccn2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 N07 compound treatment 8.3565 -1.4605 -0.3919 10.3119 0.071096 0.0168 -0.2652 -0.6761 3103678 BSPBio_003465 N/C(=N\C(=O)c1nc(Cl)c(N)nc1N)/NCc2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 N08 compound treatment 9.5348 -0.28218 -0.0757 10.171 -0.069836 -0.0165 -0.0652 -0.8418 2060303 BSPBio_003466 Cc1occc(=O)c1/C=C/O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 N09 compound treatment 10.4894 0.67242 0.1804 9.0608 -1.18 -0.2796 -0.0701 -0.2107 1494 BSPBio_003467 C1CN(CCN1)c2ccc3ccccc3n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 N10 compound treatment 9.8328 0.015783 0.0042 10.1837 -0.057069 -0.0135 -0.0066 -0.4634 3060195 BSPBio_003468 COC(C)(C)CCC[C@H](C)C/C=C/C(=C/C(=O)OC(C)C)/C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 N11 compound treatment 9.9819 0.16495 0.0443 9.0276 -1.2132 -0.2875 -0.172 -0.5913 1002022 BSPBio_003469 NC(CCC(=O)O)C=C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 N12 compound treatment 8.1265 -1.6905 -0.4536 8.9602 -1.2806 -0.3034 -0.5353 -0.9809 1489 BSPBio_003470 CCCNCC(O)COc1ccccc1C(=O)CCc2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 N13 compound treatment 9.358 -0.45894 -0.1231 8.7533 -1.4875 -0.3524 -0.3363 -0.9008 2270 BSPBio_003471 CCCCOc1cc(CC2CNC(=O)N2)ccc1OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 N14 compound treatment 11.0519 1.2349 0.3314 8.6115 -1.6293 -0.386 -0.0387 -0.076 1442 BSPBio_003472 CC(=O)NC1SCCC1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 N15 compound treatment 9.385 -0.43201 -0.1159 10.892 0.65119 0.1543 0.0271 0.1406 3173760 BSPBio_003473 COc1cc2CCN(C)[C@@H]3Cc4cccc(Oc5ccc(C[C@@H]6N(C)CCc7cc(OC)c(Oc(c1OC)c32)cc67)c(O)c5)c4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 N16 compound treatment 9.0832 -0.73381 -0.1969 8.5994 -1.6414 -0.3889 -0.4142 -0.9503 1507 BSPBio_003474 CC(N)CCCC(C)(C)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 N17 compound treatment 8.5388 -1.2782 -0.343 9.0453 -1.1955 -0.2833 -0.4428 -0.9955 417 BSPBio_003475 CN1CCN(CC1)C2=Nc3cc(Cl)ccc3Nc4ccccc24 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 N18 compound treatment 8.0307 -1.7863 -0.4793 9.23 -1.0108 -0.2395 -0.5083 -0.9486 1524 BSPBio_003476 CC(C)Nc1c(C)n(C)n(c2ccccc2)c1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 N19 compound treatment 8.8464 -0.97059 -0.2604 9.7632 -0.47761 -0.1132 -0.2642 -0.9303 1090658 BSPBio_003477 COc1cc(O)c2C(=O)c3c(O)cc(C)cc3C(=O)c2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 N20 compound treatment 9.646 -0.17102 -0.0459 8.9487 -1.2921 -0.3062 -0.2489 -0.8041 860 BSPBio_003478 CN(C)C(=O)Oc1ccc[n+](C)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 N21 compound treatment 8.6044 -1.2126 -0.3254 9.7658 -0.47501 -0.1125 -0.3097 -0.8994 4362 BSPBio_003479 CN1CCN(CC1)C2=Nc3ccccc3Oc4ccc(Cl)cc24 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 N22 compound treatment 10.6613 0.84427 0.2265 8.1885 -2.0523 -0.4863 -0.1836 -0.3423 2060342 BSPBio_003480 O[C@@H]1[C@H](Oc2cc(O)ccc2C1=O)c3cc(O)c(O)c(O)c3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 N23 mock treatment 9.367 -0.45 -0.1207 8.1093 -2.1315 -0.505 -0.4425 -0.8521 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 N24 mock treatment 10.0522 0.23526 0.0631 8.4034 -1.8374 -0.4353 -0.2632 -0.5983 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 O01 mock treatment 9.8491 0.032156 0.0086 9.939 -0.3018 -0.0715 -0.0445 -0.6173 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 O02 mock treatment 11.9911 2.1741 0.5834 9.8553 -0.3855 -0.0913 0.3479 0.5892 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 O03 compound treatment 88.0927 78.276 21.0034 89.615 79.374 18.8066 28.1499 0.9985 2069291 BSPBio_003481 COc1cc(cc(OC)c1OC)[C@H]2[C@H]3[C@H](COC3=O)[C@@H](O)c4cc5OCOc5cc24 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 O04 compound treatment 9.5982 -0.21877 -0.0587 11.7207 1.4799 0.3506 0.2064 0.5806 1318 BSPBio_003482 CN(C(=O)CN(CCO)CC(=O)N(C)C(C)(C)Cc1ccccc1)C(C)(C)Cc2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 O05 compound treatment 135.6905 125.87 33.7751 140.408 130.17 30.8412 45.6906 0.999 3177591 BSPBio_003483 COc1cc(cc(OC)c1OC)[C@H]2[C@@H]3[C@H](COC3=O)[C@@H](OC(=O)C)c4cc5OCOc5cc24 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 O06 compound treatment 9.0823 -0.73473 -0.1971 11.0614 0.82061 0.1944 -0.0019 -0.0069 3198648 BSPBio_003484 CC(CCC(=O)O)[C@H]1CCC2C3CC=C4C[C@@H](O)CC[C@]4(C)C3CC[C@]12C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 O07 compound treatment 9.6528 -0.16419 -0.0441 8.9453 -1.2955 -0.3069 -0.2482 -0.8004 3060196 BSPBio_003485 COc1c(CN2CC[C@@H]3CCCN[C@@H]3C2)c(F)cc4c(=O)c(cn(C5CC5)c14)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 O08 compound treatment 8.8815 -0.93552 -0.251 11.8792 1.6384 0.3882 0.097 0.2098 996 BSPBio_003486 NCCc1cc(O)c(O)cc1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 O09 compound treatment 18.344 8.5271 2.288 53.4948 43.254 10.2484 8.8646 0.8442 1000322 BSPBio_003487 CCOC(=O)[C@H](CCc1ccccc1)N[C@H]2CCc3ccccc3N(CC(=O)O)C2=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 O10 compound treatment 8.2073 -1.6097 -0.4319 8.2337 -2.0071 -0.4756 -0.6417 -0.9988 2060458 BSPBio_003488 CC(=O)Oc1cccc(C(=O)O)c1OC(=O)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 O11 compound treatment 10.1757 0.35869 0.0962 10.3899 0.14905 0.0353 0.093 0.9074 1696 BSPBio_003489 CC(=O)OCC(CCn1cnc2cnc(N)nc12)COC(=O)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 O12 compound treatment 11.1449 1.3279 0.3563 10.4547 0.21392 0.0507 0.2878 0.7996 1421 BSPBio_003490 CC(=O)Nc1ccc(cc1)S(=O)(=O)Nc2ccc(cc2)[N+](=O)[O-] 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 O13 compound treatment 7.9554 -1.8615 -0.4995 8.6607 -1.5801 -0.3744 -0.6179 -0.9899 1001491 BSPBio_003491 CCCc1nc(c(C(=O)OCc2oc(=O)oc2C)n1Cc3ccc(cc3)c4ccccc4c5nn[nH]n5)C(C)(C)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 O14 compound treatment 9.1501 -0.66692 -0.179 8.5125 -1.7283 -0.4095 -0.4161 -0.9311 2060310 BSPBio_003492 CC(C)C1=CC2=CC[C@H]3[C@](C)(CO)CCC[C@]3(C)C2CC1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 O15 compound treatment 10.2531 0.43608 0.117 9.0516 -1.1892 -0.2818 -0.1165 -0.3818 3198315 BSPBio_003493 COc1ccc(cc1F)c2cc(nn2c3ccc(cc3)S(=O)(=O)N)C(F)F 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 O16 compound treatment 10.2373 0.42032 0.1128 8.5062 -1.7346 -0.411 -0.2109 -0.4948 857 BSPBio_003494 O=C(OCc1ccccc1)c2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 O17 compound treatment 7.5393 -2.2777 -0.6112 10.7042 0.46341 0.1098 -0.3545 -0.5709 1592184 BSPBio_003495 O=C1CCCC2C3CC(CN21)[C@@H]4CCCCN4C3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 O18 compound treatment 11.6199 1.8029 0.4838 10.0704 -0.17038 -0.0404 0.3135 0.6459 3177322 BSPBio_003496 CC(=O)[C@@]1(O)CCC2C3CCC4=CC(=O)CC[C@]4(C)C3CC[C@@]21C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 O19 compound treatment 7.8527 -1.9643 -0.5271 9.5097 -0.7311 -0.1732 -0.4952 -0.8925 3198437 BSPBio_003497 C[N+](C)(C)CCOP(=O)(O)OP(=O)(O)OC[C@H]1OC([C@H](O)[C@@H]1O)n2ccc(N)nc2=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 O20 compound treatment 8.8829 -0.9341 -0.2506 8.9808 -1.26 -0.2986 -0.3883 -0.9962 3173755 BSPBio_003498 C[C@@]12CC(=O)C3C(CCC4=CC(=O)CC[C@]34C)C2CC[C@]1(O)C(=O)CO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 O21 compound treatment 11.9505 2.1335 0.5725 7.8145 -2.4263 -0.5749 -0.0017 -0.0021 1005991 BSPBio_003499 O=C1c2ccccc2-c3cccc4cccc1c34 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 O22 compound treatment 9.2475 -0.56951 -0.1528 9.0134 -1.2274 -0.2908 -0.3137 -0.9549 3081177 BSPBio_003500 CC(C)CCCC(C)C1CCC2C3C(CC[C@]12C)[C@@]4(C)CC[C@@H](CC4=CC3=O)OC(=O)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 O23 mock treatment 7.7091 -2.1079 -0.5656 8.4461 -1.7947 -0.4252 -0.7006 -0.9901 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 O24 mock treatment 8.1741 -1.6428 -0.4408 9.4197 -0.82112 -0.1946 -0.4493 -0.9324 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 P01 mock treatment 8.5641 -1.2529 -0.3362 10.2965 0.055724 0.0132 -0.2284 -0.6788 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 P02 mock treatment 7.887 -1.93 -0.5179 9.6763 -0.56451 -0.1338 -0.4608 -0.8615 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 P03 compound treatment 10.1558 0.33882 0.0909 10.0163 -0.22454 -0.0532 0.0267 0.2532 3059817 BSPBio_003501 CCCCC(=O)N(Cc1ccc(cc1)c2ccccc2c3nn[nH]n3)[C@@H](C(C)C)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 P04 compound treatment 11.2161 1.3991 0.3754 10.6455 0.40473 0.0959 0.3333 0.8601 2060318 BSPBio_003502 C/C(=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@]12O[C@]2(C)C[C@@H](O)CC1(C)C)/C=C/C=C(\C)/C=C/C3=C(C)C[C@@H](O)CC3(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 P05 compound treatment 12.2807 2.4637 0.6611 10.9499 0.70908 0.168 0.5863 0.8595 1001638 BSPBio_003503 CC(C)NC(=O)NS(=O)(=O)c1cnccc1Nc2cccc(C)c2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 P06 compound treatment 10.7192 0.90216 0.2421 10.2274 -0.013424 -0.0032 0.1689 0.6978 1605 BSPBio_003504 OC(Cn1cncn1)(Cn2cncn2)c3ccc(F)cc3F 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 P07 compound treatment 10.1232 0.30623 0.0822 11.1403 0.8995 0.2131 0.2088 0.9141 2060333 BSPBio_003505 COc1ccc(/C=C/c2cc(O)cc(O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)c2)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 P08 compound treatment 9.8501 0.033163 0.0089 10.8142 0.57339 0.1359 0.1024 0.7518 3616563 BSPBio_003506 C[C@H](N)[C@H](O)c1cccc(O)c1.O[C@H]([C@@H](O)C(=O)O)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 P09 compound treatment 10.7256 0.90861 0.2438 10.5779 0.33708 0.0799 0.2289 0.8921 2971 BSPBio_003507 CCCn1cnc2n(C)c(=O)n(CCCCC(=O)C)c(=O)c12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 P10 compound treatment 7.6024 -2.2145 -0.5942 9.6105 -0.63033 -0.1493 -0.5258 -0.8581 3069629 BSPBio_003508 CC(=O)/N=c/1\sc(nn1C)S(=O)(=O)N 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 P11 compound treatment 11.2347 1.4178 0.3804 11.011 0.77017 0.1825 0.398 0.9434 1439 BSPBio_003509 CSCCC(N)C(=O)NC(CC(C)C)C(=O)NC(Cc1ccccc1)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 P12 compound treatment 14.0151 4.1981 1.1264 10.7749 0.53405 0.1265 0.886 0.7816 1457 BSPBio_003510 CC(=O)OCC(=O)[C@]12OC3(CCCC3)O[C@@H]2CC4C5CCC6=CC(=O)C=C[C@]6(C)[C@@]5(F)[C@@H](O)C[C@@]41C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 P13 compound treatment 10.6425 0.82548 0.2215 10.0201 -0.22071 -0.0523 0.1196 0.5257 1434 BSPBio_003511 CN1CCN2C(C1)c3ccccc3Cc4ccccc24 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 P14 compound treatment 11.4 1.583 0.4248 8.4817 -1.7591 -0.4168 0.0056 0.0094 3081192 BSPBio_003512 CC(=O)OC1Cc2c(OC(=O)C)cc(OC(=O)C)cc2O[C@@H]1c3cc(OC(=O)C)c(OC(=O)C)c4c(=O)c(OC(=O)C)cc(cc34)[C@H]5Oc6cc(OC(=O)C)cc(OC(=O)C)c6C[C@H]5OC(=O)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 P15 compound treatment 8.2705 -1.5465 -0.415 10.3077 0.066889 0.0158 -0.2822 -0.6796 3174224 BSPBio_003513 CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C2=O)c4c(O)c(\C=N/N5CCN(C)CC5)c(NC(=O)/C(=C\C=C\C(C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@@H](OC(=O)C)[C@@H]1C)/C)c(O)c4c(O)c3C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 P16 compound treatment 10.6906 0.87357 0.2344 11.8583 1.6175 0.3832 0.4367 0.9722 3174220 BSPBio_003514 CO[C@@H]1C[C@@H](C[C@H]2CC[C@H](C)[C@@H](O2)[C@@H](C)C(=O)O)O[C@]3(O[C@@](C)(C[C@H]3C)[C@H]4CC[C@](C)(O4)C5O[C@H](C[C@@H]5C)C6O[C@@](O)(CO)[C@H](C)C[C@@H]6C)[C@@H]1C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 P17 compound treatment 8.2496 -1.5674 -0.4206 9.557 -0.68379 -0.162 -0.4119 -0.914 3198954 BSPBio_003515 CC[C@H](C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 P18 compound treatment 9.2032 -0.61375 -0.1647 7.7835 -2.4573 -0.5822 -0.5281 -0.8729 191 BSPBio_003516 CCCc1c(O)c(ccc1OCCCCc2nnn[nH]2)C(=O)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 P19 compound treatment 9.339 -0.47804 -0.1283 7.9667 -2.2741 -0.5388 -0.4717 -0.8516 907526 BSPBio_003517 CN1CCN(CC(=O)N2c3c(C)scc3C(=O)Nc4ccccc24)CC1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 P20 compound treatment 11.5931 1.7761 0.4766 8.3251 -1.9157 -0.4539 0.016 0.0244 3173485 BSPBio_003518 OC[C@H]1O[C@H](Oc2cccc3[C@H]([C@@H]4c5cccc(O[C@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)c5C(=O)c7c(O)cc(cc47)C(=O)O)c8cc(cc(O)c8C(=O)c23)C(=O)O)[C@H](O)[C@@H](O)[C@@H]1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 P21 compound treatment 9.0443 -0.77264 -0.2073 8.3875 -1.8533 -0.4391 -0.4571 -0.9413 3081180 BSPBio_003519 CN1[C@@H]2CC[C@@H]1CC(O)C2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 P22 compound treatment 10.8951 1.0781 0.2893 9.0008 -1.24 -0.2938 -0.0032 -0.0078 2060321 BSPBio_003520 C[C@@H]1O[C@@H](O[C@@H]2[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]2Oc3cc(O)c4c(=O)cc(oc4c3)c5ccc(O)cc5)[C@H](O)[C@H](O)[C@H]1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 P23 mock treatment 8.6004 -1.2166 -0.3264 14.1443 3.9034 0.9249 0.4232 0.4314 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2463 P24 mock treatment 9.0198 -0.79723 -0.2139 10.2162 -0.024599 -0.0058 -0.1554 -0.7261 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 A01 mock treatment 11.5526 1.4847 0.3984 14.7686 4.7147 1.1171 1.0716 0.9035 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 A02 mock treatment 13.1305 3.0626 0.8218 10.0265 -0.0274 -0.0065 0.5765 0.7015 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 A03 compound treatment 12.1605 2.0926 0.5615 11.5121 1.4582 0.3455 0.6413 0.9728 3480106 BSPBio_003521 CC(C)(C(=O)O)c1ccc(cc1)C(O)CCCN2CCC(CC2)C(O)(c3ccccc3)c4ccccc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 A04 mock treatment 11.4966 1.4287 0.3834 10.1848 0.13094 0.031 0.293 0.7618 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 A05 compound treatment 18.8356 8.7677 2.3526 10.9898 0.93587 0.2217 1.8203 0.7703 BSPBio_003522 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 A06 mock treatment 9.3864 -0.68154 -0.1829 11.1805 1.1266 0.2669 0.0594 0.1837 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 A07 compound treatment 11.287 1.2191 0.3271 9.8979 -0.15598 -0.037 0.2052 0.6233 3054095 BSPBio_003523 CCC(/C=C/[C@@H](C)[C@H]1CCC2C3CC=C4C[C@@H](O)CC[C@]4(C)C3CC[C@]12C)C(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 A08 mock treatment 8.9872 -1.0807 -0.29 11.9849 1.931 0.4575 0.1185 0.2187 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 A09 compound treatment 11.0999 1.032 0.2769 11.0459 0.99206 0.2351 0.362 0.9967 2069287 BSPBio_003524 CCCCCC1C(CC(=O)OC)CCC1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 A10 mock treatment 10.9541 0.88626 0.2378 10.6132 0.55934 0.1325 0.2619 0.9619 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 A11 compound treatment 11.5188 1.4509 0.3893 9.4543 -0.59963 -0.1421 0.1748 0.4218 2069289 BSPBio_003525 CC(=O)Oc1cc2c(CC3OC34[C@@]2(C)CC[C@@]5(C)C6C[C@@](C)(CC[C@]6(C)CC[C@]45C)C(=O)O)c(C)c1OC(=O)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 A12 mock treatment 11.3167 1.2488 0.3351 11.2003 1.1464 0.2716 0.429 0.9946 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 A13 compound treatment 12.3027 2.2348 0.5997 9.728 -0.32587 -0.0772 0.3694 0.611 2475 BSPBio_003526 CC(=CC1C(C(=O)O)C1(C)C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 A14 mock treatment 9.6281 -0.43981 -0.118 10.2579 0.20405 0.0483 -0.0493 -0.3863 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 A15 compound treatment 9.6017 -0.46621 -0.1251 11.9913 1.9374 0.459 0.2361 0.4963 2060112 BSPBio_003527 COc1ccc(/C=C/c2cc(O)cc(O)c2)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 A16 mock treatment 11.8818 1.8139 0.4867 11.5965 1.5427 0.3655 0.6026 0.99 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 A17 compound treatment 9.2275 -0.84041 -0.2255 12.2379 2.184 0.5175 0.2065 0.3657 2060338 BSPBio_003528 CC(C)c1ccc2c(CC[C@H]3C4=C(CC[C@@]32C)C(=O)OC4)c1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 A18 mock treatment 9.6743 -0.39362 -0.1056 9.9214 -0.13245 -0.0314 -0.0969 -0.8792 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 A19 compound treatment 12.7007 2.6328 0.7064 9.3367 -0.71714 -0.1699 0.3794 0.5221 3174115 BSPBio_003529 CC[C@H](CCC(C)[C@H]1CCC2C3CCC4C[C@@H](O)CC[C@]4(C)C3CC[C@]12C)C(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 A20 mock treatment 9.9294 -0.13851 -0.0372 11.1104 1.0565 0.2503 0.1507 0.5956 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 A21 compound treatment 11.3639 1.296 0.3477 8.3989 -1.655 -0.3921 -0.0314 -0.0599 2060334 BSPBio_003530 C[C@H]1[C@@H](O)C[C@H]2[C@@H]1[C@H](O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)OC=C2C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 A22 mock treatment 11.3674 1.2996 0.3487 11.7499 1.696 0.4019 0.5307 0.9975 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 A23 mock treatment 9.7203 -0.34756 -0.0933 9.1203 -0.93362 -0.2212 -0.2224 -0.9263 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 A24 mock treatment 9.7428 -0.3251 -0.0872 7.7757 -2.2782 -0.5398 -0.4434 -0.8109 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 B01 mock treatment 19.0879 9.02 2.4203 10.2653 0.21138 0.0501 1.7468 0.7216 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 B02 mock treatment 9.5253 -0.54262 -0.1456 9.3475 -0.70643 -0.1674 -0.2213 -0.9976 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 B03 mock treatment 11.7699 1.7021 0.4567 8.5291 -1.5247 -0.3613 0.0675 0.1159 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 B04 mock treatment 11.5413 1.4734 0.3954 10.6312 0.57736 0.1368 0.3763 0.8995 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 B05 mock treatment 11.5897 1.5218 0.4083 11.3315 1.2776 0.3027 0.5028 0.9891 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 B06 mock treatment 10.7795 0.71164 0.191 11.6296 1.5757 0.3733 0.399 0.9515 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 B07 mock treatment 10.8024 0.73447 0.1971 11.4738 1.4199 0.3364 0.3772 0.9675 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 B08 mock treatment 8.9815 -1.0863 -0.2915 9.1967 -0.85719 -0.2031 -0.3497 -0.9844 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 B09 mock treatment 10.693 0.62511 0.1677 9.1659 -0.88797 -0.2104 -0.0302 -0.1121 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 B10 mock treatment 11.3354 1.2675 0.3401 31.9253 21.871 5.1821 3.9048 0.7519 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 B11 mock treatment 10.7624 0.69454 0.1864 9.6568 -0.39711 -0.0941 0.0652 0.3125 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 B12 mock treatment 10.3644 0.29649 0.0796 10.1167 0.06286 0.0149 0.0668 0.8251 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 B13 mock treatment 12.1435 2.0756 0.5569 8.606 -1.4479 -0.3431 0.1512 0.2312 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 B14 mock treatment 9.7403 -0.32754 -0.0879 8.5885 -1.4654 -0.3472 -0.3077 -0.859 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 B15 mock treatment 13.1751 3.1072 0.8337 8.8089 -1.245 -0.295 0.381 0.4308 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 B16 mock treatment 10.9609 0.893 0.2396 10.194 0.14014 0.0332 0.1929 0.7975 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 B17 mock treatment 10.9169 0.84899 0.2278 13.118 3.0641 0.726 0.6744 0.8864 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 B18 mock treatment 9.366 -0.70191 -0.1883 8.9936 -1.0603 -0.2512 -0.3108 -0.9899 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 B19 mock treatment 12.4194 2.3515 0.631 8.5373 -1.5166 -0.3593 0.1921 0.2645 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 B20 mock treatment 11.0685 1.0006 0.2685 10.1656 0.11176 0.0265 0.2086 0.7731 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 B21 mock treatment 7.9438 -2.1241 -0.5699 10.6695 0.61559 0.1459 -0.2999 -0.5097 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 B22 mock treatment 8.9296 -1.1383 -0.3054 8.5688 -1.485 -0.3519 -0.4648 -0.9975 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 B23 mock treatment 10.9346 0.86671 0.2326 8.7793 -1.2746 -0.302 -0.0491 -0.1288 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 B24 mock treatment 10.6102 0.54231 0.1455 10.0854 0.031497 0.0075 0.1082 0.7424 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 C01 mock treatment 9.9185 -0.14938 -0.0401 9.7339 -0.32004 -0.0758 -0.082 -0.9556 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 C02 mock treatment 10.2263 0.1584 0.0425 10.0261 -0.02781 -0.0066 0.0254 0.5904 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 C03 compound treatment 15.0511 4.9832 1.3371 11.6336 1.5797 0.3743 1.2101 0.8715 854065 BSPBio_003531 CCCCCCCCCCCC1=C(O)C(=O)C=C(O)C1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 C04 mock treatment 10.8681 0.80022 0.2147 9.2585 -0.79534 -0.1884 0.0186 0.065 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 C05 compound treatment 14.7528 4.6849 1.2571 10.5423 0.48841 0.1157 0.9707 0.7689 2060337 BSPBio_003532 COc1ccc(cc1O)c2oc3cc(O[C@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)c(OC)c(O)c3c(=O)c2OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 C06 mock treatment 10.8671 0.79919 0.2144 9.6569 -0.39697 -0.0941 0.0851 0.3635 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 C07 compound treatment 10.5877 0.51985 0.1395 9.1396 -0.91424 -0.2166 -0.0545 -0.2117 783 BSPBio_003533 CO[C@@]12C[C@@H](COC(=O)c3cncc(Br)c3)CN(C)[C@@H]2Cc4cn(C)c5cccc1c45 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 C08 mock treatment 9.755 -0.3129 -0.084 10.2426 0.18872 0.0447 -0.0277 -0.2917 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 C09 compound treatment 9.8895 -0.17834 -0.0479 9.1845 -0.86941 -0.206 -0.1795 -0.8488 3079215 BSPBio_003534 CC(C)C[C@H](N)C(=O)N[C@@H](C)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 C10 mock treatment 8.0576 -2.0103 -0.5394 9.9824 -0.071443 -0.0169 -0.3934 -0.7289 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 C11 compound treatment 9.2387 -0.8292 -0.2225 10.5366 0.48271 0.1144 -0.0765 -0.3056 3198430 BSPBio_003535 CC(C)C(NC(=O)C(Cc1ccc(O)cc1)NC(=O)C(NC(=O)C(F)(F)F)C(C)C)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 C12 mock treatment 9.3609 -0.70697 -0.1897 10.9994 0.94548 0.224 0.0243 0.0827 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 C13 compound treatment 8.4621 -1.6057 -0.4309 9.1721 -0.88181 -0.2089 -0.4524 -0.9448 3079214 BSPBio_003536 CC(C)CC(NC(=O)CN)C(=O)NC(Cc1ccccc1)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 C14 mock treatment 11.6076 1.5397 0.4131 9.8762 -0.17773 -0.0421 0.2624 0.6318 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 C15 compound treatment 11.4712 1.4034 0.3766 9.6729 -0.38095 -0.0903 0.2024 0.5228 3081193 BSPBio_003537 C/N=C(\N)/NCCC[C@H](N)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 C16 mock treatment 8.6763 -1.3916 -0.3734 9.0613 -0.99257 -0.2352 -0.4303 -0.9752 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 C17 compound treatment 10.1314 0.063477 0.017 11.1069 1.053 0.2495 0.1885 0.7536 3198433 BSPBio_003538 NC(Cc1c[nH]cn1)C(=O)Nc2ccc3ccccc3c2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 C18 mock treatment 10.326 0.25815 0.0693 8.209 -1.8449 -0.4371 -0.2601 -0.5877 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 C19 compound treatment 11.3601 1.2922 0.3467 9.5776 -0.47632 -0.1129 0.1654 0.4535 3198432 BSPBio_003539 CSC(=N)NCCC[C@@H](N)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 C20 mock treatment 8.4998 -1.5681 -0.4208 9.149 -0.90493 -0.2144 -0.4491 -0.9511 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 C21 compound treatment 10.7068 0.6389 0.1714 10.4348 0.38089 0.0902 0.185 0.9551 1466 BSPBio_003540 NCCCCC(N)C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NC(CCCCN)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 C22 mock treatment 9.9132 -0.15468 -0.0415 9.4713 -0.58259 -0.138 -0.127 -0.8808 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 C23 mock treatment 10.1206 0.052672 0.0141 14.2979 4.244 1.0056 0.721 0.717 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 C24 mock treatment 9.9078 -0.16009 -0.043 7.8781 -2.1758 -0.5155 -0.3949 -0.7634 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 D01 mock treatment 10.5919 0.52399 0.1406 10.1638 0.10995 0.0261 0.1178 0.8241 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 D02 mock treatment 11.3596 1.2917 0.3466 9.1788 -0.87506 -0.2073 0.0985 0.2438 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 D03 mock treatment 11.722 1.6542 0.4439 10.6135 0.55958 0.1326 0.4076 0.8799 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 D04 mock treatment 10.5995 0.53162 0.1426 8.8663 -1.1875 -0.2814 -0.0981 -0.3109 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 D05 mock treatment 10.301 0.23308 0.0625 10.7116 0.65768 0.1558 0.1544 0.9196 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 D06 mock treatment 10.6203 0.55242 0.1482 9.3327 -0.72115 -0.1709 -0.016 -0.0708 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 D07 mock treatment 9.6267 -0.4412 -0.1184 9.6715 -0.38235 -0.0906 -0.1478 -0.9913 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 D08 mock treatment 11.2745 1.2066 0.3238 9.9523 -0.10154 -0.0241 0.2119 0.6528 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 D09 mock treatment 10.3192 0.2513 0.0674 8.238 -1.8158 -0.4302 -0.2565 -0.5891 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 D10 mock treatment 9.733 -0.33491 -0.0899 9.5383 -0.51556 -0.1222 -0.1499 -0.9886 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 D11 mock treatment 10.1799 0.11206 0.0301 10.4847 0.43085 0.1021 0.0934 0.8781 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 D12 mock treatment 10.9708 0.90287 0.2423 9.2723 -0.78162 -0.1852 0.0404 0.1323 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 D13 mock treatment 9.7944 -0.27344 -0.0734 9.3947 -0.65919 -0.1562 -0.1623 -0.9407 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 D14 mock treatment 11.462 1.3941 0.3741 9.0751 -0.97875 -0.2319 0.1005 0.2284 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 D15 mock treatment 12.4665 2.3986 0.6436 8.9118 -1.1421 -0.2706 0.2638 0.3778 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 D16 mock treatment 9.6542 -0.41372 -0.111 8.9927 -1.0612 -0.2514 -0.2563 -0.9325 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 D17 mock treatment 10.4398 0.37187 0.0998 9.7224 -0.33149 -0.0785 0.015 0.1183 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 D18 mock treatment 11.3297 1.2618 0.3386 9.4963 -0.55758 -0.1321 0.146 0.4017 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 D19 mock treatment 11.1766 1.1087 0.2975 9.049 -1.0049 -0.2381 0.042 0.1102 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 D20 mock treatment 8.6527 -1.4152 -0.3797 9.8127 -0.24119 -0.0571 -0.3089 -0.8045 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 D21 mock treatment 9.9772 -0.090711 -0.0243 9.8232 -0.23071 -0.0547 -0.0559 -0.9336 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 D22 mock treatment 8.6816 -1.3863 -0.372 8.966 -1.0879 -0.2578 -0.4453 -0.9839 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 D23 mock treatment 10.0836 0.015699 0.0042 8.7037 -1.3502 -0.3199 -0.2232 -0.6977 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 D24 mock treatment 12.4895 2.4216 0.6498 7.479 -2.5749 -0.6101 0.0281 0.0315 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 E01 mock treatment 10.8328 0.76487 0.2052 10.3866 0.33268 0.0788 0.2009 0.9136 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 E02 mock treatment 9.4344 -0.63348 -0.17 9.4824 -0.57151 -0.1354 -0.2159 -0.9937 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 E03 compound treatment 10.5084 0.44053 0.1182 11.3668 1.3129 0.3111 0.3035 0.9122 1538 BSPBio_003541 Oc1ccc(c(O)c1)c2oc3cc(O)cc(O)c3c(=O)c2O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 E04 mock treatment 9.0413 -1.0266 -0.2755 11.0856 1.0317 0.2445 -0.0219 -0.0595 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 E05 compound treatment 9.8654 -0.20253 -0.0543 10.2902 0.23633 0.056 0.0012 0.015 873168 BSPBio_003542 OC(=O)c1cc(O)c2ccc(Cl)cc2n1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 E06 mock treatment 12.6072 2.5393 0.6814 9.2021 -0.85182 -0.2018 0.3391 0.4772 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 E07 compound treatment 8.6744 -1.3935 -0.3739 9.7697 -0.2842 -0.0673 -0.312 -0.8212 1452 BSPBio_003543 CCCCN(CCCC)CCCOC(=O)c1ccc(N)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 E08 mock treatment 9.1066 -0.96128 -0.2579 9.3301 -0.7238 -0.1715 -0.3037 -0.9803 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 E09 compound treatment 12.1622 2.0943 0.562 10.065 0.011112 0.0026 0.3992 0.7104 3079387 BSPBio_003544 CN(/C=N/c1ccc(C)cc1C)/C=N/c2ccc(C)cc2C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 E10 mock treatment 8.3787 -1.6892 -0.4533 8.6707 -1.3832 -0.3277 -0.5522 -0.9873 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 E11 compound treatment 11.2863 1.2184 0.3269 10.5081 0.45426 0.1076 0.3073 0.8928 3199905 BSPBio_003545 CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C2=O)c4c5nc6cc(C)ccn6c5c(NC(=O)/C(=C\C=C\[C@H](C)[C@H](O)[C@@H](C)C(O)[C@@H](C)[C@H](OC(=O)C)[C@@H]1C)/C)c(O)c4c(O)c3C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 E12 mock treatment 11.1001 1.0323 0.277 8.6383 -1.4156 -0.3354 -0.0413 -0.095 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 E13 compound treatment 9.4644 -0.60346 -0.1619 11.0207 0.96682 0.2291 0.0475 0.1693 3198427 BSPBio_003546 CCCCCCCCCc1ccc(OCCOCCOCCOCCOCCOCCOCCOCCOCCO)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 E14 mock treatment 9.4096 -0.65825 -0.1766 11.6137 1.5598 0.3696 0.1364 0.3331 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 E15 compound treatment 10.1438 0.075907 0.0204 8.8914 -1.1625 -0.2754 -0.1804 -0.653 1007083 BSPBio_003547 Oc1cc(O)c2C(=O)c3ccccc3C(=O)c2c1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 E16 mock treatment 9.4453 -0.62254 -0.167 10.704 0.65008 0.154 -0.0092 -0.0405 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 E17 compound treatment 10.26 0.19208 0.0515 9.4976 -0.55632 -0.1318 -0.0568 -0.401 3199906 BSPBio_003548 CC[C@H]1OC(=O)C[C@@H](O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(O)[C@@H](O)[C@H](C)O3)[C@@H]([C@H]2O)N(C)C)[C@@H](CC=O)C[C@@H](C)C(=O)/C=C/C(=C/[C@@H]1CO[C@@H]4O[C@H](C)[C@@H](O)[C@@H](OC)[C@H]4OC)/C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 E18 mock treatment 10.2521 0.1842 0.0494 8.9322 -1.1217 -0.2658 -0.153 -0.5659 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 E19 compound treatment 9.4559 -0.61201 -0.1642 7.5567 -2.4972 -0.5917 -0.5345 -0.8705 832325 BSPBio_003549 COC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CC(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 E20 mock treatment 7.9882 -2.0796 -0.558 8.7905 -1.2634 -0.2993 -0.6062 -0.9574 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 E21 compound treatment 10.5629 0.49501 0.1328 8.2667 -1.7871 -0.4234 -0.2055 -0.4631 1008492 BSPBio_003550 O=C(CC(=O)c1ccccc1)c2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 E22 mock treatment 9.4253 -0.64254 -0.1724 9.5637 -0.49024 -0.1162 -0.204 -0.9815 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 E23 mock treatment 7.6996 -2.3683 -0.6355 9.1511 -0.90279 -0.2139 -0.6006 -0.8957 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 E24 mock treatment 9.2024 -0.86553 -0.2322 10.4144 0.36049 0.0854 -0.1038 -0.4196 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 F01 mock treatment 10.7444 0.67655 0.1815 9.7594 -0.29451 -0.0698 0.079 0.4063 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 F02 mock treatment 11.7201 1.6522 0.4433 10.2492 0.19536 0.0463 0.3462 0.7767 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 F03 mock treatment 10.694 0.62612 0.168 9.5694 -0.48449 -0.1148 0.0376 0.1849 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 F04 mock treatment 11.4391 1.3712 0.3679 12.2488 2.1949 0.5201 0.6279 0.9856 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 F05 mock treatment 9.8881 -0.1798 -0.0482 11.6037 1.5498 0.3672 0.2255 0.609 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 F06 mock treatment 12.3162 2.2483 0.6033 9.6599 -0.394 -0.0934 0.3606 0.5907 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 F07 mock treatment 9.8151 -0.2528 -0.0678 10.4146 0.36074 0.0855 0.0125 0.1143 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 F08 mock treatment 8.2635 -1.8043 -0.4842 11.3108 1.2569 0.2978 -0.1318 -0.2318 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 F09 mock treatment 8.323 -1.7449 -0.4682 8.7039 -1.35 -0.3199 -0.5572 -0.9827 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 F10 mock treatment 11.2709 1.203 0.3228 9.2252 -0.82866 -0.1963 0.0894 0.2367 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 F11 mock treatment 7.8247 -2.2432 -0.6019 10.3789 0.32499 0.077 -0.3712 -0.6117 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 F12 mock treatment 8.8782 -1.1896 -0.3192 8.7676 -1.2863 -0.3048 -0.4412 -0.9997 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 F13 mock treatment 10.4942 0.42629 0.1144 9.6205 -0.43342 -0.1027 0.0083 0.0538 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 F14 mock treatment 9.578 -0.48987 -0.1314 8.97 -1.0838 -0.2568 -0.2745 -0.9516 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 F15 mock treatment 8.6158 -1.4521 -0.3896 10.1475 0.09357 0.0222 -0.2598 -0.6658 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 F16 mock treatment 9.2674 -0.80052 -0.2148 11.4237 1.3698 0.3245 0.0776 0.1994 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 F17 mock treatment 7.9858 -2.0821 -0.5587 8.7193 -1.3346 -0.3162 -0.6186 -0.9637 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 F18 mock treatment 10.1179 0.050037 0.0134 8.4049 -1.6489 -0.3907 -0.2668 -0.6824 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 F19 mock treatment 11.8879 1.82 0.4883 10.52 0.4661 0.1104 0.4234 0.8457 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 F20 mock treatment 9.9931 -0.074786 -0.0201 8.9015 -1.1524 -0.273 -0.2073 -0.757 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 F21 mock treatment 9.3418 -0.72613 -0.1948 8.5709 -1.483 -0.3514 -0.3862 -0.9613 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 F22 mock treatment 12.9537 2.8858 0.7743 10.6986 0.64475 0.1528 0.6556 0.8306 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 F23 mock treatment 13.0238 2.9559 0.7932 9.033 -1.0209 -0.2419 0.3898 0.4701 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 F24 mock treatment 9.117 -0.95086 -0.2551 7.9592 -2.0947 -0.4963 -0.5313 -0.9522 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 G01 mock treatment 10.4642 0.39627 0.1063 11.7854 1.7315 0.4102 0.3653 0.8619 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 G02 mock treatment 11.0681 1.0003 0.2684 10.1871 0.13317 0.0316 0.2121 0.7848 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 G03 compound treatment 87.1576 77.09 20.6851 75.0335 64.98 15.396 25.5132 0.9894 758 BSPBio_003551 CCCOc1ccc2nc(NC(=O)OC)[nH]c2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 G04 mock treatment 9.7853 -0.28254 -0.0758 9.4294 -0.62452 -0.148 -0.1582 -0.9517 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 G05 compound treatment 11.0105 0.94262 0.2529 10.631 0.57707 0.1367 0.2755 0.9583 1090918 BSPBio_003552 Cc1nc(C)c(Cl)c(O)c1Cl 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 G06 mock treatment 10.4878 0.41988 0.1127 11.366 1.3121 0.3109 0.2995 0.9057 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 G07 compound treatment 11.3616 1.2937 0.3471 11.4335 1.3797 0.3269 0.4766 0.9995 3199907 BSPBio_003553 OC(=O)c1cn(c2ccc(F)cc2)c3cc(N4CCNCC4)c(F)cc3c1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 G08 mock treatment 10.0081 -0.059756 -0.016 10.6588 0.60486 0.1433 0.09 0.6241 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 G09 compound treatment 9.1156 -0.95226 -0.2555 9.5012 -0.5527 -0.131 -0.2733 -0.9518 3078276 BSPBio_003554 COC(=O)N/N=C/c1c[n+]([O-])c2ccccc2[n+]1[O-] 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 G10 mock treatment 10.8221 0.75425 0.2024 9.2195 -0.83437 -0.1977 0.0033 0.0117 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 G11 compound treatment 9.4619 -0.60597 -0.1626 9.2485 -0.80543 -0.1908 -0.2499 -0.9968 3198533 BSPBio_003555 CCc1c(C)c2=Cc3c(C=C)c(C)c4C=c5c(C)c(CCC(=O)O)c6=C7C(C(=O)O)C(=O)c8c(C)c9C=c1n2[Cu](n9c78)(n43)n56 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 G12 mock treatment 8.4849 -1.5829 -0.4247 9.9365 -0.1174 -0.0278 -0.32 -0.7518 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 G13 compound treatment 8.8085 -1.2593 -0.3379 9.8899 -0.16403 -0.0389 -0.2664 -0.7833 3077147 BSPBio_003556 CC(O)Cn1c(C)ncc1[N+](=O)[O-] 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 G14 mock treatment 10.0373 -0.030551 -0.0082 9.5648 -0.48909 -0.1159 -0.0877 -0.7552 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 G15 compound treatment 16.3148 6.2469 1.6762 10.9367 0.8828 0.2092 1.3332 0.7892 907420 BSPBio_003557 CNC(=N)NCCC[C@H](N)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 G16 mock treatment 10.7888 0.72093 0.1934 10.3914 0.33752 0.08 0.1933 0.9236 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 G17 compound treatment 10.3889 0.321 0.0861 11.1332 1.0793 0.2557 0.2417 0.8958 435 BSPBio_003558 CC(C)Cn1c(=O)n(C)c(=O)c2nc[nH]c12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 G18 mock treatment 9.9974 -0.070481 -0.0189 10.2104 0.15647 0.0371 0.0128 0.3086 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 G19 compound treatment 10.7362 0.66829 0.1793 9.3192 -0.73466 -0.1741 0.0037 0.0149 3480338 BSPBio_003559 OC(=O)C(Cc1cc(=O)[nH]c2ccccc12)NC(=O)c3ccc(Cl)cc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 G20 mock treatment 10.3239 0.25603 0.0687 10.4829 0.42901 0.1016 0.1205 0.9818 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 G21 compound treatment 11.41 1.3421 0.3601 9.194 -0.85987 -0.2037 0.1106 0.2673 2801 BSPBio_003560 CCCCCCNC(=O)n1cc(F)c(=O)[nH]c1=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 G22 mock treatment 9.1385 -0.92938 -0.2494 8.8328 -1.2211 -0.2893 -0.3809 -0.9973 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 G23 mock treatment 9.893 -0.17489 -0.0469 9.421 -0.63288 -0.15 -0.1392 -0.886 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 G24 mock treatment 12.5398 2.4719 0.6633 9.9596 -0.094295 -0.0223 0.4532 0.6829 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 H01 mock treatment 11.5244 1.4565 0.3908 11.0932 1.0394 0.2463 0.4505 0.9752 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 H02 mock treatment 9.5244 -0.54344 -0.1458 12.1482 2.0943 0.4962 0.2478 0.4791 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 H03 mock treatment 11.942 1.8742 0.5029 8.7839 -1.27 -0.3009 0.1428 0.2437 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 H04 mock treatment 9.8254 -0.24244 -0.0651 9.1669 -0.88694 -0.2101 -0.1946 -0.8846 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 H05 mock treatment 11.4657 1.3978 0.3751 10.7779 0.72398 0.1715 0.3865 0.9371 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 H06 mock treatment 9.5807 -0.48718 -0.1307 9.2037 -0.85023 -0.2014 -0.2349 -0.9781 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 H07 mock treatment 10.0254 -0.042456 -0.0114 8.4651 -1.5888 -0.3764 -0.2742 -0.7282 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 H08 mock treatment 9.8072 -0.26069 -0.07 10.5987 0.54482 0.1291 0.0418 0.2848 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 H09 mock treatment 8.6094 -1.4585 -0.3913 9.9473 -0.1066 -0.0253 -0.2946 -0.7512 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 H10 mock treatment 9.7029 -0.36501 -0.0979 8.7848 -1.2691 -0.3007 -0.2819 -0.8913 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 H11 mock treatment 10.6483 0.58038 0.1557 10.2235 0.16958 0.0402 0.1385 0.8613 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 H12 mock treatment 9.2151 -0.85283 -0.2288 10.0118 -0.042045 -0.01 -0.1689 -0.7372 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 H13 mock treatment 10.9238 0.85592 0.2297 9.8546 -0.19931 -0.0472 0.129 0.5502 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 H14 mock treatment 10.3368 0.26891 0.0722 11.4567 1.4028 0.3324 0.2861 0.841 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 H15 mock treatment 10.4212 0.35331 0.0948 10.6892 0.63527 0.1505 0.1735 0.9752 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 H16 mock treatment 10.878 0.81016 0.2174 11.6032 1.5493 0.3671 0.4133 0.9687 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 H17 mock treatment 11.4111 1.3432 0.3604 10.2105 0.15662 0.0371 0.2811 0.7758 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 H18 mock treatment 11.0774 1.0096 0.2709 9.1577 -0.89618 -0.2123 0.0414 0.1203 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 H19 mock treatment 9.7886 -0.27929 -0.0749 9.5191 -0.53478 -0.1267 -0.1426 -0.9686 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 H20 mock treatment 10.837 0.76913 0.2064 8.663 -1.3909 -0.3296 -0.0871 -0.224 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 H21 mock treatment 10.6992 0.63135 0.1694 8.9904 -1.0635 -0.252 -0.0584 -0.1923 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 H22 mock treatment 8.7486 -1.3193 -0.354 9.2466 -0.8073 -0.1913 -0.3856 -0.9582 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 H23 mock treatment 10.1891 0.12117 0.0325 11.8139 1.76 0.417 0.3179 0.7599 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 H24 mock treatment 9.4404 -0.62748 -0.1684 10.4905 0.43664 0.1035 -0.0459 -0.2323 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 I01 mock treatment 12.9766 2.9087 0.7805 11.6236 1.5697 0.3719 0.8149 0.9425 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 I02 mock treatment 12.143 2.0751 0.5568 10.5964 0.54247 0.1285 0.4846 0.848 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 I03 compound treatment 11.1346 1.0667 0.2862 11.0926 1.0387 0.2461 0.3764 0.9972 2335 BSPBio_003561 COc1ccc(/C=C/C(=O)Nc2ccccc2C(=O)O)cc1OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 I04 mock treatment 10.9187 0.85083 0.2283 7.9715 -2.0824 -0.4934 -0.1874 -0.3448 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 I05 compound treatment 11.9523 1.8844 0.5056 12.1549 2.101 0.4978 0.7095 1.0 1099044 BSPBio_003562 CC(C)(C)C(=O)C(Oc1ccc(Cl)cc1)n2cncn2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 I06 mock treatment 11.4034 1.3355 0.3583 12.2417 2.1878 0.5184 0.6199 0.9837 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 I07 compound treatment 12.5702 2.5023 0.6714 11.8573 1.8034 0.4273 0.7769 0.9762 1000069 BSPBio_003563 COc1ccc2C[C@H]3N(C)CCc4cc(OC)c(Oc5c6OCOc6cc7CCN(C)[C@@H](Cc8ccc(Oc1c2)cc8)c75)cc34 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 I08 mock treatment 9.6581 -0.40976 -0.1099 8.9544 -1.0995 -0.2605 -0.262 -0.9264 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 I09 compound treatment 11.4549 1.387 0.3722 10.2049 0.15104 0.0358 0.2885 0.7715 3182 BSPBio_003564 CCCc1cc(ccn1)C(=S)N 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 I10 mock treatment 10.5037 0.43585 0.1169 10.2761 0.22226 0.0527 0.1199 0.9351 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 I11 compound treatment 28.866 18.798 5.044 29.7255 19.672 4.6609 6.8624 0.9992 3077356 BSPBio_003565 COc1cc(cc(OC)c1O)[C@H]2C3C(COC3=O)[C@H](O)c4cc5OCOc5cc24 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 I12 mock treatment 8.704 -1.3639 -0.366 8.8472 -1.2067 -0.2859 -0.4609 -0.9925 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 I13 compound treatment 9.5835 -0.4844 -0.13 10.07 0.016075 0.0038 -0.0892 -0.6861 1078453 BSPBio_003566 Fc1ccc(cc1)C(=O)CCCN2CCN(CC2)c3ccccn3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 I14 mock treatment 11.8502 1.7823 0.4782 11.0828 1.0289 0.2438 0.5105 0.9511 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 I15 compound treatment 8.7017 -1.3662 -0.3666 12.1916 2.1378 0.5065 0.0989 0.1582 3077146 BSPBio_003567 CN[C@@H]1[C@@H](O)C(OC2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](C(C)O)[C@@H](O)[C@H](O)[C@H]3N)[C@H]2O)OC[C@]1(C)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 I16 mock treatment 9.8147 -0.25315 -0.0679 10.2109 0.15698 0.0372 -0.0217 -0.2806 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 I17 compound treatment 10.0846 0.016682 0.0045 10.5147 0.46082 0.1092 0.0804 0.7355 3069053 BSPBio_003568 CCOC(=O)n1ccn(C)c1=S 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 I18 mock treatment 9.8458 -0.22207 -0.0596 9.0636 -0.99031 -0.2346 -0.208 -0.8594 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 I19 compound treatment 10.4562 0.3883 0.1042 8.4761 -1.5778 -0.3738 -0.1907 -0.4913 3078275 BSPBio_003569 C[C@@H](N)CO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 I20 mock treatment 11.3965 1.3286 0.3565 9.6345 -0.41935 -0.0994 0.1818 0.4913 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 I21 compound treatment 11.2886 1.2207 0.3275 9.2766 -0.77727 -0.1842 0.1014 0.2698 3480340 BSPBio_003570 c1cn(cn1)C(c2ccccc2)c3ccc(cc3)c4ccccc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 I22 mock treatment 11.2781 1.2102 0.3247 9.6553 -0.39861 -0.0944 0.1628 0.4815 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 I23 mock treatment 10.0017 -0.066236 -0.0178 11.3076 1.2537 0.297 0.1975 0.6636 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 I24 mock treatment 9.8487 -0.21921 -0.0588 10.5541 0.50025 0.1185 0.0422 0.3191 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 J01 mock treatment 9.6038 -0.46407 -0.1245 8.6471 -1.4067 -0.3333 -0.3237 -0.9099 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 J02 mock treatment 9.1334 -0.93446 -0.2507 9.7145 -0.33934 -0.0804 -0.2342 -0.8892 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 J03 mock treatment 13.4586 3.3907 0.9098 13.8554 3.8015 0.9007 1.2802 1.0 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 J04 mock treatment 14.8831 4.8152 1.292 9.8602 -0.19365 -0.0459 0.8812 0.6816 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 J05 mock treatment 10.8135 0.74566 0.2001 42.7848 32.731 7.7551 5.6252 0.7251 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 J06 mock treatment 10.7529 0.68505 0.1838 11.5164 1.4625 0.3465 0.375 0.956 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 J07 mock treatment 9.0063 -1.0616 -0.2849 10.5908 0.53694 0.1272 -0.1115 -0.3573 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 J08 mock treatment 8.7363 -1.3316 -0.3573 9.1004 -0.95353 -0.2259 -0.4124 -0.9756 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 J09 mock treatment 9.8936 -0.17432 -0.0468 9.4201 -0.63383 -0.1502 -0.1393 -0.8854 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 J10 mock treatment 9.5513 -0.5166 -0.1386 9.841 -0.21293 -0.0505 -0.1337 -0.9063 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 J11 mock treatment 8.7524 -1.3155 -0.353 12.848 2.7941 0.662 0.2185 0.2913 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 J12 mock treatment 11.308 1.2401 0.3327 9.4777 -0.57616 -0.1365 0.1388 0.3858 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 J13 mock treatment 10.0638 -0.0041081 -0.0011 10.535 0.48115 0.114 0.0798 0.7002 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 J14 mock treatment 10.1766 0.10866 0.0292 9.2577 -0.79615 -0.1886 -0.1128 -0.5908 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 J15 mock treatment 10.4821 0.4142 0.1111 10.6196 0.5657 0.134 0.1734 0.9957 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 J16 mock treatment 10.3189 0.25106 0.0674 9.6503 -0.40363 -0.0956 -0.02 -0.1709 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 J17 mock treatment 12.0064 1.9385 0.5202 9.3473 -0.70664 -0.1674 0.2494 0.4564 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 J18 mock treatment 10.6454 0.57756 0.155 9.0908 -0.96313 -0.2282 -0.0518 -0.1877 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 J19 mock treatment 8.9746 -1.0933 -0.2934 12.2967 2.2428 0.5314 0.1683 0.2773 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 J20 mock treatment 10.3691 0.30119 0.0808 10.9839 0.92996 0.2203 0.213 0.9074 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 J21 mock treatment 11.2628 1.195 0.3206 10.2373 0.18336 0.0434 0.2574 0.7956 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 J22 mock treatment 12.8767 2.8088 0.7537 9.0865 -0.96738 -0.2292 0.3709 0.4708 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 J23 mock treatment 8.9479 -1.12 -0.3005 12.8809 2.827 0.6698 0.2611 0.3557 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 J24 mock treatment 10.4417 0.37378 0.1003 7.9782 -2.0757 -0.4918 -0.2768 -0.5516 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 K01 mock treatment 12.412 2.3441 0.629 9.2742 -0.7797 -0.1847 0.3141 0.4792 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 K02 mock treatment 10.0839 0.016004 0.0043 9.4143 -0.63963 -0.1515 -0.1041 -0.6868 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 K03 compound treatment 9.5417 -0.52617 -0.1412 8.5456 -1.5083 -0.3574 -0.3525 -0.9175 1461079 BSPBio_003571 CCn1cc(C(=O)O)c(=O)c2cc(F)c(cc12)N3CCN(C)CC3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 K04 mock treatment 11.3804 1.3125 0.3522 8.619 -1.4349 -0.34 0.0086 0.0176 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 K05 compound treatment 15.3157 5.2478 1.4081 15.1871 5.1332 1.2162 1.8557 0.9973 3198532 BSPBio_003572 COC(=O)Nc1nc2ccc(cc2[nH]1)S(=O)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 K06 mock treatment 9.7247 -0.34322 -0.0921 8.2536 -1.8002 -0.4265 -0.3667 -0.8404 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 K07 compound treatment 10.664 0.59609 0.1599 8.8532 -1.2007 -0.2845 -0.0881 -0.2698 2109 BSPBio_003573 OCc1c[nH]c2ccccc12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 K08 mock treatment 10.6637 0.59577 0.1599 11.7267 1.6728 0.3963 0.3933 0.9203 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 K09 compound treatment 8.4967 -1.5712 -0.4216 9.3363 -0.71755 -0.17 -0.4183 -0.9202 1117560 BSPBio_003574 CC(=C)C1CCC(=CC1)CO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 K10 mock treatment 9.7566 -0.31124 -0.0835 11.2212 1.1673 0.2766 0.1365 0.4725 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 K11 compound treatment 10.6478 0.57992 0.1556 10.8618 0.80795 0.1914 0.2454 0.9947 3172846 BSPBio_003575 NC(CO)(CO)CO.OC(=O)C1CCn2c(ccc12)C(=O)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 K12 mock treatment 10.0772 0.0093119 0.0025 10.3642 0.31031 0.0735 0.0538 0.7307 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 K13 compound treatment 8.3793 -1.6886 -0.4531 11.3398 1.2859 0.3047 -0.1049 -0.1922 1017318 BSPBio_003576 NC(=O)c1ccc(N)nc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 K14 mock treatment 9.3621 -0.70581 -0.1894 9.9696 -0.08425 -0.02 -0.148 -0.7773 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 K15 compound treatment 10.4324 0.3645 0.0978 11.541 1.4871 0.3523 0.3183 0.8705 3198319 BSPBio_003577 O=C1O[C@]2(C[C@H]3C=CC2=C1)[C@H]4CCCCN34 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 K16 mock treatment 9.5793 -0.48858 -0.1311 10.5338 0.47987 0.1137 -0.0123 -0.0709 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 K17 compound treatment 10.1624 0.094537 0.0254 9.5286 -0.5253 -0.1245 -0.0701 -0.5516 3078274 BSPBio_003578 N[C@H](CO)Cc1ccccc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 K18 mock treatment 10.0846 0.016669 0.0045 9.3973 -0.65663 -0.1556 -0.1068 -0.6865 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 K19 compound treatment 10.2805 0.21258 0.057 12.1967 2.1428 0.5077 0.3993 0.7816 3078461 BSPBio_003579 NCCc1ccccc1S(=O)(=O)F 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 K20 mock treatment 10.6151 0.54717 0.1468 8.4631 -1.5908 -0.3769 -0.1627 -0.4022 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 K21 compound treatment 8.7199 -1.348 -0.3617 10.3853 0.33142 0.0785 -0.2002 -0.541 1912 BSPBio_003580 [O-][N+](=O)c1cccc2cn[nH]c12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 K22 mock treatment 9.866 -0.20187 -0.0542 9.7958 -0.25811 -0.0612 -0.0815 -0.9982 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 K23 mock treatment 9.1896 -0.87827 -0.2357 9.2372 -0.81666 -0.1935 -0.3035 -0.9952 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 K24 mock treatment 10.3233 0.25542 0.0685 12.2142 2.1603 0.5118 0.4104 0.7947 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 L01 mock treatment 10.0411 -0.026821 -0.0072 8.8678 -1.1861 -0.281 -0.2038 -0.725 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 L02 mock treatment 10.0382 -0.029721 -0.008 10.8027 0.74879 0.1774 0.1198 0.6746 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 L03 mock treatment 9.5309 -0.53694 -0.1441 10.5251 0.47126 0.1117 -0.0229 -0.1258 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 L04 mock treatment 11.0173 0.94936 0.2547 9.745 -0.30891 -0.0732 0.1284 0.4843 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 L05 mock treatment 9.7816 -0.28628 -0.0768 10.1233 0.069435 0.0165 -0.0427 -0.5433 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 L06 mock treatment 9.292 -0.77593 -0.2082 9.3552 -0.69867 -0.1655 -0.2643 -0.9935 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 L07 mock treatment 8.9286 -1.1392 -0.3057 9.8858 -0.16813 -0.0398 -0.2443 -0.7926 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 L08 mock treatment 8.5141 -1.5537 -0.4169 8.0694 -1.9845 -0.4702 -0.6273 -0.9982 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 L09 mock treatment 8.5548 -1.5131 -0.406 10.9969 0.94301 0.2234 -0.1291 -0.2786 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 L10 mock treatment 7.8261 -2.2418 -0.6015 9.3498 -0.70411 -0.1668 -0.5433 -0.8704 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 L11 mock treatment 9.953 -0.11487 -0.0308 12.3974 2.3435 0.5553 0.3708 0.6668 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 L12 mock treatment 8.816 -1.2518 -0.3359 8.5902 -1.4637 -0.3468 -0.4827 -0.9999 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 L13 mock treatment 9.1133 -0.95455 -0.2561 9.3651 -0.68876 -0.1632 -0.2965 -0.9763 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 L14 mock treatment 7.9584 -2.1095 -0.566 9.6508 -0.40308 -0.0955 -0.4678 -0.8149 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 L15 mock treatment 9.0249 -1.043 -0.2799 8.6757 -1.3782 -0.3265 -0.4288 -0.9971 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 L16 mock treatment 8.7301 -1.3378 -0.359 10.6911 0.63722 0.151 -0.1471 -0.3777 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 L17 mock treatment 9.6773 -0.39054 -0.1048 8.511 -1.5429 -0.3656 -0.3326 -0.8746 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 L18 mock treatment 7.5459 -2.522 -0.6767 8.5858 -1.4681 -0.3478 -0.7245 -0.9522 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 L19 mock treatment 9.263 -0.8049 -0.216 8.8965 -1.1574 -0.2742 -0.3466 -0.993 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 L20 mock treatment 9.0544 -1.0135 -0.272 9.157 -0.89685 -0.2125 -0.3426 -0.9926 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 L21 mock treatment 9.4521 -0.61583 -0.1652 13.3163 3.2624 0.773 0.4297 0.5437 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 L22 mock treatment 9.3705 -0.69742 -0.1871 8.118 -1.9358 -0.4587 -0.4567 -0.9218 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 L23 mock treatment 10.2745 0.20664 0.0554 10.3622 0.3083 0.073 0.0909 0.9907 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 L24 mock treatment 10.9998 0.93195 0.2501 9.508 -0.54584 -0.1293 0.0854 0.3033 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 M01 mock treatment 8.9783 -1.0896 -0.2924 9.4307 -0.62316 -0.1476 -0.3111 -0.9499 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 M02 mock treatment 10.465 0.3971 0.1066 8.6464 -1.4075 -0.3335 -0.1605 -0.4583 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 M03 compound treatment 9.2455 -0.82234 -0.2207 8.1139 -1.94 -0.4596 -0.481 -0.9435 3198318 BSPBio_003581 C[C@H]1CCCC(=O)CCC/C=C/c2cc(O)cc(O)c2C(=O)O1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 M04 mock treatment 11.6468 1.5789 0.4237 11.1561 1.1022 0.2611 0.4842 0.973 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 M05 compound treatment 15.4903 5.4225 1.455 16.9913 6.9374 1.6437 2.1911 0.9982 3198320 BSPBio_003582 Clc1ccc(CO/N=C(\Cn2ccnc2)/c3ccc(Cl)cc3Cl)c(Cl)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 M06 mock treatment 8.4124 -1.6555 -0.4442 9.1133 -0.94058 -0.2229 -0.4717 -0.9491 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 M07 compound treatment 10.0529 -0.014978 -0.004 10.0827 0.028822 0.0068 0.002 0.2508 3077148 BSPBio_003583 CCCCC(=O)Oc1ccccc1C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 M08 mock treatment 9.7406 -0.32725 -0.0878 9.3935 -0.66034 -0.1565 -0.1727 -0.9627 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 M09 compound treatment 9.8282 -0.23967 -0.0643 9.2472 -0.80664 -0.1911 -0.1806 -0.8957 3480341 BSPBio_003584 CN1CCCC(CC1)n2nc(Cc3ccc(Cl)cc3)c4ccccc4c2=O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 M10 mock treatment 10.0245 -0.043431 -0.0117 11.4944 1.4405 0.3413 0.2331 0.6826 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 M11 compound treatment 9.5423 -0.52556 -0.141 18.3707 8.3168 1.9705 1.2937 0.6548 3081194 BSPBio_003585 CC(=O)O[C@@H]1CC(=O)OC(C)(C)C2CC(=O)[C@]3(C)C(CC[C@@]4(C)[C@@H](OC(=O)[C@H]5O[C@]543)c6ccoc6)[C@]21C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 M12 mock treatment 9.8825 -0.18543 -0.0498 7.7409 -2.313 -0.548 -0.4227 -0.7681 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 M13 compound treatment 8.4534 -1.6145 -0.4332 9.715 -0.3389 -0.0803 -0.3631 -0.8241 1907763 BSPBio_003586 Oc1ccc(/C=C/C(=O)OCCc2ccccc2)cc1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 M14 mock treatment 8.7938 -1.2741 -0.3419 10.2138 0.15992 0.0379 -0.2149 -0.6249 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 M15 compound treatment 11.7159 1.648 0.4422 11.3989 1.345 0.3187 0.538 0.9871 3198321 BSPBio_003587 CCCCCCCC/C=C/CCCCCCCCOP(=O)(O)OCC[N+](C)(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 M16 mock treatment 8.6295 -1.4384 -0.3859 10.6854 0.63154 0.1496 -0.1671 -0.4037 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 M17 compound treatment 13.1891 3.1212 0.8375 10.8888 0.83491 0.1978 0.7321 0.8507 2097 BSPBio_003588 CCCCCCCCCCCCCCCCOP(=O)(O)OCC[N+](C)(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 M18 mock treatment 9.4976 -0.57025 -0.153 11.6868 1.6329 0.3869 0.1654 0.3975 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 M19 compound treatment 13.724 3.6561 0.981 12.0934 2.0395 0.4832 1.0354 0.9468 122 BSPBio_003589 C(c1c[nH]c2ccccc12)c3c[nH]c4ccccc34 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 M20 mock treatment 9.6267 -0.44121 -0.1184 10.9355 0.88158 0.2089 0.064 0.2665 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 M21 compound treatment 9.1695 -0.89838 -0.2411 9.6279 -0.42598 -0.1009 -0.2418 -0.9253 3055363 BSPBio_003590 COc1cc(/C=C/C(=C/C(=O)\C=C\c2ccc(O)c(OC)c2)/O)ccc1O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 M22 mock treatment 8.1774 -1.8905 -0.5073 10.0325 -0.021423 -0.0051 -0.3623 -0.7141 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 M23 mock treatment 9.224 -0.84393 -0.2264 10.1183 0.064455 0.0153 -0.1493 -0.6579 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 M24 mock treatment 9.2815 -0.78639 -0.211 10.5024 0.44847 0.1063 -0.0741 -0.3135 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 N01 mock treatment 11.8718 1.8039 0.484 10.0067 -0.047223 -0.0112 0.3344 0.6906 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 N02 mock treatment 8.94 -1.1278 -0.3026 9.465 -0.58885 -0.1395 -0.3126 -0.9382 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 N03 mock treatment 8.4207 -1.6471 -0.442 9.3329 -0.72098 -0.1708 -0.4333 -0.9145 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 N04 mock treatment 10.3161 0.24822 0.0666 9.8684 -0.18546 -0.0439 0.016 0.2008 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 N05 mock treatment 9.0864 -0.9815 -0.2634 11.8628 1.8089 0.4286 0.1168 0.2323 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 N06 mock treatment 9.4992 -0.56873 -0.1526 9.1289 -0.92502 -0.2192 -0.2629 -0.9843 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 N07 mock treatment 9.921 -0.14689 -0.0394 10.0931 0.039202 0.0093 -0.0213 -0.5261 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 N08 mock treatment 10.7951 0.72716 0.1951 9.3644 -0.6895 -0.1634 0.0225 0.0882 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 N09 mock treatment 9.8862 -0.18166 -0.0487 10.288 0.23411 0.0555 0.0048 0.0644 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 N10 mock treatment 8.7917 -1.2762 -0.3424 8.3602 -1.6937 -0.4013 -0.5259 -0.9969 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 N11 mock treatment 9.4901 -0.57776 -0.155 10.9625 0.90864 0.2153 0.0426 0.1606 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 N12 mock treatment 11.103 1.0351 0.2777 10.5558 0.50193 0.1189 0.2805 0.9284 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 N13 mock treatment 9.4405 -0.62742 -0.1684 9.6848 -0.36906 -0.0874 -0.1809 -0.9534 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 N14 mock treatment 9.7054 -0.36249 -0.0973 11.0323 0.97845 0.2318 0.0952 0.3785 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 N15 mock treatment 8.9169 -1.151 -0.3088 10.6197 0.56586 0.1341 -0.1236 -0.367 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 N16 mock treatment 9.4447 -0.62315 -0.1672 9.3672 -0.68664 -0.1627 -0.2333 -0.9999 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 N17 mock treatment 11.7161 1.6482 0.4423 8.5216 -1.5323 -0.3631 0.056 0.0979 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 N18 mock treatment 9.7381 -0.32976 -0.0885 11.4568 1.4029 0.3324 0.1725 0.5014 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 N19 mock treatment 10.7488 0.68094 0.1827 10.7869 0.73305 0.1737 0.252 0.9997 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 N20 mock treatment 9.5738 -0.49406 -0.1326 9.1365 -0.91742 -0.2174 -0.2474 -0.9719 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 N21 mock treatment 8.6256 -1.4423 -0.387 10.3045 0.25065 0.0594 -0.2317 -0.5917 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 N22 mock treatment 7.6555 -2.4123 -0.6473 10.5156 0.46168 0.1094 -0.3804 -0.5794 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 N23 mock treatment 9.3192 -0.74868 -0.2009 8.638 -1.4159 -0.3355 -0.3793 -0.9699 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 N24 mock treatment 11.8513 1.7834 0.4785 9.3167 -0.73722 -0.1747 0.2149 0.4218 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 O01 mock treatment 11.4065 1.3386 0.3592 10.6039 0.54997 0.1303 0.3461 0.9059 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 O02 mock treatment 8.3639 -1.704 -0.4572 8.4794 -1.5745 -0.3731 -0.5871 -0.9949 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 O03 compound treatment 11.0503 0.98245 0.2636 10.9527 0.8988 0.213 0.337 0.9944 1017172 BSPBio_003591 C=CCSCC=C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 O04 mock treatment 9.6851 -0.38275 -0.1027 11.4858 1.432 0.3393 0.1673 0.4719 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 O05 compound treatment 11.8918 1.8239 0.4894 9.8155 -0.23835 -0.0565 0.3061 0.6214 3081195 BSPBio_003592 CC(=O)O[C@@]1(CCC2C3C=C(Cl)C4=CC(=O)CC[C@]4(C)C3CC[C@@]21C)C(=O)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 O06 mock treatment 10.4502 0.38234 0.1026 10.9651 0.91126 0.2159 0.2252 0.9421 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 O07 compound treatment 9.0685 -0.99938 -0.2682 9.8884 -0.16544 -0.0392 -0.2173 -0.8019 1029168 BSPBio_003593 CC(=O)c1ccc[nH]1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 O08 mock treatment 10.4634 0.39554 0.1061 10.6076 0.55373 0.1312 0.1678 0.9945 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 O09 compound treatment 94.5079 84.44 22.6574 93.4536 83.4 19.7603 29.9939 0.9977 3198420 BSPBio_003594 CC[C@]1(O)CC2CN(C1)CCc3c([nH]c4ccccc34)[C@@](C2)(C(=O)OC)c5cc6c(cc5OC)N(C)[C@@H]7[C@@]86CCN9CC=C[C@](CC)([C@H]98)[C@@H](OC(=O)C)[C@]7(O)C(=O)OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 O10 mock treatment 9.4377 -0.63021 -0.1691 10.6901 0.63618 0.1507 -0.013 -0.0573 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 O11 compound treatment 11.0393 0.97144 0.2607 8.4399 -1.614 -0.3824 -0.0861 -0.186 2272 BSPBio_003595 OC(=O)C(Cc1ccc(O)c(O)c1)OC(=O)/C=C/c2ccc(O)c(O)c2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 O12 mock treatment 10.2398 0.17194 0.0461 10.2536 0.19966 0.0473 0.0661 0.9999 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 O13 compound treatment 13.0298 2.9619 0.7948 11.5057 1.4518 0.344 0.8052 0.9298 1478 BSPBio_003596 Cc1ccc(cc1)c2cc(nn2c3ccc(cc3)S(=O)(=O)N)C(F)(F)F 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 O14 mock treatment 9.9037 -0.16418 -0.0441 11.7928 1.7389 0.412 0.2602 0.6279 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 O15 compound treatment 9.7117 -0.35619 -0.0956 11.2817 1.2278 0.2909 0.1381 0.4511 2777 BSPBio_003597 COc1cc(N)c(Cl)cc1C(=O)NC2CCN(Cc3ccccc3)CC2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 O16 mock treatment 8.9355 -1.1324 -0.3038 11.216 1.1621 0.2753 -0.0202 -0.0492 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 O17 compound treatment 7.6362 -2.4317 -0.6525 9.3978 -0.6561 -0.1555 -0.5713 -0.8517 3173083 BSPBio_003598 CO[C@H]1[C@H](O)CC(=O)O[C@@H](C)C/C=C/C=C/[C@H](O[C@H]2CC[C@@H]([C@@H](C)O2)N(C)C)[C@H](C)C[C@H](CC=O)[C@@H]1O[C@@H]3O[C@H](C)[C@@H](O[C@H]4C[C@@](C)(O)[C@H](O)[C@H](C)O4)[C@@H]([C@H]3O)N(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 O18 mock treatment 10.1504 0.082524 0.0221 11.6112 1.5573 0.369 0.2766 0.7482 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 O19 compound treatment 8.8212 -1.2467 -0.3345 9.7602 -0.29373 -0.0696 -0.2858 -0.8363 1383 BSPBio_003599 CC[C@H]([C@H]1CC[C@H](C)[C@@H](O1)[C@@H](C)[C@H](O)[C@H](C)C(=O)[C@H](CC)[C@H]2OC3(O[C@@]4(CC[C@](C)(O4)[C@H]5CC[C@](O)(CC)[C@H](C)O5)[C@H](O)C=C3)[C@H](C)C[C@@H]2C)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 O20 mock treatment 8.1355 -1.9324 -0.5185 8.252 -1.8019 -0.4269 -0.6685 -0.9953 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 O21 compound treatment 9.0919 -0.97594 -0.2619 9.5963 -0.45758 -0.1084 -0.2618 -0.9238 1000112 BSPBio_003600 CC(=O)O[C@H]1[C@@H](O)C2C(C)(C)CC[C@H](O)[C@]2(C)[C@@]3(O)C(=O)C[C@@](C)(O[C@]13C)C=C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 O22 mock treatment 7.5298 -2.538 -0.681 9.3043 -0.74958 -0.1776 -0.6071 -0.8627 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 O23 mock treatment 8.4148 -1.6531 -0.4436 10.7777 0.72377 0.1715 -0.1924 -0.4046 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 O24 mock treatment 9.4727 -0.59515 -0.1597 12.0921 2.0382 0.4829 0.2286 0.4493 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 P01 mock treatment 9.6564 -0.4115 -0.1104 10.3393 0.28542 0.0676 -0.0303 -0.2337 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 P02 mock treatment 8.0324 -2.0355 -0.5462 8.5115 -1.5424 -0.3654 -0.6446 -0.9809 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 P03 mock treatment 9.4731 -0.59474 -0.1596 9.881 -0.17286 -0.041 -0.1418 -0.8607 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 P04 mock treatment 12.2698 2.2019 0.5908 13.5013 3.4474 0.8168 0.9953 0.9874 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 P05 mock treatment 10.9353 0.86741 0.2327 11.9191 1.8652 0.4419 0.4771 0.9551 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 P06 mock treatment 8.243 -1.8249 -0.4897 7.5064 -2.5475 -0.6036 -0.7731 -0.9946 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 P07 mock treatment 8.9492 -1.1187 -0.3002 11.3223 1.2684 0.3005 3.0E-4 6.0E-4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 P08 mock treatment 8.344 -1.7239 -0.4626 9.4067 -0.64719 -0.1533 -0.4355 -0.8937 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 P09 mock treatment 8.921 -1.1469 -0.3077 9.0939 -0.96003 -0.2275 -0.3785 -0.9889 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 P10 mock treatment 8.2251 -1.8428 -0.4945 10.5784 0.52449 0.1243 -0.2618 -0.5134 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 P11 mock treatment 8.321 -1.7469 -0.4687 14.4732 4.4193 1.0471 0.4089 0.3565 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 P12 mock treatment 9.2165 -0.85143 -0.2285 9.0096 -1.0443 -0.2474 -0.3365 -0.9992 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 P13 mock treatment 9.089 -0.97888 -0.2627 9.8035 -0.25036 -0.0593 -0.2277 -0.8455 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 P14 mock treatment 8.6283 -1.4396 -0.3863 12.9236 2.8697 0.6799 0.2077 0.2655 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 P15 mock treatment 7.5961 -2.4718 -0.6633 10.876 0.82213 0.1948 -0.3313 -0.4792 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 P16 mock treatment 9.3291 -0.73875 -0.1982 9.5136 -0.54028 -0.128 -0.2307 -0.9776 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 P17 mock treatment 9.3604 -0.70744 -0.1898 11.3476 1.2937 0.3065 0.0825 0.2289 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 P18 mock treatment 10.0231 -0.044828 -0.012 9.7359 -0.31794 -0.0753 -0.0618 -0.8098 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 P19 mock treatment 8.5114 -1.5565 -0.4176 9.1151 -0.9388 -0.2224 -0.4526 -0.9565 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 P20 mock treatment 7.5098 -2.5581 -0.6864 9.8106 -0.24328 -0.0576 -0.5261 -0.7638 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 P21 mock treatment 9.5797 -0.48823 -0.131 8.6515 -1.4023 -0.3323 -0.3276 -0.9172 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 P22 mock treatment 9.8251 -0.24282 -0.0652 8.5507 -1.5032 -0.3562 -0.2979 -0.8228 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 P23 mock treatment 9.8142 -0.25364 -0.0681 8.2861 -1.7678 -0.4189 -0.3443 -0.8114 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2464 P24 mock treatment 8.5196 -1.5483 -0.4155 6.9942 -3.0597 -0.7249 -0.8064 -0.9651 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 A01 compound treatment 13.9907 1.1978 0.3214 15.6459 3.0617 0.7254 0.7402 0.9329 3652363 HDAC1-H_000001 COc1cc2nc(Cl)nc(NC3CCN(Cc4ccccc4)CC3)c2cc1OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 A02 compound treatment 17.7684 4.9756 1.3351 13.1586 0.57438 0.1361 1.0403 0.7752 3652364 HDAC1-H_000002 ONC(=O)CCc1cn(nn1)c2cccc(c2)C(=O)N3CCN(CC3)c4ccccc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 A03 compound treatment 14.7773 1.9845 0.5325 17.0859 4.5017 1.0666 1.1307 0.9485 3652365 HDAC1-H_000003 COc1cc2nc(Cl)nc(NC3CCCCC3)c2cc1OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 A04 compound treatment 14.4102 1.6173 0.434 13.5846 1.0004 0.237 0.4745 0.9595 3652366 HDAC1-H_000004 COc1ccc(NC(=O)Cn2cc(CCC(=O)NO)nn2)cc1OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 A05 compound treatment 57.8408 45.048 12.0875 69.7998 57.216 13.5564 18.133 0.9984 3652367 HDAC1-H_000005 COc1cc2nc(Cl)nc(Nc3ccc(F)c(Cl)c3)c2cc1OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 A06 compound treatment 17.6508 4.858 1.3035 14.1013 1.5171 0.3594 1.1759 0.8696 3652368 HDAC1-H_000006 ONC(=O)CCc1cn(nn1)c2ccc3[nH]ccc3c2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 A07 compound treatment 49.8367 37.044 9.9398 49.2079 36.624 8.6774 13.1644 0.9977 3650892 HDAC1-H_000007 COc1cc2nc(nc(NC3CCN(Cc4ccccc4)CC3)c2cc1OC)N5CCCN(C)CC5 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 A08 compound treatment 15.5843 2.7915 0.749 17.7228 5.1386 1.2175 1.3906 0.9728 3652369 HDAC1-H_000008 CCOc1cc(OCC)cc(c1)C(=O)N[C@@H](Cc2ccc(cc2)n3cc(CCC(=O)NO)nn3)C(=O)OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 A09 compound treatment 35.9952 23.202 6.2258 25.1176 12.533 2.9696 6.5021 0.9426 3652371 HDAC1-H_000009 COc1cc2nc(nc(NC3CCN(Cc4ccccc4)CC3)c2cc1OC)N5CCCCCC5 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 A10 compound treatment 17.1432 4.3504 1.1673 15.6833 3.0991 0.7343 1.3447 0.975 3652372 HDAC1-H_000010 COC(=O)[C@@H](NC(=O)Cn1cc(nn1)c2cccc(/C=C/C(=O)NO)c2)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 A11 compound treatment 20.2086 7.4158 1.9898 20.7434 8.1592 1.9332 2.774 0.9999 3652374 HDAC1-H_000011 COc1cc2nc(nc(NC3CCN(Cc4ccccc4)CC3)c2cc1OC)N5CCCN(Cc6ccccc6)CC5 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 A12 compound treatment 16.2305 3.4377 0.9224 15.7932 3.209 0.7603 1.1899 0.9954 3652375 HDAC1-H_000012 CC(C)[C@H](NS(=O)(=O)c1ccc(C)cc1)C(=O)NCCn2cc(nn2)c3cccc(/C=C/C(=O)NO)c3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 A13 mock treatment 16.2537 3.4608 0.9286 14.715 2.1308 0.5049 1.0136 0.959 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 A14 mock treatment 16.0879 3.2951 0.8842 13.3545 0.77033 0.1825 0.7543 0.8355 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 A15 compound treatment 19.2966 6.5037 1.7451 29.8981 17.314 4.1023 4.1347 0.9275 3652377 HDAC1-H_000013 COc1cc2nc(nc(NC3CCCCC3)c2cc1OC)N4CCCN(C)CC4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 A16 compound treatment 251.8823 239.09 64.1538 203.1315 190.55 45.1474 77.2876 0.9852 3652378 HDAC1-H_000014 COc1ccc(cc1)n2cc(nn2)c3cccc(/C=C/C(=O)NO)c3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 A17 compound treatment 15.5405 2.7477 0.7373 15.295 2.7108 0.6423 0.9755 0.9976 3652380 HDAC1-H_000015 COc1cc2nc(nc(NC3CCCCC3)c2cc1OC)N4CCCCCC4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 A18 compound treatment 15.0055 2.2127 0.5937 14.36 1.7758 0.4208 0.7174 0.9858 3652381 HDAC1-H_000016 COC(=O)[C@@H](NC(=O)Cn1cc(CCC(=O)NO)nn1)c2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 A19 compound treatment 21.4208 8.6279 2.3151 26.997 14.413 3.4149 4.0517 0.9821 3652383 HDAC1-H_000017 COc1cc2nc(nc(NC3CCCCC3)c2cc1OC)N4CCCN(Cc5ccccc5)CC4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 A20 compound treatment 16.7279 3.9351 1.0559 14.9785 2.3943 0.5673 1.1478 0.9576 3652384 HDAC1-H_000018 CC(C)[C@H](NS(=O)(=O)c1ccc(C)cc1)C(=O)NCCn2cc(CCC(=O)NO)nn2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 A21 compound treatment 22.7243 9.9315 2.6649 22.3509 9.7667 2.3141 3.5206 0.9975 3652386 HDAC1-H_000019 COc1cc2nc(nc(Nc3ccc(F)c(Cl)c3)c2cc1OC)N4CCCN(C)CC4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 A22 compound treatment 15.6319 2.8391 0.7618 12.2537 -0.33052 -0.0783 0.4833 0.6311 3652387 HDAC1-H_000020 COc1ccc(cc1)n2cc(CCC(=O)NO)nn2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 A23 compound treatment 44.8707 32.078 8.6073 26.8066 14.222 3.3698 8.4691 0.9162 3652388 HDAC1-H_000021 COc1cc2nc(nc(Nc3ccc(F)c(Cl)c3)c2cc1OC)N4CCCCCC4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 A24 compound treatment 16.0501 3.2573 0.874 14.81 2.2258 0.5274 0.9909 0.9707 3652372 HDAC1-H_000022 COC(=O)[C@@H](NC(=O)Cn1cc(nn1)c2cccc(/C=C/C(=O)NO)c2)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 B01 compound treatment 15.7464 2.9536 0.7925 12.1504 -0.43383 -0.1028 0.4877 0.6103 1003435 HDAC1-H_000023 OC(=O)c1ccc(O)c(c1)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 B02 compound treatment 23.5751 10.782 2.8932 22.1316 9.5474 2.2621 3.6453 0.9926 3652389 HDAC1-H_000024 ONC(=O)CCCCCCC(=O)Nc1ccc(cc1)[C@@H]2O[C@H](CSc3nc(c(o3)c4ccccc4)c5ccccc5)C[C@@H](O2)c6ccccc6 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 B03 compound treatment 15.0733 2.2805 0.6119 12.9724 0.38821 0.092 0.4977 0.8044 3652390 HDAC1-H_000025 O=C(NCCCNC(=O)c1ccccn1)OCc2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 B04 compound treatment 13.0506 0.25779 0.0692 16.3886 3.8044 0.9014 0.6863 0.7591 3652391 HDAC1-H_000026 NCCCn1cc(CNc2ccc(cc2)C(=O)NCCCCCCC(=O)NO)nn1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 B05 compound treatment 12.4972 -0.29556 -0.0793 12.3936 -0.19059 -0.0452 -0.088 -0.9644 3652392 HDAC1-H_000027 COC(=O)c1ccc(nc1)C(=O)NCCCNC(=O)OCc2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 B06 compound treatment 23.3917 10.599 2.844 21.2453 8.6612 2.0521 3.4621 0.9872 3635011 HDAC1-H_000028 ONC(=O)CCCCCCC(=O)Nc1ccc(cc1)C(=O)c2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 B07 compound treatment 15.7845 2.9917 0.8027 10.9898 -1.5944 -0.3778 0.3005 0.3387 3652393 HDAC1-H_000029 O=C(NCCCCNC(=O)c1ccccn1)OCc2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 B08 compound treatment 57.3696 44.577 11.9611 49.4849 36.901 8.7431 14.6401 0.9881 3634742 HDAC1-H_000030 CN(C[C@H]1C[C@H](OC(O1)c2ccc(NC(=O)CCCCCCC(=O)NO)cc2)c3ccc(CO)cc3)Cc4ccccc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 B09 compound treatment 15.413 2.6202 0.7031 14.0524 1.4682 0.3479 0.7431 0.9474 3652394 HDAC1-H_000031 COC(=O)c1ccc(nc1)C(=O)NCCCCNC(=O)OCc2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 B10 compound treatment 13.8721 1.0792 0.2896 12.6716 0.087377 0.0207 0.2194 0.7557 3634942 HDAC1-H_000032 ONC(=O)CCCCCCC(=O)Nc1cccc(c1)C(=O)NCCOCCOCCNC(=O)c2cccc(NC(=O)CCCCCCC(=O)NO)c2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 B11 compound treatment 13.3173 0.52449 0.1407 12.8801 0.29593 0.0701 0.1491 0.9482 3652395 HDAC1-H_000033 O=C(NCCCCCNC(=O)c1ccccn1)OCc2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 B12 compound treatment 28.066 15.273 4.0982 19.1502 6.566 1.5557 3.9979 0.912 3634875 HDAC1-H_000034 ONC(=O)CCCCCCC(=O)Nc1ccc(cc1)C(=O)NCCOCCOCCNC(=O)c2ccc(NC(=O)CCCCCCC(=O)NO)cc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 B13 mock treatment 13.2383 0.44544 0.1195 12.097 -0.48724 -0.1154 0.0029 0.0174 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 B14 mock treatment 11.9058 -0.88701 -0.238 14.43 1.8458 0.4373 0.1409 0.2831 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 B15 compound treatment 14.1186 1.3258 0.3558 12.3459 -0.23827 -0.0565 0.2116 0.5875 3652396 HDAC1-H_000035 O=C(NCCCCCCNC(=O)c1ccccn1)OCc2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 B16 compound treatment 24.3846 11.592 3.1104 14.89 2.3058 0.5463 2.5857 0.8188 3652397 HDAC1-H_000036 ONC(=O)CCCCCCNC(=O)c1ccc(NCc2cn(Cc3ccc(Cn4cc(CNc5ccc(cc5)C(=O)NCCCCCCC(=O)O)nn4)cc3)nn2)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 B17 compound treatment 15.6327 2.8399 0.762 14.6376 2.0534 0.4865 0.8828 0.9765 3652398 HDAC1-H_000037 COC(=O)c1ccc(nc1)C(=O)NCCCCCCNC(=O)OCc2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 B18 compound treatment 37.5423 24.749 6.6409 33.1292 20.545 4.8678 8.1379 0.9883 3635064 HDAC1-H_000038 ONC(=O)CCCCCCC(=O)Nc1ccc(cc1)C2OC(CSc3nc4ccccc4o3)CC(O2)c5ccccc5 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 B19 compound treatment 16.2258 3.4329 0.9211 13.9015 1.3173 0.3121 0.872 0.8966 3652399 HDAC1-H_000039 CC(C)(C)OC(=O)NCCCNC(=O)c1ccccn1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 B20 compound treatment 19.899 7.1062 1.9068 24.4525 11.868 2.812 3.3367 0.9821 3634604 HDAC1-H_000040 ONC(=O)CCCCCCC(=O)Nc1ccc(cc1)C2OC(CN3CCCCCCC3)CC(O2)c4ccccc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 B21 compound treatment 14.243 1.4502 0.3891 11.8133 -0.77094 -0.1827 0.146 0.3396 3652400 HDAC1-H_000041 CC(C)(C)OC(=O)NCCCCNC(=O)c1ccccn1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 B22 compound treatment 92.996 80.203 21.5206 111.2109 98.627 23.3682 31.7411 0.9992 3634671 HDAC1-H_000042 CN(CC=C)CC1CC(OC(O1)c2ccc(NC(=O)CCCCCCC(=O)NO)cc2)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 B23 compound treatment 12.9291 0.13629 0.0366 10.7629 -1.8213 -0.4315 -0.2793 -0.6449 3652401 HDAC1-H_000043 CC(C)(C)OC(=O)NCCCCCNC(=O)c1ccccn1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 B24 compound treatment 238.4158 225.62 60.5404 215.0633 202.48 47.9744 76.7316 0.9934 3652402 HDAC1-H_000044 ONC(=O)/C=C/c1ccc(CNCCc2c[nH]c3ccccc23)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 C01 compound treatment 21.2316 8.4388 2.2643 17.3372 4.753 1.1261 2.3974 0.948 3652404 HDAC1-H_000045 COc1cc2nc(nc(Nc3ccc(F)c(Cl)c3)c2cc1OC)N4CCCN(Cc5ccccc5)CC4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 C02 compound treatment 17.3539 4.561 1.2238 15.611 3.0268 0.7172 1.3725 0.9676 3652375 HDAC1-H_000046 CC(C)[C@H](NS(=O)(=O)c1ccc(C)cc1)C(=O)NCCn2cc(nn2)c3cccc(/C=C/C(=O)NO)c3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 C03 compound treatment 12.3683 -0.42452 -0.1139 10.2747 -2.3095 -0.5472 -0.4675 -0.8364 1429650 HDAC1-H_000047 COc1cc2ncnc(NC3CCN(Cc4ccccc4)CC3)c2cc1OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 C04 compound treatment 25.4425 12.65 3.3942 24.5409 11.957 2.833 4.4033 0.996 3652405 HDAC1-H_000048 COc1ccc(OC)c(NC(=O)Cn2cc(nn2)c3cccc(/C=C/C(=O)NO)c3)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 C05 compound treatment 17.6406 4.8478 1.3008 11.7894 -0.79484 -0.1883 0.7866 0.5985 3652407 HDAC1-H_000049 COc1cc2nc(Cl)nc(OC3CCN(Cc4ccccc4)CC3)c2cc1OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 C06 compound treatment 17.8147 5.0219 1.3475 15.6583 3.0741 0.7284 1.4679 0.9583 3652408 HDAC1-H_000050 CCOC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)Cn3cc(nn3)c4cccc(/C=C/C(=O)NO)c4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 C07 compound treatment 15.6121 2.8193 0.7565 14.259 1.6748 0.3968 0.8155 0.9546 3652410 HDAC1-H_000051 COc1cc2nc(nc(OC3CCN(Cc4ccccc4)CC3)c2cc1OC)N5CCCN(C)CC5 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 C08 compound treatment 12.3752 -0.41762 -0.1121 12.6464 0.062182 0.0147 -0.0688 -0.6089 3652411 HDAC1-H_000052 ONC(=O)/C=C/c1cccc(c1)c2cn(CC(=O)N3CCOCC3)nn2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 C09 compound treatment 12.2316 -0.56121 -0.1506 10.1045 -2.4797 -0.5875 -0.5219 -0.8605 3652413 HDAC1-H_000053 Oc1nc(O)c2cc(Br)ccc2n1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 C10 compound treatment 13.97 1.1772 0.3159 12.9331 0.34891 0.0827 0.2818 0.8631 3652414 HDAC1-H_000054 CN1CCN(CC1)C(=O)Cn2cc(nn2)c3cccc(/C=C/C(=O)NO)c3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 C11 mock treatment 14.6156 1.8228 0.4891 13.8185 1.2343 0.2925 0.5526 0.9698 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 C12 mock treatment 12.5161 -0.27676 -0.0743 13.9304 1.3462 0.319 0.173 0.5284 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 C13 compound treatment 14.499 1.7062 0.4578 11.926 -0.65824 -0.156 0.2134 0.4413 3652416 HDAC1-H_000055 Clc1nc(Cl)c2cc(Br)ccc2n1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 C14 compound treatment 15.9359 3.143 0.8434 11.9108 -0.67342 -0.1596 0.4835 0.5633 3652417 HDAC1-H_000056 ONC(=O)/C=C/c1cccc(c1)c2cn(CC(=O)Nc3nccs3)nn2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 C15 mock treatment 13.8813 1.0885 0.2921 11.7066 -0.87759 -0.2079 0.0595 0.166 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 C16 mock treatment 12.33 -0.4628 -0.1242 12.9852 0.40098 0.095 -0.0206 -0.1319 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 C17 compound treatment 11.9487 -0.84416 -0.2265 12.9884 0.40421 0.0958 -0.0924 -0.3759 3652419 HDAC1-H_000057 COc1ccc2nc(O)nc(O)c2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 C18 compound treatment 12.5417 -0.25116 -0.0674 12.6166 0.032382 0.0077 -0.0422 -0.6226 3652420 HDAC1-H_000058 ONC(=O)/C=C/c1cccc(c1)c2cn(CC(=O)Nc3ccon3)nn2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 C19 compound treatment 12.6614 -0.13143 -0.0353 12.7956 0.21141 0.0501 0.0105 0.1711 3652422 HDAC1-H_000059 Clc1nc(NC2CCCCC2)c3cc(Br)ccc3n1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 C20 compound treatment 12.3529 -0.43989 -0.118 14.0931 1.5089 0.3575 0.1693 0.4498 3652423 HDAC1-H_000060 ONC(=O)/C=C/c1cccc(c1)c2cn(CCCNC(=O)Nc3ccccc3)nn2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 C21 compound treatment 43.8209 31.028 8.3256 48.9637 36.379 8.6196 11.9821 0.9998 3652425 HDAC1-H_000061 COc1ccc2nc(Cl)nc(Cl)c2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 C22 compound treatment 14.5937 1.8009 0.4832 12.6708 0.086632 0.0205 0.3562 0.7365 3652426 HDAC1-H_000062 ONC(=O)/C=C/c1cccc(c1)c2cn(CCNC(=O)Nc3ccccc3)nn2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 C23 compound treatment 16.023 3.2302 0.8668 12.7034 0.11918 0.0282 0.6329 0.7298 3652428 HDAC1-H_000063 Clc1nc(NC2CCN(Cc3ccccc3)CC2)c4cc(Br)ccc4n1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 C24 compound treatment 282.7075 269.91 72.4251 241.74 229.16 54.2951 89.6047 0.9899 3652429 HDAC1-H_000064 ONC(=O)/C=C/c1cccc(c1)c2cn(C[C@H](Cc3ccccc3)NC(=O)c4ccccc4)nn2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 D01 compound treatment 18.1894 5.3966 1.448 13.1671 0.5829 0.1381 1.1216 0.771 3652431 HDAC1-H_000065 CC(C)(C)OC(=O)NCCCCCCNC(=O)c1ccccn1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 D02 compound treatment 16.0802 3.2874 0.8821 19.1461 6.5619 1.5547 1.7231 0.964 3652432 HDAC1-H_000066 ONC(=O)/C=C/c1ccc(CN(CCc2c[nH]c3ccccc23)C(=O)CCCCC(=O)N(CCc4c[nH]c5ccccc45)Cc6ccc(\C=C\C(=O)NO)cc6)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 D03 compound treatment 15.2601 2.4673 0.662 12.6631 0.078857 0.0187 0.4813 0.7268 3652434 HDAC1-H_000067 COC(=O)[C@H](CCCCNC(=O)c1ccccn1)NC(=O)OC(C)(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 D04 compound treatment 333.0242 320.23 85.9263 325.001 312.42 74.0226 113.101 0.9972 3652436 HDAC1-H_000068 OCCN(CCc1c[nH]c2ccccc12)Cc3ccc(/C=C/C(=O)O)cc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 D05 compound treatment 14.6731 1.8802 0.5045 13.0666 0.48243 0.1143 0.4376 0.8459 3652438 HDAC1-H_000069 COC(=O)c1ccc(nc1)C(=O)NCCCNC(=O)OC(C)(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 D06 compound treatment 21.8733 9.0805 2.4365 12.5013 -0.082893 -0.0196 1.709 0.7014 3652439 HDAC1-H_000070 OC(=O)/C=C/c1ccc(CNCCc2c[nH]c3ccccc23)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 D07 compound treatment 13.1572 0.36439 0.0978 13.1906 0.60643 0.1437 0.1707 0.9824 3652441 HDAC1-H_000071 COC(=O)c1ccc(nc1)C(=O)NCCCCNC(=O)OC(C)(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 D08 compound treatment 523.3278 510.53 136.9897 497.1673 484.58 114.8148 178.0527 0.9961 3622998 HDAC1-H_000072 OCCN(CCc1c[nH]c2ccccc12)Cc3ccc(/C=C/C(=O)NO)cc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 D09 compound treatment 13.2336 0.44083 0.1183 11.3127 -1.2715 -0.3013 -0.1294 -0.3998 3652442 HDAC1-H_000073 COC(=O)c1ccc(nc1)C(=O)NCCCCCNC(=O)OC(C)(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 D10 mock treatment 13.9933 1.2005 0.3221 13.8004 1.2162 0.2882 0.4315 0.9985 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 D11 mock treatment 14.0915 1.2986 0.3485 11.726 -0.85822 -0.2033 0.1026 0.2543 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 D12 mock treatment 12.3795 -0.41331 -0.1109 12.4235 -0.16072 -0.0381 -0.1053 -0.8984 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 D13 compound treatment 14.0176 1.2248 0.3287 12.3158 -0.26838 -0.0636 0.1874 0.5599 3652443 HDAC1-H_000074 COC(=O)[C@H](CCCCNC(=O)c1ccc(cn1)C(=O)OC)NC(=O)OC(C)(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 D14 mock treatment 12.2974 -0.49546 -0.1329 12.2836 -0.30059 -0.0712 -0.1444 -0.9572 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 D15 mock treatment 15.4462 2.6534 0.712 11.0049 -1.5793 -0.3742 0.2388 0.297 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 D16 mock treatment 13.8614 1.0685 0.2867 13.4359 0.8517 0.2018 0.3454 0.9852 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 D17 compound treatment 13.2454 0.45262 0.1215 13.0469 0.46268 0.1096 0.1634 0.9987 3652445 HDAC1-H_000075 CCOC(=O)CCCNC(=O)c1ccccn1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 D18 mock treatment 13.682 0.88914 0.2386 12.8954 0.31123 0.0737 0.2208 0.8844 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 D19 compound treatment 14.7338 1.941 0.5208 12.2993 -0.28488 -0.0675 0.3205 0.6104 3652446 HDAC1-H_000076 CCOC(=O)CCCCNC(=O)c1ccccn1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 D20 mock treatment 13.7659 0.97309 0.2611 13.56 0.97578 0.2312 0.3481 0.9982 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 D21 compound treatment 11.9704 -0.8224 -0.2207 11.3271 -1.2571 -0.2978 -0.3666 -0.9891 3652447 HDAC1-H_000077 COC(=O)CCCCCNC(=O)c1ccccn1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 D22 mock treatment 11.9397 -0.85313 -0.2289 12.8024 0.21816 0.0517 -0.1253 -0.534 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 D23 compound treatment 13.7669 0.97414 0.2614 13.9407 1.3565 0.3214 0.4121 0.9947 3652448 HDAC1-H_000078 CN(CCCNC(=O)c1ccccc1)CC#C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 D24 mock treatment 13.2317 0.43889 0.1178 12.972 0.38781 0.0919 0.1482 0.9925 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 E01 mock treatment 14.8632 2.0704 0.5555 12.2126 -0.37161 -0.088 0.3306 0.5877 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 E02 mock treatment 12.8783 0.085469 0.0229 17.189 4.6048 1.091 0.7877 0.7218 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 E03 compound treatment 129.667 116.87 31.3604 116.7893 104.21 24.6899 39.6335 0.993 3652449 HDAC1-H_000079 COc1ccc2nc(Cl)nc(NC3CCN(Cc4ccccc4)CC3)c2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 E04 compound treatment 13.0139 0.22112 0.0593 11.4981 -1.0861 -0.2573 -0.14 -0.5302 3652450 HDAC1-H_000080 ONC(=O)/C=C/c1cccc(c1)c2cn(CC(=O)N3CCC4(CC3)N(CNC4=O)c5ccccc5)nn2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 E05 compound treatment 15.1848 2.392 0.6418 13.8698 1.2856 0.3046 0.6692 0.942 3652452 HDAC1-H_000081 COc1ccc2nc(Cl)nc(NC3CCCCC3)c2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 E06 compound treatment 15.1653 2.3725 0.6366 12.7963 0.21213 0.0503 0.4857 0.7606 3652453 HDAC1-H_000082 CCOC(=O)[C@H](Cc1ccccc1)NC(=O)Cn2cc(nn2)c3cccc(/C=C/C(=O)NO)c3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 E07 compound treatment 33.1514 20.359 5.4627 36.2236 23.639 5.601 7.8232 0.9999 3652455 HDAC1-H_000083 COc1cc2nc(Cl)nc(Cl)c2cc1OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 E08 compound treatment 11.6619 -1.1309 -0.3034 14.163 1.5788 0.3741 0.0499 0.1037 3652456 HDAC1-H_000084 Cc1ccc(cc1)S(=O)(=O)N[C@@H](Cc2ccccc2)C(=O)NCCn3cc(nn3)c4cccc(/C=C/C(=O)NO)c4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 E09 mock treatment 13.5981 0.80532 0.2161 11.0907 -1.4935 -0.3539 -0.0974 -0.235 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 E10 mock treatment 14.1622 1.3694 0.3674 10.4679 -2.1163 -0.5014 -0.0947 -0.1524 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 E11 compound treatment 39.0323 26.239 7.0407 45.412 32.828 7.7781 10.4785 0.9988 3652458 HDAC1-H_000085 CN1CCCN(CC1)c2nc(NC3CCN(Cc4ccccc4)CC3)c5cc(Br)ccc5n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 E12 compound treatment 13.7215 0.92869 0.2492 14.0654 1.4812 0.3509 0.4244 0.9859 3652459 HDAC1-H_000086 Cc1ccc(cc1)S(=O)(=O)N[C@@H](Cc2ccccc2)C(=O)NCCCn3cc(nn3)c4cccc(/C=C/C(=O)NO)c4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 E13 compound treatment 14.0493 1.2565 0.3371 16.5405 3.9563 0.9374 0.9012 0.9047 3652461 HDAC1-H_000087 Brc1ccc2nc(nc(NC3CCN(Cc4ccccc4)CC3)c2c1)N5CCCN(Cc6ccccc6)CC5 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 E14 compound treatment 23.2448 10.452 2.8045 18.2838 5.6996 1.3504 2.938 0.9439 3652462 HDAC1-H_000088 ONC(=O)/C=C/c1cccc(c1)c2cn(C[C@H](Cc3ccccc3)NC(=O)Nc4ccccc4)nn2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 E15 compound treatment 12.7206 -0.072181 -0.0194 12.1562 -0.42797 -0.1014 -0.0854 -0.8272 3652464 HDAC1-H_000089 Brc1ccc2nc(nc(NC3CCN(Cc4ccccc4)CC3)c2c1)N5CCCCCC5 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 E16 compound treatment 41.13 28.337 7.6036 37.8105 25.226 5.977 9.6029 0.9929 3652465 HDAC1-H_000090 Cc1ccc(cc1)S(=O)(=O)N2CCC[C@H]2Cn3cc(nn3)c4cccc(/C=C/C(=O)NO)c4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 E17 mock treatment 12.575 -0.21781 -0.0584 10.9238 -1.6604 -0.3934 -0.3195 -0.8033 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 E18 mock treatment 10.6703 -2.1225 -0.5695 14.3074 1.7232 0.4083 -0.114 -0.1627 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 E19 compound treatment 30.0716 17.279 4.6363 26.904 14.32 3.3929 5.6775 0.9882 3652467 HDAC1-H_000091 COc1ccc2nc(nc(NC3CCN(Cc4ccccc4)CC3)c2c1)N5CCCN(C)CC5 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 E20 compound treatment 13.4381 0.64532 0.1732 11.2027 -1.3815 -0.3273 -0.109 -0.2944 3652468 HDAC1-H_000092 CC(C)(C)OC(=O)N/C(=N\C(=O)OC(C)(C)C)/NCCn1cc(nn1)c2cccc(/C=C/C(=O)NO)c2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 E21 compound treatment 16.2966 3.5038 0.9402 14.1667 1.5825 0.3749 0.9299 0.9187 3652470 HDAC1-H_000093 CN1CCCN(CC1)c2nc(NC3CCCCC3)c4cc(Br)ccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 E22 compound treatment 13.9961 1.2033 0.3229 13.0998 0.51561 0.1222 0.3147 0.9116 3652471 HDAC1-H_000094 CC(C)(C)OC(=O)N/C(=N\C(=O)OC(C)(C)C)/NCCCn1cc(nn1)c2cccc(/C=C/C(=O)NO)c2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 E23 compound treatment 11.7543 -1.0385 -0.2787 13.1332 0.54896 0.1301 -0.1051 -0.3417 3652473 HDAC1-H_000095 Brc1ccc2nc(nc(NC3CCCCC3)c2c1)N4CCCCCC4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 E24 compound treatment 15.0432 2.2504 0.6038 12.8904 0.30618 0.0725 0.4783 0.7864 3652474 HDAC1-H_000096 CC(C)(C)ONC(=O)c1cccc(c1)n2cc(nn2)c3cccc(/C=C/C(=O)NO)c3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 F01 mock treatment 11.7304 -1.0624 -0.2851 13.282 0.69778 0.1653 -0.0847 -0.2569 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 F02 mock treatment 14.2583 1.4655 0.3932 12.9525 0.36826 0.0873 0.3398 0.8435 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 F03 compound treatment 14.1786 1.3857 0.3718 10.0521 -2.5321 -0.6 -0.1613 -0.2285 3652476 HDAC1-H_000097 CN(CCCCNC(=O)c1ccccc1)CC#C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 F04 mock treatment 15.3238 2.531 0.6791 12.6002 0.016032 0.0038 0.4829 0.7111 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 F05 compound treatment 11.9592 -0.83357 -0.2237 13.5157 0.93151 0.2207 -0.0021 -0.0067 3652477 HDAC1-H_000098 CN(CCCCCCNC(=O)c1ccccc1)CC#C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 F06 mock treatment 13.4627 0.66989 0.1797 11.3719 -1.2123 -0.2872 -0.076 -0.2243 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 F07 compound treatment 10.1794 -2.6134 -0.7013 12.2637 -0.32054 -0.0759 -0.5496 -0.7791 3652478 HDAC1-H_000099 COC(=O)C(=O)NCCCCCCNC(=O)c1ccccc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 F08 mock treatment 14.6367 1.8439 0.4948 15.9753 3.3911 0.8035 0.918 0.9729 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 F09 mock treatment 10.8555 -1.9374 -0.5198 11.9654 -0.61881 -0.1466 -0.4713 -0.8725 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 F10 mock treatment 14.5376 1.7448 0.4682 12.7602 0.17598 0.0417 0.3605 0.767 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 F11 compound treatment 13.2212 0.42834 0.1149 12.4012 -0.18299 -0.0434 0.0506 0.412 3652479 HDAC1-H_000100 O=C(NCCCCNC(=O)c1ccccn1)c2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 F12 mock treatment 12.1002 -0.69261 -0.1858 9.67 -2.9142 -0.6905 -0.6197 -0.8666 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 F13 compound treatment 11.8129 -0.97993 -0.2629 11.3479 -1.2363 -0.2929 -0.3931 -0.9985 3652480 HDAC1-H_000101 O=C(NCCCCCNC(=O)c1ccccn1)c2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 F14 mock treatment 11.6861 -1.1067 -0.297 12.8962 0.31203 0.0739 -0.1577 -0.5153 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 F15 compound treatment 13.7142 0.92142 0.2472 11.8543 -0.72986 -0.1729 0.0525 0.1742 3652481 HDAC1-H_000102 O=C(NCCCCCCNC(=O)c1ccccn1)c2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 F16 mock treatment 13.7237 0.93089 0.2498 13.5933 1.0091 0.2391 0.3457 0.9998 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 F17 mock treatment 13.533 0.74022 0.1986 11.9881 -0.59607 -0.1412 0.0406 0.1665 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 F18 mock treatment 14.1065 1.3137 0.3525 11.3145 -1.2697 -0.3008 0.0365 0.0788 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 F19 compound treatment 11.3979 -1.3949 -0.3743 11.6126 -0.9716 -0.2302 -0.4274 -0.9727 3652482 HDAC1-H_000103 COC(=O)c1ccc(nc1)C(=O)NCCCCCNC(=O)c2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 F20 mock treatment 12.7163 -0.076471 -0.0205 13.1193 0.53511 0.1268 0.0751 0.5851 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 F21 compound treatment 11.6304 -1.1624 -0.3119 13.8437 1.2595 0.2984 -0.0095 -0.0221 3616541 HDAC1-H_000104 N[C@H]1C[C@@H]1c2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 F22 mock treatment 11.7951 -0.99772 -0.2677 12.2554 -0.32884 -0.0779 -0.2444 -0.8765 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 F23 compound treatment 14.6297 1.8369 0.4929 14.0427 1.4585 0.3456 0.5929 0.9849 1088402 HDAC1-H_000105 COC(=O)c1ccc(nc1)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 F24 mock treatment 16.2015 3.4087 0.9146 11.0715 -1.5127 -0.3584 0.3933 0.4004 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 G01 compound treatment 12.0504 -0.74238 -0.1992 12.3346 -0.24959 -0.0591 -0.1827 -0.8791 3652483 HDAC1-H_000106 COc1cccc(c1)n2cc(nn2)C(=O)NO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 G02 compound treatment 31.4859 18.693 5.0158 28.6649 16.081 3.8101 6.2409 0.9908 3652378 HDAC1-H_000107 COc1ccc(cc1)n2cc(nn2)c3cccc(/C=C/C(=O)NO)c3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 G03 mock treatment 12.2695 -0.5233 -0.1404 11.5612 -1.023 -0.2424 -0.2707 -0.9663 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 G04 mock treatment 11.5588 -1.234 -0.3311 11.3942 -1.19 -0.2819 -0.4335 -0.9968 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 G05 compound treatment 9.9407 -2.8521 -0.7653 15.3609 2.7767 0.6579 -0.0759 -0.0753 3652484 HDAC1-H_000108 COc1ccc(cc1)n2cc(nn2)C(=O)NO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 G06 compound treatment 17.426 4.6332 1.2432 15.5212 2.937 0.6959 1.3711 0.9624 3652485 HDAC1-H_000109 COc1cccc(c1)n2cc(nn2)c3cccc(/C=C/C(=O)NO)c3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 G07 compound treatment 20.5789 7.7861 2.0892 11.9032 -0.68098 -0.1613 1.3632 0.6506 3652487 HDAC1-H_000110 ONC(=O)c1cn(nn1)c2cccc(c2)C(=O)N3CCC4(CC3)N(CNC4=O)c5ccccc5 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 G08 compound treatment 13.7709 0.97812 0.2625 12.3172 -0.26697 -0.0633 0.1409 0.5217 3652488 HDAC1-H_000111 CC(C)(C)ONC(=O)Cn1cc(nn1)c2cccc(/C=C/C(=O)NO)c2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 G09 compound treatment 12.0644 -0.72837 -0.1954 12.3124 -0.27176 -0.0644 -0.1837 -0.8929 3652490 HDAC1-H_000112 COC(=O)c1ccc(Cn2cc(nn2)C(=O)NO)o1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 G10 compound treatment 19.7422 6.9494 1.8647 19.8604 7.2762 1.724 2.5376 0.9992 3652491 HDAC1-H_000113 ONC(=O)/C=C/c1cccc(c1)c2cn(nn2)c3ccc(NC(=O)c4ccccc4)cc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 G11 compound treatment 11.4999 -1.2929 -0.3469 10.7411 -1.8431 -0.4367 -0.5541 -0.9935 3652493 HDAC1-H_000114 COC(=O)[C@@H](N)Cc1ccc(cc1)n2cc(CCC(=O)NO)nn2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 G12 compound treatment 13.7759 0.98309 0.2638 16.817 4.2328 1.0029 0.8957 0.8637 3652495 HDAC1-H_000115 Nc1ccc(cc1)n2cc(nn2)c3cccc(/C=C/C(=O)NO)c3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 G13 compound treatment 13.4223 0.62944 0.1689 13.3482 0.76403 0.181 0.2474 0.9994 3652497 HDAC1-H_000116 Nc1ccc(cc1)n2cc(CCC(=O)NO)nn2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 G14 compound treatment 13.6491 0.85629 0.2298 14.0258 1.4416 0.3416 0.404 0.9814 3652498 HDAC1-H_000117 Nc1cccc(c1)n2cc(nn2)c3cccc(/C=C/C(=O)NO)c3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 G15 compound treatment 12.5786 -0.21418 -0.0575 13.6602 1.076 0.2549 0.1396 0.5343 3652500 HDAC1-H_000118 Nc1cccc(c1)n2cc(CCC(=O)NO)nn2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 G16 compound treatment 13.7311 0.93829 0.2518 12.3751 -0.20908 -0.0495 0.143 0.5573 3652501 HDAC1-H_000119 ONC(=O)/C=C/c1cccc(c1)c2cn(nn2)c3cccc(c3)C(=O)N4CCC5(CC4)N(CNC5=O)c6ccccc6 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 G17 compound treatment 10.5918 -2.2011 -0.5906 11.0544 -1.5298 -0.3625 -0.6739 -0.9725 3652503 HDAC1-H_000120 COC(=O)[C@@H](NC(=O)Cn1cc(nn1)C(=O)NO)c2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 G18 compound treatment 21.2647 8.4719 2.2732 24.0813 11.497 2.7241 3.5336 0.996 3652505 HDAC1-H_000121 ONC(=O)/C=C/c1cccc(c1)c2cn(CC(=O)N3CCN(CC3)c4ccccc4)nn2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 G19 mock treatment 12.0604 -0.73237 -0.1965 10.6219 -1.9623 -0.4649 -0.4677 -0.9266 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 G20 mock treatment 10.4841 -2.3087 -0.6195 11.3599 -1.2243 -0.2901 -0.6432 -0.9402 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 G21 compound treatment 13.0529 0.26006 0.0698 12.6457 0.061507 0.0146 0.0596 0.8367 3652507 HDAC1-H_000122 CC(C)[C@H](NS(=O)(=O)c1ccc(C)cc1)C(=O)NCCn2cc(nn2)C(=O)NO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 G22 compound treatment 28.239 15.446 4.1446 29.2939 16.71 3.9591 5.7302 0.9997 3652509 HDAC1-H_000123 COc1ccc(cc1)C(=O)Nc2cccc(c2)n3cc(nn3)c4cccc(/C=C/C(=O)NO)c4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 G23 compound treatment 11.4251 -1.3677 -0.367 12.6585 0.074314 0.0176 -0.2471 -0.6724 3652511 HDAC1-H_000124 COc1ccc(OC)c(NC(=O)Cn2cc(nn2)C(=O)NO)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 G24 compound treatment 13.161 0.36824 0.0988 15.7318 3.1476 0.7458 0.5972 0.7939 3652512 HDAC1-H_000125 ONC(=O)/C=C/c1cccc(c1)c2cn(nn2)c3cccc(c3)C(=O)N4CCN(CC4)c5ccccc5 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 H01 compound treatment 13.4535 0.66067 0.1773 11.0178 -1.5664 -0.3711 -0.1371 -0.3333 1002773 HDAC1-H_000126 OC(=O)c1ccc(nc1)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 H02 mock treatment 13.2434 0.45057 0.1209 13.3215 0.73731 0.1747 0.209 0.9838 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 H03 mock treatment 13.6177 0.82487 0.2213 12.3351 -0.24911 -0.059 0.1148 0.501 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 H04 mock treatment 13.07 0.27722 0.0744 12.5091 -0.075118 -0.0178 0.04 0.5231 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 H05 compound treatment 12.1936 -0.59926 -0.1608 12.1108 -0.47339 -0.1122 -0.193 -0.9845 3614749 HDAC1-H_000127 COC(=O)CNC(=O)C(=O)OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 H06 mock treatment 13.1762 0.38342 0.1029 12.1553 -0.42886 -0.1016 9.0E-4 0.0062 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 H07 compound treatment 10.9989 -1.7939 -0.4813 11.843 -0.74117 -0.1756 -0.4645 -0.9066 3652514 HDAC1-H_000128 OC(=O)CNC(=O)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 H08 mock treatment 11.9377 -0.85511 -0.2294 11.172 -1.4122 -0.3346 -0.3988 -0.9831 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 H09 compound treatment 10.733 -2.0599 -0.5527 11.7689 -0.81531 -0.1932 -0.5274 -0.9008 3652515 HDAC1-H_000129 CCOC(=O)/C=C/c1ccc(O)c(O)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 H10 mock treatment 12.103 -0.68977 -0.1851 12.9983 0.41408 0.0981 -0.0615 -0.2936 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 H11 compound treatment 12.7439 -0.048906 -0.0131 12.485 -0.099191 -0.0235 -0.0259 -0.9621 1978 HDAC1-H_000130 OC(=O)/C=C/c1ccc(O)c(O)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 H12 mock treatment 11.8812 -0.91163 -0.2446 13.0052 0.42102 0.0998 -0.1024 -0.3877 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 H13 compound treatment 11.2076 -1.5852 -0.4254 16.4299 3.8457 0.9112 0.3435 0.3416 831713 HDAC1-H_000131 OC(=O)c1ccc(O)c(O)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 H14 mock treatment 12.1428 -0.65003 -0.1744 11.2868 -1.2974 -0.3074 -0.3407 -0.964 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 H15 compound treatment 12.7683 -0.024481 -0.0066 10.5103 -2.0739 -0.4914 -0.3521 -0.7165 1070606 HDAC1-H_000132 COC(=O)c1ccc(O)c(O)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 H16 mock treatment 14.5554 1.7626 0.473 10.9228 -1.6614 -0.3937 0.0561 0.0911 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 H17 compound treatment 11.7433 -1.0495 -0.2816 13.0981 0.51386 0.1218 -0.113 -0.3684 3652517 HDAC1-H_000133 COC(=O)c1ccc(nc1)C(=O)NCCCCCNC(=O)OCc2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 H18 mock treatment 13.1613 0.36847 0.0989 14.6263 2.0421 0.4838 0.412 0.8344 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 H19 mock treatment 10.7855 -2.0073 -0.5386 10.4961 -2.0881 -0.4948 -0.7307 -0.9991 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 H20 mock treatment 12.9127 0.11989 0.0322 11.2027 -1.3814 -0.3273 -0.2087 -0.6345 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 H21 compound treatment 12.2581 -0.53476 -0.1435 11.7624 -0.82182 -0.1947 -0.2391 -0.9887 3652518 HDAC1-H_000134 COC(=O)c1ccc(nc1)C(=O)NCCCCCCNC(=O)OC(C)(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 H22 mock treatment 12.918 0.12522 0.0336 9.5846 -2.9996 -0.7107 -0.4788 -0.6729 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 H23 compound treatment 15.6352 2.8424 0.7627 10.8569 -1.7273 -0.4093 0.2499 0.2887 3652519 HDAC1-H_000135 CCOC(=O)CCNC(=O)c1ccccn1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 H24 mock treatment 11.9367 -0.85613 -0.2297 13.3091 0.72488 0.1718 -0.041 -0.1429 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 I01 compound treatment 14.9356 2.1428 0.575 14.1418 1.5576 0.3691 0.6675 0.977 3652520 HDAC1-H_000136 CCOC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)Cn3cc(nn3)C(=O)NO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 I02 compound treatment 13.6067 0.81384 0.2184 13.6875 1.1033 0.2614 0.3393 0.996 3652522 HDAC1-H_000137 COc1ccc(NC(=O)Cn2cc(nn2)c3cccc(/C=C/C(=O)NO)c3)cc1OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 I03 compound treatment 12.7744 -0.018406 -0.0049 14.3442 1.76 0.417 0.2914 0.6987 3652524 HDAC1-H_000138 ONC(=O)c1cn(CCCNC(=O)Nc2ccccc2)nn1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 I04 compound treatment 48.1012 35.308 9.4741 46.385 33.801 8.0086 12.3622 0.9965 3652525 HDAC1-H_000139 ONC(=O)/C=C/c1cccc(c1)c2cn(nn2)c3ccc4[nH]ccc4c3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 I05 mock treatment 13.1355 0.34272 0.092 11.6492 -0.93501 -0.2215 -0.0916 -0.382 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 I06 mock treatment 12.4068 -0.38601 -0.1036 11.5178 -1.0664 -0.2527 -0.2519 -0.9225 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 I07 compound treatment 10.5949 -2.1979 -0.5897 14.5007 1.9165 0.4541 -0.0959 -0.1289 3652527 HDAC1-H_000140 ONC(=O)c1cn(CCNC(=O)Nc2ccccc2)nn1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 I08 compound treatment 36.6356 23.843 6.3976 22.7656 10.181 2.4123 6.2296 0.9111 3652528 HDAC1-H_000141 CCOc1cc(OCC)cc(c1)C(=O)N[C@@H](Cc2ccc(cc2)n3cc(nn3)c4cccc(/C=C/C(=O)NO)c4)C(=O)OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 I09 compound treatment 13.2758 0.48294 0.1296 12.3389 -0.24532 -0.0581 0.0505 0.3558 3652530 HDAC1-H_000142 ONC(=O)c1cn(C[C@H](Cc2ccccc2)NC(=O)c3ccccc3)nn1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 I10 compound treatment 166.269 153.48 41.1816 168.3973 155.81 36.9176 55.2245 0.9985 3622981 HDAC1-H_000143 Nc1ccccc1NC(=O)c2ccc(CNc3nccc(n3)c4cccnc4)cc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 I11 compound treatment 12.9164 0.12361 0.0332 12.8877 0.30346 0.0719 0.0743 0.9383 3652532 HDAC1-H_000144 ONC(=O)c1cn(CC(=O)N2CCC3(CC2)N(CNC3=O)c4ccccc4)nn1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 I12 compound treatment 165.2215 152.43 40.9005 161.9205 149.34 35.383 53.9406 0.9974 3652533 HDAC1-H_000145 COc1ccc(NCc2ccc(cc2)C(=O)Nc3ccccc3N)cc1OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 I13 compound treatment 12.4932 -0.29958 -0.0804 13.1859 0.60173 0.1426 0.044 0.2687 3652534 HDAC1-H_000146 CCOC(=O)[C@H](Cc1ccccc1)NC(=O)Cn2cc(nn2)C(=O)NO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 I14 compound treatment 269.74 256.95 68.9455 248.9158 236.33 55.9953 88.3465 0.9947 3652536 HDAC1-H_000147 Cc1ccc(NCc2ccc(cc2)C(=O)Nc3ccccc3N)cc1C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 I15 compound treatment 14.5054 1.7126 0.4595 13.0052 0.42101 0.0998 0.3955 0.841 3652537 HDAC1-H_000148 Cc1ccc(cc1)S(=O)(=O)N[C@@H](Cc2ccccc2)C(=O)NCCn3cc(nn3)C(=O)NO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 I16 compound treatment 11.2588 -1.534 -0.4116 12.4105 -0.17372 -0.0412 -0.3202 -0.774 3652539 HDAC1-H_000149 O=C(Nc1ccccc1)c2ccc(CNc3nccc(n3)c4cccnc4)cc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 I17 compound treatment 11.1952 -1.5977 -0.4287 12.6622 0.077979 0.0185 -0.2901 -0.676 3652540 HDAC1-H_000150 Cc1ccc(cc1)S(=O)(=O)N[C@@H](Cc2ccccc2)C(=O)NCCCn3cc(nn3)C(=O)NO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 I18 compound treatment 10.7556 -2.0372 -0.5466 9.9874 -2.5968 -0.6153 -0.8216 -0.9983 3652542 HDAC1-H_000151 COc1ccc(NCc2ccc(cc2)C(=O)Nc3ccccc3)cc1OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 I19 compound treatment 12.4303 -0.36252 -0.0973 11.2895 -1.2947 -0.3068 -0.2857 -0.8878 3652543 HDAC1-H_000152 ONC(=O)c1cn(C[C@H](Cc2ccccc2)NC(=O)Nc3ccccc3)nn1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 I20 compound treatment 37.2718 24.479 6.5683 33.7779 21.194 5.0215 8.1953 0.9912 3652545 HDAC1-H_000153 [O-][N+](=O)c1ccccc1NC(=O)c2ccc(CNc3nccc(n3)c4cccnc4)cc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 I21 mock treatment 15.2659 2.4731 0.6636 11.7348 -0.84937 -0.2012 0.3269 0.4715 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 I22 mock treatment 13.487 0.69417 0.1863 11.4345 -1.1497 -0.2724 -0.0609 -0.1846 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 I23 compound treatment 12.1824 -0.61042 -0.1638 14.868 2.2838 0.5411 0.2668 0.4719 3652546 HDAC1-H_000154 ONC(=O)c1cn(C[C@@H](Cc2ccccc2)NC(=O)Nc3ccccc3)nn1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 I24 compound treatment 12.7292 -0.063581 -0.0171 12.7079 0.12366 0.0293 0.0087 0.2552 3652547 HDAC1-H_000155 Cc1ccc(NCc2ccc(cc2)C(=O)Nc3ccccc3)cc1C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 J01 compound treatment 12.2752 -0.51761 -0.1389 11.1759 -1.4083 -0.3337 -0.3341 -0.9245 3652548 HDAC1-H_000156 CN(CCCCCNC(=O)c1ccccc1)CC#C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 J02 mock treatment 14.2993 1.5065 0.4042 13.7281 1.1439 0.271 0.4775 0.9811 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 J03 compound treatment 12.4369 -0.35596 -0.0955 12.5137 -0.070543 -0.0167 -0.0794 -0.8184 3652549 HDAC1-H_000157 COC(=O)C(=O)NCCCCCNC(=O)c1ccccc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 J04 mock treatment 12.6974 -0.095381 -0.0256 11.1684 -1.4158 -0.3355 -0.2553 -0.7588 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 J05 mock treatment 15.2956 2.5028 0.6716 14.8579 2.2737 0.5387 0.8558 0.994 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 J06 mock treatment 10.351 -2.4418 -0.6552 13.4625 0.87833 0.2081 -0.3161 -0.4599 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 J07 compound treatment 11.9705 -0.82228 -0.2206 12.6271 0.042919 0.0102 -0.1488 -0.6738 3652550 HDAC1-H_000158 COC(=O)c1ccc(nc1)C(=O)NCCCCNC(=O)c2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 J08 mock treatment 13.0763 0.28349 0.0761 11.4736 -1.1106 -0.2631 -0.1323 -0.4829 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 J09 compound treatment 11.5615 -1.2313 -0.3304 13.2656 0.6814 0.1614 -0.1195 -0.3249 1025079 HDAC1-H_000159 COC(=O)c1ccc(nc1)C(=O)OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 J10 mock treatment 12.6428 -0.14998 -0.0402 11.4043 -1.1798 -0.2795 -0.2261 -0.8006 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 J11 compound treatment 168.3363 155.54 41.7363 171.136 158.55 37.5665 56.0756 0.9986 3635106 HDAC1-H_000160 ONC(=O)CCCCCCC(=O)Nc1ccc(cc1)C2OC(COc3ccccc3)CC(O2)c4ccccc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 J12 mock treatment 11.7449 -1.048 -0.2812 13.3953 0.81108 0.1922 -0.0629 -0.1848 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 J13 compound treatment 19.8644 7.0716 1.8975 19.6656 7.0814 1.6778 2.5281 0.9981 3635115 HDAC1-H_000161 COCC1CC(OC(O1)c2ccc(cc2)C3OC(COC)CC(O3)c4ccc(NC(=O)CCCCCCC(=O)NO)cc4)c5ccc(NC(=O)CCCCCCC(=O)NO)cc5 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 J14 mock treatment 12.9192 0.12634 0.0339 13.7828 1.1986 0.284 0.2248 0.7859 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 J15 compound treatment 11.8053 -0.98753 -0.265 13.474 0.88983 0.2108 -0.0383 -0.1131 3652551 HDAC1-H_000162 ONC(=O)CCCCCCC(=O)Nc1ccc(cc1)C2OC(CC#C)CC(O2)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 J16 mock treatment 13.186 0.39317 0.1055 14.4373 1.8531 0.4391 0.3851 0.8527 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 J17 compound treatment 492.6807 479.89 128.7663 444.6302 432.05 102.367 163.4359 0.9935 3652552 HDAC1-H_000163 COC(=O)CCCCCCC(=O)Nc1ccc(cc1)C2CC(CSc3nc(c(o3)c4ccccc4)c5ccccc5)OC(O2)c6ccc(NC(=O)CCCCCCC(=O)OC)cc6 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 J18 mock treatment 11.4954 -1.2974 -0.3481 13.8213 1.2371 0.2931 -0.0389 -0.0855 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 J19 compound treatment 111.342 98.549 26.4433 107.2728 94.689 22.4351 34.5622 0.9967 3215583 HDAC1-H_000164 ONC(=O)CCCCCCC(=O)Nc1ccc(cc1)C2OC(CSc3ccccn3)CC(O2)c4ccccc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 J20 mock treatment 9.9173 -2.8755 -0.7716 11.3514 -1.2328 -0.2921 -0.7521 -0.9117 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 J21 mock treatment 13.6371 0.84427 0.2265 11.969 -0.61519 -0.1458 0.0571 0.212 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 J22 mock treatment 13.9693 1.1765 0.3157 11.5007 -1.0835 -0.2567 0.0417 0.1025 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 J23 compound treatment 23.0379 10.245 2.749 42.9839 30.4 7.2028 7.037 0.9128 3635098 HDAC1-H_000165 ONC(=O)CCCCCCC(=O)Nc1ccc(cc1)C2OC(CSc3nc4ccccc4s3)CC(O2)c5ccccc5 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 J24 mock treatment 12.1342 -0.65859 -0.1767 12.0939 -0.49029 -0.1162 -0.2071 -0.9793 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 K01 compound treatment 13.8572 1.0644 0.2856 11.7774 -0.80677 -0.1912 0.0668 0.1943 3652553 HDAC1-H_000166 Cc1ccc(cc1)S(=O)(=O)N2CCC[C@H]2Cn3cc(nn3)C(=O)NO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 K02 compound treatment 21.5498 8.757 2.3497 19.6811 7.0969 1.6815 2.8505 0.9865 3652555 HDAC1-H_000167 COc1ccc(NCc2ccc(cc2)C(=O)Nc3ccccc3[N+](=O)[O-])cc1OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 K03 compound treatment 10.3646 -2.4282 -0.6515 10.0493 -2.5349 -0.6006 -0.8854 -0.9992 3652556 HDAC1-H_000168 ONC(=O)c1cn(nn1)c2cccc(c2)C(=O)NCCc3c[nH]c4ccccc34 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 K04 compound treatment 12.3156 -0.47723 -0.1281 13.841 1.2568 0.2978 0.12 0.3703 3652557 HDAC1-H_000169 Cc1ccc(NCc2ccc(cc2)C(=O)Nc3ccccc3[N+](=O)[O-])cc1C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 K05 compound treatment 10.5153 -2.2775 -0.6111 49.4875 36.903 8.7437 5.7506 0.6561 3652558 HDAC1-H_000170 CC(C)(C)ONC(=O)c1ccc(cc1)n2cc(nn2)C(=O)NO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 K06 compound treatment 38.4427 25.65 6.8825 36.3842 23.8 5.6391 8.8541 0.9951 3614389 HDAC1-H_000171 ONC(=O)/C=C/c1ccc(OCc2ccccc2)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 K07 mock treatment 11.6524 -1.1404 -0.306 10.9048 -1.6794 -0.3979 -0.4977 -0.9916 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 K08 mock treatment 10.01 -2.7828 -0.7467 11.9927 -0.59145 -0.1401 -0.6271 -0.8254 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 K09 compound treatment 10.7383 -2.0545 -0.5513 11.0876 -1.4966 -0.3546 -0.6406 -0.9772 3652484 HDAC1-H_000172 COc1ccc(cc1)n2cc(nn2)C(=O)NO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 K10 compound treatment 15.0429 2.2501 0.6038 16.6097 4.0255 0.9538 1.1014 0.9757 3614392 HDAC1-H_000173 ONC(=O)/C=C/c1ccc(OCc2ccc(Cl)cc2)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 K11 compound treatment 11.706 -1.0868 -0.2916 12.8425 0.25828 0.0612 -0.1629 -0.5468 3652483 HDAC1-H_000174 COc1cccc(c1)n2cc(nn2)C(=O)NO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 K12 compound treatment 99.3125 86.52 23.2155 86.1301 73.546 17.4256 28.7376 0.99 3614394 HDAC1-H_000175 Nc1cccc(COc2ccc(/C=C/C(=O)NO)cc2)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 K13 compound treatment 11.7405 -1.0523 -0.2824 14.2224 1.6382 0.3881 0.0748 0.1559 3652484 HDAC1-H_000176 COc1ccc(cc1)n2cc(nn2)C(=O)NO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 K14 compound treatment 57.8359 45.043 12.0862 56.5996 44.015 10.4288 15.9205 0.9973 3614396 HDAC1-H_000177 ONC(=O)/C=C/c1ccc(OCCCc2ccccc2)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 K15 mock treatment 10.871 -1.9218 -0.5157 11.9275 -0.65668 -0.1556 -0.4747 -0.8812 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 K16 mock treatment 13.893 1.1002 0.2952 12.6167 0.032487 0.0077 0.2142 0.7253 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 K17 compound treatment 11.5612 -1.2316 -0.3305 13.5288 0.94458 0.2238 -0.0754 -0.189 3652559 HDAC1-H_000178 CCOc1cc(OCC)cc(c1)C(=O)N[C@H](Cc2ccc(cc2)n3cc(nn3)C(=O)NO)C(=O)OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 K18 compound treatment 22.0079 9.215 2.4726 22.7926 10.208 2.4187 3.4587 0.9999 3614383 HDAC1-H_000179 ONC(=O)/C=C/c1ccc(OCCc2cccs2)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 K19 compound treatment 14.0058 1.213 0.3255 11.0644 -1.5197 -0.3601 -0.0245 -0.0504 3652561 HDAC1-H_000180 COc1ccc(cc1)C(=O)Nc2cccc(c2)n3cc(nn3)C(=O)NO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 K20 compound treatment 19.6965 6.9037 1.8524 15.7122 3.128 0.7411 1.8339 0.9192 3614398 HDAC1-H_000181 ONC(=O)/C=C/c1ccc(OCCCCc2ccccc2)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 K21 compound treatment 14.6985 1.9057 0.5113 14.5443 1.9601 0.4644 0.69 0.9988 3652381 HDAC1-H_000182 COC(=O)[C@@H](NC(=O)Cn1cc(CCC(=O)NO)nn1)c2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 K22 compound treatment 225.126 212.33 56.9745 187.765 175.18 41.5065 69.6366 0.9879 3614403 HDAC1-H_000183 ONC(=O)/C=C/c1ccc(OCCn2c3ccccc3c4ccccc24)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 K23 mock treatment 11.8435 -0.94935 -0.2547 11.4363 -1.1479 -0.272 -0.3724 -0.9995 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 K24 mock treatment 16.8259 4.0331 1.0822 13.036 0.45184 0.1071 0.8409 0.7733 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 L01 compound treatment 172.8265 160.03 42.9412 176.8695 164.29 38.925 57.8881 0.9988 3215593 HDAC1-H_000184 OCCSCC1CC(OC(O1)c2ccc(NC(=O)CCCCCCC(=O)NO)cc2)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 L02 mock treatment 15.1172 2.3244 0.6237 13.3081 0.72391 0.1715 0.5623 0.8693 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 L03 compound treatment 193.3053 180.51 48.4361 216.0228 203.44 48.2018 68.3333 1.0 3635101 HDAC1-H_000185 CC(C)OCC1CC(OC(O1)c2ccc(NC(=O)CCCCCCC(=O)NO)cc2)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 L04 mock treatment 11.0296 -1.7632 -0.4731 13.6642 1.0801 0.2559 -0.1536 -0.2855 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 L05 compound treatment 579.4595 566.67 152.0512 511.215 498.63 118.1433 191.0564 0.9922 3652562 HDAC1-H_000186 CNc1ccc(cc1)C(=O)NCCCCCCC(=O)NO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 L06 mock treatment 12.208 -0.58481 -0.1569 13.9768 1.3926 0.33 0.1224 0.3349 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 L07 mock treatment 13.0456 0.25276 0.0678 14.2399 1.6557 0.3923 0.3254 0.8172 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 L08 mock treatment 13.2777 0.48484 0.1301 14.1366 1.5524 0.3678 0.3521 0.9024 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 L09 compound treatment 229.705 216.91 58.2031 216.22 203.64 48.2485 75.2727 0.9957 3652563 HDAC1-H_000187 ONC(=O)/C=C/c1ccc(CNc2ccc(cc2)C3OC(CSc4ccncc4)CC(O3)c5ccccc5)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 L10 mock treatment 11.3104 -1.4824 -0.3978 12.4947 -0.089493 -0.0212 -0.2963 -0.7437 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 L11 compound treatment 169.4315 156.64 42.0302 175.7908 163.21 38.6694 57.0632 0.9991 3652565 HDAC1-H_000188 ONC(=O)CCCCCCC(=O)Nc1ccc(cc1)C2CC(OC(O2)c3ccncc3)c4ccccc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 L12 mock treatment 11.95 -0.84278 -0.2261 12.8738 0.2896 0.0686 -0.1114 -0.4713 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 L13 mock treatment 12.3529 -0.43991 -0.118 11.2424 -1.3418 -0.3179 -0.3083 -0.909 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 L14 mock treatment 24.6795 11.887 3.1895 11.7187 -0.86548 -0.2051 2.1103 0.6603 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 L15 mock treatment 12.6455 -0.1473 -0.0395 13.1446 0.56042 0.1328 0.0659 0.476 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 L16 mock treatment 12.6361 -0.15668 -0.042 11.271 -1.3132 -0.3111 -0.2497 -0.7954 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 L17 compound treatment 30.365 17.572 4.7151 29.4786 16.894 4.0029 6.1645 0.9967 3635112 HDAC1-H_000189 ONC(=O)CCCCCCC(=O)Nc1ccc(cc1)[C@H]2O[C@@H](CSc3ccncc3)C[C@H](O2)c4ccccc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 L18 mock treatment 12.8956 0.10282 0.0276 12.6728 0.088557 0.021 0.0343 0.9909 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 L19 compound treatment 12.8334 0.040619 0.0109 12.3996 -0.18459 -0.0437 -0.0232 -0.5151 3215595 HDAC1-H_000190 ONC(=O)CCCCCCC(=O)Nc1ccc(cc1)C2OC(CSc3ccncc3)CC(O2)c4ccccc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 L20 mock treatment 11.3361 -1.4567 -0.3909 12.7907 0.2065 0.0489 -0.2418 -0.6138 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 L21 compound treatment 11.5473 -1.2455 -0.3342 11.7886 -0.79555 -0.1885 -0.3696 -0.9633 3652566 HDAC1-H_000191 ONC(=O)CCCCCCC(=O)Nc1ccc(cc1)C2OC(CN3CCNCC3)CC(O2)c4ccccc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 L22 mock treatment 12.8278 0.035019 0.0094 13.7652 1.181 0.2798 0.2045 0.7304 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 L23 mock treatment 10.8232 -1.9696 -0.5285 14.6986 2.1144 0.501 -0.0195 -0.0267 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 L24 mock treatment 12.6634 -0.12943 -0.0347 14.2905 1.7063 0.4043 0.2613 0.644 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 M01 compound treatment 10.3177 -2.4751 -0.6641 14.9913 2.4071 0.5703 -0.0663 -0.0758 3652384 HDAC1-H_000192 CC(C)[C@H](NS(=O)(=O)c1ccc(C)cc1)C(=O)NCCn2cc(CCC(=O)NO)nn2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 M02 compound treatment 398.587 385.79 103.5185 365.9488 353.36 83.7245 132.4008 0.9945 3652567 HDAC1-H_000193 C/C(=C\c1ccccc1OCc2ccc(cc2)c3ccncc3)/C=C/C(=O)NO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 M03 compound treatment 15.0324 2.2396 0.6009 13.7882 1.204 0.2853 0.6266 0.942 3652569 HDAC1-H_000194 COc1ccc(OC)c(NC(=O)Cn2cc(CCC(=O)NO)nn2)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 M04 compound treatment 55.5291 42.736 11.4672 55.5783 42.994 10.1868 15.3117 0.9983 3652570 HDAC1-H_000195 C/C(=C\c1cccc(OCc2ccc(cc2)c3ccncc3)c1)/C=C/C(=O)NO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 M05 compound treatment 13.5083 0.71552 0.192 28.6032 16.019 3.7955 2.8196 0.7419 3652572 HDAC1-H_000196 CCOC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)Cn3cc(CCC(=O)NO)nn3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 M06 compound treatment 21.1624 8.3696 2.2458 18.2563 5.6721 1.3439 2.5383 0.9699 3652574 HDAC1-H_000197 CN1C[C@H](COc2ccccc2/C=C(\C)/C=C/C(=O)NO)C=C3[C@H]1Cc4c[nH]c5cccc3c45 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 M07 compound treatment 12.0502 -0.74257 -0.1993 14.8856 2.3014 0.5453 0.2447 0.4215 3652576 HDAC1-H_000198 ONC(=O)CCc1cn(CCCNC(=O)Nc2ccccc2)nn1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 M08 compound treatment 9.3674 -3.4254 -0.9191 13.6389 1.0548 0.2499 -0.4732 -0.4968 3652577 HDAC1-H_000199 C/C(=C\c1ccccc1OC[C@H]2[C@@H](O)CC[C@H]3CN4CCc5c([nH]c6ccccc56)[C@@H]4C[C@H]23)/C=C/C(=O)NO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 M09 mock treatment 11.3564 -1.4364 -0.3854 11.9339 -0.6503 -0.1541 -0.3815 -0.9191 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 M10 mock treatment 10.5455 -2.2473 -0.603 11.4567 -1.1275 -0.2671 -0.6153 -0.9329 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 M11 compound treatment 14.4365 1.6437 0.441 14.7786 2.1944 0.5199 0.6795 0.9966 3652579 HDAC1-H_000200 ONC(=O)CCc1cn(C[C@H](Cc2ccccc2)NC(=O)c3ccccc3)nn1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 M12 compound treatment 211.4572 198.66 53.3068 201.787 189.2 44.8288 69.3924 0.9963 3652581 HDAC1-H_000201 C/C(=C\c1cccc(OC[C@H]2[C@@H](O)CC[C@H]3CN4CCc5c([nH]c6ccccc56)[C@@H]4C[C@H]23)c1)/C=C/C(=O)NO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 M13 mock treatment 10.8741 -1.9187 -0.5148 10.9732 -1.611 -0.3817 -0.6339 -0.9892 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 M14 mock treatment 13.229 0.43617 0.117 12.9414 0.35721 0.0846 0.1426 0.9873 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 M15 compound treatment 11.3704 -1.4224 -0.3817 14.6621 2.0779 0.4923 0.0782 0.1256 3652583 HDAC1-H_000202 ONC(=O)CCc1cn(CCNC(=O)Nc2ccccc2)nn1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 M16 compound treatment 21.9154 9.1226 2.4478 40.2147 27.631 6.5466 6.3601 0.91 3652584 HDAC1-H_000203 CCN(CC)CCNc1ccc(COc2ccccc2/C=C(\C)/C=C/C(=O)NO)c3sc4ccccc4c(=O)c13 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 M17 compound treatment 12.0361 -0.75668 -0.203 12.0942 -0.48998 -0.1161 -0.2257 -0.9648 3652586 HDAC1-H_000204 ONC(=O)CCc1cn(CC(=O)N2CCC3(CC2)N(CNC3=O)c4ccccc4)nn1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 M18 compound treatment 36.0142 23.221 6.2309 46.3856 33.801 8.0087 10.069 0.9923 3652587 HDAC1-H_000205 CCN(CC)CCNc1ccc(COc2cccc(/C=C(\C)/C=C/C(=O)NO)c2)c3sc4ccccc4c(=O)c13 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 M19 compound treatment 11.2013 -1.5915 -0.427 11.4779 -1.1063 -0.2621 -0.4873 -0.9725 3652589 HDAC1-H_000206 CCOC(=O)[C@H](Cc1ccccc1)NC(=O)Cn2cc(CCC(=O)NO)nn2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 M20 compound treatment 62.9064 50.114 13.4468 71.1253 58.541 13.8705 19.3162 0.9999 3652591 HDAC1-H_000207 C/C(=C\c1ccccc1OCc2ccc(COc3ccc4ccncc4c3)cc2)/C=C/C(=O)NO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 M21 compound treatment 14.7503 1.9575 0.5252 12.3591 -0.22512 -0.0533 0.3337 0.632 3652593 HDAC1-H_000208 Cc1ccc(cc1)S(=O)(=O)N[C@@H](Cc2ccccc2)C(=O)NCCn3cc(CCC(=O)NO)nn3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 M22 compound treatment 18.3348 5.542 1.4871 21.8191 9.2349 2.1881 2.5987 0.9823 3652595 HDAC1-H_000209 C/C(=C\c1cccc(OCc2ccc(COc3ccc4ccncc4c3)cc2)c1)/C=C/C(=O)NO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 M23 compound treatment 13.296 0.5032 0.135 11.8113 -0.77291 -0.1831 -0.034 -0.1495 3652597 HDAC1-H_000210 Cc1ccc(cc1)S(=O)(=O)N[C@@H](Cc2ccccc2)C(=O)NCCCn3cc(CCC(=O)NO)nn3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 M24 compound treatment 13.3766 0.58374 0.1566 12.7374 0.15324 0.0363 0.1364 0.8485 3562174 HDAC1-H_000211 OCc1ccc(cc1)c2ccncc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 N01 compound treatment 14.9514 2.1586 0.5792 16.1578 3.5736 0.8467 1.0083 0.9829 3652599 HDAC1-H_000212 CNCC1CC(OC(O1)c2ccc(NC(=O)CCCCCCC(=O)NO)cc2)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 N02 mock treatment 13.6089 0.81612 0.219 16.0847 3.5005 0.8294 0.7413 0.8642 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 N03 compound treatment 434.362 421.57 113.1179 408.2883 395.7 93.7563 146.2821 0.9956 3652600 HDAC1-H_000213 ONC(=O)CCCCCCNC(=O)c1ccc(NCc2cn(Cc3cccc(Cn4cc(CNc5ccc(cc5)C(=O)NCCCCCCC(=O)NO)nn4)c3)nn2)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 N04 mock treatment 11.2657 -1.5271 -0.4098 14.2136 1.6294 0.3861 -0.0168 -0.0298 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 N05 compound treatment 39.3274 26.535 7.1199 29.709 17.125 4.0575 7.9036 0.9645 3634810 HDAC1-H_000214 ONC(=O)CCCCCCC(=O)Nc1ccc(cc1)C(=O)c2ccc(NC(=O)CCCC#C)cc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 N06 mock treatment 11.7978 -0.99506 -0.267 10.7358 -1.8484 -0.4379 -0.4985 -0.9718 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 N07 compound treatment 315.3112 302.52 81.1735 305.907 293.32 69.4985 106.5412 0.997 3652601 HDAC1-H_000215 ONC(=O)CCCCCCNC(=O)c1ccc(NCc2cn(Cc3ccc(cc3)C(=O)c4ccc(Cn5cc(CNc6ccc(cc6)C(=O)NCCCCCCC(=O)NO)nn5)cc4)nn2)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 N08 mock treatment 13.8071 1.0142 0.2721 14.2254 1.6412 0.3888 0.4674 0.9848 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 N09 mock treatment 11.0704 -1.7224 -0.4622 10.6936 -1.8905 -0.4479 -0.6435 -0.9999 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 N10 mock treatment 12.4826 -0.31021 -0.0832 14.4632 1.879 0.4452 0.2559 0.5651 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 N11 compound treatment 537.877 525.08 140.8936 530.1365 517.55 122.6264 186.3368 0.9976 483 HDAC1-H_000216 CN(C)c1ccc(cc1)C(=O)NCCCCCCC(=O)NO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 N12 mock treatment 12.6947 -0.098081 -0.0263 11.1569 -1.4273 -0.3382 -0.2577 -0.7598 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 N13 mock treatment 10.5277 -2.2651 -0.6078 12.1119 -0.47233 -0.1119 -0.5089 -0.8235 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 N14 mock treatment 20.7604 7.9676 2.1379 12.4675 -0.11672 -0.0277 1.4922 0.6979 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 N15 compound treatment 90.0673 77.275 20.7347 77.3097 64.726 15.3358 25.5057 0.989 3652602 HDAC1-H_000217 ONC(=O)CCCCCCNC(=O)c1ccc(NCc2cn(Cc3ccc(Cn4cc(CNc5ccc(cc5)C(=O)NCCCCCCC(=O)NO)nn4)cc3)nn2)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 N16 mock treatment 11.5181 -1.2747 -0.342 15.0241 2.4399 0.5781 0.1669 0.2485 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 N17 compound treatment 447.809 435.02 116.726 440.9885 428.4 101.5041 154.312 0.9976 3652603 HDAC1-H_000218 ONC(=O)CCCCCCC(=O)Nc1ccc(/C=N/O)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 N18 mock treatment 9.2609 -3.5319 -0.9477 12.0123 -0.57186 -0.1355 -0.7659 -0.8001 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 N19 compound treatment 529.12 516.33 138.5439 491.3115 478.73 113.4274 178.1706 0.9951 468 HDAC1-H_000219 ONC(=O)CCCCCCC(=O)Nc1ccccc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 N20 mock treatment 13.2199 0.42709 0.1146 11.4499 -1.1343 -0.2688 -0.109 -0.3731 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 N21 compound treatment 12.2641 -0.52867 -0.1419 11.3072 -1.277 -0.3026 -0.3143 -0.9404 3652605 HDAC1-H_000220 COC(=O)CCCCCCNC(=O)c1ccc(NCc2cn(Cc3ccc(cc3)C(=O)c4ccc(Cn5cc(CNc6ccc(cc6)C(=O)NCCCCCCC(=O)OC)nn5)cc4)nn2)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 N22 mock treatment 10.7503 -2.0425 -0.5481 9.2458 -3.3384 -0.791 -0.9468 -0.9839 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 N23 compound treatment 16.4987 3.7059 0.9944 14.4186 1.8344 0.4346 1.0105 0.9311 3652606 HDAC1-H_000221 ONC(=O)CCCCCCC(=O)Nc1ccc(/C=N/OCc2ccccc2)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 N24 mock treatment 10.5346 -2.2582 -0.6059 10.5603 -2.0239 -0.4795 -0.7675 -0.9933 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 O01 compound treatment 12.3085 -0.48436 -0.13 15.2264 2.6422 0.626 0.3508 0.5486 3652608 HDAC1-H_000222 ONC(=O)CCc1cn(C[C@H](Cc2ccccc2)NC(=O)Nc3ccccc3)nn1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 O02 compound treatment 12.7554 -0.037388 -0.01 15.1755 2.5913 0.614 0.427 0.6955 3652610 HDAC1-H_000223 OC[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@H]12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 O03 compound treatment 14.0477 1.2549 0.3367 16.7777 4.1935 0.9936 0.9407 0.8966 3652612 HDAC1-H_000224 ONC(=O)CCc1cn(C[C@@H](Cc2ccccc2)NC(=O)Nc3ccccc3)nn1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 O04 compound treatment 14.0059 1.213 0.3255 13.3801 0.79591 0.1886 0.3635 0.9663 1105 HDAC1-H_000225 CCN(CC)CCNc1ccc(CO)c2sc3ccccc3c(=O)c12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 O05 compound treatment 11.623 -1.1698 -0.3139 13.8824 1.2982 0.3076 -0.0045 -0.0101 3652613 HDAC1-H_000226 Cc1ccc(cc1)S(=O)(=O)N2CCC[C@H]2Cn3cc(CCC(=O)NO)nn3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 O06 compound treatment 11.4968 -1.296 -0.3478 11.9381 -0.64612 -0.1531 -0.3541 -0.9321 3652615 HDAC1-H_000227 OCc1ccc(COc2ccc3ccncc3c2)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 O07 compound treatment 13.8356 1.0428 0.2798 18.4428 5.8586 1.3881 1.1794 0.8329 3652616 HDAC1-H_000228 Cc1ccc(cc1)S(=O)(=O)N(c2cccc(c2)n3cc(CCC(=O)NO)nn3)S(=O)(=O)c4ccc(C)cc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 O08 compound treatment 240.138 227.35 61.0026 244.0267 231.44 54.8369 81.9109 0.9986 3652617 HDAC1-H_000229 ONC(=O)/C=C/c1ccc(cc1)C2OC(CSc3ccncc3)CC(O2)c4ccccc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 O09 compound treatment 10.6521 -2.1407 -0.5744 12.5564 -0.027793 -0.0066 -0.4108 -0.7152 3652619 HDAC1-H_000230 ONC(=O)CCc1cn(nn1)c2cccc(c2)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 O10 compound treatment 227.6192 214.83 57.6435 218.3063 205.72 48.7428 75.2265 0.9965 3652620 HDAC1-H_000231 COc1cc2CCN(CC3CC(OC(O3)c4ccc(NC(=O)CCCCCCC(=O)NO)cc4)c5ccccc5)Cc2cc1OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 O11 mock treatment 12.0597 -0.73308 -0.1967 10.4644 -2.1198 -0.5023 -0.4942 -0.9163 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 O12 mock treatment 10.1745 -2.6183 -0.7026 11.7422 -0.84204 -0.1995 -0.6379 -0.8734 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 O13 compound treatment 11.8228 -0.96998 -0.2603 13.8211 1.2369 0.2931 0.0232 0.0592 3652621 HDAC1-H_000232 CC(C)(C)ONC(=O)c1cccc(c1)n2cc(CCC(=O)NO)nn2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 O14 compound treatment 15.1165 2.3236 0.6235 17.8518 5.2676 1.2481 1.3234 0.9486 3652622 HDAC1-H_000233 ONC(=O)CCCCCCC(=O)Nc1ccc(cc1)C2OC(CSc3nc(c(o3)c4ccccc4)c5ccccc5)CC(O2)c6ccc(cc6)[N+](=O)[O-] 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 O15 compound treatment 11.9029 -0.88989 -0.2388 16.5627 3.9785 0.9426 0.4977 0.5118 3652387 HDAC1-H_000234 COc1ccc(cc1)n2cc(CCC(=O)NO)nn2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 O16 compound treatment 87.1766 74.384 19.9591 74.6237 62.04 14.6994 24.5072 0.9887 3635093 HDAC1-H_000235 ONC(=O)CCCCCCC(=O)Nc1ccc(cc1)C2OC(CSc3ccccc3)CC(O2)c4ccccc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 O17 compound treatment 13.529 0.73624 0.1976 12.7236 0.13941 0.033 0.163 0.814 3652623 HDAC1-H_000236 COc1cccc(c1)n2cc(CCC(=O)NO)nn2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 O18 compound treatment 13.1179 0.32504 0.0872 17.2732 4.689 1.111 0.8473 0.7603 3561878 HDAC1-H_000237 ONC(=O)CCCCCCC(=O)Nc1ccc(cc1)C2CC(CSc3nc(c(o3)c4ccccc4)c5ccccc5)OC(O2)c6ccccc6 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 O19 compound treatment 13.0328 0.23997 0.0644 12.9669 0.38266 0.0907 0.1096 0.9859 3652624 HDAC1-H_000238 ONC(=O)CCc1cn(nn1)c2ccc(NC(=O)c3ccccc3)cc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 O20 compound treatment 15.56 2.7672 0.7425 14.2596 1.6754 0.397 0.8057 0.957 3635080 HDAC1-H_000239 ONC(=O)CCCCCCC(=O)Nc1ccc(cc1)C2CC(CSc3nc(c(o3)c4ccccc4)c5ccccc5)OC(O2)c6ccc(NC(=O)CCCCCCC(=O)NO)cc6 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 O21 compound treatment 10.8082 -1.9846 -0.5325 15.1797 2.5955 0.615 0.0583 0.0717 3652625 HDAC1-H_000240 ONC(=O)CCc1cn(nn1)c2cccc(c2)C(=O)N3CCC4(CC3)N(CNC4=O)c5ccccc5 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 O22 compound treatment 441.937 429.14 115.1504 394.348 381.76 90.4533 145.3838 0.9929 3635109 HDAC1-H_000241 ONC(=O)CCCCCCC(=O)Nc1ccc(cc1)[C@@H]2O[C@H](CSc3ccncc3)C[C@@H](O2)c4ccccc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 O23 compound treatment 14.7958 2.003 0.5375 10.657 -1.9272 -0.4566 0.0572 0.081 3652626 HDAC1-H_000242 COc1ccc(cc1)C(=O)Nc2cccc(c2)n3cc(CCC(=O)NO)nn3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 O24 compound treatment 354.009 341.22 91.5571 361.8897 349.31 82.7628 123.2628 0.9987 3215599 HDAC1-H_000243 COCC1CC(OC(O1)c2ccc(NC(=O)CCCCCCC(=O)NO)cc2)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 P01 compound treatment 18.0155 5.2226 1.4014 14.5915 2.0073 0.4756 1.3272 0.8968 3652627 HDAC1-H_000244 COC(=O)CCCCCCC(=O)Nc1ccc(/C=N/OCc2ccccc2)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 P02 mock treatment 10.636 -2.1568 -0.5787 13.3691 0.78489 0.186 -0.2777 -0.4569 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 P03 compound treatment 239.8198 227.03 60.9172 255.1505 242.57 57.4725 83.7142 0.9996 3652629 HDAC1-H_000245 ONC(=O)CCCCCCNC(=O)c1ccc(NCc2cn(Cc3ccccc3Cn4cc(CNc5ccc(cc5)C(=O)NCCCCCCC(=O)NO)nn4)nn2)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 P04 mock treatment 14.011 1.2182 0.3269 13.5788 0.99457 0.2356 0.3978 0.9871 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 P05 compound treatment 460.042 447.25 120.0085 510.1613 497.58 117.8936 168.2222 1.0 3652630 HDAC1-H_000246 ONC(=O)CCCCCCNC(=O)c1ccc(cc1)N(CC#C)CC#C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 P06 mock treatment 13.5477 0.75492 0.2026 14.2905 1.7063 0.4043 0.4291 0.9489 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 P07 compound treatment 228.0218 215.23 57.7515 239.906 227.32 53.8606 78.9216 0.9994 3652631 HDAC1-H_000247 ONC(=O)CCCCCCNC(=O)c1ccc(NCc2cn(Cc3ccccc3)nn2)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 P08 mock treatment 11.0839 -1.7089 -0.4586 17.5652 4.981 1.1802 0.5103 0.403 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 P09 compound treatment 36.3454 23.553 6.3198 34.5846 22.0 5.2127 8.1547 0.9954 3634807 HDAC1-H_000248 ONC(=O)CCCCCCC(=O)Nc1ccc(cc1)C2CC(OC(O2)c3ccccc3)c4ccccc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 P10 mock treatment 11.2905 -1.5024 -0.4031 11.1203 -1.4639 -0.3468 -0.5303 -0.9972 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 P11 mock treatment 11.751 -1.0418 -0.2795 12.8478 0.26363 0.0625 -0.1535 -0.5359 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 P12 mock treatment 11.2327 -1.5601 -0.4186 9.9558 -2.6284 -0.6228 -0.7364 -0.9813 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 P13 compound treatment 12.5634 -0.22944 -0.0616 16.0218 3.4376 0.8145 0.5324 0.6518 3652632 HDAC1-H_000249 ONC(=O)CCCCCCC(=O)Nc1ccc(cc1)C2CC(OC(O2)c3ccc(Oc4ccccc4)cc3)c5ccccc5 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 P14 mock treatment 11.6619 -1.1309 -0.3034 11.1817 -1.4025 -0.3323 -0.4495 -0.999 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 P15 compound treatment 14.5563 1.7635 0.4732 12.9307 0.34653 0.0821 0.3926 0.8176 3652633 HDAC1-H_000250 ONC(=O)CCCCCCC(=O)Nc1ccc(cc1)C2CC(OC(O2)c3cccc(Oc4ccccc4)c3)c5ccccc5 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 P16 mock treatment 11.9652 -0.82761 -0.2221 13.9148 1.3306 0.3153 0.0659 0.1709 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 P17 compound treatment 12.7057 -0.087088 -0.0234 11.4857 -1.0985 -0.2603 -0.2006 -0.7675 3634674 HDAC1-H_000251 OCc1ccc(cc1)[C@@H]2C[C@H](CSc3nc(c(o3)c4ccccc4)c5ccccc5)OC(O2)c6ccc(NC(=O)CCCCCCC(=O)O)cc6 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 P18 mock treatment 10.5319 -2.2609 -0.6066 11.2768 -1.3074 -0.3098 -0.648 -0.9513 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 P19 compound treatment 17.2959 4.5031 1.2083 11.7682 -0.81602 -0.1933 0.7177 0.5865 2027357 HDAC1-H_000252 OCc1ccc(cc1)[C@@H]2C[C@H](CSc3nc(c(o3)c4ccccc4)c5ccccc5)O[C@@H](O2)c6ccc(NC(=O)CCCCCCC(=O)NO)cc6 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 P20 mock treatment 11.5496 -1.2432 -0.3336 15.3502 2.766 0.6554 0.2275 0.3094 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 P21 compound treatment 13.2057 0.41293 0.1108 11.7404 -0.84381 -0.1999 -0.063 -0.2757 3562114 HDAC1-H_000253 ONC(=O)CCCCCCC(=O)Nc1ccc(cc1)C2OC(CSc3nc(c(o3)c4ccccc4)c5ccccc5)CC(O2)c6ccccc6 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 P22 mock treatment 12.873 0.080157 0.0215 14.8043 2.2201 0.526 0.3872 0.7354 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 P23 compound treatment 39.5284 26.736 7.1738 35.6561 23.072 5.4666 8.9381 0.991 3652634 HDAC1-H_000254 ONC(=O)CCCCCCC(=O)Nc1ccc(cc1)[C@H]2O[C@@H](CSc3nc(c(o3)c4ccccc4)c5ccccc5)C[C@H](O2)c6ccccc6 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2467 P24 mock treatment 13.0907 0.29792 0.0799 14.9379 2.3537 0.5577 0.4509 0.8003 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 A01 compound treatment 11.2679 -1.1309 -0.3035 12.6842 0.0017778 4.0E-4 -0.2143 -0.7061 3652363 HDAC1-H_000255 COc1cc2nc(Cl)nc(NC3CCN(Cc4ccccc4)CC3)c2cc1OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 A02 compound treatment 13.7255 1.3266 0.356 14.0355 1.3531 0.3206 0.4784 0.9986 3652364 HDAC1-H_000256 ONC(=O)CCc1cn(nn1)c2cccc(c2)C(=O)N3CCN(CC3)c4ccccc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 A03 compound treatment 13.4367 1.0379 0.2785 13.3547 0.6723 0.1593 0.3096 0.9649 3652365 HDAC1-H_000257 COc1cc2nc(Cl)nc(NC3CCCCC3)c2cc1OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 A04 compound treatment 12.1398 -0.25906 -0.0695 15.3714 2.6889 0.6371 0.4013 0.6262 3652366 HDAC1-H_000258 COc1ccc(NC(=O)Cn2cc(CCC(=O)NO)nn2)cc1OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 A05 compound treatment 12.8137 0.41479 0.1113 16.1567 3.4743 0.8232 0.6608 0.7955 3652367 HDAC1-H_000259 COc1cc2nc(Cl)nc(Nc3ccc(F)c(Cl)c3)c2cc1OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 A06 compound treatment 11.6022 -0.79664 -0.2138 13.392 0.70955 0.1681 -0.0323 -0.1187 3652368 HDAC1-H_000260 ONC(=O)CCc1cn(nn1)c2ccc3[nH]ccc3c2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 A07 compound treatment 14.7648 2.3659 0.6348 13.7914 1.1089 0.2627 0.6347 0.9238 3650892 HDAC1-H_000261 COc1cc2nc(nc(NC3CCN(Cc4ccccc4)CC3)c2cc1OC)N5CCCN(C)CC5 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 A08 compound treatment 15.3022 2.9033 0.779 13.2795 0.59705 0.1415 0.6509 0.8221 3652369 HDAC1-H_000262 CCOc1cc(OCC)cc(c1)C(=O)N[C@@H](Cc2ccc(cc2)n3cc(CCC(=O)NO)nn3)C(=O)OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 A09 compound treatment 14.2067 1.8079 0.4851 13.6741 0.99167 0.235 0.5092 0.9446 3652371 HDAC1-H_000263 COc1cc2nc(nc(NC3CCN(Cc4ccccc4)CC3)c2cc1OC)N5CCCCCC5 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 A10 compound treatment 14.7812 2.3823 0.6392 12.3219 -0.36048 -0.0854 0.3916 0.6072 3652372 HDAC1-H_000264 COC(=O)[C@@H](NC(=O)Cn1cc(nn1)c2cccc(/C=C/C(=O)NO)c2)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 A11 compound treatment 12.7055 0.30664 0.0823 15.4053 2.7228 0.6451 0.5144 0.7909 3652374 HDAC1-H_000265 COc1cc2nc(nc(NC3CCN(Cc4ccccc4)CC3)c2cc1OC)N5CCCN(Cc6ccccc6)CC5 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 A12 compound treatment 15.1241 2.7252 0.7312 11.6577 -1.0248 -0.2428 0.3454 0.4482 3652375 HDAC1-H_000266 CC(C)[C@H](NS(=O)(=O)c1ccc(C)cc1)C(=O)NCCn2cc(nn2)c3cccc(/C=C/C(=O)NO)c3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 A13 mock treatment 11.9466 -0.45231 -0.1214 13.4587 0.77625 0.1839 0.0442 0.2007 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 A14 mock treatment 14.0117 1.6128 0.4328 13.6089 0.92645 0.2195 0.4612 0.9505 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 A15 compound treatment 15.2966 2.8977 0.7775 14.6417 1.9593 0.4642 0.8781 0.9696 3652377 HDAC1-H_000267 COc1cc2nc(nc(NC3CCCCC3)c2cc1OC)N4CCCN(C)CC4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 A16 compound treatment 13.7317 1.3328 0.3576 14.1097 1.4273 0.3382 0.492 0.9996 3652378 HDAC1-H_000268 COc1ccc(cc1)n2cc(nn2)c3cccc(/C=C/C(=O)NO)c3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 A17 compound treatment 14.4242 2.0253 0.5434 14.0505 1.368 0.3241 0.6135 0.9695 3652380 HDAC1-H_000269 COc1cc2nc(nc(NC3CCCCC3)c2cc1OC)N4CCCCCC4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 A18 compound treatment 14.1742 1.7753 0.4764 11.6895 -0.9929 -0.2353 0.1705 0.3209 3652381 HDAC1-H_000270 COC(=O)[C@@H](NC(=O)Cn1cc(CCC(=O)NO)nn1)c2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 A19 compound treatment 13.3331 0.93421 0.2507 13.6541 0.97162 0.2302 0.34 0.9991 3652383 HDAC1-H_000271 COc1cc2nc(nc(NC3CCCCC3)c2cc1OC)N4CCCN(Cc5ccccc5)CC4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 A20 compound treatment 14.1649 1.7661 0.4739 11.331 -1.3514 -0.3202 0.1087 0.19 3652384 HDAC1-H_000272 CC(C)[C@H](NS(=O)(=O)c1ccc(C)cc1)C(=O)NCCn2cc(CCC(=O)NO)nn2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 A21 compound treatment 13.4538 1.0549 0.2831 13.4713 0.78885 0.1869 0.3323 0.9797 3652386 HDAC1-H_000273 COc1cc2nc(nc(Nc3ccc(F)c(Cl)c3)c2cc1OC)N4CCCN(C)CC4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 A22 compound treatment 11.8252 -0.57364 -0.1539 12.0189 -0.66355 -0.1572 -0.22 -0.9999 3652387 HDAC1-H_000274 COc1ccc(cc1)n2cc(CCC(=O)NO)nn2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 A23 compound treatment 13.6954 1.2965 0.3479 13.0011 0.31872 0.0755 0.2994 0.841 3652388 HDAC1-H_000275 COc1cc2nc(nc(Nc3ccc(F)c(Cl)c3)c2cc1OC)N4CCCCCC4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 A24 compound treatment 12.9088 0.50999 0.1368 16.1719 3.4894 0.8268 0.6814 0.8131 3652372 HDAC1-H_000276 COC(=O)[C@@H](NC(=O)Cn1cc(nn1)c2cccc(/C=C/C(=O)NO)c2)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 B01 compound treatment 13.5246 1.1258 0.3021 14.3127 1.6302 0.3863 0.4867 0.9926 1003435 HDAC1-H_000277 OC(=O)c1ccc(O)c(c1)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 B02 compound treatment 12.5638 0.16491 0.0442 13.2335 0.55107 0.1306 0.1236 0.8967 3652389 HDAC1-H_000278 ONC(=O)CCCCCCC(=O)Nc1ccc(cc1)[C@@H]2O[C@H](CSc3nc(c(o3)c4ccccc4)c5ccccc5)C[C@@H](O2)c6ccccc6 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 B03 compound treatment 13.0188 0.61996 0.1664 11.3564 -1.326 -0.3142 -0.1045 -0.294 3652390 HDAC1-H_000279 O=C(NCCCNC(=O)c1ccccn1)OCc2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 B04 compound treatment 13.5728 1.174 0.315 13.3875 0.70512 0.1671 0.3409 0.956 3652391 HDAC1-H_000280 NCCCn1cc(CNc2ccc(cc2)C(=O)NCCCCCCC(=O)NO)nn1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 B05 compound treatment 16.1887 3.7898 1.0169 28.5965 15.914 3.7706 3.3853 0.8668 3652392 HDAC1-H_000281 COC(=O)c1ccc(nc1)C(=O)NCCCNC(=O)OCc2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 B06 compound treatment 16.6633 4.2644 1.1442 14.6422 1.9598 0.4643 1.1374 0.9211 3635011 HDAC1-H_000282 ONC(=O)CCCCCCC(=O)Nc1ccc(cc1)C(=O)c2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 B07 compound treatment 15.0155 2.6166 0.7021 12.8629 0.1805 0.0428 0.5267 0.7488 3652393 HDAC1-H_000283 O=C(NCCCCNC(=O)c1ccccn1)OCc2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 B08 compound treatment 13.595 1.1962 0.321 13.262 0.57958 0.1373 0.3241 0.9282 3634742 HDAC1-H_000284 CN(C[C@H]1C[C@H](OC(O1)c2ccc(NC(=O)CCCCCCC(=O)NO)cc2)c3ccc(CO)cc3)Cc4ccccc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 B09 compound treatment 15.3079 2.909 0.7806 12.6691 -0.013377 -0.0032 0.5497 0.7042 3652394 HDAC1-H_000285 COC(=O)c1ccc(nc1)C(=O)NCCCCNC(=O)OCc2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 B10 compound treatment 18.6045 6.2056 1.6651 13.901 1.2186 0.2887 1.3816 0.8175 3634942 HDAC1-H_000286 ONC(=O)CCCCCCC(=O)Nc1cccc(c1)C(=O)NCCOCCOCCNC(=O)c2cccc(NC(=O)CCCCCCC(=O)NO)c2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 B11 compound treatment 15.1378 2.739 0.7349 13.0861 0.40367 0.0956 0.5873 0.7924 3652395 HDAC1-H_000287 O=C(NCCCCCNC(=O)c1ccccn1)OCc2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 B12 compound treatment 12.6334 0.23454 0.0629 16.4035 3.7211 0.8817 0.6679 0.7557 3634875 HDAC1-H_000288 ONC(=O)CCCCCCC(=O)Nc1ccc(cc1)C(=O)NCCOCCOCCNC(=O)c2ccc(NC(=O)CCCCCCC(=O)NO)cc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 B13 mock treatment 13.4544 1.0555 0.2832 13.2789 0.59642 0.1413 0.3002 0.9484 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 B14 mock treatment 13.5838 1.1849 0.318 14.7989 2.1164 0.5015 0.5794 0.9758 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 B15 compound treatment 12.7483 0.3494 0.0938 15.1657 2.4833 0.5884 0.4823 0.8096 3652396 HDAC1-H_000289 O=C(NCCCCCCNC(=O)c1ccccn1)OCc2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 B16 compound treatment 14.8359 2.437 0.6539 12.6011 -0.081377 -0.0193 0.4488 0.686 3652397 HDAC1-H_000290 ONC(=O)CCCCCCNC(=O)c1ccc(NCc2cn(Cc3ccc(Cn4cc(CNc5ccc(cc5)C(=O)NCCCCCCC(=O)O)nn4)cc3)nn2)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 B17 compound treatment 13.4723 1.0734 0.288 13.388 0.70559 0.1672 0.3219 0.9665 3652398 HDAC1-H_000291 COC(=O)c1ccc(nc1)C(=O)NCCCCCCNC(=O)OCc2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 B18 compound treatment 15.4176 3.0188 0.81 10.8332 -1.8492 -0.4381 0.263 0.2855 3635064 HDAC1-H_000292 ONC(=O)CCCCCCC(=O)Nc1ccc(cc1)C2OC(CSc3nc4ccccc4o3)CC(O2)c5ccccc5 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 B19 compound treatment 13.653 1.2541 0.3365 16.1626 3.4801 0.8246 0.821 0.9219 3652399 HDAC1-H_000293 CC(C)(C)OC(=O)NCCCNC(=O)c1ccccn1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 B20 compound treatment 13.2934 0.89453 0.24 13.0202 0.3378 0.08 0.2263 0.8945 3634604 HDAC1-H_000294 ONC(=O)CCCCCCC(=O)Nc1ccc(cc1)C2OC(CN3CCCCCCC3)CC(O2)c4ccccc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 B21 compound treatment 14.5259 2.127 0.5707 12.748 0.065623 0.0155 0.4146 0.7261 3652400 HDAC1-H_000295 CC(C)(C)OC(=O)NCCCCNC(=O)c1ccccn1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 B22 compound treatment 14.7651 2.3663 0.6349 14.7743 2.0919 0.4956 0.7994 0.9925 3634671 HDAC1-H_000296 CN(CC=C)CC1CC(OC(O1)c2ccc(NC(=O)CCCCCCC(=O)NO)cc2)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 B23 compound treatment 14.4923 2.0934 0.5617 12.0699 -0.6125 -0.1451 0.2946 0.5077 3652401 HDAC1-H_000297 CC(C)(C)OC(=O)NCCCCCNC(=O)c1ccccn1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 B24 compound treatment 339.2163 326.82 87.6935 348.084 335.4 79.4685 118.2014 0.9988 3652402 HDAC1-H_000298 ONC(=O)/C=C/c1ccc(CNCCc2c[nH]c3ccccc23)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 C01 compound treatment 16.3081 3.9092 1.0489 18.2823 5.5999 1.3268 1.6799 0.9932 3652404 HDAC1-H_000299 COc1cc2nc(nc(Nc3ccc(F)c(Cl)c3)c2cc1OC)N4CCCN(Cc5ccccc5)CC4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 C02 compound treatment 12.6207 0.22186 0.0595 12.9705 0.2881 0.0683 0.0904 0.9977 3652375 HDAC1-H_000300 CC(C)[C@H](NS(=O)(=O)c1ccc(C)cc1)C(=O)NCCn2cc(nn2)c3cccc(/C=C/C(=O)NO)c3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 C03 compound treatment 11.6592 -0.73969 -0.1985 14.4207 1.7382 0.4119 0.1509 0.33 1429650 HDAC1-H_000301 COc1cc2ncnc(NC3CCN(Cc4ccccc4)CC3)c2cc1OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 C04 compound treatment 13.7546 1.3557 0.3638 11.4179 -1.2646 -0.2996 0.0454 0.0963 3652405 HDAC1-H_000302 COc1ccc(OC)c(NC(=O)Cn2cc(nn2)c3cccc(/C=C/C(=O)NO)c3)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 C05 compound treatment 12.0909 -0.30797 -0.0826 13.7505 1.068 0.2531 0.1205 0.4527 3652407 HDAC1-H_000303 COc1cc2nc(Cl)nc(OC3CCN(Cc4ccccc4)CC3)c2cc1OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 C06 compound treatment 11.7131 -0.68573 -0.184 10.0134 -2.669 -0.6324 -0.5773 -0.8765 3652408 HDAC1-H_000304 CCOC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)Cn3cc(nn3)c4cccc(/C=C/C(=O)NO)c4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 C07 compound treatment 13.4753 1.0764 0.2888 11.9781 -0.70428 -0.1669 0.0862 0.2585 3652410 HDAC1-H_000305 COc1cc2nc(nc(OC3CCN(Cc4ccccc4)CC3)c2cc1OC)N5CCCN(C)CC5 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 C08 compound treatment 14.3253 1.9264 0.5169 15.1227 2.4403 0.5782 0.7744 0.9984 3652411 HDAC1-H_000306 ONC(=O)/C=C/c1cccc(c1)c2cn(CC(=O)N3CCOCC3)nn2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 C09 compound treatment 11.3438 -1.055 -0.2831 10.9076 -1.7749 -0.4205 -0.4975 -0.9815 3652413 HDAC1-H_000307 Oc1nc(O)c2cc(Br)ccc2n1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 C10 compound treatment 13.4019 1.003 0.2691 13.637 0.95452 0.2262 0.3502 0.9963 3652414 HDAC1-H_000308 CN1CCN(CC1)C(=O)Cn2cc(nn2)c3cccc(/C=C/C(=O)NO)c3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 C11 mock treatment 11.0544 -1.3445 -0.3608 12.015 -0.66748 -0.1581 -0.3669 -0.9315 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 C12 mock treatment 14.3908 1.9919 0.5345 11.7983 -0.88415 -0.2095 0.2298 0.4003 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 C13 compound treatment 14.5488 2.1499 0.5769 11.9846 -0.69786 -0.1653 0.291 0.4849 3652416 HDAC1-H_000309 Clc1nc(Cl)c2cc(Br)ccc2n1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 C14 compound treatment 21.7861 9.3872 2.5188 11.8487 -0.8337 -0.1975 1.6414 0.6497 3652417 HDAC1-H_000310 ONC(=O)/C=C/c1cccc(c1)c2cn(CC(=O)Nc3nccs3)nn2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 C15 mock treatment 12.3202 -0.078679 -0.0211 13.8981 1.2156 0.288 0.1887 0.6535 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 C16 mock treatment 13.0497 0.65086 0.1746 12.7394 0.056948 0.0135 0.133 0.7595 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 C17 compound treatment 12.536 0.13719 0.0368 12.841 0.1586 0.0376 0.0526 0.9999 3652419 HDAC1-H_000311 COc1ccc2nc(O)nc(O)c2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 C18 compound treatment 10.7076 -1.6913 -0.4538 12.856 0.17358 0.0411 -0.2918 -0.6404 3652420 HDAC1-H_000312 ONC(=O)/C=C/c1cccc(c1)c2cn(CC(=O)Nc3ccon3)nn2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 C19 compound treatment 13.9581 1.5592 0.4184 10.753 -1.9295 -0.4572 -0.0274 -0.0442 3652422 HDAC1-H_000313 Clc1nc(NC2CCCCC2)c3cc(Br)ccc3n1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 C20 compound treatment 14.6321 2.2332 0.5992 15.0295 2.347 0.5561 0.8169 0.9993 3652423 HDAC1-H_000314 ONC(=O)/C=C/c1cccc(c1)c2cn(CCCNC(=O)Nc3ccccc3)nn2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 C21 compound treatment 28.7674 16.369 4.3921 22.1755 9.4931 2.2493 4.6961 0.9517 3652425 HDAC1-H_000315 COc1ccc2nc(Cl)nc(Cl)c2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 C22 compound treatment 12.4507 0.051861 0.0139 11.7055 -0.9769 -0.2315 -0.1538 -0.6634 3652426 HDAC1-H_000316 ONC(=O)/C=C/c1cccc(c1)c2cn(CCNC(=O)Nc3ccccc3)nn2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 C23 compound treatment 15.2677 2.8688 0.7698 13.101 0.4186 0.0992 0.6144 0.7917 3652428 HDAC1-H_000317 Clc1nc(NC2CCN(Cc3ccccc3)CC2)c4cc(Br)ccc4n1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 C24 compound treatment 15.6543 3.2554 0.8735 12.501 -0.18148 -0.043 0.5873 0.6715 3652429 HDAC1-H_000318 ONC(=O)/C=C/c1cccc(c1)c2cn(C[C@H](Cc3ccccc3)NC(=O)c4ccccc4)nn2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 D01 compound treatment 11.7876 -0.61121 -0.164 16.0123 3.3298 0.789 0.4419 0.5484 3652431 HDAC1-H_000319 CC(C)(C)OC(=O)NCCCCCCNC(=O)c1ccccn1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 D02 compound treatment 14.264 1.8652 0.5005 17.0822 4.3997 1.0425 1.091 0.9435 3652432 HDAC1-H_000320 ONC(=O)/C=C/c1ccc(CN(CCc2c[nH]c3ccccc23)C(=O)CCCCC(=O)N(CCc4c[nH]c5ccccc45)Cc6ccc(\C=C\C(=O)NO)cc6)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 D03 compound treatment 11.8927 -0.50621 -0.1358 14.4998 1.8174 0.4306 0.2084 0.4616 3652434 HDAC1-H_000321 COC(=O)[C@H](CCCCNC(=O)c1ccccn1)NC(=O)OC(C)(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 D04 compound treatment 18.5341 6.1352 1.6462 18.7147 6.0323 1.4293 2.1747 0.9975 3652436 HDAC1-H_000322 OCCN(CCc1c[nH]c2ccccc12)Cc3ccc(/C=C/C(=O)O)cc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 D05 compound treatment 12.7616 0.36276 0.0973 15.5978 2.9154 0.6908 0.5573 0.7989 3652438 HDAC1-H_000323 COC(=O)c1ccc(nc1)C(=O)NCCCNC(=O)OC(C)(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 D06 compound treatment 13.9897 1.5908 0.4269 14.2953 1.6128 0.3821 0.572 0.9985 3652439 HDAC1-H_000324 OC(=O)/C=C/c1ccc(CNCCc2c[nH]c3ccccc23)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 D07 compound treatment 12.7482 0.34934 0.0937 12.6881 0.0056978 0.0014 0.0672 0.7172 3652441 HDAC1-H_000325 COC(=O)c1ccc(nc1)C(=O)NCCCCNC(=O)OC(C)(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 D08 compound treatment 514.161 501.76 134.6357 458.494 445.81 105.6285 169.8924 0.9928 3622998 HDAC1-H_000326 OCCN(CCc1c[nH]c2ccccc12)Cc3ccc(/C=C/C(=O)NO)cc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 D09 compound treatment 11.717 -0.68189 -0.183 22.3393 9.6568 2.288 1.4885 0.6485 3652442 HDAC1-H_000327 COC(=O)c1ccc(nc1)C(=O)NCCCCCNC(=O)OC(C)(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 D10 mock treatment 13.9592 1.5604 0.4187 14.0067 1.3243 0.3138 0.5179 0.9899 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 D11 mock treatment 12.2126 -0.18626 -0.05 15.3531 2.6707 0.6328 0.4121 0.6492 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 D12 mock treatment 12.0262 -0.3727 -0.1 13.933 1.2506 0.2963 0.1388 0.4439 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 D13 compound treatment 11.623 -0.77581 -0.2082 13.3106 0.62815 0.1488 -0.042 -0.164 3652443 HDAC1-H_000328 COC(=O)[C@H](CCCCNC(=O)c1ccc(cn1)C(=O)OC)NC(=O)OC(C)(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 D14 mock treatment 13.376 0.97717 0.2622 15.3877 2.7053 0.641 0.6386 0.9222 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 D15 mock treatment 13.4025 1.0036 0.2693 12.2166 -0.46585 -0.1104 0.1124 0.3861 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 D16 mock treatment 12.8576 0.45878 0.1231 13.9734 1.2909 0.3059 0.3033 0.92 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 D17 compound treatment 11.6937 -0.70515 -0.1892 13.8569 1.1745 0.2783 0.063 0.1872 3652445 HDAC1-H_000329 CCOC(=O)CCCNC(=O)c1ccccn1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 D18 mock treatment 10.4368 -1.9621 -0.5265 12.5559 -0.12651 -0.03 -0.3935 -0.7462 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 D19 compound treatment 11.0782 -1.3207 -0.3544 11.9626 -0.71987 -0.1706 -0.3712 -0.9438 3652446 HDAC1-H_000330 CCOC(=O)CCCCNC(=O)c1ccccn1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 D20 mock treatment 13.2576 0.85874 0.2304 11.593 -1.0894 -0.2581 -0.0196 -0.0566 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 D21 compound treatment 12.0666 -0.33228 -0.0892 11.2994 -1.383 -0.3277 -0.2947 -0.868 3652447 HDAC1-H_000331 COC(=O)CCCCCNC(=O)c1ccccn1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 D22 mock treatment 12.1957 -0.20313 -0.0545 12.7924 0.10995 0.0261 -0.0201 -0.3331 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 D23 compound treatment 13.8366 1.4377 0.3858 14.1465 1.4641 0.3469 0.5181 0.9986 3652448 HDAC1-H_000332 CN(CCCNC(=O)c1ccccc1)CC#C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 D24 mock treatment 12.3184 -0.080504 -0.0216 14.4422 1.7597 0.4169 0.2796 0.6696 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 E01 mock treatment 11.9788 -0.42006 -0.1127 12.701 0.018523 0.0044 -0.0766 -0.6791 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 E02 mock treatment 12.9793 0.58039 0.1557 15.6327 2.9503 0.699 0.6044 0.844 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 E03 compound treatment 12.654 0.25518 0.0685 12.888 0.20555 0.0487 0.0829 0.9861 3652449 HDAC1-H_000333 COc1ccc2nc(Cl)nc(NC3CCN(Cc4ccccc4)CC3)c2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 E04 compound treatment 11.2939 -1.1049 -0.2965 11.82 -0.86243 -0.2043 -0.3541 -0.9835 3652450 HDAC1-H_000334 ONC(=O)/C=C/c1cccc(c1)c2cn(CC(=O)N3CCC4(CC3)N(CNC4=O)c5ccccc5)nn2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 E05 compound treatment 10.8809 -1.5179 -0.4073 12.4589 -0.22353 -0.053 -0.3255 -0.7924 3652452 HDAC1-H_000335 COc1ccc2nc(Cl)nc(NC3CCCCC3)c2c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 E06 compound treatment 12.3292 -0.069639 -0.0187 12.0921 -0.59033 -0.1399 -0.1121 -0.7945 3652453 HDAC1-H_000336 CCOC(=O)[C@H](Cc1ccccc1)NC(=O)Cn2cc(nn2)c3cccc(/C=C/C(=O)NO)c3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 E07 compound treatment 28.6844 16.286 4.3698 24.1002 11.418 2.7053 5.0029 0.9734 3652455 HDAC1-H_000337 COc1cc2nc(Cl)nc(Cl)c2cc1OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 E08 compound treatment 10.9864 -1.4124 -0.379 10.6962 -1.9863 -0.4706 -0.6008 -0.9942 3652456 HDAC1-H_000338 Cc1ccc(cc1)S(=O)(=O)N[C@@H](Cc2ccccc2)C(=O)NCCn3cc(nn3)c4cccc(/C=C/C(=O)NO)c4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 E09 mock treatment 11.5528 -0.84611 -0.227 11.693 -0.98947 -0.2344 -0.3263 -0.9999 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 E10 mock treatment 10.5025 -1.8964 -0.5089 12.5294 -0.15299 -0.0362 -0.3854 -0.7556 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 E11 compound treatment 12.4587 0.059836 0.0161 13.0127 0.33027 0.0783 0.0667 0.8348 3652458 HDAC1-H_000339 CN1CCCN(CC1)c2nc(NC3CCN(Cc4ccccc4)CC3)c5cc(Br)ccc5n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 E12 compound treatment 12.8211 0.42223 0.1133 13.4553 0.77292 0.1831 0.2096 0.9734 3652459 HDAC1-H_000340 Cc1ccc(cc1)S(=O)(=O)N[C@@H](Cc2ccccc2)C(=O)NCCCn3cc(nn3)c4cccc(/C=C/C(=O)NO)c4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 E13 compound treatment 14.0803 1.6815 0.4512 12.9832 0.30075 0.0713 0.3694 0.8088 3652461 HDAC1-H_000341 Brc1ccc2nc(nc(NC3CCN(Cc4ccccc4)CC3)c2c1)N5CCCN(Cc6ccccc6)CC5 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 E14 compound treatment 11.4268 -0.97206 -0.2608 12.6316 -0.05086 -0.0121 -0.193 -0.739 3652462 HDAC1-H_000342 ONC(=O)/C=C/c1cccc(c1)c2cn(C[C@H](Cc3ccccc3)NC(=O)Nc4ccccc4)nn2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 E15 compound treatment 11.6431 -0.75574 -0.2028 14.1071 1.4247 0.3376 0.0953 0.242 3652464 HDAC1-H_000343 Brc1ccc2nc(nc(NC3CCN(Cc4ccccc4)CC3)c2c1)N5CCCCCC5 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 E16 compound treatment 15.5711 3.1723 0.8512 14.7233 2.0409 0.4836 0.9438 0.9641 3652465 HDAC1-H_000344 Cc1ccc(cc1)S(=O)(=O)N2CCC[C@H]2Cn3cc(nn3)c4cccc(/C=C/C(=O)NO)c4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 E17 mock treatment 11.2159 -1.183 -0.3174 11.1267 -1.5557 -0.3686 -0.4851 -0.9972 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 E18 mock treatment 12.8278 0.42894 0.1151 10.8876 -1.7948 -0.4253 -0.2193 -0.4978 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 E19 compound treatment 18.0214 5.6225 1.5087 13.8141 1.1317 0.2681 1.2564 0.8199 3652467 HDAC1-H_000345 COc1ccc2nc(nc(NC3CCN(Cc4ccccc4)CC3)c2c1)N5CCCN(C)CC5 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 E20 compound treatment 10.5487 -1.8501 -0.4964 11.5061 -1.1763 -0.2787 -0.5481 -0.9627 3652468 HDAC1-H_000346 CC(C)(C)OC(=O)N/C(=N\C(=O)OC(C)(C)C)/NCCn1cc(nn1)c2cccc(/C=C/C(=O)NO)c2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 E21 compound treatment 11.0527 -1.3461 -0.3612 11.9492 -0.73323 -0.1737 -0.3783 -0.9437 3652470 HDAC1-H_000347 CN1CCCN(CC1)c2nc(NC3CCCCC3)c4cc(Br)ccc4n2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 E22 compound treatment 14.4361 2.0372 0.5466 14.3917 1.7093 0.405 0.6729 0.9891 3652471 HDAC1-H_000348 CC(C)(C)OC(=O)N/C(=N\C(=O)OC(C)(C)C)/NCCCn1cc(nn1)c2cccc(/C=C/C(=O)NO)c2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 E23 compound treatment 12.6488 0.24994 0.0671 12.9119 0.2295 0.0544 0.0859 0.9946 3652473 HDAC1-H_000349 Brc1ccc2nc(nc(NC3CCCCC3)c2c1)N4CCCCCC4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 E24 compound treatment 13.2317 0.83281 0.2235 13.0247 0.34232 0.0811 0.2154 0.9059 3652474 HDAC1-H_000350 CC(C)(C)ONC(=O)c1cccc(c1)n2cc(nn2)c3cccc(/C=C/C(=O)NO)c3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 F01 mock treatment 13.4959 1.0971 0.2944 14.1705 1.488 0.3526 0.4575 0.996 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 F02 mock treatment 15.7149 3.316 0.8898 12.8623 0.17992 0.0426 0.6593 0.7401 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 F03 compound treatment 12.2115 -0.18734 -0.0503 13.2802 0.59777 0.1416 0.0646 0.4299 3652476 HDAC1-H_000351 CN(CCCCNC(=O)c1ccccc1)CC#C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 F04 mock treatment 14.9407 2.5418 0.682 12.1895 -0.49293 -0.1168 0.3997 0.5776 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 F05 compound treatment 12.8876 0.48876 0.1311 10.572 -2.1104 -0.5 -0.2608 -0.5046 3652477 HDAC1-H_000352 CN(CCCCCCNC(=O)c1ccccc1)CC#C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 F06 mock treatment 14.5693 2.1704 0.5824 13.1776 0.4952 0.1173 0.4948 0.8328 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 F07 compound treatment 12.0877 -0.31121 -0.0835 10.0981 -2.5843 -0.6123 -0.492 -0.7962 3652478 HDAC1-H_000353 COC(=O)C(=O)NCCCCCCNC(=O)c1ccccc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 F08 mock treatment 15.4594 3.0605 0.8212 12.0803 -0.60208 -0.1427 0.4798 0.5757 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 F09 mock treatment 12.5396 0.14076 0.0378 11.2594 -1.423 -0.3372 -0.2117 -0.624 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 F10 mock treatment 11.0671 -1.3318 -0.3574 12.7871 0.10466 0.0248 -0.2352 -0.6565 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 F11 compound treatment 13.7157 1.3168 0.3533 10.9631 -1.7193 -0.4074 -0.0382 -0.0708 3652479 HDAC1-H_000354 O=C(NCCCCNC(=O)c1ccccn1)c2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 F12 mock treatment 10.5399 -1.859 -0.4988 12.6877 0.0052978 0.0013 -0.3518 -0.7053 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 F13 compound treatment 12.7518 0.35296 0.0947 10.9046 -1.7778 -0.4212 -0.2309 -0.5348 3652480 HDAC1-H_000355 O=C(NCCCCCNC(=O)c1ccccn1)c2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 F14 mock treatment 13.1623 0.76341 0.2048 12.3531 -0.32932 -0.078 0.0897 0.4091 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 F15 compound treatment 15.6741 3.2753 0.8788 13.3403 0.65787 0.1559 0.7317 0.8197 3652481 HDAC1-H_000356 O=C(NCCCCCCNC(=O)c1ccccn1)c2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 F16 mock treatment 11.0551 -1.3437 -0.3606 10.791 -1.8914 -0.4481 -0.5718 -0.9942 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 F17 mock treatment 12.7042 0.30534 0.0819 14.3746 1.6922 0.4009 0.3414 0.8344 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 F18 mock treatment 12.8767 0.47784 0.1282 13.6766 0.99417 0.2356 0.2572 0.9591 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 F19 compound treatment 13.8241 1.4252 0.3824 10.6283 -2.0541 -0.4867 -0.0737 -0.1191 3652482 HDAC1-H_000357 COC(=O)c1ccc(nc1)C(=O)NCCCCCNC(=O)c2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 F20 mock treatment 13.1303 0.73139 0.1962 17.1421 4.4597 1.0567 0.8859 0.8243 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 F21 compound treatment 15.0774 2.6785 0.7187 11.5216 -1.1608 -0.275 0.3137 0.4077 3616541 HDAC1-H_000358 N[C@H]1C[C@@H]1c2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 F22 mock treatment 12.9632 0.56431 0.1514 11.6888 -0.99363 -0.2354 -0.0594 -0.2122 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 F23 compound treatment 12.4528 0.053886 0.0145 11.6486 -1.0339 -0.245 -0.163 -0.6642 1088402 HDAC1-H_000359 COC(=O)c1ccc(nc1)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 F24 mock treatment 14.6794 2.2805 0.6119 11.3745 -1.3079 -0.3099 0.2136 0.3114 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 G01 compound treatment 11.7929 -0.606 -0.1626 12.6377 -0.044727 -0.0106 -0.1225 -0.7516 3652483 HDAC1-H_000360 COc1cccc(c1)n2cc(nn2)C(=O)NO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 G02 compound treatment 12.7967 0.39782 0.1067 14.8729 2.1905 0.519 0.4425 0.8351 3652378 HDAC1-H_000361 COc1ccc(cc1)n2cc(nn2)c3cccc(/C=C/C(=O)NO)c3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 G03 mock treatment 10.5085 -1.8904 -0.5072 12.1857 -0.49673 -0.1177 -0.4419 -0.8486 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 G04 mock treatment 9.9141 -2.4848 -0.6667 14.315 1.6326 0.3868 -0.1979 -0.2568 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 G05 compound treatment 12.6336 0.23476 0.063 14.73 2.0476 0.4851 0.3876 0.7923 3652484 HDAC1-H_000362 COc1ccc(cc1)n2cc(nn2)C(=O)NO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 G06 compound treatment 13.0907 0.69185 0.1856 11.5771 -1.1053 -0.2619 -0.0539 -0.1679 3652485 HDAC1-H_000363 COc1cccc(c1)n2cc(nn2)c3cccc(/C=C/C(=O)NO)c3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 G07 compound treatment 11.0324 -1.3665 -0.3667 13.981 1.2986 0.3077 -0.0417 -0.0871 3652487 HDAC1-H_000364 ONC(=O)c1cn(nn1)c2cccc(c2)C(=O)N3CCC4(CC3)N(CNC4=O)c5ccccc5 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 G08 compound treatment 12.1359 -0.26298 -0.0706 10.5619 -2.1205 -0.5024 -0.4052 -0.7986 3652488 HDAC1-H_000365 CC(C)(C)ONC(=O)Cn1cc(nn1)c2cccc(/C=C/C(=O)NO)c2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 G09 compound treatment 11.4517 -0.94714 -0.2541 12.0935 -0.58889 -0.1395 -0.2784 -0.9601 3652490 HDAC1-H_000366 COC(=O)c1ccc(Cn2cc(nn2)C(=O)NO)o1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 G10 compound treatment 12.3471 -0.051756 -0.0139 10.3519 -2.3306 -0.5522 -0.4003 -0.7247 3652491 HDAC1-H_000367 ONC(=O)/C=C/c1cccc(c1)c2cn(nn2)c3ccc(NC(=O)c4ccccc4)cc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 G11 compound treatment 11.8749 -0.52396 -0.1406 12.1622 -0.5202 -0.1233 -0.1866 -0.9978 3652493 HDAC1-H_000368 COC(=O)[C@@H](N)Cc1ccc(cc1)n2cc(CCC(=O)NO)nn2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 G12 compound treatment 10.6841 -1.7148 -0.4601 11.6079 -1.0746 -0.2546 -0.5054 -0.9611 3652495 HDAC1-H_000369 Nc1ccc(cc1)n2cc(nn2)c3cccc(/C=C/C(=O)NO)c3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 G13 compound treatment 9.2819 -3.117 -0.8364 9.1713 -3.5111 -0.8319 -1.1797 -1.0 3652497 HDAC1-H_000370 Nc1ccc(cc1)n2cc(CCC(=O)NO)nn2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 G14 compound treatment 13.2671 0.86826 0.233 11.2087 -1.4737 -0.3492 -0.0822 -0.1958 3652498 HDAC1-H_000371 Nc1cccc(c1)n2cc(nn2)c3cccc(/C=C/C(=O)NO)c3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 G15 compound treatment 10.7995 -1.5994 -0.4292 11.1781 -1.5043 -0.3564 -0.5555 -0.9957 3652500 HDAC1-H_000372 Nc1cccc(c1)n2cc(CCC(=O)NO)nn2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 G16 compound treatment 12.5153 0.11645 0.0312 11.566 -1.1164 -0.2645 -0.165 -0.6193 3652501 HDAC1-H_000373 ONC(=O)/C=C/c1cccc(c1)c2cn(nn2)c3cccc(c3)C(=O)N4CCC5(CC4)N(CNC5=O)c6ccccc6 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 G17 compound treatment 12.2395 -0.15934 -0.0428 10.3913 -2.2911 -0.5428 -0.4141 -0.7604 3652503 HDAC1-H_000374 COC(=O)[C@@H](NC(=O)Cn1cc(nn1)C(=O)NO)c2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 G18 compound treatment 12.6868 0.28789 0.0772 12.7863 0.10382 0.0246 0.072 0.8883 3652505 HDAC1-H_000375 ONC(=O)/C=C/c1cccc(c1)c2cn(CC(=O)N3CCN(CC3)c4ccccc4)nn2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 G19 mock treatment 12.7224 0.32353 0.0868 9.0843 -3.5981 -0.8525 -0.5414 -0.6318 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 G20 mock treatment 12.433 0.034086 0.0091 10.7065 -1.9759 -0.4682 -0.3246 -0.6932 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 G21 compound treatment 11.5848 -0.81406 -0.2184 12.0504 -0.63204 -0.1498 -0.2603 -0.983 3652507 HDAC1-H_000376 CC(C)[C@H](NS(=O)(=O)c1ccc(C)cc1)C(=O)NCCn2cc(nn2)C(=O)NO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 G22 compound treatment 13.7992 1.4003 0.3757 12.8392 0.15677 0.0371 0.292 0.7732 3652509 HDAC1-H_000377 COc1ccc(cc1)C(=O)Nc2cccc(c2)n3cc(nn3)c4cccc(/C=C/C(=O)NO)c4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 G23 compound treatment 15.3088 2.9099 0.7808 12.7851 0.10269 0.0243 0.5693 0.7288 3652511 HDAC1-H_000378 COc1ccc(OC)c(NC(=O)Cn2cc(nn2)C(=O)NO)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 G24 compound treatment 12.3186 -0.080284 -0.0215 12.8127 0.13032 0.0309 0.0066 0.1753 3652512 HDAC1-H_000379 ONC(=O)/C=C/c1cccc(c1)c2cn(nn2)c3cccc(c3)C(=O)N4CCN(CC4)c5ccccc5 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 H01 compound treatment 9.7889 -2.6099 -0.7003 14.4819 1.7994 0.4263 -0.1937 -0.2363 1002773 HDAC1-H_000380 OC(=O)c1ccc(nc1)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 H02 mock treatment 13.6253 1.2265 0.3291 14.5441 1.8617 0.4411 0.5446 0.9896 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 H03 mock treatment 11.6685 -0.73039 -0.196 12.7866 0.10422 0.0247 -0.1211 -0.6132 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 H04 mock treatment 12.2166 -0.18226 -0.0489 12.5142 -0.16823 -0.0399 -0.0628 -0.9948 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 H05 compound treatment 12.5568 0.15791 0.0424 12.3315 -0.3509 -0.0831 -0.0288 -0.3089 3614749 HDAC1-H_000381 COC(=O)CNC(=O)C(=O)OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 H06 mock treatment 12.74 0.34111 0.0915 11.0271 -1.6553 -0.3922 -0.2126 -0.5279 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 H07 compound treatment 11.5052 -0.89366 -0.2398 12.7529 0.070498 0.0167 -0.1577 -0.6563 3652514 HDAC1-H_000382 OC(=O)CNC(=O)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 H08 mock treatment 12.6571 0.25826 0.0693 11.9773 -0.7051 -0.1671 -0.0691 -0.3822 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 H09 compound treatment 11.2101 -1.1888 -0.319 10.5741 -2.1084 -0.4995 -0.5788 -0.9765 3652515 HDAC1-H_000383 CCOC(=O)/C=C/c1ccc(O)c(O)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 H10 mock treatment 11.8962 -0.50264 -0.1349 11.879 -0.80343 -0.1904 -0.23 -0.9858 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 H11 compound treatment 13.2116 0.81271 0.2181 13.7243 1.0418 0.2468 0.3287 0.9981 1978 HDAC1-H_000384 OC(=O)/C=C/c1ccc(O)c(O)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 H12 mock treatment 15.1715 2.7726 0.744 13.3999 0.71747 0.17 0.6463 0.8469 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 H13 compound treatment 17.5873 5.1885 1.3922 10.4897 -2.1928 -0.5195 0.6171 0.4153 831713 HDAC1-H_000385 OC(=O)c1ccc(O)c(O)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 H14 mock treatment 13.6863 1.2875 0.3455 11.9385 -0.7439 -0.1763 0.1196 0.3085 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 H15 compound treatment 10.6831 -1.7157 -0.4604 11.9712 -0.71124 -0.1685 -0.4447 -0.9071 1070606 HDAC1-H_000386 COC(=O)c1ccc(O)c(O)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 H16 mock treatment 14.0403 1.6414 0.4404 12.2924 -0.39 -0.0924 0.2461 0.5468 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 H17 compound treatment 11.5849 -0.81399 -0.2184 11.2253 -1.4571 -0.3452 -0.3986 -0.9756 3652517 HDAC1-H_000387 COC(=O)c1ccc(nc1)C(=O)NCCCCCNC(=O)OCc2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 H18 mock treatment 13.8635 1.4647 0.393 10.5772 -2.1052 -0.4988 -0.0748 -0.1178 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 H19 mock treatment 11.6185 -0.78035 -0.2094 11.4408 -1.2416 -0.2942 -0.3561 -0.9861 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 H20 mock treatment 11.4853 -0.91355 -0.2451 11.7054 -0.97705 -0.2315 -0.337 -0.9996 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 H21 compound treatment 13.3816 0.98269 0.2637 12.6894 0.0069728 0.0017 0.1876 0.7115 3652518 HDAC1-H_000388 COC(=O)c1ccc(nc1)C(=O)NCCCCCCNC(=O)OC(C)(C)C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 H22 mock treatment 15.0866 2.6877 0.7212 12.0701 -0.61237 -0.1451 0.4074 0.5538 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 H23 compound treatment 12.5889 0.19004 0.051 11.8659 -0.81653 -0.1935 -0.1007 -0.5035 3652519 HDAC1-H_000389 CCOC(=O)CCNC(=O)c1ccccn1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 H24 mock treatment 12.4605 0.061611 0.0165 11.7093 -0.9731 -0.2306 -0.1513 -0.6547 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 I01 compound treatment 12.3973 -0.0015388 -4.0E-4 12.0932 -0.58921 -0.1396 -0.099 -0.7092 3652520 HDAC1-H_000390 CCOC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)Cn3cc(nn3)C(=O)NO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 I02 compound treatment 16.9033 4.5045 1.2087 17.3529 4.6705 1.1066 1.6371 0.999 3652522 HDAC1-H_000391 COc1ccc(NC(=O)Cn2cc(nn2)c3cccc(/C=C/C(=O)NO)c3)cc1OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 I03 compound treatment 9.5478 -2.8511 -0.765 13.3308 0.64832 0.1536 -0.4323 -0.5541 3652524 HDAC1-H_000392 ONC(=O)c1cn(CCCNC(=O)Nc2ccccc2)nn1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 I04 compound treatment 12.3584 -0.040414 -0.0108 12.7976 0.11515 0.0273 0.0116 0.3959 3652525 HDAC1-H_000393 ONC(=O)/C=C/c1cccc(c1)c2cn(nn2)c3ccc4[nH]ccc4c3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 I05 mock treatment 12.2675 -0.13136 -0.0352 13.4164 0.73397 0.1739 0.098 0.5525 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 I06 mock treatment 12.2144 -0.18444 -0.0495 11.0236 -1.6588 -0.393 -0.3129 -0.7899 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 I07 compound treatment 11.1954 -1.2034 -0.3229 10.7735 -1.9089 -0.4523 -0.5481 -0.9864 3652527 HDAC1-H_000394 ONC(=O)c1cn(CCNC(=O)Nc2ccccc2)nn1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 I08 compound treatment 12.6822 0.28333 0.076 12.7664 0.083948 0.0199 0.0678 0.8631 3652528 HDAC1-H_000395 CCOc1cc(OCC)cc(c1)C(=O)N[C@@H](Cc2ccc(cc2)n3cc(nn3)c4cccc(/C=C/C(=O)NO)c4)C(=O)OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 I09 compound treatment 10.2522 -2.1467 -0.576 12.8448 0.16242 0.0385 -0.3801 -0.6584 3652530 HDAC1-H_000396 ONC(=O)c1cn(C[C@H](Cc2ccccc2)NC(=O)c3ccccc3)nn1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 I10 compound treatment 58.8149 46.416 12.4546 58.2982 45.616 10.808 16.4491 0.9975 3622981 HDAC1-H_000397 Nc1ccccc1NC(=O)c2ccc(CNc3nccc(n3)c4cccnc4)cc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 I11 compound treatment 11.8076 -0.59127 -0.1587 12.7035 0.021098 0.005 -0.1087 -0.6845 3652532 HDAC1-H_000398 ONC(=O)c1cn(CC(=O)N2CCC3(CC2)N(CNC3=O)c4ccccc4)nn1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 I12 compound treatment 25.1054 12.707 3.4095 21.2874 8.605 2.0388 3.8525 0.9698 3652533 HDAC1-H_000399 COc1ccc(NCc2ccc(cc2)C(=O)Nc3ccccc3N)cc1OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 I13 compound treatment 10.8615 -1.5374 -0.4125 11.9901 -0.69235 -0.164 -0.4077 -0.9183 3652534 HDAC1-H_000400 CCOC(=O)[C@H](Cc1ccccc1)NC(=O)Cn2cc(nn2)C(=O)NO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 I14 compound treatment 12.4245 0.025661 0.0069 15.6802 2.9977 0.7103 0.5071 0.7139 3652536 HDAC1-H_000401 Cc1ccc(NCc2ccc(cc2)C(=O)Nc3ccccc3N)cc1C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 I15 compound treatment 11.0727 -1.3261 -0.3558 12.6645 -0.017972 -0.0043 -0.2546 -0.7155 3652537 HDAC1-H_000402 Cc1ccc(cc1)S(=O)(=O)N[C@@H](Cc2ccccc2)C(=O)NCCn3cc(nn3)C(=O)NO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 I16 compound treatment 8.7935 -3.6054 -0.9674 11.4367 -1.2457 -0.2952 -0.8928 -0.8827 3652539 HDAC1-H_000403 O=C(Nc1ccccc1)c2ccc(CNc3nccc(n3)c4cccnc4)cc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 I17 compound treatment 11.0454 -1.3535 -0.3632 11.8697 -0.81273 -0.1926 -0.393 -0.956 3652540 HDAC1-H_000404 Cc1ccc(cc1)S(=O)(=O)N[C@@H](Cc2ccccc2)C(=O)NCCCn3cc(nn3)C(=O)NO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 I18 compound treatment 10.8362 -1.5626 -0.4193 11.4761 -1.2064 -0.2858 -0.4986 -0.9826 3652542 HDAC1-H_000405 COc1ccc(NCc2ccc(cc2)C(=O)Nc3ccccc3)cc1OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 I19 compound treatment 10.2452 -2.1537 -0.5779 10.8493 -1.8331 -0.4343 -0.7157 -0.9901 3652543 HDAC1-H_000406 ONC(=O)c1cn(C[C@H](Cc2ccccc2)NC(=O)Nc3ccccc3)nn1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 I20 compound treatment 10.181 -2.2179 -0.5951 14.3005 1.6181 0.3834 -0.1497 -0.2115 3652545 HDAC1-H_000407 [O-][N+](=O)c1ccccc1NC(=O)c2ccc(CNc3nccc(n3)c4cccnc4)cc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 I21 mock treatment 16.7446 4.3457 1.1661 12.3548 -0.32763 -0.0776 0.7696 0.6586 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 I22 mock treatment 13.4582 1.0594 0.2843 13.3341 0.65165 0.1544 0.3102 0.9589 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 I23 compound treatment 13.5528 1.1539 0.3096 11.974 -0.70842 -0.1678 0.1003 0.2846 3652546 HDAC1-H_000408 ONC(=O)c1cn(C[C@@H](Cc2ccccc2)NC(=O)Nc3ccccc3)nn1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 I24 compound treatment 14.7769 2.378 0.6381 13.8357 1.1533 0.2733 0.6444 0.9284 3652547 HDAC1-H_000409 Cc1ccc(NCc2ccc(cc2)C(=O)Nc3ccccc3)cc1C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 J01 compound treatment 32.324 19.925 5.3464 13.8515 1.1691 0.277 3.9764 0.7427 3652548 HDAC1-H_000410 CN(CCCCCNC(=O)c1ccccc1)CC#C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 J02 mock treatment 12.8932 0.49434 0.1326 21.2381 8.5556 2.0271 1.5272 0.7518 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 J03 compound treatment 11.6715 -0.72738 -0.1952 14.3917 1.7093 0.405 0.1484 0.33 3652549 HDAC1-H_000411 COC(=O)C(=O)NCCCCCNC(=O)c1ccccc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 J04 mock treatment 14.7761 2.3772 0.6379 13.534 0.85159 0.2018 0.5937 0.8874 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 J05 mock treatment 13.1284 0.72957 0.1958 9.7576 -2.9248 -0.693 -0.3516 -0.4883 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 J06 mock treatment 11.9301 -0.46874 -0.1258 12.3814 -0.301 -0.0713 -0.1394 -0.9639 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 J07 compound treatment 10.777 -1.6219 -0.4352 9.922 -2.7604 -0.654 -0.7702 -0.9804 3652550 HDAC1-H_000412 COC(=O)c1ccc(nc1)C(=O)NCCCCNC(=O)c2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 J08 mock treatment 11.9134 -0.48551 -0.1303 15.7308 3.0484 0.7223 0.4186 0.5704 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 J09 compound treatment 12.28 -0.1189 -0.0319 10.4654 -2.2171 -0.5253 -0.394 -0.7487 1025079 HDAC1-H_000413 COC(=O)c1ccc(nc1)C(=O)OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 J10 mock treatment 11.9403 -0.45856 -0.123 10.5259 -2.1566 -0.511 -0.4483 -0.853 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 J11 compound treatment 12.1509 -0.24794 -0.0665 11.8593 -0.82308 -0.195 -0.1849 -0.8975 3635106 HDAC1-H_000414 ONC(=O)CCCCCCC(=O)Nc1ccc(cc1)C2OC(COc3ccccc3)CC(O2)c4ccccc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 J12 mock treatment 10.2804 -2.1185 -0.5684 11.431 -1.2514 -0.2965 -0.6116 -0.954 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 J13 compound treatment 13.5074 1.1085 0.2974 10.709 -1.9734 -0.4676 -0.1203 -0.2171 3635115 HDAC1-H_000415 COCC1CC(OC(O1)c2ccc(cc2)C3OC(COC)CC(O3)c4ccc(NC(=O)CCCCCCC(=O)NO)cc4)c5ccc(NC(=O)CCCCCCC(=O)NO)cc5 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 J14 mock treatment 10.7472 -1.6517 -0.4432 11.6377 -1.0448 -0.2475 -0.4884 -0.9621 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 J15 compound treatment 11.1043 -1.2946 -0.3474 10.9705 -1.7119 -0.4056 -0.5324 -0.997 3652551 HDAC1-H_000416 ONC(=O)CCCCCCC(=O)Nc1ccc(cc1)C2OC(CC#C)CC(O2)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 J16 mock treatment 11.8932 -0.50571 -0.1357 11.6289 -1.0535 -0.2496 -0.2725 -0.959 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 J17 compound treatment 12.4346 0.035686 0.0096 13.4336 0.75117 0.178 0.1326 0.7441 3652552 HDAC1-H_000417 COC(=O)CCCCCCC(=O)Nc1ccc(cc1)C2CC(CSc3nc(c(o3)c4ccccc4)c5ccccc5)OC(O2)c6ccc(NC(=O)CCCCCCC(=O)OC)cc6 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 J18 mock treatment 12.2067 -0.19221 -0.0516 12.5959 -0.08653 -0.0205 -0.051 -0.9183 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 J19 compound treatment 12.0679 -0.33096 -0.0888 11.3786 -1.3038 -0.3089 -0.2812 -0.8749 3215583 HDAC1-H_000418 ONC(=O)CCCCCCC(=O)Nc1ccc(cc1)C2OC(CSc3ccccn3)CC(O2)c4ccccc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 J20 mock treatment 12.1059 -0.29296 -0.0786 12.4546 -0.22785 -0.054 -0.0938 -0.9832 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 J21 mock treatment 11.3662 -1.0327 -0.2771 11.7252 -0.95727 -0.2268 -0.3563 -0.9951 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 J22 mock treatment 12.6285 0.22959 0.0616 12.1679 -0.51453 -0.1219 -0.0426 -0.3122 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 J23 compound treatment 13.0212 0.62231 0.167 12.4064 -0.27603 -0.0654 0.0718 0.4005 3635098 HDAC1-H_000419 ONC(=O)CCCCCCC(=O)Nc1ccc(cc1)C2OC(CSc3nc4ccccc4s3)CC(O2)c5ccccc5 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 J24 mock treatment 13.6263 1.2274 0.3293 15.6944 3.0119 0.7136 0.7375 0.9383 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 K01 compound treatment 12.6167 0.21786 0.0585 15.6026 2.9202 0.6919 0.5306 0.7641 3652553 HDAC1-H_000420 Cc1ccc(cc1)S(=O)(=O)N2CCC[C@H]2Cn3cc(nn3)C(=O)NO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 K02 compound treatment 14.6418 2.2429 0.6018 13.2181 0.53562 0.1269 0.5153 0.8378 3652555 HDAC1-H_000421 COc1ccc(NCc2ccc(cc2)C(=O)Nc3ccccc3[N+](=O)[O-])cc1OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 K03 compound treatment 11.0164 -1.3824 -0.3709 12.1606 -0.52183 -0.1236 -0.3497 -0.8944 3652556 HDAC1-H_000422 ONC(=O)c1cn(nn1)c2cccc(c2)C(=O)NCCc3c[nH]c4ccccc34 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 K04 compound treatment 12.4289 0.029986 0.008 18.4895 5.8071 1.3759 0.9786 0.7112 3652557 HDAC1-H_000423 Cc1ccc(NCc2ccc(cc2)C(=O)Nc3ccccc3[N+](=O)[O-])cc1C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 K05 compound treatment 11.1624 -1.2365 -0.3318 10.3841 -2.2983 -0.5445 -0.6197 -0.9718 3652558 HDAC1-H_000424 CC(C)(C)ONC(=O)c1ccc(cc1)n2cc(nn2)C(=O)NO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 K06 compound treatment 12.7272 0.32831 0.0881 11.5472 -1.1353 -0.269 -0.1279 -0.4519 3614389 HDAC1-H_000425 ONC(=O)/C=C/c1ccc(OCc2ccccc2)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 K07 mock treatment 12.3645 -0.034356 -0.0092 12.9787 0.29625 0.0702 0.0431 0.609 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 K08 mock treatment 11.8667 -0.53219 -0.1428 10.5945 -2.088 -0.4947 -0.4508 -0.8755 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 K09 compound treatment 13.4908 1.0919 0.293 10.1155 -2.567 -0.6082 -0.2229 -0.3302 3652484 HDAC1-H_000426 COc1ccc(cc1)n2cc(nn2)C(=O)NO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 K10 compound treatment 10.162 -2.2369 -0.6002 11.0688 -1.6137 -0.3823 -0.6948 -0.9763 3614392 HDAC1-H_000427 ONC(=O)/C=C/c1ccc(OCc2ccc(Cl)cc2)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 K11 compound treatment 11.0173 -1.3816 -0.3707 11.0375 -1.6449 -0.3897 -0.5377 -0.9997 3652483 HDAC1-H_000428 COc1cccc(c1)n2cc(nn2)C(=O)NO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 K12 compound treatment 13.8541 1.4552 0.3905 12.9154 0.23292 0.0552 0.3151 0.7991 3614394 HDAC1-H_000429 Nc1cccc(COc2ccc(/C=C/C(=O)NO)cc2)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 K13 compound treatment 9.4145 -2.9844 -0.8008 10.6773 -2.0052 -0.4751 -0.9022 -0.9689 3652484 HDAC1-H_000430 COc1ccc(cc1)n2cc(nn2)C(=O)NO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 K14 compound treatment 11.4775 -0.92141 -0.2472 10.2376 -2.4449 -0.5793 -0.5844 -0.9279 3614396 HDAC1-H_000431 ONC(=O)/C=C/c1ccc(OCCCc2ccccc2)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 K15 mock treatment 10.9218 -1.4771 -0.3963 11.1201 -1.5623 -0.3702 -0.542 -0.9994 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 K16 mock treatment 13.0662 0.66729 0.1791 13.5075 0.8251 0.1955 0.2648 0.999 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 K17 compound treatment 9.856 -2.5429 -0.6823 9.9098 -2.7726 -0.6569 -0.947 -0.9998 3652559 HDAC1-H_000432 CCOc1cc(OCC)cc(c1)C(=O)N[C@H](Cc2ccc(cc2)n3cc(nn3)C(=O)NO)C(=O)OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 K18 compound treatment 13.2496 0.8507 0.2283 10.7877 -1.8947 -0.4489 -0.156 -0.3098 3614383 HDAC1-H_000433 ONC(=O)/C=C/c1ccc(OCCc2cccs2)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 K19 compound treatment 12.9001 0.50125 0.1345 12.0467 -0.63568 -0.1506 -0.0114 -0.0564 3652561 HDAC1-H_000434 COc1ccc(cc1)C(=O)Nc2cccc(c2)n3cc(nn3)C(=O)NO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 K20 compound treatment 9.3788 -3.0201 -0.8104 11.2267 -1.4557 -0.3449 -0.8169 -0.9275 3614398 HDAC1-H_000435 ONC(=O)/C=C/c1ccc(OCCCCc2ccccc2)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 K21 compound treatment 11.9442 -0.45464 -0.122 13.158 0.4756 0.1127 -0.0066 -0.0396 3652381 HDAC1-H_000436 COC(=O)[C@@H](NC(=O)Cn1cc(CCC(=O)NO)nn1)c2ccccc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 K22 compound treatment 16.4254 4.0265 1.0804 12.8237 0.1413 0.0335 0.7876 0.7287 3614403 HDAC1-H_000437 ONC(=O)/C=C/c1ccc(OCCn2c3ccccc3c4ccccc24)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 K23 mock treatment 11.6085 -0.79039 -0.2121 11.884 -0.79842 -0.1892 -0.2837 -0.9984 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 K24 mock treatment 14.608 2.2092 0.5928 11.5507 -1.1317 -0.2681 0.2295 0.3528 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 L01 compound treatment 12.3268 -0.072064 -0.0193 12.214 -0.46846 -0.111 -0.0922 -0.818 3215593 HDAC1-H_000438 OCCSCC1CC(OC(O1)c2ccc(NC(=O)CCCCCCC(=O)NO)cc2)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 L02 mock treatment 11.9475 -0.45134 -0.1211 15.1072 2.4247 0.5745 0.3206 0.546 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 L03 compound treatment 12.3554 -0.043451 -0.0117 12.2801 -0.40235 -0.0953 -0.0757 -0.7877 3635101 HDAC1-H_000439 CC(C)OCC1CC(OC(O1)c2ccc(NC(=O)CCCCCCC(=O)NO)cc2)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 L04 mock treatment 11.4161 -0.98273 -0.2637 11.8262 -0.85625 -0.2029 -0.3299 -0.9916 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 L05 compound treatment 34.2533 21.854 5.8641 32.2406 19.558 4.634 7.4233 0.9932 3652562 HDAC1-H_000440 CNc1ccc(cc1)C(=O)NCCCCCCC(=O)NO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 L06 mock treatment 12.8229 0.42401 0.1138 12.1283 -0.55409 -0.1313 -0.0124 -0.0713 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 L07 mock treatment 11.5462 -0.8527 -0.2288 10.7237 -1.9587 -0.4641 -0.49 -0.9469 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 L08 mock treatment 13.5434 1.1445 0.3071 10.971 -1.7114 -0.4055 -0.0696 -0.1368 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 L09 compound treatment 15.9856 3.5867 0.9624 13.7211 1.0386 0.2461 0.8545 0.8602 3652563 HDAC1-H_000441 ONC(=O)/C=C/c1ccc(CNc2ccc(cc2)C3OC(CSc4ccncc4)CC(O3)c5ccccc5)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 L10 mock treatment 10.1876 -2.2113 -0.5934 11.4774 -1.205 -0.2855 -0.6214 -0.9438 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 L11 compound treatment 11.6546 -0.74427 -0.1997 10.8275 -1.8549 -0.4395 -0.452 -0.9363 3652565 HDAC1-H_000442 ONC(=O)CCCCCCC(=O)Nc1ccc(cc1)C2CC(OC(O2)c3ccncc3)c4ccccc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 L12 mock treatment 11.5239 -0.87495 -0.2348 10.8265 -1.8559 -0.4397 -0.4769 -0.9568 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 L13 mock treatment 12.0877 -0.31112 -0.0835 11.2014 -1.481 -0.3509 -0.3072 -0.8516 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 L14 mock treatment 11.038 -1.3609 -0.3652 9.4579 -3.2245 -0.764 -0.7984 -0.9429 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 L15 mock treatment 11.8624 -0.53642 -0.1439 9.7957 -2.8867 -0.684 -0.5854 -0.8376 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 L16 mock treatment 12.9771 0.57827 0.1552 11.9494 -0.73308 -0.1737 -0.0131 -0.0562 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 L17 compound treatment 11.5132 -0.88569 -0.2377 12.0746 -0.60783 -0.144 -0.2699 -0.9712 3635112 HDAC1-H_000443 ONC(=O)CCCCCCC(=O)Nc1ccc(cc1)[C@H]2O[C@@H](CSc3ccncc3)C[C@H](O2)c4ccccc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 L18 mock treatment 11.8488 -0.55004 -0.1476 12.2413 -0.44115 -0.1045 -0.1783 -0.9857 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 L19 compound treatment 12.9118 0.51299 0.1376 9.7569 -2.9255 -0.6932 -0.3928 -0.5558 3215595 HDAC1-H_000444 ONC(=O)CCCCCCC(=O)Nc1ccc(cc1)C2OC(CSc3ccncc3)CC(O2)c4ccccc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 L20 mock treatment 10.836 -1.5629 -0.4194 10.5978 -2.0846 -0.4939 -0.6458 -0.9967 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 L21 compound treatment 12.4403 0.041426 0.0111 14.3388 1.6563 0.3924 0.2854 0.7268 3652566 HDAC1-H_000445 ONC(=O)CCCCCCC(=O)Nc1ccc(cc1)C2OC(CN3CCNCC3)CC(O2)c4ccccc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 L22 mock treatment 10.1408 -2.258 -0.6059 15.2427 2.5603 0.6066 5.0E-4 6.0E-4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 L23 mock treatment 12.3619 -0.036989 -0.0099 14.2361 1.5537 0.3681 0.2533 0.6878 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 L24 mock treatment 12.5711 0.17219 0.0462 25.1094 12.427 2.9444 2.1147 0.7181 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 M01 compound treatment 12.6442 0.24535 0.0658 12.256 -0.42648 -0.101 -0.0249 -0.2065 3652384 HDAC1-H_000446 CC(C)[C@H](NS(=O)(=O)c1ccc(C)cc1)C(=O)NCCn2cc(CCC(=O)NO)nn2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 M02 compound treatment 18.6666 6.2677 1.6818 17.3901 4.7077 1.1154 1.9779 0.9801 3652567 HDAC1-H_000447 C/C(=C\c1ccccc1OCc2ccc(cc2)c3ccncc3)/C=C/C(=O)NO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 M03 compound treatment 11.6245 -0.77433 -0.2078 15.8446 3.1621 0.7492 0.3829 0.4924 3652569 HDAC1-H_000448 COc1ccc(OC)c(NC(=O)Cn2cc(CCC(=O)NO)nn2)c1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 M04 compound treatment 12.2713 -0.12759 -0.0342 12.8903 0.20787 0.0493 0.0106 0.177 3652570 HDAC1-H_000449 C/C(=C\c1cccc(OCc2ccc(cc2)c3ccncc3)c1)/C=C/C(=O)NO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 M05 compound treatment 9.9724 -2.4265 -0.6511 10.3278 -2.3546 -0.5579 -0.8549 -0.997 3652572 HDAC1-H_000450 CCOC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)Cn3cc(CCC(=O)NO)nn3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 M06 compound treatment 11.6669 -0.73194 -0.1964 10.393 -2.2894 -0.5424 -0.5224 -0.9056 3652574 HDAC1-H_000451 CN1C[C@H](COc2ccccc2/C=C(\C)/C=C/C(=O)NO)C=C3[C@H]1Cc4c[nH]c5cccc3c45 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 M07 compound treatment 12.1264 -0.27242 -0.0731 13.4272 0.7448 0.1765 0.0731 0.3827 3652576 HDAC1-H_000452 ONC(=O)CCc1cn(CCCNC(=O)Nc2ccccc2)nn1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 M08 compound treatment 10.7406 -1.6583 -0.445 13.2645 0.58211 0.1379 -0.2171 -0.4661 3652577 HDAC1-H_000453 C/C(=C\c1ccccc1OC[C@H]2[C@@H](O)CC[C@H]3CN4CCc5c([nH]c6ccccc56)[C@@H]4C[C@H]23)/C=C/C(=O)NO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 M09 mock treatment 9.4643 -2.9346 -0.7874 10.9589 -1.7235 -0.4084 -0.8455 -0.9533 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 M10 mock treatment 11.8015 -0.59741 -0.1603 12.842 0.15957 0.0378 -0.0866 -0.5259 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 M11 compound treatment 11.5581 -0.84078 -0.2256 9.9131 -2.7693 -0.6561 -0.6235 -0.8986 3652579 HDAC1-H_000454 ONC(=O)CCc1cn(C[C@H](Cc2ccccc2)NC(=O)c3ccccc3)nn1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 M12 compound treatment 9.0372 -3.3617 -0.902 12.7828 0.1004 0.0238 -0.621 -0.6882 3652581 HDAC1-H_000455 C/C(=C\c1cccc(OC[C@H]2[C@@H](O)CC[C@H]3CN4CCc5c([nH]c6ccccc56)[C@@H]4C[C@H]23)c1)/C=C/C(=O)NO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 M13 mock treatment 11.8295 -0.56934 -0.1528 10.9911 -1.6913 -0.4007 -0.3914 -0.9126 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 M14 mock treatment 11.1261 -1.2728 -0.3415 10.95 -1.7324 -0.4105 -0.5317 -0.9958 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 M15 compound treatment 11.7149 -0.68397 -0.1835 11.1496 -1.5328 -0.3632 -0.3866 -0.95 3652583 HDAC1-H_000456 ONC(=O)CCc1cn(CCNC(=O)Nc2ccccc2)nn1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 M16 compound treatment 11.5562 -0.84266 -0.2261 11.8882 -0.79425 -0.1882 -0.293 -0.9958 3652584 HDAC1-H_000457 CCN(CC)CCNc1ccc(COc2ccccc2/C=C(\C)/C=C/C(=O)NO)c3sc4ccccc4c(=O)c13 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 M17 compound treatment 10.9466 -1.4523 -0.3897 12.4668 -0.21563 -0.0511 -0.3117 -0.793 3652586 HDAC1-H_000458 ONC(=O)CCc1cn(CC(=O)N2CCC3(CC2)N(CNC3=O)c4ccccc4)nn1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 M18 compound treatment 10.1403 -2.2585 -0.606 11.3962 -1.2863 -0.3048 -0.644 -0.9494 3652587 HDAC1-H_000459 CCN(CC)CCNc1ccc(COc2cccc(/C=C(\C)/C=C/C(=O)NO)c2)c3sc4ccccc4c(=O)c13 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 M19 compound treatment 11.2166 -1.1823 -0.3172 13.4969 0.8145 0.193 -0.0879 -0.2366 3652589 HDAC1-H_000460 CCOC(=O)[C@H](Cc1ccccc1)NC(=O)Cn2cc(CCC(=O)NO)nn2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 M20 compound treatment 12.1926 -0.20624 -0.0553 14.2813 1.5988 0.3788 0.2287 0.5975 3652591 HDAC1-H_000461 C/C(=C\c1ccccc1OCc2ccc(COc3ccc4ccncc4c3)cc2)/C=C/C(=O)NO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 M21 compound treatment 10.5056 -1.8932 -0.508 11.0466 -1.6358 -0.3876 -0.6333 -0.9911 3652593 HDAC1-H_000462 Cc1ccc(cc1)S(=O)(=O)N[C@@H](Cc2ccccc2)C(=O)NCCn3cc(CCC(=O)NO)nn3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 M22 compound treatment 13.4175 1.0187 0.2733 12.1274 -0.55503 -0.1315 0.1003 0.3306 3652595 HDAC1-H_000463 C/C(=C\c1cccc(OCc2ccc(COc3ccc4ccncc4c3)cc2)c1)/C=C/C(=O)NO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 M23 compound treatment 13.7062 1.3073 0.3508 11.477 -1.2054 -0.2856 0.0461 0.1019 3652597 HDAC1-H_000464 Cc1ccc(cc1)S(=O)(=O)N[C@@H](Cc2ccccc2)C(=O)NCCCn3cc(CCC(=O)NO)nn3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 M24 compound treatment 11.5147 -0.88416 -0.2372 15.3443 2.6619 0.6307 0.2782 0.4129 3562174 HDAC1-H_000465 OCc1ccc(cc1)c2ccncc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 N01 compound treatment 9.2541 -3.1448 -0.8438 13.8726 1.1902 0.282 -0.3973 -0.4465 3652599 HDAC1-H_000466 CNCC1CC(OC(O1)c2ccc(NC(=O)CCCCCCC(=O)NO)cc2)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 N02 mock treatment 7.4698 -4.9291 -1.3226 14.2151 1.5326 0.3631 -0.6784 -0.4947 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 N03 compound treatment 9.1238 -3.2751 -0.8788 18.1497 5.4673 1.2954 0.2946 0.1882 3652600 HDAC1-H_000467 ONC(=O)CCCCCCNC(=O)c1ccc(NCc2cn(Cc3cccc(Cn4cc(CNc5ccc(cc5)C(=O)NCCCCCCC(=O)NO)nn4)c3)nn2)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 N04 mock treatment 6.5535 -5.8454 -1.5685 13.8626 1.1802 0.2796 -0.9113 -0.572 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 N05 compound treatment 8.6485 -3.7503 -1.0063 11.9226 -0.7598 -0.18 -0.8389 -0.8206 3634810 HDAC1-H_000468 ONC(=O)CCCCCCC(=O)Nc1ccc(cc1)C(=O)c2ccc(NC(=O)CCCC#C)cc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 N06 mock treatment 8.1123 -4.2865 -1.1502 12.1955 -0.48692 -0.1154 -0.8949 -0.7741 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 N07 compound treatment 11.8619 -0.53694 -0.1441 11.7166 -0.9658 -0.2288 -0.2637 -0.9751 3652601 HDAC1-H_000469 ONC(=O)CCCCCCNC(=O)c1ccc(NCc2cn(Cc3ccc(cc3)C(=O)c4ccc(Cn5cc(CNc6ccc(cc6)C(=O)NCCCCCCC(=O)NO)nn5)cc4)nn2)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 N08 mock treatment 11.165 -1.2339 -0.3311 12.9168 0.23435 0.0555 -0.1948 -0.5804 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 N09 mock treatment 10.5365 -1.8624 -0.4997 13.6339 0.95145 0.2254 -0.194 -0.3538 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 N10 mock treatment 14.1913 1.7924 0.4809 13.4135 0.73105 0.1732 0.4626 0.9049 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 N11 compound treatment 155.687 143.29 38.4479 117.77 105.09 24.899 44.793 0.9779 483 HDAC1-H_000470 CN(C)c1ccc(cc1)C(=O)NCCCCCCC(=O)NO 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 N12 mock treatment 14.9387 2.5398 0.6815 11.0399 -1.6425 -0.3892 0.2067 0.2634 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 N13 mock treatment 14.5742 2.1753 0.5837 12.1684 -0.51405 -0.1218 0.3266 0.5478 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 N14 mock treatment 14.8485 2.4496 0.6573 12.4506 -0.23182 -0.0549 0.4259 0.6458 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 N15 compound treatment 13.4404 1.0415 0.2795 13.0233 0.34092 0.0808 0.2547 0.8756 3652602 HDAC1-H_000471 ONC(=O)CCCCCCNC(=O)c1ccc(NCc2cn(Cc3ccc(Cn4cc(CNc5ccc(cc5)C(=O)NCCCCCCC(=O)NO)nn4)cc3)nn2)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 N16 mock treatment 10.9939 -1.405 -0.377 12.721 0.038548 0.0091 -0.2601 -0.6898 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 N17 compound treatment 15.9622 3.5633 0.9561 12.6956 0.013135 0.0031 0.6783 0.7094 3652603 HDAC1-H_000472 ONC(=O)CCCCCCC(=O)Nc1ccc(/C=N/O)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 N18 mock treatment 13.313 0.91409 0.2453 10.4295 -2.2529 -0.5338 -0.204 -0.3473 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 N19 compound treatment 49.2571 36.858 9.89 25.1659 12.484 2.9578 9.0848 0.8801 468 HDAC1-H_000473 ONC(=O)CCCCCCC(=O)Nc1ccccc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 N20 mock treatment 13.3015 0.90264 0.2422 12.3657 -0.31674 -0.075 0.1182 0.4661 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 N21 compound treatment 12.1791 -0.21976 -0.059 11.4061 -1.2763 -0.3024 -0.2555 -0.8294 3652605 HDAC1-H_000474 COC(=O)CCCCCCNC(=O)c1ccc(NCc2cn(Cc3ccc(cc3)C(=O)c4ccc(Cn5cc(CNc6ccc(cc6)C(=O)NCCCCCCC(=O)OC)nn5)cc4)nn2)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 N22 mock treatment 13.4234 1.0246 0.2749 15.6821 2.9997 0.7107 0.697 0.9146 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 N23 compound treatment 11.314 -1.0848 -0.2911 12.9404 0.25795 0.0611 -0.1626 -0.5467 3652606 HDAC1-H_000475 ONC(=O)CCCCCCC(=O)Nc1ccc(/C=N/OCc2ccccc2)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 N24 mock treatment 13.8625 1.4636 0.3927 11.3593 -1.3231 -0.3135 0.056 0.1115 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 O01 compound treatment 15.1763 2.7775 0.7453 15.6617 2.9793 0.7059 1.0261 0.9996 3652608 HDAC1-H_000476 ONC(=O)CCc1cn(C[C@H](Cc2ccccc2)NC(=O)Nc3ccccc3)nn1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 O02 compound treatment 14.9178 2.5189 0.6759 15.3598 2.6774 0.6344 0.9265 0.9995 3652610 HDAC1-H_000477 OC[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@H]12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 O03 compound treatment 14.7678 2.3689 0.6356 13.8227 1.1403 0.2702 0.6405 0.9274 3652612 HDAC1-H_000478 ONC(=O)CCc1cn(C[C@@H](Cc2ccccc2)NC(=O)Nc3ccccc3)nn1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 O04 compound treatment 10.9292 -1.4697 -0.3943 11.6164 -1.0661 -0.2526 -0.4574 -0.9768 1105 HDAC1-H_000479 CCN(CC)CCNc1ccc(CO)c2sc3ccccc3c(=O)c12 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 O05 compound treatment 12.8182 0.41936 0.1125 11.4436 -1.2388 -0.2935 -0.128 -0.4071 3652613 HDAC1-H_000480 Cc1ccc(cc1)S(=O)(=O)N2CCC[C@H]2Cn3cc(CCC(=O)NO)nn3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 O06 compound treatment 14.4872 2.0884 0.5604 10.6389 -2.0435 -0.4842 0.0539 0.0727 3652615 HDAC1-H_000481 OCc1ccc(COc2ccc3ccncc3c2)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 O07 compound treatment 11.9029 -0.49596 -0.1331 11.8643 -0.8181 -0.1938 -0.2312 -0.9832 3652616 HDAC1-H_000482 Cc1ccc(cc1)S(=O)(=O)N(c2cccc(c2)n3cc(CCC(=O)NO)nn3)S(=O)(=O)c4ccc(C)cc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 O08 compound treatment 13.1358 0.73691 0.1977 13.9358 1.2534 0.297 0.3498 0.9805 3652617 HDAC1-H_000483 ONC(=O)/C=C/c1ccc(cc1)C2OC(CSc3ccncc3)CC(O2)c4ccccc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 O09 compound treatment 11.5217 -0.87715 -0.2354 8.5058 -4.1766 -0.9896 -0.8662 -0.8515 3652619 HDAC1-H_000484 ONC(=O)CCc1cn(nn1)c2cccc(c2)C(=O)O 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 O10 compound treatment 10.8076 -1.5913 -0.427 11.4714 -1.211 -0.2869 -0.5048 -0.9813 3652620 HDAC1-H_000485 COc1cc2CCN(CC3CC(OC(O3)c4ccc(NC(=O)CCCCCCC(=O)NO)cc4)c5ccccc5)Cc2cc1OC 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 O11 mock treatment 9.2856 -3.1132 -0.8354 12.1663 -0.51615 -0.1223 -0.6772 -0.8021 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 O12 mock treatment 10.271 -2.1278 -0.571 10.392 -2.2904 -0.5427 -0.7875 -0.9997 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 O13 compound treatment 13.9113 1.5124 0.4058 10.8556 -1.8269 -0.4328 -0.0191 -0.0322 3652621 HDAC1-H_000486 CC(C)(C)ONC(=O)c1cccc(c1)n2cc(CCC(=O)NO)nn2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 O14 compound treatment 11.1685 -1.2304 -0.3301 11.7831 -0.89932 -0.2131 -0.3841 -0.9776 3652622 HDAC1-H_000487 ONC(=O)CCCCCCC(=O)Nc1ccc(cc1)C2OC(CSc3nc(c(o3)c4ccccc4)c5ccccc5)CC(O2)c6ccc(cc6)[N+](=O)[O-] 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 O15 compound treatment 12.3778 -0.021039 -0.0056 10.8841 -1.7983 -0.4261 -0.3053 -0.7164 3652387 HDAC1-H_000488 COc1ccc(cc1)n2cc(CCC(=O)NO)nn2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 O16 compound treatment 11.1774 -1.2214 -0.3277 11.2295 -1.4529 -0.3442 -0.4752 -0.9997 3635093 HDAC1-H_000489 ONC(=O)CCCCCCC(=O)Nc1ccc(cc1)C2OC(CSc3ccccc3)CC(O2)c4ccccc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 O17 compound treatment 11.7499 -0.64893 -0.1741 10.4461 -2.2363 -0.5299 -0.4978 -0.8925 3652623 HDAC1-H_000490 COc1cccc(c1)n2cc(CCC(=O)NO)nn2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 O18 compound treatment 13.2202 0.82134 0.2204 12.8263 0.14385 0.0341 0.1799 0.8069 3561878 HDAC1-H_000491 ONC(=O)CCCCCCC(=O)Nc1ccc(cc1)C2CC(CSc3nc(c(o3)c4ccccc4)c5ccccc5)OC(O2)c6ccccc6 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 O19 compound treatment 14.5397 2.1408 0.5744 12.1386 -0.54385 -0.1289 0.3151 0.5352 3652624 HDAC1-H_000492 ONC(=O)CCc1cn(nn1)c2ccc(NC(=O)c3ccccc3)cc2 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 O20 compound treatment 12.0731 -0.32576 -0.0874 12.9968 0.31432 0.0745 -0.0091 -0.0797 3635080 HDAC1-H_000493 ONC(=O)CCCCCCC(=O)Nc1ccc(cc1)C2CC(CSc3nc(c(o3)c4ccccc4)c5ccccc5)OC(O2)c6ccc(NC(=O)CCCCCCC(=O)NO)cc6 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 O21 compound treatment 11.7779 -0.62094 -0.1666 12.2425 -0.43993 -0.1042 -0.1915 -0.9745 3652625 HDAC1-H_000494 ONC(=O)CCc1cn(nn1)c2cccc(c2)C(=O)N3CCC4(CC3)N(CNC4=O)c5ccccc5 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 O22 compound treatment 13.8592 1.4603 0.3918 13.202 0.5196 0.1231 0.3641 0.8865 3635109 HDAC1-H_000495 ONC(=O)CCCCCCC(=O)Nc1ccc(cc1)[C@@H]2O[C@H](CSc3ccncc3)C[C@@H](O2)c4ccccc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 O23 compound treatment 14.2127 1.8138 0.4867 10.9664 -1.716 -0.4066 0.0566 0.0893 3652626 HDAC1-H_000496 COc1ccc(cc1)C(=O)Nc2cccc(c2)n3cc(CCC(=O)NO)nn3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 O24 compound treatment 19.6112 7.2123 1.9353 12.8357 0.15329 0.0363 1.3941 0.7203 3215599 HDAC1-H_000497 COCC1CC(OC(O1)c2ccc(NC(=O)CCCCCCC(=O)NO)cc2)c3ccccc3 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 P01 compound treatment 16.1169 3.7181 0.9977 13.2058 0.5234 0.124 0.7931 0.7889 3652627 HDAC1-H_000498 COC(=O)CCCCCCC(=O)Nc1ccc(/C=N/OCc2ccccc2)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 P02 mock treatment 14.4613 2.0624 0.5534 11.2921 -1.3904 -0.3294 0.1584 0.2459 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 P03 compound treatment 15.5741 3.1752 0.852 18.7742 6.0917 1.4434 1.623 0.9684 3652629 HDAC1-H_000499 ONC(=O)CCCCCCNC(=O)c1ccc(NCc2cn(Cc3ccccc3Cn4cc(CNc5ccc(cc5)C(=O)NCCCCCCC(=O)NO)nn4)nn2)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 P04 mock treatment 10.2484 -2.1505 -0.577 13.0163 0.33392 0.0791 -0.3521 -0.6045 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 P05 compound treatment 52.1425 39.744 10.6642 35.2407 22.558 5.3448 11.3201 0.949 3652630 HDAC1-H_000500 ONC(=O)CCCCCCNC(=O)c1ccc(cc1)N(CC#C)CC#C 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 P06 mock treatment 13.0872 0.68837 0.1847 13.5127 0.83025 0.1967 0.2697 0.9995 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 P07 compound treatment 15.0129 2.614 0.7014 14.0948 1.4124 0.3346 0.7326 0.9427 3652631 HDAC1-H_000501 ONC(=O)CCCCCCNC(=O)c1ccc(NCc2cn(Cc3ccccc3)nn2)cc1 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 P08 mock treatment 13.2015 0.80263 0.2154 10.5228 -2.1596 -0.5117 -0.2095 -0.3774 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 P09 compound treatment 14.5465 2.1476 0.5763 12.6697 -0.012702 -0.003 0.4054 0.7034 3634807 HDAC1-H_000502 ONC(=O)CCCCCCC(=O)Nc1ccc(cc1)C2CC(OC(O2)c3ccccc3)c4ccccc4 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 P10 mock treatment 14.2921 1.8932 0.508 18.4372 5.7548 1.3635 1.3233 0.9095 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 P11 mock treatment 11.8287 -0.57021 -0.153 11.9045 -0.77793 -0.1843 -0.2385 -0.9957 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 P12 mock treatment 13.4743 1.0755 0.2886 13.2678 0.58541 0.1387 0.3021 0.9436 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 P13 compound treatment 13.4049 1.006 0.2699 14.2231 1.5406 0.365 0.449 0.989 3652632 HDAC1-H_000503 ONC(=O)CCCCCCC(=O)Nc1ccc(cc1)C2CC(OC(O2)c3ccc(Oc4ccccc4)cc3)c5ccccc5 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 P14 mock treatment 11.9227 -0.47619 -0.1278 11.7024 -0.98003 -0.2322 -0.2545 -0.9604 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 P15 compound treatment 14.4949 2.096 0.5624 12.3395 -0.34295 -0.0813 0.3402 0.5987 3652633 HDAC1-H_000504 ONC(=O)CCCCCCC(=O)Nc1ccc(cc1)C2CC(OC(O2)c3cccc(Oc4ccccc4)c3)c5ccccc5 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 P16 mock treatment 11.8162 -0.58269 -0.1564 11.9002 -0.78225 -0.1853 -0.2416 -0.9964 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 P17 compound treatment 12.0794 -0.31944 -0.0857 10.974 -1.7085 -0.4048 -0.3468 -0.8382 3634674 HDAC1-H_000505 OCc1ccc(cc1)[C@@H]2C[C@H](CSc3nc(c(o3)c4ccccc4)c5ccccc5)OC(O2)c6ccc(NC(=O)CCCCCCC(=O)O)cc6 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 P18 mock treatment 12.4365 0.037599 0.0101 11.1335 -1.5489 -0.367 -0.2524 -0.6874 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 P19 compound treatment 11.4276 -0.97125 -0.2606 11.6992 -0.98325 -0.233 -0.349 -0.9984 2027357 HDAC1-H_000506 OCc1ccc(cc1)[C@@H]2C[C@H](CSc3nc(c(o3)c4ccccc4)c5ccccc5)O[C@@H](O2)c6ccc(NC(=O)CCCCCCC(=O)NO)cc6 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 P20 mock treatment 12.9786 0.57978 0.1556 9.7575 -2.9249 -0.693 -0.38 -0.5351 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 P21 compound treatment 12.6536 0.25472 0.0683 10.3249 -2.3575 -0.5586 -0.3466 -0.616 3562114 HDAC1-H_000507 ONC(=O)CCCCCCC(=O)Nc1ccc(cc1)C2OC(CSc3nc(c(o3)c4ccccc4)c5ccccc5)CC(O2)c6ccccc6 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 P22 mock treatment 13.1754 0.77649 0.2084 11.0118 -1.6706 -0.3958 -0.1326 -0.2964 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 P23 compound treatment 12.1417 -0.25714 -0.069 11.546 -1.1364 -0.2693 -0.2392 -0.8605 3652634 HDAC1-H_000508 ONC(=O)CCCCCCC(=O)Nc1ccc(cc1)[C@H]2O[C@@H](CSc3nc(c(o3)c4ccccc4)c5ccccc5)C[C@H](O2)c6ccccc6 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.2476 P24 mock treatment 10.9973 -1.4016 -0.3761 22.1537 9.4712 2.2441 1.3209 0.5805 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base A01 mock treatment 20.7 8.1028 2.1742 14.1955 0.56746 0.1345 1.6324 0.7494 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base A02 mock treatment 11.741 -0.85625 -0.2298 14.7811 1.153 0.2732 0.0307 0.0861 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base A03 mock treatment 13.4636 0.8664 0.2325 15.0526 1.4245 0.3375 0.403 0.9834 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base A04 mock treatment 12.4649 -0.13229 -0.0355 14.2079 0.57981 0.1374 0.072 0.5077 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base A05 mock treatment 24.1681 11.571 3.1048 10.9589 -2.6692 -0.6324 1.7482 0.5517 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base A06 mock treatment 13.7442 1.1469 0.3078 12.4035 -1.2246 -0.2901 0.0125 0.0294 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base A07 mock treatment 12.3935 -0.20376 -0.0547 13.0132 -0.61489 -0.1457 -0.1417 -0.9105 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base A08 mock treatment 12.0895 -0.50776 -0.1362 14.6891 1.061 0.2514 0.0814 0.2848 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base A09 mock treatment 15.2777 2.6805 0.7193 21.5244 7.8964 1.8709 1.8315 0.9137 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base A10 mock treatment 14.9761 2.3788 0.6383 11.4924 -2.1357 -0.506 0.0935 0.1148 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base A11 mock treatment 12.8224 0.22515 0.0604 15.2942 1.6661 0.3948 0.3219 0.8059 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base A12 mock treatment 10.8667 -1.7305 -0.4643 10.4313 -3.1968 -0.7574 -0.8639 -0.9724 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base A13 mock treatment 13.3193 0.72212 0.1938 13.4711 -0.15694 -0.0372 0.1107 0.5612 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base A14 mock treatment 14.7467 2.1494 0.5767 15.6804 2.0523 0.4863 0.7517 0.9964 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base A15 mock treatment 13.4653 0.86804 0.2329 14.4156 0.78756 0.1866 0.2966 0.994 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base A16 mock treatment 9.4011 -3.1961 -0.8576 12.1981 -1.43 -0.3388 -0.846 -0.9175 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base A17 mock treatment 14.8676 2.2703 0.6092 15.2167 1.5886 0.3764 0.6969 0.9732 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base A18 mock treatment 14.5593 1.962 0.5265 17.2997 3.6716 0.8699 0.9874 0.9711 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base A19 mock treatment 17.1763 4.5791 1.2287 11.3342 -2.2939 -0.5435 0.4845 0.3606 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base A20 mock treatment 12.7521 0.15482 0.0415 14.6734 1.0453 0.2477 0.2045 0.8143 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base A21 mock treatment 12.7196 0.1224 0.0328 11.0337 -2.5944 -0.6147 -0.4114 -0.6684 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base A22 mock treatment 10.4031 -2.1941 -0.5887 13.3937 -0.23439 -0.0555 -0.4556 -0.7704 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base A23 mock treatment 15.1262 2.529 0.6786 14.3023 0.67421 0.1597 0.5928 0.8503 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base A24 mock treatment 14.9973 2.4001 0.644 16.2581 2.63 0.6231 0.896 0.9999 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base B01 mock treatment 14.815 2.2177 0.5951 13.1709 -0.45714 -0.1083 0.3442 0.5691 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base B02 mock treatment 15.8987 3.3014 0.8859 17.5885 3.9605 0.9384 1.2899 0.9996 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base B03 mock treatment 11.2163 -1.3809 -0.3705 20.366 6.7379 1.5965 0.8669 0.5289 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base B04 mock treatment 12.4961 -0.10108 -0.0271 14.272 0.64393 0.1526 0.0887 0.5724 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base B05 mock treatment 13.1776 0.58037 0.1557 12.1157 -1.5124 -0.3583 -0.1433 -0.3667 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base B06 mock treatment 14.4038 1.8066 0.4847 11.6724 -1.9557 -0.4634 0.0151 0.0225 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base B07 mock treatment 17.8773 5.28 1.4168 15.7881 2.16 0.5118 1.3637 0.9053 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base B08 mock treatment 12.0523 -0.54498 -0.1462 13.3389 -0.28922 -0.0685 -0.1519 -0.9403 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base B09 mock treatment 13.598 1.0008 0.2685 13.4612 -0.16687 -0.0395 0.1619 0.5966 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base B10 mock treatment 12.9712 0.37395 0.1003 12.0589 -1.5691 -0.3718 -0.1919 -0.4984 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base B11 mock treatment 15.9177 3.3205 0.891 14.0869 0.45883 0.1087 0.7069 0.7875 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base B12 mock treatment 14.0934 1.4961 0.4014 13.4888 -0.13926 -0.033 0.2605 0.6468 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base B13 mock treatment 10.8918 -1.7054 -0.4576 14.3465 0.71843 0.1702 -0.2032 -0.4162 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base B14 mock treatment 13.659 1.0618 0.2849 13.2613 -0.36673 -0.0869 0.14 0.4701 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base B15 mock treatment 16.6012 4.004 1.0744 14.3056 0.67753 0.1605 0.8732 0.8038 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base B16 mock treatment 14.5465 1.9492 0.523 12.8862 -0.74192 -0.1758 0.2455 0.445 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base B17 mock treatment 11.3241 -1.2732 -0.3416 13.1489 -0.47914 -0.1135 -0.3218 -0.894 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base B18 mock treatment 14.706 2.1087 0.5658 11.6817 -1.9464 -0.4612 0.074 0.1014 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base B19 mock treatment 13.3611 0.76389 0.205 13.5549 -0.073145 -0.0173 0.1327 0.645 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base B20 mock treatment 9.6954 -2.9018 -0.7786 12.8222 -0.80592 -0.191 -0.6856 -0.8552 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base B21 mock treatment 17.665 5.0677 1.3598 13.4902 -0.13787 -0.0327 0.9384 0.6899 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base B22 mock treatment 13.983 1.3857 0.3718 13.6144 -0.013645 -0.0032 0.2606 0.7009 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base B23 mock treatment 13.357 0.75982 0.2039 15.7945 2.1664 0.5133 0.5071 0.9182 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base B24 mock treatment 11.6876 -0.90959 -0.2441 13.0893 -0.53879 -0.1277 -0.2629 -0.9543 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base C01 mock treatment 13.5865 0.98923 0.2654 15.0601 1.432 0.3393 0.4276 0.9926 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base C02 mock treatment 16.192 3.5948 0.9646 13.219 -0.40904 -0.0969 0.6135 0.6329 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base C03 mock treatment 13.8725 1.2753 0.3422 13.1912 -0.43692 -0.1035 0.1688 0.4721 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base C04 mock treatment 13.6179 1.0206 0.2739 12.3524 -1.2757 -0.3023 -0.0201 -0.0492 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base C05 mock treatment 11.9865 -0.61069 -0.1639 14.1015 0.47343 0.1122 -0.0366 -0.1841 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base C06 mock treatment 13.5533 0.95609 0.2565 17.1437 3.5156 0.833 0.7704 0.8839 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base C07 mock treatment 12.0135 -0.58368 -0.1566 14.159 0.53088 0.1258 -0.0218 -0.1085 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base C08 mock treatment 11.9785 -0.61876 -0.166 11.7726 -1.8555 -0.4396 -0.4283 -0.9113 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base C09 mock treatment 12.306 -0.29121 -0.0781 15.0972 1.4691 0.3481 0.1909 0.5351 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base C10 mock treatment 13.0567 0.45952 0.1233 14.6599 1.0319 0.2445 0.2601 0.9498 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base C11 mock treatment 11.1545 -1.4428 -0.3871 12.6574 -0.9707 -0.23 -0.4364 -0.9691 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base C12 mock treatment 12.7479 0.15067 0.0404 9.6 -4.028 -0.9544 -0.6463 -0.6765 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base C13 mock treatment 12.0225 -0.57471 -0.1542 14.4383 0.81018 0.192 0.0267 0.1084 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base C14 mock treatment 12.6402 0.04297 0.0115 13.9629 0.33488 0.0793 0.0643 0.8014 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base C15 mock treatment 12.5144 -0.082855 -0.0222 15.9674 2.3394 0.5543 0.3762 0.6782 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base C16 mock treatment 11.5995 -0.99775 -0.2677 13.1565 -0.47152 -0.1117 -0.2683 -0.9249 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base C17 mock treatment 12.6662 0.068938 0.0185 12.8405 -0.78757 -0.1866 -0.1189 -0.6339 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base C18 mock treatment 13.532 0.93472 0.2508 11.1809 -2.4472 -0.5798 -0.2326 -0.3683 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base C19 mock treatment 12.6347 0.03751 0.0101 13.2237 -0.40434 -0.0958 -0.0606 -0.6294 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base C20 mock treatment 12.8535 0.25627 0.0688 11.1863 -2.4418 -0.5785 -0.3605 -0.6187 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base C21 mock treatment 19.4173 6.8201 1.83 15.3425 1.7144 0.4062 1.5812 0.8435 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base C22 mock treatment 12.3185 -0.27875 -0.0748 10.818 -2.81 -0.6658 -0.5237 -0.7816 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base C23 mock treatment 14.7579 2.1607 0.5798 15.5175 1.8894 0.4477 0.7265 0.9918 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base C24 mock treatment 12.1837 -0.4135 -0.111 11.7432 -1.8849 -0.4466 -0.3942 -0.8567 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base D01 mock treatment 15.2825 2.6852 0.7205 14.1946 0.56653 0.1342 0.6044 0.8247 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base D02 mock treatment 15.5906 2.9934 0.8032 14.8494 1.2214 0.2894 0.7726 0.9049 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base D03 mock treatment 13.9153 1.3181 0.3537 13.4845 -0.14359 -0.034 0.226 0.6361 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base D04 mock treatment 13.1886 0.5914 0.1587 11.2331 -2.395 -0.5675 -0.289 -0.4905 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base D05 mock treatment 12.9639 0.3667 0.0984 13.4508 -0.17723 -0.042 0.0399 0.3728 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base D06 mock treatment 16.8565 4.2593 1.1429 22.7006 9.0726 2.1496 2.3281 0.9563 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base D07 mock treatment 12.8603 0.26309 0.0706 13.4926 -0.13545 -0.0321 0.0272 0.3511 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base D08 mock treatment 18.9699 6.3727 1.71 15.4551 1.827 0.4329 1.5152 0.859 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base D09 mock treatment 13.428 0.8308 0.2229 14.4501 0.82203 0.1948 0.2954 0.9977 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base D10 mock treatment 13.9131 1.3159 0.3531 14.1702 0.54213 0.1284 0.3405 0.9062 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base D11 mock treatment 14.0456 1.4483 0.3886 13.5299 -0.09817 -0.0233 0.2584 0.6636 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base D12 mock treatment 12.3831 -0.21416 -0.0575 14.6159 0.98778 0.234 0.1249 0.5181 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base D13 mock treatment 17.5387 4.9414 1.3259 14.0095 0.38145 0.0904 1.0015 0.7536 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base D14 mock treatment 13.5087 0.91152 0.2446 14.6727 1.0446 0.2475 0.348 1.0 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base D15 mock treatment 13.7018 1.1046 0.2964 13.5876 -0.040515 -0.0096 0.2028 0.6838 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base D16 mock treatment 14.2524 1.6552 0.4441 12.979 -0.64909 -0.1538 0.2053 0.4368 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base D17 mock treatment 13.4714 0.8742 0.2346 13.0787 -0.54932 -0.1302 0.0738 0.2752 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base D18 mock treatment 12.0174 -0.57986 -0.1556 14.4395 0.81143 0.1923 0.0259 0.1048 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base D19 mock treatment 10.2221 -2.3752 -0.6373 12.1219 -1.5062 -0.3569 -0.703 -0.9624 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base D20 mock treatment 12.0001 -0.59714 -0.1602 16.4116 2.7836 0.6595 0.3531 0.5202 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base D21 mock treatment 9.7186 -2.8786 -0.7724 19.8223 6.1943 1.4676 0.4916 0.2964 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base D22 mock treatment 14.898 2.3008 0.6174 19.2879 5.6598 1.341 1.3848 0.938 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base D23 mock treatment 12.5225 -0.074745 -0.0201 14.1132 0.48513 0.1149 0.0671 0.575 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base D24 mock treatment 9.4955 -3.1017 -0.8323 14.8987 1.2706 0.3011 -0.3756 -0.4244 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base E01 mock treatment 13.2904 0.69314 0.186 11.7273 -1.9008 -0.4504 -0.1869 -0.3837 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base E02 mock treatment 11.1279 -1.4694 -0.3943 12.0191 -1.609 -0.3812 -0.5484 -0.9999 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base E03 mock treatment 9.8626 -2.7346 -0.7338 17.6378 4.0098 0.9501 0.1529 0.1274 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base E04 mock treatment 10.6443 -1.953 -0.524 19.6432 6.0152 1.4252 0.6372 0.4196 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base E05 mock treatment 11.7499 -0.84734 -0.2274 12.2831 -1.3449 -0.3187 -0.3861 -0.9863 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base E06 mock treatment 14.3744 1.7771 0.4768 13.2664 -0.36167 -0.0857 0.2766 0.5709 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base E07 mock treatment 12.6266 0.029345 0.0079 11.8212 -1.8068 -0.4281 -0.2971 -0.694 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base E08 mock treatment 11.4748 -1.1224 -0.3012 15.0866 1.4585 0.3456 0.0314 0.0685 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base E09 mock treatment 11.0184 -1.5788 -0.4236 12.1104 -1.5177 -0.3596 -0.5538 -0.9967 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base E10 mock treatment 12.6664 0.069195 0.0186 13.7572 0.12912 0.0306 0.0348 0.9714 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base E11 mock treatment 11.6649 -0.93236 -0.2502 12.8344 -0.79364 -0.188 -0.3099 -0.9901 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base E12 mock treatment 11.5267 -1.0705 -0.2873 17.5011 3.8731 0.9177 0.4458 0.4636 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base E13 mock treatment 13.4887 0.8915 0.2392 15.7956 2.1675 0.5136 0.5323 0.9395 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base E14 mock treatment 12.4228 -0.17439 -0.0468 11.7982 -1.8299 -0.4336 -0.3397 -0.7789 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base E15 mock treatment 7.5542 -5.043 -1.3532 14.4247 0.79663 0.1887 -0.8234 -0.6026 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base E16 mock treatment 10.31 -2.2872 -0.6137 13.5415 -0.08654 -0.0205 -0.4485 -0.7303 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base E17 mock treatment 13.9067 1.3095 0.3514 13.0111 -0.61694 -0.1462 0.1451 0.3813 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base E18 mock treatment 13.6964 1.0992 0.2949 17.0928 3.4647 0.8209 0.789 0.9045 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base E19 mock treatment 11.7922 -0.80507 -0.216 14.9058 1.2777 0.3027 0.0613 0.1649 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base E20 mock treatment 9.8946 -2.7026 -0.7252 15.8259 2.1978 0.5207 -0.1446 -0.1619 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base E21 mock treatment 10.7239 -1.8734 -0.5027 11.9924 -1.6357 -0.3876 -0.6295 -0.9917 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base E22 mock treatment 13.0562 0.459 0.1232 15.5347 1.9067 0.4518 0.4065 0.8682 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base E23 mock treatment 10.4771 -2.1202 -0.5689 14.1082 0.48008 0.1137 -0.3218 -0.5547 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base E24 mock treatment 10.0309 -2.5663 -0.6886 10.2946 -3.3335 -0.7898 -1.0454 -0.9977 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base F01 mock treatment 11.246 -1.3512 -0.3626 16.8911 3.2631 0.7731 0.2903 0.34 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base F02 mock treatment 10.9681 -1.6291 -0.4371 16.9392 3.3111 0.7845 0.2456 0.2735 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base F03 mock treatment 11.9233 -0.6739 -0.1808 12.1837 -1.4444 -0.3422 -0.3699 -0.9555 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base F04 mock treatment 12.885 0.28777 0.0772 13.9781 0.35006 0.0829 0.1132 0.9994 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base F05 mock treatment 12.2287 -0.36855 -0.0989 16.2701 2.642 0.626 0.3727 0.5881 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base F06 mock treatment 10.9496 -1.6476 -0.4421 12.9438 -0.68424 -0.1621 -0.4272 -0.9073 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base F07 mock treatment 11.6184 -0.97887 -0.2627 11.4728 -2.1553 -0.5107 -0.5468 -0.9522 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base F08 mock treatment 14.2904 1.6931 0.4543 14.2645 0.63643 0.1508 0.4279 0.8939 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base F09 mock treatment 11.3968 -1.2004 -0.3221 13.6121 -0.015945 -0.0038 -0.2304 -0.7154 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base F10 mock treatment 10.7217 -1.8755 -0.5032 14.1289 0.50086 0.1187 -0.2719 -0.5259 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base F11 mock treatment 11.4156 -1.1816 -0.317 11.2856 -2.3424 -0.555 -0.6166 -0.9647 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base F12 mock treatment 12.6741 0.076883 0.0206 13.5489 -0.079155 -0.0188 0.0013 0.0476 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base F13 mock treatment 10.8253 -1.7719 -0.4754 15.1144 1.4864 0.3522 -0.0872 -0.1473 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base F14 mock treatment 14.868 2.2707 0.6093 14.012 0.38393 0.091 0.4952 0.8038 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base F15 mock treatment 11.7688 -0.82848 -0.2223 11.0384 -2.5897 -0.6136 -0.5911 -0.9057 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base F16 mock treatment 10.2748 -2.3225 -0.6232 14.8667 1.2386 0.2935 -0.2331 -0.3385 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base F17 mock treatment 12.8823 0.2851 0.0765 11.7171 -1.9109 -0.4528 -0.2661 -0.5794 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base F18 mock treatment 10.0273 -2.5699 -0.6896 14.4661 0.83803 0.1986 -0.3472 -0.4838 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base F19 mock treatment 13.0878 0.4906 0.1316 12.4573 -1.1707 -0.2774 -0.1031 -0.3357 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base F20 mock treatment 8.823 -3.7742 -1.0127 14.0667 0.43861 0.1039 -0.6426 -0.6312 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base F21 mock treatment 11.9357 -0.66158 -0.1775 13.2635 -0.36456 -0.0864 -0.1866 -0.9452 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base F22 mock treatment 12.0913 -0.50597 -0.1358 11.6864 -1.9416 -0.46 -0.4213 -0.8783 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base F23 mock treatment 12.0351 -0.56215 -0.1508 11.2967 -2.3313 -0.5524 -0.4973 -0.8684 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base F24 mock treatment 11.5836 -1.0136 -0.272 14.6976 1.0695 0.2534 -0.0131 -0.0353 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base G01 mock treatment 11.7247 -0.87254 -0.2341 15.5881 1.96 0.4644 0.1628 0.3131 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base G02 mock treatment 12.5013 -0.095905 -0.0257 13.0424 -0.58572 -0.1388 -0.1163 -0.8242 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base G03 mock treatment 13.2286 0.63133 0.1694 11.3682 -2.2599 -0.5355 -0.2588 -0.4609 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base G04 mock treatment 4.5615 -8.0357 -2.1562 15.6891 2.061 0.4883 -1.1794 -0.5335 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base G05 mock treatment 10.3826 -2.2146 -0.5942 15.7133 2.0853 0.4941 -0.0708 -0.0917 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base G06 mock treatment 13.6458 1.0486 0.2814 11.8799 -1.7482 -0.4142 -0.0939 -0.1876 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base G07 mock treatment 12.2368 -0.36044 -0.0967 12.3391 -1.289 -0.3054 -0.2843 -0.8876 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base G08 mock treatment 12.3416 -0.25568 -0.0686 12.2201 -1.408 -0.3336 -0.2844 -0.835 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base G09 mock treatment 14.4114 1.8141 0.4868 12.2855 -1.3426 -0.3181 0.1193 0.2051 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base G10 mock treatment 11.4491 -1.1481 -0.3081 15.6538 2.0257 0.48 0.1216 0.2131 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base G11 mock treatment 13.4022 0.80497 0.216 11.8054 -1.8227 -0.4319 -0.1526 -0.3161 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base G12 mock treatment 10.482 -2.1152 -0.5676 13.1214 -0.50662 -0.12 -0.4862 -0.8381 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base G13 mock treatment 10.2513 -2.3459 -0.6295 16.1383 2.5103 0.5948 -0.0245 -0.0283 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base G14 mock treatment 11.5029 -1.0943 -0.2936 12.1438 -1.4842 -0.3517 -0.4563 -0.996 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base G15 mock treatment 13.0821 0.4849 0.1301 12.7647 -0.86336 -0.2046 -0.0526 -0.2172 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base G16 mock treatment 11.0131 -1.5841 -0.4251 12.5868 -1.0413 -0.2467 -0.475 -0.9665 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base G17 mock treatment 12.2469 -0.35037 -0.094 10.1 -3.5281 -0.8359 -0.6576 -0.7817 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base G18 mock treatment 9.8762 -2.7211 -0.7301 11.5671 -2.061 -0.4883 -0.8616 -0.9809 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base G19 mock treatment 12.5514 -0.045855 -0.0123 12.8402 -0.78784 -0.1867 -0.1407 -0.7521 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base G20 mock treatment 11.7747 -0.82253 -0.2207 12.5708 -1.0572 -0.2505 -0.3332 -0.998 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base G21 mock treatment 11.8413 -0.75591 -0.2028 15.4703 1.8422 0.4365 0.1652 0.3433 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base G22 mock treatment 11.622 -0.97518 -0.2617 11.6028 -2.0252 -0.4798 -0.5243 -0.9593 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base G23 mock treatment 10.517 -2.0802 -0.5582 12.1817 -1.4464 -0.3427 -0.637 -0.9726 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base G24 mock treatment 11.9237 -0.67351 -0.1807 8.9996 -4.6284 -1.0966 -0.9032 -0.8127 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base H01 mock treatment 13.094 0.49675 0.1333 15.5996 1.9715 0.4671 0.4246 0.874 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base H02 mock treatment 13.5515 0.95422 0.256 60.0189 46.391 10.9916 7.9533 0.7234 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base H03 mock treatment 9.8366 -2.7606 -0.7407 19.6038 5.9758 1.4159 0.4774 0.2988 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base H04 mock treatment 14.3266 1.7293 0.464 14.3221 0.69401 0.1644 0.4444 0.9027 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base H05 mock treatment 12.471 -0.12624 -0.0339 13.7434 0.11533 0.0273 -0.0046 -0.1064 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base H06 mock treatment 13.2716 0.67434 0.1809 12.282 -1.3461 -0.3189 -0.0976 -0.2661 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base H07 mock treatment 10.6142 -1.983 -0.5321 14.4526 0.82456 0.1954 -0.2381 -0.4201 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base H08 mock treatment 11.3262 -1.2711 -0.3411 11.741 -1.8871 -0.4471 -0.5573 -0.9911 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base H09 mock treatment 12.9019 0.30467 0.0818 35.3463 21.718 5.1458 3.6964 0.7182 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base H10 mock treatment 15.9498 3.3526 0.8996 13.2536 -0.37449 -0.0887 0.5734 0.6343 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base H11 mock treatment 12.2094 -0.38781 -0.1041 14.0283 0.40021 0.0948 -0.0065 -0.0464 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base H12 mock treatment 11.288 -1.3092 -0.3513 11.0159 -2.6122 -0.6189 -0.6861 -0.964 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base H13 mock treatment 12.5198 -0.077457 -0.0208 15.1869 1.5588 0.3693 0.2465 0.6663 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base H14 mock treatment 11.5471 -1.0501 -0.2818 12.4365 -1.1916 -0.2823 -0.3989 -1.0 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base H15 mock treatment 11.3207 -1.2765 -0.3425 13.3621 -0.26599 -0.063 -0.2868 -0.8234 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base H16 mock treatment 8.9185 -3.6787 -0.9871 11.1394 -2.4887 -0.5897 -1.1149 -0.9697 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base H17 mock treatment 10.3194 -2.2779 -0.6112 13.9633 0.33523 0.0794 -0.376 -0.6101 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base H18 mock treatment 11.8813 -0.71595 -0.1921 14.0261 0.39803 0.0943 -0.0692 -0.3231 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base H19 mock treatment 11.2054 -1.3919 -0.3735 13.5681 -0.059945 -0.0142 -0.2741 -0.7335 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base H20 mock treatment 13.1592 0.56197 0.1508 12.9037 -0.72434 -0.1716 -0.0147 -0.0645 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base H21 mock treatment 12.8554 0.25822 0.0693 15.3587 1.7306 0.41 0.3389 0.815 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base H22 mock treatment 15.603 3.0058 0.8065 11.5174 -2.1107 -0.5001 0.2167 0.2283 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base H23 mock treatment 11.2978 -1.2994 -0.3487 11.4119 -2.2162 -0.5251 -0.6178 -0.9802 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base H24 mock treatment 14.0313 1.4341 0.3848 13.2893 -0.33879 -0.0803 0.2153 0.5478 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base I01 mock treatment 10.5265 -2.0708 -0.5556 14.9123 1.2842 0.3043 -0.1777 -0.2806 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base I02 mock treatment 16.1053 3.508 0.9413 11.4675 -2.1606 -0.5119 0.3036 0.2834 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base I03 mock treatment 12.8539 0.2567 0.0689 9.9463 -3.6818 -0.8723 -0.5681 -0.6493 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base I04 mock treatment 10.939 -1.6582 -0.4449 10.0743 -3.5537 -0.842 -0.91 -0.9556 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base I05 mock treatment 11.5569 -1.0403 -0.2791 10.7311 -2.897 -0.6864 -0.6827 -0.9214 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base I06 mock treatment 9.3627 -3.2345 -0.8679 14.4474 0.81936 0.1941 -0.4764 -0.5357 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base I07 mock treatment 11.2652 -1.332 -0.3574 14.9602 1.3321 0.3156 -0.0295 -0.062 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base I08 mock treatment 13.8531 1.2559 0.337 14.4064 0.77833 0.1844 0.3687 0.9598 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base I09 mock treatment 11.0937 -1.5035 -0.4034 14.0594 0.43136 0.1022 -0.213 -0.5118 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base I10 mock treatment 10.4881 -2.1091 -0.5659 12.8454 -0.78269 -0.1854 -0.5313 -0.8921 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base I11 mock treatment 11.2234 -1.3738 -0.3686 13.2538 -0.37425 -0.0887 -0.3234 -0.8529 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base I12 mock treatment 13.3672 0.77 0.2066 14.0106 0.38251 0.0906 0.2102 0.9316 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base I13 mock treatment 10.907 -1.6903 -0.4535 13.7943 0.16623 0.0394 -0.2928 -0.6433 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base I14 mock treatment 11.3054 -1.2919 -0.3466 11.2941 -2.334 -0.553 -0.6361 -0.9747 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base I15 mock treatment 8.5862 -4.011 -1.0763 10.5824 -3.0457 -0.7216 -1.2713 -0.9811 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base I16 mock treatment 14.6922 2.095 0.5621 13.4329 -0.19522 -0.0463 0.3648 0.6467 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base I17 mock treatment 12.185 -0.41225 -0.1106 14.5973 0.96921 0.2296 0.0842 0.3302 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base I18 mock treatment 15.0951 2.4979 0.6703 11.3165 -2.3116 -0.5477 0.0867 0.1001 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base I19 mock treatment 10.2525 -2.3448 -0.6292 11.3724 -2.2556 -0.5344 -0.8228 -0.9967 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base I20 mock treatment 17.2462 4.6489 1.2474 13.1618 -0.46624 -0.1105 0.8039 0.642 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base I21 mock treatment 13.4722 0.87493 0.2348 16.4469 2.8188 0.6679 0.6383 0.9016 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base I22 mock treatment 10.2379 -2.3594 -0.6331 12.1597 -1.4684 -0.3479 -0.6937 -0.9603 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base I23 mock treatment 11.8853 -0.71192 -0.191 12.5833 -1.0447 -0.2475 -0.3101 -0.9918 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base I24 mock treatment 12.4946 -0.10266 -0.0275 13.0012 -0.62684 -0.1485 -0.1245 -0.8242 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base J01 mock treatment 12.423 -0.17426 -0.0468 16.6321 3.004 0.7117 0.4702 0.6592 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base J02 mock treatment 10.7894 -1.8079 -0.4851 12.751 -0.87709 -0.2078 -0.49 -0.9284 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base J03 mock treatment 15.1062 2.509 0.6732 14.8395 1.2115 0.287 0.679 0.9278 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base J04 mock treatment 12.0189 -0.57836 -0.1552 12.2204 -1.4077 -0.3335 -0.3456 -0.9394 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base J05 mock treatment 11.9494 -0.64785 -0.1738 12.782 -0.84612 -0.2005 -0.2647 -0.9975 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base J06 mock treatment 12.5825 -0.01478 -0.004 15.0216 1.3936 0.3302 0.2307 0.6986 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base J07 mock treatment 13.1479 0.55067 0.1478 13.0627 -0.56534 -0.134 0.0098 0.049 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base J08 mock treatment 14.8289 2.2317 0.5988 13.5183 -0.10982 -0.026 0.405 0.6757 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base J09 mock treatment 13.3609 0.76365 0.2049 12.4428 -1.1853 -0.2808 -0.0537 -0.1544 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base J10 mock treatment 12.7213 0.1241 0.0333 12.3976 -1.2305 -0.2915 -0.1826 -0.6223 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base J11 mock treatment 12.946 0.34872 0.0936 12.525 -1.1031 -0.2614 -0.1186 -0.4274 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base J12 mock treatment 12.8522 0.25496 0.0684 13.4843 -0.14379 -0.0341 0.0243 0.3177 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base J13 mock treatment 12.6447 0.04747 0.0127 12.4542 -1.1738 -0.2781 -0.1877 -0.674 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base J14 mock treatment 14.5792 1.982 0.5318 12.1795 -1.4486 -0.3432 0.1334 0.2107 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base J15 mock treatment 14.8344 2.2372 0.6003 12.784 -0.84407 -0.2 0.2831 0.4474 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base J16 mock treatment 10.5758 -2.0214 -0.5424 12.5362 -1.0918 -0.2587 -0.5665 -0.9426 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base J17 mock treatment 12.8826 0.28535 0.0766 12.0662 -1.5619 -0.3701 -0.2075 -0.5492 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base J18 mock treatment 13.4461 0.84885 0.2278 12.766 -0.86207 -0.2043 0.0166 0.0543 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base J19 mock treatment 11.1502 -1.447 -0.3883 14.002 0.37396 0.0886 -0.2119 -0.5321 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base J20 mock treatment 14.8999 2.3027 0.6179 12.1643 -1.4637 -0.3468 0.1917 0.2705 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base J21 mock treatment 11.1653 -1.4319 -0.3842 14.0661 0.43798 0.1038 -0.1983 -0.4983 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base J22 mock treatment 11.1035 -1.4937 -0.4008 13.8658 0.23773 0.0563 -0.2436 -0.6018 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base J23 mock treatment 9.108 -3.4892 -0.9362 13.3439 -0.28422 -0.0673 -0.7096 -0.756 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base J24 mock treatment 15.7014 3.1042 0.8329 9.7323 -3.8957 -0.923 -0.0637 -0.0512 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base K01 mock treatment 17.0814 4.4841 1.2032 13.4626 -0.16549 -0.0392 0.8231 0.6837 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base K02 mock treatment 11.1757 -1.4215 -0.3814 15.5089 1.8808 0.4456 0.0454 0.0774 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base K03 mock treatment 12.3903 -0.20693 -0.0555 13.9024 0.27431 0.065 0.0067 0.0783 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base K04 mock treatment 11.1734 -1.4239 -0.3821 13.3453 -0.28273 -0.067 -0.3175 -0.8186 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base K05 mock treatment 9.3319 -3.2654 -0.8762 14.7642 1.1361 0.2692 -0.4292 -0.4683 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base K06 mock treatment 12.8763 0.27902 0.0749 14.1765 0.54841 0.1299 0.1448 0.9657 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base K07 mock treatment 10.4522 -2.145 -0.5756 14.0708 0.44268 0.1049 -0.3328 -0.5689 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base K08 mock treatment 12.5528 -0.044435 -0.0119 15.2696 1.6415 0.3889 0.2666 0.6851 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base K09 mock treatment 10.279 -2.3182 -0.622 12.881 -0.74712 -0.177 -0.565 -0.8736 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base K10 mock treatment 12.4766 -0.12065 -0.0324 14.629 1.0009 0.2372 0.1448 0.605 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base K11 mock treatment 13.0398 0.4426 0.1188 12.789 -0.83909 -0.1988 -0.0566 -0.2444 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base K12 mock treatment 11.6159 -0.98135 -0.2633 13.1861 -0.44202 -0.1047 -0.2603 -0.9184 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base K13 mock treatment 10.0836 -2.5136 -0.6745 12.9919 -0.63617 -0.1507 -0.5835 -0.8443 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base K14 mock treatment 12.8417 0.24445 0.0656 13.6375 0.0094604 0.0022 0.048 0.7308 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base K15 mock treatment 12.0743 -0.52295 -0.1403 11.781 -1.847 -0.4376 -0.4087 -0.8892 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base K16 mock treatment 13.93 1.3327 0.3576 11.7665 -1.8616 -0.4411 -0.059 -0.1039 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base K17 mock treatment 11.8497 -0.74749 -0.2006 18.4529 4.8249 1.1432 0.6665 0.5743 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base K18 mock treatment 12.8639 0.26665 0.0715 13.2664 -0.36167 -0.0857 -0.01 -0.0896 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base K19 mock treatment 13.5146 0.91735 0.2461 14.5686 0.94053 0.2228 0.3316 0.9988 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base K20 mock treatment 11.7321 -0.86514 -0.2321 16.4144 2.7864 0.6602 0.3027 0.4325 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base K21 mock treatment 10.3976 -2.1996 -0.5902 13.8235 0.19541 0.0463 -0.3846 -0.6496 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base K22 mock treatment 12.1581 -0.4391 -0.1178 15.4423 1.8143 0.4299 0.2206 0.495 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base K23 mock treatment 10.0339 -2.5633 -0.6878 16.4049 2.7768 0.6579 -0.0211 -0.0222 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base K24 mock treatment 10.8722 -1.725 -0.4629 13.9309 0.30278 0.0717 -0.2766 -0.5905 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base L01 mock treatment 9.7365 -2.8608 -0.7676 15.8127 2.1846 0.5176 -0.1768 -0.1909 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base L02 mock treatment 11.2814 -1.3158 -0.3531 12.742 -0.88607 -0.2099 -0.3981 -0.9692 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base L03 mock treatment 12.7158 0.11852 0.0318 10.8007 -2.8274 -0.6699 -0.4512 -0.6728 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base L04 mock treatment 11.2958 -1.3014 -0.3492 12.3346 -1.2935 -0.3065 -0.4636 -0.9979 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base L05 mock treatment 12.9393 0.34207 0.0918 14.0917 0.46368 0.1099 0.1426 0.996 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base L06 mock treatment 11.7938 -0.80347 -0.2156 11.1724 -2.4557 -0.5818 -0.5639 -0.9087 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base L07 mock treatment 15.3611 2.7638 0.7416 13.6918 0.06368 0.0151 0.5351 0.7213 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base L08 mock treatment 12.3217 -0.27553 -0.0739 13.2657 -0.36236 -0.0859 -0.113 -0.9972 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base L09 mock treatment 15.3708 2.7736 0.7442 15.7412 2.1132 0.5007 0.8803 0.9814 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base L10 mock treatment 10.1797 -2.4176 -0.6487 15.3602 1.7322 0.4104 -0.1685 -0.2195 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base L11 mock treatment 12.0419 -0.55538 -0.149 13.6474 0.01933 0.0046 -0.1021 -0.6851 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base L12 mock treatment 12.212 -0.38519 -0.1034 12.6677 -0.96037 -0.2275 -0.234 -0.9362 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base L13 mock treatment 13.413 0.81578 0.2189 12.7825 -0.84553 -0.2003 0.0131 0.0442 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base L14 mock treatment 12.2667 -0.33058 -0.0887 13.2172 -0.41087 -0.0973 -0.1316 -0.9989 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base L15 mock treatment 13.1677 0.57043 0.1531 15.504 1.8759 0.4445 0.4225 0.8988 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base L16 mock treatment 11.984 -0.61324 -0.1645 15.7228 2.0948 0.4963 0.2346 0.4487 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base L17 mock treatment 11.4423 -1.1549 -0.3099 12.2277 -1.4004 -0.3318 -0.4537 -0.9994 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base L18 mock treatment 13.6903 1.0931 0.2933 15.4166 1.7886 0.4238 0.5071 0.9838 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base L19 mock treatment 11.4744 -1.1228 -0.3013 14.1298 0.50176 0.1189 -0.129 -0.3982 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base L20 mock treatment 15.5517 2.9545 0.7928 13.6485 0.02043 0.0048 0.564 0.7114 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base L21 mock treatment 14.4489 1.8517 0.4969 12.8921 -0.73597 -0.1744 0.228 0.433 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base L22 mock treatment 14.6023 2.0051 0.538 9.6452 -3.9829 -0.9437 -0.2869 -0.2641 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base L23 mock treatment 12.4198 -0.17742 -0.0476 10.4638 -3.1642 -0.7497 -0.5638 -0.7505 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base L24 mock treatment 11.8889 -0.70834 -0.1901 13.3767 -0.25136 -0.0596 -0.1765 -0.8862 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base M01 mock treatment 10.7855 -1.8117 -0.4861 15.2939 1.6658 0.3947 -0.0647 -0.1033 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base M02 mock treatment 13.4772 0.87995 0.2361 19.3387 5.7106 1.353 1.1237 0.8181 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base M03 mock treatment 12.9205 0.32323 0.0867 13.0215 -0.60657 -0.1437 -0.0403 -0.2401 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base M04 mock treatment 13.2026 0.6054 0.1624 15.025 1.3969 0.331 0.3489 0.9463 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base M05 mock treatment 12.0637 -0.53353 -0.1432 14.4891 0.86102 0.204 0.043 0.1726 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base M06 mock treatment 13.6651 1.0679 0.2865 12.5272 -1.1009 -0.2608 0.0182 0.0469 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base M07 mock treatment 11.9496 -0.64767 -0.1738 14.7199 1.0918 0.2587 0.06 0.1926 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base M08 mock treatment 10.5229 -2.0743 -0.5566 11.5145 -2.1135 -0.5008 -0.7477 -0.9986 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base M09 mock treatment 9.9606 -2.6366 -0.7075 12.0852 -1.5429 -0.3656 -0.7587 -0.9528 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base M10 mock treatment 10.5983 -1.9989 -0.5364 12.8077 -0.82034 -0.1944 -0.5167 -0.9057 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base M11 mock treatment 12.4687 -0.12853 -0.0345 13.4705 -0.15755 -0.0373 -0.0508 -0.9992 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base M12 mock treatment 11.2516 -1.3456 -0.3611 12.5247 -1.1033 -0.2614 -0.4402 -0.9874 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base M13 mock treatment 10.824 -1.7733 -0.4758 16.2353 2.6072 0.6177 0.1004 0.1287 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base M14 mock treatment 12.366 -0.23128 -0.0621 12.1538 -1.4743 -0.3493 -0.2909 -0.8199 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base M15 mock treatment 15.8005 3.2032 0.8595 12.9054 -0.72264 -0.1712 0.4867 0.5553 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base M16 mock treatment 17.9146 5.3174 1.4268 12.777 -0.85104 -0.2016 0.8663 0.6012 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base M17 mock treatment 10.5547 -2.0425 -0.5481 12.7042 -0.92384 -0.2189 -0.5423 -0.9189 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base M18 mock treatment 10.3558 -2.2414 -0.6014 14.5005 0.87246 0.2067 -0.2791 -0.4389 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base M19 mock treatment 11.4762 -1.121 -0.3008 12.6604 -0.96767 -0.2293 -0.3748 -0.991 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base M20 mock treatment 11.5294 -1.0678 -0.2865 16.6874 3.0593 0.7249 0.31 0.3977 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base M21 mock treatment 11.4081 -1.1892 -0.3191 13.4012 -0.22682 -0.0537 -0.2636 -0.8147 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base M22 mock treatment 15.4484 2.8511 0.765 14.1406 0.51256 0.1214 0.6268 0.8092 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base M23 mock treatment 9.4476 -3.1496 -0.8451 16.4148 2.7867 0.6603 -0.1307 -0.1219 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base M24 mock treatment 12.1477 -0.44954 -0.1206 10.2872 -3.3409 -0.7916 -0.645 -0.8056 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base N01 mock treatment 11.3154 -1.2818 -0.3439 15.5123 1.8842 0.4464 0.0725 0.1286 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base N02 mock treatment 12.6265 0.029275 0.0079 17.5579 3.9298 0.9311 0.6639 0.713 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base N03 mock treatment 15.083 2.4858 0.667 13.2983 -0.32978 -0.0781 0.4164 0.62 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base N04 mock treatment 14.1918 1.5946 0.4279 11.016 -2.6121 -0.6189 -0.1351 -0.1795 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base N05 mock treatment 11.6331 -0.96415 -0.2587 12.0611 -1.567 -0.3713 -0.4455 -0.9844 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base N06 mock treatment 12.784 0.18674 0.0501 12.4591 -1.169 -0.277 -0.1604 -0.5699 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base N07 mock treatment 12.907 0.30977 0.0831 11.4086 -2.2195 -0.5259 -0.3131 -0.588 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base N08 mock treatment 11.7662 -0.83103 -0.223 11.8402 -1.7879 -0.4236 -0.4572 -0.9551 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base N09 mock treatment 10.6072 -1.9901 -0.534 14.9608 1.3327 0.3158 -0.1543 -0.2487 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base N10 mock treatment 14.5271 1.9299 0.5178 11.3115 -2.3165 -0.5489 -0.0219 -0.0291 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base N11 mock treatment 15.8432 3.2459 0.871 12.2246 -1.4034 -0.3325 0.3807 0.4084 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base N12 mock treatment 12.5247 -0.07253 -0.0195 11.2964 -2.3316 -0.5524 -0.4044 -0.7316 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base N13 mock treatment 14.0005 1.4032 0.3765 17.5367 3.9086 0.9261 0.9211 0.9214 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base N14 mock treatment 15.4025 2.8053 0.7527 12.8017 -0.82641 -0.1958 0.3938 0.5063 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base N15 mock treatment 12.0706 -0.5266 -0.1413 14.7211 1.093 0.259 0.0832 0.2821 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base N16 mock treatment 12.35 -0.24727 -0.0663 12.0296 -1.5984 -0.3787 -0.3147 -0.8185 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base N17 mock treatment 12.8163 0.21905 0.0588 13.1884 -0.43972 -0.1042 -0.0321 -0.2684 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base N18 mock treatment 12.2872 -0.30999 -0.0832 12.8118 -0.81624 -0.1934 -0.1956 -0.929 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base N19 mock treatment 10.9711 -1.6262 -0.4363 13.565 -0.063095 -0.0149 -0.3191 -0.7309 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base N20 mock treatment 10.5297 -2.0676 -0.5548 11.2706 -2.3575 -0.5586 -0.7873 -1.0 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base N21 mock treatment 11.9263 -0.67098 -0.18 11.9588 -1.6693 -0.3955 -0.407 -0.9365 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base N22 mock treatment 9.9746 -2.6227 -0.7037 12.5517 -1.0764 -0.255 -0.678 -0.9057 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base N23 mock treatment 11.134 -1.4632 -0.3926 15.634 2.0059 0.4753 0.0584 0.0948 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base N24 mock treatment 10.6228 -1.9744 -0.5298 10.5271 -3.101 -0.7347 -0.8941 -0.9871 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base O01 mock treatment 10.0751 -2.5221 -0.6767 14.6512 1.0232 0.2424 -0.3071 -0.4272 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base O02 mock treatment 14.6183 2.0211 0.5423 12.3457 -1.2823 -0.3038 0.1686 0.2713 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base O03 mock treatment 12.3121 -0.2851 -0.0765 11.0626 -2.5655 -0.6079 -0.4839 -0.7899 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base O04 mock treatment 10.598 -1.9992 -0.5364 11.813 -1.8151 -0.4301 -0.6834 -0.994 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base O05 mock treatment 12.7569 0.15962 0.0428 13.6364 0.0083554 0.002 0.0317 0.739 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base O06 mock treatment 10.0319 -2.5653 -0.6883 13.7049 0.07683 0.0182 -0.4739 -0.6882 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base O07 mock treatment 13.3212 0.724 0.1943 9.7601 -3.8679 -0.9165 -0.5107 -0.5451 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base O08 mock treatment 11.3427 -1.2545 -0.3366 11.7717 -1.8564 -0.4398 -0.549 -0.9913 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base O09 mock treatment 9.9046 -2.6926 -0.7225 12.0122 -1.6158 -0.3828 -0.7816 -0.9559 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base O10 mock treatment 14.4648 1.8675 0.5011 12.0185 -1.6096 -0.3814 0.0847 0.1345 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base O11 mock treatment 10.4073 -2.19 -0.5876 11.6247 -2.0034 -0.4747 -0.7512 -0.9944 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base O12 mock treatment 12.5889 -0.0083447 -0.0022 11.619 -2.009 -0.476 -0.3382 -0.7104 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base O13 mock treatment 15.0597 2.4625 0.6607 14.3714 0.74331 0.1761 0.5917 0.8654 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base O14 mock treatment 13.2969 0.69968 0.1877 11.5125 -2.1155 -0.5012 -0.2217 -0.4142 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base O15 mock treatment 12.4647 -0.13251 -0.0356 14.098 0.46993 0.1113 0.0536 0.4585 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base O16 mock treatment 11.8415 -0.75578 -0.2028 12.2304 -1.3977 -0.3312 -0.3776 -0.9723 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base O17 mock treatment 11.3311 -1.2661 -0.3397 12.3693 -1.2587 -0.2982 -0.4511 -0.9979 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base O18 mock treatment 12.0873 -0.50996 -0.1368 14.8417 1.2137 0.2876 0.1066 0.3347 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base O19 mock treatment 15.0735 2.4763 0.6645 11.7414 -1.8867 -0.447 0.1537 0.192 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base O20 mock treatment 11.3689 -1.2283 -0.3296 11.7077 -1.9203 -0.455 -0.5548 -0.9875 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base O21 mock treatment 10.9281 -1.6691 -0.4479 14.5897 0.96163 0.2278 -0.1556 -0.3096 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base O22 mock treatment 12.2948 -0.3024 -0.0811 13.8906 0.26253 0.0622 -0.0134 -0.131 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base O23 mock treatment 13.6443 1.047 0.2809 14.6579 1.0298 0.244 0.3712 0.9975 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base O24 mock treatment 11.562 -1.0353 -0.2778 13.908 0.27988 0.0663 -0.1495 -0.5236 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base P01 mock treatment 15.1468 2.5496 0.6841 14.0925 0.46441 0.11 0.5616 0.8104 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base P02 mock treatment 19.6669 7.0697 1.897 14.564 0.93591 0.2217 1.4982 0.7844 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base P03 mock treatment 10.8992 -1.698 -0.4556 15.9535 2.3254 0.551 0.0674 0.0943 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base P04 mock treatment 15.1679 2.5707 0.6898 12.7704 -0.85772 -0.2032 0.344 0.4784 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base P05 mock treatment 14.2147 1.6174 0.434 16.4721 2.8441 0.6739 0.7834 0.9774 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base P06 mock treatment 13.1072 0.50994 0.1368 14.8901 1.2621 0.299 0.3082 0.9372 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base P07 mock treatment 10.5005 -2.0967 -0.5626 15.3345 1.7064 0.4043 -0.1119 -0.1616 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base P08 mock treatment 12.724 0.12676 0.034 12.3134 -1.3147 -0.3115 -0.1962 -0.6262 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base P09 mock treatment 13.6149 1.0176 0.2731 10.6158 -3.0123 -0.7137 -0.3116 -0.4078 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base P10 mock treatment 16.6244 4.0272 1.0806 15.4468 1.8187 0.4309 1.0688 0.9187 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base P11 mock treatment 12.7649 0.16762 0.045 15.4635 1.8354 0.4349 0.3393 0.7761 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base P12 mock treatment 11.5138 -1.0834 -0.2907 13.1047 -0.52339 -0.124 -0.2932 -0.9279 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base P13 mock treatment 12.6547 0.057488 0.0154 12.5294 -1.0987 -0.2603 -0.1732 -0.664 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base P14 mock treatment 11.4518 -1.1454 -0.3074 13.0275 -0.60061 -0.1423 -0.318 -0.9388 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base P15 mock treatment 11.7708 -0.8264 -0.2217 13.0163 -0.61172 -0.1449 -0.2593 -0.9788 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base P16 mock treatment 11.3138 -1.2835 -0.3444 11.6806 -1.9475 -0.4614 -0.5698 -0.9896 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base P17 mock treatment 13.2241 0.62687 0.1682 13.3065 -0.32159 -0.0762 0.0651 0.3523 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base P18 mock treatment 14.1685 1.5712 0.4216 13.3582 -0.26985 -0.0639 0.2529 0.5931 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base P19 mock treatment 11.6763 -0.92092 -0.2471 12.9575 -0.67062 -0.1589 -0.2871 -0.9772 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base P20 mock treatment 13.7804 1.1832 0.3175 13.3619 -0.26614 -0.0631 0.1799 0.5558 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base P21 mock treatment 11.2205 -1.3768 -0.3694 13.4887 -0.13938 -0.033 -0.2846 -0.7673 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base P22 mock treatment 14.2313 1.6341 0.4385 12.2487 -1.3794 -0.3268 0.0789 0.1444 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base P23 mock treatment 14.5683 1.9711 0.5289 12.8941 -0.73397 -0.1739 0.251 0.4509 1152.0003 AvgIn(1152.0003) BetaCatenin 1152.0003.Base P24 mock treatment 11.5549 -1.0423 -0.2797 16.5715 2.9435 0.6974 0.2954 0.3931